Term|Overlap|P.value|Adjusted.P.value|Old.P.value|Old.Adjusted.P.value|Odds.Ratio|Combined.Score|Genes|cluster
1|neutrophil degranulation (GO:0043312)|26/480|1.56952933943156e-19|8.00930821911927e-16|0|0|10.4166666666667|451.024385169504|CD63;CSTB;B4GALT1;HEXB;CTSS;SYNGR1;GM2A;FTH1;CREG1;PSAP;TIMP2;CTSH;B2M;CTSD;CTSB;GSN;ANXA3;ARG1;PGAM1;NME2;CYBA;TYROBP;LRG1;FABP5;MAN2B1;CD68|0
2|neutrophil activation involved in immune response (GO:0002283)|26/484|1.92896805280773e-19|4.92176198673893e-16|0|0|10.3305785123967|445.166648704865|CD63;CSTB;B4GALT1;HEXB;CTSS;SYNGR1;GM2A;FTH1;CREG1;PSAP;TIMP2;CTSH;B2M;CTSD;CTSB;GSN;ANXA3;ARG1;PGAM1;NME2;CYBA;TYROBP;LRG1;FABP5;MAN2B1;CD68|0
3|neutrophil mediated immunity (GO:0002446)|26/488|2.36627989504838e-19|4.02504210147729e-16|0|0|10.2459016393443|439.424156859533|CD63;CSTB;B4GALT1;HEXB;CTSS;SYNGR1;GM2A;FTH1;CREG1;PSAP;TIMP2;CTSH;B2M;CTSD;CTSB;GSN;ANXA3;ARG1;PGAM1;NME2;CYBA;TYROBP;LRG1;FABP5;MAN2B1;CD68|0
4|cellular response to thyroid hormone stimulus (GO:0097067)|4/10|1.4142531860496e-07|0.000180423350210278|0|0|76.9230769230769|1213.19184945388|CTSL;CTSH;CTSS;CTSB|0
5|extracellular matrix disassembly (GO:0022617)|7/79|1.78709930181598e-07|0.000182391354743339|0|0|17.0399221032132|264.757821156825|CTSL;CTSK;TIMP2;SPP1;FN1;MMP19;CTSS|0
6|pattern recognition receptor signaling pathway (GO:0002221)|6/49|1.99343067641776e-07|0.000169541279029331|0|0|23.5478806907378|363.302320373617|CTSL;S100A1;CTSK;CTSS;CTSB;LGMN|0
7|response to thyroid hormone (GO:0097066)|4/11|2.21352778128877e-07|0.000161366175255951|0|0|69.9300699300699|1071.57399489546|CTSL;CTSH;CTSS;CTSB|0
8|cellular protein catabolic process (GO:0044257)|6/63|9.13284654818063e-07|0.000582561449192072|0|0|18.3150183150183|254.69264148896|CTSL;CTSK;CTSH;CTSS;CTSB;LGMN|0
9|regulation of peptidase activity (GO:0052547)|4/18|1.9958764016325e-06|0.00113166191972563|0|0|42.7350427350427|560.872961753082|CSTB;ECM1;CAV1;CTSH|0
10|hydrogen peroxide metabolic process (GO:0042743)|4/20|3.1349655682652e-06|0.00159977292948573|0|0|38.4615384615385|487.418937190354|PRDX2;PRDX5;PRDX1;CYBA|0
11|regulation of fibroblast proliferation (GO:0048145)|5/47|4.44978040327821e-06|0.00206429358162988|0|0|20.4582651391162|252.100159790951|CD74;FTH1;FN1;S100A6;IGF1|0
12|toll-like receptor signaling pathway (GO:0002224)|6/87|6.13748542455083e-06|0.00260996567679024|0|0|13.262599469496|159.165722011473|CTSL;S100A1;CTSK;CTSS;CTSB;LGMN|0
13|triglyceride metabolic process (GO:0006641)|5/53|8.12141150850184e-06|0.00318796637906807|0|0|18.1422351233672|212.645257398427|PLA2G16;FABP5;CAV1;LPL;APOE|0
14|cellular protein metabolic process (GO:0044267)|12/485|8.27275242622607e-06|0.0030154182593594|0|0|4.75812846946868|55.6822043634461|MRPL52;LGALS1;GSN;FN1;SPP1;CTSH;MAN2B1;APOE;IGF1;MFGE8;B2M;LGMN|0
15|proteolysis involved in cellular protein catabolic process (GO:0051603)|6/94|9.60969949536371e-06|0.00326921976832273|0|0|12.2749590834697|141.809381409137|CTSL;CTSK;CTSH;CTSS;CTSB;LGMN|0
16|regulation of viral entry into host cell (GO:0046596)|4/27|1.10424327764912e-05|0.00352184590365216|0|0|28.4900284900285|325.17849519093|CD74;IFITM2;LGALS1;GSN|0
17|positive regulation of fibroblast proliferation (GO:0048146)|4/29|1.48251584501154e-05|0.00445016373946701|0|0|26.525198938992|294.938592177794|CD74;FN1;S100A6;IGF1|0
18|acylglycerol metabolic process (GO:0006639)|4/37|3.99286442078416e-05|0.0113197706329231|0|0|20.7900207900208|210.569991511215|PLA2G16;CAV1;LPL;APOE|0
19|hydrogen peroxide catabolic process (GO:0042744)|3/14|4.76886479410875e-05|0.0128081668654405|0|0|41.2087912087912|410.061147405916|PRDX2;PRDX5;PRDX1|0
20|cellular response to hormone stimulus (GO:0032870)|5/81|6.46220796625901e-05|0.0164883236259099|0|0|11.8708452041785|114.517502553777|CTSL;CAV1;CTSH;CTSS;CTSB|0
21|regulated exocytosis (GO:0045055)|6/149|0.000128678128191065|0.0312687851504288|0|0|7.74393391843056|69.371680964866|CD63;SYNGR1;ECM1;PSAP;FN1;IGF1|0
22|proteolysis (GO:0006508)|8/292|0.000143784696425402|0.0333515139026738|0|0|5.26870389884088|46.6132431031266|CTSL;CTSK;CTSH;MMP19;CTSD;CTSS;LGMN;CTSB|0
23|antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886)|5/98|0.000159734679604393|0.035440263913966|0|0|9.8116169544741|85.7731198157915|CD74;CTSL;CTSD;CTSS;LGMN|0
24|antigen processing and presentation of exogenous peptide antigen (GO:0002478)|5/98|0.000159734679604393|0.0339635862508841|0|0|9.8116169544741|85.7731198157915|CD74;CTSL;CTSD;CTSS;LGMN|0
25|antigen processing and presentation of peptide antigen via MHC class II (GO:0002495)|5/99|0.000167542388662213|0.0341987523737309|0|0|9.71250971250971|84.4432223395011|CD74;CTSL;CTSD;CTSS;LGMN|0
26|triglyceride catabolic process (GO:0019433)|3/22|0.000195746856835632|0.0384190850166242|0|0|26.2237762237762|223.916650706016|FABP5;LPL;APOE|0
27|extracellular matrix organization (GO:0030198)|7/230|0.000200347635019053|0.037865703018601|0|0|5.85284280936455|49.8396284919679|CTSL;CTSK;FN1;TIMP2;SPP1;MMP19;CTSS|0
28|positive regulation of intracellular signal transduction (GO:1902533)|10/480|0.000200989924978707|0.0366304138273694|0|0|4.00641025641026|34.1035888447336|BCAP31;CD74;ECM1;LGALS1;CAV1;HMOX1;S100A4;TREM2;IGF1;LAMTOR4|0
29|positive regulation of angiogenesis (GO:0045766)|5/104|0.000211048380489744|0.0371372374358333|0|0|9.24556213017752|78.2491046537618|ECM1;S100A1;ANXA3;HMOX1;CTSH|0
30|negative regulation of apoptotic process (GO:0043066)|10/486|0.000222052876100836|0.0377711942247522|0|0|3.95694840139285|33.2882044310624|PRDX2;CD74;PRDX5;CAV1;PDPN;NME2;CTSH;APOE;IGF1;LGMN|0
31|regulation of protein activation cascade (GO:2000257)|5/109|0.000262673377004696|0.0432394271888698|0|0|8.82145377558222|72.7293508303514|C1QB;C1QA;IGKC;CFB;C1QC|0
32|regulation of complement activation (GO:0030449)|5/110|0.000274055993040917|0.0437033666402437|0|0|8.74125874125874|71.6973611738614|C1QB;C1QA;IGKC;CFB;C1QC|0
33|regulation of humoral immune response (GO:0002920)|5/114|0.000323373719059658|0.0500053360109525|0|0|8.43454790823212|67.7859470194554|C1QB;C1QA;IGKC;CFB;C1QC|0
34|regulation of immune effector process (GO:0002697)|5/115|0.000336690239773005|0.0505332439282837|0|0|8.36120401337793|66.8590904692355|C1QB;C1QA;IGKC;CFB;C1QC|0
35|cellular response to oxidative stress (GO:0034599)|5/116|0.000350417951602431|0.0510909373436344|0|0|8.28912466843502|65.9514586246041|PRDX2;PRDX5;PRDX1;HMOX1;CYBA|0
36|positive regulation of endocytosis (GO:0045807)|4/65|0.00036611187551038|0.0518963583535964|0|0|11.8343195266272|93.6399005973647|CD63;CYBA;APOE;B2M|0
37|positive regulation of cholesterol storage (GO:0010886)|2/6|0.00039627536149657|0.0546538694518108|0|0|64.1025641025641|502.141104554109|MSR1;LPL|0
38|regulation of acute inflammatory response (GO:0002673)|5/122|0.000441888626422278|0.0593409910692865|0|0|7.88146279949559|60.8799864758682|C1QB;C1QA;IGKC;CFB;C1QC|0
39|platelet degranulation (GO:0002576)|5/125|0.000493862090558077|0.0646199550799453|0|0|7.69230769230769|58.5634942204771|CD63;ECM1;PSAP;FN1;IGF1|0
40|regulation of keratinocyte differentiation (GO:0045616)|3/30|0.000500704383845033|0.0638773617690301|0|0|19.2307692307692|146.144128523735|CTSL;CTSK;NME2|0
41|negative regulation of endothelial cell proliferation (GO:0001937)|3/31|0.000552264039865007|0.0687366681812472|0|0|18.6104218362283|139.605787089886|CAV1;ATPIF1;APOE|0
42|acylglycerol catabolic process (GO:0046464)|3/31|0.000552264039865007|0.0671000808435984|0|0|18.6104218362283|139.605787089886|FABP5;LPL;APOE|0
43|positive regulation of lipid transport (GO:0032370)|2/7|0.000552903300532864|0.0656154777353304|0|0|54.9450549450549|412.105903029938|SPP1;APOE|0
44|regulation of sterol transport (GO:0032371)|2/7|0.000552903300532864|0.0641242168777092|0|0|54.9450549450549|412.105903029938|TSPO;APOE|0
45|heme catabolic process (GO:0042167)|2/7|0.000552903300532864|0.0626992342804268|0|0|54.9450549450549|412.105903029938|HMOX1;BLVRB|0
46|positive regulation of ER-associated ubiquitin-dependent protein catabolic process (GO:1903071)|2/7|0.000552903300532864|0.0613362074482436|0|0|54.9450549450549|412.105903029938|BCAP31;CAV1|0
47|porphyrin-containing compound catabolic process (GO:0006787)|2/7|0.000552903300532864|0.0600311817578554|0|0|54.9450549450549|412.105903029938|HMOX1;BLVRB|0
48|regulation of protein processing (GO:0070613)|5/129|0.000570161996488883|0.0606153472517243|0|0|7.45378652355397|55.6767295255488|C1QB;C1QA;IGKC;CFB;C1QC|0
49|positive regulation of apoptotic signaling pathway (GO:2001235)|4/77|0.000697715893557856|0.0726621266290967|0|0|9.99000999000999|72.6043812921833|BCAP31;GSN;CAV1;CTSH|0
50|positive regulation of viral entry into host cell (GO:0046598)|2/8|0.000734703967300096|0.0749838869026478|0|0|48.0769230769231|346.925139685643|CD74;LGALS1|0
51|positive regulation of chemokine production (GO:0032722)|3/35|0.000792094641480553|0.0792560579504953|0|0|16.4835164835165|117.705983678079|CD74;LPL;HMOX1|0
52|regulation of endothelial cell proliferation (GO:0001936)|4/80|0.000805772307510194|0.0790741554850869|0|0|9.61538461538462|68.4972053101252|ECM1;CAV1;ATPIF1;APOE|0
53|positive regulation of binding (GO:0051099)|4/82|0.00088405542262616|0.0851195249370055|0|0|9.38086303939963|65.9567617449666|CAV1;APOE;IGF1;B2M|0
54|regulation of nitric-oxide synthase activity (GO:0050999)|3/37|0.000933288145677208|0.0881957297664961|0|0|15.5925155925156|108.785809256554|S100A1;CAV1;APOE|0
55|very-low-density lipoprotein particle remodeling (GO:0034372)|2/9|0.00094141640800522|0.0873463260009207|0|0|42.7350427350427|297.783119648848|LPL;APOE|0
56|regulation of ER-associated ubiquitin-dependent protein catabolic process (GO:1903069)|2/9|0.00094141640800522|0.0857865701794757|0|0|42.7350427350427|297.783119648848|BCAP31;CAV1|0
57|chylomicron remodeling (GO:0034371)|2/9|0.00094141640800522|0.0842815426324673|0|0|42.7350427350427|297.783119648848|LPL;APOE|0
58|retina homeostasis (GO:0001895)|3/39|0.00108948723417289|0.0958560923445559|0|0|14.792899408284|100.917871609335|IGKC;PRDX1;B2M|0
59|regulation of mast cell activation (GO:0033003)|2/10|0.00117278165192452|0.101435674063913|0|0|38.4615384615385|259.552956601147|CD84;CD300LF|0
60|negative regulation of proteolysis (GO:0045861)|3/42|0.00135319742855847|0.115089441298898|0|0|13.7362637362637|90.7319371061359|CSTB;ECM1;TIMP2|0
61|negative regulation of leukocyte activation (GO:0002695)|2/11|0.00142854269862059|0.11950579329608|0|0|34.965034965035|229.059456161232|CD84;CD300LF|0
62|cholesterol transport (GO:0030301)|3/45|0.00165386760289973|0.136123973832215|0|0|12.8205128205128|82.1107529769099|MSR1;CAV1;APOE|0
63|positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123)|5/164|0.00166921623032972|0.135206514656707|0|0|5.86303939962477|37.4964885428935|CD74;ECM1;LGALS1;HMOX1;S100A4|0
64|regulation of cholesterol storage (GO:0010885)|2/12|0.00170844450643344|0.136221754942654|0|0|32.0512820512821|204.23628101944|MSR1;LPL|0
65|prostanoid biosynthetic process (GO:0046457)|2/13|0.00201223397992977|0.157975846147409|0|0|29.5857988165681|183.68372015664|CD74;PTGS1|0
66|positive regulation of ERAD pathway (GO:1904294)|2/13|0.00201223397992977|0.155582272720933|0|0|29.5857988165681|183.68372015664|BCAP31;CAV1|0
67|triglyceride-rich lipoprotein particle remodeling (GO:0034370)|2/13|0.00201223397992977|0.153260149247487|0|0|29.5857988165681|183.68372015664|LPL;APOE|0
68|positive regulation of vasculature development (GO:1904018)|4/105|0.00220576989195875|0.165530055274493|0|0|7.32600732600733|44.810832774166|ECM1;ANXA3;HMOX1;CTSH|0
69|regulation of angiogenesis (GO:0045765)|5/178|0.0023863507160894|0.176486198611655|0|0|5.4019014693172|32.6166269283043|ECM1;GPNMB;ANXA3;HMOX1;CTSH|0
70|positive regulation of proteolysis (GO:0045862)|3/53|0.0026494970110091|0.193148332102563|0|0|10.8853410740203|64.5869245010818|ATPIF1;CTSH;APOE|0
71|negative regulation of viral entry into host cell (GO:0046597)|2/15|0.00269047319620573|0.193373024228702|0|0|25.6410256410256|151.744569012012|GSN;IFITM2|0
72|glycosphingolipid metabolic process (GO:0006687)|3/55|0.0029450101063205|0.208727591285465|0|0|10.4895104895105|61.129122694371|GM2A;HEXB;PSAP|0
73|positive regulation of nitric-oxide synthase activity (GO:0051000)|2/16|0.00306442636565179|0.21421599649207|0|0|24.0384615384615|139.132088545772|S100A1;APOE|0
74|heme biosynthetic process (GO:0006783)|2/16|0.00306442636565179|0.211321185728664|0|0|24.0384615384615|139.132088545772|ATPIF1;TSPO|0
75|positive regulation of macrophage derived foam cell differentiation (GO:0010744)|2/16|0.00306442636565179|0.208503569918948|0|0|24.0384615384615|139.132088545772|MSR1;LPL|0
76|positive regulation of cellular protein catabolic process (GO:1903364)|2/17|0.00346127402732154|0.232406333702919|0|0|22.6244343891403|128.192727187749|ATPIF1;APOE|0
77|sterol homeostasis (GO:0055092)|3/59|0.00359496481285653|0.238248122597492|0|0|9.77835723598436|55.0347562808773|CAV1;LPL;APOE|0
78|cholesterol homeostasis (GO:0042632)|3/59|0.00359496481285653|0.235193659487268|0|0|9.77835723598436|55.0347562808773|CAV1;LPL;APOE|0
79|porphyrin-containing compound biosynthetic process (GO:0006779)|2/18|0.00388077262796116|0.25067826228463|0|0|21.3675213675214|118.62651739857|ATPIF1;TSPO|0
80|prostaglandin biosynthetic process (GO:0001516)|2/18|0.00388077262796116|0.247544784006072|0|0|21.3675213675214|118.62651739857|CD74;PTGS1|0
81|response to reactive oxygen species (GO:0000302)|3/61|0.00395018809470131|0.248861849966182|0|0|9.4577553593947|52.3391432751368|PRDX5;HMOX1;APOE|0
82|positive regulation of protein binding (GO:0032092)|3/61|0.00395018809470131|0.245826949356839|0|0|9.4577553593947|52.3391432751368|CAV1;APOE;B2M|0
83|complement activation, classical pathway (GO:0006958)|4/124|0.00401595507556934|0.246908659646148|0|0|6.20347394540943|34.2275439393145|C1QB;C1QA;IGKC;C1QC|0
84|humoral immune response mediated by circulating immunoglobulin (GO:0002455)|4/126|0.00425108438606847|0.25825337645366|0|0|6.1050061050061|33.3368814342355|C1QB;C1QA;IGKC;C1QC|0
85|positive regulation of toll-like receptor signaling pathway (GO:0034123)|2/19|0.00432268048476494|0.259513394279476|0|0|20.2429149797571|110.199991630797|CAV1;CYBA|0
86|positive regulation of lipid storage (GO:0010884)|2/19|0.00432268048476494|0.256495796671575|0|0|20.2429149797571|110.199991630797|MSR1;LPL|0
87|negative regulation of peptidase activity (GO:0010466)|3/63|0.00432606606400111|0.253746150857444|0|0|9.15750915750916|49.8452076940044|CSTB;ECM1;TIMP2|0
88|diterpenoid metabolic process (GO:0016101)|3/63|0.00432606606400111|0.250862671870428|0|0|9.15750915750916|49.8452076940044|SDC3;LPL;APOE|0
89|regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122)|5/205|0.00436493605005348|0.250272681611493|0|0|4.69043151969981|25.4885166060772|CD74;ECM1;LGALS1;HMOX1;S100A4|0
90|iron ion homeostasis (GO:0055072)|3/64|0.00452185932231551|0.256389423575289|0|0|9.01442307692308|48.6673559064887|FTH1;HMOX1;B2M|0
91|positive regulation of signal transduction (GO:0009967)|5/207|0.00454716403315272|0.254990967705256|0|0|4.64511334076551|25.0522646310008|CD63;CD74;CTSH;TREM2;IGF1|0
92|regulation of epidermal cell differentiation (GO:0045604)|2/20|0.00478675777140461|0.265508966385628|0|0|19.2307692307692|102.728884061309|CTSL;CTSK|0
93|regulation of cholesterol transport (GO:0032374)|2/20|0.00478675777140461|0.262654031263202|0|0|19.2307692307692|102.728884061309|TSPO;APOE|0
94|glycolipid metabolic process (GO:0006664)|3/66|0.00492936243758713|0.267601452329863|0|0|8.74125874125874|46.4383358592231|GM2A;HEXB;PSAP|0
95|negative regulation of epithelial cell proliferation (GO:0050680)|3/67|0.00514115232365325|0.2761610558695|0|0|8.61079219288174|45.3829911351333|CAV1;ATPIF1;APOE|0
96|ERK1 and ERK2 cascade (GO:0070371)|2/21|0.00527276651045041|0.280280494821129|0|0|18.3150183150183|96.065935890561|CTSH;IGF1|0
97|negative regulation of programmed cell death (GO:0043069)|7/409|0.00552328594705783|0.290570393689032|0|0|3.29132969719767|17.1109066243964|PRDX2;CD74;PRDX5;PDPN;NME2;CTSH;IGF1|0
98|phagocytosis (GO:0006909)|4/136|0.00556691507402527|0.289877220640316|0|0|5.65610859728507|29.360374576622|MSR1;GSN;IGKC;ANXA3|0
99|acylglycerol homeostasis (GO:0055090)|2/22|0.00578047055548635|0.29795698226916|0|0|17.4825174825175|90.0921361648208|LPL;APOE|0
100|regulation of membrane protein ectodomain proteolysis (GO:0051043)|2/22|0.00578047055548635|0.294977412446468|0|0|17.4825174825175|90.0921361648208|TIMP2;APOE|0
101|positive regulation of biosynthetic process (GO:0009891)|2/22|0.00578047055548635|0.292056844006404|0|0|17.4825174825175|90.0921361648208|CYBA;APOE|0
102|regulation of ERBB signaling pathway (GO:1901184)|2/22|0.00578047055548635|0.289193541614185|0|0|17.4825174825175|90.0921361648208|PTPN18;LGMN|0
103|sterol transport (GO:0015918)|2/22|0.00578047055548635|0.286385837326668|0|0|17.4825174825175|90.0921361648208|MSR1;CAV1|0
104|positive regulation of cell migration (GO:0030335)|5/222|0.00609059217415319|0.298848960237536|0|0|4.33125433125433|22.0937715040384|GPNMB;PDPN;FN1;CTSH;IGF1|0
105|positive regulation of ion transmembrane transporter activity (GO:0032414)|2/23|0.00630963558145633|0.306648289258778|0|0|16.7224080267559|84.710323689621|GLRX;CTSS|0
106|positive regulation of monooxygenase activity (GO:0032770)|2/23|0.00630963558145633|0.303755380869544|0|0|16.7224080267559|84.710323689621|S100A1;APOE|0
107|positive regulation of cell proliferation (GO:0008284)|7/425|0.00677020199592938|0.322881689581566|0|0|3.16742081447964|15.8219775968783|CD74;S100A6;FN1;NME2;HMOX1;CTSH;IGF1|0
108|retinoid metabolic process (GO:0001523)|3/76|0.007295012532188|0.344689342145883|0|0|7.59109311740891|37.3524623919089|SDC3;LPL;APOE|0
109|regulation of neuronal synaptic plasticity (GO:0048168)|2/25|0.00743142031551661|0.347913191468635|0|0|15.3846153846154|75.4159735225083|SYNGR1;APOE|0
110|transition metal ion homeostasis (GO:0055076)|2/25|0.00743142031551661|0.344750344273466|0|0|15.3846153846154|75.4159735225083|HMOX1;B2M|0
111|negative regulation of T cell proliferation (GO:0042130)|2/25|0.00743142031551661|0.341644485316047|0|0|15.3846153846154|75.4159735225083|GPNMB;ARG1|0
112|prostaglandin metabolic process (GO:0006693)|2/26|0.00802358036899565|0.365574380562364|0|0|14.792899408284|71.3812208087963|CD74;PTGS1|0
113|phosphatidylcholine acyl-chain remodeling (GO:0036151)|2/28|0.00926930003824975|0.418595027391048|0|0|13.7362637362637|64.3001017930589|PLA2G16;DBI|0
114|response to hexose (GO:0009746)|2/28|0.00926930003824975|0.414923141185864|0|0|13.7362637362637|64.3001017930589|LPL;IGF1|0
115|negative regulation of myeloid leukocyte differentiation (GO:0002762)|2/28|0.00926930003824975|0.411315113871204|0|0|13.7362637362637|64.3001017930589|MAFB;C1QC|0
116|negative regulation of neuron death (GO:1901215)|3/84|0.009596900561156|0.422180892789475|0|0|6.86813186813187|31.9115047448571|GPNMB;APOE;LGMN|0
117|regulation of vasculature development (GO:1901342)|2/29|0.00992241060002349|0.432769754631794|0|0|13.262599469496|61.1798326680561|GPNMB;HMOX1|0
118|positive regulation of calcium-mediated signaling (GO:0050850)|2/29|0.00992241060002349|0.429102214338304|0|0|13.262599469496|61.1798326680561|TREM2;IGF1|0
119|triglyceride homeostasis (GO:0070328)|2/29|0.00992241060002349|0.425496313377478|0|0|13.262599469496|61.1798326680561|LPL;APOE|0
120|antigen processing and presentation of peptide antigen via MHC class I (GO:0002474)|2/29|0.00992241060002349|0.421950510765999|0|0|13.262599469496|61.1798326680561|BCAP31;B2M|0
121|positive regulation of sprouting angiogenesis (GO:1903672)|2/29|0.00992241060002349|0.418463316462148|0|0|13.262599469496|61.1798326680561|S100A1;HMOX1|0
122|regulation of immune response (GO:0050776)|5/252|0.0102216164268995|0.427548431364494|0|0|3.81562881562882|17.4879828434498|TYROBP;IGKC;TREM2;CD300LF;B2M|0
123|regulation of peptidyl-tyrosine phosphorylation (GO:0050730)|3/86|0.0102310534824736|0.424463950577746|0|0|6.70840787119857|30.7401233761631|CD74;TREM2;IGF1|0
124|regulation of macrophage derived foam cell differentiation (GO:0010743)|2/30|0.0105953918520934|0.436034553397036|0|0|12.8205128205128|58.2991808118153|MSR1;LPL|0
125|superoxide metabolic process (GO:0006801)|2/30|0.0105953918520934|0.43254627696986|0|0|12.8205128205128|58.2991808118153|PRDX2;CYBA|0
126|negative regulation of lymphocyte proliferation (GO:0050672)|2/30|0.0105953918520934|0.429113370009781|0|0|12.8205128205128|58.2991808118153|GPNMB;ARG1|0
127|regulation of developmental growth (GO:0048638)|2/31|0.0112880236020325|0.45356523182025|0|0|12.4069478908189|55.6329153044411|APOE;IGF1|0
128|regulation of blood coagulation (GO:0030193)|2/31|0.0112880236020325|0.450021753446654|0|0|12.4069478908189|55.6329153044411|CAV1;APOE|0
129|nucleobase-containing small molecule interconversion (GO:0015949)|2/32|0.0120000873782114|0.474701130938085|0|0|12.0192307692308|53.1591508137383|NME2;GLRX|0
130|protein destabilization (GO:0031648)|2/32|0.0120000873782114|0.471049583777022|0|0|12.0192307692308|53.1591508137383|GSN;CTSH|0
131|lipid transport (GO:0006869)|3/92|0.0122771203845777|0.47824538414122|0|0|6.27090301003344|27.5920853687183|CAV1;PSAP;APOE|0
132|endocytosis (GO:0006897)|5/264|0.0123107136723396|0.475920999014763|0|0|3.64219114219114|16.0157538077615|MSR1;IGKC;ANXA3;CAV1;APOE|0
133|regulation of potassium ion transmembrane transport (GO:1901379)|2/33|0.0127313664066011|0.488482426863799|0|0|11.6550116550117|50.8588174202252|CD63;CAV1|0
134|positive regulation of cytokine-mediated signaling pathway (GO:0001961)|2/34|0.0134816456100268|0.513409235432586|0|0|11.3122171945701|48.7152274101099|CD74;CD300LF|0
135|positive regulation of intrinsic apoptotic signaling pathway (GO:2001244)|2/34|0.0134816456100268|0.509606204059011|0|0|11.3122171945701|48.7152274101099|BCAP31;CAV1|0
136|keratan sulfate metabolic process (GO:0042339)|2/35|0.0142507115808119|0.534716038212378|0|0|10.989010989011|46.7137190991059|B4GALT1;HEXB|0
137|negative regulation of T cell activation (GO:0050868)|2/35|0.0142507115808119|0.530813001437105|0|0|10.989010989011|46.7137190991059|GPNMB;ARG1|0
138|macromolecule catabolic process (GO:0009057)|2/35|0.0142507115808119|0.526966530412198|0|0|10.989010989011|46.7137190991059|CTSD;LGMN|0
139|positive regulation of cell motility (GO:2000147)|4/180|0.0145327728821256|0.533530503722927|0|0|4.27350427350427|18.0826879538262|GPNMB;PDPN;CTSH;IGF1|0
140|positive regulation of macromolecule metabolic process (GO:0010604)|5/277|0.0148824949981329|0.542466942681945|0|0|3.47125798389336|14.6055595286979|CD63;GSN;FN1;CTSH;IGF1|0
141|carbohydrate catabolic process (GO:0016052)|2/36|0.0150383525901269|0.544260377783104|0|0|10.6837606837607|44.8413621975511|PGAM1;MAN2B1|0
142|protein processing (GO:0016485)|3/102|0.0161738251345937|0.581232603252334|0|0|5.65610859728507|23.3278341395908|CTSH;CTSS;LGMN|0
143|positive regulation of smooth muscle cell proliferation (GO:0048661)|2/38|0.0166685210500975|0.59482141901152|0|0|10.1214574898785|41.4396083543069|HMOX1;IGF1|0
144|plasma membrane invagination (GO:0099024)|3/104|0.0170270706512324|0.603396816203049|0|0|5.54733727810651|22.5940318612475|MSR1;GSN;IGKC|0
145|receptor-mediated endocytosis (GO:0006898)|4/189|0.017081928786178|0.601166086868044|0|0|4.07000407000407|16.563834637388|MSR1;IGKC;CAV1;APOE|0
146|phagocytosis, engulfment (GO:0006911)|3/105|0.0174629922343205|0.610367461450255|0|0|5.49450549450549|22.2399525643838|MSR1;GSN;IGKC|0
147|regulation of cellular amide metabolic process (GO:0034248)|2/39|0.0175106332735594|0.607869126496419|0|0|9.86193293885602|39.8909957292341|RBM3;PGAM1|0
148|protein homooligomerization (GO:0051260)|4/191|0.0176839682127021|0.609738444523101|0|0|4.02738622633911|16.2508932764284|B4GALT1;CAV1;ATPIF1;HMOX1|0
149|positive regulation of phagocytosis (GO:0050766)|2/40|0.0183704900515062|0.629158461294201|0|0|9.61538461538462|38.4327856094445|CYBA;CD300LF|0
150|positive regulation of epithelial cell proliferation (GO:0050679)|3/108|0.0188080322670817|0.639849257726121|0|0|5.34188034188034|21.2258079708427|ECM1;NME2;IGF1|0
151|positive regulation of cell differentiation (GO:0045597)|4/195|0.0189274517542338|0.639647591403014|0|0|3.94477317554241|15.6494750965178|MSR1;PDPN;LPL;IGF1|0
152|response to peptide hormone (GO:0043434)|2/41|0.0192478878212215|0.646197181261141|0|0|9.38086303939963|37.0577293418511|CAV1;IGF1|0
153|negative regulation of hydrolase activity (GO:0051346)|3/109|0.0192688225178687|0.642671903978326|0|0|5.29287226534933|20.9029652585072|CSTB;ECM1;ATPIF1|0
154|cellular response to peptide (GO:1901653)|2/42|0.0201426246241397|0.667453334136266|0|0|9.15750915750916|35.7593139304792|CAV1;IGF1|0
155|positive regulation of receptor-mediated endocytosis (GO:0048260)|2/42|0.0201426246241397|0.663147183593452|0|0|9.15750915750916|35.7593139304792|CD63;B2M|0
156|regulation of MAPK cascade (GO:0043408)|4/204|0.0219200614440562|0.71703893300653|0|0|3.77073906485671|14.4055543506844|CD74;CAV1;FN1;IGF1|0
157|regulation of ATP metabolic process (GO:1903578)|2/44|0.021983315423336|0.714527761817093|0|0|8.74125874125874|33.3695061468116|PGAM1;ATPIF1|0
158|negative regulation of ERBB signaling pathway (GO:1901185)|2/44|0.021983315423336|0.710005434210656|0|0|8.74125874125874|33.3695061468116|PTPN18;LGMN|0
159|membrane depolarization (GO:0051899)|2/44|0.021983315423336|0.705539991228199|0|0|8.74125874125874|33.3695061468116|CAV1;ATPIF1|0
160|positive regulation of transport (GO:0051050)|2/45|0.0229288734091663|0.731287756293596|0|0|8.54700854700855|32.2680197868451|CD63;APOE|0
161|amide biosynthetic process (GO:0043604)|2/45|0.0229288734091663|0.726745596316617|0|0|8.54700854700855|32.2680197868451|ARG1;ATPIF1|0
162|positive regulation of viral life cycle (GO:1903902)|2/45|0.0229288734091663|0.722259512388737|0|0|8.54700854700855|32.2680197868451|CD74;LGALS1|0
163|regulation of T cell activation (GO:0050863)|2/45|0.0229288734091663|0.717828472435432|0|0|8.54700854700855|32.2680197868451|GSN;GPNMB|0
164|regulation of smooth muscle cell proliferation (GO:0048660)|2/45|0.0229288734091663|0.713451469554728|0|0|8.54700854700855|32.2680197868451|HMOX1;IGF1|0
165|positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731)|3/117|0.0231796386878286|0.716883007418117|0|0|4.93096646942801|18.5625297259851|CD74;TREM2;IGF1|0
166|sphingolipid metabolic process (GO:0006665)|3/117|0.0231796386878286|0.712564435084273|0|0|4.93096646942801|18.5625297259851|GM2A;HEXB;PSAP|0
167|response to glucose (GO:0009749)|2/48|0.025864054347731|0.790324966086654|0|0|8.01282051282051|29.2860668050682|LPL;IGF1|0
168|regulation of intrinsic apoptotic signaling pathway (GO:2001242)|2/48|0.025864054347731|0.785620650812329|0|0|8.01282051282051|29.2860668050682|BCAP31;CAV1|0
169|regulation of apoptotic process (GO:0042981)|9/816|0.0262980010028538|0.794075142707474|0|0|2.1210407239819|7.71690260926864|PRDX2;CD74;PRDX5;LGALS1;PDPN;NME2;CTSH;IGF1;CTSB|0
170|regulation of mitochondrion organization (GO:0010821)|2/49|0.0268746417135921|0.806713509790945|0|0|7.84929356357928|28.3875362967853|CTSK;ATPIF1|0
171|protein oligomerization (GO:0051259)|4/218|0.0271226871932146|0.809398086239613|0|0|3.52858151023289|12.728951078063|B4GALT1;CAV1;ATPIF1;HMOX1|0
172|regulation of cellular protein metabolic process (GO:0032268)|2/51|0.0289429675166677|0.858697460683462|0|0|7.54147812971342|26.7151434594447|RBM3;APOE|0
173|wound healing (GO:0042060)|2/51|0.0289429675166677|0.853733891546563|0|0|7.54147812971342|26.7151434594447|MYOF;HMOX1|0
174|regulation of macromolecule metabolic process (GO:0060255)|3/130|0.0303858673052973|0.891144142867426|0|0|4.43786982248521|15.5049304878929|APOE;IGF1;CRIP1|0
175|polyamine biosynthetic process (GO:0006596)|1/6|0.0308008128994233|0.898151704147183|0|0|32.0512820512821|111.545326811297|SAT1|0
176|regulation of cellular carbohydrate catabolic process (GO:0043471)|1/6|0.0308008128994233|0.893048569464529|0|0|32.0512820512821|111.545326811297|PGAM1|0
177|positive regulation of protein import into nucleus, translocation (GO:0033160)|1/6|0.0308008128994233|0.888003097320661|0|0|32.0512820512821|111.545326811297|IGF1|0
178|regulation of keratinocyte apoptotic process (GO:1902172)|1/6|0.0308008128994233|0.88301431587504|0|0|32.0512820512821|111.545326811297|GSN|0
179|positive regulation of toll-like receptor 3 signaling pathway (GO:0034141)|1/6|0.0308008128994233|0.878081275004229|0|0|32.0512820512821|111.545326811297|CAV1|0
180|regulation of extent of cell growth (GO:0061387)|1/6|0.0308008128994233|0.87320304569865|0|0|32.0512820512821|111.545326811297|APOE|0
181|folic acid-containing compound biosynthetic process (GO:0009396)|1/6|0.0308008128994233|0.868378719479321|0|0|32.0512820512821|111.545326811297|ATPIF1|0
182|cellular response to iron ion (GO:0071281)|1/6|0.0308008128994233|0.86360740783383|0|0|32.0512820512821|111.545326811297|B2M|0
183|negative regulation of erythrocyte differentiation (GO:0045647)|1/6|0.0308008128994233|0.858888241670804|0|0|32.0512820512821|111.545326811297|MAFB|0
184|lipoprotein metabolic process (GO:0042157)|1/6|0.0308008128994233|0.854220370792158|0|0|32.0512820512821|111.545326811297|APOE|0
185|positive regulation of receptor binding (GO:1900122)|1/6|0.0308008128994233|0.849602963382471|0|0|32.0512820512821|111.545326811297|B2M|0
186|ceramide transport (GO:0035627)|1/6|0.0308008128994233|0.845035205514823|0|0|32.0512820512821|111.545326811297|PSAP|0
187|negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471)|1/6|0.0308008128994233|0.840516300672498|0|0|32.0512820512821|111.545326811297|BCAP31|0
188|positive regulation of phospholipid transport (GO:2001140)|1/6|0.0308008128994233|0.836045469285942|0|0|32.0512820512821|111.545326811297|APOE|0
189|negative regulation of muscle cell apoptotic process (GO:0010656)|1/6|0.0308008128994233|0.831621948284429|0|0|32.0512820512821|111.545326811297|IGF1|0
190|positive regulation of sodium ion transmembrane transport (GO:1902307)|1/6|0.0308008128994233|0.827244990661879|0|0|32.0512820512821|111.545326811297|GLRX|0
191|lipoprotein catabolic process (GO:0042159)|1/6|0.0308008128994233|0.82291386505632|0|0|32.0512820512821|111.545326811297|APOE|0
192|regulation of protein targeting (GO:1903533)|1/6|0.0308008128994233|0.818627855342485|0|0|32.0512820512821|111.545326811297|ATPIF1|0
193|protein localization to endoplasmic reticulum exit site (GO:0070973)|1/6|0.0308008128994233|0.814386260237083|0|0|32.0512820512821|111.545326811297|BCAP31|0
194|positive regulation of cGMP biosynthetic process (GO:0030828)|1/6|0.0308008128994233|0.810188392916273|0|0|32.0512820512821|111.545326811297|APOE|0
195|spermine metabolic process (GO:0008215)|1/6|0.0308008128994233|0.806033580644908|0|0|32.0512820512821|111.545326811297|SAT1|0
196|surfactant homeostasis (GO:0043129)|1/6|0.0308008128994233|0.801921164417128|0|0|32.0512820512821|111.545326811297|CTSH|0
197|negative regulation of interferon-gamma-mediated signaling pathway (GO:0060336)|1/6|0.0308008128994233|0.797850498607904|0|0|32.0512820512821|111.545326811297|ARG1|0
198|negative regulation of response to interferon-gamma (GO:0060331)|1/6|0.0308008128994233|0.793820950635137|0|0|32.0512820512821|111.545326811297|ARG1|0
199|antigen processing and presentation of endogenous peptide antigen (GO:0002483)|1/6|0.0308008128994233|0.789831900631945|0|0|32.0512820512821|111.545326811297|B2M|0
200|negative regulation of leukocyte degranulation (GO:0043301)|1/6|0.0308008128994233|0.785882741128785|0|0|32.0512820512821|111.545326811297|CD84|0
201|chemical homeostasis within a tissue (GO:0048875)|1/6|0.0308008128994233|0.78197287674506|0|0|32.0512820512821|111.545326811297|CTSH|0
202|positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081)|1/6|0.0308008128994233|0.778101723889886|0|0|32.0512820512821|111.545326811297|CD74|0
203|positive regulation of cytosolic calcium ion concentration (GO:0007204)|3/134|0.0328141827800793|0.824880663678545|0|0|4.30539609644087|14.7110840494507|BCAP31;CD52;CAV1|0
204|regulation of cytosolic calcium ion concentration (GO:0051480)|3/138|0.0353410094156357|0.884044956117593|0|0|4.18060200668896|13.974545357528|BCAP31;CD52;CAV1|0
205|cellular iron ion homeostasis (GO:0006879)|2/57|0.0355118023978855|0.883984037250778|0|0|6.74763832658569|22.5228756804434|FTH1;HMOX1|0
206|glycosaminoglycan catabolic process (GO:0006027)|2/57|0.0355118023978855|0.87969285260393|0|0|6.74763832658569|22.5228756804434|HEXB;SDC3|0
207|angiotensin-activated signaling pathway (GO:0038166)|1/7|0.0358421454858948|0.883586803934885|0|0|27.4725274725275|91.4459019170173|CAV1|0
208|positive regulation of insulin-like growth factor receptor signaling pathway (GO:0043568)|1/7|0.0358421454858948|0.879338790454429|0|0|27.4725274725275|91.4459019170173|IGF1|0
209|protein localization to basolateral plasma membrane (GO:1903361)|1/7|0.0358421454858948|0.875131427820676|0|0|27.4725274725275|91.4459019170173|CAV1|0
210|regulation of entry of bacterium into host cell (GO:2000535)|1/7|0.0358421454858948|0.870964135307244|0|0|27.4725274725275|91.4459019170173|CAV1|0
211|negative regulation of membrane protein ectodomain proteolysis (GO:0051045)|1/7|0.0358421454858948|0.866836343196783|0|0|27.4725274725275|91.4459019170173|TIMP2|0
212|negative regulation of nitric oxide metabolic process (GO:1904406)|1/7|0.0358421454858948|0.862747492521327|0|0|27.4725274725275|91.4459019170173|CAV1|0
213|negative regulation of leukocyte migration (GO:0002686)|1/7|0.0358421454858948|0.858697034809959|0|0|27.4725274725275|91.4459019170173|HMOX1|0
214|flavin-containing compound metabolic process (GO:0042726)|1/7|0.0358421454858948|0.854684431843557|0|0|27.4725274725275|91.4459019170173|ACP5|0
215|positive regulation of calcineurin-NFAT signaling cascade (GO:0070886)|1/7|0.0358421454858948|0.850709155416378|0|0|27.4725274725275|91.4459019170173|IGF1|0
216|regulation of pinocytosis (GO:0048548)|1/7|0.0358421454858948|0.846770687104265|0|0|27.4725274725275|91.4459019170173|CAV1|0
217|regulation of dendritic spine maintenance (GO:1902950)|1/7|0.0358421454858948|0.842868518039268|0|0|27.4725274725275|91.4459019170173|APOE|0
218|regulation of toll-like receptor 3 signaling pathway (GO:0034139)|1/7|0.0358421454858948|0.839002148690464|0|0|27.4725274725275|91.4459019170173|CAV1|0
219|positive regulation of extracellular matrix disassembly (GO:0090091)|1/7|0.0358421454858948|0.835171088650782|0|0|27.4725274725275|91.4459019170173|PDPN|0
220|positive regulation of sequestering of triglyceride (GO:0010890)|1/7|0.0358421454858948|0.831374856429642|0|0|27.4725274725275|91.4459019170173|LPL|0
221|riboflavin metabolic process (GO:0006771)|1/7|0.0358421454858948|0.827612979251227|0|0|27.4725274725275|91.4459019170173|ACP5|0
222|positive regulation of apoptotic cell clearance (GO:2000427)|1/7|0.0358421454858948|0.823884992858204|0|0|27.4725274725275|91.4459019170173|CD300LF|0
223|mannose metabolic process (GO:0006013)|1/7|0.0358421454858948|0.820190441320723|0|0|27.4725274725275|91.4459019170173|MAN2B1|0
224|pteridine-containing compound biosynthetic process (GO:0042559)|1/7|0.0358421454858948|0.816528876850541|0|0|27.4725274725275|91.4459019170173|ATPIF1|0
225|regulation of NADP metabolic process (GO:1902031)|1/7|0.0358421454858948|0.812899859620094|0|0|27.4725274725275|91.4459019170173|PGAM1|0
226|positive regulation of insulin receptor signaling pathway (GO:0046628)|1/7|0.0358421454858948|0.809302957586377|0|0|27.4725274725275|91.4459019170173|IGF1|0
227|positive regulation of autophagy of mitochondrion (GO:1903599)|1/7|0.0358421454858948|0.805737746319477|0|0|27.4725274725275|91.4459019170173|ATPIF1|0
228|positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903589)|1/7|0.0358421454858948|0.802203808835619|0|0|27.4725274725275|91.4459019170173|HMOX1|0
229|tetrahydrofolate interconversion (GO:0035999)|1/7|0.0358421454858948|0.798700735434591|0|0|27.4725274725275|91.4459019170173|ATPIF1|0
230|negative regulation of synapse organization (GO:1905809)|1/7|0.0358421454858948|0.795228123541397|0|0|27.4725274725275|91.4459019170173|APOE|0
231|negative regulation of nitric oxide biosynthetic process (GO:0045019)|1/7|0.0358421454858948|0.79178557755204|0|0|27.4725274725275|91.4459019170173|CAV1|0
232|lymphatic endothelial cell differentiation (GO:0060836)|1/7|0.0358421454858948|0.788372708683281|0|0|27.4725274725275|91.4459019170173|PDPN|0
233|regulation of chemokine biosynthetic process (GO:0045073)|1/7|0.0358421454858948|0.784989134826271|0|0|27.4725274725275|91.4459019170173|HMOX1|0
234|gas homeostasis (GO:0033483)|1/7|0.0358421454858948|0.781634480403937|0|0|27.4725274725275|91.4459019170173|CAV1|0
235|regulation of interleukin-18 production (GO:0032661)|1/7|0.0358421454858948|0.778308376232005|0|0|27.4725274725275|91.4459019170173|CD84|0
236|spermidine metabolic process (GO:0008216)|1/7|0.0358421454858948|0.775010459383564|0|0|27.4725274725275|91.4459019170173|SAT1|0
237|chylomicron remnant clearance (GO:0034382)|1/7|0.0358421454858948|0.771740373057052|0|0|27.4725274725275|91.4459019170173|APOE|0
238|regulation of Cdc42 protein signal transduction (GO:0032489)|1/7|0.0358421454858948|0.768497766447568|0|0|27.4725274725275|91.4459019170173|APOE|0
239|response to cytokine (GO:0034097)|3/139|0.0359880370966855|0.768397294160612|0|0|4.15052573325955|13.7987079356144|PTPN18;IFITM2;TIMP2|0
240|regulation of glycolytic process (GO:0006110)|2/58|0.0366577622878735|0.77943567064591|0|0|6.63129973474801|21.9239395095771|PGAM1;IGF1|0
241|receptor metabolic process (GO:0043112)|2/59|0.0378178625945237|0.800765779335497|0|0|6.51890482398957|21.3492420636575|CAV1;LGMN|0
242|regulation of extrinsic apoptotic signaling pathway (GO:2001236)|2/60|0.0389919283697527|0.822214092854743|0|0|6.41025641025641|20.7974398663514|CAV1;IGF1|0
243|post-translational protein modification (GO:0043687)|5/358|0.0391028570746608|0.821159998567877|0|0|2.68586162440911|8.70638091882568|LGALS1;FN1;SPP1;APOE;MFGE8|0
244|regulation of ERK1 and ERK2 cascade (GO:0070372)|4/248|0.0405789670365726|0.848665855687009|0|0|3.10173697270471|9.93953287809183|CD74;GPNMB;FN1;TREM2|0
245|positive regulation of monocyte differentiation (GO:0045657)|1/8|0.0408575074552191|0.851003512424421|0|0|24.0384615384615|76.8669397482758|CD74|0
246|regulation of nitrogen compound metabolic process (GO:0051171)|1/8|0.0408575074552191|0.847544148552777|0|0|24.0384615384615|76.8669397482758|APOE|0
247|regulation of establishment of protein localization to mitochondrion (GO:1903747)|1/8|0.0408575074552191|0.844112795724628|0|0|24.0384615384615|76.8669397482758|ATPIF1|0
248|positive regulation of mitochondrial calcium ion concentration (GO:0051561)|1/8|0.0408575074552191|0.840709115096706|0|0|24.0384615384615|76.8669397482758|BCAP31|0
249|cGMP-mediated signaling (GO:0019934)|1/8|0.0408575074552191|0.837332773269009|0|0|24.0384615384615|76.8669397482758|APOE|0
250|positive regulation of membrane potential (GO:0045838)|1/8|0.0408575074552191|0.833983442175933|0|0|24.0384615384615|76.8669397482758|GLRX|0
251|amyloid fibril formation (GO:1990000)|1/8|0.0408575074552191|0.830660798980013|0|0|24.0384615384615|76.8669397482758|GSN|0
252|regulation of smooth muscle cell apoptotic process (GO:0034391)|1/8|0.0408575074552191|0.827364525968187|0|0|24.0384615384615|76.8669397482758|IGF1|0
253|cellular response to UV-B (GO:0071493)|1/8|0.0408575074552191|0.824094310450526|0|0|24.0384615384615|76.8669397482758|CRIP1|0
254|regulation of amyloid fibril formation (GO:1905906)|1/8|0.0408575074552191|0.820849844661351|0|0|24.0384615384615|76.8669397482758|APOE|0
255|positive regulation of chemokine secretion (GO:0090197)|1/8|0.0408575074552191|0.817630825662679|0|0|24.0384615384615|76.8669397482758|LPL|0
256|regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043619)|1/8|0.0408575074552191|0.814436955249934|0|0|24.0384615384615|76.8669397482758|HMOX1|0
257|negative regulation of voltage-gated potassium channel activity (GO:1903817)|1/8|0.0408575074552191|0.811267939859857|0|0|24.0384615384615|76.8669397482758|CAV1|0
258|regulation of toll-like receptor 2 signaling pathway (GO:0034135)|1/8|0.0408575074552191|0.808123490480555|0|0|24.0384615384615|76.8669397482758|CYBA|0
259|immunoglobulin mediated immune response (GO:0016064)|1/8|0.0408575074552191|0.805003322563642|0|0|24.0384615384615|76.8669397482758|CD74|0
260|regulation of store-operated calcium entry (GO:2001256)|1/8|0.0408575074552191|0.801907155938397|0|0|24.0384615384615|76.8669397482758|CD84|0
261|regulation of chemokine secretion (GO:0090196)|1/8|0.0408575074552191|0.798834714727905|0|0|24.0384615384615|76.8669397482758|LPL|0
262|arginine catabolic process (GO:0006527)|1/8|0.0408575074552191|0.795785727267111|0|0|24.0384615384615|76.8669397482758|ARG1|0
263|regulation of receptor binding (GO:1900120)|1/8|0.0408575074552191|0.79275992602275|0|0|24.0384615384615|76.8669397482758|B2M|0
264|response to vitamin D (GO:0033280)|1/8|0.0408575074552191|0.789757047515088|0|0|24.0384615384615|76.8669397482758|SPP1|0
265|B cell mediated immunity (GO:0019724)|1/8|0.0408575074552191|0.786776832241446|0|0|24.0384615384615|76.8669397482758|CD74|0
266|regulation of cardiac muscle cell action potential involved in regulation of contraction (GO:0098909)|1/8|0.0408575074552191|0.783819024601441|0|0|24.0384615384615|76.8669397482758|CAV1|0
267|regulation of apoptotic cell clearance (GO:2000425)|1/8|0.0408575074552191|0.780883372823907|0|0|24.0384615384615|76.8669397482758|CD300LF|0
268|negative regulation of MAP kinase activity (GO:0043407)|2/62|0.0413812636267176|0.787942493608731|0|0|6.20347394540943|19.7576120967386|CAV1;APOE|0
269|negative regulation of viral life cycle (GO:1903901)|2/62|0.0413812636267176|0.785013339357397|0|0|6.20347394540943|19.7576120967386|IFITM2;GSN|0
270|regulation of T cell proliferation (GO:0042129)|2/63|0.0425961902322259|0.80506799538907|0|0|6.1050061050061|19.2673410309794|GPNMB;ARG1|0
271|oligosaccharide metabolic process (GO:0009311)|2/64|0.0438243965341732|0.825224706693305|0|0|6.00961538461539|18.7954604457255|B4GALT1;MAN2B1|0
272|regulation of proteolysis (GO:0030162)|2/64|0.0438243965341732|0.822190792330462|0|0|6.00961538461539|18.7954604457255|CSTB;CAV1|0
273|negative regulation of neuron apoptotic process (GO:0043524)|2/64|0.0438243965341732|0.819179104446468|0|0|6.00961538461539|18.7954604457255|APOE;LGMN|0
274|nucleoside triphosphate biosynthetic process (GO:0009142)|1/9|0.0458470310594364|0.853859122249285|0|0|21.3675213675214|65.8642058913377|NME2|0
275|removal of superoxide radicals (GO:0019430)|1/9|0.0458470310594364|0.85075417998656|0|0|21.3675213675214|65.8642058913377|PRDX2|0
276|negative regulation of phagocytosis (GO:0050765)|1/9|0.0458470310594364|0.84767173730545|0|0|21.3675213675214|65.8642058913377|CD300LF|0
277|ornithine metabolic process (GO:0006591)|1/9|0.0458470310594364|0.844611550528174|0|0|21.3675213675214|65.8642058913377|ARG1|0
278|negative regulation of alcohol biosynthetic process (GO:1902931)|1/9|0.0458470310594364|0.841573379483108|0|0|21.3675213675214|65.8642058913377|APOE|0
279|regulation of macrophage cytokine production (GO:0010935)|1/9|0.0458470310594364|0.83855698744195|0|0|21.3675213675214|65.8642058913377|CD74|0
280|integrin activation (GO:0033622)|1/9|0.0458470310594364|0.835562141058229|0|0|21.3675213675214|65.8642058913377|FN1|0
281|actin filament reorganization (GO:0090527)|1/9|0.0458470310594364|0.832588610307132|0|0|21.3675213675214|65.8642058913377|GSN|0
282|basement membrane organization (GO:0071711)|1/9|0.0458470310594364|0.82963616842661|0|0|21.3675213675214|65.8642058913377|CTSS|0
283|cellular response to superoxide (GO:0071451)|1/9|0.0458470310594364|0.826704591859732|0|0|21.3675213675214|65.8642058913377|PRDX2|0
284|oligosaccharide catabolic process (GO:0009313)|1/9|0.0458470310594364|0.823793660198254|0|0|21.3675213675214|65.8642058913377|MAN2B1|0
285|sterol catabolic process (GO:0016127)|1/9|0.0458470310594364|0.820903156127383|0|0|21.3675213675214|65.8642058913377|APOE|0
286|regulation of leukocyte activation (GO:0002694)|1/9|0.0458470310594364|0.818032865371693|0|0|21.3675213675214|65.8642058913377|CD74|0
287|regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267)|1/9|0.0458470310594364|0.815182576642175|0|0|21.3675213675214|65.8642058913377|GSN|0
288|positive regulation of cholesterol esterification (GO:0010873)|1/9|0.0458470310594364|0.812352081584389|0|0|21.3675213675214|65.8642058913377|APOE|0
289|cholesterol catabolic process (GO:0006707)|1/9|0.0458470310594364|0.809541174727696|0|0|21.3675213675214|65.8642058913377|APOE|0
290|ether lipid metabolic process (GO:0046485)|1/9|0.0458470310594364|0.806749653435531|0|0|21.3675213675214|65.8642058913377|PLA2G16|0
291|regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844)|1/9|0.0458470310594364|0.803977317856715|0|0|21.3675213675214|65.8642058913377|CAV1|0
292|endosome to melanosome transport (GO:0035646)|1/9|0.0458470310594364|0.801223970877754|0|0|21.3675213675214|65.8642058913377|CD63|0
293|endosome to pigment granule transport (GO:0043485)|1/9|0.0458470310594364|0.798489418076123|0|0|21.3675213675214|65.8642058913377|CD63|0
294|negative regulation of amyloid-beta formation (GO:1902430)|1/9|0.0458470310594364|0.795773467674504|0|0|21.3675213675214|65.8642058913377|APOE|0
295|negative regulation of potassium ion transmembrane transport (GO:1901380)|1/9|0.0458470310594364|0.793075930495946|0|0|21.3675213675214|65.8642058913377|CAV1|0
296|antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (GO:0002480)|1/9|0.0458470310594364|0.790396619919946|0|0|21.3675213675214|65.8642058913377|B2M|0
297|nucleoside phosphate biosynthetic process (GO:1901293)|1/9|0.0458470310594364|0.787735351839408|0|0|21.3675213675214|65.8642058913377|NME2|0
298|fatty acid homeostasis (GO:0055089)|1/9|0.0458470310594364|0.78509194461847|0|0|21.3675213675214|65.8642058913377|APOE|0
299|protein localization to vacuole (GO:0072665)|1/9|0.0458470310594364|0.782466219051184|0|0|21.3675213675214|65.8642058913377|LAMTOR4|0
300|regulation of glycoprotein biosynthetic process (GO:0010559)|1/9|0.0458470310594364|0.779857998321014|0|0|21.3675213675214|65.8642058913377|IGF1|0
301|response to vitamin (GO:0033273)|1/9|0.0458470310594364|0.777267107961143|0|0|21.3675213675214|65.8642058913377|SPP1|0
302|positive regulation of endothelial cell proliferation (GO:0001938)|2/68|0.0488666790135652|0.825717427172924|0|0|5.65610859728507|17.0738660946419|ECM1;HMOX1|0
303|negative regulation of protein binding (GO:0032091)|2/68|0.0488666790135652|0.822992287149251|0|0|5.65610859728507|17.0738660946419|CAV1;B2M|0
304|actin filament capping (GO:0051693)|1/10|0.0508108479280287|0.85292025321293|0|0|19.2307692307692|57.3008731789268|GSN|0
305|protein deglycosylation (GO:0006517)|1/10|0.0508108479280287|0.85012379336633|0|0|19.2307692307692|57.3008731789268|MAN2B1|0
306|positive regulation of protein exit from endoplasmic reticulum (GO:0070863)|1/10|0.0508108479280287|0.847345611035067|0|0|19.2307692307692|57.3008731789268|BCAP31|0
307|cytochrome complex assembly (GO:0017004)|1/10|0.0508108479280287|0.8445855276115|0|0|19.2307692307692|57.3008731789268|CYBA|0
308|regulation of coagulation (GO:0050818)|1/10|0.0508108479280287|0.841843366807567|0|0|19.2307692307692|57.3008731789268|CAV1|0
309|neuron projection regeneration (GO:0031102)|1/10|0.0508108479280287|0.839118954617251|0|0|19.2307692307692|57.3008731789268|APOE|0
310|positive regulation of steroid metabolic process (GO:0045940)|1/10|0.0508108479280287|0.836412119279776|0|0|19.2307692307692|57.3008731789268|APOE|0
311|superoxide anion generation (GO:0042554)|1/10|0.0508108479280287|0.833722691243507|0|0|19.2307692307692|57.3008731789268|CYBA|0
312|positive regulation of smooth muscle cell migration (GO:0014911)|1/10|0.0508108479280287|0.831050503130547|0|0|19.2307692307692|57.3008731789268|IGF1|0
313|epithelial cell apoptotic process (GO:1904019)|1/10|0.0508108479280287|0.828395389702015|0|0|19.2307692307692|57.3008731789268|GSN|0
314|regulation of podosome assembly (GO:0071801)|1/10|0.0508108479280287|0.825757187823983|0|0|19.2307692307692|57.3008731789268|GSN|0
315|positive regulation of bone resorption (GO:0045780)|1/10|0.0508108479280287|0.823135736434065|0|0|19.2307692307692|57.3008731789268|SPP1|0
316|response to acidic pH (GO:0010447)|1/10|0.0508108479280287|0.820530876508641|0|0|19.2307692307692|57.3008731789268|CTSS|0
317|positive regulation of bone remodeling (GO:0046852)|1/10|0.0508108479280287|0.817942451030696|0|0|19.2307692307692|57.3008731789268|SPP1|0
318|regulation of actin filament-based movement (GO:1903115)|1/10|0.0508108479280287|0.815370304958272|0|0|19.2307692307692|57.3008731789268|PDPN|0
319|regulation of amyloid-beta clearance (GO:1900221)|1/10|0.0508108479280287|0.812814285193513|0|0|19.2307692307692|57.3008731789268|APOE|0
320|positive regulation of cardiac muscle cell differentiation (GO:2000727)|1/10|0.0508108479280287|0.810274240552283|0|0|19.2307692307692|57.3008731789268|IGF1|0
321|negative regulation of protein autophosphorylation (GO:0031953)|1/10|0.0508108479280287|0.807750021734363|0|0|19.2307692307692|57.3008731789268|CAV1|0
322|chylomicron assembly (GO:0034378)|1/10|0.0508108479280287|0.805241481294194|0|0|19.2307692307692|57.3008731789268|APOE|0
323|regulation of granulocyte differentiation (GO:0030852)|1/10|0.0508108479280287|0.802748473612169|0|0|19.2307692307692|57.3008731789268|C1QC|0
324|negative regulation of cell activation (GO:0050866)|1/10|0.0508108479280287|0.800270854866453|0|0|19.2307692307692|57.3008731789268|APOE|0
325|sequestering of actin monomers (GO:0042989)|1/10|0.0508108479280287|0.797808483005325|0|0|19.2307692307692|57.3008731789268|GSN|0
326|insulin-like growth factor receptor signaling pathway (GO:0048009)|1/10|0.0508108479280287|0.795361217720033|0|0|19.2307692307692|57.3008731789268|IGF1|0
327|response to organic cyclic compound (GO:0014070)|2/70|0.0514631944898668|0.803109117681315|0|0|5.49450549450549|16.3015845984095|SPP1;HMOX1|0
328|regulation of endocytosis (GO:0030100)|2/70|0.0514631944898668|0.80066061427375|0|0|5.49450549450549|16.3015845984095|CD63;APOE|0
329|regulation of programmed cell death (GO:0043067)|4/269|0.0518991314664579|0.804988656149954|0|0|2.85959393766085|8.45997490334759|PRDX2;LGALS1;NME2;CTSB|0
330|phospholipid metabolic process (GO:0006644)|2/71|0.0527797300437958|0.816166552768151|0|0|5.41711809317443|15.9351466016486|PLA2G16;LPL|0
331|positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436)|2/71|0.0527797300437958|0.81370079279|0|0|5.41711809317443|15.9351466016486|BCAP31;CAV1|0
332|phosphatidylcholine metabolic process (GO:0046470)|2/72|0.0541082387934357|0.831669706514767|0|0|5.34188034188034|15.5810300026219|PLA2G16;DBI|0
333|response to metal ion (GO:0010038)|2/73|0.0554485633443925|0.849711768007312|0|0|5.26870389884088|15.2386695181744|CAV1;CRIP1|0
334|regulation of neuron death (GO:1901214)|2/73|0.0554485633443925|0.847167720797709|0|0|5.26870389884088|15.2386695181744|GPNMB;APOE|0
335|regulation of epithelial cell proliferation (GO:0050678)|2/73|0.0554485633443925|0.844638861929657|0|0|5.26870389884088|15.2386695181744|NME2;IGF1|0
336|regulation of cholesterol esterification (GO:0010872)|1/11|0.0557490891026063|0.846689290745833|0|0|17.4825174825175|50.4701784570296|APOE|0
337|negative regulation of potassium ion transport (GO:0043267)|1/11|0.0557490891026063|0.844176859616023|0|0|17.4825174825175|50.4701784570296|CAV1|0
338|arginine metabolic process (GO:0006525)|1/11|0.0557490891026063|0.841679294942603|0|0|17.4825174825175|50.4701784570296|ARG1|0
339|positive regulation by host of viral process (GO:0044794)|1/11|0.0557490891026063|0.839196465164011|0|0|17.4825174825175|50.4701784570296|APOE|0
340|regulation of lamellipodium morphogenesis (GO:2000392)|1/11|0.0557490891026063|0.83672824026647|0|0|17.4825174825175|50.4701784570296|PDPN|0
341|positive regulation of extracellular matrix organization (GO:1903055)|1/11|0.0557490891026063|0.83427449176129|0|0|17.4825174825175|50.4701784570296|PDPN|0
342|negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166)|1/11|0.0557490891026063|0.831835092662572|0|0|17.4825174825175|50.4701784570296|CD74|0
343|negative regulation of leukocyte cell-cell adhesion (GO:1903038)|1/11|0.0557490891026063|0.829409917465305|0|0|17.4825174825175|50.4701784570296|GPNMB|0
344|negative regulation of bone mineralization (GO:0030502)|1/11|0.0557490891026063|0.826998842123836|0|0|17.4825174825175|50.4701784570296|ECM1|0
345|regulation of vascular endothelial growth factor signaling pathway (GO:1900746)|1/11|0.0557490891026063|0.824601744030724|0|0|17.4825174825175|50.4701784570296|CD63|0
346|cellular response to increased oxygen levels (GO:0036295)|1/11|0.0557490891026063|0.822218501995953|0|0|17.4825174825175|50.4701784570296|CAV1|0
347|modulation by host of viral process (GO:0044788)|1/11|0.0557490891026063|0.819848996226512|0|0|17.4825174825175|50.4701784570296|APOE|0
348|urea cycle (GO:0000050)|1/11|0.0557490891026063|0.817493108306321|0|0|17.4825174825175|50.4701784570296|ARG1|0
349|cyclooxygenase pathway (GO:0019371)|1/11|0.0557490891026063|0.815150721176503|0|0|17.4825174825175|50.4701784570296|PTGS1|0
350|regulation of ventricular cardiac muscle cell action potential (GO:0098911)|1/11|0.0557490891026063|0.812821719115999|0|0|17.4825174825175|50.4701784570296|CAV1|0
351|positive regulation of sodium ion transmembrane transporter activity (GO:2000651)|1/11|0.0557490891026063|0.810505987722506|0|0|17.4825174825175|50.4701784570296|GLRX|0
352|regulation of integrin-mediated signaling pathway (GO:2001044)|1/11|0.0557490891026063|0.808203413893749|0|0|17.4825174825175|50.4701784570296|CD63|0
353|negative regulation of peptide secretion (GO:0002792)|1/11|0.0557490891026063|0.805913885809064|0|0|17.4825174825175|50.4701784570296|CD74|0
354|negative regulation of amyloid precursor protein catabolic process (GO:1902992)|1/11|0.0557490891026063|0.803637292911299|0|0|17.4825174825175|50.4701784570296|APOE|0
355|regulation of short-term neuronal synaptic plasticity (GO:0048172)|1/11|0.0557490891026063|0.801373525889013|0|0|17.4825174825175|50.4701784570296|SYNGR1|0
356|regulation of symbiosis, encompassing mutualism through parasitism (GO:0043903)|1/11|0.0557490891026063|0.799122476658988|0|0|17.4825174825175|50.4701784570296|CAV1|0
357|positive regulation of glycoprotein biosynthetic process (GO:0010560)|1/11|0.0557490891026063|0.796884038349019|0|0|17.4825174825175|50.4701784570296|IGF1|0
358|regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587)|1/11|0.0557490891026063|0.794658105281005|0|0|17.4825174825175|50.4701784570296|HMOX1|0
359|alcohol catabolic process (GO:0046164)|1/11|0.0557490891026063|0.792444572954317|0|0|17.4825174825175|50.4701784570296|APOE|0
360|negative regulation of receptor binding (GO:1900121)|1/11|0.0557490891026063|0.790243338029444|0|0|17.4825174825175|50.4701784570296|B2M|0
361|positive regulation of epithelial cell migration (GO:0010634)|2/75|0.0581640366818659|0.822191355090199|0|0|5.12820512820513|14.587118162402|ANXA3;CTSH|0
362|positive regulation of defense response (GO:0031349)|2/75|0.0581640366818659|0.819920108252933|0|0|5.12820512820513|14.587118162402|LPL;CYBA|0
363|antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)|2/76|0.059538877067809|0.836988676796224|0|0|5.06072874493927|14.2769523466762|CYBA;B2M|0
364|regulation of retrograde protein transport, ER to cytosol (GO:1904152)|1/12|0.0606618849615518|0.850432964172524|0|0|16.025641025641|44.9108926762009|BCAP31|0
365|negative regulation of ATPase activity (GO:0032780)|1/12|0.0606618849615518|0.848103010846024|0|0|16.025641025641|44.9108926762009|ATPIF1|0
366|positive regulation of peptidase activity (GO:0010952)|1/12|0.0606618849615518|0.845785789504915|0|0|16.025641025641|44.9108926762009|CTSH|0
367|regulation of protein import into nucleus, translocation (GO:0033158)|1/12|0.0606618849615518|0.843481196073021|0|0|16.025641025641|44.9108926762009|IGF1|0
368|regulation of sequestering of triglyceride (GO:0010889)|1/12|0.0606618849615518|0.841189127605431|0|0|16.025641025641|44.9108926762009|LPL|0
369|negative regulation of epithelial cell differentiation (GO:0030857)|1/12|0.0606618849615518|0.838909482273167|0|0|16.025641025641|44.9108926762009|CAV1|0
370|regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165)|1/12|0.0606618849615518|0.836642159348105|0|0|16.025641025641|44.9108926762009|CD74|0
371|regulation of long-term neuronal synaptic plasticity (GO:0048169)|1/12|0.0606618849615518|0.834387059188137|0|0|16.025641025641|44.9108926762009|SYNGR1|0
372|phospholipid efflux (GO:0033700)|1/12|0.0606618849615518|0.832144083222577|0|0|16.025641025641|44.9108926762009|APOE|0
373|negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)|1/12|0.0606618849615518|0.829913133937798|0|0|16.025641025641|44.9108926762009|CD74|0
374|positive regulation of keratinocyte differentiation (GO:0045618)|1/12|0.0606618849615518|0.827694114863098|0|0|16.025641025641|44.9108926762009|NME2|0
375|polyamine metabolic process (GO:0006595)|1/12|0.0606618849615518|0.825486930556797|0|0|16.025641025641|44.9108926762009|SAT1|0
376|regulation of cell communication by electrical coupling (GO:0010649)|1/12|0.0606618849615518|0.82329148659255|0|0|16.025641025641|44.9108926762009|CAV1|0
377|keratan sulfate catabolic process (GO:0042340)|1/12|0.0606618849615518|0.821107689545885|0|0|16.025641025641|44.9108926762009|HEXB|0
378|positive regulation of T cell cytokine production (GO:0002726)|1/12|0.0606618849615518|0.818935446980949|0|0|16.025641025641|44.9108926762009|B2M|0
379|negative regulation of extrinsic apoptotic signaling pathway (GO:2001237)|2/77|0.060924916430042|0.820316223067293|0|0|4.995004995005|13.976588667121|HMOX1;IGF1|0
380|antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590)|2/79|0.0637299891037906|0.855826669464851|0|0|4.86854917234664|13.4036029241992|CYBA;B2M|0
381|positive regulation of protein phosphorylation (GO:0001934)|5/413|0.0644493091792514|0.863214763101628|0|0|2.32818029428199|6.38358229736139|CD74;GPNMB;CAV1;TREM2;IGF1|0
382|positive regulation of MAPK cascade (GO:0043410)|4/290|0.0647761233935687|0.86532083161618|0|0|2.6525198938992|7.25946474714289|CD74;GPNMB;TREM2;IGF1|0
383|negative regulation of reactive oxygen species biosynthetic process (GO:1903427)|1/13|0.0655493652791093|0.873363997439412|0|0|14.792899408284|40.3099371571447|CAV1|0
384|response to iron ion (GO:0010039)|1/13|0.0655493652791093|0.871089612029413|0|0|14.792899408284|40.3099371571447|B2M|0
385|protein localization to endoplasmic reticulum (GO:0070972)|1/13|0.0655493652791093|0.868827041608558|0|0|14.792899408284|40.3099371571447|BCAP31|0
386|cellular response to low-density lipoprotein particle stimulus (GO:0071404)|1/13|0.0655493652791093|0.866576194350504|0|0|14.792899408284|40.3099371571447|LPL|0
387|negative regulation of hemostasis (GO:1900047)|1/13|0.0655493652791093|0.864336979378022|0|0|14.792899408284|40.3099371571447|APOE|0
388|cellular response to exogenous dsRNA (GO:0071360)|1/13|0.0655493652791093|0.862109306750759|0|0|14.792899408284|40.3099371571447|CAV1|0
389|renal absorption (GO:0070293)|1/13|0.0655493652791093|0.8598930874532|0|0|14.792899408284|40.3099371571447|GSN|0
390|steroid catabolic process (GO:0006706)|1/13|0.0655493652791093|0.857688233382807|0|0|14.792899408284|40.3099371571447|SPP1|0
391|regulation of T cell cytokine production (GO:0002724)|1/13|0.0655493652791093|0.855494657338349|0|0|14.792899408284|40.3099371571447|B2M|0
392|chondroitin sulfate catabolic process (GO:0030207)|1/13|0.0655493652791093|0.853312273008405|0|0|14.792899408284|40.3099371571447|HEXB|0
393|positive regulation of glycogen biosynthetic process (GO:0045725)|1/13|0.0655493652791093|0.851140994960037|0|0|14.792899408284|40.3099371571447|IGF1|0
394|positive regulation of cholesterol efflux (GO:0010875)|1/13|0.0655493652791093|0.848980738627651|0|0|14.792899408284|40.3099371571447|APOE|0
395|positive regulation of actin nucleation (GO:0051127)|1/13|0.0655493652791093|0.846831420302012|0|0|14.792899408284|40.3099371571447|GSN|0
396|regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645)|1/13|0.0655493652791093|0.844692957119431|0|0|14.792899408284|40.3099371571447|CD84|0
397|regulation of macrophage differentiation (GO:0045649)|1/13|0.0655493652791093|0.84256526705112|0|0|14.792899408284|40.3099371571447|C1QC|0
398|regulation of leukocyte migration (GO:0002685)|1/13|0.0655493652791093|0.8404482688927|0|0|14.792899408284|40.3099371571447|HMOX1|0
399|response to UV-B (GO:0010224)|1/13|0.0655493652791093|0.838341882253871|0|0|14.792899408284|40.3099371571447|CRIP1|0
400|high-density lipoprotein particle assembly (GO:0034380)|1/13|0.0655493652791093|0.836246027548237|0|0|14.792899408284|40.3099371571447|APOE|0
401|amyloid precursor protein metabolic process (GO:0042982)|1/13|0.0655493652791093|0.834160625983278|0|0|14.792899408284|40.3099371571447|APOE|0
402|tetrahydrofolate metabolic process (GO:0046653)|1/13|0.0655493652791093|0.832085599550484|0|0|14.792899408284|40.3099371571447|ATPIF1|0
403|leukocyte differentiation (GO:0002521)|1/13|0.0655493652791093|0.830020871015619|0|0|14.792899408284|40.3099371571447|TREM2|0
404|regulation of hydrolase activity (GO:0051336)|2/81|0.0665780610565628|0.840960013791188|0|0|4.74833808167141|12.8650530354676|CAV1;ATPIF1|0
405|negative regulation of MAPK cascade (GO:0043409)|2/81|0.0665780610565628|0.838883569312691|0|0|4.74833808167141|12.8650530354676|CAV1;APOE|0
406|protein catabolic process (GO:0030163)|2/82|0.0680178541248241|0.854914063051669|0|0|4.69043151969981|12.6078097917911|APOE;CTSD|0
407|negative regulation of cell death (GO:0060548)|2/82|0.0680178541248241|0.852813537098225|0|0|4.69043151969981|12.6078097917911|GPNMB;APOE|0
408|regulation of anatomical structure morphogenesis (GO:0022603)|2/83|0.0694679582579952|0.868860272035661|0|0|4.6339202965709|12.358154147259|GPNMB;HMOX1|0
409|regulation of fatty acid metabolic process (GO:0019217)|1/14|0.0704116591696319|0.87851026098443|0|0|13.7362637362637|36.447752971504|CAV1|0
410|epiboly involved in wound healing (GO:0090505)|1/14|0.0704116591696319|0.876367553030809|0|0|13.7362637362637|36.447752971504|PDPN|0
411|regulation of lipase activity (GO:0060191)|1/14|0.0704116591696319|0.874235271879883|0|0|13.7362637362637|36.447752971504|LPL|0
412|positive regulation of vascular smooth muscle cell proliferation (GO:1904707)|1/14|0.0704116591696319|0.87211334160833|0|0|13.7362637362637|36.447752971504|IGF1|0
413|fatty acid transport (GO:0015908)|1/14|0.0704116591696319|0.870001687028164|0|0|13.7362637362637|36.447752971504|APOE|0
414|myotube cell development (GO:0014904)|1/14|0.0704116591696319|0.867900233677855|0|0|13.7362637362637|36.447752971504|IGF1|0
415|regulation of platelet aggregation (GO:0090330)|1/14|0.0704116591696319|0.865808907813571|0|0|13.7362637362637|36.447752971504|PDPN|0
416|positive regulation of response to cytokine stimulus (GO:0060760)|1/14|0.0704116591696319|0.863727636400557|0|0|13.7362637362637|36.447752971504|CD74|0
417|regulation of extracellular matrix disassembly (GO:0010715)|1/14|0.0704116591696319|0.861656347104633|0|0|13.7362637362637|36.447752971504|PDPN|0
418|regulation of calcineurin-NFAT signaling cascade (GO:0070884)|1/14|0.0704116591696319|0.859594968283808|0|0|13.7362637362637|36.447752971504|IGF1|0
419|regulation of monocyte differentiation (GO:0045655)|1/14|0.0704116591696319|0.857543428980028|0|0|13.7362637362637|36.447752971504|CD74|0
420|nucleoside triphosphate metabolic process (GO:0009141)|1/14|0.0704116591696319|0.855501658911028|0|0|13.7362637362637|36.447752971504|NME2|0
421|negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254)|1/14|0.0704116591696319|0.853469588462308|0|0|13.7362637362637|36.447752971504|CD74|0
422|positive regulation of muscle hypertrophy (GO:0014742)|1/14|0.0704116591696319|0.851447148679222|0|0|13.7362637362637|36.447752971504|IGF1|0
423|negative regulation of secretion (GO:0051048)|1/14|0.0704116591696319|0.849434271259177|0|0|13.7362637362637|36.447752971504|CD74|0
424|negative regulation of biomineral tissue development (GO:0070168)|1/14|0.0704116591696319|0.847430888543943|0|0|13.7362637362637|36.447752971504|ECM1|0
425|negative regulation of cation transmembrane transport (GO:1904063)|1/14|0.0704116591696319|0.845436933512075|0|0|13.7362637362637|36.447752971504|CAV1|0
426|positive regulation of glycogen metabolic process (GO:0070875)|1/14|0.0704116591696319|0.843452339771436|0|0|13.7362637362637|36.447752971504|IGF1|0
427|positive regulation of blood vessel diameter (GO:0097755)|1/14|0.0704116591696319|0.841477041551831|0|0|13.7362637362637|36.447752971504|HMOX1|0
428|positive regulation of homeostatic process (GO:0032846)|2/84|0.0709282297124001|0.845669991173779|0|0|4.57875457875458|12.1157818787293|CAV1;SPP1|0
429|myotube differentiation (GO:0014902)|1/15|0.0752488951179903|0.895093500669241|0|0|12.8205128205128|33.1660776702353|IGF1|0
430|regulation of mast cell degranulation (GO:0043304)|1/15|0.0752488951179903|0.893011887876987|0|0|12.8205128205128|33.1660776702353|CD84|0
431|vitamin D metabolic process (GO:0042359)|1/15|0.0752488951179903|0.890939934540846|0|0|12.8205128205128|33.1660776702353|LGMN|0
432|positive regulation of membrane protein ectodomain proteolysis (GO:0051044)|1/15|0.0752488951179903|0.88887757358126|0|0|12.8205128205128|33.1660776702353|APOE|0
433|regulation of protein homooligomerization (GO:0032462)|1/15|0.0752488951179903|0.886824738538347|0|0|12.8205128205128|33.1660776702353|APOE|0
434|negative regulation of signal transduction by p53 class mediator (GO:1901797)|1/15|0.0752488951179903|0.884781363564757|0|0|12.8205128205128|33.1660776702353|CD74|0
435|positive regulation of vasoconstriction (GO:0045907)|1/15|0.0752488951179903|0.882747383418631|0|0|12.8205128205128|33.1660776702353|CAV1|0
436|positive regulation of cellular response to insulin stimulus (GO:1900078)|1/15|0.0752488951179903|0.880722733456662|0|0|12.8205128205128|33.1660776702353|IGF1|0
437|positive regulation of glycolytic process (GO:0045821)|1/15|0.0752488951179903|0.878707349627241|0|0|12.8205128205128|33.1660776702353|IGF1|0
438|negative regulation of platelet activation (GO:0010544)|1/15|0.0752488951179903|0.876701168463709|0|0|12.8205128205128|33.1660776702353|APOE|0
439|positive regulation of small GTPase mediated signal transduction (GO:0051057)|1/15|0.0752488951179903|0.874704127077687|0|0|12.8205128205128|33.1660776702353|IGF1|0
440|positive regulation of coenzyme metabolic process (GO:0051197)|1/15|0.0752488951179903|0.87271616315251|0|0|12.8205128205128|33.1660776702353|IGF1|0
441|positive regulation of cytokine production involved in immune response (GO:0002720)|1/15|0.0752488951179903|0.870737214936745|0|0|12.8205128205128|33.1660776702353|B2M|0
442|regulation of establishment of cell polarity (GO:2000114)|1/15|0.0752488951179903|0.868767221237793|0|0|12.8205128205128|33.1660776702353|GSN|0
443|negative regulation of coagulation (GO:0050819)|1/15|0.0752488951179903|0.866806121415586|0|0|12.8205128205128|33.1660776702353|APOE|0
444|positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001269)|1/15|0.0752488951179903|0.864853855376361|0|0|12.8205128205128|33.1660776702353|GSN|0
445|regulation of peptide secretion (GO:0002791)|1/15|0.0752488951179903|0.862910363566527|0|0|12.8205128205128|33.1660776702353|CD74|0
446|negative regulation of anoikis (GO:2000811)|1/15|0.0752488951179903|0.860975586966602|0|0|12.8205128205128|33.1660776702353|CAV1|0
447|nitric oxide mediated signal transduction (GO:0007263)|1/15|0.0752488951179903|0.859049467085245|0|0|12.8205128205128|33.1660776702353|APOE|0
448|negative regulation of release of cytochrome c from mitochondria (GO:0090201)|1/15|0.0752488951179903|0.857131945953358|0|0|12.8205128205128|33.1660776702353|IGF1|0
449|cellular biogenic amine biosynthetic process (GO:0042401)|1/15|0.0752488951179903|0.855222966118273|0|0|12.8205128205128|33.1660776702353|SAT1|0
450|organic substance transport (GO:0071702)|2/88|0.07686815547514|0.871684883088088|0|0|4.37062937062937|11.2135646472421|CAV1;PSAP|0
451|regulation of protein targeting to mitochondrion (GO:1903214)|2/89|0.0783771488070497|0.886826142710365|0|0|4.32152117545376|11.0035560216467|CTSK;ATPIF1|0
452|negative regulation of cellular protein metabolic process (GO:0032269)|2/90|0.079895471726147|0.902005734996744|0|0|4.27350427350427|10.7992995815468|CSTB;APOE|0
453|regulation of neuron apoptotic process (GO:0043523)|2/90|0.079895471726147|0.900014552358782|0|0|4.27350427350427|10.7992995815468|APOE;LGMN|0
454|positive regulation of epithelial cell apoptotic process (GO:1904037)|1/16|0.0800612009686615|0.899894952738061|0|0|12.0192307692308|30.3481240946225|GSN|0
455|regulation of actin nucleation (GO:0051125)|1/16|0.0800612009686615|0.897917161633142|0|0|12.0192307692308|30.3481240946225|GSN|0
456|postsynaptic membrane organization (GO:0001941)|1/16|0.0800612009686615|0.895948045050614|0|0|12.0192307692308|30.3481240946225|APOE|0
457|regulation of steroid metabolic process (GO:0019218)|1/16|0.0800612009686615|0.893987546046126|0|0|12.0192307692308|30.3481240946225|APOE|0
458|C21-steroid hormone biosynthetic process (GO:0006700)|1/16|0.0800612009686615|0.892035608172663|0|0|12.0192307692308|30.3481240946225|TSPO|0
459|positive regulation of secretion (GO:0051047)|1/16|0.0800612009686615|0.890092175475119|0|0|12.0192307692308|30.3481240946225|SPP1|0
460|positive regulation of cardiac muscle tissue growth (GO:0055023)|1/16|0.0800612009686615|0.888157192484956|0|0|12.0192307692308|30.3481240946225|IGF1|0
461|cellular response to dsRNA (GO:0071359)|1/16|0.0800612009686615|0.886230604214924|0|0|12.0192307692308|30.3481240946225|CAV1|0
462|positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050)|1/16|0.0800612009686615|0.884312356153852|0|0|12.0192307692308|30.3481240946225|HMOX1|0
463|phosphatidylinositol acyl-chain remodeling (GO:0036149)|1/16|0.0800612009686615|0.882402394261511|0|0|12.0192307692308|30.3481240946225|PLA2G16|0
464|hyaluronan catabolic process (GO:0030214)|1/16|0.0800612009686615|0.880500664963534|0|0|12.0192307692308|30.3481240946225|HEXB|0
465|regulation of reactive oxygen species biosynthetic process (GO:1903426)|1/16|0.0800612009686615|0.878607115146408|0|0|12.0192307692308|30.3481240946225|CYBA|0
466|negative regulation of steroid biosynthetic process (GO:0010894)|1/16|0.0800612009686615|0.876721692152532|0|0|12.0192307692308|30.3481240946225|APOE|0
467|positive regulation of cardiac muscle hypertrophy (GO:0010613)|1/16|0.0800612009686615|0.874844343775331|0|0|12.0192307692308|30.3481240946225|IGF1|0
468|regulation of membrane repolarization (GO:0060306)|1/16|0.0800612009686615|0.872975018254444|0|0|12.0192307692308|30.3481240946225|CAV1|0
469|glutamine family amino acid catabolic process (GO:0009065)|1/16|0.0800612009686615|0.871113664270959|0|0|12.0192307692308|30.3481240946225|ARG1|0
470|myoblast differentiation (GO:0045445)|1/16|0.0800612009686615|0.869260230942723|0|0|12.0192307692308|30.3481240946225|IGF1|0
471|positive regulation of response to external stimulus (GO:0032103)|2/91|0.0814229886430396|0.882168813259938|0|0|4.22654268808115|10.6005816994223|LPL;CYBA|0
472|protein tetramerization (GO:0051262)|2/91|0.0814229886430396|0.88029981153693|0|0|4.22654268808115|10.6005816994223|CD74;ATPIF1|0
473|regulation of cell migration (GO:0030334)|4/317|0.0835584663328173|0.901477491958492|0|0|2.4265954865324|6.02331641966828|GPNMB;PDPN;CTSH;IGF1|0
474|positive regulation of cellular metabolic process (GO:0031325)|2/93|0.0845050678078527|0.909766584437706|0|0|4.13564929693962|10.2189568749378|CD63;APOE|0
475|positive regulation of protein processing (GO:0010954)|1/17|0.0848487039018828|0.911543023181701|0|0|11.3122171945701|27.9059452781436|GSN|0
476|high-density lipoprotein particle remodeling (GO:0034375)|1/17|0.0848487039018828|0.909628016830479|0|0|11.3122171945701|27.9059452781436|APOE|0
477|positive regulation of cholesterol transport (GO:0032376)|1/17|0.0848487039018828|0.907721039855991|0|0|11.3122171945701|27.9059452781436|APOE|0
478|regulation of tissue remodeling (GO:0034103)|1/17|0.0848487039018828|0.905822041864661|0|0|11.3122171945701|27.9059452781436|GPNMB|0
479|reverse cholesterol transport (GO:0043691)|1/17|0.0848487039018828|0.903930972883733|0|0|11.3122171945701|27.9059452781436|APOE|0
480|regulation of protein localization to membrane (GO:1905475)|1/17|0.0848487039018828|0.902047783356892|0|0|11.3122171945701|27.9059452781436|GSN|0
481|response to interferon-alpha (GO:0035455)|1/17|0.0848487039018828|0.900172424139933|0|0|11.3122171945701|27.9059452781436|IFITM2|0
482|regulation of insulin-like growth factor receptor signaling pathway (GO:0043567)|1/17|0.0848487039018828|0.898304846496489|0|0|11.3122171945701|27.9059452781436|IGF1|0
483|positive regulation of epidermal cell differentiation (GO:0045606)|1/17|0.0848487039018828|0.896445002093805|0|0|11.3122171945701|27.9059452781436|NME2|0
484|long-term memory (GO:0007616)|1/17|0.0848487039018828|0.89459284299857|0|0|11.3122171945701|27.9059452781436|APOE|0
485|virion assembly (GO:0019068)|1/17|0.0848487039018828|0.8927483216728|0|0|11.3122171945701|27.9059452781436|APOE|0
486|positive regulation of response to biotic stimulus (GO:0002833)|1/17|0.0848487039018828|0.890911390969769|0|0|11.3122171945701|27.9059452781436|CYBA|0
487|regulation of lamellipodium organization (GO:1902743)|1/17|0.0848487039018828|0.889082004129996|0|0|11.3122171945701|27.9059452781436|PDPN|0
488|positive chemotaxis (GO:0050918)|1/17|0.0848487039018828|0.88726011477727|0|0|11.3122171945701|27.9059452781436|GPNMB|0
489|positive regulation of cation transmembrane transport (GO:1904064)|1/17|0.0848487039018828|0.88544567691474|0|0|11.3122171945701|27.9059452781436|CTSS|0
490|negative regulation of intracellular transport (GO:0032387)|1/17|0.0848487039018828|0.883638644921037|0|0|11.3122171945701|27.9059452781436|CD84|0
491|cellular transition metal ion homeostasis (GO:0046916)|2/94|0.0860593645280113|0.89442146066485|0|0|4.09165302782324|10.0356707678251|FTH1;HMOX1|0
492|positive regulation of ERK1 and ERK2 cascade (GO:0070374)|3/202|0.0883849451287423|0.916724339414577|0|0|2.85605483625286|6.92894219673099|CD74;GPNMB;TREM2|0
493|positive regulation of multicellular organismal process (GO:0051240)|3/203|0.0893871086781505|0.925238165486008|0|0|2.84198560060629|6.86276659368476|PDPN;NME2;CTSH|0
494|regulation of multicellular organism growth (GO:0040014)|1/18|0.0896115305088418|0.925683482159149|0|0|10.6837606837607|25.7721290445105|IGF1|0
495|regulation of cholesterol efflux (GO:0010874)|1/18|0.0896115305088418|0.923813414518423|0|0|10.6837606837607|25.7721290445105|APOE|0
496|regulation of amyloid-beta formation (GO:1902003)|1/18|0.0896115305088418|0.921950887473023|0|0|10.6837606837607|25.7721290445105|APOE|0
497|negative regulation of peptidyl-serine phosphorylation (GO:0033137)|1/18|0.0896115305088418|0.920095855506277|0|0|10.6837606837607|25.7721290445105|CAV1|0
498|response to nutrient levels (GO:0031667)|1/18|0.0896115305088418|0.918248273467108|0|0|10.6837606837607|25.7721290445105|IGF1|0
499|actin filament polymerization (GO:0030041)|1/18|0.0896115305088418|0.916408096566372|0|0|10.6837606837607|25.7721290445105|GSN|0
500|negative regulation of osteoclast differentiation (GO:0045671)|1/18|0.0896115305088418|0.914575280373239|0|0|10.6837606837607|25.7721290445105|MAFB|0
501|calcium-mediated signaling using intracellular calcium source (GO:0035584)|1/18|0.0896115305088418|0.912749780811616|0|0|10.6837606837607|25.7721290445105|BCAP31|0
502|endoplasmic reticulum calcium ion homeostasis (GO:0032469)|1/18|0.0896115305088418|0.910931554156613|0|0|10.6837606837607|25.7721290445105|BCAP31|0
503|positive regulation of cyclic nucleotide biosynthetic process (GO:0030804)|1/18|0.0896115305088418|0.909120557031053|0|0|10.6837606837607|25.7721290445105|APOE|0
504|negative regulation of fibroblast proliferation (GO:0048147)|1/18|0.0896115305088418|0.907316746402023|0|0|10.6837606837607|25.7721290445105|FTH1|0
505|regulation of epithelial cell differentiation (GO:0030856)|1/18|0.0896115305088418|0.905520079577465|0|0|10.6837606837607|25.7721290445105|CAV1|0
506|positive regulation of carbohydrate metabolic process (GO:0045913)|1/18|0.0896115305088418|0.903730514202806|0|0|10.6837606837607|25.7721290445105|IGF1|0
507|regulation of smooth muscle cell migration (GO:0014910)|1/18|0.0896115305088418|0.901948008257632|0|0|10.6837606837607|25.7721290445105|IGF1|0
508|anion homeostasis (GO:0055081)|1/18|0.0896115305088418|0.900172520052401|0|0|10.6837606837607|25.7721290445105|APOE|0
509|regulation of autophagy (GO:0010506)|3/204|0.090394080321556|0.906249492889784|0|0|2.82805429864253|6.79744484416502|CTSK;PSAP;LAMTOR4|0
510|primary alcohol metabolic process (GO:0034308)|1/19|0.0943498067238512|0.944053066101593|0|0|10.1214574898785|23.8941908468777|IGF1|0
511|negative regulation of lymphocyte activation (GO:0051250)|1/19|0.0943498067238512|0.942205604132705|0|0|10.1214574898785|23.8941908468777|GPNMB|0
512|regulation of sprouting angiogenesis (GO:1903670)|1/19|0.0943498067238512|0.940365358812134|0|0|10.1214574898785|23.8941908468777|S100A1|0
513|regulation of platelet activation (GO:0010543)|1/19|0.0943498067238512|0.938532287937256|0|0|10.1214574898785|23.8941908468777|APOE|0
514|regulation of long-term synaptic potentiation (GO:1900271)|1/19|0.0943498067238512|0.936706349633876|0|0|10.1214574898785|23.8941908468777|APOE|0
515|positive regulation of activated T cell proliferation (GO:0042104)|1/19|0.0943498067238512|0.934887502353034|0|0|10.1214574898785|23.8941908468777|IGF1|0
516|acylglycerol biosynthetic process (GO:0046463)|1/19|0.0943498067238512|0.933075704867854|0|0|10.1214574898785|23.8941908468777|LPL|0
517|protein heterotetramerization (GO:0051290)|1/19|0.0943498067238512|0.93127091627043|0|0|10.1214574898785|23.8941908468777|CD74|0
518|mitochondrial calcium ion homeostasis (GO:0051560)|1/19|0.0943498067238512|0.92947309596875|0|0|10.1214574898785|23.8941908468777|BCAP31|0
519|positive regulation of transcription regulatory region DNA binding (GO:2000679)|1/19|0.0943498067238512|0.927682203683646|0|0|10.1214574898785|23.8941908468777|IGF1|0
520|triglyceride biosynthetic process (GO:0019432)|1/19|0.0943498067238512|0.925898199445793|0|0|10.1214574898785|23.8941908468777|LPL|0
521|response to interferon-beta (GO:0035456)|1/19|0.0943498067238512|0.92412104359273|0|0|10.1214574898785|23.8941908468777|IFITM2|0
522|positive regulation of phosphorylation (GO:0042327)|3/209|0.0955001272015326|0.933596071090844|0|0|2.7603974972396|6.48314602376643|CD74;GPNMB;IGF1|0
523|steroid metabolic process (GO:0008202)|2/100|0.0955625544444408|0.932420105793464|0|0|3.84615384615385|9.03067009833469|TSPO;LGMN|0
524|glycosaminoglycan biosynthetic process (GO:0006024)|2/100|0.0955625544444408|0.930640678110652|0|0|3.84615384615385|9.03067009833469|B4GALT1;SDC3|0
525|regulation of lipid metabolic process (GO:0019216)|2/101|0.0971747997119183|0.944539053199846|0|0|3.80807311500381|8.87754708055243|CAV1;PSAP|0
526|proteoglycan metabolic process (GO:0006029)|1/20|0.0990636578243203|0.961068148056096|0|0|9.61538461538462|22.2306983380996|IGF1|0
527|positive regulation of dendritic spine development (GO:0060999)|1/20|0.0990636578243203|0.959244489331131|0|0|9.61538461538462|22.2306983380996|APOE|0
528|wound healing, spreading of cells (GO:0044319)|1/20|0.0990636578243203|0.957427738404368|0|0|9.61538461538462|22.2306983380996|PDPN|0
529|regulation of lipoprotein lipase activity (GO:0051004)|1/20|0.0990636578243203|0.955617856101146|0|0|9.61538461538462|22.2306983380996|LPL|0
530|inactivation of MAPK activity (GO:0000188)|1/20|0.0990636578243203|0.953814803542465|0|0|9.61538461538462|22.2306983380996|CAV1|0
531|response to progesterone (GO:0032570)|1/20|0.0990636578243203|0.952018542142196|0|0|9.61538461538462|22.2306983380996|CAV1|0
532|androgen metabolic process (GO:0008209)|1/20|0.0990636578243203|0.950229033604335|0|0|9.61538461538462|22.2306983380996|SPP1|0
533|regulation of anoikis (GO:2000209)|1/20|0.0990636578243203|0.948446239920274|0|0|9.61538461538462|22.2306983380996|CAV1|0
534|striated muscle cell development (GO:0055002)|1/20|0.0990636578243203|0.946670123366117|0|0|9.61538461538462|22.2306983380996|IGF1|0
535|regulation of glycogen biosynthetic process (GO:0005979)|1/20|0.0990636578243203|0.944900646500012|0|0|9.61538461538462|22.2306983380996|IGF1|0
536|hyaluronan metabolic process (GO:0030212)|1/21|0.103753208511938|0.987784744470931|0|0|9.15750915750916|20.7485365836377|HEXB|0
537|negative regulation of protein tyrosine kinase activity (GO:0061099)|1/21|0.103753208511938|0.985945294295008|0|0|9.15750915750916|20.7485365836377|CAV1|0
538|positive regulation of cellular component movement (GO:0051272)|1/21|0.103753208511938|0.984112682223827|0|0|9.15750915750916|20.7485365836377|PDPN|0
539|dendritic cell differentiation (GO:0097028)|1/21|0.103753208511938|0.982286870197438|0|0|9.15750915750916|20.7485365836377|TREM2|0
540|response to nicotine (GO:0035094)|1/21|0.103753208511938|0.980467820437813|0|0|9.15750915750916|20.7485365836377|HMOX1|0
541|regulation of ruffle assembly (GO:1900027)|1/21|0.103753208511938|0.978655495446246|0|0|9.15750915750916|20.7485365836377|CAV1|0
542|positive regulation of T cell mediated immunity (GO:0002711)|1/21|0.103753208511938|0.976849858000773|0|0|9.15750915750916|20.7485365836377|B2M|0
543|positive regulation of lipid metabolic process (GO:0045834)|1/21|0.103753208511938|0.975050871153626|0|0|9.15750915750916|20.7485365836377|APOE|0
544|regulation of cardiac muscle hypertrophy (GO:0010611)|1/21|0.103753208511938|0.973258498228711|0|0|9.15750915750916|20.7485365836377|IGF1|0
545|lipid catabolic process (GO:0016042)|1/21|0.103753208511938|0.971472702819117|0|0|9.15750915750916|20.7485365836377|PLA2G16|0
546|positive regulation of receptor internalization (GO:0002092)|1/21|0.103753208511938|0.96969344878465|0|0|9.15750915750916|20.7485365836377|CD63|0
547|phosphatidylserine acyl-chain remodeling (GO:0036150)|1/21|0.103753208511938|0.967920700249395|0|0|9.15750915750916|20.7485365836377|PLA2G16|0
548|regulation of macrophage activation (GO:0043030)|1/21|0.103753208511938|0.966154421599305|0|0|9.15750915750916|20.7485365836377|CD74|0
549|positive regulation of cellular component organization (GO:0051130)|2/107|0.107007309099274|0.994641709168661|0|0|3.59453630481668|8.03327871140977|CD63;APOE|0
550|positive regulation of cellular catabolic process (GO:0031331)|2/107|0.107007309099274|0.992833269697445|0|0|3.59453630481668|8.03327871140977|APOE;IGF1|0
551|positive regulation of gene expression (GO:0010628)|7/772|0.107502326414558|0.995615919588913|0|0|1.74372259864488|3.88892475440426|RBM3;CD74;GSN;FN1;SPP1;CTSH;IGF1|0
552|regulation of calcium ion transport into cytosol (GO:0010522)|1/22|0.108418582791051|1|0|0|8.74125874125874|19.4209421040818|CAV1|0
553|regulation of interferon-gamma-mediated signaling pathway (GO:0060334)|1/22|0.108418582791051|1|0|0|8.74125874125874|19.4209421040818|ARG1|0
554|positive regulation of protein autophosphorylation (GO:0031954)|1/22|0.108418582791051|0.998664310438147|0|0|8.74125874125874|19.4209421040818|GPNMB|0
555|beta-catenin destruction complex disassembly (GO:1904886)|1/22|0.108418582791051|0.996864915284204|0|0|8.74125874125874|19.4209421040818|CAV1|0
556|glutathione derivative biosynthetic process (GO:1901687)|1/22|0.108418582791051|0.9950719927747|0|0|8.74125874125874|19.4209421040818|ESD|0
557|C21-steroid hormone metabolic process (GO:0008207)|1/22|0.108418582791051|0.993285508047995|0|0|8.74125874125874|19.4209421040818|TSPO|0
558|positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052)|1/22|0.108418582791051|0.991505426492354|0|0|8.74125874125874|19.4209421040818|ATPIF1|0
559|negative regulation of cell cycle G1/S phase transition (GO:1902807)|1/22|0.108418582791051|0.989731713743709|0|0|8.74125874125874|19.4209421040818|GPNMB|0
560|regulation of transcription from RNA polymerase III promoter (GO:0006359)|1/22|0.108418582791051|0.987964335683452|0|0|8.74125874125874|19.4209421040818|PRDX5|0
561|regulation of bone resorption (GO:0045124)|1/22|0.108418582791051|0.986203258436245|0|0|8.74125874125874|19.4209421040818|SPP1|0
562|negative regulation of myeloid cell differentiation (GO:0045638)|1/22|0.108418582791051|0.984448448367853|0|0|8.74125874125874|19.4209421040818|MAFB|0
563|negative regulation of actin filament polymerization (GO:0030837)|1/22|0.108418582791051|0.982699872083008|0|0|8.74125874125874|19.4209421040818|GSN|0
564|glutathione derivative metabolic process (GO:1901685)|1/22|0.108418582791051|0.980957496423286|0|0|8.74125874125874|19.4209421040818|ESD|0
565|positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280)|2/110|0.11202042902595|1|0|0|3.4965034965035|7.65410497308691|BCAP31;GSN|0
566|positive regulation of ATP metabolic process (GO:1903580)|1/23|0.113059904110392|1|0|0|8.36120401337793|18.2260658517192|IGF1|0
567|regulation of protein oligomerization (GO:0032459)|1/23|0.113059904110392|1|0|0|8.36120401337793|18.2260658517192|APOE|0
568|cholesterol efflux (GO:0033344)|1/23|0.113059904110392|1|0|0|8.36120401337793|18.2260658517192|APOE|0
569|regulation of smooth muscle contraction (GO:0006940)|1/23|0.113059904110392|1|0|0|8.36120401337793|18.2260658517192|CAV1|0
570|positive regulation of blood circulation (GO:1903524)|1/23|0.113059904110392|1|0|0|8.36120401337793|18.2260658517192|CAV1|0
571|glycolytic process (GO:0006096)|1/23|0.113059904110392|1|0|0|8.36120401337793|18.2260658517192|PGAM1|0
572|folic acid-containing compound metabolic process (GO:0006760)|1/23|0.113059904110392|1|0|0|8.36120401337793|18.2260658517192|ATPIF1|0
573|regulation of proteolysis involved in cellular protein catabolic process (GO:1903050)|1/23|0.113059904110392|1|0|0|8.36120401337793|18.2260658517192|ATPIF1|0
574|response to alkaloid (GO:0043279)|1/23|0.113059904110392|1|0|0|8.36120401337793|18.2260658517192|HMOX1|0
575|divalent inorganic cation homeostasis (GO:0072507)|1/23|0.113059904110392|1|0|0|8.36120401337793|18.2260658517192|CAV1|0
576|regulation of monooxygenase activity (GO:0032768)|1/23|0.113059904110392|1|0|0|8.36120401337793|18.2260658517192|CAV1|0
577|metanephros development (GO:0001656)|1/23|0.113059904110392|0.999904143284803|0|0|8.36120401337793|18.2260658517192|CTSH|0
578|cellular response to amyloid-beta (GO:1904646)|1/23|0.113059904110392|0.998174205320643|0|0|8.36120401337793|18.2260658517192|IGF1|0
579|regulation of cell size (GO:0008361)|1/23|0.113059904110392|0.996450242962576|0|0|8.36120401337793|18.2260658517192|LAMTOR4|0
580|positive regulation of cell junction assembly (GO:1901890)|1/23|0.113059904110392|0.994732225302296|0|0|8.36120401337793|18.2260658517192|CAV1|0
581|peroxisome organization (GO:0007031)|1/23|0.113059904110392|0.993020121644288|0|0|8.36120401337793|18.2260658517192|PLA2G16|0
582|negative regulation of cytokine production (GO:0001818)|2/111|0.113705041953818|0.996970496718788|0|0|3.46500346500347|7.5334287416773|CD84;GPNMB|0
583|cellular response to peptide hormone stimulus (GO:0071375)|2/111|0.113705041953818|0.995260427256148|0|0|3.46500346500347|7.5334287416773|CAV1;GNG12|0
584|regulation of protein binding (GO:0043393)|2/112|0.115396251551688|1|0|0|3.43406593406593|7.41546499882133|CAV1;B2M|0
585|negative regulation of cell proliferation (GO:0008285)|4/364|0.121826197965051|1|0|0|2.11327134404058|4.44877400002079|GPNMB;FTH1;PDPN;HMOX1|0
586|positive regulation of neutrophil chemotaxis (GO:0090023)|1/25|0.12227087840991|1|0|0|7.69230769230769|16.1655106205387|CD74|0
587|positive regulation of purine nucleotide biosynthetic process (GO:1900373)|1/25|0.12227087840991|1|0|0|7.69230769230769|16.1655106205387|APOE|0
588|negative regulation of G1/S transition of mitotic cell cycle (GO:2000134)|1/25|0.12227087840991|1|0|0|7.69230769230769|16.1655106205387|GPNMB|0
589|cellular modified amino acid biosynthetic process (GO:0042398)|1/25|0.12227087840991|1|0|0|7.69230769230769|16.1655106205387|ATPIF1|0
590|ATP generation from ADP (GO:0006757)|1/25|0.12227087840991|1|0|0|7.69230769230769|16.1655106205387|PGAM1|0
591|receptor catabolic process (GO:0032801)|1/25|0.12227087840991|1|0|0|7.69230769230769|16.1655106205387|LGMN|0
592|mammary gland development (GO:0030879)|1/25|0.12227087840991|1|0|0|7.69230769230769|16.1655106205387|CAV1|0
593|regulation of cardiac muscle cell action potential (GO:0098901)|1/25|0.12227087840991|1|0|0|7.69230769230769|16.1655106205387|CAV1|0
594|proteoglycan biosynthetic process (GO:0030166)|1/25|0.12227087840991|1|0|0|7.69230769230769|16.1655106205387|IGF1|0
595|negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230)|1/25|0.12227087840991|1|0|0|7.69230769230769|16.1655106205387|CD74|0
596|glycolytic process through glucose-6-phosphate (GO:0061620)|1/26|0.126840775121276|1|0|0|7.39644970414201|15.2723573839838|PGAM1|0
597|negative regulation of wound healing (GO:0061045)|1/26|0.126840775121276|1|0|0|7.39644970414201|15.2723573839838|APOE|0
598|regulation of apoptotic signaling pathway (GO:2001233)|1/26|0.126840775121276|1|0|0|7.39644970414201|15.2723573839838|CTSH|0
599|canonical glycolysis (GO:0061621)|1/26|0.126840775121276|1|0|0|7.39644970414201|15.2723573839838|PGAM1|0
600|long-chain fatty acid transport (GO:0015909)|1/26|0.126840775121276|1|0|0|7.39644970414201|15.2723573839838|APOE|0
601|glucose catabolic process to pyruvate (GO:0061718)|1/26|0.126840775121276|1|0|0|7.39644970414201|15.2723573839838|PGAM1|0
602|respiratory tube development (GO:0030323)|1/26|0.126840775121276|1|0|0|7.39644970414201|15.2723573839838|PDPN|0
603|positive regulation of neutrophil migration (GO:1902624)|1/26|0.126840775121276|1|0|0|7.39644970414201|15.2723573839838|CD74|0
604|peptide catabolic process (GO:0043171)|1/26|0.126840775121276|1|0|0|7.39644970414201|15.2723573839838|CTSH|0
605|response to amyloid-beta (GO:1904645)|1/26|0.126840775121276|1|0|0|7.39644970414201|15.2723573839838|IGF1|0
606|positive regulation of nuclear division (GO:0051785)|1/26|0.126840775121276|1|0|0|7.39644970414201|15.2723573839838|IGF1|0
607|regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)|1/26|0.126840775121276|1|0|0|7.39644970414201|15.2723573839838|CD74|0
608|regulation of vascular smooth muscle cell proliferation (GO:1904705)|1/26|0.126840775121276|1|0|0|7.39644970414201|15.2723573839838|IGF1|0
609|positive regulation of embryonic development (GO:0040019)|1/26|0.126840775121276|1|0|0|7.39644970414201|15.2723573839838|IGF1|0
610|positive regulation of glucose transport (GO:0010828)|1/26|0.126840775121276|1|0|0|7.39644970414201|15.2723573839838|IGF1|0
611|positive regulation of B cell activation (GO:0050871)|2/120|0.129150121493712|1|0|0|3.20512820512821|6.56019172667586|CD74;IGKC|0
612|regulation of phosphorylation (GO:0042325)|2/120|0.129150121493712|1|0|0|3.20512820512821|6.56019172667586|PGAM1;FN1|0
613|positive regulation of glucose import (GO:0046326)|1/27|0.131387106346972|1|0|0|7.12250712250712|14.4558924712216|IGF1|0
614|regulation of cardiac muscle cell contraction (GO:0086004)|1/27|0.131387106346972|1|0|0|7.12250712250712|14.4558924712216|CAV1|0
615|regulation of muscle contraction (GO:0006937)|1/27|0.131387106346972|1|0|0|7.12250712250712|14.4558924712216|CAV1|0
616|regulation of transcription regulatory region DNA binding (GO:2000677)|1/27|0.131387106346972|1|0|0|7.12250712250712|14.4558924712216|IGF1|0
617|fat-soluble vitamin metabolic process (GO:0006775)|1/27|0.131387106346972|1|0|0|7.12250712250712|14.4558924712216|LGMN|0
618|phosphatidylethanolamine acyl-chain remodeling (GO:0036152)|1/27|0.131387106346972|1|0|0|7.12250712250712|14.4558924712216|PLA2G16|0
619|positive regulation of granulocyte chemotaxis (GO:0071624)|1/27|0.131387106346972|1|0|0|7.12250712250712|14.4558924712216|CD74|0
620|response to ketone (GO:1901654)|1/27|0.131387106346972|1|0|0|7.12250712250712|14.4558924712216|CAV1|0
621|regulation of supramolecular fiber organization (GO:1902903)|1/27|0.131387106346972|1|0|0|7.12250712250712|14.4558924712216|APOE|0
622|negative regulation of catalytic activity (GO:0043086)|1/27|0.131387106346972|1|0|0|7.12250712250712|14.4558924712216|ATPIF1|0
623|sulfur compound biosynthetic process (GO:0044272)|2/123|0.134403473405312|1|0|0|3.12695434646654|6.27551284376957|B4GALT1;ESD|0
624|positive regulation of cellular process (GO:0048522)|5/520|0.134606509813327|1|0|0|1.8491124260355|3.70820913239719|CAV1;PDPN;FN1;CTSH;IGF1|0
625|negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732)|1/28|0.135909992410469|1|0|0|6.86813186813187|13.707159566327|CAV1|0
626|negative regulation of smooth muscle cell proliferation (GO:0048662)|1/28|0.135909992410469|1|0|0|6.86813186813187|13.707159566327|HMOX1|0
627|phosphatidylserine metabolic process (GO:0006658)|1/28|0.135909992410469|1|0|0|6.86813186813187|13.707159566327|PLA2G16|0
628|regulation of blood vessel diameter (GO:0097746)|1/28|0.135909992410469|1|0|0|6.86813186813187|13.707159566327|HMOX1|0
629|regulation of autophagy of mitochondrion (GO:1903146)|1/28|0.135909992410469|1|0|0|6.86813186813187|13.707159566327|CTSK|0
630|negative regulation of endocytosis (GO:0045806)|1/29|0.140409553068589|1|0|0|6.63129973474801|13.0185129171492|CAV1|0
631|cellular response to ketone (GO:1901655)|1/29|0.140409553068589|1|0|0|6.63129973474801|13.0185129171492|SPP1|0
632|negative regulation of homeostatic process (GO:0032845)|1/29|0.140409553068589|1|0|0|6.63129973474801|13.0185129171492|MAFB|0
633|carboxylic acid catabolic process (GO:0046395)|1/29|0.140409553068589|1|0|0|6.63129973474801|13.0185129171492|HEXB|0
634|synaptic transmission, cholinergic (GO:0007271)|1/29|0.140409553068589|1|0|0|6.63129973474801|13.0185129171492|APOE|0
635|regulation of lipid biosynthetic process (GO:0046890)|1/29|0.140409553068589|1|0|0|6.63129973474801|13.0185129171492|APOE|0
636|negative regulation of response to DNA damage stimulus (GO:2001021)|1/29|0.140409553068589|1|0|0|6.63129973474801|13.0185129171492|CD74|0
637|regulation of receptor internalization (GO:0002090)|1/29|0.140409553068589|1|0|0|6.63129973474801|13.0185129171492|CD63|0
638|regulation of defense response to virus by virus (GO:0050690)|1/29|0.140409553068589|1|0|0|6.63129973474801|13.0185129171492|B2M|0
639|positive regulation of lipid biosynthetic process (GO:0046889)|1/29|0.140409553068589|1|0|0|6.63129973474801|13.0185129171492|APOE|0
640|positive regulation of extrinsic apoptotic signaling pathway (GO:2001238)|1/29|0.140409553068589|1|0|0|6.63129973474801|13.0185129171492|CAV1|0
641|regulation of cell morphogenesis (GO:0022604)|1/29|0.140409553068589|1|0|0|6.63129973474801|13.0185129171492|PDPN|0
642|keratan sulfate biosynthetic process (GO:0018146)|1/30|0.144885907414704|1|0|0|6.41025641025641|12.3833890493765|B4GALT1|0
643|TRIF-dependent toll-like receptor signaling pathway (GO:0035666)|1/30|0.144885907414704|1|0|0|6.41025641025641|12.3833890493765|CD300LF|0
644|coenzyme biosynthetic process (GO:0009108)|1/30|0.144885907414704|1|0|0|6.41025641025641|12.3833890493765|ATPIF1|0
645|lung development (GO:0030324)|1/30|0.144885907414704|1|0|0|6.41025641025641|12.3833890493765|PDPN|0
646|regulation of vasoconstriction (GO:0019229)|1/30|0.144885907414704|1|0|0|6.41025641025641|12.3833890493765|CAV1|0
647|regulation of activated T cell proliferation (GO:0046006)|1/30|0.144885907414704|1|0|0|6.41025641025641|12.3833890493765|IGF1|0
648|skeletal muscle organ development (GO:0060538)|1/30|0.144885907414704|1|0|0|6.41025641025641|12.3833890493765|CAV1|0
649|respiratory system development (GO:0060541)|1/30|0.144885907414704|1|0|0|6.41025641025641|12.3833890493765|PDPN|0
650|regulation of neutrophil chemotaxis (GO:0090022)|1/30|0.144885907414704|1|0|0|6.41025641025641|12.3833890493765|CD74|0
651|striated muscle tissue development (GO:0014706)|1/30|0.144885907414704|1|0|0|6.41025641025641|12.3833890493765|CAV1|0
652|positive regulation of cation channel activity (GO:2001259)|1/31|0.149339173990176|1|0|0|6.20347394540943|11.7961242212081|CTSS|0
653|protein localization to lysosome (GO:0061462)|1/31|0.149339173990176|1|0|0|6.20347394540943|11.7961242212081|LAMTOR4|0
654|regulation of cell migration involved in sprouting angiogenesis (GO:0090049)|1/31|0.149339173990176|1|0|0|6.20347394540943|11.7961242212081|HMOX1|0
655|aminoglycan metabolic process (GO:0006022)|1/31|0.149339173990176|1|0|0|6.20347394540943|11.7961242212081|SDC3|0
656|phosphatidylinositol 3-kinase signaling (GO:0014065)|1/31|0.149339173990176|1|0|0|6.20347394540943|11.7961242212081|IGF1|0
657|positive regulation of B cell proliferation (GO:0030890)|1/31|0.149339173990176|1|0|0|6.20347394540943|11.7961242212081|CD74|0
658|activation of protein kinase B activity (GO:0032148)|1/31|0.149339173990176|1|0|0|6.20347394540943|11.7961242212081|IGF1|0
659|regulation of cation transmembrane transport (GO:1904062)|1/31|0.149339173990176|1|0|0|6.20347394540943|11.7961242212081|CD63|0
660|chondroitin sulfate metabolic process (GO:0030204)|1/31|0.149339173990176|1|0|0|6.20347394540943|11.7961242212081|HEXB|0
661|positive regulation of reactive oxygen species biosynthetic process (GO:1903428)|1/31|0.149339173990176|1|0|0|6.20347394540943|11.7961242212081|CYBA|0
662|MyD88-independent toll-like receptor signaling pathway (GO:0002756)|1/31|0.149339173990176|1|0|0|6.20347394540943|11.7961242212081|CD300LF|0
663|cellular protein modification process (GO:0006464)|8/1002|0.150447687955519|1|0|0|1.53539075694764|2.90824480815516|PTPN18;LGALS1;FN1;SPP1;MAN2B1;GLRX;APOE;MFGE8|0
664|negative regulation of toll-like receptor signaling pathway (GO:0034122)|1/32|0.153769470708343|1|0|0|6.00961538461539|11.2518073411062|CD300LF|0
665|regulation of dendritic spine development (GO:0060998)|1/32|0.153769470708343|1|0|0|6.00961538461539|11.2518073411062|APOE|0
666|negative regulation of blood vessel endothelial cell migration (GO:0043537)|1/32|0.153769470708343|1|0|0|6.00961538461539|11.2518073411062|APOE|0
667|regulation of glucose import (GO:0046324)|1/32|0.153769470708343|1|0|0|6.00961538461539|11.2518073411062|IGF1|0
668|regulation of protein tyrosine kinase activity (GO:0061097)|1/32|0.153769470708343|1|0|0|6.00961538461539|11.2518073411062|CAV1|0
669|secondary alcohol metabolic process (GO:1902652)|1/32|0.153769470708343|1|0|0|6.00961538461539|11.2518073411062|APOE|0
670|negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042)|1/32|0.153769470708343|1|0|0|6.00961538461539|11.2518073411062|HMOX1|0
671|regulation of protein autophosphorylation (GO:0031952)|1/32|0.153769470708343|1|0|0|6.00961538461539|11.2518073411062|GPNMB|0
672|regulation of protein phosphorylation (GO:0001932)|3/262|0.156078350457442|1|0|0|2.20199647680564|4.08998198317845|CD74;GPNMB;FN1|0
673|positive regulation of TOR signaling (GO:0032008)|1/33|0.158176914917624|1|0|0|5.82750582750583|10.7461605926549|LAMTOR4|0
674|positive regulation of calcium ion transport into cytosol (GO:0010524)|1/33|0.158176914917624|1|0|0|5.82750582750583|10.7461605926549|CAV1|0
675|cellular response to amino acid stimulus (GO:0071230)|1/33|0.158176914917624|1|0|0|5.82750582750583|10.7461605926549|LAMTOR4|0
676|response to zinc ion (GO:0010043)|1/33|0.158176914917624|1|0|0|5.82750582750583|10.7461605926549|CRIP1|0
677|endodermal cell differentiation (GO:0035987)|1/33|0.158176914917624|1|0|0|5.82750582750583|10.7461605926549|FN1|0
678|cellular response to glucagon stimulus (GO:0071377)|1/33|0.158176914917624|1|0|0|5.82750582750583|10.7461605926549|GNG12|0
679|positive regulation of dendrite development (GO:1900006)|1/33|0.158176914917624|1|0|0|5.82750582750583|10.7461605926549|APOE|0
680|substrate adhesion-dependent cell spreading (GO:0034446)|1/33|0.158176914917624|1|0|0|5.82750582750583|10.7461605926549|FN1|0
681|regulation of erythrocyte differentiation (GO:0045646)|1/33|0.158176914917624|1|0|0|5.82750582750583|10.7461605926549|MAFB|0
682|regulation of nitric oxide biosynthetic process (GO:0045428)|1/33|0.158176914917624|1|0|0|5.82750582750583|10.7461605926549|CAV1|0
683|cyclic-nucleotide-mediated signaling (GO:0019935)|1/33|0.158176914917624|1|0|0|5.82750582750583|10.7461605926549|APOE|0
684|negative regulation of receptor activity (GO:2000272)|1/33|0.158176914917624|1|0|0|5.82750582750583|10.7461605926549|CAV1|0
685|aminoglycan catabolic process (GO:0006026)|1/33|0.158176914917624|1|0|0|5.82750582750583|10.7461605926549|SDC3|0
686|positive regulation of myeloid leukocyte differentiation (GO:0002763)|1/33|0.158176914917624|1|0|0|5.82750582750583|10.7461605926549|CD74|0
687|positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557)|1/33|0.158176914917624|1|0|0|5.82750582750583|10.7461605926549|CYBA|0
688|vasculogenesis (GO:0001570)|1/33|0.158176914917624|1|0|0|5.82750582750583|10.7461605926549|CAV1|0
689|oligosaccharide biosynthetic process (GO:0009312)|1/34|0.162561623323309|1|0|0|5.65610859728507|10.2754419041126|B4GALT1|0
690|negative regulation of mitochondrion organization (GO:0010823)|1/34|0.162561623323309|1|0|0|5.65610859728507|10.2754419041126|IGF1|0
691|positive regulation of calcium ion transport (GO:0051928)|1/34|0.162561623323309|1|0|0|5.65610859728507|10.2754419041126|CAV1|0
692|regulation of cell-substrate adhesion (GO:0010810)|1/34|0.162561623323309|1|0|0|5.65610859728507|10.2754419041126|PDPN|0
693|response to exogenous dsRNA (GO:0043330)|1/34|0.162561623323309|1|0|0|5.65610859728507|10.2754419041126|CAV1|0
694|positive regulation of catalytic activity (GO:0043085)|1/34|0.162561623323309|1|0|0|5.65610859728507|10.2754419041126|CAV1|0
695|regulation of primary metabolic process (GO:0080090)|2/140|0.164997616104941|1|0|0|2.74725274725275|4.95006662921641|PSAP;APOE|0
696|response to lipid (GO:0033993)|2/141|0.166834986880132|1|0|0|2.72776868521549|4.88475193010002|SPP1;CTSH|0
697|negative regulation of cellular metabolic process (GO:0031324)|1/35|0.166923712082108|1|0|0|5.49450549450549|9.83636475173749|APOE|0
698|response to amino acid (GO:0043200)|1/35|0.166923712082108|1|0|0|5.49450549450549|9.83636475173749|LAMTOR4|0
699|regulation of axon extension (GO:0030516)|1/35|0.166923712082108|1|0|0|5.49450549450549|9.83636475173749|APOE|0
700|regulation of insulin receptor signaling pathway (GO:0046626)|1/35|0.166923712082108|1|0|0|5.49450549450549|9.83636475173749|IGF1|0
701|negative regulation of endothelial cell migration (GO:0010596)|1/35|0.166923712082108|1|0|0|5.49450549450549|9.83636475173749|APOE|0
702|positive regulation of cell development (GO:0010720)|1/35|0.166923712082108|1|0|0|5.49450549450549|9.83636475173749|IGF1|0
703|regulation of wound healing (GO:0061041)|1/35|0.166923712082108|1|0|0|5.49450549450549|9.83636475173749|CAV1|0
704|response to glucagon (GO:0033762)|1/35|0.166923712082108|1|0|0|5.49450549450549|9.83636475173749|GNG12|0
705|positive regulation of DNA binding (GO:0043388)|1/35|0.166923712082108|1|0|0|5.49450549450549|9.83636475173749|IGF1|0
706|positive regulation of macromolecule biosynthetic process (GO:0010557)|2/143|0.170520500980773|1|0|0|2.68961807423346|4.7576647367682|RBM3;IGF1|0
707|regulation of heart rate by cardiac conduction (GO:0086091)|1/36|0.171263296777162|1|0|0|5.34188034188034|9.42603183461519|CAV1|0
708|positive regulation of peptide secretion (GO:0002793)|1/36|0.171263296777162|1|0|0|5.34188034188034|9.42603183461519|IGF1|0
709|erythrocyte differentiation (GO:0030218)|1/36|0.171263296777162|1|0|0|5.34188034188034|9.42603183461519|ATPIF1|0
710|regulation of mitochondrial membrane potential (GO:0051881)|1/36|0.171263296777162|1|0|0|5.34188034188034|9.42603183461519|ATPIF1|0
711|positive regulation of DNA replication (GO:0045740)|1/36|0.171263296777162|1|0|0|5.34188034188034|9.42603183461519|IGF1|0
712|membrane protein proteolysis (GO:0033619)|1/36|0.171263296777162|1|0|0|5.34188034188034|9.42603183461519|CTSH|0
713|positive regulation of osteoblast differentiation (GO:0045669)|1/36|0.171263296777162|1|0|0|5.34188034188034|9.42603183461519|IGF1|0
714|sulfur compound catabolic process (GO:0044273)|1/36|0.171263296777162|1|0|0|5.34188034188034|9.42603183461519|HEXB|0
715|protein kinase B signaling (GO:0043491)|1/36|0.171263296777162|1|0|0|5.34188034188034|9.42603183461519|IGF1|0
716|cholesterol biosynthetic process (GO:0006695)|1/36|0.171263296777162|1|0|0|5.34188034188034|9.42603183461519|APOE|0
717|regulation of gene expression (GO:0010468)|8/1038|0.1723332875274|1|0|0|1.48214021046391|2.60608412470773|MSR1;MAFB;GSN;FN1;NME2;CTSH;IGF1;CRIP1|0
718|regulation of potassium ion transport (GO:0043266)|1/37|0.175580492342194|1|0|0|5.1975051975052|9.04187991370893|CD63|0
719|actin polymerization or depolymerization (GO:0008154)|1/37|0.175580492342194|1|0|0|5.1975051975052|9.04187991370893|GSN|0
720|regulation of receptor-mediated endocytosis (GO:0048259)|1/37|0.175580492342194|1|0|0|5.1975051975052|9.04187991370893|B2M|0
721|regulation of cell morphogenesis involved in differentiation (GO:0010769)|1/37|0.175580492342194|1|0|0|5.1975051975052|9.04187991370893|PDPN|0
722|muscle cell differentiation (GO:0042692)|1/37|0.175580492342194|1|0|0|5.1975051975052|9.04187991370893|IGF1|0
723|carbohydrate biosynthetic process (GO:0016051)|1/37|0.175580492342194|1|0|0|5.1975051975052|9.04187991370893|B4GALT1|0
724|natural killer cell activation (GO:0030101)|1/37|0.175580492342194|1|0|0|5.1975051975052|9.04187991370893|PRDX1|0
725|endoderm formation (GO:0001706)|1/37|0.175580492342194|1|0|0|5.1975051975052|9.04187991370893|FN1|0
726|negative regulation of blood coagulation (GO:0030195)|1/37|0.175580492342194|1|0|0|5.1975051975052|9.04187991370893|APOE|0
727|regulation of blood circulation (GO:1903522)|1/37|0.175580492342194|1|0|0|5.1975051975052|9.04187991370893|S100A1|0
728|plasma membrane organization (GO:0007009)|1/37|0.175580492342194|1|0|0|5.1975051975052|9.04187991370893|MYOF|0
729|secondary alcohol biosynthetic process (GO:1902653)|1/37|0.175580492342194|1|0|0|5.1975051975052|9.04187991370893|APOE|0
730|zymogen activation (GO:0031638)|1/37|0.175580492342194|1|0|0|5.1975051975052|9.04187991370893|CTSH|0
731|skeletal system development (GO:0001501)|2/147|0.177932234931163|1|0|0|2.61643118785976|4.51688253220725|PRDX1;IGF1|0
732|regulation of osteoclast differentiation (GO:0045670)|1/38|0.179875413216285|1|0|0|5.06072874493927|8.68163368692263|MAFB|0
733|epithelial to mesenchymal transition (GO:0001837)|1/38|0.179875413216285|1|0|0|5.06072874493927|8.68163368692263|S100A4|0
734|regulation of carbohydrate catabolic process (GO:0043470)|1/38|0.179875413216285|1|0|0|5.06072874493927|8.68163368692263|PGAM1|0
735|response to steroid hormone (GO:0048545)|1/38|0.179875413216285|1|0|0|5.06072874493927|8.68163368692263|CAV1|0
736|regulation of sodium ion transmembrane transporter activity (GO:2000649)|1/38|0.179875413216285|1|0|0|5.06072874493927|8.68163368692263|GLRX|0
737|positive regulation of multi-organism process (GO:0043902)|1/38|0.179875413216285|1|0|0|5.06072874493927|8.68163368692263|CYBA|0
738|negative regulation of canonical Wnt signaling pathway (GO:0090090)|2/149|0.181657119962718|1|0|0|2.58131130614352|4.40277316735099|CAV1;APOE|0
739|positive regulation of reactive oxygen species metabolic process (GO:2000379)|1/40|0.188398885447354|1|0|0|4.80769230769231|8.0249703497207|CYBA|0
740|negative regulation of protein catabolic process (GO:0042177)|1/40|0.188398885447354|1|0|0|4.80769230769231|8.0249703497207|TIMP2|0
741|skeletal muscle tissue development (GO:0007519)|1/40|0.188398885447354|1|0|0|4.80769230769231|8.0249703497207|CAV1|0
742|regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041)|1/40|0.188398885447354|1|0|0|4.80769230769231|8.0249703497207|HMOX1|0
743|inositol lipid-mediated signaling (GO:0048017)|1/40|0.188398885447354|1|0|0|4.80769230769231|8.0249703497207|IGF1|0
744|regulation of plasma membrane bounded cell projection assembly (GO:0120032)|1/40|0.188398885447354|1|0|0|4.80769230769231|8.0249703497207|CAV1|0
745|ERBB2 signaling pathway (GO:0038128)|1/40|0.188398885447354|1|0|0|4.80769230769231|8.0249703497207|PTPN18|0
746|acyl-CoA metabolic process (GO:0006637)|1/40|0.188398885447354|1|0|0|4.80769230769231|8.0249703497207|DBI|0
747|regulation of coenzyme metabolic process (GO:0051196)|1/40|0.188398885447354|1|0|0|4.80769230769231|8.0249703497207|PGAM1|0
748|regulation of cell proliferation (GO:0042127)|6/741|0.188602422732624|1|0|0|1.55714730613516|2.59749931950655|GPNMB;FTH1;PDPN;FN1;CTSH;IGF1|0
749|regulation of cellular localization (GO:0060341)|1/41|0.192627662698804|1|0|0|4.69043151969981|7.7251227120635|GSN|0
750|regulation of release of cytochrome c from mitochondria (GO:0090199)|1/41|0.192627662698804|1|0|0|4.69043151969981|7.7251227120635|IGF1|0
751|negative regulation of cytokine-mediated signaling pathway (GO:0001960)|1/41|0.192627662698804|1|0|0|4.69043151969981|7.7251227120635|ARG1|0
752|positive regulation of epithelial to mesenchymal transition (GO:0010718)|1/41|0.192627662698804|1|0|0|4.69043151969981|7.7251227120635|PDPN|0
753|sensory organ development (GO:0007423)|1/41|0.192627662698804|1|0|0|4.69043151969981|7.7251227120635|MAFB|0
754|regulation of cholesterol biosynthetic process (GO:0045540)|1/41|0.192627662698804|1|0|0|4.69043151969981|7.7251227120635|APOE|0
755|positive regulation of cytokine biosynthetic process (GO:0042108)|1/41|0.192627662698804|1|0|0|4.69043151969981|7.7251227120635|HMOX1|0
756|regulation of ATPase activity (GO:0043462)|1/41|0.192627662698804|1|0|0|4.69043151969981|7.7251227120635|ATPIF1|0
757|positive regulation of mitotic nuclear division (GO:0045840)|1/41|0.192627662698804|1|0|0|4.69043151969981|7.7251227120635|IGF1|0
758|positive regulation of Ras protein signal transduction (GO:0046579)|1/41|0.192627662698804|1|0|0|4.69043151969981|7.7251227120635|IGF1|0
759|sterol biosynthetic process (GO:0016126)|1/41|0.192627662698804|1|0|0|4.69043151969981|7.7251227120635|APOE|0
760|negative regulation of cytokine secretion (GO:0050710)|1/41|0.192627662698804|1|0|0|4.69043151969981|7.7251227120635|FN1|0
761|regulation of phagocytosis (GO:0050764)|1/42|0.196834617086978|1|0|0|4.57875457875458|7.44226836080743|CYBA|0
762|mesenchymal cell differentiation (GO:0048762)|1/42|0.196834617086978|1|0|0|4.57875457875458|7.44226836080743|S100A4|0
763|regulation of cholesterol metabolic process (GO:0090181)|1/42|0.196834617086978|1|0|0|4.57875457875458|7.44226836080743|APOE|0
764|regulation of calcium-mediated signaling (GO:0050848)|1/42|0.196834617086978|1|0|0|4.57875457875458|7.44226836080743|TREM2|0
765|negative regulation of STAT cascade (GO:1904893)|1/42|0.196834617086978|1|0|0|4.57875457875458|7.44226836080743|CAV1|0
766|negative regulation of cell projection organization (GO:0031345)|1/42|0.196834617086978|1|0|0|4.57875457875458|7.44226836080743|APOE|0
767|regulation of substrate adhesion-dependent cell spreading (GO:1900024)|1/42|0.196834617086978|1|0|0|4.57875457875458|7.44226836080743|PDPN|0
768|gluconeogenesis (GO:0006094)|1/42|0.196834617086978|1|0|0|4.57875457875458|7.44226836080743|PGAM1|0
769|regulation of interleukin-6 production (GO:0032675)|1/43|0.201019860066377|1|0|0|4.47227191413238|7.17509646468559|CYBA|0
770|regulation of protein modification process (GO:0031399)|1/43|0.201019860066377|1|0|0|4.47227191413238|7.17509646468559|FN1|0
771|positive regulation of cellular biosynthetic process (GO:0031328)|2/160|0.202338258103409|1|0|0|2.40384615384615|3.84090008894689|RBM3;IGF1|0
772|regulation of B cell proliferation (GO:0030888)|1/44|0.205183502646368|1|0|0|4.37062937062937|6.92242379972765|CD74|0
773|positive regulation of protein localization to plasma membrane (GO:1903078)|1/44|0.205183502646368|1|0|0|4.37062937062937|6.92242379972765|TREM2|0
774|negative regulation of protein metabolic process (GO:0051248)|1/44|0.205183502646368|1|0|0|4.37062937062937|6.92242379972765|APOE|0
775|substantia nigra development (GO:0021762)|1/44|0.205183502646368|1|0|0|4.37062937062937|6.92242379972765|S100A1|0
776|response to hydrogen peroxide (GO:0042542)|1/44|0.205183502646368|1|0|0|4.37062937062937|6.92242379972765|HMOX1|0
777|positive regulation of interleukin-6 production (GO:0032755)|1/44|0.205183502646368|1|0|0|4.37062937062937|6.92242379972765|CYBA|0
778|regulation of multicellular organismal development (GO:2000026)|1/44|0.205183502646368|1|0|0|4.37062937062937|6.92242379972765|PLA2G16|0
779|carboxylic acid biosynthetic process (GO:0046394)|1/45|0.209325655205567|1|0|0|4.27350427350427|6.68317983251725|ATPIF1|0
780|negative regulation of immune system process (GO:0002683)|1/45|0.209325655205567|1|0|0|4.27350427350427|6.68317983251725|HMOX1|0
781|hexose biosynthetic process (GO:0019319)|1/45|0.209325655205567|1|0|0|4.27350427350427|6.68317983251725|PGAM1|0
782|posttranscriptional regulation of gene expression (GO:0010608)|1/45|0.209325655205567|1|0|0|4.27350427350427|6.68317983251725|RBM3|0
783|positive regulation of viral process (GO:0048524)|1/45|0.209325655205567|1|0|0|4.27350427350427|6.68317983251725|APOE|0
784|myeloid cell differentiation (GO:0030099)|1/45|0.209325655205567|1|0|0|4.27350427350427|6.68317983251725|ATPIF1|0
785|positive regulation of protein modification process (GO:0031401)|2/164|0.209927251680524|1|0|0|2.34521575984991|3.66086826653628|CD74;GPNMB|0
786|hexose metabolic process (GO:0019318)|1/46|0.21344642763908|1|0|0|4.18060200668896|6.45639382193718|MAN2B1|0
787|protein polymerization (GO:0051258)|1/46|0.21344642763908|1|0|0|4.18060200668896|6.45639382193718|GSN|0
788|positive regulation of blood vessel endothelial cell migration (GO:0043536)|1/46|0.21344642763908|1|0|0|4.18060200668896|6.45639382193718|HMOX1|0
789|nicotinamide nucleotide metabolic process (GO:0046496)|1/46|0.21344642763908|1|0|0|4.18060200668896|6.45639382193718|PGAM1|0
790|metal ion homeostasis (GO:0055065)|1/46|0.21344642763908|1|0|0|4.18060200668896|6.45639382193718|CAV1|0
791|negative regulation of ossification (GO:0030279)|1/46|0.21344642763908|1|0|0|4.18060200668896|6.45639382193718|ECM1|0
792|regulation of inflammatory response (GO:0050727)|2/167|0.215638427225214|1|0|0|2.30308613542147|3.5332847119896|LPL;APOE|0
793|protein complex disassembly (GO:0043241)|1/47|0.217545929155662|1|0|0|4.09165302782324|6.24118364244909|CAV1|0
794|regulation of G1/S transition of mitotic cell cycle (GO:2000045)|1/47|0.217545929155662|1|0|0|4.09165302782324|6.24118364244909|GPNMB|0
795|positive regulation of protein localization to cell periphery (GO:1904377)|1/47|0.217545929155662|1|0|0|4.09165302782324|6.24118364244909|TREM2|0
796|regulation of cellular component movement (GO:0051270)|1/47|0.217545929155662|1|0|0|4.09165302782324|6.24118364244909|PDPN|0
797|negative regulation of protein modification by small protein conjugation or removal (GO:1903321)|1/47|0.217545929155662|1|0|0|4.09165302782324|6.24118364244909|CAV1|0
798|pyruvate metabolic process (GO:0006090)|1/47|0.217545929155662|1|0|0|4.09165302782324|6.24118364244909|PGAM1|0
799|aminoglycan biosynthetic process (GO:0006023)|1/47|0.217545929155662|1|0|0|4.09165302782324|6.24118364244909|SDC3|0
800|regulation of generation of precursor metabolites and energy (GO:0043467)|1/47|0.217545929155662|1|0|0|4.09165302782324|6.24118364244909|PGAM1|0
801|peptide cross-linking (GO:0018149)|1/48|0.221624268522213|1|0|0|4.00641025641026|6.03674605414023|FN1|0
802|fatty acid biosynthetic process (GO:0006633)|1/48|0.221624268522213|1|0|0|4.00641025641026|6.03674605414023|LPL|0
803|negative regulation of cellular biosynthetic process (GO:0031327)|1/48|0.221624268522213|1|0|0|4.00641025641026|6.03674605414023|CAV1|0
804|positive regulation of tumor necrosis factor production (GO:0032760)|1/48|0.221624268522213|1|0|0|4.00641025641026|6.03674605414023|CYBA|0
805|cellular response to heat (GO:0034605)|1/48|0.221624268522213|1|0|0|4.00641025641026|6.03674605414023|HMOX1|0
806|regulation of organelle assembly (GO:1902115)|1/48|0.221624268522213|1|0|0|4.00641025641026|6.03674605414023|GSN|0
807|negative regulation of JAK-STAT cascade (GO:0046426)|1/48|0.221624268522213|1|0|0|4.00641025641026|6.03674605414023|CAV1|0
808|intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630)|1/49|0.225681553965819|1|0|0|3.92464678178964|5.8423482205945|CRIP1|0
809|regulation of epithelial cell migration (GO:0010632)|1/49|0.225681553965819|1|0|0|3.92464678178964|5.8423482205945|CTSH|0
810|glycoprotein metabolic process (GO:0009100)|1/49|0.225681553965819|1|0|0|3.92464678178964|5.8423482205945|MAN2B1|0
811|protein heterooligomerization (GO:0051291)|1/50|0.229717893074581|1|0|0|3.84615384615385|5.65732028745754|CD74|0
812|establishment of protein localization to mitochondrion (GO:0072655)|1/50|0.229717893074581|1|0|0|3.84615384615385|5.65732028745754|TSPO|0
813|lipid homeostasis (GO:0055088)|1/50|0.229717893074581|1|0|0|3.84615384615385|5.65732028745754|APOE|0
814|negative regulation of Wnt signaling pathway (GO:0030178)|2/175|0.230934641832495|1|0|0|2.1978021978022|3.22114405337207|CAV1;APOE|0
815|regulation of bone mineralization (GO:0030500)|1/51|0.233733392926841|1|0|0|3.77073906485671|5.48104886741905|ECM1|0
816|receptor internalization (GO:0031623)|1/51|0.233733392926841|1|0|0|3.77073906485671|5.48104886741905|CAV1|0
817|blood circulation (GO:0008015)|1/51|0.233733392926841|1|0|0|3.77073906485671|5.48104886741905|MYOF|0
818|regulation of blood vessel endothelial cell migration (GO:0043535)|1/51|0.233733392926841|1|0|0|3.77073906485671|5.48104886741905|APOE|0
819|negative regulation of protein ubiquitination (GO:0031397)|1/51|0.233733392926841|1|0|0|3.77073906485671|5.48104886741905|CAV1|0
820|negative regulation of viral genome replication (GO:0045071)|1/51|0.233733392926841|1|0|0|3.77073906485671|5.48104886741905|IFITM2|0
821|cytokine-mediated signaling pathway (GO:0019221)|5/634|0.234375078287583|1|0|0|1.51662217908275|2.20036482078151|IFITM2;FN1;HMOX1;CD300LF;B2M|0
822|negative regulation of neuron projection development (GO:0010977)|1/52|0.237728160114747|1|0|0|3.69822485207101|5.31297131099184|APOE|0
823|arachidonic acid metabolic process (GO:0019369)|1/52|0.237728160114747|1|0|0|3.69822485207101|5.31297131099184|PTGS1|0
824|coenzyme metabolic process (GO:0006732)|1/52|0.237728160114747|1|0|0|3.69822485207101|5.31297131099184|DBI|0
825|positive regulation of developmental growth (GO:0048639)|1/52|0.237728160114747|1|0|0|3.69822485207101|5.31297131099184|IGF1|0
826|carboxylic acid transport (GO:0046942)|1/52|0.237728160114747|1|0|0|3.69822485207101|5.31297131099184|PSAP|0
827|positive regulation of actin filament polymerization (GO:0030838)|1/52|0.237728160114747|1|0|0|3.69822485207101|5.31297131099184|GSN|0
828|positive regulation of cell-substrate adhesion (GO:0010811)|1/53|0.241702300664446|1|0|0|3.62844702467344|5.15257065544307|FN1|0
829|positive regulation of ossification (GO:0045778)|1/53|0.241702300664446|1|0|0|3.62844702467344|5.15257065544307|IGF1|0
830|positive regulation of mitotic cell cycle (GO:0045931)|1/53|0.241702300664446|1|0|0|3.62844702467344|5.15257065544307|IGF1|0
831|regulation of DNA binding (GO:0051101)|1/53|0.241702300664446|1|0|0|3.62844702467344|5.15257065544307|IGF1|0
832|regulation of calcium ion transport (GO:0051924)|1/53|0.241702300664446|1|0|0|3.62844702467344|5.15257065544307|CD84|0
833|positive regulation of secretion by cell (GO:1903532)|1/53|0.241702300664446|1|0|0|3.62844702467344|5.15257065544307|IGF1|0
834|organonitrogen compound biosynthetic process (GO:1901566)|2/182|0.244377688146673|1|0|0|2.11327134404058|2.97768459047828|ARG1;ESD|0
835|positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068)|1/54|0.245655919987799|1|0|0|3.56125356125356|4.9993711587579|IGF1|0
836|negative regulation of cellular response to transforming growth factor beta stimulus (GO:1903845)|1/54|0.245655919987799|1|0|0|3.56125356125356|4.9993711587579|CAV1|0
837|positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531)|1/54|0.245655919987799|1|0|0|3.56125356125356|4.9993711587579|IGF1|0
838|positive regulation of protein import into nucleus (GO:0042307)|1/54|0.245655919987799|1|0|0|3.56125356125356|4.9993711587579|IGF1|0
839|phosphate-containing compound metabolic process (GO:0006796)|2/184|0.248225505202262|1|0|0|2.09030100334448|2.91266231355594|PLA2G16;LPL|0
840|cell morphogenesis involved in differentiation (GO:0000904)|1/55|0.249589123102619|1|0|0|3.4965034965035|4.85293433828534|FN1|0
841|protein targeting to mitochondrion (GO:0006626)|1/55|0.249589123102619|1|0|0|3.4965034965035|4.85293433828534|TSPO|0
842|regulation of cellular catabolic process (GO:0031329)|1/56|0.253502014351789|1|0|0|3.43406593406593|4.71285545955208|PSAP|0
843|positive regulation of cysteine-type endopeptidase activity (GO:2001056)|1/56|0.253502014351789|1|0|0|3.43406593406593|4.71285545955208|BCAP31|0
844|negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512)|1/56|0.253502014351789|1|0|0|3.43406593406593|4.71285545955208|CAV1|0
845|regulation of axonogenesis (GO:0050770)|1/56|0.253502014351789|1|0|0|3.43406593406593|4.71285545955208|APOE|0
846|protein import (GO:0017038)|1/57|0.257394697635161|1|0|0|3.37381916329285|4.57876040398207|APOE|0
847|anion transport (GO:0006820)|1/57|0.257394697635161|1|0|0|3.37381916329285|4.57876040398207|TSPO|0
848|cellular defense response (GO:0006968)|1/57|0.257394697635161|1|0|0|3.37381916329285|4.57876040398207|TYROBP|0
849|phosphatidylinositol-mediated signaling (GO:0048015)|1/57|0.257394697635161|1|0|0|3.37381916329285|4.57876040398207|IGF1|0
850|negative regulation of cellular catabolic process (GO:0031330)|1/57|0.257394697635161|1|0|0|3.37381916329285|4.57876040398207|TIMP2|0
851|organonitrogen compound catabolic process (GO:1901565)|1/57|0.257394697635161|1|0|0|3.37381916329285|4.57876040398207|CTSD|0
852|positive regulation of protein transport (GO:0051222)|1/57|0.257394697635161|1|0|0|3.37381916329285|4.57876040398207|IGF1|0
853|regulation of Rho protein signal transduction (GO:0035023)|1/58|0.261267276286204|1|0|0|3.31564986737401|4.45030287985538|APOE|0
854|protein homotetramerization (GO:0051289)|1/58|0.261267276286204|1|0|0|3.31564986737401|4.45030287985538|ATPIF1|0
855|response to retinoic acid (GO:0032526)|1/58|0.261267276286204|1|0|0|3.31564986737401|4.45030287985538|CTSH|0
856|phospholipid transport (GO:0015914)|1/59|0.265119853222339|1|0|0|3.25945241199478|4.32716192611246|APOE|0
857|integrin-mediated signaling pathway (GO:0007229)|1/59|0.265119853222339|1|0|0|3.25945241199478|4.32716192611246|NME2|0
858|regulation of protein metabolic process (GO:0051246)|1/60|0.268952530616884|1|0|0|3.20512820512821|4.20903968288625|APOE|0
859|cell morphogenesis (GO:0000902)|1/60|0.268952530616884|1|0|0|3.20512820512821|4.20903968288625|PDPN|0
860|sterol metabolic process (GO:0016125)|1/60|0.268952530616884|1|0|0|3.20512820512821|4.20903968288625|APOE|0
861|muscle organ development (GO:0007517)|1/61|0.272765410358622|1|0|0|3.15258511979824|4.09565938185708|IGF1|0
862|actin cytoskeleton reorganization (GO:0031532)|1/62|0.276558593709845|1|0|0|3.10173697270471|3.98676354937537|GSN|0
863|regulation of tyrosine phosphorylation of STAT protein (GO:0042509)|1/62|0.276558593709845|1|0|0|3.10173697270471|3.98676354937537|IGF1|0
864|positive regulation of T cell proliferation (GO:0042102)|1/62|0.276558593709845|1|0|0|3.10173697270471|3.98676354937537|IGF1|0
865|regulation of DNA replication (GO:0006275)|1/62|0.276558593709845|1|0|0|3.10173697270471|3.98676354937537|IGF1|0
866|glycosaminoglycan metabolic process (GO:0030203)|1/62|0.276558593709845|1|0|0|3.10173697270471|3.98676354937537|SDC3|0
867|regulation of cellular ketone metabolic process (GO:0010565)|1/62|0.276558593709845|1|0|0|3.10173697270471|3.98676354937537|CAV1|0
868|regulation of tumor necrosis factor production (GO:0032680)|1/62|0.276558593709845|1|0|0|3.10173697270471|3.98676354937537|CYBA|0
869|positive regulation of cellular amide metabolic process (GO:0034250)|1/62|0.276558593709845|1|0|0|3.10173697270471|3.98676354937537|RBM3|0
870|second-messenger-mediated signaling (GO:0019932)|1/63|0.280332181450425|1|0|0|3.05250305250305|3.88211238297202|APOE|0
871|kidney development (GO:0001822)|1/64|0.284086273780162|1|0|0|3.00480769230769|3.78148228977448|CTSH|0
872|carbohydrate homeostasis (GO:0033500)|1/64|0.284086273780162|1|0|0|3.00480769230769|3.78148228977448|IGF1|0
873|adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway (GO:0007193)|1/64|0.284086273780162|1|0|0|3.00480769230769|3.78148228977448|PSAP|0
874|regulation of viral genome replication (GO:0045069)|1/64|0.284086273780162|1|0|0|3.00480769230769|3.78148228977448|IFITM2|0
875|positive regulation of cell projection organization (GO:0031346)|1/64|0.284086273780162|1|0|0|3.00480769230769|3.78148228977448|APOE|0
876|homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156)|1/65|0.287820970456112|1|0|0|2.95857988165681|3.68466456360703|CD84|0
877|positive regulation of JAK-STAT cascade (GO:0046427)|1/65|0.287820970456112|1|0|0|2.95857988165681|3.68466456360703|IGF1|0
878|glucose metabolic process (GO:0006006)|1/65|0.287820970456112|1|0|0|2.95857988165681|3.68466456360703|PGAM1|0
879|cellular response to decreased oxygen levels (GO:0036294)|1/65|0.287820970456112|1|0|0|2.95857988165681|3.68466456360703|HMOX1|0
880|negative regulation of neuron differentiation (GO:0045665)|1/65|0.287820970456112|1|0|0|2.95857988165681|3.68466456360703|APOE|0
881|cellular response to type I interferon (GO:0071357)|1/66|0.291536370748866|1|0|0|2.91375291375291|3.59146418987975|IFITM2|0
882|positive regulation of protein modification by small protein conjugation or removal (GO:1903322)|1/66|0.291536370748866|1|0|0|2.91375291375291|3.59146418987975|CAV1|0
883|regulation of JAK-STAT cascade (GO:0046425)|1/66|0.291536370748866|1|0|0|2.91375291375291|3.59146418987975|CAV1|0
884|cellular response to reactive oxygen species (GO:0034614)|1/66|0.291536370748866|1|0|0|2.91375291375291|3.59146418987975|PRDX5|0
885|negative regulation of apoptotic signaling pathway (GO:2001234)|1/66|0.291536370748866|1|0|0|2.91375291375291|3.59146418987975|IGF1|0
886|type I interferon signaling pathway (GO:0060337)|1/66|0.291536370748866|1|0|0|2.91375291375291|3.59146418987975|IFITM2|0
887|negative regulation of protein serine/threonine kinase activity (GO:0071901)|1/68|0.29890967659679|1|0|0|2.82805429864253|3.41519750053414|APOE|0
888|regulation of cardiac conduction (GO:1903779)|1/68|0.29890967659679|1|0|0|2.82805429864253|3.41519750053414|CAV1|0
889|cellular response to UV (GO:0034644)|1/68|0.29890967659679|1|0|0|2.82805429864253|3.41519750053414|CRIP1|0
890|regulation of TOR signaling (GO:0032006)|1/68|0.29890967659679|1|0|0|2.82805429864253|3.41519750053414|LAMTOR4|0
891|regulation of protein localization to plasma membrane (GO:1903076)|1/68|0.29890967659679|1|0|0|2.82805429864253|3.41519750053414|TREM2|0
892|regulation of epithelial to mesenchymal transition (GO:0010717)|1/69|0.302567778091139|1|0|0|2.78706800445931|3.3318003534099|PDPN|0
893|monocarboxylic acid biosynthetic process (GO:0072330)|1/69|0.302567778091139|1|0|0|2.78706800445931|3.3318003534099|LPL|0
894|response to interferon-gamma (GO:0034341)|1/69|0.302567778091139|1|0|0|2.78706800445931|3.3318003534099|IFITM2|0
895|regulation of endopeptidase activity (GO:0052548)|1/69|0.302567778091139|1|0|0|2.78706800445931|3.3318003534099|TIMP2|0
896|cholesterol metabolic process (GO:0008203)|1/69|0.302567778091139|1|0|0|2.78706800445931|3.3318003534099|APOE|0
897|negative regulation of cellular process (GO:0048523)|4/535|0.303239516101936|1|0|0|1.43781452192667|1.71564673408289|GPNMB;FTH1;CAV1;PDPN|0
898|regulation of canonical Wnt signaling pathway (GO:0060828)|2/214|0.30597058384895|1|0|0|1.79726815240834|2.12844412807915|CAV1;APOE|0
899|regulation of endothelial cell migration (GO:0010594)|1/70|0.306206975198901|1|0|0|2.74725274725275|3.25135718719553|ANXA3|0
900|regulation of osteoblast differentiation (GO:0045667)|1/70|0.306206975198901|1|0|0|2.74725274725275|3.25135718719553|IGF1|0
901|positive regulation of endothelial cell migration (GO:0010595)|1/71|0.309827364586572|1|0|0|2.70855904658722|3.17372704510648|ANXA3|0
902|interferon-gamma-mediated signaling pathway (GO:0060333)|1/71|0.309827364586572|1|0|0|2.70855904658722|3.17372704510648|B2M|0
903|vascular endothelial growth factor receptor signaling pathway (GO:0048010)|1/71|0.309827364586572|1|0|0|2.70855904658722|3.17372704510648|CYBA|0
904|calcium-mediated signaling (GO:0019722)|1/71|0.309827364586572|1|0|0|2.70855904658722|3.17372704510648|BCAP31|0
905|regulation of cation channel activity (GO:2001257)|1/72|0.313429042536388|1|0|0|2.67094017094017|3.09877746828174|CTSS|0
906|positive regulation of lymphocyte proliferation (GO:0050671)|1/72|0.313429042536388|1|0|0|2.67094017094017|3.09877746828174|CD74|0
907|response to insulin (GO:0032868)|1/72|0.313429042536388|1|0|0|2.67094017094017|3.09877746828174|IGF1|0
908|lipid biosynthetic process (GO:0008610)|1/73|0.317012104825752|1|0|0|2.63435194942044|3.02638387846078|LPL|0
909|glycoprotein biosynthetic process (GO:0009101)|1/73|0.317012104825752|1|0|0|2.63435194942044|3.02638387846078|IGF1|0
910|Rho protein signal transduction (GO:0007266)|1/73|0.317012104825752|1|0|0|2.63435194942044|3.02638387846078|PDPN|0
911|viral process (GO:0016032)|2/221|0.319369699288995|1|0|0|1.74034110685694|1.9864356340064|APOE;B2M|0
912|positive regulation of inflammatory response (GO:0050729)|1/74|0.320576646762167|1|0|0|2.5987525987526|2.95642901182108|LPL|0
913|protein N-linked glycosylation (GO:0006487)|1/74|0.320576646762167|1|0|0|2.5987525987526|2.95642901182108|B4GALT1|0
914|canonical Wnt signaling pathway (GO:0060070)|1/74|0.320576646762167|1|0|0|2.5987525987526|2.95642901182108|CAV1|0
915|regulation of protein complex assembly (GO:0043254)|1/74|0.320576646762167|1|0|0|2.5987525987526|2.95642901182108|GSN|0
916|positive regulation of cytokine secretion (GO:0050715)|1/74|0.320576646762167|1|0|0|2.5987525987526|2.95642901182108|LPL|0
917|glucose homeostasis (GO:0042593)|1/75|0.324122763089818|1|0|0|2.56410256410256|2.88880240135468|IGF1|0
918|Ras protein signal transduction (GO:0007265)|2/224|0.325094777468198|1|0|0|1.71703296703297|1.92932437532116|PDPN;IGF1|0
919|axonogenesis (GO:0007409)|2/224|0.325094777468198|1|0|0|1.71703296703297|1.92932437532116|DOK2;S100A6|0
920|gland development (GO:0048732)|1/76|0.327650548241275|1|0|0|2.53036437246964|2.82339989940599|CAV1|0
921|negative regulation of cellular amide metabolic process (GO:0034249)|1/76|0.327650548241275|1|0|0|2.53036437246964|2.82339989940599|APOE|0
922|C-terminal protein lipidation (GO:0006501)|1/76|0.327650548241275|1|0|0|2.53036437246964|2.82339989940599|CD52|0
923|regulation of defense response (GO:0031347)|1/76|0.327650548241275|1|0|0|2.53036437246964|2.82339989940599|APOE|0
924|negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101)|1/78|0.334651499613662|1|0|0|2.465483234714|2.69887965558443|CAV1|0
925|water-soluble vitamin metabolic process (GO:0006767)|1/78|0.334651499613662|1|0|0|2.465483234714|2.69887965558443|ACP5|0
926|positive regulation of translation (GO:0045727)|1/79|0.338124852204166|1|0|0|2.43427458617332|2.63958146661543|RBM3|0
927|negative regulation of inflammatory response (GO:0050728)|1/79|0.338124852204166|1|0|0|2.43427458617332|2.63958146661543|APOE|0
928|steroid biosynthetic process (GO:0006694)|1/80|0.341580246038698|1|0|0|2.40384615384615|2.58214578484466|TSPO|0
929|negative regulation of mitotic cell cycle phase transition (GO:1901991)|1/80|0.341580246038698|1|0|0|2.40384615384615|2.58214578484466|GPNMB|0
930|response to calcium ion (GO:0051592)|1/80|0.341580246038698|1|0|0|2.40384615384615|2.58214578484466|CAV1|0
931|regulation of transforming growth factor beta receptor signaling pathway (GO:0017015)|1/80|0.341580246038698|1|0|0|2.40384615384615|2.58214578484466|CAV1|0
932|regulation of phosphatidylinositol 3-kinase signaling (GO:0014066)|1/81|0.345017773141698|1|0|0|2.37416904083571|2.52649417598517|IGF1|0
933|ERBB signaling pathway (GO:0038127)|1/81|0.345017773141698|1|0|0|2.37416904083571|2.52649417598517|PTPN18|0
934|negative regulation of defense response (GO:0031348)|1/81|0.345017773141698|1|0|0|2.37416904083571|2.52649417598517|APOE|0
935|positive regulation of protein targeting to mitochondrion (GO:1903955)|1/82|0.348437524976898|1|0|0|2.34521575984991|2.47255237619846|CTSK|0
936|epidermis development (GO:0008544)|1/82|0.348437524976898|1|0|0|2.34521575984991|2.47255237619846|FABP5|0
937|positive regulation of protein catabolic process (GO:0045732)|1/82|0.348437524976898|1|0|0|2.34521575984991|2.47255237619846|APOE|0
938|positive regulation of protein secretion (GO:0050714)|1/83|0.351839592581442|1|0|0|2.31696014828545|2.42025002349812|IGF1|0
939|positive regulation of DNA metabolic process (GO:0051054)|1/83|0.351839592581442|1|0|0|2.31696014828545|2.42025002349812|IGF1|0
940|C-terminal protein amino acid modification (GO:0018410)|1/83|0.351839592581442|1|0|0|2.31696014828545|2.42025002349812|CD52|0
941|negative regulation of binding (GO:0051100)|1/83|0.351839592581442|1|0|0|2.31696014828545|2.42025002349812|CAV1|0
942|positive regulation of protein ubiquitination (GO:0031398)|1/84|0.355224066533209|1|0|0|2.28937728937729|2.36952041043921|CAV1|0
943|negative regulation of endopeptidase activity (GO:0010951)|1/84|0.355224066533209|1|0|0|2.28937728937729|2.36952041043921|TIMP2|0
944|positive regulation of peptidyl-serine phosphorylation (GO:0033138)|1/84|0.355224066533209|1|0|0|2.28937728937729|2.36952041043921|CAV1|0
945|protein maturation (GO:0051604)|1/84|0.355224066533209|1|0|0|2.28937728937729|2.36952041043921|CTSS|0
946|positive regulation of supramolecular fiber organization (GO:1902905)|1/85|0.358591036946614|1|0|0|2.26244343891403|2.3203002549663|APOE|0
947|protein modification process (GO:0036211)|1/85|0.358591036946614|1|0|0|2.26244343891403|2.3203002549663|MAN2B1|0
948|regulation of mitotic nuclear division (GO:0007088)|1/85|0.358591036946614|1|0|0|2.26244343891403|2.3203002549663|IGF1|0
949|defense response to bacterium (GO:0042742)|2/242|0.359160300935774|1|0|0|1.58931977113795|1.62744194126209|IGKC;ANXA3|0
950|regulation of peptidyl-serine phosphorylation (GO:0033135)|1/87|0.365272825193939|1|0|0|2.210433244916|2.22615105731361|CAV1|0
951|mitochondrial translational elongation (GO:0070125)|1/88|0.368587820969487|1|0|0|2.18531468531469|2.1811107421595|MRPL52|0
952|calcium ion homeostasis (GO:0055074)|1/88|0.368587820969487|1|0|0|2.18531468531469|2.1811107421595|CAV1|0
953|regulation of MAP kinase activity (GO:0043405)|1/88|0.368587820969487|1|0|0|2.18531468531469|2.1811107421595|APOE|0
954|divalent metal ion transport (GO:0070838)|1/89|0.371885669070365|1|0|0|2.16076058772688|2.13735698607752|CAV1|0
955|mitochondrial translational termination (GO:0070126)|1/90|0.375166457303627|1|0|0|2.13675213675214|2.09484073794238|MRPL52|0
956|cell-matrix adhesion (GO:0007160)|1/91|0.37843027311941|1|0|0|2.11327134404058|2.05351530440872|CD63|0
957|regulation of Ras protein signal transduction (GO:0046578)|1/91|0.37843027311941|1|0|0|2.11327134404058|2.05351530440872|IGF1|0
958|regulation of cytokine-mediated signaling pathway (GO:0001959)|1/91|0.37843027311941|1|0|0|2.11327134404058|2.05351530440872|CD74|0
959|inflammatory response (GO:0006954)|2/253|0.379680914942682|1|0|0|1.52021891152326|1.47221659550685|PRDX5;CYBA|0
960|positive regulation of cellular protein metabolic process (GO:0032270)|1/92|0.381677203450944|1|0|0|2.09030100334448|2.01333621393798|RBM3|0
961|cellular response to acid chemical (GO:0071229)|1/92|0.381677203450944|1|0|0|2.09030100334448|2.01333621393798|LAMTOR4|0
962|regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618)|1/94|0.388120753293855|1|0|0|2.04582651391162|1.93624952526225|HMOX1|0
963|regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281)|1/94|0.388120753293855|1|0|0|2.04582651391162|1.93624952526225|BCAP31|0
964|axon development (GO:0061564)|1/95|0.391317544490511|1|0|0|2.02429149797571|1.89926298451926|S100A6|0
965|positive regulation of protein localization to membrane (GO:1905477)|1/96|0.394497793652641|1|0|0|2.00320512820513|1.86326468645997|TREM2|0
966|regulation of B cell activation (GO:0050864)|1/96|0.394497793652641|1|0|0|2.00320512820513|1.86326468645997|IGKC|0
967|regulation of heart contraction (GO:0008016)|1/96|0.394497793652641|1|0|0|2.00320512820513|1.86326468645997|S100A1|0
968|positive regulation of protein metabolic process (GO:0051247)|1/97|0.397661585494419|1|0|0|1.98255352894528|1.82821951447224|APOE|0
969|translational termination (GO:0006415)|1/97|0.397661585494419|1|0|0|1.98255352894528|1.82821951447224|MRPL52|0
970|epithelial cell differentiation (GO:0030855)|1/97|0.397661585494419|1|0|0|1.98255352894528|1.82821951447224|CTSB|0
971|cellular metal ion homeostasis (GO:0006875)|1/97|0.397661585494419|1|0|0|1.98255352894528|1.82821951447224|CAV1|0
972|cell morphogenesis involved in neuron differentiation (GO:0048667)|1/98|0.400809004398637|1|0|0|1.96232339089482|1.79409392346816|S100A6|0
973|positive regulation of neuron projection development (GO:0010976)|1/98|0.400809004398637|1|0|0|1.96232339089482|1.79409392346816|APOE|0
974|cellular response to organonitrogen compound (GO:0071417)|1/98|0.400809004398637|1|0|0|1.96232339089482|1.79409392346816|LAMTOR4|0
975|positive regulation of cell growth (GO:0030307)|1/99|0.403940134304531|1|0|0|1.94250194250194|1.76085585550819|IGF1|0
976|positive regulation of neuron differentiation (GO:0045666)|1/99|0.403940134304531|1|0|0|1.94250194250194|1.76085585550819|APOE|0
977|small GTPase mediated signal transduction (GO:0007264)|1/100|0.407055058636552|1|0|0|1.92307692307692|1.7284746605455|IGF1|0
978|cellular response to metal ion (GO:0071248)|1/101|0.410153860479893|1|0|0|1.9040365575019|1.69692102097602|B2M|0
979|cellular divalent inorganic cation homeostasis (GO:0072503)|1/102|0.413236622501037|1|0|0|1.88536953242836|1.66616688206696|CAV1|0
980|regulation of protein ubiquitination (GO:0031396)|1/102|0.413236622501037|1|0|0|1.88536953242836|1.66616688206696|CAV1|0
981|regulation of kinase activity (GO:0043549)|1/102|0.413236622501037|1|0|0|1.88536953242836|1.66616688206696|CD74|0
982|intrinsic apoptotic signaling pathway (GO:0097193)|1/102|0.413236622501037|1|0|0|1.88536953242836|1.66616688206696|CRIP1|0
983|cellular response to oxygen-containing compound (GO:1901701)|2/275|0.419870241665258|1|0|0|1.3986013986014|1.21371966972751|PRDX5;LAMTOR4|0
984|B cell receptor signaling pathway (GO:0050853)|1/105|0.422389489743689|1|0|0|1.83150183150183|1.57843851489971|IGKC|0
985|positive regulation of lymphocyte activation (GO:0051251)|1/105|0.422389489743689|1|0|0|1.83150183150183|1.57843851489971|IGKC|0
986|translational elongation (GO:0006414)|1/106|0.425408910429119|1|0|0|1.81422351233672|1.55062487379114|MRPL52|0
987|cellular response to cytokine stimulus (GO:0071345)|3/457|0.425493990644706|1|0|0|1.26241373506144|1.07873815954293|PTPN18;FN1;HMOX1|0
988|MAPK cascade (GO:0000165)|2/279|0.427040038557381|1|0|0|1.37854976564654|1.17297698240429|CTSH;IGF1|0
989|fatty acid metabolic process (GO:0006631)|1/107|0.428412698260455|1|0|0|1.79726815240834|1.52348723888746|LPL|0
990|negative regulation of response to external stimulus (GO:0032102)|1/108|0.431400933441513|1|0|0|1.78062678062678|1.49700388404553|APOE|0
991|regulation of protein secretion (GO:0050708)|1/108|0.431400933441513|1|0|0|1.78062678062678|1.49700388404553|IGF1|0
992|viral life cycle (GO:0019058)|1/108|0.431400933441513|1|0|0|1.78062678062678|1.49700388404553|APOE|0
993|mitochondrial translation (GO:0032543)|1/108|0.431400933441513|1|0|0|1.78062678062678|1.49700388404553|MRPL52|0
994|regulation of response to external stimulus (GO:0032101)|1/108|0.431400933441513|1|0|0|1.78062678062678|1.49700388404553|CAV1|0
995|positive regulation of cell cycle process (GO:0090068)|1/108|0.431400933441513|1|0|0|1.78062678062678|1.49700388404553|IGF1|0
996|monocarboxylic acid metabolic process (GO:0032787)|1/109|0.434373695593162|1|0|0|1.76429075511644|1.47115396192411|IGF1|0
997|regulation of cytokine production (GO:0001817)|1/109|0.434373695593162|1|0|0|1.76429075511644|1.47115396192411|GPNMB|0
998|negative regulation of signal transduction (GO:0009968)|2/284|0.43593803258493|1|0|0|1.35427952329361|1.12439757967619|PTPN18;LGMN|0
999|circulatory system development (GO:0072359)|1/110|0.437331064095217|1|0|0|1.74825174825175|1.44591745973137|CRIP1|0
1000|negative regulation of protein kinase activity (GO:0006469)|1/110|0.437331064095217|1|0|0|1.74825174825175|1.44591745973137|CAV1|0
1001|positive regulation of establishment of protein localization to mitochondrion (GO:1903749)|1/111|0.440273117947782|1|0|0|1.73250173250173|1.42127515944184|CTSK|0
1002|phosphatidylinositol metabolic process (GO:0046488)|1/113|0.446111595340578|1|0|0|1.70183798502383|1.37370004168177|PLA2G16|0
1003|positive regulation of kinase activity (GO:0033674)|1/114|0.449008174732391|1|0|0|1.68690958164642|1.35073243062531|CD74|0
1004|positive regulation of canonical Wnt signaling pathway (GO:0090263)|1/114|0.449008174732391|1|0|0|1.68690958164642|1.35073243062531|CAV1|0
1005|epithelium development (GO:0060429)|1/116|0.454756401895657|1|0|0|1.657824933687|1.30635507932291|CTSB|0
1006|regulation of macroautophagy (GO:0016241)|1/117|0.457608203052954|1|0|0|1.64365548980934|1.28491438662909|LAMTOR4|0
1007|cellular response to interferon-gamma (GO:0071346)|1/117|0.457608203052954|1|0|0|1.64365548980934|1.28491438662909|B2M|0
1008|activation of MAPK activity (GO:0000187)|1/118|0.460445231058563|1|0|0|1.62972620599739|1.26395267927056|IGF1|0
1009|protein localization to cell periphery (GO:1990778)|1/118|0.460445231058563|1|0|0|1.62972620599739|1.26395267927056|CAV1|0
1010|calcium ion transport (GO:0006816)|1/119|0.463267561542036|1|0|0|1.61603102779573|1.24345589060805|CAV1|0
1011|plasma membrane bounded cell projection organization (GO:0120036)|1/119|0.463267561542036|1|0|0|1.61603102779573|1.24345589060805|PDPN|0
1012|regulation of neuron projection development (GO:0010975)|1/120|0.466075270133533|1|0|0|1.6025641025641|1.22341047116726|APOE|0
1013|actin filament organization (GO:0007015)|1/121|0.468868431656648|1|0|0|1.58931977113795|1.20380336841762|GSN|0
1014|DNA replication (GO:0006260)|1/121|0.468868431656648|1|0|0|1.58931977113795|1.20380336841762|IGF1|0
1015|macromolecular complex assembly (GO:0065003)|1/121|0.468868431656648|1|0|0|1.58931977113795|1.20380336841762|CD74|0
1016|negative regulation of cell migration (GO:0030336)|1/122|0.471647120876721|1|0|0|1.57629255989912|1.18462200231542|HMOX1|0
1017|cellular calcium ion homeostasis (GO:0006874)|1/124|0.477161378895785|1|0|0|1.55086848635236|1.14748840690919|CAV1|0
1018|positive regulation of apoptotic process (GO:0043065)|2/308|0.477589446919807|1|0|0|1.24875124875125|0.922831934580323|BCAP31;CTSH|0
1019|dephosphorylation (GO:0016311)|1/125|0.479897095148671|1|0|0|1.53846153846154|1.12951320487832|PTPN18|0
1020|negative regulation of macromolecule metabolic process (GO:0010605)|1/125|0.479897095148671|1|0|0|1.53846153846154|1.12951320487832|MSR1|0
1021|protein dephosphorylation (GO:0006470)|1/126|0.482618633755137|1|0|0|1.52625152625153|1.11191775848181|PTPN18|0
1022|negative regulation of multicellular organismal process (GO:0051241)|1/126|0.482618633755137|1|0|0|1.52625152625153|1.11191775848181|GPNMB|0
1023|cytoskeleton organization (GO:0007010)|1/127|0.485326067677058|1|0|0|1.51423379769836|1.09469156488688|APOE|0
1024|positive regulation of nucleic acid-templated transcription (GO:1903508)|3/503|0.48782938609228|1|0|0|1.14696436764031|0.823279040667385|CD74;SPP1;IGF1|0
1025|vesicle organization (GO:0016050)|1/128|0.488019469161478|1|0|0|1.50240384615385|1.07782448633129|CAV1|0
1026|protein lipidation (GO:0006497)|1/128|0.488019469161478|1|0|0|1.50240384615385|1.07782448633129|CD52|0
1027|positive regulation of mitochondrion organization (GO:0010822)|1/129|0.490698910224265|1|0|0|1.49075730471079|1.06130673337538|CTSK|0
1028|protein glycosylation (GO:0006486)|1/131|0.496016197552214|1|0|0|1.46799765120376|1.02928170351607|B4GALT1|0
1029|cellular response to hypoxia (GO:0071456)|1/133|0.501278498632988|1|0|0|1.44592249855408|0.998544602153549|HMOX1|0
1030|Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096)|1/134|0.50388920548158|1|0|0|1.43513203214696|0.983637866634187|IGKC|0
1031|protein targeting (GO:0006605)|1/134|0.50388920548158|1|0|0|1.43513203214696|0.983637866634187|TSPO|0
1032|cellular response to organic substance (GO:0071310)|1/134|0.50388920548158|1|0|0|1.43513203214696|0.983637866634187|PTPN18|0
1033|adenylate cyclase-modulating G-protein coupled receptor signaling pathway (GO:0007188)|1/135|0.506486376487758|1|0|0|1.42450142450142|0.969028280646664|PSAP|0
1034|Fc-gamma receptor signaling pathway (GO:0038094)|1/135|0.506486376487758|1|0|0|1.42450142450142|0.969028280646664|IGKC|0
1035|Fc receptor mediated stimulatory signaling pathway (GO:0002431)|1/136|0.509070081208654|1|0|0|1.41402714932127|0.954708127553386|IGKC|0
1036|cellular response to organic cyclic compound (GO:0071407)|1/136|0.509070081208654|1|0|0|1.41402714932127|0.954708127553386|SPP1|0
1037|mitochondrial transport (GO:0006839)|1/136|0.509070081208654|1|0|0|1.41402714932127|0.954708127553386|TSPO|0
1038|protein transport (GO:0015031)|2/327|0.509229315323487|1|0|0|1.1761938367443|0.793762458976277|CD74;APOE|0
1039|cellular protein localization (GO:0034613)|2/328|0.51086025691044|1|0|0|1.17260787992495|0.787592865877944|CD63;CD74|0
1040|muscle contraction (GO:0006936)|1/138|0.514197367801836|1|0|0|1.39353400222965|0.926906498299493|MYOF|0
1041|positive regulation of transferase activity (GO:0051347)|1/138|0.514197367801836|1|0|0|1.39353400222965|0.926906498299493|CD74|0
1042|regulation of cellular component organization (GO:0051128)|1/141|0.521789017437466|1|0|0|1.36388434260775|0.887195790994267|GSN|0
1043|positive regulation of Wnt signaling pathway (GO:0030177)|1/141|0.521789017437466|1|0|0|1.36388434260775|0.887195790994267|CAV1|0
1044|cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742)|1/143|0.526784720890206|1|0|0|1.34480903711673|0.861973255996366|CD84|0
1045|cellular protein complex assembly (GO:0043623)|1/145|0.531728732420551|1|0|0|1.3262599469496|0.837694723010057|CYBA|0
1046|heart development (GO:0007507)|1/150|0.543866072137421|1|0|0|1.28205128205128|0.780836222256426|CRIP1|0
1047|negative regulation of cell differentiation (GO:0045596)|1/151|0.546255885851797|1|0|0|1.27356087620988|0.77008119920486|CAV1|0
1048|positive regulation of intracellular protein transport (GO:0090316)|1/153|0.550998373416186|1|0|0|1.2569130216189|0.749149600165056|CTSK|0
1049|protein stabilization (GO:0050821)|1/153|0.550998373416186|1|0|0|1.2569130216189|0.749149600165056|IGF1|0
1050|axon guidance (GO:0007411)|1/159|0.564933265661726|1|0|0|1.20948234155781|0.69067207146195|DOK2|0
1051|protein localization to membrane (GO:0072657)|1/161|0.569482367170098|1|0|0|1.19445771619685|0.672512492263662|CAV1|0
1052|negative regulation of intracellular signal transduction (GO:1902532)|1/162|0.571739220087638|1|0|0|1.18708452041785|0.663666073715708|CAV1|0
1053|cellular macromolecule biosynthetic process (GO:0034645)|2/368|0.573163194891788|1|0|0|1.04515050167224|0.581714877694795|MRPL52;IGF1|0
1054|neuron projection morphogenesis (GO:0048812)|1/164|0.576217833000832|1|0|0|1.17260787992495|0.646422968440471|S100A6|0
1055|neuron projection development (GO:0031175)|1/168|0.585036363567034|1|0|0|1.14468864468864|0.613646146678665|APOE|0
1056|mitochondrion organization (GO:0007005)|1/168|0.585036363567034|1|0|0|1.14468864468864|0.613646146678665|TSPO|0
1057|positive regulation of hydrolase activity (GO:0051345)|1/173|0.595804337375292|1|0|0|1.11160515784793|0.575636903969771|CTSH|0
1058|peptide biosynthetic process (GO:0043043)|1/175|0.60003362307854|1|0|0|1.0989010989011|0.561285260298739|MRPL52|0
1059|positive regulation of MAP kinase activity (GO:0043406)|1/178|0.606295507379914|1|0|0|1.08038029386344|0.540609092294877|IGF1|0
1060|cellular response to lipid (GO:0071396)|1/179|0.608361148316695|1|0|0|1.07434464976364|0.533934872602719|SPP1|0
1061|negative regulation of protein phosphorylation (GO:0001933)|1/179|0.608361148316695|1|0|0|1.07434464976364|0.533934872602719|CAV1|0
1062|ER to Golgi vesicle-mediated transport (GO:0006888)|1/181|0.612460282980084|1|0|0|1.06247343816405|0.520900109200886|BCAP31|0
1063|transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169)|2/397|0.614658775947465|1|0|0|0.968804495252858|0.471505523165832|CYBA;IGF1|0
1064|Fc-epsilon receptor signaling pathway (GO:0038095)|1/183|0.616516921692546|1|0|0|1.05086170659941|0.508269765398847|IGKC|0
1065|Fc receptor signaling pathway (GO:0038093)|1/184|0.618529441554061|1|0|0|1.04515050167224|0.502101261224887|IGKC|0
1066|protein complex assembly (GO:0006461)|1/190|0.630386760482412|1|0|0|1.01214574898785|0.467026055092946|FN1|0
1067|RNA metabolic process (GO:0016070)|1/192|0.634257503018601|1|0|0|1.00160256410256|0.456029898661105|RBM3|0
1068|gene expression (GO:0010467)|2/412|0.634897730247191|1|0|0|0.933532486930545|0.42409573169248|RBM3;MRPL52|0
1069|cilium organization (GO:0044782)|1/193|0.636177791906817|1|0|0|0.996412913511359|0.4506548502239|GSN|0
1070|RNA processing (GO:0006396)|1/194|0.638088095057311|1|0|0|0.991276764472641|0.445359759260887|RBM3|0
1071|regulation of cellular macromolecule biosynthetic process (GO:2000112)|3/632|0.642675146480213|1|0|0|0.912852969814995|0.403586810342183|RBM3;MAFB;NME2|0
1072|regulation of translation (GO:0006417)|1/214|0.67427443844323|1|0|0|0.89863407620417|0.354167929767637|RBM3|0
1073|positive regulation of sequence-specific DNA binding transcription factor activity (GO:0051091)|1/216|0.677689695666164|1|0|0|0.89031339031339|0.346390466360381|ANXA3|0
1074|positive regulation of cytokine production (GO:0001819)|1/221|0.686073460273673|1|0|0|0.870170553428472|0.327854657189689|CYBA|0
1075|apoptotic process (GO:0006915)|1/232|0.703765061805426|1|0|0|0.828912466843501|0.291205816932248|TSPO|0
1076|translation (GO:0006412)|1/233|0.705323554631276|1|0|0|0.825354902608121|0.288130272955165|MRPL52|0
1077|regulation of signal transduction (GO:0009966)|1/234|0.706873926665639|1|0|0|0.821827744904668|0.285094469538655|CD63|0
1078|activation of protein kinase activity (GO:0032147)|1/234|0.706873926665639|1|0|0|0.821827744904668|0.285094469538655|IGF1|0
1079|plasma membrane bounded cell projection assembly (GO:0120031)|1/242|0.718989536164475|1|0|0|0.794659885568976|0.262165030741281|GSN|0
1080|regulation of transcription, DNA-templated (GO:0006355)|7/1599|0.735064435808013|1|0|0|0.841872324048684|0.259125873252662|CD74;MAFB;CREG1;NME2;SPP1;APOE;IGF1|0
1081|antigen receptor-mediated signaling pathway (GO:0050851)|1/258|0.741752423790763|1|0|0|0.745378652355397|0.222674233863453|IGKC|0
1082|Golgi vesicle transport (GO:0048193)|1/272|0.76016566746238|1|0|0|0.707013574660634|0.193876474797497|BCAP31|0
1083|cilium assembly (GO:0060271)|1/289|0.780784212734176|1|0|0|0.665424540857067|0.16466360356286|GSN|0
1084|chemical synaptic transmission (GO:0007268)|1/290|0.781940840068685|1|0|0|0.663129973474801|0.163114186594609|APOE|0
1085|ion transport (GO:0006811)|1/290|0.781940840068685|1|0|0|0.663129973474801|0.163114186594609|TSPO|0
1086|DNA metabolic process (GO:0006259)|1/315|0.808971117322508|1|0|0|0.610500610500611|0.129421284654259|IGF1|0
1087|cellular response to DNA damage stimulus (GO:0006974)|1/330|0.823567432145441|1|0|0|0.582750582750583|0.113117626982208|CRIP1|0
1088|regulation of nucleic acid-templated transcription (GO:1903506)|2/608|0.828907681155058|1|0|0|0.632591093117409|0.118703499331199|MAFB;NME2|0
1089|intracellular protein transport (GO:0006886)|1/348|0.83963130141495|1|0|0|0.552608311229001|0.0965917387203494|CD74|0
1090|positive regulation of transcription, DNA-templated (GO:0045893)|4/1121|0.841436884878349|1|0|0|0.686200507788376|0.118468586618816|CD74;NME2;SPP1;IGF1|0
1091|organelle assembly (GO:0070925)|1/377|0.862518497837472|1|0|0|0.510099979596001|0.0754431154552731|GSN|0
1092|regulation of transcription from RNA polymerase II promoter (GO:0006357)|5/1479|0.891116731071209|1|0|0|0.650127424975295|0.0749465912449249|CAV1;CREG1;NME2;APOE;IGF1|0
1093|nervous system development (GO:0007399)|1/456|0.909725794305006|1|0|0|0.421727395411606|0.0399004933444149|MAFB|0
1094|negative regulation of transcription, DNA-templated (GO:0045892)|2/814|0.928613222189656|1|0|0|0.472500472500473|0.034994785794102|PRDX5;CAV1|0
1095|positive regulation of transcription from RNA polymerase II promoter (GO:0045944)|2/849|0.93882689280467|1|0|0|0.453021654435082|0.0285966156924916|NME2;IGF1|0
1096|negative regulation of transcription from RNA polymerase II promoter (GO:0000122)|1/566|0.949885327205609|1|0|0|0.339766240826312|0.017468744862053|CAV1|0
1097|negative regulation of gene expression (GO:0010629)|1/619|0.962303859496569|1|0|0|0.310674785634398|0.0119376835863884|MSR1|0
1098|neutrophil mediated immunity (GO:0002446)|24/488|1.26281326928018e-08|6.44413611313675e-05|0|0|3.9344262295082|71.556742656322|KMT2E;HSPA8;HSP90AA1;HSP90AB1;JUP;ANXA2;C5AR1;FPR1;MGST1;MCEMP1;FPR2;IQGAP1;PYGL;RAB44;CYB5R3;SLPI;TMBIM1;SIRPA;QSOX1;CD36;CAPN1;S100A9;CD44;HSPA1A|1
1099|neutrophil degranulation (GO:0043312)|23/480|4.15413077386657e-08|0.000105992646695206|0|0|3.83333333333333|65.1535472273227|HSPA8;HSP90AA1;HSP90AB1;JUP;ANXA2;C5AR1;FPR1;MGST1;MCEMP1;FPR2;IQGAP1;PYGL;RAB44;CYB5R3;SLPI;TMBIM1;SIRPA;QSOX1;CD36;CAPN1;S100A9;CD44;HSPA1A|1
1100|neutrophil activation involved in immune response (GO:0002283)|23/484|4.83166683309205e-08|8.21866528308958e-05|0|0|3.80165289256198|64.040702879909|HSPA8;HSP90AA1;HSP90AB1;JUP;ANXA2;C5AR1;FPR1;MGST1;MCEMP1;FPR2;IQGAP1;PYGL;RAB44;CYB5R3;SLPI;TMBIM1;SIRPA;QSOX1;CD36;CAPN1;S100A9;CD44;HSPA1A|1
1101|regulation of apoptotic process (GO:0042981)|30/816|1.29590932765552e-07|0.000165325632475653|0|0|2.94117647058824|46.6437735844251|FLT1;PREX1;CCND2;MIEN1;MYC;PERP;UBC;FFAR4;FLNA;JUN;XBP1;TGFB1;HSPA5;DAPK1;MERTK;CIDEC;GADD45G;RHOB;NET1;FABP1;DNAJA1;SON;PPT1;ARHGEF3;TMBIM6;ANGPTL4;SGK1;CD44;ATF4;HSPA1A|1
1102|response to unfolded protein (GO:0006986)|7/44|1.13243883691129e-06|0.00115576707695166|0|0|12.7272727272727|174.250834395146|DNAJA1;HSPA8;HSP90AA1;HSP90AB1;HSPA5;HERPUD1;HSPA1A|1
1103|negative regulation of programmed cell death (GO:0043069)|18/409|4.29551223151186e-06|0.00365333315290084|0|0|3.52078239608802|43.509616714403|XBP1;FLT1;HSPA5;MERTK;FABP1;DNAJA1;CCND2;SON;MIEN1;MYC;UBC;PPT1;FFAR4;FLNA;TMBIM6;ANGPTL4;CD44;HSPA1A|1
1104|negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236)|4/14|2.16185173408674e-05|0.0157598991414923|0|0|22.8571428571429|245.530521742469|XBP1;TMBIM6;HERPUD1;HSPA1A|1
1105|mitochondrial electron transport, NADH to ubiquinone (GO:0006120)|6/47|2.51111965477562e-05|0.0160178044979|0|0|10.2127659574468|108.175626216406|MT-ND4L;MT-ND4;MT-ND5;NDUFA4;MT-ND2;MT-ND3|1
1106|negative regulation of apoptotic process (GO:0043066)|18/486|4.33437344790295e-05|0.0245758974496097|0|0|2.96296296296296|29.7669582178945|XBP1;FLT1;HSPA5;MERTK;FABP1;DNAJA1;CCND2;SON;MIEN1;MYC;UBC;PPT1;FFAR4;FLNA;TMBIM6;ANGPTL4;CD44;HSPA1A|1
1107|regulation of cellular response to heat (GO:1900034)|7/79|5.90873653880588e-05|0.0301522825575264|0|0|7.08860759493671|69.0181813470281|HSPA8;HSP90AA1;CAMK2D;HSP90AB1;FKBP4;IER5;HSPA1A|1
1108|fatty acid metabolic process (GO:0006631)|8/107|5.98473974564637e-05|0.0277637517473031|0|0|5.98130841121495|58.1605240304596|PLA2G15;XBP1;ABCD2;PNPLA8;ACOT1;LTC4S;LPIN1;ADIPOR2|1
1109|regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235)|4/20|9.86373255131275e-05|0.0419455226744574|0|0|16|147.584973009434|XBP1;TMBIM6;HERPUD1;HSPA1A|1
1110|phosphatidylethanolamine metabolic process (GO:0046337)|4/20|9.86373255131275e-05|0.0387189440071915|0|0|16|147.584973009434|PLA2G15;CHKA;PNPLA8;LPIN1|1
1111|negative regulation of response to endoplasmic reticulum stress (GO:1903573)|4/22|0.000146024740264553|0.0532260178264297|0|0|14.5454545454545|128.461592679925|XBP1;TMBIM6;HERPUD1;HSPA1A|1
1112|regulation of cell migration (GO:0030334)|13/317|0.000189512206311338|0.0644720525871173|0|0|3.2807570977918|28.1195564894459|XBP1;CLIC4;TGFB1;FLT1;HSPA5;LMO4;PLET1;SYNE2;RHOB;MIEN1;MYADM;FLNA;SGK1|1
1113|membrane raft organization (GO:0031579)|3/10|0.000217014209133454|0.0692139693255011|0|0|24|202.453145440557|ANXA2;PPT1;MYADM|1
1114|complement receptor mediated signaling pathway (GO:0002430)|3/10|0.000217014209133454|0.0651425593651775|0|0|24|202.453145440557|C5AR1;FPR1;FPR2|1
1115|positive regulation of ERK1 and ERK2 cascade (GO:0070374)|10/202|0.000237824125841329|0.0674231396760167|0|0|3.96039603960396|33.0454618792744|MARCO;TGFB1;FLT1;C5AR1;FFAR4;FPR2;CD36;MERTK;SCIMP;CD44|1
1116|regulation of ERK1 and ERK2 cascade (GO:0070372)|11/248|0.000303238472248952|0.0814434696782317|0|0|3.54838709677419|28.7454520237711|MARCO;TGFB1;FLT1;C5AR1;FFAR4;FPR2;CD36;EZR;MERTK;SCIMP;CD44|1
1117|positive regulation of cellular process (GO:0048522)|17/520|0.000311462884933138|0.0794697550906901|0|0|2.61538461538462|21.1172179073193|JUN;XBP1;JUND;TGFB1;HSP90AB1;FLT1;CD81;CCND2;EPCAM;MYC;RARA;FLNA;CD36;CAPN1;EZR;IER5;S100A9|1
1118|PERK-mediated unfolded protein response (GO:0036499)|3/12|0.000390556016187716|0.094905111933615|0|0|20|156.958783032568|HSPA5;HERPUD1;ATF4|1
1119|response to endoplasmic reticulum stress (GO:0034976)|7/107|0.000395460070453804|0.0917287608875345|0|0|5.23364485981308|41.0080188026954|JUN;HSPA5;FAM129A;DNAJB9;PDIA6;ATF4;HERPUD1|1
1120|response to lipid (GO:0033993)|8/141|0.000404179583754895|0.0896751485174447|0|0|4.53900709219858|35.4662185056478|JUN;TGFB1;JUND;SLPI;RARA;CD36;TRIB1;ABCG1|1
1121|fatty acid beta-oxidation (GO:0006635)|5/51|0.00043087222004998|0.091614205788127|0|0|7.84313725490196|60.7819528236808|HADHA;ABCD2;SCP2;HSD17B4;ACOX3|1
1122|positive regulation of transcription from RNA polymerase II promoter (GO:0045944)|23/849|0.00043503553009302|0.0887994524025872|0|0|2.16725559481743|16.7747378649927|TCF7L2;JUN;XBP1;JUND;TGFB1;JUP;CD81;IL18;FOS;PBX1;RUNX1;PLSCR1;GAL;EPCAM;MYC;UBC;NRIP1;RARA;CCNL1;LPIN1;IER5;IER2;ATF4|1
1123|cellular response to low-density lipoprotein particle stimulus (GO:0071404)|3/13|0.000503045178178171|0.0987322901632002|0|0|18.4615384615385|140.212256759008|CD81;CD9;CD36|1
1124|positive regulation of cell-substrate adhesion (GO:0010811)|5/53|0.000515805565214829|0.0974872518256026|0|0|7.54716981132075|57.1304201893827|CDK6;JUP;MYADM;FLNA;CD36|1
1125|positive regulation of apoptotic process (GO:0043065)|12/308|0.000526964566351436|0.0960392922175493|0|0|3.11688311688312|23.5274096048047|NET1;DNAJA1;PREX1;JUN;DAPK1;MYC;STK17B;UBC;ARHGEF3;ATF4;GADD45G;RHOB|1
1126|ERBB signaling pathway (GO:0038127)|6/81|0.000532948529952848|0.0937805637361857|0|0|5.92592592592593|44.6642115860971|HSP90AA1;TGFB1;UBC;IQGAP1;PTPN12;PAG1|1
1127|acylglycerol catabolic process (GO:0046464)|4/31|0.000575058843563357|0.097817509290127|0|0|10.3225806451613|77.0171683692494|ABHD12;FABP1;MGLL;PNPLA2|1
1128|regulated exocytosis (GO:0045055)|8/149|0.000583572197487456|0.0960635136702738|0|0|4.29530201342282|31.984289426566|RAB11FIP1;TGFB1;APLP2;FLNA;CD9;TAGLN2;QSOX1;CD36|1
1129|regulation of protein modification by small protein conjugation or removal (GO:1903320)|3/14|0.000634344208550911|0.101158078007353|0|0|17.1428571428571|126.221465745549|HSP90AA1;HSP90AB1;HSPA1A|1
1130|receptor-mediated endocytosis (GO:0006898)|9/189|0.000641703343797334|0.0992306716181151|0|0|3.80952380952381|28.005274066207|MARCO;HSP90AA1;CD81;PPT1;CD9;FPR2;ADRB2;CD36;RAMP1|1
1131|long-chain fatty acid metabolic process (GO:0001676)|5/56|0.00066603931838099|0.0999646659322997|0|0|7.14285714285714|52.2440132325599|SCP2;PNPLA8;ACOT1;HSD17B4;MGLL|1
1132|mitochondrial ATP synthesis coupled electron transport (GO:0042775)|6/86|0.000733112843438832|0.106887852573382|0|0|5.58139534883721|40.2876888587924|MT-ND4L;MT-ND4;MT-ND5;NDUFA4;MT-ND2;MT-ND3|1
1133|activation of protein kinase activity (GO:0032147)|10/234|0.000755254365729669|0.107057306342181|0|0|3.41880341880342|24.5759178024098|DUSP5;PRKAR2B;CD81;C5AR1;UBC;FPR1;IL18;ADCY3;ADRB2;GADD45G|1
1134|fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540)|3/15|0.000785633481140693|0.108353720385431|0|0|16|114.384322932355|SCP2;HSD17B4;ACOX3|1
1135|glycerophospholipid catabolic process (GO:0046475)|3/15|0.000785633481140693|0.105502306691078|0|0|16|114.384322932355|PLA2G15;ABHD12;PNPLA8|1
1136|receptor metabolic process (GO:0043112)|5/59|0.000846835167586866|0.110805124620405|0|0|6.77966101694915|47.9593524717705|TGFB1;CD81;CD9;CD36;RAMP1|1
1137|platelet degranulation (GO:0002576)|7/125|0.00100069003628763|0.127663031379395|0|0|4.48|30.9436533533571|TGFB1;APLP2;FLNA;CD9;TAGLN2;QSOX1;CD36|1
1138|actin filament bundle organization (GO:0061572)|4/36|0.00102518616488355|0.127598170717092|0|0|8.88888888888889|61.181164965394|LIMA1;NEDD9;EZR;RHOB|1
1139|regulation of cell proliferation (GO:0042127)|20/741|0.00107579830510046|0.130709494069706|0|0|2.15924426450742|14.7577701130465|CD164;TCF7L2;JUN;XBP1;BTG2;JUND;TGFB1;FLT1;JUP;CD81;BMX;CCND2;CDK6;EPCAM;MYC;RARA;CAPN1;SGK1;IER5;HSPA1A|1
1140|positive regulation of MAPK cascade (GO:0043410)|11/290|0.00110956077461708|0.131676479834208|0|0|3.03448275862069|20.6459866056867|MARCO;TGFB1;FLT1;C5AR1;FFAR4;FPR2;CD36;ADRB2;MERTK;SCIMP;CD44|1
1141|negative regulation of intrinsic apoptotic signaling pathway (GO:2001243)|5/63|0.00114182498894803|0.13242574815004|0|0|6.34920634920635|43.0166820895233|DNAJA1;XBP1;TMBIM6;HERPUD1;HSPA1A|1
1142|regulation of tissue remodeling (GO:0034103)|3/17|0.00115264244589889|0.130709653364934|0|0|14.1176470588235|95.5157392012484|TGFB1;IL18;LEPR|1
1143|positive regulation of cellular protein catabolic process (GO:1903364)|3/17|0.00115264244589889|0.127868139161348|0|0|14.1176470588235|95.5157392012484|HSP90AA1;CD81;EZR|1
1144|chaperone-mediated protein complex assembly (GO:0051131)|3/17|0.00115264244589889|0.125147540455788|0|0|14.1176470588235|95.5157392012484|HSP90AA1;HSP90AB1;HSPA1A|1
1145|respiratory electron transport chain (GO:0022904)|6/95|0.00123477977127394|0.131272524433561|0|0|5.05263157894737|33.8367796934335|MT-ND4L;MT-ND4;MT-ND5;NDUFA4;MT-ND2;MT-ND3|1
1146|actin filament bundle assembly (GO:0051017)|4/38|0.00125983496062605|0.131202812328056|0|0|8.42105263157895|56.2254698966566|LIMA1;NEDD9;EZR;RHOB|1
1147|cellular response to reactive oxygen species (GO:0034614)|5/66|0.00140847147953416|0.143748599201256|0|0|6.06060606060606|39.7893952707569|NET1;FABP1;JUN;FOS;RHOB|1
1148|fatty acid catabolic process (GO:0009062)|5/66|0.00140847147953416|0.140929999216918|0|0|6.06060606060606|39.7893952707569|PLA2G15;HADHA;ABCD2;HSD17B4;LPIN1|1
1149|cellular response to organic substance (GO:0071310)|7/134|0.00149868324109827|0.147072703448547|0|0|4.17910447761194|27.1774201610019|JUN;TGFB1;JUND;FFAR4;IL18;PTPN12;RAMP1|1
1150|adenylate cyclase-modulating G-protein coupled receptor signaling pathway (GO:0007188)|7/135|0.00156415393715854|0.150601463043774|0|0|4.14814814814815|26.7987386754756|MARCO;FPR1;ADCY3;ADRB1;FPR2;ADRB2;RAMP1|1
1151|positive regulation of pri-miRNA transcription from RNA polymerase II promoter (GO:1902895)|3/19|0.00161248682734834|0.152380005184418|0|0|12.6315789473684|81.2207706747033|JUN;TGFB1;FOS|1
1152|regulation of cell cycle (GO:0051726)|9/216|0.00163743767626484|0.151924444763263|0|0|3.33333333333333|21.3820755049182|JUN;JUND;TGFB1;SON;CDK6;RARA;IQGAP1;GADD45G;RHOB|1
1153|positive regulation of transferase activity (GO:0051347)|7/138|0.00177401049179392|0.161656706064721|0|0|4.05797101449275|25.7052680384773|HSP90AA1;TGFB1;FLT1;HSP90AB1;LMO4;MYC;MERTK|1
1154|positive regulation of MAP kinase activity (GO:0043406)|8/178|0.00183592755139967|0.164363829733202|0|0|3.59550561797753|22.6524240812022|DUSP5;TGFB1;FLT1;CD81;C5AR1;UBC;FPR1;GADD45G|1
1155|cellular response to peptide (GO:1901653)|4/42|0.00183727145397852|0.161648210856075|0|0|7.61904761904762|47.9959901973346|XBP1;FPR2;ADRB2;CD36|1
1156|wound healing, spreading of cells (GO:0044319)|3/20|0.0018796380491126|0.16257276211223|0|0|12|75.3201125729251|FLNA;PLET1;CD44|1
1157|telomere maintenance via telomerase (GO:0007004)|3/20|0.0018796380491126|0.159863216077026|0|0|12|75.3201125729251|HSP90AA1;HSP90AB1;NOP10|1
1158|immune response-activating cell surface receptor signaling pathway (GO:0002429)|3/20|0.0018796380491126|0.157242507616747|0|0|12|75.3201125729251|C5AR1;FPR1;FPR2|1
1159|positive regulation of angiogenesis (GO:0045766)|6/104|0.00196462348643076|0.161701187923487|0|0|4.61538461538461|28.7651753629816|XBP1;FLT1;JUP;ANGPTL4;RUNX1;RHOB|1
1160|positive regulation of cell motility (GO:2000147)|8/180|0.00196900809705917|0.159489655861793|0|0|3.55555555555556|22.151912416227|XBP1;TGFB1;FLT1;MIEN1;HSPA5;MYADM;PLET1;SYNE2|1
1161|regulation of cellular response to stress (GO:0080135)|6/105|0.00206232617201524|0.164438288371777|0|0|4.57142857142857|28.2693518790503|HSPA8;HSP90AA1;CAMK2D;HSP90AB1;FKBP4;HSPA1A|1
1162|positive regulation of vasculature development (GO:1904018)|6/105|0.00206232617201524|0.161908468550673|0|0|4.57142857142857|28.2693518790503|XBP1;FLT1;JUP;ANGPTL4;RUNX1;RHOB|1
1163|RNA-dependent DNA biosynthetic process (GO:0006278)|3/21|0.00217280337151818|0.167997206134201|0|0|11.4285714285714|70.0769950732374|HSP90AA1;HSP90AB1;NOP10|1
1164|energy reserve metabolic process (GO:0006112)|3/21|0.00217280337151818|0.165489785147123|0|0|11.4285714285714|70.0769950732374|MYC;LEPR;PYGL|1
1165|hepaticobiliary system development (GO:0061008)|3/21|0.00217280337151818|0.163056111836136|0|0|11.4285714285714|70.0769950732374|XBP1;RARA;LSR|1
1166|sphingosine-1-phosphate signaling pathway (GO:0003376)|2/6|0.00225831449082148|0.167017084734232|0|0|26.6666666666667|162.483641185786|SPNS1;EZR|1
1167|regulation of adiponectin secretion (GO:0070163)|2/6|0.00225831449082148|0.164631126380886|0|0|26.6666666666667|162.483641185786|HCAR2;RAB11FIP1|1
1168|positive regulation of T-helper 2 cell differentiation (GO:0045630)|2/6|0.00225831449082148|0.162312378122|0|0|26.6666666666667|162.483641185786|RARA;IL18|1
1169|regulation of blood vessel remodeling (GO:0060312)|2/6|0.00225831449082148|0.160058039536972|0|0|26.6666666666667|162.483641185786|TGFB1;TMBIM1|1
1170|negative regulation of systemic arterial blood pressure (GO:0003085)|2/6|0.00225831449082148|0.157865463652904|0|0|26.6666666666667|162.483641185786|ADRB1;ADRB2|1
1171|unsaturated fatty acid metabolic process (GO:0033559)|4/45|0.00237525527567907|0.163796319889058|0|0|7.11111111111111|42.9699581352898|SCP2;PNPLA8;HSD17B4;MGLL|1
1172|cellular response to unfolded protein (GO:0034620)|3/22|0.00249282249943507|0.169611642861562|0|0|10.9090909090909|65.3927964715673|HSPA8;HSPA5;HSPA1A|1
1173|positive regulation of RNA splicing (GO:0033120)|3/22|0.00249282249943507|0.167379910718647|0|0|10.9090909090909|65.3927964715673|POLR2A;TRA2B;HSPA1A|1
1174|regulation of cell motility (GO:2000145)|6/110|0.00260695267431974|0.172769863598099|0|0|4.36363636363636|25.9617743891169|TGFB1;CDK6;LMO4;FLNA;SGK1;RHOB|1
1175|cellular response to amyloid-beta (GO:1904646)|3/23|0.00284049150449012|0.185833694197603|0|0|10.4347826086957|61.1872505407484|FPR2;ADRB2;CD36|1
1176|cellular response to heat (GO:0034605)|4/48|0.00301275983405448|0.194609030799747|0|0|6.66666666666667|38.6993248794437|HSPA8;HSPA5;IER5;HSPA1A|1
1177|leukocyte aggregation (GO:0070486)|2/7|0.00313561234654534|0.200012872555261|0|0|22.8571428571429|131.76984681415|S100A9;CD44|1
1178|cellular response to hormone stimulus (GO:0032870)|5/81|0.00347189802128046|0.218729575340669|0|0|4.93827160493827|27.9656980462539|JUN;XBP1;JUND;FFAR4;RAMP1|1
1179|lipid homeostasis (GO:0055088)|4/50|0.00349720414443198|0.217636984744346|0|0|6.4|36.1970652517553|XBP1;ACOX3;ABCG1;PNPLA2|1
1180|negative regulation of cytoskeleton organization (GO:0051494)|3/25|0.00362175231333119|0.222672313914808|0|0|9.6|53.9596541357734|LIMA1;MYADM;FKBP4|1
1181|chaperone mediated protein folding requiring cofactor (GO:0051085)|3/25|0.00362175231333119|0.22002145303487|0|0|9.6|53.9596541357734|HSPA8;HSPA5;HSPA1A|1
1182|regulation of cardiac muscle cell action potential (GO:0098901)|3/25|0.00362175231333119|0.217432965352107|0|0|9.6|53.9596541357734|CAMK2D;JUP;FLNA|1
1183|fatty acid oxidation (GO:0019395)|4/51|0.00375816946576244|0.222999288183555|0|0|6.27450980392157|35.0357539409542|HADHA;ABCD2;HSD17B4;ADIPOR2|1
1184|receptor internalization (GO:0031623)|4/51|0.00375816946576244|0.220436077974549|0|0|6.27450980392157|35.0357539409542|CD81;CD9;CD36;RAMP1|1
1185|positive regulation of protein secretion (GO:0050714)|5/83|0.00385611532286836|0.223610869234059|0|0|4.81927710843373|26.7859999773406|HCAR2;TCF7L2;XBP1;TGFB1;EZR|1
1186|positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552)|3/26|0.0040567285820846|0.232600965779525|0|0|9.23076923076923|50.8373390596933|FLT1;TGFB1;FPR2|1
1187|response to amyloid-beta (GO:1904645)|3/26|0.0040567285820846|0.230016510604197|0|0|9.23076923076923|50.8373390596933|FPR2;ADRB2;CD36|1
1188|positive regulation of nitric oxide biosynthetic process (GO:0045429)|3/26|0.0040567285820846|0.227488856641513|0|0|9.23076923076923|50.8373390596933|HSP90AA1;HSP90AB1;CD36|1
1189|positive regulation of nitric oxide metabolic process (GO:1904407)|3/26|0.0040567285820846|0.225016151678019|0|0|9.23076923076923|50.8373390596933|HSP90AA1;HSP90AB1;CD36|1
1190|lipoprotein transport (GO:0042953)|2/8|0.00414643179513327|0.227518725274893|0|0|20|109.710142459768|UNC119;CD36|1
1191|positive regulation of tissue remodeling (GO:0034105)|2/8|0.00414643179513327|0.225098313303884|0|0|20|109.710142459768|TMBIM1;IL18|1
1192|desmosome organization (GO:0002934)|2/8|0.00414643179513327|0.222728857374369|0|0|20|109.710142459768|JUP;PERP|1
1193|angiogenesis involved in wound healing (GO:0060055)|2/8|0.00414643179513327|0.220408765110053|0|0|20|109.710142459768|MCAM;ADIPOR2|1
1194|regulation of T-helper 2 cell differentiation (GO:0045628)|2/8|0.00414643179513327|0.21813650979964|0|0|20|109.710142459768|RARA;IL18|1
1195|acylglycerol acyl-chain remodeling (GO:0036155)|2/8|0.00414643179513327|0.215910627046582|0|0|20|109.710142459768|MGLL;PNPLA2|1
1196|lipoprotein localization (GO:0044872)|2/8|0.00414643179513327|0.213729711621869|0|0|20|109.710142459768|UNC119;CD36|1
1197|regulation of cell-matrix adhesion (GO:0001952)|4/53|0.00431906534558933|0.220401904585423|0|0|6.0377358490566|32.8737585226985|CDK6;JUP;CD36;PLET1|1
1198|regulation of cell differentiation (GO:0045595)|6/122|0.00434896579716343|0.219730420425|0|0|3.9344262295082|21.3946906620061|JUN;TGFB1;JUND;CDK6;HSP90AB1;RUNX1|1
1199|regulation of pri-miRNA transcription from RNA polymerase II promoter (GO:1902893)|3/27|0.00452212588862475|0.226239298133844|0|0|8.88888888888889|47.989093923257|JUN;TGFB1;FOS|1
1200|inflammatory response (GO:0006954)|9/253|0.0046922059987669|0.23246919623017|0|0|2.84584980237154|15.2590267206616|TGFB1;C5AR1;FPR1;IL18;LY75;FPR2;FOS;S100A9;MGLL|1
1201|positive regulation of phosphorylation (GO:0042327)|8/209|0.00489379458492393|0.240125324681412|0|0|3.0622009569378|16.2902577230452|MARCO;CCND2;TGFB1;FLT1;LMO4;FAM129A;FPR2;MERTK|1
1202|telomere maintenance via telomere lengthening (GO:0010833)|3/28|0.00501853933011645|0.24390101144366|0|0|8.57142857142857|45.38242592327|HSP90AA1;HSP90AB1;NOP10|1
1203|positive regulation of lipid kinase activity (GO:0090218)|3/28|0.00501853933011645|0.241600058505512|0|0|8.57142857142857|45.38242592327|FLT1;TGFB1;CD81|1
1204|negative regulation of myeloid leukocyte differentiation (GO:0002762)|3/28|0.00501853933011645|0.239342114033498|0|0|8.57142857142857|45.38242592327|CDK6;MYC;RARA|1
1205|cellular response to topologically incorrect protein (GO:0035967)|3/28|0.00501853933011645|0.237125983348002|0|0|8.57142857142857|45.38242592327|HSPA8;HSPA5;HSPA1A|1
1206|ATF6-mediated unfolded protein response (GO:0036500)|2/9|0.00528732472038491|0.247534110533249|0|0|17.7777777777778|93.198984621657|XBP1;HSPA5|1
1207|vasodilation (GO:0042311)|2/9|0.00528732472038491|0.245283800437493|0|0|17.7777777777778|93.198984621657|ADRB1;ADRB2|1
1208|regulation of endoplasmic reticulum unfolded protein response (GO:1900101)|2/9|0.00528732472038491|0.243074036469587|0|0|17.7777777777778|93.198984621657|XBP1;HSPA5|1
1209|granulocyte activation (GO:0036230)|2/9|0.00528732472038491|0.240903732572537|0|0|17.7777777777778|93.198984621657|KMT2E;PREX1|1
1210|cytoskeletal anchoring at plasma membrane (GO:0007016)|2/9|0.00528732472038491|0.238771841133842|0|0|17.7777777777778|93.198984621657|JUP;EZR|1
1211|positive regulation of programmed cell death (GO:0043068)|9/258|0.00532063018009133|0.23816820885093|0|0|2.7906976744186|14.6125493797379|NET1;DNAJA1;PREX1;JUN;UBC;ARHGEF3;ATF4;GADD45G;RHOB|1
1212|cellular response to hydrogen peroxide (GO:0070301)|3/29|0.00554652707643302|0.246121110182937|0|0|8.27586206896552|42.9896548889573|NET1;FABP1;RHOB|1
1213|positive regulation of phospholipid metabolic process (GO:1903727)|3/29|0.00554652707643302|0.243999376474463|0|0|8.27586206896552|42.9896548889573|FLT1;TGFB1;CD81|1
1214|triglyceride homeostasis (GO:0070328)|3/29|0.00554652707643302|0.241913911718271|0|0|8.27586206896552|42.9896548889573|XBP1;IL18;ANGPTL4|1
1215|IRE1-mediated unfolded protein response (GO:0036498)|4/58|0.00596189733234592|0.257826797347129|0|0|5.51724137931034|28.2613324370336|XBP1;HSPA5;DNAJB9;PDIA6|1
1216|positive regulation of cellular protein metabolic process (GO:0032270)|5/92|0.00596777912303198|0.255912410628842|0|0|4.34782608695652|22.2668714216582|HSP90AA1;TGFB1;PERP;FAM129A;EZR|1
1217|positive regulation of protein phosphorylation (GO:0001934)|12/413|0.00600204212995526|0.255236841576347|0|0|2.32445520581114|11.8911120875603|MARCO;CCND2;TGFB1;FLT1;CD81;FAM129A;FPR2;IQGAP1;ADRB2;CCNL1;MERTK;CD44|1
1218|regulation of macrophage derived foam cell differentiation (GO:0010743)|3/30|0.00610661140575685|0.257537504161795|0|0|8|40.7870660617667|IL18;CD36;ABCG1|1
1219|astrocyte development (GO:0014002)|2/10|0.00655490773049433|0.274177820891087|0|0|16|80.4406598090845|CDK6;FPR2|1
1220|regulation of granulocyte differentiation (GO:0030852)|2/10|0.00655490773049433|0.271948732916362|0|0|16|80.4406598090845|RARA;RUNX1|1
1221|virion attachment to host cell (GO:0019062)|2/10|0.00655490773049433|0.269755597973489|0|0|16|80.4406598090845|HSP90AB1;CD81|1
1222|negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201)|2/10|0.00655490773049433|0.267597553189701|0|0|16|80.4406598090845|JUN;HSPA1A|1
1223|protein kinase A signaling (GO:0010737)|2/10|0.00655490773049433|0.26547376308502|0|0|16|80.4406598090845|GAL;EZR|1
1224|negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102)|2/10|0.00655490773049433|0.2633834184938|0|0|16|80.4406598090845|HSPA5;DNAJB9|1
1225|positive regulation of type 2 immune response (GO:0002830)|2/10|0.00655490773049433|0.261325735536817|0|0|16|80.4406598090845|RARA;IL18|1
1226|'de novo' posttranslational protein folding (GO:0051084)|3/31|0.00669927971804189|0.265011041869518|0|0|7.74193548387097|38.754234295232|HSPA8;HSPA5;HSPA1A|1
1227|positive regulation of reactive oxygen species biosynthetic process (GO:1903428)|3/31|0.00669927971804189|0.262972495393598|0|0|7.74193548387097|38.754234295232|HSP90AA1;HSP90AB1;CD36|1
1228|positive regulation of cytokine production (GO:0001819)|8/221|0.00679053093564284|0.264519689805995|0|0|2.89592760180995|14.4571254927252|TGFB1;IL18;RARA;LRRFIP1;CARD11;RUNX1;ATF4;HSPA1A|1
1229|positive regulation of cell migration (GO:0030335)|8/222|0.00697058314223829|0.269476407385167|0|0|2.88288288288288|14.316558971136|XBP1;TGFB1;FLT1;MIEN1;HSPA5;MYADM;PLET1;SYNE2|1
1230|positive regulation of transcription, DNA-templated (GO:0045893)|24/1121|0.00725880675427377|0.278508953887662|0|0|1.71275646743979|8.43625018673778|KMT2E;TCF7L2;JUN;XBP1;JUND;TGFB1;JUP;CD81;NCOA4;IL18;FOS;RUNX1;PLSCR1;GAL;EPCAM;MYC;UBC;NRIP1;RARA;CCNL1;LPIN1;IER5;IER2;ATF4|1
1231|negative regulation of cell-cell adhesion (GO:0022408)|3/32|0.00732498552435667|0.278950754707404|0|0|7.5|36.873480752085|TGFB1;EPCAM;MYADM|1
1232|liver development (GO:0001889)|3/32|0.00732498552435667|0.276884452820682|0|0|7.5|36.873480752085|XBP1;RARA;LSR|1
1233|cellular response to organic cyclic compound (GO:0071407)|6/136|0.00732527351603944|0.274859343767274|0|0|3.52941176470588|17.3520874754205|TGFB1;JUP;NRIP1;IL18;ADCY3;EZR|1
1234|positive regulation of cell proliferation (GO:0008284)|12/425|0.00746582827594554|0.278088479504745|0|0|2.25882352941176|11.0624050437238|XBP1;CCND2;TGFB1;CDK6;FLT1;EPCAM;CD81;MYC;C5AR1;IL18;RARA;CAPN1|1
1235|actin cytoskeleton reorganization (GO:0031532)|4/62|0.00754148918267817|0.278871154342078|0|0|5.16129032258065|25.2249579980888|MYH9;NEDD9;FLNA;EZR|1
1236|positive regulation of superoxide anion generation (GO:0032930)|2/11|0.00794586109135659|0.291710281648868|0|0|14.5454545454545|70.3287869574347|TGFB1;FPR2|1
1237|positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440)|2/11|0.00794586109135659|0.289626636779948|0|0|14.5454545454545|70.3287869574347|HSPA5;ATF4|1
1238|negative regulation of cell division (GO:0051782)|2/11|0.00794586109135659|0.287572547157395|0|0|14.5454545454545|70.3287869574347|MYC;TXNIP|1
1239|positive regulation of T-helper cell differentiation (GO:0045624)|2/11|0.00794586109135659|0.285547388374596|0|0|14.5454545454545|70.3287869574347|RARA;IL18|1
1240|cyclic-nucleotide-mediated signaling (GO:0019935)|3/33|0.00798414941624517|0.284916884413281|0|0|7.27272727272727|35.1294329140983|GAL;ADCY3;CD36|1
1241|activation of adenylate cyclase activity (GO:0007190)|3/33|0.00798414941624517|0.282938294938188|0|0|7.27272727272727|35.1294329140983|ADCY3;ADRB1;ADRB2|1
1242|regulation of nitric oxide biosynthetic process (GO:0045428)|3/33|0.00798414941624517|0.280986996352408|0|0|7.27272727272727|35.1294329140983|HSP90AA1;HSP90AB1;CD36|1
1243|carbohydrate homeostasis (GO:0033500)|4/64|0.00842531529813931|0.294482081961677|0|0|5|23.8825718966624|TCF7L2;LEPR;PYGL;ADIPOR2|1
1244|adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway (GO:0007193)|4/64|0.00842531529813931|0.29247880249255|0|0|5|23.8825718966624|MARCO;ADCY3;FLNA;FPR2|1
1245|positive regulation of adenylate cyclase activity (GO:0045762)|3/34|0.00867716001514773|0.299186132143911|0|0|7.05882352941176|33.5086658191218|ADCY3;ADRB1;ADRB2|1
1246|regulation of T cell differentiation (GO:0045580)|3/34|0.00867716001514773|0.297178171525496|0|0|7.05882352941176|33.5086658191218|CD2;XBP1;RUNX1|1
1247|positive regulation of cell-matrix adhesion (GO:0001954)|3/34|0.00867716001514773|0.295196983715326|0|0|7.05882352941176|33.5086658191218|CDK6;JUP;CD36|1
1248|cellular response to glucose starvation (GO:0042149)|3/34|0.00867716001514773|0.293242036803304|0|0|7.05882352941176|33.5086658191218|XBP1;HSPA5;ATF4|1
1249|positive regulation of nucleocytoplasmic transport (GO:0046824)|3/34|0.00867716001514773|0.291312812876966|0|0|7.05882352941176|33.5086658191218|TCF7L2;TGFB1;JUP|1
1250|regulation of cellular component organization (GO:0051128)|6/141|0.00867870756675999|0.289460422961936|0|0|3.40425531914894|16.1596005420765|NET1;HSPA8;HSP90AA1;CAMK2D;UNC119;SGK1|1
1251|cellular response to metal ion (GO:0071248)|5/101|0.00878514432457619|0.291107736937093|0|0|3.96039603960396|18.7512599166528|JUN;CLIC4;CAMK2D;IQGAP1;FOS|1
1252|regulation of lipid metabolic process (GO:0019216)|5/101|0.00878514432457619|0.289229622505241|0|0|3.96039603960396|18.7512599166528|FABP1;G0S2;PLIN2;CD36;ANGPTL4|1
1253|NADH dehydrogenase complex assembly (GO:0010257)|4/65|0.00889156825581112|0.29085687698336|0|0|4.92307692307692|23.2499782807939|MT-ND4;MT-ND5;MT-ND2;MT-ND3|1
1254|mitochondrial respiratory chain complex I biogenesis (GO:0097031)|4/65|0.00889156825581112|0.289004285410218|0|0|4.92307692307692|23.2499782807939|MT-ND4;MT-ND5;MT-ND2;MT-ND3|1
1255|mitochondrial respiratory chain complex I assembly (GO:0032981)|4/65|0.00889156825581112|0.287175144363317|0|0|4.92307692307692|23.2499782807939|MT-ND4;MT-ND5;MT-ND2;MT-ND3|1
1256|regulation of protein ubiquitination (GO:0031396)|5/102|0.00914624734920419|0.293542768698044|0|0|3.92156862745098|18.4094572925071|DNAJA1;HSP90AA1;HSP90AB1;ADRB2;HSPA1A|1
1257|negative regulation of apoptotic signaling pathway (GO:2001234)|4/66|0.00937434991772295|0.298983172688376|0|0|4.84848484848485|22.6413481291612|TCF7L2;TMBIM6;HERPUD1;HSPA1A|1
1258|regulation of IRE1-mediated unfolded protein response (GO:1903894)|2/12|0.00945692767867181|0.299743490337032|0|0|13.3333333333333|62.146769578185|HSPA5;DNAJB9|1
1259|carbohydrate derivative transport (GO:1901264)|2/12|0.00945692767867181|0.297893221878162|0|0|13.3333333333333|62.146769578185|SLC29A1;ABCG1|1
1260|phosphorylation (GO:0016310)|11/387|0.00975511224524153|0.305400845321887|0|0|2.27390180878553|10.5280830561151|CAMK2D;SNRK;TGFB1;CDK6;DAPK1;STK17B;RARA;TOP1;SGK1;BMX;MERTK|1
1261|positive regulation of RNA metabolic process (GO:0051254)|3/36|0.0101661214946917|0.316327548703731|0|0|6.66666666666667|30.5912967263174|TGFB1;POLR2A;HSPA1A|1
1262|positive regulation of telomerase activity (GO:0051973)|3/36|0.0101661214946917|0.31441041204492|0|0|6.66666666666667|30.5912967263174|HSP90AA1;HSP90AB1;MYC|1
1263|negative regulation of protein binding (GO:0032091)|4/68|0.0103903711643669|0.319410024408218|0|0|4.70588235294118|21.4911800060158|SLPI;HSPA5;TMBIM6;ADRB2|1
1264|actin polymerization or depolymerization (GO:0008154)|3/37|0.0109626979981233|0.334985915475587|0|0|6.48648648648649|29.2751796327217|PREX1;DSTN;EVL|1
1265|acylglycerol metabolic process (GO:0006639)|3/37|0.0109626979981233|0.332991951692994|0|0|6.48648648648649|29.2751796327217|ABHD12;MGLL;PNPLA2|1
1266|regulation of superoxide anion generation (GO:0032928)|2/13|0.0110849119456192|0.334711867801745|0|0|12.3076923076923|55.4113277477791|TGFB1;FPR2|1
1267|glycerolipid catabolic process (GO:0046503)|2/13|0.0110849119456192|0.332742974461735|0|0|12.3076923076923|55.4113277477791|ABHD12;MGLL|1
1268|regulation of NMDA receptor activity (GO:2000310)|2/13|0.0110849119456192|0.330797109114005|0|0|12.3076923076923|55.4113277477791|DAPK1;CAPN1|1
1269|alpha-linolenic acid metabolic process (GO:0036109)|2/13|0.0110849119456192|0.328873870107528|0|0|12.3076923076923|55.4113277477791|SCP2;HSD17B4|1
1270|prostanoid biosynthetic process (GO:0046457)|2/13|0.0110849119456192|0.326972865078005|0|0|12.3076923076923|55.4113277477791|PNPLA8;MGST1|1
1271|regulation of cAMP-dependent protein kinase activity (GO:2000479)|2/13|0.0110849119456192|0.325093710681005|0|0|12.3076923076923|55.4113277477791|PRKAR2B;ADRB2|1
1272|positive regulation of interleukin-17 production (GO:0032740)|2/13|0.0110849119456192|0.323236032334257|0|0|12.3076923076923|55.4113277477791|TGFB1;IL18|1
1273|positive regulation of cellular catabolic process (GO:0031331)|5/107|0.0111060426185871|0.322012133424147|0|0|3.73831775700935|16.8234240700263|ABCD2;HSP90AA1;DAPK1;EZR;PNPLA2|1
1274|positive regulation of cell differentiation (GO:0045597)|7/195|0.0115317447704689|0.332466065331653|0|0|2.87179487179487|12.8158200706313|XBP1;JUN;JUND;TGFB1;HSP90AB1;IL18;CD36|1
1275|phosphatidylcholine metabolic process (GO:0046470)|4/72|0.0126300198212928|0.362084219932906|0|0|4.44444444444444|19.4296834366183|PLA2G15;CHKA;PNPLA8;LPIN1|1
1276|cellular response to cytokine stimulus (GO:0071345)|12/457|0.012760864075446|0.363791560765367|0|0|2.10065645514223|9.16174484554247|HSPA8;XBP1;HSP90AA1;TGFB1;DAPK1;MYC;UBC;FPR1;IL18;CD36;FOS;PTPN12|1
1277|regulation of monocyte differentiation (GO:0045655)|2/14|0.0128266789053476|0.363636346966606|0|0|11.4285714285714|49.7854627165037|CDK6;MYC|1
1278|neutrophil activation (GO:0042119)|2/14|0.0128266789053476|0.36162730637563|0|0|11.4285714285714|49.7854627165037|KMT2E;PREX1|1
1279|epiboly involved in wound healing (GO:0090505)|2/14|0.0128266789053476|0.359640343153786|0|0|11.4285714285714|49.7854627165037|FLNA;CD44|1
1280|regulation of epithelial cell proliferation (GO:0050678)|4/73|0.0132343170237631|0.369042184547885|0|0|4.38356164383562|18.9586500753112|TGFB1;CDK6;MYC;C5AR1|1
1281|negative regulation of cell cycle (GO:0045786)|4/73|0.0132343170237631|0.367036520501429|0|0|4.38356164383562|18.9586500753112|BTG2;TGFB1;CDK6;RHOB|1
1282|ERBB2 signaling pathway (GO:0038128)|3/40|0.0135639680818265|0.374145562819248|0|0|6|25.8020304472498|HSP90AA1;UBC;PTPN12|1
1283|positive regulation of reactive oxygen species metabolic process (GO:2000379)|3/40|0.0135639680818265|0.372134027535273|0|0|6|25.8020304472498|TGFB1;FPR2;CD36|1
1284|regulation of cell growth (GO:0001558)|7/202|0.0137813415116444|0.376075859539687|0|0|2.77227722772277|11.8776545197601|NET1;CAMK2D;TGFB1;PPT1;SGK1;S100A9;HSPA1A|1
1285|glucose homeostasis (GO:0042593)|4/75|0.0144974394353978|0.393512943823589|0|0|4.26666666666667|18.0641418061303|TCF7L2;LEPR;PYGL;ADIPOR2|1
1286|response to cAMP (GO:0051591)|3/41|0.0145022909575962|0.391561855855096|0|0|5.85365853658536|24.7811627997672|JUN;JUND;EZR|1
1287|phosphatidylethanolamine biosynthetic process (GO:0006646)|2/15|0.0146791531209121|0.394251149347446|0|0|10.6666666666667|45.0274874322242|CHKA;LPIN1|1
1288|positive regulation of protein import (GO:1904591)|2/15|0.0146791531209121|0.392187007204265|0|0|10.6666666666667|45.0274874322242|TGFB1;JUP|1
1289|nitric oxide mediated signal transduction (GO:0007263)|2/15|0.0146791531209121|0.390144366541743|0|0|10.6666666666667|45.0274874322242|FPR1;CD36|1
1290|peptide transport (GO:0015833)|3/42|0.0154765255647139|0.409205751071165|0|0|5.71428571428571|23.819605044208|PPT1;MYH9;RAMP1|1
1291|protein phosphorylation (GO:0006468)|12/471|0.0158271527300823|0.41631938341036|0|0|2.03821656050955|8.45050351430747|CAMK2D;SNRK;TGFB1;CDK6;FLT1;DAPK1;STK17B;RARA;TOP1;SGK1;BMX;MERTK|1
1292|transforming growth factor beta receptor signaling pathway (GO:0007179)|4/77|0.0158343807333694|0.414373563499406|0|0|4.15584415584416|17.2283499520679|JUN;TGFB1;UBC;FOS|1
1293|hemopoiesis (GO:0030097)|4/77|0.0158343807333694|0.412259412665225|0|0|4.15584415584416|17.2283499520679|CD164;SNRK;TGFB1;RUNX1|1
1294|positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731)|5/117|0.0158468909849867|0.410490785260849|0|0|3.41880341880342|14.1701947017641|TGFB1;CD81;IL18;UNC119;CD44|1
1295|protein localization to cell periphery (GO:1990778)|5/118|0.0163846330962711|0.422276680253896|0|0|3.38983050847458|13.9369877618365|JUP;MYADM;FLNA;EZR;RAMP1|1
1296|activation of MAPK activity (GO:0000187)|5/118|0.0163846330962711|0.420154686885786|0|0|3.38983050847458|13.9369877618365|DUSP5;CD81;C5AR1;UBC;FPR1|1
1297|cellular response to calcium ion (GO:0071277)|3/43|0.0164868121131413|0.420661011066801|0|0|5.58139534883721|22.9127133964414|CAMK2D;CLIC4;IQGAP1|1
1298|regulation of telomerase activity (GO:0051972)|3/43|0.0164868121131413|0.418568170215722|0|0|5.58139534883721|22.9127133964414|HSP90AA1;HSP90AB1;MYC|1
1299|response to ionizing radiation (GO:0010212)|4/78|0.016530928746868|0.41761054156073|0|0|4.1025641025641|16.830860238745|NET1;MYC;NABP1;RHOB|1
1300|lipopolysaccharide-mediated signaling pathway (GO:0031663)|2/16|0.016639317727007|0.418278021482349|0|0|10|40.9598684641243|TGFB1;IL18|1
1301|DNA alkylation (GO:0006305)|2/16|0.016639317727007|0.416227639024102|0|0|10|40.9598684641243|KMT2E;FOS|1
1302|hyaluronan catabolic process (GO:0030214)|2/16|0.016639317727007|0.414197260297155|0|0|10|40.9598684641243|TGFB1;CD44|1
1303|positive regulation of mRNA processing (GO:0050685)|2/16|0.016639317727007|0.412186593985033|0|0|10|40.9598684641243|TRA2B;HSPA1A|1
1304|regulation of energy homeostasis (GO:2000505)|2/16|0.016639317727007|0.410195354400564|0|0|10|40.9598684641243|LEPR;CD36|1
1305|DNA methylation or demethylation (GO:0044728)|2/16|0.016639317727007|0.408223261350561|0|0|10|40.9598684641243|KMT2E;FOS|1
1306|positive regulation of macrophage derived foam cell differentiation (GO:0010744)|2/16|0.016639317727007|0.406270040004386|0|0|10|40.9598684641243|IL18;CD36|1
1307|mRNA transcription from RNA polymerase II promoter (GO:0042789)|2/16|0.016639317727007|0.40433542076627|0|0|10|40.9598684641243|C5AR1;ATF4|1
1308|positive regulation of G1/S transition of mitotic cell cycle (GO:1900087)|2/16|0.016639317727007|0.402419139151264|0|0|10|40.9598684641243|KMT2E;CCND2|1
1309|activation of protein kinase A activity (GO:0034199)|2/16|0.016639317727007|0.400520935664702|0|0|10|40.9598684641243|PRKAR2B;ADCY3|1
1310|negative regulation of lipid storage (GO:0010888)|2/16|0.016639317727007|0.398640555685055|0|0|10|40.9598684641243|ABCG1;PNPLA2|1
1311|positive regulation of protein serine/threonine kinase activity (GO:0071902)|5/119|0.0169343844656775|0.403813850132487|0|0|3.36134453781513|13.7089382865467|CCND2;TGFB1;FLT1;ADRB2;CCNL1|1
1312|adenylate cyclase-activating G-protein coupled receptor signaling pathway (GO:0007189)|4/79|0.0172463936422444|0.409341147704062|0|0|4.0506329113924|16.4461862139927|ADCY3;ADRB1;ADRB2;RAMP1|1
1313|positive regulation of protein modification process (GO:0031401)|6/164|0.0172632096017977|0.40784332684247|0|0|2.92682926829268|11.8805199645156|MARCO;CCND2;TGFB1;FAM129A;FPR2;RAMP1|1
1314|positive regulation of gene expression (GO:0010628)|17/772|0.017455812684535|0.410493143452451|0|0|1.76165803108808|7.131337188745|KMT2E;JUN;TGFB1;NCOA4;FAM129A;FOS;RUNX1;PLSCR1;TAF1D;POLR2A;MYC;NRIP1;RARA;CD36;EZR;ATF4;HSPA1A|1
1315|response to hydrogen peroxide (GO:0042542)|3/44|0.0175332672526909|0.41042322380955|0|0|5.45454545454545|22.0563011823906|NET1;FABP1;RHOB|1
1316|regulation of transforming growth factor beta receptor signaling pathway (GO:0017015)|4/80|0.017980916792384|0.418979992655414|0|0|4|16.0737770466932|HSP90AB1;TGFB1;UBC;HSPA1A|1
1317|actin filament organization (GO:0007015)|5/121|0.0180703215719418|0.419149322643723|0|0|3.30578512396694|13.2677169541645|DSTN;NEDD9;FLNA;EVL;RHOB|1
1318|regulation of transcription from RNA polymerase II promoter (GO:0006357)|28/1479|0.0184027393069567|0.424928410332126|0|0|1.51453684922245|6.05096205554882|CAMK2D;CD81;ZBTB4;EPCAM;MYC;UBC;NRIP1;LRRFIP1;CCNL1;IER5;IER2;BRD2;TCF7L2;JUN;XBP1;JUND;TGFB1;JUP;IL18;FOS;RUNX1;PLSCR1;GAL;RARA;FOSB;EZR;LPIN1;ATF4|1
1319|regulation of T cell activation (GO:0050863)|3/45|0.018615984783386|0.427916082655941|0|0|5.33333333333333|21.2465849086766|CD2;SIRPA;PAG1|1
1320|regulation of smooth muscle cell proliferation (GO:0048660)|3/45|0.018615984783386|0.42599717645569|0|0|5.33333333333333|21.2465849086766|TCF7L2;IL18;TRIB1|1
1321|regulation of cellular protein catabolic process (GO:1903362)|2/17|0.0187042134455942|0.426105362557443|0|0|9.41176470588235|37.4494725887591|HSP90AA1;EZR|1
1322|response to purine-containing compound (GO:0014074)|2/17|0.0187042134455942|0.424211560946076|0|0|9.41176470588235|37.4494725887591|JUN;JUND|1
1323|regulation of transcription from RNA polymerase I promoter (GO:0006356)|2/17|0.0187042134455942|0.422334518641005|0|0|9.41176470588235|37.4494725887591|FLNA;ATF4|1
1324|positive regulation of cell cycle (GO:0045787)|4/83|0.0203001583285963|0.456351136347254|0|0|3.85542168674699|15.0250663846808|HSP90AB1;CCND2;RARA;CCNL1|1
1325|positive regulation of lipid catabolic process (GO:0050996)|2/18|0.0208709376424232|0.467124538549497|0|0|8.88888888888889|34.3946456101227|ABCD2;PNPLA2|1
1326|endoplasmic reticulum calcium ion homeostasis (GO:0032469)|2/18|0.0208709376424232|0.465084693402993|0|0|8.88888888888889|34.3946456101227|CAMK2D;HERPUD1|1
1327|positive regulation of cyclic nucleotide biosynthetic process (GO:0030804)|2/18|0.0208709376424232|0.463062586040371|0|0|8.88888888888889|34.3946456101227|ADRB1;RAMP1|1
1328|anion homeostasis (GO:0055081)|2/18|0.0208709376424232|0.461057986100802|0|0|8.88888888888889|34.3946456101227|XBP1;ABCG1|1
1329|prostaglandin biosynthetic process (GO:0001516)|2/18|0.0208709376424232|0.459070667195195|0|0|8.88888888888889|34.3946456101227|PNPLA8;MGST1|1
1330|DNA methylation (GO:0006306)|2/18|0.0208709376424232|0.457100406820967|0|0|8.88888888888889|34.3946456101227|KMT2E;FOS|1
1331|response to organophosphorus (GO:0046683)|2/18|0.0208709376424232|0.455146986278997|0|0|8.88888888888889|34.3946456101227|JUN;JUND|1
1332|regulation of G1/S transition of mitotic cell cycle (GO:2000045)|3/47|0.0208904723881267|0.453634385517493|0|0|5.1063829787234|19.7538489730057|KMT2E;CCND2;CDK2AP2|1
1333|cartilage development (GO:0051216)|3/47|0.0208904723881267|0.451712205917842|0|0|5.1063829787234|19.7538489730057|TGFB1;CD44;RUNX1|1
1334|icosanoid metabolic process (GO:0006690)|3/47|0.0208904723881267|0.449806247243084|0|0|5.1063829787234|19.7538489730057|PNPLA8;LTC4S;MGLL|1
1335|cytoskeleton organization (GO:0007010)|5/127|0.0217765403256471|0.466914644041081|0|0|3.1496062992126|12.0532977023111|JUP;DST;NEDD9;EZR;SYNE2|1
1336|response to glucose (GO:0009749)|3/48|0.0220823223159138|0.471489919573674|0|0|5|19.0648894287641|TCF7L2;XBP1;TRA2B|1
1337|positive regulation of NF-kappaB transcription factor activity (GO:0051092)|5/129|0.0231138221873483|0.491457644258493|0|0|3.10077519379845|11.6816262862435|UBC;CD36;S100A9;CARD11;HSPA1A|1
1338|negative regulation of protein localization to plasma membrane (GO:1903077)|2/19|0.0231366433650134|0.489901622786984|0|0|8.42105263157895|31.716527372044|TGFB1;TMBIM1|1
1339|protein targeting to lysosome (GO:0006622)|2/19|0.0231366433650134|0.487877235915963|0|0|8.42105263157895|31.716527372044|HSPA8;NCOA4|1
1340|endothelial cell development (GO:0001885)|2/19|0.0231366433650134|0.48586951066528|0|0|8.42105263157895|31.716527372044|MYADM;EZR|1
1341|regulation of heterotypic cell-cell adhesion (GO:0034114)|2/19|0.0231366433650134|0.483878242178947|0|0|8.42105263157895|31.716527372044|MYADM;CD44|1
1342|fatty-acyl-CoA metabolic process (GO:0035337)|2/19|0.0231366433650134|0.481903228945564|0|0|8.42105263157895|31.716527372044|PPT1;HSD17B4|1
1343|negative regulation of protein localization to cell periphery (GO:1904376)|2/19|0.0231366433650134|0.479944272730338|0|0|8.42105263157895|31.716527372044|TGFB1;TMBIM1|1
1344|regulation of cAMP biosynthetic process (GO:0030817)|2/19|0.0231366433650134|0.478001178508758|0|0|8.42105263157895|31.716527372044|ADRB1;RAMP1|1
1345|positive regulation of macromolecule metabolic process (GO:0010604)|8/277|0.0236077403281954|0.48576733425315|0|0|2.31046931407942|8.65543541537266|PLSCR1;TGFB1;ANXA2;MYC;CD36;EZR;ATF4;HSPA1A|1
1346|protein localization to plasma membrane (GO:0072659)|5/131|0.0245031552814881|0.502167073901341|0|0|3.05343511450382|11.325048496868|JUP;MYADM;FLNA;EZR;RAMP1|1
1347|regulation of angiogenesis (GO:0045765)|6/178|0.024669766906006|0.503559282085395|0|0|2.69662921348315|9.98339810417582|XBP1;FLT1;JUP;ANGPTL4;RUNX1;RHOB|1
1348|positive regulation of protein complex assembly (GO:0031334)|4/89|0.0254695735572024|0.517813680726709|0|0|3.59550561797753|13.1964790402714|JUN;TPPP3;TGFB1;CD36|1
1349|vacuolar acidification (GO:0007035)|2/20|0.0254985384266288|0.516345403139234|0|0|8|29.3530731605056|DMXL2;PPT1|1
1350|adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880)|2/20|0.0254985384266288|0.514304512217735|0|0|8|29.3530731605056|ADRB1;ADRB2|1
1351|adrenergic receptor signaling pathway (GO:0071875)|2/20|0.0254985384266288|0.512279691303492|0|0|8|29.3530731605056|ADRB1;ADRB2|1
1352|positive regulation of cAMP biosynthetic process (GO:0030819)|2/20|0.0254985384266288|0.510270751337596|0|0|8|29.3530731605056|ADRB1;RAMP1|1
1353|organonitrogen compound biosynthetic process (GO:1901566)|6/182|0.0271229809338706|0.540658483224772|0|0|2.63736263736264|9.5139531573881|GSTM1;CHKA;MGST1;IL18;LPIN1;GLUL|1
1354|hyaluronan metabolic process (GO:0030212)|2/21|0.0279538844885679|0.555053200564832|0|0|7.61904761904762|27.254850355237|TGFB1;CD44|1
1355|positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522)|2/21|0.0279538844885679|0.552901831570395|0|0|7.61904761904762|27.254850355237|XBP1;ATF4|1
1356|mRNA transcription (GO:0009299)|2/21|0.0279538844885679|0.550767075463945|0|0|7.61904761904762|27.254850355237|C5AR1;ATF4|1
1357|regulation of interleukin-17 production (GO:0032660)|2/21|0.0279538844885679|0.548648740558315|0|0|7.61904761904762|27.254850355237|TGFB1;IL18|1
1358|positive regulation of leukocyte cell-cell adhesion (GO:1903039)|2/21|0.0279538844885679|0.546546638104068|0|0|7.61904761904762|27.254850355237|SIRPA;CD44|1
1359|cellular protein complex localization (GO:0034629)|2/21|0.0279538844885679|0.544460582233442|0|0|7.61904761904762|27.254850355237|TNFAIP2;EZR|1
1360|establishment of endothelial barrier (GO:0061028)|2/21|0.0279538844885679|0.542390389905558|0|0|7.61904761904762|27.254850355237|MYADM;EZR|1
1361|regulation of signal transduction (GO:0009966)|7/234|0.0281427992411544|0.543987517150041|0|0|2.39316239316239|8.54469958873758|PLSCR1;FLT1;CD36;MERTK;MGLL;DHRS3;RUNX1|1
1362|triglyceride metabolic process (GO:0006641)|3/53|0.0285874495121662|0.550497188153147|0|0|4.52830188679245|16.097150878712|FABP1;LPIN1;PNPLA2|1
1363|cytokine-mediated signaling pathway (GO:0019221)|14/634|0.0288774063881263|0.553990243603792|0|0|1.76656151419558|6.26192313652233|HSPA8;HSP90AA1;CAMK2D;TGFB1;ANXA2;FPR1;IL18;FOS;ADIPOR2;MYC;UBC;LEPR;CD36;CD44|1
1364|negative regulation of cellular response to transforming growth factor beta stimulus (GO:1903845)|3/54|0.0299973269476374|0.573319698179003|0|0|4.44444444444444|15.5850977912675|TGFB1;UBC;HSPA1A|1
1365|positive regulation of protein import into nucleus (GO:0042307)|3/54|0.0299973269476374|0.571180445573857|0|0|4.44444444444444|15.5850977912675|TGFB1;JUP;FLNA|1
1366|regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281)|4/94|0.0303301537508082|0.575370909257896|0|0|3.40425531914894|11.8999587677599|FABP1;DAPK1;MYC;CD44|1
1367|acylglycerol homeostasis (GO:0055090)|2/22|0.0304999961587269|0.576449927399938|0|0|7.27272727272727|25.3820270640884|IL18;ANGPTL4|1
1368|glutathione derivative biosynthetic process (GO:1901687)|2/22|0.0304999961587269|0.574322805896617|0|0|7.27272727272727|25.3820270640884|GSTM1;MGST1|1
1369|cellular response to hexose stimulus (GO:0071331)|2/22|0.0304999961587269|0.572211324992585|0|0|7.27272727272727|25.3820270640884|XBP1;TRA2B|1
1370|sterol transport (GO:0015918)|2/22|0.0304999961587269|0.570115312813125|0|0|7.27272727272727|25.3820270640884|CD36;ABCG1|1
1371|triglyceride catabolic process (GO:0019433)|2/22|0.0304999961587269|0.568034599992639|0|0|7.27272727272727|25.3820270640884|FABP1;PNPLA2|1
1372|glutathione derivative metabolic process (GO:1901685)|2/22|0.0304999961587269|0.56596901962903|0|0|7.27272727272727|25.3820270640884|GSTM1;MGST1|1
1373|cellular response to growth factor stimulus (GO:0071363)|5/140|0.0314148503834851|0.580833266329437|0|0|2.85714285714286|9.88707015920174|TGFB1;FLT1;IQGAP1;PTPN12;CD44|1
1374|regulation of primary metabolic process (GO:0080090)|5/140|0.0314148503834851|0.578736395331858|0|0|2.85714285714286|9.88707015920174|FABP1;G0S2;PLIN2;CD36;ANGPTL4|1
1375|neuron differentiation (GO:0030182)|5/140|0.0314148503834851|0.576654609737139|0|0|2.85714285714286|9.88707015920174|XBP1;PPT1;UNC119;IER2;RUNX1|1
1376|positive regulation of response to stimulus (GO:0048584)|3/55|0.0314432999698614|0.575108099448756|0|0|4.36363636363636|15.0963026446066|TGFB1;MYC;IER5|1
1377|negative regulation of supramolecular fiber organization (GO:1902904)|3/55|0.0314432999698614|0.573054141950725|0|0|4.36363636363636|15.0963026446066|LIMA1;HSPA8;MYADM|1
1378|regulation of cytoskeleton organization (GO:0051493)|4/96|0.0324172005950605|0.588700977354426|0|0|3.33333333333333|11.4302203816285|CLIC4;CDK2AP2;S100A9;RHOB|1
1379|protein complex assembly (GO:0006461)|6/190|0.0325023679326006|0.588154551631421|0|0|2.52631578947368|8.65627536716446|TCF7L2;CAMK2D;ST13;MYC;TRA2B;SLC6A4|1
1380|positive regulation of cysteine-type endopeptidase activity (GO:2001056)|3/56|0.0329252554204813|0.59370169049723|0|0|4.28571428571429|14.6293511731598|DAPK1;MYC;PERP|1
1381|negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512)|3/56|0.0329252554204813|0.591611191587029|0|0|4.28571428571429|14.6293511731598|TGFB1;UBC;HSPA1A|1
1382|regulation of RNA splicing (GO:0043484)|3/56|0.0329252554204813|0.589535362844618|0|0|4.28571428571429|14.6293511731598|SON;POLR2A;TRA2B|1
1383|positive regulation of DNA biosynthetic process (GO:2000573)|3/56|0.0329252554204813|0.58747405038712|0|0|4.28571428571429|14.6293511731598|HSP90AA1;HSP90AB1;MYC|1
1384|Notch signaling pathway (GO:0007219)|3/56|0.0329252554204813|0.585427102476363|0|0|4.28571428571429|14.6293511731598|MYC;UBC;PBX1|1
1385|regulation of cell death (GO:0010941)|4/97|0.0334915265007943|0.593427985185949|0|0|3.29896907216495|11.2048257729343|JUN;JUND;CD36;HSPA1A|1
1386|chromosome organization (GO:0051276)|3/57|0.0344430649671382|0.608176334004519|0|0|4.21052631578947|14.1829373009781|TCF7L2;MYC;UBC|1
1387|organonitrogen compound catabolic process (GO:1901565)|3/57|0.0344430649671382|0.60607917423209|0|0|4.21052631578947|14.1829373009781|PLA2G15;PNPLA8;PPT1|1
1388|ATP metabolic process (GO:0046034)|3/57|0.0344430649671382|0.603996427928887|0|0|4.21052631578947|14.1829373009781|HSPA8;TGFB1;HSPA1A|1
1389|mitochondrial respiratory chain complex assembly (GO:0033108)|4/98|0.0345864370900523|0.604433522159373|0|0|3.26530612244898|10.9854487032955|MT-ND4;MT-ND5;MT-ND2;MT-ND3|1
1390|response to molecule of bacterial origin (GO:0002237)|4/99|0.0357019627948475|0.62179903120173|0|0|3.23232323232323|10.7718775319922|JUN;JUND;SLPI;TRIB1|1
1391|cellular protein complex assembly (GO:0043623)|5/145|0.035732697965233|0.620217543253687|0|0|2.75862068965517|9.19086648274573|HSP90AA1;TGFB1;HSP90AB1;ADRB2;HSPA1A|1
1392|positive regulation of cell cycle G1/S phase transition (GO:1902808)|2/24|0.0358540341663551|0.620214021528508|0|0|6.66666666666667|22.1886612614658|KMT2E;CCND2|1
1393|epidermal growth factor receptor signaling pathway (GO:0007173)|3/58|0.0359965856359093|0.620576271959612|0|0|4.13793103448276|13.7558531936728|TGFB1;IQGAP1;PAG1|1
1394|negative regulation of cellular process (GO:0048523)|12/535|0.0373222892635681|0.641264788255851|0|0|1.79439252336449|5.90025790818712|CD164;BTG2;TGFB1;CDK6;MYC;PPT1;TXNIP;MYH9;CD9;TMBIM6;RHOB;HSPA1A|1
1395|cholesterol homeostasis (GO:0042632)|3/59|0.0375856603501862|0.643622901902685|0|0|4.06779661016949|13.3469803728528|XBP1;IL18;ABCG1|1
1396|integrin-mediated signaling pathway (GO:0007229)|3/59|0.0375856603501862|0.641470316946488|0|0|4.06779661016949|13.3469803728528|DST;MYH9;NEDD9|1
1397|sterol homeostasis (GO:0055092)|3/59|0.0375856603501862|0.639332082556667|0|0|4.06779661016949|13.3469803728528|XBP1;IL18;ABCG1|1
1398|cellular response to transforming growth factor beta stimulus (GO:0071560)|4/101|0.0379949542273635|0.644147014691814|0|0|3.16831683168317|10.3613525910897|JUN;TGFB1;UBC;FOS|1
1399|cellular lipid catabolic process (GO:0044242)|2/25|0.0386568465329632|0.653198304164606|0|0|6.4|20.8194008177571|PLA2G15;LPIN1|1
1400|negative regulation of protein localization to membrane (GO:1905476)|2/25|0.0386568465329632|0.651042534183865|0|0|6.4|20.8194008177571|TGFB1;TMBIM1|1
1401|positive regulation of purine nucleotide biosynthetic process (GO:1900373)|2/25|0.0386568465329632|0.648900946900366|0|0|6.4|20.8194008177571|ADRB1;RAMP1|1
1402|negative regulation of developmental growth (GO:0048640)|2/25|0.0386568465329632|0.646773402812168|0|0|6.4|20.8194008177571|GAL;SLC6A4|1
1403|positive regulation of vascular endothelial growth factor production (GO:0010575)|2/25|0.0386568465329632|0.644659764240886|0|0|6.4|20.8194008177571|TGFB1;ATF4|1
1404|mitotic cytokinesis (GO:0000281)|3/60|0.0392101184424837|0.651756463882718|0|0|4|12.9552817678445|SON;UNC119;RHOB|1
1405|cell chemotaxis (GO:0060326)|3/61|0.0408697761837984|0.677137882681568|0|0|3.9344262295082|12.5797945877373|C5AR1;FPR1;FPR2|1
1406|heterotypic cell-cell adhesion (GO:0034113)|2/26|0.0415401948666291|0.686018169593554|0|0|6.15384615384615|19.5759616583708|CD2;JUP|1
1407|prostaglandin metabolic process (GO:0006693)|2/26|0.0415401948666291|0.683805207756156|0|0|6.15384615384615|19.5759616583708|PNPLA8;MGST1|1
1408|monocarboxylic acid catabolic process (GO:0072329)|2/26|0.0415401948666291|0.681606477184592|0|0|6.15384615384615|19.5759616583708|PLA2G15;LPIN1|1
1409|cellular response to epidermal growth factor stimulus (GO:0071364)|2/26|0.0415401948666291|0.67942184103977|0|0|6.15384615384615|19.5759616583708|IQGAP1;PTPN12|1
1410|peptidyl-tyrosine dephosphorylation (GO:0035335)|2/26|0.0415401948666291|0.677251164231336|0|0|6.15384615384615|19.5759616583708|DUSP5;PTPN12|1
1411|regulation of protein import into nucleus (GO:0042306)|2/26|0.0415401948666291|0.675094313389835|0|0|6.15384615384615|19.5759616583708|TGFB1;JUP|1
1412|peptide metabolic process (GO:0006518)|4/105|0.0428290635059341|0.693830828796132|0|0|3.04761904761905|9.60164069476628|HSPA8;HSP90AA1;GSTM1;MGST1|1
1413|second-messenger-mediated signaling (GO:0019932)|3/63|0.0442938931930551|0.715290306848609|0|0|3.80952380952381|11.8739370004037|FPR1;CD36;FPR2|1
1414|positive regulation of cyclin-dependent protein kinase activity (GO:1904031)|2/27|0.0445016454668419|0.716378223398405|0|0|5.92592592592593|18.4428391923591|CCND2;CCNL1|1
1415|bile acid biosynthetic process (GO:0006699)|2/27|0.0445016454668419|0.714125461689605|0|0|5.92592592592593|18.4428391923591|SCP2;HSD17B4|1
1416|apoptotic cell clearance (GO:0043277)|2/27|0.0445016454668419|0.711886823878666|0|0|5.92592592592593|18.4428391923591|RARA;PDIA6|1
1417|regulation of p38MAPK cascade (GO:1900744)|2/27|0.0445016454668419|0.709662177554045|0|0|5.92592592592593|18.4428391923591|EZR;GADD45G|1
1418|positive regulation of cAMP metabolic process (GO:0030816)|2/27|0.0445016454668419|0.707451391954188|0|0|5.92592592592593|18.4428391923591|ADRB1;RAMP1|1
1419|regulation of cardiac muscle cell contraction (GO:0086004)|2/27|0.0445016454668419|0.705254337941908|0|0|5.92592592592593|18.4428391923591|CAMK2D;JUP|1
1420|negative regulation of protein modification process (GO:0031400)|3/64|0.0460579239788098|0.727658161188441|0|0|3.75|11.5419579664167|TGFB1;MYADM;FAM129A|1
1421|response to lipopolysaccharide (GO:0032496)|5/156|0.0464674871560895|0.73186292270841|0|0|2.56410256410256|7.86923695355928|XBP1;JUN;JUND;SLPI;TRIB1|1
1422|cellular response to starvation (GO:0009267)|4/108|0.0466717614196756|0.732818456998783|0|0|2.96296296296296|9.08034363769229|HSPA8;XBP1;HSPA5;ATF4|1
1423|regulation of protein transport (GO:0051223)|2/28|0.0475388124645912|0.744142822106776|0|0|5.71428571428571|17.4069074118399|DNAJA1;HSPA8|1
1424|positive regulation of substrate adhesion-dependent cell spreading (GO:1900026)|2/28|0.0475388124645912|0.741867155984125|0|0|5.71428571428571|17.4069074118399|MYADM;FLNA|1
1425|regulation of vascular endothelial growth factor production (GO:0010574)|2/28|0.0475388124645912|0.739605365874417|0|0|5.71428571428571|17.4069074118399|TGFB1;ATF4|1
1426|cellular response to glucose stimulus (GO:0071333)|2/28|0.0475388124645912|0.737357325248659|0|0|5.71428571428571|17.4069074118399|XBP1;TRA2B|1
1427|positive regulation of endocytosis (GO:0045807)|3/65|0.0478562983956277|0.74003239609966|0|0|3.69230769230769|11.2229632313818|PPT1;SIRPA;MERTK|1
1428|endocytosis (GO:0006897)|7/264|0.0486688805189598|0.750324160991698|0|0|2.12121212121212|6.41182066606866|MARCO;HSP90AA1;PPT1;FPR2;CD36;ADRB2;MERTK|1
1429|regulation of myeloid cell differentiation (GO:0045637)|3/66|0.0496887744665115|0.763740409947614|0|0|3.63636363636364|10.9162772263856|KMT2E;CDK6;RUNX1|1
1430|regulation of cell division (GO:0051302)|3/66|0.0496887744665115|0.761446895203027|0|0|3.63636363636364|10.9162772263856|MYC;CDK2AP2;TXNIP|1
1431|carboxylic acid catabolic process (GO:0046395)|2/29|0.0506493570161388|0.773843319920228|0|0|5.51724137931034|16.4569861683577|TGFB1;CD44|1
1432|chondrocyte differentiation (GO:0002062)|2/29|0.0506493570161388|0.771533339860765|0|0|5.51724137931034|16.4569861683577|TGFB1;RUNX1|1
1433|primary neural tube formation (GO:0014020)|2/29|0.0506493570161388|0.769237109682608|0|0|5.51724137931034|16.4569861683577|TGFB1;LMO4|1
1434|positive regulation of fibroblast proliferation (GO:0048146)|2/29|0.0506493570161388|0.766954506983253|0|0|5.51724137931034|16.4569861683577|CDK6;MYC|1
1435|positive regulation of cellular biosynthetic process (GO:0031328)|5/160|0.0507979791684261|0.766929253539877|0|0|2.5|7.44974676334511|HSP90AA1;HSP90AB1;MYC;FAM129A;CD36|1
1436|protein localization to membrane (GO:0072657)|5/161|0.0519163974372746|0.781502584431895|0|0|2.48447204968944|7.34936793986339|JUP;MYADM;FLNA;EZR;RAMP1|1
1437|regulation of protein binding (GO:0043393)|4/112|0.0520840232410721|0.781719913527032|0|0|2.85714285714286|8.44256295112252|TCF7L2;SLPI;TMBIM6;CD36|1
1438|negative regulation of transcription from RNA polymerase II promoter (GO:0000122)|12/566|0.0530307850668277|0.793595590017659|0|0|1.69611307420495|4.98128511729882|TCF7L2;JUN;JUND;MYC;UBC;NRIP1;RARA;FOSB;LRRFIP1;EZR;ZBTB4;HSPA1A|1
1439|cellular response to cadmium ion (GO:0071276)|2/30|0.0538309865100738|0.803214982926627|0|0|5.33333333333333|15.5834987742822|JUN;FOS|1
1440|very long-chain fatty acid metabolic process (GO:0000038)|2/30|0.0538309865100738|0.800873248282526|0|0|5.33333333333333|15.5834987742822|ABCD2;ACOT1|1
1441|tube closure (GO:0060606)|2/30|0.0538309865100738|0.798545128374728|0|0|5.33333333333333|15.5834987742822|TGFB1;LMO4|1
1442|positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003)|2/30|0.0538309865100738|0.796230504814222|0|0|5.33333333333333|15.5834987742822|HSPA5;ATF4|1
1443|MyD88-dependent toll-like receptor signaling pathway (GO:0002755)|2/30|0.0538309865100738|0.793929260580655|0|0|5.33333333333333|15.5834987742822|UBC;CD36|1
1444|protein transport (GO:0015031)|8/327|0.0538439787821125|0.791832345029164|0|0|1.95718654434251|5.71824283060572|RAB44;PPT1;UNC119;MYH9;CD36;RAMP1;TMED5;ABCG1|1
1445|positive regulation of sequence-specific DNA binding transcription factor activity (GO:0051091)|6/216|0.0545726080752959|0.80024143393171|0|0|2.22222222222222|6.46271823493164|JUP;UBC;CD36;S100A9;CARD11;HSPA1A|1
1446|positive regulation of kinase activity (GO:0033674)|4/114|0.0549132986060611|0.802929979331604|0|0|2.80701754385965|8.14596414467033|FLT1;LMO4;IQGAP1;MERTK|1
1447|positive regulation of developmental process (GO:0051094)|4/114|0.0549132986060611|0.800635893676371|0|0|2.80701754385965|8.14596414467033|XBP1;JUN;JUND;HSP90AB1|1
1448|monocarboxylic acid biosynthetic process (GO:0072330)|3/69|0.0553882415361796|0.805259819256765|0|0|3.47826086956522|10.0639581022461|XBP1;SCP2;HSD17B4|1
1449|negative regulation of stress-activated MAPK cascade (GO:0032873)|2/31|0.057081453746826|0.827518916108105|0|0|5.16129032258065|14.7781988031635|MYC;EZR|1
1450|beta-catenin-TCF complex assembly (GO:1904837)|2/31|0.057081453746826|0.825174669886836|0|0|5.16129032258065|14.7781988031635|TCF7L2;MYC|1
1451|connective tissue development (GO:0061448)|2/31|0.057081453746826|0.8228436679945|0|0|5.16129032258065|14.7781988031635|XBP1;CD44|1
1452|positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737)|2/31|0.057081453746826|0.820525798507192|0|0|5.16129032258065|14.7781988031635|CCND2;CCNL1|1
1453|positive regulation of cation channel activity (GO:2001259)|2/31|0.057081453746826|0.818220950758576|0|0|5.16129032258065|14.7781988031635|GAL;ADRB2|1
1454|protein localization to lysosome (GO:0061462)|2/31|0.057081453746826|0.815929015322277|0|0|5.16129032258065|14.7781988031635|CD81;NCOA4|1
1455|positive regulation of phospholipase C activity (GO:0010863)|2/31|0.057081453746826|0.813649883994561|0|0|5.16129032258065|14.7781988031635|FLT1;C5AR1|1
1456|response to estradiol (GO:0032355)|2/31|0.057081453746826|0.811383449777306|0|0|5.16129032258065|14.7781988031635|TGFB1;NRIP1|1
1457|bile acid metabolic process (GO:0008206)|2/31|0.057081453746826|0.809129606861258|0|0|5.16129032258065|14.7781988031635|SCP2;HSD17B4|1
1458|regulation of innate immune response (GO:0045088)|3/70|0.0573545054657768|0.810748037096562|0|0|3.42857142857143|9.80058472328418|PLSCR1;HSP90AB1;CD36|1
1459|negative regulation of cell growth (GO:0030308)|4/116|0.0578241986069818|0.815129517932122|0|0|2.75862068965517|7.86302877213084|TGFB1;GAL;PPT1;HSPA1A|1
1460|cellular response to oxidative stress (GO:0034599)|4/116|0.0578241986069818|0.81288398207005|0|0|2.75862068965517|7.86302877213084|JUN;DAPK1;FOS;HSPA1A|1
1461|cellular response to oxygen-containing compound (GO:1901701)|7/275|0.058092176181091|0.814407623769526|0|0|2.03636363636364|5.79492945400075|JUN;XBP1;DAPK1;NRIP1;RARA;FOS;EZR|1
1462|positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436)|3/71|0.0593535154493483|0.829810929693217|0|0|3.38028169014085|9.54674003551322|TRIB1;HERPUD1;HSPA1A|1
1463|cytoskeleton-dependent cytokinesis (GO:0061640)|3/71|0.0593535154493483|0.827543686715913|0|0|3.38028169014085|9.54674003551322|SON;UNC119;RHOB|1
1464|negative regulation of developmental process (GO:0051093)|3/71|0.0593535154493483|0.82528879928617|0|0|3.38028169014085|9.54674003551322|TGFB1;CDK6;ANXA2|1
1465|negative regulation of blood vessel endothelial cell migration (GO:0043537)|2/32|0.0603985562282847|0.83753758813298|0|0|5|14.0339503891614|TGFB1;JUP|1
1466|positive regulation of protein dephosphorylation (GO:0035307)|2/32|0.0603985562282847|0.835267838571644|0|0|5|14.0339503891614|HSP90AB1;TGFB1|1
1467|renal water homeostasis (GO:0003091)|2/32|0.0603985562282847|0.833010357926856|0|0|5|14.0339503891614|PRKAR2B;ADCY3|1
1468|skeletal system morphogenesis (GO:0048705)|2/32|0.0603985562282847|0.830765046989048|0|0|5|14.0339503891614|ANKRD11;RARA|1
1469|response to cadmium ion (GO:0046686)|2/32|0.0603985562282847|0.828531807615421|0|0|5|14.0339503891614|JUN;FOS|1
1470|mitotic cell cycle phase transition (GO:0044772)|6/222|0.0606976883115766|0.830402958321649|0|0|2.16216216216216|6.05805333074799|HSP90AA1;CDK6;PRKAR2B;MYC;UBC;PHLDA1|1
1471|regulation of cation channel activity (GO:2001257)|3/72|0.0613849740008914|0.837560220124462|0|0|3.33333333333333|9.30196732297049|CAMK2D;DAPK1;CAPN1|1
1472|Ras protein signal transduction (GO:0007265)|6/224|0.0628266989774523|0.854945719685171|0|0|2.14285714285714|5.93008961336267|RAB44;JUN;CDC42EP3;ARHGEF3;RALGDS;RHOB|1
1473|cell-cell junction organization (GO:0045216)|3/73|0.063448575792531|0.861111920928951|0|0|3.28767123287671|9.06583736288832|TGFB1;JUP;PERP|1
1474|lysosomal transport (GO:0007041)|3/73|0.063448575792531|0.858827804427813|0|0|3.28767123287671|9.06583736288832|NCOA4;ADRB2;RHOB|1
1475|Rho protein signal transduction (GO:0007266)|3/73|0.063448575792531|0.856555773199168|0|0|3.28767123287671|9.06583736288832|CDC42EP3;ARHGEF3;RHOB|1
1476|regulation of glutamate receptor signaling pathway (GO:1900449)|2/33|0.0637801353673388|0.858759975671583|0|0|4.84848484848485|13.3445502787492|DAPK1;CAPN1|1
1477|phosphatidylcholine biosynthetic process (GO:0006656)|2/33|0.0637801353673388|0.856500080998764|0|0|4.84848484848485|13.3445502787492|CHKA;LPIN1|1
1478|cellular response to glucagon stimulus (GO:0071377)|2/33|0.0637801353673388|0.854252049290105|0|0|4.84848484848485|13.3445502787492|PRKAR2B;ADCY3|1
1479|purine ribonucleoside triphosphate metabolic process (GO:0009205)|2/33|0.0637801353673388|0.852015787380969|0|0|4.84848484848485|13.3445502787492|HSPA8;HSPA1A|1
1480|regulation of cell-cell adhesion (GO:0022407)|2/33|0.0637801353673388|0.849791203079713|0|0|4.84848484848485|13.3445502787492|TGFB1;SIRPA|1
1481|regulation of erythrocyte differentiation (GO:0045646)|2/33|0.0637801353673388|0.847578205155026|0|0|4.84848484848485|13.3445502787492|CDK6;HSPA1A|1
1482|vasculogenesis (GO:0001570)|2/33|0.0637801353673388|0.845376703323455|0|0|4.84848484848485|13.3445502787492|FLT1;TGFB1|1
1483|brain development (GO:0007420)|4/120|0.0638890373793814|0.844626315406692|0|0|2.66666666666667|7.33495331019918|PPT1;RARA;PHGDH;SLC6A4|1
1484|enzyme linked receptor protein signaling pathway (GO:0007167)|4/121|0.06545549060894|0.863099143610907|0|0|2.64462809917355|7.21027411574441|FLT1;NEDD9;BMX;PAG1|1
1485|regulation of protein complex assembly (GO:0043254)|3/74|0.0655440079453539|0.862038846765827|0|0|3.24324324324324|8.83794643758146|HSPA8;HSP90AA1;TGFB1|1
1486|negative regulation of signal transduction (GO:0009968)|7/284|0.0665875761238796|0.8735125988693|0|0|1.97183098591549|5.34215798441334|FLT1;UBC;TMBIM1;TMBIM6;PTPN12;TRIB1;MERTK|1
1487|negative regulation of cell migration (GO:0030336)|4/122|0.0670418915064916|0.877217365019555|0|0|2.62295081967213|7.08836094061822|CLIC4;EVL;TRIB1;RHOB|1
1488|glycogen metabolic process (GO:0005977)|2/34|0.0672240757204007|0.877351556013311|0|0|4.70588235294118|12.7045827104351|UBC;PYGL|1
1489|positive regulation of cell-cell adhesion (GO:0022409)|2/34|0.0672240757204007|0.875113414288788|0|0|4.70588235294118|12.7045827104351|SIRPA;CD44|1
1490|entry into host cell (GO:0030260)|2/34|0.0672240757204007|0.872886662598485|0|0|4.70588235294118|12.7045827104351|CD81;UBC|1
1491|neural tube closure (GO:0001843)|2/34|0.0672240757204007|0.870671214216256|0|0|4.70588235294118|12.7045827104351|TGFB1;LMO4|1
1492|platelet aggregation (GO:0070527)|2/34|0.0672240757204007|0.868466983294189|0|0|4.70588235294118|12.7045827104351|FLNA;MYH9|1
1493|regulation of phosphatidylinositol 3-kinase activity (GO:0043551)|2/34|0.0672240757204007|0.866273884851527|0|0|4.70588235294118|12.7045827104351|FLT1;TGFB1|1
1494|negative regulation of multi-organism process (GO:0043901)|2/34|0.0672240757204007|0.86409183476374|0|0|4.70588235294118|12.7045827104351|ANXA2;TRIB1|1
1495|cellular glucose homeostasis (GO:0001678)|2/34|0.0672240757204007|0.861920749751771|0|0|4.70588235294118|12.7045827104351|XBP1;TRA2B|1
1496|regulation of neurotransmitter receptor activity (GO:0099601)|2/34|0.0672240757204007|0.859760547371441|0|0|4.70588235294118|12.7045827104351|DAPK1;CAPN1|1
1497|positive regulation of organelle organization (GO:0010638)|2/34|0.0672240757204007|0.857611146003012|0|0|4.70588235294118|12.7045827104351|ANXA2;ADRB2|1
1498|positive regulation of defense response (GO:0031349)|3/75|0.0676709504672433|0.86115925245472|0|0|3.2|8.61791450628673|PLSCR1;IL18;S100A9|1
1499|negative regulation of phosphorylation (GO:0042326)|3/76|0.069829076496827|0.886412381500767|0|0|3.1578947368421|8.40538353862744|TGFB1;MYADM;FAM129A|1
1500|gland development (GO:0048732)|3/76|0.069829076496827|0.884212847055355|0|0|3.1578947368421|8.40538353862744|XBP1;RARA;LSR|1
1501|cAMP-mediated signaling (GO:0019933)|3/76|0.069829076496827|0.882024201394327|0|0|3.1578947368421|8.40538353862744|GAL;ADCY3;RAMP1|1
1502|protein autophosphorylation (GO:0046777)|5/176|0.0704097678550006|0.887163074973008|0|0|2.27272727272727|6.03050744886908|CAMK2D;FLT1;DAPK1;STK17B;BMX|1
1503|response to amino acid (GO:0043200)|2/35|0.0707283043124075|0.888981617995605|0|0|4.57142857142857|12.1093003077236|XBP1;TMBIM6|1
1504|negative regulation of endothelial cell migration (GO:0010596)|2/35|0.0707283043124075|0.88679738797596|0|0|4.57142857142857|12.1093003077236|TGFB1;JUP|1
1505|response to glucagon (GO:0033762)|2/35|0.0707283043124075|0.884623864966215|0|0|4.57142857142857|12.1093003077236|PRKAR2B;ADCY3|1
1506|macromolecule catabolic process (GO:0009057)|2/35|0.0707283043124075|0.882460970430845|0|0|4.57142857142857|12.1093003077236|TGFB1;PPT1|1
1507|apoptotic process (GO:0006915)|6/232|0.0717796140743406|0.893393586881366|0|0|2.06896551724138|5.44997538575989|CD2;PLSCR1;DAPK1;MYC;CIDEC;RHOB|1
1508|negative regulation of extrinsic apoptotic signaling pathway (GO:2001237)|3/77|0.0720180527533684|0.894180348419559|0|0|3.11688311688312|8.20001597519563|TCF7L2;TMBIM1;HSPA1A|1
1509|regulation of protein localization to early endosome (GO:1902965)|1/6|0.0727034754007667|0.900499599442021|0|0|13.3333333333333|34.9515478786396|EZR|1
1510|positive regulation of protein glycosylation (GO:0060050)|1/6|0.0727034754007667|0.898319213002694|0|0|13.3333333333333|34.9515478786396|RAMP1|1
1511|negative regulation of cholesterol storage (GO:0010887)|1/6|0.0727034754007667|0.89614935983119|0|0|13.3333333333333|34.9515478786396|ABCG1|1
1512|positive regulation of interferon-gamma secretion (GO:1902715)|1/6|0.0727034754007667|0.893989963783404|0|0|13.3333333333333|34.9515478786396|CD2|1
1513|negative regulation of transforming growth factor beta production (GO:0071635)|1/6|0.0727034754007667|0.891840949447386|0|0|13.3333333333333|34.9515478786396|HSP90AB1|1
1514|amylin receptor signaling pathway (GO:0097647)|1/6|0.0727034754007667|0.889702242134563|0|0|13.3333333333333|34.9515478786396|RAMP1|1
1515|negative regulation of translation in response to stress (GO:0032055)|1/6|0.0727034754007667|0.887573767871083|0|0|13.3333333333333|34.9515478786396|ATF4|1
1516|regulation of translational initiation in response to stress (GO:0043558)|1/6|0.0727034754007667|0.88545545338929|0|0|13.3333333333333|34.9515478786396|ATF4|1
1517|lipoxin biosynthetic process (GO:2001301)|1/6|0.0727034754007667|0.883347226119316|0|0|13.3333333333333|34.9515478786396|LTC4S|1
1518|peripheral nervous system neuron development (GO:0048935)|1/6|0.0727034754007667|0.88124901418079|0|0|13.3333333333333|34.9515478786396|RUNX1|1
1519|positive regulation of protein localization to early endosome (GO:1902966)|1/6|0.0727034754007667|0.879160746374675|0|0|13.3333333333333|34.9515478786396|EZR|1
1520|negative regulation of cellular response to hypoxia (GO:1900038)|1/6|0.0727034754007667|0.877082352175207|0|0|13.3333333333333|34.9515478786396|TMBIM6|1
1521|activation of transmembrane receptor protein tyrosine kinase activity (GO:0007171)|1/6|0.0727034754007667|0.875013761721964|0|0|13.3333333333333|34.9515478786396|ADRB2|1
1522|cellular triglyceride homeostasis (GO:0035356)|1/6|0.0727034754007667|0.87295490581203|0|0|13.3333333333333|34.9515478786396|XBP1|1
1523|astral microtubule organization (GO:0030953)|1/6|0.0727034754007667|0.870905715892283|0|0|13.3333333333333|34.9515478786396|EZR|1
1524|snRNA modification (GO:0040031)|1/6|0.0727034754007667|0.868866124051786|0|0|13.3333333333333|34.9515478786396|NOP10|1
1525|regulation of digestive system process (GO:0044058)|1/6|0.0727034754007667|0.866836063014282|0|0|13.3333333333333|34.9515478786396|SGK1|1
1526|positive regulation of receptor binding (GO:1900122)|1/6|0.0727034754007667|0.864815466130799|0|0|13.3333333333333|34.9515478786396|ANXA2|1
1527|bundle of His cell-Purkinje myocyte adhesion involved in cell communication (GO:0086073)|1/6|0.0727034754007667|0.862804267372355|0|0|13.3333333333333|34.9515478786396|JUP|1
1528|regulation of cardiac muscle cell apoptotic process (GO:0010665)|1/6|0.0727034754007667|0.860802401322767|0|0|13.3333333333333|34.9515478786396|CAMK2D|1
1529|cardiolipin acyl-chain remodeling (GO:0035965)|1/6|0.0727034754007667|0.858809803171557|0|0|13.3333333333333|34.9515478786396|HADHA|1
1530|positive regulation of fibroblast migration (GO:0010763)|1/6|0.0727034754007667|0.856826408706958|0|0|13.3333333333333|34.9515478786396|TGFB1|1
1531|positive regulation of cardiac muscle tissue development (GO:0055025)|1/6|0.0727034754007667|0.854852154309015|0|0|13.3333333333333|34.9515478786396|TGFB1|1
1532|positive regulation of vesicle fusion (GO:0031340)|1/6|0.0727034754007667|0.852886976942788|0|0|13.3333333333333|34.9515478786396|ANXA2|1
1533|monoamine transport (GO:0015844)|1/6|0.0727034754007667|0.850930814151635|0|0|13.3333333333333|34.9515478786396|SLC6A4|1
1534|positive regulation of granulocyte differentiation (GO:0030854)|1/6|0.0727034754007667|0.848983604050601|0|0|13.3333333333333|34.9515478786396|RUNX1|1
1535|regulation of histone deacetylase activity (GO:1901725)|1/6|0.0727034754007667|0.847045285319892|0|0|13.3333333333333|34.9515478786396|CAMK2D|1
1536|nucleus localization (GO:0051647)|1/6|0.0727034754007667|0.845115797198434|0|0|13.3333333333333|34.9515478786396|SYNE2|1
1537|membrane raft assembly (GO:0001765)|1/6|0.0727034754007667|0.843195079477529|0|0|13.3333333333333|34.9515478786396|ANXA2|1
1538|regulation of relaxation of cardiac muscle (GO:1901897)|1/6|0.0727034754007667|0.841283072494587|0|0|13.3333333333333|34.9515478786396|CAMK2D|1
1539|glandular epithelial cell development (GO:0002068)|1/6|0.0727034754007667|0.839379717126952|0|0|13.3333333333333|34.9515478786396|CDK6|1
1540|type B pancreatic cell development (GO:0003323)|1/6|0.0727034754007667|0.837484954785807|0|0|13.3333333333333|34.9515478786396|CDK6|1
1541|regulation of hyaluronan biosynthetic process (GO:1900125)|1/6|0.0727034754007667|0.835598727410164|0|0|13.3333333333333|34.9515478786396|TGFB1|1
1542|macrophage derived foam cell differentiation (GO:0010742)|1/6|0.0727034754007667|0.833720977460927|0|0|13.3333333333333|34.9515478786396|TGFB1|1
1543|hormone transport (GO:0009914)|1/6|0.0727034754007667|0.831851647915051|0|0|13.3333333333333|34.9515478786396|FFAR4|1
1544|gland morphogenesis (GO:0022612)|1/6|0.0727034754007667|0.82999068225976|0|0|13.3333333333333|34.9515478786396|TGFB1|1
1545|positive regulation of protein localization to endosome (GO:1905668)|1/6|0.0727034754007667|0.828138024486859|0|0|13.3333333333333|34.9515478786396|EZR|1
1546|cellular response to bacterial lipopeptide (GO:0071221)|1/6|0.0727034754007667|0.826293619087111|0|0|13.3333333333333|34.9515478786396|CD36|1
1547|lipoprotein catabolic process (GO:0042159)|1/6|0.0727034754007667|0.824457411044695|0|0|13.3333333333333|34.9515478786396|PPT1|1
1548|positive regulation of autophagosome maturation (GO:1901098)|1/6|0.0727034754007667|0.822629345831735|0|0|13.3333333333333|34.9515478786396|ADRB2|1
1549|morphogenesis of an endothelium (GO:0003159)|1/6|0.0727034754007667|0.820809369402904|0|0|13.3333333333333|34.9515478786396|RHOB|1
1550|regulation of natural killer cell proliferation (GO:0032817)|1/6|0.0727034754007667|0.818997428190094|0|0|13.3333333333333|34.9515478786396|IL18|1
1551|astrocyte differentiation (GO:0048708)|1/6|0.0727034754007667|0.817193469097165|0|0|13.3333333333333|34.9515478786396|CDK6|1
1552|sterol import (GO:0035376)|1/6|0.0727034754007667|0.815397439494753|0|0|13.3333333333333|34.9515478786396|CD36|1
1553|astrocyte activation (GO:0048143)|1/6|0.0727034754007667|0.813609287215159|0|0|13.3333333333333|34.9515478786396|FPR2|1
1554|glutamate catabolic process (GO:0006538)|1/6|0.0727034754007667|0.811828960547292|0|0|13.3333333333333|34.9515478786396|GLUL|1
1555|positive regulation of fibroblast apoptotic process (GO:2000271)|1/6|0.0727034754007667|0.810056408231687|0|0|13.3333333333333|34.9515478786396|STK17B|1
1556|cholesterol import (GO:0070508)|1/6|0.0727034754007667|0.808291579455583|0|0|13.3333333333333|34.9515478786396|CD36|1
1557|foam cell differentiation (GO:0090077)|1/6|0.0727034754007667|0.806534423848071|0|0|13.3333333333333|34.9515478786396|TGFB1|1
1558|regulation of microtubule nucleation (GO:0010968)|1/6|0.0727034754007667|0.804784891475299|0|0|13.3333333333333|34.9515478786396|HSPA1A|1
1559|negative regulation of multicellular organismal process (GO:0051241)|4/126|0.0735852807030572|0.812782873220132|0|0|2.53968253968254|6.6268197173223|RAB11FIP1;GAL;EVL;SLC6A4|1
1560|negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101)|3/78|0.0742375397989441|0.818216340375835|0|0|3.07692307692308|8.00149332165334|TGFB1;UBC;HSPA1A|1
1561|ERAD pathway (GO:0036503)|3/78|0.0742375397989441|0.816452943090542|0|0|3.07692307692308|8.00149332165334|HSPA5;DNAJB9;HERPUD1|1
1562|regulation of heart rate by cardiac conduction (GO:0086091)|2/36|0.0742907898337033|0.815281506497608|0|0|4.44444444444444|11.5545257516068|CAMK2D;JUP|1
1563|antibacterial humoral response (GO:0019731)|2/36|0.0742907898337033|0.813531975367785|0|0|4.44444444444444|11.5545257516068|SLPI;RNASE6|1
1564|positive regulation of peptide secretion (GO:0002793)|2/36|0.0742907898337033|0.811789936876634|0|0|4.44444444444444|11.5545257516068|TGFB1;EZR|1
1565|membrane protein proteolysis (GO:0033619)|2/36|0.0742907898337033|0.810055342994419|0|0|4.44444444444444|11.5545257516068|TGFB1;MYH9|1
1566|negative regulation of protein phosphorylation (GO:0001933)|5/179|0.0744924081790581|0.810521874067662|0|0|2.23463687150838|5.80348170374515|PREX1;TGFB1;MYADM;FAM129A;TRIB1|1
1567|G2/M transition of mitotic cell cycle (GO:0000086)|4/127|0.0752701191353663|0.817241314782498|0|0|2.51968503937008|6.51759885899435|HSP90AA1;PRKAR2B;UBC;PHLDA1|1
1568|negative regulation of response to stimulus (GO:0048585)|4/128|0.0769743593235037|0.833970606428534|0|0|2.5|6.4107072709563|TGFB1;CDK6;FLT1;MERTK|1
1569|cell cycle G2/M phase transition (GO:0044839)|4/128|0.0769743593235037|0.832203719550508|0|0|2.5|6.4107072709563|HSP90AA1;PRKAR2B;UBC;PHLDA1|1
1570|response to calcium ion (GO:0051592)|3/80|0.0787666596721421|0.849780685638354|0|0|3|7.62379641677386|CLIC4;CAMK2D;IQGAP1|1
1571|cell-cell junction assembly (GO:0007043)|3/80|0.0787666596721421|0.847987899381733|0|0|3|7.62379641677386|PATJ;JUP;CD9|1
1572|positive regulation of intracellular signal transduction (GO:1902533)|10/480|0.0801227783983418|0.860771659298396|0|0|1.66666666666667|4.20699181803909|TCF7L2;TGFB1;FLT1;UBC;IL18;FLNA;ADRB1;ADRB2;MERTK;S100A9|1
1573|positive regulation of receptor activity (GO:2000273)|2/38|0.0815826108825163|0.874613578431683|0|0|4.21052631578947|10.5521648069535|ANXA2;ADRB2|1
1574|positive regulation of smooth muscle cell proliferation (GO:0048661)|2/38|0.0815826108825163|0.87278000698843|0|0|4.21052631578947|10.5521648069535|JUN;IL18|1
1575|generation of neurons (GO:0048699)|4/131|0.0822024393210808|0.87757122982317|0|0|2.44274809160305|6.10337783675449|CDK6;UNC119;IER2;RUNX1|1
1576|protein catabolic process (GO:0030163)|3/82|0.0834136097305293|0.888642276523781|0|0|2.92682926829268|7.27007940501506|HSPA8;HSP90AA1;PPT1|1
1577|membrane raft polarization (GO:0001766)|1/7|0.0842981386900492|0.896194586948586|0|0|11.4285714285714|28.2673770721621|CD2|1
1578|cardiac muscle cell-cardiac muscle cell adhesion (GO:0086042)|1/7|0.0842981386900492|0.894331396539129|0|0|11.4285714285714|28.2673770721621|JUP|1
1579|intracellular sterol transport (GO:0032366)|1/7|0.0842981386900492|0.89247593721021|0|0|11.4285714285714|28.2673770721621|ABCG1|1
1580|negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901029)|1/7|0.0842981386900492|0.890628160942694|0|0|11.4285714285714|28.2673770721621|HSPA1A|1
1581|negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799)|1/7|0.0842981386900492|0.8887880201143|0|0|11.4285714285714|28.2673770721621|TGFB1|1
1582|cellular response to interleukin-18 (GO:0071351)|1/7|0.0842981386900492|0.886955467495508|0|0|11.4285714285714|28.2673770721621|IL18|1
1583|regulation of interleukin-13 production (GO:0032656)|1/7|0.0842981386900492|0.885130456245517|0|0|11.4285714285714|28.2673770721621|RARA|1
1584|positive regulation of glutamate receptor signaling pathway (GO:1900451)|1/7|0.0842981386900492|0.883312939908257|0|0|11.4285714285714|28.2673770721621|ADRB2|1
1585|oxygen transport (GO:0015671)|1/7|0.0842981386900492|0.881502872408445|0|0|11.4285714285714|28.2673770721621|MYC|1
1586|bone cell development (GO:0098751)|1/7|0.0842981386900492|0.879700208047692|0|0|11.4285714285714|28.2673770721621|ANXA2|1
1587|negative regulation of stress-activated protein kinase signaling cascade (GO:0070303)|1/7|0.0842981386900492|0.877904901500656|0|0|11.4285714285714|28.2673770721621|MYC|1
1588|regulation of low-density lipoprotein particle clearance (GO:0010988)|1/7|0.0842981386900492|0.876116907811245|0|0|11.4285714285714|28.2673770721621|ANXA2|1
1589|negative regulation of striated muscle tissue development (GO:0045843)|1/7|0.0842981386900492|0.874336182388864|0|0|11.4285714285714|28.2673770721621|TGFB1|1
1590|retrograde axonal transport (GO:0008090)|1/7|0.0842981386900492|0.872562681004708|0|0|11.4285714285714|28.2673770721621|DST|1
1591|cellular response to leptin stimulus (GO:0044320)|1/7|0.0842981386900492|0.8707963597881|0|0|11.4285714285714|28.2673770721621|LEPR|1
1592|membrane raft distribution (GO:0031580)|1/7|0.0842981386900492|0.869037175222871|0|0|11.4285714285714|28.2673770721621|CD2|1
1593|activation of MAPKKK activity (GO:0000185)|1/7|0.0842981386900492|0.867285084143793|0|0|11.4285714285714|28.2673770721621|GADD45G|1
1594|negative regulation of platelet-derived growth factor receptor-beta signaling pathway (GO:2000587)|1/7|0.0842981386900492|0.865540043733041|0|0|11.4285714285714|28.2673770721621|PTPN12|1
1595|retinoic acid receptor signaling pathway (GO:0048384)|1/7|0.0842981386900492|0.863802011516709|0|0|11.4285714285714|28.2673770721621|RARA|1
1596|positive regulation of B cell differentiation (GO:0045579)|1/7|0.0842981386900492|0.862070945361365|0|0|11.4285714285714|28.2673770721621|XBP1|1
1597|positive regulation of ER-associated ubiquitin-dependent protein catabolic process (GO:1903071)|1/7|0.0842981386900492|0.860346803470643|0|0|11.4285714285714|28.2673770721621|HERPUD1|1
1598|negative regulation of nitrogen compound metabolic process (GO:0051172)|1/7|0.0842981386900492|0.858629544381879|0|0|11.4285714285714|28.2673770721621|TGFB1|1
1599|regulation of atrial cardiac muscle cell membrane repolarization (GO:0060372)|1/7|0.0842981386900492|0.856919126962791|0|0|11.4285714285714|28.2673770721621|FLNA|1
1600|positive regulation of NK T cell activation (GO:0051135)|1/7|0.0842981386900492|0.855215510408193|0|0|11.4285714285714|28.2673770721621|IL18|1
1601|lysosomal lumen acidification (GO:0007042)|1/7|0.0842981386900492|0.853518654236749|0|0|11.4285714285714|28.2673770721621|PPT1|1
1602|cellular lipid biosynthetic process (GO:0097384)|1/7|0.0842981386900492|0.851828518287765|0|0|11.4285714285714|28.2673770721621|DHRS7B|1
1603|positive regulation of protein kinase A signaling (GO:0010739)|1/7|0.0842981386900492|0.850145062718026|0|0|11.4285714285714|28.2673770721621|ADRB2|1
1604|positive regulation of triglyceride catabolic process (GO:0010898)|1/7|0.0842981386900492|0.848468247998661|0|0|11.4285714285714|28.2673770721621|PNPLA2|1
1605|regulation of pinocytosis (GO:0048548)|1/7|0.0842981386900492|0.84679803491205|0|0|11.4285714285714|28.2673770721621|PPT1|1
1606|positive regulation of tumor necrosis factor-mediated signaling pathway (GO:1903265)|1/7|0.0842981386900492|0.845134384548765|0|0|11.4285714285714|28.2673770721621|HSPA1A|1
1607|positive regulation of fatty acid beta-oxidation (GO:0032000)|1/7|0.0842981386900492|0.843477258304551|0|0|11.4285714285714|28.2673770721621|ABCD2|1
1608|regulation of establishment of protein localization (GO:0070201)|1/7|0.0842981386900492|0.841826617877341|0|0|11.4285714285714|28.2673770721621|DNAJA1|1
1609|wound healing, spreading of epidermal cells (GO:0035313)|1/7|0.0842981386900492|0.840182425264299|0|0|11.4285714285714|28.2673770721621|PLET1|1
1610|positive regulation of interleukin-5 production (GO:0032754)|1/7|0.0842981386900492|0.838544642758911|0|0|11.4285714285714|28.2673770721621|RARA|1
1611|xenobiotic catabolic process (GO:0042178)|1/7|0.0842981386900492|0.836913232948096|0|0|11.4285714285714|28.2673770721621|GSTM1|1
1612|positive regulation of isomerase activity (GO:0010912)|1/7|0.0842981386900492|0.835288158709362|0|0|11.4285714285714|28.2673770721621|PLSCR1|1
1613|positive regulation of myeloid cell apoptotic process (GO:0033034)|1/7|0.0842981386900492|0.833669383207987|0|0|11.4285714285714|28.2673770721621|HCAR2|1
1614|outer mitochondrial membrane organization (GO:0007008)|1/7|0.0842981386900492|0.832056869894238|0|0|11.4285714285714|28.2673770721621|HSP90AA1|1
1615|regulation of protein heterodimerization activity (GO:0043497)|1/7|0.0842981386900492|0.83045058250062|0|0|11.4285714285714|28.2673770721621|CD36|1
1616|T-helper 1 type immune response (GO:0042088)|1/7|0.0842981386900492|0.828850485039155|0|0|11.4285714285714|28.2673770721621|IL18|1
1617|calcitonin family receptor signaling pathway (GO:0097646)|1/7|0.0842981386900492|0.827256541798695|0|0|11.4285714285714|28.2673770721621|RAMP1|1
1618|regulation of relaxation of muscle (GO:1901077)|1/7|0.0842981386900492|0.825668717342267|0|0|11.4285714285714|28.2673770721621|CAMK2D|1
1619|long-chain fatty acid import (GO:0044539)|1/7|0.0842981386900492|0.824086976504447|0|0|11.4285714285714|28.2673770721621|CD36|1
1620|microglial cell activation (GO:0001774)|1/7|0.0842981386900492|0.82251128438876|0|0|11.4285714285714|28.2673770721621|FPR2|1
1621|negative regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle (GO:0031658)|1/7|0.0842981386900492|0.820941606365117|0|0|11.4285714285714|28.2673770721621|CDK6|1
1622|leucine metabolic process (GO:0006551)|1/7|0.0842981386900492|0.819377908067279|0|0|11.4285714285714|28.2673770721621|MCCC2|1
1623|positive regulation of neuron death (GO:1901216)|2/39|0.0853080860282497|0.827618180612468|0|0|4.1025641025641|10.0984042412487|FOS;ATF4|1
1624|homotypic cell-cell adhesion (GO:0034109)|2/39|0.0853080860282497|0.826047747632179|0|0|4.1025641025641|10.0984042412487|FLNA;MYH9|1
1625|chemical homeostasis (GO:0048878)|2/39|0.0853080860282497|0.824483263261663|0|0|4.1025641025641|10.0984042412487|ACOX3;PNPLA2|1
1626|negative regulation of binding (GO:0051100)|3/83|0.0857803661137818|0.827480544950148|0|0|2.89156626506024|7.10158592341368|JUN;SLPI;TMBIM6|1
1627|positive regulation of cytosolic calcium ion concentration (GO:0007204)|4/134|0.0876012134762921|0.843450928999091|0|0|2.38805970149254|5.81483087442782|C5AR1;FPR1;FPR2;CD36|1
1628|positive regulation of phagocytosis (GO:0050766)|2/40|0.08908409599258|0.856113261488014|0|0|4|9.67269782637126|SIRPA;MERTK|1
1629|purine ribonucleoside monophosphate metabolic process (GO:0009167)|2/40|0.08908409599258|0.854504026034089|0|0|4|9.67269782637126|HSPA8;HSPA1A|1
1630|regulation of RNA metabolic process (GO:0051252)|2/40|0.08908409599258|0.852900828987121|0|0|4|9.67269782637126|SON;TRA2B|1
1631|regulation of cell cycle G2/M phase transition (GO:1902749)|3/85|0.0905985926262844|0.865776438524212|0|0|2.82352941176471|6.78018804700257|HSP90AA1;CDK6;PRKAR2B|1
1632|phagocytosis (GO:0006909)|4/136|0.0912936434855744|0.870787780760534|0|0|2.35294117647059|5.63217439079488|RARA;MYH9;MERTK;PDIA6|1
1633|positive regulation of epithelial to mesenchymal transition (GO:0010718)|2/41|0.0929088076016026|0.884540382818989|0|0|3.90243902439024|9.27272909392908|TCF7L2;TGFB1|1
1634|positive regulation of mitotic cell cycle phase transition (GO:1901992)|2/41|0.0929088076016026|0.882893194024168|0|0|3.90243902439024|9.27272909392908|KMT2E;CCND2|1
1635|negative regulation of cytokine secretion (GO:0050710)|2/41|0.0929088076016026|0.881252128607766|0|0|3.90243902439024|9.27272909392908|FFAR4;EZR|1
1636|androgen receptor signaling pathway (GO:0030521)|2/41|0.0929088076016026|0.8796171524879|0|0|3.90243902439024|9.27272909392908|NRIP1;NCOA4|1
1637|negative regulation of catabolic process (GO:0009895)|2/41|0.0929088076016026|0.877988231835145|0|0|3.90243902439024|9.27272909392908|HCAR2;FLNA|1
1638|regulation of peptidyl-tyrosine phosphorylation (GO:0050730)|3/86|0.0930493111611173|0.877690637440261|0|0|2.7906976744186|6.62686241528634|TGFB1;CD81;CD44|1
1639|regulation of cytosolic calcium ion concentration (GO:0051480)|4/138|0.0950594938680654|0.894997411824239|0|0|2.31884057971015|5.45681700209225|C5AR1;FPR1;FPR2;CD36|1
1640|toll-like receptor signaling pathway (GO:0002224)|3/87|0.0955272594131836|0.897745128518371|0|0|2.75862068965517|6.47818933336242|UBC;CD36;S100A9|1
1641|exocyst localization (GO:0051601)|1/8|0.0957483995431995|0.898169269979682|0|0|10|23.4603136601461|TNFAIP2|1
1642|positive regulation of extracellular matrix assembly (GO:1901203)|1/8|0.0957483995431995|0.896521252970545|0|0|10|23.4603136601461|TGFB1|1
1643|regulation of establishment of protein localization to mitochondrion (GO:1903747)|1/8|0.0957483995431995|0.894879272653749|0|0|10|23.4603136601461|DNAJA1|1
1644|regulation of fibroblast apoptotic process (GO:2000269)|1/8|0.0957483995431995|0.893243295921293|0|0|10|23.4603136601461|STK17B|1
1645|regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514)|1/8|0.0957483995431995|0.891613289906838|0|0|10|23.4603136601461|CAMK2D|1
1646|interleukin-18-mediated signaling pathway (GO:0035655)|1/8|0.0957483995431995|0.88998922198351|0|0|10|23.4603136601461|IL18|1
1647|positive regulation of isotype switching (GO:0045830)|1/8|0.0957483995431995|0.888371059761722|0|0|10|23.4603136601461|TGFB1|1
1648|cellular response to forskolin (GO:1904322)|1/8|0.0957483995431995|0.886758771087018|0|0|10|23.4603136601461|ADCY3|1
1649|glomerular visceral epithelial cell development (GO:0072015)|1/8|0.0957483995431995|0.885152324037948|0|0|10|23.4603136601461|IQGAP1|1
1650|negative regulation of platelet aggregation (GO:0090331)|1/8|0.0957483995431995|0.883551686923955|0|0|10|23.4603136601461|CD9|1
1651|amyloid fibril formation (GO:1990000)|1/8|0.0957483995431995|0.881956828283298|0|0|10|23.4603136601461|CD36|1
1652|negative regulation of lipase activity (GO:0060192)|1/8|0.0957483995431995|0.880367716880986|0|0|10|23.4603136601461|ANGPTL4|1
1653|microvillus organization (GO:0032528)|1/8|0.0957483995431995|0.878784321706739|0|0|10|23.4603136601461|EZR|1
1654|positive regulation of steroid biosynthetic process (GO:0010893)|1/8|0.0957483995431995|0.877206611972975|0|0|10|23.4603136601461|ABCG1|1
1655|cytoskeletal anchoring at nuclear membrane (GO:0090286)|1/8|0.0957483995431995|0.875634557112809|0|0|10|23.4603136601461|SYNE2|1
1656|intestinal cholesterol absorption (GO:0030299)|1/8|0.0957483995431995|0.874068126778081|0|0|10|23.4603136601461|CD36|1
1657|SMAD protein complex assembly (GO:0007183)|1/8|0.0957483995431995|0.872507290837406|0|0|10|23.4603136601461|TGFB1|1
1658|regulation of PERK-mediated unfolded protein response (GO:1903897)|1/8|0.0957483995431995|0.870952019374237|0|0|10|23.4603136601461|HSPA5|1
1659|regulation of muscle organ development (GO:0048634)|1/8|0.0957483995431995|0.869402282684959|0|0|10|23.4603136601461|TGFB1|1
1660|microvillus assembly (GO:0030033)|1/8|0.0957483995431995|0.867858051276993|0|0|10|23.4603136601461|EZR|1
1661|arachidonic acid secretion (GO:0050482)|1/8|0.0957483995431995|0.866319295866928|0|0|10|23.4603136601461|PNPLA8|1
1662|positive regulation of early endosome to late endosome transport (GO:2000643)|1/8|0.0957483995431995|0.864785987378668|0|0|10|23.4603136601461|EZR|1
1663|response to forskolin (GO:1904321)|1/8|0.0957483995431995|0.863258096941603|0|0|10|23.4603136601461|ADCY3|1
1664|positive regulation of cAMP-mediated signaling (GO:0043950)|1/8|0.0957483995431995|0.861735595888796|0|0|10|23.4603136601461|ADRB1|1
1665|desensitization of G-protein coupled receptor protein signaling pathway (GO:0002029)|1/8|0.0957483995431995|0.860218455755189|0|0|10|23.4603136601461|ADRB2|1
1666|bundle of His cell to Purkinje myocyte communication (GO:0086069)|1/8|0.0957483995431995|0.85870664827583|0|0|10|23.4603136601461|JUP|1
1667|regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043619)|1/8|0.0957483995431995|0.857200145384118|0|0|10|23.4603136601461|ATF4|1
1668|TORC1 signaling (GO:0038202)|1/8|0.0957483995431995|0.855698919210065|0|0|10|23.4603136601461|CARD11|1
1669|positive regulation of IRE1-mediated unfolded protein response (GO:1903896)|1/8|0.0957483995431995|0.854202942078579|0|0|10|23.4603136601461|HSPA1A|1
1670|dimeric G-protein coupled receptor signaling pathway (GO:0038042)|1/8|0.0957483995431995|0.852712186507761|0|0|10|23.4603136601461|RAMP1|1
1671|positive regulation of protein localization to cell surface (GO:2000010)|1/8|0.0957483995431995|0.851226625207225|0|0|10|23.4603136601461|HSP90AB1|1
1672|positive regulation of metanephros development (GO:0072216)|1/8|0.0957483995431995|0.84974623107643|0|0|10|23.4603136601461|MYC|1
1673|negative regulation of establishment of protein localization (GO:1904950)|1/8|0.0957483995431995|0.848270977203033|0|0|10|23.4603136601461|DNAJA1|1
1674|amyloid precursor protein catabolic process (GO:0042987)|1/8|0.0957483995431995|0.84680083686126|0|0|10|23.4603136601461|ABCG1|1
1675|arachidonate transport (GO:1903963)|1/8|0.0957483995431995|0.845335783510289|0|0|10|23.4603136601461|PNPLA8|1
1676|phospholipid homeostasis (GO:0055091)|1/8|0.0957483995431995|0.843875790792655|0|0|10|23.4603136601461|ABCG1|1
1677|phospholipid scrambling (GO:0017121)|1/8|0.0957483995431995|0.842420832532668|0|0|10|23.4603136601461|PLSCR1|1
1678|cGMP-mediated signaling (GO:0019934)|1/8|0.0957483995431995|0.840970882734849|0|0|10|23.4603136601461|CD36|1
1679|leptin-mediated signaling pathway (GO:0033210)|1/8|0.0957483995431995|0.839525915582383|0|0|10|23.4603136601461|LEPR|1
1680|membrane lipid catabolic process (GO:0046466)|1/8|0.0957483995431995|0.838085905435587|0|0|10|23.4603136601461|PPT1|1
1681|rRNA pseudouridine synthesis (GO:0031118)|1/8|0.0957483995431995|0.836650826830389|0|0|10|23.4603136601461|NOP10|1
1682|regulation of sensory perception (GO:0051931)|1/8|0.0957483995431995|0.835220654476833|0|0|10|23.4603136601461|MGLL|1
1683|regulation of MHC class II biosynthetic process (GO:0045346)|1/8|0.0957483995431995|0.833795363257589|0|0|10|23.4603136601461|XBP1|1
1684|glomerular epithelial cell development (GO:0072310)|1/8|0.0957483995431995|0.832374928226486|0|0|10|23.4603136601461|IQGAP1|1
1685|response to hydroperoxide (GO:0033194)|1/8|0.0957483995431995|0.830959324607053|0|0|10|23.4603136601461|DAPK1|1
1686|negative regulation of cAMP-dependent protein kinase activity (GO:2000480)|1/8|0.0957483995431995|0.829548527791082|0|0|10|23.4603136601461|PRKAR2B|1
1687|positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800)|1/8|0.0957483995431995|0.828142513337199|0|0|10|23.4603136601461|TGFB1|1
1688|response to leptin (GO:0044321)|1/8|0.0957483995431995|0.826741256969454|0|0|10|23.4603136601461|LEPR|1
1689|interleukin-1 beta secretion (GO:0050702)|1/8|0.0957483995431995|0.825344734575924|0|0|10|23.4603136601461|CD36|1
1690|regulation of cardiac muscle cell action potential involved in regulation of contraction (GO:0098909)|1/8|0.0957483995431995|0.823952922207331|0|0|10|23.4603136601461|CAMK2D|1
1691|regulation of phagocytosis (GO:0050764)|2/42|0.0967804252629394|0.831431835213434|0|0|3.80952380952381|8.89642104192975|SIRPA;MERTK|1
1692|positive regulation of receptor-mediated endocytosis (GO:0048260)|2/42|0.0967804252629394|0.830034470784504|0|0|3.80952380952381|8.89642104192975|ANXA2;PPT1|1
1693|regulation of substrate adhesion-dependent cell spreading (GO:1900024)|2/42|0.0967804252629394|0.828641795497953|0|0|3.80952380952381|8.89642104192975|MYADM;FLNA|1
1694|positive regulation of viral transcription (GO:0050434)|2/42|0.0967804252629394|0.827253785790251|0|0|3.80952380952381|8.89642104192975|JUN;POLR2A|1
1695|response to cytokine (GO:0034097)|4/139|0.0969696222283033|0.827484920118782|0|0|2.30215827338129|5.37175832502266|JUN;PLSCR1;JUND;PTPN12|1
1696|organic substance transport (GO:0071702)|3/88|0.0980320528528899|0.835154533736723|0|0|2.72727272727273|6.33398395598134|SCP2;CHKA;SLC6A4|1
1697|regulation of MAP kinase activity (GO:0043405)|3/88|0.0980320528528899|0.833762609513829|0|0|2.72727272727273|6.33398395598134|FLT1;TGFB1;TRIB1|1
1698|regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434)|3/89|0.100563303891623|0.853867786620551|0|0|2.69662921348315|6.19407063454713|HSP90AB1;TRIB1;HSPA1A|1
1699|cellular response to radiation (GO:0071478)|2/43|0.100697190315599|0.853584322558973|0|0|3.72093023255814|8.54190653462382|NET1;RHOB|1
1700|positive regulation of protein localization to nucleus (GO:1900182)|2/43|0.100697190315599|0.852168759834995|0|0|3.72093023255814|8.54190653462382|TGFB1;JUP|1
1701|negative regulation of protein secretion (GO:0050709)|2/43|0.100697190315599|0.850757884404804|0|0|3.72093023255814|8.54190653462382|RAB11FIP1;FFAR4|1
1702|regulation of small GTPase mediated signal transduction (GO:0051056)|4/141|0.100843602904309|0.850586620860644|0|0|2.26950354609929|5.20665974100543|NET1;PREX1;ARHGEF3;RHOB|1
1703|positive regulation of nucleic acid-templated transcription (GO:1903508)|10/503|0.10106480556091|0.851045714153999|0|0|1.59045725646123|3.64531742136999|KMT2E;JUN;TGFB1;MYC;NCOA4;NRIP1;RARA;FOS;RUNX1;ATF4|1
1704|positive regulation of interferon-gamma production (GO:0032729)|2/44|0.104657380487332|0.879846149302895|0|0|3.63636363636364|8.20750293504212|CD2;IL18|1
1705|negative regulation of ERBB signaling pathway (GO:1901185)|2/44|0.104657380487332|0.878399033925752|0|0|3.63636363636364|8.20750293504212|UBC;PTPN12|1
1706|RNA catabolic process (GO:0006401)|2/44|0.104657380487332|0.876956670980061|0|0|3.63636363636364|8.20750293504212|RNASE6;HSPA1A|1
1707|regulation of interferon-gamma production (GO:0032649)|2/44|0.104657380487332|0.875519037093209|0|0|3.63636363636364|8.20750293504212|IL18;RARA|1
1708|positive regulation of macromolecule biosynthetic process (GO:0010557)|4/143|0.104788275914001|0.875179332224464|0|0|2.23776223776224|5.0479740070553|XBP1;TGFB1;MYC;FAM129A|1
1709|regulation of cytokine-mediated signaling pathway (GO:0001959)|3/91|0.105703614712743|0.881381610913604|0|0|2.63736263736264|5.92646027826119|HSP90AB1;UBC;RUNX1|1
1710|positive regulation of response to external stimulus (GO:0032103)|3/91|0.105703614712743|0.879943794256322|0|0|2.63736263736264|5.92646027826119|TGFB1;IL18;S100A9|1
1711|type B pancreatic cell differentiation (GO:0003309)|1/9|0.107056048841162|0.889750842404641|0|0|8.88888888888889|19.8613578730764|CDK6|1
1712|regulation of immunoglobulin secretion (GO:0051023)|1/9|0.107056048841162|0.888304093067398|0|0|8.88888888888889|19.8613578730764|XBP1|1
1713|positive regulation of production of molecular mediator of immune response (GO:0002702)|1/9|0.107056048841162|0.886862040968262|0|0|8.88888888888889|19.8613578730764|XBP1|1
1714|regulation of macrophage cytokine production (GO:0010935)|1/9|0.107056048841162|0.885424663268152|0|0|8.88888888888889|19.8613578730764|TGFB1|1
1715|actin filament reorganization (GO:0090527)|1/9|0.107056048841162|0.883991937275808|0|0|8.88888888888889|19.8613578730764|NEDD9|1
1716|regulation of organ growth (GO:0046620)|1/9|0.107056048841162|0.882563840446607|0|0|8.88888888888889|19.8613578730764|SLC6A4|1
1717|actin crosslink formation (GO:0051764)|1/9|0.107056048841162|0.88114035038137|0|0|8.88888888888889|19.8613578730764|FLNA|1
1718|cellular response to interleukin-4 (GO:0071353)|1/9|0.107056048841162|0.879721444825201|0|0|8.88888888888889|19.8613578730764|XBP1|1
1719|regulation of interferon-gamma secretion (GO:1902713)|1/9|0.107056048841162|0.878307101666318|0|0|8.88888888888889|19.8613578730764|CD2|1
1720|regulation of ER-associated ubiquitin-dependent protein catabolic process (GO:1903069)|1/9|0.107056048841162|0.876897298934911|0|0|8.88888888888889|19.8613578730764|HERPUD1|1
1721|nuclear migration (GO:0007097)|1/9|0.107056048841162|0.875492014802003|0|0|8.88888888888889|19.8613578730764|SYNE2|1
1722|adipose tissue development (GO:0060612)|1/9|0.107056048841162|0.874091227578319|0|0|8.88888888888889|19.8613578730764|XBP1|1
1723|positive regulation of immunoglobulin secretion (GO:0051024)|1/9|0.107056048841162|0.872694915713178|0|0|8.88888888888889|19.8613578730764|XBP1|1
1724|interleukin-1 beta production (GO:0032611)|1/9|0.107056048841162|0.871303057793381|0|0|8.88888888888889|19.8613578730764|CD36|1
1725|regulation of platelet-derived growth factor receptor-beta signaling pathway (GO:2000586)|1/9|0.107056048841162|0.869915632542117|0|0|8.88888888888889|19.8613578730764|PTPN12|1
1726|positive regulation of leukocyte apoptotic process (GO:2000108)|1/9|0.107056048841162|0.868532618817885|0|0|8.88888888888889|19.8613578730764|HCAR2|1
1727|maintenance of protein localization in endoplasmic reticulum (GO:0035437)|1/9|0.107056048841162|0.867153995613412|0|0|8.88888888888889|19.8613578730764|HSPA5|1
1728|response to dopamine (GO:1903350)|1/9|0.107056048841162|0.865779742054595|0|0|8.88888888888889|19.8613578730764|ATF4|1
1729|regulation of sensory perception of pain (GO:0051930)|1/9|0.107056048841162|0.864409837399446|0|0|8.88888888888889|19.8613578730764|MGLL|1
1730|myelin assembly (GO:0032288)|1/9|0.107056048841162|0.863044261037045|0|0|8.88888888888889|19.8613578730764|CD9|1
1731|L-ascorbic acid metabolic process (GO:0019852)|1/9|0.107056048841162|0.861682992486514|0|0|8.88888888888889|19.8613578730764|CYB5R3|1
1732|interleukin-1 secretion (GO:0050701)|1/9|0.107056048841162|0.860326011395984|0|0|8.88888888888889|19.8613578730764|CD36|1
1733|positive regulation of phosphorylation of RNA polymerase II C-terminal domain (GO:1901409)|1/9|0.107056048841162|0.858973297541587|0|0|8.88888888888889|19.8613578730764|CCNL1|1
1734|protein localization to vacuole (GO:0072665)|1/9|0.107056048841162|0.857624830826451|0|0|8.88888888888889|19.8613578730764|CD81|1
1735|regulation of striated muscle tissue development (GO:0016202)|1/9|0.107056048841162|0.856280591279702|0|0|8.88888888888889|19.8613578730764|TGFB1|1
1736|myeloid leukocyte mediated immunity (GO:0002444)|1/9|0.107056048841162|0.854940559055477|0|0|8.88888888888889|19.8613578730764|KMT2E|1
1737|intestinal lipid absorption (GO:0098856)|1/9|0.107056048841162|0.853604714431953|0|0|8.88888888888889|19.8613578730764|CD36|1
1738|pinocytosis (GO:0006907)|1/9|0.107056048841162|0.852273037810374|0|0|8.88888888888889|19.8613578730764|PPT1|1
1739|negative regulation of heterotypic cell-cell adhesion (GO:0034115)|1/9|0.107056048841162|0.850945509714096|0|0|8.88888888888889|19.8613578730764|MYADM|1
1740|regulation of cell-cell adhesion involved in gastrulation (GO:0070587)|1/9|0.107056048841162|0.849622110787635|0|0|8.88888888888889|19.8613578730764|MYADM|1
1741|regulation of cell-cell adhesion mediated by cadherin (GO:2000047)|1/9|0.107056048841162|0.848302821795729|0|0|8.88888888888889|19.8613578730764|EPCAM|1
1742|regulation of leukocyte activation (GO:0002694)|1/9|0.107056048841162|0.846987623622403|0|0|8.88888888888889|19.8613578730764|PLSCR1|1
1743|response to interleukin-4 (GO:0070670)|1/9|0.107056048841162|0.845676497270046|0|0|8.88888888888889|19.8613578730764|XBP1|1
1744|ether lipid metabolic process (GO:0046485)|1/9|0.107056048841162|0.8443694238585|0|0|8.88888888888889|19.8613578730764|DHRS7B|1
1745|regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844)|1/9|0.107056048841162|0.843066384624151|0|0|8.88888888888889|19.8613578730764|CAMK2D|1
1746|proton-transporting V-type ATPase complex assembly (GO:0070070)|1/9|0.107056048841162|0.841767360919029|0|0|8.88888888888889|19.8613578730764|DMXL2|1
1747|fatty acid homeostasis (GO:0055089)|1/9|0.107056048841162|0.840472334209923|0|0|8.88888888888889|19.8613578730764|XBP1|1
1748|DNA topological change (GO:0006265)|1/9|0.107056048841162|0.839181286077496|0|0|8.88888888888889|19.8613578730764|TOP1|1
1749|cellular response to lipopolysaccharide (GO:0071222)|3/92|0.108311886221517|0.847723244460739|0|0|2.60869565217391|5.79845316067737|XBP1;TGFB1;IL18|1
1750|phospholipase C-activating G-protein coupled receptor signaling pathway (GO:0007200)|3/92|0.108311886221517|0.846425046536603|0|0|2.60869565217391|5.79845316067737|C5AR1;FPR1;FPR2|1
1751|cholesterol transport (GO:0030301)|2/45|0.108659309107876|0.847841673360079|0|0|3.55555555555556|7.89169029750057|CD36;ABCG1|1
1752|positive regulation of interleukin-8 production (GO:0032757)|2/45|0.108659309107876|0.84654725859159|0|0|3.55555555555556|7.89169029750057|CD2;HSPA1A|1
1753|positive regulation of transport (GO:0051050)|2/45|0.108659309107876|0.845256790209591|0|0|3.55555555555556|7.89169029750057|ANXA2;SGK1|1
1754|myeloid cell differentiation (GO:0030099)|2/45|0.108659309107876|0.843970250194051|0|0|3.55555555555556|7.89169029750057|KMT2E;SNRK|1
1755|neuron development (GO:0048666)|4/145|0.108802479723791|0.843797954453658|0|0|2.20689655172414|4.89538461404922|XBP1;BTG2;PPT1;RUNX1|1
1756|transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178)|4/145|0.108802479723791|0.842517532671482|0|0|2.20689655172414|4.89538461404922|JUN;TGFB1;UBC;FOS|1
1757|regulation of protein phosphorylation (GO:0001932)|6/262|0.111483355288146|0.86196903338698|0|0|1.83206106870229|4.01932209921026|MARCO;CCND2;TGFB1;FAM129A;MYADM;FPR2|1
1758|positive regulation of multicellular organismal process (GO:0051240)|5/203|0.111599535707918|0.861561922416801|0|0|1.97044334975369|4.3208638214126|HCAR2;XBP1;TGFB1;IL18;CARD11|1
1759|protein polymerization (GO:0051258)|2/46|0.112701324632512|0.868753564350016|0|0|3.47826086956522|7.59309253700722|PREX1;TPPP3|1
1760|regulation of MAPK cascade (GO:0043408)|5/204|0.11331073260764|0.87213373830586|0|0|1.96078431372549|4.26984585900857|TGFB1;FLT1;ADRB2;TRIB1;MERTK|1
1761|regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618)|3/94|0.113602674451499|0.873063927298194|0|0|2.5531914893617|5.55331463046472|UBC;ATF4;HSPA1A|1
1762|cellular response to fibroblast growth factor stimulus (GO:0044344)|3/95|0.116284390742009|0.892329693167624|0|0|2.52631578947368|5.43591522675831|POLR2A;UBC;CD44|1
1763|cellular response to ionizing radiation (GO:0071479)|2/47|0.116781809997768|0.894801165793706|0|0|3.40425531914894|7.31046113033754|NET1;RHOB|1
1764|negative regulation of protein modification by small protein conjugation or removal (GO:1903321)|2/47|0.116781809997768|0.893459634810507|0|0|3.40425531914894|7.31046113033754|DNAJA1;HSPA1A|1
1765|regulation of fibroblast proliferation (GO:0048145)|2/47|0.116781809997768|0.892122120387138|0|0|3.40425531914894|7.31046113033754|CDK6;MYC|1
1766|regulation of cellular component movement (GO:0051270)|2/47|0.116781809997768|0.89078860451212|0|0|3.40425531914894|7.31046113033754|CDK6;CD9|1
1767|negative regulation of autophagy (GO:0010507)|2/47|0.116781809997768|0.889459069281505|0|0|3.40425531914894|7.31046113033754|LEPR;QSOX1|1
1768|glomerular filtration (GO:0003094)|1/10|0.11822285551261|0.899092744680851|0|0|8|17.0814706372121|MCAM|1
1769|regulation of phospholipase C activity (GO:1900274)|1/10|0.11822285551261|0.897754809048886|0|0|8|17.0814706372121|FLT1|1
1770|negative regulation of cellular protein catabolic process (GO:1903363)|1/10|0.11822285551261|0.896420849451488|0|0|8|17.0814706372121|ANXA2|1
1771|negative regulation of sodium ion transmembrane transport (GO:1902306)|1/10|0.11822285551261|0.895090848191174|0|0|8|17.0814706372121|CAMK2D|1
1772|vacuolar proton-transporting V-type ATPase complex assembly (GO:0070072)|1/10|0.11822285551261|0.893764787675335|0|0|8|17.0814706372121|DMXL2|1
1773|adenylate cyclase-inhibiting dopamine receptor signaling pathway (GO:0007195)|1/10|0.11822285551261|0.89244265041546|0|0|8|17.0814706372121|FLNA|1
1774|negative regulation of oxidative stress-induced neuron death (GO:1903204)|1/10|0.11822285551261|0.891124419026368|0|0|8|17.0814706372121|ATF4|1
1775|positive regulation of cytoplasmic transport (GO:1903651)|1/10|0.11822285551261|0.889810076225444|0|0|8|17.0814706372121|EZR|1
1776|energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988)|1/10|0.11822285551261|0.888499604831887|0|0|8|17.0814706372121|MT-ND4|1
1777|positive regulation of alcohol biosynthetic process (GO:1902932)|1/10|0.11822285551261|0.887192987765958|0|0|8|17.0814706372121|ABCG1|1
1778|positive regulation of receptor recycling (GO:0001921)|1/10|0.11822285551261|0.88589020804824|0|0|8|17.0814706372121|ANXA2|1
1779|regulation of mast cell activation (GO:0033003)|1/10|0.11822285551261|0.884591248798902|0|0|8|17.0814706372121|PLSCR1|1
1780|regulation of triglyceride catabolic process (GO:0010896)|1/10|0.11822285551261|0.883296093236971|0|0|8|17.0814706372121|PNPLA2|1
1781|cellular response to dopamine (GO:1903351)|1/10|0.11822285551261|0.882004724679607|0|0|8|17.0814706372121|ATF4|1
1782|regulation of NLRP3 inflammasome complex assembly (GO:1900225)|1/10|0.11822285551261|0.880717126541389|0|0|8|17.0814706372121|CD36|1
1783|glutamine metabolic process (GO:0006541)|1/10|0.11822285551261|0.879433282333602|0|0|8|17.0814706372121|GLUL|1
1784|negative regulation of inclusion body assembly (GO:0090084)|1/10|0.11822285551261|0.878153175663539|0|0|8|17.0814706372121|HSPA1A|1
1785|regulation of DNA-templated transcription, initiation (GO:2000142)|1/10|0.11822285551261|0.876876790233795|0|0|8|17.0814706372121|JUN|1
1786|positive regulation of cardiac muscle cell differentiation (GO:2000727)|1/10|0.11822285551261|0.875604109841584|0|0|8|17.0814706372121|TGFB1|1
1787|negative regulation of gene silencing by miRNA (GO:0060965)|1/10|0.11822285551261|0.874335118378045|0|0|8|17.0814706372121|TGFB1|1
1788|positive regulation of natural killer cell activation (GO:0032816)|1/10|0.11822285551261|0.87306979982757|0|0|8|17.0814706372121|IL18|1
1789|glycerolipid metabolic process (GO:0046486)|1/10|0.11822285551261|0.871808138267126|0|0|8|17.0814706372121|PLA2G15|1
1790|actin filament depolymerization (GO:0030042)|1/10|0.11822285551261|0.870550117865586|0|0|8|17.0814706372121|DSTN|1
1791|negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665)|1/10|0.11822285551261|0.869295722883071|0|0|8|17.0814706372121|TRIB1|1
1792|regulation of fatty acid beta-oxidation (GO:0031998)|1/10|0.11822285551261|0.868044937670289|0|0|8|17.0814706372121|ABCD2|1
1793|actin filament-based transport (GO:0099515)|1/10|0.11822285551261|0.86679774666789|0|0|8|17.0814706372121|SYNE2|1
1794|negative regulation of sodium ion transmembrane transporter activity (GO:2000650)|1/10|0.11822285551261|0.865554134405812|0|0|8|17.0814706372121|CAMK2D|1
1795|positive regulation of interleukin-13 production (GO:0032736)|1/10|0.11822285551261|0.864314085502652|0|0|8|17.0814706372121|RARA|1
1796|chaperone-mediated protein transport (GO:0072321)|1/10|0.11822285551261|0.863077584665023|0|0|8|17.0814706372121|HSPA8|1
1797|regulation of immunoglobulin production (GO:0002637)|1/10|0.11822285551261|0.86184461668693|0|0|8|17.0814706372121|XBP1|1
1798|negative regulation of homotypic cell-cell adhesion (GO:0034111)|1/10|0.11822285551261|0.860615166449146|0|0|8|17.0814706372121|CD9|1
1799|endothelial tube morphogenesis (GO:0061154)|1/10|0.11822285551261|0.859389218918591|0|0|8|17.0814706372121|RHOB|1
1800|positive regulation of vacuole organization (GO:0044090)|1/10|0.11822285551261|0.858166759147726|0|0|8|17.0814706372121|ANXA2|1
1801|positive regulation of mRNA splicing, via spliceosome (GO:0048026)|1/10|0.11822285551261|0.856947772273936|0|0|8|17.0814706372121|TRA2B|1
1802|regulation of lysosomal lumen pH (GO:0035751)|1/10|0.11822285551261|0.855732243518938|0|0|8|17.0814706372121|PPT1|1
1803|positive regulation of nuclease activity (GO:0032075)|1/10|0.11822285551261|0.854520158188175|0|0|8|17.0814706372121|HSPA1A|1
1804|intracellular cholesterol transport (GO:0032367)|1/10|0.11822285551261|0.853311501670228|0|0|8|17.0814706372121|ABCG1|1
1805|regulation of G2/M transition of mitotic cell cycle (GO:0010389)|4/150|0.119134236675489|0.858675155021215|0|0|2.13333333333333|4.53867601565662|HSP90AA1;CDK6;PRKAR2B;UBC|1
1806|regulation of intrinsic apoptotic signaling pathway (GO:2001242)|2/48|0.12089918194213|0.870167172709014|0|0|3.33333333333333|7.04266095928396|S100A9;HERPUD1|1
1807|regulation of programmed cell death (GO:0043067)|6/269|0.122090150531213|0.877501462198279|0|0|1.78438661710037|3.75255714798386|TGFB1;DAPK1;PERP;UBC;SGK1;CIDEC|1
1808|cellular response to organonitrogen compound (GO:0071417)|3/98|0.124469993756272|0.893347929870968|0|0|2.44897959183673|5.1029157701186|XBP1;JUP;EZR|1
1809|negative regulation of mitotic cell cycle (GO:0045930)|2/49|0.125051890573787|0.8962637606714|0|0|3.26530612244898|6.78865796973032|BTG2;TGFB1|1
1810|endosome to lysosome transport (GO:0008333)|2/49|0.125051890573787|0.895006728749|0|0|3.26530612244898|6.78865796973032|ADRB2;RHOB|1
1811|pattern recognition receptor signaling pathway (GO:0002221)|2/49|0.125051890573787|0.893753217924422|0|0|3.26530612244898|6.78865796973032|CD36;S100A9|1
1812|positive regulation of intracellular protein transport (GO:0090316)|4/153|0.125530125334126|0.895916405007059|0|0|2.09150326797386|4.34030746502043|TCF7L2;TGFB1;JUP;KCNN3|1
1813|protein stabilization (GO:0050821)|4/153|0.125530125334126|0.894665125111798|0|0|2.09150326797386|4.34030746502043|HSP90AA1;HSP90AB1;FLNA;HSPA1A|1
1814|transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169)|8/397|0.126044185899408|0.897075984162732|0|0|1.61209068010076|3.33883768546305|HSP90AA1;FLT1;POLR2A;UBC;NEDD9;ADRB2;BMX;PAG1|1
1815|protein heterooligomerization (GO:0051291)|2/50|0.12923841864445|0.918528760922879|0|0|3.2|6.54750839650101|MCCC2;ANXA2|1
1816|organic hydroxy compound biosynthetic process (GO:1901617)|2/50|0.12923841864445|0.917251252215059|0|0|3.2|6.54750839650101|SCP2;HSD17B4|1
1817|glutathione metabolic process (GO:0006749)|2/50|0.12923841864445|0.915977292142538|0|0|3.2|6.54750839650101|GSTM1;MGST1|1
1818|antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844)|2/50|0.12923841864445|0.914706865939844|0|0|3.2|6.54750839650101|RNASE6;S100A9|1
1819|regulation of megakaryocyte differentiation (GO:0045652)|2/50|0.12923841864445|0.913439958923307|0|0|3.2|6.54750839650101|KMT2E;RUNX1|1
1820|regulation of histone deacetylation (GO:0031063)|1/11|0.129250566671765|0.912262298376234|0|0|7.27272727272727|14.8800173185131|CAMK2D|1
1821|regulation of feeding behavior (GO:0060259)|1/11|0.129250566671765|0.911002267577372|0|0|7.27272727272727|14.8800173185131|LEPR|1
1822|mononuclear cell differentiation (GO:1903131)|1/11|0.129250566671765|0.909745712725541|0|0|7.27272727272727|14.8800173185131|MYH9|1
1823|regulation of lamellipodium morphogenesis (GO:2000392)|1/11|0.129250566671765|0.908492619457324|0|0|7.27272727272727|14.8800173185131|CD44|1
1824|gas transport (GO:0015669)|1/11|0.129250566671765|0.907242973488332|0|0|7.27272727272727|14.8800173185131|MYC|1
1825|positive regulation of extracellular matrix organization (GO:1903055)|1/11|0.129250566671765|0.905996760612661|0|0|7.27272727272727|14.8800173185131|TGFB1|1
1826|negative regulation of leukocyte cell-cell adhesion (GO:1903038)|1/11|0.129250566671765|0.904753966702356|0|0|7.27272727272727|14.8800173185131|PAG1|1
1827|negative regulation of JUN kinase activity (GO:0043508)|1/11|0.129250566671765|0.903514577706873|0|0|7.27272727272727|14.8800173185131|DNAJA1|1
1828|positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213)|1/11|0.129250566671765|0.902278579652554|0|0|7.27272727272727|14.8800173185131|BTG2|1
1829|Golgi ribbon formation (GO:0090161)|1/11|0.129250566671765|0.9010459586421|0|0|7.27272727272727|14.8800173185131|TMED5|1
1830|low-density lipoprotein particle remodeling (GO:0034374)|1/11|0.129250566671765|0.899816700854048|0|0|7.27272727272727|14.8800173185131|ABCG1|1
1831|brain morphogenesis (GO:0048854)|1/11|0.129250566671765|0.898590792542258|0|0|7.27272727272727|14.8800173185131|SLC6A4|1
1832|regulation of actin filament depolymerization (GO:0030834)|1/11|0.129250566671765|0.897368220035398|0|0|7.27272727272727|14.8800173185131|LIMA1|1
1833|biotin metabolic process (GO:0006768)|1/11|0.129250566671765|0.896148969736436|0|0|7.27272727272727|14.8800173185131|MCCC2|1
1834|regulation of ventricular cardiac muscle cell action potential (GO:0098911)|1/11|0.129250566671765|0.89493302812214|0|0|7.27272727272727|14.8800173185131|JUP|1
1835|regulation of protein kinase C signaling (GO:0090036)|1/11|0.129250566671765|0.893720381742571|0|0|7.27272727272727|14.8800173185131|MYADM|1
1836|relaxation of cardiac muscle (GO:0055119)|1/11|0.129250566671765|0.892511017220592|0|0|7.27272727272727|14.8800173185131|CAMK2D|1
1837|regulation of integrin-mediated signaling pathway (GO:2001044)|1/11|0.129250566671765|0.891304921251375|0|0|7.27272727272727|14.8800173185131|FLNA|1
1838|regulation of hemopoiesis (GO:1903706)|1/11|0.129250566671765|0.890102080601913|0|0|7.27272727272727|14.8800173185131|RUNX1|1
1839|negative regulation of myotube differentiation (GO:0010832)|1/11|0.129250566671765|0.888902482110535|0|0|7.27272727272727|14.8800173185131|XBP1|1
1840|regulation of phosphorylation of RNA polymerase II C-terminal domain (GO:1901407)|1/11|0.129250566671765|0.88770611268643|0|0|7.27272727272727|14.8800173185131|CCNL1|1
1841|monocyte differentiation (GO:0030224)|1/11|0.129250566671765|0.886512959309163|0|0|7.27272727272727|14.8800173185131|MYH9|1
1842|positive regulation of mesenchymal cell proliferation (GO:0002053)|1/11|0.129250566671765|0.885323009028211|0|0|7.27272727272727|14.8800173185131|MYC|1
1843|renal filtration (GO:0097205)|1/11|0.129250566671765|0.88413624896249|0|0|7.27272727272727|14.8800173185131|MCAM|1
1844|sphingolipid catabolic process (GO:0030149)|1/11|0.129250566671765|0.882952666299889|0|0|7.27272727272727|14.8800173185131|PPT1|1
1845|negative regulation of cellular senescence (GO:2000773)|1/11|0.129250566671765|0.881772248296815|0|0|7.27272727272727|14.8800173185131|CDK6|1
1846|positive regulation of glycoprotein biosynthetic process (GO:0010560)|1/11|0.129250566671765|0.880594982277727|0|0|7.27272727272727|14.8800173185131|RAMP1|1
1847|regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211)|1/11|0.129250566671765|0.87942085563469|0|0|7.27272727272727|14.8800173185131|BTG2|1
1848|response to sterol (GO:0036314)|1/11|0.129250566671765|0.87824985582692|0|0|7.27272727272727|14.8800173185131|TGFB1|1
1849|relaxation of muscle (GO:0090075)|1/11|0.129250566671765|0.877081970380342|0|0|7.27272727272727|14.8800173185131|CAMK2D|1
1850|icosanoid biosynthetic process (GO:0046456)|1/11|0.129250566671765|0.875917186887141|0|0|7.27272727272727|14.8800173185131|LTC4S|1
1851|regulation of cholesterol esterification (GO:0010872)|1/11|0.129250566671765|0.874755493005328|0|0|7.27272727272727|14.8800173185131|ABCG1|1
1852|protein localization to mitochondrion (GO:0070585)|1/11|0.129250566671765|0.873596876458301|0|0|7.27272727272727|14.8800173185131|DNAJA1|1
1853|negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166)|1/11|0.129250566671765|0.872441325034414|0|0|7.27272727272727|14.8800173185131|CD44|1
1854|positive regulation of fatty acid oxidation (GO:0046321)|1/11|0.129250566671765|0.871288826586548|0|0|7.27272727272727|14.8800173185131|ABCD2|1
1855|epithelial cell-cell adhesion (GO:0090136)|1/11|0.129250566671765|0.870139369031685|0|0|7.27272727272727|14.8800173185131|JUP|1
1856|icosanoid secretion (GO:0032309)|1/11|0.129250566671765|0.868992940350484|0|0|7.27272727272727|14.8800173185131|PNPLA8|1
1857|regulation of cardiac muscle cell differentiation (GO:2000725)|1/11|0.129250566671765|0.867849528586865|0|0|7.27272727272727|14.8800173185131|TGFB1|1
1858|regulation of autophagosome maturation (GO:1901096)|1/11|0.129250566671765|0.866709121847592|0|0|7.27272727272727|14.8800173185131|ADRB2|1
1859|small GTPase mediated signal transduction (GO:0007264)|3/100|0.13004005535563|0.870858795905221|0|0|2.4|4.89579061887592|JUN;RIN2;RALGDS|1
1860|regulation of blood vessel endothelial cell migration (GO:0043535)|2/51|0.133457281032269|0.892572090573617|0|0|3.13725490196078|6.31834931644841|TGFB1;JUP|1
1861|negative regulation of protein ubiquitination (GO:0031397)|2/51|0.133457281032269|0.89140380249695|0|0|3.13725490196078|6.31834931644841|DNAJA1;HSPA1A|1
1862|negative regulation of viral genome replication (GO:0045071)|2/51|0.133457281032269|0.890238568768196|0|0|3.13725490196078|6.31834931644841|PLSCR1;SLPI|1
1863|regulation of kinase activity (GO:0043549)|3/102|0.135696714035814|0.903995211128929|0|0|2.35294117647059|4.69960688788499|FLT1;LMO4;MERTK|1
1864|arachidonic acid metabolic process (GO:0019369)|2/52|0.137707024184285|0.916191583327777|0|0|3.07692307692308|6.10039035005973|PNPLA8;MGLL|1
1865|MAPK cascade (GO:0000165)|6/279|0.138070597054714|0.917414396836204|0|0|1.72043010752688|3.4064346697178|DUSP5;CAMK2D;TGFB1;MYC;UBC;IL18|1
1866|regulation of mesenchymal cell proliferation (GO:0010464)|1/12|0.140140907911488|0.929959756921095|0|0|6.66666666666667|13.1007125163819|MYC|1
1867|regulation of inclusion body assembly (GO:0090083)|1/12|0.140140907911488|0.928752016977042|0|0|6.66666666666667|13.1007125163819|HSPA1A|1
1868|regulation of leukocyte cell-cell adhesion (GO:1903037)|1/12|0.140140907911488|0.927547409951132|0|0|6.66666666666667|13.1007125163819|PAG1|1
1869|regulation of protein glycosylation (GO:0060049)|1/12|0.140140907911488|0.926345923668811|0|0|6.66666666666667|13.1007125163819|RAMP1|1
1870|retinol metabolic process (GO:0042572)|1/12|0.140140907911488|0.925147546018528|0|0|6.66666666666667|13.1007125163819|DHRS3|1
1871|vesicle budding from membrane (GO:0006900)|1/12|0.140140907911488|0.923952264951321|0|0|6.66666666666667|13.1007125163819|ANXA2|1
1872|modification-dependent macromolecule catabolic process (GO:0043632)|1/12|0.140140907911488|0.922760068480416|0|0|6.66666666666667|13.1007125163819|UBC|1
1873|regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165)|1/12|0.140140907911488|0.921570944680828|0|0|6.66666666666667|13.1007125163819|CD44|1
1874|entry of bacterium into host cell (GO:0035635)|1/12|0.140140907911488|0.920384881688961|0|0|6.66666666666667|13.1007125163819|UBC|1
1875|regulation of cholesterol storage (GO:0010885)|1/12|0.140140907911488|0.919201867702214|0|0|6.66666666666667|13.1007125163819|ABCG1|1
1876|phospholipid efflux (GO:0033700)|1/12|0.140140907911488|0.918021890978591|0|0|6.66666666666667|13.1007125163819|ABCG1|1
1877|positive regulation of potassium ion transmembrane transporter activity (GO:1901018)|1/12|0.140140907911488|0.916844939836311|0|0|6.66666666666667|13.1007125163819|GAL|1
1878|regulation of bone remodeling (GO:0046850)|1/12|0.140140907911488|0.915671002653422|0|0|6.66666666666667|13.1007125163819|LEPR|1
1879|positive regulation of cardiocyte differentiation (GO:1905209)|1/12|0.140140907911488|0.91450006786742|0|0|6.66666666666667|13.1007125163819|TGFB1|1
1880|regulation of cell communication by electrical coupling (GO:0010649)|1/12|0.140140907911488|0.913332123974869|0|0|6.66666666666667|13.1007125163819|CAMK2D|1
1881|cellular glucan metabolic process (GO:0006073)|1/12|0.140140907911488|0.912167159531024|0|0|6.66666666666667|13.1007125163819|PYGL|1
1882|negative regulation by host of viral transcription (GO:0043922)|1/12|0.140140907911488|0.911005163149455|0|0|6.66666666666667|13.1007125163819|JUN|1
1883|positive regulation of pseudopodium assembly (GO:0031274)|1/12|0.140140907911488|0.909846123501682|0|0|6.66666666666667|13.1007125163819|CDC42EP3|1
1884|positive regulation of heterotypic cell-cell adhesion (GO:0034116)|1/12|0.140140907911488|0.908690029316801|0|0|6.66666666666667|13.1007125163819|CD44|1
1885|regulation of skeletal muscle tissue development (GO:0048641)|1/12|0.140140907911488|0.90753686938112|0|0|6.66666666666667|13.1007125163819|TGFB1|1
1886|activation of cysteine-type endopeptidase activity (GO:0097202)|1/12|0.140140907911488|0.906386632537798|0|0|6.66666666666667|13.1007125163819|PERP|1
1887|regulation of pseudopodium assembly (GO:0031272)|1/12|0.140140907911488|0.905239307686484|0|0|6.66666666666667|13.1007125163819|CDC42EP3|1
1888|regulation of sequestering of triglyceride (GO:0010889)|1/12|0.140140907911488|0.904094883782961|0|0|6.66666666666667|13.1007125163819|PNPLA2|1
1889|positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103)|1/12|0.140140907911488|0.902953349838791|0|0|6.66666666666667|13.1007125163819|XBP1|1
1890|negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)|1/12|0.140140907911488|0.901814694920961|0|0|6.66666666666667|13.1007125163819|CD44|1
1891|establishment of protein localization to mitochondrial membrane (GO:0090151)|1/12|0.140140907911488|0.90067890815154|0|0|6.66666666666667|13.1007125163819|HSP90AA1|1
1892|L-serine metabolic process (GO:0006563)|1/12|0.140140907911488|0.899545978707324|0|0|6.66666666666667|13.1007125163819|PHGDH|1
1893|regulation of vascular endothelial cell proliferation (GO:1905562)|1/12|0.140140907911488|0.898415895819501|0|0|6.66666666666667|13.1007125163819|FLT1|1
1894|regulation of antigen receptor-mediated signaling pathway (GO:0050854)|1/12|0.140140907911488|0.897288648773303|0|0|6.66666666666667|13.1007125163819|RUNX1|1
1895|negative regulation of myoblast differentiation (GO:0045662)|1/12|0.140140907911488|0.896164226907672|0|0|6.66666666666667|13.1007125163819|TGFB1|1
1896|negative regulation of leukocyte apoptotic process (GO:2000107)|1/12|0.140140907911488|0.895042619614922|0|0|6.66666666666667|13.1007125163819|MERTK|1
1897|positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949)|1/12|0.140140907911488|0.893923816340403|0|0|6.66666666666667|13.1007125163819|FLT1|1
1898|positive regulation of SMAD protein import into nucleus (GO:0060391)|1/12|0.140140907911488|0.892807806582175|0|0|6.66666666666667|13.1007125163819|TGFB1|1
1899|positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725)|1/12|0.140140907911488|0.891694579890676|0|0|6.66666666666667|13.1007125163819|IL18|1
1900|regulation of DNA binding (GO:0051101)|2/53|0.141986225642462|0.902310970676814|0|0|3.0188679245283|5.89290635050204|JUN;TGFB1|1
1901|positive regulation of secretion by cell (GO:1903532)|2/53|0.141986225642462|0.901188693350102|0|0|3.0188679245283|5.89290635050204|TGFB1;EZR|1
1902|negative regulation of transcription, DNA-templated (GO:0045892)|14/814|0.142715129347979|0.90468981995371|0|0|1.37592137592138|2.67878784597822|HSPA8;TCF7L2;JUN;JUND;TGFB1;ZBTB4;MYC;UBC;NRIP1;RARA;FLNA;FOSB;LRRFIP1;EZR|1
1903|positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068)|2/54|0.146293493319672|0.926222948399858|0|0|2.96296296296296|5.69523095366489|FLT1;IL18|1
1904|embryonic organ development (GO:0048568)|2/54|0.146293493319672|0.925075212404319|0|0|2.96296296296296|5.69523095366489|TGFB1;RARA|1
1905|T cell receptor signaling pathway (GO:0050852)|4/164|0.150163278954275|0.948370312504533|0|0|1.95121951219512|3.6995747327596|UBC;BMX;CARD11;PAG1|1
1906|cellular response to nutrient levels (GO:0031669)|2/55|0.15062746513678|0.950126025454871|0|0|2.90909090909091|5.50675086201549|HSPA8;XBP1|1
1907|negative regulation of cellular component organization (GO:0051129)|2/55|0.15062746513678|0.948953030361717|0|0|2.90909090909091|5.50675086201549|HSPA8;HSPA1A|1
1908|positive regulation of immune response (GO:0050778)|2/55|0.15062746513678|0.947782927981493|0|0|2.90909090909091|5.50675086201549|PLSCR1;XBP1|1
1909|positive regulation of histone H3-K4 methylation (GO:0051571)|1/13|0.150895583494132|0.948300692820883|0|0|6.15384615384615|11.6379518855538|KMT2E|1
1910|negative regulation of macrophage derived foam cell differentiation (GO:0010745)|1/13|0.150895583494132|0.947134271304498|0|0|6.15384615384615|11.6379518855538|ABCG1|1
1911|regulation of lymphocyte activation (GO:0051249)|1/13|0.150895583494132|0.945970715688645|0|0|6.15384615384615|11.6379518855538|PAG1|1
1912|intestinal absorption (GO:0050892)|1/13|0.150895583494132|0.944810015423996|0|0|6.15384615384615|11.6379518855538|CD36|1
1913|renal absorption (GO:0070293)|1/13|0.150895583494132|0.943652160012938|0|0|6.15384615384615|11.6379518855538|SGK1|1
1914|serine family amino acid biosynthetic process (GO:0009070)|1/13|0.150895583494132|0.94249713900925|0|0|6.15384615384615|11.6379518855538|PHGDH|1
1915|regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798)|1/13|0.150895583494132|0.941344942017796|0|0|6.15384615384615|11.6379518855538|TGFB1|1
1916|regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645)|1/13|0.150895583494132|0.940195558694209|0|0|6.15384615384615|11.6379518855538|IL18|1
1917|positive regulation of protein complex disassembly (GO:0043243)|1/13|0.150895583494132|0.939048978744582|0|0|6.15384615384615|11.6379518855538|ADRB2|1
1918|pathway-restricted SMAD protein phosphorylation (GO:0060389)|1/13|0.150895583494132|0.937905191925161|0|0|6.15384615384615|11.6379518855538|TGFB1|1
1919|glutamine family amino acid biosynthetic process (GO:0009084)|1/13|0.150895583494132|0.93676418804204|0|0|6.15384615384615|11.6379518855538|GLUL|1
1920|regulation of cAMP metabolic process (GO:0030814)|1/13|0.150895583494132|0.935625956950859|0|0|6.15384615384615|11.6379518855538|RAMP1|1
1921|cardiolipin metabolic process (GO:0032048)|1/13|0.150895583494132|0.934490488556501|0|0|6.15384615384615|11.6379518855538|HADHA|1
1922|sensory perception of taste (GO:0050909)|1/13|0.150895583494132|0.933357772812796|0|0|6.15384615384615|11.6379518855538|CD36|1
1923|protein localization to endoplasmic reticulum (GO:0070972)|1/13|0.150895583494132|0.932227799722224|0|0|6.15384615384615|11.6379518855538|HSPA5|1
1924|regulation of necrotic cell death (GO:0010939)|1/13|0.150895583494132|0.931100559335619|0|0|6.15384615384615|11.6379518855538|UBC|1
1925|dicarboxylic acid catabolic process (GO:0043649)|1/13|0.150895583494132|0.92997604175188|0|0|6.15384615384615|11.6379518855538|GLUL|1
1926|negative regulation of hormone secretion (GO:0046888)|1/13|0.150895583494132|0.92885423711768|0|0|6.15384615384615|11.6379518855538|RAB11FIP1|1
1927|positive regulation of ERAD pathway (GO:1904294)|1/13|0.150895583494132|0.927735135627177|0|0|6.15384615384615|11.6379518855538|HERPUD1|1
1928|positive regulation of alpha-beta T cell proliferation (GO:0046641)|1/13|0.150895583494132|0.926618727521729|0|0|6.15384615384615|11.6379518855538|IL18|1
1929|regulation of retinoic acid receptor signaling pathway (GO:0048385)|1/13|0.150895583494132|0.925505003089612|0|0|6.15384615384615|11.6379518855538|DHRS3|1
1930|glomerular visceral epithelial cell differentiation (GO:0072112)|1/13|0.150895583494132|0.924393952665735|0|0|6.15384615384615|11.6379518855538|IQGAP1|1
1931|amyloid precursor protein metabolic process (GO:0042982)|1/13|0.150895583494132|0.923285566631363|0|0|6.15384615384615|11.6379518855538|ABCG1|1
1932|response to fatty acid (GO:0070542)|1/13|0.150895583494132|0.922179835413841|0|0|6.15384615384615|11.6379518855538|CD36|1
1933|glycerophospholipid biosynthetic process (GO:0046474)|4/165|0.152489488015076|0.930806049450878|0|0|1.93939393939394|3.64733986202997|PLSCR1;CHKA;BMX;LPIN1|1
1934|viral life cycle (GO:0019058)|3/108|0.153153635452281|0.933743132273585|0|0|2.22222222222222|4.16958601806995|HSP90AB1;CD81;UBC|1
1935|positive regulation of epithelial cell proliferation (GO:0050679)|3/108|0.153153635452281|0.932628880325764|0|0|2.22222222222222|4.16958601806995|XBP1;MYC;C5AR1|1
1936|negative regulation of gene expression (GO:0010629)|11/619|0.154292971553839|0.938447001000285|0|0|1.421647819063|2.65692055353037|HSPA8;TCF7L2;JUN;BTG2;TGFB1;DAPK1;RARA;MYADM;LRRFIP1;ZBTB4;HSPA1A|1
1937|monocarboxylic acid metabolic process (GO:0032787)|3/109|0.156129854078903|0.948488863529334|0|0|2.20183486238532|4.08895534688136|MCCC2;PNPLA8;ACOT1|1
1938|regulation of inflammatory response (GO:0050727)|4/167|0.157182802718489|0.953750109717538|0|0|1.91616766467066|3.54557279508781|FFAR4;IL18;S100A9;MGLL|1
1939|positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280)|3/110|0.159124054501086|0.964382482326655|0|0|2.18181818181818|4.01033708505816|DAPK1;MYC;S100A9|1
1940|Wnt signaling pathway (GO:0016055)|3/110|0.159124054501086|0.963238493616896|0|0|2.18181818181818|4.01033708505816|TCF7L2;MYC;UBC|1
1941|regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803)|2/57|0.159370219315398|0.96358557958113|0|0|2.80701754385965|5.15515890518388|UBC;HSPA1A|1
1942|cellular defense response (GO:0006968)|2/57|0.159370219315398|0.962445241617129|0|0|2.80701754385965|5.15515890518388|C5AR1;LSP1|1
1943|positive regulation of protein transport (GO:0051222)|2/57|0.159370219315398|0.961307599487558|0|0|2.80701754385965|5.15515890518388|TGFB1;EZR|1
1944|cellular iron ion homeostasis (GO:0006879)|2/57|0.159370219315398|0.960172643644007|0|0|2.80701754385965|5.15515890518388|MYC;UBC|1
1945|glycosaminoglycan catabolic process (GO:0006027)|2/57|0.159370219315398|0.959040364583106|0|0|2.80701754385965|5.15515890518388|TGFB1;CD44|1
1946|regulation of fibroblast migration (GO:0010762)|1/14|0.161516276710355|0.970809846941035|0|0|5.71428571428571|10.4179963246492|TGFB1|1
1947|negative regulation of receptor-mediated endocytosis (GO:0048261)|1/14|0.161516276710355|0.96966771770934|0|0|5.71428571428571|10.4179963246492|UNC119|1
1948|lipid particle organization (GO:0034389)|1/14|0.161516276710355|0.968528272682655|0|0|5.71428571428571|10.4179963246492|CIDEC|1
1949|gliogenesis (GO:0042063)|1/14|0.161516276710355|0.967391502409553|0|0|5.71428571428571|10.4179963246492|CDK6|1
1950|regulation of nucleocytoplasmic transport (GO:0046822)|1/14|0.161516276710355|0.96625739748293|0|0|5.71428571428571|10.4179963246492|TGFB1|1
1951|establishment or maintenance of actin cytoskeleton polarity (GO:0030950)|1/14|0.161516276710355|0.965125948539741|0|0|5.71428571428571|10.4179963246492|RHOB|1
1952|regulation of platelet aggregation (GO:0090330)|1/14|0.161516276710355|0.963997146260748|0|0|5.71428571428571|10.4179963246492|CD9|1
1953|neurotransmitter biosynthetic process (GO:0042136)|1/14|0.161516276710355|0.962870981370256|0|0|5.71428571428571|10.4179963246492|SLC6A4|1
1954|regulation of extracellular matrix disassembly (GO:0010715)|1/14|0.161516276710355|0.961747444635868|0|0|5.71428571428571|10.4179963246492|TGFB1|1
1955|regulation of secretion (GO:0051046)|1/14|0.161516276710355|0.960626526868227|0|0|5.71428571428571|10.4179963246492|SGK1|1
1956|acyl-CoA biosynthetic process (GO:0071616)|1/14|0.161516276710355|0.959508218920767|0|0|5.71428571428571|10.4179963246492|PPT1|1
1957|negative regulation of hemopoiesis (GO:1903707)|1/14|0.161516276710355|0.958392511689464|0|0|5.71428571428571|10.4179963246492|CDK6|1
1958|negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254)|1/14|0.161516276710355|0.957279396112589|0|0|5.71428571428571|10.4179963246492|CD44|1
1959|cell surface receptor signaling pathway involved in heart development (GO:0061311)|1/14|0.161516276710355|0.956168863170463|0|0|5.71428571428571|10.4179963246492|TGFB1|1
1960|pancreas development (GO:0031016)|1/14|0.161516276710355|0.955060903885213|0|0|5.71428571428571|10.4179963246492|TCF7L2|1
1961|regulation of lymphocyte differentiation (GO:0045619)|1/14|0.161516276710355|0.953955509320531|0|0|5.71428571428571|10.4179963246492|CD2|1
1962|regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle (GO:0031657)|1/14|0.161516276710355|0.952852670581433|0|0|5.71428571428571|10.4179963246492|CDK6|1
1963|regulation of fatty acid metabolic process (GO:0019217)|1/14|0.161516276710355|0.951752378814017|0|0|5.71428571428571|10.4179963246492|ADIPOR2|1
1964|cAMP biosynthetic process (GO:0006171)|1/14|0.161516276710355|0.950654625205235|0|0|5.71428571428571|10.4179963246492|ADCY3|1
1965|adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460)|1/14|0.161516276710355|0.949559400982649|0|0|5.71428571428571|10.4179963246492|IL18|1
1966|positive regulation of vascular smooth muscle cell proliferation (GO:1904707)|1/14|0.161516276710355|0.948466697414199|0|0|5.71428571428571|10.4179963246492|JUN|1
1967|negative regulation of smooth muscle cell migration (GO:0014912)|1/14|0.161516276710355|0.947376505807976|0|0|5.71428571428571|10.4179963246492|TRIB1|1
1968|positive regulation of purine nucleotide metabolic process (GO:1900544)|1/14|0.161516276710355|0.946288817511985|0|0|5.71428571428571|10.4179963246492|RAMP1|1
1969|positive regulation of heart rate (GO:0010460)|1/14|0.161516276710355|0.945203623913921|0|0|5.71428571428571|10.4179963246492|ADRB1|1
1970|positive regulation of muscle hypertrophy (GO:0014742)|1/14|0.161516276710355|0.944120916440938|0|0|5.71428571428571|10.4179963246492|CAMK2D|1
1971|positive regulation of transporter activity (GO:0032411)|1/14|0.161516276710355|0.943040686559427|0|0|5.71428571428571|10.4179963246492|SGK1|1
1972|regulation of response to interferon-gamma (GO:0060330)|1/14|0.161516276710355|0.941962925774788|0|0|5.71428571428571|10.4179963246492|HSP90AB1|1
1973|estrogen metabolic process (GO:0008210)|1/14|0.161516276710355|0.940887625631209|0|0|5.71428571428571|10.4179963246492|HSD17B4|1
1974|negative regulation of T cell receptor signaling pathway (GO:0050860)|1/14|0.161516276710355|0.939814777711447|0|0|5.71428571428571|10.4179963246492|EZR|1
1975|negative regulation of cation transmembrane transport (GO:1904063)|1/14|0.161516276710355|0.938744373636605|0|0|5.71428571428571|10.4179963246492|CAMK2D|1
1976|positive regulation of interleukin-8 secretion (GO:2000484)|1/14|0.161516276710355|0.937676405065915|0|0|5.71428571428571|10.4179963246492|CD2|1
1977|negative regulation of cytokine production (GO:0001818)|3/111|0.162135831699804|0.940203578595569|0|0|2.16216216216216|3.93366665466884|UBC;FFAR4;RARA|1
1978|cellular response to peptide hormone stimulus (GO:0071375)|3/111|0.162135831699804|0.939136378165835|0|0|2.16216216216216|3.93366665466884|XBP1;PRKAR2B;ADCY3|1
1979|positive regulation of cell death (GO:0010942)|2/58|0.163776422480513|0.947563587208681|0|0|2.75862068965517|4.99104292089397|CD36;FOS|1
1980|I-kappaB kinase/NF-kappaB signaling (GO:0007249)|2/58|0.163776422480513|0.946490468763371|0|0|2.75862068965517|4.99104292089397|UBC;CARD11|1
1981|phospholipid transport (GO:0015914)|2/59|0.168204170420362|0.970979504134735|0|0|2.71186440677966|4.8341064063379|SCP2;ABCG1|1
1982|ubiquitin-dependent ERAD pathway (GO:0030433)|2/59|0.168204170420362|0.969882352152661|0|0|2.71186440677966|4.8341064063379|HSPA5;DNAJB9|1
1983|regulation of epidermal growth factor receptor signaling pathway (GO:0042058)|2/59|0.168204170420362|0.968787676811631|0|0|2.71186440677966|4.8341064063379|UBC;PTPN12|1
1984|positive regulation of cell morphogenesis involved in differentiation (GO:0010770)|2/59|0.168204170420362|0.967695469735181|0|0|2.71186440677966|4.8341064063379|MYADM;FLNA|1
1985|regulation of organelle organization (GO:0033043)|3/114|0.171272588657494|0.984238761170259|0|0|2.10526315789474|3.7147345388824|CLIC4;EZR;S100A9|1
1986|myeloid cell development (GO:0061515)|1/15|0.172004649979259|0.9873337782274|0|0|5.33333333333333|9.38791342811191|ANXA2|1
1987|pseudouridine synthesis (GO:0001522)|1/15|0.172004649979259|0.986224414431638|0|0|5.33333333333333|9.38791342811191|NOP10|1
1988|regulation of B cell differentiation (GO:0045577)|1/15|0.172004649979259|0.985117540790301|0|0|5.33333333333333|9.38791342811191|XBP1|1
1989|negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642)|1/15|0.172004649979259|0.984013148928429|0|0|5.33333333333333|9.38791342811191|PTPN12|1
1990|transport along microtubule (GO:0010970)|1/15|0.172004649979259|0.982911230508576|0|0|5.33333333333333|9.38791342811191|HSPA8|1
1991|lipoxygenase pathway (GO:0019372)|1/15|0.172004649979259|0.981811777230602|0|0|5.33333333333333|9.38791342811191|LTC4S|1
1992|positive regulation of potassium ion transmembrane transport (GO:1901381)|1/15|0.172004649979259|0.980714780831462|0|0|5.33333333333333|9.38791342811191|FLNA|1
1993|regulation of interleukin-4 production (GO:0032673)|1/15|0.172004649979259|0.979620233084998|0|0|5.33333333333333|9.38791342811191|RARA|1
1994|sodium ion import (GO:0097369)|1/15|0.172004649979259|0.978528125801737|0|0|5.33333333333333|9.38791342811191|SLC9A4|1
1995|unsaturated fatty acid biosynthetic process (GO:0006636)|1/15|0.172004649979259|0.977438450828684|0|0|5.33333333333333|9.38791342811191|LTC4S|1
1996|positive regulation of telomerase RNA localization to Cajal body (GO:1904874)|1/15|0.172004649979259|0.976351200049119|0|0|5.33333333333333|9.38791342811191|NOP10|1
1997|negative regulation of cell aging (GO:0090344)|1/15|0.172004649979259|0.975266365382398|0|0|5.33333333333333|9.38791342811191|CDK6|1
1998|negative regulation of interleukin-2 production (GO:0032703)|1/15|0.172004649979259|0.974183938783749|0|0|5.33333333333333|9.38791342811191|EZR|1
1999|regulation of clathrin-dependent endocytosis (GO:2000369)|1/15|0.172004649979259|0.973103912244078|0|0|5.33333333333333|9.38791342811191|UNC119|1
2000|negative regulation of lipid catabolic process (GO:0050995)|1/15|0.172004649979259|0.972026277789765|0|0|5.33333333333333|9.38791342811191|HCAR2|1
2001|positive regulation of phosphoprotein phosphatase activity (GO:0032516)|1/15|0.172004649979259|0.970951027482476|0|0|5.33333333333333|9.38791342811191|HSP90AB1|1
2002|negative regulation of cellular component movement (GO:0051271)|1/15|0.172004649979259|0.969878153418959|0|0|5.33333333333333|9.38791342811191|CD9|1
2003|fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539)|1/15|0.172004649979259|0.968807647730859|0|0|5.33333333333333|9.38791342811191|ACOX3|1
2004|response to cholesterol (GO:0070723)|1/15|0.172004649979259|0.967739502584518|0|0|5.33333333333333|9.38791342811191|TGFB1|1
2005|negative regulation of muscle cell differentiation (GO:0051148)|1/15|0.172004649979259|0.966673710180791|0|0|5.33333333333333|9.38791342811191|TGFB1|1
2006|sodium ion import across plasma membrane (GO:0098719)|1/15|0.172004649979259|0.96561026275485|0|0|5.33333333333333|9.38791342811191|SLC9A4|1
2007|negative regulation of signal transduction by p53 class mediator (GO:1901797)|1/15|0.172004649979259|0.964549152575998|0|0|5.33333333333333|9.38791342811191|CD44|1
2008|cofactor transport (GO:0051181)|1/15|0.172004649979259|0.963490371947484|0|0|5.33333333333333|9.38791342811191|PPT1|1
2009|negative regulation of platelet activation (GO:0010544)|1/15|0.172004649979259|0.962433913206314|0|0|5.33333333333333|9.38791342811191|CD9|1
2010|negative regulation of cytokine production involved in immune response (GO:0002719)|1/15|0.172004649979259|0.961379768723065|0|0|5.33333333333333|9.38791342811191|TGFB1|1
2011|positive regulation of interleukin-4 production (GO:0032753)|1/15|0.172004649979259|0.960327930901705|0|0|5.33333333333333|9.38791342811191|RARA|1
2012|positive regulation of collagen metabolic process (GO:0010714)|1/15|0.172004649979259|0.959278392179408|0|0|5.33333333333333|9.38791342811191|TGFB1|1
2013|filopodium assembly (GO:0046847)|1/15|0.172004649979259|0.958231145026374|0|0|5.33333333333333|9.38791342811191|EZR|1
2014|negative regulation of RNA metabolic process (GO:0051253)|1/15|0.172004649979259|0.957186181945647|0|0|5.33333333333333|9.38791342811191|TGFB1|1
2015|negative regulation of mRNA processing (GO:0050686)|1/15|0.172004649979259|0.956143495472939|0|0|5.33333333333333|9.38791342811191|TMBIM6|1
2016|positive regulation of collagen biosynthetic process (GO:0032967)|1/15|0.172004649979259|0.955103078176451|0|0|5.33333333333333|9.38791342811191|TGFB1|1
2017|positive regulation of potassium ion transport (GO:0043268)|1/15|0.172004649979259|0.954064922656694|0|0|5.33333333333333|9.38791342811191|FLNA|1
2018|positive regulation of protein export from nucleus (GO:0046827)|1/15|0.172004649979259|0.953029021546317|0|0|5.33333333333333|9.38791342811191|TCF7L2|1
2019|cytoplasmic sequestering of protein (GO:0051220)|1/15|0.172004649979259|0.951995367509933|0|0|5.33333333333333|9.38791342811191|FLNA|1
2020|endoderm development (GO:0007492)|1/15|0.172004649979259|0.950963953243942|0|0|5.33333333333333|9.38791342811191|DUSP5|1
2021|regulation of cell junction assembly (GO:1901888)|1/15|0.172004649979259|0.949934771476362|0|0|5.33333333333333|9.38791342811191|RUNX1|1
2022|negative regulation of cell proliferation (GO:0008285)|7/364|0.172454040977808|0.951386995794331|0|0|1.53846153846154|2.7040377032668|CD164;BTG2;TGFB1;CDK6;MYC;TRIB1;HSPA1A|1
2023|regulation of extrinsic apoptotic signaling pathway (GO:2001236)|2/60|0.172652242960984|0.951451831349788|0|0|2.66666666666667|4.68393563694666|TCF7L2;G0S2|1
2024|keratinocyte differentiation (GO:0030216)|2/60|0.172652242960984|0.950425453969691|0|0|2.66666666666667|4.68393563694666|CLIC4;TXNIP|1
2025|regulation of mRNA splicing, via spliceosome (GO:0048024)|2/61|0.177119446947924|0.973966096740576|0|0|2.62295081967213|4.54014670819084|SON;TRA2B|1
2026|response to reactive oxygen species (GO:0000302)|2/61|0.177119446947924|0.972917694053019|0|0|2.62295081967213|4.54014670819084|JUN;FOS|1
2027|epithelium development (GO:0060429)|3/116|0.177444266917422|0.973653864601726|0|0|2.06896551724138|3.57744560393631|TGFB1;RARA;TAGLN2|1
2028|cellular response to interferon-gamma (GO:0071346)|3/117|0.180553061061703|0.989647981308134|0|0|2.05128205128205|3.511242209863|CAMK2D;DAPK1;CD44|1
2029|chromatin remodeling (GO:0006338)|3/117|0.180553061061703|0.988586127250936|0|0|2.05128205128205|3.511242209863|MYC;BAZ1A;TOP1|1
2030|negative regulation of viral life cycle (GO:1903901)|2/62|0.181604615549113|0.993277977649647|0|0|2.58064516129032|4.40238296030602|PLSCR1;SLPI|1
2031|regulation of tumor necrosis factor production (GO:0032680)|2/62|0.181604615549113|0.992214510864155|0|0|2.58064516129032|4.40238296030602|CD2;RARA|1
2032|peptidyl-threonine dephosphorylation (GO:0035970)|1/16|0.182362345296033|0.995288821439207|0|0|5|8.50879831458303|DUSP5|1
2033|neural tube development (GO:0021915)|1/16|0.182362345296033|0.994225478681259|0|0|5|8.50879831458303|TGFB1|1
2034|positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)|1/16|0.182362345296033|0.993164405598355|0|0|5|8.50879831458303|BTG2|1
2035|positive regulation of secretion (GO:0051047)|1/16|0.182362345296033|0.992105594931406|0|0|5|8.50879831458303|XBP1|1
2036|regulation of reactive oxygen species biosynthetic process (GO:1903426)|1/16|0.182362345296033|0.991049039452246|0|0|5|8.50879831458303|CD36|1
2037|protein deacylation (GO:0035601)|1/16|0.182362345296033|0.989994731963467|0|0|5|8.50879831458303|PPT1|1
2038|negative regulation of striated muscle cell differentiation (GO:0051154)|1/16|0.182362345296033|0.988942665298256|0|0|5|8.50879831458303|XBP1|1
2039|positive regulation of lymphocyte differentiation (GO:0045621)|1/16|0.182362345296033|0.987892832320232|0|0|5|8.50879831458303|XBP1|1
2040|regulation of bicellular tight junction assembly (GO:2000810)|1/16|0.182362345296033|0.986845225923286|0|0|5|8.50879831458303|RUNX1|1
2041|extracellular matrix assembly (GO:0085029)|1/16|0.182362345296033|0.985799839031418|0|0|5|8.50879831458303|TGFB1|1
2042|positive regulation of cardiac muscle hypertrophy (GO:0010613)|1/16|0.182362345296033|0.98475666459858|0|0|5|8.50879831458303|CAMK2D|1
2043|negative regulation of translational initiation (GO:0045947)|1/16|0.182362345296033|0.983715695608519|0|0|5|8.50879831458303|ATF4|1
2044|positive regulation of immune system process (GO:0002684)|1/16|0.182362345296033|0.982676925074613|0|0|5|8.50879831458303|HCAR2|1
2045|glutamine family amino acid catabolic process (GO:0009065)|1/16|0.182362345296033|0.981640346039724|0|0|5|8.50879831458303|GLUL|1
2046|negative regulation of DNA replication (GO:0008156)|1/16|0.182362345296033|0.980605951576036|0|0|5|8.50879831458303|TGFB1|1
2047|regulation of steroid metabolic process (GO:0019218)|1/16|0.182362345296033|0.979573734784904|0|0|5|8.50879831458303|ABCG1|1
2048|bone morphogenesis (GO:0060349)|1/16|0.182362345296033|0.978543688796697|0|0|5|8.50879831458303|RARA|1
2049|positive regulation of triglyceride metabolic process (GO:0090208)|1/16|0.182362345296033|0.97751580677065|0|0|5|8.50879831458303|PNPLA2|1
2050|regulation of SMAD protein import into nucleus (GO:0060390)|1/16|0.182362345296033|0.97649008189471|0|0|5|8.50879831458303|TGFB1|1
2051|positive regulation of cyclic nucleotide metabolic process (GO:0030801)|1/16|0.182362345296033|0.975466507385386|0|0|5|8.50879831458303|RAMP1|1
2052|regulation of protein homodimerization activity (GO:0043496)|1/16|0.182362345296033|0.974445076487601|0|0|5|8.50879831458303|HSPA5|1
2053|odontogenesis of dentin-containing tooth (GO:0042475)|1/16|0.182362345296033|0.973425782474538|0|0|5|8.50879831458303|ANKRD11|1
2054|regulation of stem cell proliferation (GO:0072091)|1/16|0.182362345296033|0.972408618647501|0|0|5|8.50879831458303|EPCAM|1
2055|regulation of necroptotic process (GO:0060544)|1/16|0.182362345296033|0.971393578335761|0|0|5|8.50879831458303|UBC|1
2056|endoplasmic reticulum to cytosol transport (GO:1903513)|1/16|0.182362345296033|0.970380654896411|0|0|5|8.50879831458303|HERPUD1|1
2057|ruffle organization (GO:0031529)|1/16|0.182362345296033|0.969369841714228|0|0|5|8.50879831458303|LIMA1|1
2058|myoblast differentiation (GO:0045445)|1/16|0.182362345296033|0.968361132201518|0|0|5|8.50879831458303|TCF7L2|1
2059|linoleic acid metabolic process (GO:0043651)|1/16|0.182362345296033|0.967354519797982|0|0|5|8.50879831458303|PNPLA8|1
2060|neurotransmitter transport (GO:0006836)|1/16|0.182362345296033|0.96634999797057|0|0|5|8.50879831458303|GLUL|1
2061|regulation of glucose transport (GO:0010827)|1/16|0.182362345296033|0.965347560213339|0|0|5|8.50879831458303|FFAR4|1
2062|positive regulation of response to endoplasmic reticulum stress (GO:1905898)|1/16|0.182362345296033|0.964347200047315|0|0|5|8.50879831458303|XBP1|1
2063|positive regulation of DNA-templated transcription, initiation (GO:2000144)|1/16|0.182362345296033|0.96334891102035|0|0|5|8.50879831458303|JUN|1
2064|cellular amide metabolic process (GO:0043603)|2/63|0.186106607995071|0.982111706927455|0|0|2.53968253968254|4.27031265574423|MCCC2;PLA2G15|1
2065|stress-activated MAPK cascade (GO:0051403)|2/63|0.186106607995071|0.98109712871782|0|0|2.53968253968254|4.27031265574423|UBC;TRIB1|1
2066|DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)|2/63|0.186106607995071|0.980084644580856|0|0|2.53968253968254|4.27031265574423|BTG2;UBC|1
2067|cellular response to lipid (GO:0071396)|4/179|0.186409671912018|0.980668614192812|0|0|1.7877094972067|3.00300959130595|XBP1;NRIP1;RARA;ADCY3|1
2068|cellular protein modification process (GO:0006464)|16/1002|0.189457163390541|0.995674464245035|0|0|1.27744510978044|2.12514788754972|DUSP5;CAMK2D;TGFB1;DAPK1;APLP2;PTPN12;BMX;MERTK;PDIA6;SNRK;CDK6;STK17B;RARA;QSOX1;SGK1;PNPLA2|1
2069|iron ion homeostasis (GO:0055072)|2/64|0.190624308923901|1|0|0|2.5|4.14362689236068|MYC;UBC|1
2070|regulation of viral genome replication (GO:0045069)|2/64|0.190624308923901|0.999749073421037|0|0|2.5|4.14362689236068|PLSCR1;SLPI|1
2071|regulation of proteolysis (GO:0030162)|2/64|0.190624308923901|0.998722637000687|0|0|2.5|4.14362689236068|ABTB1;PERP|1
2072|signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431)|2/64|0.190624308923901|0.997698306090942|0|0|2.5|4.14362689236068|BTG2;UBC|1
2073|positive regulation of protein processing (GO:0010954)|1/17|0.192590984279439|1|0|0|4.70588235294118|7.75146631204035|MYH9|1
2074|high-density lipoprotein particle remodeling (GO:0034375)|1/17|0.192590984279439|1|0|0|4.70588235294118|7.75146631204035|ABCG1|1
2075|positive regulation of cholesterol transport (GO:0032376)|1/17|0.192590984279439|1|0|0|4.70588235294118|7.75146631204035|SCP2|1
2076|reverse cholesterol transport (GO:0043691)|1/17|0.192590984279439|1|0|0|4.70588235294118|7.75146631204035|ABCG1|1
2077|regulation of membrane depolarization (GO:0003254)|1/17|0.192590984279439|1|0|0|4.70588235294118|7.75146631204035|CAMK2D|1
2078|negative regulation of antigen receptor-mediated signaling pathway (GO:0050858)|1/17|0.192590984279439|1|0|0|4.70588235294118|7.75146631204035|EZR|1
2079|positive regulation of interleukin-6 secretion (GO:2000778)|1/17|0.192590984279439|1|0|0|4.70588235294118|7.75146631204035|XBP1|1
2080|positive regulation of monocyte chemotaxis (GO:0090026)|1/17|0.192590984279439|0.999788192042703|0|0|4.70588235294118|7.75146631204035|FPR2|1
2081|regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028)|1/17|0.192590984279439|0.99877214713209|0|0|4.70588235294118|7.75146631204035|HSPA1A|1
2082|positive regulation of striated muscle cell differentiation (GO:0051155)|1/17|0.192590984279439|0.997758165256829|0|0|4.70588235294118|7.75146631204035|TGFB1|1
2083|positive regulation of dendrite extension (GO:1903861)|1/17|0.192590984279439|0.996746240139936|0|0|4.70588235294118|7.75146631204035|CPNE5|1
2084|positive regulation of hormone secretion (GO:0046887)|1/17|0.192590984279439|0.995736365529865|0|0|4.70588235294118|7.75146631204035|HCAR2|1
2085|positive regulation of stem cell proliferation (GO:2000648)|1/17|0.192590984279439|0.994728535200381|0|0|4.70588235294118|7.75146631204035|EPCAM|1
2086|negative regulation of intracellular transport (GO:0032387)|1/17|0.192590984279439|0.993722742950432|0|0|4.70588235294118|7.75146631204035|HSPA1A|1
2087|regulation of collagen biosynthetic process (GO:0032965)|1/17|0.192590984279439|0.992718982604017|0|0|4.70588235294118|7.75146631204035|TGFB1|1
2088|regulation of receptor recycling (GO:0001919)|1/17|0.192590984279439|0.991717248010067|0|0|4.70588235294118|7.75146631204035|ANXA2|1
2089|phospholipid catabolic process (GO:0009395)|1/17|0.192590984279439|0.990717533042315|0|0|4.70588235294118|7.75146631204035|ABHD12|1
2090|long-term memory (GO:0007616)|1/17|0.192590984279439|0.989719831599171|0|0|4.70588235294118|7.75146631204035|SGK1|1
2091|macrophage activation (GO:0042116)|1/17|0.192590984279439|0.988724137603598|0|0|4.70588235294118|7.75146631204035|FPR2|1
2092|virion assembly (GO:0019068)|1/17|0.192590984279439|0.987730445002992|0|0|4.70588235294118|7.75146631204035|UBC|1
2093|defense response to fungus (GO:0050832)|1/17|0.192590984279439|0.986738747769053|0|0|4.70588235294118|7.75146631204035|S100A9|1
2094|regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881)|1/17|0.192590984279439|0.98574903989767|0|0|4.70588235294118|7.75146631204035|CAMK2D|1
2095|positive regulation by host of viral transcription (GO:0043923)|1/17|0.192590984279439|0.984761315408794|0|0|4.70588235294118|7.75146631204035|JUN|1
2096|regulation of lamellipodium organization (GO:1902743)|1/17|0.192590984279439|0.983775568346323|0|0|4.70588235294118|7.75146631204035|CD44|1
2097|positive chemotaxis (GO:0050918)|1/17|0.192590984279439|0.982791792777977|0|0|4.70588235294118|7.75146631204035|FPR2|1
2098|regulation of B cell receptor signaling pathway (GO:0050855)|1/17|0.192590984279439|0.981809982795182|0|0|4.70588235294118|7.75146631204035|RUNX1|1
2099|detection of mechanical stimulus (GO:0050982)|1/17|0.192590984279439|0.980830132512951|0|0|4.70588235294118|7.75146631204035|JUP|1
2100|positive regulation of leukocyte activation (GO:0002696)|1/17|0.192590984279439|0.979852236069767|0|0|4.70588235294118|7.75146631204035|CD2|1
2101|regulation of early endosome to late endosome transport (GO:2000641)|1/17|0.192590984279439|0.978876287627467|0|0|4.70588235294118|7.75146631204035|EZR|1
2102|positive regulation of cation transmembrane transport (GO:1904064)|1/17|0.192590984279439|0.977902281371121|0|0|4.70588235294118|7.75146631204035|FLNA|1
2103|positive regulation of transcription of Notch receptor target (GO:0007221)|1/17|0.192590984279439|0.976930211508923|0|0|4.70588235294118|7.75146631204035|PBX1|1
2104|viral entry into host cell (GO:0046718)|1/17|0.192590984279439|0.975960072272072|0|0|4.70588235294118|7.75146631204035|CD81|1
2105|DNA replication (GO:0006260)|3/121|0.193132052680279|0.977731016693913|0|0|1.98347107438017|3.26158237341636|BAZ1A;TOP1;PTMS|1
2106|negative regulation of growth (GO:0045926)|3/121|0.193132052680279|0.976762006766565|0|0|1.98347107438017|3.26158237341636|TGFB1;PPT1;HSPA1A|1
2107|negative regulation of cellular macromolecule biosynthetic process (GO:2000113)|9/513|0.194527524481522|0.982845502405154|0|0|1.40350877192982|2.29779875353262|HSPA8;TCF7L2;JUN;BTG2;TGFB1;DAPK1;RARA;LRRFIP1;ZBTB4|1
2108|positive regulation of protein polymerization (GO:0032273)|2/65|0.195156628114211|0.985048737158078|0|0|2.46153846153846|4.02203771502599|TPPP3;CDC42EP3|1
2109|glycerophospholipid metabolic process (GO:0006650)|2/65|0.195156628114211|0.984075368840728|0|0|2.46153846153846|4.02203771502599|ABHD12;PLA2G15|1
2110|cellular response to decreased oxygen levels (GO:0036294)|2/65|0.195156628114211|0.983103922277213|0|0|2.46153846153846|4.02203771502599|FABP1;MYC|1
2111|Fc-epsilon receptor signaling pathway (GO:0038095)|4/183|0.19652214739701|0.989006428172528|0|0|1.74863387978142|2.84499260262209|JUN;UBC;FOS;CARD11|1
2112|phosphate-containing compound metabolic process (GO:0006796)|4/184|0.199076480713133|1|0|0|1.73913043478261|2.80707165721744|PLA2G15;DUSP5;TGFB1;TOP1|1
2113|Fc receptor signaling pathway (GO:0038093)|4/184|0.199076480713133|0.999889056180235|0|0|1.73913043478261|2.80707165721744|JUN;UBC;FOS;CARD11|1
2114|negative regulation of cell adhesion (GO:0007162)|2/66|0.199702499817384|1|0|0|2.42424242424242|3.905276414|CD164;TGFB1|1
2115|regulation of mitotic cell cycle phase transition (GO:1901990)|4/185|0.201640915455707|1|0|0|1.72972972972973|2.76975880601581|HSP90AA1;CDK6;PRKAR2B;UBC|1
2116|glucan catabolic process (GO:0009251)|1/18|0.202692168590286|1|0|0|4.44444444444444|7.09363049662346|PYGL|1
2117|regulation of telomerase RNA localization to Cajal body (GO:1904872)|1/18|0.202692168590286|1|0|0|4.44444444444444|7.09363049662346|NOP10|1
2118|membrane protein ectodomain proteolysis (GO:0006509)|1/18|0.202692168590286|1|0|0|4.44444444444444|7.09363049662346|MYH9|1
2119|actin filament polymerization (GO:0030041)|1/18|0.202692168590286|1|0|0|4.44444444444444|7.09363049662346|PREX1|1
2120|regulation of cellular response to transforming growth factor beta stimulus (GO:1903844)|1/18|0.202692168590286|1|0|0|4.44444444444444|7.09363049662346|TGFB1|1
2121|cardiac muscle cell contraction (GO:0086003)|1/18|0.202692168590286|1|0|0|4.44444444444444|7.09363049662346|CAMK2D|1
2122|regulation of lipid catabolic process (GO:0050994)|1/18|0.202692168590286|1|0|0|4.44444444444444|7.09363049662346|HCAR2|1
2123|glucan biosynthetic process (GO:0009250)|1/18|0.202692168590286|1|0|0|4.44444444444444|7.09363049662346|UBC|1
2124|maintenance of protein localization in organelle (GO:0072595)|1/18|0.202692168590286|1|0|0|4.44444444444444|7.09363049662346|HSPA5|1
2125|leukotriene biosynthetic process (GO:0019370)|1/18|0.202692168590286|1|0|0|4.44444444444444|7.09363049662346|LTC4S|1
2126|negative regulation of fibroblast proliferation (GO:0048147)|1/18|0.202692168590286|1|0|0|4.44444444444444|7.09363049662346|MYC|1
2127|regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664)|1/18|0.202692168590286|1|0|0|4.44444444444444|7.09363049662346|TRIB1|1
2128|establishment or maintenance of apical/basal cell polarity (GO:0035088)|1/18|0.202692168590286|1|0|0|4.44444444444444|7.09363049662346|CLIC4|1
2129|negative regulation of RNA splicing (GO:0033119)|1/18|0.202692168590286|1|0|0|4.44444444444444|7.09363049662346|TMBIM6|1
2130|modulation by virus of host morphology or physiology (GO:0019048)|1/18|0.202692168590286|1|0|0|4.44444444444444|7.09363049662346|TGFB1|1
2131|retrograde protein transport, ER to cytosol (GO:0030970)|1/18|0.202692168590286|1|0|0|4.44444444444444|7.09363049662346|HERPUD1|1
2132|regulation of cardiac muscle cell membrane repolarization (GO:0099623)|1/18|0.202692168590286|0.999360518179934|0|0|4.44444444444444|7.09363049662346|FLNA|1
2133|positive regulation of p38MAPK cascade (GO:1900745)|1/18|0.202692168590286|0.998395884475127|0|0|4.44444444444444|7.09363049662346|GADD45G|1
2134|glycogen catabolic process (GO:0005980)|1/18|0.202692168590286|0.997433111201766|0|0|4.44444444444444|7.09363049662346|PYGL|1
2135|acute-phase response (GO:0006953)|1/18|0.202692168590286|0.996472192982882|0|0|4.44444444444444|7.09363049662346|PLSCR1|1
2136|glycogen biosynthetic process (GO:0005978)|1/18|0.202692168590286|0.995513124462206|0|0|4.44444444444444|7.09363049662346|UBC|1
2137|regulation of cAMP-mediated signaling (GO:0043949)|1/18|0.202692168590286|0.994555900304069|0|0|4.44444444444444|7.09363049662346|ADRB1|1
2138|DNA conformation change (GO:0071103)|1/18|0.202692168590286|0.993600515193306|0|0|4.44444444444444|7.09363049662346|TOP1|1
2139|blood vessel endothelial cell migration (GO:0043534)|1/18|0.202692168590286|0.992646963835155|0|0|4.44444444444444|7.09363049662346|MYH9|1
2140|regulation of microtubule polymerization or depolymerization (GO:0031110)|1/18|0.202692168590286|0.99169524095516|0|0|4.44444444444444|7.09363049662346|FKBP4|1
2141|regulation of dendrite extension (GO:1903859)|1/18|0.202692168590286|0.990745341299072|0|0|4.44444444444444|7.09363049662346|CPNE5|1
2142|regulation of smooth muscle cell migration (GO:0014910)|1/18|0.202692168590286|0.989797259632758|0|0|4.44444444444444|7.09363049662346|TRIB1|1
2143|DNA metabolic process (GO:0006259)|6/315|0.20282161685704|0.989482515125694|0|0|1.52380952380952|2.43112902239755|TCF7L2;BTG2;UBC;NABP1;TOP1;PTMS|1
2144|cellular response to light stimulus (GO:0071482)|2/67|0.204260882576678|0.995552324535615|0|0|2.38805970149254|3.79309197848888|MYC;ATF4|1
2145|intracellular steroid hormone receptor signaling pathway (GO:0030518)|2/67|0.204260882576678|0.994602370027471|0|0|2.38805970149254|3.79309197848888|NCOA4;NRIP1|1
2146|purine ribonucleotide metabolic process (GO:0009150)|2/67|0.204260882576678|0.993654226681401|0|0|2.38805970149254|3.79309197848888|HSPA8;HSPA1A|1
2147|negative regulation of epithelial cell proliferation (GO:0050680)|2/67|0.204260882576678|0.992707889322656|0|0|2.38805970149254|3.79309197848888|TGFB1;CDK6|1
2148|JNK cascade (GO:0007254)|2/67|0.204260882576678|0.991763352796184|0|0|2.38805970149254|3.79309197848888|UBC;TRIB1|1
2149|epidermal cell differentiation (GO:0009913)|2/68|0.208830758565683|1|0|0|2.35294117647059|3.68524970043423|CLIC4;TXNIP|1
2150|regulation of gene silencing by miRNA (GO:0060964)|2/68|0.208830758565683|1|0|0|2.35294117647059|3.68524970043423|TGFB1;POLR2A|1
2151|extrinsic apoptotic signaling pathway (GO:0097191)|2/68|0.208830758565683|1|0|0|2.35294117647059|3.68524970043423|TGFB1;G0S2|1
2152|regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079)|2/68|0.208830758565683|1|0|0|2.35294117647059|3.68524970043423|CCND2;CCNL1|1
2153|cellular response to UV (GO:0034644)|2/68|0.208830758565683|1|0|0|2.35294117647059|3.68524970043423|MYC;ATF4|1
2154|regulation of protein localization to plasma membrane (GO:1903076)|2/68|0.208830758565683|1|0|0|2.35294117647059|3.68524970043423|TGFB1;TMBIM1|1
2155|G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)|3/126|0.209150164191854|1|0|0|1.9047619047619|2.98038627819183|FPR1;ADRB1;ADRB2|1
2156|regulation of mitotic spindle assembly (GO:1901673)|1/19|0.212667480025115|1|0|0|4.21052631578947|6.51800193576111|HSPA1A|1
2157|positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511)|1/19|0.212667480025115|1|0|0|4.21052631578947|6.51800193576111|HSP90AB1|1
2158|regulation of protein kinase A signaling (GO:0010738)|1/19|0.212667480025115|1|0|0|4.21052631578947|6.51800193576111|ADRB2|1
2159|primary alcohol metabolic process (GO:0034308)|1/19|0.212667480025115|1|0|0|4.21052631578947|6.51800193576111|DHRS3|1
2160|negative regulation of lymphocyte activation (GO:0051250)|1/19|0.212667480025115|1|0|0|4.21052631578947|6.51800193576111|PAG1|1
2161|error-free translesion synthesis (GO:0070987)|1/19|0.212667480025115|1|0|0|4.21052631578947|6.51800193576111|UBC|1
2162|protein exit from endoplasmic reticulum (GO:0032527)|1/19|0.212667480025115|1|0|0|4.21052631578947|6.51800193576111|HERPUD1|1
2163|positive regulation of activated T cell proliferation (GO:0042104)|1/19|0.212667480025115|1|0|0|4.21052631578947|6.51800193576111|IL18|1
2164|acylglycerol biosynthetic process (GO:0046463)|1/19|0.212667480025115|1|0|0|4.21052631578947|6.51800193576111|LPIN1|1
2165|regulation of myotube differentiation (GO:0010830)|1/19|0.212667480025115|1|0|0|4.21052631578947|6.51800193576111|XBP1|1
2166|positive regulation of mononuclear cell migration (GO:0071677)|1/19|0.212667480025115|1|0|0|4.21052631578947|6.51800193576111|FPR2|1
2167|cyclic nucleotide biosynthetic process (GO:0009190)|1/19|0.212667480025115|1|0|0|4.21052631578947|6.51800193576111|ADCY3|1
2168|negative regulation of lipid metabolic process (GO:0045833)|1/19|0.212667480025115|1|0|0|4.21052631578947|6.51800193576111|HCAR2|1
2169|osteoclast differentiation (GO:0030316)|1/19|0.212667480025115|1|0|0|4.21052631578947|6.51800193576111|ANXA2|1
2170|regulation of transcription factor import into nucleus (GO:0042990)|1/19|0.212667480025115|1|0|0|4.21052631578947|6.51800193576111|FLNA|1
2171|leukotriene metabolic process (GO:0006691)|1/19|0.212667480025115|1|0|0|4.21052631578947|6.51800193576111|LTC4S|1
2172|insulin secretion (GO:0030073)|1/19|0.212667480025115|1|0|0|4.21052631578947|6.51800193576111|GAL|1
2173|positive regulation of immunoglobulin production (GO:0002639)|1/19|0.212667480025115|1|0|0|4.21052631578947|6.51800193576111|XBP1|1
2174|positive regulation of phospholipase activity (GO:0010518)|1/19|0.212667480025115|1|0|0|4.21052631578947|6.51800193576111|FLT1|1
2175|negative regulation of calcium ion transport (GO:0051926)|1/19|0.212667480025115|1|0|0|4.21052631578947|6.51800193576111|TMBIM6|1
2176|protein heterotetramerization (GO:0051290)|1/19|0.212667480025115|1|0|0|4.21052631578947|6.51800193576111|ANXA2|1
2177|positive regulation of transcription regulatory region DNA binding (GO:2000679)|1/19|0.212667480025115|1|0|0|4.21052631578947|6.51800193576111|TGFB1|1
2178|triglyceride biosynthetic process (GO:0019432)|1/19|0.212667480025115|1|0|0|4.21052631578947|6.51800193576111|LPIN1|1
2179|positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846)|1/19|0.212667480025115|1|0|0|4.21052631578947|6.51800193576111|HSP90AB1|1
2180|response to interferon-beta (GO:0035456)|1/19|0.212667480025115|1|0|0|4.21052631578947|6.51800193576111|PLSCR1|1
2181|positive regulation of neuron apoptotic process (GO:0043525)|1/19|0.212667480025115|1|0|0|4.21052631578947|6.51800193576111|ATF4|1
2182|negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154)|2/69|0.213411133254545|1|0|0|2.31884057971015|3.58152990295198|FABP1;CD44|1
2183|regulation of actin filament polymerization (GO:0030833)|2/69|0.213411133254545|1|0|0|2.31884057971015|3.58152990295198|CDC42EP3;MYADM|1
2184|positive regulation of T cell activation (GO:0050870)|2/69|0.213411133254545|1|0|0|2.31884057971015|3.58152990295198|XBP1;SIRPA|1
2185|positive regulation of protein kinase B signaling (GO:0051897)|3/128|0.215639154707563|1|0|0|1.875|2.87652909061964|TCF7L2;TGFB1;IL18|1
2186|response to organic cyclic compound (GO:0014070)|2/70|0.218001035060907|1|0|0|2.28571428571429|3.48172678449944|TGFB1;IL18|1
2187|positive regulation of plasma membrane bounded cell projection assembly (GO:0120034)|2/70|0.218001035060907|1|0|0|2.28571428571429|3.48172678449944|MIEN1;CDC42EP3|1
2188|regulation of mRNA stability (GO:0043488)|3/129|0.218899661298966|1|0|0|1.86046511627907|2.82631036602996|HSPA8;UBC;HSPA1A|1
2189|positive regulation of interleukin-2 production (GO:0032743)|1/20|0.222518480827523|1|0|0|4|6.01098048370457|RUNX1|1
2190|regulation of vacuole organization (GO:0044088)|1/20|0.222518480827523|1|0|0|4|6.01098048370457|ANXA2|1
2191|regulation of epidermal cell differentiation (GO:0045604)|1/20|0.222518480827523|1|0|0|4|6.01098048370457|RUNX1|1
2192|ureteric bud morphogenesis (GO:0060675)|1/20|0.222518480827523|1|0|0|4|6.01098048370457|MYC|1
2193|negative regulation of macromolecule biosynthetic process (GO:0010558)|1/20|0.222518480827523|1|0|0|4|6.01098048370457|TGFB1|1
2194|regulation of regulatory T cell differentiation (GO:0045589)|1/20|0.222518480827523|1|0|0|4|6.01098048370457|RUNX1|1
2195|cellular polysaccharide catabolic process (GO:0044247)|1/20|0.222518480827523|1|0|0|4|6.01098048370457|PYGL|1
2196|regulation of lipoprotein lipase activity (GO:0051004)|1/20|0.222518480827523|1|0|0|4|6.01098048370457|ANGPTL4|1
2197|endoplasmic reticulum mannose trimming (GO:1904380)|1/20|0.222518480827523|1|0|0|4|6.01098048370457|UBC|1
2198|response to progesterone (GO:0032570)|1/20|0.222518480827523|1|0|0|4|6.01098048370457|TGFB1|1
2199|error-prone translesion synthesis (GO:0042276)|1/20|0.222518480827523|1|0|0|4|6.01098048370457|UBC|1
2200|regulation of calcium ion transmembrane transport (GO:1903169)|1/20|0.222518480827523|1|0|0|4|6.01098048370457|CAMK2D|1
2201|androgen metabolic process (GO:0008209)|1/20|0.222518480827523|1|0|0|4|6.01098048370457|HSD17B4|1
2202|negative regulation of response to biotic stimulus (GO:0002832)|1/20|0.222518480827523|1|0|0|4|6.01098048370457|TRIB1|1
2203|negative regulation of protein depolymerization (GO:1901880)|1/20|0.222518480827523|1|0|0|4|6.01098048370457|LIMA1|1
2204|positive regulation of gene silencing by miRNA (GO:2000637)|1/20|0.222518480827523|1|0|0|4|6.01098048370457|TGFB1|1
2205|glial cell development (GO:0021782)|1/20|0.222518480827523|1|0|0|4|6.01098048370457|CDK6|1
2206|regulation of response to cytokine stimulus (GO:0060759)|1/20|0.222518480827523|1|0|0|4|6.01098048370457|RUNX1|1
2207|branching involved in ureteric bud morphogenesis (GO:0001658)|1/20|0.222518480827523|1|0|0|4|6.01098048370457|MYC|1
2208|regulation of toll-like receptor signaling pathway (GO:0034121)|1/20|0.222518480827523|1|0|0|4|6.01098048370457|CD36|1
2209|negative regulation of plasma membrane bounded cell projection assembly (GO:0120033)|1/20|0.222518480827523|1|0|0|4|6.01098048370457|EVL|1
2210|negative regulation of interferon-gamma production (GO:0032689)|1/20|0.222518480827523|1|0|0|4|6.01098048370457|RARA|1
2211|cellular response to estradiol stimulus (GO:0071392)|1/20|0.222518480827523|1|0|0|4|6.01098048370457|NRIP1|1
2212|regulation of transport (GO:0051049)|1/20|0.222518480827523|1|0|0|4|6.01098048370457|FFAR4|1
2213|positive regulation of endothelial cell migration (GO:0010595)|2/71|0.222599514796343|1|0|0|2.25352112676056|3.38564736868511|TGFB1;RHOB|1
2214|vascular endothelial growth factor receptor signaling pathway (GO:0048010)|2/71|0.222599514796343|1|0|0|2.25352112676056|3.38564736868511|HSP90AA1;FLT1|1
2215|snRNA transcription (GO:0009301)|2/71|0.222599514796343|1|0|0|2.25352112676056|3.38564736868511|POLR2A;NABP1|1
2216|interferon-gamma-mediated signaling pathway (GO:0060333)|2/71|0.222599514796343|1|0|0|2.25352112676056|3.38564736868511|CAMK2D;CD44|1
2217|snRNA transcription from RNA polymerase II promoter (GO:0042795)|2/71|0.222599514796343|1|0|0|2.25352112676056|3.38564736868511|POLR2A;NABP1|1
2218|regulation of cell communication (GO:0010646)|2/72|0.227205645375168|1|0|0|2.22222222222222|3.29311054409303|CAMK2D;MGLL|1
2219|actomyosin structure organization (GO:0031032)|2/72|0.227205645375168|1|0|0|2.22222222222222|3.29311054409303|KRT19;MYH9|1
2220|positive regulation of lymphocyte proliferation (GO:0050671)|2/72|0.227205645375168|1|0|0|2.22222222222222|3.29311054409303|CD81;IL18|1
2221|lipid biosynthetic process (GO:0008610)|2/73|0.231818521345191|1|0|0|2.19178082191781|3.20394618959516|XBP1;SCP2|1
2222|negative regulation of cysteine-type endopeptidase activity (GO:2000117)|2/73|0.231818521345191|1|0|0|2.19178082191781|3.20394618959516|FABP1;CD44|1
2223|regulation of fat cell differentiation (GO:0045598)|2/73|0.231818521345191|1|0|0|2.19178082191781|3.20394618959516|XBP1;TGFB1|1
2224|cellular response to hypoxia (GO:0071456)|3/133|0.232039820774706|1|0|0|1.80451127819549|2.63611358936701|FABP1;MYC;UBC|1
2225|positive regulation of transcription from RNA polymerase I promoter (GO:0045943)|1/21|0.2322467140394|1|0|0|3.80952380952381|5.56173352291604|ATF4|1
2226|regulation of ruffle assembly (GO:1900027)|1/21|0.2322467140394|1|0|0|3.80952380952381|5.56173352291604|EVL|1
2227|mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)|1/21|0.2322467140394|1|0|0|3.80952380952381|5.56173352291604|NDUFA4|1
2228|mesoderm development (GO:0007498)|1/21|0.2322467140394|1|0|0|3.80952380952381|5.56173352291604|BMX|1
2229|ventricular cardiac muscle tissue development (GO:0003229)|1/21|0.2322467140394|1|0|0|3.80952380952381|5.56173352291604|TGFB1|1
2230|negative regulation of ion transmembrane transporter activity (GO:0032413)|1/21|0.2322467140394|1|0|0|3.80952380952381|5.56173352291604|CAMK2D|1
2231|negative regulation of macroautophagy (GO:0016242)|1/21|0.2322467140394|1|0|0|3.80952380952381|5.56173352291604|QSOX1|1
2232|regulation of cardiac muscle hypertrophy (GO:0010611)|1/21|0.2322467140394|1|0|0|3.80952380952381|5.56173352291604|CAMK2D|1
2233|branched-chain amino acid catabolic process (GO:0009083)|1/21|0.2322467140394|1|0|0|3.80952380952381|5.56173352291604|MCCC2|1
2234|regulation of interleukin-2 production (GO:0032663)|1/21|0.2322467140394|1|0|0|3.80952380952381|5.56173352291604|RUNX1|1
2235|meiosis I (GO:0007127)|1/21|0.2322467140394|1|0|0|3.80952380952381|5.56173352291604|SCIMP|1
2236|protein-DNA complex disassembly (GO:0032986)|1/21|0.2322467140394|1|0|0|3.80952380952381|5.56173352291604|MYC|1
2237|lipid catabolic process (GO:0016042)|1/21|0.2322467140394|1|0|0|3.80952380952381|5.56173352291604|PPT1|1
2238|ERK1 and ERK2 cascade (GO:0070371)|1/21|0.2322467140394|1|0|0|3.80952380952381|5.56173352291604|MYC|1
2239|negative regulation of cell cycle arrest (GO:0071157)|1/21|0.2322467140394|1|0|0|3.80952380952381|5.56173352291604|HSP90AB1|1
2240|glutamate metabolic process (GO:0006536)|1/21|0.2322467140394|1|0|0|3.80952380952381|5.56173352291604|GLUL|1
2241|positive regulation of inflammatory response (GO:0050729)|2/74|0.236437258510838|1|0|0|2.16216216216216|3.11799437395708|IL18;S100A9|1
2242|transcription-coupled nucleotide-excision repair (GO:0006283)|2/74|0.236437258510838|1|0|0|2.16216216216216|3.11799437395708|POLR2A;UBC|1
2243|lymphocyte differentiation (GO:0030098)|2/74|0.236437258510838|1|0|0|2.16216216216216|3.11799437395708|LEPR;DNAJB9|1
2244|positive regulation of cytokine secretion (GO:0050715)|2/74|0.236437258510838|1|0|0|2.16216216216216|3.11799437395708|CD2;XBP1|1
2245|nucleic acid phosphodiester bond hydrolysis (GO:0090305)|2/74|0.236437258510838|1|0|0|2.16216216216216|3.11799437395708|UBC;RNASE6|1
2246|canonical Wnt signaling pathway (GO:0060070)|2/74|0.236437258510838|1|0|0|2.16216216216216|3.11799437395708|TCF7L2;MYC|1
2247|positive regulation of proteasomal protein catabolic process (GO:1901800)|2/74|0.236437258510838|1|0|0|2.16216216216216|3.11799437395708|TRIB1;HSPA1A|1
2248|nitrogen compound transport (GO:0071705)|2/75|0.241060993617795|1|0|0|2.13333333333333|3.03510462285058|SLC38A2;SLC6A4|1
2249|regulation of calcium ion transport into cytosol (GO:0010522)|1/22|0.24185370354343|1|0|0|3.63636363636364|5.16153551432782|TMBIM6|1
2250|regulation of interferon-gamma-mediated signaling pathway (GO:0060334)|1/22|0.24185370354343|1|0|0|3.63636363636364|5.16153551432782|HSP90AB1|1
2251|regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947)|1/22|0.24185370354343|1|0|0|3.63636363636364|5.16153551432782|FLT1|1
2252|negative regulation of protein polymerization (GO:0032272)|1/22|0.24185370354343|1|0|0|3.63636363636364|5.16153551432782|MYADM|1
2253|protein homotrimerization (GO:0070207)|1/22|0.24185370354343|1|0|0|3.63636363636364|5.16153551432782|MGST1|1
2254|regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882)|1/22|0.24185370354343|1|0|0|3.63636363636364|5.16153551432782|CAMK2D|1
2255|activation of phospholipase C activity (GO:0007202)|1/22|0.24185370354343|1|0|0|3.63636363636364|5.16153551432782|C5AR1|1
2256|hematopoietic progenitor cell differentiation (GO:0002244)|1/22|0.24185370354343|1|0|0|3.63636363636364|5.16153551432782|TGFB1|1
2257|regulation of DNA biosynthetic process (GO:2000278)|1/22|0.24185370354343|1|0|0|3.63636363636364|5.16153551432782|MYC|1
2258|negative regulation of cell cycle G1/S phase transition (GO:1902807)|1/22|0.24185370354343|1|0|0|3.63636363636364|5.16153551432782|CDK2AP2|1
2259|negative regulation of myeloid cell differentiation (GO:0045638)|1/22|0.24185370354343|1|0|0|3.63636363636364|5.16153551432782|CDK6|1
2260|negative regulation of actin filament polymerization (GO:0030837)|1/22|0.24185370354343|1|0|0|3.63636363636364|5.16153551432782|MYADM|1
2261|positive regulation of erythrocyte differentiation (GO:0045648)|1/22|0.24185370354343|1|0|0|3.63636363636364|5.16153551432782|HSPA1A|1
2262|protein localization to cell surface (GO:0034394)|1/22|0.24185370354343|1|0|0|3.63636363636364|5.16153551432782|FLNA|1
2263|rRNA modification (GO:0000154)|1/22|0.24185370354343|1|0|0|3.63636363636364|5.16153551432782|NOP10|1
2264|nucleotide-excision repair, DNA duplex unwinding (GO:0000717)|1/22|0.24185370354343|1|0|0|3.63636363636364|5.16153551432782|UBC|1
2265|branched-chain amino acid metabolic process (GO:0009081)|1/22|0.24185370354343|1|0|0|3.63636363636364|5.16153551432782|MCCC2|1
2266|positive regulation of biosynthetic process (GO:0009891)|1/22|0.24185370354343|1|0|0|3.63636363636364|5.16153551432782|CD36|1
2267|regulation of ERBB signaling pathway (GO:1901184)|1/22|0.24185370354343|1|0|0|3.63636363636364|5.16153551432782|PTPN12|1
2268|protein complex localization (GO:0031503)|1/22|0.24185370354343|1|0|0|3.63636363636364|5.16153551432782|EZR|1
2269|regulation of monocyte chemotaxis (GO:0090025)|1/22|0.24185370354343|1|0|0|3.63636363636364|5.16153551432782|FPR2|1
2270|positive regulation of phosphatase activity (GO:0010922)|1/22|0.24185370354343|1|0|0|3.63636363636364|5.16153551432782|HSP90AB1|1
2271|negative regulation of cellular amide metabolic process (GO:0034249)|2/76|0.245688883821451|1|0|0|2.10526315789474|2.95513524920091|BTG2;DAPK1|1
2272|purine ribonucleotide biosynthetic process (GO:0009152)|2/76|0.245688883821451|1|0|0|2.10526315789474|2.95513524920091|TGFB1;ADCY3|1
2273|regulation of hematopoietic stem cell differentiation (GO:1902036)|2/77|0.250320106482708|1|0|0|2.07792207792208|2.87795273607327|UBC;RUNX1|1
2274|nucleic acid-templated transcription (GO:0097659)|2/77|0.250320106482708|1|0|0|2.07792207792208|2.87795273607327|POLR2A;BAZ1A|1
2275|positive regulation of apoptotic signaling pathway (GO:2001235)|2/77|0.250320106482708|1|0|0|2.07792207792208|2.87795273607327|G0S2;S100A9|1
2276|cellular response to catecholamine stimulus (GO:0071870)|1/23|0.251340954359694|1|0|0|3.47826086956522|4.80328653118593|ATF4|1
2277|cholesterol efflux (GO:0033344)|1/23|0.251340954359694|1|0|0|3.47826086956522|4.80328653118593|ABCG1|1
2278|negative regulation of viral transcription (GO:0032897)|1/23|0.251340954359694|1|0|0|3.47826086956522|4.80328653118593|JUN|1
2279|nucleotide-excision repair, DNA gap filling (GO:0006297)|1/23|0.251340954359694|1|0|0|3.47826086956522|4.80328653118593|UBC|1
2280|microtubule polymerization or depolymerization (GO:0031109)|1/23|0.251340954359694|1|0|0|3.47826086956522|4.80328653118593|TPPP3|1
2281|positive regulation of ERBB signaling pathway (GO:1901186)|1/23|0.251340954359694|1|0|0|3.47826086956522|4.80328653118593|UBC|1
2282|cellular amino acid catabolic process (GO:0009063)|1/23|0.251340954359694|1|0|0|3.47826086956522|4.80328653118593|MCCC2|1
2283|TOR signaling (GO:0031929)|1/23|0.251340954359694|1|0|0|3.47826086956522|4.80328653118593|CARD11|1
2284|nucleotide-excision repair, DNA damage recognition (GO:0000715)|1/23|0.251340954359694|1|0|0|3.47826086956522|4.80328653118593|UBC|1
2285|membrane assembly (GO:0071709)|1/23|0.251340954359694|1|0|0|3.47826086956522|4.80328653118593|ANXA2|1
2286|cellular response to ammonium ion (GO:0071242)|1/23|0.251340954359694|1|0|0|3.47826086956522|4.80328653118593|ATF4|1
2287|regulation of smooth muscle contraction (GO:0006940)|1/23|0.251340954359694|1|0|0|3.47826086956522|4.80328653118593|ADRB2|1
2288|negative regulation of signal transduction in absence of ligand (GO:1901099)|1/23|0.251340954359694|1|0|0|3.47826086956522|4.80328653118593|HSPA1A|1
2289|regulation of interleukin-8 secretion (GO:2000482)|1/23|0.251340954359694|1|0|0|3.47826086956522|4.80328653118593|CD2|1
2290|negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240)|1/23|0.251340954359694|1|0|0|3.47826086956522|4.80328653118593|HSPA1A|1
2291|regulation of monooxygenase activity (GO:0032768)|1/23|0.251340954359694|1|0|0|3.47826086956522|4.80328653118593|HSP90AA1|1
2292|regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880)|1/23|0.251340954359694|1|0|0|3.47826086956522|4.80328653118593|CAMK2D|1
2293|regulation of microtubule cytoskeleton organization (GO:0070507)|1/23|0.251340954359694|1|0|0|3.47826086956522|4.80328653118593|CDK2AP2|1
2294|regulation of ion homeostasis (GO:2000021)|1/23|0.251340954359694|1|0|0|3.47826086956522|4.80328653118593|CAMK2D|1
2295|water-soluble vitamin metabolic process (GO:0006767)|2/78|0.254953858658564|1|0|0|2.05128205128205|2.80343117258153|MCCC2;CYB5R3|1
2296|regulation of hematopoietic progenitor cell differentiation (GO:1901532)|2/78|0.254953858658564|1|0|0|2.05128205128205|2.80343117258153|UBC;RUNX1|1
2297|negative regulation of sequence-specific DNA binding transcription factor activity (GO:0043433)|3/141|0.258716542917752|1|0|0|1.70212765957447|2.30131446041907|TCF7L2;FLNA;TRIB1|1
2298|positive regulation of translation (GO:0045727)|2/79|0.259589356849642|1|0|0|2.0253164556962|2.73145173318602|TGFB1;FAM129A|1
2299|negative regulation of cell communication (GO:0010648)|2/79|0.259589356849642|1|0|0|2.0253164556962|2.73145173318602|FLT1;MERTK|1
2300|extracellular matrix disassembly (GO:0022617)|2/79|0.259589356849642|1|0|0|2.0253164556962|2.73145173318602|CAPN1;CD44|1
2301|fibroblast growth factor receptor signaling pathway (GO:0008543)|2/79|0.259589356849642|1|0|0|2.0253164556962|2.73145173318602|POLR2A;UBC|1
2302|ammonium transport (GO:0015696)|1/24|0.260709952988131|1|0|0|3.33333333333333|4.48115593611537|SLC6A4|1
2303|negative regulation of mitotic cell cycle phase transition (GO:1901991)|2/80|0.264225836590883|1|0|0|2|2.6619021997707|UBC;CDK2AP2|1
2304|peptidyl-tyrosine phosphorylation (GO:0018108)|2/80|0.264225836590883|1|0|0|2|2.6619021997707|FLT1;BMX|1
2305|steroid biosynthetic process (GO:0006694)|2/80|0.264225836590883|1|0|0|2|2.6619021997707|SCP2;HSD17B4|1
2306|regulation of phosphatidylinositol 3-kinase signaling (GO:0014066)|2/81|0.268862552009277|1|0|0|1.97530864197531|2.59467652155593|FLT1;IL18|1
2307|regulation of protein serine/threonine kinase activity (GO:0071900)|2/81|0.268862552009277|1|0|0|1.97530864197531|2.59467652155593|ADRB2;TRIB1|1
2308|negative regulation of MAPK cascade (GO:0043409)|2/81|0.268862552009277|1|0|0|1.97530864197531|2.59467652155593|MYC;EZR|1
2309|positive regulation of microtubule polymerization (GO:0031116)|1/25|0.269962167437764|1|0|0|3.2|4.19031504128782|HSPA1A|1
2310|membrane protein intracellular domain proteolysis (GO:0031293)|1/25|0.269962167437764|1|0|0|3.2|4.19031504128782|TGFB1|1
2311|positive regulation of immune effector process (GO:0002699)|1/25|0.269962167437764|1|0|0|3.2|4.19031504128782|XBP1|1
2312|regulation of chromosome organization (GO:0033044)|1/25|0.269962167437764|1|0|0|3.2|4.19031504128782|MYC|1
2313|receptor clustering (GO:0043113)|1/25|0.269962167437764|1|0|0|3.2|4.19031504128782|FLNA|1
2314|negative regulation of G1/S transition of mitotic cell cycle (GO:2000134)|1/25|0.269962167437764|1|0|0|3.2|4.19031504128782|CDK2AP2|1
2315|cellular modified amino acid biosynthetic process (GO:0042398)|1/25|0.269962167437764|1|0|0|3.2|4.19031504128782|PLSCR1|1
2316|intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059)|1/25|0.269962167437764|1|0|0|3.2|4.19031504128782|ATF4|1
2317|negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736)|1/25|0.269962167437764|1|0|0|3.2|4.19031504128782|CDK6|1
2318|receptor catabolic process (GO:0032801)|1/25|0.269962167437764|1|0|0|3.2|4.19031504128782|TGFB1|1
2319|regulation of chemotaxis (GO:0050920)|1/25|0.269962167437764|1|0|0|3.2|4.19031504128782|TGFB1|1
2320|negative regulation of oxidative stress-induced cell death (GO:1903202)|1/25|0.269962167437764|1|0|0|3.2|4.19031504128782|ATF4|1
2321|regulation of AMPA receptor activity (GO:2000311)|1/25|0.269962167437764|1|0|0|3.2|4.19031504128782|ADRB2|1
2322|positive regulation of dephosphorylation (GO:0035306)|1/25|0.269962167437764|1|0|0|3.2|4.19031504128782|TGFB1|1
2323|fatty acid derivative biosynthetic process (GO:1901570)|1/25|0.269962167437764|1|0|0|3.2|4.19031504128782|PPT1|1
2324|protein alpha-1,2-demannosylation (GO:0036508)|1/25|0.269962167437764|1|0|0|3.2|4.19031504128782|UBC|1
2325|negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435)|1/25|0.269962167437764|1|0|0|3.2|4.19031504128782|HSP90AB1|1
2326|negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230)|1/25|0.269962167437764|1|0|0|3.2|4.19031504128782|CD44|1
2327|cGMP biosynthetic process (GO:0006182)|1/25|0.269962167437764|1|0|0|3.2|4.19031504128782|ADCY3|1
2328|cytoplasmic pattern recognition receptor signaling pathway (GO:0002753)|1/25|0.269962167437764|1|0|0|3.2|4.19031504128782|UBC|1
2329|cAMP metabolic process (GO:0046058)|1/25|0.269962167437764|1|0|0|3.2|4.19031504128782|ADCY3|1
2330|regulation of cellular senescence (GO:2000772)|1/25|0.269962167437764|1|0|0|3.2|4.19031504128782|CDK6|1
2331|positive regulation of binding (GO:0051099)|2/82|0.273498775736409|1|0|0|1.95121951219512|2.5296744066611|TCF7L2;RARA|1
2332|positive regulation of protein catabolic process (GO:0045732)|2/82|0.273498775736409|1|0|0|1.95121951219512|2.5296744066611|HSP90AA1;EZR|1
2333|peptidyl-serine phosphorylation (GO:0018105)|3/146|0.275594196214811|1|0|0|1.64383561643836|2.11861775143804|CAMK2D;TOP1;SGK1|1
2334|DNA damage response, signal transduction by p53 class mediator (GO:0030330)|2/83|0.278133798343923|1|0|0|1.92771084337349|2.46680094856287|BTG2;UBC|1
2335|positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100)|2/83|0.278133798343923|1|0|0|1.92771084337349|2.46680094856287|HSP90AB1;TGFB1|1
2336|positive regulation of cell cycle arrest (GO:0071158)|2/83|0.278133798343923|1|0|0|1.92771084337349|2.46680094856287|BTG2;UBC|1
2337|organophosphate ester transport (GO:0015748)|1/26|0.27909904772167|1|0|0|3.07692307692308|3.92673400125149|SCP2|1
2338|regulation of spindle assembly (GO:0090169)|1/26|0.27909904772167|1|0|0|3.07692307692308|3.92673400125149|HSPA1A|1
2339|regulation of telomere maintenance (GO:0032204)|1/26|0.27909904772167|1|0|0|3.07692307692308|3.92673400125149|MYC|1
2340|protein import into nucleus, translocation (GO:0000060)|1/26|0.27909904772167|1|0|0|3.07692307692308|3.92673400125149|TGFB1|1
2341|nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)|1/26|0.27909904772167|1|0|0|3.07692307692308|3.92673400125149|UBC|1
2342|cyclic nucleotide metabolic process (GO:0009187)|1/26|0.27909904772167|1|0|0|3.07692307692308|3.92673400125149|ADCY3|1
2343|inorganic cation import across plasma membrane (GO:0098659)|1/26|0.27909904772167|1|0|0|3.07692307692308|3.92673400125149|SLC9A4|1
2344|regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314)|1/26|0.27909904772167|1|0|0|3.07692307692308|3.92673400125149|CAMK2D|1
2345|regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)|1/26|0.27909904772167|1|0|0|3.07692307692308|3.92673400125149|CD44|1
2346|positive regulation of filopodium assembly (GO:0051491)|1/26|0.27909904772167|1|0|0|3.07692307692308|3.92673400125149|MIEN1|1
2347|RNA splicing, via transesterification reactions (GO:0000375)|1/26|0.27909904772167|1|0|0|3.07692307692308|3.92673400125149|TRA2B|1
2348|response to alcohol (GO:0097305)|1/26|0.27909904772167|1|0|0|3.07692307692308|3.92673400125149|TGFB1|1
2349|negative regulation of cellular protein localization (GO:1903828)|1/26|0.27909904772167|1|0|0|3.07692307692308|3.92673400125149|DNAJA1|1
2350|cellular response to vascular endothelial growth factor stimulus (GO:0035924)|1/26|0.27909904772167|1|0|0|3.07692307692308|3.92673400125149|FLT1|1
2351|regulation of apoptotic signaling pathway (GO:2001233)|1/26|0.27909904772167|1|0|0|3.07692307692308|3.92673400125149|TMBIM6|1
2352|long-chain fatty acid transport (GO:0015909)|1/26|0.27909904772167|1|0|0|3.07692307692308|3.92673400125149|CD36|1
2353|peptide hormone secretion (GO:0030072)|1/26|0.27909904772167|1|0|0|3.07692307692308|3.92673400125149|GAL|1
2354|protein depolymerization (GO:0051261)|1/26|0.27909904772167|1|0|0|3.07692307692308|3.92673400125149|DSTN|1
2355|regulation of vascular smooth muscle cell proliferation (GO:1904705)|1/26|0.27909904772167|1|0|0|3.07692307692308|3.92673400125149|JUN|1
2356|positive regulation of peptidyl-threonine phosphorylation (GO:0010800)|1/26|0.27909904772167|1|0|0|3.07692307692308|3.92673400125149|TGFB1|1
2357|regulation of translation (GO:0006417)|4/214|0.279544535177855|1|0|0|1.49532710280374|1.90593444536817|BTG2;POLR2A;DAPK1;FAM129A|1
2358|regulation of protein kinase activity (GO:0045859)|3/148|0.282377745393128|1|0|0|1.62162162162162|2.05055607848672|PREX1;IQGAP1;TRIB1|1
2359|negative regulation of signaling (GO:0023057)|2/84|0.282766927963323|1|0|0|1.9047619047619|2.40596627955304|FLT1;MERTK|1
2360|negative regulation of neuron death (GO:1901215)|2/84|0.282766927963323|1|0|0|1.9047619047619|2.40596627955304|PPT1;ATF4|1
2361|positive regulation of peptidyl-serine phosphorylation (GO:0033138)|2/84|0.282766927963323|1|0|0|1.9047619047619|2.40596627955304|TGFB1;CD44|1
2362|positive regulation of homeostatic process (GO:0032846)|2/84|0.282766927963323|1|0|0|1.9047619047619|2.40596627955304|HCAR2;HSPA1A|1
2363|mRNA processing (GO:0006397)|5/284|0.282847009476288|1|0|0|1.40845070422535|1.77866074658371|HSPA8;SON;POLR2A;TRA2B;TRA2A|1
2364|response to growth factor (GO:0070848)|1/27|0.288122025798216|1|0|0|2.96296296296296|3.68702574190736|MYC|1
2365|response to gamma radiation (GO:0010332)|1/27|0.288122025798216|1|0|0|2.96296296296296|3.68702574190736|MYC|1
2366|regulation of transcription regulatory region DNA binding (GO:2000677)|1/27|0.288122025798216|1|0|0|2.96296296296296|3.68702574190736|TGFB1|1
2367|nucleotide biosynthetic process (GO:0009165)|1/27|0.288122025798216|1|0|0|2.96296296296296|3.68702574190736|ADCY3|1
2368|positive regulation of wound healing (GO:0090303)|1/27|0.288122025798216|1|0|0|2.96296296296296|3.68702574190736|XBP1|1
2369|response to ketone (GO:1901654)|1/27|0.288122025798216|1|0|0|2.96296296296296|3.68702574190736|TGFB1|1
2370|regulation of supramolecular fiber organization (GO:1902903)|1/27|0.288122025798216|1|0|0|2.96296296296296|3.68702574190736|HSPA8|1
2371|negative regulation of catalytic activity (GO:0043086)|1/27|0.288122025798216|1|0|0|2.96296296296296|3.68702574190736|TMBIM1|1
2372|regulation of microtubule-based process (GO:0032886)|1/27|0.288122025798216|1|0|0|2.96296296296296|3.68702574190736|CDK2AP2|1
2373|phosphatidylethanolamine acyl-chain remodeling (GO:0036152)|1/27|0.288122025798216|1|0|0|2.96296296296296|3.68702574190736|PNPLA8|1
2374|regulation of T cell receptor signaling pathway (GO:0050856)|1/27|0.288122025798216|1|0|0|2.96296296296296|3.68702574190736|EZR|1
2375|RNA biosynthetic process (GO:0032774)|1/27|0.288122025798216|1|0|0|2.96296296296296|3.68702574190736|POLR2A|1
2376|protein oligomerization (GO:0051259)|4/218|0.290685752894094|1|0|0|1.46788990825688|1.81359630425036|MCCC2;CAMK2D;TRA2B;SLC6A4|1
2377|regulation of type I interferon production (GO:0032479)|2/86|0.292024827798737|1|0|0|1.86046511627907|2.29007712301473|UBC;LRRFIP1|1
2378|negative regulation of cell differentiation (GO:0045596)|3/151|0.29257994576917|1|0|0|1.58940397350993|1.95340502906394|TGFB1;CDK6;ABCG1|1
2379|regulation of peptidyl-serine phosphorylation (GO:0033135)|2/87|0.296648299883969|1|0|0|1.83908045977011|2.23486531925346|TGFB1;CD44|1
2380|regulation of calcium ion transmembrane transporter activity (GO:1901019)|1/28|0.297032515938126|1|0|0|2.85714285714286|3.46832475685406|CAMK2D|1
2381|phosphatidylcholine acyl-chain remodeling (GO:0036151)|1/28|0.297032515938126|1|0|0|2.85714285714286|3.46832475685406|PNPLA8|1
2382|regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143)|1/28|0.297032515938126|1|0|0|2.85714285714286|3.46832475685406|RUNX1|1
2383|response to hexose (GO:0009746)|1/28|0.297032515938126|1|0|0|2.85714285714286|3.46832475685406|TCF7L2|1
2384|negative regulation of smooth muscle cell proliferation (GO:0048662)|1/28|0.297032515938126|1|0|0|2.85714285714286|3.46832475685406|TRIB1|1
2385|leukocyte cell-cell adhesion (GO:0007159)|1/28|0.297032515938126|1|0|0|2.85714285714286|3.46832475685406|EZR|1
2386|negative regulation of microtubule polymerization or depolymerization (GO:0031111)|1/28|0.297032515938126|1|0|0|2.85714285714286|3.46832475685406|FKBP4|1
2387|modulation by host of viral transcription (GO:0043921)|1/28|0.297032515938126|1|0|0|2.85714285714286|3.46832475685406|JUN|1
2388|regulation of protein localization to nucleus (GO:1900180)|1/28|0.297032515938126|1|0|0|2.85714285714286|3.46832475685406|TGFB1|1
2389|regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239)|1/28|0.297032515938126|1|0|0|2.85714285714286|3.46832475685406|HSPA1A|1
2390|negative regulation of cell-matrix adhesion (GO:0001953)|1/28|0.297032515938126|1|0|0|2.85714285714286|3.46832475685406|PLET1|1
2391|negative regulation of osteoblast differentiation (GO:0045668)|1/28|0.297032515938126|1|0|0|2.85714285714286|3.46832475685406|CDK6|1
2392|microtubule polymerization (GO:0046785)|1/28|0.297032515938126|1|0|0|2.85714285714286|3.46832475685406|TPPP3|1
2393|purine ribonucleoside triphosphate biosynthetic process (GO:0009206)|1/28|0.297032515938126|1|0|0|2.85714285714286|3.46832475685406|TGFB1|1
2394|phosphatidylserine metabolic process (GO:0006658)|1/28|0.297032515938126|1|0|0|2.85714285714286|3.46832475685406|PLSCR1|1
2395|protein targeting to vacuole (GO:0006623)|1/28|0.297032515938126|1|0|0|2.85714285714286|3.46832475685406|NCOA4|1
2396|regulation of protein localization to cell surface (GO:2000008)|1/28|0.297032515938126|1|0|0|2.85714285714286|3.46832475685406|HSP90AB1|1
2397|negative regulation of endocytosis (GO:0045806)|1/29|0.305831914947797|1|0|0|2.75862068965517|3.26819207035902|UNC119|1
2398|neuron projection extension (GO:1990138)|1/29|0.305831914947797|1|0|0|2.75862068965517|3.26819207035902|IQGAP1|1
2399|cellular response to ketone (GO:1901655)|1/29|0.305831914947797|1|0|0|2.75862068965517|3.26819207035902|ADCY3|1
2400|cellular response to alcohol (GO:0097306)|1/29|0.305831914947797|1|0|0|2.75862068965517|3.26819207035902|JUP|1
2401|negative regulation of homeostatic process (GO:0032845)|1/29|0.305831914947797|1|0|0|2.75862068965517|3.26819207035902|TMBIM6|1
2402|RNA phosphodiester bond hydrolysis (GO:0090501)|1/29|0.305831914947797|1|0|0|2.75862068965517|3.26819207035902|RNASE6|1
2403|negative regulation of proteasomal protein catabolic process (GO:1901799)|1/29|0.305831914947797|1|0|0|2.75862068965517|3.26819207035902|HSP90AB1|1
2404|acute inflammatory response (GO:0002526)|1/29|0.305831914947797|1|0|0|2.75862068965517|3.26819207035902|PLSCR1|1
2405|cellular amino acid biosynthetic process (GO:0008652)|1/29|0.305831914947797|1|0|0|2.75862068965517|3.26819207035902|GLUL|1
2406|negative regulation of response to DNA damage stimulus (GO:2001021)|1/29|0.305831914947797|1|0|0|2.75862068965517|3.26819207035902|CD44|1
2407|regulation of mRNA processing (GO:0050684)|1/29|0.305831914947797|1|0|0|2.75862068965517|3.26819207035902|SON|1
2408|aerobic respiration (GO:0009060)|1/29|0.305831914947797|1|0|0|2.75862068965517|3.26819207035902|MT-ND4|1
2409|positive regulation of protein tyrosine kinase activity (GO:0061098)|1/29|0.305831914947797|1|0|0|2.75862068965517|3.26819207035902|UNC119|1
2410|positive regulation of extrinsic apoptotic signaling pathway (GO:2001238)|1/29|0.305831914947797|1|0|0|2.75862068965517|3.26819207035902|G0S2|1
2411|regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092)|1/29|0.305831914947797|1|0|0|2.75862068965517|3.26819207035902|TGFB1|1
2412|negative regulation of JNK cascade (GO:0046329)|1/29|0.305831914947797|1|0|0|2.75862068965517|3.26819207035902|DNAJA1|1
2413|regulation of lipid biosynthetic process (GO:0046890)|1/29|0.305831914947797|1|0|0|2.75862068965517|3.26819207035902|ADIPOR2|1
2414|cGMP metabolic process (GO:0046068)|1/29|0.305831914947797|1|0|0|2.75862068965517|3.26819207035902|ADCY3|1
2415|dopamine receptor signaling pathway (GO:0007212)|1/29|0.305831914947797|1|0|0|2.75862068965517|3.26819207035902|FLNA|1
2416|regulation of fatty acid biosynthetic process (GO:0042304)|1/29|0.305831914947797|1|0|0|2.75862068965517|3.26819207035902|ADIPOR2|1
2417|nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423)|1/29|0.305831914947797|1|0|0|2.75862068965517|3.26819207035902|UBC|1
2418|regulation of cell morphogenesis (GO:0022604)|1/29|0.305831914947797|1|0|0|2.75862068965517|3.26819207035902|CD44|1
2419|protein export from nucleus (GO:0006611)|1/29|0.305831914947797|1|0|0|2.75862068965517|3.26819207035902|TGFB1|1
2420|bicellular tight junction assembly (GO:0070830)|1/29|0.305831914947797|1|0|0|2.75862068965517|3.26819207035902|PATJ|1
2421|transcription elongation from RNA polymerase I promoter (GO:0006362)|1/29|0.305831914947797|1|0|0|2.75862068965517|3.26819207035902|TAF1D|1
2422|T cell activation (GO:0042110)|2/89|0.305881166522647|1|0|0|1.79775280898876|2.12954354544237|CD2;LEPR|1
2423|regulation of stem cell differentiation (GO:2000736)|2/89|0.305881166522647|1|0|0|1.79775280898876|2.12954354544237|UBC;RUNX1|1
2424|negative regulation of translation (GO:0017148)|2/89|0.305881166522647|1|0|0|1.79775280898876|2.12954354544237|BTG2;DAPK1|1
2425|negative regulation of cellular protein metabolic process (GO:0032269)|2/90|0.310489360448486|1|0|0|1.77777777777778|2.07929892277704|BTG2;DAPK1|1
2426|regulation of neuron apoptotic process (GO:0043523)|2/90|0.310489360448486|1|0|0|1.77777777777778|2.07929892277704|PPT1;ATF4|1
2427|nucleotide-excision repair, preincision complex assembly (GO:0006294)|1/30|0.31452160237251|1|0|0|2.66666666666667|3.08454004589774|UBC|1
2428|TRIF-dependent toll-like receptor signaling pathway (GO:0035666)|1/30|0.31452160237251|1|0|0|2.66666666666667|3.08454004589774|UBC|1
2429|superoxide metabolic process (GO:0006801)|1/30|0.31452160237251|1|0|0|2.66666666666667|3.08454004589774|PREX1|1
2430|cortical cytoskeleton organization (GO:0030865)|1/30|0.31452160237251|1|0|0|2.66666666666667|3.08454004589774|EZR|1
2431|positive regulation of myeloid cell differentiation (GO:0045639)|1/30|0.31452160237251|1|0|0|2.66666666666667|3.08454004589774|HSPA1A|1
2432|protein alkylation (GO:0008213)|1/30|0.31452160237251|1|0|0|2.66666666666667|3.08454004589774|HSPA8|1
2433|negative regulation of Notch signaling pathway (GO:0045746)|1/30|0.31452160237251|1|0|0|2.66666666666667|3.08454004589774|UBC|1
2434|regulation of keratinocyte differentiation (GO:0045616)|1/30|0.31452160237251|1|0|0|2.66666666666667|3.08454004589774|RUNX1|1
2435|negative regulation of epithelial cell apoptotic process (GO:1904036)|1/30|0.31452160237251|1|0|0|2.66666666666667|3.08454004589774|TCF7L2|1
2436|regulation of activated T cell proliferation (GO:0046006)|1/30|0.31452160237251|1|0|0|2.66666666666667|3.08454004589774|IL18|1
2437|positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742)|1/30|0.31452160237251|1|0|0|2.66666666666667|3.08454004589774|UBC|1
2438|semaphorin-plexin signaling pathway (GO:0071526)|1/30|0.31452160237251|1|0|0|2.66666666666667|3.08454004589774|FLNA|1
2439|amino acid transmembrane transport (GO:0003333)|1/30|0.31452160237251|1|0|0|2.66666666666667|3.08454004589774|SLC38A2|1
2440|regulation of cellular biosynthetic process (GO:0031326)|1/30|0.31452160237251|1|0|0|2.66666666666667|3.08454004589774|ADIPOR2|1
2441|regulation of myoblast differentiation (GO:0045661)|1/30|0.31452160237251|1|0|0|2.66666666666667|3.08454004589774|TGFB1|1
2442|regulation of gene expression (GO:0010468)|15/1038|0.318763976833476|1|0|0|1.15606936416185|1.32173911512312|TCF7L2;TGFB1;BAZ1A;PLSCR1;SON;CDK6;POLR2A;MYC;TRA2B;MYADM;CD36;EZR;ABCG1;ATF4;HSPA1A|1
2443|lipid transport (GO:0006869)|2/92|0.319686384410369|1|0|0|1.73913043478261|1.9833301086395|SCP2;CHKA|1
2444|cellular response to acid chemical (GO:0071229)|2/92|0.319686384410369|1|0|0|1.73913043478261|1.9833301086395|XBP1;RARA|1
2445|negative regulation of kinase activity (GO:0033673)|2/92|0.319686384410369|1|0|0|1.73913043478261|1.9833301086395|PREX1;TRIB1|1
2446|protein-DNA complex assembly (GO:0065004)|2/92|0.319686384410369|1|0|0|1.73913043478261|1.9833301086395|BRD2;UBC|1
2447|negative regulation of nucleic acid-templated transcription (GO:1903507)|7/445|0.322555452310063|1|0|0|1.25842696629213|1.42388521108457|HSPA8;TCF7L2;JUN;TGFB1;RARA;LRRFIP1;ZBTB4|1
2448|negative regulation of endothelial cell proliferation (GO:0001937)|1/31|0.323102940663213|1|0|0|2.58064516129032|2.9155723994591|FLT1|1
2449|cellular response to cAMP (GO:0071320)|1/31|0.323102940663213|1|0|0|2.58064516129032|2.9155723994591|EZR|1
2450|cellular response to drug (GO:0035690)|1/31|0.323102940663213|1|0|0|2.58064516129032|2.9155723994591|MYC|1
2451|activation of protein kinase B activity (GO:0032148)|1/31|0.323102940663213|1|0|0|2.58064516129032|2.9155723994591|IL18|1
2452|cyclic purine nucleotide metabolic process (GO:0052652)|1/31|0.323102940663213|1|0|0|2.58064516129032|2.9155723994591|ADCY3|1
2453|fatty-acyl-CoA biosynthetic process (GO:0046949)|1/31|0.323102940663213|1|0|0|2.58064516129032|2.9155723994591|PPT1|1
2454|regulation of ARF protein signal transduction (GO:0032012)|1/31|0.323102940663213|1|0|0|2.58064516129032|2.9155723994591|APLP2|1
2455|MyD88-independent toll-like receptor signaling pathway (GO:0002756)|1/31|0.323102940663213|1|0|0|2.58064516129032|2.9155723994591|UBC|1
2456|regulation of intracellular estrogen receptor signaling pathway (GO:0033146)|1/31|0.323102940663213|1|0|0|2.58064516129032|2.9155723994591|RUNX1|1
2457|positive regulation of B cell proliferation (GO:0030890)|1/31|0.323102940663213|1|0|0|2.58064516129032|2.9155723994591|CD81|1
2458|regulation of protein polymerization (GO:0032271)|1/31|0.323102940663213|1|0|0|2.58064516129032|2.9155723994591|TPPP3|1
2459|regulation of sodium ion transmembrane transport (GO:1902305)|1/31|0.323102940663213|1|0|0|2.58064516129032|2.9155723994591|CAMK2D|1
2460|positive regulation of cellular metabolic process (GO:0031325)|2/93|0.324274105836303|1|0|0|1.72043010752688|1.93749009063792|TGFB1;ANXA2|1
2461|cell cycle G1/S phase transition (GO:0044843)|2/93|0.324274105836303|1|0|0|1.72043010752688|1.93749009063792|CDK6;MYC|1
2462|cellular transition metal ion homeostasis (GO:0046916)|2/94|0.328853919070241|1|0|0|1.70212765957447|1.8930070498803|MYC;UBC|1
2463|negative regulation of intracellular signal transduction (GO:1902532)|3/162|0.330140702165429|1|0|0|1.48148148148148|1.64183162250857|PREX1;MYADM;HERPUD1|1
2464|negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556)|1/32|0.331577275401584|1|0|0|2.5|2.75973597055334|RARA|1
2465|regulation of protein tyrosine kinase activity (GO:0061097)|1/32|0.331577275401584|1|0|0|2.5|2.75973597055334|UNC119|1
2466|secondary alcohol metabolic process (GO:1902652)|1/32|0.331577275401584|1|0|0|2.5|2.75973597055334|ABCG1|1
2467|regulation of protein export from nucleus (GO:0046825)|1/32|0.331577275401584|1|0|0|2.5|2.75973597055334|TCF7L2|1
2468|negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042)|1/32|0.331577275401584|1|0|0|2.5|2.75973597055334|TMBIM1|1
2469|cellular zinc ion homeostasis (GO:0006882)|1/32|0.331577275401584|1|0|0|2.5|2.75973597055334|S100A9|1
2470|positive regulation of insulin secretion (GO:0032024)|1/32|0.331577275401584|1|0|0|2.5|2.75973597055334|TCF7L2|1
2471|termination of RNA polymerase I transcription (GO:0006363)|1/32|0.331577275401584|1|0|0|2.5|2.75973597055334|TAF1D|1
2472|regulation of cytokine secretion (GO:0050707)|1/32|0.331577275401584|1|0|0|2.5|2.75973597055334|FFAR4|1
2473|sarcomere organization (GO:0045214)|1/32|0.331577275401584|1|0|0|2.5|2.75973597055334|KRT19|1
2474|positive regulation of bone mineralization (GO:0030501)|1/32|0.331577275401584|1|0|0|2.5|2.75973597055334|TGFB1|1
2475|skin development (GO:0043588)|2/95|0.333425306275082|1|0|0|1.68421052631579|1.84982973962352|CLIC4;TXNIP|1
2476|regulation of protein kinase B signaling (GO:0051896)|3/164|0.33697593891611|1|0|0|1.46341463414634|1.59182012056649|TCF7L2;TGFB1;IL18|1
2477|7-methylguanosine mRNA capping (GO:0006370)|1/33|0.339945935590424|1|0|0|2.42424242424242|2.6156816654186|POLR2A|1
2478|cellular response to amino acid stimulus (GO:0071230)|1/33|0.339945935590424|1|0|0|2.42424242424242|2.6156816654186|XBP1|1
2479|protein trimerization (GO:0070206)|1/33|0.339945935590424|1|0|0|2.42424242424242|2.6156816654186|MGST1|1
2480|microtubule bundle formation (GO:0001578)|1/33|0.339945935590424|1|0|0|2.42424242424242|2.6156816654186|TPPP3|1
2481|7-methylguanosine RNA capping (GO:0009452)|1/33|0.339945935590424|1|0|0|2.42424242424242|2.6156816654186|POLR2A|1
2482|regulation of potassium ion transmembrane transport (GO:1901379)|1/33|0.339945935590424|1|0|0|2.42424242424242|2.6156816654186|FLNA|1
2483|ATP biosynthetic process (GO:0006754)|1/33|0.339945935590424|1|0|0|2.42424242424242|2.6156816654186|TGFB1|1
2484|positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557)|1/33|0.339945935590424|1|0|0|2.42424242424242|2.6156816654186|CD2|1
2485|negative regulation of fat cell differentiation (GO:0045599)|1/33|0.339945935590424|1|0|0|2.42424242424242|2.6156816654186|TGFB1|1
2486|positive regulation of T cell differentiation (GO:0045582)|1/33|0.339945935590424|1|0|0|2.42424242424242|2.6156816654186|XBP1|1
2487|positive regulation of transcription factor import into nucleus (GO:0042993)|1/33|0.339945935590424|1|0|0|2.42424242424242|2.6156816654186|FLNA|1
2488|positive regulation of myeloid leukocyte differentiation (GO:0002763)|1/33|0.339945935590424|1|0|0|2.42424242424242|2.6156816654186|RUNX1|1
2489|global genome nucleotide-excision repair (GO:0070911)|1/33|0.339945935590424|1|0|0|2.42424242424242|2.6156816654186|UBC|1
2490|epithelial cell differentiation (GO:0030855)|2/97|0.342540801057506|1|0|0|1.64948453608247|1.76719917723668|RARA;TAGLN2|1
2491|ciliary basal body-plasma membrane docking (GO:0097711)|2/97|0.342540801057506|1|0|0|1.64948453608247|1.76719917723668|HSP90AA1;PRKAR2B|1
2492|regulation of mitotic cell cycle (GO:0007346)|3/166|0.343807622900318|1|0|0|1.44578313253012|1.54362363440135|BTG2;TGFB1;IQGAP1|1
2493|RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)|4/237|0.344240203789098|1|0|0|1.35021097046413|1.43988604010778|HSPA8;POLR2A;TRA2B;TRA2A|1
2494|mRNA metabolic process (GO:0016071)|2/98|0.347083942194552|1|0|0|1.63265306122449|1.72765488971222|SON;HSPA1A|1
2495|positive regulation of neuron projection development (GO:0010976)|2/98|0.347083942194552|1|0|0|1.63265306122449|1.72765488971222|CPNE5;S100A9|1
2496|negative regulation of cell motility (GO:2000146)|2/98|0.347083942194552|1|0|0|1.63265306122449|1.72765488971222|CLIC4;RHOB|1
2497|intracellular pH reduction (GO:0051452)|1/34|0.348210233715441|1|0|0|2.35294117647059|2.48223261586507|DMXL2|1
2498|positive regulation of cytokine-mediated signaling pathway (GO:0001961)|1/34|0.348210233715441|1|0|0|2.35294117647059|2.48223261586507|HSPA1A|1
2499|negative regulation of mitochondrion organization (GO:0010823)|1/34|0.348210233715441|1|0|0|2.35294117647059|2.48223261586507|HSPA1A|1
2500|stem cell differentiation (GO:0048863)|1/34|0.348210233715441|1|0|0|2.35294117647059|2.48223261586507|EPCAM|1
2501|positive regulation of intrinsic apoptotic signaling pathway (GO:2001244)|1/34|0.348210233715441|1|0|0|2.35294117647059|2.48223261586507|S100A9|1
2502|transcription initiation from RNA polymerase I promoter (GO:0006361)|1/34|0.348210233715441|1|0|0|2.35294117647059|2.48223261586507|TAF1D|1
2503|carboxylic acid metabolic process (GO:0019752)|1/34|0.348210233715441|1|0|0|2.35294117647059|2.48223261586507|CYB5R3|1
2504|positive regulation of biomineral tissue development (GO:0070169)|1/34|0.348210233715441|1|0|0|2.35294117647059|2.48223261586507|TGFB1|1
2505|transcription from RNA polymerase I promoter (GO:0006360)|1/34|0.348210233715441|1|0|0|2.35294117647059|2.48223261586507|TAF1D|1
2506|positive regulation of locomotion (GO:0040017)|1/34|0.348210233715441|1|0|0|2.35294117647059|2.48223261586507|TGFB1|1
2507|regulation of intracellular protein transport (GO:0033157)|1/34|0.348210233715441|1|0|0|2.35294117647059|2.48223261586507|TGFB1|1
2508|response to UV (GO:0009411)|2/99|0.351616723872954|1|0|0|1.61616161616162|1.6892340189873|MYC;ATF4|1
2509|positive regulation of cell growth (GO:0030307)|2/99|0.351616723872954|1|0|0|1.61616161616162|1.6892340189873|CPNE5;S100A9|1
2510|steroid metabolic process (GO:0008202)|2/100|0.356138695932175|1|0|0|1.6|1.65189604590009|SCP2;HSD17B4|1
2511|epithelial tube morphogenesis (GO:0060562)|1/35|0.356371466189317|1|0|0|2.28571428571429|2.3583580520863|RHOB|1
2512|regulation of interleukin-8 production (GO:0032677)|1/35|0.356371466189317|1|0|0|2.28571428571429|2.3583580520863|HSPA1A|1
2513|negative regulation of DNA binding (GO:0043392)|1/35|0.356371466189317|1|0|0|2.28571428571429|2.3583580520863|JUN|1
2514|regulation of JUN kinase activity (GO:0043506)|1/35|0.356371466189317|1|0|0|2.28571428571429|2.3583580520863|DNAJA1|1
2515|positive regulation of DNA binding (GO:0043388)|1/35|0.356371466189317|1|0|0|2.28571428571429|2.3583580520863|TGFB1|1
2516|bone development (GO:0060348)|1/35|0.356371466189317|1|0|0|2.28571428571429|2.3583580520863|RARA|1
2517|ventricular cardiac muscle tissue morphogenesis (GO:0055010)|1/35|0.356371466189317|1|0|0|2.28571428571429|2.3583580520863|TGFB1|1
2518|negative regulation of T cell activation (GO:0050868)|1/35|0.356371466189317|1|0|0|2.28571428571429|2.3583580520863|PAG1|1
2519|peptidyl-serine modification (GO:0018209)|3/171|0.360857991789357|1|0|0|1.40350877192982|1.43055547029619|CAMK2D;TOP1;SGK1|1
2520|negative regulation of cell-substrate adhesion (GO:0010812)|1/36|0.364430913057475|1|0|0|2.22222222222222|2.24315174318926|PLET1|1
2521|erythrocyte differentiation (GO:0030218)|1/36|0.364430913057475|1|0|0|2.22222222222222|2.24315174318926|KMT2E|1
2522|endothelial cell migration (GO:0043542)|1/36|0.364430913057475|1|0|0|2.22222222222222|2.24315174318926|MYH9|1
2523|negative regulation of epithelial cell migration (GO:0010633)|1/36|0.364430913057475|1|0|0|2.22222222222222|2.24315174318926|EVL|1
2524|apical junction assembly (GO:0043297)|1/36|0.364430913057475|1|0|0|2.22222222222222|2.24315174318926|PATJ|1
2525|regulation of mitotic spindle organization (GO:0060236)|1/36|0.364430913057475|1|0|0|2.22222222222222|2.24315174318926|HSPA1A|1
2526|positive regulation of ATPase activity (GO:0032781)|1/36|0.364430913057475|1|0|0|2.22222222222222|2.24315174318926|PLSCR1|1
2527|regulation of phosphoprotein phosphatase activity (GO:0043666)|1/36|0.364430913057475|1|0|0|2.22222222222222|2.24315174318926|HSP90AB1|1
2528|carboxylic acid transmembrane transport (GO:1905039)|1/36|0.364430913057475|1|0|0|2.22222222222222|2.24315174318926|SLC38A2|1
2529|negative regulation of tumor necrosis factor production (GO:0032720)|1/36|0.364430913057475|1|0|0|2.22222222222222|2.24315174318926|RARA|1
2530|flagellated sperm motility (GO:0030317)|1/36|0.364430913057475|1|0|0|2.22222222222222|2.24315174318926|ADCY3|1
2531|protein kinase B signaling (GO:0043491)|1/36|0.364430913057475|1|0|0|2.22222222222222|2.24315174318926|TGFB1|1
2532|intrinsic apoptotic signaling pathway (GO:0097193)|2/102|0.365148474321984|1|0|0|1.56862745098039|1.58031565356461|KRCC1;ATF4|1
2533|positive regulation of protein kinase activity (GO:0045860)|3/173|0.367661476999607|1|0|0|1.38728323699422|1.38810542932434|UNC119;IQGAP1;ADRB2|1
2534|regulation of receptor-mediated endocytosis (GO:0048259)|1/37|0.37238983888448|1|0|0|2.16216216216216|2.13581409608414|PPT1|1
2535|organic hydroxy compound transport (GO:0015850)|1/37|0.37238983888448|1|0|0|2.16216216216216|2.13581409608414|SLC6A4|1
2536|regulation of nitric-oxide synthase activity (GO:0050999)|1/37|0.37238983888448|1|0|0|2.16216216216216|2.13581409608414|HSP90AA1|1
2537|positive regulation of signaling (GO:0023056)|1/37|0.37238983888448|1|0|0|2.16216216216216|2.13581409608414|ANXA2|1
2538|natural killer cell activation (GO:0030101)|1/37|0.37238983888448|1|0|0|2.16216216216216|2.13581409608414|CD2|1
2539|endoderm formation (GO:0001706)|1/37|0.37238983888448|1|0|0|2.16216216216216|2.13581409608414|DUSP5|1
2540|regulation of filopodium assembly (GO:0051489)|1/37|0.37238983888448|1|0|0|2.16216216216216|2.13581409608414|MIEN1|1
2541|regulation of response to DNA damage stimulus (GO:2001020)|1/37|0.37238983888448|1|0|0|2.16216216216216|2.13581409608414|MYC|1
2542|mRNA catabolic process (GO:0006402)|1/37|0.37238983888448|1|0|0|2.16216216216216|2.13581409608414|HSPA1A|1
2543|regulation of blood circulation (GO:1903522)|1/37|0.37238983888448|1|0|0|2.16216216216216|2.13581409608414|CAMK2D|1
2544|plasma membrane organization (GO:0007009)|1/37|0.37238983888448|1|0|0|2.16216216216216|2.13581409608414|PLSCR1|1
2545|zymogen activation (GO:0031638)|1/37|0.37238983888448|1|0|0|2.16216216216216|2.13581409608414|PERP|1
2546|Wnt signaling pathway, calcium modulating pathway (GO:0007223)|1/37|0.37238983888448|1|0|0|2.16216216216216|2.13581409608414|TCF7L2|1
2547|cardiac muscle contraction (GO:0060048)|1/37|0.37238983888448|1|0|0|2.16216216216216|2.13581409608414|CAMK2D|1
2548|cardiac muscle tissue morphogenesis (GO:0055008)|1/37|0.37238983888448|1|0|0|2.16216216216216|2.13581409608414|TGFB1|1
2549|axonal transport (GO:0098930)|1/37|0.37238983888448|1|0|0|2.16216216216216|2.13581409608414|DST|1
2550|epithelial to mesenchymal transition (GO:0001837)|1/38|0.380249492414189|1|0|0|2.10526315789474|2.0356372267738|TGFB1|1
2551|protein peptidyl-prolyl isomerization (GO:0000413)|1/38|0.380249492414189|1|0|0|2.10526315789474|2.0356372267738|FKBP4|1
2552|regulation of sodium ion transmembrane transporter activity (GO:2000649)|1/38|0.380249492414189|1|0|0|2.10526315789474|2.0356372267738|CAMK2D|1
2553|regulation of peptidyl-threonine phosphorylation (GO:0010799)|1/38|0.380249492414189|1|0|0|2.10526315789474|2.0356372267738|TGFB1|1
2554|positive regulation of stress fiber assembly (GO:0051496)|1/38|0.380249492414189|1|0|0|2.10526315789474|2.0356372267738|EVL|1
2555|response to steroid hormone (GO:0048545)|1/38|0.380249492414189|1|0|0|2.10526315789474|2.0356372267738|TGFB1|1
2556|nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)|1/38|0.380249492414189|1|0|0|2.10526315789474|2.0356372267738|UBC|1
2557|organic cyclic compound biosynthetic process (GO:1901362)|1/38|0.380249492414189|1|0|0|2.10526315789474|2.0356372267738|SCP2|1
2558|G1/S transition of mitotic cell cycle (GO:0000082)|2/106|0.383019897900034|1|0|0|1.50943396226415|1.44855598250473|CDK6;MYC|1
2559|DNA-templated transcription, termination (GO:0006353)|2/107|0.387454641495474|1|0|0|1.49532710280374|1.41780409905846|TAF1D;POLR2A|1
2560|T cell differentiation (GO:0030217)|1/39|0.388011106898023|1|0|0|2.05128205128205|1.94199243844666|LEPR|1
2561|positive regulation of innate immune response (GO:0045089)|1/39|0.388011106898023|1|0|0|2.05128205128205|1.94199243844666|PLSCR1|1
2562|regulation of cellular pH (GO:0030641)|1/39|0.388011106898023|1|0|0|2.05128205128205|1.94199243844666|SLC9A4|1
2563|negative regulation of response to external stimulus (GO:0032102)|2/108|0.391875414113138|1|0|0|1.48148148148148|1.38786860866292|FFAR4;TRIB1|1
2564|regulation of protein secretion (GO:0050708)|2/108|0.391875414113138|1|0|0|1.48148148148148|1.38786860866292|TGFB1;EZR|1
2565|signal transduction by p53 class mediator (GO:0072331)|1/40|0.395675900461579|1|0|0|2|1.85431967200954|KRCC1|1
2566|negative regulation of protein catabolic process (GO:0042177)|1/40|0.395675900461579|1|0|0|2|1.85431967200954|FLNA|1
2567|regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041)|1/40|0.395675900461579|1|0|0|2|1.85431967200954|TMBIM1|1
2568|regulation of type I interferon-mediated signaling pathway (GO:0060338)|1/40|0.395675900461579|1|0|0|2|1.85431967200954|HSP90AB1|1
2569|regulation of alternative mRNA splicing, via spliceosome (GO:0000381)|1/40|0.395675900461579|1|0|0|2|1.85431967200954|TRA2B|1
2570|purine ribonucleoside monophosphate biosynthetic process (GO:0009168)|1/40|0.395675900461579|1|0|0|2|1.85431967200954|TGFB1|1
2571|positive regulation of peptide hormone secretion (GO:0090277)|1/40|0.395675900461579|1|0|0|2|1.85431967200954|TCF7L2|1
2572|positive regulation of fat cell differentiation (GO:0045600)|1/40|0.395675900461579|1|0|0|2|1.85431967200954|XBP1|1
2573|inositol lipid-mediated signaling (GO:0048017)|1/40|0.395675900461579|1|0|0|2|1.85431967200954|EZR|1
2574|alpha-amino acid catabolic process (GO:1901606)|1/40|0.395675900461579|1|0|0|2|1.85431967200954|MCCC2|1
2575|cellular response to amino acid starvation (GO:0034198)|1/40|0.395675900461579|1|0|0|2|1.85431967200954|ATF4|1
2576|acyl-CoA metabolic process (GO:0006637)|1/40|0.395675900461579|1|0|0|2|1.85431967200954|ACOT1|1
2577|regulation of protein activation cascade (GO:2000257)|2/109|0.396281872049263|1|0|0|1.46788990825688|1.35872223534911|CD81;C5AR1|1
2578|nucleotide-excision repair (GO:0006289)|2/109|0.396281872049263|1|0|0|1.46788990825688|1.35872223534911|POLR2A;UBC|1
2579|DNA-templated transcription, elongation (GO:0006354)|2/109|0.396281872049263|1|0|0|1.46788990825688|1.35872223534911|TAF1D;POLR2A|1
2580|regulation of cytokine production (GO:0001817)|2/109|0.396281872049263|1|0|0|1.46788990825688|1.35872223534911|UBC;CARD11|1
2581|circulatory system development (GO:0072359)|2/110|0.400673682328186|1|0|0|1.45454545454545|1.33033882580055|TGFB1;RARA|1
2582|negative regulation of protein kinase activity (GO:0006469)|2/110|0.400673682328186|1|0|0|1.45454545454545|1.33033882580055|PREX1;TRIB1|1
2583|regulation of complement activation (GO:0030449)|2/110|0.400673682328186|1|0|0|1.45454545454545|1.33033882580055|CD81;C5AR1|1
2584|negative regulation of TOR signaling (GO:0032007)|1/41|0.403245076062049|1|0|0|1.95121951219512|1.77211858084849|PREX1|1
2585|nucleotide-excision repair, DNA incision (GO:0033683)|1/41|0.403245076062049|1|0|0|1.95121951219512|1.77211858084849|UBC|1
2586|regulation of cellular localization (GO:0060341)|1/41|0.403245076062049|1|0|0|1.95121951219512|1.77211858084849|CAMK2D|1
2587|negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059)|1/41|0.403245076062049|1|0|0|1.95121951219512|1.77211858084849|UBC|1
2588|regulation of protein dephosphorylation (GO:0035304)|1/41|0.403245076062049|1|0|0|1.95121951219512|1.77211858084849|TGFB1|1
2589|peptidyl-proline modification (GO:0018208)|1/41|0.403245076062049|1|0|0|1.95121951219512|1.77211858084849|FKBP4|1
2590|response to peptide hormone (GO:0043434)|1/41|0.403245076062049|1|0|0|1.95121951219512|1.77211858084849|XBP1|1
2591|negative regulation of ERK1 and ERK2 cascade (GO:0070373)|1/41|0.403245076062049|1|0|0|1.95121951219512|1.77211858084849|EZR|1
2592|regulation of cholesterol biosynthetic process (GO:0045540)|1/41|0.403245076062049|1|0|0|1.95121951219512|1.77211858084849|ABCG1|1
2593|regulation of viral transcription (GO:0046782)|1/41|0.403245076062049|1|0|0|1.95121951219512|1.77211858084849|POLR2A|1
2594|antigen receptor-mediated signaling pathway (GO:0050851)|4/258|0.40365953744808|1|0|0|1.24031007751938|1.12518881910782|UBC;BMX;PAG1;CARD11|1
2595|transcription from RNA polymerase II promoter (GO:0006366)|7/486|0.405931729061574|1|0|0|1.1522633744856|1.03884642300997|XBP1;POLR2A;LMO4;C5AR1;RARA;NABP1;ATF4|1
2596|odontogenesis (GO:0042476)|1/42|0.410719821842797|1|0|0|1.9047619047619|1.69494094405224|ANKRD11|1
2597|mesenchymal cell differentiation (GO:0048762)|1/42|0.410719821842797|1|0|0|1.9047619047619|1.69494094405224|TGFB1|1
2598|regulation of calcium-mediated signaling (GO:0050848)|1/42|0.410719821842797|1|0|0|1.9047619047619|1.69494094405224|CAMK2D|1
2599|DNA duplex unwinding (GO:0032508)|1/42|0.410719821842797|1|0|0|1.9047619047619|1.69494094405224|UBC|1
2600|regulation of stress-activated MAPK cascade (GO:0032872)|1/42|0.410719821842797|1|0|0|1.9047619047619|1.69494094405224|MYC|1
2601|negative regulation of cell projection organization (GO:0031345)|1/42|0.410719821842797|1|0|0|1.9047619047619|1.69494094405224|FKBP4|1
2602|monocyte chemotaxis (GO:0002548)|1/42|0.410719821842797|1|0|0|1.9047619047619|1.69494094405224|FLT1|1
2603|regulation of cellular metabolic process (GO:0031323)|1/42|0.410719821842797|1|0|0|1.9047619047619|1.69494094405224|ABCG1|1
2604|gluconeogenesis (GO:0006094)|1/42|0.410719821842797|1|0|0|1.9047619047619|1.69494094405224|ATF4|1
2605|DNA-templated transcription, initiation (GO:0006352)|3/187|0.414842806155184|1|0|0|1.28342245989305|1.12922645243524|TAF1D;POLR2A;RARA|1
2606|mRNA splicing, via spliceosome (GO:0000398)|4/262|0.414897218269827|1|0|0|1.22137404580153|1.07447261831527|HSPA8;POLR2A;TRA2B;TRA2A|1
2607|positive regulation of canonical Wnt signaling pathway (GO:0090263)|2/114|0.418088149521641|1|0|0|1.40350877192982|1.22394804865576|JUP;UBC|1
2608|regulation of humoral immune response (GO:0002920)|2/114|0.418088149521641|1|0|0|1.40350877192982|1.22394804865576|CD81;C5AR1|1
2609|ceramide metabolic process (GO:0006672)|1/43|0.418101311058768|1|0|0|1.86046511627907|1.62238419510788|PLA2G15|1
2610|cellular response to retinoic acid (GO:0071300)|1/43|0.418101311058768|1|0|0|1.86046511627907|1.62238419510788|RARA|1
2611|translesion synthesis (GO:0019985)|1/43|0.418101311058768|1|0|0|1.86046511627907|1.62238419510788|UBC|1
2612|regulation of immune effector process (GO:0002697)|2/115|0.422402086361144|1|0|0|1.39130434782609|1.19902275798307|CD81;C5AR1|1
2613|regulation of B cell proliferation (GO:0030888)|1/44|0.42539070279467|1|0|0|1.81818181818182|1.55408587574994|CD81|1
2614|cardiac ventricle morphogenesis (GO:0003208)|1/44|0.42539070279467|1|0|0|1.81818181818182|1.55408587574994|TGFB1|1
2615|male gonad development (GO:0008584)|1/44|0.42539070279467|1|0|0|1.81818181818182|1.55408587574994|NCOA4|1
2616|negative regulation of protein metabolic process (GO:0051248)|1/44|0.42539070279467|1|0|0|1.81818181818182|1.55408587574994|FLNA|1
2617|protein transmembrane import into intracellular organelle (GO:0044743)|1/44|0.42539070279467|1|0|0|1.81818181818182|1.55408587574994|HSP90AA1|1
2618|development of primary male sexual characteristics (GO:0046546)|1/44|0.42539070279467|1|0|0|1.81818181818182|1.55408587574994|NCOA4|1
2619|intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332)|1/44|0.42539070279467|1|0|0|1.81818181818182|1.55408587574994|KRCC1|1
2620|negative regulation of DNA metabolic process (GO:0051053)|1/44|0.42539070279467|1|0|0|1.81818181818182|1.55408587574994|TGFB1|1
2621|positive regulation of interleukin-6 production (GO:0032755)|1/44|0.42539070279467|1|0|0|1.81818181818182|1.55408587574994|XBP1|1
2622|substantia nigra development (GO:0021762)|1/44|0.42539070279467|1|0|0|1.81818181818182|1.55408587574994|HSPA5|1
2623|nucleobase-containing compound catabolic process (GO:0034655)|1/44|0.42539070279467|1|0|0|1.81818181818182|1.55408587574994|RNASE6|1
2624|branching morphogenesis of an epithelial tube (GO:0048754)|1/44|0.42539070279467|1|0|0|1.81818181818182|1.55408587574994|MYC|1
2625|regulation of macroautophagy (GO:0016241)|2/117|0.430980398402|1|0|0|1.36752136752137|1.15103271009684|QSOX1;CAPN1|1
2626|sphingolipid metabolic process (GO:0006665)|2/117|0.430980398402|1|0|0|1.36752136752137|1.15103271009684|PLA2G15;PPT1|1
2627|RNA metabolic process (GO:0016070)|3/192|0.431437533918377|1|0|0|1.25|1.05079067987665|RBM39;POLR2A;RNASE6|1
2628|sprouting angiogenesis (GO:0002040)|1/45|0.432589141413427|1|0|0|1.77777777777778|1.48971887383665|FLT1|1
2629|adherens junction organization (GO:0034332)|1/45|0.432589141413427|1|0|0|1.77777777777778|1.48971887383665|JUP|1
2630|hexose biosynthetic process (GO:0019319)|1/45|0.432589141413427|1|0|0|1.77777777777778|1.48971887383665|ATF4|1
2631|positive regulation of macroautophagy (GO:0016239)|1/45|0.432589141413427|1|0|0|1.77777777777778|1.48971887383665|ADRB2|1
2632|negative regulation of type I interferon production (GO:0032480)|1/45|0.432589141413427|1|0|0|1.77777777777778|1.48971887383665|UBC|1
2633|regulation of intracellular pH (GO:0051453)|1/45|0.432589141413427|1|0|0|1.77777777777778|1.48971887383665|SLC9A4|1
2634|carboxylic acid biosynthetic process (GO:0046394)|1/45|0.432589141413427|1|0|0|1.77777777777778|1.48971887383665|GLUL|1
2635|mitotic nuclear envelope disassembly (GO:0007077)|1/45|0.432589141413427|1|0|0|1.77777777777778|1.48971887383665|LPIN1|1
2636|inorganic anion transport (GO:0015698)|1/45|0.432589141413427|1|0|0|1.77777777777778|1.48971887383665|CLIC4|1
2637|positive regulation of actin filament bundle assembly (GO:0032233)|1/45|0.432589141413427|1|0|0|1.77777777777778|1.48971887383665|EVL|1
2638|positive regulation of viral process (GO:0048524)|1/45|0.432589141413427|1|0|0|1.77777777777778|1.48971887383665|POLR2A|1
2639|regulation of intracellular signal transduction (GO:1902531)|6/423|0.435175149784164|1|0|0|1.13475177304965|0.944121061844516|NET1;PREX1;TGFB1;UBC;ARHGEF3;RHOB|1
2640|plasma membrane bounded cell projection organization (GO:0120036)|2/119|0.439490914682932|1|0|0|1.34453781512605|1.10539594488644|LIMA1;BTG2|1
2641|calcium ion transport (GO:0006816)|2/119|0.439490914682932|1|0|0|1.34453781512605|1.10539594488644|MCOLN3;RAMP1|1
2642|regulation of transcription, DNA-templated (GO:0006355)|21/1599|0.439641251362928|1|0|0|1.05065666041276|0.863425674619151|KMT2E;BRD2;HSPA8;TCF7L2;JUN;CAMK2D;JUND;TGFB1;NCOA4;BAZ1A;FOS;ZBTB4;RUNX1;POLR2A;MYC;NRIP1;RARA;FOSB;LRRFIP1;ABCG1;ATF4|1
2643|positive regulation of blood vessel endothelial cell migration (GO:0043536)|1/46|0.439697757308293|1|0|0|1.73913043478261|1.42898731010888|TGFB1|1
2644|mitochondrial gene expression (GO:0140053)|1/46|0.439697757308293|1|0|0|1.73913043478261|1.42898731010888|MRPS6|1
2645|protein complex subunit organization (GO:0071822)|1/46|0.439697757308293|1|0|0|1.73913043478261|1.42898731010888|ST13|1
2646|peptidyl-tyrosine autophosphorylation (GO:0038083)|1/46|0.439697757308293|1|0|0|1.73913043478261|1.42898731010888|BMX|1
2647|negative regulation of ossification (GO:0030279)|1/46|0.439697757308293|1|0|0|1.73913043478261|1.42898731010888|CDK6|1
2648|positive regulation of B cell activation (GO:0050871)|2/120|0.44372014025063|1|0|0|1.33333333333333|1.0834149733768|XBP1;CD81|1
2649|regulation of neuron projection development (GO:0010975)|2/120|0.44372014025063|1|0|0|1.33333333333333|1.0834149733768|FKBP4;S100A9|1
2650|interleukin-12-mediated signaling pathway (GO:0035722)|1/47|0.446717666860379|1|0|0|1.70212765957447|1.37162298159169|ANXA2|1
2651|protein methylation (GO:0006479)|1/47|0.446717666860379|1|0|0|1.70212765957447|1.37162298159169|HSPA8|1
2652|nuclear envelope disassembly (GO:0051081)|1/47|0.446717666860379|1|0|0|1.70212765957447|1.37162298159169|LPIN1|1
2653|cellular response to interleukin-12 (GO:0071349)|1/47|0.446717666860379|1|0|0|1.70212765957447|1.37162298159169|ANXA2|1
2654|mitotic spindle assembly (GO:0090307)|1/47|0.446717666860379|1|0|0|1.70212765957447|1.37162298159169|FLNA|1
2655|regulation of DNA metabolic process (GO:0051052)|1/47|0.446717666860379|1|0|0|1.70212765957447|1.37162298159169|MYC|1
2656|regulation of acute inflammatory response (GO:0002673)|2/122|0.45212538345424|1|0|0|1.31147540983607|1.04104359422255|CD81;C5AR1|1
2657|stimulatory C-type lectin receptor signaling pathway (GO:0002223)|2/122|0.45212538345424|1|0|0|1.31147540983607|1.04104359422255|UBC;CARD11|1
2658|myofibril assembly (GO:0030239)|1/48|0.453649972588319|1|0|0|1.66666666666667|1.31738227298539|KRT19|1
2659|negative regulation of cellular biosynthetic process (GO:0031327)|1/48|0.453649972588319|1|0|0|1.66666666666667|1.31738227298539|TGFB1|1
2660|positive regulation of tumor necrosis factor production (GO:0032760)|1/48|0.453649972588319|1|0|0|1.66666666666667|1.31738227298539|CD2|1
2661|regulation of organelle assembly (GO:1902115)|1/48|0.453649972588319|1|0|0|1.66666666666667|1.31738227298539|EZR|1
2662|postreplication repair (GO:0006301)|1/48|0.453649972588319|1|0|0|1.66666666666667|1.31738227298539|UBC|1
2663|positive regulation of gene expression, epigenetic (GO:0045815)|1/48|0.453649972588319|1|0|0|1.66666666666667|1.31738227298539|TAF1D|1
2664|fatty acid biosynthetic process (GO:0006633)|1/48|0.453649972588319|1|0|0|1.66666666666667|1.31738227298539|XBP1|1
2665|heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157)|1/48|0.453649972588319|1|0|0|1.66666666666667|1.31738227298539|CD164|1
2666|positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862)|1/48|0.453649972588319|1|0|0|1.66666666666667|1.31738227298539|TGFB1|1
2667|sulfur compound biosynthetic process (GO:0044272)|2/123|0.456300968984518|1|0|0|1.30081300813008|1.02062135607424|GSTM1;MGST1|1
2668|cellular calcium ion homeostasis (GO:0006874)|2/124|0.46045825588977|1|0|0|1.29032258064516|1.00068784119911|CAMK2D;HERPUD1|1
2669|cytoplasmic microtubule organization (GO:0031122)|1/49|0.460495763488239|1|0|0|1.63265306122449|1.2660434663469|EZR|1
2670|regulation of cell cycle arrest (GO:0071156)|1/49|0.460495763488239|1|0|0|1.63265306122449|1.2660434663469|HSP90AB1|1
2671|regulation of epithelial cell migration (GO:0010632)|1/49|0.460495763488239|1|0|0|1.63265306122449|1.2660434663469|EVL|1
2672|interstrand cross-link repair (GO:0036297)|1/49|0.460495763488239|1|0|0|1.63265306122449|1.2660434663469|UBC|1
2673|positive regulation of chemotaxis (GO:0050921)|1/49|0.460495763488239|1|0|0|1.63265306122449|1.2660434663469|TGFB1|1
2674|cellular macromolecule catabolic process (GO:0044265)|1/49|0.460495763488239|1|0|0|1.63265306122449|1.2660434663469|RNASE6|1
2675|amino acid transport (GO:0006865)|1/49|0.460495763488239|1|0|0|1.63265306122449|1.2660434663469|SLC38A2|1
2676|transcription, DNA-templated (GO:0006351)|5/357|0.462092647449407|1|0|0|1.12044817927171|0.864974646947001|XBP1;POLR2A;LMO4;BAZ1A;ATF4|1
2677|innate immune response activating cell surface receptor signaling pathway (GO:0002220)|2/125|0.464597048172934|1|0|0|1.28|0.981228559547606|UBC;CARD11|1
2678|dephosphorylation (GO:0016311)|2/125|0.464597048172934|1|0|0|1.28|0.981228559547606|DUSP5;PTPN12|1
2679|negative regulation of macromolecule metabolic process (GO:0010605)|2/125|0.464597048172934|1|0|0|1.28|0.981228559547606|TGFB1;MYADM|1
2680|positive regulation of response to DNA damage stimulus (GO:2001022)|1/50|0.467256114895877|1|0|0|1.6|1.21740439318805|MYC|1
2681|gonad development (GO:0008406)|1/50|0.467256114895877|1|0|0|1.6|1.21740439318805|NCOA4|1
2682|regulation of release of sequestered calcium ion into cytosol (GO:0051279)|1/50|0.467256114895877|1|0|0|1.6|1.21740439318805|CAMK2D|1
2683|protein dephosphorylation (GO:0006470)|2/126|0.468717157538323|1|0|0|1.26984126984127|0.962229546756002|DUSP5;PTPN12|1
2684|regulation of autophagy (GO:0010506)|3/204|0.470527816372029|1|0|0|1.17647058823529|0.886941412739467|DAPK1;LEPR;CAPN1|1
2685|regulation of bone mineralization (GO:0030500)|1/51|0.473932088902915|1|0|0|1.56862745098039|1.17128037632666|TGFB1|1
2686|regulation of cellular protein metabolic process (GO:0032268)|1/51|0.473932088902915|1|0|0|1.56862745098039|1.17128037632666|TGFB1|1
2687|myeloid leukocyte differentiation (GO:0002573)|1/51|0.473932088902915|1|0|0|1.56862745098039|1.17128037632666|MYH9|1
2688|blood circulation (GO:0008015)|1/51|0.473932088902915|1|0|0|1.56862745098039|1.17128037632666|CYB5R3|1
2689|neurogenesis (GO:0022008)|1/51|0.473932088902915|1|0|0|1.56862745098039|1.17128037632666|CDK6|1
2690|non-canonical Wnt signaling pathway (GO:0035567)|2/128|0.476900611767666|1|0|0|1.25|0.925558963597569|TCF7L2;UBC|1
2691|positive regulation of signal transduction (GO:0009967)|3/207|0.480114874792425|1|0|0|1.15942028985507|0.8507013115699|XBP1;FLT1;FLNA|1
2692|peptidyl-tyrosine modification (GO:0018212)|1/52|0.480524734483999|1|0|0|1.53846153846154|1.12750242360473|FLT1|1
2693|negative regulation of neuron projection development (GO:0010977)|1/52|0.480524734483999|1|0|0|1.53846153846154|1.12750242360473|FKBP4|1
2694|carboxylic acid transport (GO:0046942)|1/52|0.480524734483999|1|0|0|1.53846153846154|1.12750242360473|SLC38A2|1
2695|positive regulation of actin filament polymerization (GO:0030838)|1/52|0.480524734483999|1|0|0|1.53846153846154|1.12750242360473|CDC42EP3|1
2696|coenzyme metabolic process (GO:0006732)|1/52|0.480524734483999|1|0|0|1.53846153846154|1.12750242360473|ACOT1|1
2697|positive regulation of developmental growth (GO:0048639)|1/52|0.480524734483999|1|0|0|1.53846153846154|1.12750242360473|CPNE5|1
2698|regulation of protein processing (GO:0070613)|2/129|0.480963617117109|1|0|0|1.24031007751938|0.907861893738173|CD81;C5AR1|1
2699|regulation of macromolecule metabolic process (GO:0060255)|2/130|0.485007260169937|1|0|0|1.23076923076923|0.89057405382664|CDK6;MYC|1
2700|positive regulation of proteolysis (GO:0045862)|1/53|0.487035087594695|1|0|0|1.50943396226415|1.08591563780505|PERP|1
2701|positive regulation of ossification (GO:0045778)|1/53|0.487035087594695|1|0|0|1.50943396226415|1.08591563780505|TGFB1|1
2702|plasma membrane bounded cell projection morphogenesis (GO:0120039)|1/53|0.487035087594695|1|0|0|1.50943396226415|1.08591563780505|SGK1|1
2703|B cell differentiation (GO:0030183)|1/53|0.487035087594695|1|0|0|1.50943396226415|1.08591563780505|DNAJB9|1
2704|cellular macromolecule biosynthetic process (GO:0034645)|5/368|0.488501542928328|1|0|0|1.08695652173913|0.778709401089219|POLR2A;BAZ1A;TOP1;MRPS6;PTMS|1
2705|cilium assembly (GO:0060271)|4/289|0.489184184393981|1|0|0|1.10726643598616|0.791713445228083|HSP90AA1;PRKAR2B;UNC119;FLNA|1
2706|ion transport (GO:0006811)|4/290|0.491867319026834|1|0|0|1.10344827586207|0.782947614492554|SLC9A4;UBC;SGK1;SLC15A3|1
2707|neutrophil chemotaxis (GO:0030593)|1/54|0.493464171453638|1|0|0|1.48148148148148|1.04637781281283|S100A9|1
2708|positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531)|1/54|0.493464171453638|1|0|0|1.48148148148148|1.04637781281283|IL18|1
2709|proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161)|4/292|0.497216128548114|1|0|0|1.0958904109589|0.765732034102421|ABTB1;HSPA5;UBC;DNAJB9|1
2710|sensory perception (GO:0007600)|1/55|0.499812996411047|1|0|0|1.45454545454545|1.00875819301233|C5AR1|1
2711|protein targeting to mitochondrion (GO:0006626)|1/55|0.499812996411047|1|0|0|1.45454545454545|1.00875819301233|HSP90AA1|1
2712|RNA modification (GO:0009451)|1/55|0.499812996411047|1|0|0|1.45454545454545|1.00875819301233|NOP10|1
2713|intracellular transport of virus (GO:0075733)|1/55|0.499812996411047|1|0|0|1.45454545454545|1.00875819301233|UBC|1
2714|transport of virus (GO:0046794)|1/55|0.499812996411047|1|0|0|1.45454545454545|1.00875819301233|UBC|1
2715|Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096)|2/134|0.500985268027083|1|0|0|1.19402985074627|0.82528786085394|HSP90AA1;HSP90AB1|1
2716|regulation of canonical Wnt signaling pathway (GO:0060828)|3/214|0.502161763688566|1|0|0|1.1214953271028|0.772522960121068|TCF7L2;JUP;UBC|1
2717|Fc-gamma receptor signaling pathway (GO:0038094)|2/135|0.504929951374976|1|0|0|1.18518518518519|0.809879193453609|HSP90AA1;HSP90AB1|1
2718|regulation of cellular catabolic process (GO:0031329)|1/56|0.50608256047932|1|0|0|1.42857142857143|0.972936371430998|DAPK1|1
2719|regulation of gene silencing by RNA (GO:0060966)|1/56|0.50608256047932|1|0|0|1.42857142857143|0.972936371430998|POLR2A|1
2720|regulation of posttranscriptional gene silencing (GO:0060147)|1/56|0.50608256047932|1|0|0|1.42857142857143|0.972936371430998|POLR2A|1
2721|fat cell differentiation (GO:0045444)|1/56|0.50608256047932|1|0|0|1.42857142857143|0.972936371430998|TCF7L2|1
2722|Fc receptor mediated stimulatory signaling pathway (GO:0002431)|2/136|0.508854458592687|1|0|0|1.17647058823529|0.794815575630956|HSP90AA1;HSP90AB1|1
2723|DNA-dependent DNA replication (GO:0006261)|1/57|0.512273849272943|1|0|0|1.40350877192982|0.938801312377592|BAZ1A|1
2724|granulocyte chemotaxis (GO:0071621)|1/57|0.512273849272943|1|0|0|1.40350877192982|0.938801312377592|S100A9|1
2725|chordate embryonic development (GO:0043009)|1/57|0.512273849272943|1|0|0|1.40350877192982|0.938801312377592|TGFB1|1
2726|phosphatidylinositol-mediated signaling (GO:0048015)|1/57|0.512273849272943|1|0|0|1.40350877192982|0.938801312377592|EZR|1
2727|negative regulation of cellular catabolic process (GO:0031330)|1/57|0.512273849272943|1|0|0|1.40350877192982|0.938801312377592|LEPR|1
2728|central nervous system development (GO:0007417)|3/218|0.514545064346536|1|0|0|1.10091743119266|0.731528960279655|PPT1;RARA;PHGDH|1
2729|chloride transmembrane transport (GO:1902476)|1/58|0.518387836079742|1|0|0|1.37931034482759|0.906250480788571|CLIC4|1
2730|cellular respiration (GO:0045333)|1/58|0.518387836079742|1|0|0|1.37931034482759|0.906250480788571|MT-ND4|1
2731|response to retinoic acid (GO:0032526)|1/58|0.518387836079742|1|0|0|1.37931034482759|0.906250480788571|RARA|1
2732|neutrophil migration (GO:1990266)|1/59|0.524425482361259|1|0|0|1.35593220338983|0.875189064280634|S100A9|1
2733|sodium ion transport (GO:0006814)|1/59|0.524425482361259|1|0|0|1.35593220338983|0.875189064280634|SGK1|1
2734|positive regulation of Wnt signaling pathway (GO:0030177)|2/141|0.528170586051378|1|0|0|1.13475177304965|0.724352871276145|JUP;UBC|1
2735|regulation of protein metabolic process (GO:0051246)|1/60|0.530387737478692|1|0|0|1.33333333333333|0.845529279682408|ABTB1|1
2736|cell junction assembly (GO:0034329)|1/60|0.530387737478692|1|0|0|1.33333333333333|0.845529279682408|FLNA|1
2737|regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393)|1/60|0.530387737478692|1|0|0|1.33333333333333|0.845529279682408|TGFB1|1
2738|sterol metabolic process (GO:0016125)|1/60|0.530387737478692|1|0|0|1.33333333333333|0.845529279682408|ABCG1|1
2739|modification-dependent protein catabolic process (GO:0019941)|2/142|0.531971856760057|1|0|0|1.12676056338028|0.711171483793522|XBP1;UBC|1
2740|nucleosome assembly (GO:0006334)|1/61|0.536275539088222|1|0|0|1.31147540983607|0.817189750209336|BRD2|1
2741|positive regulation of protein binding (GO:0032092)|1/61|0.536275539088222|1|0|0|1.31147540983607|0.817189750209336|TCF7L2|1
2742|regulation of stress fiber assembly (GO:0051492)|1/61|0.536275539088222|1|0|0|1.31147540983607|0.817189750209336|EVL|1
2743|regulation of tyrosine phosphorylation of STAT protein (GO:0042509)|1/62|0.542089813195746|1|0|0|1.29032258064516|0.790094947441495|IL18|1
2744|regulation of vesicle fusion (GO:0031338)|1/62|0.542089813195746|1|0|0|1.29032258064516|0.790094947441495|ANXA2|1
2745|positive regulation of T cell proliferation (GO:0042102)|1/62|0.542089813195746|1|0|0|1.29032258064516|0.790094947441495|IL18|1
2746|positive regulation of leukocyte chemotaxis (GO:0002690)|1/62|0.542089813195746|1|0|0|1.29032258064516|0.790094947441495|FPR2|1
2747|negative regulation of MAP kinase activity (GO:0043407)|1/62|0.542089813195746|1|0|0|1.29032258064516|0.790094947441495|DNAJA1|1
2748|regulation of DNA replication (GO:0006275)|1/62|0.542089813195746|1|0|0|1.29032258064516|0.790094947441495|TGFB1|1
2749|positive regulation of cellular amide metabolic process (GO:0034250)|1/62|0.542089813195746|1|0|0|1.29032258064516|0.790094947441495|FAM129A|1
2750|positive regulation of type I interferon production (GO:0032481)|1/63|0.547831474529684|1|0|0|1.26984126984127|0.764174688966513|LRRFIP1|1
2751|negative regulation of G2/M transition of mitotic cell cycle (GO:0010972)|1/63|0.547831474529684|1|0|0|1.26984126984127|0.764174688966513|UBC|1
2752|diterpenoid metabolic process (GO:0016101)|1/63|0.547831474529684|1|0|0|1.26984126984127|0.764174688966513|DHRS3|1
2753|regulation of actin filament-based process (GO:0032970)|1/63|0.547831474529684|1|0|0|1.26984126984127|0.764174688966513|RHOB|1
2754|skeletal system development (GO:0001501)|2/147|0.550664043768528|1|0|0|1.08843537414966|0.649393607306536|ANKRD11;CD44|1
2755|endosomal transport (GO:0016197)|3/230|0.550683447926878|1|0|0|1.04347826086957|0.622534058702792|UBC;ADRB2;RHOB|1
2756|extracellular matrix organization (GO:0030198)|3/230|0.550683447926878|1|0|0|1.04347826086957|0.622534058702792|TGFB1;CAPN1;CD44|1
2757|negative regulation of neuron apoptotic process (GO:0043524)|1/64|0.553501426111844|1|0|0|1.25|0.739363687877834|PPT1|1
2758|positive regulation of cell projection organization (GO:0031346)|1/64|0.553501426111844|1|0|0|1.25|0.739363687877834|S100A9|1
2759|negative regulation of canonical Wnt signaling pathway (GO:0090090)|2/149|0.557993126062312|1|0|0|1.0738255033557|0.626479071743838|TCF7L2;UBC|1
2760|inorganic anion transmembrane transport (GO:0098661)|1/65|0.559100560218539|1|0|0|1.23076923076923|0.715601143322378|CLIC4|1
2761|positive regulation of JAK-STAT cascade (GO:0046427)|1/65|0.559100560218539|1|0|0|1.23076923076923|0.715601143322378|IL18|1
2762|glucose metabolic process (GO:0006006)|1/65|0.559100560218539|1|0|0|1.23076923076923|0.715601143322378|ATF4|1
2763|negative regulation of neuron differentiation (GO:0045665)|1/65|0.559100560218539|1|0|0|1.23076923076923|0.715601143322378|FKBP4|1
2764|positive regulation of cell adhesion (GO:0045785)|1/65|0.559100560218539|1|0|0|1.23076923076923|0.715601143322378|SIRPA|1
2765|heart development (GO:0007507)|2/150|0.561625787097685|1|0|0|1.06666666666667|0.615380810803163|TGFB1;RARA|1
2766|chromatin assembly (GO:0031497)|1/66|0.564629757685559|1|0|0|1.21212121212121|0.692830374264005|BRD2|1
2767|positive regulation of protein modification by small protein conjugation or removal (GO:1903322)|1/66|0.564629757685559|1|0|0|1.21212121212121|0.692830374264005|ADRB2|1
2768|DNA synthesis involved in DNA repair (GO:0000731)|1/66|0.564629757685559|1|0|0|1.21212121212121|0.692830374264005|UBC|1
2769|defense response to Gram-positive bacterium (GO:0050830)|1/66|0.564629757685559|1|0|0|1.21212121212121|0.692830374264005|RNASE6|1
2770|cellular protein metabolic process (GO:0044267)|6/485|0.567431480083827|1|0|0|0.989690721649484|0.560793676064289|APLP2;UBC;QSOX1;MRPS6;PDIA6;PNPLA2|1
2771|positive regulation of cellular protein localization (GO:1903829)|1/67|0.570089888649279|1|0|0|1.19402985074627|0.670998485017412|HSP90AB1|1
2772|negative regulation of protein serine/threonine kinase activity (GO:0071901)|1/68|0.575481812486138|1|0|0|1.17647058823529|0.650056063879559|PRKAR2B|1
2773|regulation of TOR signaling (GO:0032006)|1/68|0.575481812486138|1|0|0|1.17647058823529|0.650056063879559|PREX1|1
2774|positive regulation of autophagy (GO:0010508)|1/68|0.575481812486138|1|0|0|1.17647058823529|0.650056063879559|DAPK1|1
2775|regulation of cardiac conduction (GO:1903779)|1/68|0.575481812486138|1|0|0|1.17647058823529|0.650056063879559|CAMK2D|1
2776|spermatogenesis (GO:0007283)|2/154|0.575942986558702|1|0|0|1.03896103896104|0.573243225822519|BRD2;SPAG11B|1
2777|male gamete generation (GO:0048232)|2/155|0.579468772325311|1|0|0|1.03225806451613|0.563244908312029|BRD2;SPAG11B|1
2778|regulation of epithelial to mesenchymal transition (GO:0010717)|1/69|0.580806377721199|1|0|0|1.15942028985507|0.629956909689173|TGFB1|1
2779|protein sumoylation (GO:0016925)|1/69|0.580806377721199|1|0|0|1.15942028985507|0.629956909689173|TOP1|1
2780|response to interferon-gamma (GO:0034341)|1/69|0.580806377721199|1|0|0|1.15942028985507|0.629956909689173|DAPK1|1
2781|cholesterol metabolic process (GO:0008203)|1/69|0.580806377721199|1|0|0|1.15942028985507|0.629956909689173|ABCG1|1
2782|peptidyl-threonine phosphorylation (GO:0018107)|1/69|0.580806377721199|1|0|0|1.15942028985507|0.629956909689173|CAMK2D|1
2783|plasma membrane bounded cell projection assembly (GO:0120031)|3/242|0.585197275206728|1|0|0|0.991735537190083|0.531378115062575|UNC119;FLNA;EZR|1
2784|defense response to bacterium (GO:0042742)|3/242|0.585197275206728|1|0|0|0.991735537190083|0.531378115062575|SLPI;RNASE6;S100A9|1
2785|regulation of endothelial cell migration (GO:0010594)|1/70|0.586064422559339|1|0|0|1.14285714285714|0.610657782102364|RHOB|1
2786|regulation of endocytosis (GO:0030100)|1/70|0.586064422559339|1|0|0|1.14285714285714|0.610657782102364|UNC119|1
2787|regulation of osteoblast differentiation (GO:0045667)|1/70|0.586064422559339|1|0|0|1.14285714285714|0.610657782102364|CDK6|1
2788|negative regulation of cell cycle G2/M phase transition (GO:1902750)|1/70|0.586064422559339|1|0|0|1.14285714285714|0.610657782102364|UBC|1
2789|ribonucleoprotein complex assembly (GO:0022618)|2/157|0.586455969160611|1|0|0|1.01910828025478|0.543854968256555|HSP90AA1;HSP90AB1|1
2790|vesicle-mediated transport (GO:0016192)|5/411|0.586517154543655|1|0|0|0.97323600973236|0.519273345311496|HSPA8;ANXA2;APLP2;ADRB2;RHOB|1
2791|cellular protein localization (GO:0034613)|4/328|0.588858225431944|1|0|0|0.975609756097561|0.516653490882986|RAB44;FLNA;EZR;TMED5|1
2792|regulation of Notch signaling pathway (GO:0008593)|1/71|0.59125677475942|1|0|0|1.12676056338028|0.59211817563353|UBC|1
2793|stress-activated protein kinase signaling cascade (GO:0031098)|1/71|0.59125677475942|1|0|0|1.12676056338028|0.59211817563353|UBC|1
2794|protein ubiquitination involved in ubiquitin-dependent protein catabolic process (GO:0042787)|1/71|0.59125677475942|1|0|0|1.12676056338028|0.59211817563353|ABTB1|1
2795|phospholipid metabolic process (GO:0006644)|1/71|0.59125677475942|1|0|0|1.12676056338028|0.59211817563353|PLA2G15|1
2796|Rab protein signal transduction (GO:0032482)|1/71|0.59125677475942|1|0|0|1.12676056338028|0.59211817563353|RAB44|1
2797|neuropeptide signaling pathway (GO:0007218)|1/71|0.59125677475942|1|0|0|1.12676056338028|0.59211817563353|GAL|1
2798|calcium-mediated signaling (GO:0019722)|1/71|0.59125677475942|1|0|0|1.12676056338028|0.59211817563353|FPR2|1
2799|axon guidance (GO:0007411)|2/159|0.59335724072372|1|0|0|1.0062893081761|0.525241390511987|EVL;EZR|1
2800|cellular response to DNA damage stimulus (GO:0006974)|4/330|0.593660679210881|1|0|0|0.96969696969697|0.505645934509596|BTG2;MYC;NABP1;ZBTB4|1
2801|recombinational repair (GO:0000725)|1/72|0.59638425178044|1|0|0|1.11111111111111|0.574300113228418|NABP1|1
2802|negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436)|1/72|0.59638425178044|1|0|0|1.11111111111111|0.574300113228418|UBC|1
2803|defense response to Gram-negative bacterium (GO:0050829)|1/72|0.59638425178044|1|0|0|1.11111111111111|0.574300113228418|RNASE6|1
2804|positive regulation of growth (GO:0045927)|1/72|0.59638425178044|1|0|0|1.11111111111111|0.574300113228418|S100A9|1
2805|response to insulin (GO:0032868)|1/72|0.59638425178044|1|0|0|1.11111111111111|0.574300113228418|XBP1|1
2806|transcription initiation from RNA polymerase II promoter (GO:0006367)|2/161|0.60017252713712|1|0|0|0.993788819875776|0.507367075647864|POLR2A;RARA|1
2807|regulation of neuron death (GO:1901214)|1/73|0.601447661037257|1|0|0|1.0958904109589|0.557167957723557|FOS|1
2808|SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146)|1/73|0.601447661037257|1|0|0|1.0958904109589|0.557167957723557|UBC|1
2809|regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439)|1/73|0.601447661037257|1|0|0|1.0958904109589|0.557167957723557|UBC|1
2810|B cell activation (GO:0042113)|1/74|0.606447799789694|1|0|0|1.08108108108108|0.540688240270091|DNAJB9|1
2811|chloride transport (GO:0006821)|1/74|0.606447799789694|1|0|0|1.08108108108108|0.540688240270091|CLIC4|1
2812|neuron projection morphogenesis (GO:0048812)|2/164|0.610234240144572|1|0|0|0.975609756097561|0.481865751499511|IQGAP1;SGK1|1
2813|positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123)|2/164|0.610234240144572|1|0|0|0.975609756097561|0.481865751499511|UBC;FLNA|1
2814|positive regulation of epithelial cell migration (GO:0010634)|1/75|0.611385455634701|1|0|0|1.06666666666667|0.524829502328869|RHOB|1
2815|mitotic spindle organization (GO:0007052)|1/75|0.611385455634701|1|0|0|1.06666666666667|0.524829502328869|FLNA|1
2816|regulation of gene expression, epigenetic (GO:0040029)|1/75|0.611385455634701|1|0|0|1.06666666666667|0.524829502328869|TAF1D|1
2817|regulation of G-protein coupled receptor protein signaling pathway (GO:0008277)|1/75|0.611385455634701|1|0|0|1.06666666666667|0.524829502328869|MGLL|1
2818|mitotic nuclear division (GO:0140014)|1/75|0.611385455634701|1|0|0|1.06666666666667|0.524829502328869|FLNA|1
2819|regulation of immune response (GO:0050776)|3/252|0.612643199051376|1|0|0|0.952380952380952|0.466640542399339|PLSCR1;CD81;CLEC2D|1
2820|retinoid metabolic process (GO:0001523)|1/76|0.61626140617266|1|0|0|1.05263157894737|0.509562152414987|DHRS3|1
2821|C-terminal protein lipidation (GO:0006501)|1/76|0.61626140617266|1|0|0|1.05263157894737|0.509562152414987|PLET1|1
2822|regulation of actin cytoskeleton organization (GO:0032956)|1/76|0.61626140617266|1|0|0|1.05263157894737|0.509562152414987|RHOB|1
2823|regulation of defense response (GO:0031347)|1/76|0.61626140617266|1|0|0|1.05263157894737|0.509562152414987|MGLL|1
2824|antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)|1/76|0.61626140617266|1|0|0|1.05263157894737|0.509562152414987|CD36|1
2825|double-strand break repair via homologous recombination (GO:0000724)|1/77|0.621076419495264|1|0|0|1.03896103896104|0.494858333351924|NABP1|1
2826|positive regulation of JNK cascade (GO:0046330)|1/77|0.621076419495264|1|0|0|1.03896103896104|0.494858333351924|GADD45G|1
2827|positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition (GO:0051437)|1/77|0.621076419495264|1|0|0|1.03896103896104|0.494858333351924|UBC|1
2828|neuron projection development (GO:0031175)|2/168|0.623349308738106|1|0|0|0.952380952380952|0.450141170608016|BTG2;SGK1|1
2829|negative regulation of ubiquitin protein ligase activity (GO:1904667)|1/78|0.625831254135234|1|0|0|1.02564102564103|0.480691801338172|UBC|1
2830|positive regulation of cytoskeleton organization (GO:0051495)|1/78|0.625831254135234|1|0|0|1.02564102564103|0.480691801338172|CDC42EP3|1
2831|protein deubiquitination (GO:0016579)|3/258|0.628518341308085|1|0|0|0.930232558139535|0.431990761588517|MYC;UBC;ADRB2|1
2832|antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590)|1/79|0.630526659251788|1|0|0|1.0126582278481|0.467037814436539|CD36|1
2833|regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418)|1/79|0.630526659251788|1|0|0|1.0126582278481|0.467037814436539|UBC|1
2834|visual perception (GO:0007601)|1/79|0.630526659251788|1|0|0|1.0126582278481|0.467037814436539|DHRS3|1
2835|negative regulation of inflammatory response (GO:0050728)|1/79|0.630526659251788|1|0|0|1.0126582278481|0.467037814436539|FFAR4|1
2836|nucleosome organization (GO:0034728)|1/80|0.635163374679895|1|0|0|1|0.453873030220565|BRD2|1
2837|anaphase-promoting complex-dependent catabolic process (GO:0031145)|1/80|0.635163374679895|1|0|0|1|0.453873030220565|UBC|1
2838|activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919)|1/80|0.635163374679895|1|0|0|1|0.453873030220565|S100A9|1
2839|protein modification by small protein removal (GO:0070646)|3/262|0.638851278720547|1|0|0|0.916030534351145|0.41045825253374|MYC;UBC;ADRB2|1
2840|positive regulation of hydrolase activity (GO:0051345)|2/173|0.639261897469154|1|0|0|0.92485549132948|0.413818315262896|NET1;ADRB1|1
2841|spindle assembly (GO:0051225)|1/81|0.639742131049501|1|0|0|0.987654320987654|0.441175411415055|FLNA|1
2842|nucleic acid metabolic process (GO:0090304)|1/81|0.639742131049501|1|0|0|0.987654320987654|0.441175411415055|POLR2A|1
2843|NIK/NF-kappaB signaling (GO:0038061)|1/81|0.639742131049501|1|0|0|0.987654320987654|0.441175411415055|UBC|1
2844|positive regulation of stress-activated MAPK cascade (GO:0032874)|1/81|0.639742131049501|1|0|0|0.987654320987654|0.441175411415055|GADD45G|1
2845|regulation of hydrolase activity (GO:0051336)|1/81|0.639742131049501|1|0|0|0.987654320987654|0.441175411415055|CAMK2D|1
2846|negative regulation of defense response (GO:0031348)|1/81|0.639742131049501|1|0|0|0.987654320987654|0.441175411415055|FFAR4|1
2847|positive regulation of protein targeting to mitochondrion (GO:1903955)|1/82|0.644263650016182|1|0|0|0.975609756097561|0.428924138752932|KCNN3|1
2848|BMP signaling pathway (GO:0030509)|1/82|0.644263650016182|1|0|0|0.975609756097561|0.428924138752932|TGFB1|1
2849|sensory perception of light stimulus (GO:0050953)|1/82|0.644263650016182|1|0|0|0.975609756097561|0.428924138752932|DHRS3|1
2850|negative regulation of cell death (GO:0060548)|1/82|0.644263650016182|1|0|0|0.975609756097561|0.428924138752932|HSPA1A|1
2851|negative regulation of cell cycle process (GO:0010948)|1/82|0.644263650016182|1|0|0|0.975609756097561|0.428924138752932|HSP90AB1|1
2852|negative regulation of Wnt signaling pathway (GO:0030178)|2/175|0.645477966530818|1|0|0|0.914285714285714|0.400241557243357|TCF7L2;UBC|1
2853|regulation of anatomical structure morphogenesis (GO:0022603)|1/83|0.648728644349886|1|0|0|0.963855421686747|0.417099530789704|TGFB1|1
2854|positive regulation of ubiquitin protein ligase activity (GO:1904668)|1/83|0.648728644349886|1|0|0|0.963855421686747|0.417099530789704|UBC|1
2855|positive regulation of DNA metabolic process (GO:0051054)|1/83|0.648728644349886|1|0|0|0.963855421686747|0.417099530789704|MYC|1
2856|C-terminal protein amino acid modification (GO:0018410)|1/83|0.648728644349886|1|0|0|0.963855421686747|0.417099530789704|PLET1|1
2857|positive regulation of protein ubiquitination (GO:0031398)|1/84|0.653137817662293|1|0|0|0.952380952380952|0.405682970373964|ADRB2|1
2858|post-translational protein modification (GO:0043687)|4/358|0.657305634945311|1|0|0|0.893854748603352|0.37506696838669|APLP2;QSOX1;PDIA6;PNPLA2|1
2859|positive regulation of supramolecular fiber organization (GO:1902905)|1/85|0.657491865277335|1|0|0|0.941176470588235|0.394656835019789|CDC42EP3|1
2860|regulation of mitotic nuclear division (GO:0007088)|1/85|0.657491865277335|1|0|0|0.941176470588235|0.394656835019789|HSPA1A|1
2861|cellular response to molecule of bacterial origin (GO:0071219)|1/85|0.657491865277335|1|0|0|0.941176470588235|0.394656835019789|XBP1|1
2862|calcium ion transmembrane transport (GO:0070588)|1/87|0.666037320293862|1|0|0|0.919540229885057|0.373709952675368|MCOLN3|1
2863|mitochondrial translational elongation (GO:0070125)|1/88|0.670230075351781|1|0|0|0.909090909090909|0.363758390451472|MRPS6|1
2864|cellular response to BMP stimulus (GO:0071773)|1/88|0.670230075351781|1|0|0|0.909090909090909|0.363758390451472|TGFB1|1
2865|positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process (GO:2000060)|1/88|0.670230075351781|1|0|0|0.909090909090909|0.363758390451472|UBC|1
2866|positive regulation of cellular component biogenesis (GO:0044089)|1/88|0.670230075351781|1|0|0|0.909090909090909|0.363758390451472|TGFB1|1
2867|divalent metal ion transport (GO:0070838)|1/89|0.674370399806617|1|0|0|0.898876404494382|0.354135518571181|RAMP1|1
2868|regulation of protein targeting to mitochondrion (GO:1903214)|1/89|0.674370399806617|1|0|0|0.898876404494382|0.354135518571181|KCNN3|1
2869|Wnt signaling pathway, planar cell polarity pathway (GO:0060071)|1/89|0.674370399806617|1|0|0|0.898876404494382|0.354135518571181|UBC|1
2870|nervous system development (GO:0007399)|5/456|0.677237710543122|1|0|0|0.87719298245614|0.341871003769566|CAMK2D;TGFB1;PPT1;EVL;NAV2|1
2871|mitochondrial translational termination (GO:0070126)|1/90|0.678458946767901|1|0|0|0.888888888888889|0.344827828805993|MRPS6|1
2872|regulation of establishment of planar polarity (GO:0090175)|1/90|0.678458946767901|1|0|0|0.888888888888889|0.344827828805993|UBC|1
2873|peptidyl-threonine modification (GO:0018210)|1/90|0.678458946767901|1|0|0|0.888888888888889|0.344827828805993|CAMK2D|1
2874|cell-matrix adhesion (GO:0007160)|1/91|0.682496361126594|1|0|0|0.879120879120879|0.335822491094402|CD44|1
2875|protein tetramerization (GO:0051262)|1/91|0.682496361126594|1|0|0|0.879120879120879|0.335822491094402|ANXA2|1
2876|regulation of Ras protein signal transduction (GO:0046578)|1/91|0.682496361126594|1|0|0|0.879120879120879|0.335822491094402|APLP2|1
2877|regulation of JNK cascade (GO:0046328)|1/91|0.682496361126594|1|0|0|0.879120879120879|0.335822491094402|GADD45G|1
2878|regulation of protein catabolic process (GO:0042176)|1/92|0.686483279877292|1|0|0|0.869565217391304|0.327107312761333|FLNA|1
2879|regulation of GTPase activity (GO:0043087)|2/189|0.686641693378062|1|0|0|0.846560846560847|0.318258349540641|NET1;ADRB1|1
2880|nuclear export (GO:0051168)|1/93|0.690420332015386|1|0|0|0.860215053763441|0.318670701100926|TGFB1|1
2881|proteolysis involved in cellular protein catabolic process (GO:0051603)|1/94|0.694308138759287|1|0|0|0.851063829787234|0.310501628119159|UBC|1
2882|cilium organization (GO:0044782)|2/193|0.697661455343341|1|0|0|0.829015544041451|0.29846326622058|UNC119;FLNA|1
2883|positive regulation of GTPase activity (GO:0043547)|2/193|0.697661455343341|1|0|0|0.829015544041451|0.29846326622058|NET1;ADRB1|1
2884|RNA processing (GO:0006396)|2/194|0.70036596112682|1|0|0|0.824742268041237|0.293733838302795|RBM39;SON|1
2885|transmembrane transport (GO:0055085)|4/379|0.700446636544505|1|0|0|0.844327176781003|0.300611795420421|ABCD2;UBC;SGK1;ABCG1|1
2886|transcription elongation from RNA polymerase II promoter (GO:0006368)|1/96|0.701938462699711|1|0|0|0.833333333333333|0.294924615642173|POLR2A|1
2887|regulation of heart contraction (GO:0008016)|1/96|0.701938462699711|1|0|0|0.833333333333333|0.294924615642173|CAMK2D|1
2888|interleukin-1-mediated signaling pathway (GO:0070498)|1/96|0.701938462699711|1|0|0|0.833333333333333|0.294924615642173|UBC|1
2889|DNA repair (GO:0006281)|3/289|0.703302791494789|1|0|0|0.830449826989619|0.2922915708274|BTG2;UBC;NABP1|1
2890|positive regulation of protein metabolic process (GO:0051247)|1/97|0.7056821842291|1|0|0|0.824742268041237|0.287497160267681|TGFB1|1
2891|translational termination (GO:0006415)|1/97|0.7056821842291|1|0|0|0.824742268041237|0.287497160267681|MRPS6|1
2892|protein localization to organelle (GO:0033365)|1/98|0.709379069144318|1|0|0|0.816326530612245|0.280298156808274|DNAJA1|1
2893|phosphatidylinositol biosynthetic process (GO:0006661)|1/99|0.713029701119641|1|0|0|0.808080808080808|0.273318951827204|BMX|1
2894|regulation of insulin secretion (GO:0050796)|1/99|0.713029701119641|1|0|0|0.808080808080808|0.273318951827204|TCF7L2|1
2895|positive regulation of neuron differentiation (GO:0045666)|1/99|0.713029701119641|1|0|0|0.808080808080808|0.273318951827204|S100A9|1
2896|metal ion transport (GO:0030001)|1/102|0.723709807689216|1|0|0|0.784313725490196|0.253619439258265|SGK1|1
2897|regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122)|2/205|0.728811005210683|1|0|0|0.780487804878049|0.246900162104712|UBC;FLNA|1
2898|plasma membrane invagination (GO:0099024)|1/104|0.730608992187572|1|0|0|0.769230769230769|0.241443735959732|MYH9|1
2899|protein import into nucleus (GO:0006606)|1/104|0.730608992187572|1|0|0|0.769230769230769|0.241443735959732|TGFB1|1
2900|B cell receptor signaling pathway (GO:0050853)|1/105|0.733993963448521|1|0|0|0.761904761904762|0.235622456827441|BMX|1
2901|monovalent inorganic cation transport (GO:0015672)|1/105|0.733993963448521|1|0|0|0.761904761904762|0.235622456827441|SGK1|1
2902|positive regulation of lymphocyte activation (GO:0051251)|1/105|0.733993963448521|1|0|0|0.761904761904762|0.235622456827441|SIRPA|1
2903|phagocytosis, engulfment (GO:0006911)|1/105|0.733993963448521|1|0|0|0.761904761904762|0.235622456827441|MYH9|1
2904|translational elongation (GO:0006414)|1/106|0.737336569324243|1|0|0|0.754716981132075|0.229970427352116|MRPS6|1
2905|positive regulation of cellular component organization (GO:0051130)|1/107|0.740637337946884|1|0|0|0.747663551401869|0.224481641843859|TGFB1|1
2906|RNA splicing (GO:0008380)|1/107|0.740637337946884|1|0|0|0.747663551401869|0.224481641843859|TRA2B|1
2907|mitochondrial translation (GO:0032543)|1/108|0.743896790877733|1|0|0|0.740740740740741|0.21915035237804|MRPS6|1
2908|regulation of response to external stimulus (GO:0032101)|1/108|0.743896790877733|1|0|0|0.740740740740741|0.21915035237804|MGLL|1
2909|regulation of Wnt signaling pathway (GO:0030111)|1/110|0.750293803697131|1|0|0|0.727272727272727|0.208938480653338|RUNX1|1
2910|macroautophagy (GO:0016236)|1/111|0.753432374718618|1|0|0|0.720720720720721|0.204047577052273|UBC|1
2911|positive regulation of establishment of protein localization to mitochondrion (GO:1903749)|1/111|0.753432374718618|1|0|0|0.720720720720721|0.204047577052273|KCNN3|1
2912|cellular response to insulin stimulus (GO:0032869)|1/111|0.753432374718618|1|0|0|0.720720720720721|0.204047577052273|XBP1|1
2913|phosphatidylinositol metabolic process (GO:0046488)|1/113|0.759592126512209|1|0|0|0.707964601769911|0.194671621526023|BMX|1
2914|gene expression (GO:0010467)|4/412|0.760127468414331|1|0|0|0.776699029126213|0.213024573334098|RBM39;POLR2A;BAZ1A;MRPS6|1
2915|ion transmembrane transport (GO:0034220)|2/220|0.763893899411503|1|0|0|0.727272727272727|0.195873726963994|UBC;SGK1|1
2916|peptidyl-lysine modification (GO:0018205)|1/116|0.768545537877361|1|0|0|0.689655172413793|0.181555491190138|TOP1|1
2917|axonogenesis (GO:0007409)|2/224|0.772561635734671|1|0|0|0.714285714285714|0.184316775738773|EVL;EZR|1
2918|sensory perception of chemical stimulus (GO:0007606)|3/328|0.780428415132474|1|0|0|0.731707317073171|0.181399214569263|C5AR1;ADCY3;CD36|1
2919|macromolecular complex assembly (GO:0065003)|1/121|0.782735822587987|1|0|0|0.661157024793388|0.161957045455464|ST13|1
2920|Golgi organization (GO:0007030)|1/122|0.785468135859767|1|0|0|0.655737704918033|0.158344516414986|TMED5|1
2921|tumor necrosis factor-mediated signaling pathway (GO:0033209)|1/124|0.790830510990456|1|0|0|0.645161290322581|0.15140103612508|UBC|1
2922|organic anion transport (GO:0015711)|1/125|0.793461421576345|1|0|0|0.64|0.148064229279234|SCP2|1
2923|proteasomal protein catabolic process (GO:0010498)|2/238|0.800751938545735|1|0|0|0.672268907563025|0.149380887114781|ABTB1;UBC|1
2924|vesicle organization (GO:0016050)|1/128|0.801158028013267|1|0|0|0.625|0.138560664354063|ANXA2|1
2925|protein lipidation (GO:0006497)|1/128|0.801158028013267|1|0|0|0.625|0.138560664354063|PLET1|1
2926|positive regulation of mitochondrion organization (GO:0010822)|1/129|0.803659542427367|1|0|0|0.62015503875969|0.135553211893183|KCNN3|1
2927|ubiquitin-dependent protein catabolic process (GO:0006511)|3/342|0.803782177414119|1|0|0|0.701754385964912|0.153282084297462|ABTB1;XBP1;UBC|1
2928|anterograde trans-synaptic signaling (GO:0098916)|2/241|0.806375890052865|1|0|0|0.663900414937759|0.142874874927754|PPT1;UNC119|1
2929|intracellular protein transport (GO:0006886)|3/348|0.813136736613275|1|0|0|0.689655172413793|0.142659307489717|RAB44;TGFB1;TMED5|1
2930|mitochondrial transport (GO:0006839)|1/136|0.820314024104225|1|0|0|0.588235294117647|0.116510621063643|HSP90AA1|1
2931|muscle contraction (GO:0006936)|1/138|0.824808538878067|1|0|0|0.579710144927536|0.111654489082902|MYL12B|1
2932|regulation of signal transduction by p53 class mediator (GO:1901796)|1/139|0.827013626575431|1|0|0|0.575539568345324|0.109314593943936|UBC|1
2933|regulation of vesicle-mediated transport (GO:0060627)|1/139|0.827013626575431|1|0|0|0.575539568345324|0.109314593943936|UNC119|1
2934|inorganic cation transmembrane transport (GO:0098662)|1/141|0.831341210487746|1|0|0|0.567375886524823|0.104802817661888|MCOLN3|1
2935|double-strand break repair (GO:0006302)|1/142|0.833464392930581|1|0|0|0.563380281690141|0.102627773320071|NABP1|1
2936|cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742)|1/143|0.835560952630902|1|0|0|0.559440559440559|0.100504604268321|CD164|1
2937|cellular response to interleukin-1 (GO:0071347)|1/151|0.851414056664768|1|0|0|0.529801324503311|0.0852221010144348|UBC|1
2938|chemical synaptic transmission (GO:0007268)|2/290|0.88016777777598|1|0|0|0.551724137931034|0.0704235768931992|PPT1;UNC119|1
2939|regulation of nucleic acid-templated transcription (GO:1903506)|5/608|0.880447065008814|1|0|0|0.657894736842105|0.0837667579562673|TCF7L2;POLR2A;BAZ1A;ABCG1;ATF4|1
2940|proteolysis (GO:0006508)|2/292|0.882543769287769|1|0|0|0.547945205479452|0.0684640517687242|CAPN1;AMZ1|1
2941|peptide biosynthetic process (GO:0043043)|1/175|0.890405376580572|1|0|0|0.457142857142857|0.053064430011954|MRPS6|1
2942|ER to Golgi vesicle-mediated transport (GO:0006888)|1/181|0.898441310851709|1|0|0|0.441988950276243|0.0473343177554569|TMED5|1
2943|regulation of cellular macromolecule biosynthetic process (GO:2000112)|5/632|0.899674526691344|1|0|0|0.632911392405063|0.0669127962492891|TCF7L2;POLR2A;BAZ1A;ABCG1;ATF4|1
2944|protein homooligomerization (GO:0051260)|1/191|0.910551193829734|1|0|0|0.418848167539267|0.0392482326001213|MGST1|1
2945|cellular response to tumor necrosis factor (GO:0071356)|1/195|0.914982224176982|1|0|0|0.41025641025641|0.036451545035613|UBC|1
2946|viral process (GO:0016032)|1/221|0.938908623512109|1|0|0|0.361990950226244|0.0228188659050544|UBC|1
2947|translation (GO:0006412)|1/233|0.947558883950596|1|0|0|0.343347639484979|0.0184948316933469|MRPS6|1
2948|organelle assembly (GO:0070925)|2/377|0.951131726295712|1|0|0|0.424403183023873|0.0212637506944688|UNC119;FLNA|1
2949|sensory perception of smell (GO:0007608)|1/242|0.95323567633422|1|0|0|0.330578512396694|0.0158324318991987|ADCY3|1
2950|protein modification by small protein conjugation (GO:0032446)|2/399|0.96132752811056|1|0|0|0.401002506265664|0.0158155821488061|UBC;TOP1|1
2951|Golgi vesicle transport (GO:0048193)|1/272|0.968092361622165|1|0|0|0.294117647058823|0.00953758275245337|TMED5|1
2952|protein polyubiquitination (GO:0000209)|1/284|0.97262104586138|1|0|0|0.28169014084507|0.00781992746001861|UBC|1
2953|protein ubiquitination (GO:0016567)|2/507|0.988126478354531|1|0|0|0.315581854043393|0.00376949109224521|ABTB1;UBC|1
2954|DNA metabolic process (GO:0006259)|33/315|3.32445820789305e-18|1.69647102348783e-14|0|0|6.80272108843537|273.777040530997|TOP2A;DNMT1;SET;PCNA;MCM7;UHRF1;HMGB2;PARK7;HMGB1;TYMS;RAD51AP1;RAD21;PCLAF;TK1;CLSPN;TOPBP1;KPNA2;HELLS;TIPIN;DUT;LIG1;RFC2;RPA2;NAP1L1;DBF4;NASP;POLE3;CDK1;MCM3;MCM5;MCM6;DCTPP1;RAN|2
2955|G1/S transition of mitotic cell cycle (GO:0000082)|20/106|1.7896491009583e-16|4.56628968109511e-13|0|0|12.2518990443519|444.245796621579|CDKN2D;RANBP1;PCNA;CDKN2C;RRM2;MCM7;RPA2;TYMS;DHFR;TFDP1;DBF4;CCNE2;NASP;CDK4;POLE3;MCM3;MCM5;FBXO5;MCM6;CDKN3|2
2956|mitotic cell cycle phase transition (GO:0044772)|26/222|9.55847327880669e-16|1.62589630472502e-12|0|0|7.6050076050076|263.011077069168|MCM7;ARPP19;AURKA;CCNB2;CCNB1;PLK4;CDKN2D;RANBP1;CDKN2C;UBE2C;PLK1;RPA2;TUBB4B;CCNA2;DBF4;CCNE2;NASP;UBE2S;CDK4;POLE3;TACC3;CDK1;MCM3;MCM5;MCM6;CDKN3|2
2957|anaphase-promoting complex-dependent catabolic process (GO:0031145)|17/80|4.19534955482941e-15|5.35221719457361e-12|0|0|13.7987012987013|456.803243054151|UBE2C;PLK1;BUB1B;AURKB;AURKA;ANAPC11;CDC20;PSMB6;PSMB7;CCNB1;PSMA4;PSMC3;UBE2S;CDK1;ANAPC5;BUB3;MAD2L1|2
2958|regulation of mitotic cell cycle phase transition (GO:1901990)|23/185|1.2447159249632e-14|1.27035707301744e-11|0|0|8.07300807300807|258.475791971702|PLK4;UBE2C;PLK1;BUB1B;HMMR;TUBB4B;ANAPC11;AURKA;CDC20;PSMB6;TPX2;ANLN;PSMB7;CENPE;CCNB1;CENPF;PSMA4;PSMC3;CDK1;ANAPC5;FBXO5;BUB3;MAD2L1|2
2959|cellular macromolecule biosynthetic process (GO:0034645)|30/368|1.05428304080199e-13|8.9666772620209e-11|0|0|5.29361942405421|158.177293488107|RPL3;SET;MCM7;MRPL18;TYMS;MRPL13;PCLAF;RPL14;RPS2;CLSPN;TOPBP1;TIPIN;DUT;RFC2;RPS6;MRPL28;RPA2;RPSA;NAP1L1;EEF1G;MRPL51;DBF4;NASP;POLE3;NHP2;CDK1;MCM3;MCM5;MCM6;PTMA|2
2960|mitotic sister chromatid segregation (GO:0000070)|16/83|1.38444689056999e-13|1.00926178322552e-10|0|0|12.5176028790487|370.625010246118|PLK1;CDCA8;KIF23;KIF22;SMC4;KNSTRN;NCAPH;SMC2;CENPE;CCNB1;KIFC1;PRC1;NUSAP1;KIF2C;NCAPD2;RAN|2
2961|positive regulation of ubiquitin protein ligase activity (GO:1904668)|16/83|1.38444689056999e-13|8.83104060322331e-11|0|0|12.5176028790487|370.625010246118|UBE2C;PLK1;BUB1B;ANAPC11;CDC20;PSMB6;PSMB7;CCNB1;PSMA4;PSMC3;UBE2S;CDK1;ANAPC5;FBXO5;BUB3;MAD2L1|2
2962|centromere complex assembly (GO:0034508)|12/37|1.88642571806695e-13|1.06960338214396e-10|0|0|21.0600210600211|617.035921196279|HELLS;CENPE;CENPF;CENPW;RBBP4;NASP;MIS18BP1;HJURP;CENPM;RBBP7;KNL1;CENPA|2
2963|regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439)|15/73|3.01026995280697e-13|1.5361407569174e-10|0|0|13.3428215619996|384.694579908362|UBE2C;PLK1;BUB1B;ANAPC11;CDC20;PSMB6;PSMB7;CCNB1;PSMA4;PSMC3;CDK1;ANAPC5;FBXO5;BUB3;MAD2L1|2
2964|positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition (GO:0051437)|15/77|6.90971230193989e-13|3.20547835243629e-10|0|0|12.6496879743633|354.199842389613|UBE2C;PLK1;BUB1B;ANAPC11;CDC20;PSMB6;PSMB7;CCNB1;PSMA4;PSMC3;CDK1;ANAPC5;FBXO5;BUB3;MAD2L1|2
2965|negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436)|14/72|4.20966529911498e-12|1.79016016844865e-09|0|0|12.6262626262626|330.727752181724|UBE2C;BUB1B;ANAPC11;CDC20;PSMB6;PSMB7;CCNB1;PSMA4;PSMC3;CDK1;ANAPC5;FBXO5;BUB3;MAD2L1|2
2966|DNA replication (GO:0006260)|17/121|5.17757425216413e-12|2.03239703144566e-09|0|0|9.12310829666202|237.079336603666|TIPIN;DUT;SET;MCM7;RFC2;RPA2;NAP1L1;DBF4;NASP;POLE3;PCLAF;CDK1;MCM3;MCM5;CLSPN;TOPBP1;MCM6|2
2967|positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process (GO:2000060)|15/88|5.3379947605597e-12|1.94569909022401e-09|0|0|11.0684769775679|287.29528165381|UBE2C;PLK1;BUB1B;ANAPC11;CDC20;PSMB6;PSMB7;CCNB1;PSMA4;PSMC3;CDK1;ANAPC5;FBXO5;BUB3;MAD2L1|2
2968|histone exchange (GO:0043486)|11/37|5.78824963905338e-12|1.96916252720596e-09|0|0|19.3050193050193|499.521065205365|CENPW;RBBP4;NASP;MIS18BP1;HJURP;ANP32E;CENPM;RBBP7;KNL1;ANP32B;CENPA|2
2969|mitotic spindle organization (GO:0007052)|14/75|7.5778213619783e-12|2.41685140063595e-09|0|0|12.1212121212121|310.373277295166|KIF23;KIF11;AURKB;AURKA;CENPE;TPX2;CCNB1;KIFC1;PRC1;NUF2;STMN1;BIRC5;RAN;SPC25|2
2970|cell cycle G1/S phase transition (GO:0044843)|15/93|1.22634198724396e-11|3.68119009465053e-09|0|0|10.4733975701718|263.13783283168|CDKN2D;RANBP1;CDKN2C;MCM7;RPA2;CCNA2;DBF4;CCNE2;NASP;CDK4;POLE3;MCM3;MCM5;MCM6;CDKN3|2
2971|negative regulation of ubiquitin protein ligase activity (GO:1904667)|14/78|1.32753476012616e-11|3.76356104495765e-09|0|0|11.6550116550117|291.901076509218|UBE2C;BUB1B;ANAPC11;CDC20;PSMB6;PSMB7;CCNB1;PSMA4;PSMC3;CDK1;ANAPC5;FBXO5;BUB3;MAD2L1|2
2972|DNA replication-independent nucleosome assembly (GO:0006336)|11/40|1.50211828873083e-11|4.03437348810181e-09|0|0|17.8571428571429|445.027852116878|CENPW;RBBP4;NASP;MIS18BP1;HAT1;HJURP;CENPM;RBBP7;KNL1;CENPA;ASF1B|2
2973|RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)|22/237|1.83507844976865e-11|4.68220266458471e-09|0|0|6.02772754671489|149.013555095987|HNRNPA3;ALYREF;HNRNPU;U2AF1;LSM5;LSM4;LSM3;LSM2;NUDT21;LSM6;SNRPD2;SNRPD1;HNRNPA2B1;SNRPG;SRSF2;SRSF3;SNRPE;RALY;SNRPF;SNRNP25;HNRNPA1;SRSF7|2
2974|chromatin remodeling at centromere (GO:0031055)|10/33|4.38721791868043e-11|1.06609395423934e-08|0|0|19.6772924045651|469.298322082802|HELLS;CENPW;RBBP4;NASP;MIS18BP1;HJURP;CENPM;RBBP7;KNL1;CENPA|2
2975|microtubule cytoskeleton organization involved in mitosis (GO:1902850)|11/45|6.15928258628601e-11|1.42867359262807e-08|0|0|15.8730158730159|373.182154213281|CENPE;CCNB1;NUF2;STMN1;NUSAP1;TACC3;KIF11;AURKB;RAN;AURKA;SPC25|2
2976|mRNA processing (GO:0006397)|23/284|1.0095273308803e-10|2.23983389977485e-08|0|0|5.25882568136089|121.039070799955|HNRNPA3;ALYREF;HNRNPU;U2AF1;LSM5;LSM4;THOC7;LSM3;LSM2;NUDT21;LSM6;SNRPD2;SNRPD1;HNRNPA2B1;SNRPG;SRSF2;SRSF3;SNRPE;RALY;SNRPF;SNRNP25;HNRNPA1;SRSF7|2
2977|mRNA splicing, via spliceosome (GO:0000398)|22/262|1.30140830264029e-10|2.76711940348892e-08|0|0|5.4525627044711|124.113434798834|HNRNPA3;ALYREF;HNRNPU;U2AF1;LSM5;LSM4;LSM3;LSM2;NUDT21;LSM6;SNRPD2;SNRPD1;HNRNPA2B1;SNRPG;SRSF2;SRSF3;SNRPE;RALY;SNRPF;SNRNP25;HNRNPA1;SRSF7|2
2978|regulation of ubiquitin protein ligase activity (GO:1904666)|10/37|1.56351618049199e-10|3.19144922762024e-08|0|0|17.5500175500176|396.260331400257|CDC20;CCNB1;UBE2C;UBE2S;PLK1;CDK1;ANAPC5;FBXO5;ANAPC11;MAD2L1|2
2979|RNA export from nucleus (GO:0006405)|15/120|5.11338680846884e-10|1.00360049552371e-07|0|0|8.11688311688312|173.652507830719|EIF5A;NDC1;SLBP;RANBP1;NXT1;ALYREF;RPSA;U2AF1;THOC7;HNRNPA2B1;SRSF2;SRSF3;HNRNPA1;SRSF7;RAN|2
2980|CENP-A containing nucleosome assembly (GO:0034080)|9/31|6.49043320179295e-10|1.22669187513887e-07|0|0|18.8521156263092|398.82634032464|CENPW;RBBP4;NASP;MIS18BP1;HJURP;CENPM;RBBP7;KNL1;CENPA|2
2981|CENP-A containing chromatin organization (GO:0061641)|9/31|6.49043320179295e-10|1.18288145102676e-07|0|0|18.8521156263092|398.82634032464|CENPW;RBBP4;NASP;MIS18BP1;HJURP;CENPM;RBBP7;KNL1;CENPA|2
2982|cytoskeleton-dependent cytokinesis (GO:0061640)|12/71|8.17279968275195e-10|1.43813092348563e-07|0|0|10.9749405524053|229.651063486468|ANLN;RACGAP1;INCENP;STMN1;PLK1;NUSAP1;CKAP2;KIF23;KIF20A;CENPA;AURKB;CIT|2
2983|mitotic nuclear division (GO:0140014)|12/75|1.5785580435843e-09|2.68512723213689e-07|0|0|10.3896103896104|210.563678309104|TPX2;KIFC1;UBE2C;UBE2S;PLK1;NUSAP1;BIRC5;CDCA8;KIF11;SMC4;KNSTRN;RAN|2
2984|mitotic cytokinesis (GO:0000281)|11/60|1.69374267175656e-09|2.78811898515282e-07|0|0|11.9047619047619|240.432442356525|ANLN;RACGAP1;INCENP;STMN1;PLK1;NUSAP1;CKAP2;KIF23;KIF20A;CENPA;CIT|2
2985|nucleocytoplasmic transport (GO:0006913)|10/47|2.02851673460366e-09|3.23485028021328e-07|0|0|13.8159712627798|276.539941745967|EIF5A;SET;NXT1;SNRPD2;SNRPD1;ANP32E;SNRPG;SNRPE;SNRPF;HNRNPA1|2
2986|negative regulation of cell cycle process (GO:0010948)|12/82|4.54765673447665e-09|7.03233100485889e-07|0|0|9.5026924295217|182.533928476925|TFDP1;CBX5;RRM2;RBBP4;CBX3;CDK4;FBXO5;MIF;RBBP7;SMC3;AURKB;EZH2|2
2987|gene expression (GO:0010467)|25/412|6.34585401606937e-09|9.52438030705941e-07|0|0|3.94023452275879|74.373755469582|SLBP;RPL3;NXT1;MRPL18;HNRNPU;U2AF1;MRPL13;RBM3;RPL14;RPS2;NDC1;EIF5A;ALYREF;RPS6;MRPL28;RPSA;THOC7;MRPL51;HNRNPA2B1;SNRPG;NHP2;SRSF2;SRSF3;PTMA;SRSF7|2
2988|termination of RNA polymerase II transcription (GO:0006369)|11/69|7.97045061143366e-09|1.16209169914703e-06|0|0|10.351966873706|193.03855908172|SLBP;NUDT21;ALYREF;SNRPG;SRSF2;SRSF3;SNRPE;U2AF1;SNRPF;SRSF7;THOC7|2
2989|sister chromatid segregation (GO:0000819)|8/33|2.86979199388768e-08|4.06793015133579e-06|0|0|15.7418339236521|273.379633102002|TOP2A;KIFC1;PLK1;NUSAP1;CDCA8;SMC4;KNSTRN;RAN|2
2990|nucleosome assembly (GO:0006334)|10/61|2.92034704684985e-08|4.02771107569589e-06|0|0|10.6450926123057|184.681480552199|H2AFY;RBBP4;NASP;H2AFX;HAT1;HMGB2;ANP32E;ANP32B;CENPA;ASF1B|2
2991|RNA transport (GO:0050658)|11/81|4.49736962623202e-08|6.03949400070052e-06|0|0|8.81834215167548|149.181552430184|SLBP;RANBP1;NXT1;ALYREF;HNRNPA2B1;SRSF2;SRSF3;U2AF1;HNRNPA1;SRSF7;THOC7|2
2992|RNA processing (GO:0006396)|16/194|5.87451739552269e-08|7.68658006906469e-06|0|0|5.35546927299505|89.1688677613561|HNRNPU;U2AF1;LSM5;LSM4;LSM3;RBM3;NUDT21;LSM6;SNRPD2;SNRPD1;HNRNPA2B1;SNRPG;SRSF2;SNRPF;SNRNP25;SRSF7|2
2993|regulation of G2/M transition of mitotic cell cycle (GO:0010389)|14/150|8.60366310755355e-08|1.09761232094614e-05|0|0|6.06060606060606|98.596925385709|PLK4;PLK1;HMMR;TUBB4B;AURKA;PSMB6;TPX2;PSMB7;CCNB1;CENPF;PSMA4;PSMC3;CDK4;CDK1|2
2994|protein sumoylation (GO:0016925)|10/69|9.87769712202396e-08|1.22941191252898e-05|0|0|9.41087897609637|151.801254885907|TOP2A;NDC1;PCNA;INCENP;SUMO2;BIRC5;CDCA8;RANGAP1;SAE1;AURKB|2
2995|regulation of cell cycle process (GO:0010564)|11/91|1.53147630048774e-07|1.86074370509261e-05|0|0|7.84929356357928|123.170043002303|TIPIN;RACGAP1;PRC1;PLK1;FBXO5;KIF20A;MKI67;KIF20B;KNSTRN;AURKB;AURKA|2
2996|nuclear export (GO:0051168)|11/93|1.91967971449909e-07|2.27816874025322e-05|0|0|7.68049155145929|118.786000723494|EIF5A;RANBP1;NXT1;ALYREF;SRSF2;SRSF3;U2AF1;HNRNPA1;SRSF7;THOC7;RAN|2
2997|mRNA metabolic process (GO:0016071)|11/98|3.29555557549451e-07|3.82209547767011e-05|0|0|7.28862973760933|108.786595375616|SLBP;NUDT21;HNRNPA2B1;SNRPG;SRSF2;SNRPE;U2AF1;SNRPF;LSM5;SRSF7;LSM3|2
2998|mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427)|11/101|4.48744192301633e-07|5.08875914070052e-05|0|0|7.07213578500707|103.372085142673|EIF5A;NDC1;SLBP;NXT1;ALYREF;HNRNPA2B1;SRSF2;SRSF3;U2AF1;SRSF7;THOC7|2
2999|kinetochore organization (GO:0051383)|5/12|6.07765830308608e-07|6.74223702622789e-05|0|0|27.0562770562771|387.269377074874|CENPE;CENPF;CENPW;NUF2;CENPA|2
3000|mRNA transport (GO:0051028)|11/105|6.66084986875395e-07|7.2319823149471e-05|0|0|6.80272108843537|96.7472691607225|EIF5A;NDC1;SLBP;NXT1;ALYREF;HNRNPA2B1;SRSF2;SRSF3;U2AF1;SRSF7;THOC7|2
3001|regulation of mitotic nuclear division (GO:0007088)|10/85|7.31561784210374e-07|7.77741621838654e-05|0|0|7.63941940412529|107.930360257457|ANLN;PLK1;NUSAP1;HNRNPU;KIF11;FBXO5;MKI67;SMC3;KIF20B;AURKA|2
3002|mRNA export from nucleus (GO:0006406)|11/106|7.3314627367469e-07|7.63519476441213e-05|0|0|6.73854447439353|95.1881442059272|EIF5A;NDC1;SLBP;NXT1;ALYREF;HNRNPA2B1;SRSF2;SRSF3;U2AF1;SRSF7;THOC7|2
3003|DNA-templated transcription, termination (GO:0006353)|11/107|8.06087743164477e-07|8.22693150673666e-05|0|0|6.67556742323097|93.6653754197458|SLBP;NUDT21;ALYREF;SNRPG;SRSF2;SRSF3;SNRPE;U2AF1;SNRPF;SRSF7;THOC7|2
3004|chromosome condensation (GO:0030261)|6/23|1.02848043049926e-06|0.000102908541898779|0|0|16.9395821569735|233.553271969383|TOP2A;NUSAP1;NCAPD2;SMC4;NCAPH;SMC2|2
3005|nuclear import (GO:0051170)|9/72|1.57591133511343e-06|0.000154651452751612|0|0|8.11688311688312|108.447052171729|RANBP1;NXT1;SNRPD2;SNRPD1;SNRPG;SNRPE;SNRPF;HNRNPA1;RAN|2
3006|negative regulation of G0 to G1 transition (GO:0070317)|7/38|1.60783681919111e-06|0.000154807382798722|0|0|11.9617224880383|159.576804700473|RRM2;CBX5;TFDP1;RBBP4;CBX3;RBBP7;EZH2|2
3007|peptidyl-lysine modification (GO:0018205)|11/116|1.80893180164348e-06|0.000170944055255309|0|0|6.1576354679803|81.4210224860851|TOP2A;NDC1;PCNA;INCENP;SUMO2;CDCA8;BIRC5;PARK7;SAE1;RANGAP1;AURKB|2
3008|regulation of mitotic cell cycle (GO:0007346)|13/166|1.8659609273827e-06|0.000173127247498799|0|0|5.08527616961352|67.0836125547438|PLK1;HNRNPU;MKI67;CKS1B;TPX2;CCNB1;CDK1;CKS2;TACC3;BIRC5;FBXO5;KIF20B;MAD2L1|2
3009|regulation of mitotic metaphase/anaphase transition (GO:0030071)|5/15|2.21849950649565e-06|0.000202160767529416|0|0|21.6450216450216|281.789599319849|CENPE;UBE2C;PLK1;ANAPC5;ANAPC11|2
3010|protein localization to chromosome, centromeric region (GO:0071459)|5/15|2.21849950649565e-06|0.000198614087397321|0|0|21.6450216450216|281.789599319849|CDK1;BUB1B;KNL1;CENPA;AURKB|2
3011|mitotic chromosome condensation (GO:0007076)|5/15|2.21849950649565e-06|0.000195189706580126|0|0|21.6450216450216|281.789599319849|NUSAP1;NCAPD2;SMC4;NCAPH;SMC2|2
3012|glycolytic process through glucose-6-phosphate (GO:0061620)|6/26|2.25612476369043e-06|0.000195135672357835|0|0|14.985014985015|194.833095746304|TPI1;PKM;PGAM1;PGK1;ENO1;GAPDH|2
3013|canonical glycolysis (GO:0061621)|6/26|2.25612476369043e-06|0.000191883411151871|0|0|14.985014985015|194.833095746304|TPI1;PKM;PGAM1;PGK1;ENO1;GAPDH|2
3014|glucose catabolic process to pyruvate (GO:0061718)|6/26|2.25612476369043e-06|0.000188737781460857|0|0|14.985014985015|194.833095746304|TPI1;PKM;PGAM1;PGK1;ENO1;GAPDH|2
3015|regulation of G0 to G1 transition (GO:0070316)|7/40|2.31339902028207e-06|0.000190407664524184|0|0|11.3636363636364|147.463553154343|RRM2;CBX5;TFDP1;RBBP4;CBX3;RBBP7;EZH2|2
3016|positive regulation of mitotic cell cycle phase transition (GO:1901992)|7/41|2.75315703262907e-06|0.000223005719642955|0|0|11.0864745011086|141.937497703796|CCNB1;UBE2C;CDK4;CDK1;ANAPC5;AIF1;ANAPC11|2
3017|regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083)|6/27|2.86336272925305e-06|0.000228308437615286|0|0|14.4300144300144|184.177688951814|DHFR;PCNA;RRM2;TFDP1;FBXO5;TYMS|2
3018|regulation of cytokinesis (GO:0032465)|9/78|3.11462112692479e-06|0.00024452171708765|0|0|7.49250749250749|95.0005222905928|RACGAP1;PRC1;PLK1;KIF23;KIF20A;KIF20B;AURKB;CIT;AURKA|2
3019|proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161)|17/292|3.13565783080852e-06|0.000242443362282059|0|0|3.78046610923323|47.90860538951|UBE2C;PLK1;BUB1B;AURKB;ANAPC11;AURKA;CDC20;PSMB6;PSMB7;CCNB1;PSMA4;PSMC3;UBE2S;CDK1;ANAPC5;BUB3;MAD2L1|2
3020|kinetochore assembly (GO:0051382)|4/8|3.67741969637925e-06|0.000280087652397363|0|0|32.4675324675325|406.275948739606|CENPE;CENPF;CENPW;CENPA|2
3021|mitotic metaphase plate congression (GO:0007080)|7/44|4.51088633590731e-06|0.000338515484884338|0|0|10.3305785123967|127.159265464358|CENPE;CCNB1;KIFC1;NUF2;CDCA8;KIF2C;KIF22|2
3022|metaphase plate congression (GO:0051310)|7/45|5.27194035708209e-06|0.000389894371625941|0|0|10.1010101010101|122.758707817943|CENPE;CCNB1;CENPF;KIFC1;CDCA8;KIF2C;KIF22|2
3023|regulation of chromosome segregation (GO:0051983)|6/30|5.52466814640889e-06|0.000402748307873208|0|0|12.987012987013|157.224511381335|RACGAP1;KIF2C;SMC6;MKI67;KNSTRN;AURKB|2
3024|DNA ligation (GO:0006266)|5/18|6.09383781951066e-06|0.000437983864689618|0|0|18.037518037518|216.598710153269|TOP2A;PCNA;LIG1;HMGB2;HMGB1|2
3025|RNA splicing (GO:0008380)|10/107|6.0971756487921e-06|0.00043213732410814|0|0|6.0686976574827|72.8710092389928|LSM6;SNRPD2;SNRPD1;SNRPG;SRSF2;U2AF1;SNRPF;SNRNP25;SRSF7;LSM4|2
3026|regulation of cell cycle G2/M phase transition (GO:1902749)|9/85|6.40019525469697e-06|0.000447399950475597|0|0|6.87547746371276|82.2250867346513|PLK4;TPX2;CENPF;H2AFY;PLK1;CDK1;HMMR;TUBB4B;AURKA|2
3027|positive regulation of cell cycle process (GO:0090068)|10/108|6.6289989064646e-06|0.000457132181347146|0|0|6.01250601250601|71.6934629609631|CCNB1;RACGAP1;RAD21;NUSAP1;KIF23;KIF20B;AURKB;CIT;AURKA;MAD2L1|2
3028|regulation of cell cycle (GO:0051726)|14/216|6.95168020327141e-06|0.000472992321030587|0|0|4.20875420875421|49.985383719442|PLK1;GMNN;HNRNPU;CKS1B;CCNB2;CENPF;CCNB1;RBBP4;CDK4;PCLAF;CKS2;CDK1;BIRC5;FBXO5|2
3029|mitotic spindle assembly (GO:0090307)|7/47|7.11646212009976e-06|0.000477832976300909|0|0|9.67117988394584|114.633460824731|TPX2;RACGAP1;KIFC1;BIRC5;KIF23;KIF11;AURKB|2
3030|regulation of DNA metabolic process (GO:0051052)|7/47|7.11646212009976e-06|0.000471627353232066|0|0|9.67117988394584|114.633460824731|UHRF1;ALYREF;USP1;NUCKS1;ESCO2;SMC3;KPNA2|2
3031|positive regulation of ubiquitin-protein transferase activity (GO:0051443)|6/32|8.21588030941063e-06|0.000537508169473365|0|0|12.1753246753247|142.566253897307|CDC20;UBE2C;UBE2S;PLK1;FBXO5;RPS2|2
3032|nucleobase-containing small molecule interconversion (GO:0015949)|6/32|8.21588030941063e-06|0.000530704268593955|0|0|12.1753246753247|142.566253897307|DTYMK;DUT;RRM1;RRM2;GLRX;TYMS|2
3033|DNA replication-dependent nucleosome assembly (GO:0006335)|4/10|1.07662277445931e-05|0.000686750752258235|0|0|25.974025974026|297.119386597164|RBBP4;NASP;HAT1;ASF1B|2
3034|DNA replication-dependent nucleosome organization (GO:0034723)|4/10|1.07662277445931e-05|0.000678272347909368|0|0|25.974025974026|297.119386597164|RBBP4;NASP;HAT1;ASF1B|2
3035|mitotic spindle elongation (GO:0000022)|4/11|1.67132529753779e-05|0.00104009426747992|0|0|23.6127508854782|259.723932985329|RACGAP1;PRC1;KIF23;AURKB|2
3036|nuclear transport (GO:0051169)|5/22|1.78058365981162e-05|0.00109473715855647|0|0|14.7579693034238|161.392919947502|EIF5A;SET;NXT1;ANP32E;BANF1|2
3037|mRNA 3'-end processing (GO:0031124)|8/75|1.99101721775287e-05|0.00120954295978487|0|0|6.92640692640693|74.9733665256039|SLBP;NUDT21;ALYREF;SRSF2;SRSF3;U2AF1;SRSF7;THOC7|2
3038|antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886)|9/98|2.05423385428547e-05|0.00123326533628456|0|0|5.96342433077127|64.3633730198268|CD74;CENPE;RACGAP1;AP2S1;KIF23;KIF2C;KIF11;KIF22;KIF15|2
3039|antigen processing and presentation of exogenous peptide antigen (GO:0002478)|9/98|2.05423385428547e-05|0.0012189250416766|0|0|5.96342433077127|64.3633730198268|CD74;CENPE;RACGAP1;AP2S1;KIF23;KIF2C;KIF11;KIF22;KIF15|2
3040|antigen processing and presentation of peptide antigen via MHC class II (GO:0002495)|9/99|2.22953155092429e-05|0.00130773557521456|0|0|5.90318772136954|63.2298345242941|CD74;CENPE;RACGAP1;AP2S1;KIF23;KIF2C;KIF11;KIF22;KIF15|2
3041|glycolytic process (GO:0006096)|5/23|2.24662563565376e-05|0.00130278757031149|0|0|14.1163184641446|151.093959513594|LDHA;TPI1;PKM;PGAM1;PGK1|2
3042|spliceosomal snRNP assembly (GO:0000387)|6/38|2.31596452989535e-05|0.00132790640405123|0|0|10.2529049897471|109.430272255166|SNRPD2;SNRPD1;SNRPG;SNRPE;SNRPF;LSM4|2
3043|protein localization to kinetochore (GO:0034501)|4/12|2.47660823760485e-05|0.00140423687072195|0|0|21.6450216450216|229.567867684025|CDK1;BUB1B;KNL1;AURKB|2
3044|nucleosome organization (GO:0034728)|8/80|3.20086398567732e-05|0.0017949460350452|0|0|6.49350649350649|67.2045759485884|SET;H2AFY;NASP;H2AFX;HMGB2;ANP32E;ANP32B;CENPA|2
3045|ATP generation from ADP (GO:0006757)|5/25|3.45883482934433e-05|0.00191852544936349|0|0|12.987012987013|133.402515417401|LDHA;TPI1;PKM;PGAM1;PGK1|2
3046|nucleic acid metabolic process (GO:0090304)|8/81|3.50474714829259e-05|0.00192308867717603|0|0|6.41333974667308|65.7932152469029|HNRNPA3;HNRNPA2B1;HNRNPU;TOPBP1;TK1;KPNA2;HNRNPA1;RAN|2
3047|DNA replication-independent nucleosome organization (GO:0034724)|4/13|3.53399213460467e-05|0.00191850658115826|0|0|19.98001998002|204.805141193018|NASP;RBBP4;HAT1;ASF1B|2
3048|establishment of chromosome localization (GO:0051303)|4/13|3.53399213460467e-05|0.0018983117750408|0|0|19.98001998002|204.805141193018|CENPE;CENPF;KIF2C;KIF22|2
3049|positive regulation of mitotic nuclear division (GO:0045840)|6/41|3.62860161021833e-05|0.00192882854343168|0|0|9.5026924295217|97.1562697712284|RANBP1;H2AFY;UBE2C;NUSAP1;HNRNPU;AURKA|2
3050|viral process (GO:0016032)|13/221|4.09623421369207e-05|0.00215495703015161|0|0|3.81970970206264|38.5899824208962|NDC1;RANBP1;RPL3;RPS6;NUCKS1;RPSA;DEK;AP2S1;RPL14;CCL2;RPS2;PPIA;RAN|2
3051|negative regulation of gene expression, epigenetic (GO:0045814)|5/26|4.22865608965925e-05|0.00220192163525828|0|0|12.4875124875125|125.762253143016|DNMT1;RBBP4;H2AFY;RBBP7;EZH2|2
3052|DNA repair (GO:0006281)|15/289|4.55033872979768e-05|0.00234549278163208|0|0|3.37033209005527|33.69564931246|CDKN2D;PCNA;LIG1;RFC2;H2AFX;HMGB2;RPA2;NUCKS1;PARK7;HMGB1;RAD51AP1;RAD21;USP1;CDK1;TOPBP1|2
3053|RNA 3'-end processing (GO:0031123)|7/62|4.56894160275889e-05|0.00233153089988786|0|0|7.33137829912023|73.2671838977806|NUDT21;ALYREF;SRSF2;SRSF3;U2AF1;SRSF7;THOC7|2
3054|protein modification by small protein conjugation (GO:0032446)|18/399|5.12759236169027e-05|0.00259070334868371|0|0|2.92940142564203|28.9374745859633|TOP2A;NDC1;UBL4A;PCNA;UBE2C;UHRF1;PLK1;CDCA8;COMMD1;RANGAP1;AURKB;ANAPC11;INCENP;UBE2S;SUMO2;BIRC5;ELOB;SAE1|2
3055|mitotic nuclear envelope disassembly (GO:0007077)|6/45|6.24217962499088e-05|0.00312292574767926|0|0|8.65800865800866|83.8233423783792|NDC1;CCNB2;CCNB1;PLK1;CDK1;BANF1|2
3056|regulation of mitotic sister chromatid separation (GO:0010965)|4/15|6.58437096285196e-05|0.00326214029353724|0|0|17.3160173160173|166.722539568843|CENPE;UBE2C;PLK1;TACC3|2
3057|chromatin assembly (GO:0031497)|7/66|6.86523400055377e-05|0.00336858549084864|0|0|6.8870523415978|66.0224196990865|H2AFY;RBBP4;H2AFX;HMGB2;ANP32E;ANP32B;CENPA|2
3058|pyrimidine deoxyribonucleotide biosynthetic process (GO:0009221)|3/6|6.9890409957472e-05|0.00339667392393314|0|0|32.4675324675325|310.668250478556|DTYMK;DUT;TYMS|2
3059|nuclear envelope disassembly (GO:0051081)|6/47|8.01936578023147e-05|0.00386064373363407|0|0|8.28958275766786|78.1796031444356|NDC1;CCNB2;CCNB1;PLK1;CDK1;BANF1|2
3060|regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079)|7/68|8.32467483429219e-05|0.0039701696896629|0|0|6.68449197860962|62.7921222514066|CDKN2D;CDKN2C;CCNE2;PLK1;CKS2;CKS1B;CDKN3|2
3061|chromatin remodeling (GO:0006338)|9/117|8.35672179769137e-05|0.00394855104940917|0|0|4.995004995005|46.9023938273688|ELOF1;RBBP4;CBX3;ANP32E;HMGB2;ANP32B;HMGB1;DEK;SSRP1|2
3062|protein localization to chromatin (GO:0071168)|4/16|8.67296871279967e-05|0.00406038159095566|0|0|16.2337662337662|151.829777933438|H2AFY;RAD21;PLK1;HIST1H1B|2
3063|negative regulation of gene expression (GO:0010629)|23/619|9.73186161022123e-05|0.00451469907245081|0|0|2.4127730105113|22.2880395679245|MSR1;DNMT1;SET;CBX5;H2AFY;CBX3;GMNN;HMGB2;ENO1;MIF;PA2G4;PARK7;TYMS;AES;DHFR;CENPF;YWHAQ;RBBP4;NCL;BIRC5;RBBP7;GAPDH;EZH2|2
3064|negative regulation of cell cycle G2/M phase transition (GO:1902750)|7/70|0.000100275795656092|0.00460997644354089|0|0|6.49350649350649|59.7895208545406|PSMB6;PSMB7;PSMA4;H2AFY;PSMC3;PLK1;AURKA|2
3065|spindle assembly checkpoint (GO:0071173)|4/17|0.000112044516148433|0.00510502826701297|0|0|15.2788388082506|138.985703590935|CENPF;PLK1;BUB1B;BUB3|2
3066|mitotic spindle assembly checkpoint (GO:0007094)|4/17|0.000112044516148433|0.00505985102571197|0|0|15.2788388082506|138.985703590935|CENPF;PLK1;BUB1B;BUB3|2
3067|mitotic spindle checkpoint (GO:0071174)|4/17|0.000112044516148433|0.00501546636759169|0|0|15.2788388082506|138.985703590935|CENPF;PLK1;BUB1B;BUB3|2
3068|negative regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle (GO:0031658)|3/7|0.00012091275842523|0.00536537222820823|0|0|27.8293135435993|251.032688603895|CDKN2D;CDKN2C;CDK4|2
3069|DNA conformation change (GO:0071103)|4/18|0.000142316370487734|0.00626069343619746|0|0|14.4300144300144|127.813247004431|TOP2A;HAT1;HMGB2;HMGB1|2
3070|G2/M transition of mitotic cell cycle (GO:0000086)|9/127|0.000156863665340133|0.00684166909598888|0|0|4.60169751508334|40.3114845748565|PLK4;CCNA2;CCNB2;CCNB1;PLK1;CDK1;TUBB4B;ARPP19;AURKA|2
3071|exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay (GO:0043928)|5/34|0.000161721801235791|0.00699378264157832|0|0|9.54927425515661|83.3616594276493|LSM6;LSM5;LSM4;LSM3;LSM2|2
3072|ribonucleoprotein complex assembly (GO:0022618)|10/157|0.00016532143285946|0.00708937203262036|0|0|4.13599139713789|36.0146368647972|RPL3;SNRPD2;SNRPD1;SNRPG;RPS27L;RPSA;SNRPE;SNRPF;LSM4;LSM3|2
3073|cell cycle G2/M phase transition (GO:0044839)|9/128|0.000166486259212844|0.00707982817302621|0|0|4.56574675324675|39.7247260616861|PLK4;CCNA2;CCNB2;CCNB1;PLK1;CDK1;TUBB4B;ARPP19;AURKA|2
3074|positive regulation of cytokinesis (GO:0032467)|5/35|0.000186316316873597|0.00785762119839642|0|0|9.27643784786642|79.6666484260612|RACGAP1;KIF23;KIF20B;AURKB;CIT|2
3075|regulation of metaphase/anaphase transition of cell cycle (GO:1902099)|3/8|0.000191254595970567|0.00799977215768693|0|0|24.3506493506493|208.487947751487|CENPE;UBE2C;PLK1|2
3076|cellular response to DNA damage stimulus (GO:0006974)|15/330|0.000198538683740394|0.00823693417176609|0|0|2.95159386068477|25.1609403675309|TOP2A;LIG1;MCM7;RFC2;H2AFX;SMC6;PARK7;CRIP1;PYCARD;RAD51AP1;HPF1;PCLAF;CDK1;CLSPN;TOPBP1|2
3077|transcription from RNA polymerase II promoter (GO:0006366)|19/486|0.000208133323646556|0.00856535766587398|0|0|2.53861364972476|21.5206699783702|SLBP;ELOF1;ALYREF;U2AF1;DEK;SSRP1;PMF1;THOC7;NUDT21;CCNB1;CDK4;SNRPG;SRSF2;CDK1;SRSF3;ELOB;SNRPE;SNRPF;SRSF7|2
3078|nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)|5/36|0.000213662922555167|0.00872257515039214|0|0|9.01875901875902|76.2185327652236|LSM6;LSM5;LSM4;LSM3;LSM2|2
3079|regulation of mitotic spindle organization (GO:0060236)|5/36|0.000213662922555167|0.00865334836348427|0|0|9.01875901875902|76.2185327652236|TPX2;PLK1;TACC3;HNRNPU;SMC3|2
3080|carbohydrate catabolic process (GO:0016052)|5/36|0.000213662922555167|0.00858521176219699|0|0|9.01875901875902|76.2185327652236|LDHA;TPI1;PKM;PGAM1;PGK1|2
3081|retrograde vesicle-mediated transport, Golgi to ER (GO:0006890)|7/81|0.000251855461557784|0.0100407689088232|0|0|5.61167227833894|46.501993267403|CENPE;RACGAP1;KIF23;KIF2C;KIF11;KIF22;KIF15|2
3082|regulation of protein serine/threonine kinase activity (GO:0071900)|7/81|0.000251855461557784|0.00996293349092535|0|0|5.61167227833894|46.501993267403|PYCARD;CDKN2D;CDKN2C;H2AFY;CCNE2;CDKN3;EZH2|2
3083|mitochondrial ATP synthesis coupled proton transport (GO:0042776)|4/21|0.000268393686589216|0.0105354844820367|0|0|12.3685837971552|101.707553191568|ATP5G3;CYC1;COX5B;ATP5F1|2
3084|translation (GO:0006412)|12/233|0.000279510600116927|0.010888111392341|0|0|3.34429518978875|27.3645962013403|EEF1G;RPL3;MRPL51;MRPL18;RPS6;RPL14;NHP2;MRPL28;RPL22L1;RPSA;RPS2;MRPL13|2
3085|DNA topological change (GO:0006265)|3/9|0.000283613127462693|0.0109642256775918|0|0|21.6450216450216|176.794360946366|TOP2A;HMGB2;HMGB1|2
3086|ubiquitin-dependent protein catabolic process (GO:0006511)|15/342|0.00029106814683058|0.0111678252126049|0|0|2.84802916381864|23.1885199836541|RANBP1;UBE2C;UHRF1;BUB1B;ANAPC11;CDC20;PSMB6;PSMB7;PSMA4;PSMC3;UBE2S;CDK1;ANAPC5;BUB3;MAD2L1|2
3087|regulation of signal transduction by p53 class mediator (GO:1901796)|9/139|0.000308955586909454|0.0117656743283503|0|0|4.20442866486032|33.9815085526179|TPX2;RBBP4;RFC2;RPA2;TOPBP1;RBBP7;SSRP1;AURKB;AURKA|2
3088|proteasomal protein catabolic process (GO:0010498)|12/238|0.000339013680892852|0.0128147171377498|0|0|3.27403688748227|26.1578198017529|CDC20;PSMB6;PSMB7;PSMA4;PSMC3;UBE2C;CDK1;BUB1B;ANAPC5;BUB3;ANAPC11;MAD2L1|2
3089|mitotic DNA damage checkpoint (GO:0044773)|5/40|0.000354648057684538|0.0133071252820897|0|0|8.11688311688312|64.4836416155999|TIPIN;RPS27L;RPA2;CLSPN;TOPBP1|2
3090|mitochondrial ATP synthesis coupled electron transport (GO:0042775)|7/86|0.000364564247103241|0.0135793529413711|0|0|5.28541226215645|41.8435928178301|NDUFB8;NDUFB6;NDUFA5;NDUFA12;CYCS;CYC1;COX5B|2
3091|regulation of DNA replication (GO:0006275)|6/62|0.000378493037662755|0.0139960142840075|0|0|6.28403854210306|49.5139058219908|DBF4;PCNA;GMNN;NUCKS1;ESCO2;SMC3|2
3092|nucleotide-excision repair, DNA gap filling (GO:0006297)|4/23|0.000387578311604948|0.0142288642023025|0|0|11.2930547713156|88.7136378896084|PCNA;LIG1;RFC2;RPA2|2
3093|peptide biosynthetic process (GO:0043043)|10/175|0.000396159153639636|0.0144400011501647|0|0|3.71057513914657|29.0675121496135|RPL3;MRPL51;MRPL18;RPS6;NHP2;RPL14;MRPL28;RPSA;RPS2;MRPL13|2
3094|regulation of attachment of spindle microtubules to kinetochore (GO:0051988)|3/10|0.000400548390794828|0.0144964428242979|0|0|19.4805194805195|152.389791677924|CCNB1;RACGAP1;KNSTRN|2
3095|negative regulation of G2/M transition of mitotic cell cycle (GO:0010972)|6/63|0.00041299454783906|0.0148416280114276|0|0|6.18429189857761|48.1884735092677|PSMB6;PSMB7;PSMA4;PSMC3;AURKB;AURKA|2
3096|positive regulation of cell division (GO:0051781)|5/42|0.00044711888031669|0.0159555779458466|0|0|7.73036487322202|59.621877297604|RACGAP1;KIF23;KIF20B;AURKB;CIT|2
3097|spliceosomal complex assembly (GO:0000245)|5/42|0.00044711888031669|0.0158447753212227|0|0|7.73036487322202|59.621877297604|SNRPD2;SNRPD1;SNRPG;SNRPE;LSM4|2
3098|gluconeogenesis (GO:0006094)|5/42|0.00044711888031669|0.0157355010086625|0|0|7.73036487322202|59.621877297604|TPI1;PGAM1;PGK1;ENO1;GAPDH|2
3099|DNA synthesis involved in DNA repair (GO:0000731)|6/66|0.000531400324320109|0.0185735332534625|0|0|5.90318772136954|44.510005397439|RAD51AP1;CDKN2D;PCNA;RFC2;PCLAF;RPA2|2
3100|histone mRNA metabolic process (GO:0008334)|4/25|0.000540424061355139|0.018760435272757|0|0|10.3896103896104|78.1626641847887|SLBP;SNRPG;SNRPE;SNRPF|2
3101|negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736)|4/25|0.000540424061355139|0.0186336755749681|0|0|10.3896103896104|78.1626641847887|CDKN2D;CDKN2C;CDK4;PLK1|2
3102|mitotic spindle midzone assembly (GO:0051256)|3/11|0.000544487568184882|0.0186477856405869|0|0|17.7095631641086|133.099151962248|RACGAP1;KIF23;AURKB|2
3103|positive regulation of chromosome segregation (GO:0051984)|3/11|0.000544487568184882|0.0185234670696497|0|0|17.7095631641086|133.099151962248|CCNB1;RAD21;SMC6|2
3104|protein-DNA complex assembly (GO:0065004)|7/92|0.000549615386402801|0.0185740881908178|0|0|4.94071146245059|37.0864220445144|H2AFY;H2AFX;HMGB2;ANP32E;RPA2;ANP32B;CENPA|2
3105|hexose biosynthetic process (GO:0019319)|5/45|0.000618455041159682|0.0207630004936701|0|0|7.21500721500721|53.3065372214687|TPI1;PGAM1;PGK1;ENO1;GAPDH|2
3106|respiratory electron transport chain (GO:0022904)|7/95|0.000666657778549748|0.0222349976728063|0|0|4.78468899521531|34.9915488964333|NDUFB8;NDUFB6;NDUFA5;NDUFA12;CYCS;CYC1;COX5B|2
3107|nicotinamide nucleotide metabolic process (GO:0046496)|5/46|0.000685234689150462|0.0227061858359403|0|0|7.05815923207228|51.4239777419651|LDHA;TPI1;PKM;PGAM1;PGK1|2
3108|attachment of mitotic spindle microtubules to kinetochore (GO:0051315)|3/12|0.000717729186321608|0.0236294970180591|0|0|16.2337662337662|117.523023342379|CENPE;NUF2;KIF2C|2
3109|DNA ligation involved in DNA repair (GO:0051103)|3/12|0.000717729186321608|0.023478025883328|0|0|16.2337662337662|117.523023342379|LIG1;HMGB2;HMGB1|2
3110|pyruvate metabolic process (GO:0006090)|5/47|0.000757263726772287|0.024613482788019|0|0|6.90798563138989|49.639396111406|LDHA;TPI1;PKM;PGAM1;PGK1|2
3111|RNA metabolic process (GO:0016070)|10/192|0.000815899275674526|0.0263514810365007|0|0|3.38203463203463|24.0503911231483|RBM3;RNASEH2C;RNASEH2B;HNRNPA3;PCNA;LIG1;HNRNPA2B1;SNRPG;HNRNPU;HNRNPA1|2
3112|ATP synthesis coupled proton transport (GO:0015986)|4/28|0.000843524717360868|0.0270723687590724|0|0|9.27643784786642|65.6578975238887|ATP5G3;CYC1;COX5B;ATP5F1|2
3113|protein localization to chromosome (GO:0034502)|4/28|0.000843524717360868|0.0269031664543282|0|0|9.27643784786642|65.6578975238887|RAD21;PLK1;RPA2;CENPA|2
3114|tetrahydrofolate metabolic process (GO:0046653)|3/13|0.000922447209428963|0.0292375658988571|0|0|14.985014985015|104.72248365492|DHFR;ATPIF1;TYMS|2
3115|mitotic DNA integrity checkpoint (GO:0044774)|3/13|0.000922447209428963|0.0290570870970123|0|0|14.985014985015|104.72248365492|TOP2A;CLSPN;TOPBP1|2
3116|protein K11-linked ubiquitination (GO:0070979)|4/29|0.000966728219665063|0.0302651172082872|0|0|8.95656068069861|62.1728003329103|UBE2C;UBE2S;ANAPC5;ANAPC11|2
3117|positive regulation of fibroblast proliferation (GO:0048146)|4/29|0.000966728219665063|0.0300805738106757|0|0|8.95656068069861|62.1728003329103|CD74;CDK4;S100A6;MIF|2
3118|regulation of gene expression, epigenetic (GO:0040029)|6/75|0.00104936486584693|0.032453993396466|0|0|5.19480519480519|35.6341308441655|DNMT1;H2AFY;RBBP4;RBBP7;DEK;EZH2|2
3119|regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle (GO:0031657)|3/14|0.00116069502617117|0.0356808838466957|0|0|13.9146567717996|94.0454957253681|CDKN2D;CDKN2C;CDK4|2
3120|regulation of cellular amine metabolic process (GO:0033238)|5/52|0.00120521728347834|0.0368276874107185|0|0|6.24375624375624|41.9648814314161|PSMB6;PSMB7;PSMA4;PSMC3;ODC1|2
3121|regulation of cellular amino acid metabolic process (GO:0006521)|5/52|0.00120521728347834|0.0366084749856547|0|0|6.24375624375624|41.9648814314161|PSMB6;PSMB7;PSMA4;PSMC3;ODC1|2
3122|ATP-dependent chromatin remodeling (GO:0043044)|4/31|0.00125013092133783|0.037748036044893|0|0|8.37871805613741|56.0075994644509|RBBP4;NASP;ANP32E;ANP32B|2
3123|chemokine-mediated signaling pathway (GO:0070098)|5/53|0.00131423025178006|0.0394500998519625|0|0|6.12594952217594|40.6426374945201|CCL4;CCL2;CCL17;CCR2;PF4|2
3124|negative regulation of DNA-dependent DNA replication (GO:2000104)|3/15|0.00143440933338199|0.0428057943172415|0|0|12.987012987013|85.0260016737006|TIPIN;GMNN;SMC3|2
3125|DNA strand elongation involved in DNA replication (GO:0006271)|3/16|0.00174541391994588|0.0517839955435105|0|0|12.1753246753247|77.3226081337092|GINS2;PCNA;LIG1|2
3126|positive regulation of G2/M transition of mitotic cell cycle (GO:0010971)|3/16|0.00174541391994588|0.0514846660895018|0|0|12.1753246753247|77.3226081337092|CCNB1;CDK4;CDK1|2
3127|DNA damage response, signal transduction by p53 class mediator (GO:0030330)|6/83|0.00177576555515198|0.0520789174019572|0|0|4.69410107964325|29.7302002051015|CCNB1;TFDP1;PCNA;CDK1;RPS27L;AURKA|2
3128|regulation of DNA recombination (GO:0000018)|4/34|0.00177704851162842|0.0518187345990846|0|0|7.63941940412529|48.378926130234|RAD51AP1;ALYREF;RPA2;KPNA2|2
3129|positive regulation of cell cycle G2/M phase transition (GO:1902751)|3/17|0.0020954233492802|0.0607553713146412|0|0|11.4591291061879|70.6799045453848|CCNB1;CDK4;CDK1|2
3130|positive regulation of lymphocyte migration (GO:2000403)|3/17|0.0020954233492802|0.0604121206292477|0|0|11.4591291061879|70.6799045453848|PYCARD;CCL4;AIF1|2
3131|positive regulation of monocyte chemotaxis (GO:0090026)|3/17|0.0020954233492802|0.0600727266931283|0|0|11.4591291061879|70.6799045453848|HMGB1;AIF1;CCR2|2
3132|DNA replication checkpoint (GO:0000076)|3/17|0.0020954233492802|0.0597371248680271|0|0|11.4591291061879|70.6799045453848|TIPIN;CLSPN;TOPBP1|2
3133|regulation of cyclin-dependent protein kinase activity (GO:1904029)|4/36|0.00220338632077023|0.0624660021938359|0|0|7.21500721500721|44.1396815679275|CDKN2D;CDKN2C;CCNE2;CDKN3|2
3134|DNA-dependent DNA replication maintenance of fidelity (GO:0045005)|4/36|0.00220338632077023|0.0621208861596158|0|0|7.21500721500721|44.1396815679275|TIPIN;PCNA;ALYREF;NUCKS1|2
3135|cellular response to interleukin-1 (GO:0071347)|8/151|0.00239893384242301|0.0672624142740913|0|0|3.44026834093059|20.7542130305406|PYCARD;PSMB6;PSMB7;PSMA4;PSMC3;CCL4;CCL2;CCL17|2
3136|positive regulation of leukocyte chemotaxis (GO:0002690)|5/62|0.00264877834368019|0.073861835452459|0|0|5.23669878508588|31.0727730816041|CCL4;HMGB1;AIF1;CCR2;PF4|2
3137|regulation of cellular ketone metabolic process (GO:0010565)|5/62|0.00264877834368019|0.0734604124336956|0|0|5.23669878508588|31.0727730816041|PSMB6;PSMB7;PSMA4;PSMC3;ODC1|2
3138|regulation of DNA repair (GO:0006282)|4/38|0.00269542111064135|0.0743499131221775|0|0|6.83526999316473|40.4388300106647|PCNA;H2AFX;USP1;DEK|2
3139|DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)|5/63|0.00284151898013363|0.077958448148505|0|0|5.15357658214801|30.2175660566467|CCNB1;TFDP1;PCNA;CDK1;AURKA|2
3140|regulation of mitotic spindle assembly (GO:1901673)|3/19|0.00291879031125661|0.0796501976381951|0|0|10.2529049897471|59.8419619839912|PLK1;HNRNPU;SMC3|2
3141|error-free translesion synthesis (GO:0070987)|3/19|0.00291879031125661|0.0792265263741621|0|0|10.2529049897471|59.8419619839912|PCNA;RFC2;RPA2|2
3142|positive regulation of mononuclear cell migration (GO:0071677)|3/19|0.00291879031125661|0.0788073384039285|0|0|10.2529049897471|59.8419619839912|HMGB1;AIF1;CCR2|2
3143|signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431)|5/64|0.00304419900222906|0.0817607763598679|0|0|5.07305194805195|29.3958881183039|CCNB1;TFDP1;PCNA;CDK1;AURKA|2
3144|nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)|5/64|0.00304419900222906|0.0813327094679314|0|0|5.07305194805195|29.3958881183039|LSM6;LSM5;LSM4;LSM3;LSM2|2
3145|glucose metabolic process (GO:0006006)|5/65|0.00325710526763378|0.0865677509413291|0|0|4.995004995005|28.6059761877243|TPI1;PGAM1;PGK1;ENO1;GAPDH|2
3146|DNA biosynthetic process (GO:0071897)|4/40|0.00325788150453469|0.0861397373971011|0|0|6.49350649350649|37.1862216888261|RAD51AP1;CDKN2D;TYMS;PPIA|2
3147|cotranslational protein targeting to membrane (GO:0006613)|6/94|0.00332933912778188|0.08757534829418|0|0|4.14479137883393|23.6459579503088|RPL3;SSR2;RPS6;RPL14;RPSA;RPS2|2
3148|cellular response to tumor necrosis factor (GO:0071356)|9/195|0.00333617664381864|0.0873051764790079|0|0|2.997002997003|17.0916978374701|PSMB6;PYCARD;PSMB7;PSMA4;PSMC3;CCL4;CCL2;CCL17;YBX3|2
3149|error-prone translesion synthesis (GO:0042276)|3/20|0.00339506267859846|0.0883928818820814|0|0|9.74025974025974|55.3775947023696|PCNA;RFC2;RPA2|2
3150|positive regulation of T cell migration (GO:2000406)|3/20|0.00339506267859846|0.0879441870501926|0|0|9.74025974025974|55.3775947023696|PYCARD;AIF1;CCR2|2
3151|rRNA transport (GO:0051029)|2/6|0.00340374278642698|0.0877237345410952|0|0|21.6450216450216|123.006052668403|MRPL18;RPSA|2
3152|centromeric sister chromatid cohesion (GO:0070601)|2/6|0.00340374278642698|0.0872829117544565|0|0|21.6450216450216|123.006052668403|SGO1;BUB1B|2
3153|folic acid-containing compound biosynthetic process (GO:0009396)|2/6|0.00340374278642698|0.0868464971956843|0|0|21.6450216450216|123.006052668403|DHFR;ATPIF1|2
3154|regulation of cell division (GO:0051302)|5/66|0.00348052441962884|0.0883637617580397|0|0|4.91932310114128|27.8461840872368|PRC1;PLK1;KIF20A;AURKB;AURKA|2
3155|positive regulation of leukocyte cell-cell adhesion (GO:1903039)|3/21|0.00391617627465045|0.0989319184630756|0|0|9.27643784786642|51.4159512186576|PYCARD;CCL2;CCR2|2
3156|regulation of nuclear division (GO:0051783)|3/21|0.00391617627465045|0.0984445691110407|0|0|9.27643784786642|51.4159512186576|FBXO5;MKI67;KIF20B|2
3157|response to interferon-gamma (GO:0034341)|5/69|0.00421671796973245|0.10547995980169|0|0|4.70543948804818|25.7326283917549|CCL4;CCL2;GAPDH;AIF1;CCL17|2
3158|translesion synthesis (GO:0019985)|4/43|0.00424365257313369|0.10563589795464|0|0|6.04047115675023|32.9950523989774|PCNA;RFC2;PCLAF;RPA2|2
3159|regulation of monocyte chemotaxis (GO:0090025)|3/22|0.00448335151867862|0.111060887377752|0|0|8.85478158205431|47.8812078400217|HMGB1;AIF1;CCR2|2
3160|positive regulation of lipid transport (GO:0032370)|2/7|0.00471688133821288|0.116281379076813|0|0|18.5528756957328|99.3804718217937|PRELID1;SPP1|2
3161|rRNA-containing ribonucleoprotein complex export from nucleus (GO:0071428)|2/7|0.00471688133821288|0.115722333985098|0|0|18.5528756957328|99.3804718217937|RPSA;RAN|2
3162|positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101)|2/7|0.00471688133821288|0.115168638607179|0|0|18.5528756957328|99.3804718217937|ANAPC5;ANAPC11|2
3163|regulation of natural killer cell chemotaxis (GO:2000501)|2/7|0.00471688133821288|0.114620216518573|0|0|18.5528756957328|99.3804718217937|CCL4;CCL2|2
3164|pteridine-containing compound biosynthetic process (GO:0042559)|2/7|0.00471688133821288|0.114076992743604|0|0|18.5528756957328|99.3804718217937|DHFR;ATPIF1|2
3165|positive regulation of autophagy of mitochondrion (GO:1903599)|2/7|0.00471688133821288|0.113538893721228|0|0|18.5528756957328|99.3804718217937|ATPIF1;PARK7|2
3166|V(D)J recombination (GO:0033151)|2/7|0.00471688133821288|0.113005847271833|0|0|18.5528756957328|99.3804718217937|HMGB2;HMGB1|2
3167|tetrahydrofolate interconversion (GO:0035999)|2/7|0.00471688133821288|0.112477782564955|0|0|18.5528756957328|99.3804718217937|ATPIF1;TYMS|2
3168|positive regulation of isomerase activity (GO:0010912)|2/7|0.00471688133821288|0.111954630087909|0|0|18.5528756957328|99.3804718217937|UHRF1;HNRNPU|2
3169|ribosomal small subunit biogenesis (GO:0042274)|4/45|0.00500200140638228|0.118172283225781|0|0|5.77200577200577|30.5796084580823|LSM6;RPS6;RPS27L;RPSA|2
3170|positive regulation of viral life cycle (GO:1903902)|4/45|0.00500200140638228|0.117627710492022|0|0|5.77200577200577|30.5796084580823|TOP2A;CD74;LGALS1;PPIA|2
3171|regulation of T cell activation (GO:0050863)|4/45|0.00500200140638228|0.117088133838389|0|0|5.77200577200577|30.5796084580823|PYCARD;PRELID1;CCL2;CCR2|2
3172|apoptotic nuclear changes (GO:0030262)|3/23|0.00509771976880025|0.118783853790811|0|0|8.46979107848673|44.7117047717917|TOP2A;HMGB2;HMGB1|2
3173|regulation of microtubule cytoskeleton organization (GO:0070507)|3/23|0.00509771976880025|0.118243927182671|0|0|8.46979107848673|44.7117047717917|STMN1;SKA1;AURKA|2
3174|transcription-coupled nucleotide-excision repair (GO:0006283)|5/74|0.00568050307425521|0.131165643384273|0|0|4.38750438750439|22.6865368583713|PCNA;LIG1;RFC2;RPA2;HMGN1|2
3175|interleukin-12-mediated signaling pathway (GO:0035722)|4/47|0.00584622785376927|0.134384237557588|0|0|5.52638850511191|28.4164611054993|HNRNPA2B1;MIF;PPIA;LMNB1|2
3176|cellular response to interleukin-12 (GO:0071349)|4/47|0.00584622785376927|0.133781617658227|0|0|5.52638850511191|28.4164611054993|HNRNPA2B1;MIF;PPIA;LMNB1|2
3177|regulation of fibroblast proliferation (GO:0048145)|4/47|0.00584622785376927|0.133184378293681|0|0|5.52638850511191|28.4164611054993|CD74;CDK4;S100A6;MIF|2
3178|mitochondrial electron transport, NADH to ubiquinone (GO:0006120)|4/47|0.00584622785376927|0.132592447723487|0|0|5.52638850511191|28.4164611054993|NDUFB8;NDUFB6;NDUFA5;NDUFA12|2
3179|translational elongation (GO:0006414)|6/106|0.00598906599827294|0.135230990217641|0|0|3.67556971330556|18.81090347652|EEF1G;MRPL51;MRPL18;MRPL28;MRPL12;MRPL13|2
3180|negative regulation of cellular macromolecule biosynthetic process (GO:2000113)|16/513|0.00621895262860791|0.139803150941789|0|0|2.02526518315992|10.28865856377|SET;CBX5;CBX3;GMNN;HMGB2;ENO1;PA2G4;TYMS;AES;DHFR;CENPF;YWHAQ;NCL;BIRC5;GAPDH;EZH2|2
3181|establishment of integrated proviral latency (GO:0075713)|2/8|0.00622543033682954|0.139334960565093|0|0|16.2337662337662|82.4531283864672|BANF1;PPIA|2
3182|translocation of molecules into host (GO:0044417)|2/8|0.00622543033682954|0.138726510955638|0|0|16.2337662337662|82.4531283864672|ALYREF;THOC7|2
3183|protein localization to microtubule (GO:0035372)|2/8|0.00622543033682954|0.138123352212353|0|0|16.2337662337662|82.4531283864672|HNRNPU;KIF20B|2
3184|establishment of protein localization to chromatin (GO:0071169)|2/8|0.00622543033682954|0.137525415622689|0|0|16.2337662337662|82.4531283864672|H2AFY;HIST1H1B|2
3185|positive regulation of mitotic sister chromatid separation (GO:1901970)|2/8|0.00622543033682954|0.136932633658798|0|0|16.2337662337662|82.4531283864672|ANAPC5;ANAPC11|2
3186|positive regulation of viral entry into host cell (GO:0046598)|2/8|0.00622543033682954|0.136344939952108|0|0|16.2337662337662|82.4531283864672|CD74;LGALS1|2
3187|viral mRNA export from host cell nucleus (GO:0046784)|2/8|0.00622543033682954|0.135762269268552|0|0|16.2337662337662|82.4531283864672|ALYREF;THOC7|2
3188|response to vitamin D (GO:0033280)|2/8|0.00622543033682954|0.13518455748443|0|0|16.2337662337662|82.4531283864672|CDKN2D;SPP1|2
3189|regulation of apoptotic cell clearance (GO:2000425)|2/8|0.00622543033682954|0.134611741562886|0|0|16.2337662337662|82.4531283864672|CCL2;HMGB1|2
3190|positive regulation of tumor necrosis factor production (GO:0032760)|4/48|0.00630181376503774|0.135688420434547|0|0|5.41125541125541|27.4183862976587|PYCARD;MIF;CCR2;PF4|2
3191|postreplication repair (GO:0006301)|4/48|0.00630181376503774|0.135118301020956|0|0|5.41125541125541|27.4183862976587|PCNA;RFC2;PCLAF;RPA2|2
3192|positive regulation of gene expression, epigenetic (GO:0045815)|4/48|0.00630181376503774|0.13455295248112|0|0|5.41125541125541|27.4183862976587|ELOF1;H2AFY;ATAD2;DEK|2
3193|proteasomal ubiquitin-independent protein catabolic process (GO:0010499)|3/25|0.00647213366049644|0.137613741956306|0|0|7.79220779220779|39.2746710181008|PSMB6;PSMB7;PSMA4|2
3194|DNA geometric change (GO:0032392)|3/25|0.00647213366049644|0.137042730578893|0|0|7.79220779220779|39.2746710181008|HNRNPA2B1;HMGB2;HMGB1|2
3195|negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230)|3/25|0.00647213366049644|0.136476438303774|0|0|7.79220779220779|39.2746710181008|CDKN2D;CD74;MIF|2
3196|viral life cycle (GO:0019058)|6/108|0.00654988897454544|0.137547668465454|0|0|3.60750360750361|18.1396362912327|NDC1;CCL2;DEK;KPNA2;PPIA;RAN|2
3197|response to interleukin-1 (GO:0070555)|5/77|0.00671313159740689|0.140397994022817|0|0|4.2165626581211|21.0983712719263|PYCARD;CCL4;CCL2;CCL17;AES|2
3198|interstrand cross-link repair (GO:0036297)|4/49|0.00678036786790676|0.141225376448687|0|0|5.30082162735224|26.4708397598642|RAD51AP1;USP1;RPA2;NUCKS1|2
3199|nucleotide-excision repair (GO:0006289)|6/109|0.00684416226919273|0.141974634388986|0|0|3.57440724413201|17.8161296802063|PCNA;LIG1;RFC2;SUMO2;RPA2;HMGN1|2
3200|protein deubiquitination (GO:0016579)|10/258|0.00690217470146724|0.142598370451771|0|0|2.51686298197926|12.5237056853674|CDC20;PSMB6;CCNA2;PSMB7;PSMA4;PSMC3;USP1;CDK1;CLSPN;UCHL5|2
3201|positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280)|6/110|0.00714790069148744|0.147079585599437|0|0|3.54191263282172|17.5003656728576|PYCARD;CYCS;RPS27L;ANP32B;HMGB1;S100A9|2
3202|regulation of spindle assembly (GO:0090169)|3/26|0.00723402380155899|0.148253909475323|0|0|7.49250749250749|36.9302686455253|PLK1;HNRNPU;SMC3|2
3203|antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844)|4/50|0.00728236471159535|0.148647628493084|0|0|5.19480519480519|25.570387774004|HMGN2;S100A9;GAPDH;PF4|2
3204|cellular protein complex assembly (GO:0043623)|7/145|0.00728481687520009|0.148105261012534|0|0|3.13479623824451|15.4293510247392|NDC1;ANLN;CENPE;CENPF;CENPW;AP2S1;CENPA|2
3205|viral gene expression (GO:0019080)|6/111|0.00746127147562677|0.151090747381442|0|0|3.51000351000351|17.1921005271938|NDC1;RPL3;RPS6;RPL14;RPSA;RPS2|2
3206|regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418)|5/79|0.00747041054653745|0.150677885450516|0|0|4.10981423639651|20.1249602251019|PSMB6;PSMB7;PSMA4;PSMC3;ELOB|2
3207|protein modification by small protein removal (GO:0070646)|10/262|0.00765446729669958|0.153782466988417|0|0|2.47843759294141|12.0761025112256|CDC20;PSMB6;CCNA2;PSMB7;PSMA4;PSMC3;USP1;CDK1;CLSPN;UCHL5|2
3208|regulation of protein binding (GO:0043393)|6/112|0.00778444119731223|0.15578040560739|0|0|3.47866419294991|16.8911001473098|PLK1;PARK7;AURKB;RAN;AES;AURKA|2
3209|negative regulation of mitotic cell cycle phase transition (GO:1901991)|5/80|0.00787050566425751|0.156887462518383|0|0|4.05844155844156|19.6616597665893|PSMB6;PSMB7;PSMA4;PSMC3;AURKA|2
3210|activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919)|5/80|0.00787050566425751|0.156277005465782|0|0|4.05844155844156|19.6616597665893|PYCARD;RPS27L;CYCS;ANP32B;S100A9|2
3211|ornithine metabolic process (GO:0006591)|2/9|0.00792309930336656|0.156711533895657|0|0|14.4300144300144|69.8120176554297|ARG1;ODC1|2
3212|positive regulation of mitotic metaphase/anaphase transition (GO:0045842)|2/9|0.00792309930336656|0.156106470058222|0|0|14.4300144300144|69.8120176554297|ANAPC5;ANAPC11|2
3213|ATP synthesis coupled electron transport (GO:0042773)|2/9|0.00792309930336656|0.155506060557998|0|0|14.4300144300144|69.8120176554297|NDUFB6;NDUFA12|2
3214|establishment of viral latency (GO:0019043)|2/9|0.00792309930336656|0.154910251896857|0|0|14.4300144300144|69.8120176554297|BANF1;PPIA|2
3215|negative regulation of histone methylation (GO:0031061)|2/9|0.00792309930336656|0.154318991393433|0|0|14.4300144300144|69.8120176554297|DNMT1;H2AFY|2
3216|mitotic DNA replication checkpoint (GO:0033314)|2/9|0.00792309930336656|0.153732227167603|0|0|14.4300144300144|69.8120176554297|CLSPN;TOPBP1|2
3217|regulation of methylation-dependent chromatin silencing (GO:0090308)|2/9|0.00792309930336656|0.153149908125301|0|0|14.4300144300144|69.8120176554297|DNMT1;UHRF1|2
3218|regulation of leukocyte activation (GO:0002694)|2/9|0.00792309930336656|0.152571983943697|0|0|14.4300144300144|69.8120176554297|CD74;MIF|2
3219|response to vitamin (GO:0033273)|2/9|0.00792309930336656|0.15199840505669|0|0|14.4300144300144|69.8120176554297|CDKN2D;SPP1|2
3220|viral transcription (GO:0019083)|6/114|0.00846084003024454|0.16170661675782|0|0|3.41763499658236|16.310002788579|NDC1;RPL3;RPS6;RPL14;RPSA;RPS2|2
3221|cellular protein metabolic process (GO:0044267)|15/485|0.0085425364971543|0.162658819943949|0|0|2.00830097737314|9.5649296456618|UBL4A;RPL3;MRPL18;RPS6;MRPL28;RPSA;MRPL13;LGALS1;MRPL51;UBE2S;SPP1;RPL14;NHP2;RPS2;TGFBI|2
3222|positive regulation of binding (GO:0051099)|5/82|0.00871490781829325|0.165324069132901|0|0|3.95945517896737|18.7785879689093|GMNN;STMN1;HMGB2;HMGB1;RAN|2
3223|modulation by host of viral transcription (GO:0043921)|3/28|0.00891119751163455|0.168421632969893|0|0|6.95732838589981|32.8416974420702|PSMC3;CCL4;NUCKS1|2
3224|regulation of protein localization to nucleus (GO:1900180)|3/28|0.00891119751163455|0.167800150929414|0|0|6.95732838589981|32.8416974420702|PLK1;CDK1;PARK7|2
3225|purine ribonucleoside triphosphate biosynthetic process (GO:0009206)|3/28|0.00891119751163455|0.16718323860982|0|0|6.95732838589981|32.8416974420702|IMPDH2;ATP5G3;ATP5F1|2
3226|positive regulation of mitotic cell cycle (GO:0045931)|4/53|0.00893356756703088|0.166988993752962|0|0|4.90075961774075|23.1214871859209|CCNB1;NUSAP1;AURKA;MAD2L1|2
3227|positive regulation of cell cycle (GO:0045787)|5/83|0.00915972565774162|0.170591532961516|0|0|3.91175089970271|18.3576085541105|CCNB1;CDK4;CKS2;MIF;CKS1B|2
3228|positive regulation of DNA metabolic process (GO:0051054)|5/83|0.00915972565774162|0.169971200114384|0|0|3.91175089970271|18.3576085541105|DNMT1;DBF4;PCNA;H2AFX;HMGB1|2
3229|positive regulation of cell cycle arrest (GO:0071158)|5/83|0.00915972565774162|0.16935536243281|0|0|3.91175089970271|18.3576085541105|CCNB1;TFDP1;PCNA;CDK1;AURKA|2
3230|neutrophil chemotaxis (GO:0030593)|4/54|0.00953382640313462|0.175635798322007|0|0|4.81000481000481|22.380515298477|CCL4;CCL2;S100A9;CCL17|2
3231|regulation of chromatin organization (GO:1902275)|2/10|0.00980374404614016|0.179958654199472|0|0|12.987012987013|60.0648171524924|HNRNPU;MKI67|2
3232|mitotic G1 DNA damage checkpoint (GO:0031571)|2/10|0.00980374404614016|0.179313641101983|0|0|12.987012987013|60.0648171524924|RPA2;RPS27L|2
3233|G1 DNA damage checkpoint (GO:0044783)|2/10|0.00980374404614016|0.178673235240904|0|0|12.987012987013|60.0648171524924|RPA2;RPS27L|2
3234|mitotic G1/S transition checkpoint (GO:0044819)|2/10|0.00980374404614016|0.178037387428659|0|0|12.987012987013|60.0648171524924|RPA2;RPS27L|2
3235|positive regulation of nuclease activity (GO:0032075)|2/10|0.00980374404614016|0.177406049175366|0|0|12.987012987013|60.0648171524924|PCNA;HMGB2|2
3236|negative regulation of response to DNA damage stimulus (GO:2001021)|3/29|0.00982786972053973|0.177214202063301|0|0|6.71742051052396|31.0514985245818|CDKN2D;CD74;MIF|2
3237|regulation of phosphorylation (GO:0042325)|6/120|0.0107422753793671|0.193020532608839|0|0|3.24675324675325|14.7193777664428|NDC1;CDKN2D;CDKN2C;MCM7;PGAM1;MIF|2
3238|regulation of neutrophil chemotaxis (GO:0090022)|3/30|0.0107974073272581|0.193330419617538|0|0|6.49350649350649|29.4055145192366|CD74;KIF20B;PF4|2
3239|carbohydrate derivative biosynthetic process (GO:1901137)|3/30|0.0107974073272581|0.192654439129365|0|0|6.49350649350649|29.4055145192366|RRM1;RRM2;TPI1|2
3240|DNA recombination (GO:0006310)|4/56|0.0108116081499068|0.192235666860537|0|0|4.63821892393321|20.9978427336349|RAD51AP1;RAD21;NUCKS1;HMGB1|2
3241|chromosome organization (GO:0051276)|4/57|0.0114899093577134|0.203586831431983|0|0|4.55684666210982|20.3521807972221|TOP2A;CENPW;NUF2;CDCA8|2
3242|DNA-dependent DNA replication (GO:0006261)|4/57|0.0114899093577134|0.202882378728067|0|0|4.55684666210982|20.3521807972221|GINS2;RFC2;POLE3;TOPBP1|2
3243|granulocyte chemotaxis (GO:0071621)|4/57|0.0114899093577134|0.202182784318659|0|0|4.55684666210982|20.3521807972221|CCL4;CCL2;S100A9;CCL17|2
3244|mitochondrial translational elongation (GO:0070125)|5/88|0.0116198874218601|0.20376730417097|0|0|3.68949232585596|16.4368256195151|MRPL51;MRPL18;MRPL28;MRPL12;MRPL13|2
3245|replication fork processing (GO:0031297)|3/31|0.0118203325714454|0.206572455863307|0|0|6.28403854210306|27.8881491269454|PCNA;ALYREF;NUCKS1|2
3246|regulation of histone H3-K9 methylation (GO:0051570)|2/11|0.0118613636806705|0.206582043899186|0|0|11.8063754427391|52.3550048467017|DNMT1;HIST1H1B|2
3247|positive regulation by host of viral process (GO:0044794)|2/11|0.0118613636806705|0.205879383885923|0|0|11.8063754427391|52.3550048467017|NUCKS1;SMC3|2
3248|regulation of mitotic centrosome separation (GO:0046602)|2/11|0.0118613636806705|0.205181487669361|0|0|11.8063754427391|52.3550048467017|RANBP1;KIF11|2
3249|cytoplasmic mRNA processing body assembly (GO:0033962)|2/11|0.0118613636806705|0.204488306967775|0|0|11.8063754427391|52.3550048467017|LSM4;LSM3|2
3250|negative regulation of nucleocytoplasmic transport (GO:0046823)|2/11|0.0118613636806705|0.203799794149702|0|0|11.8063754427391|52.3550048467017|PARK7;RANGAP1|2
3251|regulation of RNA polymerase II transcriptional preinitiation complex assembly (GO:0045898)|2/11|0.0118613636806705|0.203115902223025|0|0|11.8063754427391|52.3550048467017|PSMC3;HMGB1|2
3252|negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166)|2/11|0.0118613636806705|0.202436584824286|0|0|11.8063754427391|52.3550048467017|CD74;MIF|2
3253|glycerol metabolic process (GO:0006071)|2/11|0.0118613636806705|0.201761796208205|0|0|11.8063754427391|52.3550048467017|TPI1;PGP|2
3254|regulation of chromatin silencing (GO:0031935)|2/11|0.0118613636806705|0.201091491237414|0|0|11.8063754427391|52.3550048467017|UHRF1;ATAD2|2
3255|regulation of stem cell differentiation (GO:2000736)|5/89|0.0121608091274014|0.20548546018917|0|0|3.64803735590252|16.0861552042006|PSMB6;PSMB7;PSMA4;PSMC3;HNRNPU|2
3256|Wnt signaling pathway, planar cell polarity pathway (GO:0060071)|5/89|0.0121608091274014|0.204807290353562|0|0|3.64803735590252|16.0861552042006|PSMB6;PSMB7;PSMA4;PSMC3;AP2S1|2
3257|protein ubiquitination (GO:0016567)|15/507|0.0124449878474678|0.208903858505356|0|0|1.92115576730961|8.42702935461121|UBL4A;PCNA;UBE2C;UHRF1;PLK1;COMMD1;ANAPC11;PSMB6;PSMB7;PSMA4;PSMC3;UBE2S;BIRC5;ELOB;SAE1|2
3258|mitochondrial translational termination (GO:0070126)|5/90|0.0127185670930882|0.212796222544358|0|0|3.60750360750361|15.7456434968618|MRPL51;MRPL18;MRPL28;MRPL12;MRPL13|2
3259|SRP-dependent cotranslational protein targeting to membrane (GO:0006614)|5/90|0.0127185670930882|0.212100810052383|0|0|3.60750360750361|15.7456434968618|RPL3;RPS6;RPL14;RPSA;RPS2|2
3260|regulation of establishment of planar polarity (GO:0090175)|5/90|0.0127185670930882|0.211409927934948|0|0|3.60750360750361|15.7456434968618|PSMB6;PSMB7;PSMA4;PSMC3;AP2S1|2
3261|regulation of ubiquitin-protein transferase activity (GO:0051438)|3/32|0.0128971033544972|0.213681553305192|0|0|6.08766233766234|26.4859123721091|PLK1;PARK7;RPS2|2
3262|regulation of protein export from nucleus (GO:0046825)|3/32|0.0128971033544972|0.212990027242715|0|0|6.08766233766234|26.4859123721091|PARK7;ANP32B;RANGAP1|2
3263|positive regulation of viral genome replication (GO:0045070)|3/32|0.0128971033544972|0.212302962638707|0|0|6.08766233766234|26.4859123721091|TOP2A;NUCKS1;PPIA|2
3264|neutrophil migration (GO:1990266)|4/59|0.0129271747412292|0.212113738599654|0|0|4.40237728373322|19.1434013393462|CCL4;CCL2;S100A9;CCL17|2
3265|rRNA processing (GO:0006364)|8/203|0.0136319402341979|0.222960868638179|0|0|2.55901733734246|10.9918487445032|NOP58;RPL3;LSM6;RPS6;RPL14;NHP2;RPSA;RPS2|2
3266|positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557)|3/33|0.0140281156108843|0.228707584544226|0|0|5.90318772136954|25.1870820856005|PYCARD;MIF;PF4|2
3267|G2 DNA damage checkpoint (GO:0031572)|3/33|0.0140281156108843|0.227979216440582|0|0|5.90318772136954|25.1870820856005|PLK1;CLSPN;TOPBP1|2
3268|mismatch repair (GO:0006298)|3/33|0.0140281156108843|0.227255472896326|0|0|5.90318772136954|25.1870820856005|PCNA;LIG1;RPA2|2
3269|regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter (GO:1901836)|2/12|0.0140900976960631|0.227537242224716|0|0|10.8225108225108|46.1286041058361|H2AFY;NCL|2
3270|regulation of DNA-dependent DNA replication (GO:0090329)|2/12|0.0140900976960631|0.226819459126215|0|0|10.8225108225108|46.1286041058361|TIPIN;GMNN|2
3271|pyrimidine nucleoside salvage (GO:0043097)|2/12|0.0140900976960631|0.226106190386825|0|0|10.8225108225108|46.1286041058361|TK1;DCK|2
3272|regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165)|2/12|0.0140900976960631|0.225397393551756|0|0|10.8225108225108|46.1286041058361|CD74;MIF|2
3273|exit from mitosis (GO:0010458)|2/12|0.0140900976960631|0.224693026696907|0|0|10.8225108225108|46.1286041058361|UBE2C;UBE2S|2
3274|negative regulation of histone modification (GO:0031057)|2/12|0.0140900976960631|0.223993048420593|0|0|10.8225108225108|46.1286041058361|SET;H2AFY|2
3275|negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)|2/12|0.0140900976960631|0.223297417835435|0|0|10.8225108225108|46.1286041058361|CD74;MIF|2
3276|pyrimidine-containing compound salvage (GO:0008655)|2/12|0.0140900976960631|0.222606094560403|0|0|10.8225108225108|46.1286041058361|TK1;DCK|2
3277|pyrimidine deoxyribonucleotide catabolic process (GO:0009223)|2/12|0.0140900976960631|0.221919038712994|0|0|10.8225108225108|46.1286041058361|DUT;DCTPP1|2
3278|regulation of mRNA splicing, via spliceosome (GO:0048024)|4/61|0.0144742844107077|0.227268533377974|0|0|4.25803704492229|18.0344121480333|HNRNPU;SRSF3;HNRNPA1;SRSF7|2
3279|regulation of mRNA stability (GO:0043488)|6/129|0.0149343403836427|0.233772818950089|0|0|3.02023557837511|12.6973482153379|PSMB6;PSMB7;SET;PSMA4;PSMC3;HNRNPU|2
3280|negative regulation of transcription, DNA-templated (GO:0045892)|21/814|0.0150344759727162|0.234620583757709|0|0|1.67522894795622|7.03162159421886|SET;CBX5;H2AFY;CBX3;UHRF1;CNBP;PLK1;GMNN;HMGB2;HNRNPU;ENO1;PA2G4;HMGB1;AURKB;AES;CENPF;YWHAQ;BIRC5;HDGF;HIST1H1B;EZH2|2
3281|positive regulation of cell proliferation (GO:0008284)|13/425|0.0150353277938042|0.23391852967007|0|0|1.98624904507257|8.33698771420873|EIF5A;CD74;TIPIN;CNBP;HNRNPU;NAP1L1;MIF;AIF1;CDK4;PRC1;S100A6;BIRC5;KIF20B|2
3282|regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618)|5/94|0.0151223562041268|0.234557397293797|0|0|3.45399281569494|14.4776909600901|PSMB6;PSMB7;PSMA4;PSMC3;ELOB|2
3283|positive regulation of T cell proliferation (GO:0042102)|4/62|0.0152898382635823|0.23643649896685|0|0|4.18935902806871|17.513895421108|PYCARD;HMGB1;AIF1;CCR2|2
3284|negative regulation of intrinsic apoptotic signaling pathway (GO:2001243)|4/63|0.0161337938417199|0.248733383608148|0|0|4.12286126571841|17.0143855305165|CDKN2D;PARK7;ENO1;YBX3|2
3285|regulation of double-strand break repair (GO:2000779)|3/35|0.0164541523600775|0.252908251486372|0|0|5.56586270871985|22.8599855873048|RAD51AP1;RPA2;DEK|2
3286|positive regulation of telomere maintenance via telomere lengthening (GO:1904358)|3/35|0.0164541523600775|0.252148767247674|0|0|5.56586270871985|22.8599855873048|HNRNPA2B1;HNRNPA1;AURKB|2
3287|positive regulation of DNA binding (GO:0043388)|3/35|0.0164541523600775|0.251393830818789|0|0|5.56586270871985|22.8599855873048|HMGB2;PARK7;HMGB1|2
3288|regulation of macrophage differentiation (GO:0045649)|2/13|0.0164842230856883|0.251101463899305|0|0|9.99000999000999|41.0125028184719|C1QC;PF4|2
3289|prostanoid biosynthetic process (GO:0046457)|2/13|0.0164842230856883|0.250354138113891|0|0|9.99000999000999|41.0125028184719|CD74;MIF|2
3290|nucleotide metabolic process (GO:0009117)|2/13|0.0164842230856883|0.249611247496342|0|0|9.99000999000999|41.0125028184719|PARK7;DCK|2
3291|energy coupled proton transport, down electrochemical gradient (GO:0015985)|2/13|0.0164842230856883|0.248872752681264|0|0|9.99000999000999|41.0125028184719|ATP5G3;ATP5F1|2
3292|negative regulation of ubiquitin-protein transferase activity (GO:0051444)|2/13|0.0164842230856883|0.24813861476775|0|0|9.99000999000999|41.0125028184719|PARK7;MAD2L1|2
3293|translational termination (GO:0006415)|5/97|0.0171124621581032|0.256837924684708|0|0|3.3471682956219|13.6161075770851|MRPL51;MRPL18;MRPL28;MRPL12;MRPL13|2
3294|protein localization to nucleus (GO:0034504)|5/97|0.0171124621581032|0.256084734289739|0|0|3.3471682956219|13.6161075770851|RANBP1;NXT1;PLK1;HNRNPU;RAN|2
3295|cellular response to hypoxia (GO:0071456)|6/133|0.0171188281143873|0.255430935285726|0|0|2.92940142564203|11.9155639933811|PSMB6;PSMB7;PSMA4;PSMC3;PGK1;ELOB|2
3296|neutrophil degranulation (GO:0043312)|14/480|0.0172708263484451|0.256947600163602|0|0|1.89393939393939|7.68700102118831|ARG1;PGAM1;MIF;PA2G4;HMGB1;TUBB4B;PYCARD;PSMB7;PRDX4;PKM;PSMC3;IMPDH2;PPIA;S100A9|2
3297|regulation of mitochondrial membrane potential (GO:0051881)|3/36|0.0177496794948533|0.263304111808827|0|0|5.41125541125541|21.8148691550418|PRELID1;ATPIF1;PARK7|2
3298|positive regulation of ATPase activity (GO:0032781)|3/36|0.0177496794948533|0.262540911484744|0|0|5.41125541125541|21.8148691550418|UHRF1;HNRNPU;DNAJC9|2
3299|protein targeting to ER (GO:0045047)|5/98|0.0178125619691308|0.262709548348192|0|0|3.31301351709515|13.3443259408646|RPL3;RPS6;RPL14;RPSA;RPS2|2
3300|response to tumor necrosis factor (GO:0034612)|5/98|0.0178125619691308|0.261952460312607|0|0|3.31301351709515|13.3443259408646|PYCARD;CCL4;CCL2;YBX3;CCL17|2
3301|NADH dehydrogenase complex assembly (GO:0010257)|4/65|0.0179080324117465|0.262599682175696|0|0|3.996003996004|16.0739497650424|NDUFB8;NDUFB6;NDUFA5;NDUFA12|2
3302|mitochondrial respiratory chain complex I biogenesis (GO:0097031)|4/65|0.0179080324117465|0.261847247556281|0|0|3.996003996004|16.0739497650424|NDUFB8;NDUFB6;NDUFA5;NDUFA12|2
3303|mitochondrial respiratory chain complex I assembly (GO:0032981)|4/65|0.0179080324117465|0.261099112563263|0|0|3.996003996004|16.0739497650424|NDUFB8;NDUFB6;NDUFA5;NDUFA12|2
3304|regulation of translation (GO:0006417)|8/214|0.0181601024927138|0.264019951624839|0|0|2.42747906299308|9.73061842930698|DHFR;NDC1;RBM3;NCL;RPS27L;TYMS;GAPDH;RAN|2
3305|neutrophil activation involved in immune response (GO:0002283)|14/484|0.018409050662515|0.266878936167086|0|0|1.87828700225394|7.50359288405345|ARG1;PGAM1;MIF;PA2G4;HMGB1;TUBB4B;PYCARD;PSMB7;PRDX4;PKM;PSMC3;IMPDH2;PPIA;S100A9|2
3306|response to UV (GO:0009411)|5/99|0.0185313410427291|0.26789074600863|0|0|3.27954873409419|13.0797975530187|CDKN2D;PCNA;PCLAF;USP1;AURKB|2
3307|mitochondrial transport (GO:0006839)|6/136|0.0188948650838222|0.272374283962555|0|0|2.86478227654698|11.3699343464016|NDUFB8;TSPO;CYC1;ATP5G3;ATP5F1;COX5B|2
3308|nuclear-transcribed mRNA catabolic process (GO:0000956)|7/175|0.0189707779757781|0.272698253550411|0|0|2.5974025974026|10.2983259351392|RPL3;RPS6;RPL14;RPSA;RPS2;LSM5;LSM4|2
3309|nucleoside salvage (GO:0043174)|2/14|0.0190381515254407|0.272897997849225|0|0|9.27643784786642|36.7468491473071|TK1;DCK|2
3310|myeloid dendritic cell activation (GO:0001773)|2/14|0.0190381515254407|0.272133577687182|0|0|9.27643784786642|36.7468491473071|PYCARD;HMGB1|2
3311|mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)|2/14|0.0190381515254407|0.271373428028838|0|0|9.27643784786642|36.7468491473071|CYCS;CYC1|2
3312|negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254)|2/14|0.0190381515254407|0.270617513187532|0|0|9.27643784786642|36.7468491473071|CD74;MIF|2
3313|establishment of protein localization to chromosome (GO:0070199)|2/14|0.0190381515254407|0.269865797873122|0|0|9.27643784786642|36.7468491473071|H2AFY;HIST1H1B|2
3314|regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266)|2/14|0.0190381515254407|0.269118247186493|0|0|9.27643784786642|36.7468491473071|CCNB1;MAD2L1|2
3315|neutrophil mediated immunity (GO:0002446)|14/488|0.0196034672625283|0.27634390453227|0|0|1.8628912071535|7.32497918636629|ARG1;PGAM1;MIF;PA2G4;HMGB1;TUBB4B;PYCARD;PSMB7;PRDX4;PKM;PSMC3;IMPDH2;PPIA;S100A9|2
3316|positive regulation of cellular protein localization (GO:1903829)|4/67|0.019799103164902|0.27833284697106|0|0|3.87672029463074|15.2049569180438|PLK1;CDK1;PARK7;KIF20B|2
3317|nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)|3/38|0.0205066066981225|0.287486851594833|0|0|5.12645249487355|19.9265627142907|PCNA;RFC2;RPA2|2
3318|negative regulation of protein binding (GO:0032091)|4/68|0.0207890460658901|0.290647950888321|0|0|3.81970970206264|14.794992599089|PARK7;AURKB;AES;AURKA|2
3319|regulation of primary metabolic process (GO:0080090)|6/140|0.021453197236143|0.299113840153109|0|0|2.78293135435993|10.6916927349287|PSMB6;PSMB7;PSMA4;H2AFY;PSMC3;ODC1|2
3320|apoptotic DNA fragmentation (GO:0006309)|2/15|0.0217464266048587|0.302376062573826|0|0|8.65800865800866|33.1455050127677|HMGB2;HMGB1|2
3321|pyrimidine nucleoside biosynthetic process (GO:0046134)|2/15|0.0217464266048587|0.301554388490745|0|0|8.65800865800866|33.1455050127677|TK1;DCK|2
3322|regulation of exit from mitosis (GO:0007096)|2/15|0.0217464266048587|0.300737167925729|0|0|8.65800865800866|33.1455050127677|ANLN;UBE2C|2
3323|negative regulation of signal transduction by p53 class mediator (GO:1901797)|2/15|0.0217464266048587|0.299924364769173|0|0|8.65800865800866|33.1455050127677|CD74;MIF|2
3324|microtubule depolymerization (GO:0007019)|2/15|0.0217464266048587|0.299115943300793|0|0|8.65800865800866|33.1455050127677|STMN1;KIF2C|2
3325|positive regulation of T cell activation (GO:0050870)|4/69|0.0218088834557403|0.29916863514689|0|0|3.76435159043855|14.4002932212389|PYCARD;CCL2;AIF1;CCR2|2
3326|positive regulation of DNA repair (GO:0045739)|3/39|0.0219681971609695|0.300546139711602|0|0|4.995004995005|19.0717255498508|PCNA;H2AFX;HMGB1|2
3327|regulation of transcription, DNA-templated (GO:0006355)|35/1599|0.0222220656700636|0.303206420091803|0|0|1.42134288475752|5.41058265768701|SET;PCNA;GMNN;HMGB2;NUCKS1;ENO1;PARK7;HMGB1;MRPL12;TYMS;CKS1B;HINT1;YWHAQ;RAD21;SPP1;FBXO5;TCEAL9;CD74;CBX5;RRM2;CBX3;CNBP;ATAD2;PA2G4;DEK;SSRP1;HNRNPAB;AES;DHFR;CENPF;TFDP1;CKS2;BIRC5;RAN;EZH2|2
3328|double-strand break repair (GO:0006302)|6/142|0.0228161398811859|0.310482031503177|0|0|2.74373513810134|10.3721065591686|RAD51AP1;RAD21;H2AFX;NSD2;RPA2;NUCKS1|2
3329|response to organic cyclic compound (GO:0014070)|4/70|0.0228588149782286|0.31023545966463|0|0|3.71057513914657|14.0201056036432|CDKN2D;DHFR;SPP1;CCL2|2
3330|purine ribonucleoside monophosphate biosynthetic process (GO:0009168)|3/40|0.0234852528012271|0.31789189667019|0|0|4.87012987012987|18.269720431126|IMPDH2;ATP5G3;ATP5F1|2
3331|dendritic cell chemotaxis (GO:0002407)|2/16|0.0246037211188184|0.332150235104049|0|0|8.11688311688312|30.0718959617743|HMGB1;CCR2|2
3332|regulation of histone H3-K4 methylation (GO:0051569)|2/16|0.0246037211188184|0.331273849259447|0|0|8.11688311688312|30.0718959617743|DNMT1;H2AFY|2
3333|heme biosynthetic process (GO:0006783)|2/16|0.0246037211188184|0.330402075971922|0|0|8.11688311688312|30.0718959617743|ATPIF1;TSPO|2
3334|positive regulation of macrophage derived foam cell differentiation (GO:0010744)|2/16|0.0246037211188184|0.329534878922127|0|0|8.11688311688312|30.0718959617743|MSR1;PF4|2
3335|neuron apoptotic process (GO:0051402)|2/16|0.0246037211188184|0.328672222171022|0|0|8.11688311688312|30.0718959617743|GAPDH;CIT|2
3336|pyrimidine-containing compound metabolic process (GO:0072527)|2/16|0.0246037211188184|0.32781407015491|0|0|8.11688311688312|30.0718959617743|ERH;DCK|2
3337|regulation of stem cell proliferation (GO:0072091)|2/16|0.0246037211188184|0.326960387680548|0|0|8.11688311688312|30.0718959617743|HMGB2;HNRNPU|2
3338|nucleotide-excision repair, DNA incision (GO:0033683)|3/41|0.025057752197522|0.332129115490792|0|0|4.75134621476085|17.516180061913|PCNA;RFC2;RPA2|2
3339|mitochondrial translation (GO:0032543)|5/108|0.0258690450585894|0.341994137134667|0|0|3.00625300625301|10.986977502846|MRPL51;MRPL18;MRPL28;MRPL12;MRPL13|2
3340|SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146)|4/73|0.0261909630412845|0.345355256846705|0|0|3.55808574986657|12.9597610738401|PSMB6;PSMB7;PSMA4;PSMC3|2
3341|monocyte chemotaxis (GO:0002548)|3/42|0.0266856306697065|0.350971065225547|0|0|4.63821892393321|16.8071894044981|CCL4;CCL2;CCL17|2
3342|positive regulation of cytokine secretion (GO:0050715)|4/74|0.0273629911814503|0.358954611822471|0|0|3.51000351000351|12.6309717985122|PYCARD;HMGB1;MIF;GAPDH|2
3343|positive regulation of interleukin-6 secretion (GO:2000778)|2/17|0.0276048343856469|0.361198640692196|0|0|7.63941940412529|27.4237155286273|PYCARD;HMGB1|2
3344|DNA packaging (GO:0006323)|2/17|0.0276048343856469|0.360274859002446|0|0|7.63941940412529|27.4237155286273|RBBP4;HAT1|2
3345|defense response to fungus (GO:0050832)|2/17|0.0276048343856469|0.359355790484582|0|0|7.63941940412529|27.4237155286273|S100A9;GAPDH|2
3346|regulation of T cell migration (GO:2000404)|2/17|0.0276048343856469|0.358441399160194|0|0|7.63941940412529|27.4237155286273|PYCARD;AIF1|2
3347|nucleobase-containing compound biosynthetic process (GO:0034654)|2/17|0.0276048343856469|0.357531649416133|0|0|7.63941940412529|27.4237155286273|TYMS;DCK|2
3348|mitotic G2 DNA damage checkpoint (GO:0007095)|2/17|0.0276048343856469|0.356626505999889|0|0|7.63941940412529|27.4237155286273|CLSPN;TOPBP1|2
3349|positive regulation of protein localization to nucleus (GO:1900182)|3/43|0.02836878206297|0.365570441584181|0|0|4.53035336756267|16.1392296656841|PLK1;CDK1;PARK7|2
3350|negative regulation of phosphorylation (GO:0042326)|4/76|0.0297998230399254|0.383044072979192|0|0|3.41763499658236|12.007015802276|CDKN2D;CDKN2C;HNRNPU;PARK7|2
3351|negative regulation of cellular amide metabolic process (GO:0034249)|4/76|0.0297998230399254|0.382081650685274|0|0|3.41763499658236|12.007015802276|DHFR;NCL;TYMS;GAPDH|2
3352|antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)|4/76|0.0297998230399254|0.381124052563256|0|0|3.41763499658236|12.007015802276|PSMB6;PSMB7;PSMA4;PSMC3|2
3353|intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332)|3/44|0.0301070604904704|0.384090824207176|0|0|4.42739079102715|15.5091303140982|PYCARD;HINT1;RPS27L|2
3354|regulation of ATP metabolic process (GO:1903578)|3/44|0.0301070604904704|0.383132991727857|0|0|4.42739079102715|15.5091303140982|NDC1;PGAM1;ATPIF1|2
3355|regulation of multicellular organismal development (GO:2000026)|3/44|0.0301070604904704|0.382179924584255|0|0|4.42739079102715|15.5091303140982|RACGAP1;CDK1;HMGB1|2
3356|regulation of interferon-gamma production (GO:0032649)|3/44|0.0301070604904704|0.381231587302408|0|0|4.42739079102715|15.5091303140982|PYCARD;HMGB1;CCR2|2
3357|nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)|5/113|0.030647342151503|0.387112344057228|0|0|2.87323296172854|10.0138183440438|RPL3;RPS6;RPL14;RPSA;RPS2|2
3358|porphyrin-containing compound biosynthetic process (GO:0006779)|2/18|0.0307446896728709|0.387383089878174|0|0|7.21500721500721|25.1229292439252|ATPIF1;TSPO|2
3359|regulation of spindle organization (GO:0090224)|2/18|0.0307446896728709|0.386428944336602|0|0|7.21500721500721|25.1229292439252|TPX2;TACC3|2
3360|establishment of mitotic spindle localization (GO:0040001)|2/18|0.0307446896728709|0.38547948747091|0|0|7.21500721500721|25.1229292439252|NUSAP1;CENPA|2
3361|prostaglandin biosynthetic process (GO:0001516)|2/18|0.0307446896728709|0.38453468480554|0|0|7.21500721500721|25.1229292439252|CD74;MIF|2
3362|regulation of microtubule polymerization or depolymerization (GO:0031110)|2/18|0.0307446896728709|0.383594502202103|0|0|7.21500721500721|25.1229292439252|STMN1;SKA1|2
3363|double-strand break repair via homologous recombination (GO:0000724)|4/77|0.0310648490987489|0.386643719392477|0|0|3.37325012649688|11.7108394436677|RAD51AP1;GINS2;RPA2;NUCKS1|2
3364|regulation of hematopoietic stem cell differentiation (GO:1902036)|4/77|0.0310648490987489|0.385702980415853|0|0|3.37325012649688|11.7108394436677|PSMB6;PSMB7;PSMA4;PSMC3|2
3365|regulation of intracellular signal transduction (GO:1902531)|12/423|0.0316459811232603|0.39196466425242|0|0|1.84212950170397|6.36113865189718|PYCARD;ARHGAP11A;TPX2;RACGAP1;RBBP4;RFC2;RPA2;TOPBP1;RBBP7;SSRP1;AURKB;AURKA|2
3366|lymphocyte chemotaxis (GO:0048247)|3/45|0.0319002820269323|0.394157721993791|0|0|4.32900432900433|14.9140278279686|CCL4;CCL2;CCL17|2
3367|regulation of hematopoietic progenitor cell differentiation (GO:1901532)|4/78|0.0323610748733697|0.398885422895666|0|0|3.33000333000333|11.4245719987744|PSMB6;PSMB7;PSMA4;PSMC3|2
3368|positive regulation of translation (GO:0045727)|4/79|0.0336885788494937|0.414247753901124|0|0|3.28785138911721|11.1477771021168|RBM3;EIF5A;RPS27L;YBX3|2
3369|antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590)|4/79|0.0336885788494937|0.413251966031169|0|0|3.28785138911721|11.1477771021168|PSMB6;PSMB7;PSMA4;PSMC3|2
3370|protein polymerization (GO:0051258)|3/46|0.0337482263577478|0.412990885140497|0|0|4.23489553924337|14.3513301047751|UBE2C;UBE2S;AIF1|2
3371|positive regulation of chromosome organization (GO:2001252)|2/19|0.0340183315901975|0.415300349532961|0|0|6.83526999316473|23.1090617583412|RAD21;HNRNPU|2
3372|positive regulation of activated T cell proliferation (GO:0042104)|2/19|0.0340183315901975|0.41430917924768|0|0|6.83526999316473|23.1090617583412|PYCARD;HMGB1|2
3373|ribosomal small subunit assembly (GO:0000028)|2/19|0.0340183315901975|0.4133227288209|0|0|6.83526999316473|23.1090617583412|RPS27L;RPSA|2
3374|protein heterotetramerization (GO:0051290)|2/19|0.0340183315901975|0.412340964619425|0|0|6.83526999316473|23.1090617583412|CD74;NUDT21|2
3375|cellular response to interferon-gamma (GO:0071346)|5/117|0.0348442645474049|0.42135137911234|0|0|2.77500277500278|9.31531449305388|CCL4;CCL2;GAPDH;AIF1;CCL17|2
3376|cellular response to ionizing radiation (GO:0071479)|3/47|0.0356506383615339|0.430083232999781|0|0|4.14479137883393|13.8186856559592|RAD51AP1;TMEM109;NUCKS1|2
3377|spindle assembly (GO:0051225)|4/81|0.0364376713736189|0.438541125046173|0|0|3.20666987333654|10.6209783923726|TPX2;KIFC1;BIRC5;KIF11|2
3378|NIK/NF-kappaB signaling (GO:0038061)|4/81|0.0364376713736189|0.437509263575476|0|0|3.20666987333654|10.6209783923726|PSMB6;PSMB7;PSMA4;PSMC3|2
3379|cytokine-mediated signaling pathway (GO:0019221)|16/634|0.0372494359363867|0.446206271322491|0|0|1.63873980908681|5.39164812473851|MIF;LMNB1;PSMB6;PYCARD;PSMB7;PSMA4;PSMC3;HNRNPA2B1;CCL4;BIRC5;CCL2;PLP2;CCL17;PPIA;CCR2;PF4|2
3380|positive regulation of ERK1 and ERK2 cascade (GO:0070374)|7/202|0.0373457757416307|0.446312631404078|0|0|2.25022502250225|7.39769458390305|PYCARD;CD74;CCL4;CCL2;MIF;HMGB1;CCL17|2
3381|regulation of gluconeogenesis (GO:0006111)|2/20|0.0374209236028602|0.446165825106064|0|0|6.49350649350649|21.334579716728|PGP;ARPP19|2
3382|negative regulation of intracellular protein transport (GO:0090317)|2/20|0.0374209236028602|0.445125811527728|0|0|6.49350649350649|21.334579716728|PARK7;RANGAP1|2
3383|negative regulation of phosphate metabolic process (GO:0045936)|2/20|0.0374209236028602|0.44409063522185|0|0|6.49350649350649|21.334579716728|CDKN2D;CDKN2C|2
3384|regulation of DNA-templated transcription, elongation (GO:0032784)|2/20|0.0374209236028602|0.443060262518319|0|0|6.49350649350649|21.334579716728|ALYREF;HMGN1|2
3385|negative regulation of telomere maintenance via telomerase (GO:0032211)|2/20|0.0374209236028602|0.442034660058786|0|0|6.49350649350649|21.334579716728|HNRNPU;HNRNPA1|2
3386|covalent chromatin modification (GO:0016569)|2/20|0.0374209236028602|0.441013794793061|0|0|6.49350649350649|21.334579716728|HELLS;AURKB|2
3387|positive regulation of cellular biosynthetic process (GO:0031328)|6/160|0.0377501350523441|0.443868523438046|0|0|2.43506493506493|7.97913853672394|RBM3;DBF4;PCNA;RPS27L;PARK7;ARPP19|2
3388|negative regulation of cellular process (GO:0048523)|14/535|0.0383902709465711|0.450357592276672|0|0|1.69923534409516|5.53942431989141|CDKN2D;CDKN2C;GMNN;ENO1;MIF;EMP3;PARK7;RBBP4;TMEM109;ANP32B;TGFBI;RBBP7;CDKN3;PF4|2
3389|negative regulation of binding (GO:0051100)|4/83|0.0393125010105926|0.460118561140032|0|0|3.12940071976217|10.1274064115626|PARK7;AURKB;AES;AURKA|2
3390|intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630)|3/49|0.0396176801751542|0.462629340809638|0|0|3.97561622051418|12.835196625854|PYCARD;RPS27L;CRIP1|2
3391|positive regulation of chemotaxis (GO:0050921)|3/49|0.0396176801751542|0.461573109437927|0|0|3.97561622051418|12.835196625854|AIF1;CCR2;PF4|2
3392|RNA-dependent DNA biosynthetic process (GO:0006278)|2/21|0.0409477455632217|0.475982564029886|0|0|6.18429189857761|19.7616482597386|NHP2;PPIA|2
3393|mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)|2/21|0.0409477455632217|0.474900785475273|0|0|6.18429189857761|19.7616482597386|CYCS;COX5B|2
3394|intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771)|2/21|0.0409477455632217|0.473823912945851|0|0|6.18429189857761|19.7616482597386|PYCARD;RPS27L|2
3395|regulation of macrophage activation (GO:0043030)|2/21|0.0409477455632217|0.472751913142806|0|0|6.18429189857761|19.7616482597386|CD74;MIF|2
3396|negative regulation of cell cycle arrest (GO:0071157)|2/21|0.0409477455632217|0.471684753067991|0|0|6.18429189857761|19.7616482597386|CDK4;MIF|2
3397|tumor necrosis factor-mediated signaling pathway (GO:0033209)|5/124|0.0430077653060801|0.494298708011097|0|0|2.61834939254294|8.23830799926483|PYCARD;PSMB6;PSMB7;PSMA4;PSMC3|2
3398|negative regulation of nucleic acid-templated transcription (GO:1903507)|12/445|0.0437619021086349|0.501835924630031|0|0|1.75105793083321|5.47904565296287|CENPF;SET;CBX5;YWHAQ;CBX3;GMNN;HMGB2;BIRC5;ENO1;PA2G4;EZH2;AES|2
3399|GTP metabolic process (GO:0046039)|2/22|0.0445941912826823|0.510233538375623|0|0|5.90318772136954|18.3598091424836|IMPDH2;RAN|2
3400|DNA catabolic process, endonucleolytic (GO:0000737)|2/22|0.0445941912826823|0.509092076321091|0|0|5.90318772136954|18.3598091424836|HMGB2;HMGB1|2
3401|positive regulation of interleukin-10 production (GO:0032733)|2/22|0.0445941912826823|0.507955710079303|0|0|5.90318772136954|18.3598091424836|PYCARD;HMGB1|2
3402|rRNA modification (GO:0000154)|2/22|0.0445941912826823|0.506824405602512|0|0|5.90318772136954|18.3598091424836|NOP58;NHP2|2
3403|STAT cascade (GO:0097696)|2/22|0.0445941912826823|0.505698129145617|0|0|5.90318772136954|18.3598091424836|CCL2;CCR2|2
3404|viral genome replication (GO:0019079)|2/22|0.0445941912826823|0.504576847262811|0|0|5.90318772136954|18.3598091424836|CCL2;DEK|2
3405|regulation of telomere maintenance via telomerase (GO:0032210)|3/52|0.0459685397186638|0.518976677398985|0|0|3.74625374625375|11.537704928691|HNRNPU;HNRNPA1;AURKB|2
3406|telomere maintenance (GO:0000723)|3/52|0.0459685397186638|0.517831033519517|0|0|3.74625374625375|11.537704928691|PCNA;RPA2;SMC6|2
3407|non-canonical Wnt signaling pathway (GO:0035567)|5/128|0.0481473379875568|0.541180321036349|0|0|2.53652597402597|7.69452472628522|PSMB6;PSMB7;PSMA4;PSMC3;AP2S1|2
3408|regulation of DNA binding (GO:0051101)|3/53|0.0481906409583895|0.540476573210245|0|0|3.67556971330556|11.1464976026721|HJURP;HMGB2;HMGB1|2
3409|mitotic G2/M transition checkpoint (GO:0044818)|2/23|0.0483557661681577|0.541139199026554|0|0|5.64652738565782|17.1042902613581|CLSPN;TOPBP1|2
3410|microtubule polymerization or depolymerization (GO:0031109)|2/23|0.0483557661681577|0.539955086993674|0|0|5.64652738565782|17.1042902613581|STMN1;KIF2C|2
3411|regulation of proteolysis involved in cellular protein catabolic process (GO:1903050)|2/23|0.0483557661681577|0.538776145755696|0|0|5.64652738565782|17.1042902613581|ATPIF1;UCHL5|2
3412|folic acid-containing compound metabolic process (GO:0006760)|2/23|0.0483557661681577|0.537602341516577|0|0|5.64652738565782|17.1042902613581|DHFR;ATPIF1|2
3413|positive regulation of monooxygenase activity (GO:0032770)|2/23|0.0483557661681577|0.53643364077415|0|0|5.64652738565782|17.1042902613581|DHFR;PARK7|2
3414|regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434)|4/89|0.0486922291421161|0.538994458377914|0|0|2.91842988472202|8.82018335764158|SUMO2;PLK1;PARK7;COMMD1|2
3415|negative regulation of translation (GO:0017148)|4/89|0.0486922291421161|0.537827803706101|0|0|2.91842988472202|8.82018335764158|DHFR;NCL;TYMS;GAPDH|2
3416|negative regulation of cellular protein metabolic process (GO:0032269)|4/90|0.0503654245558199|0.555107476259933|0|0|2.88600288600289|8.62467636375919|DHFR;NCL;TYMS;GAPDH|2
3417|post-translational protein modification (GO:0043687)|10/358|0.0514284911924311|0.565602565851241|0|0|1.81382862947109|5.38265065068506|PSMB6;PSMB7;LGALS1;PSMA4;PSMC3;SPP1;ELOB;ESCO2;COMMD1;RBBP7|2
3418|cellular response to cytokine stimulus (GO:0071345)|12/457|0.0515792818951873|0.566041022604604|0|0|1.70507829151155|5.05493512310433|PYCARD;CCL4;HNRNPU;BIRC5;CCL2;PLP2;AIF1;CCL17;YBX3;GAPDH;CCR2;PF4|2
3419|positive regulation of hydrolase activity (GO:0051345)|6/173|0.0517041468508419|0.566193693948168|0|0|2.25208317693867|6.67115972705541|CCL4;HMGB2;CCL2;DNAJC9;CCL17;EZH2|2
3420|positive regulation of response to external stimulus (GO:0032103)|4/91|0.0520698879995159|0.568977812551455|0|0|2.85428856857428|8.43490356149446|CCL4;LY86;S100A9;CCR2|2
3421|protein tetramerization (GO:0051262)|4/91|0.0520698879995159|0.567762047994721|0|0|2.85428856857428|8.43490356149446|CD74;NUDT21;ATPIF1;TK1|2
3422|intracellular transport of virus (GO:0075733)|3/55|0.0527898577142634|0.574385168264149|0|0|3.54191263282172|10.4183100193613|NDC1;KPNA2;RAN|2
3423|transport of virus (GO:0046794)|3/55|0.0527898577142634|0.57316307216146|0|0|3.54191263282172|10.4183100193613|NDC1;KPNA2;RAN|2
3424|positive regulation of cellular protein metabolic process (GO:0032270)|4/92|0.0538055447456368|0.582950519823746|0|0|2.82326369282891|8.25064583551209|RBM3;UHRF1;PLK1;RPS27L|2
3425|positive regulation of cysteine-type endopeptidase activity (GO:2001056)|3/56|0.0551659878808469|0.596423805415173|0|0|3.47866419294991|10.0791118176606|PYCARD;CYCS;HMGB1|2
3426|positive regulation of DNA biosynthetic process (GO:2000573)|3/56|0.0551659878808469|0.59516286713734|0|0|3.47866419294991|10.0791118176606|RFC2;HNRNPA1;AURKB|2
3427|positive regulation of histone methylation (GO:0031062)|2/25|0.0562068691425022|0.605113192477192|0|0|5.19480519480519|14.9543704042424|DNMT1;HIST1H1B|2
3428|positive regulation of neutrophil chemotaxis (GO:0090023)|2/25|0.0562068691425022|0.603839269966713|0|0|5.19480519480519|14.9543704042424|CD74;PF4|2
3429|regulation of chromosome organization (GO:0033044)|2/25|0.0562068691425022|0.602570700071825|0|0|5.19480519480519|14.9543704042424|HNRNPU;MKI67|2
3430|cellular modified amino acid biosynthetic process (GO:0042398)|2/25|0.0562068691425022|0.601307449128278|0|0|5.19480519480519|14.9543704042424|GATM;ATPIF1|2
3431|positive regulation of DNA-templated transcription, elongation (GO:0032786)|2/25|0.0562068691425022|0.600049483753533|0|0|5.19480519480519|14.9543704042424|ALYREF;HMGN1|2
3432|positive regulation of endopeptidase activity (GO:0010950)|2/25|0.0562068691425022|0.598796770843818|0|0|5.19480519480519|14.9543704042424|PYCARD;PRELID1|2
3433|eosinophil chemotaxis (GO:0048245)|2/25|0.0562068691425022|0.597549277571227|0|0|5.19480519480519|14.9543704042424|CCL4;CCL2|2
3434|eosinophil migration (GO:0072677)|2/25|0.0562068691425022|0.59630697138085|0|0|5.19480519480519|14.9543704042424|CCL4;CCL2|2
3435|DNA replication initiation (GO:0006270)|2/25|0.0562068691425022|0.595069819987944|0|0|5.19480519480519|14.9543704042424|POLE3;TOPBP1|2
3436|regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281)|4/94|0.0573700870916971|0.606127441881843|0|0|2.76319425255595|7.8978509043911|PYCARD;CDKN2D;CYCS;HMGB1|2
3437|proteolysis involved in cellular protein catabolic process (GO:0051603)|4/94|0.0573700870916971|0.604875112456467|0|0|2.76319425255595|7.8978509043911|PSMB6;UBL4A;PSMB7;PSMA4|2
3438|ribosome assembly (GO:0042255)|3/57|0.0575924394855979|0.605967461226817|0|0|3.41763499658236|9.75517422702013|RPL3;RPS27L;RPSA|2
3439|protein import (GO:0017038)|3/57|0.0575924394855979|0.604720614598778|0|0|3.41763499658236|9.75517422702013|RANBP1;NXT1;RAN|2
3440|prostaglandin metabolic process (GO:0006693)|2/26|0.0602879453102327|0.631723582994081|0|0|4.995004995005|14.0290864494031|CD74;MIF|2
3441|positive regulation of nuclear division (GO:0051785)|2/26|0.0602879453102327|0.630429067455159|0|0|4.995004995005|14.0290864494031|NUSAP1;AURKA|2
3442|regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)|2/26|0.0602879453102327|0.629139846458318|0|0|4.995004995005|14.0290864494031|CD74;MIF|2
3443|negative regulation of cellular protein localization (GO:1903828)|2/26|0.0602879453102327|0.627855887587995|0|0|4.995004995005|14.0290864494031|H2AFY;COMMD1|2
3444|positive regulation of neutrophil migration (GO:1902624)|2/26|0.0602879453102327|0.626577158692704|0|0|4.995004995005|14.0290864494031|CD74;PF4|2
3445|protein depolymerization (GO:0051261)|2/26|0.0602879453102327|0.625303627882353|0|0|4.995004995005|14.0290864494031|STMN1;KIF2C|2
3446|Golgi vesicle transport (GO:0048193)|8/272|0.060394123081605|0.625134300376127|0|0|1.90985485103132|5.36070183107094|CENPE;SNX2;RACGAP1;KIF23;KIF2C;KIF11;KIF22;KIF15|2
3447|cellular protein modification process (GO:0006464)|22/1002|0.0606464624228162|0.626475501505326|0|0|1.42571998859424|3.99585681926024|PLK4;UBL4A;PLK1;GLRX;COMMD1;PARK7;AURKB;AURKA;PSMB6;PSMB7;LGALS1;PSMA4;PSMC3;UBE2S;CDK4;SPP1;PGP;CDK1;BIRC5;CCL2;ELOB;RBBP7|2
3448|interleukin-1-mediated signaling pathway (GO:0070498)|4/96|0.06105824808061|0.629455030212834|0|0|2.70562770562771|7.56473751043184|PSMB6;PSMB7;PSMA4;PSMC3|2
3449|ribosome biogenesis (GO:0042254)|7/227|0.0623795840156685|0.641780276677331|0|0|2.00240288346015|5.55570131433248|NOP58;RPL3;RPS6;RPL14;RPSA;RPS2;RAN|2
3450|positive regulation of transferase activity (GO:0051347)|5/138|0.0625202678058442|0.641933453950147|0|0|2.35271974402409|6.5223614010805|CD74;RFC2;PLK1;RPS2;AURKB|2
3451|response to light stimulus (GO:0009416)|3/59|0.0625941071612983|0.641401061935954|0|0|3.30178296279991|9.14951840230217|CDKN2D;PCLAF;USP1|2
3452|ciliary basal body-plasma membrane docking (GO:0097711)|4/97|0.0629483911701714|0.643738757798366|0|0|2.67773463649752|7.40511467688666|PLK4;PLK1;CDK1;TUBB4B|2
3453|ncRNA processing (GO:0034470)|7/228|0.06355193353301|0.648611033637901|0|0|1.99362041467305|5.49421422732809|NOP58;RPL3;HNRNPA2B1;RPS6;RPL14;RPSA;RPS2|2
3454|positive regulation of cyclin-dependent protein kinase activity (GO:1904031)|2/27|0.0644672423634751|0.65663939676809|0|0|4.81000481000481|13.18709982936|CKS2;CKS1B|2
3455|cytoskeleton-dependent intracellular transport (GO:0030705)|2/27|0.0644672423634751|0.655331350160983|0|0|4.81000481000481|13.18709982936|TUBA1C;TUBA1B|2
3456|regulation of centrosome cycle (GO:0046605)|2/27|0.0644672423634751|0.65402850453442|0|0|4.81000481000481|13.18709982936|KIF11;AURKA|2
3457|nucleotide biosynthetic process (GO:0009165)|2/27|0.0644672423634751|0.652730828930185|0|0|4.81000481000481|13.18709982936|RRM1;RRM2|2
3458|positive regulation of granulocyte chemotaxis (GO:0071624)|2/27|0.0644672423634751|0.651438292635274|0|0|4.81000481000481|13.18709982936|CD74;PF4|2
3459|regulation of viral entry into host cell (GO:0046596)|2/27|0.0644672423634751|0.650150865179473|0|0|4.81000481000481|13.18709982936|CD74;LGALS1|2
3460|negative regulation of telomere maintenance via telomere lengthening (GO:1904357)|2/27|0.0644672423634751|0.648868516332965|0|0|4.81000481000481|13.18709982936|HNRNPU;HNRNPA1|2
3461|mitochondrial respiratory chain complex assembly (GO:0033108)|4/98|0.0648690664885191|0.651627650178963|0|0|2.65041081367612|7.24989239956745|NDUFB8;NDUFB6;NDUFA5;NDUFA12|2
3462|histone modification (GO:0016570)|4/99|0.0668201303390003|0.669907907897678|0|0|2.62363898727535|7.0989135286811|CCNA2;UHRF1;AURKB;EZH2|2
3463|cristae formation (GO:0042407)|2/28|0.0687407896709783|0.687812254296083|0|0|4.63821892393321|12.4184254166612|ATP5G3;ATP5F1|2
3464|regulation of double-strand break repair via homologous recombination (GO:0010569)|2/28|0.0687407896709783|0.686466242056756|0|0|4.63821892393321|12.4184254166612|RAD51AP1;RPA2|2
3465|modification-dependent protein catabolic process (GO:0019941)|5/142|0.0688781434073591|0.686494464468268|0|0|2.28644594841778|6.11719492693022|UBL4A;RANBP1;UBE2C;UBE2S;UHRF1|2
3466|regulation of tumor necrosis factor production (GO:0032680)|3/62|0.0704597938958694|0.700889528753648|0|0|3.14201927105153|8.33487546458676|PYCARD;MIF;PF4|2
3467|positive regulation of macromolecule biosynthetic process (GO:0010557)|5/143|0.0705215930339447|0.700139473253346|0|0|2.27045681591136|6.02087987442082|RBM3;DBF4;PCNA;RPS27L;CCL2|2
3468|intrinsic apoptotic signaling pathway (GO:0097193)|4/102|0.0728540817667478|0.721891998554784|0|0|2.54647313470843|6.66996872464461|PYCARD;HINT1;CYCS;CRIP1|2
3469|protein export from nucleus (GO:0006611)|2/29|0.0731047149157742|0.722971628324023|0|0|4.47828034034931|11.7145652251438|EIF5A;RAN|2
3470|establishment of protein localization to organelle (GO:0072594)|3/63|0.0731760964863773|0.722277795686621|0|0|3.09214594928881|8.08561058156068|RANBP1;NXT1;RAN|2
3471|protein polyubiquitination (GO:0000209)|8/284|0.0735484588762505|0.72455170974036|0|0|1.82915675873422|4.7737530374433|PSMB6;PSMB7;PSMA4;PSMC3;UBE2C;UBE2S;ANAPC5;ANAPC11|2
3472|negative regulation of apoptotic process (GO:0043066)|12/486|0.0742512540859075|0.730065798844674|0|0|1.60333493666827|4.16915281609118|CDKN2D;CD74;PRELID1;SET;PLK1;CDK1;BIRC5;CCL2;MIF;PA2G4;PARK7;MAD2L1|2
3473|regulation of viral genome replication (GO:0045069)|3/64|0.0759385413904366|0.745219955221919|0|0|3.04383116883117|7.84648213806141|TOP2A;BANF1;PPIA|2
3474|negative regulation of neuron apoptotic process (GO:0043524)|3/64|0.0759385413904366|0.743789590624565|0|0|3.04383116883117|7.84648213806141|SET;CCL2;PARK7|2
3475|ribosomal large subunit biogenesis (GO:0042273)|3/64|0.0759385413904366|0.742364706351337|0|0|3.04383116883117|7.84648213806141|RPL3;NHP2;RPL14|2
3476|plasma membrane invagination (GO:0099024)|4/104|0.0770256273148229|0.751552153322259|0|0|2.4975024975025|6.40264008549219|MSR1;IGKC;AIF1;AURKB|2
3477|protein import into nucleus (GO:0006606)|4/104|0.0770256273148229|0.750117893487674|0|0|2.4975024975025|6.40264008549219|RANBP1;NXT1;KPNA2;RAN|2
3478|regulation of macrophage derived foam cell differentiation (GO:0010743)|2/30|0.0775552419564994|0.753836951817174|0|0|4.32900432900433|11.0682458749134|MSR1;PF4|2
3479|regulation of embryonic development (GO:0045995)|2/30|0.0775552419564994|0.752403801718662|0|0|4.32900432900433|11.0682458749134|RACGAP1;CDK1|2
3480|positive regulation of interleukin-1 secretion (GO:0050716)|2/30|0.0775552419564994|0.750976090519955|0|0|4.32900432900433|11.0682458749134|PYCARD;HMGB1|2
3481|coenzyme biosynthetic process (GO:0009108)|2/30|0.0775552419564994|0.749553787318213|0|0|4.32900432900433|11.0682458749134|DHFR;ATPIF1|2
3482|regulation of activated T cell proliferation (GO:0046006)|2/30|0.0775552419564994|0.748136861444265|0|0|4.32900432900433|11.0682458749134|PYCARD;HMGB1|2
3483|positive regulation of lymphocyte activation (GO:0051251)|4/105|0.0791555134345618|0.762133179352016|0|0|2.47371675943105|6.27418883619625|PYCARD;IGKC;CCL2;CCR2|2
3484|positive regulation of MAPK cascade (GO:0043410)|8/290|0.080729157196584|0.775820883567171|0|0|1.79131213613972|4.50811547767025|PYCARD;CD74;CCL4;CCL2;MIF;HMGB1;CCL17;EZH2|2
3485|negative regulation of canonical Wnt signaling pathway (GO:0090090)|5/149|0.0808315099380855|0.77534435190611|0|0|2.17902902466661|5.48110436458231|PSMB6;PSMB7;PSMA4;PSMC3;AES|2
3486|negative regulation of blood vessel morphogenesis (GO:2000181)|3/66|0.0815992185353894|0.781239797722499|0|0|2.95159386068477|7.39650411402043|PGK1;CCR2;PF4|2
3487|regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739)|2/31|0.0820886888895104|0.784454268545265|0|0|4.18935902806871|10.4732092349057|TFDP1;YWHAQ|2
3488|positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737)|2/31|0.0820886888895104|0.782987998884433|0|0|4.18935902806871|10.4732092349057|CKS2;CKS1B|2
3489|negative regulation of transferase activity (GO:0051348)|2/31|0.0820886888895104|0.781527200379051|0|0|4.18935902806871|10.4732092349057|HNRNPU;PARK7|2
3490|negative regulation of DNA biosynthetic process (GO:2000279)|2/31|0.0820886888895104|0.780071842464007|0|0|4.18935902806871|10.4732092349057|HNRNPU;HNRNPA1|2
3491|positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740)|2/31|0.0820886888895104|0.778621894801434|0|0|4.18935902806871|10.4732092349057|TFDP1;YWHAQ|2
3492|positive regulation of B cell proliferation (GO:0030890)|2/31|0.0820886888895104|0.777177327278611|0|0|4.18935902806871|10.4732092349057|CD74;MIF|2
3493|regulation of cytokine secretion (GO:0050707)|2/32|0.0867014660139328|0.819328853831665|0|0|4.05844155844156|9.92404418139893|MIF;GAPDH|2
3494|negative regulation of protein serine/threonine kinase activity (GO:0071901)|3/68|0.0874364293736825|0.824746948417563|0|0|2.86478227654698|6.98102541378953|PYCARD;H2AFY;PLK1|2
3495|cellular response to UV (GO:0034644)|3/68|0.0874364293736825|0.823225275080999|0|0|2.86478227654698|6.98102541378953|PCNA;CRIP1;AURKB|2
3496|regulation of protein activation cascade (GO:2000257)|4/109|0.0879643351694019|0.826670354271562|0|0|2.38293816275468|5.79250286862584|C1QB;C1QA;IGKC;C1QC|2
3497|negative regulation of membrane potential (GO:0045837)|1/6|0.0889251949266158|0.834164098732574|0|0|10.8225108225108|26.1900407912999|PRELID1|2
3498|positive regulation of DNA-directed DNA polymerase activity (GO:1900264)|1/6|0.0889251949266158|0.832633522404624|0|0|10.8225108225108|26.1900407912999|RFC2|2
3499|macropinocytosis (GO:0044351)|1/6|0.0889251949266158|0.83110855258337|0|0|10.8225108225108|26.1900407912999|PYCARD|2
3500|regulation of fat cell proliferation (GO:0070344)|1/6|0.0889251949266158|0.829589158520147|0|0|10.8225108225108|26.1900407912999|TFDP1|2
3501|regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903376)|1/6|0.0889251949266158|0.82807530969073|0|0|10.8225108225108|26.1900407912999|PARK7|2
3502|positive regulation of adaptive immune response (GO:0002821)|1/6|0.0889251949266158|0.826566975793297|0|0|10.8225108225108|26.1900407912999|PYCARD|2
3503|positive regulation of cellular extravasation (GO:0002693)|1/6|0.0889251949266158|0.825064126746401|0|0|10.8225108225108|26.1900407912999|CCR2|2
3504|regulation of histone H3-K27 methylation (GO:0061085)|1/6|0.0889251949266158|0.82356673268697|0|0|10.8225108225108|26.1900407912999|H2AFY|2
3505|histone-serine phosphorylation (GO:0035404)|1/6|0.0889251949266158|0.822074763968334|0|0|10.8225108225108|26.1900407912999|AURKB|2
3506|negative regulation of chromosome organization (GO:2001251)|1/6|0.0889251949266158|0.820588191158264|0|0|10.8225108225108|26.1900407912999|TOP2A|2
3507|protein localization to nuclear envelope (GO:0090435)|1/6|0.0889251949266158|0.81910698503704|0|0|10.8225108225108|26.1900407912999|PLK1|2
3508|viral release from host cell (GO:0019076)|1/6|0.0889251949266158|0.817631116595532|0|0|10.8225108225108|26.1900407912999|PPIA|2
3509|cellular hyperosmotic response (GO:0071474)|1/6|0.0889251949266158|0.81616055703331|0|0|10.8225108225108|26.1900407912999|YBX3|2
3510|regulation of superoxide metabolic process (GO:0090322)|1/6|0.0889251949266158|0.814695277756769|0|0|10.8225108225108|26.1900407912999|DHFR|2
3511|positive regulation of ATP biosynthetic process (GO:2001171)|1/6|0.0889251949266158|0.813235250377276|0|0|10.8225108225108|26.1900407912999|ENO1|2
3512|negative regulation of cellular response to hypoxia (GO:1900038)|1/6|0.0889251949266158|0.811780446709339|0|0|10.8225108225108|26.1900407912999|ENO1|2
3513|regulation of nuclear cell cycle DNA replication (GO:0033262)|1/6|0.0889251949266158|0.810330838768786|0|0|10.8225108225108|26.1900407912999|TIPIN|2
3514|regulation of nuclease activity (GO:0032069)|1/6|0.0889251949266158|0.808886398770981|0|0|10.8225108225108|26.1900407912999|HMGB2|2
3515|negative regulation of necroptotic process (GO:0060546)|1/6|0.0889251949266158|0.80744709912904|0|0|10.8225108225108|26.1900407912999|YBX3|2
3516|snRNA modification (GO:0040031)|1/6|0.0889251949266158|0.806012912452079|0|0|10.8225108225108|26.1900407912999|NHP2|2
3517|negative regulation of meiotic cell cycle (GO:0051447)|1/6|0.0889251949266158|0.804583811543476|0|0|10.8225108225108|26.1900407912999|FBXO5|2
3518|regulation of NAD(P)H oxidase activity (GO:0033860)|1/6|0.0889251949266158|0.803159769399151|0|0|10.8225108225108|26.1900407912999|PARK7|2
3519|regulation of protein targeting (GO:1903533)|1/6|0.0889251949266158|0.801740759205866|0|0|10.8225108225108|26.1900407912999|ATPIF1|2
3520|negative regulation of interferon-gamma-mediated signaling pathway (GO:0060336)|1/6|0.0889251949266158|0.800326754339542|0|0|10.8225108225108|26.1900407912999|ARG1|2
3521|negative regulation of response to interferon-gamma (GO:0060331)|1/6|0.0889251949266158|0.798917728363592|0|0|10.8225108225108|26.1900407912999|ARG1|2
3522|regulation of cellular response to oxidative stress (GO:1900407)|1/6|0.0889251949266158|0.797513655027276|0|0|10.8225108225108|26.1900407912999|DHFR|2
3523|regulation of glial cell apoptotic process (GO:0034350)|1/6|0.0889251949266158|0.796114508264071|0|0|10.8225108225108|26.1900407912999|CCL2|2
3524|negative regulation of leukocyte degranulation (GO:0043301)|1/6|0.0889251949266158|0.794720262190053|0|0|10.8225108225108|26.1900407912999|CCR2|2
3525|positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081)|1/6|0.0889251949266158|0.793330891102308|0|0|10.8225108225108|26.1900407912999|CD74|2
3526|Golgi disassembly (GO:0090166)|1/6|0.0889251949266158|0.791946369477348|0|0|10.8225108225108|26.1900407912999|CDK1|2
3527|regulation of glial cell differentiation (GO:0045685)|1/6|0.0889251949266158|0.790566671969547|0|0|10.8225108225108|26.1900407912999|CDK1|2
3528|regulation of cellular carbohydrate catabolic process (GO:0043471)|1/6|0.0889251949266158|0.7891917734096|0|0|10.8225108225108|26.1900407912999|PGAM1|2
3529|ribosomal small subunit export from nucleus (GO:0000056)|1/6|0.0889251949266158|0.787821648802987|0|0|10.8225108225108|26.1900407912999|RAN|2
3530|regulation of mitotic spindle checkpoint (GO:1903504)|1/6|0.0889251949266158|0.786456273328458|0|0|10.8225108225108|26.1900407912999|CCNB1|2
3531|dosage compensation by inactivation of X chromosome (GO:0009048)|1/6|0.0889251949266158|0.78509562233654|0|0|10.8225108225108|26.1900407912999|HNRNPU|2
3532|positive regulation of cholesterol storage (GO:0010886)|1/6|0.0889251949266158|0.783739671348049|0|0|10.8225108225108|26.1900407912999|MSR1|2
3533|regulation of cell cycle checkpoint (GO:1901976)|1/6|0.0889251949266158|0.782388396052621|0|0|10.8225108225108|26.1900407912999|RPA2|2
3534|regulation of interleukin-10 secretion (GO:2001179)|1/6|0.0889251949266158|0.781041772307264|0|0|10.8225108225108|26.1900407912999|PYCARD|2
3535|positive regulation of phospholipid transport (GO:2001140)|1/6|0.0889251949266158|0.779699776134914|0|0|10.8225108225108|26.1900407912999|PRELID1|2
3536|positive regulation of sodium ion transmembrane transport (GO:1902307)|1/6|0.0889251949266158|0.778362383723019|0|0|10.8225108225108|26.1900407912999|GLRX|2
3537|monoubiquitinated protein deubiquitination (GO:0035520)|1/6|0.0889251949266158|0.777029571422124|0|0|10.8225108225108|26.1900407912999|USP1|2
3538|positive regulation of megakaryocyte differentiation (GO:0045654)|1/6|0.0889251949266158|0.775701315744479|0|0|10.8225108225108|26.1900407912999|HMGB2|2
3539|positive regulation of centrosome cycle (GO:0046607)|1/6|0.0889251949266158|0.774377593362663|0|0|10.8225108225108|26.1900407912999|RANBP1|2
3540|negative regulation of meiotic nuclear division (GO:0045835)|1/6|0.0889251949266158|0.773058381108212|0|0|10.8225108225108|26.1900407912999|FBXO5|2
3541|protein localization to nucleolus (GO:1902570)|1/6|0.0889251949266158|0.771743655970273|0|0|10.8225108225108|26.1900407912999|RAN|2
3542|negative regulation of cell cycle phase transition (GO:1901988)|1/6|0.0889251949266158|0.770433395094262|0|0|10.8225108225108|26.1900407912999|H2AFY|2
3543|nucleoside phosphate catabolic process (GO:1901292)|1/6|0.0889251949266158|0.769127575780543|0|0|10.8225108225108|26.1900407912999|DCTPP1|2
3544|regulation of DNA-directed DNA polymerase activity (GO:1900262)|1/6|0.0889251949266158|0.767826175483114|0|0|10.8225108225108|26.1900407912999|RFC2|2
3545|positive regulation of gene expression (GO:0010628)|17/772|0.089483366977205|0.771340577170063|0|0|1.42991723302604|3.45139482131445|CD74;DNMT1;H2AFY;CNBP;ATAD2;HMGB2;RPS27L;PARK7;DEK;MRPL12;HNRNPAB;CKS1B;RBM3;CKS2;SPP1;RAN;PF4|2
3546|regulation of ERK1 and ERK2 cascade (GO:0070372)|7/248|0.0898056195516866|0.772812945315779|0|0|1.83284457478006|4.41735287226056|PYCARD;CD74;CCL4;CCL2;MIF;HMGB1;CCL17|2
3547|regulation of complement activation (GO:0030449)|4/110|0.090237755241634|0.775224351848583|0|0|2.36127508854782|5.67959236591958|C1QB;C1QA;IGKC;C1QC|2
3548|negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154)|3/69|0.0904195019778772|0.775480199316147|0|0|2.82326369282891|6.78513637777122|CDKN2D;BIRC5;PARK7|2
3549|rRNA metabolic process (GO:0016072)|6/201|0.0912178841578591|0.781014870566367|0|0|1.93836014731537|4.64141171332517|NOP58;RPL3;RPS6;RPL14;RPSA;RPS2|2
3550|microtubule bundle formation (GO:0001578)|2/33|0.0913900738529528|0.781178470471722|0|0|3.93545848091303|9.41605040374168|PLK1;KIF20A|2
3551|ATP biosynthetic process (GO:0006754)|2/33|0.0913900738529528|0.779872151959228|0|0|3.93545848091303|9.41605040374168|ATP5G3;ATP5F1|2
3552|positive regulation of telomere maintenance via telomerase (GO:0032212)|2/33|0.0913900738529528|0.778570195111216|0|0|3.93545848091303|9.41605040374168|HNRNPA1;AURKB|2
3553|positive regulation of telomere maintenance (GO:0032206)|2/33|0.0913900738529528|0.777272578119363|0|0|3.93545848091303|9.41605040374168|HNRNPA2B1;AURKB|2
3554|positive regulation of myeloid leukocyte differentiation (GO:0002763)|2/33|0.0913900738529528|0.775979279320496|0|0|3.93545848091303|9.41605040374168|CD74;PF4|2
3555|positive regulation of establishment of protein localization to mitochondrion (GO:1903749)|4/111|0.0925391948374083|0.784431081819426|0|0|2.34000234000234|5.56949338069292|PSMB7;TFDP1;YWHAQ;SAE1|2
3556|regulation of cell growth (GO:0001558)|6/202|0.0928670312123226|0.785904577572939|0|0|1.92876430500193|4.583875364868|CDKN2D;CDKN2C;ENO1;RBBP7;S100A9;HIST1H1B|2
3557|negative regulation of angiogenesis (GO:0016525)|3/70|0.0934446096487541|0.789483183837073|0|0|2.78293135435993|6.59662271355887|PGK1;CCR2;PF4|2
3558|protein acetylation (GO:0006473)|2/34|0.0961511012835828|0.811006727024997|0|0|3.81970970206264|8.94512739956276|HAT1;ESCO2|2
3559|positive regulation of calcium ion transport (GO:0051928)|2/34|0.0961511012835828|0.809668432095913|0|0|3.81970970206264|8.94512739956276|CCL4;CCL2|2
3560|tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431)|2/34|0.0961511012835828|0.80833454670531|0|0|3.81970970206264|8.94512739956276|NDC1;RAN|2
3561|tRNA export from nucleus (GO:0006409)|2/34|0.0961511012835828|0.807005049095597|0|0|3.81970970206264|8.94512739956276|NDC1;RAN|2
3562|platelet aggregation (GO:0070527)|2/34|0.0961511012835828|0.80567991765209|0|0|3.81970970206264|8.94512739956276|CSRP1;CLIC1|2
3563|mRNA stabilization (GO:0048255)|2/34|0.0961511012835828|0.804359130901841|0|0|3.81970970206264|8.94512739956276|HNRNPU;YBX3|2
3564|inflammatory response (GO:0006954)|7/253|0.0971993812900108|0.811797778597259|0|0|1.79662234998203|4.18791040759093|CCL4;CCL2;HMGB1;AIF1;CCL17;S100A9;PF4|2
3565|positive regulation of canonical Wnt signaling pathway (GO:0090263)|4/114|0.0996091511642912|0.830564539855193|0|0|2.27842333105491|5.25518623707602|PSMB6;PSMB7;PSMA4;PSMC3|2
3566|regulation of humoral immune response (GO:0002920)|4/114|0.0996091511642912|0.829209622171906|0|0|2.27842333105491|5.25518623707602|C1QB;C1QA;IGKC;C1QC|2
3567|recombinational repair (GO:0000725)|3/72|0.0996180518765369|0.827933092387569|0|0|2.70562770562771|6.24029190225627|RAD51AP1;RPA2;NUCKS1|2
3568|positive regulation of lymphocyte proliferation (GO:0050671)|3/72|0.0996180518765369|0.826586859717021|0|0|2.70562770562771|6.24029190225627|CD74;MIF;AIF1|2
3569|negative regulation of transcription from RNA polymerase II promoter (GO:0000122)|13/566|0.0997930738487465|0.826694895860638|0|0|1.49144142077004|3.43726016234002|CBX5;H2AFY;UHRF1;CNBP;PLK1;HNRNPU;ENO1;HMGB1;AURKB;AES;HDGF;HIST1H1B;EZH2|2
3570|positive regulation of chemokine production (GO:0032722)|2/35|0.100981223675145|0.835181822389407|0|0|3.71057513914657|8.50768342719738|PYCARD;CD74|2
3571|regulation of immune effector process (GO:0002697)|4/115|0.102020158342976|0.842409171560205|0|0|2.25861095426313|5.15547115620728|C1QB;C1QA;IGKC;C1QC|2
3572|negative regulation of programmed cell death (GO:0043069)|10/409|0.102137717433468|0.842017402363467|0|0|1.58765439939034|3.62212746553625|CD74;PRELID1;PLK1;CDK1;BIRC5;MIF;PA2G4;PARK7;YBX3;MAD2L1|2
3573|negative regulation of cell cycle (GO:0045786)|3/73|0.102764929266505|0.845821667817704|0|0|2.66856431239993|6.07181410557577|GMNN;PLK1;MAD2L1|2
3574|axon regeneration (GO:0031103)|1/7|0.102959933608422|0.846062063130078|0|0|9.27643784786642|21.0891962942794|DHFR|2
3575|modulation by symbiont of host cellular process (GO:0044068)|1/7|0.102959933608422|0.844701834732763|0|0|9.27643784786642|21.0891962942794|KPNA2|2
3576|replication fork protection (GO:0048478)|1/7|0.102959933608422|0.843345973039773|0|0|9.27643784786642|21.0891962942794|TIPIN|2
3577|bleb assembly (GO:0032060)|1/7|0.102959933608422|0.841994457057337|0|0|9.27643784786642|21.0891962942794|EMP3|2
3578|negative regulation of glial cell apoptotic process (GO:0034351)|1/7|0.102959933608422|0.840647265926045|0|0|9.27643784786642|21.0891962942794|CCL2|2
3579|negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244)|1/7|0.102959933608422|0.839304378919774|0|0|9.27643784786642|21.0891962942794|HNRNPU|2
3580|regulation of DNA endoreduplication (GO:0032875)|1/7|0.102959933608422|0.837965775444622|0|0|9.27643784786642|21.0891962942794|SMC3|2
3581|positive regulation of histone H3-K9 methylation (GO:0051574)|1/7|0.102959933608422|0.836631435037864|0|0|9.27643784786642|21.0891962942794|HIST1H1B|2
3582|negative regulation of type 2 immune response (GO:0002829)|1/7|0.102959933608422|0.835301337366897|0|0|9.27643784786642|21.0891962942794|CCR2|2
3583|leukocyte aggregation (GO:0070486)|1/7|0.102959933608422|0.833975462228219|0|0|9.27643784786642|21.0891962942794|S100A9|2
3584|nucleic acid transport (GO:0050657)|1/7|0.102959933608422|0.8326537895464|0|0|9.27643784786642|21.0891962942794|HNRNPA2B1|2
3585|positive regulation of apoptotic cell clearance (GO:2000427)|1/7|0.102959933608422|0.831336299373067|0|0|9.27643784786642|21.0891962942794|CCL2|2
3586|negative regulation of cytokinesis (GO:0032466)|1/7|0.102959933608422|0.830022971885906|0|0|9.27643784786642|21.0891962942794|AURKB|2
3587|regulation of sterol transport (GO:0032371)|1/7|0.102959933608422|0.828713787387663|0|0|9.27643784786642|21.0891962942794|TSPO|2
3588|exit from host cell (GO:0035891)|1/7|0.102959933608422|0.827408726305163|0|0|9.27643784786642|21.0891962942794|PPIA|2
3589|regulation of toll-like receptor 9 signaling pathway (GO:0034163)|1/7|0.102959933608422|0.826107769188331|0|0|9.27643784786642|21.0891962942794|HMGB1|2
3590|chromatin-mediated maintenance of transcription (GO:0048096)|1/7|0.102959933608422|0.824810896709228|0|0|9.27643784786642|21.0891962942794|ELOF1|2
3591|positive regulation of lymphocyte apoptotic process (GO:0070230)|1/7|0.102959933608422|0.823518089661095|0|0|9.27643784786642|21.0891962942794|PRELID1|2
3592|positive regulation of protein kinase A signaling (GO:0010739)|1/7|0.102959933608422|0.8222293289574|0|0|9.27643784786642|21.0891962942794|MIF|2
3593|regulation of RNA biosynthetic process (GO:2001141)|1/7|0.102959933608422|0.820944595630904|0|0|9.27643784786642|21.0891962942794|RALY|2
3594|regulation of dendritic cell differentiation (GO:2001198)|1/7|0.102959933608422|0.819663870832728|0|0|9.27643784786642|21.0891962942794|HMGB1|2
3595|regulation of meiotic nuclear division (GO:0040020)|1/7|0.102959933608422|0.81838713583143|0|0|9.27643784786642|21.0891962942794|FBXO5|2
3596|negative regulation of B cell apoptotic process (GO:0002903)|1/7|0.102959933608422|0.817114372012097|0|0|9.27643784786642|21.0891962942794|AURKB|2
3597|endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000447)|1/7|0.102959933608422|0.815845560875432|0|0|9.27643784786642|21.0891962942794|RPSA|2
3598|regulation of NADP metabolic process (GO:1902031)|1/7|0.102959933608422|0.814580684036866|0|0|9.27643784786642|21.0891962942794|PGAM1|2
3599|activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO:0008635)|1/7|0.102959933608422|0.813319723225663|0|0|9.27643784786642|21.0891962942794|CYCS|2
3600|positive regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090267)|1/7|0.102959933608422|0.812062660284047|0|0|9.27643784786642|21.0891962942794|MAD2L1|2
3601|G-quadruplex DNA unwinding (GO:0044806)|1/7|0.102959933608422|0.810809477166325|0|0|9.27643784786642|21.0891962942794|HNRNPA2B1|2
3602|cleavage furrow formation (GO:0036089)|1/7|0.102959933608422|0.809560155938025|0|0|9.27643784786642|21.0891962942794|AURKB|2
3603|negative regulation of retinoic acid receptor signaling pathway (GO:0048387)|1/7|0.102959933608422|0.808314678775044|0|0|9.27643784786642|21.0891962942794|EZH2|2
3604|T-helper 1 type immune response (GO:0042088)|1/7|0.102959933608422|0.807073027962793|0|0|9.27643784786642|21.0891962942794|HMGB1|2
3605|negative regulation of necrotic cell death (GO:0060547)|1/7|0.102959933608422|0.805835185895366|0|0|9.27643784786642|21.0891962942794|YBX3|2
3606|hyperosmotic response (GO:0006972)|1/7|0.102959933608422|0.804601135074699|0|0|9.27643784786642|21.0891962942794|YBX3|2
3607|regulation of cellular response to insulin stimulus (GO:1900076)|1/7|0.102959933608422|0.803370858109753|0|0|9.27643784786642|21.0891962942794|NUCKS1|2
3608|microglial cell activation (GO:0001774)|1/7|0.102959933608422|0.802144337715692|0|0|9.27643784786642|21.0891962942794|AIF1|2
3609|negative regulation of cell growth (GO:0030308)|4/116|0.104457899616721|0.812574179488002|0|0|2.23914017017465|5.05815307486371|CDKN2D;CDKN2C;ENO1;RBBP7|2
3610|anatomical structure homeostasis (GO:0060249)|2/36|0.105877200966318|0.822361273258933|0|0|3.60750360750361|8.10056038195616|PCNA;RPA2|2
3611|positive regulation of DNA replication (GO:0045740)|2/36|0.105877200966318|0.821111484089847|0|0|3.60750360750361|8.10056038195616|PCNA;DBF4|2
3612|tRNA transport (GO:0051031)|2/36|0.105877200966318|0.819865487907616|0|0|3.60750360750361|8.10056038195616|NDC1;RAN|2
3613|positive regulation of telomerase activity (GO:0051973)|2/36|0.105877200966318|0.818623267471393|0|0|3.60750360750361|8.10056038195616|HNRNPA2B1;AURKB|2
3614|positive regulation of inflammatory response (GO:0050729)|3/74|0.105950928749611|0.817953993054867|0|0|2.63250263250263|5.9093872281044|CCL4;S100A9;CCR2|2
3615|nucleic acid phosphodiester bond hydrolysis (GO:0090305)|3/74|0.105950928749611|0.816718413004935|0|0|2.63250263250263|5.9093872281044|PCNA;RFC2;RPA2|2
3616|positive regulation of cellular process (GO:0048522)|12/520|0.107956732613267|0.830924896720214|0|0|1.4985014985015|3.33570143268786|EIF5A;TIPIN;CDK4;PRC1;CNBP;BIRC5;NAP1L1;SMC6;PA2G4;KIF20B;S100A9;HIST1H1B|2
3617|positive regulation of defense response (GO:0031349)|3/75|0.109175306779732|0.839038539905076|0|0|2.5974025974026|5.75272823281285|CCL4;S100A9;CCR2|2
3618|glucose homeostasis (GO:0042593)|3/75|0.109175306779732|0.837776827814994|0|0|2.5974025974026|5.75272823281285|RPS6;NUCKS1;PARK7|2
3619|regulation of response to DNA damage stimulus (GO:2001020)|2/37|0.110835875937007|0.849242454814637|0|0|3.51000351000351|7.72097145325534|USP1;RPA2|2
3620|mRNA catabolic process (GO:0006402)|2/37|0.110835875937007|0.84796922774595|0|0|3.51000351000351|7.72097145325534|LSM5;LSM4|2
3621|inner mitochondrial membrane organization (GO:0007007)|2/37|0.110835875937007|0.846699812734354|0|0|3.51000351000351|7.72097145325534|ATP5G3;ATP5F1|2
3622|purine ribonucleotide biosynthetic process (GO:0009152)|3/76|0.112437314968077|0.857649653635421|0|0|2.56322624743677|5.60157060726723|IMPDH2;ATP5G3;ATP5F1|2
3623|protein phosphorylation (GO:0006468)|11/471|0.113215607122451|0.862297377829649|0|0|1.51653017895056|3.30370223022458|PLK4;CCNA2;PRDX4;CDK4;PLK1;CDK1;BIRC5;CCL2;CLSPN;AURKB;AURKA|2
3624|epithelial to mesenchymal transition (GO:0001837)|2/38|0.115854172473734|0.881078751316637|0|0|3.41763499658236|7.36644912022736|S100A4;HNRNPAB|2
3625|base-excision repair (GO:0006284)|2/38|0.115854172473734|0.879767622222416|0|0|3.41763499658236|7.36644912022736|LIG1;RPA2|2
3626|protein peptidyl-prolyl isomerization (GO:0000413)|2/38|0.115854172473734|0.878460389499946|0|0|3.41763499658236|7.36644912022736|PPIA;FKBP3|2
3627|positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030)|2/38|0.115854172473734|0.877157035806326|0|0|3.41763499658236|7.36644912022736|TFDP1;YWHAQ|2
3628|regulation of carbohydrate catabolic process (GO:0043470)|2/38|0.115854172473734|0.875857543901427|0|0|3.41763499658236|7.36644912022736|NDC1;PGAM1|2
3629|peptidyl-cysteine modification (GO:0018198)|1/8|0.116779165256214|0.881544497488848|0|0|8.11688311688312|17.4307678908706|PARK7|2
3630|positive regulation of macrophage differentiation (GO:0045651)|1/8|0.116779165256214|0.880242363814566|0|0|8.11688311688312|17.4307678908706|PF4|2
3631|regulation of establishment of protein localization to mitochondrion (GO:1903747)|1/8|0.116779165256214|0.878944071242568|0|0|8.11688311688312|17.4307678908706|ATPIF1|2
3632|ribosomal large subunit export from nucleus (GO:0000055)|1/8|0.116779165256214|0.877649602801857|0|0|8.11688311688312|17.4307678908706|RAN|2
3633|defense response to protozoan (GO:0042832)|1/8|0.116779165256214|0.876358941621266|0|0|8.11688311688312|17.4307678908706|PF4|2
3634|positive regulation of membrane potential (GO:0045838)|1/8|0.116779165256214|0.875072070928724|0|0|8.11688311688312|17.4307678908706|GLRX|2
3635|lagging strand elongation (GO:0006273)|1/8|0.116779165256214|0.87378897405053|0|0|8.11688311688312|17.4307678908706|LIG1|2
3636|positive regulation of chromatin binding (GO:0035563)|1/8|0.116779165256214|0.872509634410631|0|0|8.11688311688312|17.4307678908706|GMNN|2
3637|positive regulation of RNA polymerase II transcriptional preinitiation complex assembly (GO:0045899)|1/8|0.116779165256214|0.871234035529914|0|0|8.11688311688312|17.4307678908706|PSMC3|2
3638|regulation of muscle organ development (GO:0048634)|1/8|0.116779165256214|0.869962161025491|0|0|8.11688311688312|17.4307678908706|CENPF|2
3639|regulation of T cell mediated immunity (GO:0002709)|1/8|0.116779165256214|0.868693994610002|0|0|8.11688311688312|17.4307678908706|HMGB1|2
3640|protein K6-linked ubiquitination (GO:0085020)|1/8|0.116779165256214|0.867429520090919|0|0|8.11688311688312|17.4307678908706|UBE2S|2
3641|regulation of ATP biosynthetic process (GO:2001169)|1/8|0.116779165256214|0.866168721369856|0|0|8.11688311688312|17.4307678908706|ENO1|2
3642|regulation of endodeoxyribonuclease activity (GO:0032071)|1/8|0.116779165256214|0.864911582441889|0|0|8.11688311688312|17.4307678908706|HMGB1|2
3643|cellular response to UV-B (GO:0071493)|1/8|0.116779165256214|0.863658087394871|0|0|8.11688311688312|17.4307678908706|CRIP1|2
3644|plasma membrane to endosome transport (GO:0048227)|1/8|0.116779165256214|0.862408220408772|0|0|8.11688311688312|17.4307678908706|COMMD1|2
3645|positive regulation of cAMP-mediated signaling (GO:0043950)|1/8|0.116779165256214|0.861161965755002|0|0|8.11688311688312|17.4307678908706|PF4|2
3646|positive regulation of spindle checkpoint (GO:0090232)|1/8|0.116779165256214|0.859919307795759|0|0|8.11688311688312|17.4307678908706|MAD2L1|2
3647|regulation of chemokine secretion (GO:0090196)|1/8|0.116779165256214|0.858680230983374|0|0|8.11688311688312|17.4307678908706|PYCARD|2
3648|protein localization to microtubule cytoskeleton (GO:0072698)|1/8|0.116779165256214|0.857444719859656|0|0|8.11688311688312|17.4307678908706|KIF20B|2
3649|positive regulation of tumor necrosis factor biosynthetic process (GO:0042535)|1/8|0.116779165256214|0.85621275905526|0|0|8.11688311688312|17.4307678908706|CCR2|2
3650|negative regulation of biosynthetic process (GO:0009890)|1/8|0.116779165256214|0.85498433328904|0|0|8.11688311688312|17.4307678908706|PARK7|2
3651|B cell mediated immunity (GO:0019724)|1/8|0.116779165256214|0.853759427367423|0|0|8.11688311688312|17.4307678908706|CD74|2
3652|heterochromatin assembly (GO:0031507)|1/8|0.116779165256214|0.852538026183779|0|0|8.11688311688312|17.4307678908706|HELLS|2
3653|positive regulation of monocyte differentiation (GO:0045657)|1/8|0.116779165256214|0.851320114717802|0|0|8.11688311688312|17.4307678908706|CD74|2
3654|positive regulation of mRNA 3'-end processing (GO:0031442)|1/8|0.116779165256214|0.850105678034895|0|0|8.11688311688312|17.4307678908706|NUDT21|2
3655|membrane fusion involved in viral entry into host cell (GO:0039663)|1/8|0.116779165256214|0.848894701285557|0|0|8.11688311688312|17.4307678908706|PPIA|2
3656|alpha-amino acid biosynthetic process (GO:1901607)|1/8|0.116779165256214|0.847687169704781|0|0|8.11688311688312|17.4307678908706|GATM|2
3657|rRNA pseudouridine synthesis (GO:0031118)|1/8|0.116779165256214|0.846483068611451|0|0|8.11688311688312|17.4307678908706|NHP2|2
3658|regulation of MHC class II biosynthetic process (GO:0045346)|1/8|0.116779165256214|0.845282383407746|0|0|8.11688311688312|17.4307678908706|PF4|2
3659|regulation of response to oxidative stress (GO:1902882)|1/8|0.116779165256214|0.844085099578557|0|0|8.11688311688312|17.4307678908706|H2AFY|2
3660|fusion of virus membrane with host plasma membrane (GO:0019064)|1/8|0.116779165256214|0.842891202690893|0|0|8.11688311688312|17.4307678908706|PPIA|2
3661|positive regulation of chromatin silencing (GO:0031937)|1/8|0.116779165256214|0.841700678393307|0|0|8.11688311688312|17.4307678908706|DNMT1|2
3662|positive regulation of chemokine secretion (GO:0090197)|1/8|0.116779165256214|0.840513512415319|0|0|8.11688311688312|17.4307678908706|PYCARD|2
3663|positive regulation of protein homodimerization activity (GO:0090073)|1/8|0.116779165256214|0.839329690566847|0|0|8.11688311688312|17.4307678908706|PARK7|2
3664|aldehyde biosynthetic process (GO:0046184)|1/8|0.116779165256214|0.838149198737639|0|0|8.11688311688312|17.4307678908706|TPI1|2
3665|immunoglobulin mediated immune response (GO:0016064)|1/8|0.116779165256214|0.836972022896715|0|0|8.11688311688312|17.4307678908706|CD74|2
3666|arginine catabolic process (GO:0006527)|1/8|0.116779165256214|0.835798149091811|0|0|8.11688311688312|17.4307678908706|ARG1|2
3667|negative regulation of growth (GO:0045926)|4/121|0.117037826547306|0.836476230911628|0|0|2.14661371686165|4.60504044781082|CDKN2D;CDKN2C;ENO1;RBBP7|2
3668|response to ionizing radiation (GO:0010212)|3/78|0.119071207611378|0.849818702714492|0|0|2.4975024975025|5.31476918466936|RAD51AP1;H2AFX;TOPBP1|2
3669|regulation of acute inflammatory response (GO:0002673)|4/122|0.119630027378185|0.852614566635302|0|0|2.12901852246115|4.52065446868676|C1QB;C1QA;IGKC;C1QC|2
3670|stimulatory C-type lectin receptor signaling pathway (GO:0002223)|4/122|0.119630027378185|0.851425424980301|0|0|2.12901852246115|4.52065446868676|PSMB6;PSMB7;PSMA4;PSMC3|2
3671|regulation of cellular amide metabolic process (GO:0034248)|2/39|0.120929093674779|0.859472374683006|0|0|3.33000333000333|7.03480155790827|RBM3;PGAM1|2
3672|DNA damage checkpoint (GO:0000077)|2/39|0.120929093674779|0.858277002812793|0|0|3.33000333000333|7.03480155790827|H2AFX;CLSPN|2
3673|homotypic cell-cell adhesion (GO:0034109)|2/39|0.120929093674779|0.857084951419997|0|0|3.33000333000333|7.03480155790827|CSRP1;CLIC1|2
3674|complement activation, classical pathway (GO:0006958)|4/124|0.124888242059935|0.883917752055266|0|0|2.09467951403435|4.35763721221938|C1QB;C1QA;IGKC;C1QC|2
3675|signal transduction by p53 class mediator (GO:0072331)|2/40|0.12605772036267|0.890959206386016|0|0|3.24675324675325|6.72407590522448|PYCARD;HINT1|2
3676|regulation of alternative mRNA splicing, via spliceosome (GO:0000381)|2/40|0.12605772036267|0.88972689766349|0|0|3.24675324675325|6.72407590522448|HNRNPU;HNRNPA1|2
3677|regulation of proteasomal protein catabolic process (GO:0061136)|2/40|0.12605772036267|0.888497993108706|0|0|3.24675324675325|6.72407590522448|COMMD1;UCHL5|2
3678|positive regulation of phagocytosis (GO:0050766)|2/40|0.12605772036267|0.887272478635453|0|0|3.24675324675325|6.72407590522448|PYCARD;CCL2|2
3679|regulation of coenzyme metabolic process (GO:0051196)|2/40|0.12605772036267|0.886050340235129|0|0|3.24675324675325|6.72407590522448|NDC1;PGAM1|2
3680|positive regulation of cytokine production (GO:0001819)|6/221|0.127178251995586|0.892696863732427|0|0|1.76294293941353|3.63548031539893|PYCARD;MIF;PARK7;HMGB1;GAPDH;CCR2|2
3681|innate immune response activating cell surface receptor signaling pathway (GO:0002220)|4/125|0.127553636004567|0.894101929301247|0|0|2.07792207792208|4.27889522762963|PSMB6;PSMB7;PSMA4;PSMC3|2
3682|negative regulation of macromolecule metabolic process (GO:0010605)|4/125|0.127553636004567|0.892875452031972|0|0|2.07792207792208|4.27889522762963|MSR1;PARK7;MIF;AES|2
3683|humoral immune response mediated by circulating immunoglobulin (GO:0002455)|4/126|0.130242801182295|0.910450704703082|0|0|2.0614306328592|4.20192716782083|C1QB;C1QA;IGKC;C1QC|2
3684|positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter (GO:1901838)|1/9|0.130386188034323|0.910206179944115|0|0|7.21500721500721|14.6988063137207|NCL|2
3685|negative regulation of leukocyte chemotaxis (GO:0002689)|1/9|0.130386188034323|0.908962728878618|0|0|7.21500721500721|14.6988063137207|MIF|2
3686|negative regulation of phagocytosis (GO:0050765)|1/9|0.130386188034323|0.907722670585468|0|0|7.21500721500721|14.6988063137207|HMGB1|2
3687|regulation of protein acetylation (GO:1901983)|1/9|0.130386188034323|0.90648599119775|0|0|7.21500721500721|14.6988063137207|PARK7|2
3688|regulation of macrophage cytokine production (GO:0010935)|1/9|0.130386188034323|0.905252676924011|0|0|7.21500721500721|14.6988063137207|CD74|2
3689|negative regulation of response to reactive oxygen species (GO:1901032)|1/9|0.130386188034323|0.904022714047756|0|0|7.21500721500721|14.6988063137207|PARK7|2
3690|regulation of interleukin-1 secretion (GO:0050704)|1/9|0.130386188034323|0.902796088926931|0|0|7.21500721500721|14.6988063137207|HMGB1|2
3691|regulation of T-helper 1 type immune response (GO:0002825)|1/9|0.130386188034323|0.901572787993426|0|0|7.21500721500721|14.6988063137207|CCR2|2
3692|positive regulation of synapse maturation (GO:0090129)|1/9|0.130386188034323|0.900352797752569|0|0|7.21500721500721|14.6988063137207|CDC20|2
3693|regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267)|1/9|0.130386188034323|0.899136104782633|0|0|7.21500721500721|14.6988063137207|PARK7|2
3694|positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770)|1/9|0.130386188034323|0.897922695734343|0|0|7.21500721500721|14.6988063137207|CCL2|2
3695|multi-ciliated epithelial cell differentiation (GO:1903251)|1/9|0.130386188034323|0.896712557330388|0|0|7.21500721500721|14.6988063137207|PLK4|2
3696|positive regulation of T cell chemotaxis (GO:0010820)|1/9|0.130386188034323|0.895505676364937|0|0|7.21500721500721|14.6988063137207|CCR2|2
3697|early endosome to Golgi transport (GO:0034498)|1/9|0.130386188034323|0.894302039703156|0|0|7.21500721500721|14.6988063137207|SNX2|2
3698|regulation of protein ADP-ribosylation (GO:0010835)|1/9|0.130386188034323|0.893101634280736|0|0|7.21500721500721|14.6988063137207|HPF1|2
3699|regulation of striated muscle tissue development (GO:0016202)|1/9|0.130386188034323|0.891904447103416|0|0|7.21500721500721|14.6988063137207|CENPF|2
3700|pinocytosis (GO:0006907)|1/9|0.130386188034323|0.890710465246517|0|0|7.21500721500721|14.6988063137207|PYCARD|2
3701|negative regulation of protein sumoylation (GO:0033234)|1/9|0.130386188034323|0.889519675854476|0|0|7.21500721500721|14.6988063137207|PARK7|2
3702|negative regulation of lymphocyte apoptotic process (GO:0070229)|1/9|0.130386188034323|0.888332066140385|0|0|7.21500721500721|14.6988063137207|AURKB|2
3703|negative regulation of interferon-beta production (GO:0032688)|1/9|0.130386188034323|0.887147623385531|0|0|7.21500721500721|14.6988063137207|PYCARD|2
3704|negative regulation of chromatin silencing (GO:0031936)|1/9|0.130386188034323|0.885966334938946|0|0|7.21500721500721|14.6988063137207|ATAD2|2
3705|positive regulation of vascular endothelial cell proliferation (GO:1905564)|1/9|0.130386188034323|0.884788188216952|0|0|7.21500721500721|14.6988063137207|HMGB1|2
3706|negative regulation of microtubule polymerization (GO:0031115)|1/9|0.130386188034323|0.88361317070272|0|0|7.21500721500721|14.6988063137207|STMN1|2
3707|regulation of oxidative stress-induced cell death (GO:1903201)|1/9|0.130386188034323|0.88244126994582|0|0|7.21500721500721|14.6988063137207|PARK7|2
3708|histone phosphorylation (GO:0016572)|1/9|0.130386188034323|0.881272473561786|0|0|7.21500721500721|14.6988063137207|CCNA2|2
3709|negative regulation of DNA-templated transcription, elongation (GO:0032785)|1/9|0.130386188034323|0.880106769231678|0|0|7.21500721500721|14.6988063137207|HNRNPU|2
3710|Golgi inheritance (GO:0048313)|1/9|0.130386188034323|0.878944144701649|0|0|7.21500721500721|14.6988063137207|CDK1|2
3711|negative regulation of peptidyl-lysine acetylation (GO:2000757)|1/9|0.130386188034323|0.877784587782517|0|0|7.21500721500721|14.6988063137207|SET|2
3712|peptidyl-proline modification (GO:0018208)|2/41|0.131237209217125|0.882349774222645|0|0|3.1675641431739|6.43252719620882|PPIA;FKBP3|2
3713|regulation of release of cytochrome c from mitochondria (GO:0090199)|2/41|0.131237209217125|0.881188787677616|0|0|3.1675641431739|6.43252719620882|PYCARD;PRELID1|2
3714|regulation of ATPase activity (GO:0043462)|2/41|0.131237209217125|0.880030852345582|0|0|3.1675641431739|6.43252719620882|ATPIF1;DNAJC9|2
3715|JAK-STAT cascade (GO:0007259)|2/41|0.131237209217125|0.878875956213895|0|0|3.1675641431739|6.43252719620882|CCL2;CCR2|2
3716|protein catabolic process (GO:0030163)|3/82|0.132757224642236|0.88789006205679|0|0|2.37567310738042|4.79703800464981|PSMB6;PSMB7;PSMA4|2
3717|negative regulation of Wnt signaling pathway (GO:0030178)|5/175|0.133974624276656|0.894859303251016|0|0|1.85528756957328|3.72932257520208|PSMB6;PSMB7;PSMA4;PSMC3;AES|2
3718|positive regulation of protein secretion (GO:0050714)|3/83|0.136261403433493|0.908943714668127|0|0|2.34705053982162|4.67809455644567|MIF;PPIA;GAPDH|2
3719|mesenchymal cell differentiation (GO:0048762)|2/42|0.136464791325764|0.909112049785081|0|0|3.09214594928881|6.15859195001393|S100A4;HNRNPAB|2
3720|peptide transport (GO:0015833)|2/42|0.136464791325764|0.907926766799703|0|0|3.09214594928881|6.15859195001393|NDC1;CENPF|2
3721|telomere organization (GO:0032200)|2/42|0.136464791325764|0.906744570488765|0|0|3.09214594928881|6.15859195001393|PCNA;RPA2|2
3722|positive regulation of mitochondrion organization (GO:0010822)|4/129|0.138449711708528|0.918737163652297|0|0|2.01349038558341|3.98117006271204|PYCARD;PSMB7;PARK7;SAE1|2
3723|regulation of protein processing (GO:0070613)|4/129|0.138449711708528|0.917543998504696|0|0|2.01349038558341|3.98117006271204|C1QB;C1QA;IGKC;C1QC|2
3724|positive regulation of protein ubiquitination (GO:0031398)|3/84|0.139797118871356|0.925271981323647|0|0|2.3191094619666|4.56299410558079|PLK1;COMMD1;RPS2|2
3725|negative regulation of neuron death (GO:1901215)|3/84|0.139797118871356|0.924073442487736|0|0|2.3191094619666|4.56299410558079|SET;CCL2;PARK7|2
3726|cellular response to lipid (GO:0071396)|5/179|0.143278733449966|0.945862065711743|0|0|1.81382862947109|3.52420257011086|PYCARD;H2AFZ;HMGB2;SPP1;CCL2|2
3727|cellular response to molecule of bacterial origin (GO:0071219)|3/85|0.143363603628822|0.945199572762118|0|0|2.29182582123759|4.451576454893|PYCARD;HMGB2;CCL2|2
3728|negative regulation of response to cytokine stimulus (GO:0060761)|1/10|0.143784249875448|0.946749712405692|0|0|6.49350649350649|12.5937751148115|AES|2
3729|regulation of response to stress (GO:0080134)|1/10|0.143784249875448|0.94552967411651|0|0|6.49350649350649|12.5937751148115|H2AFY|2
3730|regulation of B cell apoptotic process (GO:0002902)|1/10|0.143784249875448|0.944312776209024|0|0|6.49350649350649|12.5937751148115|AURKB|2
3731|low-density lipoprotein particle receptor catabolic process (GO:0032802)|1/10|0.143784249875448|0.943099006573794|0|0|6.49350649350649|12.5937751148115|AP2S1|2
3732|regulation of synapse maturation (GO:0090128)|1/10|0.143784249875448|0.941888353163558|0|0|6.49350649350649|12.5937751148115|CDC20|2
3733|protein deglycosylation (GO:0006517)|1/10|0.143784249875448|0.940680803992835|0|0|6.49350649350649|12.5937751148115|PARK7|2
3734|negative regulation of sodium ion transmembrane transport (GO:1902306)|1/10|0.143784249875448|0.939476347137531|0|0|6.49350649350649|12.5937751148115|COMMD1|2
3735|positive regulation of calcium ion import (GO:0090280)|1/10|0.143784249875448|0.938274970734542|0|0|6.49350649350649|12.5937751148115|CCL2|2
3736|regulation of cellular respiration (GO:0043457)|1/10|0.143784249875448|0.937076662981369|0|0|6.49350649350649|12.5937751148115|PRELID1|2
3737|neuron projection regeneration (GO:0031102)|1/10|0.143784249875448|0.935881412135729|0|0|6.49350649350649|12.5937751148115|DHFR|2
3738|negative regulation of oxidative stress-induced neuron death (GO:1903204)|1/10|0.143784249875448|0.934689206515174|0|0|6.49350649350649|12.5937751148115|PARK7|2
3739|macrophage chemotaxis (GO:0048246)|1/10|0.143784249875448|0.933500034496707|0|0|6.49350649350649|12.5937751148115|CCL2|2
3740|establishment of spindle localization (GO:0051293)|1/10|0.143784249875448|0.932313884516406|0|0|6.49350649350649|12.5937751148115|NUSAP1|2
3741|mitotic nuclear envelope reassembly (GO:0007084)|1/10|0.143784249875448|0.93113074506905|0|0|6.49350649350649|12.5937751148115|BANF1|2
3742|cellular biogenic amine metabolic process (GO:0006576)|1/10|0.143784249875448|0.929950604707746|0|0|6.49350649350649|12.5937751148115|ODC1|2
3743|positive regulation of bone remodeling (GO:0046852)|1/10|0.143784249875448|0.928773452043559|0|0|6.49350649350649|12.5937751148115|SPP1|2
3744|regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091)|1/10|0.143784249875448|0.927599275745147|0|0|6.49350649350649|12.5937751148115|TOP2A|2
3745|positive regulation of intracellular steroid hormone receptor signaling pathway (GO:0033145)|1/10|0.143784249875448|0.926428064538399|0|0|6.49350649350649|12.5937751148115|PARK7|2
3746|creatine metabolic process (GO:0006600)|1/10|0.143784249875448|0.925259807206068|0|0|6.49350649350649|12.5937751148115|GATM|2
3747|negative regulation of gluconeogenesis (GO:0045721)|1/10|0.143784249875448|0.92409449258742|0|0|6.49350649350649|12.5937751148115|PGP|2
3748|nuclear pore complex assembly (GO:0051292)|1/10|0.143784249875448|0.922932109577876|0|0|6.49350649350649|12.5937751148115|NDC1|2
3749|regulation of granulocyte differentiation (GO:0030852)|1/10|0.143784249875448|0.921772647128658|0|0|6.49350649350649|12.5937751148115|C1QC|2
3750|glycerolipid metabolic process (GO:0046486)|1/10|0.143784249875448|0.920616094246439|0|0|6.49350649350649|12.5937751148115|PGP|2
3751|primary miRNA processing (GO:0031053)|1/10|0.143784249875448|0.919462439992997|0|0|6.49350649350649|12.5937751148115|HNRNPA2B1|2
3752|positive regulation of T cell apoptotic process (GO:0070234)|1/10|0.143784249875448|0.918311673484871|0|0|6.49350649350649|12.5937751148115|PRELID1|2
3753|macrophage migration (GO:1905517)|1/10|0.143784249875448|0.917163783893015|0|0|6.49350649350649|12.5937751148115|CCL2|2
3754|regulation of histone phosphorylation (GO:0033127)|1/10|0.143784249875448|0.916018760442461|0|0|6.49350649350649|12.5937751148115|H2AFY|2
3755|nucleoside metabolic process (GO:0009116)|1/10|0.143784249875448|0.914876592411985|0|0|6.49350649350649|12.5937751148115|ERH|2
3756|regulation of cytoplasmic translation (GO:2000765)|1/10|0.143784249875448|0.913737269133763|0|0|6.49350649350649|12.5937751148115|YBX3|2
3757|regulation of DNA damage checkpoint (GO:2000001)|1/10|0.143784249875448|0.912600779993049|0|0|6.49350649350649|12.5937751148115|RPA2|2
3758|positive regulation of smooth muscle cell migration (GO:0014911)|1/10|0.143784249875448|0.911467114427841|0|0|6.49350649350649|12.5937751148115|AIF1|2
3759|positive regulation of bone resorption (GO:0045780)|1/10|0.143784249875448|0.91033626192855|0|0|6.49350649350649|12.5937751148115|SPP1|2
3760|negative regulation of stem cell differentiation (GO:2000737)|1/10|0.143784249875448|0.909208212037685|0|0|6.49350649350649|12.5937751148115|HNRNPU|2
3761|telomere maintenance via recombination (GO:0000722)|1/10|0.143784249875448|0.908082954349519|0|0|6.49350649350649|12.5937751148115|SMC6|2
3762|regulation of mRNA 3'-end processing (GO:0031440)|1/10|0.143784249875448|0.90696047850978|0|0|6.49350649350649|12.5937751148115|NUDT21|2
3763|positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824)|1/10|0.143784249875448|0.905840774215323|0|0|6.49350649350649|12.5937751148115|CCR2|2
3764|regulation of plasminogen activation (GO:0010755)|1/10|0.143784249875448|0.904723831213824|0|0|6.49350649350649|12.5937751148115|ENO1|2
3765|regulation of T cell apoptotic process (GO:0070232)|1/10|0.143784249875448|0.903609639303463|0|0|6.49350649350649|12.5937751148115|PRELID1|2
3766|regulation of T cell chemotaxis (GO:0010819)|1/10|0.143784249875448|0.90249818833261|0|0|6.49350649350649|12.5937751148115|CCR2|2
3767|phosphorylation (GO:0016310)|9/387|0.144967679998053|0.908808441068877|0|0|1.51011778918756|2.91640661125316|PLK4;CDK4;PLK1;PGK1;CDK1;BIRC5;CCL2;AURKB;AURKA|2
3768|positive regulation of transcription, DNA-templated (GO:0045893)|22/1121|0.145539078483968|0.911271064421701|0|0|1.27437237160698|2.45611144104255|CD74;ELOF1;H2AFZ;UHRF1;ALYREF;CNBP;ATAD2;HMGB2;CKAP2;HNRNPU;PARK7;HMGB1;MRPL12;HNRNPAB;CKS1B;TFDP1;PSMC3;CKS2;SPP1;RAN;PF4;HMGN1|2
3769|positive regulation of interferon-gamma production (GO:0032729)|2/44|0.147053521372157|0.919625146522202|0|0|2.95159386068477|5.65808343418353|PYCARD;CCR2|2
3770|regulation of B cell proliferation (GO:0030888)|2/44|0.147053521372157|0.918499534347756|0|0|2.95159386068477|5.65808343418353|CD74;MIF|2
3771|RNA catabolic process (GO:0006401)|2/44|0.147053521372157|0.917376674281316|0|0|2.95159386068477|5.65808343418353|RNASEH2C;RNASEH2B|2
3772|positive regulation of interleukin-6 production (GO:0032755)|2/44|0.147053521372157|0.916256556241901|0|0|2.95159386068477|5.65808343418353|PYCARD;HMGB1|2
3773|substantia nigra development (GO:0021762)|2/44|0.147053521372157|0.915139170197704|0|0|2.95159386068477|5.65808343418353|YWHAQ;ATP5F1|2
3774|nucleobase-containing compound catabolic process (GO:0034655)|2/44|0.147053521372157|0.914024506165794|0|0|2.95159386068477|5.65808343418353|RNASEH2C;RNASEH2B|2
3775|apoptotic process (GO:0006915)|6/232|0.149489699340567|0.928036418168992|0|0|1.67935512763099|3.1916610880942|PYCARD;EIF5A;LY86;TSPO;GAPDH;CIT|2
3776|amide biosynthetic process (GO:0043604)|2/45|0.152409488724311|0.945012905176377|0|0|2.88600288600289|5.42910353736578|ARG1;ATPIF1|2
3777|positive regulation of interleukin-8 production (GO:0032757)|2/45|0.152409488724311|0.943866044854561|0|0|2.88600288600289|5.42910353736578|PYCARD;PARK7|2
3778|inorganic anion transport (GO:0015698)|2/45|0.152409488724311|0.942721964800192|0|0|2.88600288600289|5.42910353736578|RACGAP1;CLIC1|2
3779|Fc-epsilon receptor signaling pathway (GO:0038095)|5/183|0.152854529701546|0.94433010298667|0|0|1.77418210205095|3.33239052611254|PSMB6;PSMB7;PSMA4;IGKC;PSMC3|2
3780|Fc receptor signaling pathway (GO:0038093)|5/184|0.155289551696156|0.958213521530208|0|0|1.76453980801807|3.28639156777035|PSMB6;PSMB7;PSMA4;IGKC;PSMC3|2
3781|regulation of tumor necrosis factor biosynthetic process (GO:0042534)|1/11|0.156976549338037|0.967453298637687|0|0|5.90318772136954|10.9306897996687|CCR2|2
3782|negative regulation of nuclear division (GO:0051784)|1/11|0.156976549338037|0.966286286214722|0|0|5.90318772136954|10.9306897996687|FBXO5|2
3783|regulation of hydrogen peroxide-induced cell death (GO:1903205)|1/11|0.156976549338037|0.965122085869885|0|0|5.90318772136954|10.9306897996687|PARK7|2
3784|T-helper cell differentiation (GO:0042093)|1/11|0.156976549338037|0.963960687451269|0|0|5.90318772136954|10.9306897996687|HMGB1|2
3785|I-kappaB phosphorylation (GO:0007252)|1/11|0.156976549338037|0.962802080855775|0|0|5.90318772136954|10.9306897996687|PRDX4|2
3786|urea cycle (GO:0000050)|1/11|0.156976549338037|0.961646256028817|0|0|5.90318772136954|10.9306897996687|ARG1|2
3787|endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)|1/11|0.156976549338037|0.960493202964034|0|0|5.90318772136954|10.9306897996687|RPSA|2
3788|myeloid cell activation involved in immune response (GO:0002275)|1/11|0.156976549338037|0.959342911702999|0|0|5.90318772136954|10.9306897996687|PYCARD|2
3789|internal protein amino acid acetylation (GO:0006475)|1/11|0.156976549338037|0.958195372334934|0|0|5.90318772136954|10.9306897996687|HAT1|2
3790|negative regulation of peptide secretion (GO:0002792)|1/11|0.156976549338037|0.957050574996421|0|0|5.90318772136954|10.9306897996687|CD74|2
3791|negative regulation of histone acetylation (GO:0035067)|1/11|0.156976549338037|0.955908509871127|0|0|5.90318772136954|10.9306897996687|SET|2
3792|synaptonemal complex assembly (GO:0007130)|1/11|0.156976549338037|0.954769167189517|0|0|5.90318772136954|10.9306897996687|SYCE2|2
3793|regulation of chromatin binding (GO:0035561)|1/11|0.156976549338037|0.953632537228577|0|0|5.90318772136954|10.9306897996687|GMNN|2
3794|negative regulation of cell division (GO:0051782)|1/11|0.156976549338037|0.952498610311539|0|0|5.90318772136954|10.9306897996687|AURKB|2
3795|negative regulation of protein localization to cell surface (GO:2000009)|1/11|0.156976549338037|0.951367376807606|0|0|5.90318772136954|10.9306897996687|COMMD1|2
3796|positive regulation of T cell receptor signaling pathway (GO:0050862)|1/11|0.156976549338037|0.950238827131678|0|0|5.90318772136954|10.9306897996687|KCNN4|2
3797|arginine metabolic process (GO:0006525)|1/11|0.156976549338037|0.949112951744081|0|0|5.90318772136954|10.9306897996687|ARG1|2
3798|modulation by host of viral genome replication (GO:0044827)|1/11|0.156976549338037|0.947989741150301|0|0|5.90318772136954|10.9306897996687|NUCKS1|2
3799|negative regulation of chemotaxis (GO:0050922)|1/11|0.156976549338037|0.946869185900715|0|0|5.90318772136954|10.9306897996687|AIF1|2
3800|inhibition of cysteine-type endopeptidase activity involved in apoptotic process (GO:1990001)|1/11|0.156976549338037|0.945751276590324|0|0|5.90318772136954|10.9306897996687|BIRC5|2
3801|methylation-dependent chromatin silencing (GO:0006346)|1/11|0.156976549338037|0.944636003858496|0|0|5.90318772136954|10.9306897996687|HELLS|2
3802|positive regulation of sodium ion transmembrane transporter activity (GO:2000651)|1/11|0.156976549338037|0.943523358388698|0|0|5.90318772136954|10.9306897996687|GLRX|2
3803|low-density lipoprotein receptor particle metabolic process (GO:0032799)|1/11|0.156976549338037|0.942413330908241|0|0|5.90318772136954|10.9306897996687|AP2S1|2
3804|positive regulation of glucose metabolic process (GO:0010907)|1/11|0.156976549338037|0.941305912188019|0|0|5.90318772136954|10.9306897996687|ARPP19|2
3805|regulation of mRNA polyadenylation (GO:1900363)|1/11|0.156976549338037|0.940201093042259|0|0|5.90318772136954|10.9306897996687|NUDT21|2
3806|synaptonemal complex organization (GO:0070193)|1/11|0.156976549338037|0.939098864328259|0|0|5.90318772136954|10.9306897996687|SYCE2|2
3807|hepatocyte growth factor receptor signaling pathway (GO:0048012)|1/11|0.156976549338037|0.937999216946141|0|0|5.90318772136954|10.9306897996687|STMN1|2
3808|mitochondrial gene expression (GO:0140053)|2/46|0.157803185063424|0.941835851904859|0|0|2.82326369282891|5.21289296046075|MRPL51;MRPL12|2
3809|protein complex subunit organization (GO:0071822)|2/46|0.157803185063424|0.940735576376933|0|0|2.82326369282891|5.21289296046075|NDC1;NUF2|2
3810|regulation of protein targeting to mitochondrion (GO:1903214)|3/89|0.157921907925102|0.940344802965922|0|0|2.18882241354151|4.03981020380277|PSMB7;ATPIF1;SAE1|2
3811|phagocytosis (GO:0006909)|4/136|0.158369976860631|0.94191374349627|0|0|1.90985485103132|3.51952130937368|MSR1;IGKC;HMGB1;AIF1|2
3812|regulation of neuron apoptotic process (GO:0043523)|3/90|0.161630753473236|0.96018828285672|0|0|2.16450216450216|3.94467715336536|SET;CCL2;PARK7|2
3813|protein methylation (GO:0006479)|2/47|0.16323218959138|0.96857425986606|0|0|2.76319425255595|5.00851510295151|RPS2;EZH2|2
3814|regulation of generation of precursor metabolites and energy (GO:0043467)|2/47|0.16323218959138|0.967449318797691|0|0|2.76319425255595|5.00851510295151|NDC1;PGAM1|2
3815|regulation of GTPase activity (GO:0043087)|5/189|0.167701551936668|0.992785405490508|0|0|1.717858860716|3.06735613954527|RACGAP1;CCL4;CCL2;CCL17;EZH2|2
3816|regulation of intrinsic apoptotic signaling pathway (GO:2001242)|2/48|0.168694146678225|0.997504322710294|0|0|2.70562770562771|4.81511901153652|PYCARD;S100A9|2
3817|cellular response to lipopolysaccharide (GO:0071222)|3/92|0.169126242958811|0.998901872475478|0|0|2.11744776962168|3.76293727378932|PYCARD;HMGB2;CCL2|2
3818|rRNA 3'-end processing (GO:0031125)|1/12|0.169966236115744|1|0|0|5.41125541125541|9.58958589145849|RPSA|2
3819|positive regulation of lyase activity (GO:0051349)|1/12|0.169966236115744|1|0|0|5.41125541125541|9.58958589145849|PARK7|2
3820|signal transduction involved in G2 DNA damage checkpoint (GO:0072425)|1/12|0.169966236115744|1|0|0|5.41125541125541|9.58958589145849|PLK1|2
3821|peptidyl-arginine modification (GO:0018195)|1/12|0.169966236115744|0.999236984906268|0|0|5.41125541125541|9.58958589145849|PARK7|2
3822|positive regulation of interleukin-1 production (GO:0032732)|1/12|0.169966236115744|0.998087114958159|0|0|5.41125541125541|9.58958589145849|HMGB1|2
3823|negative regulation of ATPase activity (GO:0032780)|1/12|0.169966236115744|0.996939888389242|0|0|5.41125541125541|9.58958589145849|ATPIF1|2
3824|regulation of protein glycosylation (GO:0060049)|1/12|0.169966236115744|0.99579529609488|0|0|5.41125541125541|9.58958589145849|HPF1|2
3825|modification-dependent macromolecule catabolic process (GO:0043632)|1/12|0.169966236115744|0.994653329012202|0|0|5.41125541125541|9.58958589145849|UBL4A|2
3826|regulation of cholesterol storage (GO:0010885)|1/12|0.169966236115744|0.993513978119863|0|0|5.41125541125541|9.58958589145849|MSR1|2
3827|cellular response to arsenic-containing substance (GO:0071243)|1/12|0.169966236115744|0.992377234437804|0|0|5.41125541125541|9.58958589145849|HNRNPA1|2
3828|positive regulation of T-helper 1 type immune response (GO:0002827)|1/12|0.169966236115744|0.991243089027018|0|0|5.41125541125541|9.58958589145849|CCR2|2
3829|regulation of cholesterol homeostasis (GO:2000188)|1/12|0.169966236115744|0.990111532989316|0|0|5.41125541125541|9.58958589145849|RALY|2
3830|pre-mRNA cleavage required for polyadenylation (GO:0098789)|1/12|0.169966236115744|0.988982557467093|0|0|5.41125541125541|9.58958589145849|NUDT21|2
3831|positive regulation of keratinocyte differentiation (GO:0045618)|1/12|0.169966236115744|0.987856153643099|0|0|5.41125541125541|9.58958589145849|H2AFY|2
3832|response to axon injury (GO:0048678)|1/12|0.169966236115744|0.986732312740205|0|0|5.41125541125541|9.58958589145849|DHFR|2
3833|polyamine metabolic process (GO:0006595)|1/12|0.169966236115744|0.985611026021182|0|0|5.41125541125541|9.58958589145849|ODC1|2
3834|plasminogen activation (GO:0031639)|1/12|0.169966236115744|0.984492284788468|0|0|5.41125541125541|9.58958589145849|PGK1|2
3835|negative regulation by host of viral transcription (GO:0043922)|1/12|0.169966236115744|0.983376080383946|0|0|5.41125541125541|9.58958589145849|CCL4|2
3836|positive regulation of peptidase activity (GO:0010952)|1/12|0.169966236115744|0.982262404188721|0|0|5.41125541125541|9.58958589145849|PRELID1|2
3837|purine nucleoside monophosphate biosynthetic process (GO:0009127)|1/12|0.169966236115744|0.981151247622897|0|0|5.41125541125541|9.58958589145849|IMPDH2|2
3838|ribosomal subunit export from nucleus (GO:0000054)|1/12|0.169966236115744|0.980042602145357|0|0|5.41125541125541|9.58958589145849|RAN|2
3839|aromatic compound biosynthetic process (GO:0019438)|1/12|0.169966236115744|0.978936459253545|0|0|5.41125541125541|9.58958589145849|PSAT1|2
3840|L-serine metabolic process (GO:0006563)|1/12|0.169966236115744|0.977832810483248|0|0|5.41125541125541|9.58958589145849|PSAT1|2
3841|PERK-mediated unfolded protein response (GO:0036499)|1/12|0.169966236115744|0.976731647408379|0|0|5.41125541125541|9.58958589145849|CCL2|2
3842|transcription from mitochondrial promoter (GO:0006390)|1/12|0.169966236115744|0.975632961640766|0|0|5.41125541125541|9.58958589145849|MRPL12|2
3843|regulation of vascular endothelial cell proliferation (GO:1905562)|1/12|0.169966236115744|0.974536744829933|0|0|5.41125541125541|9.58958589145849|HMGB1|2
3844|positive regulation of mRNA metabolic process (GO:1903313)|1/12|0.169966236115744|0.973442988662896|0|0|5.41125541125541|9.58958589145849|NUDT21|2
3845|regulation of sister chromatid cohesion (GO:0007063)|1/12|0.169966236115744|0.972351684863947|0|0|5.41125541125541|9.58958589145849|RAD21|2
3846|positive regulation of neuron migration (GO:2001224)|1/12|0.169966236115744|0.971262825194446|0|0|5.41125541125541|9.58958589145849|KIF20B|2
3847|regulation of catabolic process (GO:0009894)|1/12|0.169966236115744|0.970176401452618|0|0|5.41125541125541|9.58958589145849|ODC1|2
3848|regulation of cell proliferation (GO:0042127)|15/741|0.171903773121669|0.980139613675839|0|0|1.31447499868552|2.31455441574082|CDKN2D;EIF5A;TIPIN;CDKN2C;CNBP;HMGB2;NAP1L1;EMP3;RBBP4;CDK4;PRC1;BIRC5;KIF20B;CDKN3;PF4|2
3849|response to lipid (GO:0033993)|4/141|0.17320824930251|0.986475107355703|0|0|1.84212950170397|3.22973317715876|CDKN2D;HMGB2;SPP1;PF4|2
3850|positive regulation of Wnt signaling pathway (GO:0030177)|4/141|0.17320824930251|0.985375358072141|0|0|1.84212950170397|3.22973317715876|PSMB6;PSMB7;PSMA4;PSMC3|2
3851|regulation of cell cycle arrest (GO:0071156)|2/49|0.174186764461618|0.989838595821422|0|0|2.65041081367612|4.63193001969431|CDK4;MIF|2
3852|pattern recognition receptor signaling pathway (GO:0002221)|2/49|0.174186764461618|0.988737551777127|0|0|2.65041081367612|4.63193001969431|HMGB1;S100A9|2
3853|cellular macromolecule catabolic process (GO:0044265)|2/49|0.174186764461618|0.987638954497374|0|0|2.65041081367612|4.63193001969431|RNASEH2C;RNASEH2B|2
3854|positive regulation of GTPase activity (GO:0043547)|5/193|0.177903583234488|1|0|0|1.68225556826593|2.90443702083762|CCL4;CCL2;RANGAP1;CCL17;EZH2|2
3855|non-recombinational repair (GO:0000726)|2/50|0.179707813401232|1|0|0|2.5974025974026|4.45824157373027|H2AFX;NSD2|2
3856|protein heterooligomerization (GO:0051291)|2/50|0.179707813401232|1|0|0|2.5974025974026|4.45824157373027|CD74;NUDT21|2
3857|organic hydroxy compound biosynthetic process (GO:1901617)|2/50|0.179707813401232|1|0|0|2.5974025974026|4.45824157373027|PSAT1;PARK7|2
3858|glutathione metabolic process (GO:0006749)|2/50|0.179707813401232|1|0|0|2.5974025974026|4.45824157373027|EEF1G;PARK7|2
3859|regulation of megakaryocyte differentiation (GO:0045652)|2/50|0.179707813401232|1|0|0|2.5974025974026|4.45824157373027|HMGB2;PF4|2
3860|establishment of protein localization to mitochondrion (GO:0072655)|2/50|0.179707813401232|1|0|0|2.5974025974026|4.45824157373027|NDUFB8;TSPO|2
3861|positive regulation of response to DNA damage stimulus (GO:2001022)|2/50|0.179707813401232|1|0|0|2.5974025974026|4.45824157373027|PCNA;H2AFX|2
3862|modulation by virus of host process (GO:0019054)|1/13|0.1827564119214|1|0|0|4.995004995005|8.48951596011252|KPNA2|2
3863|DNA strand elongation (GO:0022616)|1/13|0.1827564119214|1|0|0|4.995004995005|8.48951596011252|GINS2|2
3864|positive regulation of histone H3-K4 methylation (GO:0051571)|1/13|0.1827564119214|1|0|0|4.995004995005|8.48951596011252|DNMT1|2
3865|regulation of nitric-oxide synthase biosynthetic process (GO:0051769)|1/13|0.1827564119214|1|0|0|4.995004995005|8.48951596011252|CCL2|2
3866|signal transduction involved in DNA damage checkpoint (GO:0072422)|1/13|0.1827564119214|1|0|0|4.995004995005|8.48951596011252|PLK1|2
3867|regulation of granulocyte chemotaxis (GO:0071622)|1/13|0.1827564119214|1|0|0|4.995004995005|8.48951596011252|KIF20B|2
3868|regulation of viral life cycle (GO:1903900)|1/13|0.1827564119214|1|0|0|4.995004995005|8.48951596011252|PPIA|2
3869|regulation of cell aging (GO:0090342)|1/13|0.1827564119214|1|0|0|4.995004995005|8.48951596011252|MIF|2
3870|steroid catabolic process (GO:0006706)|1/13|0.1827564119214|1|0|0|4.995004995005|8.48951596011252|SPP1|2
3871|negative regulation of mRNA splicing, via spliceosome (GO:0048025)|1/13|0.1827564119214|1|0|0|4.995004995005|8.48951596011252|SRSF7|2
3872|chromatin assembly or disassembly (GO:0006333)|1/13|0.1827564119214|1|0|0|4.995004995005|8.48951596011252|RBBP4|2
3873|mRNA cleavage involved in mRNA processing (GO:0098787)|1/13|0.1827564119214|1|0|0|4.995004995005|8.48951596011252|NUDT21|2
3874|serine family amino acid biosynthetic process (GO:0009070)|1/13|0.1827564119214|1|0|0|4.995004995005|8.48951596011252|PSAT1|2
3875|regulation of cAMP metabolic process (GO:0030814)|1/13|0.1827564119214|1|0|0|4.995004995005|8.48951596011252|PF4|2
3876|copper ion homeostasis (GO:0055070)|1/13|0.1827564119214|1|0|0|4.995004995005|8.48951596011252|COMMD1|2
3877|response to UV-B (GO:0010224)|1/13|0.1827564119214|1|0|0|4.995004995005|8.48951596011252|CRIP1|2
3878|positive regulation of muscle contraction (GO:0045933)|1/13|0.1827564119214|1|0|0|4.995004995005|8.48951596011252|ENO1|2
3879|negative regulation of reactive oxygen species biosynthetic process (GO:1903427)|1/13|0.1827564119214|1|0|0|4.995004995005|8.48951596011252|PARK7|2
3880|positive regulation of alpha-beta T cell proliferation (GO:0046641)|1/13|0.1827564119214|1|0|0|4.995004995005|8.48951596011252|CCR2|2
3881|regulation of cytolysis (GO:0042268)|1/13|0.1827564119214|1|0|0|4.995004995005|8.48951596011252|PF4|2
3882|regulation of retinoic acid receptor signaling pathway (GO:0048385)|1/13|0.1827564119214|1|0|0|4.995004995005|8.48951596011252|EZH2|2
3883|transcription elongation from RNA polymerase II promoter (GO:0006368)|3/96|0.184407318189097|1|0|0|2.02922077922078|3.43061745567224|ELOF1;ELOB;SSRP1|2
3884|regulation of cellular protein metabolic process (GO:0032268)|2/51|0.185255124911252|1|0|0|2.54647313470843|4.29340807321248|RBM3;UHRF1|2
3885|double-strand break repair via nonhomologous end joining (GO:0006303)|2/51|0.185255124911252|1|0|0|2.54647313470843|4.29340807321248|H2AFX;NSD2|2
3886|epithelial cell differentiation (GO:0030855)|3/97|0.188283667898949|1|0|0|2.00830097737314|3.3534721814551|PCNA;PGK1;CDK1|2
3887|regulation of apoptotic process (GO:0042981)|16/816|0.19359309113755|1|0|0|1.27323656735421|2.0906503578424|TOP2A;CD74;PRELID1;PLK1;RPS6;MIF;PA2G4;PARK7;HMGB1;PYCARD;LGALS1;ANP32E;CDK1;BIRC5;ANP32B;MAD2L1|2
3888|negative regulation of hydrogen peroxide-induced cell death (GO:1903206)|1/14|0.195350131199224|1|0|0|4.63821892393321|7.57403425728297|PARK7|2
3889|ribonucleoside monophosphate biosynthetic process (GO:0009156)|1/14|0.195350131199224|1|0|0|4.63821892393321|7.57403425728297|IMPDH2|2
3890|clathrin coat assembly (GO:0048268)|1/14|0.195350131199224|1|0|0|4.63821892393321|7.57403425728297|AP2S1|2
3891|lipid particle organization (GO:0034389)|1/14|0.195350131199224|1|0|0|4.63821892393321|7.57403425728297|PPIA|2
3892|establishment of mitotic spindle orientation (GO:0000132)|1/14|0.195350131199224|1|0|0|4.63821892393321|7.57403425728297|CENPA|2
3893|regulation of phosphate metabolic process (GO:0019220)|1/14|0.195350131199224|1|0|0|4.63821892393321|7.57403425728297|MCM7|2
3894|pore complex assembly (GO:0046931)|1/14|0.195350131199224|1|0|0|4.63821892393321|7.57403425728297|NDC1|2
3895|positive regulation of response to cytokine stimulus (GO:0060760)|1/14|0.195350131199224|1|0|0|4.63821892393321|7.57403425728297|CD74|2
3896|negative regulation of Rho protein signal transduction (GO:0035024)|1/14|0.195350131199224|1|0|0|4.63821892393321|7.57403425728297|STMN1|2
3897|DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)|1/14|0.195350131199224|1|0|0|4.63821892393321|7.57403425728297|RPS27L|2
3898|regulation of monocyte differentiation (GO:0045655)|1/14|0.195350131199224|1|0|0|4.63821892393321|7.57403425728297|CD74|2
3899|negative regulation of secretion (GO:0051048)|1/14|0.195350131199224|1|0|0|4.63821892393321|7.57403425728297|CD74|2
3900|regulation of lymphocyte differentiation (GO:0045619)|1/14|0.195350131199224|1|0|0|4.63821892393321|7.57403425728297|PRELID1|2
3901|purine-containing compound salvage (GO:0043101)|1/14|0.195350131199224|1|0|0|4.63821892393321|7.57403425728297|DCK|2
3902|cellular response to osmotic stress (GO:0071470)|1/14|0.195350131199224|1|0|0|4.63821892393321|7.57403425728297|YBX3|2
3903|metallo-sulfur cluster assembly (GO:0031163)|1/14|0.195350131199224|1|0|0|4.63821892393321|7.57403425728297|NUBP1|2
3904|negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236)|1/14|0.195350131199224|1|0|0|4.63821892393321|7.57403425728297|PARK7|2
3905|negative regulation of smooth muscle cell migration (GO:0014912)|1/14|0.195350131199224|1|0|0|4.63821892393321|7.57403425728297|AIF1|2
3906|purine nucleotide catabolic process (GO:0006195)|1/14|0.195350131199224|1|0|0|4.63821892393321|7.57403425728297|HINT1|2
3907|nucleoside triphosphate metabolic process (GO:0009141)|1/14|0.195350131199224|1|0|0|4.63821892393321|7.57403425728297|DCTPP1|2
3908|positive regulation of purine nucleotide metabolic process (GO:1900544)|1/14|0.195350131199224|1|0|0|4.63821892393321|7.57403425728297|PF4|2
3909|regulation of adaptive immune response (GO:0002819)|1/14|0.195350131199224|1|0|0|4.63821892393321|7.57403425728297|PYCARD|2
3910|negative regulation of cation transmembrane transport (GO:1904063)|1/14|0.195350131199224|1|0|0|4.63821892393321|7.57403425728297|COMMD1|2
3911|positive regulation of interleukin-8 secretion (GO:2000484)|1/14|0.195350131199224|1|0|0|4.63821892393321|7.57403425728297|PYCARD|2
3912|positive regulation of proteolysis (GO:0045862)|2/53|0.19642015841756|1|0|0|2.45037980887037|3.9879912980354|ATPIF1;PLK1|2
3913|plasma membrane bounded cell projection morphogenesis (GO:0120039)|2/53|0.19642015841756|1|0|0|2.45037980887037|3.9879912980354|SNX2;KIF20B|2
3914|small GTPase mediated signal transduction (GO:0007264)|3/100|0.200035522707518|1|0|0|1.94805194805195|3.13492269091154|CCNA2;DNMT1;PARK7|2
3915|protein targeting to mitochondrion (GO:0006626)|2/55|0.207665685948174|1|0|0|2.36127508854782|3.71151303762669|NDUFB8;TSPO|2
3916|positive regulation of alpha-beta T cell activation (GO:0046635)|1/15|0.207750401742977|1|0|0|4.32900432900433|6.80267494141807|CCR2|2
3917|pseudouridine synthesis (GO:0001522)|1/15|0.207750401742977|1|0|0|4.32900432900433|6.80267494141807|NHP2|2
3918|nuclear pore organization (GO:0006999)|1/15|0.207750401742977|1|0|0|4.32900432900433|6.80267494141807|NDC1|2
3919|vitamin D metabolic process (GO:0042359)|1/15|0.207750401742977|1|0|0|4.32900432900433|6.80267494141807|SUMO2|2
3920|maintenance of protein location in nucleus (GO:0051457)|1/15|0.207750401742977|1|0|0|4.32900432900433|6.80267494141807|HNRNPU|2
3921|septin ring assembly (GO:0000921)|1/15|0.207750401742977|1|0|0|4.32900432900433|6.80267494141807|ANLN|2
3922|mitotic sister chromatid cohesion (GO:0007064)|1/15|0.207750401742977|1|0|0|4.32900432900433|6.80267494141807|SGO1|2
3923|response to X-ray (GO:0010165)|1/15|0.207750401742977|1|0|0|4.32900432900433|6.80267494141807|NUCKS1|2
3924|regulation of establishment of cell polarity (GO:2000114)|1/15|0.207750401742977|1|0|0|4.32900432900433|6.80267494141807|KIF20B|2
3925|positive regulation of telomerase RNA localization to Cajal body (GO:1904874)|1/15|0.207750401742977|1|0|0|4.32900432900433|6.80267494141807|NHP2|2
3926|regulation of centriole replication (GO:0046599)|1/15|0.207750401742977|1|0|0|4.32900432900433|6.80267494141807|PLK4|2
3927|negative regulation of cell aging (GO:0090344)|1/15|0.207750401742977|1|0|0|4.32900432900433|6.80267494141807|MIF|2
3928|pyrimidine nucleoside metabolic process (GO:0006213)|1/15|0.207750401742977|1|0|0|4.32900432900433|6.80267494141807|ERH|2
3929|intra-S DNA damage checkpoint (GO:0031573)|1/15|0.207750401742977|1|0|0|4.32900432900433|6.80267494141807|TIPIN|2
3930|negative regulation of release of cytochrome c from mitochondria (GO:0090201)|1/15|0.207750401742977|1|0|0|4.32900432900433|6.80267494141807|PRELID1|2
3931|positive regulation of acute inflammatory response (GO:0002675)|1/15|0.207750401742977|1|0|0|4.32900432900433|6.80267494141807|PARK7|2
3932|positive regulation of viral release from host cell (GO:1902188)|1/15|0.207750401742977|1|0|0|4.32900432900433|6.80267494141807|SMC3|2
3933|DNA damage response, signal transduction resulting in transcription (GO:0042772)|1/15|0.207750401742977|1|0|0|4.32900432900433|6.80267494141807|RPS27L|2
3934|regulation of macrophage chemotaxis (GO:0010758)|1/15|0.207750401742977|1|0|0|4.32900432900433|6.80267494141807|MIF|2
3935|negative regulation of mRNA processing (GO:0050686)|1/15|0.207750401742977|1|0|0|4.32900432900433|6.80267494141807|SRSF7|2
3936|positive regulation of protein export from nucleus (GO:0046827)|1/15|0.207750401742977|1|0|0|4.32900432900433|6.80267494141807|ANP32B|2
3937|sulfate transport (GO:0008272)|1/15|0.207750401742977|1|0|0|4.32900432900433|6.80267494141807|RACGAP1|2
3938|regulation of peptide secretion (GO:0002791)|1/15|0.207750401742977|1|0|0|4.32900432900433|6.80267494141807|CD74|2
3939|inhibition of cysteine-type endopeptidase activity (GO:0097340)|1/15|0.207750401742977|1|0|0|4.32900432900433|6.80267494141807|BIRC5|2
3940|cellular response to corticosteroid stimulus (GO:0071384)|1/15|0.207750401742977|1|0|0|4.32900432900433|6.80267494141807|HNRNPU|2
3941|positive regulation of intracellular protein transport (GO:0090316)|4/153|0.210604305019094|1|0|0|1.69764875647229|2.64455349767436|PSMB7;ANP32B;KIF20B;SAE1|2
3942|regulation of gene silencing by RNA (GO:0060966)|2/56|0.213313824216133|1|0|0|2.3191094619666|3.58300288605083|NDC1;RAN|2
3943|regulation of posttranscriptional gene silencing (GO:0060147)|2/56|0.213313824216133|1|0|0|2.3191094619666|3.58300288605083|NDC1;RAN|2
3944|positive regulation of protein transport (GO:0051222)|2/57|0.218976421226501|1|0|0|2.27842333105491|3.46044935200367|KIF20B;PPIA|2
3945|ATP metabolic process (GO:0046034)|2/57|0.218976421226501|1|0|0|2.27842333105491|3.46044935200367|ATP5G3;ATP5F1|2
3946|lipopolysaccharide-mediated signaling pathway (GO:0031663)|1/16|0.21996018550273|1|0|0|4.05844155844156|6.14573345777319|CCL2|2
3947|C21-steroid hormone biosynthetic process (GO:0006700)|1/16|0.21996018550273|1|0|0|4.05844155844156|6.14573345777319|TSPO|2
3948|positive regulation of secretion (GO:0051047)|1/16|0.21996018550273|1|0|0|4.05844155844156|6.14573345777319|SPP1|2
3949|DNA alkylation (GO:0006305)|1/16|0.21996018550273|1|0|0|4.05844155844156|6.14573345777319|DNMT1|2
3950|establishment of skin barrier (GO:0061436)|1/16|0.21996018550273|1|0|0|4.05844155844156|6.14573345777319|STMN1|2
3951|hyaluronan catabolic process (GO:0030214)|1/16|0.21996018550273|1|0|0|4.05844155844156|6.14573345777319|HMMR|2
3952|regulation of cell cycle phase transition (GO:1901987)|1/16|0.21996018550273|1|0|0|4.05844155844156|6.14573345777319|PLK1|2
3953|regulation of reactive oxygen species biosynthetic process (GO:1903426)|1/16|0.21996018550273|1|0|0|4.05844155844156|6.14573345777319|PARK7|2
3954|regulation of water loss via skin (GO:0033561)|1/16|0.21996018550273|1|0|0|4.05844155844156|6.14573345777319|STMN1|2
3955|stabilization of membrane potential (GO:0030322)|1/16|0.21996018550273|1|0|0|4.05844155844156|6.14573345777319|KCNN4|2
3956|positive regulation of mRNA processing (GO:0050685)|1/16|0.21996018550273|1|0|0|4.05844155844156|6.14573345777319|NUDT21|2
3957|guanosine-containing compound metabolic process (GO:1901068)|1/16|0.21996018550273|1|0|0|4.05844155844156|6.14573345777319|RAN|2
3958|DNA methylation or demethylation (GO:0044728)|1/16|0.21996018550273|1|0|0|4.05844155844156|6.14573345777319|DNMT1|2
3959|glutamine family amino acid catabolic process (GO:0009065)|1/16|0.21996018550273|1|0|0|4.05844155844156|6.14573345777319|ARG1|2
3960|negative regulation of DNA replication (GO:0008156)|1/16|0.21996018550273|1|0|0|4.05844155844156|6.14573345777319|GMNN|2
3961|miRNA metabolic process (GO:0010586)|1/16|0.21996018550273|1|0|0|4.05844155844156|6.14573345777319|RAN|2
3962|positive regulation of cyclic nucleotide metabolic process (GO:0030801)|1/16|0.21996018550273|1|0|0|4.05844155844156|6.14573345777319|PF4|2
3963|positive regulation of nitric-oxide synthase activity (GO:0051000)|1/16|0.21996018550273|1|0|0|4.05844155844156|6.14573345777319|DHFR|2
3964|regulation of protein homodimerization activity (GO:0043496)|1/16|0.21996018550273|1|0|0|4.05844155844156|6.14573345777319|PARK7|2
3965|positive regulation of G1/S transition of mitotic cell cycle (GO:1900087)|1/16|0.21996018550273|1|0|0|4.05844155844156|6.14573345777319|AIF1|2
3966|regulation of necroptotic process (GO:0060544)|1/16|0.21996018550273|1|0|0|4.05844155844156|6.14573345777319|YBX3|2
3967|ruffle organization (GO:0031529)|1/16|0.21996018550273|1|0|0|4.05844155844156|6.14573345777319|AIF1|2
3968|regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229)|1/16|0.21996018550273|1|0|0|4.05844155844156|6.14573345777319|CDKN2D|2
3969|phagocytosis, engulfment (GO:0006911)|3/105|0.219988011840558|1|0|0|1.85528756957328|2.80924346149968|MSR1;IGKC;AIF1|2
3970|response to lipopolysaccharide (GO:0032496)|4/156|0.2202929817654|1|0|0|1.66500166500166|2.51880932951291|PYCARD;HMGB2;CCL2;PF4|2
3971|regulation of glycolytic process (GO:0006110)|2/58|0.224651699239194|1|0|0|2.23914017017465|3.34349323679858|NDC1;PGAM1|2
3972|protein homotetramerization (GO:0051289)|2/58|0.224651699239194|1|0|0|2.23914017017465|3.34349323679858|ATPIF1;TK1|2
3973|regulation of protein sumoylation (GO:0033233)|1/17|0.231982399145781|1|0|0|3.81970970206264|5.58095407159941|PARK7|2
3974|positive regulation of protein processing (GO:0010954)|1/17|0.231982399145781|1|0|0|3.81970970206264|5.58095407159941|ENO1|2
3975|positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261)|1/17|0.231982399145781|1|0|0|3.81970970206264|5.58095407159941|PSMC3|2
3976|regulation of telomere maintenance via telomere lengthening (GO:1904356)|1/17|0.231982399145781|1|0|0|3.81970970206264|5.58095407159941|HNRNPA2B1|2
3977|positive regulation of epidermal cell differentiation (GO:0045606)|1/17|0.231982399145781|1|0|0|3.81970970206264|5.58095407159941|H2AFY|2
3978|RNA stabilization (GO:0043489)|1/17|0.231982399145781|1|0|0|3.81970970206264|5.58095407159941|HNRNPU|2
3979|positive regulation of response to biotic stimulus (GO:0002833)|1/17|0.231982399145781|1|0|0|3.81970970206264|5.58095407159941|LY86|2
3980|positive regulation of antigen receptor-mediated signaling pathway (GO:0050857)|1/17|0.231982399145781|1|0|0|3.81970970206264|5.58095407159941|KCNN4|2
3981|negative regulation of reactive oxygen species metabolic process (GO:2000378)|1/17|0.231982399145781|1|0|0|3.81970970206264|5.58095407159941|PARK7|2
3982|positive regulation of stem cell proliferation (GO:2000648)|1/17|0.231982399145781|1|0|0|3.81970970206264|5.58095407159941|HNRNPU|2
3983|negative regulation of stress fiber assembly (GO:0051497)|1/17|0.231982399145781|1|0|0|3.81970970206264|5.58095407159941|STMN1|2
3984|positive regulation of cellular protein catabolic process (GO:1903364)|1/17|0.231982399145781|1|0|0|3.81970970206264|5.58095407159941|ATPIF1|2
3985|negative regulation of cellular carbohydrate metabolic process (GO:0010677)|1/17|0.231982399145781|1|0|0|3.81970970206264|5.58095407159941|PGP|2
3986|3'-UTR-mediated mRNA stabilization (GO:0070935)|1/17|0.231982399145781|1|0|0|3.81970970206264|5.58095407159941|YBX3|2
3987|macrophage activation (GO:0042116)|1/17|0.231982399145781|1|0|0|3.81970970206264|5.58095407159941|AIF1|2
3988|virion assembly (GO:0019068)|1/17|0.231982399145781|1|0|0|3.81970970206264|5.58095407159941|PPIA|2
3989|positive regulation by host of viral transcription (GO:0043923)|1/17|0.231982399145781|1|0|0|3.81970970206264|5.58095407159941|NUCKS1|2
3990|regulation of establishment or maintenance of cell polarity (GO:0032878)|1/17|0.231982399145781|1|0|0|3.81970970206264|5.58095407159941|KIF20B|2
3991|septin ring organization (GO:0031106)|1/17|0.231982399145781|1|0|0|3.81970970206264|5.58095407159941|ANLN|2
3992|positive regulation of telomere capping (GO:1904355)|1/17|0.231982399145781|1|0|0|3.81970970206264|5.58095407159941|AURKB|2
3993|cellular response to glucocorticoid stimulus (GO:0071385)|1/17|0.231982399145781|1|0|0|3.81970970206264|5.58095407159941|HNRNPU|2
3994|regulation of canonical Wnt signaling pathway (GO:0060828)|5/214|0.234891707324563|1|0|0|1.51717441437068|2.1978254201717|PSMB6;PSMB7;PSMA4;PSMC3;AES|2
3995|regulation of extrinsic apoptotic signaling pathway (GO:2001236)|2/60|0.236033441139709|1|0|0|2.16450216450216|3.12506879707891|PYCARD;PARK7|2
3996|DNA-templated transcription, elongation (GO:0006354)|3/109|0.236228782736423|1|0|0|1.78720362206601|2.57885355385033|ELOF1;ELOB;SSRP1|2
3997|negative regulation of protein kinase activity (GO:0006469)|3/110|0.240321989425799|1|0|0|1.77095631641086|2.52498636163657|PYCARD;H2AFY;PARK7|2
3998|positive regulation of protein binding (GO:0032092)|2/61|0.241736599996371|1|0|0|2.12901852246115|3.02300739911083|PARK7;RAN|2
3999|regulation of telomerase RNA localization to Cajal body (GO:1904872)|1/18|0.243819914986971|1|0|0|3.60750360750361|5.09136139796705|NHP2|2
4000|mitotic recombination (GO:0006312)|1/18|0.243819914986971|1|0|0|3.60750360750361|5.09136139796705|SMC6|2
4001|iron-sulfur cluster assembly (GO:0016226)|1/18|0.243819914986971|1|0|0|3.60750360750361|5.09136139796705|NUBP1|2
4002|nuclear envelope reassembly (GO:0031468)|1/18|0.243819914986971|1|0|0|3.60750360750361|5.09136139796705|BANF1|2
4003|actin filament polymerization (GO:0030041)|1/18|0.243819914986971|1|0|0|3.60750360750361|5.09136139796705|AIF1|2
4004|cellular response to gamma radiation (GO:0071480)|1/18|0.243819914986971|1|0|0|3.60750360750361|5.09136139796705|TMEM109|2
4005|maintenance of protein localization in organelle (GO:0072595)|1/18|0.243819914986971|1|0|0|3.60750360750361|5.09136139796705|HNRNPU|2
4006|regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664)|1/18|0.243819914986971|1|0|0|3.60750360750361|5.09136139796705|LY86|2
4007|negative regulation of RNA splicing (GO:0033119)|1/18|0.243819914986971|1|0|0|3.60750360750361|5.09136139796705|SRSF7|2
4008|negative regulation of protein dephosphorylation (GO:0035308)|1/18|0.243819914986971|1|0|0|3.60750360750361|5.09136139796705|ARPP19|2
4009|modulation by virus of host morphology or physiology (GO:0019048)|1/18|0.243819914986971|1|0|0|3.60750360750361|5.09136139796705|KPNA2|2
4010|regulation of cAMP-mediated signaling (GO:0043949)|1/18|0.243819914986971|1|0|0|3.60750360750361|5.09136139796705|PF4|2
4011|negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176)|1/18|0.243819914986971|1|0|0|3.60750360750361|5.09136139796705|PARK7|2
4012|DNA methylation (GO:0006306)|1/18|0.243819914986971|1|0|0|3.60750360750361|5.09136139796705|DNMT1|2
4013|glyceraldehyde-3-phosphate metabolic process (GO:0019682)|1/18|0.243819914986971|1|0|0|3.60750360750361|5.09136139796705|TPI1|2
4014|response to organophosphorus (GO:0046683)|1/18|0.243819914986971|1|0|0|3.60750360750361|5.09136139796705|TYMS|2
4015|T cell receptor signaling pathway (GO:0050852)|4/164|0.246672265804066|1|0|0|1.58378207158695|2.21681134384539|PSMB6;PSMB7;PSMA4;PSMC3|2
4016|positive regulation of cellular amide metabolic process (GO:0034250)|2/62|0.247445827540427|1|0|0|2.09467951403435|2.92535316203467|RBM3;RPS27L|2
4017|positive regulation of nucleic acid-templated transcription (GO:1903508)|10/503|0.249293287390194|1|0|0|1.29095556530944|1.79329892675981|CD74;CNBP;ATAD2;CKS2;SPP1;HMGB2;MRPL12;HNRNPAB;RAN;CKS1B|2
4018|negative regulation of peptidase activity (GO:0010466)|2/63|0.253159589749514|1|0|0|2.0614306328592|2.83185982188195|PARK7;GAPDH|2
4019|regulation of T cell proliferation (GO:0042129)|2/63|0.253159589749514|1|0|0|2.0614306328592|2.83185982188195|ARG1;AIF1|2
4020|regulation of protein kinase A signaling (GO:0010738)|1/19|0.255475561349638|1|0|0|3.41763499658236|4.66380220166821|MIF|2
4021|protein ADP-ribosylation (GO:0006471)|1/19|0.255475561349638|1|0|0|3.41763499658236|4.66380220166821|HPF1|2
4022|histone methylation (GO:0016571)|1/19|0.255475561349638|1|0|0|3.41763499658236|4.66380220166821|EZH2|2
4023|maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)|1/19|0.255475561349638|1|0|0|3.41763499658236|4.66380220166821|RPSA|2
4024|sulfur compound transport (GO:0072348)|1/19|0.255475561349638|1|0|0|3.41763499658236|4.66380220166821|RACGAP1|2
4025|Rac protein signal transduction (GO:0016601)|1/19|0.255475561349638|1|0|0|3.41763499658236|4.66380220166821|AIF1|2
4026|positive regulation of oxidoreductase activity (GO:0051353)|1/19|0.255475561349638|1|0|0|3.41763499658236|4.66380220166821|PARK7|2
4027|positive regulation of toll-like receptor signaling pathway (GO:0034123)|1/19|0.255475561349638|1|0|0|3.41763499658236|4.66380220166821|HMGB1|2
4028|positive regulation of lipid storage (GO:0010884)|1/19|0.255475561349638|1|0|0|3.41763499658236|4.66380220166821|MSR1|2
4029|nucleosome disassembly (GO:0006337)|1/19|0.255475561349638|1|0|0|3.41763499658236|4.66380220166821|SET|2
4030|chromatin disassembly (GO:0031498)|1/19|0.255475561349638|1|0|0|3.41763499658236|4.66380220166821|SET|2
4031|purine ribonucleotide catabolic process (GO:0009154)|1/19|0.255475561349638|1|0|0|3.41763499658236|4.66380220166821|HINT1|2
4032|folic acid metabolic process (GO:0046655)|1/19|0.255475561349638|1|0|0|3.41763499658236|4.66380220166821|DHFR|2
4033|insulin secretion (GO:0030073)|1/19|0.255475561349638|1|0|0|3.41763499658236|4.66380220166821|PARK7|2
4034|regulation of neuron migration (GO:2001222)|1/19|0.255475561349638|1|0|0|3.41763499658236|4.66380220166821|KIF20B|2
4035|positive regulation of transcription regulatory region DNA binding (GO:2000679)|1/19|0.255475561349638|1|0|0|3.41763499658236|4.66380220166821|PARK7|2
4036|regulation of inflammatory response (GO:0050727)|4/167|0.256740631914194|1|0|0|1.55533089664826|2.1147661840396|CCL4;PARK7;S100A9;CCR2|2
4037|negative regulation of protein modification process (GO:0031400)|2/64|0.258876398216191|1|0|0|2.02922077922078|2.74229821054412|PARK7;ARPP19|2
4038|carbohydrate homeostasis (GO:0033500)|2/64|0.258876398216191|1|0|0|2.02922077922078|2.74229821054412|RPS6;PARK7|2
4039|negative regulation of dephosphorylation (GO:0035305)|2/64|0.258876398216191|1|0|0|2.02922077922078|2.74229821054412|KNL1;ARPP19|2
4040|mitochondrion organization (GO:0007005)|4/168|0.26011528763365|1|0|0|1.5460729746444|2.081988763559|NDUFB8;CYCS;TSPO;PARK7|2
4041|epithelium development (GO:0060429)|3/116|0.265107823278415|1|0|0|1.67935512763099|2.22954319657415|PCNA;PGK1;CDK1|2
4042|positive regulation of interleukin-2 production (GO:0032743)|1/20|0.26695212348861|1|0|0|3.24675324675325|4.28794139427626|CCR2|2
4043|regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235)|1/20|0.26695212348861|1|0|0|3.24675324675325|4.28794139427626|PARK7|2
4044|hydrogen peroxide metabolic process (GO:0042743)|1/20|0.26695212348861|1|0|0|3.24675324675325|4.28794139427626|PARK7|2
4045|negative regulation of macromolecule biosynthetic process (GO:0010558)|1/20|0.26695212348861|1|0|0|3.24675324675325|4.28794139427626|PF4|2
4046|negative regulation of actin filament bundle assembly (GO:0032232)|1/20|0.26695212348861|1|0|0|3.24675324675325|4.28794139427626|STMN1|2
4047|synapsis (GO:0007129)|1/20|0.26695212348861|1|0|0|3.24675324675325|4.28794139427626|SYCE2|2
4048|negative regulation of cyclase activity (GO:0031280)|1/20|0.26695212348861|1|0|0|3.24675324675325|4.28794139427626|CCR2|2
4049|regulation of cholesterol transport (GO:0032374)|1/20|0.26695212348861|1|0|0|3.24675324675325|4.28794139427626|TSPO|2
4050|androgen metabolic process (GO:0008209)|1/20|0.26695212348861|1|0|0|3.24675324675325|4.28794139427626|SPP1|2
4051|regulation of anoikis (GO:2000209)|1/20|0.26695212348861|1|0|0|3.24675324675325|4.28794139427626|AES|2
4052|regulation of cell development (GO:0060284)|1/20|0.26695212348861|1|0|0|3.24675324675325|4.28794139427626|HMGB2|2
4053|regulation of response to cytokine stimulus (GO:0060759)|1/20|0.26695212348861|1|0|0|3.24675324675325|4.28794139427626|AES|2
4054|organelle disassembly (GO:1903008)|1/20|0.26695212348861|1|0|0|3.24675324675325|4.28794139427626|CDK1|2
4055|telomere maintenance via telomerase (GO:0007004)|1/20|0.26695212348861|1|0|0|3.24675324675325|4.28794139427626|NHP2|2
4056|negative regulation of adenylate cyclase activity (GO:0007194)|1/20|0.26695212348861|1|0|0|3.24675324675325|4.28794139427626|CCR2|2
4057|negative regulation of interferon-gamma production (GO:0032689)|1/20|0.26695212348861|1|0|0|3.24675324675325|4.28794139427626|HMGB1|2
4058|cellular response to estradiol stimulus (GO:0071392)|1/20|0.26695212348861|1|0|0|3.24675324675325|4.28794139427626|H2AFZ|2
4059|mitochondrial RNA metabolic process (GO:0000959)|1/20|0.26695212348861|1|0|0|3.24675324675325|4.28794139427626|MRPL12|2
4060|peptidyl-serine modification (GO:0018209)|4/171|0.270290001204325|1|0|0|1.51894888736994|1.98717979472754|HPF1;PLK1;CDK1;CLSPN|2
4061|negative regulation of apoptotic signaling pathway (GO:2001234)|2/66|0.27031342140987|1|0|0|1.96772924045651|2.57413060444281|PRELID1;PARK7|2
4062|cellular response to light stimulus (GO:0071482)|2/67|0.276030877566846|1|0|0|1.93836014731537|2.49513964776189|PCNA;AURKB|2
4063|purine ribonucleotide metabolic process (GO:0009150)|2/67|0.276030877566846|1|0|0|1.93836014731537|2.49513964776189|HINT1;RAN|2
4064|positive regulation of protein kinase activity (GO:0045860)|4/173|0.277112001694979|1|0|0|1.50138878462578|1.92678254825983|TPX2;CENPE;CLSPN;EZH2|2
4065|positive regulation of protein serine/threonine kinase activity (GO:0071902)|3/119|0.277617853387096|1|0|0|1.63701844374113|2.09785507868069|CKS2;EZH2;CKS1B|2
4066|hyaluronan metabolic process (GO:0030212)|1/21|0.278252344147364|1|0|0|3.09214594928881|3.95555616652224|HMMR|2
4067|positive regulation of transcription from RNA polymerase I promoter (GO:0045943)|1/21|0.278252344147364|1|0|0|3.09214594928881|3.95555616652224|NCL|2
4068|establishment of spindle orientation (GO:0051294)|1/21|0.278252344147364|1|0|0|3.09214594928881|3.95555616652224|CENPA|2
4069|histone ubiquitination (GO:0016574)|1/21|0.278252344147364|1|0|0|3.09214594928881|3.95555616652224|UHRF1|2
4070|negative regulation of G-protein coupled receptor protein signaling pathway (GO:0045744)|1/21|0.278252344147364|1|0|0|3.09214594928881|3.95555616652224|STMN1|2
4071|regulation of interleukin-2 production (GO:0032663)|1/21|0.278252344147364|1|0|0|3.09214594928881|3.95555616652224|CCR2|2
4072|nucleotide-excision repair, preincision complex stabilization (GO:0006293)|1/21|0.278252344147364|1|0|0|3.09214594928881|3.95555616652224|RPA2|2
4073|protein-DNA complex disassembly (GO:0032986)|1/21|0.278252344147364|1|0|0|3.09214594928881|3.95555616652224|SET|2
4074|negative regulation of cAMP biosynthetic process (GO:0030818)|1/21|0.278252344147364|1|0|0|3.09214594928881|3.95555616652224|CCR2|2
4075|negative regulation of cyclin-dependent protein kinase activity (GO:1904030)|1/21|0.278252344147364|1|0|0|3.09214594928881|3.95555616652224|PLK1|2
4076|regulation of gene silencing by miRNA (GO:0060964)|2/68|0.281745860939881|1|0|0|1.90985485103132|2.41930828249014|NDC1;RAN|2
4077|positive regulation of endothelial cell proliferation (GO:0001938)|2/68|0.281745860939881|1|0|0|1.90985485103132|2.41930828249014|HMGB2;HMGB1|2
4078|positive regulation of B cell activation (GO:0050871)|3/120|0.281801115249841|1|0|0|1.62337662337662|2.05609370443492|CD74;IGKC;MIF|2
4079|regulation of endopeptidase activity (GO:0052548)|2/69|0.287457095506035|1|0|0|1.88217579521927|2.34647405026082|PRELID1;GAPDH|2
4080|regulation of interferon-gamma-mediated signaling pathway (GO:0060334)|1/22|0.289378924103386|1|0|0|2.95159386068477|3.66003038257712|ARG1|2
4081|regulation of calcium ion import (GO:0090279)|1/22|0.289378924103386|1|0|0|2.95159386068477|3.66003038257712|CCL2|2
4082|negative regulation of protein polymerization (GO:0032272)|1/22|0.289378924103386|1|0|0|2.95159386068477|3.66003038257712|STMN1|2
4083|protein homotrimerization (GO:0070207)|1/22|0.289378924103386|1|0|0|2.95159386068477|3.66003038257712|MIF|2
4084|positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052)|1/22|0.289378924103386|1|0|0|2.95159386068477|3.66003038257712|ATPIF1|2
4085|sterol transport (GO:0015918)|1/22|0.289378924103386|1|0|0|2.95159386068477|3.66003038257712|MSR1|2
4086|nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)|1/22|0.289378924103386|1|0|0|2.95159386068477|3.66003038257712|RPA2|2
4087|negative regulation of response to endoplasmic reticulum stress (GO:1903573)|1/22|0.289378924103386|1|0|0|2.95159386068477|3.66003038257712|PARK7|2
4088|negative regulation of myeloid cell differentiation (GO:0045638)|1/22|0.289378924103386|1|0|0|2.95159386068477|3.66003038257712|PF4|2
4089|histone lysine methylation (GO:0034968)|1/22|0.289378924103386|1|0|0|2.95159386068477|3.66003038257712|EZH2|2
4090|positive regulation of erythrocyte differentiation (GO:0045648)|1/22|0.289378924103386|1|0|0|2.95159386068477|3.66003038257712|HMGB2|2
4091|purine-containing compound biosynthetic process (GO:0072522)|1/22|0.289378924103386|1|0|0|2.95159386068477|3.66003038257712|DCK|2
4092|protein complex localization (GO:0031503)|1/22|0.289378924103386|1|0|0|2.95159386068477|3.66003038257712|BIRC5|2
4093|C21-steroid hormone metabolic process (GO:0008207)|1/22|0.289378924103386|1|0|0|2.95159386068477|3.66003038257712|TSPO|2
4094|regulation of bone resorption (GO:0045124)|1/22|0.289378924103386|1|0|0|2.95159386068477|3.66003038257712|SPP1|2
4095|negative regulation of lyase activity (GO:0051350)|1/22|0.289378924103386|1|0|0|2.95159386068477|3.66003038257712|CCR2|2
4096|NLS-bearing protein import into nucleus (GO:0006607)|1/22|0.289378924103386|1|0|0|2.95159386068477|3.66003038257712|KPNA2|2
4097|positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436)|2/71|0.298863411782784|1|0|0|1.82915675873422|2.20919814659596|SUMO2;PLK1|2
4098|negative regulation of developmental process (GO:0051093)|2/71|0.298863411782784|1|0|0|1.82915675873422|2.20919814659596|MIF;ANP32B|2
4099|negative regulation of viral transcription (GO:0032897)|1/23|0.300334523006447|1|0|0|2.82326369282891|3.39598630399214|CCL4|2
4100|regulation of telomere capping (GO:1904353)|1/23|0.300334523006447|1|0|0|2.82326369282891|3.39598630399214|AURKB|2
4101|regulation of transcription elongation from RNA polymerase II promoter (GO:0034243)|1/23|0.300334523006447|1|0|0|2.82326369282891|3.39598630399214|HNRNPU|2
4102|TOR signaling (GO:0031929)|1/23|0.300334523006447|1|0|0|2.82326369282891|3.39598630399214|RPS6|2
4103|positive regulation of ATP metabolic process (GO:1903580)|1/23|0.300334523006447|1|0|0|2.82326369282891|3.39598630399214|ENO1|2
4104|negative regulation of signal transduction in absence of ligand (GO:1901099)|1/23|0.300334523006447|1|0|0|2.82326369282891|3.39598630399214|PF4|2
4105|regulation of interleukin-8 secretion (GO:2000482)|1/23|0.300334523006447|1|0|0|2.82326369282891|3.39598630399214|PYCARD|2
4106|negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240)|1/23|0.300334523006447|1|0|0|2.82326369282891|3.39598630399214|PF4|2
4107|maturation of LSU-rRNA (GO:0000470)|1/23|0.300334523006447|1|0|0|2.82326369282891|3.39598630399214|NHP2|2
4108|positive regulation of ion transmembrane transporter activity (GO:0032414)|1/23|0.300334523006447|1|0|0|2.82326369282891|3.39598630399214|GLRX|2
4109|histone acetylation (GO:0016573)|2/72|0.304556136072691|1|0|0|1.8037518037518|2.14448025596129|HAT1;POLE3|2
4110|defense response to Gram-negative bacterium (GO:0050829)|2/72|0.304556136072691|1|0|0|1.8037518037518|2.14448025596129|PYCARD;HMGB2|2
4111|positive regulation of growth (GO:0045927)|2/72|0.304556136072691|1|0|0|1.8037518037518|2.14448025596129|S100A9;HIST1H1B|2
4112|positive regulation of cell cycle G1/S phase transition (GO:1902808)|1/24|0.311121759847276|1|0|0|2.70562770562771|3.15901226369129|AIF1|2
4113|regulation of androgen receptor signaling pathway (GO:0060765)|1/24|0.311121759847276|1|0|0|2.70562770562771|3.15901226369129|PARK7|2
4114|positive regulation of proteasomal protein catabolic process (GO:1901800)|2/74|0.31591510204769|1|0|0|1.75500175500176|2.02225652140754|SUMO2;PLK1|2
4115|positive regulation of intracellular signal transduction (GO:1902533)|9/480|0.321557633265134|1|0|0|1.21753246753247|1.38138614575703|CD74;LGALS1;CCL4;S100A4;MIF;PARK7;HMGB1;S100A9;PF4|2
4116|positive regulation of immune effector process (GO:0002699)|1/25|0.321743213660458|1|0|0|2.5974025974026|2.9454585056954|CCR2|2
4117|histone monoubiquitination (GO:0010390)|1/25|0.321743213660458|1|0|0|2.5974025974026|2.9454585056954|UHRF1|2
4118|response to glucocorticoid (GO:0051384)|1/25|0.321743213660458|1|0|0|2.5974025974026|2.9454585056954|HNRNPU|2
4119|positive regulation of purine nucleotide biosynthetic process (GO:1900373)|1/25|0.321743213660458|1|0|0|2.5974025974026|2.9454585056954|ENO1|2
4120|receptor catabolic process (GO:0032801)|1/25|0.321743213660458|1|0|0|2.5974025974026|2.9454585056954|AP2S1|2
4121|negative regulation of oxidative stress-induced cell death (GO:1903202)|1/25|0.321743213660458|1|0|0|2.5974025974026|2.9454585056954|PARK7|2
4122|cellular senescence (GO:0090398)|1/25|0.321743213660458|1|0|0|2.5974025974026|2.9454585056954|SMC6|2
4123|transition metal ion homeostasis (GO:0055076)|1/25|0.321743213660458|1|0|0|2.5974025974026|2.9454585056954|COMMD1|2
4124|negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435)|1/25|0.321743213660458|1|0|0|2.5974025974026|2.9454585056954|PARK7|2
4125|negative regulation of T cell proliferation (GO:0042130)|1/25|0.321743213660458|1|0|0|2.5974025974026|2.9454585056954|ARG1|2
4126|regulation of macromolecule metabolic process (GO:0060255)|3/130|0.323849967456047|1|0|0|1.4985014985015|1.68952287788817|CDK4;CDK1;CRIP1|2
4127|negative regulation of cell proliferation (GO:0008285)|7/364|0.329530008480519|1|0|0|1.24875124875125|1.38622359691301|CDKN2D;CDKN2C;TFDP1;RBBP4;EMP3;AIF1;CDKN3|2
4128|organophosphate ester transport (GO:0015748)|1/26|0.332201424047129|1|0|0|2.4975024975025|2.75228220553424|PRELID1|2
4129|protein import into nucleus, translocation (GO:0000060)|1/26|0.332201424047129|1|0|0|2.4975024975025|2.75228220553424|RAN|2
4130|lamellipodium organization (GO:0097581)|1/26|0.332201424047129|1|0|0|2.4975024975025|2.75228220553424|SNX2|2
4131|positive regulation of interleukin-12 production (GO:0032735)|1/26|0.332201424047129|1|0|0|2.4975024975025|2.75228220553424|HMGB1|2
4132|regulation of interleukin-10 production (GO:0032653)|1/26|0.332201424047129|1|0|0|2.4975024975025|2.75228220553424|HMGB1|2
4133|positive regulation of glucose transport (GO:0010828)|1/26|0.332201424047129|1|0|0|2.4975024975025|2.75228220553424|ARPP19|2
4134|positive regulation of interleukin-1 beta secretion (GO:0050718)|1/26|0.332201424047129|1|0|0|2.4975024975025|2.75228220553424|PYCARD|2
4135|regulation of apoptotic signaling pathway (GO:2001233)|1/26|0.332201424047129|1|0|0|2.4975024975025|2.75228220553424|PYCARD|2
4136|peptide hormone secretion (GO:0030072)|1/26|0.332201424047129|1|0|0|2.4975024975025|2.75228220553424|PARK7|2
4137|regulation of nervous system development (GO:0051960)|1/26|0.332201424047129|1|0|0|2.4975024975025|2.75228220553424|HMGB2|2
4138|peptidyl-tyrosine dephosphorylation (GO:0035335)|1/26|0.332201424047129|1|0|0|2.4975024975025|2.75228220553424|PGP|2
4139|positive regulation of peptidyl-threonine phosphorylation (GO:0010800)|1/26|0.332201424047129|1|0|0|2.4975024975025|2.75228220553424|PLK1|2
4140|positive regulation of JNK cascade (GO:0046330)|2/77|0.332871567464697|1|0|0|1.68662506324844|1.85528511837716|PYCARD;HMGB1|2
4141|positive regulation of apoptotic signaling pathway (GO:2001235)|2/77|0.332871567464697|1|0|0|1.68662506324844|1.85528511837716|PYCARD;S100A9|2
4142|negative regulation of extrinsic apoptotic signaling pathway (GO:2001237)|2/77|0.332871567464697|1|0|0|1.68662506324844|1.85528511837716|PARK7;PF4|2
4143|positive regulation of apoptotic process (GO:0043065)|6/308|0.338351494754983|1|0|0|1.26496879743633|1.37080873486624|TOP2A;PYCARD;RPS6;CYCS;HMGB1;AES|2
4144|positive regulation of glucose import (GO:0046326)|1/27|0.342498891961529|1|0|0|2.4050024050024|2.57692846665202|ARPP19|2
4145|apoptotic cell clearance (GO:0043277)|1/27|0.342498891961529|1|0|0|2.4050024050024|2.57692846665202|HMGB1|2
4146|response to gamma radiation (GO:0010332)|1/27|0.342498891961529|1|0|0|2.4050024050024|2.57692846665202|TMEM109|2
4147|regulation of transcription regulatory region DNA binding (GO:2000677)|1/27|0.342498891961529|1|0|0|2.4050024050024|2.57692846665202|PARK7|2
4148|regulation of supramolecular fiber organization (GO:1902903)|1/27|0.342498891961529|1|0|0|2.4050024050024|2.57692846665202|PARK7|2
4149|negative regulation of catalytic activity (GO:0043086)|1/27|0.342498891961529|1|0|0|2.4050024050024|2.57692846665202|ATPIF1|2
4150|positive regulation of cAMP metabolic process (GO:0030816)|1/27|0.342498891961529|1|0|0|2.4050024050024|2.57692846665202|PF4|2
4151|regulation of muscle contraction (GO:0006937)|1/27|0.342498891961529|1|0|0|2.4050024050024|2.57692846665202|ENO1|2
4152|regulation of histone acetylation (GO:0035065)|1/27|0.342498891961529|1|0|0|2.4050024050024|2.57692846665202|SET|2
4153|fat-soluble vitamin metabolic process (GO:0006775)|1/27|0.342498891961529|1|0|0|2.4050024050024|2.57692846665202|SUMO2|2
4154|positive regulation of release of cytochrome c from mitochondria (GO:0090200)|1/27|0.342498891961529|1|0|0|2.4050024050024|2.57692846665202|PYCARD|2
4155|strand displacement (GO:0000732)|1/27|0.342498891961529|1|0|0|2.4050024050024|2.57692846665202|RAD51AP1|2
4156|regulation of T cell receptor signaling pathway (GO:0050856)|1/27|0.342498891961529|1|0|0|2.4050024050024|2.57692846665202|KCNN4|2
4157|regulation of transcription from RNA polymerase II promoter (GO:0006357)|25/1479|0.343141048981234|1|0|0|1.09761773047777|1.17402695620172|UHRF1;HMGB2;HNRNPU;NUCKS1;ENO1;PARK7;HMGB1;AURKB;RAD21;HIST1H1B;TCEAL9;CBX5;H2AFY;H2AFZ;CNBP;PLK1;ATAD2;CKAP2;DEK;AES;TFDP1;PSMC3;HDGF;EZH2;PF4|2
4158|regulation of cellular response to heat (GO:1900034)|2/79|0.344109743590622|1|0|0|1.64392569455861|1.75373113664261|NDC1;RPA2|2
4159|cellular response to organic cyclic compound (GO:0071407)|3/136|0.349121401949982|1|0|0|1.43239113827349|1.50735613160463|H2AFZ;SPP1;CCL2|2
4160|regulation of endothelial cell proliferation (GO:0001936)|2/80|0.349706234987105|1|0|0|1.62337662337662|1.705619814189|ATPIF1;HMGB2|2
4161|mRNA polyadenylation (GO:0006378)|1/28|0.352638080020276|1|0|0|2.3191094619666|2.41723798019727|NUDT21|2
4162|regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143)|1/28|0.352638080020276|1|0|0|2.3191094619666|2.41723798019727|PARK7|2
4163|telomere maintenance via telomere lengthening (GO:0010833)|1/28|0.352638080020276|1|0|0|2.3191094619666|2.41723798019727|NHP2|2
4164|negative regulation of smooth muscle cell proliferation (GO:0048662)|1/28|0.352638080020276|1|0|0|2.3191094619666|2.41723798019727|AIF1|2
4165|negative regulation of microtubule polymerization or depolymerization (GO:0031111)|1/28|0.352638080020276|1|0|0|2.3191094619666|2.41723798019727|STMN1|2
4166|regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239)|1/28|0.352638080020276|1|0|0|2.3191094619666|2.41723798019727|PF4|2
4167|negative regulation of myeloid leukocyte differentiation (GO:0002762)|1/28|0.352638080020276|1|0|0|2.3191094619666|2.41723798019727|C1QC|2
4168|regulation of vascular endothelial growth factor production (GO:0010574)|1/28|0.352638080020276|1|0|0|2.3191094619666|2.41723798019727|CCR2|2
4169|regulation of autophagy of mitochondrion (GO:1903146)|1/28|0.352638080020276|1|0|0|2.3191094619666|2.41723798019727|PARK7|2
4170|regulation of protein localization to cell surface (GO:2000008)|1/28|0.352638080020276|1|0|0|2.3191094619666|2.41723798019727|COMMD1|2
4171|positive regulation of cell differentiation (GO:0045597)|4/195|0.35342445679184|1|0|0|1.33200133200133|1.38539529432309|MSR1;PA2G4;EZH2;PF4|2
4172|positive regulation of stress-activated MAPK cascade (GO:0032874)|2/81|0.355286509618674|1|0|0|1.60333493666827|1.65918028806106|PYCARD;HMGB1|2
4173|regulation of hydrolase activity (GO:0051336)|2/81|0.355286509618674|1|0|0|1.60333493666827|1.65918028806106|RACGAP1;ATPIF1|2
4174|positive regulation of protein targeting to mitochondrion (GO:1903955)|2/82|0.360849740712709|1|0|0|1.58378207158695|1.61433898956291|PSMB7;SAE1|2
4175|negative regulation of cell death (GO:0060548)|2/82|0.360849740712709|1|0|0|1.58378207158695|1.61433898956291|TMEM109;PARK7|2
4176|organelle assembly (GO:0070925)|7/377|0.361962471003351|1|0|0|1.20569086086327|1.22524082926461|ANLN;CENPE;CENPF;CENPW;CENPA;LSM4;LSM3|2
4177|RNA polyadenylation (GO:0043631)|1/29|0.362621413314101|1|0|0|2.23914017017465|2.2713746696927|NUDT21|2
4178|cellular response to ketone (GO:1901655)|1/29|0.362621413314101|1|0|0|2.23914017017465|2.2713746696927|SPP1|2
4179|cellular response to hydrogen peroxide (GO:0070301)|1/29|0.362621413314101|1|0|0|2.23914017017465|2.2713746696927|PARK7|2
4180|carboxylic acid catabolic process (GO:0046395)|1/29|0.362621413314101|1|0|0|2.23914017017465|2.2713746696927|HMMR|2
4181|RNA phosphodiester bond hydrolysis (GO:0090501)|1/29|0.362621413314101|1|0|0|2.23914017017465|2.2713746696927|NHP2|2
4182|negative regulation of proteasomal protein catabolic process (GO:1901799)|1/29|0.362621413314101|1|0|0|2.23914017017465|2.2713746696927|PARK7|2
4183|regulation of mRNA processing (GO:0050684)|1/29|0.362621413314101|1|0|0|2.23914017017465|2.2713746696927|SRSF3|2
4184|positive regulation of phosphate metabolic process (GO:0045937)|1/29|0.362621413314101|1|0|0|2.23914017017465|2.2713746696927|MIF|2
4185|positive regulation of extrinsic apoptotic signaling pathway (GO:2001238)|1/29|0.362621413314101|1|0|0|2.23914017017465|2.2713746696927|PYCARD|2
4186|positive regulation of calcium-mediated signaling (GO:0050850)|1/29|0.362621413314101|1|0|0|2.23914017017465|2.2713746696927|CCL4|2
4187|production of miRNAs involved in gene silencing by miRNA (GO:0035196)|1/29|0.362621413314101|1|0|0|2.23914017017465|2.2713746696927|HNRNPA2B1|2
4188|regulation of defense response to virus by virus (GO:0050690)|1/29|0.362621413314101|1|0|0|2.23914017017465|2.2713746696927|AP2S1|2
4189|regulation of adenylate cyclase activity (GO:0045761)|1/29|0.362621413314101|1|0|0|2.23914017017465|2.2713746696927|CCR2|2
4190|antigen receptor-mediated signaling pathway (GO:0050851)|5/258|0.365824719440836|1|0|0|1.25843149098963|1.26547992666583|PSMB6;PSMB7;PSMA4;IGKC;PSMC3|2
4191|negative regulation of NF-kappaB transcription factor activity (GO:0032088)|2/83|0.366395130716652|1|0|0|1.56470035988108|1.57102634298116|PYCARD;COMMD1|2
4192|regulation of cellular component organization (GO:0051128)|3/141|0.370109546355767|1|0|0|1.38159712627798|1.37324709302639|HJURP;AP2S1;PARK7|2
4193|positive regulation of peptidyl-serine phosphorylation (GO:0033138)|2/84|0.371921910358667|1|0|0|1.5460729746444|1.52917650763083|PARK7;MIF|2
4194|positive regulation of homeostatic process (GO:0032846)|2/84|0.371921910358667|1|0|0|1.5460729746444|1.52917650763083|HMGB2;SPP1|2
4195|nucleotide-excision repair, preincision complex assembly (GO:0006294)|1/30|0.37245127981827|1|0|0|2.16450216450216|2.13776848950384|RPA2|2
4196|cortical cytoskeleton organization (GO:0030865)|1/30|0.37245127981827|1|0|0|2.16450216450216|2.13776848950384|ANLN|2
4197|positive regulation of myeloid cell differentiation (GO:0045639)|1/30|0.37245127981827|1|0|0|2.16450216450216|2.13776848950384|HMGB2|2
4198|protein alkylation (GO:0008213)|1/30|0.37245127981827|1|0|0|2.16450216450216|2.13776848950384|RPS2|2
4199|negative regulation of lymphocyte proliferation (GO:0050672)|1/30|0.37245127981827|1|0|0|2.16450216450216|2.13776848950384|ARG1|2
4200|regulation of keratinocyte differentiation (GO:0045616)|1/30|0.37245127981827|1|0|0|2.16450216450216|2.13776848950384|H2AFY|2
4201|protein modification process (GO:0036211)|2/85|0.37742933824719|1|0|0|1.52788388082506|1.48872713715083|UBL4A;UBE2S|2
4202|ribosomal large subunit assembly (GO:0000027)|1/31|0.382130031169771|1|0|0|2.09467951403435|2.01506982104034|RPL3|2
4203|negative regulation of endothelial cell proliferation (GO:0001937)|1/31|0.382130031169771|1|0|0|2.09467951403435|2.01506982104034|ATPIF1|2
4204|regulation of leukocyte chemotaxis (GO:0002688)|1/31|0.382130031169771|1|0|0|2.09467951403435|2.01506982104034|PF4|2
4205|activation of protein kinase B activity (GO:0032148)|1/31|0.382130031169771|1|0|0|2.09467951403435|2.01506982104034|PARK7|2
4206|response to estradiol (GO:0032355)|1/31|0.382130031169771|1|0|0|2.09467951403435|2.01506982104034|H2AFZ|2
4207|nuclear envelope organization (GO:0006998)|1/31|0.382130031169771|1|0|0|2.09467951403435|2.01506982104034|PLK1|2
4208|regulation of sodium ion transmembrane transport (GO:1902305)|1/31|0.382130031169771|1|0|0|2.09467951403435|2.01506982104034|COMMD1|2
4209|regulation of peptidyl-tyrosine phosphorylation (GO:0050730)|2/86|0.382916700026397|1|0|0|1.51011778918756|1.44961915865339|CD74;MIF|2
4210|regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122)|4/205|0.388326027431107|1|0|0|1.26702565726956|1.19849225886544|PYCARD;CD74;LGALS1;S100A4|2
4211|toll-like receptor signaling pathway (GO:0002224)|2/87|0.388383307823403|1|0|0|1.49276011344977|1.41179656703426|HMGB1;S100A9|2
4212|regulation of peptidyl-serine phosphorylation (GO:0033135)|2/87|0.388383307823403|1|0|0|1.49276011344977|1.41179656703426|PARK7;MIF|2
4213|peptidyl-serine phosphorylation (GO:0018105)|3/146|0.390973357726192|1|0|0|1.33428215619996|1.25304553477053|PLK1;CDK1;CLSPN|2
4214|negative regulation of blood vessel endothelial cell migration (GO:0043537)|1/32|0.391659983034034|1|0|0|2.02922077922078|1.90211283646823|HMGB1|2
4215|alpha-amino acid metabolic process (GO:1901605)|1/32|0.391659983034034|1|0|0|2.02922077922078|1.90211283646823|GATM|2
4216|regulation of glucose import (GO:0046324)|1/32|0.391659983034034|1|0|0|2.02922077922078|1.90211283646823|ARPP19|2
4217|negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042)|1/32|0.391659983034034|1|0|0|2.02922077922078|1.90211283646823|PARK7|2
4218|cofactor biosynthetic process (GO:0051188)|1/32|0.391659983034034|1|0|0|2.02922077922078|1.90211283646823|NUBP1|2
4219|positive regulation of interleukin-1 beta production (GO:0032731)|1/32|0.391659983034034|1|0|0|2.02922077922078|1.90211283646823|PYCARD|2
4220|cellular zinc ion homeostasis (GO:0006882)|1/32|0.391659983034034|1|0|0|2.02922077922078|1.90211283646823|S100A9|2
4221|liver development (GO:0001889)|1/32|0.391659983034034|1|0|0|2.02922077922078|1.90211283646823|AURKA|2
4222|protein destabilization (GO:0031648)|1/32|0.391659983034034|1|0|0|2.02922077922078|1.90211283646823|PLK1|2
4223|gene silencing by miRNA (GO:0035195)|1/32|0.391659983034034|1|0|0|2.02922077922078|1.90211283646823|RAN|2
4224|vesicle-mediated transport to the plasma membrane (GO:0098876)|1/32|0.391659983034034|1|0|0|2.02922077922078|1.90211283646823|COMMD1|2
4225|regulation of programmed cell death (GO:0043067)|5/269|0.39937763699619|1|0|0|1.20697146719452|1.10781616746099|PRELID1;LGALS1;ANP32E;BIRC5;ANP32B|2
4226|response to zinc ion (GO:0010043)|1/33|0.40104341557302|1|0|0|1.96772924045651|1.7978858505987|CRIP1|2
4227|oxoacid metabolic process (GO:0043436)|1/33|0.40104341557302|1|0|0|1.96772924045651|1.7978858505987|MIF|2
4228|protein trimerization (GO:0070206)|1/33|0.40104341557302|1|0|0|1.96772924045651|1.7978858505987|MIF|2
4229|purine ribonucleoside triphosphate metabolic process (GO:0009205)|1/33|0.40104341557302|1|0|0|1.96772924045651|1.7978858505987|RAN|2
4230|regulation of erythrocyte differentiation (GO:0045646)|1/33|0.40104341557302|1|0|0|1.96772924045651|1.7978858505987|HMGB2|2
4231|global genome nucleotide-excision repair (GO:0070911)|1/33|0.40104341557302|1|0|0|1.96772924045651|1.7978858505987|SUMO2|2
4232|regulation of cytokine-mediated signaling pathway (GO:0001959)|2/91|0.41002933053777|1|0|0|1.42714428428714|1.27233706856786|PYCARD;CD74|2
4233|regulation of JNK cascade (GO:0046328)|2/91|0.41002933053777|1|0|0|1.42714428428714|1.27233706856786|PYCARD;HMGB1|2
4234|positive regulation of cytokine-mediated signaling pathway (GO:0001961)|1/34|0.410282574338274|1|0|0|1.90985485103132|1.70150716381562|CD74|2
4235|regulation of T cell differentiation (GO:0045580)|1/34|0.410282574338274|1|0|0|1.90985485103132|1.70150716381562|PRELID1|2
4236|entry into host cell (GO:0030260)|1/34|0.410282574338274|1|0|0|1.90985485103132|1.70150716381562|PPIA|2
4237|negative regulation of mitochondrion organization (GO:0010823)|1/34|0.410282574338274|1|0|0|1.90985485103132|1.70150716381562|PRELID1|2
4238|positive regulation of intrinsic apoptotic signaling pathway (GO:2001244)|1/34|0.410282574338274|1|0|0|1.90985485103132|1.70150716381562|S100A9|2
4239|cellular response to glucose starvation (GO:0042149)|1/34|0.410282574338274|1|0|0|1.90985485103132|1.70150716381562|HNRNPA1|2
4240|carboxylic acid metabolic process (GO:0019752)|1/34|0.410282574338274|1|0|0|1.90985485103132|1.70150716381562|MIF|2
4241|positive regulation of nucleocytoplasmic transport (GO:0046824)|1/34|0.410282574338274|1|0|0|1.90985485103132|1.70150716381562|ANP32B|2
4242|cellular glucose homeostasis (GO:0001678)|1/34|0.410282574338274|1|0|0|1.90985485103132|1.70150716381562|NUCKS1|2
4243|regulation of intracellular protein transport (GO:0033157)|1/34|0.410282574338274|1|0|0|1.90985485103132|1.70150716381562|KIF20B|2
4244|regulation of interleukin-12 production (GO:0032655)|1/34|0.410282574338274|1|0|0|1.90985485103132|1.70150716381562|HMGB1|2
4245|regulation of protein catabolic process (GO:0042176)|2/92|0.415382730922074|1|0|0|1.41163184641446|1.24019613293433|ODC1;MAD2L1|2
4246|negative regulation of kinase activity (GO:0033673)|2/92|0.415382730922074|1|0|0|1.41163184641446|1.24019613293433|HNRNPU;PARK7|2
4247|cellular response to oxygen-containing compound (GO:1901701)|5/275|0.417617726279527|1|0|0|1.18063754427391|1.03091947500263|PYCARD;H2AFZ;HMGB2;CCL2;PARK7|2
4248|regulation of interleukin-8 production (GO:0032677)|1/35|0.41937967047992|1|0|0|1.85528756957328|1.61220525891531|PARK7|2
4249|positive regulation of leukocyte migration (GO:0002687)|1/35|0.41937967047992|1|0|0|1.85528756957328|1.61220525891531|PF4|2
4250|ncRNA metabolic process (GO:0034660)|1/35|0.41937967047992|1|0|0|1.85528756957328|1.61220525891531|RAN|2
4251|regulation of alcohol biosynthetic process (GO:1902930)|1/35|0.41937967047992|1|0|0|1.85528756957328|1.61220525891531|RAN|2
4252|negative regulation of T cell activation (GO:0050868)|1/35|0.41937967047992|1|0|0|1.85528756957328|1.61220525891531|ARG1|2
4253|regulation of insulin receptor signaling pathway (GO:0046626)|1/35|0.41937967047992|1|0|0|1.85528756957328|1.61220525891531|NUCKS1|2
4254|negative regulation of endothelial cell migration (GO:0010596)|1/35|0.41937967047992|1|0|0|1.85528756957328|1.61220525891531|HMGB1|2
4255|regulation of interleukin-1 beta secretion (GO:0050706)|1/35|0.41937967047992|1|0|0|1.85528756957328|1.61220525891531|PYCARD|2
4256|regulation of interferon-beta production (GO:0032648)|1/35|0.41937967047992|1|0|0|1.85528756957328|1.61220525891531|PYCARD|2
4257|protein stabilization (GO:0050821)|3/153|0.419878140216993|1|0|0|1.27323656735421|1.10490291844238|PARK7;GAPDH;HIST1H1B|2
4258|positive regulation of cellular metabolic process (GO:0031325)|2/93|0.420711770041172|1|0|0|1.39645300935624|1.20905922566438|PRELID1;UHRF1|2
4259|positive regulation of peptide secretion (GO:0002793)|1/36|0.428336881305335|1|0|0|1.8037518037518|1.52930246600309|PPIA|2
4260|regulation of microtubule polymerization (GO:0031113)|1/36|0.428336881305335|1|0|0|1.8037518037518|1.52930246600309|STMN1|2
4261|erythrocyte differentiation (GO:0030218)|1/36|0.428336881305335|1|0|0|1.8037518037518|1.52930246600309|ATPIF1|2
4262|negative regulation of protein complex assembly (GO:0031333)|1/36|0.428336881305335|1|0|0|1.8037518037518|1.52930246600309|PARK7|2
4263|maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)|1/36|0.428336881305335|1|0|0|1.8037518037518|1.52930246600309|RPSA|2
4264|cholesterol biosynthetic process (GO:0006695)|1/36|0.428336881305335|1|0|0|1.8037518037518|1.52930246600309|CNBP|2
4265|actin filament bundle organization (GO:0061572)|1/36|0.428336881305335|1|0|0|1.8037518037518|1.52930246600309|AIF1|2
4266|protein kinase B signaling (GO:0043491)|1/36|0.428336881305335|1|0|0|1.8037518037518|1.52930246600309|CCL2|2
4267|MAPK cascade (GO:0000165)|5/279|0.429729789961262|1|0|0|1.1637108411302|0.982868620835803|PSMB6;PSMB7;PSMA4;PSMC3;CCL2|2
4268|cellular response to fibroblast growth factor stimulus (GO:0044344)|2/95|0.43129470612752|1|0|0|1.36705399863295|1.14964271992741|CCL2;HNRNPA1|2
4269|axon development (GO:0061564)|2/95|0.43129470612752|1|0|0|1.36705399863295|1.14964271992741|DHFR;S100A6|2
4270|positive regulation of protein localization to membrane (GO:1905477)|2/96|0.43654762748353|1|0|0|1.35281385281385|1.12129031038411|TFDP1;YWHAQ|2
4271|regulation of cytoskeleton organization (GO:0051493)|2/96|0.43654762748353|1|0|0|1.35281385281385|1.12129031038411|STMN1;S100A9|2
4272|actin polymerization or depolymerization (GO:0008154)|1/37|0.437156350896259|1|0|0|1.75500175500176|1.4522014136611|AIF1|2
4273|regulation of nitric-oxide synthase activity (GO:0050999)|1/37|0.437156350896259|1|0|0|1.75500175500176|1.4522014136611|DHFR|2
4274|lymphocyte proliferation (GO:0046651)|1/37|0.437156350896259|1|0|0|1.75500175500176|1.4522014136611|HELLS|2
4275|organophosphate biosynthetic process (GO:0090407)|1/37|0.437156350896259|1|0|0|1.75500175500176|1.4522014136611|TPI1|2
4276|zymogen activation (GO:0031638)|1/37|0.437156350896259|1|0|0|1.75500175500176|1.4522014136611|PGK1|2
4277|epithelial cell migration (GO:0010631)|1/37|0.437156350896259|1|0|0|1.75500175500176|1.4522014136611|ANLN|2
4278|regulation of cysteine-type endopeptidase activity (GO:2000116)|1/37|0.437156350896259|1|0|0|1.75500175500176|1.4522014136611|PYCARD|2
4279|secondary alcohol biosynthetic process (GO:1902653)|1/37|0.437156350896259|1|0|0|1.75500175500176|1.4522014136611|CNBP|2
4280|regulation of cell death (GO:0010941)|2/97|0.441774235355631|1|0|0|1.33886731824876|1.09379610006057|TMEM109;PARK7|2
4281|protein monoubiquitination (GO:0006513)|1/38|0.445840190706023|1|0|0|1.70881749829118|1.38037373201558|UHRF1|2
4282|positive regulation of receptor activity (GO:2000273)|1/38|0.445840190706023|1|0|0|1.70881749829118|1.38037373201558|PARK7|2
4283|positive regulation of smooth muscle cell proliferation (GO:0048661)|1/38|0.445840190706023|1|0|0|1.70881749829118|1.38037373201558|AIF1|2
4284|regulation of sodium ion transmembrane transporter activity (GO:2000649)|1/38|0.445840190706023|1|0|0|1.70881749829118|1.38037373201558|GLRX|2
4285|protein K63-linked ubiquitination (GO:0070534)|1/38|0.445840190706023|1|0|0|1.70881749829118|1.38037373201558|UBE2S|2
4286|regulation of peptidyl-threonine phosphorylation (GO:0010799)|1/38|0.445840190706023|1|0|0|1.70881749829118|1.38037373201558|PLK1|2
4287|negative regulation of Ras protein signal transduction (GO:0046580)|1/38|0.445840190706023|1|0|0|1.70881749829118|1.38037373201558|STMN1|2
4288|actin filament bundle assembly (GO:0051017)|1/38|0.445840190706023|1|0|0|1.70881749829118|1.38037373201558|AIF1|2
4289|positive regulation of multi-organism process (GO:0043902)|1/38|0.445840190706023|1|0|0|1.70881749829118|1.38037373201558|LY86|2
4290|positive regulation of cell growth (GO:0030307)|2/99|0.452146783822743|1|0|0|1.31181949363768|1.04125463583474|S100A9;HIST1H1B|2
4291|response to molecule of bacterial origin (GO:0002237)|2/99|0.452146783822743|1|0|0|1.31181949363768|1.04125463583474|HMGB2;PF4|2
4292|transcription initiation from RNA polymerase II promoter (GO:0006367)|3/161|0.452334757813154|1|0|0|1.20997015406953|0.959908960198492|CCNB1;CDK4;CDK1|2
4293|Ras protein signal transduction (GO:0007265)|4/224|0.453744484077173|1|0|0|1.1595547309833|0.916304556795822|CCNA2;DNMT1;PARK7;AIF1|2
4294|muscle filament sliding (GO:0030049)|1/39|0.454390479671991|1|0|0|1.66500166500166|1.31335058811315|TPM3|2
4295|actin-myosin filament sliding (GO:0033275)|1/39|0.454390479671991|1|0|0|1.66500166500166|1.31335058811315|TPM3|2
4296|retina homeostasis (GO:0001895)|1/39|0.454390479671991|1|0|0|1.66500166500166|1.31335058811315|IGKC|2
4297|steroid metabolic process (GO:0008202)|2/100|0.45729190962662|1|0|0|1.2987012987013|1.01614719491546|SUMO2;TSPO|2
4298|negative regulation of protein catabolic process (GO:0042177)|1/40|0.462809265274131|1|0|0|1.62337662337662|1.25071471399974|MAD2L1|2
4299|clathrin-dependent endocytosis (GO:0072583)|1/40|0.462809265274131|1|0|0|1.62337662337662|1.25071471399974|AP2S1|2
4300|purine ribonucleoside monophosphate metabolic process (GO:0009167)|1/40|0.462809265274131|1|0|0|1.62337662337662|1.25071471399974|IMPDH2|2
4301|Golgi to plasma membrane transport (GO:0006893)|1/40|0.462809265274131|1|0|0|1.62337662337662|1.25071471399974|COMMD1|2
4302|positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123)|3/164|0.464316016082103|1|0|0|1.18783655369021|0.911296194293341|CD74;LGALS1;S100A4|2
4303|regulation of protein ubiquitination (GO:0031396)|2/102|0.46749796743825|1|0|0|1.27323656735421|0.968118510298594|PARK7;COMMD1|2
4304|regulation of kinase activity (GO:0043549)|2/102|0.46749796743825|1|0|0|1.27323656735421|0.968118510298594|CD74;HNRNPU|2
4305|positive regulation of epithelial to mesenchymal transition (GO:0010718)|1/41|0.471098563362913|1|0|0|1.58378207158695|1.19209366933518|EZH2|2
4306|regulation of protein dephosphorylation (GO:0035304)|1/41|0.471098563362913|1|0|0|1.58378207158695|1.19209366933518|ARPP19|2
4307|sterol biosynthetic process (GO:0016126)|1/41|0.471098563362913|1|0|0|1.58378207158695|1.19209366933518|CNBP|2
4308|androgen receptor signaling pathway (GO:0030521)|1/41|0.471098563362913|1|0|0|1.58378207158695|1.19209366933518|RAN|2
4309|negative regulation of catabolic process (GO:0009895)|1/41|0.471098563362913|1|0|0|1.58378207158695|1.19209366933518|MAD2L1|2
4310|negative regulation of cytokine-mediated signaling pathway (GO:0001960)|1/41|0.471098563362913|1|0|0|1.58378207158695|1.19209366933518|ARG1|2
4311|regulation of cholesterol biosynthetic process (GO:0045540)|1/41|0.471098563362913|1|0|0|1.58378207158695|1.19209366933518|RAN|2
4312|positive regulation of cytokine biosynthetic process (GO:0042108)|1/41|0.471098563362913|1|0|0|1.58378207158695|1.19209366933518|CCR2|2
4313|regulation of viral transcription (GO:0046782)|1/41|0.471098563362913|1|0|0|1.58378207158695|1.19209366933518|PSMC3|2
4314|transcription, DNA-templated (GO:0006351)|6/357|0.47211411136959|1|0|0|1.09134562916076|0.819092612943254|ELOB;DEK;SSRP1;MRPL12;PTMA;PMF1|2
4315|regulation of phagocytosis (GO:0050764)|1/42|0.479260359317833|1|0|0|1.5460729746444|1.13715411503299|PYCARD|2
4316|regulation of cholesterol metabolic process (GO:0090181)|1/42|0.479260359317833|1|0|0|1.5460729746444|1.13715411503299|RAN|2
4317|regulation of calcium-mediated signaling (GO:0050848)|1/42|0.479260359317833|1|0|0|1.5460729746444|1.13715411503299|CCL4|2
4318|positive regulation of viral transcription (GO:0050434)|1/42|0.479260359317833|1|0|0|1.5460729746444|1.13715411503299|NUCKS1|2
4319|neuron projection development (GO:0031175)|3/168|0.480110409699991|1|0|0|1.1595547309833|0.850810739010295|STMN1;HMGB1;KIF20B|2
4320|regulation of cellular response to stress (GO:0080135)|2/105|0.482591414328093|1|0|0|1.23685837971552|0.90115635918489|NDC1;RPA2|2
4321|activation of protein kinase activity (GO:0032147)|4/234|0.487282519741892|1|0|0|1.11000111000111|0.797992231582156|TPX2;CDK1;PARK7;CLSPN|2
4322|regulation of interleukin-6 production (GO:0032675)|1/43|0.487296607935507|1|0|0|1.51011778918756|1.08559693460236|PYCARD|2
4323|cellular response to radiation (GO:0071478)|1/43|0.487296607935507|1|0|0|1.51011778918756|1.08559693460236|RAD51AP1|2
4324|regulation of telomerase activity (GO:0051972)|1/43|0.487296607935507|1|0|0|1.51011778918756|1.08559693460236|AURKB|2
4325|negative regulation of protein metabolic process (GO:0051248)|1/44|0.495209234311214|1|0|0|1.47579693034238|1.03715305511489|MAD2L1|2
4326|membrane depolarization (GO:0051899)|1/44|0.495209234311214|1|0|0|1.47579693034238|1.03715305511489|ATPIF1|2
4327|negative regulation of DNA metabolic process (GO:0051053)|1/44|0.495209234311214|1|0|0|1.47579693034238|1.03715305511489|GMNN|2
4328|response to hydrogen peroxide (GO:0042542)|1/44|0.495209234311214|1|0|0|1.47579693034238|1.03715305511489|PARK7|2
4329|histone H3 acetylation (GO:0043966)|1/44|0.495209234311214|1|0|0|1.47579693034238|1.03715305511489|POLE3|2
4330|negative regulation of hydrolase activity (GO:0051346)|2/109|0.502300808361639|1|0|0|1.19146908137734|0.820393326470903|ATPIF1;KNL1|2
4331|cholesterol transport (GO:0030301)|1/45|0.503000133933142|1|0|0|1.44300144300144|0.991579859471517|MSR1|2
4332|positive regulation of intracellular transport (GO:0032388)|1/45|0.503000133933142|1|0|0|1.44300144300144|0.991579859471517|KIF20B|2
4333|regulation of smooth muscle cell proliferation (GO:0048660)|1/45|0.503000133933142|1|0|0|1.44300144300144|0.991579859471517|AIF1|2
4334|negative regulation of type I interferon production (GO:0032480)|1/45|0.503000133933142|1|0|0|1.44300144300144|0.991579859471517|PYCARD|2
4335|carboxylic acid biosynthetic process (GO:0046394)|1/45|0.503000133933142|1|0|0|1.44300144300144|0.991579859471517|ATPIF1|2
4336|regulation of steroid biosynthetic process (GO:0050810)|1/45|0.503000133933142|1|0|0|1.44300144300144|0.991579859471517|RAN|2
4337|posttranscriptional regulation of gene expression (GO:0010608)|1/45|0.503000133933142|1|0|0|1.44300144300144|0.991579859471517|RBM3|2
4338|negative regulation of immune response (GO:0050777)|1/45|0.503000133933142|1|0|0|1.44300144300144|0.991579859471517|CCR2|2
4339|myeloid cell differentiation (GO:0030099)|1/45|0.503000133933142|1|0|0|1.44300144300144|0.991579859471517|ATPIF1|2
4340|regulation of cellular macromolecule biosynthetic process (GO:2000112)|10/632|0.510442024876713|1|0|0|1.02745355909913|0.690940133569145|RBM3;HINT1;CNBP;HMGB2;NUCKS1;ESCO2;HMGB1;SSRP1;SMC3;EZH2|2
4341|positive regulation of blood vessel endothelial cell migration (GO:0043536)|1/46|0.510671173496023|1|0|0|1.41163184641446|0.948658091480516|HMGB1|2
4342|nucleus organization (GO:0006997)|1/46|0.510671173496023|1|0|0|1.41163184641446|0.948658091480516|NDC1|2
4343|defense response to bacterium (GO:0042742)|4/242|0.513502949995499|1|0|0|1.07330685843083|0.715358489589747|PYCARD;IGKC;HMGB2;S100A9|2
4344|regulation of G1/S transition of mitotic cell cycle (GO:2000045)|1/47|0.518224191037696|1|0|0|1.38159712627798|0.908189180882865|AIF1|2
4345|negative regulation of protein modification by small protein conjugation or removal (GO:1903321)|1/47|0.518224191037696|1|0|0|1.38159712627798|0.908189180882865|PARK7|2
4346|positive regulation of ion transport (GO:0043270)|1/47|0.518224191037696|1|0|0|1.38159712627798|0.908189180882865|CCL4|2
4347|maturation of SSU-rRNA (GO:0030490)|1/47|0.518224191037696|1|0|0|1.38159712627798|0.908189180882865|LSM6|2
4348|regulation of angiogenesis (GO:0045765)|3/178|0.518599101756054|1|0|0|1.09441120677076|0.718616815191708|PGK1;CCR2;PF4|2
4349|negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124)|1/48|0.525660996551341|1|0|0|1.35281385281385|0.869992921087501|PYCARD|2
4350|negative regulation of cellular biosynthetic process (GO:0031327)|1/48|0.525660996551341|1|0|0|1.35281385281385|0.869992921087501|PGP|2
4351|positive regulation of organelle assembly (GO:1902117)|1/48|0.525660996551341|1|0|0|1.35281385281385|0.869992921087501|PLK4|2
4352|histone H4 acetylation (GO:0043967)|1/48|0.525660996551341|1|0|0|1.35281385281385|0.869992921087501|HAT1|2
4353|cellular response to heat (GO:0034605)|1/48|0.525660996551341|1|0|0|1.35281385281385|0.869992921087501|RBBP7|2
4354|regulation of organelle organization (GO:0033043)|2/114|0.526247984497123|1|0|0|1.13921166552745|0.73135420816483|STMN1;S100A9|2
4355|positive regulation of kinase activity (GO:0033674)|2/114|0.526247984497123|1|0|0|1.13921166552745|0.73135420816483|CD74;CENPE|2
4356|negative regulation of mitotic cell cycle (GO:0045930)|1/49|0.53298337245315|1|0|0|1.32520540683806|0.833905448516881|MAD2L1|2
4357|protein K48-linked ubiquitination (GO:0070936)|1/49|0.53298337245315|1|0|0|1.32520540683806|0.833905448516881|UBE2C|2
4358|glycoprotein metabolic process (GO:0009100)|1/49|0.53298337245315|1|0|0|1.32520540683806|0.833905448516881|PARK7|2
4359|regulation of mitochondrion organization (GO:0010821)|1/49|0.53298337245315|1|0|0|1.32520540683806|0.833905448516881|ATPIF1|2
4360|regulation of gene expression (GO:0010468)|16/1038|0.535140771472709|1|0|0|1.00092585641719|0.625804311437269|MSR1;DNMT1;H2AFY;CNBP;HMGB2;MIF;PARK7;HMGB1;SSRP1;CRIP1;AES;HINT1;CDK4;CDK1;EZH2;PF4|2
4361|cellular response to oxidative stress (GO:0034599)|2/116|0.53560724756957|1|0|0|1.11957008508733|0.699008210449376|CYCS;PARK7|2
4362|protein autoubiquitination (GO:0051865)|1/50|0.540193073661|1|0|0|1.2987012987013|0.799777479884037|UHRF1|2
4363|positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731)|2/117|0.54023918653772|1|0|0|1.11000111000111|0.683475745875341|CD74;MIF|2
4364|regulation of blood vessel endothelial cell migration (GO:0043535)|1/51|0.54729182853364|1|0|0|1.27323656735421|0.767472767316659|HMGB1|2
4365|negative regulation of protein ubiquitination (GO:0031397)|1/51|0.54729182853364|1|0|0|1.27323656735421|0.767472767316659|PARK7|2
4366|negative regulation of viral genome replication (GO:0045071)|1/51|0.54729182853364|1|0|0|1.27323656735421|0.767472767316659|BANF1|2
4367|neurogenesis (GO:0022008)|1/51|0.54729182853364|1|0|0|1.27323656735421|0.767472767316659|CIT|2
4368|plasma membrane bounded cell projection organization (GO:0120036)|2/119|0.54940703860494|1|0|0|1.09134562916076|0.653624024842721|STMN1;HMGB1|2
4369|DNA-templated transcription, initiation (GO:0006352)|3/187|0.551890505451579|1|0|0|1.04173900965345|0.619215513650353|CCNB1;CDK4;CDK1|2
4370|response to organonitrogen compound (GO:0010243)|1/52|0.554281338781281|1|0|0|1.24875124875125|0.736866745008225|DHFR|2
4371|positive regulation of actin filament polymerization (GO:0030838)|1/52|0.554281338781281|1|0|0|1.24875124875125|0.736866745008225|PYCARD|2
4372|macromolecular complex assembly (GO:0065003)|2/121|0.558446133797446|1|0|0|1.07330685843083|0.625305477207832|CD74;ELOB|2
4373|receptor-mediated endocytosis (GO:0006898)|3/189|0.559102490176973|1|0|0|1.0307153164296|0.599281052418886|MSR1;IGKC;AP2S1|2
4374|regulation of calcium ion transport (GO:0051924)|1/53|0.561163280341441|1|0|0|1.22518990443519|0.707845336320646|CCL4|2
4375|positive regulation of nervous system development (GO:0051962)|1/53|0.561163280341441|1|0|0|1.22518990443519|0.707845336320646|CDC20|2
4376|positive regulation of secretion by cell (GO:1903532)|1/53|0.561163280341441|1|0|0|1.22518990443519|0.707845336320646|PPIA|2
4377|regulation of cell differentiation (GO:0045595)|2/122|0.562917167248314|1|0|0|1.06450926123057|0.611691280723887|PA2G4;ANP32B|2
4378|positive regulation of programmed cell death (GO:0043068)|4/258|0.563994513703035|1|0|0|1.0067451927917|0.576573799464691|TOP2A;PYCARD;RPS6;HMGB1|2
4379|protein homooligomerization (GO:0051260)|3/191|0.56624447653592|1|0|0|1.01992248589107|0.580059859279003|ATPIF1;MIF;TK1|2
4380|RNA modification (GO:0009451)|1/55|0.574611032599043|1|0|0|1.18063754427391|0.654146318932284|NOP58|2
4381|cytoplasmic translation (GO:0002181)|1/55|0.574611032599043|1|0|0|1.18063754427391|0.654146318932284|RPL22L1|2
4382|positive regulation of immune response (GO:0050778)|1/55|0.574611032599043|1|0|0|1.18063754427391|0.654146318932284|PYCARD|2
4383|negative regulation of supramolecular fiber organization (GO:1902904)|1/55|0.574611032599043|1|0|0|1.18063754427391|0.654146318932284|STMN1|2
4384|regulation of cellular catabolic process (GO:0031329)|1/56|0.581180068324871|1|0|0|1.1595547309833|0.629284139469005|HMGB1|2
4385|regulation of RNA splicing (GO:0043484)|1/56|0.581180068324871|1|0|0|1.1595547309833|0.629284139469005|SRSF3|2
4386|cytoskeleton organization (GO:0007010)|2/127|0.584784523423773|1|0|0|1.0225994477963|0.548636706851822|ANLN;CCL2|2
4387|regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803)|1/57|0.587647986142516|1|0|0|1.13921166552745|0.605635877622125|PYCARD|2
4388|anion transport (GO:0006820)|1/57|0.587647986142516|1|0|0|1.13921166552745|0.605635877622125|TSPO|2
4389|cellular iron ion homeostasis (GO:0006879)|1/57|0.587647986142516|1|0|0|1.13921166552745|0.605635877622125|NUBP1|2
4390|glycosaminoglycan catabolic process (GO:0006027)|1/57|0.587647986142516|1|0|0|1.13921166552745|0.605635877622125|HMMR|2
4391|positive regulation of NF-kappaB transcription factor activity (GO:0051092)|2/129|0.593303016888829|1|0|0|1.0067451927917|0.525571348837917|PYCARD;S100A9|2
4392|IRE1-mediated unfolded protein response (GO:0036498)|1/58|0.594016337552277|1|0|0|1.11957008508733|0.583126349866732|HDGF|2
4393|regulation of Rho protein signal transduction (GO:0035023)|1/58|0.594016337552277|1|0|0|1.11957008508733|0.583126349866732|STMN1|2
4394|I-kappaB kinase/NF-kappaB signaling (GO:0007249)|1/58|0.594016337552277|1|0|0|1.11957008508733|0.583126349866732|PRDX4|2
4395|regulation of neurogenesis (GO:0050767)|1/58|0.594016337552277|1|0|0|1.11957008508733|0.583126349866732|HMGB2|2
4396|cellular respiration (GO:0045333)|1/58|0.594016337552277|1|0|0|1.11957008508733|0.583126349866732|CYCS|2
4397|response to retinoic acid (GO:0032526)|1/58|0.594016337552277|1|0|0|1.11957008508733|0.583126349866732|CDKN2D|2
4398|phospholipid transport (GO:0015914)|1/59|0.600286650368572|1|0|0|1.1005943209333|0.561686096454099|PRELID1|2
4399|ubiquitin-dependent ERAD pathway (GO:0030433)|1/59|0.600286650368572|1|0|0|1.1005943209333|0.561686096454099|PSMC3|2
4400|post-Golgi vesicle-mediated transport (GO:0006892)|1/59|0.600286650368572|1|0|0|1.1005943209333|0.561686096454099|COMMD1|2
4401|generation of neurons (GO:0048699)|2/131|0.601690715765797|1|0|0|0.991375037176564|0.503630144621987|HMGB2;CIT|2
4402|regulation of protein metabolic process (GO:0051246)|1/60|0.606460428940951|1|0|0|1.08225108225108|0.541250863280761|ODC1|2
4403|renal system development (GO:0072001)|1/60|0.606460428940951|1|0|0|1.08225108225108|0.541250863280761|CENPF|2
4404|dicarboxylic acid metabolic process (GO:0043648)|1/60|0.606460428940951|1|0|0|1.08225108225108|0.541250863280761|DHFR|2
4405|positive regulation of multicellular organismal process (GO:0051240)|3/203|0.607579578597887|1|0|0|0.959631501503423|0.478157621492138|H2AFY;ENO1;EZH2|2
4406|cell chemotaxis (GO:0060326)|1/61|0.612539154826274|1|0|0|1.06450926123057|0.521761137278553|HMGB2|2
4407|regulation of stress fiber assembly (GO:0051492)|1/61|0.612539154826274|1|0|0|1.06450926123057|0.521761137278553|STMN1|2
4408|positive regulation of protein phosphorylation (GO:0001934)|6/413|0.614018135064553|1|0|0|0.943366560799975|0.460108941859141|CD74;CENPE;PLK1;MIF;PARK7;HMGB1|2
4409|protein targeting (GO:0006605)|2/134|0.614027084340884|1|0|0|0.969180073657686|0.47268486189523|NDUFB8;TSPO|2
4410|positive regulation of cytosolic calcium ion concentration (GO:0007204)|2/134|0.614027084340884|1|0|0|0.969180073657686|0.47268486189523|HMGB1;CCR2|2
4411|cellular response to organic substance (GO:0071310)|2/134|0.614027084340884|1|0|0|0.969180073657686|0.47268486189523|CCL2;PARK7|2
4412|potassium ion transport (GO:0006813)|1/62|0.618524286692462|1|0|0|1.04733975701718|0.503161731079699|KCNN4|2
4413|negative regulation of viral life cycle (GO:1903901)|1/62|0.618524286692462|1|0|0|1.04733975701718|0.503161731079699|BANF1|2
4414|protein targeting to membrane (GO:0006612)|1/62|0.618524286692462|1|0|0|1.04733975701718|0.503161731079699|SSR2|2
4415|positive regulation of macromolecule metabolic process (GO:0010604)|4/277|0.620045245424028|1|0|0|0.937690468376389|0.448181187224237|DNMT1;HMGB2;PARK7;PF4|2
4416|intracellular protein transport (GO:0006886)|5/348|0.623753665505757|1|0|0|0.932975070906105|0.44036400523524|EIF5A;RANBP1;CD74;NXT1;RAN|2
4417|cellular protein catabolic process (GO:0044257)|1/63|0.624417260957247|1|0|0|1.0307153164296|0.48540140863023|AP2S1|2
4418|regulation of cytosolic calcium ion concentration (GO:0051480)|2/138|0.630018903623974|1|0|0|0.941087897609637|0.434787741666085|HMGB1;CCR2|2
4419|kidney development (GO:0001822)|1/64|0.630219492144034|1|0|0|1.01461038961039|0.468432548747159|CENPF|2
4420|iron ion homeostasis (GO:0055072)|1/64|0.630219492144034|1|0|0|1.01461038961039|0.468432548747159|NUBP1|2
4421|regulation of proteolysis (GO:0030162)|1/64|0.630219492144034|1|0|0|1.01461038961039|0.468432548747159|PLK1|2
4422|positive regulation of cell projection organization (GO:0031346)|1/64|0.630219492144034|1|0|0|1.01461038961039|0.468432548747159|S100A9|2
4423|positive regulation of protein polymerization (GO:0032273)|1/65|0.635932373054324|1|0|0|0.999000999000999|0.452210842129091|PYCARD|2
4424|glycerophospholipid metabolic process (GO:0006650)|1/65|0.635932373054324|1|0|0|0.999000999000999|0.452210842129091|PGP|2
4425|positive regulation of endocytosis (GO:0045807)|1/65|0.635932373054324|1|0|0|0.999000999000999|0.452210842129091|PYCARD|2
4426|cellular response to decreased oxygen levels (GO:0036294)|1/65|0.635932373054324|1|0|0|0.999000999000999|0.452210842129091|PGK1|2
4427|positive regulation of protein modification by small protein conjugation or removal (GO:1903322)|1/66|0.641557275189001|1|0|0|0.983864620228257|0.436695017401319|COMMD1|2
4428|regulation of myeloid cell differentiation (GO:0045637)|1/66|0.641557275189001|1|0|0|0.983864620228257|0.436695017401319|PF4|2
4429|cellular response to reactive oxygen species (GO:0034614)|1/66|0.641557275189001|1|0|0|0.983864620228257|0.436695017401319|PARK7|2
4430|defense response to Gram-positive bacterium (GO:0050830)|1/66|0.641557275189001|1|0|0|0.983864620228257|0.436695017401319|HMGB2|2
4431|negative regulation of cell adhesion (GO:0007162)|1/66|0.641557275189001|1|0|0|0.983864620228257|0.436695017401319|TGFBI|2
4432|regulation of small GTPase mediated signal transduction (GO:0051056)|2/141|0.641671804155555|1|0|0|0.921064750851985|0.408656456188841|ARHGAP11A;RACGAP1|2
4433|negative regulation of sequence-specific DNA binding transcription factor activity (GO:0043433)|2/141|0.641671804155555|1|0|0|0.921064750851985|0.408656456188841|PYCARD;COMMD1|2
4434|intracellular steroid hormone receptor signaling pathway (GO:0030518)|1/67|0.647095549044169|1|0|0|0.969180073657686|0.421846593578972|RAN|2
4435|negative regulation of epithelial cell proliferation (GO:0050680)|1/67|0.647095549044169|1|0|0|0.969180073657686|0.421846593578972|ATPIF1|2
4436|positive regulation of sequence-specific DNA binding transcription factor activity (GO:0051091)|3/216|0.649316611622079|1|0|0|0.901875901875902|0.389461432090019|PYCARD;PARK7;S100A9|2
4437|extrinsic apoptotic signaling pathway (GO:0097191)|1/68|0.65254852463762|1|0|0|0.954927425515661|0.407629655547819|SIVA1|2
4438|positive regulation of autophagy (GO:0010508)|1/68|0.65254852463762|1|0|0|0.954927425515661|0.407629655547819|PARK7|2
4439|cilium assembly (GO:0060271)|4/289|0.653034317224809|1|0|0|0.89875522401474|0.382982607207322|PLK4;PLK1;CDK1;TUBB4B|2
4440|protein oligomerization (GO:0051259)|3/218|0.655450557096448|1|0|0|0.893601811033004|0.377486363392426|NUDT21;SNX2;ATPIF1|2
4441|neuron development (GO:0048666)|2/145|0.656757739667199|1|0|0|0.895656068069861|0.376569696091567|STMN1;HMGB1|2
4442|regulation of epithelial to mesenchymal transition (GO:0010717)|1/69|0.657917511291299|1|0|0|0.941087897609637|0.394010651510043|EZH2|2
4443|negative regulation of phosphatase activity (GO:0010923)|1/69|0.657917511291299|1|0|0|0.941087897609637|0.394010651510043|KNL1|2
4444|monocarboxylic acid biosynthetic process (GO:0072330)|1/69|0.657917511291299|1|0|0|0.941087897609637|0.394010651510043|PARK7|2
4445|regulation of actin filament polymerization (GO:0030833)|1/69|0.657917511291299|1|0|0|0.941087897609637|0.394010651510043|PYCARD|2
4446|cholesterol metabolic process (GO:0008203)|1/69|0.657917511291299|1|0|0|0.941087897609637|0.394010651510043|CNBP|2
4447|peptidyl-threonine phosphorylation (GO:0018107)|1/69|0.657917511291299|1|0|0|0.941087897609637|0.394010651510043|CDK1|2
4448|positive regulation of transcription from RNA polymerase II promoter (GO:0045944)|12/849|0.660502625676283|1|0|0|0.917810105089257|0.380665577295067|TFDP1;PSMC3;H2AFZ;UHRF1;CNBP;ATAD2;HMGB2;CKAP2;HNRNPU;PARK7;HMGB1;PF4|2
4449|positive regulation of neurogenesis (GO:0050769)|1/70|0.663203798610269|1|0|0|0.927643784786642|0.380958207307991|KIF20B|2
4450|regulation of endocytosis (GO:0030100)|1/70|0.663203798610269|1|0|0|0.927643784786642|0.380958207307991|AP2S1|2
4451|positive regulation of plasma membrane bounded cell projection assembly (GO:0120034)|1/70|0.663203798610269|1|0|0|0.927643784786642|0.380958207307991|ANLN|2
4452|regulation of protein kinase activity (GO:0045859)|2/148|0.667736694477141|1|0|0|0.877500877500878|0.354388691729803|CENPE;PARK7|2
4453|positive regulation of endothelial cell migration (GO:0010595)|1/71|0.66840865636535|1|0|0|0.914578379367112|0.368442959090006|HMGB1|2
4454|protein ubiquitination involved in ubiquitin-dependent protein catabolic process (GO:0042787)|1/71|0.66840865636535|1|0|0|0.914578379367112|0.368442959090006|ANAPC11|2
4455|phospholipid metabolic process (GO:0006644)|1/71|0.66840865636535|1|0|0|0.914578379367112|0.368442959090006|PGP|2
4456|regulation of cell communication (GO:0010646)|1/72|0.673533334696584|1|0|0|0.901875901875902|0.356437400462289|BIRC5|2
4457|response to insulin (GO:0032868)|1/72|0.673533334696584|1|0|0|0.901875901875902|0.356437400462289|PKM|2
4458|negative regulation of cell differentiation (GO:0045596)|2/151|0.678431081568413|1|0|0|0.860067085232648|0.333682273641343|HNRNPU;ANP32B|2
4459|regulation of neuron death (GO:1901214)|1/73|0.678579064997943|1|0|0|0.889521437466643|0.344915742208598|PARK7|2
4460|negative regulation of cysteine-type endopeptidase activity (GO:2000117)|1/73|0.678579064997943|1|0|0|0.889521437466643|0.344915742208598|CDKN2D|2
4461|response to metal ion (GO:0010038)|1/73|0.678579064997943|1|0|0|0.889521437466643|0.344915742208598|CRIP1|2
4462|regulation of phosphatase activity (GO:0010921)|1/73|0.678579064997943|1|0|0|0.889521437466643|0.344915742208598|KNL1|2
4463|regulation of protein complex assembly (GO:0043254)|1/74|0.683547059416934|1|0|0|0.877500877500878|0.333853786014088|HJURP|2
4464|chloride transport (GO:0006821)|1/74|0.683547059416934|1|0|0|0.877500877500878|0.333853786014088|CLIC1|2
4465|regulation of defense response (GO:0031347)|1/76|0.693254597758009|1|0|0|0.854408749145591|0.313019448333358|PARK7|2
4466|nucleic acid-templated transcription (GO:0097659)|1/77|0.69799647457513|1|0|0|0.84331253162422|0.303205622351563|PTMA|2
4467|water-soluble vitamin metabolic process (GO:0006767)|1/78|0.702665282226216|1|0|0|0.832500832500832|0.293768421792566|DHFR|2
4468|ERAD pathway (GO:0036503)|1/78|0.702665282226216|1|0|0|0.832500832500832|0.293768421792566|PSMC3|2
4469|positive regulation of cytoskeleton organization (GO:0051495)|1/78|0.702665282226216|1|0|0|0.832500832500832|0.293768421792566|PYCARD|2
4470|sensory perception of mechanical stimulus (GO:0050954)|1/79|0.707262143005421|1|0|0|0.821962847279303|0.284690037499923|BIRC5|2
4471|extracellular matrix disassembly (GO:0022617)|1/79|0.707262143005421|1|0|0|0.821962847279303|0.284690037499923|SPP1|2
4472|fibroblast growth factor receptor signaling pathway (GO:0008543)|1/79|0.707262143005421|1|0|0|0.821962847279303|0.284690037499923|HNRNPA1|2
4473|steroid biosynthetic process (GO:0006694)|1/80|0.711788161928608|1|0|0|0.811688311688312|0.275953682809081|TSPO|2
4474|sensory perception of sound (GO:0007605)|1/82|0.720632010875716|1|0|0|0.791891035793475|0.259444614447233|BIRC5|2
4475|neuron projection morphogenesis (GO:0048812)|2/164|0.721566140946806|1|0|0|0.791891035793475|0.258418778528537|S100A6;KIF20B|2
4476|retrograde transport, endosome to Golgi (GO:0042147)|1/83|0.724951967655297|1|0|0|0.782350179940541|0.251642839799817|SNX2|2
4477|ephrin receptor signaling pathway (GO:0048013)|1/83|0.724951967655297|1|0|0|0.782350179940541|0.251642839799817|AP2S1|2
4478|negative regulation of endopeptidase activity (GO:0010951)|1/84|0.729205336572568|1|0|0|0.773036487322202|0.244124859161155|GAPDH|2
4479|positive regulation of supramolecular fiber organization (GO:1902905)|1/85|0.733393140831153|1|0|0|0.763941940412529|0.236878056493871|PYCARD|2
4480|activation of GTPase activity (GO:0090630)|1/85|0.733393140831153|1|0|0|0.763941940412529|0.236878056493871|RANGAP1|2
4481|calcium ion homeostasis (GO:0055074)|1/88|0.745573162716344|1|0|0|0.737898465171192|0.216648472896601|CCR2|2
4482|regulation of MAP kinase activity (GO:0043405)|1/88|0.745573162716344|1|0|0|0.737898465171192|0.216648472896601|EZH2|2
4483|divalent metal ion transport (GO:0070838)|1/89|0.749508629240723|1|0|0|0.729607471180505|0.210373156410267|KCNN4|2
4484|positive regulation of protein complex assembly (GO:0031334)|1/89|0.749508629240723|1|0|0|0.729607471180505|0.210373156410267|RPA2|2
4485|peptidyl-threonine modification (GO:0018210)|1/90|0.753383416163044|1|0|0|0.721500721500722|0.204315292901416|CDK1|2
4486|protein autophosphorylation (GO:0046777)|2/176|0.756962624627695|1|0|0|0.737898465171192|0.20546148153668|AURKB;AURKA|2
4487|lipid transport (GO:0006869)|1/92|0.760954667706013|1|0|0|0.705815923207228|0.192815847169161|PRELID1|2
4488|positive regulation of MAP kinase activity (GO:0043406)|2/178|0.762470102236113|1|0|0|0.729607471180505|0.197863695791227|CDK1;EZH2|2
4489|negative regulation of protein phosphorylation (GO:0001933)|2/179|0.76518316368035|1|0|0|0.725531451788435|0.194181269801051|H2AFY;PARK7|2
4490|cellular transition metal ion homeostasis (GO:0046916)|1/94|0.76829420757377|1|0|0|0.690798563138989|0.18208243742304|NUBP1|2
4491|skin development (GO:0043588)|1/95|0.771879303232419|1|0|0|0.683526999316473|0.176983652866291|STMN1|2
4492|regulation of B cell activation (GO:0050864)|1/96|0.775409104911112|1|0|0|0.676406926406926|0.172053917479939|IGKC|2
4493|endocytosis (GO:0006897)|3/264|0.77555455262218|1|0|0|0.737898465171192|0.187556784049104|MSR1;SNX2;IGKC|2
4494|phosphate-containing compound metabolic process (GO:0006796)|2/184|0.778348933693796|1|0|0|0.705815923207228|0.176863604219678|PGP;PGK1|2
4495|positive regulation of protein metabolic process (GO:0051247)|1/97|0.778884462774843|1|0|0|0.669433659124381|0.167286490096349|UHRF1|2
4496|cellular metal ion homeostasis (GO:0006875)|1/97|0.778884462774843|1|0|0|0.669433659124381|0.167286490096349|CCR2|2
4497|cell morphogenesis involved in neuron differentiation (GO:0048667)|1/98|0.782306213704839|1|0|0|0.66260270341903|0.162674951931928|S100A6|2
4498|positive regulation of neuron projection development (GO:0010976)|1/98|0.782306213704839|1|0|0|0.66260270341903|0.162674951931928|S100A9|2
4499|protein localization to organelle (GO:0033365)|1/98|0.782306213704839|1|0|0|0.66260270341903|0.162674951931928|RPA2|2
4500|positive regulation of neuron differentiation (GO:0045666)|1/99|0.78567518203119|1|0|0|0.655909746818838|0.158213187970164|S100A9|2
4501|regulation of lipid metabolic process (GO:0019216)|1/101|0.792258004741889|1|0|0|0.642921435000643|0.149715942300469|H2AFY|2
4502|cellular divalent inorganic cation homeostasis (GO:0072503)|1/102|0.795473445250309|1|0|0|0.636618283677107|0.145669603366348|CCR2|2
4503|metal ion transport (GO:0030001)|1/102|0.795473445250309|1|0|0|0.636618283677107|0.145669603366348|KCNN4|2
4504|B cell receptor signaling pathway (GO:0050853)|1/105|0.804825145907513|1|0|0|0.618429189857761|0.134279675454467|IGKC|2
4505|monovalent inorganic cation transport (GO:0015672)|1/105|0.804825145907513|1|0|0|0.618429189857761|0.134279675454467|KCNN4|2
4506|peptide metabolic process (GO:0006518)|1/105|0.804825145907513|1|0|0|0.618429189857761|0.134279675454467|EEF1G|2
4507|positive regulation of cellular component organization (GO:0051130)|1/107|0.810821580329893|1|0|0|0.60686976574827|0.127264988872078|CDC20|2
4508|regulation of response to external stimulus (GO:0032101)|1/108|0.813750573225552|1|0|0|0.601250601250601|0.123918579265852|PARK7|2
4509|cellular response to starvation (GO:0009267)|1/108|0.813750573225552|1|0|0|0.601250601250601|0.123918579265852|HNRNPA1|2
4510|positive regulation of epithelial cell proliferation (GO:0050679)|1/108|0.813750573225552|1|0|0|0.601250601250601|0.123918579265852|HMGB2|2
4511|regulation of protein secretion (GO:0050708)|1/108|0.813750573225552|1|0|0|0.601250601250601|0.123918579265852|PPIA|2
4512|monocarboxylic acid metabolic process (GO:0032787)|1/109|0.816634361831064|1|0|0|0.595734540688669|0.120674265361268|LDHA|2
4513|regulation of cytokine production (GO:0001817)|1/109|0.816634361831064|1|0|0|0.595734540688669|0.120674265361268|CCR2|2
4514|circulatory system development (GO:0072359)|1/110|0.819473641545916|1|0|0|0.590318772136954|0.117528362092069|CRIP1|2
4515|negative regulation of cytokine production (GO:0001818)|1/111|0.822269097242148|1|0|0|0.585000585000585|0.114477342103512|HMGB1|2
4516|cellular response to insulin stimulus (GO:0032869)|1/111|0.822269097242148|1|0|0|0.585000585000585|0.114477342103512|PKM|2
4517|cellular response to peptide hormone stimulus (GO:0071375)|1/111|0.822269097242148|1|0|0|0.585000585000585|0.114477342103512|PKM|2
4518|regulation of autophagy (GO:0010506)|2/204|0.824753408685996|1|0|0|0.636618283677107|0.122657776858266|HMGB1;GAPDH|2
4519|regulation of MAPK cascade (GO:0043408)|2/204|0.824753408685996|1|0|0|0.636618283677107|0.122657776858266|CD74;HMGB1|2
4520|positive regulation of developmental process (GO:0051094)|1/114|0.830399210755219|1|0|0|0.569605832763727|0.105860513220692|PA2G4|2
4521|regulation of nucleic acid-templated transcription (GO:1903506)|7/608|0.830561146829309|1|0|0|0.747607655502392|0.138796146915169|HINT1;CNBP;HMGB2;RALY;HMGB1;SSRP1;EZH2|2
4522|positive regulation of signal transduction (GO:0009967)|2/207|0.830910386473785|1|0|0|0.627391931739758|0.116213895551791|CD74;LY86|2
4523|positive regulation of phosphorylation (GO:0042327)|2/209|0.834906300279189|1|0|0|0.621388181196794|0.112120658461683|CD74;MIF|2
4524|regulation of macroautophagy (GO:0016241)|1/117|0.838158568500955|1|0|0|0.555000555000555|0.0979842234685006|GAPDH|2
4525|transmembrane transport (GO:0055085)|4/379|0.838334190656873|1|0|0|0.685330500633931|0.120850126761879|PSMB6;PSMB7;PSMA4;PSMC3|2
4526|activation of MAPK activity (GO:0000187)|1/118|0.840665566528939|1|0|0|0.550297160466652|0.0955103234511329|CDK1|2
4527|calcium ion transport (GO:0006816)|1/119|0.843133853542294|1|0|0|0.545672814580378|0.0931079074591666|KCNN4|2
4528|cytosolic transport (GO:0016482)|1/119|0.843133853542294|1|0|0|0.545672814580378|0.0931079074591666|SNX2|2
4529|regulation of neuron projection development (GO:0010975)|1/120|0.845564025501271|1|0|0|0.541125541125541|0.0907745608734896|S100A9|2
4530|brain development (GO:0007420)|1/120|0.845564025501271|1|0|0|0.541125541125541|0.0907745608734896|CENPF|2
4531|actin filament organization (GO:0007015)|1/121|0.847956669026573|1|0|0|0.536653429215413|0.0885079651936225|TPM3|2
4532|Golgi organization (GO:0007030)|1/122|0.850312361848214|1|0|0|0.532254630615286|0.0863058933768178|CDK1|2
4533|cellular calcium ion homeostasis (GO:0006874)|1/124|0.85491516171633|1|0|0|0.523669878508588|0.0820868459527545|CCR2|2
4534|platelet degranulation (GO:0002576)|1/125|0.857163380433804|1|0|0|0.519480519480519|0.0800658370256982|PF4|2
4535|dephosphorylation (GO:0016311)|1/125|0.857163380433804|1|0|0|0.519480519480519|0.0800658370256982|PGP|2
4536|organic anion transport (GO:0015711)|1/125|0.857163380433804|1|0|0|0.519480519480519|0.0800658370256982|PRELID1|2
4537|positive regulation of cell migration (GO:0030335)|2/222|0.85886580929161|1|0|0|0.585000585000585|0.0890035021391141|KIF20B;CCR2|2
4538|protein dephosphorylation (GO:0006470)|1/126|0.859376871775022|1|0|0|0.515357658214801|0.0781012781200229|PGP|2
4539|G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)|1/126|0.859376871775022|1|0|0|0.515357658214801|0.0781012781200229|CCL2|2
4540|vesicle organization (GO:0016050)|1/128|0.863701803303242|1|0|0|0.507305194805195|0.0743342658363372|SNX2|2
4541|positive regulation of protein kinase B signaling (GO:0051897)|1/128|0.863701803303242|1|0|0|0.507305194805195|0.0743342658363372|PARK7|2
4542|negative regulation of response to stimulus (GO:0048585)|1/128|0.863701803303242|1|0|0|0.507305194805195|0.0743342658363372|AES|2
4543|extracellular matrix organization (GO:0030198)|2/230|0.871989512451693|1|0|0|0.564652738565782|0.0773449362791766|SPP1;TGFBI|2
4544|Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096)|1/134|0.875897091414116|1|0|0|0.484590036828843|0.0642114123382442|IGKC|2
4545|Fc-gamma receptor signaling pathway (GO:0038094)|1/135|0.877821139545066|1|0|0|0.481000481000481|0.062680336508724|IGKC|2
4546|regulation of signal transduction (GO:0009966)|2/234|0.87812283736438|1|0|0|0.555000555000555|0.0721327501670296|BIRC5;NUCKS1|2
4547|Fc receptor mediated stimulatory signaling pathway (GO:0002431)|1/136|0.879715452677754|1|0|0|0.47746371275783|0.061190208665176|IGKC|2
4548|protein transport (GO:0015031)|3/327|0.882301307161022|1|0|0|0.595734540688669|0.0745988700209255|NDC1;CD74;CENPF|2
4549|muscle contraction (GO:0006936)|1/138|0.883416699321926|1|0|0|0.470543948804818|0.0583278169265523|TPM3|2
4550|response to cytokine (GO:0034097)|1/139|0.885224527958091|1|0|0|0.467158740540036|0.0569531730562244|AES|2
4551|regulation of vesicle-mediated transport (GO:0060627)|1/139|0.885224527958091|1|0|0|0.467158740540036|0.0569531730562244|AP2S1|2
4552|cellular response to growth factor stimulus (GO:0071363)|1/140|0.887004412153728|1|0|0|0.463821892393321|0.0556147135629488|CCL2|2
4553|plasma membrane bounded cell projection assembly (GO:0120031)|2/242|0.889585309547056|1|0|0|0.536653429215413|0.0627883810083142|EMP3;AIF1|2
4554|regulated exocytosis (GO:0045055)|1/149|0.901834774734925|1|0|0|0.435805804933322|0.0450291781867033|PF4|2
4555|heart development (GO:0007507)|1/150|0.903357836706207|1|0|0|0.432900432900433|0.0439984972464779|CRIP1|2
4556|spermatogenesis (GO:0007283)|1/154|0.909218130547571|1|0|0|0.42165626581211|0.040129130541908|RACGAP1|2
4557|male gamete generation (GO:0048232)|1/155|0.910626989822614|1|0|0|0.418935902806871|0.03922158228637|RACGAP1|2
4558|regulation of protein phosphorylation (GO:0001932)|2/262|0.914014350727832|1|0|0|0.495687518588282|0.0445667723981926|CD74;PARK7|2
4559|negative regulation of intracellular signal transduction (GO:1902532)|1/162|0.919897207925278|1|0|0|0.400833734167067|0.0334669495339795|PYCARD|2
4560|regulation of protein kinase B signaling (GO:0051896)|1/164|0.922365212911082|1|0|0|0.395945517896737|0.0319979507476054|PARK7|2
4561|positive regulation of protein modification process (GO:0031401)|1/164|0.922365212911082|1|0|0|0.395945517896737|0.0319979507476054|CD74|2
4562|ion transport (GO:0006811)|2/290|0.939820834653843|1|0|0|0.447828034034931|0.0277949052023874|TSPO;PLP2|2
4563|organonitrogen compound biosynthetic process (GO:1901566)|1/182|0.941430268594787|1|0|0|0.356786071071785|0.0215338225297202|ARG1|2
4564|transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169)|3/397|0.945893902515746|1|0|0|0.490693185907292|0.0272947446803056|STMN1;AP2S1;HNRNPA1|2
4565|protein complex assembly (GO:0006461)|1/190|0.948329197801586|1|0|0|0.341763499658236|0.0181317778336421|SNX2|2
4566|vesicle-mediated transport (GO:0016192)|3/411|0.953966505264494|1|0|0|0.473978576168357|0.0223370546667261|SNX2;KIF20A;COMMD1|2
4567|axonogenesis (GO:0007409)|1/224|0.969683226003162|1|0|0|0.289888682745826|0.00892446427163547|S100A6|2
4568|endosomal transport (GO:0016197)|1/230|0.972408305800092|1|0|0|0.282326369282891|0.0078993492461503|SNX2|2
4569|regulation of immune response (GO:0050776)|1/252|0.980470500694275|1|0|0|0.257678829107401|0.00508212733990655|IGKC|2
4570|negative regulation of signal transduction (GO:0009968)|1/284|0.988194209820247|1|0|0|0.228644594841778|0.00271539050379069|EZH2|2
4571|cellular protein localization (GO:0034613)|1/328|0.994098152018745|1|0|0|0.197972758948369|0.00117186662868624|CD74|2
4572|cellular response to cytokine stimulus (GO:0071345)|30/457|1.2908380514813e-17|6.58714657670906e-14|0|0|7.29394602479942|283.651749971895|CSF1R;IL1RN;CDKN1A;PID1;PTAFR;CXCR4;CXCL1;TNF;CXCL2;ICAM1;ZFP36L1;SOCS3;ZFP36;CCL4;PIM1;CCL3;CCR5;JUNB;MCL1;CCR2;EGR1;PTPN18;FN1;OSM;FOS;EREG;CXCL10;IL1A;IL1B;NFE2L2|3
4573|inflammatory response (GO:0006954)|18/253|1.54726158333971e-11|3.94783792989126e-08|0|0|7.90513833992095|196.774303359055|CSF1R;CEBPB;CYBB;CXCR4;CXCL1;FOS;F11R;TNF;CXCL2;CXCL10;IL1A;IL1B;CCRL2;CCL4;C3AR1;CCL3;NLRP3;FCGR2B|3
4574|regulation of transcription from RNA polymerase II promoter (GO:0006357)|41/1479|6.23784638978653e-11|1.06105767090269e-07|0|0|3.08015926677184|72.376969591211|CSRNP1;CDKN1A;CEBPB;PID1;TNF;ETS2;ZFP36;NFIL3;CUX1;NFKBIZ;NLRP3;APOE;CCNL1;JUNB;SKIL;IER2;MEF2A;KDM6B;TGIF1;EGR1;JUN;JUND;SEMA4D;GDF15;OSM;FOS;KLF4;HOPX;NFKBIA;NR4A2;MMP12;NR4A1;CXCL10;ZEB2;KLF6;BHLHE40;FOSB;NFKBID;ATF3;NFE2L2;TLR2|3
4575|cytokine-mediated signaling pathway (GO:0019221)|26/634|1.06230740386003e-10|1.35523867047443e-07|0|0|4.55660708026639|104.644338832678|CSF1R;IL1RN;CDKN1A;PTAFR;CXCL1;TNF;CXCL2;ICAM1;SOCS3;CCL4;PIM1;CCL3;CCR5;JUNB;MCL1;CCR2;EGR1;FN1;OSM;FOS;EREG;NFKBIA;CXCL10;IL1A;IL1B;BIRC3|3
4576|positive regulation of transcription from RNA polymerase II promoter (GO:0045944)|27/849|1.13350984577032e-08|1.15686014859319e-05|0|0|3.53356890459364|64.6479217910163|CSRNP1;CEBPB;PID1;PLXND1;TNF;NLRP3;CCNL1;JUNB;IER2;MEF2A;KDM6B;EGR1;JUN;JUND;OSM;FOS;KLF4;NFKBIA;NR4A2;MMP12;NR4A1;CXCL10;ZEB2;KLF6;ATF3;NFE2L2;TLR2|3
4577|response to lipopolysaccharide (GO:0032496)|12/156|1.78343928353286e-08|1.5168151106447e-05|0|0|8.54700854700855|152.496897967098|CXCL10;ZFP36;JUN;JUND;NLRP3;TNFAIP3;CXCL1;CD14;TRIB1;CCR5;JUNB;CXCL2|3
4578|response to molecule of bacterial origin (GO:0002237)|10/99|2.11663781679655e-08|1.54302896844468e-05|0|0|11.2233445566779|198.32605891884|CXCL10;JUN;JUND;TNFAIP3;CXCL1;CD14;TRIB1;FCGR2B;JUNB;CXCL2|3
4579|positive regulation of transcription, DNA-templated (GO:0045893)|31/1121|2.13889756389899e-08|1.36434928357207e-05|0|0|3.07265338487462|54.2642577407214|CSRNP1;CEBPB;PID1;TNF;ETS2;SPP1;NLRP3;CCNL1;JUNB;IER2;MEF2A;KDM6B;EGR1;CD74;JUN;JUND;OSM;FOS;KLF4;NFKBIA;NR4A2;MMP12;NR4A1;CXCL10;ZEB2;KLF6;ID2;IL1B;ATF3;NFE2L2;TLR2|3
4580|cellular response to organic substance (GO:0071310)|11/134|3.63924602327563e-08|2.06345249519728e-05|0|0|9.12106135986733|156.233786419937|CSF1R;PTPN18;JUN;PID1;JUND;IL1B;CCL3;CXCR4;KLF4;TNF;JUNB|3
4581|regulation of cell proliferation (GO:0042127)|24/741|5.72854756167108e-08|2.92327782072075e-05|0|0|3.5987404408457|60.0097839855894|CSF1R;JUN;BTG2;CDKN1A;JUND;BTG1;HILPDA;FN1;OSM;CXCL1;KLF4;CXCL2;AREG;CBFA2T3;EREG;ZFP36L1;CXCL10;IL1A;IL1B;BHLHE40;PDPN;CTSH;SGK1;JUNB|3
4582|positive regulation of intracellular signal transduction (GO:1902533)|19/480|7.25900734535243e-08|3.36751949848486e-05|0|0|4.39814814814815|72.2986841253081|CSF1R;CD74;ECM1;SEMA4D;F10;OSM;TREM2;CFLAR;TNF;MALT1;EREG;CXCL10;IL1A;CCL4;CCL3;S100A4;CD14;SASH1;BIRC3|3
4583|regulation of angiogenesis (GO:0045765)|12/178|7.73145864968413e-08|3.28780279077818e-05|0|0|7.49063670411985|122.66204643689|IL1A;ECM1;BTG1;PLXND1;ANXA3;IL1B;TNFAIP3;CTSH;KLF4;HK2;SASH1;CCR2|3
4584|negative regulation of cellular process (GO:0048523)|20/535|8.1866880220003e-08|3.21358992125135e-05|0|0|4.15368639667705|67.7805662338293|BTG2;CDKN1A;BTG1;PLXND1;HPGD;SEMA4D;OSM;CXCL1;KLF4;CBFA2T3;HOPX;EREG;NR4A1;IL1A;ADAM15;IL1B;BHLHE40;PDPN;TGFBI;SKIL|3
4585|cellular response to lipopolysaccharide (GO:0071222)|9/92|1.45005522274068e-07|5.28545128688978e-05|0|0|10.8695652173913|171.157543593503|CXCL10;ZFP36;IL1B;CCL3;TNFAIP3;NLRP3;CD14;CCR5;TNF|3
4586|apoptotic process (GO:0006915)|13/232|1.91150133443765e-07|6.5029275397569e-05|0|0|6.22605363984674|96.3183366010644|PPP1R15A;CSRNP1;LY86;CXCR4;CFLAR;HK2;NFKBIA;IL1A;IL1B;NLRP3;CD14;IER3;TLR2|3
4587|positive regulation of macromolecule metabolic process (GO:0010604)|14/277|2.26677315490065e-07|7.22958963091126e-05|0|0|5.61572402727637|85.9191082544025|EGR1;PTPN1;PID1;FN1;KLF4;TNF;OLFM1;IL1A;ID2;IL1B;CCL3;CTSH;NFE2L2;TLR2|3
4588|negative regulation of signal transduction (GO:0009968)|14/284|3.06960258470966e-07|9.2142246998667e-05|0|0|5.4773082942097|82.1407142745021|CSF1R;PTPN18;PTPN1;PID1;PLEK;TNFAIP3;EREG;NR4A2;SOCS3;RGS2;MMP14;IL1B;TRIB1;LGMN|3
4589|regulation of inflammatory response (GO:0050727)|11/167|3.45487797980274e-07|9.79457907274076e-05|0|0|7.31869594145043|108.889816117675|NFKBIA;CCL4;CCL3;NLRP3;TNFAIP3;APOE;KLF4;PLA2G7;CCR2;BIRC3;TLR2|3
4590|regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122)|12/205|3.59033883427945e-07|9.64289424806738e-05|0|0|6.50406504065041|96.5193435453936|NFKBIA;IL1A;CD74;ECM1;IL1B;NLRP3;TNFAIP3;S100A4;CFLAR;TNF;MALT1;BIRC3|3
4591|neutrophil degranulation (GO:0043312)|18/480|3.61818449946152e-07|9.23179775037607e-05|0|0|4.16666666666667|61.8005136267057|ANXA3;ARG1;HEXB;PTAFR;CYBB;CXCL1;CTSS;SYNGR1;GM2A;ANPEP;C3AR1;TIMP2;CTSH;CD14;PLEKHO2;CTSC;CTSB;TLR2|3
4592|neutrophil activation involved in immune response (GO:0002283)|18/484|4.08330070676132e-07|9.92242071743e-05|0|0|4.13223140495868|60.7900412927625|ANXA3;ARG1;HEXB;PTAFR;CYBB;CXCL1;CTSS;SYNGR1;GM2A;ANPEP;C3AR1;TIMP2;CTSH;CD14;PLEKHO2;CTSC;CTSB;TLR2|3
4593|positive regulation of angiogenesis (GO:0045766)|9/104|4.18105874163364e-07|9.69815579934385e-05|0|0|9.61538461538462|141.226261048282|IL1A;ECM1;BTG1;ANXA3;IL1B;CTSH;KLF4;HK2;SASH1|3
4594|neutrophil mediated immunity (GO:0002446)|18/488|4.60233013017449e-07|0.000102111698496871|0|0|4.09836065573771|59.8013644495021|ANXA3;ARG1;HEXB;PTAFR;CYBB;CXCL1;CTSS;SYNGR1;GM2A;ANPEP;C3AR1;TIMP2;CTSH;CD14;PLEKHO2;CTSC;CTSB;TLR2|3
4595|response to cytokine (GO:0034097)|10/139|5.31024074925741e-07|0.000112908993931086|0|0|7.99360511590727|115.495271605828|CSF1R;PTPN18;JUN;PID1;JUND;TIMP2;CXCR4;JUNB;CXCL16;MCL1|3
4596|extracellular matrix disassembly (GO:0022617)|8/79|5.57416683376357e-07|0.000113779893410782|0|0|11.2517580872011|162.024785278638|MMP12;MMP14;ADAM15;TIMP2;SPP1;FN1;FURIN;CTSS|3
4597|positive regulation of chemokine production (GO:0032722)|6/35|6.38831633305683e-07|0.000125382993259958|0|0|19.0476190476191|271.688093370318|CSF1R;EGR1;CD74;IL1B;TNF;TLR2|3
4598|protein kinase B signaling (GO:0043491)|6/36|7.60900691018665e-07|0.000143810230602528|0|0|18.5185185185185|260.903018251939|NR4A1;CDKN1A;IL1B;CCL3;TNF;ZFP36L1|3
4599|negative regulation of transcription from RNA polymerase II promoter (GO:0000122)|19/566|9.00391136426307e-07|0.000164096284613694|0|0|3.72987828818218|51.9215341319288|MEF2A;TGIF1;JUN;CEBPB;JUND;SEMA4D;KLF4;TNF;ETS2;NR4A2;ZFP36;ZEB2;NFIL3;CUX1;BHLHE40;FOSB;JUNB;SKIL;ATF3|3
4600|cellular response to molecule of bacterial origin (GO:0071219)|8/85|9.82143595789155e-07|0.000172823405838347|0|0|10.4575163398693|144.664348354416|CXCL10;ZFP36;TNFAIP3;NLRP3;CD14;CCR5;FCGR2B;TLR2|3
4601|negative regulation of cell proliferation (GO:0008285)|15/364|1.11722097025723e-06|0.000190039287040755|0|0|4.57875457875458|62.7503032631945|BTG2;CDKN1A;BTG1;OSM;TNFAIP3;CXCL1;KLF4;CBFA2T3;EREG;IL1A;ID2;IL1B;BHLHE40;PDPN;TRIB1|3
4602|negative regulation of transcription, DNA-templated (GO:0045892)|23/814|1.20362389522884e-06|0.000198132023785573|0|0|3.13950313950314|42.7919729324181|MEF2A;TGIF1;JUN;CEBPB;JUND;SEMA4D;KLF4;TNF;CBFA2T3;ETS2;EREG;NR4A2;ZFP36;ZEB2;NFIL3;CUX1;BASP1;ID2;BHLHE40;FOSB;JUNB;SKIL;ATF3|3
4603|regulation of membrane protein ectodomain proteolysis (GO:0051043)|5/22|1.29898690263671e-06|0.000207147817629848|0|0|25.2525252525253|342.270856135792|IL1B;TIMP2;FURIN;APOE;TNF|3
4604|positive regulation of leukocyte chemotaxis (GO:0002690)|7/62|1.37868268671554e-06|0.000213194477282103|0|0|12.5448028673835|169.284363130376|CXCL10;CCL4;CCL3;CXCL1;CXCL2;PLA2G7;CCR2|3
4605|positive regulation of cell differentiation (GO:0045597)|11/195|1.60671033504678e-06|0.000241148318815992|0|0|6.26780626780627|83.6208200193418|MEF2A;OLFM1;MSR1;ZFP36;JUN;CEBPB;JUND;IL1B;PDPN;JUNB;ZFP36L1|3
4606|positive regulation of response to external stimulus (GO:0032103)|8/91|1.65672454993677e-06|0.000241550439380782|0|0|9.76800976800977|130.018735702413|NFKBIA;CCL4;CCL3;LY86;PLA2G7;SASH1;CCR2;TLR2|3
4607|positive regulation of cytokine biosynthetic process (GO:0042108)|6/41|1.69221713518165e-06|0.000239871778911999|0|0|16.260162601626|216.088958935419|EGR1;IL1A;IL1B;TNF;CCR2;EREG|3
4608|positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123)|10/164|2.40895758363661e-06|0.000332240825656692|0|0|6.77506775067751|87.6444203383695|IL1A;CD74;ECM1;IL1B;S100A4;CFLAR;TNF;MALT1;BIRC3;TLR2|3
4609|regulation of NF-kappaB import into nucleus (GO:0042345)|5/27|3.83958788099069e-06|0.000515616235702513|0|0|20.5761316872428|256.587356374132|NFKBIA;IL1B;NLRP3;TNF;TLR2|3
4610|positive regulation of inflammatory response (GO:0050729)|7/74|4.60729239639591e-06|0.000602846489713033|0|0|10.5105105105105|129.151788953761|NFKBIA;CCL4;CCL3;OSM;PLA2G7;CCR2;TLR2|3
4611|positive regulation of vasculature development (GO:1904018)|8/105|4.88418215857639e-06|0.000623099538880382|0|0|8.46560846560847|103.530232426713|IL1A;ECM1;BTG1;ANXA3;IL1B;CTSH;HK2;SASH1|3
4612|positive regulation of defense response (GO:0031349)|7/75|5.04331695113832e-06|0.000627708448820947|0|0|10.3703703703704|126.492038473885|NFKBIA;CCL4;CCL3;PLA2G7;CCR2;EREG;TLR2|3
4613|response to lipid (GO:0033993)|9/141|5.35504639830293e-06|0.000650638137393806|0|0|7.09219858156028|86.0813559547501|CXCL10;JUN;JUND;SPP1;CTSH;CXCL1;TRIB1;JUNB;CXCL2|3
4614|positive regulation of cytokine production (GO:0001819)|11/221|5.3853285206637e-06|0.000639100731184811|0|0|5.53041729512318|67.0940948559747|IL1A;CEBPB;IL1B;HILPDA;NLRP3;CD14;TNF;MALT1;EREG;CCR2;TLR2|3
4615|positive regulation of fibroblast proliferation (GO:0048146)|5/29|5.56633963198513e-06|0.000645568889591367|0|0|19.1570881226054|231.777258193116|CD74;CDKN1A;FN1;S100A6;EREG|3
4616|positive regulation of cell migration (GO:0030335)|11/222|5.62231844784769e-06|0.000637570911985928|0|0|5.50550550550551|66.5547702117922|CSF1R;MMP14;SEMA4D;F10;IL1B;PDPN;FN1;CCL3;CTSH;CXCL16;CCR2|3
4617|negative regulation of extrinsic apoptotic signaling pathway (GO:2001237)|7/77|6.01880931962504e-06|0.000667695303435796|0|0|10.1010101010101|121.420415208523|IL1A;IL1B;TNFAIP3;CFLAR;TNF;ICAM1;MCL1|3
4618|positive regulation of cell proliferation (GO:0008284)|15/425|7.4006065781903e-06|0.000803516922734152|0|0|3.92156862745098|46.3292101611286|CSF1R;CD74;CDKN1A;PID1;HILPDA;FN1;OSM;TNF;AREG;EREG;ID2;IL1B;PIM1;S100A6;CTSH|3
4619|cellular response to oxygen-containing compound (GO:1901701)|12/275|7.69983425155047e-06|0.000818588628867959|0|0|4.84848484848485|57.087572145983|EGR1;CXCL10;ZFP36;JUN;PID1;NLRP3;TNFAIP3;CD14;FOS;CCR5;ZFP36L1;TLR2|3
4620|extracellular matrix organization (GO:0030198)|11/230|7.86984585754499e-06|0.000819588232878614|0|0|5.31400966183575|62.4527501931797|MMP12;MMP14;ADAM15;FN1;TIMP2;SPP1;FURIN;TGFBI;F11R;CTSS;ICAM1|3
4621|positive regulation of proteolysis (GO:0045862)|6/53|7.90116148623697e-06|0.000806392541285345|0|0|12.5786163522013|147.779884097156|IL1B;CTSH;FURIN;APOE;TNF;CTSC|3
4622|chemokine-mediated signaling pathway (GO:0070098)|6/53|7.90116148623697e-06|0.00079058092282877|0|0|12.5786163522013|147.779884097156|CXCL10;CCL4;CCL3;CXCL1;CXCL2;CCR2|3
4623|positive regulation of membrane protein ectodomain proteolysis (GO:0051044)|4/15|8.01527622280984e-06|0.000786576049326897|0|0|29.6296296296296|347.67885360782|IL1B;FURIN;APOE;TNF|3
4624|cellular response to hormone stimulus (GO:0032870)|7/81|8.44383242475124e-06|0.000812997676669917|0|0|9.60219478737997|112.173552696295|JUN;JUND;CTSH;JUNB;CTSS;CTSB;ZFP36L1|3
4625|negative regulation of erythrocyte differentiation (GO:0045647)|3/6|1.40556240991167e-05|0.00132825647736653|0|0|55.5555555555556|620.693775029323|ZFP36;MAFB;ZFP36L1|3
4626|positive regulation of leukocyte migration (GO:0002687)|5/35|1.45655193627035e-05|0.00135141536923411|0|0|15.8730158730159|176.77545253839|CXCL10;CXCL1;CXCL2;TNF;ICAM1|3
4627|regulation of MAP kinase activity (GO:0043405)|7/88|1.46222842274483e-05|0.00133245565022622|0|0|8.83838383838384|98.3974079944129|PTPN1;RGS2;DUSP1;IL1B;APOE;TRIB1;TNF|3
4628|regulation of ERK1 and ERK2 cascade (GO:0070372)|11/248|1.59628489072851e-05|0.00142909505217326|0|0|4.92831541218638|54.4344584534077|CSF1R;IL1A;CD74;PTPN1;IL1B;CCL4;FN1;CCL3;TREM2;TNF;ICAM1|3
4629|negative regulation of MAP kinase activity (GO:0043407)|6/62|1.97869750450528e-05|0.00174091264922249|0|0|10.752688172043|116.456845835846|PTPN1;RGS2;DUSP2;DUSP1;IL1B;APOE|3
4630|regulation of heterotypic cell-cell adhesion (GO:0034114)|4/19|2.21278051030209e-05|0.00191386761763925|0|0|23.3918128654971|250.729253585717|IL1RN;IL1B;KLF4;TNF|3
4631|positive regulation of mononuclear cell migration (GO:0071677)|4/19|2.21278051030209e-05|0.00188196982401193|0|0|23.3918128654971|250.729253585717|CXCL10;TNF;PLA2G7;CCR2|3
4632|positive regulation of interleukin-2 production (GO:0032743)|4/20|2.74658036153002e-05|0.00229767206309634|0|0|22.2222222222222|233.390418488526|IL1A;IL1B;MALT1;CCR2|3
4633|response to tumor necrosis factor (GO:0034612)|7/98|2.95496258683638e-05|0.00243212485171388|0|0|7.93650793650794|82.7733291679476|ZFP36;PID1;CCL4;CCL3;CXCL16;ZFP36L1;NFE2L2|3
4634|regulation of cell migration (GO:0030334)|12/317|3.15985618212589e-05|0.00255948350752197|0|0|4.20609884332282|43.5852742392958|CSF1R;MMP14;PLXND1;ADAM15;SEMA4D;F10;IL1B;PDPN;CCL3;CTSH;SGK1;CXCL16|3
4635|negative regulation of apoptotic process (GO:0043066)|15/486|3.54899424806684e-05|0.00282976838248204|0|0|3.42935528120713|35.1380700000912|CSF1R;CD74;SEMA4D;CFLAR;KLF4;MALT1;NFKBIA;NR4A2;PDPN;PIM1;CTSH;APOE;MCL1;LGMN;BIRC3|3
4636|cellular response to transforming growth factor beta stimulus (GO:0071560)|7/101|3.59158950071377e-05|0.00281967403417575|0|0|7.7007700770077|78.8122268627016|JUN;HPGD;GDF15;FURIN;FOS;F11R;ZFP36L1|3
4637|positive regulation of cell motility (GO:2000147)|9/180|3.7853157822981e-05|0.00292673733894958|0|0|5.55555555555556|56.5655341757081|CSF1R;MMP14;F10;SEMA4D;IL1B;PDPN;CCL3;CTSH;CXCL16|3
4638|regulation of transcription, DNA-templated (GO:0006355)|31/1599|3.80720624873253e-05|0.00289972738616151|0|0|2.15412410534362|21.9204311165627|CDKN1A;CEBPB;BTG1;TNF;ETS2;NFIL3;CUX1;BASP1;NFKBIZ;SPP1;APOE;JUNB;EGR1;CD74;JUN;JUND;DENND4A;FOS;KLF4;CBFA2T3;HOPX;EREG;KLF6;MAFB;ID2;IL1B;BHLHE40;FOSB;NFKBID;ATF3;NFE2L2|3
4639|protein processing (GO:0016485)|7/102|3.82727323545024e-05|0.00287214342948567|0|0|7.62527233115469|77.5549129086232|SRGN;MMP14;F10;CTSH;FURIN;CTSS;LGMN|3
4640|nuclear-transcribed mRNA catabolic process, deadenylation-independent decay (GO:0031086)|3/8|3.88360883381268e-05|0.00287218201144147|0|0|41.6666666666667|423.173359658901|ZFP36;PNRC1;ZFP36L1|3
4641|negative regulation of sequence-specific DNA binding transcription factor activity (GO:0043433)|8/141|4.21402279609841e-05|0.00307202261835574|0|0|6.30417651694247|63.5114751142154|NFKBIA;ID2;BHLHE40;PIM1;NLRP3;TNFAIP3;TRIB1;KLF4|3
4642|negative regulation of viral transcription (GO:0032897)|4/23|4.91499897339014e-05|0.0035325689804521|0|0|19.3236714975845|191.703070922588|JUN;ZFP36;CCL4;CCL3|3
4643|negative regulation of signal transduction in absence of ligand (GO:1901099)|4/23|4.91499897339014e-05|0.00348350552239026|0|0|19.3236714975845|191.703070922588|IL1A;IL1B;TNF;MCL1|3
4644|negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240)|4/23|4.91499897339014e-05|0.00343578626865889|0|0|19.3236714975845|191.703070922588|IL1A;IL1B;TNF;MCL1|3
4645|regulation of smooth muscle cell proliferation (GO:0048660)|5/45|5.0971195529653e-05|0.00351494609172729|0|0|12.3456790123457|122.027776275705|ID2;TNFAIP3;TRIB1;TNF;EREG|3
4646|regulation of gene expression (GO:0010468)|23/1038|6.06461529398374e-05|0.00412636424602653|0|0|2.46199957182616|23.907134464473|EGR1;MSR1;CEBPB;PID1;BTG1;DENND4A;FN1;KLF4;TNF;CRIP1;ZFP36L1;OLFM1;IL1A;MAFB;NFIL3;ID2;IL1B;BHLHE40;CCL3;NLRP3;CTSH;NFE2L2;TLR2|3
4647|regulation of fibroblast proliferation (GO:0048145)|5/47|6.30717619691602e-05|0.00423493685958717|0|0|11.8203309692671|114.317226961646|CD74;CDKN1A;FN1;S100A6;EREG|3
4648|transforming growth factor beta receptor signaling pathway (GO:0007179)|6/77|6.82663756081279e-05|0.00452419889257502|0|0|8.65800865800866|83.0484261214626|JUN;HPGD;GDF15;FURIN;FOS;F11R|3
4649|positive regulation of JNK cascade (GO:0046330)|6/77|6.82663756081279e-05|0.00446619634267022|0|0|8.65800865800866|83.0484261214626|IL1A;GADD45B;IL1B;FCGR2B;TNF;SASH1|3
4650|response to glucocorticoid (GO:0051384)|4/25|6.92341042974463e-05|0.00447217258518821|0|0|17.7777777777778|170.275857423581|IL1RN;ZFP36;TNF;ZFP36L1|3
4651|cellular response to tumor necrosis factor (GO:0071356)|9/195|7.04527486725755e-05|0.00449400470595191|0|0|5.12820512820513|49.0285554074171|NFKBIA;ZFP36;PID1;CCL4;CCL3;TNF;ZFP36L1;NFE2L2;BIRC3|3
4652|proteolysis (GO:0006508)|11/292|7.08415601414293e-05|0.00446301828891005|0|0|4.18569254185693|39.9945631431613|SRGN;MMP12;MMP14;ANPEP;CTSH;FURIN;CTSS;CTSC;MALT1;LGMN;CTSB|3
4653|positive regulation of gene expression (GO:0010628)|19/772|7.14435349951909e-05|0.00444605315951779|0|0|2.73459988485895|26.1061398490917|EGR1;CD74;JUN;PID1;FN1;FOS;KLF4;TNF;ETS2;OLFM1;IL1A;KLF6;ID2;IL1B;SPP1;CCL3;CTSH;NFE2L2;TLR2|3
4654|positive regulation of cellular process (GO:0048522)|15/520|7.61560647550717e-05|0.00468222166801363|0|0|3.20512820512821|30.3933520499171|CSF1R;JUN;JUND;HILPDA;FN1;OSM;AREG;CXCL16;EREG;MMP14;IL1B;PDPN;CTSH;FCGR2B;JUNB|3
4655|pattern recognition receptor signaling pathway (GO:0002221)|5/49|7.72753561715378e-05|0.00469447788742092|0|0|11.3378684807256|107.348474612399|CD14;CTSS;CTSB;TLR2;LGMN|3
4656|negative regulation of insulin receptor signaling pathway (GO:0046627)|4/26|8.12492286393097e-05|0.00487782133819291|0|0|17.0940170940171|160.991268896915|SOCS3;PTPN1;PID1;IL1B|3
4657|cellular response to thyroid hormone stimulus (GO:0097067)|3/10|8.21219627075001e-05|0.00487288808949271|0|0|33.3333333333333|313.576835520605|CTSH;CTSS;CTSB|3
4658|T cell chemotaxis (GO:0010818)|3/10|8.21219627075001e-05|0.0048168778815675|0|0|33.3333333333333|313.576835520605|CXCL10;CCL3;CXCL16|3
4659|positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731)|7/117|9.18037824356525e-05|0.00532357615646744|0|0|6.64767331433998|61.7958208996081|CSF1R;SOCS3;PTPN1;CD74;SEMA4D;OSM;TREM2|3
4660|negative regulation of cellular response to insulin stimulus (GO:1900077)|4/27|9.47118796365007e-05|0.005430502491967|0|0|16.4609053497942|152.504874414693|SOCS3;PTPN1;PID1;IL1B|3
4661|regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239)|4/28|0.000109723918841248|0.00622134619829875|0|0|15.8730158730159|144.722907552188|IL1A;IL1B;TNF;MCL1|3
4662|negative regulation of bone mineralization (GO:0030502)|3/11|0.000112170536176588|0.00629017852867172|0|0|30.3030303030303|275.620915160091|SRGN;ECM1;CCL3|3
4663|response to thyroid hormone (GO:0097066)|3/11|0.000112170536176588|0.00622180702292529|0|0|30.3030303030303|275.620915160091|CTSH;CTSS;CTSB|3
4664|negative regulation of homeostatic process (GO:0032845)|4/29|0.000126389254726357|0.00693510071901721|0|0|15.3256704980843|137.565426665768|ZFP36;MAFB;TNFAIP3;ZFP36L1|3
4665|toll-like receptor signaling pathway (GO:0002224)|6/87|0.000135004900573143|0.00732904263430586|0|0|7.66283524904215|68.2773906486045|CD14;CTSS;CTSB;TLR2;BIRC3;LGMN|3
4666|regulation of interleukin-2 biosynthetic process (GO:0045076)|3/12|0.000148571446557616|0.00798063254508961|0|0|27.7777777777778|244.845683161758|IL1A;ZFP36;IL1B|3
4667|negative regulation by host of viral transcription (GO:0043922)|3/12|0.000148571446557616|0.00789750095607826|0|0|27.7777777777778|244.845683161758|JUN;CCL4;CCL3|3
4668|positive regulation of NF-kappaB transcription factor activity (GO:0051092)|7/129|0.000169044975392618|0.00889315989101576|0|0|6.02928509905254|52.3664257218272|NFKBIA;IL1B;NLRP3;CFLAR;TNF;MALT1;TLR2|3
4669|regulation of cytokine-mediated signaling pathway (GO:0001959)|6/91|0.000172998771683675|0.00900829318267138|0|0|7.32600732600733|63.4595316013631|SOCS3;PTPN1;CD74;TNFAIP3;TNF;BIRC3|3
4670|I-kappaB kinase/NF-kappaB signaling (GO:0007249)|5/58|0.000173946479911229|0.00896615037360607|0|0|9.57854406130268|82.9191847967559|NFKBIA;CD14;TNF;TLR2;BIRC3|3
4671|regulation of cytokine secretion (GO:0050707)|4/32|0.0001873722481708|0.00956160582415592|0|0|13.8888888888889|119.200184553647|SRGN;IL1A;FCGR2B;TNF|3
4672|proteolysis involved in cellular protein catabolic process (GO:0051603)|6/94|0.000206676528649949|0.0104422804524821|0|0|7.09219858156028|60.17273510963|TNFAIP3;CTSH;CTSS;CTSC;CTSB;LGMN|3
4673|cellular response to lipid (GO:0071396)|8/179|0.000222432751019163|0.011128179690694|0|0|4.96585971446307|41.767278682324|CXCL10;ZFP36;PID1;SPP1;NLRP3;TNFAIP3;CD14;CCR5|3
4674|regulation of tumor necrosis factor production (GO:0032680)|5/62|0.000238631962604395|0.0118227078171867|0|0|8.96057347670251|74.7364524939665|ZFP36;CCL3;TNFAIP3;CD14;TLR2|3
4675|negative regulation of biomineral tissue development (GO:0070168)|3/14|0.000242578854254815|0.0119026912813685|0|0|23.8095238095238|198.194850672832|SRGN;ECM1;CCL3|3
4676|positive regulation of protein metabolic process (GO:0051247)|6/97|0.000245322664291302|0.0119226814845573|0|0|6.87285223367698|57.1335822459945|NFKBIA;TNFAIP3;APOE;KLF4;TNF;EREG|3
4677|cellular protein catabolic process (GO:0044257)|5/63|0.000257332430719265|0.012388371641136|0|0|8.81834215167549|72.8848483613878|CTSH;CTSS;CTSC;CTSB;LGMN|3
4678|second-messenger-mediated signaling (GO:0019932)|5/63|0.000257332430719265|0.0122725924669197|0|0|8.81834215167549|72.8848483613878|LAT2;CCL3;CXCR4;APOE;CCR5|3
4679|regulation of insulin receptor signaling pathway (GO:0046626)|4/35|0.000267146681011198|0.0126226806777791|0|0|12.6984126984127|104.47889121686|SOCS3;PTPN1;PID1;IL1B|3
4680|positive regulation of NIK/NF-kappaB signaling (GO:1901224)|4/36|0.000298441201571124|0.0139719766203435|0|0|12.3456790123457|100.209106471554|CD14;TNF;MALT1;SASH1|3
4681|positive regulation of acute inflammatory response (GO:0002675)|3/15|0.000301220179291295|0.0139738779538498|0|0|22.2222222222222|180.170423732526|IL1B;OSM;TNF|3
4682|positive regulation of NF-kappaB import into nucleus (GO:0042346)|3/15|0.000301220179291295|0.0138479871614728|0|0|22.2222222222222|180.170423732526|IL1B;TNF;TLR2|3
4683|endoderm formation (GO:0001706)|4/37|0.000332279733698686|0.0151394953666464|0|0|12.012012012012|96.2106110802427|DUSP2;MMP14;DUSP1;FN1|3
4684|negative regulation of protein serine/threonine kinase activity (GO:0071901)|5/68|0.000368066132804652|0.016621605979665|0|0|8.16993464052288|64.6016987519014|PTPN1;RGS2;DUSP1;IL1B;APOE|3
4685|lipopolysaccharide-mediated signaling pathway (GO:0031663)|3/16|0.000368284070412139|0.0164855579939749|0|0|20.8333333333333|164.721999731514|IL1B;CCL3;TNF|3
4686|positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)|3/16|0.000368284070412139|0.0163422053157665|0|0|20.8333333333333|164.721999731514|BTG2;ZFP36;ZFP36L1|3
4687|dendritic cell chemotaxis (GO:0002407)|3/16|0.000368284070412139|0.0162013242354581|0|0|20.8333333333333|164.721999731514|CXCR4;CCR5;CCR2|3
4688|T cell migration (GO:0072678)|3/16|0.000368284070412139|0.0160628513787448|0|0|20.8333333333333|164.721999731514|CXCL10;CCL3;CXCL16|3
4689|positive regulation of smooth muscle cell proliferation (GO:0048661)|4/38|0.00036877938937971|0.0159481459661412|0|0|11.6959064327485|92.4597889295129|JUN;ID2;TNF;EREG|3
4690|regulation of osteoclast differentiation (GO:0045670)|4/38|0.00036877938937971|0.0158141279328123|0|0|11.6959064327485|92.4597889295129|CEBPB;MAFB;CCL3;TNF|3
4691|positive regulation of neuron death (GO:1901216)|4/39|0.000408058220735807|0.0173526758367902|0|0|11.3960113960114|88.9356204656251|EGR1;CCL3;FOS;FCGR2B|3
4692|regulation of innate immune response (GO:0045088)|5/70|0.000421205589496625|0.0177637365553825|0|0|7.93650793650794|61.6856310109735|PTPN1;TNFAIP3;FCGR2B;EREG;BIRC3|3
4693|regulation of apoptotic process (GO:0042981)|18/816|0.000422961239406759|0.0176915672515794|0|0|2.45098039215686|19.0397794503055|CSF1R;CD74;JUN;GADD45B;SEMA4D;DUSP1;GDF15;CFLAR;TNF;MALT1;NFKBIA;PDPN;PIM1;CTSH;SGK1;MCL1;CTSB;BIRC3|3
4694|cellular response to interleukin-1 (GO:0071347)|7/151|0.000442179808978934|0.0183450696359309|0|0|5.15084621044886|39.7840748026196|NFKBIA;EGR1;IL1A;IL1RN;IL1B;CCL4;CCL3|3
4695|positive regulation of lymphocyte migration (GO:2000403)|3/17|0.00044424976445272|0.0182823108709857|0|0|19.6078431372549|151.355365120451|CXCL10;CCL4;CCL3|3
4696|positive regulation of monocyte chemotaxis (GO:0090026)|3/17|0.00044424976445272|0.0181360523840178|0|0|19.6078431372549|151.355365120451|CXCL10;PLA2G7;CCR2|3
4697|positive regulation of cellular protein catabolic process (GO:1903364)|3/17|0.00044424976445272|0.0179921154603351|0|0|19.6078431372549|151.355365120451|RNF128;APOE;CTSC|3
4698|response to purine-containing compound (GO:0014074)|3/17|0.00044424976445272|0.0178504452598601|0|0|19.6078431372549|151.355365120451|JUN;JUND;JUNB|3
4699|regulation of cytokine production (GO:0001817)|6/109|0.000460034714263238|0.0183402902100414|0|0|6.11620795107034|46.99821777088|CD83;HILPDA;NLRP3;TNF;EREG;CCR2|3
4700|response to cAMP (GO:0051591)|4/41|0.000495429750139498|0.0195982791857508|0|0|10.840108401084|82.4941462324952|JUN;JUND;JUNB;ZFP36L1|3
4701|negative regulation of cytokine secretion (GO:0050710)|4/41|0.000495429750139498|0.0194475231920143|0|0|10.840108401084|82.4941462324952|SRGN;FN1;FCGR2B;TNF|3
4702|positive regulation of ERK1 and ERK2 cascade (GO:0070374)|8/202|0.000500452038915226|0.0194947080502626|0|0|4.4004400440044|33.443339010534|CSF1R;IL1A;CD74;CCL4;CCL3;TREM2;TNF;ICAM1|3
4703|negative regulation of cell cycle (GO:0045786)|5/73|0.000511512684421059|0.0197746153681869|0|0|7.6103500761035|57.6722844322902|NR4A1;BTG2;BTG1;HPGD;DUSP1|3
4704|regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664)|3/18|0.000529581729031885|0.020319214761276|0|0|18.5185185185185|139.693019509236|LY86;TRIB1;SASH1|3
4705|positive regulation of p38MAPK cascade (GO:1900745)|3/18|0.000529581729031885|0.0201675788302217|0|0|18.5185185185185|139.693019509236|GADD45B;IL1B;SASH1|3
4706|acute-phase response (GO:0006953)|3/18|0.000529581729031885|0.0200181893574053|0|0|18.5185185185185|139.693019509236|IL1RN;CEBPB;IL1B|3
4707|regulation of peptidase activity (GO:0052547)|3/18|0.000529581729031885|0.0198709967886008|0|0|18.5185185185185|139.693019509236|ECM1;CTSH;FURIN|3
4708|response to organophosphorus (GO:0046683)|3/18|0.000529581729031885|0.0197259530164212|0|0|18.5185185185185|139.693019509236|JUN;JUND;JUNB|3
4709|regulation of MAPK cascade (GO:0043408)|8/204|0.000534092171192476|0.0197497996347479|0|0|4.35729847494553|32.8319918460536|CSF1R;CD74;DUSP1;GDF15;IL1B;FN1;OSM;TRIB1|3
4710|regulation of phagocytosis (GO:0050764)|4/42|0.000543762407618137|0.0199627306911896|0|0|10.5820105820106|79.5449540445889|IL1B;FCGR2B;TNF;TLR2|3
4711|regulation of calcium-mediated signaling (GO:0050848)|4/42|0.000543762407618137|0.0198201397576811|0|0|10.5820105820106|79.5449540445889|PLEK;CCL4;CCL3;TREM2|3
4712|positive regulation of cytokine secretion (GO:0050715)|5/74|0.000544626779525099|0.0197108542972807|0|0|7.50750750750751|56.4219955412921|IL1A;CSF1R;CD14;TNF;TLR2|3
4713|regulation of interleukin-6 production (GO:0032675)|4/43|0.000595353981641873|0.0213950096360456|0|0|10.3359173126615|76.7581850355393|IL1B;TNFAIP3;TNF;TLR2|3
4714|regulation of defense response (GO:0031347)|5/76|0.000615657531524448|0.021969932750834|0|0|7.30994152046784|54.0410797101511|TNFAIP3;NLRP3;APOE;FCGR2B;BIRC3|3
4715|positive regulation of cellular biosynthetic process (GO:0031328)|7/160|0.000624874294069985|0.0221439827961051|0|0|4.86111111111111|35.8650836150111|EGR1;ZEB2;IL1B;KLF4;TNF;AREG;EREG|3
4716|lymphocyte chemotaxis (GO:0048247)|4/45|0.000708799776152362|0.0249448638462449|0|0|9.87654320987654|71.6240738220798|CXCL10;CCL4;CCL3;CXCL16|3
4717|positive regulation of interleukin-8 production (GO:0032757)|4/45|0.000708799776152362|0.0247740086144213|0|0|9.87654320987654|71.6240738220798|IL1B;CD14;TNF;TLR2|3
4718|negative regulation of immune response (GO:0050777)|4/45|0.000708799776152362|0.0246054779435749|0|0|9.87654320987654|71.6240738220798|TNFAIP3;NLRP3;FCGR2B;CCR2|3
4719|negative regulation of ossification (GO:0030279)|4/46|0.000770897878324385|0.0265803504938469|0|0|9.66183574879227|69.2556004512933|SRGN;ECM1;SEMA4D;CCL3|3
4720|positive regulation of sequence-specific DNA binding transcription factor activity (GO:0051091)|8/216|0.000776480012693207|0.0265931376159291|0|0|4.11522633744856|29.46806442782|NFKBIA;ANXA3;IL1B;NLRP3;CFLAR;TNF;MALT1;TLR2|3
4721|regulation of cell cycle (GO:0051726)|8/216|0.000776480012693207|0.0264158500318229|0|0|4.11522633744856|29.46806442782|NR4A1;JUN;JUND;GADD45B;HPGD;ID2;PIM1;JUNB|3
4722|positive regulation of stress-activated MAPK cascade (GO:0032874)|5/81|0.000823530631989948|0.0278309722850643|0|0|6.85871056241427|48.709943838972|IL1A;GADD45B;IL1B;FCGR2B;SASH1|3
4723|negative regulation of MAPK cascade (GO:0043409)|5/81|0.000823530631989948|0.0276478737831888|0|0|6.85871056241427|48.709943838972|PTPN1;RGS2;DUSP1;IL1B;APOE|3
4724|regulation of acute inflammatory response (GO:0002673)|6/122|0.000834232376161629|0.0278241033696261|0|0|5.46448087431694|38.7376970815523|C1QB;C1QA;C3AR1;OSM;NLRP3;C1QC|3
4725|regulation of cell differentiation (GO:0045595)|6/122|0.000834232376161629|0.0276434273737194|0|0|5.46448087431694|38.7376970815523|JUN;JUND;KLF4;JUNB;SKIL;HOPX|3
4726|regulation of G1/S transition of mitotic cell cycle (GO:2000045)|4/47|0.000836742501026922|0.0275477224692928|0|0|9.45626477541371|67.0070371625191|CDKN1A;PID1;ID2;KLF4|3
4727|regulation of interleukin-2 production (GO:0032663)|3/21|0.000846204071316569|0.0276806370251824|0|0|15.8730158730159|112.297619180895|TNFAIP3;MALT1;CCR2|3
4728|positive regulation of protein catabolic process (GO:0045732)|5/82|0.000870698402943056|0.0283004710204995|0|0|6.77506775067751|47.7385833763768|IL1B;TNFAIP3;FURIN;APOE;TNF|3
4729|positive regulation of tumor necrosis factor production (GO:0032760)|4/48|0.000906456164184651|0.0292762392774321|0|0|9.25925925925926|64.8700730199404|CCL3;CD14;CCR2;TLR2|3
4730|negative regulation of macromolecule metabolic process (GO:0010605)|6/125|0.000946893642307847|0.0303899261427481|0|0|5.33333333333333|37.1323934998104|OLFM1;MSR1;ID2;CCL3;KLF4;TNF|3
4731|negative regulation of myeloid cell differentiation (GO:0045638)|3/22|0.000973359851351786|0.031044095759051|0|0|15.1515151515152|105.072071321238|ZFP36;MAFB;ZFP36L1|3
4732|regulation of ERBB signaling pathway (GO:1901184)|3/22|0.000973359851351786|0.0308512752884979|0|0|15.1515151515152|105.072071321238|PTPN18;EREG;LGMN|3
4733|regulation of bone resorption (GO:0045124)|3/22|0.000973359851351786|0.0306608353175813|0|0|15.1515151515152|105.072071321238|CSF1R;SPP1;TNFAIP3|3
4734|regulation of monocyte chemotaxis (GO:0090025)|3/22|0.000973359851351786|0.0304727320334243|0|0|15.1515151515152|105.072071321238|CXCL10;PLA2G7;CCR2|3
4735|negative regulation of mitotic cell cycle (GO:0045930)|4/49|0.000980161484026213|0.0304985612986937|0|0|9.0702947845805|62.8371267143378|BTG2;BTG1;DUSP1;ZFP36L1|3
4736|positive regulation of chemotaxis (GO:0050921)|4/49|0.000980161484026213|0.0303137215332471|0|0|9.0702947845805|62.8371267143378|CXCL10;CXCL1;CXCL2;CCR2|3
4737|MAPK cascade (GO:0000165)|9/279|0.000985948578771923|0.0303090096233321|0|0|3.584229390681|24.8097002009624|MEF2A;ZFP36;IL1B;CCL3;CTSH;CCR5;TNF;EREG;ZFP36L1|3
4738|positive regulation of hydrolase activity (GO:0051345)|7/173|0.000989461370762166|0.0302348585329301|0|0|4.49582530507386|31.1036922478023|SEMA4D;RGS1;CCL4;CCL3;RGS10;CTSH;F11R|3
4739|positive regulation of monooxygenase activity (GO:0032770)|3/23|0.00111199208742095|0.0337767596554114|0|0|14.4927536231884|98.5739449102566|IL1B;APOE;TNF|3
4740|cellular response to lipoteichoic acid (GO:0071223)|2/6|0.00117988835931703|0.0356270431810343|0|0|37.037037037037|249.716127989953|CD14;TLR2|3
4741|positive regulation of cellular extravasation (GO:0002693)|2/6|0.00117988835931703|0.0354174723387929|0|0|37.037037037037|249.716127989953|CCR2;ICAM1|3
4742|regulation of endothelial cell development (GO:1901550)|2/6|0.00117988835931703|0.0352103526175134|0|0|37.037037037037|249.716127989953|IL1B;TNF|3
4743|regulation of extent of cell growth (GO:0061387)|2/6|0.00117988835931703|0.035005641265086|0|0|37.037037037037|249.716127989953|OLFM1;APOE|3
4744|negative regulation of acute inflammatory response (GO:0002674)|2/6|0.00117988835931703|0.034803296517889|0|0|37.037037037037|249.716127989953|NLRP3;FCGR2B|3
4745|response to lipoteichoic acid (GO:0070391)|2/6|0.00117988835931703|0.0346032775723839|0|0|37.037037037037|249.716127989953|CD14;TLR2|3
4746|negative regulation of leukocyte degranulation (GO:0043301)|2/6|0.00117988835931703|0.0344055445576845|0|0|37.037037037037|249.716127989953|FCGR2B;CCR2|3
4747|release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0014808)|2/6|0.00117988835931703|0.0342100585090613|0|0|37.037037037037|249.716127989953|CCL3;CCR5|3
4748|regulation of keratinocyte apoptotic process (GO:1902172)|2/6|0.00117988835931703|0.0340167813423435|0|0|37.037037037037|249.716127989953|ZFP36;ZFP36L1|3
4749|cellular response to bacterial lipopeptide (GO:0071221)|2/6|0.00117988835931703|0.0338256758291842|0|0|37.037037037037|249.716127989953|CD14;TLR2|3
4750|positive regulation of fever generation (GO:0031622)|2/6|0.00117988835931703|0.0336367055731553|0|0|37.037037037037|249.716127989953|IL1B;TNF|3
4751|negative regulation of programmed cell death (GO:0043069)|11/409|0.00123462048928992|0.0350014908713691|0|0|2.98831839174137|20.0127433237537|NFKBIA;CSF1R;CD74;SEMA4D;PDPN;PIM1;CTSH;CFLAR;MALT1;MCL1;BIRC3|3
4752|positive regulation of MAPK cascade (GO:0043410)|9/290|0.00129048993484014|0.0363832604281172|0|0|3.44827586206897|22.9404597871121|CSF1R;IL1A;CD74;CCL4;CCL3;OSM;TREM2;TNF;ICAM1|3
4753|positive regulation of protein phosphorylation (GO:0001934)|11/413|0.0013341982201776|0.0374088654811333|0|0|2.95937584073177|19.5893656896917|CSF1R;CD74;CDKN1A;SEMA4D;GDF15;IL1B;OSM;TREM2;CCNL1;TNF;EREG|3
4754|positive regulation of neutrophil chemotaxis (GO:0090023)|3/25|0.00142519869310146|0.0397420160158293|0|0|13.3333333333333|87.3792538830146|CD74;CXCL1;CXCL2|3
4755|negative regulation of endothelial cell apoptotic process (GO:2000352)|3/25|0.00142519869310146|0.0395260267983519|0|0|13.3333333333333|87.3792538830146|TNFAIP3;ICAM1;NFE2L2|3
4756|cellular response to organic cyclic compound (GO:0071407)|6/136|0.00146291862715359|0.0403528311046745|0|0|4.90196078431373|31.9966753873949|EGR1;IL1B;SPP1;CCL3;TNF;ZFP36L1|3
4757|positive regulation of cellular metabolic process (GO:0031325)|5/93|0.00153199221882776|0.0420309478100971|0|0|5.97371565113501|38.7167639592042|NFKBIA;CDKN1A;PID1;APOE;KLF4|3
4758|regulation of cytosolic calcium ion concentration (GO:0051480)|6/138|0.00157609456437341|0.0430096821497193|0|0|4.83091787439614|31.1729723988963|CD52;C3AR1;CXCR4;ATP2B1;CCR5;CCR2|3
4759|positive regulation of nuclear division (GO:0051785)|3/26|0.00160049732280436|0.0434432863737799|0|0|12.8205128205128|82.5312932215424|IL1A;IL1B;EREG|3
4760|positive regulation of neutrophil migration (GO:1902624)|3/26|0.00160049732280436|0.0432134277157176|0|0|12.8205128205128|82.5312932215424|CD74;CXCL1;CXCL2|3
4761|positive regulation of nitric oxide biosynthetic process (GO:0045429)|3/26|0.00160049732280436|0.042985988622477|0|0|12.8205128205128|82.5312932215424|IL1B;KLF4;TNF|3
4762|positive regulation of nitric oxide metabolic process (GO:1904407)|3/26|0.00160049732280436|0.0427609310904221|0|0|12.8205128205128|82.5312932215424|IL1B;KLF4;TNF|3
4763|positive regulation of lipid transport (GO:0032370)|2/7|0.00164207291404988|0.0436432191687319|0|0|31.7460317460317|203.54907502554|SPP1;APOE|3
4764|regulation of dendritic spine maintenance (GO:1902950)|2/7|0.00164207291404988|0.0434170884994639|0|0|31.7460317460317|203.54907502554|APOE;FCGR2B|3
4765|cellular response to laminar fluid shear stress (GO:0071499)|2/7|0.00164207291404988|0.0431932890742089|0|0|31.7460317460317|203.54907502554|KLF4;NFE2L2|3
4766|leukocyte aggregation (GO:0070486)|2/7|0.00164207291404988|0.0429717850276745|0|0|31.7460317460317|203.54907502554|SEMA4D;IL1B|3
4767|regulation of natural killer cell chemotaxis (GO:2000501)|2/7|0.00164207291404988|0.0427525412265129|0|0|31.7460317460317|203.54907502554|CCL4;CCL3|3
4768|release of sequestered calcium ion into cytosol by endoplasmic reticulum (GO:1903514)|2/7|0.00164207291404988|0.0425355232507438|0|0|31.7460317460317|203.54907502554|CCL3;CCR5|3
4769|negative regulation of synapse organization (GO:1905809)|2/7|0.00164207291404988|0.04232069737574|0|0|31.7460317460317|203.54907502554|APOE;TLR2|3
4770|regulation of chemokine biosynthetic process (GO:0045073)|2/7|0.00164207291404988|0.0421080305547564|0|0|31.7460317460317|203.54907502554|EGR1;TNF|3
4771|activation of MAPKKK activity (GO:0000185)|2/7|0.00164207291404988|0.0418974904019826|0|0|31.7460317460317|203.54907502554|GADD45B;TNF|3
4772|regulation of calcidiol 1-monooxygenase activity (GO:0060558)|2/7|0.00164207291404988|0.0416890451761021|0|0|31.7460317460317|203.54907502554|IL1B;TNF|3
4773|regulation of GTPase activity (GO:0043087)|7/189|0.00164792048958374|0.0416303874175537|0|0|4.11522633744856|26.3713625319776|PLXND1;SEMA4D;RGS1;CCL4;CCL3;RGS10;F11R|3
4774|protein complex assembly (GO:0006461)|7/190|0.001698225560687|0.0426898770255456|0|0|4.09356725146199|26.1094734070989|FN1;NLRP3;TNFAIP3;TNF;AREG;CTSC;MALT1|3
4775|interleukin-1-mediated signaling pathway (GO:0070498)|5/96|0.00176329270346256|0.0441082483616149|0|0|5.78703703703704|36.6931271039359|NFKBIA;IL1A;EGR1;IL1RN;IL1B|3
4776|regulation of p38MAPK cascade (GO:1900744)|3/27|0.00178872141426817|0.0445260750098071|0|0|12.3456790123457|78.1019038032556|GADD45B;IL1B;SASH1|3
4777|positive regulation of granulocyte chemotaxis (GO:0071624)|3/27|0.00178872141426817|0.0443099290146138|0|0|12.3456790123457|78.1019038032556|CD74;CXCL1;CXCL2|3
4778|positive regulation of cell death (GO:0010942)|4/58|0.00184332446024471|0.0454419551721197|0|0|7.66283524904215|48.2466250248127|EGR1;FOS;FCGR2B;TNF|3
4779|modulation by host of viral transcription (GO:0043921)|3/28|0.00199020206180508|0.0488269284682275|0|0|11.9047619047619|74.0418941286299|JUN;CCL4;CCL3|3
4780|negative regulation of myeloid leukocyte differentiation (GO:0002762)|3/28|0.00199020206180508|0.0485933068009154|0|0|11.9047619047619|74.0418941286299|MAFB;CCL3;C1QC|3
4781|regulation of vascular endothelial growth factor production (GO:0010574)|3/28|0.00199020206180508|0.0483619101018634|0|0|11.9047619047619|74.0418941286299|IL1A;IL1B;CCR2|3
4782|transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178)|6/145|0.00202533899699136|0.0489824876855304|0|0|4.59770114942529|28.5150261448864|JUN;HPGD;GDF15;FURIN;FOS;F11R|3
4783|positive regulation of nucleic acid-templated transcription (GO:1903508)|12/503|0.00206081443151208|0.0496053586981422|0|0|2.65076209410205|16.3940464392576|EGR1;CD74;JUN;KLF6;ID2;IL1B;SPP1;FOS;KLF4;TNF;ETS2;NFE2L2|3
4784|regulation of PERK-mediated unfolded protein response (GO:1903897)|2/8|0.00217648832879889|0.0521437555955903|0|0|27.7777777777778|170.278959982155|PPP1R15A;PTPN1|3
4785|cellular response to UV-B (GO:0071493)|2/8|0.00217648832879889|0.0519000931862651|0|0|27.7777777777778|170.278959982155|CDKN1A;CRIP1|3
4786|B cell mediated immunity (GO:0019724)|2/8|0.00217648832879889|0.0516586974040034|0|0|27.7777777777778|170.278959982155|CD74;FCGR2B|3
4787|positive regulation of monocyte differentiation (GO:0045657)|2/8|0.00217648832879889|0.0514195367678738|0|0|27.7777777777778|170.278959982155|CD74;ZFP36L1|3
4788|membrane fusion involved in viral entry into host cell (GO:0039663)|2/8|0.00217648832879889|0.0511825803772384|0|0|27.7777777777778|170.278959982155|CXCR4;CCR5|3
4789|positive regulation of interleukin-2 biosynthetic process (GO:0045086)|2/8|0.00217648832879889|0.0509477978984437|0|0|27.7777777777778|170.278959982155|IL1A;IL1B|3
4790|fusion of virus membrane with host plasma membrane (GO:0019064)|2/8|0.00217648832879889|0.0507151595518755|0|0|27.7777777777778|170.278959982155|CXCR4;CCR5|3
4791|immunoglobulin mediated immune response (GO:0016064)|2/8|0.00217648832879889|0.050484636099367|0|0|27.7777777777778|170.278959982155|CD74;FCGR2B|3
4792|positive regulation of protein tyrosine kinase activity (GO:0061098)|3/29|0.0022052583698698|0.0509205134002064|0|0|11.4942528735632|70.3093172690069|CSF1R;PTPN1;EREG|3
4793|regulation of NIK/NF-kappaB signaling (GO:1901222)|3/29|0.0022052583698698|0.0506911417182235|0|0|11.4942528735632|70.3093172690069|CD14;TNF;SASH1|3
4794|positive regulation of calcium-mediated signaling (GO:0050850)|3/29|0.0022052583698698|0.0504638271813705|0|0|11.4942528735632|70.3093172690069|CCL4;CCL3;TREM2|3
4795|intrinsic apoptotic signaling pathway (GO:0097193)|5/102|0.00230127840968116|0.0524259987705488|0|0|5.44662309368192|33.0843708070116|PPP1R15A;CDKN1A;CEBPB;CRIP1;MCL1|3
4796|regulation of neutrophil chemotaxis (GO:0090022)|3/30|0.0024341976842087|0.0552076034778534|0|0|11.1111111111111|66.8682007764498|CD74;CXCL1;CXCL2|3
4797|positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003)|3/30|0.0024341976842087|0.0549633220465355|0|0|11.1111111111111|66.8682007764498|CEBPB;ATF3;NFE2L2|3
4798|negative regulation of lymphocyte proliferation (GO:0050672)|3/30|0.0024341976842087|0.0547211928745243|0|0|11.1111111111111|66.8682007764498|CEBPB;ARG1;FCGR2B|3
4799|negative regulation of epithelial cell apoptotic process (GO:1904036)|3/30|0.0024341976842087|0.0544811876426185|0|0|11.1111111111111|66.8682007764498|TNFAIP3;ICAM1;NFE2L2|3
4800|positive regulation of multicellular organismal process (GO:0051240)|7/203|0.00246721406883582|0.0549790104509572|0|0|3.83141762452107|23.0063818860627|OLFM1;IL1B;HILPDA;PDPN;CTSH;TNF;EREG|3
4801|regulation of protein phosphorylation (GO:0001932)|8/262|0.00263090670315952|0.0583718126357522|0|0|3.39270568278202|20.1541195526834|CSF1R;CD74;PID1;SEMA4D;GDF15;IL1B;FN1;TNF|3
4802|regulation of leukocyte chemotaxis (GO:0002688)|3/31|0.00267731581822429|0.0591443403480457|0|0|10.752688172043|63.687532760432|CXCL10;CXCL1;CXCL2|3
4803|positive regulation of reactive oxygen species biosynthetic process (GO:1903428)|3/31|0.00267731581822429|0.0588894078465455|0|0|10.752688172043|63.687532760432|IL1B;KLF4;TNF|3
4804|positive regulation of signal transduction (GO:0009967)|7/207|0.00275083381035122|0.0602468022927994|0|0|3.75738056897477|22.1529567721287|CD74;IL1B;LY86;CTSH;TREM2;SASH1;TLR2|3
4805|negative regulation of phagocytosis (GO:0050765)|2/9|0.00278181159514293|0.0606648913248478|0|0|24.6913580246914|145.300071866273|FCGR2B;TLR2|3
4806|sarcoplasmic reticulum calcium ion transport (GO:0070296)|2/9|0.00278181159514293|0.060406742851125|0|0|24.6913580246914|145.300071866273|CCL3;CCR5|3
4807|negative regulation of alcohol biosynthetic process (GO:1902931)|2/9|0.00278181159514293|0.0601507820763321|0|0|24.6913580246914|145.300071866273|PLEK;APOE|3
4808|negative regulation of heterotypic cell-cell adhesion (GO:0034115)|2/9|0.00278181159514293|0.0598969813080775|0|0|24.6913580246914|145.300071866273|IL1RN;KLF4|3
4809|regulation of cell-cell adhesion involved in gastrulation (GO:0070587)|2/9|0.00278181159514293|0.0596453133193881|0|0|24.6913580246914|145.300071866273|IL1RN;KLF4|3
4810|negative regulation of lipid localization (GO:1905953)|2/9|0.00278181159514293|0.0593957513389723|0|0|24.6913580246914|145.300071866273|NFKBIA;TNF|3
4811|positive regulation of endocytosis (GO:0045807)|4/65|0.00280170610558462|0.0595712760699929|0|0|6.83760683760684|40.1882169158294|IL1B;APOE;FCGR2B;TNF|3
4812|positive regulation of cellular catabolic process (GO:0031331)|5/107|0.00283356458924052|0.0599986726095201|0|0|5.19210799584631|30.4580466653829|PTPN1;IL1B;FURIN;APOE;TNF|3
4813|negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042)|3/32|0.00293489727613017|0.0618875239673235|0|0|10.4166666666667|60.7404461034324|TNFAIP3;CFLAR;ICAM1|3
4814|positive regulation of interleukin-1 beta production (GO:0032731)|3/32|0.00293489727613017|0.0616328427987337|0|0|10.4166666666667|60.7404461034324|EGR1;CCL3;NLRP3|3
4815|negative regulation of response to external stimulus (GO:0032102)|5/108|0.00294985761213519|0.0616931286669093|0|0|5.1440329218107|29.9691274530253|NLRP3;TNFAIP3;APOE;TRIB1;KLF4|3
4816|cellular response to reactive oxygen species (GO:0034614)|4/66|0.00296180666671731|0.0616902017153406|0|0|6.73400673400673|39.2050898078305|JUN;TNFAIP3;FOS;NFE2L2|3
4817|regulation of programmed cell death (GO:0043067)|8/269|0.00309056200499291|0.0641103167133285|0|0|3.30441966129698|19.0975706764871|DUSP1;GDF15;CFLAR;SGK1;TNF;MALT1;CTSB;BIRC3|3
4818|positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557)|3/33|0.00320721547375877|0.0662608119942955|0|0|10.1010101010101|58.0035572924602|CCL3;CD14;TLR2|3
4819|positive regulation of transcription factor import into nucleus (GO:0042993)|3/33|0.00320721547375877|0.0659936313007701|0|0|10.1010101010101|58.0035572924602|IL1B;TNF;TLR2|3
4820|regulation of erythrocyte differentiation (GO:0045646)|3/33|0.00320721547375877|0.0657285966369116|0|0|10.1010101010101|58.0035572924602|ZFP36;MAFB;ZFP36L1|3
4821|regulation of nitric oxide biosynthetic process (GO:0045428)|3/33|0.00320721547375877|0.0654656822503639|0|0|10.1010101010101|58.0035572924602|IL1B;KLF4;TNF|3
4822|positive regulation of myeloid leukocyte differentiation (GO:0002763)|3/33|0.00320721547375877|0.0652048627991673|0|0|10.1010101010101|58.0035572924602|CD74;TNF;ZFP36L1|3
4823|3'-UTR-mediated mRNA destabilization (GO:0061158)|2/10|0.00345673742500827|0.0699989328564175|0|0|22.2222222222222|125.942890566886|ZFP36;ZFP36L1|3
4824|positive regulation of alcohol biosynthetic process (GO:1902932)|2/10|0.00345673742500827|0.0697222572324791|0|0|22.2222222222222|125.942890566886|IL1B;TNF|3
4825|response to laminar fluid shear stress (GO:0034616)|2/10|0.00345673742500827|0.0694477601567607|0|0|22.2222222222222|125.942890566886|KLF4;NFE2L2|3
4826|negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102)|2/10|0.00345673742500827|0.0691754159992832|0|0|22.2222222222222|125.942890566886|PPP1R15A;PTPN1|3
4827|positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824)|2/10|0.00345673742500827|0.068905199530536|0|0|22.2222222222222|125.942890566886|IL1B;CCR2|3
4828|regulation of T cell chemotaxis (GO:0010819)|2/10|0.00345673742500827|0.0686370859136857|0|0|22.2222222222222|125.942890566886|CXCL10;CCR2|3
4829|response to organic cyclic compound (GO:0014070)|4/70|0.00366476438861279|0.0724856305236088|0|0|6.34920634920635|35.6126427465548|IL1B;SPP1;CCL3;TNF|3
4830|positive regulation of kinase activity (GO:0033674)|5/114|0.00372121033245988|0.0733179008746826|0|0|4.87329434697856|27.259777316893|CSF1R;CD74;CDKN1A;TNF;EREG|3
4831|regulation of humoral immune response (GO:0002920)|5/114|0.00372121033245988|0.0730359089482415|0|0|4.87329434697856|27.259777316893|C1QB;C1QA;C3AR1;FCGR2B;C1QC|3
4832|regulation of interleukin-8 production (GO:0032677)|3/35|0.00379710160321164|0.0742398830696896|0|0|9.52380952380953|53.0811165645508|IL1B;TNF;TLR2|3
4833|negative regulation of DNA binding (GO:0043392)|3/35|0.00379710160321164|0.0739565247373625|0|0|9.52380952380953|53.0811165645508|NFKBIA;JUN;ID2|3
4834|negative regulation of T cell activation (GO:0050868)|3/35|0.00379710160321164|0.0736753212212509|0|0|9.52380952380953|53.0811165645508|CEBPB;ARG1;FCGR2B|3
4835|calcium-mediated signaling (GO:0019722)|4/71|0.00385670029170379|0.074548263593047|0|0|6.25978090766823|34.7915074040944|LAT2;CCL3;CXCR4;CCR5|3
4836|regulation of immune effector process (GO:0002697)|5/115|0.00386256131455335|0.0743798127855312|0|0|4.83091787439614|26.8426317032186|C1QB;C1QA;C3AR1;FCGR2B;C1QC|3
4837|negative regulation of gene expression (GO:0010629)|13/619|0.00406870401021014|0.0780548743011366|0|0|2.33351283432059|12.8446598129942|MSR1;JUN;BTG2;KLF4;TNF;CBFA2T3;EREG;OLFM1;ZFP36;BASP1;ID2;BHLHE40;CCL3|3
4838|regulation of endothelial cell apoptotic process (GO:2000351)|3/36|0.00411516285647956|0.0786504721221542|0|0|9.25925925925926|50.8618228642129|TNFAIP3;ICAM1;NFE2L2|3
4839|positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213)|2/11|0.00419997804789705|0.0799719700687264|0|0|20.2020202020202|110.559110715104|BTG2;ZFP36|3
4840|positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440)|2/11|0.00419997804789705|0.0796746764996976|0|0|20.2020202020202|110.559110715104|CEBPB;ATF3|3
4841|regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211)|2/11|0.00419997804789705|0.0793795851052543|0|0|20.2020202020202|110.559110715104|BTG2;ZFP36|3
4842|response to sterol (GO:0036314)|2/11|0.00419997804789705|0.07908667150708|0|0|20.2020202020202|110.559110715104|CCL3;CCR5|3
4843|protein kinase C signaling (GO:0070528)|2/11|0.00419997804789705|0.0787959116853627|0|0|20.2020202020202|110.559110715104|ADAM15;PLEK|3
4844|response to corticosteroid (GO:0031960)|2/11|0.00419997804789705|0.0785072819722295|0|0|20.2020202020202|110.559110715104|IL1RN;TNF|3
4845|regulation of neuron death (GO:1901214)|4/73|0.00426077376462592|0.0793530237988542|0|0|6.0882800608828|33.2316864554384|EGR1;FOS;APOE;FCGR2B|3
4846|regulation of fat cell differentiation (GO:0045598)|4/73|0.00426077376462592|0.0790644673486765|0|0|6.0882800608828|33.2316864554384|ZFP36;CEBPB;TNF;ZFP36L1|3
4847|regulation of epithelial cell proliferation (GO:0050678)|4/73|0.00426077376462592|0.0787780018872683|0|0|6.0882800608828|33.2316864554384|NR4A1;ZFP36;EREG;ZFP36L1|3
4848|positive regulation of protein serine/threonine kinase activity (GO:0071902)|5/119|0.0044665747896397|0.0822849500055285|0|0|4.66853408029879|25.2620608328132|CSF1R;IL1B;CCNL1;TNF;MALT1|3
4849|cellular protein metabolic process (GO:0044267)|11/485|0.00458350998477051|0.0841354368787191|0|0|2.52004581901489|13.5711780581066|MRPL52;F10;FN1;SPP1;CTSH;FAM20C;FURIN;APOE;TGFBI;MFGE8;LGMN|3
4850|positive regulation of protein kinase activity (GO:0045860)|6/173|0.00483977127312329|0.0885209778019647|0|0|3.85356454720617|20.5429202966837|CSF1R;EGR1;PTPN1;CDKN1A;TNF;EREG|3
4851|regulation of interleukin-8 biosynthetic process (GO:0045414)|2/12|0.00501026300256218|0.0913120432216957|0|0|18.5185185185185|98.0790161063299|KLF4;TNF|3
4852|regulation of establishment of endothelial barrier (GO:1903140)|2/12|0.00501026300256218|0.090987089331227|0|0|18.5185185185185|98.0790161063299|IL1B;TNF|3
4853|cellular response to fluid shear stress (GO:0071498)|2/12|0.00501026300256218|0.0906644400782794|0|0|18.5185185185185|98.0790161063299|KLF4;NFE2L2|3
4854|positive regulation of heterotypic cell-cell adhesion (GO:0034116)|2/12|0.00501026300256218|0.0903440710320664|0|0|18.5185185185185|98.0790161063299|IL1B;TNF|3
4855|negative regulation of ATP metabolic process (GO:1903579)|2/12|0.00501026300256218|0.0900259581058971|0|0|18.5185185185185|98.0790161063299|PID1;CBFA2T3|3
4856|PERK-mediated unfolded protein response (GO:0036499)|2/12|0.00501026300256218|0.0897100775511396|0|0|18.5185185185185|98.0790161063299|ATF3;NFE2L2|3
4857|positive regulation of T cell cytokine production (GO:0002726)|2/12|0.00501026300256218|0.0893964059513104|0|0|18.5185185185185|98.0790161063299|NLRP3;MALT1|3
4858|regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041)|3/40|0.00554680841593627|0.0986249593955498|0|0|8.33333333333333|43.2877714735499|TNFAIP3;CFLAR;ICAM1|3
4859|positive regulation of phagocytosis (GO:0050766)|3/40|0.00554680841593627|0.0982825116198708|0|0|8.33333333333333|43.2877714735499|IL1B;FCGR2B;TNF|3
4860|positive regulation of fat cell differentiation (GO:0045600)|3/40|0.00554680841593627|0.0979424337249923|0|0|8.33333333333333|43.2877714735499|CEBPB;ZFP36;ZFP36L1|3
4861|negative regulation of cell communication (GO:0010648)|4/79|0.00564221764865213|0.0992835746933511|0|0|5.62587904360056|29.1278654888295|CSF1R;PTPN1;IL1B;OSM|3
4862|negative regulation of inflammatory response (GO:0050728)|4/79|0.00564221764865213|0.0989423940243018|0|0|5.62587904360056|29.1278654888295|TNFAIP3;NLRP3;APOE;KLF4|3
4863|protein dephosphorylation (GO:0006470)|5/126|0.00568081518629249|0.0992780818344198|0|0|4.40917107583774|22.7983268863908|PPP1R15A;PTPN1;PTPN18;DUSP2;DUSP1|3
4864|positive regulation of cholesterol efflux (GO:0010875)|2/13|0.00588633893765569|0.102518729006338|0|0|17.0940170940171|87.7798469594728|NFKBIA;APOE|3
4865|response to UV-B (GO:0010224)|2/13|0.00588633893765569|0.102170025846452|0|0|17.0940170940171|87.7798469594728|CDKN1A;CRIP1|3
4866|regulation of necrotic cell death (GO:0010939)|2/13|0.00588633893765569|0.101823686775786|0|0|17.0940170940171|87.7798469594728|CFLAR;BIRC3|3
4867|negative regulation of hormone secretion (GO:0046888)|2/13|0.00588633893765569|0.101479687833976|0|0|17.0940170940171|87.7798469594728|IL1B;OSM|3
4868|positive regulation of epithelial to mesenchymal transition (GO:0010718)|3/41|0.00594560282446744|0.102156266711304|0|0|8.13008130081301|41.6675069409204|OLFM1;IL1B;PDPN|3
4869|positive regulation of mitotic nuclear division (GO:0045840)|3/41|0.00594560282446744|0.101813460447172|0|0|8.13008130081301|41.6675069409204|IL1A;IL1B;EREG|3
4870|negative regulation of catabolic process (GO:0009895)|3/41|0.00594560282446744|0.10147294720153|0|0|8.13008130081301|41.6675069409204|IL1B;TNF;CBFA2T3|3
4871|negative regulation of response to stimulus (GO:0048585)|5/128|0.00606663984926514|0.103193543836|0|0|4.34027777777778|22.1569027518579|CSF1R;PTPN1;NLRP3;KLF4;FCGR2B|3
4872|negative regulation of defense response (GO:0031348)|4/81|0.0061618350540693|0.104464598939919|0|0|5.48696844993141|27.9252710420398|TNFAIP3;NLRP3;APOE;KLF4|3
4873|negative regulation of NF-kappaB transcription factor activity (GO:0032088)|4/83|0.00671233275549452|0.113420642553936|0|0|5.35475234270415|26.7941565453286|NFKBIA;TNFAIP3;NLRP3;KLF4|3
4874|negative regulation of protein secretion (GO:0050709)|3/43|0.0067935650282688|0.11441439715926|0|0|7.75193798449612|38.6959646063192|SRGN;IL1B;FCGR2B|3
4875|regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)|2/14|0.00682696940971006|0.114598766111021|0|0|15.8730158730159|79.156736846615|ZFP36;ZFP36L1|3
4876|regulation of monocyte differentiation (GO:0045655)|2/14|0.00682696940971006|0.114223032451641|0|0|15.8730158730159|79.156736846615|CD74;ZFP36L1|3
4877|positive regulation of interleukin-8 secretion (GO:2000484)|2/14|0.00682696940971006|0.113849754567812|0|0|15.8730158730159|79.156736846615|CD14;TLR2|3
4878|negative regulation of signaling (GO:0023057)|4/84|0.00699939843061365|0.116345049483457|0|0|5.29100529100529|26.2536035561032|CSF1R;PTPN1;IL1B;OSM|3
4879|protein maturation (GO:0051604)|4/84|0.00699939843061365|0.115967305816303|0|0|5.29100529100529|26.2536035561032|SRGN;MMP14;FURIN;CTSS|3
4880|positive regulation of interferon-gamma production (GO:0032729)|3/44|0.00724307176320654|0.119616165720527|0|0|7.57575757575758|37.331135499079|IL1B;CD14;CCR2|3
4881|negative regulation of ERBB signaling pathway (GO:1901185)|3/44|0.00724307176320654|0.119230307121429|0|0|7.57575757575758|37.331135499079|PTPN18;EREG;LGMN|3
4882|positive regulation of interleukin-6 production (GO:0032755)|3/44|0.00724307176320654|0.118846929928112|0|0|7.57575757575758|37.331135499079|IL1B;EREG;TLR2|3
4883|regulation of interferon-gamma production (GO:0032649)|3/44|0.00724307176320654|0.118466010280907|0|0|7.57575757575758|37.331135499079|IL1B;CD14;CCR2|3
4884|regulation of mitotic nuclear division (GO:0007088)|4/85|0.00729446542518652|0.118925421932035|0|0|5.22875816993464|25.7288333558719|IL1A;IL1B;PMEPA1;EREG|3
4885|positive regulation of cytosolic calcium ion concentration (GO:0007204)|5/134|0.00733432401251358|0.119194444063238|0|0|4.14593698175788|20.378068121064|CD52;C3AR1;CXCR4;CCR5;CCR2|3
4886|regulation of peptidyl-tyrosine phosphorylation (GO:0050730)|4/86|0.00759762452451537|0.123081517297149|0|0|5.16795865633075|25.2192229618164|CD74;SEMA4D;OSM;TREM2|3
4887|positive regulation of transport (GO:0051050)|3/45|0.00770980692877201|0.124503622650391|0|0|7.40740740740741|36.0389787658093|APOE;SGK1;TNF|3
4888|phagocytosis (GO:0006909)|5/136|0.00779503162920262|0.125482796226564|0|0|4.08496732026144|19.8295290802844|MSR1;ANXA3;PLD4;CD14;FCGR2B|3
4889|regulation of B cell differentiation (GO:0045577)|2/15|0.00783093467992641|0.12566433859014|0|0|14.8148148148148|71.8470133994895|MMP14;ZFP36L1|3
4890|regulation of interleukin-4 production (GO:0032673)|2/15|0.00783093467992641|0.125270406494246|0|0|14.8148148148148|71.8470133994895|CEBPB;NLRP3|3
4891|negative regulation of interleukin-2 production (GO:0032703)|2/15|0.00783093467992641|0.124878936473951|0|0|14.8148148148148|71.8470133994895|ZFP36;TNFAIP3|3
4892|negative regulation of lipid catabolic process (GO:0050995)|2/15|0.00783093467992641|0.124489905519204|0|0|14.8148148148148|71.8470133994895|IL1B;TNF|3
4893|response to cholesterol (GO:0070723)|2/15|0.00783093467992641|0.12410329090579|0|0|14.8148148148148|71.8470133994895|CCL3;CCR5|3
4894|positive regulation of interleukin-4 production (GO:0032753)|2/15|0.00783093467992641|0.123719070190912|0|0|14.8148148148148|71.8470133994895|CEBPB;NLRP3|3
4895|endoderm development (GO:0007492)|2/15|0.00783093467992641|0.123337221208841|0|0|14.8148148148148|71.8470133994895|DUSP2;DUSP1|3
4896|cellular response to corticosteroid stimulus (GO:0071384)|2/15|0.00783093467992641|0.12295772206666|0|0|14.8148148148148|71.8470133994895|ZFP36;ZFP36L1|3
4897|positive regulation of GTPase activity (GO:0043547)|6/193|0.00813614631338483|0.127358143058904|0|0|3.45423143350604|16.6198225801147|SEMA4D;RGS1;CCL4;CCL3;RGS10;F11R|3
4898|negative regulation of NF-kappaB import into nucleus (GO:0042347)|2/16|0.00889703152483307|0.138842666272854|0|0|13.8888888888889|65.5838554779908|NFKBIA;NLRP3|3
4899|regulation of necroptotic process (GO:0060544)|2/16|0.00889703152483307|0.138419365461046|0|0|13.8888888888889|65.5838554779908|CFLAR;BIRC3|3
4900|ruffle organization (GO:0031529)|2/16|0.00889703152483307|0.137998637906453|0|0|13.8888888888889|65.5838554779908|CSF1R;PLEK|3
4901|positive regulation of response to endoplasmic reticulum stress (GO:1905898)|2/16|0.00889703152483307|0.137580460215828|0|0|13.8888888888889|65.5838554779908|PPP1R15A;FCGR2B|3
4902|negative regulation of lipid storage (GO:0010888)|2/16|0.00889703152483307|0.13716480927862|0|0|13.8888888888889|65.5838554779908|NFKBIA;TNF|3
4903|negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124)|3/48|0.00921481958872943|0.141636217955682|0|0|6.94444444444444|32.5482101809171|NFKBIA;TNFAIP3;NLRP3|3
4904|regulation of JNK cascade (GO:0046328)|4/91|0.00923787663341325|0.141564217598522|0|0|4.88400488400488|22.8788435717491|IL1A;GADD45B;IL1B;FCGR2B|3
4905|positive regulation of cholesterol transport (GO:0032376)|2/17|0.0100240730342841|0.153152229622611|0|0|13.0718954248366|60.1668728819969|NFKBIA;APOE|3
4906|negative regulation of B cell activation (GO:0050869)|2/17|0.0100240730342841|0.152695058787916|0|0|13.0718954248366|60.1668728819969|TNFAIP3;FCGR2B|3
4907|positive regulation of response to biotic stimulus (GO:0002833)|2/17|0.0100240730342841|0.15224060920819|0|0|13.0718954248366|60.1668728819969|LY86;SASH1|3
4908|negative regulation of cellular carbohydrate metabolic process (GO:0010677)|2/17|0.0100240730342841|0.151788856658611|0|0|13.0718954248366|60.1668728819969|PLEK;CBFA2T3|3
4909|negative regulation of phosphoprotein phosphatase activity (GO:0032515)|2/17|0.0100240730342841|0.151339777201041|0|0|13.0718954248366|60.1668728819969|PPP1R15A;TNF|3
4910|long-term memory (GO:0007616)|2/17|0.0100240730342841|0.150893347179799|0|0|13.0718954248366|60.1668728819969|APOE;SGK1|3
4911|cellular response to glucocorticoid stimulus (GO:0071385)|2/17|0.0100240730342841|0.150449543217506|0|0|13.0718954248366|60.1668728819969|ZFP36;ZFP36L1|3
4912|regulation of cell growth (GO:0001558)|6/202|0.0100514968356455|0.150418734170966|0|0|3.3003300330033|15.1816294280434|CDKN1A;MMP14;BTG1;ADAM15;SGK1;CXCL16|3
4913|endocytosis (GO:0006897)|7/264|0.0101105372839913|0.150859858947975|0|0|2.94612794612795|13.5350335542142|MSR1;ANXA3;PLD4;APOE;CD14;FCGR2B;CXCL16|3
4914|regulation of bone mineralization (GO:0030500)|3/51|0.01087971815415|0.161863561926028|0|0|6.5359477124183|29.5480715218257|SRGN;ECM1;CCL3|3
4915|regulation of cellular protein metabolic process (GO:0032268)|3/51|0.01087971815415|0.161393028315778|0|0|6.5359477124183|29.5480715218257|NFKBIA;APOE;KLF4|3
4916|regulation of keratinocyte proliferation (GO:0010837)|2/18|0.011210888420193|0.165823662632593|0|0|12.3456790123457|55.4428369452839|ZFP36;ZFP36L1|3
4917|regulation of lipid catabolic process (GO:0050994)|2/18|0.011210888420193|0.165344403492037|0|0|12.3456790123457|55.4428369452839|IL1B;TNF|3
4918|negative regulation of osteoclast differentiation (GO:0045671)|2/18|0.011210888420193|0.164867906652002|0|0|12.3456790123457|55.4428369452839|MAFB;CCL3|3
4919|regulation of chemokine production (GO:0032642)|2/18|0.011210888420193|0.164394148299554|0|0|12.3456790123457|55.4428369452839|TNF;TLR2|3
4920|regulation of cholesterol efflux (GO:0010874)|2/18|0.011210888420193|0.163923104894684|0|0|12.3456790123457|55.4428369452839|NFKBIA;APOE|3
4921|mRNA destabilization (GO:0061157)|2/18|0.011210888420193|0.163454753166414|0|0|12.3456790123457|55.4428369452839|ZFP36;ZFP36L1|3
4922|regulated exocytosis (GO:0045055)|5/149|0.0112893088896437|0.164129183087897|0|0|3.72856077554064|16.7184903694064|SRGN;SYNGR1;ECM1;PLEK;FN1|3
4923|regulation of cell death (GO:0010941)|4/97|0.0114909363393463|0.166585932215012|0|0|4.58190148911798|20.4636733047729|JUN;JUND;JUNB;IER3|3
4924|positive regulation of phosphorylation (GO:0042327)|6/209|0.0117483291669725|0.169834911442098|0|0|3.18979266347687|14.1755797354344|CSF1R;CD74;SEMA4D;IL1B;TNF;EREG|3
4925|antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886)|4/98|0.0118977395911452|0.171508941055407|0|0|4.53514739229025|20.0970832073988|CD74;FCGR2B;CTSS;LGMN|3
4926|antigen processing and presentation of exogenous peptide antigen (GO:0002478)|4/98|0.0118977395911452|0.171025817277786|0|0|4.53514739229025|20.0970832073988|CD74;FCGR2B;CTSS;LGMN|3
4927|negative regulation of cell differentiation (GO:0045596)|5/151|0.0119079080435368|0.170691165017326|0|0|3.67917586460633|16.3007820386346|NFKBIA;SEMA4D;TNF;SKIL;HOPX|3
4928|positive regulation of mitotic cell cycle (GO:0045931)|3/53|0.0120799406356115|0.172672092614918|0|0|6.28930817610063|27.7748993758372|IL1A;IL1B;EREG|3
4929|regulation of DNA binding (GO:0051101)|3/53|0.0120799406356115|0.172189768333871|0|0|6.28930817610063|27.7748993758372|NFKBIA;JUN;ID2|3
4930|antigen processing and presentation of peptide antigen via MHC class II (GO:0002495)|4/99|0.0123136782089466|0.175032590251405|0|0|4.48933782267116|19.7398185632545|CD74;FCGR2B;CTSS;LGMN|3
4931|negative regulation of lymphocyte activation (GO:0051250)|2/19|0.0124563228277127|0.176568376082827|0|0|11.6959064327485|51.2927126004663|TNFAIP3;FCGR2B|3
4932|negative regulation of lipid metabolic process (GO:0045833)|2/19|0.0124563228277127|0.176079267007805|0|0|11.6959064327485|51.2927126004663|IL1B;TNF|3
4933|positive regulation of lipid storage (GO:0010884)|2/19|0.0124563228277127|0.175592860192867|0|0|11.6959064327485|51.2927126004663|MSR1;HILPDA|3
4934|regulation of platelet activation (GO:0010543)|2/19|0.0124563228277127|0.175109133305283|0|0|11.6959064327485|51.2927126004663|PLEK;APOE|3
4935|positive regulation of pri-miRNA transcription from RNA polymerase II promoter (GO:1902895)|2/19|0.0124563228277127|0.174628064257741|0|0|11.6959064327485|51.2927126004663|JUN;FOS|3
4936|positive regulation of neuron apoptotic process (GO:0043525)|2/19|0.0124563228277127|0.17414963120498|0|0|11.6959064327485|51.2927126004663|CCL3;MCL1|3
4937|positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531)|3/54|0.0127074180300098|0.177174738270875|0|0|6.17283950617284|26.9479590073123|CSF1R;SOCS3;OSM|3
4938|positive regulation of immune response (GO:0050778)|3/55|0.0133532469005227|0.185671986194461|0|0|6.06060606060606|26.1575497586981|NLRP3;FCGR2B;EREG|3
4939|regulation of protein ubiquitination (GO:0031396)|4/102|0.0136169917084665|0.188824751870393|0|0|4.35729847494553|18.7208578464066|TNFAIP3;MALT1;SASH1;BIRC3|3
4940|negative regulation of phosphate metabolic process (GO:0045936)|2/20|0.013759237140469|0.190280181918193|0|0|11.1111111111111|47.6227209820745|CDKN1A;PLEK|3
4941|regulation of epidermal cell differentiation (GO:0045604)|2/20|0.013759237140469|0.189765911156252|0|0|11.1111111111111|47.6227209820745|ZFP36;ZFP36L1|3
4942|wound healing, spreading of cells (GO:0044319)|2/20|0.013759237140469|0.189254412743432|0|0|11.1111111111111|47.6227209820745|MMP12;PDPN|3
4943|embryonic digestive tract development (GO:0048566)|2/20|0.013759237140469|0.188745664322079|0|0|11.1111111111111|47.6227209820745|ID2;TNF|3
4944|regulation of toll-like receptor signaling pathway (GO:0034121)|2/20|0.013759237140469|0.188239643774298|0|0|11.1111111111111|47.6227209820745|TLR2;BIRC3|3
4945|positive regulation of T cell migration (GO:2000406)|2/20|0.013759237140469|0.187736329218752|0|0|11.1111111111111|47.6227209820745|CXCL10;CCR2|3
4946|inactivation of MAPK activity (GO:0000188)|2/20|0.013759237140469|0.187235699007502|0|0|11.1111111111111|47.6227209820745|DUSP2;DUSP1|3
4947|entrainment of circadian clock by photoperiod (GO:0043153)|2/20|0.013759237140469|0.186737731722907|0|0|11.1111111111111|47.6227209820745|ID2;BHLHE40|3
4948|regulation of axonogenesis (GO:0050770)|3/56|0.0140174991476233|0.189738191380164|0|0|5.95238095238095|25.4014808974672|OLFM1;PLXND1;APOE|3
4949|fat cell differentiation (GO:0045444)|3/56|0.0140174991476233|0.189236238492915|0|0|5.95238095238095|25.4014808974672|NR4A2;NR4A1;KLF4|3
4950|regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803)|3/57|0.0147002399502231|0.197929616005247|0|0|5.84795321637427|24.6777278490423|TNFAIP3;TNF;BIRC3|3
4951|phosphatidylinositol-mediated signaling (GO:0048015)|3/57|0.0147002399502231|0.197408748594707|0|0|5.84795321637427|24.6777278490423|CSF1R;PTAFR;ZFP36L1|3
4952|hyaluronan metabolic process (GO:0030212)|2/21|0.015118507805493|0.202492769898768|0|0|10.5820105820106|44.3580487112576|HEXB;IL1B|3
4953|positive regulation of cellular component movement (GO:0051272)|2/21|0.015118507805493|0.201962684113693|0|0|10.5820105820106|44.3580487112576|CSF1R;PDPN|3
4954|positive regulation of leukocyte cell-cell adhesion (GO:1903039)|2/21|0.015118507805493|0.201435366400602|0|0|10.5820105820106|44.3580487112576|TNF;CCR2|3
4955|cortical actin cytoskeleton organization (GO:0030866)|2/21|0.015118507805493|0.200910795133934|0|0|10.5820105820106|44.3580487112576|PLEK;TNF|3
4956|histone lysine demethylation (GO:0070076)|2/21|0.015118507805493|0.200388948912807|0|0|10.5820105820106|44.3580487112576|KDM6B;KDM7A|3
4957|positive regulation of T cell mediated immunity (GO:0002711)|2/21|0.015118507805493|0.19986980655811|0|0|10.5820105820106|44.3580487112576|IL1B;MALT1|3
4958|regulation of cardiac muscle hypertrophy (GO:0010611)|2/21|0.015118507805493|0.19935334710964|0|0|10.5820105820106|44.3580487112576|MEF2A;RGS2|3
4959|negative regulation of cytokine biosynthetic process (GO:0042036)|2/21|0.015118507805493|0.198839549823275|0|0|10.5820105820106|44.3580487112576|ZFP36;KLF4|3
4960|negative regulation of G-protein coupled receptor protein signaling pathway (GO:0045744)|2/21|0.015118507805493|0.198328394168202|0|0|10.5820105820106|44.3580487112576|RGS2;PLEK|3
4961|regulation of macrophage activation (GO:0043030)|2/21|0.015118507805493|0.197819859824181|0|0|10.5820105820106|44.3580487112576|CD74;FCGR2B|3
4962|establishment of endothelial barrier (GO:0061028)|2/21|0.015118507805493|0.197313926678851|0|0|10.5820105820106|44.3580487112576|F11R;ICAM1|3
4963|positive regulation of lipid metabolic process (GO:0045834)|2/21|0.015118507805493|0.196810574825078|0|0|10.5820105820106|44.3580487112576|IL1B;APOE|3
4964|photoperiodism (GO:0009648)|2/21|0.015118507805493|0.196309784558348|0|0|10.5820105820106|44.3580487112576|ID2;BHLHE40|3
4965|ERK1 and ERK2 cascade (GO:0070371)|2/21|0.015118507805493|0.195811536374189|0|0|10.5820105820106|44.3580487112576|CTSH;ZFP36L1|3
4966|transcription, DNA-templated (GO:0006351)|8/357|0.0157809391447677|0.20387375305253|0|0|2.48988484282602|10.3304138200008|MEF2A;NR4A2;EGR1;CEBPB;POU2F2;KLF4;EREG;NFE2L2|3
4967|response to endoplasmic reticulum stress (GO:0034976)|4/107|0.015978045547991|0.205898905129793|0|0|4.15368639667705|17.1818884828961|PPP1R15A;JUN;CEBPB;ATF3|3
4968|regulation of response to external stimulus (GO:0032101)|4/108|0.0164791307038746|0.21182116872008|0|0|4.11522633744856|16.8957222405077|NLRP3;TNFAIP3;CXCR4;BIRC3|3
4969|positive regulation of cell cycle process (GO:0090068)|4/108|0.0164791307038746|0.211288954728321|0|0|4.11522633744856|16.8957222405077|IL1A;ID2;IL1B;EREG|3
4970|regulation of protein secretion (GO:0050708)|4/108|0.0164791307038746|0.210759408475869|0|0|4.11522633744856|16.8957222405077|IL1A;MARCKS;IL1B;TNF|3
4971|positive regulation of protein modification process (GO:0031401)|5/164|0.0164967785652783|0.210457652546538|0|0|3.38753387533875|13.9044381964942|CSF1R;CD74;SEMA4D;IL1B;TNF|3
4972|regulation of interferon-gamma-mediated signaling pathway (GO:0060334)|2/22|0.0165330266273425|0.210394101943463|0|0|10.1010101010101|41.4383362106769|SOCS3;ARG1|3
4973|regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947)|2/22|0.0165330266273425|0.209870733530668|0|0|10.1010101010101|41.4383362106769|PTPN1;IL1B|3
4974|hematopoietic progenitor cell differentiation (GO:0002244)|2/22|0.0165330266273425|0.209349962479724|0|0|10.1010101010101|41.4383362106769|PLEK;PLD4|3
4975|negative regulation of cell cycle G1/S phase transition (GO:1902807)|2/22|0.0165330266273425|0.208831769503289|0|0|10.1010101010101|41.4383362106769|CDKN1A;KLF4|3
4976|positive regulation of phosphatase activity (GO:0010922)|2/22|0.0165330266273425|0.208316135504515|0|0|10.1010101010101|41.4383362106769|PPP1R15A;PLEK|3
4977|regulation of protein metabolic process (GO:0051246)|3/60|0.0168599477795611|0.211912102263794|0|0|5.55555555555556|22.6823023539495|FURIN;APOE;KLF4|3
4978|regulation of protein activation cascade (GO:2000257)|4/109|0.0169899724636145|0.213021694058538|0|0|4.07747196738022|16.6162363467497|C1QB;C1QA;C3AR1;C1QC|3
4979|regulation of cell motility (GO:2000145)|4/110|0.0175106240876016|0.219011555683899|0|0|4.04040404040404|16.3432221880307|CSF1R;PLXND1;SGK1;EREG|3
4980|regulation of complement activation (GO:0030449)|4/110|0.0175106240876016|0.218476075107655|0|0|4.04040404040404|16.3432221880307|C1QB;C1QA;C3AR1;C1QC|3
4981|response to reactive oxygen species (GO:0000302)|3/61|0.0176171653289234|0.21926925530121|0|0|5.46448087431694|22.0703909806395|JUN;FOS;APOE|3
4982|positive regulation of mRNA catabolic process (GO:0061014)|2/23|0.0180017006118916|0.223510165991442|0|0|9.66183574879227|38.8143869286025|ZFP36;ZFP36L1|3
4983|metanephros development (GO:0001656)|2/23|0.0180017006118916|0.222967665588551|0|0|9.66183574879227|38.8143869286025|BASP1;CTSH|3
4984|regulation of interleukin-8 secretion (GO:2000482)|2/23|0.0180017006118916|0.222427792306254|0|0|9.66183574879227|38.8143869286025|CD14;TLR2|3
4985|cellular response to interleukin-6 (GO:0071354)|2/23|0.0180017006118916|0.221890527107446|0|0|9.66183574879227|38.8143869286025|SOCS3;PID1|3
4986|negative regulation of transcription factor import into nucleus (GO:0042992)|2/23|0.0180017006118916|0.221355851138513|0|0|9.66183574879227|38.8143869286025|NFKBIA;NLRP3|3
4987|negative regulation of cytokine production (GO:0001818)|4/111|0.0180411372244696|0.221307507828049|0|0|4.004004004004|16.076479388525|SRGN;TNFAIP3;FCGR2B;TNF|3
4988|regulation of tyrosine phosphorylation of STAT protein (GO:0042509)|3/62|0.0183931016285764|0.225083927123802|0|0|5.37634408602151|21.4826860008306|CSF1R;SOCS3;OSM|3
4989|positive regulation of catabolic process (GO:0009896)|3/63|0.0191877845597027|0.234247044517136|0|0|5.29100529100529|20.9178911284211|IL1B;TNFAIP3;TNF|3
4990|stress-activated MAPK cascade (GO:0051403)|3/63|0.0191877845597027|0.233687982358384|0|0|5.29100529100529|20.9178911284211|ZFP36;TRIB1;ZFP36L1|3
4991|regulation of T cell proliferation (GO:0042129)|3/63|0.0191877845597027|0.233131582400388|0|0|5.29100529100529|20.9178911284211|CEBPB;ARG1;IL1B|3
4992|positive regulation of developmental process (GO:0051094)|4/114|0.01969233801015|0.238693588754858|0|0|3.89863547758285|15.3119908475141|JUN;JUND;TNF;JUNB|3
4993|positive regulation of JAK-STAT cascade (GO:0046427)|3/65|0.0208334733365816|0.251927048427905|0|0|5.12820512820513|19.8522784142285|CSF1R;SOCS3;OSM|3
4994|glycerophospholipid metabolic process (GO:0006650)|3/65|0.0208334733365816|0.2513314762094|0|0|5.12820512820513|19.8522784142285|CSF1R;PLEK;PLA2G7|3
4995|cellular response to oxidative stress (GO:0034599)|4/116|0.0208433205083545|0.250857227722012|0|0|3.83141762452107|14.8303514995206|JUN;CYBB;FOS;NFE2L2|3
4996|positive regulation of purine nucleotide biosynthetic process (GO:1900373)|2/25|0.0210972169063333|0.253315524407103|0|0|8.88888888888889|34.2987924210977|PID1;APOE|3
4997|negative regulation of G1/S transition of mitotic cell cycle (GO:2000134)|2/25|0.0210972169063333|0.252720887025865|0|0|8.88888888888889|34.2987924210977|CDKN1A;KLF4|3
4998|intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059)|2/25|0.0210972169063333|0.252129034831425|0|0|8.88888888888889|34.2987924210977|PPP1R15A;CEBPB|3
4999|eosinophil chemotaxis (GO:0048245)|2/25|0.0210972169063333|0.251539948301445|0|0|8.88888888888889|34.2987924210977|CCL4;CCL3|3
5000|cellular senescence (GO:0090398)|2/25|0.0210972169063333|0.250953608095614|0|0|8.88888888888889|34.2987924210977|CDKN1A;ID2|3
5001|eosinophil migration (GO:0072677)|2/25|0.0210972169063333|0.250369995053532|0|0|8.88888888888889|34.2987924210977|CCL4;CCL3|3
5002|positive regulation of vascular endothelial growth factor production (GO:0010575)|2/25|0.0210972169063333|0.249789090192619|0|0|8.88888888888889|34.2987924210977|IL1A;IL1B|3
5003|regulation of neuronal synaptic plasticity (GO:0048168)|2/25|0.0210972169063333|0.249210874706062|0|0|8.88888888888889|34.2987924210977|SYNGR1;APOE|3
5004|negative regulation of interleukin-6 production (GO:0032715)|2/25|0.0210972169063333|0.248635329960782|0|0|8.88888888888889|34.2987924210977|TNFAIP3;TNF|3
5005|negative regulation of T cell proliferation (GO:0042130)|2/25|0.0210972169063333|0.248062437495435|0|0|8.88888888888889|34.2987924210977|CEBPB;ARG1|3
5006|regulation of cell cycle G1/S phase transition (GO:1902806)|2/25|0.0210972169063333|0.247492179018434|0|0|8.88888888888889|34.2987924210977|PID1;ID2|3
5007|cellular response to interferon-gamma (GO:0071346)|4/117|0.0214339971778845|0.250866255960423|0|0|3.79867046533713|14.5974433593797|PTAFR;CCL4;CCL3;ICAM1|3
5008|negative regulation of apoptotic signaling pathway (GO:2001234)|3/66|0.0216845068139335|0.253217478882157|0|0|5.05050505050505|19.3492790158739|NR4A2;CFLAR;MCL1|3
5009|negative regulation of cell adhesion (GO:0007162)|3/66|0.0216845068139335|0.252639356784253|0|0|5.05050505050505|19.3492790158739|PLXND1;SEMA4D;TGFBI|3
5010|positive regulation of apoptotic process (GO:0043065)|7/308|0.0217518246417373|0.252846380744386|0|0|2.52525252525253|9.66681220553539|JUN;BTG1;GADD45B;CCL3;NLRP3;CTSH;TNF|3
5011|positive regulation of MAP kinase activity (GO:0043406)|5/178|0.0226130241650492|0.262259687077832|0|0|3.1210986267166|11.826558202892|GADD45B;IL1B;CXCR4;TNF;SASH1|3
5012|plasma membrane bounded cell projection organization (GO:0120036)|4/119|0.0226459234462283|0.262045685592071|0|0|3.73482726423903|14.1466869226908|CSF1R;BTG2;PLEK;PDPN|3
5013|signal peptide processing (GO:0006465)|2/26|0.0227219475335714|0.262330539058405|0|0|8.54700854700855|32.3455040162021|F10;FURIN|3
5014|peptide catabolic process (GO:0043171)|2/26|0.0227219475335714|0.261738370798679|0|0|8.54700854700855|32.3455040162021|ANPEP;CTSH|3
5015|prostaglandin metabolic process (GO:0006693)|2/26|0.0227219475335714|0.261148869963547|0|0|8.54700854700855|32.3455040162021|CD74;HPGD|3
5016|response to alcohol (GO:0097305)|2/26|0.0227219475335714|0.260562018570371|0|0|8.54700854700855|32.3455040162021|CCL3;CCR5|3
5017|positive regulation of interleukin-1 beta secretion (GO:0050718)|2/26|0.0227219475335714|0.259977798797791|0|0|8.54700854700855|32.3455040162021|CCL3;NLRP3|3
5018|cellular response to epidermal growth factor stimulus (GO:0071364)|2/26|0.0227219475335714|0.259396192983926|0|0|8.54700854700855|32.3455040162021|ZFP36;ZFP36L1|3
5019|regulation of apoptotic signaling pathway (GO:2001233)|2/26|0.0227219475335714|0.258817183624587|0|0|8.54700854700855|32.3455040162021|NR4A2;CTSH|3
5020|peptidyl-tyrosine dephosphorylation (GO:0035335)|2/26|0.0227219475335714|0.258240753371526|0|0|8.54700854700855|32.3455040162021|PTPN1;DUSP1|3
5021|negative regulation of protein phosphorylation (GO:0001933)|5/179|0.0230990231737322|0.261942922790124|0|0|3.10366232153942|11.694490841713|PID1;SEMA4D;DUSP1;PMEPA1;TRIB1|3
5022|regulation of epithelial to mesenchymal transition (GO:0010717)|3/69|0.0243504172105998|0.275521461254303|0|0|4.83091787439614|17.947856500941|OLFM1;IL1B;PDPN|3
5023|response to interferon-gamma (GO:0034341)|3/69|0.0243504172105998|0.274911900499316|0|0|4.83091787439614|17.947856500941|CCL4;CCL3;CXCL16|3
5024|regulation of endopeptidase activity (GO:0052548)|3/69|0.0243504172105998|0.27430503096179|0|0|4.83091787439614|17.947856500941|TIMP2;FURIN;BIRC3|3
5025|regulation of pri-miRNA transcription from RNA polymerase II promoter (GO:1902893)|2/27|0.0243966096024381|0.274220041412426|0|0|8.23045267489712|30.5622313338048|JUN;FOS|3
5026|Fc-epsilon receptor signaling pathway (GO:0038095)|5/183|0.0251105047770078|0.281623968960595|0|0|3.03582270795386|11.1853946672312|NFKBIA;LAT2;JUN;FOS;MALT1|3
5027|Fc receptor signaling pathway (GO:0038093)|5/184|0.0256303882584738|0.286824279129368|0|0|3.01932367149758|11.062731250382|NFKBIA;LAT2;JUN;FOS;MALT1|3
5028|negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732)|2/28|0.0261201833677803|0.291665854979831|0|0|7.93650793650794|28.9289440824807|SOCS3;SEMA4D|3
5029|negative regulation of smooth muscle cell proliferation (GO:0048662)|2/28|0.0261201833677803|0.291029029968958|0|0|7.93650793650794|28.9289440824807|TNFAIP3;TRIB1|3
5030|leukocyte cell-cell adhesion (GO:0007159)|2/28|0.0261201833677803|0.290394979794734|0|0|7.93650793650794|28.9289440824807|SEMA4D;ICAM1|3
5031|regulation of protein transport (GO:0051223)|2/28|0.0261201833677803|0.289763686360397|0|0|7.93650793650794|28.9289440824807|PTPN1;TNF|3
5032|positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436)|3/71|0.0262216414077054|0.290258212805901|0|0|4.69483568075117|17.0946957804892|TRIB1;CBFA2T3;NFE2L2|3
5033|platelet degranulation (GO:0002576)|4/125|0.0265288820775699|0.293023561129522|0|0|3.55555555555556|12.9049644436229|SRGN;ECM1;PLEK;FN1|3
5034|dephosphorylation (GO:0016311)|4/125|0.0265288820775699|0.292390680867903|0|0|3.55555555555556|12.9049644436229|PTPN1;PTPN18;DUSP2;DUSP1|3
5035|regulation of cell communication (GO:0010646)|3/72|0.0271853956486449|0.298980762920334|0|0|4.62962962962963|16.690163771102|PTPN1;SASH1;BIRC3|3
5036|negative regulation of endocytosis (GO:0045806)|2/29|0.0278916632214074|0.306088510578155|0|0|7.66283524904215|27.4285627898525|FCGR2B;TLR2|3
5037|cellular response to hydrogen peroxide (GO:0070301)|2/29|0.0278916632214074|0.305431668280777|0|0|7.66283524904215|27.4285627898525|TNFAIP3;NFE2L2|3
5038|B cell activation (GO:0042113)|3/74|0.0291690697984983|0.318736109596867|0|0|4.5045045045045|15.9218305612137|LAT2;KLF6;MALT1|3
5039|regulation of peptide hormone secretion (GO:0090276)|3/74|0.0291690697984983|0.318055049533626|0|0|4.5045045045045|15.9218305612137|MARCKS;IL1B;TNF|3
5040|regulation of protein processing (GO:0070613)|4/129|0.0293259820215061|0.319084192442955|0|0|3.44530577088717|12.159453565836|C1QB;C1QA;C3AR1;C1QC|3
5041|cellular response to cadmium ion (GO:0071276)|2/30|0.0297100575159264|0.322575369156963|0|0|7.40740740740741|26.0464418785047|JUN;FOS|3
5042|regulation of macrophage derived foam cell differentiation (GO:0010743)|2/30|0.0297100575159264|0.321890495761725|0|0|7.40740740740741|26.0464418785047|NFKBIA;MSR1|3
5043|TRIF-dependent toll-like receptor signaling pathway (GO:0035666)|2/30|0.0297100575159264|0.3212085243724|0|0|7.40740740740741|26.0464418785047|CD14;BIRC3|3
5044|cortical cytoskeleton organization (GO:0030865)|2/30|0.0297100575159264|0.320529436583029|0|0|7.40740740740741|26.0464418785047|PLEK;TNF|3
5045|positive regulation of interleukin-1 secretion (GO:0050716)|2/30|0.0297100575159264|0.31985321414298|0|0|7.40740740740741|26.0464418785047|CCL3;NLRP3|3
5046|regulation of keratinocyte differentiation (GO:0045616)|2/30|0.0297100575159264|0.319179838955311|0|0|7.40740740740741|26.0464418785047|ZFP36;ZFP36L1|3
5047|MyD88-dependent toll-like receptor signaling pathway (GO:0002755)|2/30|0.0297100575159264|0.318509293075153|0|0|7.40740740740741|26.0464418785047|CD14;TLR2|3
5048|semaphorin-plexin signaling pathway (GO:0071526)|2/30|0.0297100575159264|0.317841558708119|0|0|7.40740740740741|26.0464418785047|PLXND1;SEMA4D|3
5049|skeletal muscle organ development (GO:0060538)|2/30|0.0297100575159264|0.317176618208729|0|0|7.40740740740741|26.0464418785047|BASP1;CFLAR|3
5050|respiratory system development (GO:0060541)|2/30|0.0297100575159264|0.316514454078857|0|0|7.40740740740741|26.0464418785047|BASP1;PDPN|3
5051|regulation of myoblast differentiation (GO:0045661)|2/30|0.0297100575159264|0.315855048966193|0|0|7.40740740740741|26.0464418785047|BTG1;ZFP36L1|3
5052|regulation of macromolecule metabolic process (GO:0060255)|4/130|0.0300515524221384|0.318821355530504|0|0|3.41880341880342|11.982362249685|NLRP3;APOE;CRIP1;ZFP36L1|3
5053|positive regulation of epithelial cell migration (GO:0010634)|3/75|0.0301889288181344|0.319614323151328|0|0|4.44444444444444|15.5568000766216|ANXA3;CTSH;SASH1|3
5054|negative regulation of phosphorylation (GO:0042326)|3/76|0.0312274213244343|0.329924494862502|0|0|4.3859649122807|15.2037661471907|CDKN1A;PID1;CBFA2T3|3
5055|regulation of actin cytoskeleton reorganization (GO:2000249)|2/31|0.0315743883996156|0.332901041329005|0|0|7.16845878136201|24.7699568508954|CSF1R;F11R|3
5056|MyD88-independent toll-like receptor signaling pathway (GO:0002756)|2/31|0.0315743883996156|0.332214647429357|0|0|7.16845878136201|24.7699568508954|CD14;BIRC3|3
5057|regulation of developmental growth (GO:0048638)|2/31|0.0315743883996156|0.331531078195964|0|0|7.16845878136201|24.7699568508954|OLFM1;APOE|3
5058|hemopoiesis (GO:0030097)|3/77|0.0322845062163115|0.338291242755314|0|0|4.32900432900433|14.8621984742168|CSF1R;PLEK;PLD4|3
5059|negative regulation of toll-like receptor signaling pathway (GO:0034122)|2/32|0.0334836916452246|0.350137865708158|0|0|6.94444444444444|23.5881720503141|TNFAIP3;CD14|3
5060|negative regulation of cell-cell adhesion (GO:0022408)|2/32|0.0334836916452246|0.349421837352927|0|0|6.94444444444444|23.5881720503141|IL1RN;KLF4|3
5061|negative regulation of blood vessel endothelial cell migration (GO:0043537)|2/32|0.0334836916452246|0.348708731562411|0|0|6.94444444444444|23.5881720503141|APOE;KLF4|3
5062|regulation of protein tyrosine kinase activity (GO:0061097)|2/32|0.0334836916452246|0.347998530479799|0|0|6.94444444444444|23.5881720503141|CSF1R;PTPN1|3
5063|response to cadmium ion (GO:0046686)|2/32|0.0334836916452246|0.347291216393458|0|0|6.94444444444444|23.5881720503141|JUN;FOS|3
5064|positive regulation of dendrite development (GO:1900006)|2/33|0.0354370164884384|0.366805466816432|0|0|6.73400673400673|22.4915713242591|CUX1;APOE|3
5065|endodermal cell differentiation (GO:0035987)|2/33|0.0354370164884384|0.366062945628544|0|0|6.73400673400673|22.4915713242591|MMP14;FN1|3
5066|negative regulation of mitotic cell cycle phase transition (GO:1901991)|3/80|0.0355668438060681|0.366661826146193|0|0|4.16666666666667|13.9014226202737|CDKN1A;KLF4;ZFP36L1|3
5067|regulation of endothelial cell proliferation (GO:0001936)|3/80|0.0355668438060681|0.365922588593479|0|0|4.16666666666667|13.9014226202737|NR4A1;ECM1;APOE|3
5068|ERBB signaling pathway (GO:0038127)|3/81|0.036697807423315|0.37679861424784|0|0|4.11522633744856|13.6009805306183|PTPN18;AREG;EREG|3
5069|regulation of protein serine/threonine kinase activity (GO:0071900)|3/81|0.036697807423315|0.37604199052445|0|0|4.11522633744856|13.6009805306183|CSF1R;CDKN1A;TRIB1|3
5070|positive regulation of cell-cell adhesion (GO:0022409)|2/34|0.037433425473311|0.382811162706024|0|0|6.5359477124183|21.4718381991301|IL1B;TNF|3
5071|entry into host cell (GO:0030260)|2/34|0.037433425473311|0.382045540380612|0|0|6.5359477124183|21.4718381991301|CXCR4;CCR5|3
5072|positive regulation of calcium ion transport (GO:0051928)|2/34|0.037433425473311|0.381282974431749|0|0|6.5359477124183|21.4718381991301|CCL4;CCL3|3
5073|cellular response to growth factor stimulus (GO:0071363)|4/140|0.0378907093881937|0.38517189244612|0|0|3.17460317460317|10.3906327994298|NR4A1;ZFP36;KLF4;ZFP36L1|3
5074|neuron differentiation (GO:0030182)|4/140|0.0378907093881937|0.384406143156963|0|0|3.17460317460317|10.3906327994298|NR4A2;ID2;SKIL;IER2|3
5075|regulation of anatomical structure morphogenesis (GO:0022603)|3/83|0.0390146544185043|0.395023375987356|0|0|4.01606425702811|13.0273813217263|PID1;PLXND1;TNFAIP3|3
5076|negative regulation of binding (GO:0051100)|3/83|0.0390146544185043|0.39424115148045|0|0|4.01606425702811|13.0273813217263|NFKBIA;JUN;ID2|3
5077|positive regulation of cell cycle arrest (GO:0071158)|3/83|0.0390146544185043|0.393462018770015|0|0|4.01606425702811|13.0273813217263|BTG2;CDKN1A;ID2|3
5078|positive regulation of muscle cell differentiation (GO:0051149)|2/35|0.0394719942792347|0.397289125851942|0|0|6.34920634920635|20.5216753277929|MEF2A;BTG1|3
5079|regulation of JUN kinase activity (GO:0043506)|2/35|0.0394719942792347|0.396507060643572|0|0|6.34920634920635|20.5216753277929|TNF;SASH1|3
5080|regulation of axon extension (GO:0030516)|2/35|0.0394719942792347|0.395728068382976|0|0|6.34920634920635|20.5216753277929|OLFM1;APOE|3
5081|regulation of interleukin-1 beta secretion (GO:0050706)|2/35|0.0394719942792347|0.394952130993989|0|0|6.34920634920635|20.5216753277929|CCL3;NLRP3|3
5082|positive regulation of macromolecule biosynthetic process (GO:0010557)|4/143|0.0404503561606075|0.403949447138122|0|0|3.10800310800311|9.96947888285005|KLF4;AREG;EREG;TLR2|3
5083|positive regulation of DNA replication (GO:0045740)|2/36|0.0415518115736571|0.414138465742914|0|0|6.17283950617284|19.6346553011345|AREG;EREG|3
5084|endothelial cell migration (GO:0043542)|2/36|0.0415518115736571|0.413331178285326|0|0|6.17283950617284|19.6346553011345|NR4A1;PLXND1|3
5085|negative regulation of cellular macromolecule biosynthetic process (GO:2000113)|9/513|0.0429602090105878|0.426509623698501|0|0|1.94931773879142|6.13544047476845|JUN;BTG2;BASP1;ID2;BHLHE40;KLF4;TNF;CBFA2T3;EREG|3
5086|regulation of muscle cell differentiation (GO:0051147)|2/37|0.043671978847429|0.432734190404719|0|0|6.00600600600601|18.8050966898118|MEF2A;ZFP36L1|3
5087|regulation of nitric-oxide synthase activity (GO:0050999)|2/37|0.043671978847429|0.431895558252772|0|0|6.00600600600601|18.8050966898118|IL1B;APOE|3
5088|regulation of response to DNA damage stimulus (GO:2001020)|2/37|0.043671978847429|0.431060170325784|0|0|6.00600600600601|18.8050966898118|MCL1;IER3|3
5089|zymogen activation (GO:0031638)|2/37|0.043671978847429|0.430228007834808|0|0|6.00600600600601|18.8050966898118|CTSH;FURIN|3
5090|epithelial cell migration (GO:0010631)|2/37|0.043671978847429|0.429399052135704|0|0|6.00600600600601|18.8050966898118|ZEB2;PLXND1|3
5091|regulation of cell morphogenesis involved in differentiation (GO:0010769)|2/37|0.043671978847429|0.428573284727751|0|0|6.00600600600601|18.8050966898118|SEMA4D;PDPN|3
5092|regulation of protein kinase activity (GO:0045859)|4/148|0.0449302265523218|0.44007475258445|0|0|3.003003003003|9.31725079151082|CDKN1A;TRIB1;TNF;EREG|3
5093|calcium ion homeostasis (GO:0055074)|3/88|0.0451239138684717|0.441125157990059|0|0|3.78787878787879|11.7361474697557|CCL3;ATP2B1;CCR2|3
5094|epithelial to mesenchymal transition (GO:0001837)|2/38|0.045831610269826|0.447186820663331|0|0|5.84795321637427|18.0279604991999|OLFM1;S100A4|3
5095|positive regulation of axonogenesis (GO:0050772)|2/38|0.045831610269826|0.446333410700233|0|0|5.84795321637427|18.0279604991999|PLXND1;SEMA4D|3
5096|positive regulation of multi-organism process (GO:0043902)|2/38|0.045831610269826|0.445483251822709|0|0|5.84795321637427|18.0279604991999|LY86;SASH1|3
5097|divalent metal ion transport (GO:0070838)|3/89|0.0463995216101053|0.450145929232637|0|0|3.74531835205993|11.4998731458057|CCL3;CCR5;KCNN4|3
5098|positive regulation of protein complex assembly (GO:0031334)|3/89|0.0463995216101053|0.449291762383998|0|0|3.74531835205993|11.4998731458057|JUN;PLEK;TNF|3
5099|regulation of neuron apoptotic process (GO:0043523)|3/90|0.047692853474564|0.46094058954678|0|0|3.7037037037037|11.2702730172167|CCL3;APOE;LGMN|3
5100|positive regulation of innate immune response (GO:0045089)|2/39|0.0480298325257829|0.463319915650416|0|0|5.6980056980057|17.2987632488797|EREG;TLR2|3
5101|negative regulation of nucleic acid-templated transcription (GO:1903507)|8/445|0.0486294646071471|0.468219165830701|0|0|1.99750312109863|6.03950195085123|JUN;BASP1;ID2;BHLHE40;KLF4;TNF;CBFA2T3;EREG|3
5102|ERBB2 signaling pathway (GO:0038128)|2/40|0.050265784662639|0.48306271023248|0|0|5.55555555555556|16.6135036596086|PTPN18;EREG|3
5103|positive regulation of reactive oxygen species metabolic process (GO:2000379)|2/40|0.050265784662639|0.482154697619261|0|0|5.55555555555556|16.6135036596086|CDKN1A;PID1|3
5104|inositol lipid-mediated signaling (GO:0048017)|2/40|0.050265784662639|0.481250092182827|0|0|5.55555555555556|16.6135036596086|CSF1R;PTAFR|3
5105|regulation of protein catabolic process (GO:0042176)|3/92|0.0503323300761131|0.480984794716114|0|0|3.6231884057971|10.8301002293356|TNFAIP3;FURIN;TNF|3
5106|negative regulation of cytokine-mediated signaling pathway (GO:0001960)|2/41|0.0525386179476463|0.501130032498764|0|0|5.42005420054201|15.9686005411151|IL1RN;ARG1|3
5107|JAK-STAT cascade (GO:0007259)|2/41|0.0525386179476463|0.500195088408282|0|0|5.42005420054201|15.9686005411151|PTPN1;CCR2|3
5108|regulation of fat cell proliferation (GO:0070344)|1/6|0.0528056923384244|0.501801579148938|0|0|18.5185185185185|54.4654867526127|PID1|3
5109|regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903376)|1/6|0.0528056923384244|0.50086886245907|0|0|18.5185185185185|54.4654867526127|MCL1|3
5110|granzyme-mediated apoptotic signaling pathway (GO:0008626)|1/6|0.0528056923384244|0.499939606684563|0|0|18.5185185185185|54.4654867526127|SRGN|3
5111|response to granulocyte macrophage colony-stimulating factor (GO:0097012)|1/6|0.0528056923384244|0.49901379259811|0|0|18.5185185185185|54.4654867526127|ZFP36|3
5112|mesodermal cell fate commitment (GO:0001710)|1/6|0.0528056923384244|0.498091401114565|0|0|18.5185185185185|54.4654867526127|KLF4|3
5113|negative regulation of transforming growth factor beta production (GO:0071635)|1/6|0.0528056923384244|0.49717241328963|0|0|18.5185185185185|54.4654867526127|FURIN|3
5114|positive regulation of hormone metabolic process (GO:0032352)|1/6|0.0528056923384244|0.496256810318563|0|0|18.5185185185185|54.4654867526127|EGR1|3
5115|regulation of translational initiation in response to stress (GO:0043558)|1/6|0.0528056923384244|0.495344573534889|0|0|18.5185185185185|54.4654867526127|PPP1R15A|3
5116|lipoxin biosynthetic process (GO:2001301)|1/6|0.0528056923384244|0.494435684409137|0|0|18.5185185185185|54.4654867526127|HPGD|3
5117|positive regulation of icosanoid secretion (GO:0032305)|1/6|0.0528056923384244|0.493530124547581|0|0|18.5185185185185|54.4654867526127|IL1B|3
5118|regulation of skeletal muscle satellite cell proliferation (GO:0014842)|1/6|0.0528056923384244|0.492627875691005|0|0|18.5185185185185|54.4654867526127|CFLAR|3
5119|lipoprotein metabolic process (GO:0042157)|1/6|0.0528056923384244|0.491728919713466|0|0|18.5185185185185|54.4654867526127|APOE|3
5120|positive regulation of ATP biosynthetic process (GO:2001171)|1/6|0.0528056923384244|0.490833238621092|0|0|18.5185185185185|54.4654867526127|PID1|3
5121|negative regulation of glycolytic process (GO:0045820)|1/6|0.0528056923384244|0.489940814550872|0|0|18.5185185185185|54.4654867526127|CBFA2T3|3
5122|negative regulation of necroptotic process (GO:0060546)|1/6|0.0528056923384244|0.489051629769473|0|0|18.5185185185185|54.4654867526127|BIRC3|3
5123|ventricular cardiac muscle cell development (GO:0055015)|1/6|0.0528056923384244|0.488165666672064|0|0|18.5185185185185|54.4654867526127|MEF2A|3
5124|negative regulation of meiotic cell cycle (GO:0051447)|1/6|0.0528056923384244|0.487282907781156|0|0|18.5185185185185|54.4654867526127|DUSP1|3
5125|establishment of endothelial intestinal barrier (GO:0090557)|1/6|0.0528056923384244|0.48640333574545|0|0|18.5185185185185|54.4654867526127|F11R|3
5126|regulation of digestive system process (GO:0044058)|1/6|0.0528056923384244|0.485526933338702|0|0|18.5185185185185|54.4654867526127|SGK1|3
5127|negative regulation of bone resorption (GO:0045779)|1/6|0.0528056923384244|0.484653683458596|0|0|18.5185185185185|54.4654867526127|TNFAIP3|3
5128|positive regulation of podosome assembly (GO:0071803)|1/6|0.0528056923384244|0.483783569125636|0|0|18.5185185185185|54.4654867526127|TNF|3
5129|positive regulation of humoral immune response (GO:0002922)|1/6|0.0528056923384244|0.482916573482042|0|0|18.5185185185185|54.4654867526127|FCGR2B|3
5130|regulation of adiponectin secretion (GO:0070163)|1/6|0.0528056923384244|0.482052679790661|0|0|18.5185185185185|54.4654867526127|IL1B|3
5131|positive regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902043)|1/6|0.0528056923384244|0.481191871433892|0|0|18.5185185185185|54.4654867526127|ATF3|3
5132|protein deubiquitination involved in ubiquitin-dependent protein catabolic process (GO:0071947)|1/6|0.0528056923384244|0.480334131912619|0|0|18.5185185185185|54.4654867526127|TNFAIP3|3
5133|positive regulation of cGMP biosynthetic process (GO:0030828)|1/6|0.0528056923384244|0.479479444845159|0|0|18.5185185185185|54.4654867526127|APOE|3
5134|negative regulation of neural precursor cell proliferation (GO:2000178)|1/6|0.0528056923384244|0.478627793966216|0|0|18.5185185185185|54.4654867526127|ID2|3
5135|glomerular epithelial cell differentiation (GO:0072311)|1/6|0.0528056923384244|0.47777916312585|0|0|18.5185185185185|54.4654867526127|BASP1|3
5136|renal filtration cell differentiation (GO:0061318)|1/6|0.0528056923384244|0.476933536288459|0|0|18.5185185185185|54.4654867526127|BASP1|3
5137|negative regulation of coenzyme metabolic process (GO:0051198)|1/6|0.0528056923384244|0.476090897531766|0|0|18.5185185185185|54.4654867526127|CBFA2T3|3
5138|negative regulation of interferon-gamma-mediated signaling pathway (GO:0060336)|1/6|0.0528056923384244|0.475251231045819|0|0|18.5185185185185|54.4654867526127|ARG1|3
5139|negative regulation of response to interferon-gamma (GO:0060331)|1/6|0.0528056923384244|0.474414521132006|0|0|18.5185185185185|54.4654867526127|ARG1|3
5140|positive regulation of T-helper 2 cell differentiation (GO:0045630)|1/6|0.0528056923384244|0.473580752202073|0|0|18.5185185185185|54.4654867526127|NLRP3|3
5141|regulation of protein K63-linked ubiquitination (GO:1900044)|1/6|0.0528056923384244|0.472749908777157|0|0|18.5185185185185|54.4654867526127|SASH1|3
5142|deadenylation-independent decapping of nuclear-transcribed mRNA (GO:0031087)|1/6|0.0528056923384244|0.471921975486829|0|0|18.5185185185185|54.4654867526127|PNRC1|3
5143|chemical homeostasis within a tissue (GO:0048875)|1/6|0.0528056923384244|0.471096937068146|0|0|18.5185185185185|54.4654867526127|CTSH|3
5144|positive regulation of blood pressure (GO:0045777)|1/6|0.0528056923384244|0.470274778364711|0|0|18.5185185185185|54.4654867526127|ID2|3
5145|positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081)|1/6|0.0528056923384244|0.469455484325748|0|0|18.5185185185185|54.4654867526127|CD74|3
5146|response to heparin (GO:0071503)|1/6|0.0528056923384244|0.468639040005182|0|0|18.5185185185185|54.4654867526127|EGR1|3
5147|regulation of mitotic spindle checkpoint (GO:1903504)|1/6|0.0528056923384244|0.467825430560728|0|0|18.5185185185185|54.4654867526127|DUSP1|3
5148|positive regulation of histone phosphorylation (GO:0033129)|1/6|0.0528056923384244|0.467014641252997|0|0|18.5185185185185|54.4654867526127|IL1B|3
5149|positive regulation of cholesterol storage (GO:0010886)|1/6|0.0528056923384244|0.466206657444601|0|0|18.5185185185185|54.4654867526127|MSR1|3
5150|positive regulation of cardiac muscle contraction (GO:0060452)|1/6|0.0528056923384244|0.465401464599274|0|0|18.5185185185185|54.4654867526127|RGS2|3
5151|positive regulation of phospholipid transport (GO:2001140)|1/6|0.0528056923384244|0.464599048280999|0|0|18.5185185185185|54.4654867526127|APOE|3
5152|negative regulation of phospholipase activity (GO:0010519)|1/6|0.0528056923384244|0.463799394153149|0|0|18.5185185185185|54.4654867526127|RGS2|3
5153|lipoprotein catabolic process (GO:0042159)|1/6|0.0528056923384244|0.463002487977628|0|0|18.5185185185185|54.4654867526127|APOE|3
5154|regulation of inositol phosphate biosynthetic process (GO:0010919)|1/6|0.0528056923384244|0.46220831561403|0|0|18.5185185185185|54.4654867526127|PLEK|3
5155|surfactant homeostasis (GO:0043129)|1/6|0.0528056923384244|0.461416863018801|0|0|18.5185185185185|54.4654867526127|CTSH|3
5156|cellular response to cold (GO:0070417)|1/6|0.0528056923384244|0.460628116244409|0|0|18.5185185185185|54.4654867526127|NFKBIA|3
5157|negative regulation of cell cycle phase transition (GO:1901988)|1/6|0.0528056923384244|0.459842061438532|0|0|18.5185185185185|54.4654867526127|ZFP36L1|3
5158|negative regulation of smooth muscle cell differentiation (GO:0051151)|1/6|0.0528056923384244|0.459058684843236|0|0|18.5185185185185|54.4654867526127|EREG|3
5159|cellular response to granulocyte macrophage colony-stimulating factor stimulus (GO:0097011)|1/6|0.0528056923384244|0.458277972794183|0|0|18.5185185185185|54.4654867526127|ZFP36|3
5160|regulation of NFAT protein import into nucleus (GO:0051532)|1/6|0.0528056923384244|0.457499911719829|0|0|18.5185185185185|54.4654867526127|TNF|3
5161|positive regulation of fibroblast apoptotic process (GO:2000271)|1/6|0.0528056923384244|0.456724488140643|0|0|18.5185185185185|54.4654867526127|BTG1|3
5162|regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281)|3/94|0.0530415976065694|0.457988616897333|0|0|3.54609929078014|10.4137546552151|NLRP3;KLF4;TNF|3
5163|cellular response to fibroblast growth factor stimulus (GO:0044344)|3/95|0.0544221583956397|0.46911532819755|0|0|3.50877192982456|10.2139785424725|NR4A1;ZFP36;ZFP36L1|3
5164|cellular response to peptide (GO:1901653)|2/42|0.0548474957301002|0.47198443627437|0|0|5.29100529100529|15.3608399470977|FCGR2B;ZFP36L1|3
5165|monocyte chemotaxis (GO:0002548)|2/42|0.0548474957301002|0.471189849681315|0|0|5.29100529100529|15.3608399470977|CCL4;CCL3|3
5166|negative regulation of proteolysis (GO:0045861)|2/42|0.0548474957301002|0.470397933967565|0|0|5.29100529100529|15.3608399470977|ECM1;TIMP2|3
5167|regulation of B cell activation (GO:0050864)|3/96|0.0558198684474775|0.477934209207178|0|0|3.47222222222222|10.0195326652921|TNFAIP3;FCGR2B;ZFP36L1|3
5168|epithelial cell differentiation (GO:0030855)|3/97|0.0572346232299502|0.48922660358867|0|0|3.43642611683849|9.83022770616623|KDM6B;BASP1;CTSB|3
5169|cellular metal ion homeostasis (GO:0006875)|3/97|0.0572346232299502|0.488408498900394|0|0|3.43642611683849|9.83022770616623|CCL3;ATP2B1;CCR2|3
5170|negative regulation of intracellular signal transduction (GO:1902532)|4/162|0.0588896816922033|0.501692897621559|0|0|2.74348422496571|7.76979255738002|DUSP1;PLEK;TNFAIP3;MCL1|3
5171|regulation of B cell proliferation (GO:0030888)|2/44|0.0595700975942335|0.506643680038956|0|0|5.05050505050505|14.2454623688439|CD74;FCGR2B|3
5172|response to hydrogen peroxide (GO:0042542)|2/44|0.0595700975942335|0.505800678907443|0|0|5.05050505050505|14.2454623688439|TNFAIP3;NFE2L2|3
5173|regulation of insulin secretion (GO:0050796)|3/99|0.0601148374405061|0.509578098768941|0|0|3.36700336700337|9.46632521448108|MARCKS;IL1B;TNF|3
5174|positive regulation of cell growth (GO:0030307)|3/99|0.0601148374405061|0.508733027295029|0|0|3.36700336700337|9.46632521448108|MMP14;SEMA4D;CXCL16|3
5175|regulation of signal transduction (GO:0009966)|5/234|0.0607583034056061|0.513327189203325|0|0|2.37416904083571|6.64969497751138|CSF1R;PTPN1;RGS2;SASH1;BIRC3|3
5176|activation of protein kinase activity (GO:0032147)|5/234|0.0607583034056061|0.512478714510427|0|0|2.37416904083571|6.64969497751138|GADD45B;IL1B;CXCR4;TNF;MALT1|3
5177|negative regulation of muscle hypertrophy (GO:0014741)|1/7|0.0613329802452374|0.516472274243311|0|0|15.8730158730159|44.3085328083962|RGS2|3
5178|positive regulation of epithelial cell proliferation involved in wound healing (GO:0060054)|1/7|0.0613329802452374|0.515621413824459|0|0|15.8730158730159|44.3085328083962|MMP12|3
5179|regulation of hormone biosynthetic process (GO:0046885)|1/7|0.0613329802452374|0.514773352288563|0|0|15.8730158730159|44.3085328083962|EGR1|3
5180|regulation of myosin-light-chain-phosphatase activity (GO:0035507)|1/7|0.0613329802452374|0.513928075848024|0|0|15.8730158730159|44.3085328083962|TNF|3
5181|positive regulation of sphingolipid biosynthetic process (GO:0090154)|1/7|0.0613329802452374|0.51308557080565|0|0|15.8730158730159|44.3085328083962|TNF|3
5182|regulation of monocyte chemotactic protein-1 production (GO:0071637)|1/7|0.0613329802452374|0.512245823553922|0|0|15.8730158730159|44.3085328083962|IL1B|3
5183|flavin-containing compound metabolic process (GO:0042726)|1/7|0.0613329802452374|0.511408820574259|0|0|15.8730158730159|44.3085328083962|ACP5|3
5184|negative regulation of MyD88-independent toll-like receptor signaling pathway (GO:0034128)|1/7|0.0613329802452374|0.510574548436291|0|0|15.8730158730159|44.3085328083962|CD14|3
5185|regulation of mitochondrial fusion (GO:0010635)|1/7|0.0613329802452374|0.509742993797144|0|0|15.8730158730159|44.3085328083962|PID1|3
5186|pri-miRNA transcription from RNA polymerase II promoter (GO:0061614)|1/7|0.0613329802452374|0.508914143400726|0|0|15.8730158730159|44.3085328083962|KLF4|3
5187|positive regulation of extracellular matrix disassembly (GO:0090091)|1/7|0.0613329802452374|0.508087984077024|0|0|15.8730158730159|44.3085328083962|PDPN|3
5188|riboflavin metabolic process (GO:0006771)|1/7|0.0613329802452374|0.507264502741404|0|0|15.8730158730159|44.3085328083962|ACP5|3
5189|negative regulation of type 2 immune response (GO:0002829)|1/7|0.0613329802452374|0.506443686393926|0|0|15.8730158730159|44.3085328083962|CCR2|3
5190|cytoplasmic sequestering of NF-kappaB (GO:0007253)|1/7|0.0613329802452374|0.505625522118654|0|0|15.8730158730159|44.3085328083962|NFKBIA|3
5191|death-inducing signaling complex assembly (GO:0071550)|1/7|0.0613329802452374|0.504809997082978|0|0|15.8730158730159|44.3085328083962|TNF|3
5192|positive regulation of autophagy of mitochondrion (GO:1903599)|1/7|0.0613329802452374|0.503997098536951|0|0|15.8730158730159|44.3085328083962|HK2|3
5193|regulation of sterol transport (GO:0032371)|1/7|0.0613329802452374|0.503186813812615|0|0|15.8730158730159|44.3085328083962|APOE|3
5194|lymphatic endothelial cell differentiation (GO:0060836)|1/7|0.0613329802452374|0.502379130323349|0|0|15.8730158730159|44.3085328083962|PDPN|3
5195|positive regulation of B cell differentiation (GO:0045579)|1/7|0.0613329802452374|0.501574035563216|0|0|15.8730158730159|44.3085328083962|MMP14|3
5196|regulation of interleukin-18 production (GO:0032661)|1/7|0.0613329802452374|0.500771517106314|0|0|15.8730158730159|44.3085328083962|TLR2|3
5197|regulation of smooth muscle cell differentiation (GO:0051150)|1/7|0.0613329802452374|0.499971562606145|0|0|15.8730158730159|44.3085328083962|EREG|3
5198|positive regulation of ER-associated ubiquitin-dependent protein catabolic process (GO:1903071)|1/7|0.0613329802452374|0.499174159794971|0|0|15.8730158730159|44.3085328083962|NFE2L2|3
5199|regulation of collateral sprouting (GO:0048670)|1/7|0.0613329802452374|0.498379296483195|0|0|15.8730158730159|44.3085328083962|SEMA4D|3
5200|regulation of vitamin D biosynthetic process (GO:0060556)|1/7|0.0613329802452374|0.497586960558739|0|0|15.8730158730159|44.3085328083962|TNF|3
5201|negative regulation of membrane protein ectodomain proteolysis (GO:0051045)|1/7|0.0613329802452374|0.496797139986423|0|0|15.8730158730159|44.3085328083962|TIMP2|3
5202|granulocyte migration (GO:0097530)|1/7|0.0613329802452374|0.496009822807364|0|0|15.8730158730159|44.3085328083962|CCL3|3
5203|negative regulation of macrophage activation (GO:0043031)|1/7|0.0613329802452374|0.495224997138365|0|0|15.8730158730159|44.3085328083962|FCGR2B|3
5204|regulation of dendritic cell differentiation (GO:2001198)|1/7|0.0613329802452374|0.494442651171322|0|0|15.8730158730159|44.3085328083962|FCGR2B|3
5205|positive regulation of striated muscle contraction (GO:0045989)|1/7|0.0613329802452374|0.493662773172629|0|0|15.8730158730159|44.3085328083962|RGS2|3
5206|regulation of toll-like receptor 3 signaling pathway (GO:0034139)|1/7|0.0613329802452374|0.492885351482593|0|0|15.8730158730159|44.3085328083962|TNFAIP3|3
5207|activation of signaling protein activity involved in unfolded protein response (GO:0006987)|1/7|0.0613329802452374|0.492110374514853|0|0|15.8730158730159|44.3085328083962|PTPN1|3
5208|wound healing, spreading of epidermal cells (GO:0035313)|1/7|0.0613329802452374|0.491337830755803|0|0|15.8730158730159|44.3085328083962|MMP12|3
5209|positive regulation of ceramide biosynthetic process (GO:2000304)|1/7|0.0613329802452374|0.490567708764023|0|0|15.8730158730159|44.3085328083962|TNF|3
5210|hyaluronan biosynthetic process (GO:0030213)|1/7|0.0613329802452374|0.489799997169713|0|0|15.8730158730159|44.3085328083962|IL1B|3
5211|tooth mineralization (GO:0034505)|1/7|0.0613329802452374|0.489034684674135|0|0|15.8730158730159|44.3085328083962|FAM20C|3
5212|regulation of cell projection organization (GO:0031344)|1/7|0.0613329802452374|0.488271760049059|0|0|15.8730158730159|44.3085328083962|SEMA4D|3
5213|chylomicron remnant clearance (GO:0034382)|1/7|0.0613329802452374|0.48751121213621|0|0|15.8730158730159|44.3085328083962|APOE|3
5214|negative regulation of necrotic cell death (GO:0060547)|1/7|0.0613329802452374|0.486753029846729|0|0|15.8730158730159|44.3085328083962|BIRC3|3
5215|regulation of transcription involved in cell fate commitment (GO:0060850)|1/7|0.0613329802452374|0.485997202160631|0|0|15.8730158730159|44.3085328083962|CEBPB|3
5216|regulation of Cdc42 protein signal transduction (GO:0032489)|1/7|0.0613329802452374|0.485243718126274|0|0|15.8730158730159|44.3085328083962|APOE|3
5217|cholesterol transport (GO:0030301)|2/45|0.0619822073877366|0.489621059287337|0|0|4.93827160493827|13.7328785814329|MSR1;APOE|3
5218|amide biosynthetic process (GO:0043604)|2/45|0.0619822073877366|0.488864303399722|0|0|4.93827160493827|13.7328785814329|ARG1;FURIN|3
5219|negative regulation of immune system process (GO:0002683)|2/45|0.0619822073877366|0.488109883178426|0|0|4.93827160493827|13.7328785814329|NLRP3;FCGR2B|3
5220|regulation of dendrite morphogenesis (GO:0048814)|2/45|0.0619822073877366|0.487357787826841|0|0|4.93827160493827|13.7328785814329|CUX1;SEMA4D|3
5221|cellular response to metal ion (GO:0071248)|3/101|0.0630619202394693|0.495084583049249|0|0|3.3003300330033|9.12091806712281|MEF2A;JUN;FOS|3
5222|cellular divalent inorganic cation homeostasis (GO:0072503)|3/102|0.0645602529860973|0.506069079858763|0|0|3.26797385620915|8.95475926930809|CCL3;ATP2B1;CCR2|3
5223|pyruvate metabolic process (GO:0006090)|2/47|0.0669040953982292|0.523637421498717|0|0|4.72813238770686|12.7872108605517|LDHB;HK2|3
5224|positive regulation of ion transport (GO:0043270)|2/47|0.0669040953982292|0.522835526519393|0|0|4.72813238770686|12.7872108605517|CCL4;CCL3|3
5225|regulation of cellular component movement (GO:0051270)|2/47|0.0669040953982292|0.522036083818293|0|0|4.72813238770686|12.7872108605517|PDPN;EREG|3
5226|peptide metabolic process (GO:0006518)|3/105|0.0691530047018483|0.538759974035927|0|0|3.17460317460317|8.48074212657944|F10;ANPEP;FURIN|3
5227|biomineral tissue development (GO:0031214)|1/8|0.0697839237890214|0.542846590084415|0|0|13.8888888888889|36.9771057493053|FAM20C|3
5228|regulation of fibroblast apoptotic process (GO:2000269)|1/8|0.0697839237890214|0.542020339566783|0|0|13.8888888888889|36.9771057493053|BTG1|3
5229|stress-induced premature senescence (GO:0090400)|1/8|0.0697839237890214|0.5411966004489|0|0|13.8888888888889|36.9771057493053|CDKN1A|3
5230|myelin maintenance (GO:0043217)|1/8|0.0697839237890214|0.540375361297991|0|0|13.8888888888889|36.9771057493053|CXCR4|3
5231|negative regulation of leukocyte mediated cytotoxicity (GO:0001911)|1/8|0.0697839237890214|0.53955661075057|0|0|13.8888888888889|36.9771057493053|FCGR2B|3
5232|negative regulation of lipase activity (GO:0060192)|1/8|0.0697839237890214|0.538740337511916|0|0|13.8888888888889|36.9771057493053|RGS2|3
5233|positive regulation of interleukin-8 biosynthetic process (GO:0045416)|1/8|0.0697839237890214|0.537926530355553|0|0|13.8888888888889|36.9771057493053|TNF|3
5234|positive regulation of steroid biosynthetic process (GO:0010893)|1/8|0.0697839237890214|0.537115178122739|0|0|13.8888888888889|36.9771057493053|TNF|3
5235|negative regulation of glucose import (GO:0046325)|1/8|0.0697839237890214|0.536306269721952|0|0|13.8888888888889|36.9771057493053|PID1|3
5236|regulation of T cell mediated immunity (GO:0002709)|1/8|0.0697839237890214|0.535499794128385|0|0|13.8888888888889|36.9771057493053|IL1B|3
5237|negative regulation of protein complex disassembly (GO:0043242)|1/8|0.0697839237890214|0.534695740383448|0|0|13.8888888888889|36.9771057493053|TNF|3
5238|regulation of ATP biosynthetic process (GO:2001169)|1/8|0.0697839237890214|0.533894097594267|0|0|13.8888888888889|36.9771057493053|PID1|3
5239|regulation of MyD88-independent toll-like receptor signaling pathway (GO:0034127)|1/8|0.0697839237890214|0.533094854933198|0|0|13.8888888888889|36.9771057493053|CD14|3
5240|positive regulation of cAMP-mediated signaling (GO:0043950)|1/8|0.0697839237890214|0.532298001637334|0|0|13.8888888888889|36.9771057493053|CXCL10|3
5241|regulation of toll-like receptor 2 signaling pathway (GO:0034135)|1/8|0.0697839237890214|0.531503527008024|0|0|13.8888888888889|36.9771057493053|TNFAIP3|3
5242|positive regulation of IRE1-mediated unfolded protein response (GO:1903896)|1/8|0.0697839237890214|0.530711420410397|0|0|13.8888888888889|36.9771057493053|PTPN1|3
5243|positive regulation of protein localization to cell surface (GO:2000010)|1/8|0.0697839237890214|0.529921671272881|0|0|13.8888888888889|36.9771057493053|TNF|3
5244|positive regulation of metanephros development (GO:0072216)|1/8|0.0697839237890214|0.52913426908674|0|0|13.8888888888889|36.9771057493053|BASP1|3
5245|regulation of chemokine secretion (GO:0090196)|1/8|0.0697839237890214|0.528349203405603|0|0|13.8888888888889|36.9771057493053|CSF1R|3
5246|positive regulation of tumor necrosis factor biosynthetic process (GO:0042535)|1/8|0.0697839237890214|0.527566463845002|0|0|13.8888888888889|36.9771057493053|CCR2|3
5247|regulation of nitrogen compound metabolic process (GO:0051171)|1/8|0.0697839237890214|0.526786040081918|0|0|13.8888888888889|36.9771057493053|APOE|3
5248|cGMP-mediated signaling (GO:0019934)|1/8|0.0697839237890214|0.526007921854322|0|0|13.8888888888889|36.9771057493053|APOE|3
5249|regulation of sensory perception (GO:0051931)|1/8|0.0697839237890214|0.525232098960732|0|0|13.8888888888889|36.9771057493053|CCL3|3
5250|granulocyte differentiation (GO:0030851)|1/8|0.0697839237890214|0.524458561259759|0|0|13.8888888888889|36.9771057493053|CBFA2T3|3
5251|negative regulation of bone remodeling (GO:0046851)|1/8|0.0697839237890214|0.523687298669671|0|0|13.8888888888889|36.9771057493053|TNFAIP3|3
5252|regulation of dendritic cell antigen processing and presentation (GO:0002604)|1/8|0.0697839237890214|0.522918301167953|0|0|13.8888888888889|36.9771057493053|FCGR2B|3
5253|regulation of T-helper 2 cell differentiation (GO:0045628)|1/8|0.0697839237890214|0.522151558790874|0|0|13.8888888888889|36.9771057493053|NLRP3|3
5254|regulation of amyloid fibril formation (GO:1905906)|1/8|0.0697839237890214|0.521387061633055|0|0|13.8888888888889|36.9771057493053|APOE|3
5255|positive regulation of chemokine secretion (GO:0090197)|1/8|0.0697839237890214|0.520624799847041|0|0|13.8888888888889|36.9771057493053|CSF1R|3
5256|positive regulation of viral entry into host cell (GO:0046598)|1/8|0.0697839237890214|0.519864763642885|0|0|13.8888888888889|36.9771057493053|CD74|3
5257|mammary gland epithelial cell differentiation (GO:0060644)|1/8|0.0697839237890214|0.519106943287721|0|0|13.8888888888889|36.9771057493053|ID2|3
5258|histone H3-K36 demethylation (GO:0070544)|1/8|0.0697839237890214|0.518351329105351|0|0|13.8888888888889|36.9771057493053|KDM7A|3
5259|regulation of T-helper 2 cell cytokine production (GO:2000551)|1/8|0.0697839237890214|0.517597911475838|0|0|13.8888888888889|36.9771057493053|NLRP3|3
5260|arginine catabolic process (GO:0006527)|1/8|0.0697839237890214|0.516846680835089|0|0|13.8888888888889|36.9771057493053|ARG1|3
5261|regulation of receptor binding (GO:1900120)|1/8|0.0697839237890214|0.516097627674458|0|0|13.8888888888889|36.9771057493053|ADAM15|3
5262|response to vitamin D (GO:0033280)|1/8|0.0697839237890214|0.515350742540342|0|0|13.8888888888889|36.9771057493053|SPP1|3
5263|kidney mesenchyme development (GO:0072074)|1/8|0.0697839237890214|0.514606016033781|0|0|13.8888888888889|36.9771057493053|BASP1|3
5264|intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630)|2/49|0.0719510740570036|0.529821545328845|0|0|4.53514739229025|11.9354599452846|CRIP1;MCL1|3
5265|positive regulation of cellular component organization (GO:0051130)|3/107|0.072295087537526|0.531587653752154|0|0|3.11526479750779|8.18379781204013|PPP1R15A;APOE;TNF|3
5266|transcription from RNA polymerase II promoter (GO:0006366)|8/486|0.0731948689107827|0.537429375613992|0|0|1.82898948331047|4.78213069468496|NR4A2;EGR1;NR4A1;CDKN1A;CEBPB;POU2F2;KLF4;NFE2L2|3
5267|positive regulation of epithelial cell proliferation (GO:0050679)|3/108|0.0738898306615835|0.541752594635145|0|0|3.08641975308642|8.04067922823414|MMP12;NR4A1;ECM1|3
5268|regulation of reactive oxygen species metabolic process (GO:2000377)|2/50|0.0745195887056104|0.545586027496026|0|0|4.44444444444444|11.540858900055|CDKN1A;PID1|3
5269|myeloid leukocyte differentiation (GO:0002573)|2/51|0.0771171373782471|0.563794773697987|0|0|4.35729847494553|11.1652712349751|CSF1R;CBFA2T3|3
5270|positive regulation of JUN kinase activity (GO:0043507)|2/51|0.0771171373782471|0.562988200345057|0|0|4.35729847494553|11.1652712349751|TNF;SASH1|3
5271|blood circulation (GO:0008015)|2/51|0.0771171373782471|0.562183931487421|0|0|4.35729847494553|11.1652712349751|CXCL10;C3AR1|3
5272|wound healing (GO:0042060)|2/51|0.0771171373782471|0.56138195726276|0|0|4.35729847494553|11.1652712349751|MMP12;EREG|3
5273|positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280)|3/110|0.0771260830706965|0.560647296167755|0|0|3.03030303030303|7.76458713272471|NLRP3;CFLAR;TNF|3
5274|negative regulation of protein kinase activity (GO:0006469)|3/110|0.0771260830706965|0.559849789345326|0|0|3.03030303030303|7.76458713272471|PTPN1;CDKN1A;TRIB1|3
5275|regulation of immune response (GO:0050776)|5/252|0.0779033524225116|0.564688646892155|0|0|2.20458553791887|5.6267334481539|NLRP3;TREM2;FCGR2B;ICAM1;BIRC3|3
5276|very-low-density lipoprotein particle remodeling (GO:0034372)|1/9|0.0781592023630103|0.565739588168002|0|0|12.3456790123457|31.4692281047065|APOE|3
5277|secretory granule organization (GO:0033363)|1/9|0.0781592023630103|0.564938257306574|0|0|12.3456790123457|31.4692281047065|SRGN|3
5278|ornithine metabolic process (GO:0006591)|1/9|0.0781592023630103|0.564139193293411|0|0|12.3456790123457|31.4692281047065|ARG1|3
5279|regulation of macrophage cytokine production (GO:0010935)|1/9|0.0781592023630103|0.563342386523222|0|0|12.3456790123457|31.4692281047065|CD74|3
5280|integrin activation (GO:0033622)|1/9|0.0781592023630103|0.56254782744491|0|0|12.3456790123457|31.4692281047065|FN1|3
5281|negative regulation of response to reactive oxygen species (GO:1901032)|1/9|0.0781592023630103|0.561755506561185|0|0|12.3456790123457|31.4692281047065|NFE2L2|3
5282|regulation of interleukin-6 biosynthetic process (GO:0045408)|1/9|0.0781592023630103|0.560965414428188|0|0|12.3456790123457|31.4692281047065|EREG|3
5283|negative regulation of toll-like receptor 4 signaling pathway (GO:0034144)|1/9|0.0781592023630103|0.560177541655114|0|0|12.3456790123457|31.4692281047065|TNFAIP3|3
5284|regulation of T-helper 1 type immune response (GO:0002825)|1/9|0.0781592023630103|0.559391878903845|0|0|12.3456790123457|31.4692281047065|CCR2|3
5285|sterol catabolic process (GO:0016127)|1/9|0.0781592023630103|0.558608416888573|0|0|12.3456790123457|31.4692281047065|APOE|3
5286|regulation of ER-associated ubiquitin-dependent protein catabolic process (GO:1903069)|1/9|0.0781592023630103|0.557827146375443|0|0|12.3456790123457|31.4692281047065|NFE2L2|3
5287|regulation of endothelial cell differentiation (GO:0045601)|1/9|0.0781592023630103|0.557048058182181|0|0|12.3456790123457|31.4692281047065|BTG1|3
5288|mature B cell differentiation involved in immune response (GO:0002313)|1/9|0.0781592023630103|0.556271143177743|0|0|12.3456790123457|31.4692281047065|FCGR2B|3
5289|regulation of morphogenesis of an epithelium (GO:1905330)|1/9|0.0781592023630103|0.555496392281952|0|0|12.3456790123457|31.4692281047065|CXCL10|3
5290|regulation of leukocyte mediated cytotoxicity (GO:0001910)|1/9|0.0781592023630103|0.554723796465148|0|0|12.3456790123457|31.4692281047065|ICAM1|3
5291|positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770)|1/9|0.0781592023630103|0.553953346747835|0|0|12.3456790123457|31.4692281047065|TLR2|3
5292|positive regulation of cholesterol esterification (GO:0010873)|1/9|0.0781592023630103|0.553185034200335|0|0|12.3456790123457|31.4692281047065|APOE|3
5293|negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532)|1/9|0.0781592023630103|0.55241884994244|0|0|12.3456790123457|31.4692281047065|SOCS3|3
5294|mitochondrion morphogenesis (GO:0070584)|1/9|0.0781592023630103|0.551654785143072|0|0|12.3456790123457|31.4692281047065|PID1|3
5295|regulation of integrin activation (GO:0033623)|1/9|0.0781592023630103|0.550892831019947|0|0|12.3456790123457|31.4692281047065|PLEK|3
5296|chylomicron remodeling (GO:0034371)|1/9|0.0781592023630103|0.55013297883923|0|0|12.3456790123457|31.4692281047065|APOE|3
5297|semaphorin-plexin signaling pathway involved in axon guidance (GO:1902287)|1/9|0.0781592023630103|0.549375219915208|0|0|12.3456790123457|31.4692281047065|PLXND1|3
5298|regulation of sensory perception of pain (GO:0051930)|1/9|0.0781592023630103|0.548619545609961|0|0|12.3456790123457|31.4692281047065|CCL3|3
5299|cell junction maintenance (GO:0034331)|1/9|0.0781592023630103|0.547865947333024|0|0|12.3456790123457|31.4692281047065|CSF1R|3
5300|positive regulation of T cell chemotaxis (GO:0010820)|1/9|0.0781592023630103|0.547114416541072|0|0|12.3456790123457|31.4692281047065|CCR2|3
5301|positive regulation of phosphorylation of RNA polymerase II C-terminal domain (GO:1901409)|1/9|0.0781592023630103|0.546364944737591|0|0|12.3456790123457|31.4692281047065|CCNL1|3
5302|regulation of cytokine secretion involved in immune response (GO:0002739)|1/9|0.0781592023630103|0.54561752347256|0|0|12.3456790123457|31.4692281047065|TNF|3
5303|protein localization to vacuole (GO:0072665)|1/9|0.0781592023630103|0.544872144342133|0|0|12.3456790123457|31.4692281047065|RNF128|3
5304|positive regulation of cell activation (GO:0050867)|1/9|0.0781592023630103|0.544128798988324|0|0|12.3456790123457|31.4692281047065|PLEK|3
5305|basement membrane organization (GO:0071711)|1/9|0.0781592023630103|0.543387479098694|0|0|12.3456790123457|31.4692281047065|CTSS|3
5306|negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948)|1/9|0.0781592023630103|0.542648176406043|0|0|12.3456790123457|31.4692281047065|PTPN1|3
5307|endothelial cell chemotaxis (GO:0035767)|1/9|0.0781592023630103|0.5419108826881|0|0|12.3456790123457|31.4692281047065|NR4A1|3
5308|regulation of leukocyte activation (GO:0002694)|1/9|0.0781592023630103|0.54117558976722|0|0|12.3456790123457|31.4692281047065|CD74|3
5309|cholesterol catabolic process (GO:0006707)|1/9|0.0781592023630103|0.540442289510083|0|0|12.3456790123457|31.4692281047065|APOE|3
5310|B cell homeostasis (GO:0001782)|1/9|0.0781592023630103|0.53971097382739|0|0|12.3456790123457|31.4692281047065|TNFAIP3|3
5311|negative regulation of amyloid-beta formation (GO:1902430)|1/9|0.0781592023630103|0.538981634673569|0|0|12.3456790123457|31.4692281047065|APOE|3
5312|mesodermal cell differentiation (GO:0048333)|1/9|0.0781592023630103|0.53825426404648|0|0|12.3456790123457|31.4692281047065|KDM6B|3
5313|fatty acid homeostasis (GO:0055089)|1/9|0.0781592023630103|0.537528853987118|0|0|12.3456790123457|31.4692281047065|APOE|3
5314|response to vitamin (GO:0033273)|1/9|0.0781592023630103|0.536805396579329|0|0|12.3456790123457|31.4692281047065|SPP1|3
5315|cellular response to peptide hormone stimulus (GO:0071375)|3/111|0.0787673330239266|0.540254973684271|0|0|3.003003003003|7.63140217298538|NR4A2;NR4A1;ZFP36L1|3
5316|regulation of calcium ion transport (GO:0051924)|2/53|0.0823964523038256|0.564388048464996|0|0|4.19287211740042|10.4663014572696|CCL4;CCL3|3
5317|protein deubiquitination (GO:0016579)|5/258|0.0841421445754482|0.575572873684332|0|0|2.15331610680448|5.32999076865802|NFKBIA;RNF128;NLRP3;TNFAIP3;BIRC3|3
5318|negative regulation of cellular response to transforming growth factor beta stimulus (GO:1903845)|2/54|0.0850768025446961|0.581187313769189|0|0|4.11522633744856|10.140744325541|PMEPA1;SKIL|3
5319|neutrophil chemotaxis (GO:0030593)|2/54|0.0850768025446961|0.580410325381797|0|0|4.11522633744856|10.140744325541|CCL4;CCL3|3
5320|positive regulation of epidermal growth factor-activated receptor activity (GO:0045741)|1/10|0.0864594894435786|0.589055773872605|0|0|11.1111111111111|27.2008811653017|EREG|3
5321|negative regulation of response to cytokine stimulus (GO:0060761)|1/10|0.0864594894435786|0.588270366174109|0|0|11.1111111111111|27.2008811653017|KLF4|3
5322|negative regulation of cellular protein catabolic process (GO:1903363)|1/10|0.0864594894435786|0.587487050107299|0|0|11.1111111111111|27.2008811653017|FURIN|3
5323|positive regulation of calcium ion import (GO:0090280)|1/10|0.0864594894435786|0.586705817327901|0|0|11.1111111111111|27.2008811653017|CCL3|3
5324|regulation of myeloid leukocyte differentiation (GO:0002761)|1/10|0.0864594894435786|0.585926659535965|0|0|11.1111111111111|27.2008811653017|CEBPB|3
5325|regulation of cellular respiration (GO:0043457)|1/10|0.0864594894435786|0.585149568475572|0|0|11.1111111111111|27.2008811653017|CBFA2T3|3
5326|neuron projection regeneration (GO:0031102)|1/10|0.0864594894435786|0.584374535934545|0|0|11.1111111111111|27.2008811653017|APOE|3
5327|positive regulation of steroid metabolic process (GO:0045940)|1/10|0.0864594894435786|0.583601553744155|0|0|11.1111111111111|27.2008811653017|APOE|3
5328|superoxide anion generation (GO:0042554)|1/10|0.0864594894435786|0.582830613778839|0|0|11.1111111111111|27.2008811653017|CYBB|3
5329|macrophage chemotaxis (GO:0048246)|1/10|0.0864594894435786|0.582061707955912|0|0|11.1111111111111|27.2008811653017|CCL3|3
5330|protein K11-linked deubiquitination (GO:0035871)|1/10|0.0864594894435786|0.581294828235285|0|0|11.1111111111111|27.2008811653017|TNFAIP3|3
5331|response to acidic pH (GO:0010447)|1/10|0.0864594894435786|0.580529966619186|0|0|11.1111111111111|27.2008811653017|CTSS|3
5332|embryonic digestive tract morphogenesis (GO:0048557)|1/10|0.0864594894435786|0.579767115151881|0|0|11.1111111111111|27.2008811653017|ID2|3
5333|positive regulation of bone remodeling (GO:0046852)|1/10|0.0864594894435786|0.579006265919398|0|0|11.1111111111111|27.2008811653017|SPP1|3
5334|regulation of actin filament-based movement (GO:1903115)|1/10|0.0864594894435786|0.578247411049255|0|0|11.1111111111111|27.2008811653017|PDPN|3
5335|mesenchymal to epithelial transition (GO:0060231)|1/10|0.0864594894435786|0.577490542710185|0|0|11.1111111111111|27.2008811653017|BASP1|3
5336|positive regulation of glial cell differentiation (GO:0045687)|1/10|0.0864594894435786|0.576735653111871|0|0|11.1111111111111|27.2008811653017|CXCR4|3
5337|regulation of amyloid-beta clearance (GO:1900221)|1/10|0.0864594894435786|0.575982734504676|0|0|11.1111111111111|27.2008811653017|APOE|3
5338|regulation of DNA-templated transcription, initiation (GO:2000142)|1/10|0.0864594894435786|0.575231779179376|0|0|11.1111111111111|27.2008811653017|JUN|3
5339|chylomicron assembly (GO:0034378)|1/10|0.0864594894435786|0.574482779466903|0|0|11.1111111111111|27.2008811653017|APOE|3
5340|regulation of granulocyte differentiation (GO:0030852)|1/10|0.0864594894435786|0.573735727738077|0|0|11.1111111111111|27.2008811653017|C1QC|3
5341|negative regulation of B cell proliferation (GO:0030889)|1/10|0.0864594894435786|0.572990616403353|0|0|11.1111111111111|27.2008811653017|FCGR2B|3
5342|negative regulation of reproductive process (GO:2000242)|1/10|0.0864594894435786|0.572247437912557|0|0|11.1111111111111|27.2008811653017|DUSP1|3
5343|negative regulation of cell activation (GO:0050866)|1/10|0.0864594894435786|0.571506184754639|0|0|11.1111111111111|27.2008811653017|APOE|3
5344|macrophage migration (GO:1905517)|1/10|0.0864594894435786|0.570766849457415|0|0|11.1111111111111|27.2008811653017|CCL3|3
5345|negative regulation of interleukin-1 beta secretion (GO:0050713)|1/10|0.0864594894435786|0.570029424587315|0|0|11.1111111111111|27.2008811653017|NLRP3|3
5346|regulation of histone phosphorylation (GO:0033127)|1/10|0.0864594894435786|0.569293902749137|0|0|11.1111111111111|27.2008811653017|IL1B|3
5347|virion attachment to host cell (GO:0019062)|1/10|0.0864594894435786|0.568560276585801|0|0|11.1111111111111|27.2008811653017|ICAM1|3
5348|negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665)|1/10|0.0864594894435786|0.567828538778097|0|0|11.1111111111111|27.2008811653017|TRIB1|3
5349|complement receptor mediated signaling pathway (GO:0002430)|1/10|0.0864594894435786|0.567098682044449|0|0|11.1111111111111|27.2008811653017|C3AR1|3
5350|regulation of podosome assembly (GO:0071801)|1/10|0.0864594894435786|0.566370699140669|0|0|11.1111111111111|27.2008811653017|TNF|3
5351|positive regulation of bone resorption (GO:0045780)|1/10|0.0864594894435786|0.56564458285972|0|0|11.1111111111111|27.2008811653017|SPP1|3
5352|negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201)|1/10|0.0864594894435786|0.564920326031474|0|0|11.1111111111111|27.2008811653017|JUN|3
5353|regulation of phospholipase activity (GO:0010517)|1/10|0.0864594894435786|0.564197921522483|0|0|11.1111111111111|27.2008811653017|RGS2|3
5354|negative regulation of pathway-restricted SMAD protein phosphorylation (GO:0060394)|1/10|0.0864594894435786|0.563477362235736|0|0|11.1111111111111|27.2008811653017|PMEPA1|3
5355|regulation of mRNA 3'-end processing (GO:0031440)|1/10|0.0864594894435786|0.562758641110435|0|0|11.1111111111111|27.2008811653017|ZFP36L1|3
5356|positive regulation of lipid localization (GO:1905954)|1/10|0.0864594894435786|0.56204175112176|0|0|11.1111111111111|27.2008811653017|HILPDA|3
5357|regulation of immunoglobulin production (GO:0002637)|1/10|0.0864594894435786|0.561326685280638|0|0|11.1111111111111|27.2008811653017|FCGR2B|3
5358|positive regulation of nuclease activity (GO:0032075)|1/10|0.0864594894435786|0.560613436633522|0|0|11.1111111111111|27.2008811653017|PTPN1|3
5359|negative regulation of glucose transport (GO:0010829)|1/10|0.0864594894435786|0.559901998262159|0|0|11.1111111111111|27.2008811653017|IL1B|3
5360|positive regulation of type 2 immune response (GO:0002830)|1/10|0.0864594894435786|0.559192363283373|0|0|11.1111111111111|27.2008811653017|NLRP3|3
5361|negative regulation of cell growth (GO:0030308)|3/116|0.0871995114904195|0.563264692576722|0|0|2.8735632183908|7.01021997200283|CDKN1A;BTG1;ADAM15|3
5362|glycosphingolipid metabolic process (GO:0006687)|2/55|0.0877833545366164|0.566319163337994|0|0|4.04040404040404|9.8298318391102|GM2A;HEXB|3
5363|protein modification by small protein removal (GO:0070646)|5/262|0.0884442168611008|0.569862170002775|0|0|2.12044105173876|5.14288219604706|NFKBIA;RNF128;NLRP3;TNFAIP3;BIRC3|3
5364|positive regulation of cysteine-type endopeptidase activity (GO:2001056)|2/56|0.0905154259186939|0.582471902223323|0|0|3.96825396825397|9.53267853437027|NLRP3;TNF|3
5365|negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512)|2/56|0.0905154259186939|0.581738310406921|0|0|3.96825396825397|9.53267853437027|PMEPA1;SKIL|3
5366|negative regulation of cellular response to growth factor stimulus (GO:0090288)|2/56|0.0905154259186939|0.581006564104522|0|0|3.96825396825397|9.53267853437027|PTPN1;SKIL|3
5367|activation of MAPK activity (GO:0000187)|3/118|0.0906752812770643|0.581301457734747|0|0|2.82485875706215|6.78099008978117|IL1B;CXCR4;TNF|3
5368|receptor-mediated endocytosis (GO:0006898)|4/189|0.0915284203725595|0.58603454098014|0|0|2.35155790711346|5.6228236326017|MSR1;APOE;FCGR2B;CXCL16|3
5369|calcium ion transport (GO:0006816)|3/119|0.0924346625569078|0.591095342140226|0|0|2.80112044817927|6.670177128244|CCL3;KCNN4;CCR5|3
5370|granulocyte chemotaxis (GO:0071621)|2/57|0.0932723443892305|0.595705598771268|0|0|3.89863547758285|9.24846639784396|CCL4;CCL3|3
5371|cellular defense response (GO:0006968)|2/57|0.0932723443892305|0.594960966772804|0|0|3.89863547758285|9.24846639784396|CX3CR1;CCR5|3
5372|positive regulation of protein transport (GO:0051222)|2/57|0.0932723443892305|0.594218194030266|0|0|3.89863547758285|9.24846639784396|IL1A;TNF|3
5373|protein import (GO:0017038)|2/57|0.0932723443892305|0.593477273588832|0|0|3.89863547758285|9.24846639784396|MMP12;APOE|3
5374|negative regulation of cellular catabolic process (GO:0031330)|2/57|0.0932723443892305|0.592738198528323|0|0|3.89863547758285|9.24846639784396|TIMP2;MCL1|3
5375|regulation of phosphorylation (GO:0042325)|3/120|0.0942081873094714|0.597940770945563|0|0|2.77777777777778|6.56180051962041|CDKN1A;FN1;EREG|3
5376|positive regulation of posttranscriptional gene silencing (GO:0060148)|1/11|0.0946854526218654|0.600223434446433|0|0|10.1010101010101|23.81004955543|ZFP36|3
5377|negative regulation of morphogenesis of an epithelium (GO:1905331)|1/11|0.0946854526218654|0.599478740359031|0|0|10.1010101010101|23.81004955543|TNF|3
5378|negative regulation of leukocyte activation (GO:0002695)|1/11|0.0946854526218654|0.598735891857966|0|0|10.1010101010101|23.81004955543|FCGR2B|3
5379|endothelium development (GO:0003158)|1/11|0.0946854526218654|0.597994882090815|0|0|10.1010101010101|23.81004955543|KDM6B|3
5380|regulation of tumor necrosis factor biosynthetic process (GO:0042534)|1/11|0.0946854526218654|0.597255704239035|0|0|10.1010101010101|23.81004955543|CCR2|3
5381|mononuclear cell differentiation (GO:1903131)|1/11|0.0946854526218654|0.596518351517752|0|0|10.1010101010101|23.81004955543|CSF1R|3
5382|positive regulation by host of viral process (GO:0044794)|1/11|0.0946854526218654|0.59578281717556|0|0|10.1010101010101|23.81004955543|APOE|3
5383|regulation of lamellipodium morphogenesis (GO:2000392)|1/11|0.0946854526218654|0.595049094494309|0|0|10.1010101010101|23.81004955543|PDPN|3
5384|positive regulation of extracellular matrix organization (GO:1903055)|1/11|0.0946854526218654|0.594317176788904|0|0|10.1010101010101|23.81004955543|PDPN|3
5385|regulation of hydrogen peroxide-induced cell death (GO:1903205)|1/11|0.0946854526218654|0.593587057407099|0|0|10.1010101010101|23.81004955543|NFE2L2|3
5386|T cell differentiation in thymus (GO:0033077)|1/11|0.0946854526218654|0.592858729729299|0|0|10.1010101010101|23.81004955543|ZFP36L1|3
5387|I-kappaB phosphorylation (GO:0007252)|1/11|0.0946854526218654|0.592132187168356|0|0|10.1010101010101|23.81004955543|TLR2|3
5388|modulation by host of viral process (GO:0044788)|1/11|0.0946854526218654|0.591407423169374|0|0|10.1010101010101|23.81004955543|APOE|3
5389|low-density lipoprotein particle remodeling (GO:0034374)|1/11|0.0946854526218654|0.59068443120951|0|0|10.1010101010101|23.81004955543|PLA2G7|3
5390|urea cycle (GO:0000050)|1/11|0.0946854526218654|0.589963204797776|0|0|10.1010101010101|23.81004955543|ARG1|3
5391|regulation of actin filament depolymerization (GO:0030834)|1/11|0.0946854526218654|0.589243737474852|0|0|10.1010101010101|23.81004955543|PLEK|3
5392|cell-cell junction maintenance (GO:0045217)|1/11|0.0946854526218654|0.588526022812885|0|0|10.1010101010101|23.81004955543|CSF1R|3
5393|relaxation of cardiac muscle (GO:0055119)|1/11|0.0946854526218654|0.587810054415303|0|0|10.1010101010101|23.81004955543|RGS2|3
5394|mitochondrion distribution (GO:0048311)|1/11|0.0946854526218654|0.587095825916621|0|0|10.1010101010101|23.81004955543|MEF2A|3
5395|negative regulation of peptide secretion (GO:0002792)|1/11|0.0946854526218654|0.586383330982256|0|0|10.1010101010101|23.81004955543|CD74|3
5396|negative regulation of amyloid precursor protein catabolic process (GO:1902992)|1/11|0.0946854526218654|0.585672563308338|0|0|10.1010101010101|23.81004955543|APOE|3
5397|negative regulation of myotube differentiation (GO:0010832)|1/11|0.0946854526218654|0.584963516621524|0|0|10.1010101010101|23.81004955543|CFLAR|3
5398|regulation of phosphorylation of RNA polymerase II C-terminal domain (GO:1901407)|1/11|0.0946854526218654|0.584256184678814|0|0|10.1010101010101|23.81004955543|CCNL1|3
5399|monocyte differentiation (GO:0030224)|1/11|0.0946854526218654|0.583550561267366|0|0|10.1010101010101|23.81004955543|CSF1R|3
5400|positive regulation of actin filament depolymerization (GO:0030836)|1/11|0.0946854526218654|0.582846640204317|0|0|10.1010101010101|23.81004955543|PLEK|3
5401|regulation of short-term neuronal synaptic plasticity (GO:0048172)|1/11|0.0946854526218654|0.582144415336601|0|0|10.1010101010101|23.81004955543|SYNGR1|3
5402|regulation of ceramide biosynthetic process (GO:2000303)|1/11|0.0946854526218654|0.581443880540769|0|0|10.1010101010101|23.81004955543|TNF|3
5403|relaxation of muscle (GO:0090075)|1/11|0.0946854526218654|0.580745029722811|0|0|10.1010101010101|23.81004955543|RGS2|3
5404|macrophage differentiation (GO:0030225)|1/11|0.0946854526218654|0.580047856817982|0|0|10.1010101010101|23.81004955543|CSF1R|3
5405|negative regulation of receptor binding (GO:1900121)|1/11|0.0946854526218654|0.579352355790622|0|0|10.1010101010101|23.81004955543|ADAM15|3
5406|icosanoid biosynthetic process (GO:0046456)|1/11|0.0946854526218654|0.578658520633987|0|0|10.1010101010101|23.81004955543|HPGD|3
5407|positive regulation of T cell receptor signaling pathway (GO:0050862)|1/11|0.0946854526218654|0.57796634537007|0|0|10.1010101010101|23.81004955543|KCNN4|3
5408|regulation of cholesterol esterification (GO:0010872)|1/11|0.0946854526218654|0.577275824049437|0|0|10.1010101010101|23.81004955543|APOE|3
5409|cell part morphogenesis (GO:0032990)|1/11|0.0946854526218654|0.576586950751049|0|0|10.1010101010101|23.81004955543|PID1|3
5410|arginine metabolic process (GO:0006525)|1/11|0.0946854526218654|0.575899719582096|0|0|10.1010101010101|23.81004955543|ARG1|3
5411|protein localization to mitochondrion (GO:0070585)|1/11|0.0946854526218654|0.575214124677832|0|0|10.1010101010101|23.81004955543|HK2|3
5412|negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166)|1/11|0.0946854526218654|0.574530160201402|0|0|10.1010101010101|23.81004955543|CD74|3
5413|metanephric mesenchyme development (GO:0072075)|1/11|0.0946854526218654|0.57384782034368|0|0|10.1010101010101|23.81004955543|BASP1|3
5414|negative regulation of cardiac muscle hypertrophy (GO:0010614)|1/11|0.0946854526218654|0.573167099323107|0|0|10.1010101010101|23.81004955543|RGS2|3
5415|inhibition of cysteine-type endopeptidase activity involved in apoptotic process (GO:1990001)|1/11|0.0946854526218654|0.57248799138552|0|0|10.1010101010101|23.81004955543|BIRC3|3
5416|negative regulation of translation, ncRNA-mediated (GO:0040033)|1/11|0.0946854526218654|0.571810490803999|0|0|10.1010101010101|23.81004955543|ZFP36|3
5417|miRNA mediated inhibition of translation (GO:0035278)|1/11|0.0946854526218654|0.571134591878698|0|0|10.1010101010101|23.81004955543|ZFP36|3
5418|protein carboxylation (GO:0018214)|1/11|0.0946854526218654|0.570460288936693|0|0|10.1010101010101|23.81004955543|F10|3
5419|midbrain dopaminergic neuron differentiation (GO:1904948)|1/11|0.0946854526218654|0.569787576331815|0|0|10.1010101010101|23.81004955543|NR4A2|3
5420|peptidyl-glutamic acid carboxylation (GO:0017187)|1/11|0.0946854526218654|0.569116448444498|0|0|10.1010101010101|23.81004955543|F10|3
5421|positive regulation of T-helper cell differentiation (GO:0045624)|1/11|0.0946854526218654|0.568446899681622|0|0|10.1010101010101|23.81004955543|NLRP3|3
5422|alcohol catabolic process (GO:0046164)|1/11|0.0946854526218654|0.567778924476356|0|0|10.1010101010101|23.81004955543|APOE|3
5423|negative regulation of growth (GO:0045926)|3/121|0.0959957137720044|0.574960243402041|0|0|2.75482093663912|6.45578990831777|CDKN1A;BTG1;ADAM15|3
5424|epidermal growth factor receptor signaling pathway (GO:0007173)|2/58|0.0960534475338615|0.574631585891319|0|0|3.83141762452107|8.97643868695398|AREG;EREG|3
5425|stimulatory C-type lectin receptor signaling pathway (GO:0002223)|3/122|0.0977970993565692|0.584377749433926|0|0|2.73224043715847|6.35207748992346|NFKBIA;CLEC4E;MALT1|3
5426|receptor metabolic process (GO:0043112)|2/59|0.0988580827494898|0.590026662304849|0|0|3.76647834274953|8.71589440634062|TNF;LGMN|3
5427|integrin-mediated signaling pathway (GO:0007229)|2/59|0.0988580827494898|0.589337378820848|0|0|3.76647834274953|8.71589440634062|ADAM15;PLEK|3
5428|neutrophil migration (GO:1990266)|2/59|0.0988580827494898|0.588649703933076|0|0|3.76647834274953|8.71589440634062|CCL4;CCL3|3
5429|positive regulation of cell morphogenesis involved in differentiation (GO:0010770)|2/59|0.0988580827494898|0.58796363201707|0|0|3.76647834274953|8.71589440634062|PLXND1;CUX1|3
5430|complement activation, classical pathway (GO:0006958)|3/124|0.101440873425485|0.602622557730208|0|0|2.68817204301075|6.15128811307335|C1QB;C1QA;C1QC|3
5431|tumor necrosis factor-mediated signaling pathway (GO:0033209)|3/124|0.101440873425485|0.601921833825871|0|0|2.68817204301075|6.15128811307335|NFKBIA;TNF;BIRC3|3
5432|cellular calcium ion homeostasis (GO:0006874)|3/124|0.101440873425485|0.601222737619337|0|0|2.68817204301075|6.15128811307335|CCL3;ATP2B1;CCR2|3
5433|regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393)|2/60|0.10168560708529|0.601974075355259|0|0|3.7037037037037|8.46618336738817|GDF15;PMEPA1|3
5434|positive regulation of protein depolymerization (GO:1901881)|1/12|0.102837753570142|0.60808928907119|0|0|9.25925925925926|21.0611364884627|PLEK|3
5435|regulation of myoblast fusion (GO:1901739)|1/12|0.102837753570142|0.607385482023654|0|0|9.25925925925926|21.0611364884627|CFLAR|3
5436|histone H3-K9 demethylation (GO:0033169)|1/12|0.102837753570142|0.606683302275649|0|0|9.25925925925926|21.0611364884627|KDM7A|3
5437|skeletal myofibril assembly (GO:0014866)|1/12|0.102837753570142|0.605982744189881|0|0|9.25925925925926|21.0611364884627|CFLAR|3
5438|regulation of IRE1-mediated unfolded protein response (GO:1903894)|1/12|0.102837753570142|0.60528380215506|0|0|9.25925925925926|21.0611364884627|PTPN1|3
5439|positive regulation of establishment of protein localization (GO:1904951)|1/12|0.102837753570142|0.604586470585757|0|0|9.25925925925926|21.0611364884627|TNF|3
5440|negative regulation of metabolic process (GO:0009892)|1/12|0.102837753570142|0.603890743922252|0|0|9.25925925925926|21.0611364884627|IL1B|3
5441|regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165)|1/12|0.102837753570142|0.603196616630387|0|0|9.25925925925926|21.0611364884627|CD74|3
5442|regulation of cytokine biosynthetic process (GO:0042035)|1/12|0.102837753570142|0.60250408320142|0|0|9.25925925925926|21.0611364884627|EREG|3
5443|regulation of long-term neuronal synaptic plasticity (GO:0048169)|1/12|0.102837753570142|0.601813138151877|0|0|9.25925925925926|21.0611364884627|SYNGR1|3
5444|regulation of cholesterol storage (GO:0010885)|1/12|0.102837753570142|0.60112377602341|0|0|9.25925925925926|21.0611364884627|MSR1|3
5445|cellular response to arsenic-containing substance (GO:0071243)|1/12|0.102837753570142|0.600435991382651|0|0|9.25925925925926|21.0611364884627|ATF3|3
5446|phospholipid efflux (GO:0033700)|1/12|0.102837753570142|0.599749778821071|0|0|9.25925925925926|21.0611364884627|APOE|3
5447|positive regulation of T-helper 1 type immune response (GO:0002827)|1/12|0.102837753570142|0.599065132954836|0|0|9.25925925925926|21.0611364884627|CCR2|3
5448|regulation of bone remodeling (GO:0046850)|1/12|0.102837753570142|0.598382048424671|0|0|9.25925925925926|21.0611364884627|CSF1R|3
5449|regulation of mononuclear cell migration (GO:0071675)|1/12|0.102837753570142|0.597700519895714|0|0|9.25925925925926|21.0611364884627|TNF|3
5450|positive regulation of peptidase activity (GO:0010952)|1/12|0.102837753570142|0.59702054205738|0|0|9.25925925925926|21.0611364884627|CTSH|3
5451|response to interleukin-6 (GO:0070741)|1/12|0.102837753570142|0.596342109623224|0|0|9.25925925925926|21.0611364884627|PID1|3
5452|positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103)|1/12|0.102837753570142|0.595665217330802|0|0|9.25925925925926|21.0611364884627|PTPN1|3
5453|negative regulation of interleukin-1 secretion (GO:0050711)|1/12|0.102837753570142|0.594989859941538|0|0|9.25925925925926|21.0611364884627|NLRP3|3
5454|negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)|1/12|0.102837753570142|0.594316032240585|0|0|9.25925925925926|21.0611364884627|CD74|3
5455|cellular response to fatty acid (GO:0071398)|1/12|0.102837753570142|0.593643729036693|0|0|9.25925925925926|21.0611364884627|PID1|3
5456|regulation of hormone secretion (GO:0046883)|1/12|0.102837753570142|0.592972945162075|0|0|9.25925925925926|21.0611364884627|OSM|3
5457|prostanoid metabolic process (GO:0006692)|1/12|0.102837753570142|0.592303675472276|0|0|9.25925925925926|21.0611364884627|HPGD|3
5458|keratan sulfate catabolic process (GO:0042340)|1/12|0.102837753570142|0.591635914846039|0|0|9.25925925925926|21.0611364884627|HEXB|3
5459|positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949)|1/12|0.102837753570142|0.590969658185177|0|0|9.25925925925926|21.0611364884627|IL1B|3
5460|regulation of catabolic process (GO:0009894)|1/12|0.102837753570142|0.59030490041444|0|0|9.25925925925926|21.0611364884627|FURIN|3
5461|positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725)|1/12|0.102837753570142|0.58964163648139|0|0|9.25925925925926|21.0611364884627|IL1B|3
5462|innate immune response activating cell surface receptor signaling pathway (GO:0002220)|3/125|0.103282972816812|0.591529753405378|0|0|2.66666666666667|6.05408733015137|NFKBIA;CLEC4E;MALT1|3
5463|cell chemotaxis (GO:0060326)|2/61|0.104535387181282|0.598031480701888|0|0|3.64298724954463|8.22670175441488|NR4A1;C3AR1|3
5464|muscle organ development (GO:0007517)|2/61|0.104535387181282|0.597361792593599|0|0|3.64298724954463|8.22670175441488|MEF2A;CXCL10|3
5465|post-translational protein modification (GO:0043687)|6/358|0.105137745317042|0.600131895249289|0|0|1.86219739292365|4.1945696990671|SOCS3;FN1;SPP1;FAM20C;APOE;MFGE8|3
5466|humoral immune response mediated by circulating immunoglobulin (GO:0002455)|3/126|0.105138353232133|0.599464822953712|0|0|2.64550264550265|5.95893689506217|C1QB;C1QA;C1QC|3
5467|actin cytoskeleton reorganization (GO:0031532)|2/62|0.107406799041144|0.611715285164013|0|0|3.584229390681|7.99688814741089|PTPN1;PLEK|3
5468|positive regulation of T cell proliferation (GO:0042102)|2/62|0.107406799041144|0.611033328324365|0|0|3.584229390681|7.99688814741089|IL1B;CCR2|3
5469|regulation of DNA replication (GO:0006275)|2/62|0.107406799041144|0.61035289031955|0|0|3.584229390681|7.99688814741089|AREG;EREG|3
5470|positive regulation of protein kinase B signaling (GO:0051897)|3/128|0.108888371644056|0.618083827029606|0|0|2.60416666666667|5.77456259081426|F10;CCL3;EREG|3
5471|negative regulation of intrinsic apoptotic signaling pathway (GO:2001243)|2/63|0.11029922803175|0.625396622940021|0|0|3.52733686067019|7.77621993493018|MCL1;NFE2L2|3
5472|DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)|2/63|0.11029922803175|0.624702509041087|0|0|3.52733686067019|7.77621993493018|BTG2;CDKN1A|3
5473|negative regulation of peptidase activity (GO:0010466)|2/63|0.11029922803175|0.62400993419736|0|0|3.52733686067019|7.77621993493018|ECM1;TIMP2|3
5474|establishment of protein localization to organelle (GO:0072594)|2/63|0.11029922803175|0.623318893295702|0|0|3.52733686067019|7.77621993493018|MMP12;HK2|3
5475|negative regulation of macrophage derived foam cell differentiation (GO:0010745)|1/13|0.110917048175708|0.626116921283889|0|0|8.54700854700855|18.7946382117972|NFKBIA|3
5476|regulation of nitric-oxide synthase biosynthetic process (GO:0051769)|1/13|0.110917048175708|0.625425079381918|0|0|8.54700854700855|18.7946382117972|TLR2|3
5477|negative regulation of hemostasis (GO:1900047)|1/13|0.110917048175708|0.624734764724763|0|0|8.54700854700855|18.7946382117972|APOE|3
5478|regulation of plasma membrane bounded cell projection organization (GO:0120035)|1/13|0.110917048175708|0.624045972260899|0|0|8.54700854700855|18.7946382117972|FCGR2B|3
5479|mitochondrial genome maintenance (GO:0000002)|1/13|0.110917048175708|0.623358696961052|0|0|8.54700854700855|18.7946382117972|MEF2A|3
5480|intestinal absorption (GO:0050892)|1/13|0.110917048175708|0.622672933818081|0|0|8.54700854700855|18.7946382117972|F11R|3
5481|regulation of oligodendrocyte differentiation (GO:0048713)|1/13|0.110917048175708|0.621988677846852|0|0|8.54700854700855|18.7946382117972|CXCR4|3
5482|renal absorption (GO:0070293)|1/13|0.110917048175708|0.621305924084122|0|0|8.54700854700855|18.7946382117972|SGK1|3
5483|steroid catabolic process (GO:0006706)|1/13|0.110917048175708|0.620624667588416|0|0|8.54700854700855|18.7946382117972|SPP1|3
5484|regulation of glucose import in response to insulin stimulus (GO:2001273)|1/13|0.110917048175708|0.619944903439907|0|0|8.54700854700855|18.7946382117972|PID1|3
5485|regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645)|1/13|0.110917048175708|0.619266626740302|0|0|8.54700854700855|18.7946382117972|IL1B|3
5486|positive regulation of protein complex disassembly (GO:0043243)|1/13|0.110917048175708|0.618589832612716|0|0|8.54700854700855|18.7946382117972|TNF|3
5487|regulation of macrophage differentiation (GO:0045649)|1/13|0.110917048175708|0.617914516201567|0|0|8.54700854700855|18.7946382117972|C1QC|3
5488|regulation of cAMP metabolic process (GO:0030814)|1/13|0.110917048175708|0.617240672672449|0|0|8.54700854700855|18.7946382117972|CXCL10|3
5489|cardiocyte differentiation (GO:0035051)|1/13|0.110917048175708|0.616568297212021|0|0|8.54700854700855|18.7946382117972|KDM6B|3
5490|B cell activation involved in immune response (GO:0002312)|1/13|0.110917048175708|0.615897385027895|0|0|8.54700854700855|18.7946382117972|FCGR2B|3
5491|leukocyte differentiation (GO:0002521)|1/13|0.110917048175708|0.615227931348517|0|0|8.54700854700855|18.7946382117972|TREM2|3
5492|neuron fate commitment (GO:0048663)|1/13|0.110917048175708|0.614559931423057|0|0|8.54700854700855|18.7946382117972|ID2|3
5493|protein localization to endoplasmic reticulum (GO:0070972)|1/13|0.110917048175708|0.613893380521297|0|0|8.54700854700855|18.7946382117972|PPP1R15A|3
5494|prostanoid biosynthetic process (GO:0046457)|1/13|0.110917048175708|0.613228273933516|0|0|8.54700854700855|18.7946382117972|CD74|3
5495|positive regulation of ERAD pathway (GO:1904294)|1/13|0.110917048175708|0.612564606970385|0|0|8.54700854700855|18.7946382117972|NFE2L2|3
5496|triglyceride-rich lipoprotein particle remodeling (GO:0034370)|1/13|0.110917048175708|0.611902374962849|0|0|8.54700854700855|18.7946382117972|APOE|3
5497|mammary gland epithelium development (GO:0061180)|1/13|0.110917048175708|0.611241573262025|0|0|8.54700854700855|18.7946382117972|CSF1R|3
5498|semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285)|1/13|0.110917048175708|0.610582197239089|0|0|8.54700854700855|18.7946382117972|PLXND1|3
5499|regulation of T cell cytokine production (GO:0002724)|1/13|0.110917048175708|0.609924242285168|0|0|8.54700854700855|18.7946382117972|MALT1|3
5500|chondroitin sulfate catabolic process (GO:0030207)|1/13|0.110917048175708|0.609267703811233|0|0|8.54700854700855|18.7946382117972|HEXB|3
5501|positive regulation of alpha-beta T cell proliferation (GO:0046641)|1/13|0.110917048175708|0.608612577247995|0|0|8.54700854700855|18.7946382117972|CCR2|3
5502|glomerular visceral epithelial cell differentiation (GO:0072112)|1/13|0.110917048175708|0.607958858045795|0|0|8.54700854700855|18.7946382117972|BASP1|3
5503|high-density lipoprotein particle assembly (GO:0034380)|1/13|0.110917048175708|0.607306541674502|0|0|8.54700854700855|18.7946382117972|APOE|3
5504|negative regulation of chemokine production (GO:0032682)|1/13|0.110917048175708|0.606655623623404|0|0|8.54700854700855|18.7946382117972|KLF4|3
5505|amyloid precursor protein metabolic process (GO:0042982)|1/13|0.110917048175708|0.606006099401109|0|0|8.54700854700855|18.7946382117972|APOE|3
5506|endothelial cell differentiation (GO:0045446)|1/13|0.110917048175708|0.605357964535439|0|0|8.54700854700855|18.7946382117972|KDM6B|3
5507|response to fatty acid (GO:0070542)|1/13|0.110917048175708|0.604711214573329|0|0|8.54700854700855|18.7946382117972|PID1|3
5508|negative regulation of interleukin-10 production (GO:0032693)|1/13|0.110917048175708|0.604065845080721|0|0|8.54700854700855|18.7946382117972|FCGR2B|3
5509|negative regulation of protein modification process (GO:0031400)|2/64|0.113212068723346|0.615907448502382|0|0|3.47222222222222|7.56421008587537|PPP1R15A;PID1|3
5510|vesicle coating (GO:0006901)|2/64|0.113212068723346|0.615251530026873|0|0|3.47222222222222|7.56421008587537|AREG;CTSC|3
5511|COPII vesicle coating (GO:0048208)|2/64|0.113212068723346|0.61459700712259|0|0|3.47222222222222|7.56421008587537|AREG;CTSC|3
5512|vesicle targeting, rough ER to cis-Golgi (GO:0048207)|2/64|0.113212068723346|0.613943875340313|0|0|3.47222222222222|7.56421008587537|AREG;CTSC|3
5513|negative regulation of neuron apoptotic process (GO:0043524)|2/64|0.113212068723346|0.613292130249718|0|0|3.47222222222222|7.56421008587537|APOE;LGMN|3
5514|signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431)|2/64|0.113212068723346|0.612641767439273|0|0|3.47222222222222|7.56421008587537|BTG2;CDKN1A|3
5515|generation of neurons (GO:0048699)|3/131|0.114609332814958|0.619546001435094|0|0|2.54452926208651|5.51202554667051|NR4A2;ID2;IER2|3
5516|cellular response to decreased oxygen levels (GO:0036294)|2/65|0.116144724733539|0.627181513561111|0|0|3.41880341880342|7.36040423419607|HILPDA;ZFP36L1|3
5517|negative regulation of neuron differentiation (GO:0045665)|2/65|0.116144724733539|0.626518530988636|0|0|3.41880341880342|7.36040423419607|ID2;APOE|3
5518|negative regulation of hydrogen peroxide-induced cell death (GO:1903206)|1/14|0.118923986532153|0.640833266392371|0|0|7.93650793650794|16.8989742746634|NFE2L2|3
5519|mitotic cell cycle arrest (GO:0071850)|1/14|0.118923986532153|0.640157281934151|0|0|7.93650793650794|16.8989742746634|DUSP1|3
5520|positive regulation of cardiac muscle cell proliferation (GO:0060045)|1/14|0.118923986532153|0.639482722100711|0|0|7.93650793650794|16.8989742746634|PIM1|3
5521|lipid particle organization (GO:0034389)|1/14|0.118923986532153|0.638809582393237|0|0|7.93650793650794|16.8989742746634|HILPDA|3
5522|positive regulation of osteoclast differentiation (GO:0045672)|1/14|0.118923986532153|0.638137858331835|0|0|7.93650793650794|16.8989742746634|TNF|3
5523|regulation of lipase activity (GO:0060191)|1/14|0.118923986532153|0.637467545455436|0|0|7.93650793650794|16.8989742746634|FURIN|3
5524|positive regulation of myoblast differentiation (GO:0045663)|1/14|0.118923986532153|0.636798639321695|0|0|7.93650793650794|16.8989742746634|BTG1|3
5525|regulation of platelet aggregation (GO:0090330)|1/14|0.118923986532153|0.636131135506892|0|0|7.93650793650794|16.8989742746634|PDPN|3
5526|positive regulation of response to cytokine stimulus (GO:0060760)|1/14|0.118923986532153|0.635465029605838|0|0|7.93650793650794|16.8989742746634|CD74|3
5527|regulation of extracellular matrix disassembly (GO:0010715)|1/14|0.118923986532153|0.634800317231773|0|0|7.93650793650794|16.8989742746634|PDPN|3
5528|negative regulation of interleukin-1 beta production (GO:0032691)|1/14|0.118923986532153|0.634136994016275|0|0|7.93650793650794|16.8989742746634|NLRP3|3
5529|regulation of secretion (GO:0051046)|1/14|0.118923986532153|0.63347505560916|0|0|7.93650793650794|16.8989742746634|SGK1|3
5530|negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254)|1/14|0.118923986532153|0.632814497678389|0|0|7.93650793650794|16.8989742746634|CD74|3
5531|negative regulation of secretion (GO:0051048)|1/14|0.118923986532153|0.632155315909974|0|0|7.93650793650794|16.8989742746634|CD74|3
5532|regulation of lymphocyte differentiation (GO:0045619)|1/14|0.118923986532153|0.631497506007883|0|0|7.93650793650794|16.8989742746634|ZFP36L1|3
5533|regulation of defense response to virus (GO:0050688)|1/14|0.118923986532153|0.630841063693945|0|0|7.93650793650794|16.8989742746634|TNFAIP3|3
5534|regulation of neural precursor cell proliferation (GO:2000177)|1/14|0.118923986532153|0.630185984707762|0|0|7.93650793650794|16.8989742746634|ID2|3
5535|cell migration involved in sprouting angiogenesis (GO:0002042)|1/14|0.118923986532153|0.629532264806613|0|0|7.93650793650794|16.8989742746634|NR4A1|3
5536|cellular response to osmotic stress (GO:0071470)|1/14|0.118923986532153|0.628879899765363|0|0|7.93650793650794|16.8989742746634|ZFP36L1|3
5537|negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051)|1/14|0.118923986532153|0.628228885376372|0|0|7.93650793650794|16.8989742746634|KLF4|3
5538|necroptotic process (GO:0070266)|1/14|0.118923986532153|0.627579217449406|0|0|7.93650793650794|16.8989742746634|CD14|3
5539|epiboly involved in wound healing (GO:0090505)|1/14|0.118923986532153|0.626930891811545|0|0|7.93650793650794|16.8989742746634|PDPN|3
5540|positive regulation of vascular smooth muscle cell proliferation (GO:1904707)|1/14|0.118923986532153|0.626283904307095|0|0|7.93650793650794|16.8989742746634|JUN|3
5541|fatty acid transport (GO:0015908)|1/14|0.118923986532153|0.6256382507975|0|0|7.93650793650794|16.8989742746634|APOE|3
5542|negative regulation of smooth muscle cell migration (GO:0014912)|1/14|0.118923986532153|0.624993927161251|0|0|7.93650793650794|16.8989742746634|TRIB1|3
5543|positive regulation of purine nucleotide metabolic process (GO:1900544)|1/14|0.118923986532153|0.624350929293802|0|0|7.93650793650794|16.8989742746634|CXCL10|3
5544|positive regulation of muscle hypertrophy (GO:0014742)|1/14|0.118923986532153|0.623709253107477|0|0|7.93650793650794|16.8989742746634|MEF2A|3
5545|interleukin-6-mediated signaling pathway (GO:0070102)|1/14|0.118923986532153|0.623068894531391|0|0|7.93650793650794|16.8989742746634|SOCS3|3
5546|regulation of protein modification by small protein conjugation or removal (GO:1903320)|1/14|0.118923986532153|0.622429849511359|0|0|7.93650793650794|16.8989742746634|EGR1|3
5547|positive regulation of transporter activity (GO:0032411)|1/14|0.118923986532153|0.621792114009811|0|0|7.93650793650794|16.8989742746634|SGK1|3
5548|regulation of response to interferon-gamma (GO:0060330)|1/14|0.118923986532153|0.621155684005706|0|0|7.93650793650794|16.8989742746634|SOCS3|3
5549|regulation of adaptive immune response (GO:0002819)|1/14|0.118923986532153|0.620520555494453|0|0|7.93650793650794|16.8989742746634|FCGR2B|3
5550|regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266)|1/14|0.118923986532153|0.619886724487819|0|0|7.93650793650794|16.8989742746634|DUSP1|3
5551|glycolipid metabolic process (GO:0006664)|2/66|0.119096608667195|0.620153055131322|0|0|3.36700336700337|7.16437803937038|GM2A;HEXB|3
5552|positive regulation of protein modification by small protein conjugation or removal (GO:1903322)|2/66|0.119096608667195|0.619520890956877|0|0|3.36700336700337|7.16437803937038|MALT1;BIRC3|3
5553|negative regulation of blood vessel morphogenesis (GO:2000181)|2/66|0.119096608667195|0.618890014285841|0|0|3.36700336700337|7.16437803937038|KLF4;CCR2|3
5554|negative regulation of epithelial cell proliferation (GO:0050680)|2/67|0.122067142025483|0.6336812062625|0|0|3.3167495854063|6.97573479655619|APOE;EREG|3
5555|positive regulation of endothelial cell proliferation (GO:0001938)|2/68|0.125055754993881|0.648536095257901|0|0|3.26797385620915|6.79410327181385|NR4A1;ECM1|3
5556|extrinsic apoptotic signaling pathway (GO:0097191)|2/68|0.125055754993881|0.647877682978451|0|0|3.26797385620915|6.79410327181385|TNF;MCL1|3
5557|regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079)|2/68|0.125055754993881|0.647220606220867|0|0|3.26797385620915|6.79410327181385|CDKN1A;CCNL1|3
5558|cellular response to UV (GO:0034644)|2/68|0.125055754993881|0.64656486092581|0|0|3.26797385620915|6.79410327181385|CDKN1A;CRIP1|3
5559|regulation of protein localization to plasma membrane (GO:1903076)|2/68|0.125055754993881|0.645910443050379|0|0|3.26797385620915|6.79410327181385|PID1;TREM2|3
5560|positive regulation of peptidyl-lysine acetylation (GO:2000758)|1/15|0.126859212982619|0.654562754145909|0|0|7.40740740740741|15.2939064194203|IL1B|3
5561|atrioventricular valve morphogenesis (GO:0003181)|1/15|0.126859212982619|0.653901579646771|0|0|7.40740740740741|15.2939064194203|OLFM1|3
5562|myeloid cell development (GO:0061515)|1/15|0.126859212982619|0.653241739505856|0|0|7.40740740740741|15.2939064194203|TLR2|3
5563|positive regulation of alpha-beta T cell activation (GO:0046635)|1/15|0.126859212982619|0.652583229687806|0|0|7.40740740740741|15.2939064194203|CCR2|3
5564|vitamin D metabolic process (GO:0042359)|1/15|0.126859212982619|0.651926046173518|0|0|7.40740740740741|15.2939064194203|LGMN|3
5565|digestive tract morphogenesis (GO:0048546)|1/15|0.126859212982619|0.651270184960064|0|0|7.40740740740741|15.2939064194203|ID2|3
5566|regulation of protein homooligomerization (GO:0032462)|1/15|0.126859212982619|0.650615642060607|0|0|7.40740740740741|15.2939064194203|APOE|3
5567|positive regulation of mesonephros development (GO:0061213)|1/15|0.126859212982619|0.649962413504321|0|0|7.40740740740741|15.2939064194203|BASP1|3
5568|lipoxygenase pathway (GO:0019372)|1/15|0.126859212982619|0.649310495336313|0|0|7.40740740740741|15.2939064194203|HPGD|3
5569|positive regulation of cytokine production involved in immune response (GO:0002720)|1/15|0.126859212982619|0.648659883617539|0|0|7.40740740740741|15.2939064194203|MALT1|3
5570|unsaturated fatty acid biosynthetic process (GO:0006636)|1/15|0.126859212982619|0.648010574424728|0|0|7.40740740740741|15.2939064194203|HPGD|3
5571|cardiac muscle cell differentiation (GO:0055007)|1/15|0.126859212982619|0.647362563850304|0|0|7.40740740740741|15.2939064194203|KDM6B|3
5572|negative regulation of coagulation (GO:0050819)|1/15|0.126859212982619|0.646715848002301|0|0|7.40740740740741|15.2939064194203|APOE|3
5573|mitochondrion localization (GO:0051646)|1/15|0.126859212982619|0.646070423004295|0|0|7.40740740740741|15.2939064194203|MEF2A|3
5574|nitric oxide mediated signal transduction (GO:0007263)|1/15|0.126859212982619|0.645426284995318|0|0|7.40740740740741|15.2939064194203|APOE|3
5575|positive regulation of phosphoprotein phosphatase activity (GO:0032516)|1/15|0.126859212982619|0.644783430129785|0|0|7.40740740740741|15.2939064194203|PPP1R15A|3
5576|negative regulation of muscle cell differentiation (GO:0051148)|1/15|0.126859212982619|0.644141854577417|0|0|7.40740740740741|15.2939064194203|EREG|3
5577|negative regulation of signal transduction by p53 class mediator (GO:1901797)|1/15|0.126859212982619|0.643501554523165|0|0|7.40740740740741|15.2939064194203|CD74|3
5578|negative regulation of axon extension involved in axon guidance (GO:0048843)|1/15|0.126859212982619|0.642862526167134|0|0|7.40740740740741|15.2939064194203|SEMA4D|3
5579|negative regulation of platelet activation (GO:0010544)|1/15|0.126859212982619|0.642224765724508|0|0|7.40740740740741|15.2939064194203|APOE|3
5580|negative regulation of cytokine production involved in immune response (GO:0002719)|1/15|0.126859212982619|0.641588269425474|0|0|7.40740740740741|15.2939064194203|TNF|3
5581|negative regulation of DNA-dependent DNA replication (GO:2000104)|1/15|0.126859212982619|0.640953033515152|0|0|7.40740740740741|15.2939064194203|PID1|3
5582|JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397)|1/15|0.126859212982619|0.640319054253515|0|0|7.40740740740741|15.2939064194203|PTPN1|3
5583|regulation of protein complex disassembly (GO:0043244)|1/15|0.126859212982619|0.63968632791532|0|0|7.40740740740741|15.2939064194203|TNF|3
5584|toll-like receptor 4 signaling pathway (GO:0034142)|1/15|0.126859212982619|0.639054850790033|0|0|7.40740740740741|15.2939064194203|CD14|3
5585|positive regulation of protein export from nucleus (GO:0046827)|1/15|0.126859212982619|0.638424619181759|0|0|7.40740740740741|15.2939064194203|IL1B|3
5586|cytoplasmic sequestering of protein (GO:0051220)|1/15|0.126859212982619|0.637795629409166|0|0|7.40740740740741|15.2939064194203|NFKBIA|3
5587|regulation of peptide secretion (GO:0002791)|1/15|0.126859212982619|0.637167877805417|0|0|7.40740740740741|15.2939064194203|CD74|3
5588|negative regulation of anoikis (GO:2000811)|1/15|0.126859212982619|0.636541360718096|0|0|7.40740740740741|15.2939064194203|MCL1|3
5589|inhibition of cysteine-type endopeptidase activity (GO:0097340)|1/15|0.126859212982619|0.635916074509139|0|0|7.40740740740741|15.2939064194203|BIRC3|3
5590|negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154)|2/69|0.128061886461871|0.641314824941046|0|0|3.22061191626409|6.61913572921678|KLF4;BIRC3|3
5591|negative regulation of phosphatase activity (GO:0010923)|2/69|0.128061886461871|0.640686084916594|0|0|3.22061191626409|6.61913572921678|PPP1R15A;SEMA4D|3
5592|COPII-coated vesicle budding (GO:0090114)|2/69|0.128061886461871|0.640058576508253|0|0|3.22061191626409|6.61913572921678|AREG;CTSC|3
5593|positive regulation of T cell activation (GO:0050870)|2/69|0.128061886461871|0.639432296100711|0|0|3.22061191626409|6.61913572921678|IL1B;CCR2|3
5594|positive regulation of transferase activity (GO:0051347)|3/138|0.128385096720699|0.64041950006425|0|0|2.41545893719807|4.95826319714071|CSF1R;CD74;KLF4|3
5595|regulation of endothelial cell migration (GO:0010594)|2/70|0.131084983815741|0.653248703527077|0|0|3.17460317460317|6.45050614189961|ANXA3;SASH1|3
5596|regulation of endocytosis (GO:0030100)|2/70|0.131084983815741|0.652611387718758|0|0|3.17460317460317|6.45050614189961|PTPN1;APOE|3
5597|negative regulation of angiogenesis (GO:0016525)|2/70|0.131084983815741|0.651975314241449|0|0|3.17460317460317|6.45050614189961|KLF4;CCR2|3
5598|positive regulation of endothelial cell migration (GO:0010595)|2/71|0.134124502865758|0.666443367209311|0|0|3.12989045383412|6.28790855880319|ANXA3;SASH1|3
5599|interferon-gamma-mediated signaling pathway (GO:0060333)|2/71|0.134124502865758|0.665795075996072|0|0|3.12989045383412|6.28790855880319|PTAFR;ICAM1|3
5600|negative regulation of developmental process (GO:0051093)|2/71|0.134124502865758|0.665148044824065|0|0|3.12989045383412|6.28790855880319|SKIL;HOPX|3
5601|regulation of cellular component organization (GO:0051128)|3/141|0.134462178092774|0.666175237677111|0|0|2.36406619385343|4.74343338831356|PTPN1;SEMA4D;SGK1|3
5602|peptidyl-threonine dephosphorylation (GO:0035970)|1/16|0.134723366224801|0.666821860179591|0|0|6.94444444444444|13.9203593192864|DUSP1|3
5603|postsynaptic membrane organization (GO:0001941)|1/16|0.134723366224801|0.666175714966239|0|0|6.94444444444444|13.9203593192864|APOE|3
5604|positive regulation of secretion (GO:0051047)|1/16|0.134723366224801|0.665530820760076|0|0|6.94444444444444|13.9203593192864|SPP1|3
5605|positive regulation of cardiac muscle tissue growth (GO:0055023)|1/16|0.134723366224801|0.664887173931488|0|0|6.94444444444444|13.9203593192864|PIM1|3
5606|DNA alkylation (GO:0006305)|1/16|0.134723366224801|0.664244770864888|0|0|6.94444444444444|13.9203593192864|FOS|3
5607|positive regulation of dendrite morphogenesis (GO:0050775)|1/16|0.134723366224801|0.663603607958647|0|0|6.94444444444444|13.9203593192864|CUX1|3
5608|leukocyte tethering or rolling (GO:0050901)|1/16|0.134723366224801|0.662963681625032|0|0|6.94444444444444|13.9203593192864|TNF|3
5609|hyaluronan catabolic process (GO:0030214)|1/16|0.134723366224801|0.662324988290134|0|0|6.94444444444444|13.9203593192864|HEXB|3
5610|regulation of RIG-I signaling pathway (GO:0039535)|1/16|0.134723366224801|0.6616875243938|0|0|6.94444444444444|13.9203593192864|BIRC3|3
5611|activation of NF-kappaB-inducing kinase activity (GO:0007250)|1/16|0.134723366224801|0.661051286389576|0|0|6.94444444444444|13.9203593192864|MALT1|3
5612|cytoplasmic sequestering of transcription factor (GO:0042994)|1/16|0.134723366224801|0.660416270744629|0|0|6.94444444444444|13.9203593192864|NFKBIA|3
5613|stabilization of membrane potential (GO:0030322)|1/16|0.134723366224801|0.659782473939692|0|0|6.94444444444444|13.9203593192864|KCNN4|3
5614|negative regulation of steroid biosynthetic process (GO:0010894)|1/16|0.134723366224801|0.659149892468992|0|0|6.94444444444444|13.9203593192864|APOE|3
5615|leukocyte adhesion to vascular endothelial cell (GO:0061756)|1/16|0.134723366224801|0.65851852284019|0|0|6.94444444444444|13.9203593192864|TNF|3
5616|positive regulation of lymphocyte differentiation (GO:0045621)|1/16|0.134723366224801|0.657888361574315|0|0|6.94444444444444|13.9203593192864|MMP14|3
5617|regulation of bicellular tight junction assembly (GO:2000810)|1/16|0.134723366224801|0.657259405205697|0|0|6.94444444444444|13.9203593192864|TNF|3
5618|positive regulation of cardiac muscle hypertrophy (GO:0010613)|1/16|0.134723366224801|0.656631650281909|0|0|6.94444444444444|13.9203593192864|MEF2A|3
5619|DNA methylation or demethylation (GO:0044728)|1/16|0.134723366224801|0.656005093363701|0|0|6.94444444444444|13.9203593192864|FOS|3
5620|glutamine family amino acid catabolic process (GO:0009065)|1/16|0.134723366224801|0.655379731024937|0|0|6.94444444444444|13.9203593192864|ARG1|3
5621|positive regulation of macrophage derived foam cell differentiation (GO:0010744)|1/16|0.134723366224801|0.654755559852532|0|0|6.94444444444444|13.9203593192864|MSR1|3
5622|positive regulation of myotube differentiation (GO:0010831)|1/16|0.134723366224801|0.654132576446393|0|0|6.94444444444444|13.9203593192864|MMP14|3
5623|regulation of steroid metabolic process (GO:0019218)|1/16|0.134723366224801|0.653510777419352|0|0|6.94444444444444|13.9203593192864|APOE|3
5624|positive regulation of cyclic nucleotide metabolic process (GO:0030801)|1/16|0.134723366224801|0.652890159397112|0|0|6.94444444444444|13.9203593192864|CXCL10|3
5625|positive regulation of nitric-oxide synthase activity (GO:0051000)|1/16|0.134723366224801|0.652270719018177|0|0|6.94444444444444|13.9203593192864|APOE|3
5626|cardiac epithelial to mesenchymal transition (GO:0060317)|1/16|0.134723366224801|0.6516524529338|0|0|6.94444444444444|13.9203593192864|OLFM1|3
5627|G-protein coupled acetylcholine receptor signaling pathway (GO:0007213)|1/16|0.134723366224801|0.651035357807915|0|0|6.94444444444444|13.9203593192864|RGS10|3
5628|regulation of stem cell proliferation (GO:0072091)|1/16|0.134723366224801|0.650419430317085|0|0|6.94444444444444|13.9203593192864|ZFP36L1|3
5629|regulation of glucose transport (GO:0010827)|1/16|0.134723366224801|0.649804667150434|0|0|6.94444444444444|13.9203593192864|IL1B|3
5630|programmed necrotic cell death (GO:0097300)|1/16|0.134723366224801|0.649191065009593|0|0|6.94444444444444|13.9203593192864|CD14|3
5631|positive regulation of DNA-templated transcription, initiation (GO:2000144)|1/16|0.134723366224801|0.64857862060864|0|0|6.94444444444444|13.9203593192864|JUN|3
5632|positive regulation of lymphocyte proliferation (GO:0050671)|2/72|0.137179907755477|0.659782346160413|0|0|3.08641975308642|6.13105561526353|CD74;IL1B|3
5633|positive regulation of growth (GO:0045927)|2/72|0.137179907755477|0.659161082180978|0|0|3.08641975308642|6.13105561526353|MMP14;CXCL16|3
5634|response to metal ion (GO:0010038)|2/73|0.140250670832588|0.673282383122011|0|0|3.0441400304414|5.97967717342682|IL1A;CRIP1|3
5635|regulation of protein sumoylation (GO:0033233)|1/17|0.142517079195594|0.683519412720972|0|0|6.5359477124183|12.7339440029489|EGR1|3
5636|cardiac myofibril assembly (GO:0055003)|1/17|0.142517079195594|0.682877610455506|0|0|6.5359477124183|12.7339440029489|MEF2A|3
5637|high-density lipoprotein particle remodeling (GO:0034375)|1/17|0.142517079195594|0.68223701232187|0|0|6.5359477124183|12.7339440029489|APOE|3
5638|reverse cholesterol transport (GO:0043691)|1/17|0.142517079195594|0.681597614934502|0|0|6.5359477124183|12.7339440029489|APOE|3
5639|negative regulation of axon guidance (GO:1902668)|1/17|0.142517079195594|0.680959414920519|0|0|6.5359477124183|12.7339440029489|SEMA4D|3
5640|regulation of toll-like receptor 4 signaling pathway (GO:0034143)|1/17|0.142517079195594|0.680322408919657|0|0|6.5359477124183|12.7339440029489|TNFAIP3|3
5641|positive regulation of nitrogen compound metabolic process (GO:0051173)|1/17|0.142517079195594|0.679686593584218|0|0|6.5359477124183|12.7339440029489|KLF4|3
5642|positive regulation of striated muscle cell differentiation (GO:0051155)|1/17|0.142517079195594|0.679051965579004|0|0|6.5359477124183|12.7339440029489|MMP14|3
5643|positive regulation of antigen receptor-mediated signaling pathway (GO:0050857)|1/17|0.142517079195594|0.678418521581263|0|0|6.5359477124183|12.7339440029489|KCNN4|3
5644|negative regulation of interleukin-8 production (GO:0032717)|1/17|0.142517079195594|0.677786258280628|0|0|6.5359477124183|12.7339440029489|KLF4|3
5645|3'-UTR-mediated mRNA stabilization (GO:0070935)|1/17|0.142517079195594|0.677155172379063|0|0|6.5359477124183|12.7339440029489|ZFP36|3
5646|virion assembly (GO:0019068)|1/17|0.142517079195594|0.676525260590804|0|0|6.5359477124183|12.7339440029489|APOE|3
5647|chaperone-mediated protein complex assembly (GO:0051131)|1/17|0.142517079195594|0.675896519642299|0|0|6.5359477124183|12.7339440029489|HOPX|3
5648|positive regulation by host of viral transcription (GO:0043923)|1/17|0.142517079195594|0.675268946272158|0|0|6.5359477124183|12.7339440029489|JUN|3
5649|regulation of T cell migration (GO:2000404)|1/17|0.142517079195594|0.674642537231089|0|0|6.5359477124183|12.7339440029489|CXCL10|3
5650|regulation of lamellipodium organization (GO:1902743)|1/17|0.142517079195594|0.674017289281848|0|0|6.5359477124183|12.7339440029489|PDPN|3
5651|positive regulation of cation transmembrane transport (GO:1904064)|1/17|0.142517079195594|0.673393199199179|0|0|6.5359477124183|12.7339440029489|CTSS|3
5652|platelet-derived growth factor receptor signaling pathway (GO:0048008)|1/17|0.142517079195594|0.672770263769763|0|0|6.5359477124183|12.7339440029489|PTPN1|3
5653|positive regulation of transcription of Notch receptor target (GO:0007221)|1/17|0.142517079195594|0.672148479792157|0|0|6.5359477124183|12.7339440029489|PLXND1|3
5654|positive regulation of proteasomal protein catabolic process (GO:1901800)|2/74|0.143336272594381|0.675387810756351|0|0|3.003003003003|5.83351907717858|TRIB1;CBFA2T3|3
5655|regulation of G-protein coupled receptor protein signaling pathway (GO:0008277)|2/75|0.146436201498844|0.689357874768083|0|0|2.96296296296296|5.69234201489043|RGS2;PLEK|3
5656|negative regulation of cellular amide metabolic process (GO:0034249)|2/76|0.149549953957273|0.703367202805495|0|0|2.92397660818713|5.55592047304494|BTG2;APOE|3
5657|regulation of actin cytoskeleton organization (GO:0032956)|2/76|0.149549953957273|0.702719535031273|0|0|2.92397660818713|5.55592047304494|CSF1R;F11R|3
5658|regulation of amyloid-beta formation (GO:1902003)|1/18|0.150240979381305|0.70531712767507|0|0|6.17283950617284|11.7007083010171|APOE|3
5659|positive regulation of lipid catabolic process (GO:0050996)|1/18|0.150240979381305|0.704668858256251|0|0|6.17283950617284|11.7007083010171|IL1B|3
5660|maintenance of protein localization in organelle (GO:0072595)|1/18|0.150240979381305|0.704021779414878|0|0|6.17283950617284|11.7007083010171|HK2|3
5661|positive regulation of cyclic nucleotide biosynthetic process (GO:0030804)|1/18|0.150240979381305|0.70337588787413|0|0|6.17283950617284|11.7007083010171|APOE|3
5662|anion homeostasis (GO:0055081)|1/18|0.150240979381305|0.702731180369204|0|0|6.17283950617284|11.7007083010171|APOE|3
5663|regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175)|1/18|0.150240979381305|0.702087653647254|0|0|6.17283950617284|11.7007083010171|NFE2L2|3
5664|negative regulation of protein dephosphorylation (GO:0035308)|1/18|0.150240979381305|0.701445304467339|0|0|6.17283950617284|11.7007083010171|PPP1R15A|3
5665|prostaglandin biosynthetic process (GO:0001516)|1/18|0.150240979381305|0.700804129600367|0|0|6.17283950617284|11.7007083010171|CD74|3
5666|regulation of cardiac muscle cell proliferation (GO:0060043)|1/18|0.150240979381305|0.700164125829043|0|0|6.17283950617284|11.7007083010171|PIM1|3
5667|regulation of cAMP-mediated signaling (GO:0043949)|1/18|0.150240979381305|0.699525289947812|0|0|6.17283950617284|11.7007083010171|CXCL10|3
5668|negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176)|1/18|0.150240979381305|0.698887618762809|0|0|6.17283950617284|11.7007083010171|NFE2L2|3
5669|blood vessel endothelial cell migration (GO:0043534)|1/18|0.150240979381305|0.698251109091805|0|0|6.17283950617284|11.7007083010171|NR4A1|3
5670|regulation of epithelial cell differentiation (GO:0030856)|1/18|0.150240979381305|0.697615757764151|0|0|6.17283950617284|11.7007083010171|CEBPB|3
5671|DNA methylation (GO:0006306)|1/18|0.150240979381305|0.696981561620729|0|0|6.17283950617284|11.7007083010171|FOS|3
5672|regulation of smooth muscle cell migration (GO:0014910)|1/18|0.150240979381305|0.696348517513898|0|0|6.17283950617284|11.7007083010171|TRIB1|3
5673|negative regulation of calcium-mediated signaling (GO:0050849)|1/18|0.150240979381305|0.695716622307442|0|0|6.17283950617284|11.7007083010171|PLEK|3
5674|nucleic acid-templated transcription (GO:0097659)|2/77|0.152677034129714|0.706356215017163|0|0|2.88600288600289|5.42404177978408|MEF2A;NR4A2|3
5675|response to interleukin-1 (GO:0070555)|2/77|0.152677034129714|0.70571639960501|0|0|2.88600288600289|5.42404177978408|CCL4;CCL3|3
5676|negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101)|2/78|0.155816953985371|0.719578204694432|0|0|2.84900284900285|5.29650522097156|PMEPA1;SKIL|3
5677|regulation of mitotic spindle assembly (GO:1901673)|1/19|0.157895688585912|0.728518715057783|0|0|5.84795321637427|10.7942728819048|PMEPA1|3
5678|regulation of sprouting angiogenesis (GO:1903670)|1/19|0.157895688585912|0.727860613237496|0|0|5.84795321637427|10.7942728819048|KLF4|3
5679|negative regulation of cell junction assembly (GO:1901889)|1/19|0.157895688585912|0.727203699326632|0|0|5.84795321637427|10.7942728819048|TNF|3
5680|negative regulation of protein localization to plasma membrane (GO:1903077)|1/19|0.157895688585912|0.72654797011173|0|0|5.84795321637427|10.7942728819048|PID1|3
5681|positive regulation of heart contraction (GO:0045823)|1/19|0.157895688585912|0.725893422390908|0|0|5.84795321637427|10.7942728819048|RGS2|3
5682|regulation of long-term synaptic potentiation (GO:1900271)|1/19|0.157895688585912|0.725240052973815|0|0|5.84795321637427|10.7942728819048|APOE|3
5683|acetylcholine receptor signaling pathway (GO:0095500)|1/19|0.157895688585912|0.724587858681572|0|0|5.84795321637427|10.7942728819048|RGS10|3
5684|endothelial cell development (GO:0001885)|1/19|0.157895688585912|0.723936836346728|0|0|5.84795321637427|10.7942728819048|ICAM1|3
5685|regulation of myotube differentiation (GO:0010830)|1/19|0.157895688585912|0.723286982813203|0|0|5.84795321637427|10.7942728819048|MMP14|3
5686|positive regulation of oxidoreductase activity (GO:0051353)|1/19|0.157895688585912|0.72263829493624|0|0|5.84795321637427|10.7942728819048|TNF|3
5687|positive regulation of toll-like receptor signaling pathway (GO:0034123)|1/19|0.157895688585912|0.721990769582355|0|0|5.84795321637427|10.7942728819048|TLR2|3
5688|osteoclast differentiation (GO:0030316)|1/19|0.157895688585912|0.721344403629282|0|0|5.84795321637427|10.7942728819048|CSF1R|3
5689|regulation of transcription factor import into nucleus (GO:0042990)|1/19|0.157895688585912|0.720699193965928|0|0|5.84795321637427|10.7942728819048|NFKBIA|3
5690|extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192)|1/19|0.157895688585912|0.720055137492322|0|0|5.84795321637427|10.7942728819048|MCL1|3
5691|striated muscle cell differentiation (GO:0051146)|1/19|0.157895688585912|0.719412231119561|0|0|5.84795321637427|10.7942728819048|KDM6B|3
5692|macromolecule biosynthetic process (GO:0009059)|1/19|0.157895688585912|0.718770471769766|0|0|5.84795321637427|10.7942728819048|TNF|3
5693|negative regulation of protein localization to cell periphery (GO:1904376)|1/19|0.157895688585912|0.718129856376032|0|0|5.84795321637427|10.7942728819048|PID1|3
5694|positive regulation of blood coagulation (GO:0030194)|1/19|0.157895688585912|0.717490381882376|0|0|5.84795321637427|10.7942728819048|PLEK|3
5695|positive regulation of epithelial cell differentiation (GO:0030858)|1/19|0.157895688585912|0.71685204524369|0|0|5.84795321637427|10.7942728819048|BTG1|3
5696|protein heterotetramerization (GO:0051290)|1/19|0.157895688585912|0.716214843425696|0|0|5.84795321637427|10.7942728819048|CD74|3
5697|activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919)|2/80|0.16213339829193|0.734783953360319|0|0|2.77777777777778|5.05371065652536|CFLAR;TNF|3
5698|regulation of transforming growth factor beta receptor signaling pathway (GO:0017015)|2/80|0.16213339829193|0.734131971147932|0|0|2.77777777777778|5.05371065652536|PMEPA1;SKIL|3
5699|RNA transport (GO:0050658)|2/81|0.165308984268871|0.747847293195081|0|0|2.74348422496571|4.93810404482386|ZFP36;ZFP36L1|3
5700|regulation of phosphatidylinositol 3-kinase signaling (GO:0014066)|2/81|0.165308984268871|0.747184895238309|0|0|2.74348422496571|4.93810404482386|SEMA4D;IER3|3
5701|NIK/NF-kappaB signaling (GO:0038061)|2/81|0.165308984268871|0.746523669667302|0|0|2.74348422496571|4.93810404482386|MALT1;BIRC3|3
5702|negative regulation of innate immune response (GO:0045824)|1/20|0.16548182319021|0.746643451582351|0|0|5.55555555555556|9.99385511035082|TNFAIP3|3
5703|mesoderm formation (GO:0001707)|1/20|0.16548182319021|0.745983872561519|0|0|5.55555555555556|9.99385511035082|KDM6B|3
5704|positive regulation of dendritic spine development (GO:0060999)|1/20|0.16548182319021|0.745325457846107|0|0|5.55555555555556|9.99385511035082|APOE|3
5705|regulation of lipoprotein lipase activity (GO:0051004)|1/20|0.16548182319021|0.744668204355943|0|0|5.55555555555556|9.99385511035082|FURIN|3
5706|negative regulation of cyclase activity (GO:0031280)|1/20|0.16548182319021|0.744012109021709|0|0|5.55555555555556|9.99385511035082|CCR2|3
5707|regulation of cholesterol transport (GO:0032374)|1/20|0.16548182319021|0.743357168784894|0|0|5.55555555555556|9.99385511035082|APOE|3
5708|androgen metabolic process (GO:0008209)|1/20|0.16548182319021|0.742703380597748|0|0|5.55555555555556|9.99385511035082|SPP1|3
5709|negative regulation of response to biotic stimulus (GO:0002832)|1/20|0.16548182319021|0.742050741423233|0|0|5.55555555555556|9.99385511035082|TRIB1|3
5710|regulation of anoikis (GO:2000209)|1/20|0.16548182319021|0.741399248234977|0|0|5.55555555555556|9.99385511035082|MCL1|3
5711|positive regulation of gene silencing by miRNA (GO:2000637)|1/20|0.16548182319021|0.740748898017227|0|0|5.55555555555556|9.99385511035082|ZFP36|3
5712|glial cell development (GO:0021782)|1/20|0.16548182319021|0.740099687764802|0|0|5.55555555555556|9.99385511035082|TLR2|3
5713|regulation of response to cytokine stimulus (GO:0060759)|1/20|0.16548182319021|0.739451614483047|0|0|5.55555555555556|9.99385511035082|KLF4|3
5714|growth hormone receptor signaling pathway (GO:0060396)|1/20|0.16548182319021|0.738804675187786|0|0|5.55555555555556|9.99385511035082|PTPN1|3
5715|negative regulation of adenylate cyclase activity (GO:0007194)|1/20|0.16548182319021|0.738158866905279|0|0|5.55555555555556|9.99385511035082|CCR2|3
5716|immune response-activating cell surface receptor signaling pathway (GO:0002429)|1/20|0.16548182319021|0.737514186672174|0|0|5.55555555555556|9.99385511035082|C3AR1|3
5717|dopaminergic neuron differentiation (GO:0071542)|1/20|0.16548182319021|0.736870631535462|0|0|5.55555555555556|9.99385511035082|NR4A2|3
5718|DNA damage response, signal transduction by p53 class mediator (GO:0030330)|2/83|0.171692592781858|0.763859896221293|0|0|2.67737617135208|4.71766975227855|BTG2;CDKN1A|3
5719|positive regulation of protein secretion (GO:0050714)|2/83|0.171692592781858|0.763194513036431|0|0|2.67737617135208|4.71766975227855|IL1A;TNF|3
5720|positive regulation of DNA metabolic process (GO:0051054)|2/83|0.171692592781858|0.762530288046843|0|0|2.67737617135208|4.71766975227855|AREG;EREG|3
5721|axon guidance (GO:0007411)|3/159|0.172840419822544|0.766960575960383|0|0|2.09643605870021|3.68005563722223|DOK2;PLXND1;CXCR4|3
5722|positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522)|1/21|0.172999994091333|0.767001711423175|0|0|5.29100529100529|9.28287681819312|NFE2L2|3
5723|mRNA transcription (GO:0009299)|1/21|0.172999994091333|0.766335911326454|0|0|5.29100529100529|9.28287681819312|EREG|3
5724|dendritic cell differentiation (GO:0097028)|1/21|0.172999994091333|0.76567126613016|0|0|5.29100529100529|9.28287681819312|TREM2|3
5725|energy reserve metabolic process (GO:0006112)|1/21|0.172999994091333|0.765007772831954|0|0|5.29100529100529|9.28287681819312|PID1|3
5726|positive regulation of translational initiation (GO:0045948)|1/21|0.172999994091333|0.764345428439892|0|0|5.29100529100529|9.28287681819312|PPP1R15A|3
5727|positive regulation of histone acetylation (GO:0035066)|1/21|0.172999994091333|0.763684229972383|0|0|5.29100529100529|9.28287681819312|IL1B|3
5728|response to nicotine (GO:0035094)|1/21|0.172999994091333|0.763024174458146|0|0|5.29100529100529|9.28287681819312|TNF|3
5729|negative regulation of viral process (GO:0048525)|1/21|0.172999994091333|0.762365258936161|0|0|5.29100529100529|9.28287681819312|ZFP36|3
5730|cellular response to alkaloid (GO:0071312)|1/21|0.172999994091333|0.76170748045563|0|0|5.29100529100529|9.28287681819312|TNF|3
5731|negative regulation of cAMP biosynthetic process (GO:0030818)|1/21|0.172999994091333|0.761050836075926|0|0|5.29100529100529|9.28287681819312|CCR2|3
5732|negative regulation of cyclin-dependent protein kinase activity (GO:1904030)|1/21|0.172999994091333|0.760395322866559|0|0|5.29100529100529|9.28287681819312|CDKN1A|3
5733|positive regulation of protein ubiquitination (GO:0031398)|2/84|0.17489972053599|0.768083712474319|0|0|2.64550264550265|4.61254628256379|MALT1;BIRC3|3
5734|negative regulation of neuron death (GO:1901215)|2/84|0.17489972053599|0.767423279359552|0|0|2.64550264550265|4.61254628256379|APOE;LGMN|3
5735|positive regulation of peptidyl-serine phosphorylation (GO:0033138)|2/84|0.17489972053599|0.766763981009586|0|0|2.64550264550265|4.61254628256379|OSM;TNF|3
5736|transcription initiation from RNA polymerase II promoter (GO:0006367)|3/161|0.177284325530649|0.776550998440261|0|0|2.0703933747412|3.58178152441527|NR4A2;NR4A1;CDKN1A|3
5737|cellular response to DNA damage stimulus (GO:0006974)|5/330|0.177494221405389|0.776803612205576|0|0|1.68350168350168|2.91046671053738|PPP1R15A;BTG2;CDKN1A;CRIP1;MCL1|3
5738|positive regulation of supramolecular fiber organization (GO:1902905)|2/85|0.178116479266191|0.778858949181982|0|0|2.61437908496732|4.510634156345|PLEK;APOE|3
5739|regulation of calcium ion import (GO:0090279)|1/22|0.180450806786163|0.788390810813177|0|0|5.05050505050505|8.64796503502729|CCL3|3
5740|acylglycerol homeostasis (GO:0055090)|1/22|0.180450806786163|0.787716396090497|0|0|5.05050505050505|8.64796503502729|APOE|3
5741|positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052)|1/22|0.180450806786163|0.787043134213497|0|0|5.05050505050505|8.64796503502729|CTSC|3
5742|sterol transport (GO:0015918)|1/22|0.180450806786163|0.786371022228686|0|0|5.05050505050505|8.64796503502729|MSR1|3
5743|negative regulation of sprouting angiogenesis (GO:1903671)|1/22|0.180450806786163|0.785700057192655|0|0|5.05050505050505|8.64796503502729|KLF4|3
5744|triglyceride catabolic process (GO:0019433)|1/22|0.180450806786163|0.78503023617203|0|0|5.05050505050505|8.64796503502729|APOE|3
5745|STAT cascade (GO:0097696)|1/22|0.180450806786163|0.784361556243434|0|0|5.05050505050505|8.64796503502729|CCR2|3
5746|positive regulation of biosynthetic process (GO:0009891)|1/22|0.180450806786163|0.783694014493439|0|0|5.05050505050505|8.64796503502729|APOE|3
5747|negative regulation of nervous system development (GO:0051961)|1/22|0.180450806786163|0.78302760801853|0|0|5.05050505050505|8.64796503502729|TLR2|3
5748|negative regulation of GTPase activity (GO:0034260)|1/22|0.180450806786163|0.782362333925056|0|0|5.05050505050505|8.64796503502729|F11R|3
5749|negative regulation of lyase activity (GO:0051350)|1/22|0.180450806786163|0.781698189329195|0|0|5.05050505050505|8.64796503502729|CCR2|3
5750|regulation of intracellular signal transduction (GO:1902531)|6/423|0.182757919125608|0.791020917131449|0|0|1.57604412923562|2.67863333046878|GDF15;IL1B;NLRP3;TNF;IER3;BIRC3|3
5751|neuron projection morphogenesis (GO:0048812)|3/164|0.184008993482213|0.795760926898079|0|0|2.03252032520325|3.44059074176199|MEF2A;S100A6;SGK1|3
5752|regulation of protein kinase B signaling (GO:0051896)|3/164|0.184008993482213|0.795087124250409|0|0|2.03252032520325|3.44059074176199|F10;CCL3;EREG|3
5753|regulation of peptidyl-serine phosphorylation (GO:0033135)|2/87|0.184577177301044|0.796867458347906|0|0|2.55427841634738|4.3159325614612|OSM;TNF|3
5754|positive regulation of cellular component biogenesis (GO:0044089)|2/88|0.187820277529983|0.810183327333477|0|0|2.52525252525253|4.22290339386032|PLEK;TNF|3
5755|regulation of axon extension involved in axon guidance (GO:0048841)|1/23|0.187834861371431|0.809561906738526|0|0|4.83091787439614|8.07822270110791|SEMA4D|3
5756|regulation of protein oligomerization (GO:0032459)|1/23|0.187834861371431|0.808878732133683|0|0|4.83091787439614|8.07822270110791|APOE|3
5757|cholesterol efflux (GO:0033344)|1/23|0.187834861371431|0.808196709593941|0|0|4.83091787439614|8.07822270110791|APOE|3
5758|glycolytic process (GO:0006096)|1/23|0.187834861371431|0.807515836207594|0|0|4.83091787439614|8.07822270110791|HK2|3
5759|regulation of proteolysis involved in cellular protein catabolic process (GO:1903050)|1/23|0.187834861371431|0.806836109072739|0|0|4.83091787439614|8.07822270110791|CTSC|3
5760|protein K48-linked deubiquitination (GO:0071108)|1/23|0.187834861371431|0.806157525297237|0|0|4.83091787439614|8.07822270110791|TNFAIP3|3
5761|positive regulation of ATP metabolic process (GO:1903580)|1/23|0.187834861371431|0.805480081998668|0|0|4.83091787439614|8.07822270110791|PID1|3
5762|regulation of monooxygenase activity (GO:0032768)|1/23|0.187834861371431|0.804803776304294|0|0|4.83091787439614|8.07822270110791|IL1B|3
5763|positive regulation of ion transmembrane transporter activity (GO:0032414)|1/23|0.187834861371431|0.804128605351019|0|0|4.83091787439614|8.07822270110791|CTSS|3
5764|cellular response to amyloid-beta (GO:1904646)|1/23|0.187834861371431|0.803454566285343|0|0|4.83091787439614|8.07822270110791|FCGR2B|3
5765|regulation of cell size (GO:0008361)|1/23|0.187834861371431|0.802781656263329|0|0|4.83091787439614|8.07822270110791|PLEK|3
5766|negative regulation of axon extension (GO:0030517)|1/23|0.187834861371431|0.802109872450556|0|0|4.83091787439614|8.07822270110791|SEMA4D|3
5767|regulation of mitotic cell cycle (GO:0007346)|3/166|0.188529600708482|0.804403471919215|0|0|2.00803212851406|3.35040211141809|BTG2;BTG1;PIM1|3
5768|regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434)|2/89|0.191071330438607|0.814567250817218|0|0|2.49687890137328|4.1326054003989|TRIB1;CBFA2T3|3
5769|cellular protein modification process (GO:0006464)|12/1002|0.192808270165881|0.82128597884515|0|0|1.33067198935462|2.19036460768385|SOCS3;PTPN18;PTPN1;DUSP2;DUSP1;PIM1;FN1;SPP1;FAM20C;APOE;SGK1;MFGE8|3
5770|mitochondrion organization (GO:0007005)|3/168|0.193078845038004|0.821752582342732|0|0|1.98412698412698|3.26320763886367|MEF2A;PID1;HK2|3
5771|neuron projection development (GO:0031175)|3/168|0.193078845038004|0.821067788524113|0|0|1.98412698412698|3.26320763886367|BTG2;APOE;SGK1|3
5772|negative regulation of cellular protein metabolic process (GO:0032269)|2/90|0.194329933195999|0.825699957617971|0|0|2.46913580246914|4.04493303178111|BTG2;APOE|3
5773|positive regulation of cellular protein metabolic process (GO:0032270)|2/92|0.20086820953125|0.852770776404299|0|0|2.41545893719807|3.87706826073703|NFKBIA;KLF4|3
5774|cellular response to acid chemical (GO:0071229)|2/92|0.20086820953125|0.852061906265975|0|0|2.41545893719807|3.87706826073703|EGR1;PID1|3
5775|positive regulation of immune effector process (GO:0002699)|1/25|0.202405070343507|0.857868001630328|0|0|4.44444444444444|7.09993018123697|CCR2|3
5776|negative regulation of protein localization to membrane (GO:1905476)|1/25|0.202405070343507|0.857156077977523|0|0|4.44444444444444|7.09993018123697|PID1|3
5777|proteasomal ubiquitin-independent protein catabolic process (GO:0010499)|1/25|0.202405070343507|0.856445334960958|0|0|4.44444444444444|7.09993018123697|NFE2L2|3
5778|regulation of actin filament bundle assembly (GO:0032231)|1/25|0.202405070343507|0.85573576964616|0|0|4.44444444444444|7.09993018123697|PLEK|3
5779|ATP generation from ADP (GO:0006757)|1/25|0.202405070343507|0.855027379108373|0|0|4.44444444444444|7.09993018123697|HK2|3
5780|receptor catabolic process (GO:0032801)|1/25|0.202405070343507|0.854320160432519|0|0|4.44444444444444|7.09993018123697|LGMN|3
5781|regulation of epidermal growth factor-activated receptor activity (GO:0007176)|1/25|0.202405070343507|0.853614110713153|0|0|4.44444444444444|7.09993018123697|EREG|3
5782|regulation of chemotaxis (GO:0050920)|1/25|0.202405070343507|0.85290922705443|0|0|4.44444444444444|7.09993018123697|CXCR4|3
5783|negative regulation of oxidative stress-induced cell death (GO:1903202)|1/25|0.202405070343507|0.852205506570062|0|0|4.44444444444444|7.09993018123697|NFE2L2|3
5784|negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230)|1/25|0.202405070343507|0.851502946383277|0|0|4.44444444444444|7.09993018123697|CD74|3
5785|cytoplasmic pattern recognition receptor signaling pathway (GO:0002753)|1/25|0.202405070343507|0.850801543626783|0|0|4.44444444444444|7.09993018123697|TNFAIP3|3
5786|regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618)|2/94|0.207432013043508|0.871214454782732|0|0|2.36406619385343|3.71856179901373|ATF3;NFE2L2|3
5787|nuclear-transcribed mRNA catabolic process (GO:0000956)|3/175|0.209210107072888|0.877959849007358|0|0|1.90476190476191|2.97984044760093|ZFP36;PNRC1;ZFP36L1|3
5788|glycolytic process through glucose-6-phosphate (GO:0061620)|1/26|0.209592398561143|0.878841421411268|0|0|4.27350427350427|6.67773757948569|HK2|3
5789|negative regulation of wound healing (GO:0061045)|1/26|0.209592398561143|0.878119876730306|0|0|4.27350427350427|6.67773757948569|APOE|3
5790|canonical glycolysis (GO:0061621)|1/26|0.209592398561143|0.87739951587983|0|0|4.27350427350427|6.67773757948569|HK2|3
5791|glucose catabolic process to pyruvate (GO:0061718)|1/26|0.209592398561143|0.876680335948781|0|0|4.27350427350427|6.67773757948569|HK2|3
5792|regulation of spindle assembly (GO:0090169)|1/26|0.209592398561143|0.875962334035637|0|0|4.27350427350427|6.67773757948569|PMEPA1|3
5793|response to copper ion (GO:0046688)|1/26|0.209592398561143|0.875245507248374|0|0|4.27350427350427|6.67773757948569|IL1A|3
5794|protein import into nucleus, translocation (GO:0000060)|1/26|0.209592398561143|0.874529852704426|0|0|4.27350427350427|6.67773757948569|TNF|3
5795|nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)|1/26|0.209592398561143|0.873815367530648|0|0|4.27350427350427|6.67773757948569|TNFAIP3|3
5796|positive regulation of interleukin-12 production (GO:0032735)|1/26|0.209592398561143|0.873102048863276|0|0|4.27350427350427|6.67773757948569|TLR2|3
5797|response to amyloid-beta (GO:1904645)|1/26|0.209592398561143|0.87238989384789|0|0|4.27350427350427|6.67773757948569|FCGR2B|3
5798|regulation of interleukin-10 production (GO:0032653)|1/26|0.209592398561143|0.871678899639375|0|0|4.27350427350427|6.67773757948569|FCGR2B|3
5799|regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)|1/26|0.209592398561143|0.870969063401883|0|0|4.27350427350427|6.67773757948569|CD74|3
5800|cellular response to vascular endothelial growth factor stimulus (GO:0035924)|1/26|0.209592398561143|0.870260382308798|0|0|4.27350427350427|6.67773757948569|NR4A1|3
5801|long-chain fatty acid transport (GO:0015909)|1/26|0.209592398561143|0.869552853542693|0|0|4.27350427350427|6.67773757948569|APOE|3
5802|respiratory tube development (GO:0030323)|1/26|0.209592398561143|0.868846474295299|0|0|4.27350427350427|6.67773757948569|PDPN|3
5803|regulation of vascular smooth muscle cell proliferation (GO:1904705)|1/26|0.209592398561143|0.868141241767462|0|0|4.27350427350427|6.67773757948569|JUN|3
5804|positive regulation of calcium ion transmembrane transport (GO:1904427)|1/26|0.209592398561143|0.86743715316911|0|0|4.27350427350427|6.67773757948569|CXCL10|3
5805|regulation of cellular protein localization (GO:1903827)|1/26|0.209592398561143|0.866734205719216|0|0|4.27350427350427|6.67773757948569|PTPN1|3
5806|positive regulation of cyclin-dependent protein kinase activity (GO:1904031)|1/27|0.216715316545038|0.895464178404314|0|0|4.11522633744856|6.29288350644136|CCNL1|3
5807|response to growth factor (GO:0070848)|1/27|0.216715316545038|0.894739692823081|0|0|4.11522633744856|6.29288350644136|KLF4|3
5808|positive regulation of interferon-beta production (GO:0032728)|1/27|0.216715316545038|0.894016378600912|0|0|4.11522633744856|6.29288350644136|TLR2|3
5809|negative chemotaxis (GO:0050919)|1/27|0.216715316545038|0.893294232899296|0|0|4.11522633744856|6.29288350644136|SEMA4D|3
5810|regulation of supramolecular fiber organization (GO:1902903)|1/27|0.216715316545038|0.892573252888885|0|0|4.11522633744856|6.29288350644136|APOE|3
5811|positive regulation of cAMP metabolic process (GO:0030816)|1/27|0.216715316545038|0.891853435749458|0|0|4.11522633744856|6.29288350644136|CXCL10|3
5812|regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083)|1/27|0.216715316545038|0.891134778669886|0|0|4.11522633744856|6.29288350644136|ID2|3
5813|regulation of histone acetylation (GO:0035065)|1/27|0.216715316545038|0.89041727884809|0|0|4.11522633744856|6.29288350644136|IL1B|3
5814|regulation of viral entry into host cell (GO:0046596)|1/27|0.216715316545038|0.889700933491012|0|0|4.11522633744856|6.29288350644136|CD74|3
5815|fat-soluble vitamin metabolic process (GO:0006775)|1/27|0.216715316545038|0.888985739814572|0|0|4.11522633744856|6.29288350644136|LGMN|3
5816|T cell activation involved in immune response (GO:0002286)|1/27|0.216715316545038|0.888271695043637|0|0|4.11522633744856|6.29288350644136|ICAM1|3
5817|regulation of T cell receptor signaling pathway (GO:0050856)|1/27|0.216715316545038|0.887558796411981|0|0|4.11522633744856|6.29288350644136|KCNN4|3
5818|mRNA metabolic process (GO:0016071)|2/98|0.220624327798158|0.902843580396151|0|0|2.26757369614512|3.42697029049078|ZFP36;EREG|3
5819|cell morphogenesis involved in neuron differentiation (GO:0048667)|2/98|0.220624327798158|0.902120148040064|0|0|2.26757369614512|3.42697029049078|MEF2A;S100A6|3
5820|positive regulation of neuron projection development (GO:0010976)|2/98|0.220624327798158|0.901397874102482|0|0|2.26757369614512|3.42697029049078|PLXND1;APOE|3
5821|cellular response to organonitrogen compound (GO:0071417)|2/98|0.220624327798158|0.9006767558032|0|0|2.26757369614512|3.42697029049078|EGR1;ZFP36L1|3
5822|ER to Golgi vesicle-mediated transport (GO:0006888)|3/181|0.223267981853293|0.910740616624584|0|0|1.84162062615101|2.76129376915975|F10;AREG;CTSC|3
5823|negative regulation of synaptic transmission (GO:0050805)|1/28|0.223774398275383|0.91207727987163|0|0|3.96825396825397|5.94094002063625|IL1B|3
5824|peptidyl-glutamic acid modification (GO:0018200)|1/28|0.223774398275383|0.911349365043321|0|0|3.96825396825397|5.94094002063625|F10|3
5825|negative regulation of cell-matrix adhesion (GO:0001953)|1/28|0.223774398275383|0.910622611163701|0|0|3.96825396825397|5.94094002063625|ADAM15|3
5826|negative regulation of osteoblast differentiation (GO:0045668)|1/28|0.223774398275383|0.909897015457594|0|0|3.96825396825397|5.94094002063625|SEMA4D|3
5827|extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625)|1/28|0.223774398275383|0.909172575158663|0|0|3.96825396825397|5.94094002063625|TNF|3
5828|regulation of protein localization to cell surface (GO:2000008)|1/28|0.223774398275383|0.908449287509372|0|0|3.96825396825397|5.94094002063625|TNF|3
5829|small GTPase mediated signal transduction (GO:0007264)|2/100|0.227247144429194|0.921814131973113|0|0|2.22222222222222|3.29270469282583|JUN;CDKN1A|3
5830|Golgi vesicle transport (GO:0048193)|4/272|0.23001594205|0.932304489500515|0|0|1.63398692810458|2.40131807058844|CUX1;F10;AREG;CTSC|3
5831|regulation of lipid metabolic process (GO:0019216)|2/101|0.230564018219926|0.9337842737907|0|0|2.2002200220022|3.22822160350931|ID2;IL1B|3
5832|regulation of vasculature development (GO:1901342)|1/29|0.230770212707056|0.933878188298259|0|0|3.83141762452107|5.61813338597154|PLXND1|3
5833|cellular response to ketone (GO:1901655)|1/29|0.230770212707056|0.933138189733839|0|0|3.83141762452107|5.61813338597154|SPP1|3
5834|carboxylic acid catabolic process (GO:0046395)|1/29|0.230770212707056|0.932399362980289|0|0|3.83141762452107|5.61813338597154|HEXB|3
5835|acute inflammatory response (GO:0002526)|1/29|0.230770212707056|0.931661705256412|0|0|3.83141762452107|5.61813338597154|CEBPB|3
5836|synaptic transmission, cholinergic (GO:0007271)|1/29|0.230770212707056|0.930925213789806|0|0|3.83141762452107|5.61813338597154|APOE|3
5837|negative regulation of response to DNA damage stimulus (GO:2001021)|1/29|0.230770212707056|0.930189885816828|0|0|3.83141762452107|5.61813338597154|CD74|3
5838|regulation of mRNA processing (GO:0050684)|1/29|0.230770212707056|0.929455718582561|0|0|3.83141762452107|5.61813338597154|ZFP36L1|3
5839|positive regulation of phosphate metabolic process (GO:0045937)|1/29|0.230770212707056|0.928722709340777|0|0|3.83141762452107|5.61813338597154|EREG|3
5840|positive regulation of sprouting angiogenesis (GO:1903672)|1/29|0.230770212707056|0.927990855353904|0|0|3.83141762452107|5.61813338597154|KLF4|3
5841|neural crest cell migration (GO:0001755)|1/29|0.230770212707056|0.927260153892996|0|0|3.83141762452107|5.61813338597154|SEMA4D|3
5842|regulation of lipid biosynthetic process (GO:0046890)|1/29|0.230770212707056|0.926530602237691|0|0|3.83141762452107|5.61813338597154|APOE|3
5843|triglyceride homeostasis (GO:0070328)|1/29|0.230770212707056|0.925802197676183|0|0|3.83141762452107|5.61813338597154|APOE|3
5844|positive regulation of lipid biosynthetic process (GO:0046889)|1/29|0.230770212707056|0.925074937505188|0|0|3.83141762452107|5.61813338597154|APOE|3
5845|nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423)|1/29|0.230770212707056|0.92434881902991|0|0|3.83141762452107|5.61813338597154|TNFAIP3|3
5846|regulation of adenylate cyclase activity (GO:0045761)|1/29|0.230770212707056|0.923623839564004|0|0|3.83141762452107|5.61813338597154|CCR2|3
5847|protein K63-linked deubiquitination (GO:0070536)|1/29|0.230770212707056|0.922899996429549|0|0|3.83141762452107|5.61813338597154|TNFAIP3|3
5848|regulation of cell morphogenesis (GO:0022604)|1/29|0.230770212707056|0.922177286957012|0|0|3.83141762452107|5.61813338597154|PDPN|3
5849|bicellular tight junction assembly (GO:0070830)|1/29|0.230770212707056|0.921455708485215|0|0|3.83141762452107|5.61813338597154|F11R|3
5850|regulation of mitotic cell cycle phase transition (GO:1901990)|3/185|0.232742716823491|0.928605225918902|0|0|1.8018018018018|2.62670568496897|PID1;ID2;ZFP36L1|3
5851|metal ion transport (GO:0030001)|2/102|0.233884094058161|0.932430103108436|0|0|2.17864923747277|3.16542398883645|KCNN4;SGK1|3
5852|regulation of kinase activity (GO:0043549)|2/102|0.233884094058161|0.931702210756282|0|0|2.17864923747277|3.16542398883645|CSF1R;CD74|3
5853|DNA-templated transcription, initiation (GO:0006352)|3/187|0.237507686052004|0.945399159066597|0|0|1.7825311942959|2.56248715455769|NR4A2;NR4A1;CDKN1A|3
5854|lung development (GO:0030324)|1/30|0.237703323740004|0.945440421703227|0|0|3.7037037037037|5.3212293399781|PDPN|3
5855|superoxide metabolic process (GO:0006801)|1/30|0.237703323740004|0.944704097387258|0|0|3.7037037037037|5.3212293399781|CYBB|3
5856|positive regulation of histone modification (GO:0031058)|1/30|0.237703323740004|0.943968919101354|0|0|3.7037037037037|5.3212293399781|IL1B|3
5857|negative regulation of Notch signaling pathway (GO:0045746)|1/30|0.237703323740004|0.943234884172037|0|0|3.7037037037037|5.3212293399781|MMP14|3
5858|nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289)|1/30|0.237703323740004|0.942501989934141|0|0|3.7037037037037|5.3212293399781|ZFP36|3
5859|positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742)|1/30|0.237703323740004|0.941770233730776|0|0|3.7037037037037|5.3212293399781|EREG|3
5860|amino acid transmembrane transport (GO:0003333)|1/30|0.237703323740004|0.941039612913297|0|0|3.7037037037037|5.3212293399781|SLC7A11|3
5861|striated muscle tissue development (GO:0014706)|1/30|0.237703323740004|0.940310124841271|0|0|3.7037037037037|5.3212293399781|CFLAR|3
5862|plasma membrane invagination (GO:0099024)|2/104|0.240532560610328|0.950765032373745|0|0|2.13675213675214|3.04465771676753|MSR1;FCGR2B|3
5863|protein import into nucleus (GO:0006606)|2/104|0.240532560610328|0.950029146125777|0|0|2.13675213675214|3.04465771676753|MMP12;TNF|3
5864|regulation of cellular response to stress (GO:0080135)|2/105|0.243860319445654|0.96242785006278|0|0|2.11640211640212|2.98658133099632|IER3;MCL1|3
5865|monovalent inorganic cation transport (GO:0015672)|2/105|0.243860319445654|0.96168408820029|0|0|2.11640211640212|2.98658133099632|KCNN4;SGK1|3
5866|mRNA transport (GO:0051028)|2/105|0.243860319445654|0.960941475004768|0|0|2.11640211640212|2.98658133099632|ZFP36;ZFP36L1|3
5867|phagocytosis, engulfment (GO:0006911)|2/105|0.243860319445654|0.960200007817265|0|0|2.11640211640212|2.98658133099632|MSR1;FCGR2B|3
5868|regulation of cell migration involved in sprouting angiogenesis (GO:0090049)|1/31|0.244574290263877|0.962268776574065|0|0|3.584229390681|5.04744147153737|KLF4|3
5869|regulation of defense response to virus by host (GO:0050691)|1/31|0.244574290263877|0.961527429288569|0|0|3.584229390681|5.04744147153737|TNFAIP3|3
5870|negative regulation of endothelial cell proliferation (GO:0001937)|1/31|0.244574290263877|0.960787223415368|0|0|3.584229390681|5.04744147153737|APOE|3
5871|replication fork processing (GO:0031297)|1/31|0.244574290263877|0.960048156320433|0|0|3.584229390681|5.04744147153737|BHLHE40|3
5872|acylglycerol catabolic process (GO:0046464)|1/31|0.244574290263877|0.959310225377834|0|0|3.584229390681|5.04744147153737|APOE|3
5873|positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737)|1/31|0.244574290263877|0.95857342796971|0|0|3.584229390681|5.04744147153737|CCNL1|3
5874|cellular response to cAMP (GO:0071320)|1/31|0.244574290263877|0.957837761486234|0|0|3.584229390681|5.04744147153737|ZFP36L1|3
5875|cellular response to drug (GO:0035690)|1/31|0.244574290263877|0.957103223325585|0|0|3.584229390681|5.04744147153737|IL1B|3
5876|negative regulation of transferase activity (GO:0051348)|1/31|0.244574290263877|0.956369810893918|0|0|3.584229390681|5.04744147153737|ZFP36|3
5877|negative regulation of secretion by cell (GO:1903531)|1/31|0.244574290263877|0.955637521605331|0|0|3.584229390681|5.04744147153737|OSM|3
5878|positive regulation of cation channel activity (GO:2001259)|1/31|0.244574290263877|0.954906352881838|0|0|3.584229390681|5.04744147153737|CTSS|3
5879|protein localization to lysosome (GO:0061462)|1/31|0.244574290263877|0.954176302153335|0|0|3.584229390681|5.04744147153737|RNF128|3
5880|phosphatidylinositol 3-kinase signaling (GO:0014065)|1/31|0.244574290263877|0.953447366857573|0|0|3.584229390681|5.04744147153737|ZFP36L1|3
5881|artery morphogenesis (GO:0048844)|1/31|0.244574290263877|0.952719544440124|0|0|3.584229390681|5.04744147153737|HPGD|3
5882|regulation of blood coagulation (GO:0030193)|1/31|0.244574290263877|0.951992832354357|0|0|3.584229390681|5.04744147153737|APOE|3
5883|positive regulation of B cell proliferation (GO:0030890)|1/31|0.244574290263877|0.951267228061404|0|0|3.584229390681|5.04744147153737|CD74|3
5884|chondroitin sulfate metabolic process (GO:0030204)|1/31|0.244574290263877|0.950542729030131|0|0|3.584229390681|5.04744147153737|HEXB|3
5885|regulation of dendritic spine development (GO:0060998)|1/32|0.251383666208758|0.976263963975108|0|0|3.47222222222222|4.79435748702175|APOE|3
5886|negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556)|1/32|0.251383666208758|0.975521557918853|0|0|3.47222222222222|4.79435748702175|TNFAIP3|3
5887|positive regulation of release of sequestered calcium ion into cytosol (GO:0051281)|1/32|0.251383666208758|0.97478028013928|0|0|3.47222222222222|4.79435748702175|CXCL10|3
5888|positive regulation of protein dephosphorylation (GO:0035307)|1/32|0.251383666208758|0.974040128066281|0|0|3.47222222222222|4.79435748702175|PPP1R15A|3
5889|secondary alcohol metabolic process (GO:1902652)|1/32|0.251383666208758|0.973301099137551|0|0|3.47222222222222|4.79435748702175|APOE|3
5890|regulation of protein export from nucleus (GO:0046825)|1/32|0.251383666208758|0.972563190798553|0|0|3.47222222222222|4.79435748702175|IL1B|3
5891|liver development (GO:0001889)|1/32|0.251383666208758|0.971826400502494|0|0|3.47222222222222|4.79435748702175|CEBPB|3
5892|protein destabilization (GO:0031648)|1/32|0.251383666208758|0.971090725710289|0|0|3.47222222222222|4.79435748702175|CTSH|3
5893|gene silencing by miRNA (GO:0035195)|1/32|0.251383666208758|0.970356163890538|0|0|3.47222222222222|4.79435748702175|ZFP36|3
5894|viral life cycle (GO:0019058)|2/108|0.253854019092026|0.979151216497814|0|0|2.05761316872428|2.82097922873906|FURIN;APOE|3
5895|negative regulation of hydrolase activity (GO:0051346)|2/109|0.257187735534646|0.991260584919409|0|0|2.03873598369011|2.76849943384729|ECM1;F11R|3
5896|dendrite morphogenesis (GO:0048813)|1/33|0.258132000553754|0.994149131189288|0|0|3.36700336700337|4.55987944392337|MEF2A|3
5897|positive regulation of calcium ion transport into cytosol (GO:0010524)|1/33|0.258132000553754|0.993399395796234|0|0|3.36700336700337|4.55987944392337|CXCL10|3
5898|response to zinc ion (GO:0010043)|1/33|0.258132000553754|0.99265079037363|0|0|3.36700336700337|4.55987944392337|CRIP1|3
5899|central nervous system neuron differentiation (GO:0021953)|1/33|0.258132000553754|0.99190331236883|0|0|3.36700336700337|4.55987944392337|NR4A2|3
5900|negative regulation of BMP signaling pathway (GO:0030514)|1/33|0.258132000553754|0.991156959236875|0|0|3.36700336700337|4.55987944392337|SKIL|3
5901|cyclic-nucleotide-mediated signaling (GO:0019935)|1/33|0.258132000553754|0.990411728440456|0|0|3.36700336700337|4.55987944392337|APOE|3
5902|substrate adhesion-dependent cell spreading (GO:0034446)|1/33|0.258132000553754|0.989667617449892|0|0|3.36700336700337|4.55987944392337|FN1|3
5903|negative regulation of fat cell differentiation (GO:0045599)|1/33|0.258132000553754|0.988924623743098|0|0|3.36700336700337|4.55987944392337|TNF|3
5904|circulatory system development (GO:0072359)|2/110|0.26052221084432|0.997332964695098|0|0|2.02020202020202|2.71730739205073|MEF2A;CRIP1|3
5905|positive regulation of cytokine-mediated signaling pathway (GO:0001961)|1/34|0.264819837572612|1|0|0|3.26797385620915|4.3421749752316|CD74|3
5906|negative regulation of neurogenesis (GO:0050768)|1/34|0.264819837572612|1|0|0|3.26797385620915|4.3421749752316|ID2|3
5907|regulation of cell-substrate adhesion (GO:0010810)|1/34|0.264819837572612|1|0|0|3.26797385620915|4.3421749752316|PDPN|3
5908|platelet aggregation (GO:0070527)|1/34|0.264819837572612|1|0|0|3.26797385620915|4.3421749752316|PLEK|3
5909|embryonic organ morphogenesis (GO:0048562)|1/34|0.264819837572612|1|0|0|3.26797385620915|4.3421749752316|ID2|3
5910|mRNA stabilization (GO:0048255)|1/34|0.264819837572612|1|0|0|3.26797385620915|4.3421749752316|ZFP36|3
5911|positive regulation of nucleocytoplasmic transport (GO:0046824)|1/34|0.264819837572612|1|0|0|3.26797385620915|4.3421749752316|IL1B|3
5912|negative regulation of multi-organism process (GO:0043901)|1/34|0.264819837572612|1|0|0|3.26797385620915|4.3421749752316|TRIB1|3
5913|positive regulation of locomotion (GO:0040017)|1/34|0.264819837572612|1|0|0|3.26797385620915|4.3421749752316|CSF1R|3
5914|cellular glucose homeostasis (GO:0001678)|1/34|0.264819837572612|1|0|0|3.26797385620915|4.3421749752316|HK2|3
5915|regulation of intracellular protein transport (GO:0033157)|1/34|0.264819837572612|1|0|0|3.26797385620915|4.3421749752316|PTPN1|3
5916|regulation of interleukin-12 production (GO:0032655)|1/34|0.264819837572612|1|0|0|3.26797385620915|4.3421749752316|TLR2|3
5917|phosphatidylinositol metabolic process (GO:0046488)|2/113|0.270527394091596|1|0|0|1.96656833824975|2.57105587761182|CSF1R;PLEK|3
5918|epithelial tube morphogenesis (GO:0060562)|1/35|0.271447716503948|1|0|0|3.17460317460317|4.13963724089565|CSF1R|3
5919|apoptotic mitochondrial changes (GO:0008637)|1/35|0.271447716503948|1|0|0|3.17460317460317|4.13963724089565|HK2|3
5920|negative regulation of cellular metabolic process (GO:0031324)|1/35|0.271447716503948|1|0|0|3.17460317460317|4.13963724089565|APOE|3
5921|keratan sulfate metabolic process (GO:0042339)|1/35|0.271447716503948|1|0|0|3.17460317460317|4.13963724089565|HEXB|3
5922|regulation of wound healing (GO:0061041)|1/35|0.271447716503948|1|0|0|3.17460317460317|4.13963724089565|TNFAIP3|3
5923|negative regulation of endothelial cell migration (GO:0010596)|1/35|0.271447716503948|1|0|0|3.17460317460317|4.13963724089565|APOE|3
5924|anterior/posterior pattern specification (GO:0009952)|1/35|0.271447716503948|1|0|0|3.17460317460317|4.13963724089565|BASP1|3
5925|regulation of interferon-beta production (GO:0032648)|1/35|0.271447716503948|1|0|0|3.17460317460317|4.13963724089565|TLR2|3
5926|macromolecule catabolic process (GO:0009057)|1/35|0.271447716503948|1|0|0|3.17460317460317|4.13963724089565|LGMN|3
5927|regulation of cyclin-dependent protein kinase activity (GO:1904029)|1/36|0.278016171948126|1|0|0|3.08641975308642|3.95085183490179|CDKN1A|3
5928|negative regulation of cell-substrate adhesion (GO:0010812)|1/36|0.278016171948126|1|0|0|3.08641975308642|3.95085183490179|ADAM15|3
5929|positive regulation of peptide secretion (GO:0002793)|1/36|0.278016171948126|1|0|0|3.08641975308642|3.95085183490179|IL1A|3
5930|negative regulation of protein complex assembly (GO:0031333)|1/36|0.278016171948126|1|0|0|3.08641975308642|3.95085183490179|PMEPA1|3
5931|apical junction assembly (GO:0043297)|1/36|0.278016171948126|1|0|0|3.08641975308642|3.95085183490179|F11R|3
5932|regulation of mitotic spindle organization (GO:0060236)|1/36|0.278016171948126|1|0|0|3.08641975308642|3.95085183490179|PMEPA1|3
5933|cholesterol biosynthetic process (GO:0006695)|1/36|0.278016171948126|1|0|0|3.08641975308642|3.95085183490179|APOE|3
5934|regulation of synapse assembly (GO:0051963)|1/36|0.278016171948126|1|0|0|3.08641975308642|3.95085183490179|TLR2|3
5935|regulation of mitochondrial membrane potential (GO:0051881)|1/36|0.278016171948126|1|0|0|3.08641975308642|3.95085183490179|PID1|3
5936|membrane protein proteolysis (GO:0033619)|1/36|0.278016171948126|1|0|0|3.08641975308642|3.95085183490179|CTSH|3
5937|regulation of phosphoprotein phosphatase activity (GO:0043666)|1/36|0.278016171948126|1|0|0|3.08641975308642|3.95085183490179|PPP1R15A|3
5938|carboxylic acid transmembrane transport (GO:1905039)|1/36|0.278016171948126|1|0|0|3.08641975308642|3.95085183490179|SLC7A11|3
5939|positive regulation of telomerase activity (GO:0051973)|1/36|0.278016171948126|1|0|0|3.08641975308642|3.95085183490179|KLF4|3
5940|negative regulation of tumor necrosis factor production (GO:0032720)|1/36|0.278016171948126|1|0|0|3.08641975308642|3.95085183490179|TNFAIP3|3
5941|regulation of cardiac muscle contraction (GO:0055117)|1/36|0.278016171948126|1|0|0|3.08641975308642|3.95085183490179|RGS2|3
5942|carbohydrate catabolic process (GO:0016052)|1/36|0.278016171948126|1|0|0|3.08641975308642|3.95085183490179|HK2|3
5943|neural crest cell development (GO:0014032)|1/36|0.278016171948126|1|0|0|3.08641975308642|3.95085183490179|SEMA4D|3
5944|DNA-dependent DNA replication maintenance of fidelity (GO:0045005)|1/36|0.278016171948126|1|0|0|3.08641975308642|3.95085183490179|BHLHE40|3
5945|sulfur compound catabolic process (GO:0044273)|1/36|0.278016171948126|1|0|0|3.08641975308642|3.95085183490179|HEXB|3
5946|sphingolipid metabolic process (GO:0006665)|2/117|0.283861709894968|1|0|0|1.89933523266857|2.39177226287331|GM2A;HEXB|3
5947|mRNA catabolic process (GO:0006402)|1/37|0.284525733691024|1|0|0|3.003003003003|3.77456930079665|ZFP36|3
5948|plasma membrane organization (GO:0007009)|1/37|0.284525733691024|1|0|0|3.003003003003|3.77456930079665|CXCR4|3
5949|acylglycerol metabolic process (GO:0006639)|1/37|0.284525733691024|1|0|0|3.003003003003|3.77456930079665|APOE|3
5950|negative regulation of blood coagulation (GO:0030195)|1/37|0.284525733691024|1|0|0|3.003003003003|3.77456930079665|APOE|3
5951|cardiac muscle tissue development (GO:0048738)|1/37|0.284525733691024|1|0|0|3.003003003003|3.77456930079665|KDM6B|3
5952|regulation of cysteine-type endopeptidase activity (GO:2000116)|1/37|0.284525733691024|1|0|0|3.003003003003|3.77456930079665|BIRC3|3
5953|secondary alcohol biosynthetic process (GO:1902653)|1/37|0.284525733691024|1|0|0|3.003003003003|3.77456930079665|APOE|3
5954|protein localization to cell periphery (GO:1990778)|2/118|0.287192510402726|1|0|0|1.88323917137476|2.34953393622042|F11R;TNF|3
5955|myelination (GO:0042552)|1/38|0.290976926953403|1|0|0|2.92397660818713|3.60968217477804|CXCR4|3
5956|positive regulation of receptor activity (GO:2000273)|1/38|0.290976926953403|1|0|0|2.92397660818713|3.60968217477804|EREG|3
5957|regulation of dendrite development (GO:0050773)|1/38|0.290976926953403|1|0|0|2.92397660818713|3.60968217477804|SEMA4D|3
5958|positive regulation of B cell activation (GO:0050871)|2/120|0.293849052062628|1|0|0|1.85185185185185|2.26794272565062|CD74;MMP14|3
5959|T cell differentiation (GO:0030217)|1/39|0.297370272082005|1|0|0|2.84900284900285|3.4552057245781|ZFP36L1|3
5960|homotypic cell-cell adhesion (GO:0034109)|1/39|0.297370272082005|1|0|0|2.84900284900285|3.4552057245781|PLEK|3
5961|negative regulation of cell migration (GO:0030336)|2/122|0.30049727171813|1|0|0|1.82149362477231|2.19001202948832|ADAM15;TRIB1|3
5962|negative regulation of protein catabolic process (GO:0042177)|1/40|0.303706284980439|1|0|0|2.77777777777778|3.31026170123446|TIMP2|3
5963|skeletal muscle tissue development (GO:0007519)|1/40|0.303706284980439|1|0|0|2.77777777777778|3.31026170123446|CFLAR|3
5964|regulation of type I interferon-mediated signaling pathway (GO:0060338)|1/40|0.303706284980439|1|0|0|2.77777777777778|3.31026170123446|PTPN1|3
5965|cellular response to amino acid starvation (GO:0034198)|1/40|0.303706284980439|1|0|0|2.77777777777778|3.31026170123446|CDKN1A|3
5966|negative regulation of transport (GO:0051051)|1/41|0.309985476932023|1|0|0|2.710027100271|3.17406458321613|IL1B|3
5967|regulation of protein dephosphorylation (GO:0035304)|1/41|0.309985476932023|1|0|0|2.710027100271|3.17406458321613|PPP1R15A|3
5968|sensory organ development (GO:0007423)|1/41|0.309985476932023|1|0|0|2.710027100271|3.17406458321613|MAFB|3
5969|ameboidal-type cell migration (GO:0001667)|1/41|0.309985476932023|1|0|0|2.710027100271|3.17406458321613|SEMA4D|3
5970|sterol biosynthetic process (GO:0016126)|1/41|0.309985476932023|1|0|0|2.710027100271|3.17406458321613|APOE|3
5971|androgen receptor signaling pathway (GO:0030521)|1/41|0.309985476932023|1|0|0|2.710027100271|3.17406458321613|PMEPA1|3
5972|response to peptide hormone (GO:0043434)|1/41|0.309985476932023|1|0|0|2.710027100271|3.17406458321613|ZFP36L1|3
5973|negative regulation of ERK1 and ERK2 cascade (GO:0070373)|1/41|0.309985476932023|1|0|0|2.710027100271|3.17406458321613|PTPN1|3
5974|neuron migration (GO:0001764)|1/41|0.309985476932023|1|0|0|2.710027100271|3.17406458321613|NR4A2|3
5975|regulation of cholesterol biosynthetic process (GO:0045540)|1/41|0.309985476932023|1|0|0|2.710027100271|3.17406458321613|APOE|3
5976|regulation of intracellular transport (GO:0032386)|1/41|0.309985476932023|1|0|0|2.710027100271|3.17406458321613|PTPN1|3
5977|regulation of viral transcription (GO:0046782)|1/41|0.309985476932023|1|0|0|2.710027100271|3.17406458321613|ZFP36|3
5978|protein oligomerization (GO:0051259)|3/218|0.312917119895042|1|0|0|1.52905198776758|1.77647846509686|NLRP3;TNFAIP3;MALT1|3
5979|negative regulation of multicellular organismal process (GO:0051241)|2/126|0.313761489031983|1|0|0|1.7636684303351|2.04430717950256|IL1B;TNF|3
5980|mesenchymal cell differentiation (GO:0048762)|1/42|0.316208354636715|1|0|0|2.64550264550265|3.04590987448366|S100A4|3
5981|regulation of cholesterol metabolic process (GO:0090181)|1/42|0.316208354636715|1|0|0|2.64550264550265|3.04590987448366|APOE|3
5982|negative regulation of cell projection organization (GO:0031345)|1/42|0.316208354636715|1|0|0|2.64550264550265|3.04590987448366|APOE|3
5983|regulation of substrate adhesion-dependent cell spreading (GO:1900024)|1/42|0.316208354636715|1|0|0|2.64550264550265|3.04590987448366|PDPN|3
5984|positive regulation of viral transcription (GO:0050434)|1/42|0.316208354636715|1|0|0|2.64550264550265|3.04590987448366|JUN|3
5985|negative regulation of STAT cascade (GO:1904893)|1/42|0.316208354636715|1|0|0|2.64550264550265|3.04590987448366|SOCS3|3
5986|regulation of cellular metabolic process (GO:0031323)|1/42|0.316208354636715|1|0|0|2.64550264550265|3.04590987448366|PID1|3
5987|cytoskeleton organization (GO:0007010)|2/127|0.317069562726497|1|0|0|1.74978127734033|2.00985842239872|CCL3;APOE|3
5988|cellular response to calcium ion (GO:0071277)|1/43|0.322375420429726|1|0|0|2.58397932816537|2.92516411012384|MEF2A|3
5989|regulation of protein modification process (GO:0031399)|1/43|0.322375420429726|1|0|0|2.58397932816537|2.92516411012384|FN1|3
5990|cellular response to radiation (GO:0071478)|1/43|0.322375420429726|1|0|0|2.58397932816537|2.92516411012384|CDKN1A|3
5991|regulation of telomerase activity (GO:0051972)|1/43|0.322375420429726|1|0|0|2.58397932816537|2.92516411012384|KLF4|3
5992|regulation of mRNA stability (GO:0043488)|2/129|0.323674676068214|1|0|0|1.72265288544358|1.94318062675499|ZFP36;ZFP36L1|3
5993|Ras protein signal transduction (GO:0007265)|3/224|0.327679079451223|1|0|0|1.48809523809524|1.66029846111148|JUN;CDKN1A;PDPN|3
5994|axonogenesis (GO:0007409)|3/224|0.327679079451223|1|0|0|1.48809523809524|1.66029846111148|DOK2;S100A6;CXCR4|3
5995|negative regulation of protein metabolic process (GO:0051248)|1/44|0.328487172027665|1|0|0|2.52525252525253|2.81125629283849|APOE|3
5996|RNA catabolic process (GO:0006401)|1/44|0.328487172027665|1|0|0|2.52525252525253|2.81125629283849|ZFP36|3
5997|positive regulation of protein localization to plasma membrane (GO:1903078)|1/44|0.328487172027665|1|0|0|2.52525252525253|2.81125629283849|TREM2|3
5998|substantia nigra development (GO:0021762)|1/44|0.328487172027665|1|0|0|2.52525252525253|2.81125629283849|BASP1|3
5999|digestive tract development (GO:0048565)|1/44|0.328487172027665|1|0|0|2.52525252525253|2.81125629283849|TNF|3
6000|regulation of multicellular organismal development (GO:2000026)|1/44|0.328487172027665|1|0|0|2.52525252525253|2.81125629283849|CXCL10|3
6001|protein localization to plasma membrane (GO:0072659)|2/131|0.330263748680125|1|0|0|1.69635284139101|1.87932774439006|F11R;TNF|3
6002|sprouting angiogenesis (GO:0002040)|1/45|0.334544102810763|1|0|0|2.46913580246914|2.70367052132593|NR4A1|3
6003|positive regulation of viral life cycle (GO:1903902)|1/45|0.334544102810763|1|0|0|2.46913580246914|2.70367052132593|CD74|3
6004|regulation of T cell activation (GO:0050863)|1/45|0.334544102810763|1|0|0|2.46913580246914|2.70367052132593|CCR2|3
6005|negative regulation of type I interferon production (GO:0032480)|1/45|0.334544102810763|1|0|0|2.46913580246914|2.70367052132593|TNFAIP3|3
6006|carboxylic acid biosynthetic process (GO:0046394)|1/45|0.334544102810763|1|0|0|2.46913580246914|2.70367052132593|IL1B|3
6007|regulation of steroid biosynthetic process (GO:0050810)|1/45|0.334544102810763|1|0|0|2.46913580246914|2.70367052132593|EGR1|3
6008|positive regulation of actin filament bundle assembly (GO:0032233)|1/45|0.334544102810763|1|0|0|2.46913580246914|2.70367052132593|PLEK|3
6009|positive regulation of viral process (GO:0048524)|1/45|0.334544102810763|1|0|0|2.46913580246914|2.70367052132593|APOE|3
6010|cellular response to hypoxia (GO:0071456)|2/133|0.336835239715824|1|0|0|1.67084377610693|1.81814765430607|HILPDA;ZFP36L1|3
6011|nicotinamide nucleotide metabolic process (GO:0046496)|1/46|0.340546701830439|1|0|0|2.41545893719807|2.60193962843907|HK2|3
6012|nucleocytoplasmic transport (GO:0006913)|1/47|0.346495453744792|1|0|0|2.36406619385343|2.50563967126219|MALT1|3
6013|cellular response to ionizing radiation (GO:0071479)|1/47|0.346495453744792|1|0|0|2.36406619385343|2.50563967126219|CDKN1A|3
6014|positive regulation of protein localization to cell periphery (GO:1904377)|1/47|0.346495453744792|1|0|0|2.36406619385343|2.50563967126219|TREM2|3
6015|negative regulation of protein modification by small protein conjugation or removal (GO:1903321)|1/47|0.346495453744792|1|0|0|2.36406619385343|2.50563967126219|TNFAIP3|3
6016|mitotic spindle assembly (GO:0090307)|1/47|0.346495453744792|1|0|0|2.36406619385343|2.50563967126219|BIRC3|3
6017|icosanoid metabolic process (GO:0006690)|1/47|0.346495453744792|1|0|0|2.36406619385343|2.50563967126219|HPGD|3
6018|negative regulation of autophagy (GO:0010507)|1/47|0.346495453744792|1|0|0|2.36406619385343|2.50563967126219|MCL1|3
6019|myofibril assembly (GO:0030239)|1/48|0.35239083888696|1|0|0|2.31481481481481|2.41438514260657|CFLAR|3
6020|peptide cross-linking (GO:0018149)|1/48|0.35239083888696|1|0|0|2.31481481481481|2.41438514260657|FN1|3
6021|polyol metabolic process (GO:0019751)|1/48|0.35239083888696|1|0|0|2.31481481481481|2.41438514260657|PLD4|3
6022|regulation of intrinsic apoptotic signaling pathway (GO:2001242)|1/48|0.35239083888696|1|0|0|2.31481481481481|2.41438514260657|MCL1|3
6023|negative regulation of cellular biosynthetic process (GO:0031327)|1/48|0.35239083888696|1|0|0|2.31481481481481|2.41438514260657|PLEK|3
6024|negative regulation of JAK-STAT cascade (GO:0046426)|1/48|0.35239083888696|1|0|0|2.31481481481481|2.41438514260657|SOCS3|3
6025|positive regulation of organelle assembly (GO:1902117)|1/48|0.35239083888696|1|0|0|2.31481481481481|2.41438514260657|TNF|3
6026|heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157)|1/48|0.35239083888696|1|0|0|2.31481481481481|2.41438514260657|ICAM1|3
6027|inositol phosphate metabolic process (GO:0043647)|1/48|0.35239083888696|1|0|0|2.31481481481481|2.41438514260657|PLD4|3
6028|cellular response to heat (GO:0034605)|1/48|0.35239083888696|1|0|0|2.31481481481481|2.41438514260657|IL1A|3
6029|positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862)|1/48|0.35239083888696|1|0|0|2.31481481481481|2.41438514260657|GDF15|3
6030|protein K48-linked ubiquitination (GO:0070936)|1/49|0.358233333402858|1|0|0|2.26757369614512|2.32782479729946|TNFAIP3|3
6031|regulation of cell cycle arrest (GO:0071156)|1/49|0.358233333402858|1|0|0|2.26757369614512|2.32782479729946|ID2|3
6032|regulation of epithelial cell migration (GO:0010632)|1/49|0.358233333402858|1|0|0|2.26757369614512|2.32782479729946|CTSH|3
6033|regulation of mitochondrion organization (GO:0010821)|1/49|0.358233333402858|1|0|0|2.26757369614512|2.32782479729946|PID1|3
6034|amino acid transport (GO:0006865)|1/49|0.358233333402858|1|0|0|2.26757369614512|2.32782479729946|SLC7A11|3
6035|cellular response to mechanical stimulus (GO:0071260)|1/49|0.358233333402858|1|0|0|2.26757369614512|2.32782479729946|IL1B|3
6036|regulation of primary metabolic process (GO:0080090)|2/140|0.359676139807779|1|0|0|1.58730158730159|1.62309724455626|ID2;APOE|3
6037|protein heterooligomerization (GO:0051291)|1/50|0.364023409135543|1|0|0|2.22222222222222|2.24563800578071|CD74|3
6038|establishment of protein localization to mitochondrion (GO:0072655)|1/50|0.364023409135543|1|0|0|2.22222222222222|2.24563800578071|HK2|3
6039|gonad development (GO:0008406)|1/50|0.364023409135543|1|0|0|2.22222222222222|2.24563800578071|BASP1|3
6040|lipid homeostasis (GO:0055088)|1/50|0.364023409135543|1|0|0|2.22222222222222|2.24563800578071|APOE|3
6041|regulation of release of sequestered calcium ion into cytosol (GO:0051279)|1/50|0.364023409135543|1|0|0|2.22222222222222|2.24563800578071|CXCL10|3
6042|regulation of blood vessel endothelial cell migration (GO:0043535)|1/51|0.369761533768041|1|0|0|2.17864923747277|2.16753155654693|APOE|3
6043|negative regulation of protein ubiquitination (GO:0031397)|1/51|0.369761533768041|1|0|0|2.17864923747277|2.16753155654693|TNFAIP3|3
6044|negative regulation of viral genome replication (GO:0045071)|1/51|0.369761533768041|1|0|0|2.17864923747277|2.16753155654693|TNF|3
6045|heart morphogenesis (GO:0003007)|1/51|0.369761533768041|1|0|0|2.17864923747277|2.16753155654693|OLFM1|3
6046|defense response to bacterium (GO:0042742)|3/242|0.371870893463221|1|0|0|1.37741046831956|1.36254620596583|CEBPB;ANXA3;TLR2|3
6047|peptidyl-tyrosine modification (GO:0018212)|1/52|0.375448170886902|1|0|0|2.13675213675214|2.09323684666003|CSF1R|3
6048|negative regulation of neuron projection development (GO:0010977)|1/52|0.375448170886902|1|0|0|2.13675213675214|2.09323684666003|APOE|3
6049|carboxylic acid transport (GO:0046942)|1/52|0.375448170886902|1|0|0|2.13675213675214|2.09323684666003|SLC7A11|3
6050|positive regulation of developmental growth (GO:0048639)|1/52|0.375448170886902|1|0|0|2.13675213675214|2.09323684666003|SEMA4D|3
6051|neuron development (GO:0048666)|2/145|0.375816010387583|1|0|0|1.53256704980843|1.4998553094725|BTG2;SKIL|3
6052|regulation of cell-matrix adhesion (GO:0001952)|1/53|0.381083779921797|1|0|0|2.09643605870021|2.02250740717168|ADAM15|3
6053|plasma membrane bounded cell projection morphogenesis (GO:0120039)|1/53|0.381083779921797|1|0|0|2.09643605870021|2.02250740717168|SGK1|3
6054|B cell differentiation (GO:0030183)|1/53|0.381083779921797|1|0|0|2.09643605870021|2.02250740717168|KLF6|3
6055|positive regulation of cell-substrate adhesion (GO:0010811)|1/53|0.381083779921797|1|0|0|2.09643605870021|2.02250740717168|FN1|3
6056|triglyceride metabolic process (GO:0006641)|1/53|0.381083779921797|1|0|0|2.09643605870021|2.02250740717168|APOE|3
6057|positive regulation of secretion by cell (GO:1903532)|1/53|0.381083779921797|1|0|0|2.09643605870021|2.02250740717168|IL1A|3
6058|positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068)|1/54|0.386668816246115|1|0|0|2.05761316872428|1.95511671668332|SEMA4D|3
6059|embryonic organ development (GO:0048568)|1/54|0.386668816246115|1|0|0|2.05761316872428|1.95511671668332|TNF|3
6060|nervous system development (GO:0007399)|5/456|0.391769281481038|1|0|0|1.21832358674464|1.14166932275343|OLFM1;ZEB2;MAFB;PLXND1;CXCL1|3
6061|heart development (GO:0007507)|2/150|0.391788620380433|1|0|0|1.48148148148148|1.38819676793163|MEF2A;CRIP1|3
6062|cell morphogenesis involved in differentiation (GO:0000904)|1/55|0.392203731116955|1|0|0|2.02020202020202|1.89085626659267|FN1|3
6063|negative regulation of cellular component organization (GO:0051129)|1/55|0.392203731116955|1|0|0|2.02020202020202|1.89085626659267|TNF|3
6064|positive regulation of response to stimulus (GO:0048584)|1/55|0.392203731116955|1|0|0|2.02020202020202|1.89085626659267|FCGR2B|3
6065|positive regulation of DNA biosynthetic process (GO:2000573)|1/56|0.397688971923368|1|0|0|1.98412698412698|1.82953384283722|KLF4|3
6066|Notch signaling pathway (GO:0007219)|1/56|0.397688971923368|1|0|0|1.98412698412698|1.82953384283722|PLXND1|3
6067|regulation of BMP signaling pathway (GO:0030510)|1/57|0.403124981911432|1|0|0|1.94931773879142|1.77097200059058|SKIL|3
6068|organonitrogen compound catabolic process (GO:1901565)|1/57|0.403124981911432|1|0|0|1.94931773879142|1.77097200059058|ANPEP|3
6069|glycosaminoglycan catabolic process (GO:0006027)|1/57|0.403124981911432|1|0|0|1.94931773879142|1.77097200059058|HEXB|3
6070|regulation of glycolytic process (GO:0006110)|1/58|0.408512200526296|1|0|0|1.91570881226054|1.71500670206636|CBFA2T3|3
6071|regulation of Rho protein signal transduction (GO:0035023)|1/58|0.408512200526296|1|0|0|1.91570881226054|1.71500670206636|APOE|3
6072|response to retinoic acid (GO:0032526)|1/58|0.408512200526296|1|0|0|1.91570881226054|1.71500670206636|CTSH|3
6073|positive regulation of programmed cell death (GO:0043068)|3/258|0.410708146218125|1|0|0|1.29198966408269|1.14970597319923|JUN;GADD45B;TNF|3
6074|antigen receptor-mediated signaling pathway (GO:0050851)|3/258|0.410708146218125|1|0|0|1.29198966408269|1.14970597319923|NFKBIA;LAT2;MALT1|3
6075|phospholipid transport (GO:0015914)|1/59|0.413851063321835|1|0|0|1.88323917137476|1.66148610228415|APOE|3
6076|cholesterol homeostasis (GO:0042632)|1/59|0.413851063321835|1|0|0|1.88323917137476|1.66148610228415|APOE|3
6077|sterol homeostasis (GO:0055092)|1/59|0.413851063321835|1|0|0|1.88323917137476|1.66148610228415|APOE|3
6078|sodium ion transport (GO:0006814)|1/59|0.413851063321835|1|0|0|1.88323917137476|1.66148610228415|SGK1|3
6079|protein phosphorylation (GO:0006468)|5/471|0.41848446182985|1|0|0|1.1795234725171|1.02750120073834|CSF1R;PIM1;FAM20C;SGK1;TLR2|3
6080|regulation of extrinsic apoptotic signaling pathway (GO:2001236)|1/60|0.419142001845464|1|0|0|1.85185185185185|1.61026946282117|CFLAR|3
6081|sterol metabolic process (GO:0016125)|1/60|0.419142001845464|1|0|0|1.85185185185185|1.61026946282117|APOE|3
6082|keratinocyte differentiation (GO:0030216)|1/60|0.419142001845464|1|0|0|1.85185185185185|1.61026946282117|EREG|3
6083|cell morphogenesis (GO:0000902)|1/60|0.419142001845464|1|0|0|1.85185185185185|1.61026946282117|PDPN|3
6084|positive regulation of protein binding (GO:0032092)|1/61|0.424385443957065|1|0|0|1.82149362477231|1.56122617625482|APOE|3
6085|protein localization to membrane (GO:0072657)|2/161|0.426259754472308|1|0|0|1.38026224982747|1.17695840752759|F11R;TNF|3
6086|potassium ion transport (GO:0006813)|1/62|0.429581813686149|1|0|0|1.7921146953405|1.514234892144|KCNN4|3
6087|negative regulation of viral life cycle (GO:1903901)|1/62|0.429581813686149|1|0|0|1.7921146953405|1.514234892144|TNF|3
6088|positive regulation of cellular amide metabolic process (GO:0034250)|1/62|0.429581813686149|1|0|0|1.7921146953405|1.514234892144|TNF|3
6089|positive regulation of type I interferon production (GO:0032481)|1/63|0.434731531250908|1|0|0|1.7636684303351|1.46918273008662|TLR2|3
6090|diterpenoid metabolic process (GO:0016101)|1/63|0.434731531250908|1|0|0|1.7636684303351|1.46918273008662|APOE|3
6091|T cell receptor signaling pathway (GO:0050852)|2/164|0.435486399175284|1|0|0|1.3550135501355|1.12641153596748|NFKBIA;MALT1|3
6092|synapse assembly (GO:0007416)|1/64|0.439835013206886|1|0|0|1.73611111111111|1.42596457009202|PLXND1|3
6093|kidney development (GO:0001822)|1/64|0.439835013206886|1|0|0|1.73611111111111|1.42596457009202|CTSH|3
6094|adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway (GO:0007193)|1/64|0.439835013206886|1|0|0|1.73611111111111|1.42596457009202|RGS1|3
6095|regulation of viral genome replication (GO:0045069)|1/64|0.439835013206886|1|0|0|1.73611111111111|1.42596457009202|TNF|3
6096|negative regulation of dephosphorylation (GO:0035305)|1/64|0.439835013206886|1|0|0|1.73611111111111|1.42596457009202|PPP1R15A|3
6097|positive regulation of cell projection organization (GO:0031346)|1/64|0.439835013206886|1|0|0|1.73611111111111|1.42596457009202|APOE|3
6098|nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)|1/64|0.439835013206886|1|0|0|1.73611111111111|1.42596457009202|ZFP36|3
6099|positive regulation of cell adhesion (GO:0045785)|1/65|0.444892672333223|1|0|0|1.70940170940171|1.38448241311778|TNF|3
6100|cellular response to type I interferon (GO:0071357)|1/66|0.449904917764864|1|0|0|1.68350168350168|1.34464480201906|EGR1|3
6101|regulation of JAK-STAT cascade (GO:0046425)|1/66|0.449904917764864|1|0|0|1.68350168350168|1.34464480201906|SOCS3|3
6102|type I interferon signaling pathway (GO:0060337)|1/66|0.449904917764864|1|0|0|1.68350168350168|1.34464480201906|EGR1|3
6103|defense response to Gram-positive bacterium (GO:0050830)|1/66|0.449904917764864|1|0|0|1.68350168350168|1.34464480201906|TLR2|3
6104|intracellular steroid hormone receptor signaling pathway (GO:0030518)|1/67|0.454872155026247|1|0|0|1.65837479270315|1.30636629764044|PMEPA1|3
6105|JNK cascade (GO:0007254)|1/67|0.454872155026247|1|0|0|1.65837479270315|1.30636629764044|TRIB1|3
6106|positive regulation of cellular protein localization (GO:1903829)|1/67|0.454872155026247|1|0|0|1.65837479270315|1.30636629764044|TNF|3
6107|epidermal cell differentiation (GO:0009913)|1/68|0.459794786071558|1|0|0|1.63398692810458|1.26956700371673|EREG|3
6108|regulation of gene silencing by miRNA (GO:0060964)|1/68|0.459794786071558|1|0|0|1.63398692810458|1.26956700371673|ZFP36|3
6109|negative regulation of protein binding (GO:0032091)|1/68|0.459794786071558|1|0|0|1.63398692810458|1.26956700371673|ADAM15|3
6110|regulation of cardiac conduction (GO:1903779)|1/68|0.459794786071558|1|0|0|1.63398692810458|1.26956700371673|ATP2B1|3
6111|cholesterol metabolic process (GO:0008203)|1/69|0.464673209278437|1|0|0|1.61030595813205|1.23417213559213|APOE|3
6112|regulation of nucleic acid-templated transcription (GO:1903506)|6/608|0.467871427547049|1|0|0|1.09649122807018|0.832852794158514|CEBPB;MAFB;BTG1;NFIL3;DENND4A;BHLHE40|3
6113|peptide biosynthetic process (GO:0043043)|2/175|0.468616973882432|1|0|0|1.26984126984127|0.962500991776586|MRPL52;FURIN|3
6114|regulation of osteoblast differentiation (GO:0045667)|1/70|0.469507819337092|1|0|0|1.58730158730159|1.20011162836097|SEMA4D|3
6115|protein autophosphorylation (GO:0046777)|2/176|0.47157188953059|1|0|0|1.26262626262626|0.949095604405032|CSF1R;PIM1|3
6116|regulation of Notch signaling pathway (GO:0008593)|1/71|0.474299007706901|1|0|0|1.56494522691706|1.16731977812522|MMP14|3
6117|vascular endothelial growth factor receptor signaling pathway (GO:0048010)|1/71|0.474299007706901|1|0|0|1.56494522691706|1.16731977812522|CYBB|3
6118|snRNA transcription (GO:0009301)|1/71|0.474299007706901|1|0|0|1.56494522691706|1.16731977812522|POU2F2|3
6119|snRNA transcription from RNA polymerase II promoter (GO:0042795)|1/71|0.474299007706901|1|0|0|1.56494522691706|1.16731977812522|POU2F2|3
6120|actomyosin structure organization (GO:0031032)|1/72|0.479047162115276|1|0|0|1.54320987654321|1.1357349180358|F11R|3
6121|nuclear import (GO:0051170)|1/72|0.479047162115276|1|0|0|1.54320987654321|1.1357349180358|MMP12|3
6122|regulation of cation channel activity (GO:2001257)|1/72|0.479047162115276|1|0|0|1.54320987654321|1.1357349180358|CTSS|3
6123|response to insulin (GO:0032868)|1/72|0.479047162115276|1|0|0|1.54320987654321|1.1357349180358|ZFP36L1|3
6124|cell-cell junction organization (GO:0045216)|1/73|0.483752666934385|1|0|0|1.5220700152207|1.10529911965097|CSF1R|3
6125|negative regulation of cysteine-type endopeptidase activity (GO:2000117)|1/73|0.483752666934385|1|0|0|1.5220700152207|1.10529911965097|KLF4|3
6126|Rho protein signal transduction (GO:0007266)|1/73|0.483752666934385|1|0|0|1.5220700152207|1.10529911965097|PDPN|3
6127|lymphocyte differentiation (GO:0030098)|1/74|0.488415903186455|1|0|0|1.5015015015015|1.07595792112445|KLF6|3
6128|regulation of protein complex assembly (GO:0043254)|1/74|0.488415903186455|1|0|0|1.5015015015015|1.07595792112445|TNF|3
6129|nucleic acid phosphodiester bond hydrolysis (GO:0090305)|1/74|0.488415903186455|1|0|0|1.5015015015015|1.07595792112445|PNRC1|3
6130|canonical Wnt signaling pathway (GO:0060070)|1/74|0.488415903186455|1|0|0|1.5015015015015|1.07595792112445|NR4A2|3
6131|organonitrogen compound biosynthetic process (GO:1901566)|2/182|0.489093452746296|1|0|0|1.22100122100122|0.873262146344092|ARG1;FURIN|3
6132|mitotic spindle organization (GO:0007052)|1/75|0.493037248471167|1|0|0|1.48148148148148|1.0476600786449|BIRC3|3
6133|glucose homeostasis (GO:0042593)|1/75|0.493037248471167|1|0|0|1.48148148148148|1.0476600786449|HK2|3
6134|mitotic nuclear division (GO:0140014)|1/75|0.493037248471167|1|0|0|1.48148148148148|1.0476600786449|BIRC3|3
6135|nitrogen compound transport (GO:0071705)|1/75|0.493037248471167|1|0|0|1.48148148148148|1.0476600786449|SLC7A11|3
6136|phosphate-containing compound metabolic process (GO:0006796)|2/184|0.494853359587451|1|0|0|1.20772946859903|0.849630197536018|PLD4;FAM20C|3
6137|retinoid metabolic process (GO:0001523)|1/76|0.497617077027439|1|0|0|1.46198830409357|1.02035733824707|APOE|3
6138|C-terminal protein lipidation (GO:0006501)|1/76|0.497617077027439|1|0|0|1.46198830409357|1.02035733824707|CD52|3
6139|antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)|1/76|0.497617077027439|1|0|0|1.46198830409357|1.02035733824707|CYBB|3
6140|positive regulation of apoptotic signaling pathway (GO:2001235)|1/77|0.502155759632707|1|0|0|1.44300144300144|0.994004226932059|CTSH|3
6141|regulation of cellular macromolecule biosynthetic process (GO:2000112)|6/632|0.505362205829149|1|0|0|1.05485232067511|0.719915472082588|CEBPB;MAFB;BTG1;NFIL3;DENND4A;BHLHE40|3
6142|water-soluble vitamin metabolic process (GO:0006767)|1/78|0.506653664105885|1|0|0|1.42450142450142|0.968557859099908|ACP5|3
6143|response to ionizing radiation (GO:0010212)|1/78|0.506653664105885|1|0|0|1.42450142450142|0.968557859099908|CDKN1A|3
6144|positive regulation of cytoskeleton organization (GO:0051495)|1/78|0.506653664105885|1|0|0|1.42450142450142|0.968557859099908|PLEK|3
6145|antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590)|1/79|0.511111154650373|1|0|0|1.40646976090014|0.943977761822309|CYBB|3
6146|regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418)|1/79|0.511111154650373|1|0|0|1.40646976090014|0.943977761822309|NFE2L2|3
6147|peptidyl-tyrosine phosphorylation (GO:0018108)|1/80|0.515528592406908|1|0|0|1.38888888888889|0.920225710661729|CSF1R|3
6148|response to calcium ion (GO:0051592)|1/80|0.515528592406908|1|0|0|1.38888888888889|0.920225710661729|MEF2A|3
6149|cell-cell junction assembly (GO:0007043)|1/80|0.515528592406908|1|0|0|1.38888888888889|0.920225710661729|F11R|3
6150|spindle assembly (GO:0051225)|1/81|0.519906335274931|1|0|0|1.37174211248285|0.89726558038726|BIRC3|3
6151|regulation of hydrolase activity (GO:0051336)|1/81|0.519906335274931|1|0|0|1.37174211248285|0.89726558038726|PLXND1|3
6152|BMP signaling pathway (GO:0030509)|1/82|0.524244738040839|1|0|0|1.3550135501355|0.875063206461483|GDF15|3
6153|negative regulation of cell death (GO:0060548)|1/82|0.524244738040839|1|0|0|1.3550135501355|0.875063206461483|APOE|3
6154|positive regulation of binding (GO:0051099)|1/82|0.524244738040839|1|0|0|1.3550135501355|0.875063206461483|APOE|3
6155|protein catabolic process (GO:0030163)|1/82|0.524244738040839|1|0|0|1.3550135501355|0.875063206461483|APOE|3
6156|modulation of chemical synaptic transmission (GO:0050804)|1/83|0.528544152130266|1|0|0|1.33868808567604|0.853586258118536|IL1B|3
6157|positive regulation of cell cycle (GO:0045787)|1/83|0.528544152130266|1|0|0|1.33868808567604|0.853586258118536|CCNL1|3
6158|positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100)|1/83|0.528544152130266|1|0|0|1.33868808567604|0.853586258118536|GDF15|3
6159|C-terminal protein amino acid modification (GO:0018410)|1/83|0.528544152130266|1|0|0|1.33868808567604|0.853586258118536|CD52|3
6160|negative regulation of endopeptidase activity (GO:0010951)|1/84|0.532804926158375|1|0|0|1.32275132275132|0.832804119055495|TIMP2|3
6161|positive regulation of homeostatic process (GO:0032846)|1/84|0.532804926158375|1|0|0|1.32275132275132|0.832804119055495|SPP1|3
6162|regulation of neuron differentiation (GO:0045664)|1/85|0.537027405326113|1|0|0|1.30718954248366|0.812687779932848|ID2|3
6163|regulation of type I interferon production (GO:0032479)|1/86|0.541211932034075|1|0|0|1.29198966408269|0.793209735869884|TNFAIP3|3
6164|mitochondrial translational elongation (GO:0070125)|1/88|0.549468481761649|1|0|0|1.26262626262626|0.756065485877617|MRPL52|3
6165|cellular response to BMP stimulus (GO:0071773)|1/88|0.549468481761649|1|0|0|1.26262626262626|0.756065485877617|GDF15|3
6166|negative regulation of translation (GO:0017148)|1/89|0.553541174238601|1|0|0|1.24843945068664|0.738350987180856|BTG2|3
6167|mitochondrial translational termination (GO:0070126)|1/90|0.557577253158822|1|0|0|1.23456790123457|0.721178042665957|MRPL52|3
6168|cell-matrix adhesion (GO:0007160)|1/91|0.561577045826088|1|0|0|1.22100122100122|0.704525396730949|ADAM15|3
6169|protein tetramerization (GO:0051262)|1/91|0.561577045826088|1|0|0|1.22100122100122|0.704525396730949|CD74|3
6170|lipid transport (GO:0006869)|1/92|0.565540876759345|1|0|0|1.20772946859903|0.688372828212686|APOE|3
6171|negative regulation of kinase activity (GO:0033673)|1/92|0.565540876759345|1|0|0|1.20772946859903|0.688372828212686|TRIB1|3
6172|phospholipase C-activating G-protein coupled receptor signaling pathway (GO:0007200)|1/92|0.565540876759345|1|0|0|1.20772946859903|0.688372828212686|C3AR1|3
6173|nuclear export (GO:0051168)|1/93|0.569469067407383|1|0|0|1.194743130227|0.672701090706599|MALT1|3
6174|cell cycle G1/S phase transition (GO:0044843)|1/93|0.569469067407383|1|0|0|1.194743130227|0.672701090706599|CDKN1A|3
6175|skin development (GO:0043588)|1/95|0.577219799697067|1|0|0|1.16959064327485|0.642727660422556|EREG|3
6176|axon development (GO:0061564)|1/95|0.577219799697067|1|0|0|1.16959064327485|0.642727660422556|S100A6|3
6177|positive regulation of protein localization to membrane (GO:1905477)|1/96|0.581042970313594|1|0|0|1.15740740740741|0.628391858372009|TREM2|3
6178|regulation of heart contraction (GO:0008016)|1/96|0.581042970313594|1|0|0|1.15740740740741|0.628391858372009|ATP2B1|3
6179|translational termination (GO:0006415)|1/97|0.584831758468504|1|0|0|1.1454753722795|0.614468574426604|MRPL52|3
6180|protein localization to nucleus (GO:0034504)|1/97|0.584831758468504|1|0|0|1.1454753722795|0.614468574426604|MMP12|3
6181|negative regulation of cell motility (GO:2000146)|1/98|0.588586471667838|1|0|0|1.13378684807256|0.60094266140765|ADAM15|3
6182|protein localization to organelle (GO:0033365)|1/98|0.588586471667838|1|0|0|1.13378684807256|0.60094266140765|PPP1R15A|3
6183|ion transmembrane transport (GO:0034220)|2/220|0.59123846733539|1|0|0|1.01010101010101|0.530844287808135|ATP2B1;SGK1|3
6184|positive regulation of neuron differentiation (GO:0045666)|1/99|0.592307414693297|1|0|0|1.12233445566779|0.587799660271197|APOE|3
6185|viral process (GO:0016032)|2/221|0.593712817215484|1|0|0|1.00553041729512|0.524242885099355|FURIN;APOE|3
6186|steroid metabolic process (GO:0008202)|1/100|0.595994889569521|1|0|0|1.11111111111111|0.575025762779258|LGMN|3
6187|glycosaminoglycan biosynthetic process (GO:0006024)|1/100|0.595994889569521|1|0|0|1.11111111111111|0.575025762779258|IL1B|3
6188|ubiquitin-dependent protein catabolic process (GO:0006511)|3/342|0.597139022031404|1|0|0|0.974658869395712|0.502539303094269|RNF128;TNFAIP3;NFE2L2|3
6189|intracellular protein transport (GO:0006886)|3/348|0.608937306466999|1|0|0|0.957854406130268|0.475134062851939|MMP12;CD74;TNF|3
6190|B cell receptor signaling pathway (GO:0050853)|1/105|0.613940626821326|1|0|0|1.05820105820106|0.516250851321389|LAT2|3
6191|positive regulation of lymphocyte activation (GO:0051251)|1/105|0.613940626821326|1|0|0|1.05820105820106|0.516250851321389|CCR2|3
6192|translational elongation (GO:0006414)|1/106|0.617433487052903|1|0|0|1.0482180293501|0.505433888423635|MRPL52|3
6193|G1/S transition of mitotic cell cycle (GO:0000082)|1/106|0.617433487052903|1|0|0|1.0482180293501|0.505433888423635|CDKN1A|3
6194|fatty acid metabolic process (GO:0006631)|1/107|0.620894919653531|1|0|0|1.03842159916926|0.494904904334934|HPGD|3
6195|mitochondrial translation (GO:0032543)|1/108|0.624325205682766|1|0|0|1.02880658436214|0.484654201047124|MRPL52|3
6196|cellular response to starvation (GO:0009267)|1/108|0.624325205682766|1|0|0|1.02880658436214|0.484654201047124|CDKN1A|3
6197|monocarboxylic acid metabolic process (GO:0032787)|1/109|0.627724624007362|1|0|0|1.01936799184506|0.474672482655799|LDHB|3
6198|Wnt signaling pathway (GO:0016055)|1/110|0.631093450716943|1|0|0|1.01010101010101|0.464950836377394|NR4A2|3
6199|regulation of Wnt signaling pathway (GO:0030111)|1/110|0.631093450716943|1|0|0|1.01010101010101|0.464950836377394|TLR2|3
6200|viral gene expression (GO:0019080)|1/111|0.634431959663257|1|0|0|1.001001001001|0.455480712863871|FURIN|3
6201|cellular response to insulin stimulus (GO:0032869)|1/111|0.634431959663257|1|0|0|1.001001001001|0.455480712863871|ZFP36L1|3
6202|nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)|1/113|0.641019107170602|1|0|0|0.983284169124877|0.437262550764261|PNRC1|3
6203|regulation of organelle organization (GO:0033043)|1/114|0.644268281138147|1|0|0|0.974658869395712|0.428499077979767|ZEB2|3
6204|cellular macromolecule biosynthetic process (GO:0034645)|3/368|0.646590418440807|1|0|0|0.905797101449275|0.394965790011212|MEF2A;NR4A2;MRPL52|3
6205|epithelium development (GO:0060429)|1/116|0.650679150341629|1|0|0|0.957854406130268|0.411627025752292|CTSB|3
6206|chromatin remodeling (GO:0006338)|1/117|0.653841366822868|1|0|0|0.949667616334283|0.403504762888697|KDM6B|3
6207|regulation of neuron projection development (GO:0010975)|1/120|0.663158223041182|1|0|0|0.925925925925926|0.380316361247251|APOE|3
6208|enzyme linked receptor protein signaling pathway (GO:0007167)|1/121|0.666208086040927|1|0|0|0.918273645546373|0.372959794066608|CSF1R|3
6209|macromolecular complex assembly (GO:0065003)|1/121|0.666208086040927|1|0|0|0.918273645546373|0.372959794066608|CD74|3
6210|phosphorylation (GO:0016310)|3/387|0.679936654948385|1|0|0|0.861326442721792|0.332261532849959|PIM1;FAM20C;SGK1|3
6211|G2/M transition of mitotic cell cycle (GO:0000086)|1/127|0.683939083253229|1|0|0|0.874890638670166|0.3323590769002|CDKN1A|3
6212|vesicle organization (GO:0016050)|1/128|0.68680179738158|1|0|0|0.868055555555556|0.326136747330221|SRGN|3
6213|protein lipidation (GO:0006497)|1/128|0.68680179738158|1|0|0|0.868055555555556|0.326136747330221|CD52|3
6214|cell cycle G2/M phase transition (GO:0044839)|1/128|0.68680179738158|1|0|0|0.868055555555556|0.326136747330221|CDKN1A|3
6215|Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096)|1/134|0.703444581096828|1|0|0|0.829187396351575|0.291680084172844|FCGR2B|3
6216|adenylate cyclase-modulating G-protein coupled receptor signaling pathway (GO:0007188)|1/135|0.706131570030451|1|0|0|0.823045267489712|0.286381645296482|RGS1|3
6217|Fc-gamma receptor signaling pathway (GO:0038094)|1/135|0.706131570030451|1|0|0|0.823045267489712|0.286381645296482|FCGR2B|3
6218|Fc receptor mediated stimulatory signaling pathway (GO:0002431)|1/136|0.70879434687949|1|0|0|0.816993464052288|0.281200862209607|FCGR2B|3
6219|regulation of vesicle-mediated transport (GO:0060627)|1/139|0.716639565400476|1|0|0|0.799360511590728|0.266332744175728|PTPN1|3
6220|gene expression (GO:0010467)|3/412|0.720206269499042|1|0|0|0.809061488673139|0.265548238338035|MEF2A;NR4A2;MRPL52|3
6221|positive regulation of Wnt signaling pathway (GO:0030177)|1/141|0.721752577428928|1|0|0|0.788022064617809|0.256952631491556|TLR2|3
6222|modification-dependent protein catabolic process (GO:0019941)|1/142|0.72427457137308|1|0|0|0.782472613458529|0.252413705995749|RNF128|3
6223|cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742)|1/143|0.726773831943681|1|0|0|0.777000777000777|0.247971987248368|ICAM1|3
6224|protein polyubiquitination (GO:0000209)|2/284|0.727594247131258|1|0|0|0.782472613458529|0.248835476530486|TNFAIP3;SASH1|3
6225|cellular protein complex assembly (GO:0043623)|1/145|0.731704966618983|1|0|0|0.766283524904215|0.239370036271802|HOPX|3
6226|peptidyl-serine phosphorylation (GO:0018105)|1/146|0.734137242851265|1|0|0|0.76103500761035|0.235204937963993|SGK1|3
6227|skeletal system development (GO:0001501)|1/147|0.736547590053732|1|0|0|0.755857898715042|0.231127308136807|ETS2|3
6228|ion transport (GO:0006811)|2/290|0.738182023262476|1|0|0|0.766283524904215|0.232616736249959|ATP2B1;SGK1|3
6229|negative regulation of canonical Wnt signaling pathway (GO:0090090)|1/149|0.741303282181932|1|0|0|0.745712155108128|0.223225540437358|APOE|3
6230|positive regulation of intracellular protein transport (GO:0090316)|1/153|0.750560052964813|1|0|0|0.726216412490922|0.208377352095084|IL1B|3
6231|protein stabilization (GO:0050821)|1/153|0.750560052964813|1|0|0|0.726216412490922|0.208377352095084|CDKN1A|3
6232|peptidyl-serine modification (GO:0018209)|1/171|0.788303203940313|1|0|0|0.649772579597141|0.154563019205834|SGK1|3
6233|negative regulation of Wnt signaling pathway (GO:0030178)|1/175|0.795886485512196|1|0|0|0.634920634920635|0.144951561553926|APOE|3
6234|protein transport (GO:0015031)|2/327|0.796004460827153|1|0|0|0.679578661230037|0.155046203941042|CD74;APOE|3
6235|protein ubiquitination (GO:0016567)|3/507|0.838184541852763|1|0|0|0.657462195923734|0.116053245059954|SASH1;NFE2L2;BIRC3|3
6236|regulation of autophagy (GO:0010506)|1/204|0.843354642991752|1|0|0|0.544662309368192|0.0927928746613583|MCL1|3
6237|regulation of canonical Wnt signaling pathway (GO:0060828)|1/214|0.857031948383402|1|0|0|0.519210799584631|0.0801038846064507|APOE|3
6238|regulation of translation (GO:0006417)|1/214|0.857031948383402|1|0|0|0.519210799584631|0.0801038846064507|BTG2|3
6239|transmembrane transport (GO:0055085)|2/379|0.858197855290873|1|0|0|0.58633831720903|0.0896632104991421|ATP2B1;SGK1|3
6240|central nervous system development (GO:0007417)|1/218|0.862164222147757|1|0|0|0.509683995922528|0.0755909854899569|NR4A2|3
6241|mitotic cell cycle phase transition (GO:0044772)|1/222|0.867113241402314|1|0|0|0.500500500500501|0.0713642131180893|CDKN1A|3
6242|transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169)|2/397|0.875352088991262|1|0|0|0.559753708368318|0.074519499659694|CSF1R;CYBB|3
6243|protein modification by small protein conjugation (GO:0032446)|2/399|0.877136032550511|1|0|0|0.556947925368978|0.0730120787560029|NFE2L2;BIRC3|3
6244|translation (GO:0006412)|1/233|0.879830453787936|1|0|0|0.476871721506915|0.0610520058285478|MRPL52|3
6245|proteasomal protein catabolic process (GO:0010498)|1/238|0.885203534759781|1|0|0|0.466853408029879|0.0569270203719791|NFE2L2|3
6246|DNA repair (GO:0006281)|1/289|0.928053679002241|1|0|0|0.384467512495194|0.0287065375303371|BTG2|3
6247|chemical synaptic transmission (GO:0007268)|1/290|0.928710671240061|1|0|0|0.383141762452107|0.0283364098668594|APOE|3
6248|proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161)|1/292|0.93000680971169|1|0|0|0.380517503805175|0.0276116326449806|NFE2L2|3
6249|DNA metabolic process (GO:0006259)|1/315|0.943329470191899|1|0|0|0.352733686067019|0.0205783676276131|BTG2|3
6250|cellular protein localization (GO:0034613)|1/328|0.949710141363423|1|0|0|0.338753387533875|0.0174791515239489|CD74|3
6251|vesicle-mediated transport (GO:0016192)|1/411|0.976586737870665|1|0|0|0.270343336036767|0.0064048952002583|CUX1|3
6252|DNA metabolic process (GO:0006259)|56/315|7.1452694834736e-39|3.64623101741658e-35|0|0|9.71463266545234|853.278621490961|TOP2A;FEN1;MCM7;HMGB2;MCM10;HMGB1;PCLAF;TK1;TOPBP1;RFC5;WDHD1;HELLS;TIPIN;RFC3;RFC4;LIG1;RFC1;TERF1;SMC1A;NSMCE4A;DBF4;MCM3;MCM4;MCM5;MCM6;DCTPP1;RHNO1;MCM2;PRIM2;PCNA;UHRF1;TYMS;RAD51AP1;POLD3;BRIP1;ORC6;CDC45;RAD21;POLD2;RBBP8;RAD54L;CLSPN;CTC1;DUT;RPA2;NAP1L1;FAM111A;POLA1;RAD51;NASP;RPA3;UBE2T;CDK2;CDK1;RAN;CENPS|4
6253|mitotic cell cycle phase transition (GO:0044772)|44/222|9.85296543544143e-33|2.51398413085288e-29|0|0|10.8305026337813|798.181353413503|PRIM2;CDKN1A;MCM7;SSNA1;MCM10;PKMYT1;FOXM1;CCNB2;CCNB1;ORC6;CDC45;CNTRL;RCC1;PCNT;PLK4;CDKN2D;CDT1;HSP90AA1;CDKN2C;UBE2C;PLK1;HAUS4;RPA2;TUBB4B;CKAP5;CDC25B;CCNA2;POLA1;DBF4;CCNE2;NASP;CCNE1;UBE2S;RPA3;CDK2;TACC3;CDK1;MCM3;MCM4;MCM5;MCM6;MAPRE1;CDKN3;MCM2|4
6254|DNA replication (GO:0006260)|33/121|1.26491746865515e-29|2.15162461418241e-26|0|0|14.903129657228|991.653663471625|FEN1;MCM7;MCM10;BRIP1;ORC6;CDC45;POLD2;PCLAF;RBBP8;CLSPN;TOPBP1;RFC5;WDHD1;TIPIN;RFC3;DUT;RFC4;RFC1;RPA2;NAP1L1;FAM111A;POLA1;DBF4;NASP;RPA3;CDK2;CDK1;MCM3;MCM4;MCM5;MCM6;RHNO1;MCM2|4
6255|G1/S transition of mitotic cell cycle (GO:0000082)|29/106|3.34690833001303e-26|4.26981830201412e-23|0|0|14.9499948448294|876.954369603109|PRIM2;CDKN1A;PCNA;MCM7;MCM10;TYMS;ORC6;CDC45;RCC1;FBXO5;CDKN2D;CDT1;CDKN2C;RRM2;RPA2;DHFR;POLA1;DBF4;CCNE2;NASP;CCNE1;RPA3;CDK2;MCM3;MCM4;MCM5;MCM6;MCM2;CDKN3|4
6256|cell cycle G1/S phase transition (GO:0044843)|25/93|1.55615948341325e-22|1.58821636877157e-19|0|0|14.6894647159058|737.626345989751|PRIM2;CDKN1A;MCM7;MCM10;ORC6;CDC45;RCC1;CDKN2D;CDT1;CDKN2C;RPA2;CCNA2;POLA1;DBF4;CCNE2;NASP;CCNE1;RPA3;CDK2;MCM3;MCM4;MCM5;MCM6;MCM2;CDKN3|4
6257|centromere complex assembly (GO:0034508)|17/37|2.27732295431297e-20|1.93686317264318e-17|0|0|25.1070742874022|1135.56036219656|HELLS;CENPW;HJURP;KNL1;CENPA;CENPE;CENPF;RBBP4;NASP;CENPH;MIS18BP1;CENPK;CENPL;CENPM;RBBP7;CENPQ;CENPS|4
6258|mitotic sister chromatid segregation (GO:0000070)|22/83|7.91715594520562e-20|5.77160668405489e-17|0|0|14.4841661728883|637.052298347627|SPAG5;CDCA5;PLK1;CDCA8;KIF23;KIF22;SMC1A;SMC4;KNSTRN;NCAPH;SMC2;CENPE;CCNB1;ESPL1;KIFC1;PRC1;NUSAP1;NCAPD2;NCAPD3;DLGAP5;KPNB1;RAN|4
6259|cellular macromolecule biosynthetic process (GO:0034645)|40/368|1.04256055025445e-19|6.65023310993558e-17|0|0|5.93965312425754|259.607014802233|FEN1;MCM7;MCM10;TYMS;RPL6;RPS17;BRIP1;ORC6;CDC45;POLD2;PCLAF;RBBP8;CLSPN;TOPBP1;RFC5;TIPIN;RFC3;DUT;RFC4;RPS5;RPA2;RPSA;NAP1L1;BAZ1B;FAM111A;POLA1;MRPL51;DBF4;NASP;RPA3;CDK2;CDK1;MCM3;MCM4;RPS20;MCM5;MCM6;PTMA;RHNO1;MCM2|4
6260|histone exchange (GO:0043486)|16/37|1.03567808499883e-18|5.87229474194337e-16|0|0|23.6301875646138|978.560928834319|CENPW;HJURP;KNL1;CENPA;RBBP4;NASP;CENPH;MIS18BP1;CENPK;CENPL;ANP32E;CENPM;RBBP7;ANP32B;CENPQ;CENPS|4
6261|DNA replication-independent nucleosome assembly (GO:0006336)|16/40|4.81002514356272e-18|2.45455583076006e-15|0|0|21.8579234972678|871.602827594249|CENPW;HJURP;KNL1;CENPA;RBBP4;NASP;CENPH;MIS18BP1;HAT1;CENPK;CENPL;CENPM;RBBP7;CENPQ;ASF1B;CENPS|4
6262|chromatin remodeling at centromere (GO:0031055)|15/33|4.99487566111407e-18|2.31716822715137e-15|0|0|24.8385494287134|989.521091772777|HELLS;CENPW;HJURP;KNL1;CENPA;RBBP4;NASP;CENPH;MIS18BP1;CENPK;CENPL;CENPM;RBBP7;CENPQ;CENPS|4
6263|DNA repair (GO:0006281)|33/289|4.46618687172546e-17|1.89924596720125e-14|0|0|6.23971864541381|234.909256019475|FEN1;PCNA;CDCA5;HMGB2;NUCKS1;HMGB1;RAD51AP1;POLD3;BRIP1;RAD21;POLD2;USP1;RBBP8;RAD54L;TOPBP1;CDKN2D;RFC5;WDHD1;RFC3;RFC4;LIG1;H2AFX;RPA2;SMC1A;RNF168;POLA1;NSMCE4A;RAD51;RPA3;UBE2T;CDK1;RHNO1;CENPS|4
6264|CENP-A containing nucleosome assembly (GO:0034080)|14/31|7.37688117828375e-17|2.89570958867554e-14|0|0|24.6783007227217|916.690179634205|CENPW;HJURP;KNL1;CENPA;RBBP4;NASP;CENPH;MIS18BP1;CENPK;CENPL;CENPM;RBBP7;CENPQ;CENPS|4
6265|CENP-A containing chromatin organization (GO:0061641)|14/31|7.37688117828375e-17|2.68887318948443e-14|0|0|24.6783007227217|916.690179634205|CENPW;HJURP;KNL1;CENPA;RBBP4;NASP;CENPH;MIS18BP1;CENPK;CENPL;CENPM;RBBP7;CENPQ;CENPS|4
6266|regulation of mitotic cell cycle phase transition (GO:1901990)|26/185|6.79789808589397e-16|2.31264492882113e-13|0|0|7.67981095849948|268.215462632269|SSNA1;BUB1B;HMMR;ANAPC11;CDC20;CCNB1;FZR1;CNTRL;FBXO5;PCNT;PLK4;HSP90AA1;UBE2C;PLK1;HAUS4;TUBB4B;CKAP5;TPX2;ANLN;CENPE;CENPF;CDK2;CDK1;ANAPC5;MAPRE1;MAD2L1|4
6267|mitotic spindle organization (GO:0007052)|18/75|1.29234547742622e-15|4.12177435706624e-13|0|0|13.1147540983607|449.60416561188|SUN2;KIF23;KIF11;RHOA;AURKB;CENPE;TPX2;CCNB1;KIFC1;PRC1;NUF2;STMN1;RCC1;BIRC5;PCNT;KPNB1;RAN;SPC25|4
6268|microtubule cytoskeleton organization involved in mitosis (GO:1902850)|15/45|1.36123725725949e-15|4.08611395517362e-13|0|0|18.2149362477231|623.504232436206|SUN2;KIF11;AURKB;CENPE;CCNB1;ESPL1;NUF2;STMN1;NUSAP1;TACC3;RCC1;PCNT;KPNB1;RAN;SPC25|4
6269|DNA synthesis involved in DNA repair (GO:0000731)|17/66|2.22504694720651e-15|6.30800809533047e-13|0|0|14.0751780096042|474.88240805928|RFC5;CDKN2D;RFC3;RFC4;PCNA;RFC1;RPA2;RAD51AP1;POLD3;POLA1;BRIP1;RAD51;RPA3;POLD2;PCLAF;RBBP8;DTL|4
6270|cellular response to DNA damage stimulus (GO:0006974)|32/330|1.49277901189548e-14|4.0092901566856e-12|0|0|5.29889054479218|168.693104476689|TOP2A;FEN1;CDKN1A;MCM7;MCM10;SMC6;RAD51AP1;BRIP1;MRNIP;POLD2;PCLAF;RBBP8;RAD54L;CLSPN;TOPBP1;RFC5;WDHD1;RFC3;RFC4;LIG1;H2AFX;BAZ1B;SMC1A;RNF168;POLA1;NSMCE4A;RAD51;UBE2T;CDK1;DTL;RHNO1;CENPS|4
6271|mitotic nuclear division (GO:0140014)|17/75|2.2597291744823e-14|5.76569898869158e-12|0|0|12.3861566484517|389.184763287374|SPAG5;UBE2C;PLK1;CDCA8;KIF11;SMC1A;SMC4;KNSTRN;RHOA;TPX2;ESPL1;KIFC1;UBE2S;NUSAP1;BIRC5;KPNB1;RAN|4
6272|cytoskeleton-dependent cytokinesis (GO:0061640)|16/71|1.46447432000806e-13|3.55867259761958e-11|0|0|12.3143230970523|363.914228975972|PLK1;CKAP2;KIF23;CENPA;RHOA;AURKB;CIT;ANLN;ESPL1;RACGAP1;INCENP;STMN1;NUSAP1;KIF20A;ECT2;CEP55|4
6273|mitotic cytokinesis (GO:0000281)|15/60|1.63733160793189e-13|3.79786508876202e-11|0|0|13.6612021857923|402.19314700183|PLK1;CKAP2;KIF23;CENPA;CIT;ANLN;ESPL1;RACGAP1;INCENP;STMN1;NUSAP1;KIF20A;CNTROB;ECT2;CEP55|4
6274|regulation of cell cycle process (GO:0010564)|17/91|6.70766340607014e-13|1.48822636352939e-10|0|0|10.2083708641086|286.144264848082|TIPIN;SPAG5;PLK1;MKI67;FOXM1;PKMYT1;KNSTRN;AURKB;RACGAP1;PRC1;RCC1;CALM3;FBXO5;KIF20A;KIF20B;ECT2;CALM2|4
6275|DNA-dependent DNA replication (GO:0006261)|14/57|1.39206000472638e-12|2.95986758504946e-10|0|0|13.4215319720065|366.410996331535|RFC5;WDHD1;PRIM2;RFC3;RFC4;RFC1;MCM10;POLA1;ORC6;CDC45;RAD51;POLD2;TOPBP1;MCM2|4
6276|regulation of ubiquitin protein ligase activity (GO:1904666)|12/37|1.44693077913428e-12|2.95347510636889e-10|0|0|17.7226406734603|483.147124624292|CDC20;FZR1;CCNB1;UBE2C;UBE2S;PLK1;CDK2;CDK1;ANAPC5;FBXO5;ANAPC11;MAD2L1|4
6277|G2/M transition of mitotic cell cycle (GO:0000086)|19/127|1.88391696891274e-12|3.69754934321603e-10|0|0|8.17520760724582|220.711540913261|PLK4;CDKN1A;HSP90AA1;SSNA1;PLK1;HAUS4;PKMYT1;FOXM1;TUBB4B;CKAP5;CDC25B;CCNA2;CCNB2;CCNB1;CDK2;CNTRL;CDK1;MAPRE1;PCNT|4
6278|cell cycle G2/M phase transition (GO:0044839)|19/128|2.17580865807096e-12|4.11227836375412e-10|0|0|8.11133879781421|217.818815637716|PLK4;CDKN1A;HSP90AA1;SSNA1;PLK1;HAUS4;PKMYT1;FOXM1;TUBB4B;CKAP5;CDC25B;CCNA2;CCNB2;CCNB1;CDK2;CNTRL;CDK1;MAPRE1;PCNT|4
6279|regulation of cell cycle G2/M phase transition (GO:1902749)|16/85|2.85273221255911e-12|5.19910445738898e-10|0|0|10.2860816457731|273.432274224944|PLK4;HSP90AA1;H2AFY;SSNA1;PLK1;HAUS4;HMMR;TUBB4B;CKAP5;TPX2;CENPF;CNTRL;CDK2;CDK1;MAPRE1;PCNT|4
6280|nucleotide-excision repair, DNA gap filling (GO:0006297)|10/23|3.45006316414689e-12|6.07092149194536e-10|0|0|23.7586124970302|627.052235129591|RFC5;POLD3;RFC3;PCNA;RFC4;LIG1;RFC1;RPA3;POLD2;RPA2|4
6281|sister chromatid segregation (GO:0000819)|11/33|8.95739932872749e-12|1.52365362581655e-09|0|0|18.2149362477231|463.361405911906|TOP2A;SPAG5;ESPL1;KIFC1;PLK1;NUSAP1;CDCA8;SMC1A;SMC4;KNSTRN;RAN|4
6282|negative regulation of cell cycle process (GO:0010948)|15/82|2.13046585102667e-11|3.50702168960938e-09|0|0|9.99600159936026|245.622704495446|CDT1;CBX5;RRM2;CBX3;SMC3;SMC1A;AURKB;HMGN5;RAD51;RBBP4;RBBP8;FBXO5;RBBP7;E2F8;EZH2|4
6283|nucleosome assembly (GO:0006334)|13/61|6.20528181590884e-11|9.89548534580712e-09|0|0|11.6456149780525|273.707298612243|H2AFY;H2AFX;HMGB2;CENPA;CHAF1B;CHAF1A;HIST1H3A;RBBP4;NASP;HAT1;ANP32E;ANP32B;ASF1B|4
6284|DNA replication-dependent nucleosome organization (GO:0034723)|7/10|7.429947470617e-11|1.14894005886541e-08|0|0|38.2513661202186|892.133446114389|CHAF1B;CHAF1A;HIST1H3A;RBBP4;NASP;HAT1;ASF1B|4
6285|DNA replication-dependent nucleosome assembly (GO:0006335)|7/10|7.429947470617e-11|1.1151477041929e-08|0|0|38.2513661202186|892.133446114389|CHAF1B;CHAF1A;HIST1H3A;RBBP4;NASP;HAT1;ASF1B|4
6286|positive regulation of cell cycle process (GO:0090068)|16/108|1.25985456134920e-10|1.83686795044713e-08|0|0|8.09552722121028|184.536366267071|FEN1;SPAG5;KIF23;RHOA;AURKB;CDC25B;CIT;CCNB1;RACGAP1;RAD21;NUSAP1;KIF20B;ECT2;RHNO1;E2F8;MAD2L1|4
6287|positive regulation of mitotic cell cycle phase transition (GO:1901992)|11/41|1.28273791397353e-10|1.81828099305748e-08|0|0|14.6608023457284|333.926956620307|CCNB1;LSM11;CDC45;ESPL1;UBE2C;CDCA5;CDK1;ANAPC5;DTL;DLGAP5;ANAPC11|4
6288|regulation of cytokinesis (GO:0032465)|14/78|1.30856256638066e-10|1.80475534492987e-08|0|0|9.80804259492784|223.200857095761|PLK1;KIF23;RHOA;AURKB;CDC25B;CIT;RACGAP1;PRC1;CALM3;KIF20A;KIF20B;ECT2;CALM2;E2F8|4
6289|translesion synthesis (GO:0019985)|11/43|2.2600849540915e-10|3.0350561896655e-08|0|0|13.9789045622061|310.477740243518|POLD3;RFC5;RFC3;PCNA;RFC4;RFC1;RPA3;POLD2;PCLAF;RPA2;DTL|4
6290|kinetochore organization (GO:0051383)|7/12|4.75118023889765e-10|6.21673660489608e-08|0|0|31.8761384335155|684.299658924756|CDT1;CENPE;CENPF;CENPW;CENPH;NUF2;CENPA|4
6291|regulation of signal transduction by p53 class mediator (GO:1901796)|17/139|7.19887092829506e-10|9.18395958677242e-08|0|0|6.68317804772575|140.693774595828|RFC5;RFC3;RFC4;TAF15;RPA2;SSRP1;AURKB;TPX2;BRIP1;RBBP4;RPA3;CDK2;RBBP8;KMT5A;TOPBP1;RBBP7;RHNO1|4
6292|regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083)|9/27|7.3121582202843e-10|9.10096180441727e-08|0|0|18.2149362477231|383.175090302026|DHFR;CDT1;POLA1;PCNA;CDC45;RRM2;CCNE1;FBXO5;TYMS|4
6293|postreplication repair (GO:0006301)|11/48|8.18053815587228e-10|9.93935385938482e-08|0|0|12.5227686703097|262.027576178162|POLD3;RFC5;RFC3;PCNA;RFC4;RFC1;RPA3;POLD2;PCLAF;RPA2;DTL|4
6294|DNA biosynthetic process (GO:0071897)|10/40|1.93817221897298e-09|2.30011461242305e-07|0|0|13.6612021857923|274.06448720146|RAD51AP1;POLD3;CDKN2D;POLA1;BRIP1;RFC3;RAD51;RBBP8;TYMS;PPIA|4
6295|regulation of G2/M transition of mitotic cell cycle (GO:0010389)|17/150|2.36586898850495e-09|2.74387032916835e-07|0|0|6.19307832422586|123.007667604134|PLK4;HSP90AA1;SSNA1;PLK1;HAUS4;HMMR;TUBB4B;CKAP5;TPX2;CCNB1;CENPF;CDK2;CNTRL;CDK1;MAPRE1;PCNT;DTL|4
6296|RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)|21/237|2.9259539944413e-09|3.31803182969644e-07|0|0|4.84194507850868|95.1425031489589|SF3B5;HSPA8;SF3B2;HNRNPU;PPWD1;PRPF8;LSM3;LSM2;DDX39B;SNRPD1;HNRNPF;MAGOH;PCBP2;DHX15;SNRPG;PPIH;SNRPE;RALY;SNRPF;DNAJC8;SNRPB|4
6297|regulation of mitotic metaphase/anaphase transition (GO:0030071)|7/15|3.68158843824497e-09|4.08416213051393e-07|0|0|25.5009107468124|495.225685826877|CENPE;ESPL1;UBE2C;PLK1;ANAPC5;DLGAP5;ANAPC11|4
6298|mitotic chromosome condensation (GO:0007076)|7/15|3.68158843824497e-09|3.99726506390725e-07|0|0|25.5009107468124|495.225685826877|CDCA5;NUSAP1;NCAPD2;NCAPD3;SMC4;NCAPH;SMC2|4
6299|chromosome condensation (GO:0030261)|8/23|4.49521007380672e-09|4.77897020971577e-07|0|0|19.0068899976241|365.317242767763|TOP2A;CDCA5;NUSAP1;NCAPD2;NCAPD3;SMC4;NCAPH;SMC2|4
6300|regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439)|12/73|7.94652519873995e-09|8.27573838554489e-07|0|0|8.98270828654839|167.532280132475|CDC20;FZR1;CCNB1;UBE2C;PLK1;CDK2;CDK1;BUB1B;ANAPC5;FBXO5;ANAPC11;MAD2L1|4
6301|regulation of mitotic cell cycle (GO:0007346)|17/166|1.11618984249576e-08|1.13918335325117e-06|0|0|5.59615511225229|102.469851978356|PLK1;HNRNPU;MKI67;PKMYT1;CDC25B;CKS1B;TPX2;CCNB1;RBL1;CDK1;CKS2;TACC3;RCC1;BIRC5;FBXO5;KIF20B;MAD2L1|4
6302|mRNA splicing, via spliceosome (GO:0000398)|21/262|1.73399473296294e-08|1.73501472986468e-06|0|0|4.37992741834564|78.2704106630829|SF3B5;HSPA8;SF3B2;HNRNPU;PPWD1;PRPF8;LSM3;LSM2;DDX39B;SNRPD1;HNRNPF;MAGOH;PCBP2;DHX15;SNRPG;PPIH;SNRPE;RALY;SNRPF;DNAJC8;SNRPB|4
6303|DNA ligation (GO:0006266)|7/18|1.73644035500494e-08|1.70404906376735e-06|0|0|21.250758955677|379.72648601744|TOP2A;POLD3;PCNA;LIG1;POLD2;HMGB2;HMGB1|4
6304|nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)|9/38|2.12927219203154e-08|2.05012754640319e-06|0|0|12.9421915444349|228.622526097976|POLD3;RFC5;RFC3;PCNA;RFC4;RFC1;RPA3;POLD2;RPA2|4
6305|anaphase-promoting complex-dependent catabolic process (GO:0031145)|12/80|2.32126333574928e-08|2.19359385228307e-06|0|0|8.19672131147541|144.086632501735|CDC20;FZR1;CCNB1;UBE2C;UBE2S;PLK1;CDK1;BUB1B;ANAPC5;AURKB;ANAPC11;MAD2L1|4
6306|error-free translesion synthesis (GO:0070987)|7/19|2.70628762723269e-08|2.51094286577608e-06|0|0|20.1322979580098|350.807364084473|RFC5;RFC3;PCNA;RFC4;RFC1;RPA3;RPA2|4
6307|chromatin assembly (GO:0031497)|11/66|2.89712938781058e-08|2.64000915464239e-06|0|0|9.10746812386157|158.077963237462|CHAF1B;CHAF1A;HIST1H3A;H2AFY;RBBP4;H2AFX;HMGB2;ANP32E;CTCF;ANP32B;CENPA|4
6308|regulation of G0 to G1 transition (GO:0070316)|9/40|3.45824259091364e-08|3.09603718270742e-06|0|0|12.2950819672131|211.228527118278|RRM2;CBX5;RAD51;RBBP4;CBX3;RBBP8;RBBP7;RHNO1;EZH2|4
6309|positive regulation of ubiquitin protein ligase activity (GO:1904668)|12/83|3.55233181971464e-08|3.12543953034548e-06|0|0|7.90045427612088|135.517096626294|CDC20;FZR1;CCNB1;UBE2C;UBE2S;PLK1;CDK1;BUB1B;ANAPC5;FBXO5;ANAPC11;MAD2L1|4
6310|error-prone translesion synthesis (GO:0042276)|7/20|4.09829812998894e-08|3.54468056903959e-06|0|0|19.1256830601093|325.329952531797|RFC5;RFC3;PCNA;RFC4;RFC1;RPA3;RPA2|4
6311|nucleotide-excision repair, DNA incision (GO:0033683)|9/41|4.3599544335271e-08|3.7081412457148e-06|0|0|11.9952019192323|203.297310727772|POLD3;RFC5;RFC3;PCNA;RFC4;RFC1;RPA3;POLD2;RPA2|4
6312|regulation of mitotic nuclear division (GO:0007088)|12/85|4.66986007854362e-08|3.90660589849313e-06|0|0|7.7145612343298|130.218334692292|ANLN;PLK1;NUSAP1;HNRNPU;RCC1;KIF11;FBXO5;MKI67;SMC3;SMC1A;KIF20B;PKMYT1|4
6313|protein sumoylation (GO:0016925)|11/69|4.68405110039893e-08|3.8552762524735e-06|0|0|8.71149124891106|147.019633543861|TOP2A;NDC1;NUP205;PCNA;INCENP;BIRC5;CDCA8;RANGAP1;AAAS;SAE1;AURKB|4
6314|double-strand break repair (GO:0006302)|15/142|5.41475151183784e-08|4.38594872458865e-06|0|0|5.77233895174325|96.5801994539922|FEN1;CDCA5;H2AFX;RPA2;NUCKS1;RAD51AP1;RNF168;POLA1;MMS22L;BRIP1;RAD51;RAD21;RPA3;NSD2;RBBP8|4
6315|DNA recombination (GO:0006310)|10/56|6.27672097251744e-08|5.0047042379307e-06|0|0|9.75800156128025|161.825068676503|RAD51AP1;BRIP1;RAD51;RAD21;RBBP8;RAD54L;NUCKS1;HMGB1;RHNO1;CENPS|4
6316|mRNA processing (GO:0006397)|21/284|6.9790549039092e-08|5.47909494994595e-06|0|0|4.04063726622027|66.5806803616495|SF3B5;HSPA8;SF3B2;HNRNPU;PPWD1;PRPF8;LSM3;LSM2;DDX39B;SNRPD1;HNRNPF;MAGOH;PCBP2;DHX15;SNRPG;PPIH;SNRPE;RALY;SNRPF;DNAJC8;SNRPB|4
6317|negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436)|11/72|7.39085284967152e-08|5.7144730442233e-06|0|0|8.3485124468731|137.08622776803|CDC20;FZR1;CCNB1;UBE2C;CDK2;CDK1;BUB1B;ANAPC5;FBXO5;ANAPC11;MAD2L1|4
6318|mitotic metaphase plate congression (GO:0007080)|9/44|8.40571457158465e-08|6.4021435013129e-06|0|0|11.177347242921|182.098758903861|CDT1;CENPE;CCNB1;KIFC1;CDCA5;NUF2;CDCA8;KIF22;KPNB1|4
6319|regulation of cell cycle (GO:0051726)|18/216|1.02449344338083e-07|7.68822064937114e-06|0|0|4.55373406193078|73.2873286070377|PLK1;GMNN;HNRNPU;PKMYT1;FOXM1;CKS1B;CCNB2;CENPF;CCNB1;RBL1;RBBP4;ID1;PCLAF;CKS2;CDK1;BIRC5;FBXO5;DTL|4
6320|metaphase plate congression (GO:0051310)|9/45|1.03390548051324e-07|7.64640531457837e-06|0|0|10.9289617486339|175.789642519631|CENPE;CCNB1;CENPF;KIFC1;CDCA5;CDCA8;KIF22;CENPQ;KPNB1|4
6321|protein-DNA complex assembly (GO:0065004)|12/92|1.14812362106482e-07|8.36982119756252e-06|0|0|7.12758374910905|113.898550784063|CHAF1B;CHAF1A;HIST1H3A;RAD51;H2AFY;RPA3;H2AFX;HMGB2;ANP32E;RPA2;ANP32B;CENPA|4
6322|positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition (GO:0051437)|11/77|1.50586449985517e-07|1.08231359757196e-05|0|0|7.8064012490242|122.628637776458|CDC20;FZR1;CCNB1;UBE2C;PLK1;CDK1;BUB1B;ANAPC5;FBXO5;ANAPC11;MAD2L1|4
6323|nucleocytoplasmic transport (GO:0006913)|9/47|1.53938167675158e-07|1.09103676339768e-05|0|0|10.4638995465644|164.144208131446|NUP205;SNRPD1;ANP32E;SNRPG;SNRPE;SNRPF;NXT2;AAAS;SNRPB|4
6324|mitotic spindle assembly (GO:0090307)|9/47|1.53938167675158e-07|1.07609105431004e-05|0|0|10.4638995465644|164.144208131446|TPX2;RACGAP1;KIFC1;BIRC5;KIF23;KIF11;AURKB;RHOA;KPNB1|4
6325|protein localization to chromosome, centromeric region (GO:0071459)|6/15|1.56954056632508e-07|1.08234669053471e-05|0|0|21.8579234972678|342.454922564753|CDK1;BUB1B;KNL1;CTCF;CENPA;AURKB|4
6326|negative regulation of ubiquitin protein ligase activity (GO:1904667)|11/78|1.72470839581688e-07|1.17349159251381e-05|0|0|7.70631918172902|120.010798842195|CDC20;FZR1;CCNB1;UBE2C;CDK2;CDK1;BUB1B;ANAPC5;FBXO5;ANAPC11;MAD2L1|4
6327|positive regulation of cytokinesis (GO:0032467)|8/35|1.78111162810793e-07|1.19592271555721e-05|0|0|12.4902419984387|194.109076926235|RACGAP1;KIF23;ECT2;KIF20B;AURKB;RHOA;CIT;CDC25B|4
6328|ciliary basal body-plasma membrane docking (GO:0097711)|12/97|2.07819201567474e-07|1.37727452675171e-05|0|0|6.76018252492817|104.016206580848|PLK4;HSP90AA1;SSNA1;PLK1;CNTRL;CDK1;HAUS4;MAPRE1;PCNT;TUBB4B;CKAP5;CEP89|4
6329|interstrand cross-link repair (GO:0036297)|9/49|2.24728331446916e-07|1.47024189150463e-05|0|0|10.0368016058883|153.647108531755|RNF168;RAD51AP1;RAD51;UBE2T;RPA3;USP1;RPA2;NUCKS1;CENPS|4
6330|nucleosome organization (GO:0034728)|11/80|2.24851913516595e-07|1.45242951224707e-05|0|0|7.51366120218579|115.017801877949|CHAF1B;CHAF1A;HIST1H3A;H2AFY;NASP;H2AFX;HMGB2;ANP32E;CTCF;ANP32B;CENPA|4
6331|DNA replication initiation (GO:0006270)|7/25|2.34854219051711e-07|1.4980763497761e-05|0|0|15.3005464480874|233.552144302282|PRIM2;POLA1;ORC6;CDC45;MCM10;TOPBP1;MCM2|4
6332|positive regulation of mitotic metaphase/anaphase transition (GO:0045842)|5/9|2.36897295514298e-07|1.49245296174008e-05|0|0|30.3582270795386|463.134157316207|CDT1;ESPL1;ANAPC5;DLGAP5;ANAPC11|4
6333|DNA strand elongation involved in DNA replication (GO:0006271)|6/16|2.47262444759543e-07|1.53875640927799e-05|0|0|20.4918032786885|311.738023258451|POLA1;RFC3;PCNA;RFC4;LIG1;POLD2|4
6334|regulation of protein serine/threonine kinase activity (GO:0071900)|11/81|2.5597374700877e-07|1.57377594094669e-05|0|0|7.42089995277609|112.635836492746|CDKN2D;CDKN1A;CDKN2C;H2AFY;CCNE2;CALM3;PKMYT1;CALM2;RHOA;CDKN3;EZH2|4
6335|negative regulation of G0 to G1 transition (GO:0070317)|8/38|3.52775072837703e-07|2.14310856748905e-05|0|0|11.5041702617199|170.922463854264|RRM2;CBX5;RAD51;RBBP4;CBX3;RBBP8;RBBP7;EZH2|4
6336|telomere maintenance (GO:0000723)|9/52|3.8344666213083e-07|2.30203331394544e-05|0|0|9.4577553593947|139.729495343086|POLD3;CTC1;PCNA;RAD51;RPA3;POLD2;RPA2;SMC6;TERF1|4
6337|regulation of attachment of spindle microtubules to kinetochore (GO:0051988)|5/10|4.66681862451462e-07|2.76915993498815e-05|0|0|27.3224043715847|398.295575085938|CCNB1;RACGAP1;SPAG5;ECT2;KNSTRN|4
6338|positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process (GO:2000060)|11/88|6.02803575214166e-07|3.53575476358378e-05|0|0|6.83060109289617|97.8256450764989|CDC20;FZR1;CCNB1;UBE2C;PLK1;CDK1;BUB1B;ANAPC5;FBXO5;ANAPC11;MAD2L1|4
6339|positive regulation of cell division (GO:0051781)|8/42|7.98783449047459e-07|4.63203629601044e-05|0|0|10.4085349986989|146.137662819565|RACGAP1;KIF23;ECT2;KIF20B;AURKB;RHOA;CIT;CDC25B|4
6340|telomere organization (GO:0032200)|8/42|7.98783449047459e-07|4.57999094436987e-05|0|0|10.4085349986989|146.137662819565|POLD3;CTC1;PCNA;HIST1H3A;RPA3;POLD2;RPA2;TERF1|4
6341|regulation of chromosome segregation (GO:0051983)|7/30|9.19239999005792e-07|5.21209079436284e-05|0|0|12.7504553734062|177.227741665528|RACGAP1;SPAG5;SMC6;MKI67;ECT2;KNSTRN;AURKB|4
6342|nucleic acid phosphodiester bond hydrolysis (GO:0090305)|10/74|9.45575079282455e-07|5.30249409843776e-05|0|0|7.38443361394181|102.432968136454|RFC5;POLD3;FEN1;RFC3;RFC4;PCNA;RFC1;RPA3;POLD2;RPA2|4
6343|transcription-coupled nucleotide-excision repair (GO:0006283)|10/74|9.45575079282455e-07|5.24485829301996e-05|0|0|7.38443361394181|102.432968136454|RFC5;POLD3;RFC3;RFC4;PCNA;LIG1;RFC1;RPA3;POLD2;RPA2|4
6344|mitotic nuclear envelope disassembly (GO:0007077)|8/45|1.3906294567526e-06|7.63051840624573e-05|0|0|9.71463266545234|131.00914697502|NDC1;CCNB2;NUP205;CCNB1;PLK1;CDK1;BANF1;AAAS|4
6345|regulation of sister chromatid cohesion (GO:0007063)|5/12|1.42302748623738e-06|7.72522261943546e-05|0|0|22.7686703096539|306.528322480549|FEN1;ESPL1;CDCA5;RAD21;CTCF|4
6346|mRNA metabolic process (GO:0016071)|11/98|1.79281809262177e-06|9.63026392278829e-05|0|0|6.13360098137616|81.158101956928|SLBP;SF3B2;LSM11;PCBP2;SNRPG;DHX15;SNRPE;SNRPF;PRPF8;LSM3;SNRPB|4
6347|G2 DNA damage checkpoint (GO:0031572)|7/33|1.83996425169997e-06|9.78055997544264e-05|0|0|11.5913230667329|153.072281676921|FZR1;MRNIP;PLK1;RBBP8;CLSPN;TOPBP1;DTL|4
6348|nuclear envelope disassembly (GO:0051081)|8/47|1.96504413610262e-06|0.000103377528108574|0|0|9.30124404139054|122.218308120213|NDC1;CCNB2;NUP205;CCNB1;PLK1;CDK1;BANF1;AAAS|4
6349|nuclear transport (GO:0051169)|6/22|2.09932440516051e-06|0.000109314820811573|0|0|14.903129657228|194.841951964584|NUP205;ANP32E;PSIP1;BANF1;NXT2;AAAS|4
6350|anatomical structure homeostasis (GO:0060249)|7/36|3.42951101519499e-06|0.000176775704146869|0|0|10.6253794778385|133.700136728625|POLD3;CTC1;PCNA;RPA3;POLD2;RPA2;TERF1|4
6351|positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101)|4/7|3.6968428801761e-06|0.000188649892175386|0|0|31.2256049960968|390.570847094115|ESPL1;ANAPC5;DLGAP5;ANAPC11|4
6352|regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079)|9/68|3.97020680363533e-06|0.000200593716029219|0|0|7.23240115718419|89.9471483102176|CDKN2D;CDKN1A;CDKN2C;CCNE2;PLK1;CKS2;PKMYT1;CKS1B;CDKN3|4
6353|termination of RNA polymerase II transcription (GO:0006369)|9/69|4.49293852740868e-06|0.00022477907162124|0|0|7.12758374910905|87.7619644321353|SLBP;LSM11;DDX39B;MAGOH;MAZ;SNRPG;SNRPE;SNRPF;SNRPB|4
6354|histone mRNA metabolic process (GO:0008334)|6/25|4.75690502554446e-06|0.000235674624712169|0|0|13.1147540983607|160.733289257879|SLBP;LSM11;SNRPG;SNRPE;SNRPF;SNRPB|4
6355|nucleotide-excision repair (GO:0006289)|11/109|5.1326702782503e-06|0.00025184631182607|0|0|5.51461372637489|67.1673583162538|RFC5;POLD3;RFC3;RFC4;PCNA;LIG1;RFC1;RPA3;POLD2;RBBP8;RPA2|4
6356|recombinational repair (GO:0000725)|9/72|6.43016341906112e-06|0.000312505942166371|0|0|6.83060109289617|81.6564932031603|RAD51AP1;MMS22L;FEN1;RAD51;RPA3;RBBP8;RPA2;NUCKS1;RHNO1|4
6357|nuclear import (GO:0051170)|9/72|6.43016341906112e-06|0.00030955777290065|0|0|6.83060109289617|81.6564932031603|SNRPD1;SNRPG;HIKESHI;SNRPE;SNRPF;NXT2;KPNB1;RAN;SNRPB|4
6358|positive regulation of mitotic sister chromatid separation (GO:1901970)|4/8|7.28684398774858e-06|0.000347521167004496|0|0|27.3224043715847|323.208743966487|ESPL1;ANAPC5;DLGAP5;ANAPC11|4
6359|kinetochore assembly (GO:0051382)|4/8|7.28684398774858e-06|0.000344303378421121|0|0|27.3224043715847|323.208743966487|CENPE;CENPF;CENPW;CENPA|4
6360|protein localization to chromatin (GO:0071168)|5/16|7.38812137563401e-06|0.000345886086053765|0|0|17.0765027322404|201.769758657929|MRNIP;H2AFY;RAD21;PLK1;HIST1H1B|4
6361|regulation of gene expression, epigenetic (GO:0040029)|9/75|9.04221237300965e-06|0.000419476452176984|0|0|6.55737704918033|76.1547979145865|TAF1D;HIST1H3A;H2AFY;RBBP4;CTCF;RBBP7;DEK;BAZ1B;EZH2|4
6362|peptidyl-lysine modification (GO:0018205)|11/116|9.38283607592344e-06|0.000431356869328264|0|0|5.18183531185227|59.9881822868352|TOP2A;NDC1;NUP205;PCNA;INCENP;CDCA8;BIRC5;AAAS;SAE1;RANGAP1;AURKB|4
6363|protein localization to chromosome (GO:0034502)|6/28|9.66064709999644e-06|0.000440163233493588|0|0|11.7096018735363|135.216041269393|MRNIP;RAD21;PLK1;RPA2;CTCF;CENPA|4
6364|DNA replication checkpoint (GO:0000076)|5/17|1.03097639631719e-05|0.000465581641628905|0|0|16.0720025715204|184.545470173051|CDT1;TIPIN;CDC45;CLSPN;TOPBP1|4
6365|double-strand break repair via homologous recombination (GO:0000724)|9/77|1.12473443160427e-05|0.00050346664951549|0|0|6.38705556738344|72.7829158056852|RAD51AP1;MMS22L;FEN1;CDC45;RAD51;RPA3;RBBP8;RPA2;NUCKS1|4
6366|protein K11-linked ubiquitination (GO:0070979)|6/29|1.19940698278695e-05|0.000532223811579286|0|0|11.3058224985868|128.107385091406|FZR1;UBE2C;UBE2S;UBE2T;ANAPC5;ANAPC11|4
6367|response to ionizing radiation (GO:0010212)|9/78|1.25119338674539e-05|0.000550417228669116|0|0|6.30517023959647|71.1779801999046|RNF168;RAD51AP1;CDKN1A;MRNIP;RAD51;H2AFX;TOPBP1;ECT2;RHNO1|4
6368|regulation of DNA replication (GO:0006275)|8/62|1.66409758739638e-05|0.000725802563118265|0|0|7.05094306363476|77.5860566051047|CTC1;DBF4;PCNA;GMNN;NUCKS1;ESCO2;SMC3;TERF1|4
6369|establishment of spindle localization (GO:0051293)|4/10|2.12337618402369e-05|0.000918270226023125|0|0|21.8579234972678|235.189466740962|ESPL1;SPAG5;NUSAP1;KPNB1|4
6370|cellular response to ionizing radiation (GO:0071479)|7/47|2.17364059065448e-05|0.000932108229757128|0|0|8.13858853621672|87.3801349626449|RAD51AP1;CDKN1A;RAD51;TMEM109;NUCKS1;ECT2;RHNO1|4
6371|positive regulation of ubiquitin-protein transferase activity (GO:0051443)|6/32|2.18452831928355e-05|0.000928970667775331|0|0|10.2459016393443|109.95415504004|CDC20;FZR1;UBE2C;UBE2S;PLK1;FBXO5|4
6372|mismatch repair (GO:0006298)|6/33|2.62909463863073e-05|0.0011087826397465|0|0|9.93541977148534|104.781777664309|POLD3;PCNA;LIG1;RPA3;POLD2;RPA2|4
6373|DNA-templated transcription, termination (GO:0006353)|10/107|2.71136368341759e-05|0.00113410564561311|0|0|5.10699147132424|53.7024347705953|SLBP;TAF1D;LSM11;DDX39B;MAGOH;MAZ;SNRPG;SNRPE;SNRPF;SNRPB|4
6374|regulation of nuclear division (GO:0051783)|5/21|3.1919461723935e-05|0.00132426839981496|0|0|13.0106687483737|134.690276461229|RCC1;FBXO5;MKI67;PKMYT1;KIF20B|4
6375|mitotic spindle elongation (GO:0000022)|4/11|3.28858952617834e-05|0.00135336067355549|0|0|19.8708395429707|205.116079633681|RACGAP1;PRC1;KIF23;AURKB|4
6376|positive regulation of chromosome segregation (GO:0051984)|4/11|3.28858952617834e-05|0.00134253378816705|0|0|19.8708395429707|205.116079633681|FEN1;CCNB1;RAD21;SMC6|4
6377|ribonucleoprotein complex assembly (GO:0022618)|12/157|3.32485960781348e-05|0.00134656814116446|0|0|4.17667327973269|43.0677582331328|RPS17;HSP90AA1;DDX39B;SNRPD1;RPS5;SNRPG;RPSA;SNRPE;SNRPF;RPL6;LSM3;SNRPB|4
6378|regulation of double-strand break repair (GO:2000779)|6/35|3.73594183256351e-05|0.00150114261193477|0|0|9.36768149882904|95.5028151210037|RAD51AP1;MRNIP;RAD51;RPA2;DEK;FOXM1|4
6379|regulation of intracellular signal transduction (GO:1902531)|21/423|3.83075120861537e-05|0.0015272127669972|0|0|2.71286284540557|27.5894476614866|ARHGAP11A;RFC5;RFC3;RFC4;TAF15;RPA2;SSRP1;RHOA;AURKB;TPX2;BRIP1;RACGAP1;RBBP4;RPA3;CDK2;RBBP8;KMT5A;TOPBP1;RBBP7;ECT2;RHNO1|4
6380|regulation of cyclin-dependent protein kinase activity (GO:1904029)|6/36|4.41454514177969e-05|0.00174631192701564|0|0|9.10746812386157|91.3298785233723|CDKN2D;CDKN1A;CDKN2C;CCNE2;PKMYT1;CDKN3|4
6381|regulation of mitotic spindle organization (GO:0060236)|6/36|4.41454514177969e-05|0.00173287875834629|0|0|9.10746812386157|91.3298785233723|TPX2;PLK1;TACC3;HNRNPU;SMC3;SMC1A|4
6382|DNA-dependent DNA replication maintenance of fidelity (GO:0045005)|6/36|4.41454514177969e-05|0.00171965067622151|0|0|9.10746812386157|91.3298785233723|MMS22L;TIPIN;PCNA;RAD51;NUCKS1;CENPS|4
6383|protein localization to kinetochore (GO:0034501)|4/12|4.86174825365366e-05|0.00187950767715111|0|0|18.2149362477231|180.902137864638|CDK1;BUB1B;KNL1;AURKB|4
6384|viral process (GO:0016032)|14/221|6.04668483274609e-05|0.00232001749635363|0|0|3.46166209232747|33.6245615471156|NDC1;NUP205;RPS5;NUCKS1;RPSA;DEK;AAAS;RPL6;RPS17;PCBP2;RCC1;RPS20;PPIA;RAN|4
6385|spliceosomal snRNP assembly (GO:0000387)|6/38|6.06701610740854e-05|0.00231044650717208|0|0|8.6281276962899|83.7796252035559|SNRPD1;SNRPG;SNRPE;SNRPF;PRPF8;SNRPB|4
6386|RNA processing (GO:0006396)|13/194|6.2338713511178e-05|0.00235640337072253|0|0|3.66176553433609|35.4566117307073|RBM39;SF3B2;HNRNPU;PRPF8;LSM3;DDX39B;SNRPD1;HNRNPF;MAGOH;DHX15;SNRPG;SNRPF;SNRPB|4
6387|DNA strand elongation (GO:0022616)|4/13|6.92131116394433e-05|0.0025970184462947|0|0|16.8137873055906|161.047839238844|POLA1;RFC3;RFC4;POLD2|4
6388|DNA replication-independent nucleosome organization (GO:0034724)|4/13|6.92131116394433e-05|0.00257806210727065|0|0|16.8137873055906|161.047839238844|NASP;RBBP4;HAT1;ASF1B|4
6389|chromatin assembly or disassembly (GO:0006333)|4/13|6.92131116394433e-05|0.00255938049779768|0|0|16.8137873055906|161.047839238844|CHAF1B;CHAF1A;HIRIP3;RBBP4|4
6390|establishment of chromosome localization (GO:0051303)|4/13|6.92131116394433e-05|0.002540967688461|0|0|16.8137873055906|161.047839238844|CENPE;CENPF;KIF22;CENPQ|4
6391|chromosome organization (GO:0051276)|7/57|7.81195465255485e-05|0.00284745747085624|0|0|6.71076598600326|63.4655275598887|TOP2A;CDT1;HIST1H3A;CENPW;CENPH;NUF2;CDCA8|4
6392|gene expression (GO:0010467)|20/412|7.95581556859645e-05|0.00287932814514523|0|0|2.65266061860046|25.0385226952901|NDC1;SLBP;RBM39;NUP205;RPS5;HNRNPU;RPSA;AAAS;BAZ1B;RPL6;LMF2;RPS17;MRPL51;DDX39B;HNRNPF;MAGOH;DHX15;SNRPG;RPS20;PTMA|4
6393|mitotic DNA damage checkpoint (GO:0044773)|6/40|8.17957828859402e-05|0.00293946394413347|0|0|8.19672131147541|77.1416792593945|TIPIN;MRNIP;CDK2;RPA2;CLSPN;TOPBP1|4
6394|regulation of spindle assembly (GO:0090169)|5/26|9.57048908182315e-05|0.00341525914577228|0|0|10.5086170659941|97.2492765351258|SPAG5;PLK1;HNRNPU;SMC3;SMC1A|4
6395|negative regulation of gene expression, epigenetic (GO:0045814)|5/26|9.57048908182315e-05|0.00339154206837108|0|0|10.5086170659941|97.2492765351258|HIST1H3A;RBBP4;H2AFY;RBBP7;EZH2|4
6396|regulation of cellular response to heat (GO:1900034)|8/79|9.80435168591937e-05|0.00345045563125838|0|0|5.53365151829563|51.0761520551757|NDC1;HSPA8;HSP90AA1;NUP205;RPA3;RPA2;HIKESHI;AAAS|4
6397|positive regulation of DNA-directed DNA polymerase activity (GO:1900264)|3/6|0.000116686068665643|0.00407841786575873|0|0|27.3224043715847|247.43233341878|RFC5;RFC3;RFC4|4
6398|regulation of DNA-directed DNA polymerase activity (GO:1900262)|3/6|0.000116686068665643|0.00405067352653588|0|0|27.3224043715847|247.43233341878|RFC5;RFC3;RFC4|4
6399|spindle assembly (GO:0051225)|8/81|0.000117106683224211|0.00403780678711586|0|0|5.39701814747352|48.8561031704508|TPX2;KIFC1;HAUS4;RCC1;BIRC5;KIF11;RHOA;KPNB1|4
6400|regulation of mitotic sister chromatid separation (GO:0010965)|4/15|0.000128355918127254|0.00439597483357971|0|0|14.5719489981785|130.574915007957|CENPE;UBE2C;PLK1;TACC3|4
6401|negative regulation of DNA-dependent DNA replication (GO:2000104)|4/15|0.000128355918127254|0.00436666833468918|0|0|14.5719489981785|130.574915007957|TIPIN;GMNN;SMC1A;SMC3|4
6402|telomere maintenance via telomere lengthening (GO:0010833)|5/28|0.000138757257664057|0.00468926017125619|0|0|9.75800156128025|86.6782250118757|CTC1;HSP90AA1;RAD51;RFC1;TERF1|4
6403|DNA damage response, signal transduction by p53 class mediator (GO:0030330)|8/83|0.000139132776973606|0.00467101684800206|0|0|5.26696951741392|46.7711204200382|CDKN1A;CCNB1;PCNA;CNOT1;CDK2;CDK1;FOXM1;E2F8|4
6404|DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)|7/63|0.000148831947456268|0.00496398318868846|0|0|6.07164541590771|53.5075455856904|CDKN1A;CCNB1;PCNA;CNOT1;CDK2;CDK1;E2F8|4
6405|protein modification by small protein conjugation (GO:0032446)|19/399|0.000153265450121731|0.00507865968812464|0|0|2.60213374967473|22.8554232937147|TOP2A;NDC1;NUP205;PCNA;UBE2C;UHRF1;CCNF;PLK1;CDCA8;AAAS;RANGAP1;AURKB;ANAPC11;RNF168;INCENP;UBE2S;UBE2T;BIRC5;SAE1|4
6406|RNA splicing (GO:0008380)|9/107|0.000154613785667241|0.00509028482748343|0|0|4.59629232419182|40.3305358781147|SF3B2;DDX39B;SNRPD1;MAGOH;SNRPG;DHX15;SNRPF;PRPF8;SNRPB|4
6407|signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431)|7/64|0.000164518039518803|0.00538163817733623|0|0|5.97677595628415|52.0726027299364|CDKN1A;CCNB1;PCNA;CNOT1;CDK2;CDK1;E2F8|4
6408|regulation of cell division (GO:0051302)|7/66|0.000199903577876303|0.00649750291657818|0|0|5.79566153336645|49.3655637754694|ORC6;PRC1;PLK1;CALM3;KIF20A;CALM2;AURKB|4
6409|regulation of DNA endoreduplication (GO:0032875)|3/7|0.000201428782075427|0.00650563971475257|0|0|23.4192037470726|199.299172784154|SMC1A;SMC3;E2F8|4
6410|DNA packaging (GO:0006323)|4/17|0.000217408115895286|0.00697756990826192|0|0|12.8576020572163|108.437598873017|CHAF1B;CHAF1A;RBBP4;HAT1|4
6411|replication fork processing (GO:0031297)|5/31|0.000229328708477704|0.00731415249601078|0|0|8.81367882954345|73.8617501800108|MMS22L;PCNA;RAD51;NUCKS1;CENPS|4
6412|positive regulation of gene expression, epigenetic (GO:0045815)|6/48|0.000231240267033683|0.00732931107250238|0|0|6.83060109289617|57.1861562224076|TAF1D;HIST1H3A;H2AFY;ATAD2;DEK;BAZ1B|4
6413|DNA conformation change (GO:0071103)|4/18|0.000275507585730969|0.00867848895052553|0|0|12.1432908318154|99.537284703542|TOP2A;HAT1;HMGB2;HMGB1|4
6414|establishment of mitotic spindle localization (GO:0040001)|4/18|0.000275507585730969|0.00862524668702538|0|0|12.1432908318154|99.537284703542|ESPL1;NUSAP1;CENPA;KPNB1|4
6415|establishment of integrated proviral latency (GO:0075713)|3/8|0.000317914911709457|0.00989219386861804|0|0|20.4918032786885|165.035384922723|PSIP1;BANF1;PPIA|4
6416|protein localization to microtubule (GO:0035372)|3/8|0.000317914911709457|0.00983224117850521|0|0|20.4918032786885|165.035384922723|HNRNPU;KIF20B;MAPRE1|4
6417|regulation of metaphase/anaphase transition of cell cycle (GO:1902099)|3/8|0.000317914911709457|0.00977301080995999|0|0|20.4918032786885|165.035384922723|CENPE;UBE2C;PLK1|4
6418|regulation of mitotic spindle assembly (GO:1901673)|4/19|0.000343963996265901|0.0105104687002688|0|0|11.5041702617199|91.7454537599776|PLK1;HNRNPU;SMC1A;SMC3|4
6419|positive regulation of chromosome organization (GO:2001252)|4/19|0.000343963996265901|0.0104479063865767|0|0|11.5041702617199|91.7454537599776|FEN1;RAD21;HNRNPU;TERF1|4
6420|regulation of DNA binding (GO:0051101)|6/53|0.000400659288434269|0.0120980138986987|0|0|6.18620476337767|48.3909628617154|CDT1;CDCA5;ID1;HJURP;HMGB2;HMGB1|4
6421|response to UV (GO:0009411)|8/99|0.000468988535719779|0.0140779323398708|0|0|4.41574212066015|33.8463641172867|CDKN2D;FEN1;PCNA;PCLAF;USP1;DTL;AURKB;RHNO1|4
6422|establishment of viral latency (GO:0019043)|3/9|0.000470410072589213|0.014038026903057|0|0|18.2149362477231|139.561124750308|PSIP1;BANF1;PPIA|4
6423|histone phosphorylation (GO:0016572)|3/9|0.000470410072589213|0.0139564104675741|0|0|18.2149362477231|139.561124750308|CCNA2;CDK2;BAZ1B|4
6424|DNA topological change (GO:0006265)|3/9|0.000470410072589213|0.013875737574698|0|0|18.2149362477231|139.561124750308|TOP2A;HMGB2;HMGB1|4
6425|RNA-dependent DNA biosynthetic process (GO:0006278)|4/21|0.000515987117928128|0.0151326566826853|0|0|10.4085349986989|78.7866641483207|HSP90AA1;RFC1;TERF1;PPIA|4
6426|regulation of response to DNA damage stimulus (GO:2001020)|5/37|0.000537762039981101|0.0156811410858489|0|0|7.38443361394181|55.5907133400973|NSMCE4A;USP1;RPA2;KMT5A;WDR76|4
6427|regulation of DNA repair (GO:0006282)|5/38|0.000610049054656057|0.0176879563972151|0|0|7.19010641357492|53.220960501591|RNF168;PCNA;H2AFX;USP1;DEK|4
6428|regulation of DNA damage checkpoint (GO:2000001)|3/10|0.000662915521353268|0.0191121915563035|0|0|16.3934426229508|119.981360568364|DDX39B;RPA2;WDR76|4
6429|DNA damage checkpoint (GO:0000077)|5/39|0.000689379422519346|0.0197635010849226|0|0|7.00574471066274|50.9998511469653|BRIP1;H2AFX;RBBP8;CLSPN;RHNO1|4
6430|positive regulation of DNA repair (GO:0045739)|5/39|0.000689379422519346|0.0196530904643365|0|0|7.00574471066274|50.9998511469653|RNF168;PCNA;H2AFX;HMGB1;FOXM1|4
6431|regulation of cellular response to stress (GO:0080135)|8/105|0.000694866881511359|0.019699476090847|0|0|4.16341399947957|30.2754734036486|NDC1;HSPA8;NUP205;HSP90AA1;RPA3;RPA2;HIKESHI;AAAS|4
6432|nucleic acid metabolic process (GO:0090304)|7/81|0.000706454782123136|0.0199173411777589|0|0|4.72239087903933|34.2621328501731|FEN1;HNRNPF;PCBP2;HNRNPU;TOPBP1;TK1;RAN|4
6433|apoptotic nuclear changes (GO:0030262)|4/23|0.000741692667684134|0.0207959213362205|0|0|9.50344499881207|68.4872947977658|TOP2A;HMGB2;HMGB1;KPNB1|4
6434|positive regulation of DNA metabolic process (GO:0051054)|7/83|0.000817698071315646|0.022801711791933|0|0|4.60859832773718|32.7626056806129|RNF168;CTC1;DBF4;PCNA;RAD51;H2AFX;HMGB1|4
6435|positive regulation of cell cycle arrest (GO:0071158)|7/83|0.000817698071315646|0.0226777894452377|0|0|4.60859832773718|32.7626056806129|CDKN1A;CCNB1;PCNA;CNOT1;CDK2;CDK1;E2F8|4
6436|positive regulation of mitotic nuclear division (GO:0045840)|5/41|0.000870875602664027|0.0240220443264569|0|0|6.66400106624017|46.9546275662599|H2AFY;UBE2C;CDCA5;NUSAP1;HNRNPU|4
6437|mitotic spindle midzone assembly (GO:0051256)|3/11|0.000899178118774056|0.0246693867747527|0|0|14.903129657228|104.530989764896|RACGAP1;KIF23;AURKB|4
6438|regulation of chromatin silencing (GO:0031935)|3/11|0.000899178118774056|0.0245374649203423|0|0|14.903129657228|104.530989764896|CDC45;UHRF1;ATAD2|4
6439|negative regulation of cell division (GO:0051782)|3/11|0.000899178118774056|0.0244069464899149|0|0|14.903129657228|104.530989764896|ORC6;AURKB;E2F8|4
6440|viral gene expression (GO:0019080)|8/111|0.00100118837690745|0.0270320861765012|0|0|3.9383645941023|27.2005813326859|NDC1;RPS17;NUP205;RPS5;RPSA;RPS20;AAAS;RPL6|4
6441|proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161)|14/292|0.00103692979048824|0.0278497511624288|0|0|2.61995658357661|18.0030082323969|UBE2C;CCNF;PLK1;BUB1B;AURKB;ANAPC11;CDC20;CCNB1;FZR1;UBE2S;PCBP2;CDK1;ANAPC5;MAD2L1|4
6442|cellular response to radiation (GO:0071478)|5/43|0.00108573746466945|0.0290079491215089|0|0|6.35404752827551|43.3695249201639|RAD51AP1;CDKN1A;RAD51;ECT2;RHNO1|4
6443|signal transduction involved in G2 DNA damage checkpoint (GO:0072425)|3/12|0.00118269998695681|0.0314339480908363|0|0|13.6612021857923|92.0758924827257|FZR1;PLK1;DTL|4
6444|regulation of DNA-dependent DNA replication (GO:0090329)|3/12|0.00118269998695681|0.0312710778934745|0|0|13.6612021857923|92.0758924827257|CDT1;TIPIN;GMNN|4
6445|attachment of mitotic spindle microtubules to kinetochore (GO:0051315)|3/12|0.00118269998695681|0.0311098867703123|0|0|13.6612021857923|92.0758924827257|CENPE;CDT1;NUF2|4
6446|DNA ligation involved in DNA repair (GO:0051103)|3/12|0.00118269998695681|0.0309503488894389|0|0|13.6612021857923|92.0758924827257|LIG1;HMGB2;HMGB1|4
6447|viral transcription (GO:0019083)|8/114|0.00119041699143398|0.0309933566698347|0|0|3.83472342057329|25.8209246295437|NDC1;RPS17;NUP205;RPS5;RPSA;RPS20;AAAS;RPL6|4
6448|positive regulation of protein kinase activity (GO:0045860)|10/173|0.00135622706107194|0.0351310999626909|0|0|3.15865946492309|20.8567821292962|TPX2;CENPE;CDKN1A;MRNIP;CALM3;CLSPN;ECT2;CALM2;RHOA;EZH2|4
6449|strand displacement (GO:0000732)|4/27|0.00138765095718898|0.0357635496693705|0|0|8.09552722121028|53.2697261306433|RAD51AP1;BRIP1;RAD51;RBBP8|4
6450|positive regulation of cellular protein localization (GO:1903829)|6/67|0.00140600129283728|0.036054394961551|0|0|4.89356496207487|32.1360683439181|CDT1;PLK1;CDK1;KIF20B;PCNT;CENPQ|4
6451|chromatin remodeling (GO:0006338)|8/117|0.00140712147610172|0.0359027044627354|0|0|3.73639717902013|24.5339654107418|RBBP4;CBX3;ANP32E;HMGB2;ANP32B;HMGB1;DEK;SSRP1|4
6452|protein complex subunit organization (GO:0071822)|5/46|0.00147848208203018|0.0375357913661692|0|0|5.93965312425754|38.7071711675239|NDC1;CDT1;NUP205;CENPH;NUF2|4
6453|signal transduction involved in DNA damage checkpoint (GO:0072422)|3/13|0.00151674786957828|0.0383166553389007|0|0|12.6103404791929|81.8560756083145|FZR1;PLK1;DTL|4
6454|tetrahydrofolate metabolic process (GO:0046653)|3/13|0.00151674786957828|0.0381279033421574|0|0|12.6103404791929|81.8560756083145|DHFR;MTHFD2;TYMS|4
6455|mitotic DNA integrity checkpoint (GO:0044774)|3/13|0.00151674786957828|0.037941001855186|0|0|12.6103404791929|81.8560756083145|TOP2A;CLSPN;TOPBP1|4
6456|regulation of double-strand break repair via homologous recombination (GO:0010569)|4/28|0.00159580084649131|0.039723764486074|0|0|7.8064012490242|50.2761871244398|RAD51AP1;MRNIP;RAD51;RPA2|4
6457|regulation of DNA metabolic process (GO:0051052)|5/47|0.00163003215851513|0.0403789034218578|0|0|5.81327752586908|37.316332607881|UHRF1;USP1;NUCKS1;ESCO2;SMC3|4
6458|RNA export from nucleus (GO:0006405)|8/120|0.00165404526982068|0.0407758116516663|0|0|3.64298724954463|23.3316259120274|NDC1;SLBP;NUP205;DDX39B;MAGOH;RPSA;AAAS;RAN|4
6459|cotranslational protein targeting to membrane (GO:0006613)|7/94|0.00169944816363226|0.0416936729760356|0|0|4.06929426810836|25.9517276082526|RPS17;ARL6IP1;RPS5;RPSA;RPS20;SEC62;RPL6|4
6460|regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266)|3/14|0.00190436220236735|0.04649741779273|0|0|11.7096018735363|73.3443574750474|CDT1;CCNB1;MAD2L1|4
6461|regulation of translation (GO:0006417)|11/214|0.00203463758943362|0.0494416934232369|0|0|2.80884530922833|17.4076434327803|DHFR;NDC1;NUP205;HIST1H3A;CNOT1;NCL;VIM;AAAS;TYMS;RAN;EIF1|4
6462|regulation of exit from mitosis (GO:0007096)|3/15|0.00234836590345398|0.0567948398356667|0|0|10.9289617486339|66.1643229828795|ANLN;UBE2C;CDCA5|4
6463|apoptotic DNA fragmentation (GO:0006309)|3/15|0.00234836590345398|0.0565269396477626|0|0|10.9289617486339|66.1643229828795|HMGB2;HMGB1;KPNB1|4
6464|mitotic sister chromatid cohesion (GO:0007064)|3/15|0.00234836590345398|0.0562615549545806|0|0|10.9289617486339|66.1643229828795|SGO1;CDCA5;SMC1A|4
6465|ATP-dependent chromatin remodeling (GO:0043044)|4/31|0.00234888160374095|0.0560109477751872|0|0|7.05094306363476|42.6851117744437|RBBP4;NASP;ANP32E;ANP32B|4
6466|nucleobase-containing small molecule interconversion (GO:0015949)|4/32|0.0026461870273531|0.0628069413980598|0|0|6.83060109289617|40.5371279558487|DUT;RRM1;RRM2;TYMS|4
6467|positive regulation of viral genome replication (GO:0045070)|4/32|0.0026461870273531|0.0625161685212169|0|0|6.83060109289617|40.5371279558487|TOP2A;NUCKS1;PPIH;PPIA|4
6468|cilium assembly (GO:0060271)|13/289|0.00270728028200604|0.0636647524381419|0|0|2.45807098152665|14.5316504135127|PLK4;HSP90AA1;SSNA1;PLK1;HAUS4;TUBB4B;CKAP5;CNTRL;CDK1;TRIM59;MAPRE1;PCNT;CEP89|4
6469|positive regulation of G2/M transition of mitotic cell cycle (GO:0010971)|3/16|0.00285137288960118|0.066745669062545|0|0|10.2459016393443|60.0405193139322|CCNB1;CDK1;DTL|4
6470|RNA metabolic process (GO:0016070)|10/192|0.00291561997874237|0.0679379395046681|0|0|2.84608378870674|16.6145059088091|POLA1;RBM39;PCNA;LIG1;DDX39B;HNRNPF;PCBP2;SNRPG;DHX15;HNRNPU|4
6471|intracellular transport of virus (GO:0075733)|5/55|0.00328226950365269|0.0761337330779077|0|0|4.96770988574267|28.41142659716|NDC1;NUP205;AAAS;KPNB1;RAN|4
6472|transport of virus (GO:0046794)|5/55|0.00328226950365269|0.0757892365481434|0|0|4.96770988574267|28.41142659716|NDC1;NUP205;AAAS;KPNB1;RAN|4
6473|tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431)|4/34|0.00331620251839304|0.076227844375494|0|0|6.42880102860816|36.7016070104529|NDC1;NUP205;AAAS;RAN|4
6474|tRNA export from nucleus (GO:0006409)|4/34|0.00331620251839304|0.0758860154769492|0|0|6.42880102860816|36.7016070104529|NDC1;NUP205;AAAS;RAN|4
6475|positive regulation of cell cycle G2/M phase transition (GO:1902751)|3/17|0.0034157963261581|0.0778161100552892|0|0|9.64320154291225|54.7670648825784|CCNB1;CDK1;DTL|4
6476|spindle assembly checkpoint (GO:0071173)|3/17|0.0034157963261581|0.0774702606772657|0|0|9.64320154291225|54.7670648825784|CENPF;PLK1;BUB1B|4
6477|mitotic spindle assembly checkpoint (GO:0007094)|3/17|0.0034157963261581|0.077127471913207|0|0|9.64320154291225|54.7670648825784|CENPF;PLK1;BUB1B|4
6478|mitotic spindle checkpoint (GO:0071174)|3/17|0.0034157963261581|0.0767877033144704|0|0|9.64320154291225|54.7670648825784|CENPF;PLK1;BUB1B|4
6479|mitotic G2 DNA damage checkpoint (GO:0007095)|3/17|0.0034157963261581|0.0764509151420385|0|0|9.64320154291225|54.7670648825784|MRNIP;CLSPN;TOPBP1|4
6480|regulation of gene silencing by RNA (GO:0060966)|5/56|0.00355100353083052|0.0791300044446643|0|0|4.87900078064012|27.5201260280134|NDC1;NUP205;HIST1H3A;AAAS;RAN|4
6481|regulation of posttranscriptional gene silencing (GO:0060147)|5/56|0.00355100353083052|0.0787859609470788|0|0|4.87900078064012|27.5201260280134|NDC1;NUP205;HIST1H3A;AAAS;RAN|4
6482|positive regulation of DNA biosynthetic process (GO:2000573)|5/56|0.00355100353083052|0.0784448961810741|0|0|4.87900078064012|27.5201260280134|RFC5;HSP90AA1;RFC3;RFC4;AURKB|4
6483|retrograde vesicle-mediated transport, Golgi to ER (GO:0006890)|6/81|0.00369513513086777|0.0812770455724924|0|0|4.04776361060514|22.6704640921833|CENPE;RACGAP1;KIF23;KIF11;KIF22;KIF15|4
6484|viral life cycle (GO:0019058)|7/108|0.00372805638155052|0.0816492348285505|0|0|3.5417931592795|19.8052407454295|NDC1;NUP205;DEK;AAAS;PPIA;KPNB1;RAN|4
6485|transcription from RNA polymerase II promoter (GO:0006366)|18/486|0.00387794207266565|0.0845689675077471|0|0|2.02388180530257|11.2375038650036|SLBP;CDKN1A;TAF15;CBFB;LMO4;MAZ;DEK;SSRP1;PMF1;CCNB1;LSM11;DDX39B;MAGOH;SNRPG;CDK1;SNRPE;SNRPF;SNRPB|4
6486|positive regulation of binding (GO:0051099)|6/82|0.00392681991908123|0.0852704767960489|0|0|3.9984006397441|22.1508411097957|CDT1;GMNN;STMN1;HMGB2;HMGB1;RAN|4
6487|mitotic recombination (GO:0006312)|3/18|0.00404385661817395|0.0874398318751765|0|0|9.10746812386157|50.1872170664761|RAD51;SMC6;CENPS|4
6488|positive regulation of DNA replication (GO:0045740)|4/36|0.00409319932364644|0.0881333170825645|0|0|6.07164541590771|33.3845074923499|CTC1;CDT1;PCNA;DBF4|4
6489|tRNA transport (GO:0051031)|4/36|0.00409319932364644|0.0877630090275957|0|0|6.07164541590771|33.3845074923499|NDC1;NUP205;AAAS;RAN|4
6490|ribosomal small subunit assembly (GO:0000028)|3/19|0.00473758915169937|0.101154466280845|0|0|8.6281276962899|46.1796970703192|RPS17;RPS5;RPSA|4
6491|regulation of cell cycle checkpoint (GO:1901976)|2/6|0.00477155477516597|0.101455183406966|0|0|18.2149362477231|97.3603475140165|RPA2;WDR76|4
6492|nucleus localization (GO:0051647)|2/6|0.00477155477516597|0.101034207542207|0|0|18.2149362477231|97.3603475140165|SUN2;SYNE2|4
6493|centromeric sister chromatid cohesion (GO:0070601)|2/6|0.00477155477516597|0.100616710816826|0|0|18.2149362477231|97.3603475140165|SGO1;BUB1B|4
6494|pyrimidine deoxyribonucleotide biosynthetic process (GO:0009221)|2/6|0.00477155477516597|0.100202650278485|0|0|18.2149362477231|97.3603475140165|DUT;TYMS|4
6495|negative regulation of gene expression (GO:0010629)|21/619|0.00519586798983426|0.108666042426739|0|0|1.853862655261|9.75111658313784|HSPA8;CBX5;H2AFY;CBX3;GMNN;HMGB2;CTCF;TYMS;FOXM1;DHFR;CENPF;HIST1H3A;RBL1;RBBP4;CNOT1;NCL;ID1;BIRC5;KMT5A;RBBP7;EZH2|4
6496|cellular protein complex assembly (GO:0043623)|8/145|0.00530010569950437|0.110393630141105|0|0|3.01488599962314|15.7980886084649|NDC1;ANLN;CENPE;NUP205;HSP90AA1;CENPF;CENPW;CENPA|4
6497|negative regulation of phosphate metabolic process (GO:0045936)|3/20|0.0054988517880183|0.114067645017306|0|0|8.19672131147541|42.64931126519|CDKN2D;CDKN1A;CDKN2C|4
6498|telomere maintenance via telomerase (GO:0007004)|3/20|0.0054988517880183|0.113605832689301|0|0|8.19672131147541|42.64931126519|HSP90AA1;RFC1;TERF1|4
6499|negative regulation of telomere maintenance via telomerase (GO:0032211)|3/20|0.0054988517880183|0.113147744654264|0|0|8.19672131147541|42.64931126519|CTC1;HNRNPU;TERF1|4
6500|regulation of viral genome replication (GO:0045069)|5/64|0.00629659323290521|0.129042229990021|0|0|4.26912568306011|21.6348469455601|TOP2A;FAM111A;BANF1;PPIH;PPIA|4
6501|regulation of cyclic nucleotide metabolic process (GO:0030799)|2/7|0.00659961343781106|0.134711309492599|0|0|15.6128024980484|78.387887614265|CALM3;CALM2|4
6502|regulation of cyclic-nucleotide phosphodiesterase activity (GO:0051342)|2/7|0.00659961343781106|0.134174611048406|0|0|15.6128024980484|78.387887614265|CALM3;CALM2|4
6503|rRNA-containing ribonucleoprotein complex export from nucleus (GO:0071428)|2/7|0.00659961343781106|0.133642172115674|0|0|15.6128024980484|78.387887614265|RPSA;RAN|4
6504|negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244)|2/7|0.00659961343781106|0.133113942186363|0|0|15.6128024980484|78.387887614265|RNF168;HNRNPU|4
6505|V(D)J recombination (GO:0033151)|2/7|0.00659961343781106|0.132589871547834|0|0|15.6128024980484|78.387887614265|HMGB2;HMGB1|4
6506|negative regulation of cytokinesis (GO:0032466)|2/7|0.00659961343781106|0.132069911267254|0|0|15.6128024980484|78.387887614265|AURKB;E2F8|4
6507|positive regulation of isomerase activity (GO:0010912)|2/7|0.00659961343781106|0.131554013176367|0|0|15.6128024980484|78.387887614265|UHRF1;HNRNPU|4
6508|cleavage furrow formation (GO:0036089)|2/7|0.00659961343781106|0.131042129856614|0|0|15.6128024980484|78.387887614265|RHOA;AURKB|4
6509|negative regulation of retinoic acid receptor signaling pathway (GO:0048387)|2/7|0.00659961343781106|0.130534214624612|0|0|15.6128024980484|78.387887614265|CNOT1;EZH2|4
6510|negative regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle (GO:0031658)|2/7|0.00659961343781106|0.130030221517953|0|0|15.6128024980484|78.387887614265|CDKN2D;CDKN2C|4
6511|regulation of phosphorylation (GO:0042325)|7/120|0.00661113188997018|0.129756177055838|0|0|3.18761384335155|15.9986351572209|NDC1;CDKN2D;NUP205;CDKN1A;CDKN2C;MCM7;AAAS|4
6512|spliceosomal complex assembly (GO:0000245)|4/42|0.00713910492815676|0.139581810147065|0|0|5.20426749934947|25.7203636257665|DDX39B;SNRPD1;SNRPG;SNRPE|4
6513|DNA catabolic process, endonucleolytic (GO:0000737)|3/22|0.00723055450990652|0.140830227725393|0|0|7.45156482861401|36.7320383759542|HMGB2;HMGB1;KPNB1|4
6514|regulation of gene silencing by miRNA (GO:0060964)|5/68|0.00811525419455891|0.157460616558305|0|0|4.0180006428801|19.3426942882889|NDC1;NUP205;HIST1H3A;AAAS;RAN|4
6515|mitotic G2/M transition checkpoint (GO:0044818)|3/23|0.0082038868664193|0.1585774040884|0|0|7.12758374910905|34.2348341334167|MRNIP;CLSPN;TOPBP1|4
6516|microtubule polymerization or depolymerization (GO:0031109)|3/23|0.0082038868664193|0.157978998789953|0|0|7.12758374910905|34.2348341334167|TPPP3;STMN1;CKAP5|4
6517|establishment of protein localization to chromatin (GO:0071169)|2/8|0.0086935213887102|0.166778344536046|0|0|13.6612021857923|64.8248251187002|H2AFY;HIST1H1B|4
6518|cytoskeletal anchoring at nuclear membrane (GO:0090286)|2/8|0.0086935213887102|0.166153706541529|0|0|13.6612021857923|64.8248251187002|SUN2;SYNE2|4
6519|lagging strand elongation (GO:0006273)|2/8|0.0086935213887102|0.165533730024583|0|0|13.6612021857923|64.8248251187002|POLA1;LIG1|4
6520|positive regulation of chromatin binding (GO:0035563)|2/8|0.0086935213887102|0.164918362998469|0|0|13.6612021857923|64.8248251187002|CDT1;GMNN|4
6521|protein K6-linked ubiquitination (GO:0085020)|2/8|0.0086935213887102|0.164307554246623|0|0|13.6612021857923|64.8248251187002|UBE2S;UBE2T|4
6522|positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316)|2/8|0.0086935213887102|0.163701253308443|0|0|13.6612021857923|64.8248251187002|CALM3;CALM2|4
6523|protein localization to microtubule cytoskeleton (GO:0072698)|2/8|0.0086935213887102|0.163099410465398|0|0|13.6612021857923|64.8248251187002|KIF20B;MAPRE1|4
6524|regulation of apoptotic cell clearance (GO:2000425)|2/8|0.0086935213887102|0.162501976727429|0|0|13.6612021857923|64.8248251187002|C3;HMGB1|4
6525|protein localization to nucleus (GO:0034504)|6/97|0.00883213646837269|0.164490483204766|0|0|3.38009126246409|15.9856627952838|PLK1;HNRNPU;HIKESHI;NXT2;KPNB1;RAN|4
6526|protein targeting to ER (GO:0045047)|6/98|0.00926734782315647|0.171968276151154|0|0|3.34560053529609|15.6616194163903|RPS17;RPS5;RPSA;RPS20;SEC62;RPL6|4
6527|antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886)|6/98|0.00926734782315647|0.171345202686839|0|0|3.34560053529609|15.6616194163903|CENPE;RACGAP1;KIF23;KIF11;KIF22;KIF15|4
6528|antigen processing and presentation of exogenous peptide antigen (GO:0002478)|6/98|0.00926734782315647|0.170726627947897|0|0|3.34560053529609|15.6616194163903|CENPE;RACGAP1;KIF23;KIF11;KIF22;KIF15|4
6529|antigen processing and presentation of peptide antigen via MHC class II (GO:0002495)|6/99|0.00971766209030898|0.178378523909521|0|0|3.31180659049512|15.3462832095682|CENPE;RACGAP1;KIF23;KIF11;KIF22;KIF15|4
6530|histone modification (GO:0016570)|6/99|0.00971766209030898|0.177739174361458|0|0|3.31180659049512|15.3462832095682|CCNA2;UHRF1;CDK2;BAZ1B;AURKB;EZH2|4
6531|protein polymerization (GO:0051258)|4/46|0.00983220685190669|0.179191969875999|0|0|4.75172249940603|21.9628979249223|TPPP3;UBE2C;UBE2S;CKAP5|4
6532|nucleus organization (GO:0006997)|4/46|0.00983220685190669|0.178554276033024|0|0|4.75172249940603|21.9628979249223|NDC1;SUN2;NUP205;REEP4|4
6533|positive regulation of dephosphorylation (GO:0035306)|3/25|0.0103716102510085|0.187682011031547|0|0|6.55737704918033|29.958576977346|CDCA2;CALM3;CALM2|4
6534|histone monoubiquitination (GO:0010390)|3/25|0.0103716102510085|0.187018823713414|0|0|6.55737704918033|29.958576977346|RNF168;UHRF1;TRIM37|4
6535|regulation of chromosome organization (GO:0033044)|3/25|0.0103716102510085|0.186360306728508|0|0|6.55737704918033|29.958576977346|CDT1;HNRNPU;MKI67|4
6536|negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736)|3/25|0.0103716102510085|0.185706410915425|0|0|6.55737704918033|29.958576977346|CDKN2D;CDKN2C;PLK1|4
6537|regulation of G1/S transition of mitotic cell cycle (GO:2000045)|4/47|0.0105952017214829|0.189046553792753|0|0|4.65062202069527|21.1480248721485|CDKN1A;LSM11;CDC45;RBL1|4
6538|mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427)|6/101|0.0106646800739273|0.18962321399739|0|0|3.24622626197046|14.7405223998222|NDC1;SLBP;NUP205;DDX39B;MAGOH;AAAS|4
6539|mitotic DNA replication checkpoint (GO:0033314)|2/9|0.011042990311315|0.195667984578612|0|0|12.1432908318154|54.7171756317838|CLSPN;TOPBP1|4
6540|nuclear migration (GO:0007097)|2/9|0.011042990311315|0.194990932728859|0|0|12.1432908318154|54.7171756317838|SUN2;SYNE2|4
6541|regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844)|2/9|0.011042990311315|0.194318550202208|0|0|12.1432908318154|54.7171756317838|CALM3;CALM2|4
6542|negative regulation of microtubule polymerization (GO:0031115)|2/9|0.011042990311315|0.193650788861307|0|0|12.1432908318154|54.7171756317838|STMN1;MAPRE1|4
6543|negative regulation of DNA-templated transcription, elongation (GO:0032785)|2/9|0.011042990311315|0.19298760122822|0|0|12.1432908318154|54.7171756317838|RNF168;HNRNPU|4
6544|regulation of transcription, DNA-templated (GO:0006355)|42/1599|0.0113620254202605|0.197885377882557|0|0|1.43532330657481|6.42662937139242|CDKN1A;PCNA;CBFB;GMNN;HP1BP3;HMGB2;NUCKS1;CTCF;HMGB1;TYMS;FOXM1;RPL6;CKS1B;BRIP1;HINT1;HMGN5;CDC45;RAD21;RBBP8;FBXO5;BRD8;KMT5A;PCBD2;TCF19;CDT1;HSPA8;CBX5;RRM2;TAF15;CBX3;ATAD2;DEK;SSRP1;DHFR;POLA1;CENPF;CCNE1;ID1;CKS2;BIRC5;RAN;EZH2|4
6545|positive regulation of peptidyl-threonine phosphorylation (GO:0010800)|3/26|0.0115680131186228|0.200787656273238|0|0|6.30517023959647|28.1179790638223|PLK1;CALM3;CALM2|4
6546|mRNA transport (GO:0051028)|6/105|0.0127516959142877|0.220582726273254|0|0|3.12256049960968|13.6208930627254|NDC1;SLBP;NUP205;DDX39B;MAGOH;AAAS|4
6547|negative regulation of telomere maintenance via telomere lengthening (GO:1904357)|3/27|0.0128405617598853|0.221369549529374|0|0|6.07164541590771|26.4429036484971|CTC1;HNRNPU;TERF1|4
6548|non-recombinational repair (GO:0000726)|4/50|0.0131100782448827|0.225254980752984|0|0|4.37158469945355|18.9480831164525|RNF168;POLA1;H2AFX;NSD2|4
6549|positive regulation of response to DNA damage stimulus (GO:2001022)|4/50|0.0131100782448827|0.224499091555827|0|0|4.37158469945355|18.9480831164525|RNF168;NSMCE4A;PCNA;H2AFX|4
6550|mRNA export from nucleus (GO:0006406)|6/106|0.0133151672697536|0.227248490225929|0|0|3.09310238168883|13.3586498524287|NDC1;SLBP;NUP205;DDX39B;MAGOH;AAAS|4
6551|regulation of chromatin organization (GO:1902275)|2/10|0.0136380176012145|0.231982679396659|0|0|10.9289617486339|46.9387319593842|HNRNPU;MKI67|4
6552|negative regulation of centrosome duplication (GO:0010826)|2/10|0.0136380176012145|0.23121197282059|0|0|10.9289617486339|46.9387319593842|CCNF;TRIM37|4
6553|telomere maintenance via recombination (GO:0000722)|2/10|0.0136380176012145|0.230446370261582|0|0|10.9289617486339|46.9387319593842|RAD51;SMC6|4
6554|actin filament-based transport (GO:0099515)|2/10|0.0136380176012145|0.229685821184811|0|0|10.9289617486339|46.9387319593842|SUN2;SYNE2|4
6555|mitotic nuclear envelope reassembly (GO:0007084)|2/10|0.0136380176012145|0.228930275720387|0|0|10.9289617486339|46.9387319593842|REEP4;BANF1|4
6556|mitotic G1/S transition checkpoint (GO:0044819)|2/10|0.0136380176012145|0.228179684652451|0|0|10.9289617486339|46.9387319593842|CDK2;RPA2|4
6557|mitotic G1 DNA damage checkpoint (GO:0031571)|2/10|0.0136380176012145|0.227433999408489|0|0|10.9289617486339|46.9387319593842|CDK2;RPA2|4
6558|nuclear pore complex assembly (GO:0051292)|2/10|0.0136380176012145|0.226693172048852|0|0|10.9289617486339|46.9387319593842|NDC1;NUP205|4
6559|G1 DNA damage checkpoint (GO:0044783)|2/10|0.0136380176012145|0.225957155256486|0|0|10.9289617486339|46.9387319593842|CDK2;RPA2|4
6560|positive regulation of nuclease activity (GO:0032075)|2/10|0.0136380176012145|0.225225902326853|0|0|10.9289617486339|46.9387319593842|PCNA;HMGB2|4
6561|positive regulation of transferase activity (GO:0051347)|7/138|0.0136636503497866|0.224921315274068|0|0|2.77183812465352|11.8995460600016|RFC5;HSP90AA1;RFC3;RFC4;LMO4;PLK1;AURKB|4
6562|negative regulation of cellular macromolecule biosynthetic process (GO:2000113)|17/513|0.0139746174540522|0.22930055584575|0|0|1.81084161527072|7.73322199601928|HSPA8;CBX5;CBX3;GMNN;HMGB2;CTCF;TERF1;TYMS;FOXM1;DHFR;CENPF;CNOT1;NCL;ID1;BIRC5;KMT5A;EZH2|4
6563|double-strand break repair via nonhomologous end joining (GO:0006303)|4/51|0.0140256608106205|0.229400471527552|0|0|4.28586735240544|18.2872247382902|RNF168;POLA1;H2AFX;NSD2|4
6564|negative regulation of microtubule polymerization or depolymerization (GO:0031111)|3/28|0.0141899364945486|0.231345833647545|0|0|5.85480093676815|24.9134792926625|SPEF1;STMN1;MAPRE1|4
6565|regulation of telomere maintenance via telomerase (GO:0032210)|4/52|0.0149808146686295|0.243462093165658|0|0|4.20344682639765|17.6586167239099|CTC1;HNRNPU;TERF1;AURKB|4
6566|negative regulation of transcription, DNA-templated (GO:0045892)|24/814|0.0152238431653961|0.246626259279416|0|0|1.61114915213276|6.74248592393991|HSPA8;CBX5;H2AFY;CBX3;UHRF1;PLK1;GMNN;HMGB2;HNRNPU;GPS2;CTCF;HMGB1;FOXM1;AURKB;CENPF;CNOT1;ID1;BIRC5;HDGF;TRIM37;KMT5A;HIST1H1B;EZH2;E2F8|4
6567|nuclear-transcribed mRNA catabolic process (GO:0000956)|8/175|0.0154899081467923|0.250142409092029|0|0|2.49804839968774|10.4107829618362|RPS17;CNOT1;RPS5;MAGOH;EXOSC8;RPSA;RPS20;RPL6|4
6568|positive regulation of mitotic cell cycle (GO:0045931)|4/53|0.0159760529568398|0.257179174254742|0|0|4.12413650891845|17.0601685456211|CCNB1;NUSAP1;CDC25B;MAD2L1|4
6569|positive regulation by host of viral process (GO:0044794)|2/11|0.0164688794085017|0.264278904470391|0|0|9.93541977148534|40.797643074512|NUCKS1;SMC3|4
6570|negative regulation of release of sequestered calcium ion into cytosol (GO:0051280)|2/11|0.0164688794085017|0.26345044395481|0|0|9.93541977148534|40.797643074512|CALM3;CALM2|4
6571|regulation of chromatin binding (GO:0035561)|2/11|0.0164688794085017|0.262627161317451|0|0|9.93541977148534|40.797643074512|CDT1;GMNN|4
6572|negative regulation of transcription from RNA polymerase II promoter (GO:0000122)|18/566|0.0170027642442965|0.270296280182695|0|0|1.73782077275097|7.08054106274451|CBX5;H2AFY;UHRF1;PLK1;HNRNPU;GPS2;CTCF;HMGB1;FOXM1;AURKB;RNF168;CNOT1;HDGF;TRIM37;KMT5A;HIST1H1B;EZH2;E2F8|4
6573|carbohydrate derivative biosynthetic process (GO:1901137)|3/30|0.0171212908960907|0.271335240505438|0|0|5.46448087431694|22.2264071491921|ALG8;RRM1;RRM2|4
6574|nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)|6/113|0.017754476145652|0.280498736133939|0|0|2.90149426954882|11.6962646674371|RPS17;RPS5;MAGOH;RPSA;RPS20;RPL6|4
6575|negative regulation of supramolecular fiber organization (GO:1902904)|4/55|0.0180886931235026|0.284896916695165|0|0|3.97416790859414|15.9462224549201|HSPA8;SPEF1;STMN1;MAPRE1|4
6576|positive regulation of cell cycle (GO:0045787)|5/83|0.0181353402675025|0.284752742723278|0|0|3.2918559483837|13.1999892797283|CCNB1;HMGN5;CKS2;CKS1B;CDC25B|4
6577|nuclear envelope organization (GO:0006998)|3/31|0.0187040525830309|0.292781534758302|0|0|5.28820729772607|21.0418564935534|SUN2;REEP4;PLK1|4
6578|negative regulation of DNA biosynthetic process (GO:2000279)|3/31|0.0187040525830309|0.291886178382895|0|0|5.28820729772607|21.0418564935534|CTC1;HNRNPU;TERF1|4
6579|rRNA 3'-end processing (GO:0031125)|2/12|0.0195261238343727|0.303786005874402|0|0|9.10746812386157|35.8470129888356|EXOSC8;RPSA|4
6580|regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter (GO:1901836)|2/12|0.0195261238343727|0.302862644154419|0|0|9.10746812386157|35.8470129888356|H2AFY;NCL|4
6581|negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315)|2/12|0.0195261238343727|0.301944878566073|0|0|9.10746812386157|35.8470129888356|CALM3;CALM2|4
6582|pyrimidine nucleoside salvage (GO:0043097)|2/12|0.0195261238343727|0.301032658389136|0|0|9.10746812386157|35.8470129888356|TK1;DCK|4
6583|positive regulation of DNA-dependent DNA replication (GO:2000105)|2/12|0.0195261238343727|0.30012593351447|0|0|9.10746812386157|35.8470129888356|CDT1;E2F8|4
6584|L-serine metabolic process (GO:0006563)|2/12|0.0195261238343727|0.299224654434847|0|0|9.10746812386157|35.8470129888356|PHGDH;SERINC3|4
6585|pyrimidine-containing compound salvage (GO:0008655)|2/12|0.0195261238343727|0.29832877223594|0|0|9.10746812386157|35.8470129888356|TK1;DCK|4
6586|pyrimidine deoxyribonucleotide catabolic process (GO:0009223)|2/12|0.0195261238343727|0.297438238587475|0|0|9.10746812386157|35.8470129888356|DUT;DCTPP1|4
6587|exit from mitosis (GO:0010458)|2/12|0.0195261238343727|0.296553005734536|0|0|9.10746812386157|35.8470129888356|UBE2C;UBE2S|4
6588|regulation of cell communication by electrical coupling (GO:0010649)|2/12|0.0195261238343727|0.295673026489033|0|0|9.10746812386157|35.8470129888356|CALM3;CALM2|4
6589|positive regulation of protein dephosphorylation (GO:0035307)|3/32|0.0203652146631027|0.307466539721341|0|0|5.12295081967213|19.9483965018008|CDCA2;CALM3;CALM2|4
6590|ribosome assembly (GO:0042255)|4/57|0.0203671176650533|0.30658820485182|0|0|3.83472342057329|14.9317747397983|RPS17;RPS5;RPSA;RPL6|4
6591|protein import (GO:0017038)|4/57|0.0203671176650533|0.30568647483755|0|0|3.83472342057329|14.9317747397983|HIKESHI;NXT2;KPNB1;RAN|4
6592|microtubule bundle formation (GO:0001578)|3/33|0.0221049096346314|0.330795759136434|0|0|4.96770988574267|18.9366892186692|TPPP3;PLK1;KIF20A|4
6593|positive regulation of protein serine/threonine kinase activity (GO:0071902)|6/119|0.0222911000272824|0.332606676722872|0|0|2.75520044083207|10.4795916299601|CKS2;CALM3;CALM2;RHOA;EZH2;CKS1B|4
6594|nucleotide metabolic process (GO:0009117)|2/13|0.0228005642891311|0.339216558505645|0|0|8.40689365279529|31.7862126423263|DCK;NUDT4|4
6595|serine family amino acid biosynthetic process (GO:0009070)|2/13|0.0228005642891311|0.338230463858826|0|0|8.40689365279529|31.7862126423263|PHGDH;SERINC3|4
6596|regulation of retinoic acid receptor signaling pathway (GO:0048385)|2/13|0.0228005642891311|0.337250085702713|0|0|8.40689365279529|31.7862126423263|CNOT1;EZH2|4
6597|detection of calcium ion (GO:0005513)|2/13|0.0228005642891311|0.336275374472359|0|0|8.40689365279529|31.7862126423263|CALM3;CALM2|4
6598|response to light stimulus (GO:0009416)|4/59|0.0228144096864486|0.335509892305323|0|0|3.70473279614708|14.0052345609352|CDKN2D;PCLAF;USP1;DTL|4
6599|regulation of DNA recombination (GO:0000018)|3/34|0.0239231752246923|0.350804491872428|0|0|4.82160077145612|17.9985902372331|RAD51AP1;RAD51;RPA2|4
6600|exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay (GO:0043928)|3/34|0.0239231752246923|0.34979932140861|0|0|4.82160077145612|17.9985902372331|EXOSC8;LSM3;LSM2|4
6601|ubiquitin-dependent protein catabolic process (GO:0006511)|12/342|0.0242804893258144|0.354009534370375|0|0|1.91736171028665|7.12890836840556|CDC20;RNF168;UBE2C;UBE2S;UHRF1;PCBP2;CDK1;BUB1B;ANAPC5;DTL;ANAPC11;MAD2L1|4
6602|SRP-dependent cotranslational protein targeting to membrane (GO:0006614)|5/90|0.0247849599850324|0.360335187474702|0|0|3.03582270795386|11.225009902836|RPS17;RPS5;RPSA;RPS20;RPL6|4
6603|nucleoside salvage (GO:0043174)|2/14|0.0262832729854002|0.38103278989914|0|0|7.8064012490242|28.4061089016166|TK1;DCK|4
6604|lipid particle organization (GO:0034389)|2/14|0.0262832729854002|0.379953376896593|0|0|7.8064012490242|28.4061089016166|PPIA;CIDEC|4
6605|regulation of nucleocytoplasmic transport (GO:0046822)|2/14|0.0262832729854002|0.378880062272592|0|0|7.8064012490242|28.4061089016166|AAAS;NUDT4|4
6606|pore complex assembly (GO:0046931)|2/14|0.0262832729854002|0.377812794491542|0|0|7.8064012490242|28.4061089016166|NDC1;NUP205|4
6607|establishment of protein localization to chromosome (GO:0070199)|2/14|0.0262832729854002|0.376751522596903|0|0|7.8064012490242|28.4061089016166|H2AFY;HIST1H1B|4
6608|regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle (GO:0031657)|2/14|0.0262832729854002|0.375696196203074|0|0|7.8064012490242|28.4061089016166|CDKN2D;CDKN2C|4
6609|positive regulation of cellular protein metabolic process (GO:0032270)|5/92|0.0269371719724725|0.383967565853427|0|0|2.96982656212877|10.733689975494|HSP90AA1;UHRF1;PLK1;VIM;CLN6|4
6610|nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)|3/36|0.0277951225610042|0.395093343812826|0|0|4.55373406193078|16.315549731895|EXOSC8;LSM3;LSM2|4
6611|positive regulation of ATPase activity (GO:0032781)|3/36|0.0277951225610042|0.393995862302235|0|0|4.55373406193078|16.315549731895|UHRF1;HNRNPU;DNAJC9|4
6612|establishment of protein localization to organelle (GO:0072594)|4/63|0.0282256878045111|0.398990816804488|0|0|3.46951166623298|12.3775619762887|HIKESHI;NXT2;KPNB1;RAN|4
6613|nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)|4/64|0.0296876296693076|0.418497166305185|0|0|3.41530054644809|12.0116968216822|CNOT1;EXOSC8;LSM3;LSM2|4
6614|nuclear pore organization (GO:0006999)|2/15|0.0299655745917572|0.421251589922141|0|0|7.28597449908925|25.5570569750523|NDC1;NUP205|4
6615|negative regulation of peptidyl-threonine phosphorylation (GO:0010801)|2/15|0.0299655745917572|0.420094305334442|0|0|7.28597449908925|25.5570569750523|CALM3;CALM2|4
6616|maintenance of protein location in nucleus (GO:0051457)|2/15|0.0299655745917572|0.418943362032156|0|0|7.28597449908925|25.5570569750523|SUN2;HNRNPU|4
6617|pyrimidine nucleoside biosynthetic process (GO:0046134)|2/15|0.0299655745917572|0.417798708037533|0|0|7.28597449908925|25.5570569750523|TK1;DCK|4
6618|microtubule depolymerization (GO:0007019)|2/15|0.0299655745917572|0.416660291939338|0|0|7.28597449908925|25.5570569750523|STMN1;CKAP5|4
6619|positive regulation of double-strand break repair (GO:2000781)|2/15|0.0299655745917572|0.415528062885155|0|0|7.28597449908925|25.5570569750523|MRNIP;FOXM1|4
6620|regulation of centriole replication (GO:0046599)|2/15|0.0299655745917572|0.414401970573813|0|0|7.28597449908925|25.5570569750523|PLK4;TRIM37|4
6621|negative regulation of cell aging (GO:0090344)|2/15|0.0299655745917572|0.413281965247938|0|0|7.28597449908925|25.5570569750523|RBL1;FOXM1|4
6622|sulfate transport (GO:0008272)|2/15|0.0299655745917572|0.412167997686623|0|0|7.28597449908925|25.5570569750523|RACGAP1;SLC25A10|4
6623|positive regulation of phosphoprotein phosphatase activity (GO:0032516)|2/15|0.0299655745917572|0.411060019198218|0|0|7.28597449908925|25.5570569750523|CALM3;CALM2|4
6624|regulation of peptidyl-threonine phosphorylation (GO:0010799)|3/38|0.0319796324573573|0.437512237077465|0|0|4.31406384814495|14.8518380695988|PLK1;CALM3;CALM2|4
6625|protein monoubiquitination (GO:0006513)|3/38|0.0319796324573573|0.43634241826175|0|0|4.31406384814495|14.8518380695988|UHRF1;UBE2T;DTL|4
6626|base-excision repair (GO:0006284)|3/38|0.0319796324573573|0.435178838479718|0|0|4.31406384814495|14.8518380695988|LIG1;RPA3;RPA2|4
6627|protein peptidyl-prolyl isomerization (GO:0000413)|3/38|0.0319796324573573|0.434021447951847|0|0|4.31406384814495|14.8518380695988|PPWD1;PPIH;PPIA|4
6628|regulation of carbohydrate catabolic process (GO:0043470)|3/38|0.0319796324573573|0.432870197426776|0|0|4.31406384814495|14.8518380695988|NDC1;NUP205;AAAS|4
6629|protein K63-linked ubiquitination (GO:0070534)|3/38|0.0319796324573573|0.431725038174324|0|0|4.31406384814495|14.8518380695988|RNF168;UBE2S;UBE2T|4
6630|positive regulation of cyclic nucleotide metabolic process (GO:0030801)|2/16|0.0338390400321545|0.455621692042439|0|0|6.83060109289617|23.129372353078|CALM3;CALM2|4
6631|regulation of stem cell proliferation (GO:0072091)|2/16|0.0338390400321545|0.454422687589696|0|0|6.83060109289617|23.129372353078|HMGB2;HNRNPU|4
6632|positive regulation of G1/S transition of mitotic cell cycle (GO:1900087)|2/16|0.0338390400321545|0.453229977123581|0|0|6.83060109289617|23.129372353078|LSM11;CDC45|4
6633|negative regulation of DNA replication (GO:0008156)|2/16|0.0338390400321545|0.452043511214881|0|0|6.83060109289617|23.129372353078|GMNN;TERF1|4
6634|cellular response to UV (GO:0034644)|4/68|0.0359772683960199|0.47935248204932|0|0|3.21440051430408|10.6874573237158|CDKN1A;PCNA;AURKB;RHNO1|4
6635|regulation of coenzyme metabolic process (GO:0051196)|3/40|0.0364740401937789|0.48470579976264|0|0|4.0983606557377|13.5703053237857|NDC1;NUP205;AAAS|4
6636|protein polyubiquitination (GO:0000209)|10/284|0.0369634184181597|0.48993330957888|0|0|1.92411298391442|6.34539087742773|RNF168;FZR1;CBFB;UBE2C;UBE2S;UBE2T;CCNF;ANAPC5;DTL;ANAPC11|4
6637|positive regulation of lymphocyte migration (GO:2000403)|2/17|0.0378954804016605|0.500986104895527|0|0|6.42880102860816|21.040973478756|SPN;RHOA|4
6638|positive regulation of calcium ion transmembrane transporter activity (GO:1901021)|2/17|0.0378954804016605|0.499691567156778|0|0|6.42880102860816|21.040973478756|CALM3;CALM2|4
6639|histone H2A ubiquitination (GO:0033522)|2/17|0.0378954804016605|0.498403702292972|0|0|6.42880102860816|21.040973478756|RNF168;TRIM37|4
6640|regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881)|2/17|0.0378954804016605|0.497122458842348|0|0|6.42880102860816|21.040973478756|CALM3;CALM2|4
6641|regulation of T cell migration (GO:2000404)|2/17|0.0378954804016605|0.495847785870957|0|0|6.42880102860816|21.040973478756|SPN;RHOA|4
6642|histone H2A monoubiquitination (GO:0035518)|2/17|0.0378954804016605|0.494579632965916|0|0|6.42880102860816|21.040973478756|RNF168;TRIM37|4
6643|nucleobase-containing compound biosynthetic process (GO:0034654)|2/17|0.0378954804016605|0.493317950228758|0|0|6.42880102860816|21.040973478756|TYMS;DCK|4
6644|peptidyl-proline modification (GO:0018208)|3/41|0.0388363146548677|0.504279169678854|0|0|3.9984006397441|12.9884027403558|PPWD1;PPIH;PPIA|4
6645|regulation of protein dephosphorylation (GO:0035304)|3/41|0.0388363146548677|0.502999273309111|0|0|3.9984006397441|12.9884027403558|CDCA2;CALM3;CALM2|4
6646|negative regulation of cell cycle G2/M phase transition (GO:1902750)|4/70|0.0393887191432729|0.508862364020561|0|0|3.12256049960968|10.0992219198599|FZR1;H2AFY;PLK1;DTL|4
6647|positive regulation of hydrolase activity (GO:0051345)|7/173|0.0403260320629472|0.519655913174797|0|0|2.21106162544616|7.09918393875685|HMGB2;CALM3;DNAJC9;ECT2;CALM2;RHOA;EZH2|4
6648|peptide transport (GO:0015833)|3/42|0.0412745651149517|0.530539309273548|0|0|3.9032006245121|12.4414864383828|NDC1;CENPF;HIKESHI|4
6649|regulation of spindle organization (GO:0090224)|2/18|0.042126941062326|0.540135126233793|0|0|6.07164541590771|19.2293127670936|TPX2;TACC3|4
6650|nuclear envelope reassembly (GO:0031468)|2/18|0.042126941062326|0.538781404112906|0|0|6.07164541590771|19.2293127670936|REEP4;BANF1|4
6651|positive regulation of cyclic nucleotide biosynthetic process (GO:0030804)|2/18|0.042126941062326|0.537434450602624|0|0|6.07164541590771|19.2293127670936|CALM3;CALM2|4
6652|regulation of microtubule polymerization or depolymerization (GO:0031110)|2/18|0.042126941062326|0.536094215064962|0|0|6.07164541590771|19.2293127670936|STMN1;SKA1|4
6653|response to organophosphorus (GO:0046683)|2/18|0.042126941062326|0.534760647365795|0|0|6.07164541590771|19.2293127670936|RFC3;TYMS|4
6654|negative regulation of calcium-mediated signaling (GO:0050849)|2/18|0.042126941062326|0.53343369786861|0|0|6.07164541590771|19.2293127670936|CALM3;CALM2|4
6655|regulation of telomerase activity (GO:0051972)|3/43|0.0437881636621625|0.553096532594098|0|0|3.81242851696531|11.9267698594882|HSP90AA1;TERF1;AURKB|4
6656|positive regulation of protein localization to nucleus (GO:1900182)|3/43|0.0437881636621625|0.551730862143248|0|0|3.81242851696531|11.9267698594882|PLK1;CDK1;ECT2|4
6657|regulation of ATP metabolic process (GO:1903578)|3/44|0.0463764267247878|0.582903708316729|0|0|3.725782414307|11.4417436422235|NDC1;NUP205;AAAS|4
6658|substantia nigra development (GO:0021762)|3/44|0.0463764267247878|0.581471512473199|0|0|3.725782414307|11.4417436422235|CALM3;CALM2;RHOA|4
6659|regulation of multicellular organismal development (GO:2000026)|3/44|0.0463764267247878|0.580046337197529|0|0|3.725782414307|11.4417436422235|RACGAP1;CDK1;HMGB1|4
6660|maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)|2/19|0.0465256958406312|0.580490527811103|0|0|5.75208513085994|17.6459621529596|EXOSC8;RPSA|4
6661|sulfur compound transport (GO:0072348)|2/19|0.0465256958406312|0.579074697255466|0|0|5.75208513085994|17.6459621529596|RACGAP1;SLC25A10|4
6662|telomere capping (GO:0016233)|2/19|0.0465256958406312|0.577665756386232|0|0|5.75208513085994|17.6459621529596|CTC1;TERF1|4
6663|protein heterotetramerization (GO:0051290)|2/19|0.0465256958406312|0.57626365503578|0|0|5.75208513085994|17.6459621529596|HIST1H3A;RCC1|4
6664|regulation of cAMP biosynthetic process (GO:0030817)|2/19|0.0465256958406312|0.574868343522376|0|0|5.75208513085994|17.6459621529596|CALM3;CALM2|4
6665|purine ribonucleotide catabolic process (GO:0009154)|2/19|0.0465256958406312|0.573479772644302|0|0|5.75208513085994|17.6459621529596|HINT1;NUDT4|4
6666|folic acid metabolic process (GO:0046655)|2/19|0.0465256958406312|0.572097893674075|0|0|5.75208513085994|17.6459621529596|DHFR;MTHFD2|4
6667|regulation of protein complex assembly (GO:0043254)|4/74|0.0467464510376801|0.573430624147312|0|0|2.95377344557672|9.04745810001931|CDT1;HSPA8;HSP90AA1;HJURP|4
6668|mRNA 3'-end processing (GO:0031124)|4/75|0.0486971514905685|0.59592701212559|0|0|2.9143897996357|8.80767866392036|SLBP;LSM11;DDX39B;MAGOH|4
6669|ribosomal small subunit biogenesis (GO:0042274)|3/45|0.0490386182168971|0.598670020958913|0|0|3.64298724954463|10.9841426754279|RPS17;RPS5;RPSA|4
6670|positive regulation of viral life cycle (GO:1903902)|3/45|0.0490386182168971|0.597241214226315|0|0|3.64298724954463|10.9841426754279|TOP2A;PPIH;PPIA|4
6671|inorganic anion transport (GO:0015698)|3/45|0.0490386182168971|0.5958192113353|0|0|3.64298724954463|10.9841426754279|RACGAP1;SLC25A10;CLIC1|4
6672|positive regulation of intracellular transport (GO:0032388)|3/45|0.0490386182168971|0.594403963802437|0|0|3.64298724954463|10.9841426754279|SPAG5;PCNT;KIF20B|4
6673|negative regulation of phosphorylation (GO:0042326)|4/76|0.0506922140207656|0.612991393715561|0|0|2.87604256542997|8.57630989297718|CDKN2D;CDKN1A;CDKN2C;HNRNPU|4
6674|negative regulation of cellular amide metabolic process (GO:0034249)|4/76|0.0506922140207656|0.611542241484555|0|0|2.87604256542997|8.57630989297718|DHFR;CNOT1;NCL;TYMS|4
6675|covalent chromatin modification (GO:0016569)|2/20|0.0510842413346979|0.614818121535291|0|0|5.46448087431694|16.2528919021177|HELLS;AURKB|4
6676|positive regulation of T cell migration (GO:2000406)|2/20|0.0510842413346979|0.613371490661091|0|0|5.46448087431694|16.2528919021177|SPN;RHOA|4
6677|positive regulation of cAMP biosynthetic process (GO:0030819)|2/20|0.0510842413346979|0.611931651481135|0|0|5.46448087431694|16.2528919021177|CALM3;CALM2|4
6678|interleukin-12-mediated signaling pathway (GO:0035722)|3/47|0.054581598171985|0.652294837170116|0|0|3.48796651552145|10.1432106133788|HNRNPF;PPIA;LMNB1|4
6679|protein methylation (GO:0006479)|3/47|0.054581598171985|0.650770783812242|0|0|3.48796651552145|10.1432106133788|HSPA8;SNRPB;EZH2|4
6680|cellular response to interleukin-12 (GO:0071349)|3/47|0.054581598171985|0.649253835598227|0|0|3.48796651552145|10.1432106133788|HNRNPF;PPIA;LMNB1|4
6681|regulation of generation of precursor metabolites and energy (GO:0043467)|3/47|0.054581598171985|0.647743942957301|0|0|3.48796651552145|10.1432106133788|NDC1;NUP205;AAAS|4
6682|regulation of cell proliferation (GO:0042127)|20/741|0.0547234337001749|0.647920376269124|0|0|1.47489362329742|4.28524923086933|CDKN2D;TIPIN;CDKN1A;CDKN2C;HP1BP3;HMGB2;NAP1L1;CTCF;FOXM1;SHCBP1;RHOA;CDC25B;HMGN5;RBBP4;PRC1;CDK2;BIRC5;KIF20B;HIST1H2AC;CDKN3|4
6683|nucleotide-excision repair, preincision complex stabilization (GO:0006293)|2/21|0.0557952914711015|0.659081880502386|0|0|5.20426749934947|15.019858419951|RPA3;RPA2|4
6684|establishment of spindle orientation (GO:0051294)|2/21|0.0557952914711015|0.657559751448108|0|0|5.20426749934947|15.019858419951|SPAG5;CENPA|4
6685|negative regulation of cyclin-dependent protein kinase activity (GO:1904030)|2/21|0.0557952914711015|0.656044636813435|0|0|5.20426749934947|15.019858419951|CDKN1A;PLK1|4
6686|DNA-templated transcription, initiation (GO:0006352)|7/187|0.0568440798554073|0.666839860924467|0|0|2.04552760001169|5.8654342079591|CCNB1;CDKN1A;TAF1D;TAF15;CBFB;MAZ;CDK1|4
6687|positive regulation of organelle assembly (GO:1902117)|3/48|0.0574606792206026|0.672527169868658|0|0|3.41530054644809|9.75633334954066|PLK4;SPAG5;CNOT1|4
6688|cellular response to heat (GO:0034605)|3/48|0.0574606792206026|0.670988206093215|0|0|3.41530054644809|9.75633334954066|HSPA8;HIKESHI;RBBP7|4
6689|positive regulation of protein autophosphorylation (GO:0031954)|2/22|0.0606517720032776|0.706634686147775|0|0|4.96770988574267|13.9225356539843|CALM3;CALM2|4
6690|GTP metabolic process (GO:0046039)|2/22|0.0606517720032776|0.705025039937872|0|0|4.96770988574267|13.9225356539843|IMPDH2;RAN|4
6691|negative regulation of protein polymerization (GO:0032272)|2/22|0.0606517720032776|0.703422710301649|0|0|4.96770988574267|13.9225356539843|STMN1;MAPRE1|4
6692|regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882)|2/22|0.0606517720032776|0.701827647466498|0|0|4.96770988574267|13.9225356539843|CALM3;CALM2|4
6693|nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)|2/22|0.0606517720032776|0.700239802110239|0|0|4.96770988574267|13.9225356539843|RPA3;RPA2|4
6694|viral genome replication (GO:0019079)|2/22|0.0606517720032776|0.69865912535604|0|0|4.96770988574267|13.9225356539843|PCBP2;DEK|4
6695|negative regulation of cell cycle G1/S phase transition (GO:1902807)|2/22|0.0606517720032776|0.6970855687674|0|0|4.96770988574267|13.9225356539843|CDKN1A;RBL1|4
6696|positive regulation of phosphatase activity (GO:0010922)|2/22|0.0606517720032776|0.695519084343204|0|0|4.96770988574267|13.9225356539843|CALM3;CALM2|4
6697|RNA transport (GO:0050658)|4/81|0.0613283341092075|0.701700647890776|0|0|2.69850907373676|7.53292403009462|SLBP;DDX39B;MAGOH;CKAP5|4
6698|regulation of megakaryocyte differentiation (GO:0045652)|3/50|0.0634294445358772|0.724117350037095|0|0|3.27868852459016|9.04205606719572|HIST1H3A;CBFB;HMGB2|4
6699|protein autoubiquitination (GO:0051865)|3/50|0.0634294445358772|0.722501016666476|0|0|3.27868852459016|9.04205606719572|UHRF1;UBE2T;TRIM37|4
6700|folic acid-containing compound metabolic process (GO:0006760)|2/23|0.065646815285917|0.746092869496736|0|0|4.75172249940603|12.9411555709495|DHFR;MTHFD2|4
6701|regulation of transcription elongation from RNA polymerase II promoter (GO:0034243)|2/23|0.065646815285917|0.744434885342298|0|0|4.75172249940603|12.9411555709495|RNF168;HNRNPU|4
6702|regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880)|2/23|0.065646815285917|0.742784253667482|0|0|4.75172249940603|12.9411555709495|CALM3;CALM2|4
6703|regulation of microtubule cytoskeleton organization (GO:0070507)|2/23|0.065646815285917|0.741140925672642|0|0|4.75172249940603|12.9411555709495|STMN1;SKA1|4
6704|positive regulation of cell cycle G1/S phase transition (GO:1902808)|2/24|0.0707737551189527|0.797259320909527|0|0|4.55373406193078|12.0595038133671|LSM11;CDC45|4
6705|proteasomal protein catabolic process (GO:0010498)|8/238|0.0721136249075604|0.810563497584319|0|0|1.83680029388805|4.82988892901438|CDC20;UBE2C;PCBP2;CDK1;BUB1B;ANAPC5;ANAPC11;MAD2L1|4
6706|transcription initiation from RNA polymerase II promoter (GO:0006367)|6/161|0.0759488371421755|0.851795419640707|0|0|2.03645249974544|5.24935416126939|CCNB1;CDKN1A;TAF15;CBFB;MAZ;CDK1|4
6707|positive regulation of purine nucleotide biosynthetic process (GO:1900373)|2/25|0.0760261216827846|0.850792322252741|0|0|4.37158469945355|11.2641673940847|CALM3;CALM2|4
6708|negative regulation of G1/S transition of mitotic cell cycle (GO:2000134)|2/25|0.0760261216827846|0.848930632269693|0|0|4.37158469945355|11.2641673940847|CDKN1A;RBL1|4
6709|DNA geometric change (GO:0032392)|2/25|0.0760261216827846|0.847077071937227|0|0|4.37158469945355|11.2641673940847|HMGB2;HMGB1|4
6710|cellular senescence (GO:0090398)|2/25|0.0760261216827846|0.84523158812037|0|0|4.37158469945355|11.2641673940847|CDKN1A;SMC6|4
6711|negative regulation of translation (GO:0017148)|4/89|0.0805868001923079|0.893987916046407|0|0|2.45594646036716|6.18510569707723|DHFR;CNOT1;NCL;TYMS|4
6712|positive regulation of protein complex assembly (GO:0031334)|4/89|0.0805868001923079|0.892048679786002|0|0|2.45594646036716|6.18510569707723|CDT1;TPPP3;RPA3;RPA2|4
6713|protein import into nucleus, translocation (GO:0000060)|2/26|0.0813976366360135|0.899073895570513|0|0|4.20344682639765|10.5439640199695|KPNB1;RAN|4
6714|regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314)|2/26|0.0813976366360135|0.897132051303622|0|0|4.20344682639765|10.5439640199695|CALM3;CALM2|4
6715|protein depolymerization (GO:0051261)|2/26|0.0813976366360135|0.895198577055123|0|0|4.20344682639765|10.5439640199695|STMN1;CKAP5|4
6716|negative regulation of cellular protein localization (GO:1903828)|2/26|0.0813976366360135|0.893273418824897|0|0|4.20344682639765|10.5439640199695|CDT1;H2AFY|4
6717|negative regulation of cellular protein metabolic process (GO:0032269)|4/90|0.0831822365248351|0.910899040742991|0|0|2.42865816636308|6.0393963746383|DHFR;CNOT1;NCL;TYMS|4
6718|protein ubiquitination (GO:0016567)|14/507|0.0840901720387427|0.91886969574669|0|0|1.5089296299889|3.73590693240173|PCNA;CBFB;UBE2C;UHRF1;CCNF;PLK1;ANAPC11;RNF168;UBE2S;UBE2T;BIRC5;TRIM37;SAE1;DTL|4
6719|positive regulation of protein transport (GO:0051222)|3/57|0.0864243576752905|0.94235790003634|0|0|2.87604256542997|7.04194916699835|KIF20B;PCNT;PPIA|4
6720|positive regulation of cyclin-dependent protein kinase activity (GO:1904031)|2/27|0.0868822083116242|0.945330296405582|0|0|4.04776361060514|9.88950416987682|CKS2;CKS1B|4
6721|nucleotide biosynthetic process (GO:0009165)|2/27|0.0868822083116242|0.9433189553494|0|0|4.04776361060514|9.88950416987682|RRM1;RRM2|4
6722|positive regulation of cAMP metabolic process (GO:0030816)|2/27|0.0868822083116242|0.941316155019571|0|0|4.04776361060514|9.88950416987682|CALM3;CALM2|4
6723|organelle assembly (GO:0070925)|11/377|0.0875685832330236|0.946742542877372|0|0|1.59441086518531|3.88292137044597|ANLN;CENPE;CENPF;CENPW;HAUS4;RCC1;TRIM59;PCNT;CENPA;LSM3;CEP89|4
6724|regulation of mRNA stability (GO:0043488)|5/129|0.0884990364971191|0.954779245760674|0|0|2.1180158427585|5.13568774953556|HSPA8;EXOSC8;SERBP1;HNRNPU;VIM|4
6725|regulation of glycolytic process (GO:0006110)|3/58|0.0899618992380426|0.968513864581712|0|0|2.82645562464669|6.80714821957557|NDC1;NUP205;AAAS|4
6726|nuclear export (GO:0051168)|4/93|0.0912111011779414|0.979895261707442|0|0|2.35031435454492|5.62801261147472|DDX39B;MAGOH;CCHCR1;RAN|4
6727|microtubule polymerization (GO:0046785)|2/28|0.0924739269602527|0.991374893441532|0|0|3.9032006245121|9.2928514632972|TPPP3;CKAP5|4
6728|purine ribonucleoside triphosphate biosynthetic process (GO:0009206)|2/28|0.0924739269602527|0.989296539367231|0|0|3.9032006245121|9.2928514632972|IMPDH2;ATP5G2|4
6729|regulation of protein localization to nucleus (GO:1900180)|2/28|0.0924739269602527|0.987226881335082|0|0|3.9032006245121|9.2928514632972|PLK1;CDK1|4
6730|positive regulation of calcium-mediated signaling (GO:0050850)|2/29|0.0981670602692225|1|0|0|3.76860749952892|8.747256661138|CALM3;CALM2|4
6731|negative regulation of response to DNA damage stimulus (GO:2001021)|2/29|0.0981670602692225|1|0|0|3.76860749952892|8.747256661138|CDKN2D;DDX39B|4
6732|protein export from nucleus (GO:0006611)|2/29|0.0981670602692225|1|0|0|3.76860749952892|8.747256661138|CCHCR1;RAN|4
6733|epithelial cell differentiation (GO:0030855)|4/97|0.10246718656136|1|0|0|2.25339417497606|5.13371114363193|PCNA;CDK1;TAGLN2;E2F8|4
6734|peptide biosynthetic process (GO:0043043)|6/175|0.10288434714405|1|0|0|1.87353629976581|4.26070213559707|RPS17;MRPL51;RPS5;RPSA;RPS20;RPL6|4
6735|regulation of striated muscle contraction (GO:0006942)|2/30|0.103956048771023|1|0|0|3.64298724954463|8.24694745768895|CALM3;CALM2|4
6736|nucleotide-excision repair, preincision complex assembly (GO:0006294)|2/30|0.103956048771023|1|0|0|3.64298724954463|8.24694745768895|RPA3;RPA2|4
6737|regulation of keratinocyte differentiation (GO:0045616)|2/30|0.103956048771023|1|0|0|3.64298724954463|8.24694745768895|CBFB;H2AFY|4
6738|protein alkylation (GO:0008213)|2/30|0.103956048771023|1|0|0|3.64298724954463|8.24694745768895|HSPA8;SNRPB|4
6739|regulation of embryonic development (GO:0045995)|2/30|0.103956048771023|1|0|0|3.64298724954463|8.24694745768895|RACGAP1;CDK1|4
6740|regulation of glial cell differentiation (GO:0045685)|1/6|0.104909744759646|1|0|0|9.10746812386157|20.5341973787577|CDK1|4
6741|mRNA 5'-splice site recognition (GO:0000395)|1/6|0.104909744759646|1|0|0|9.10746812386157|20.5341973787577|PSIP1|4
6742|positive regulation of interferon-gamma secretion (GO:1902715)|1/6|0.104909744759646|1|0|0|9.10746812386157|20.5341973787577|CD2|4
6743|polyamine biosynthetic process (GO:0006596)|1/6|0.104909744759646|1|0|0|9.10746812386157|20.5341973787577|SMS|4
6744|purine ribonucleoside monophosphate catabolic process (GO:0009169)|1/6|0.104909744759646|1|0|0|9.10746812386157|20.5341973787577|NUDT4|4
6745|response to chemokine (GO:1990868)|1/6|0.104909744759646|1|0|0|9.10746812386157|20.5341973787577|RHOA|4
6746|regulation of histone H3-K27 methylation (GO:0061085)|1/6|0.104909744759646|1|0|0|9.10746812386157|20.5341973787577|H2AFY|4
6747|histone-serine phosphorylation (GO:0035404)|1/6|0.104909744759646|1|0|0|9.10746812386157|20.5341973787577|AURKB|4
6748|negative regulation of chromosome organization (GO:2001251)|1/6|0.104909744759646|1|0|0|9.10746812386157|20.5341973787577|TOP2A|4
6749|cellular response to chemokine (GO:1990869)|1/6|0.104909744759646|1|0|0|9.10746812386157|20.5341973787577|RHOA|4
6750|ribosomal small subunit export from nucleus (GO:0000056)|1/6|0.104909744759646|1|0|0|9.10746812386157|20.5341973787577|RAN|4
6751|regulation of mitotic spindle checkpoint (GO:1903504)|1/6|0.104909744759646|1|0|0|9.10746812386157|20.5341973787577|CCNB1|4
6752|protein localization to nuclear envelope (GO:0090435)|1/6|0.104909744759646|1|0|0|9.10746812386157|20.5341973787577|PLK1|4
6753|nuclear polyadenylation-dependent ncRNA catabolic process (GO:0071046)|1/6|0.104909744759646|1|0|0|9.10746812386157|20.5341973787577|EXOSC8|4
6754|dosage compensation by inactivation of X chromosome (GO:0009048)|1/6|0.104909744759646|1|0|0|9.10746812386157|20.5341973787577|HNRNPU|4
6755|folic acid-containing compound biosynthetic process (GO:0009396)|1/6|0.104909744759646|1|0|0|9.10746812386157|20.5341973787577|DHFR|4
6756|viral release from host cell (GO:0019076)|1/6|0.104909744759646|1|0|0|9.10746812386157|20.5341973787577|PPIA|4
6757|regulation of superoxide metabolic process (GO:0090322)|1/6|0.104909744759646|1|0|0|9.10746812386157|20.5341973787577|DHFR|4
6758|regulation of nuclear cell cycle DNA replication (GO:0033262)|1/6|0.104909744759646|1|0|0|9.10746812386157|20.5341973787577|TIPIN|4
6759|regulation of nuclease activity (GO:0032069)|1/6|0.104909744759646|1|0|0|9.10746812386157|20.5341973787577|HMGB2|4
6760|astral microtubule organization (GO:0030953)|1/6|0.104909744759646|1|0|0|9.10746812386157|20.5341973787577|KPNB1|4
6761|negative regulation of meiotic cell cycle (GO:0051447)|1/6|0.104909744759646|1|0|0|9.10746812386157|20.5341973787577|FBXO5|4
6762|nuclear polyadenylation-dependent rRNA catabolic process (GO:0071035)|1/6|0.104909744759646|1|0|0|9.10746812386157|20.5341973787577|EXOSC8|4
6763|response to DNA damage checkpoint signaling (GO:0072423)|1/6|0.104909744759646|1|0|0|9.10746812386157|20.5341973787577|SMC1A|4
6764|rRNA transport (GO:0051029)|1/6|0.104909744759646|1|0|0|9.10746812386157|20.5341973787577|RPSA|4
6765|monoubiquitinated protein deubiquitination (GO:0035520)|1/6|0.104909744759646|1|0|0|9.10746812386157|20.5341973787577|USP1|4
6766|positive regulation of megakaryocyte differentiation (GO:0045654)|1/6|0.104909744759646|1|0|0|9.10746812386157|20.5341973787577|HMGB2|4
6767|negative regulation of meiotic nuclear division (GO:0045835)|1/6|0.104909744759646|1|0|0|9.10746812386157|20.5341973787577|FBXO5|4
6768|spermine metabolic process (GO:0008215)|1/6|0.104909744759646|1|0|0|9.10746812386157|20.5341973787577|SMS|4
6769|protein localization to nucleolus (GO:1902570)|1/6|0.104909744759646|1|0|0|9.10746812386157|20.5341973787577|RAN|4
6770|negative regulation of cell cycle phase transition (GO:1901988)|1/6|0.104909744759646|1|0|0|9.10746812386157|20.5341973787577|H2AFY|4
6771|tRNA catabolic process (GO:0016078)|1/6|0.104909744759646|1|0|0|9.10746812386157|20.5341973787577|EXOSC8|4
6772|regulation of cellular response to oxidative stress (GO:1900407)|1/6|0.104909744759646|1|0|0|9.10746812386157|20.5341973787577|DHFR|4
6773|negative regulation of cell size (GO:0045792)|1/6|0.104909744759646|1|0|0|9.10746812386157|20.5341973787577|RHOA|4
6774|nucleoside phosphate catabolic process (GO:1901292)|1/6|0.104909744759646|1|0|0|9.10746812386157|20.5341973787577|DCTPP1|4
6775|endoplasmic reticulum membrane organization (GO:0090158)|1/6|0.104909744759646|1|0|0|9.10746812386157|20.5341973787577|ARL6IP1|4
6776|Golgi disassembly (GO:0090166)|1/6|0.104909744759646|1|0|0|9.10746812386157|20.5341973787577|CDK1|4
6777|positive regulation of cation channel activity (GO:2001259)|2/31|0.109835501533247|1|0|0|3.52547153181738|7.7869609486476|CALM3;CALM2|4
6778|regulation of intracellular estrogen receptor signaling pathway (GO:0033146)|2/31|0.109835501533247|1|0|0|3.52547153181738|7.7869609486476|CBFB;CNOT1|4
6779|negative regulation of stress-activated MAPK cascade (GO:0032873)|2/31|0.109835501533247|1|0|0|3.52547153181738|7.7869609486476|GPS2;FOXM1|4
6780|negative regulation of cation channel activity (GO:2001258)|2/31|0.109835501533247|1|0|0|3.52547153181738|7.7869609486476|CALM3;CALM2|4
6781|positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737)|2/31|0.109835501533247|1|0|0|3.52547153181738|7.7869609486476|CKS2;CKS1B|4
6782|negative regulation of transferase activity (GO:0051348)|2/31|0.109835501533247|1|0|0|3.52547153181738|7.7869609486476|HNRNPU;TERF1|4
6783|negative regulation of cellular process (GO:0048523)|14/535|0.115736181458451|1|0|0|1.42995761197079|3.08362061805544|CDKN2D;CDKN1A;CDKN2C;GMNN;CTCF;FOXM1;SPN;ORC6;RBBP4;TMEM109;ANP32B;RBBP7;HIST1H2AC;CDKN3|4
6784|negative regulation of blood vessel endothelial cell migration (GO:0043537)|2/32|0.11580019184962|1|0|0|3.41530054644809|7.36300907483657|HMGB1;RHOA|4
6785|positive regulation of release of sequestered calcium ion into cytosol (GO:0051281)|2/32|0.11580019184962|1|0|0|3.41530054644809|7.36300907483657|CALM3;CALM2|4
6786|regulation of protein export from nucleus (GO:0046825)|2/32|0.11580019184962|1|0|0|3.41530054644809|7.36300907483657|ANP32B;RANGAP1|4
6787|gene silencing by miRNA (GO:0035195)|2/32|0.11580019184962|1|0|0|3.41530054644809|7.36300907483657|CNOT1;RAN|4
6788|regulation of protein autophosphorylation (GO:0031952)|2/32|0.11580019184962|1|0|0|3.41530054644809|7.36300907483657|CALM3;CALM2|4
6789|regulation of small GTPase mediated signal transduction (GO:0051056)|5/141|0.117250115116129|1|0|0|1.9377591752897|4.15348193980458|ARHGAP11A;RACGAP1;ECT2;FOXM1;RHOA|4
6790|regulation of kinase activity (GO:0043549)|4/102|0.117382875886878|1|0|0|2.14293367620272|4.59083733739877|RBL1;LMO4;HNRNPU;ECT2|4
6791|negative regulation of nucleic acid-templated transcription (GO:1903507)|12/445|0.118093635811449|1|0|0|1.4735678762203|3.14794981818266|HSPA8;CENPF;CBX5;CBX3;ID1;GMNN;HMGB2;BIRC5;CTCF;KMT5A;FOXM1;EZH2|4
6792|modification-dependent protein catabolic process (GO:0019941)|5/142|0.119825365718418|1|0|0|1.92411298391442|4.08242877287122|RNF168;UBE2C;UBE2S;UHRF1;DTL|4
6793|lysosomal lumen acidification (GO:0007042)|1/7|0.121294786117616|1|0|0|7.8064012490242|16.4678489252356|CLN6|4
6794|membrane raft polarization (GO:0001766)|1/7|0.121294786117616|1|0|0|7.8064012490242|16.4678489252356|CD2|4
6795|axon regeneration (GO:0031103)|1/7|0.121294786117616|1|0|0|7.8064012490242|16.4678489252356|DHFR|4
6796|modulation by symbiont of host cellular process (GO:0044068)|1/7|0.121294786117616|1|0|0|7.8064012490242|16.4678489252356|KPNB1|4
6797|replication fork protection (GO:0048478)|1/7|0.121294786117616|1|0|0|7.8064012490242|16.4678489252356|TIPIN|4
6798|exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000467)|1/7|0.121294786117616|1|0|0|7.8064012490242|16.4678489252356|EXOSC8|4
6799|protein C-linked glycosylation via tryptophan (GO:0018317)|1/7|0.121294786117616|1|0|0|7.8064012490242|16.4678489252356|DPM3|4
6800|regulation of RNA biosynthetic process (GO:2001141)|1/7|0.121294786117616|1|0|0|7.8064012490242|16.4678489252356|RALY|4
6801|regulation of dendritic cell differentiation (GO:2001198)|1/7|0.121294786117616|1|0|0|7.8064012490242|16.4678489252356|HMGB1|4
6802|regulation of meiotic nuclear division (GO:0040020)|1/7|0.121294786117616|1|0|0|7.8064012490242|16.4678489252356|FBXO5|4
6803|exonucleolytic trimming involved in rRNA processing (GO:0000459)|1/7|0.121294786117616|1|0|0|7.8064012490242|16.4678489252356|EXOSC8|4
6804|positive regulation of histone H3-K9 methylation (GO:0051574)|1/7|0.121294786117616|1|0|0|7.8064012490242|16.4678489252356|HIST1H1B|4
6805|regulation of lymphocyte migration (GO:2000401)|1/7|0.121294786117616|1|0|0|7.8064012490242|16.4678489252356|SPN|4
6806|negative regulation of stress-activated protein kinase signaling cascade (GO:0070303)|1/7|0.121294786117616|1|0|0|7.8064012490242|16.4678489252356|FOXM1|4
6807|negative regulation of B cell apoptotic process (GO:0002903)|1/7|0.121294786117616|1|0|0|7.8064012490242|16.4678489252356|AURKB|4
6808|endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000447)|1/7|0.121294786117616|1|0|0|7.8064012490242|16.4678489252356|RPSA|4
6809|ribosomal protein import into nucleus (GO:0006610)|1/7|0.121294786117616|1|0|0|7.8064012490242|16.4678489252356|KPNB1|4
6810|posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620)|1/7|0.121294786117616|1|0|0|7.8064012490242|16.4678489252356|SEC62|4
6811|nucleic acid transport (GO:0050657)|1/7|0.121294786117616|1|0|0|7.8064012490242|16.4678489252356|CKAP5|4
6812|positive regulation of apoptotic cell clearance (GO:2000427)|1/7|0.121294786117616|1|0|0|7.8064012490242|16.4678489252356|C3|4
6813|pteridine-containing compound biosynthetic process (GO:0042559)|1/7|0.121294786117616|1|0|0|7.8064012490242|16.4678489252356|DHFR|4
6814|membrane raft distribution (GO:0031580)|1/7|0.121294786117616|1|0|0|7.8064012490242|16.4678489252356|CD2|4
6815|positive regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090267)|1/7|0.121294786117616|1|0|0|7.8064012490242|16.4678489252356|MAD2L1|4
6816|tetrahydrofolate interconversion (GO:0035999)|1/7|0.121294786117616|1|0|0|7.8064012490242|16.4678489252356|TYMS|4
6817|exit from host cell (GO:0035891)|1/7|0.121294786117616|1|0|0|7.8064012490242|16.4678489252356|PPIA|4
6818|regulation of toll-like receptor 9 signaling pathway (GO:0034163)|1/7|0.121294786117616|1|0|0|7.8064012490242|16.4678489252356|HMGB1|4
6819|regulation of microtubule binding (GO:1904526)|1/7|0.121294786117616|1|0|0|7.8064012490242|16.4678489252356|MAPRE1|4
6820|strand invasion (GO:0042148)|1/7|0.121294786117616|1|0|0|7.8064012490242|16.4678489252356|RAD51|4
6821|outer mitochondrial membrane organization (GO:0007008)|1/7|0.121294786117616|1|0|0|7.8064012490242|16.4678489252356|HSP90AA1|4
6822|T-helper 1 type immune response (GO:0042088)|1/7|0.121294786117616|1|0|0|7.8064012490242|16.4678489252356|HMGB1|4
6823|protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan (GO:0018406)|1/7|0.121294786117616|1|0|0|7.8064012490242|16.4678489252356|DPM3|4
6824|regulation of cellular response to insulin stimulus (GO:1900076)|1/7|0.121294786117616|1|0|0|7.8064012490242|16.4678489252356|NUCKS1|4
6825|negative regulation of calcium ion transmembrane transporter activity (GO:1901020)|2/33|0.121845053068184|1|0|0|3.31180659049512|6.97136975748548|CALM3;CALM2|4
6826|purine ribonucleoside triphosphate metabolic process (GO:0009205)|2/33|0.121845053068184|1|0|0|3.31180659049512|6.97136975748548|HSPA8;RAN|4
6827|negative regulation of receptor activity (GO:2000272)|2/33|0.121845053068184|1|0|0|3.31180659049512|6.97136975748548|CALM3;CALM2|4
6828|protein import into nucleus (GO:0006606)|4/104|0.123599877186695|1|0|0|2.10172341319882|4.3940851777936|HIKESHI;NXT2;KPNB1;RAN|4
6829|ribosome biogenesis (GO:0042254)|7/227|0.124230524873456|1|0|0|1.68508220793914|3.51443503388512|RPS17;RPS5;EXOSC8;RPS20;RPSA;RPL6;RAN|4
6830|cellular response to light stimulus (GO:0071482)|3/67|0.124335956523717|1|0|0|2.44678248103744|5.10097394221436|PCNA;AURKB;RHNO1|4
6831|purine ribonucleotide metabolic process (GO:0009150)|3/67|0.124335956523717|1|0|0|2.44678248103744|5.10097394221436|HSPA8;HINT1;RAN|4
6832|protein acetylation (GO:0006473)|2/34|0.12796517451511|1|0|0|3.21440051430408|6.60879821980744|HAT1;ESCO2|4
6833|regulation of T cell differentiation (GO:0045580)|2/34|0.12796517451511|1|0|0|3.21440051430408|6.60879821980744|CD2;CBFB|4
6834|positive regulation of nucleocytoplasmic transport (GO:0046824)|2/34|0.12796517451511|1|0|0|3.21440051430408|6.60879821980744|ANP32B;ECT2|4
6835|regulation of intracellular protein transport (GO:0033157)|2/34|0.12796517451511|1|0|0|3.21440051430408|6.60879821980744|PCNT;KIF20B|4
6836|negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154)|3/69|0.132539205576194|1|0|0|2.37586124970302|4.801322846714|CDKN2D;ARL6IP1;BIRC5|4
6837|regulation of alcohol biosynthetic process (GO:1902930)|2/35|0.134155797512002|1|0|0|3.12256049960968|6.27245429010526|KPNB1;RAN|4
6838|positive regulation of DNA binding (GO:0043388)|2/35|0.134155797512002|1|0|0|3.12256049960968|6.27245429010526|HMGB2;HMGB1|4
6839|positive regulation of neurogenesis (GO:0050769)|3/70|0.136710124834234|1|0|0|2.34192037470726|4.6601697234355|KIF20B;ECT2;RHOA|4
6840|membrane fusion involved in viral entry into host cell (GO:0039663)|1/8|0.137380697359063|1|0|0|6.83060109289617|13.5587390305801|PPIA|4
6841|phosphate ion transmembrane transport (GO:0035435)|1/8|0.137380697359063|1|0|0|6.83060109289617|13.5587390305801|SLC25A10|4
6842|cellular response to nitric oxide (GO:0071732)|1/8|0.137380697359063|1|0|0|6.83060109289617|13.5587390305801|CDK2|4
6843|histone H2A-K119 monoubiquitination (GO:0036353)|1/8|0.137380697359063|1|0|0|6.83060109289617|13.5587390305801|TRIM37|4
6844|ribosomal large subunit export from nucleus (GO:0000055)|1/8|0.137380697359063|1|0|0|6.83060109289617|13.5587390305801|RAN|4
6845|stress-induced premature senescence (GO:0090400)|1/8|0.137380697359063|1|0|0|6.83060109289617|13.5587390305801|CDKN1A|4
6846|DNA recombinase assembly (GO:0000730)|1/8|0.137380697359063|1|0|0|6.83060109289617|13.5587390305801|RAD51|4
6847|regulation of cytoplasmic mRNA processing body assembly (GO:0010603)|1/8|0.137380697359063|1|0|0|6.83060109289617|13.5587390305801|CNOT1|4
6848|translocation of molecules into host (GO:0044417)|1/8|0.137380697359063|1|0|0|6.83060109289617|13.5587390305801|DDX39B|4
6849|DNA repair complex assembly (GO:0090735)|1/8|0.137380697359063|1|0|0|6.83060109289617|13.5587390305801|RAD51|4
6850|positive regulation of DNA recombination (GO:0045911)|1/8|0.137380697359063|1|0|0|6.83060109289617|13.5587390305801|MRNIP|4
6851|regulation of muscle organ development (GO:0048634)|1/8|0.137380697359063|1|0|0|6.83060109289617|13.5587390305801|CENPF|4
6852|regulation of T cell mediated immunity (GO:0002709)|1/8|0.137380697359063|1|0|0|6.83060109289617|13.5587390305801|HMGB1|4
6853|regulation of response to oxidative stress (GO:1902882)|1/8|0.137380697359063|1|0|0|6.83060109289617|13.5587390305801|H2AFY|4
6854|fusion of virus membrane with host plasma membrane (GO:0019064)|1/8|0.137380697359063|1|0|0|6.83060109289617|13.5587390305801|PPIA|4
6855|regulation of endodeoxyribonuclease activity (GO:0032071)|1/8|0.137380697359063|1|0|0|6.83060109289617|13.5587390305801|HMGB1|4
6856|cellular response to UV-B (GO:0071493)|1/8|0.137380697359063|1|0|0|6.83060109289617|13.5587390305801|CDKN1A|4
6857|positive regulation of spindle checkpoint (GO:0090232)|1/8|0.137380697359063|1|0|0|6.83060109289617|13.5587390305801|MAD2L1|4
6858|T-helper cell lineage commitment (GO:0002295)|1/8|0.137380697359063|1|0|0|6.83060109289617|13.5587390305801|SPN|4
6859|U4 snRNA 3'-end processing (GO:0034475)|1/8|0.137380697359063|1|0|0|6.83060109289617|13.5587390305801|EXOSC8|4
6860|peptidyl-lysine monomethylation (GO:0018026)|1/8|0.137380697359063|1|0|0|6.83060109289617|13.5587390305801|KMT5A|4
6861|nose development (GO:0043584)|1/8|0.137380697359063|1|0|0|6.83060109289617|13.5587390305801|SMCHD1|4
6862|TORC1 signaling (GO:0038202)|1/8|0.137380697359063|1|0|0|6.83060109289617|13.5587390305801|CARD11|4
6863|viral mRNA export from host cell nucleus (GO:0046784)|1/8|0.137380697359063|1|0|0|6.83060109289617|13.5587390305801|DDX39B|4
6864|negative regulation of telomerase activity (GO:0051974)|1/8|0.137380697359063|1|0|0|6.83060109289617|13.5587390305801|TERF1|4
6865|telomeric D-loop disassembly (GO:0061820)|1/8|0.137380697359063|1|0|0|6.83060109289617|13.5587390305801|TERF1|4
6866|positive regulation of tumor necrosis factor biosynthetic process (GO:0042535)|1/8|0.137380697359063|1|0|0|6.83060109289617|13.5587390305801|SPN|4
6867|negative regulation of centriole replication (GO:0046600)|1/8|0.137380697359063|1|0|0|6.83060109289617|13.5587390305801|TRIM37|4
6868|response to vitamin D (GO:0033280)|1/8|0.137380697359063|1|0|0|6.83060109289617|13.5587390305801|CDKN2D|4
6869|negative regulation of establishment of protein localization (GO:1904950)|1/8|0.137380697359063|1|0|0|6.83060109289617|13.5587390305801|TERF1|4
6870|double-strand break repair via synthesis-dependent strand annealing (GO:0045003)|1/8|0.137380697359063|1|0|0|6.83060109289617|13.5587390305801|RAD51|4
6871|heterochromatin assembly (GO:0031507)|1/8|0.137380697359063|1|0|0|6.83060109289617|13.5587390305801|HELLS|4
6872|regulation of microtubule polymerization (GO:0031113)|2/36|0.140412311457476|1|0|0|3.03582270795386|5.95984244927526|STMN1;MAPRE1|4
6873|endothelial cell migration (GO:0043542)|2/36|0.140412311457476|1|0|0|3.03582270795386|5.95984244927526|ID1;RHOA|4
6874|apical junction assembly (GO:0043297)|2/36|0.140412311457476|1|0|0|3.03582270795386|5.95984244927526|ECT2;RHOA|4
6875|regulation of phosphoprotein phosphatase activity (GO:0043666)|2/36|0.140412311457476|1|0|0|3.03582270795386|5.95984244927526|CALM3;CALM2|4
6876|positive regulation of telomerase activity (GO:0051973)|2/36|0.140412311457476|1|0|0|3.03582270795386|5.95984244927526|HSP90AA1;AURKB|4
6877|regulation of cardiac muscle contraction (GO:0055117)|2/36|0.140412311457476|1|0|0|3.03582270795386|5.95984244927526|CALM3;CALM2|4
6878|epithelial cell migration (GO:0010631)|2/37|0.146730250044309|1|0|0|2.95377344557672|5.66876210796786|ANLN;RHOA|4
6879|regulation of nitric-oxide synthase activity (GO:0050999)|2/37|0.146730250044309|1|0|0|2.95377344557672|5.66876210796786|DHFR;HSP90AA1|4
6880|negative regulation of cell cycle (GO:0045786)|3/73|0.149484538764198|1|0|0|2.2456770716371|4.26804920533809|GMNN;PLK1;MAD2L1|4
6881|positive regulation of intracellular protein transport (GO:0090316)|5/153|0.149839703051124|1|0|0|1.78577806350227|3.38974463841804|ANP32B;KIF20B;ECT2;SAE1;PCNT|4
6882|positive regulation of receptor activity (GO:2000273)|2/38|0.153105287609628|1|0|0|2.87604256542997|5.39726614882949|CALM3;CALM2|4
6883|regulation of striated muscle tissue development (GO:0016202)|1/9|0.153172924347737|1|0|0|6.07164541590771|11.3915468811023|CENPF|4
6884|positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter (GO:1901838)|1/9|0.153172924347737|1|0|0|6.07164541590771|11.3915468811023|NCL|4
6885|negative regulation of phagocytosis (GO:0050765)|1/9|0.153172924347737|1|0|0|6.07164541590771|11.3915468811023|HMGB1|4
6886|negative regulation of lymphocyte apoptotic process (GO:0070229)|1/9|0.153172924347737|1|0|0|6.07164541590771|11.3915468811023|AURKB|4
6887|regulation of interleukin-1 secretion (GO:0050704)|1/9|0.153172924347737|1|0|0|6.07164541590771|11.3915468811023|HMGB1|4
6888|regulation of methylation-dependent chromatin silencing (GO:0090308)|1/9|0.153172924347737|1|0|0|6.07164541590771|11.3915468811023|UHRF1|4
6889|cellular response to reactive nitrogen species (GO:1902170)|1/9|0.153172924347737|1|0|0|6.07164541590771|11.3915468811023|CDK2|4
6890|regulation of interferon-gamma secretion (GO:1902713)|1/9|0.153172924347737|1|0|0|6.07164541590771|11.3915468811023|CD2|4
6891|positive regulation of synapse maturation (GO:0090129)|1/9|0.153172924347737|1|0|0|6.07164541590771|11.3915468811023|CDC20|4
6892|somatic recombination of immunoglobulin genes involved in immune response (GO:0002204)|1/9|0.153172924347737|1|0|0|6.07164541590771|11.3915468811023|RNF168|4
6893|multi-ciliated epithelial cell differentiation (GO:1903251)|1/9|0.153172924347737|1|0|0|6.07164541590771|11.3915468811023|PLK4|4
6894|negative regulation of chromatin silencing (GO:0031936)|1/9|0.153172924347737|1|0|0|6.07164541590771|11.3915468811023|ATAD2|4
6895|positive regulation of vascular endothelial cell proliferation (GO:1905564)|1/9|0.153172924347737|1|0|0|6.07164541590771|11.3915468811023|HMGB1|4
6896|heterochromatin organization (GO:0070828)|1/9|0.153172924347737|1|0|0|6.07164541590771|11.3915468811023|HP1BP3|4
6897|nuclear RNA surveillance (GO:0071027)|1/9|0.153172924347737|1|0|0|6.07164541590771|11.3915468811023|EXOSC8|4
6898|establishment of epithelial cell apical/basal polarity (GO:0045198)|1/9|0.153172924347737|1|0|0|6.07164541590771|11.3915468811023|RHOA|4
6899|negative regulation of histone methylation (GO:0031061)|1/9|0.153172924347737|1|0|0|6.07164541590771|11.3915468811023|H2AFY|4
6900|nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' (GO:0034427)|1/9|0.153172924347737|1|0|0|6.07164541590771|11.3915468811023|EXOSC8|4
6901|Golgi inheritance (GO:0048313)|1/9|0.153172924347737|1|0|0|6.07164541590771|11.3915468811023|CDK1|4
6902|response to vitamin (GO:0033273)|1/9|0.153172924347737|1|0|0|6.07164541590771|11.3915468811023|CDKN2D|4
6903|positive regulation of kinase activity (GO:0033674)|4/114|0.156654788477245|1|0|0|1.91736171028665|3.55423390672196|CENPE;CDKN1A;MRNIP;LMO4|4
6904|positive regulation of cell proliferation (GO:0008284)|11/425|0.158469728590642|1|0|0|1.4143362262938|2.60547844395555|TIPIN;CDKN1A;HMGN5;PRC1;CDK2;HNRNPU;BIRC5;NAP1L1;KIF20B;FOXM1;CDC25B|4
6905|negative regulation of cell growth (GO:0030308)|4/116|0.163628428896892|1|0|0|1.88430374976446|3.41088580958448|CDKN2D;CDKN1A;CDKN2C;RBBP7|4
6906|rRNA metabolic process (GO:0016072)|6/201|0.164117647497098|1|0|0|1.63118832069162|2.94783744482906|RPS17;RPS5;EXOSC8;RPS20;RPSA;RPL6|4
6907|regulation of alternative mRNA splicing, via spliceosome (GO:0000381)|2/40|0.166010037927901|1|0|0|2.73224043715847|4.90630334155358|MAGOH;HNRNPU|4
6908|purine ribonucleoside monophosphate biosynthetic process (GO:0009168)|2/40|0.166010037927901|1|0|0|2.73224043715847|4.90630334155358|IMPDH2;ATP5G2|4
6909|purine ribonucleoside monophosphate metabolic process (GO:0009167)|2/40|0.166010037927901|1|0|0|2.73224043715847|4.90630334155358|HSPA8;IMPDH2|4
6910|regulation of response to stress (GO:0080134)|1/10|0.168676814309851|1|0|0|5.46448087431694|9.72552314907192|H2AFY|4
6911|regulation of B cell apoptotic process (GO:0002902)|1/10|0.168676814309851|1|0|0|5.46448087431694|9.72552314907192|AURKB|4
6912|IRES-dependent viral translational initiation (GO:0075522)|1/10|0.168676814309851|1|0|0|5.46448087431694|9.72552314907192|PCBP2|4
6913|regulation of synapse maturation (GO:0090128)|1/10|0.168676814309851|1|0|0|5.46448087431694|9.72552314907192|CDC20|4
6914|neuron projection regeneration (GO:0031102)|1/10|0.168676814309851|1|0|0|5.46448087431694|9.72552314907192|DHFR|4
6915|negative regulation of stem cell differentiation (GO:2000737)|1/10|0.168676814309851|1|0|0|5.46448087431694|9.72552314907192|HNRNPU|4
6916|polarized epithelial cell differentiation (GO:0030859)|1/10|0.168676814309851|1|0|0|5.46448087431694|9.72552314907192|RHOA|4
6917|cellular biogenic amine metabolic process (GO:0006576)|1/10|0.168676814309851|1|0|0|5.46448087431694|9.72552314907192|SMS|4
6918|contractile actin filament bundle assembly (GO:0030038)|1/10|0.168676814309851|1|0|0|5.46448087431694|9.72552314907192|RHOA|4
6919|negative regulation of intracellular estrogen receptor signaling pathway (GO:0033147)|1/10|0.168676814309851|1|0|0|5.46448087431694|9.72552314907192|CNOT1|4
6920|aspartate family amino acid metabolic process (GO:0009066)|1/10|0.168676814309851|1|0|0|5.46448087431694|9.72552314907192|SMS|4
6921|regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091)|1/10|0.168676814309851|1|0|0|5.46448087431694|9.72552314907192|TOP2A|4
6922|stress fiber assembly (GO:0043149)|1/10|0.168676814309851|1|0|0|5.46448087431694|9.72552314907192|RHOA|4
6923|UV protection (GO:0009650)|1/10|0.168676814309851|1|0|0|5.46448087431694|9.72552314907192|FEN1|4
6924|positive regulation of lipase activity (GO:0060193)|1/10|0.168676814309851|1|0|0|5.46448087431694|9.72552314907192|RHOA|4
6925|positive regulation of lipid localization (GO:1905954)|1/10|0.168676814309851|1|0|0|5.46448087431694|9.72552314907192|C3|4
6926|chaperone-mediated protein transport (GO:0072321)|1/10|0.168676814309851|1|0|0|5.46448087431694|9.72552314907192|HSPA8|4
6927|endothelial tube morphogenesis (GO:0061154)|1/10|0.168676814309851|1|0|0|5.46448087431694|9.72552314907192|RHOA|4
6928|regulation of histone phosphorylation (GO:0033127)|1/10|0.168676814309851|1|0|0|5.46448087431694|9.72552314907192|H2AFY|4
6929|regulation of lysosomal lumen pH (GO:0035751)|1/10|0.168676814309851|1|0|0|5.46448087431694|9.72552314907192|CLN6|4
6930|telomeric loop disassembly (GO:0090657)|1/10|0.168676814309851|1|0|0|5.46448087431694|9.72552314907192|TERF1|4
6931|regulation of establishment of protein localization to telomere (GO:0070203)|1/10|0.168676814309851|1|0|0|5.46448087431694|9.72552314907192|TERF1|4
6932|nuclear mRNA surveillance (GO:0071028)|1/10|0.168676814309851|1|0|0|5.46448087431694|9.72552314907192|EXOSC8|4
6933|rRNA processing (GO:0006364)|6/203|0.169370362166071|1|0|0|1.61511749979811|2.86791160424518|RPS17;RPS5;EXOSC8;RPS20;RPSA;RPL6|4
6934|positive regulation of cellular biosynthetic process (GO:0031328)|5/160|0.170431287230175|1|0|0|1.70765027322404|3.02155579053201|CTC1;HSP90AA1;DBF4;PCNA;VIM|4
6935|androgen receptor signaling pathway (GO:0030521)|2/41|0.172531769965567|1|0|0|2.66560042649607|4.68392345929678|CCNE1;RAN|4
6936|regulation of cholesterol biosynthetic process (GO:0045540)|2/41|0.172531769965567|1|0|0|2.66560042649607|4.68392345929678|KPNB1;RAN|4
6937|regulation of intracellular transport (GO:0032386)|2/41|0.172531769965567|1|0|0|2.66560042649607|4.68392345929678|SPAG5;AAAS|4
6938|regulation of cholesterol metabolic process (GO:0090181)|2/42|0.179094632675761|1|0|0|2.60213374967473|4.47525615059608|KPNB1;RAN|4
6939|response to calcium ion (GO:0051592)|3/80|0.180652496610282|1|0|0|2.04918032786885|3.50651639617411|CALM3;ECT2;CALM2|4
6940|negative regulation of growth (GO:0045926)|4/121|0.181533620152239|1|0|0|1.80643995845188|3.08235452726831|CDKN2D;CDKN1A;CDKN2C;RBBP7|4
6941|isotype switching (GO:0045190)|1/11|0.183897617379186|1|0|0|4.96770988574267|8.41220120975307|RNF168|4
6942|formation of extrachromosomal circular DNA (GO:0001325)|1/11|0.183897617379186|1|0|0|4.96770988574267|8.41220120975307|TERF1|4
6943|regulation of stem cell population maintenance (GO:2000036)|1/11|0.183897617379186|1|0|0|4.96770988574267|8.41220120975307|CNOT1|4
6944|methionine metabolic process (GO:0006555)|1/11|0.183897617379186|1|0|0|4.96770988574267|8.41220120975307|SMS|4
6945|regulation of histone H3-K9 methylation (GO:0051570)|1/11|0.183897617379186|1|0|0|4.96770988574267|8.41220120975307|HIST1H1B|4
6946|negative regulation of defense response to virus (GO:0050687)|1/11|0.183897617379186|1|0|0|4.96770988574267|8.41220120975307|PCBP2|4
6947|regulation of tumor necrosis factor biosynthetic process (GO:0042534)|1/11|0.183897617379186|1|0|0|4.96770988574267|8.41220120975307|SPN|4
6948|regulation of lipid kinase activity (GO:0043550)|1/11|0.183897617379186|1|0|0|4.96770988574267|8.41220120975307|RBL1|4
6949|negative regulation of nuclear division (GO:0051784)|1/11|0.183897617379186|1|0|0|4.96770988574267|8.41220120975307|FBXO5|4
6950|t-circle formation (GO:0090656)|1/11|0.183897617379186|1|0|0|4.96770988574267|8.41220120975307|TERF1|4
6951|response to nitric oxide (GO:0071731)|1/11|0.183897617379186|1|0|0|4.96770988574267|8.41220120975307|CDK2|4
6952|positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213)|1/11|0.183897617379186|1|0|0|4.96770988574267|8.41220120975307|CNOT1|4
6953|T-helper cell differentiation (GO:0042093)|1/11|0.183897617379186|1|0|0|4.96770988574267|8.41220120975307|HMGB1|4
6954|modulation by host of viral genome replication (GO:0044827)|1/11|0.183897617379186|1|0|0|4.96770988574267|8.41220120975307|NUCKS1|4
6955|chromatin silencing at rDNA (GO:0000183)|1/11|0.183897617379186|1|0|0|4.96770988574267|8.41220120975307|HIST1H3A|4
6956|endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)|1/11|0.183897617379186|1|0|0|4.96770988574267|8.41220120975307|RPSA|4
6957|regulation of mitotic centrosome separation (GO:0046602)|1/11|0.183897617379186|1|0|0|4.96770988574267|8.41220120975307|KIF11|4
6958|inhibition of cysteine-type endopeptidase activity involved in apoptotic process (GO:1990001)|1/11|0.183897617379186|1|0|0|4.96770988574267|8.41220120975307|BIRC5|4
6959|methylation-dependent chromatin silencing (GO:0006346)|1/11|0.183897617379186|1|0|0|4.96770988574267|8.41220120975307|HELLS|4
6960|internal protein amino acid acetylation (GO:0006475)|1/11|0.183897617379186|1|0|0|4.96770988574267|8.41220120975307|HAT1|4
6961|regulation of hemopoiesis (GO:1903706)|1/11|0.183897617379186|1|0|0|4.96770988574267|8.41220120975307|CBFB|4
6962|telomere maintenance via telomere trimming (GO:0090737)|1/11|0.183897617379186|1|0|0|4.96770988574267|8.41220120975307|TERF1|4
6963|negative regulation of cellular senescence (GO:2000773)|1/11|0.183897617379186|1|0|0|4.96770988574267|8.41220120975307|RBL1|4
6964|synaptonemal complex assembly (GO:0007130)|1/11|0.183897617379186|1|0|0|4.96770988574267|8.41220120975307|SYCE2|4
6965|regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211)|1/11|0.183897617379186|1|0|0|4.96770988574267|8.41220120975307|CNOT1|4
6966|synaptonemal complex organization (GO:0070193)|1/11|0.183897617379186|1|0|0|4.96770988574267|8.41220120975307|SYCE2|4
6967|cytoplasmic mRNA processing body assembly (GO:0033962)|1/11|0.183897617379186|1|0|0|4.96770988574267|8.41220120975307|LSM3|4
6968|negative regulation of nucleocytoplasmic transport (GO:0046823)|1/11|0.183897617379186|1|0|0|4.96770988574267|8.41220120975307|RANGAP1|4
6969|hepatocyte growth factor receptor signaling pathway (GO:0048012)|1/11|0.183897617379186|1|0|0|4.96770988574267|8.41220120975307|STMN1|4
6970|regulation of RNA polymerase II transcriptional preinitiation complex assembly (GO:0045898)|1/11|0.183897617379186|1|0|0|4.96770988574267|8.41220120975307|HMGB1|4
6971|regulation of transcription from RNA polymerase II promoter (GO:0006357)|32/1479|0.184019124540442|1|0|0|1.18230823514633|2.00131158069972|CDKN1A;CBFB;UHRF1;HMGB2;HNRNPU;GPS2;NUCKS1;CTCF;HMGB1;FOXM1;AURKB;BRIP1;HMGN5;RAD21;RBBP8;BRD8;KMT5A;HIST1H1B;E2F8;TCF19;CBX5;H2AFY;H2AFZ;PLK1;ATAD2;CKAP2;DEK;RBL1;CNOT1;HDGF;TRIM37;EZH2|4
6972|protein catabolic process (GO:0030163)|3/82|0.189861714349023|1|0|0|1.99920031987205|3.32158994607419|HSPA8;HSP90AA1;CLN6|4
6973|positive regulation of protein catabolic process (GO:0045732)|3/82|0.189861714349023|1|0|0|1.99920031987205|3.32158994607419|HSP90AA1;FZR1;DTL|4
6974|response to unfolded protein (GO:0006986)|2/44|0.192329168044626|1|0|0|2.48385494287134|4.09475151015992|HSPA8;HSP90AA1|4
6975|negative regulation of DNA metabolic process (GO:0051053)|2/44|0.192329168044626|1|0|0|2.48385494287134|4.09475151015992|GMNN;TERF1|4
6976|regulation of double-strand break repair via nonhomologous end joining (GO:2001032)|1/12|0.198840488419465|1|0|0|4.55373406193078|7.35542960571293|MRNIP|4
6977|positive regulation of interleukin-1 production (GO:0032732)|1/12|0.198840488419465|1|0|0|4.55373406193078|7.35542960571293|HMGB1|4
6978|negative regulation of histone modification (GO:0031057)|1/12|0.198840488419465|1|0|0|4.55373406193078|7.35542960571293|H2AFY|4
6979|establishment of apical/basal cell polarity (GO:0035089)|1/12|0.198840488419465|1|0|0|4.55373406193078|7.35542960571293|RHOA|4
6980|purine nucleoside monophosphate biosynthetic process (GO:0009127)|1/12|0.198840488419465|1|0|0|4.55373406193078|7.35542960571293|IMPDH2|4
6981|viral RNA genome replication (GO:0039694)|1/12|0.198840488419465|1|0|0|4.55373406193078|7.35542960571293|PCBP2|4
6982|ribosomal subunit export from nucleus (GO:0000054)|1/12|0.198840488419465|1|0|0|4.55373406193078|7.35542960571293|RAN|4
6983|regulation of cholesterol homeostasis (GO:2000188)|1/12|0.198840488419465|1|0|0|4.55373406193078|7.35542960571293|RALY|4
6984|establishment of protein localization to mitochondrial membrane (GO:0090151)|1/12|0.198840488419465|1|0|0|4.55373406193078|7.35542960571293|HSP90AA1|4
6985|positive regulation of keratinocyte differentiation (GO:0045618)|1/12|0.198840488419465|1|0|0|4.55373406193078|7.35542960571293|H2AFY|4
6986|protein O-linked mannosylation (GO:0035269)|1/12|0.198840488419465|1|0|0|4.55373406193078|7.35542960571293|DPM3|4
6987|regulation of vascular endothelial cell proliferation (GO:1905562)|1/12|0.198840488419465|1|0|0|4.55373406193078|7.35542960571293|HMGB1|4
6988|regulation of antigen receptor-mediated signaling pathway (GO:0050854)|1/12|0.198840488419465|1|0|0|4.55373406193078|7.35542960571293|CBFB|4
6989|response to axon injury (GO:0048678)|1/12|0.198840488419465|1|0|0|4.55373406193078|7.35542960571293|DHFR|4
6990|polyamine metabolic process (GO:0006595)|1/12|0.198840488419465|1|0|0|4.55373406193078|7.35542960571293|SMS|4
6991|positive regulation of mRNA metabolic process (GO:1903313)|1/12|0.198840488419465|1|0|0|4.55373406193078|7.35542960571293|CNOT1|4
6992|positive regulation of neuron migration (GO:2001224)|1/12|0.198840488419465|1|0|0|4.55373406193078|7.35542960571293|KIF20B|4
6993|spliceosomal tri-snRNP complex assembly (GO:0000244)|1/12|0.198840488419465|1|0|0|4.55373406193078|7.35542960571293|PRPF8|4
6994|positive regulation of transport (GO:0051050)|2/45|0.198993846698469|1|0|0|2.42865816636308|3.92102337789662|C3;SPAG5|4
6995|regulation of steroid biosynthetic process (GO:0050810)|2/45|0.198993846698469|1|0|0|2.42865816636308|3.92102337789662|KPNB1;RAN|4
6996|regulation of neuron differentiation (GO:0045664)|3/85|0.203891461910971|1|0|0|1.92864030858245|3.06686109196236|ID1;ECT2;RHOA|4
6997|modulation by virus of host process (GO:0019054)|1/13|0.213510488685083|1|0|0|4.20344682639765|6.4904132836888|KPNB1|4
6998|regulation of granulocyte chemotaxis (GO:0071622)|1/13|0.213510488685083|1|0|0|4.20344682639765|6.4904132836888|KIF20B|4
6999|regulation of viral life cycle (GO:1903900)|1/13|0.213510488685083|1|0|0|4.20344682639765|6.4904132836888|PPIA|4
7000|regulation of cell aging (GO:0090342)|1/13|0.213510488685083|1|0|0|4.20344682639765|6.4904132836888|FOXM1|4
7001|viral translation (GO:0019081)|1/13|0.213510488685083|1|0|0|4.20344682639765|6.4904132836888|PCBP2|4
7002|regulation of triglyceride biosynthetic process (GO:0010866)|1/13|0.213510488685083|1|0|0|4.20344682639765|6.4904132836888|C3|4
7003|placenta development (GO:0001890)|1/13|0.213510488685083|1|0|0|4.20344682639765|6.4904132836888|E2F8|4
7004|energy coupled proton transport, down electrochemical gradient (GO:0015985)|1/13|0.213510488685083|1|0|0|4.20344682639765|6.4904132836888|ATP5G2|4
7005|negative regulation of ubiquitin-protein transferase activity (GO:0051444)|1/13|0.213510488685083|1|0|0|4.20344682639765|6.4904132836888|MAD2L1|4
7006|response to UV-B (GO:0010224)|1/13|0.213510488685083|1|0|0|4.20344682639765|6.4904132836888|CDKN1A|4
7007|phosphate ion transport (GO:0006817)|1/13|0.213510488685083|1|0|0|4.20344682639765|6.4904132836888|SLC25A10|4
7008|B cell activation involved in immune response (GO:0002312)|1/13|0.213510488685083|1|0|0|4.20344682639765|6.4904132836888|RNF168|4
7009|generation of neurons (GO:0048699)|4/131|0.219107076017528|1|0|0|1.66854377841739|2.53317438295892|MYEF2;ID1;HMGB2;CIT|4
7010|histone H4 acetylation (GO:0043967)|2/48|0.219137954008819|1|0|0|2.27686703096539|3.45640669513991|HAT1;BRD8|4
7011|positive regulation of tumor necrosis factor production (GO:0032760)|2/48|0.219137954008819|1|0|0|2.27686703096539|3.45640669513991|SPN;CD2|4
7012|regulation of stem cell differentiation (GO:2000736)|3/89|0.222949890445989|1|0|0|1.84195984527537|2.76442851223529|HIST1H3A;CBFB;HNRNPU|4
7013|negative regulation of mitotic cell cycle (GO:0045930)|2/49|0.225892324405954|1|0|0|2.23040035686406|3.31815954929273|CDT1;MAD2L1|4
7014|protein K48-linked ubiquitination (GO:0070936)|2/49|0.225892324405954|1|0|0|2.23040035686406|3.31815954929273|UBE2C;UBE2T|4
7015|regulation of cell cycle arrest (GO:0071156)|2/49|0.225892324405954|1|0|0|2.23040035686406|3.31815954929273|HMGN5;FOXM1|4
7016|ribonucleoside monophosphate biosynthetic process (GO:0009156)|1/14|0.227912587614703|1|0|0|3.9032006245121|5.77202619513796|IMPDH2|4
7017|regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)|1/14|0.227912587614703|1|0|0|3.9032006245121|5.77202619513796|CNOT1|4
7018|negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051)|1/14|0.227912587614703|1|0|0|3.9032006245121|5.77202619513796|RHOA|4
7019|oligosaccharide-lipid intermediate biosynthetic process (GO:0006490)|1/14|0.227912587614703|1|0|0|3.9032006245121|5.77202619513796|ALG8|4
7020|myeloid dendritic cell activation (GO:0001773)|1/14|0.227912587614703|1|0|0|3.9032006245121|5.77202619513796|HMGB1|4
7021|epiboly involved in wound healing (GO:0090505)|1/14|0.227912587614703|1|0|0|3.9032006245121|5.77202619513796|RHOA|4
7022|regulation of lipase activity (GO:0060191)|1/14|0.227912587614703|1|0|0|3.9032006245121|5.77202619513796|RHOA|4
7023|establishment of mitotic spindle orientation (GO:0000132)|1/14|0.227912587614703|1|0|0|3.9032006245121|5.77202619513796|CENPA|4
7024|establishment or maintenance of actin cytoskeleton polarity (GO:0030950)|1/14|0.227912587614703|1|0|0|3.9032006245121|5.77202619513796|RHOA|4
7025|regulation of phosphate metabolic process (GO:0019220)|1/14|0.227912587614703|1|0|0|3.9032006245121|5.77202619513796|MCM7|4
7026|endoplasmic reticulum tubular network organization (GO:0071786)|1/14|0.227912587614703|1|0|0|3.9032006245121|5.77202619513796|ARL6IP1|4
7027|negative regulation of Rho protein signal transduction (GO:0035024)|1/14|0.227912587614703|1|0|0|3.9032006245121|5.77202619513796|STMN1|4
7028|DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)|1/14|0.227912587614703|1|0|0|3.9032006245121|5.77202619513796|FOXM1|4
7029|purine nucleotide catabolic process (GO:0006195)|1/14|0.227912587614703|1|0|0|3.9032006245121|5.77202619513796|HINT1|4
7030|nucleoside triphosphate metabolic process (GO:0009141)|1/14|0.227912587614703|1|0|0|3.9032006245121|5.77202619513796|DCTPP1|4
7031|regulation of protein modification by small protein conjugation or removal (GO:1903320)|1/14|0.227912587614703|1|0|0|3.9032006245121|5.77202619513796|HSP90AA1|4
7032|regulation of lymphocyte differentiation (GO:0045619)|1/14|0.227912587614703|1|0|0|3.9032006245121|5.77202619513796|CD2|4
7033|regulation of mRNA catabolic process (GO:0061013)|1/14|0.227912587614703|1|0|0|3.9032006245121|5.77202619513796|CNOT1|4
7034|regulation of defense response to virus (GO:0050688)|1/14|0.227912587614703|1|0|0|3.9032006245121|5.77202619513796|PCBP2|4
7035|regulation of neural precursor cell proliferation (GO:2000177)|1/14|0.227912587614703|1|0|0|3.9032006245121|5.77202619513796|SHCBP1|4
7036|purine-containing compound salvage (GO:0043101)|1/14|0.227912587614703|1|0|0|3.9032006245121|5.77202619513796|DCK|4
7037|positive regulation of interleukin-8 secretion (GO:2000484)|1/14|0.227912587614703|1|0|0|3.9032006245121|5.77202619513796|CD2|4
7038|protein tetramerization (GO:0051262)|3/91|0.232608708213263|1|0|0|1.80147721131328|2.62727004327201|HIST1H3A;RCC1;TK1|4
7039|protein heterooligomerization (GO:0051291)|2/50|0.2326616121682|1|0|0|2.18579234972678|3.18725724443561|HIST1H3A;RCC1|4
7040|regulation of reactive oxygen species metabolic process (GO:2000377)|2/50|0.2326616121682|1|0|0|2.18579234972678|3.18725724443561|CDKN1A;FOXM1|4
7041|regulation of release of sequestered calcium ion into cytosol (GO:0051279)|2/50|0.2326616121682|1|0|0|2.18579234972678|3.18725724443561|CALM3;CALM2|4
7042|regulation of protein catabolic process (GO:0042176)|3/92|0.237466481743128|1|0|0|1.78189593727726|2.56188309866316|FZR1;DTL;MAD2L1|4
7043|negative regulation of viral genome replication (GO:0045071)|2/51|0.239443018345641|1|0|0|2.14293367620272|3.06319470623233|FAM111A;BANF1|4
7044|ncRNA processing (GO:0034470)|6/228|0.240311993178558|1|0|0|1.43802128271498|2.05035551954889|RPS17;RPS5;EXOSC8;RPS20;RPSA;RPL6|4
7045|myotube differentiation (GO:0014902)|1/15|0.242051664276408|1|0|0|3.64298724954463|5.16795660060271|MYEF2|4
7046|ganglioside metabolic process (GO:0001573)|1/15|0.242051664276408|1|0|0|3.64298724954463|5.16795660060271|CLN6|4
7047|positive regulation of viral release from host cell (GO:1902188)|1/15|0.242051664276408|1|0|0|3.64298724954463|5.16795660060271|SMC3|4
7048|DNA damage response, signal transduction resulting in transcription (GO:0042772)|1/15|0.242051664276408|1|0|0|3.64298724954463|5.16795660060271|FOXM1|4
7049|septin ring assembly (GO:0000921)|1/15|0.242051664276408|1|0|0|3.64298724954463|5.16795660060271|ANLN|4
7050|response to X-ray (GO:0010165)|1/15|0.242051664276408|1|0|0|3.64298724954463|5.16795660060271|NUCKS1|4
7051|positive regulation of collagen metabolic process (GO:0010714)|1/15|0.242051664276408|1|0|0|3.64298724954463|5.16795660060271|VIM|4
7052|positive regulation of NF-kappaB import into nucleus (GO:0042346)|1/15|0.242051664276408|1|0|0|3.64298724954463|5.16795660060271|RHOA|4
7053|transport along microtubule (GO:0010970)|1/15|0.242051664276408|1|0|0|3.64298724954463|5.16795660060271|HSPA8|4
7054|positive regulation of protein import (GO:1904591)|1/15|0.242051664276408|1|0|0|3.64298724954463|5.16795660060271|ECT2|4
7055|regulation of establishment of cell polarity (GO:2000114)|1/15|0.242051664276408|1|0|0|3.64298724954463|5.16795660060271|KIF20B|4
7056|positive regulation of collagen biosynthetic process (GO:0032967)|1/15|0.242051664276408|1|0|0|3.64298724954463|5.16795660060271|VIM|4
7057|regulation of RNA export from nucleus (GO:0046831)|1/15|0.242051664276408|1|0|0|3.64298724954463|5.16795660060271|NUDT4|4
7058|positive regulation of protein export from nucleus (GO:0046827)|1/15|0.242051664276408|1|0|0|3.64298724954463|5.16795660060271|ANP32B|4
7059|regulation of cell-substrate junction assembly (GO:0090109)|1/15|0.242051664276408|1|0|0|3.64298724954463|5.16795660060271|RHOA|4
7060|inhibition of cysteine-type endopeptidase activity (GO:0097340)|1/15|0.242051664276408|1|0|0|3.64298724954463|5.16795660060271|BIRC5|4
7061|intra-S DNA damage checkpoint (GO:0031573)|1/15|0.242051664276408|1|0|0|3.64298724954463|5.16795660060271|TIPIN|4
7062|regulation of cell junction assembly (GO:1901888)|1/15|0.242051664276408|1|0|0|3.64298724954463|5.16795660060271|CBFB|4
7063|cellular biogenic amine biosynthetic process (GO:0042401)|1/15|0.242051664276408|1|0|0|3.64298724954463|5.16795660060271|SMS|4
7064|cellular response to corticosteroid stimulus (GO:0071384)|1/15|0.242051664276408|1|0|0|3.64298724954463|5.16795660060271|HNRNPU|4
7065|positive regulation of cellular process (GO:0048522)|12/520|0.246097340162401|1|0|0|1.26103404791929|1.7680052075637|TIPIN;HMGN5;NSMCE4A;PRC1;CDK2;BIRC5;NAP1L1;SMC6;KIF20B;FOXM1;HIST1H1B;CDC25B|4
7066|protein phosphorylation (GO:0006468)|11/471|0.24659272740942|1|0|0|1.27620572436277|1.78670993949165|PLK4;CCNA2;CCNE1;PLK1;CDK2;CDK1;BIRC5;CLSPN;BAZ1B;AURKB;CDC25B|4
7067|regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281)|3/94|0.2472331363557|1|0|0|1.74398325776073|2.4370832152698|CDKN2D;ARL6IP1;HMGB1|4
7068|positive regulation of gene expression (GO:0010628)|17/772|0.250358070689379|1|0|0|1.20331832724596|1.6664311526881|TAF15;H2AFY;ATAD2;HMGB2;CTCF;DEK;BAZ1B;FOXM1;CKS1B;TAF1D;HIST1H3A;HMGN5;CCNE1;CKS2;PCBD2;VIM;RAN|4
7069|positive regulation of proteolysis (GO:0045862)|2/53|0.253031471975708|1|0|0|2.06206825445922|2.83377957073956|PLK1;CLN6|4
7070|translation (GO:0006412)|6/233|0.255481149813065|1|0|0|1.40716245690565|1.92022324590129|RPS17;MRPL51;RPS5;RPS20;RPSA;RPL6|4
7071|miRNA metabolic process (GO:0010586)|1/16|0.255932509306186|1|0|0|3.41530054644809|4.65451333600833|RAN|4
7072|protein localization to microtubule organizing center (GO:1905508)|1/16|0.255932509306186|1|0|0|3.41530054644809|4.65451333600833|SPAG5|4
7073|regulation of osteoblast proliferation (GO:0033688)|1/16|0.255932509306186|1|0|0|3.41530054644809|4.65451333600833|RHOA|4
7074|positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)|1/16|0.255932509306186|1|0|0|3.41530054644809|4.65451333600833|CNOT1|4
7075|dendritic cell chemotaxis (GO:0002407)|1/16|0.255932509306186|1|0|0|3.41530054644809|4.65451333600833|HMGB1|4
7076|establishment of skin barrier (GO:0061436)|1/16|0.255932509306186|1|0|0|3.41530054644809|4.65451333600833|STMN1|4
7077|positive regulation of nitric-oxide synthase activity (GO:0051000)|1/16|0.255932509306186|1|0|0|3.41530054644809|4.65451333600833|DHFR|4
7078|leukocyte tethering or rolling (GO:0050901)|1/16|0.255932509306186|1|0|0|3.41530054644809|4.65451333600833|SPN|4
7079|hyaluronan catabolic process (GO:0030214)|1/16|0.255932509306186|1|0|0|3.41530054644809|4.65451333600833|HMMR|4
7080|histone H2A acetylation (GO:0043968)|1/16|0.255932509306186|1|0|0|3.41530054644809|4.65451333600833|BRD8|4
7081|regulation of cell cycle phase transition (GO:1901987)|1/16|0.255932509306186|1|0|0|3.41530054644809|4.65451333600833|PLK1|4
7082|regulation of water loss via skin (GO:0033561)|1/16|0.255932509306186|1|0|0|3.41530054644809|4.65451333600833|STMN1|4
7083|regulation of histone H3-K4 methylation (GO:0051569)|1/16|0.255932509306186|1|0|0|3.41530054644809|4.65451333600833|H2AFY|4
7084|leukocyte adhesion to vascular endothelial cell (GO:0061756)|1/16|0.255932509306186|1|0|0|3.41530054644809|4.65451333600833|SPN|4
7085|guanosine-containing compound metabolic process (GO:1901068)|1/16|0.255932509306186|1|0|0|3.41530054644809|4.65451333600833|RAN|4
7086|regulation of bicellular tight junction assembly (GO:2000810)|1/16|0.255932509306186|1|0|0|3.41530054644809|4.65451333600833|CBFB|4
7087|regulation of glucose transport (GO:0010827)|1/16|0.255932509306186|1|0|0|3.41530054644809|4.65451333600833|C3|4
7088|neuron apoptotic process (GO:0051402)|1/16|0.255932509306186|1|0|0|3.41530054644809|4.65451333600833|CIT|4
7089|pyrimidine-containing compound metabolic process (GO:0072527)|1/16|0.255932509306186|1|0|0|3.41530054644809|4.65451333600833|DCK|4
7090|regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229)|1/16|0.255932509306186|1|0|0|3.41530054644809|4.65451333600833|CDKN2D|4
7091|positive regulation of protein metabolic process (GO:0051247)|3/97|0.261994428618935|1|0|0|1.69004563123204|2.26370126797425|FZR1;UHRF1;DTL|4
7092|positive regulation of macromolecule biosynthetic process (GO:0010557)|4/143|0.266578760097154|1|0|0|1.52852611869005|2.0208422850921|CTC1;DBF4;PCNA;VIM|4
7093|cytoplasmic translation (GO:0002181)|2/55|0.266637185585646|1|0|0|1.98708395429707|2.62665951345792|RPS20;RPL6|4
7094|rRNA catabolic process (GO:0016075)|1/17|0.269559826155468|1|0|0|3.21440051430408|4.21396632537431|EXOSC8|4
7095|regulation of cellular protein catabolic process (GO:1903362)|1/17|0.269559826155468|1|0|0|3.21440051430408|4.21396632537431|HSP90AA1|4
7096|regulation of collagen biosynthetic process (GO:0032965)|1/17|0.269559826155468|1|0|0|3.21440051430408|4.21396632537431|VIM|4
7097|negative regulation of immune effector process (GO:0002698)|1/17|0.269559826155468|1|0|0|3.21440051430408|4.21396632537431|PCBP2|4
7098|positive regulation of G-protein coupled receptor protein signaling pathway (GO:0045745)|1/17|0.269559826155468|1|0|0|3.21440051430408|4.21396632537431|C3|4
7099|regulation of telomere maintenance via telomere lengthening (GO:1904356)|1/17|0.269559826155468|1|0|0|3.21440051430408|4.21396632537431|TERF1|4
7100|positive regulation of epidermal cell differentiation (GO:0045606)|1/17|0.269559826155468|1|0|0|3.21440051430408|4.21396632537431|H2AFY|4
7101|positive regulation of interleukin-6 secretion (GO:2000778)|1/17|0.269559826155468|1|0|0|3.21440051430408|4.21396632537431|HMGB1|4
7102|virion assembly (GO:0019068)|1/17|0.269559826155468|1|0|0|3.21440051430408|4.21396632537431|PPIA|4
7103|RNA stabilization (GO:0043489)|1/17|0.269559826155468|1|0|0|3.21440051430408|4.21396632537431|HNRNPU|4
7104|negative regulation of telomere maintenance (GO:0032205)|1/17|0.269559826155468|1|0|0|3.21440051430408|4.21396632537431|TERF1|4
7105|positive regulation of monocyte chemotaxis (GO:0090026)|1/17|0.269559826155468|1|0|0|3.21440051430408|4.21396632537431|HMGB1|4
7106|mRNA cis splicing, via spliceosome (GO:0045292)|1/17|0.269559826155468|1|0|0|3.21440051430408|4.21396632537431|PSIP1|4
7107|chaperone-mediated protein complex assembly (GO:0051131)|1/17|0.269559826155468|1|0|0|3.21440051430408|4.21396632537431|HSP90AA1|4
7108|positive regulation by host of viral transcription (GO:0043923)|1/17|0.269559826155468|1|0|0|3.21440051430408|4.21396632537431|NUCKS1|4
7109|regulation of establishment or maintenance of cell polarity (GO:0032878)|1/17|0.269559826155468|1|0|0|3.21440051430408|4.21396632537431|KIF20B|4
7110|regulation of B cell receptor signaling pathway (GO:0050855)|1/17|0.269559826155468|1|0|0|3.21440051430408|4.21396632537431|CBFB|4
7111|septin ring organization (GO:0031106)|1/17|0.269559826155468|1|0|0|3.21440051430408|4.21396632537431|ANLN|4
7112|positive regulation of telomere capping (GO:1904355)|1/17|0.269559826155468|1|0|0|3.21440051430408|4.21396632537431|AURKB|4
7113|positive regulation of leukocyte activation (GO:0002696)|1/17|0.269559826155468|1|0|0|3.21440051430408|4.21396632537431|CD2|4
7114|cellular response to inorganic substance (GO:0071241)|1/17|0.269559826155468|1|0|0|3.21440051430408|4.21396632537431|CDK2|4
7115|positive regulation of transcription of Notch receptor target (GO:0007221)|1/17|0.269559826155468|1|0|0|3.21440051430408|4.21396632537431|DLGAP5|4
7116|cellular response to glucocorticoid stimulus (GO:0071385)|1/17|0.269559826155468|1|0|0|3.21440051430408|4.21396632537431|HNRNPU|4
7117|positive regulation of stem cell proliferation (GO:2000648)|1/17|0.269559826155468|1|0|0|3.21440051430408|4.21396632537431|HNRNPU|4
7118|peptidyl-lysine methylation (GO:0018022)|1/17|0.269559826155468|1|0|0|3.21440051430408|4.21396632537431|KMT5A|4
7119|negative regulation of stress fiber assembly (GO:0051497)|1/17|0.269559826155468|1|0|0|3.21440051430408|4.21396632537431|STMN1|4
7120|positive regulation of cellular protein catabolic process (GO:1903364)|1/17|0.269559826155468|1|0|0|3.21440051430408|4.21396632537431|HSP90AA1|4
7121|small GTPase mediated signal transduction (GO:0007264)|3/100|0.276863720805979|1|0|0|1.63934426229508|2.10529487952109|CCNA2;CDKN1A;CDK2|4
7122|peptidyl-serine phosphorylation (GO:0018105)|4/146|0.278741030770318|1|0|0|1.49711804775807|1.91252658632264|PLK1;CDK2;CDK1;CLSPN|4
7123|ATP metabolic process (GO:0046034)|2/57|0.280241088820805|1|0|0|1.91736171028665|2.43908544681237|HSPA8;ATP5G2|4
7124|modulation by virus of host morphology or physiology (GO:0019048)|1/18|0.28293823296818|1|0|0|3.03582270795386|3.83280711361148|KPNB1|4
7125|negative regulation of microtubule depolymerization (GO:0007026)|1/18|0.28293823296818|1|0|0|3.03582270795386|3.83280711361148|SPEF1|4
7126|regulation of adherens junction organization (GO:1903391)|1/18|0.28293823296818|1|0|0|3.03582270795386|3.83280711361148|RHOA|4
7127|protein localization to centrosome (GO:0071539)|1/18|0.28293823296818|1|0|0|3.03582270795386|3.83280711361148|SPAG5|4
7128|dolichol-linked oligosaccharide biosynthetic process (GO:0006488)|1/18|0.28293823296818|1|0|0|3.03582270795386|3.83280711361148|ALG8|4
7129|cellular response to gamma radiation (GO:0071480)|1/18|0.28293823296818|1|0|0|3.03582270795386|3.83280711361148|TMEM109|4
7130|maintenance of protein localization in organelle (GO:0072595)|1/18|0.28293823296818|1|0|0|3.03582270795386|3.83280711361148|HNRNPU|4
7131|protein mannosylation (GO:0035268)|1/18|0.28293823296818|1|0|0|3.03582270795386|3.83280711361148|DPM3|4
7132|blood vessel endothelial cell migration (GO:0043534)|1/18|0.28293823296818|1|0|0|3.03582270795386|3.83280711361148|ID1|4
7133|establishment of epithelial cell polarity (GO:0090162)|1/18|0.28293823296818|1|0|0|3.03582270795386|3.83280711361148|RHOA|4
7134|regulation of protein kinase activity (GO:0045859)|4/148|0.28689819406466|1|0|0|1.47688672278836|1.84408189435167|CENPE;CDKN1A;MRNIP;ECT2|4
7135|IRE1-mediated unfolded protein response (GO:0036498)|2/58|0.28703677415171|1|0|0|1.88430374976446|2.35188418786141|HDGF;SEC62|4
7136|striated muscle cell differentiation (GO:0051146)|1/19|0.29607226401247|1|0|0|2.87604256542997|3.50058015322679|MYEF2|4
7137|cellular response to interleukin-7 (GO:0098761)|1/19|0.29607226401247|1|0|0|2.87604256542997|3.50058015322679|HIST1H3A|4
7138|histone methylation (GO:0016571)|1/19|0.29607226401247|1|0|0|2.87604256542997|3.50058015322679|EZH2|4
7139|regulation of neuron migration (GO:2001222)|1/19|0.29607226401247|1|0|0|2.87604256542997|3.50058015322679|KIF20B|4
7140|protein targeting to lysosome (GO:0006622)|1/19|0.29607226401247|1|0|0|2.87604256542997|3.50058015322679|HSPA8|4
7141|posttranscriptional gene silencing by RNA (GO:0035194)|1/19|0.29607226401247|1|0|0|2.87604256542997|3.50058015322679|CNOT1|4
7142|positive regulation of activated T cell proliferation (GO:0042104)|1/19|0.29607226401247|1|0|0|2.87604256542997|3.50058015322679|HMGB1|4
7143|DNA double-strand break processing (GO:0000729)|1/19|0.29607226401247|1|0|0|2.87604256542997|3.50058015322679|RBBP8|4
7144|interleukin-7-mediated signaling pathway (GO:0038111)|1/19|0.29607226401247|1|0|0|2.87604256542997|3.50058015322679|HIST1H3A|4
7145|positive regulation of mononuclear cell migration (GO:0071677)|1/19|0.29607226401247|1|0|0|2.87604256542997|3.50058015322679|HMGB1|4
7146|positive regulation of toll-like receptor signaling pathway (GO:0034123)|1/19|0.29607226401247|1|0|0|2.87604256542997|3.50058015322679|HMGB1|4
7147|positive regulation of lipid storage (GO:0010884)|1/19|0.29607226401247|1|0|0|2.87604256542997|3.50058015322679|C3|4
7148|plasma membrane invagination (GO:0099024)|3/104|0.296809765420688|1|0|0|1.57629255989912|1.91466561454819|C3;RHOA;AURKB|4
7149|renal system development (GO:0072001)|2/60|0.300605145483631|1|0|0|1.82149362477231|2.18935825943974|CENPF;CEP55|4
7150|dicarboxylic acid metabolic process (GO:0043648)|2/60|0.300605145483631|1|0|0|1.82149362477231|2.18935825943974|DHFR;MTHFD2|4
7151|sterol metabolic process (GO:0016125)|2/60|0.300605145483631|1|0|0|1.82149362477231|2.18935825943974|LBR;CLN6|4
7152|regulation of stress fiber assembly (GO:0051492)|2/61|0.307373876931628|1|0|0|1.79163307354654|2.11357239486264|STMN1;RHOA|4
7153|regulation of mRNA splicing, via spliceosome (GO:0048024)|2/61|0.307373876931628|1|0|0|1.79163307354654|2.11357239486264|MAGOH;HNRNPU|4
7154|vacuolar acidification (GO:0007035)|1/20|0.308966370986572|1|0|0|2.73224043715847|3.20907879717395|CLN6|4
7155|negative regulation of intracellular protein transport (GO:0090317)|1/20|0.308966370986572|1|0|0|2.73224043715847|3.20907879717395|RANGAP1|4
7156|regulation of epidermal cell differentiation (GO:0045604)|1/20|0.308966370986572|1|0|0|2.73224043715847|3.20907879717395|CBFB|4
7157|regulation of regulatory T cell differentiation (GO:0045589)|1/20|0.308966370986572|1|0|0|2.73224043715847|3.20907879717395|CBFB|4
7158|negative regulation of actin filament bundle assembly (GO:0032232)|1/20|0.308966370986572|1|0|0|2.73224043715847|3.20907879717395|STMN1|4
7159|wound healing, spreading of cells (GO:0044319)|1/20|0.308966370986572|1|0|0|2.73224043715847|3.20907879717395|RHOA|4
7160|synapsis (GO:0007129)|1/20|0.308966370986572|1|0|0|2.73224043715847|3.20907879717395|SYCE2|4
7161|inactivation of MAPK activity (GO:0000188)|1/20|0.308966370986572|1|0|0|2.73224043715847|3.20907879717395|GPS2|4
7162|regulation of DNA-templated transcription, elongation (GO:0032784)|1/20|0.308966370986572|1|0|0|2.73224043715847|3.20907879717395|DDX39B|4
7163|negative regulation of response to biotic stimulus (GO:0002832)|1/20|0.308966370986572|1|0|0|2.73224043715847|3.20907879717395|PCBP2|4
7164|negative regulation of interferon-gamma production (GO:0032689)|1/20|0.308966370986572|1|0|0|2.73224043715847|3.20907879717395|HMGB1|4
7165|cellular response to estradiol stimulus (GO:0071392)|1/20|0.308966370986572|1|0|0|2.73224043715847|3.20907879717395|H2AFZ|4
7166|regulation of cell development (GO:0060284)|1/20|0.308966370986572|1|0|0|2.73224043715847|3.20907879717395|HMGB2|4
7167|negative regulation of protein depolymerization (GO:1901880)|1/20|0.308966370986572|1|0|0|2.73224043715847|3.20907879717395|SPEF1|4
7168|regulation of response to cytokine stimulus (GO:0060759)|1/20|0.308966370986572|1|0|0|2.73224043715847|3.20907879717395|CBFB|4
7169|organelle disassembly (GO:1903008)|1/20|0.308966370986572|1|0|0|2.73224043715847|3.20907879717395|CDK1|4
7170|regulation of cell growth (GO:0001558)|5/202|0.311253720901861|1|0|0|1.35259427582102|1.57867618429084|CDKN2D;CDKN1A;CDKN2C;RBBP7;HIST1H1B|4
7171|negative regulation of viral life cycle (GO:1903901)|2/62|0.314129793405763|1|0|0|1.76273576590869|2.04115815915039|FAM111A;BANF1|4
7172|RNA 3'-end processing (GO:0031123)|2/62|0.314129793405763|1|0|0|1.76273576590869|2.04115815915039|DDX39B;MAGOH|4
7173|protein targeting to membrane (GO:0006612)|2/62|0.314129793405763|1|0|0|1.76273576590869|2.04115815915039|ARL6IP1;SEC62|4
7174|positive regulation of nucleic acid-templated transcription (GO:1903508)|11/503|0.31639095202394|1|0|0|1.19501569816076|1.37519615003789|HMGN5;TAF15;CCNE1;ATAD2;CKS2;HMGB2;CTCF;PCBD2;FOXM1;RAN;CKS1B|4
7175|positive regulation of catabolic process (GO:0009896)|2/63|0.32087110062328|1|0|0|1.73475583311649|1.97192435109361|FZR1;DTL|4
7176|hyaluronan metabolic process (GO:0030212)|1/21|0.321624925020727|1|0|0|2.60213374967473|2.95178048791735|HMMR|4
7177|positive regulation of transcription from RNA polymerase I promoter (GO:0045943)|1/21|0.321624925020727|1|0|0|2.60213374967473|2.95178048791735|NCL|4
7178|mitochondrial ATP synthesis coupled proton transport (GO:0042776)|1/21|0.321624925020727|1|0|0|2.60213374967473|2.95178048791735|ATP5G2|4
7179|non-motile cilium assembly (GO:1905515)|1/21|0.321624925020727|1|0|0|2.60213374967473|2.95178048791735|CEP89|4
7180|cellular response to alkaloid (GO:0071312)|1/21|0.321624925020727|1|0|0|2.60213374967473|2.95178048791735|RAD51|4
7181|histone ubiquitination (GO:0016574)|1/21|0.321624925020727|1|0|0|2.60213374967473|2.95178048791735|UHRF1|4
7182|negative regulation of G-protein coupled receptor protein signaling pathway (GO:0045744)|1/21|0.321624925020727|1|0|0|2.60213374967473|2.95178048791735|STMN1|4
7183|negative regulation of cell cycle arrest (GO:0071157)|1/21|0.321624925020727|1|0|0|2.60213374967473|2.95178048791735|HMGN5|4
7184|DNA-templated transcription, elongation (GO:0006354)|3/109|0.321848843804554|1|0|0|1.50398556173861|1.70502823406904|TAF1D;TAF15;SSRP1|4
7185|regulation of proteolysis (GO:0030162)|2/64|0.327596073936471|1|0|0|1.70765027322404|1.90569315470619|PLK1;CLN6|4
7186|negative regulation of dephosphorylation (GO:0035305)|2/64|0.327596073936471|1|0|0|1.70765027322404|1.90569315470619|KNL1;PKMYT1|4
7187|transcription, DNA-templated (GO:0006351)|8/357|0.330795054154494|1|0|0|1.2245335292587|1.35464789102845|TAF15;CBFB;LMO4;DEK;SSRP1;BAZ1B;PTMA;PMF1|4
7188|purine-containing compound biosynthetic process (GO:0072522)|1/22|0.334052217566752|1|0|0|2.48385494287134|2.72344251913823|DCK|4
7189|regulation of microtubule depolymerization (GO:0031114)|1/22|0.334052217566752|1|0|0|2.48385494287134|2.72344251913823|SPEF1|4
7190|urogenital system development (GO:0001655)|1/22|0.334052217566752|1|0|0|2.48385494287134|2.72344251913823|CEP55|4
7191|protein complex localization (GO:0031503)|1/22|0.334052217566752|1|0|0|2.48385494287134|2.72344251913823|BIRC5|4
7192|cellular response to unfolded protein (GO:0034620)|1/22|0.334052217566752|1|0|0|2.48385494287134|2.72344251913823|HSPA8|4
7193|ncRNA catabolic process (GO:0034661)|1/22|0.334052217566752|1|0|0|2.48385494287134|2.72344251913823|EXOSC8|4
7194|sulfur amino acid metabolic process (GO:0000096)|1/22|0.334052217566752|1|0|0|2.48385494287134|2.72344251913823|SMS|4
7195|regulation of monocyte chemotaxis (GO:0090025)|1/22|0.334052217566752|1|0|0|2.48385494287134|2.72344251913823|HMGB1|4
7196|positive regulation of interleukin-10 production (GO:0032733)|1/22|0.334052217566752|1|0|0|2.48385494287134|2.72344251913823|HMGB1|4
7197|histone lysine methylation (GO:0034968)|1/22|0.334052217566752|1|0|0|2.48385494287134|2.72344251913823|EZH2|4
7198|positive regulation of erythrocyte differentiation (GO:0045648)|1/22|0.334052217566752|1|0|0|2.48385494287134|2.72344251913823|HMGB2|4
7199|NLS-bearing protein import into nucleus (GO:0006607)|1/22|0.334052217566752|1|0|0|2.48385494287134|2.72344251913823|KPNB1|4
7200|negative regulation of sprouting angiogenesis (GO:1903671)|1/22|0.334052217566752|1|0|0|2.48385494287134|2.72344251913823|RHOA|4
7201|positive regulation of protein polymerization (GO:0032273)|2/65|0.334303056539492|1|0|0|1.68137873055906|1.84229902058749|TPPP3;MAPRE1|4
7202|protein deubiquitination (GO:0016579)|6/258|0.33448568366143|1|0|0|1.2708095056551|1.39174126261051|CDC20;CCNA2;USP1;CDK1;CLSPN;RHOA|4
7203|regulation of protein binding (GO:0043393)|3/112|0.336885562394072|1|0|0|1.46370023419204|1.59252339544046|PLK1;AURKB;RAN|4
7204|regulation of myeloid cell differentiation (GO:0045637)|2/66|0.34099045705641|1|0|0|1.65590329524756|1.78158765898664|HIST1H3A;CBFB|4
7205|cellular response to reactive oxygen species (GO:0034614)|2/66|0.34099045705641|1|0|0|1.65590329524756|1.78158765898664|CDK2;ECT2|4
7206|negative regulation of cell adhesion (GO:0007162)|2/66|0.34099045705641|1|0|0|1.65590329524756|1.78158765898664|SPN;RHOA|4
7207|regulation of interleukin-8 secretion (GO:2000482)|1/23|0.346252462217717|1|0|0|2.37586124970302|2.51980781755232|CD2|4
7208|regulation of telomere capping (GO:1904353)|1/23|0.346252462217717|1|0|0|2.37586124970302|2.51980781755232|AURKB|4
7209|TOR signaling (GO:0031929)|1/23|0.346252462217717|1|0|0|2.37586124970302|2.51980781755232|CARD11|4
7210|positive regulation of mRNA catabolic process (GO:0061014)|1/23|0.346252462217717|1|0|0|2.37586124970302|2.51980781755232|CNOT1|4
7211|negative regulation of axonogenesis (GO:0050771)|1/23|0.346252462217717|1|0|0|2.37586124970302|2.51980781755232|RHOA|4
7212|regulation of monooxygenase activity (GO:0032768)|1/23|0.346252462217717|1|0|0|2.37586124970302|2.51980781755232|HSP90AA1|4
7213|positive regulation of monooxygenase activity (GO:0032770)|1/23|0.346252462217717|1|0|0|2.37586124970302|2.51980781755232|DHFR|4
7214|regulation of cell size (GO:0008361)|1/23|0.346252462217717|1|0|0|2.37586124970302|2.51980781755232|RHOA|4
7215|protein modification by small protein removal (GO:0070646)|6/262|0.347447378285759|1|0|0|1.25140783381304|1.32291584887671|CDC20;CCNA2;USP1;CDK1;CLSPN;RHOA|4
7216|intracellular steroid hormone receptor signaling pathway (GO:0030518)|2/67|0.347656748370245|1|0|0|1.63118832069162|1.72341512312868|CCNE1;RAN|4
7217|positive regulation of protein modification process (GO:0031401)|4/164|0.353014884654499|1|0|0|1.33280021324803|1.38777163371685|C3;CDCA2;CALM3;CALM2|4
7218|negative regulation of protein serine/threonine kinase activity (GO:0071901)|2/68|0.354300465357501|1|0|0|1.60720025715204|1.66764698433857|H2AFY;PLK1|4
7219|positive regulation of endothelial cell proliferation (GO:0001938)|2/68|0.354300465357501|1|0|0|1.60720025715204|1.66764698433857|HMGB2;HMGB1|4
7220|negative regulation of protein binding (GO:0032091)|2/68|0.354300465357501|1|0|0|1.60720025715204|1.66764698433857|MAPRE1;AURKB|4
7221|regulation of cardiac conduction (GO:1903779)|2/68|0.354300465357501|1|0|0|1.60720025715204|1.66764698433857|CALM3;CALM2|4
7222|epithelium development (GO:0060429)|3/116|0.356902704306587|1|0|0|1.41322781232335|1.45603740998273|PCNA;CDK1;TAGLN2|4
7223|negative regulation of phosphatase activity (GO:0010923)|2/69|0.360920203231785|1|0|0|1.58390749980201|1.61415758099671|KNL1;PKMYT1|4
7224|cholesterol metabolic process (GO:0008203)|2/69|0.360920203231785|1|0|0|1.58390749980201|1.61415758099671|LBR;CLN6|4
7225|response to organic cyclic compound (GO:0014070)|2/70|0.36751461597666|1|0|0|1.56128024980484|1.56282933607345|CDKN2D;DHFR|4
7226|positive regulation of histone methylation (GO:0031062)|1/25|0.369988280782429|1|0|0|2.18579234972678|2.17329824569724|HIST1H1B|4
7227|cilium-dependent cell motility (GO:0060285)|1/25|0.369988280782429|1|0|0|2.18579234972678|2.17329824569724|SPEF1|4
7228|positive regulation of microtubule polymerization (GO:0031116)|1/25|0.369988280782429|1|0|0|2.18579234972678|2.17329824569724|MAPRE1|4
7229|response to glucocorticoid (GO:0051384)|1/25|0.369988280782429|1|0|0|2.18579234972678|2.17329824569724|HNRNPU|4
7230|positive regulation of vascular endothelial growth factor production (GO:0010575)|1/25|0.369988280782429|1|0|0|2.18579234972678|2.17329824569724|C3|4
7231|chaperone mediated protein folding requiring cofactor (GO:0051085)|1/25|0.369988280782429|1|0|0|2.18579234972678|2.17329824569724|HSPA8|4
7232|positive regulation of DNA-templated transcription, elongation (GO:0032786)|1/25|0.369988280782429|1|0|0|2.18579234972678|2.17329824569724|DDX39B|4
7233|positive regulation of microtubule polymerization or depolymerization (GO:0031112)|1/25|0.369988280782429|1|0|0|2.18579234972678|2.17329824569724|MAPRE1|4
7234|mRNA splice site selection (GO:0006376)|1/25|0.369988280782429|1|0|0|2.18579234972678|2.17329824569724|PSIP1|4
7235|negative regulation of T cell proliferation (GO:0042130)|1/25|0.369988280782429|1|0|0|2.18579234972678|2.17329824569724|SPN|4
7236|negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230)|1/25|0.369988280782429|1|0|0|2.18579234972678|2.17329824569724|CDKN2D|4
7237|regulation of cellular senescence (GO:2000772)|1/25|0.369988280782429|1|0|0|2.18579234972678|2.17329824569724|RBL1|4
7238|negative regulation of developmental process (GO:0051093)|2/71|0.374082414606466|1|0|0|1.53929038713153|1.51355213720149|ANP32B;FOXM1|4
7239|vascular endothelial growth factor receptor signaling pathway (GO:0048010)|2/71|0.374082414606466|1|0|0|1.53929038713153|1.51355213720149|HSP90AA1;RHOA|4
7240|Golgi vesicle transport (GO:0048193)|6/272|0.380014039605359|1|0|0|1.20540019286403|1.16628143757752|CENPE;RACGAP1;KIF23;KIF11;KIF22;KIF15|4
7241|actomyosin structure organization (GO:0031032)|2/72|0.380622365401754|1|0|0|1.51791135397693|1.46622277217778|KRT19;RHOA|4
7242|histone acetylation (GO:0016573)|2/72|0.380622365401754|1|0|0|1.51791135397693|1.46622277217778|HAT1;BRD8|4
7243|heterotypic cell-cell adhesion (GO:0034113)|1/26|0.381531904551747|1|0|0|2.10172341319882|2.02513829870332|CD2|4
7244|regulation of centrosome duplication (GO:0010824)|1/26|0.381531904551747|1|0|0|2.10172341319882|2.02513829870332|CCNF|4
7245|cyclic nucleotide metabolic process (GO:0009187)|1/26|0.381531904551747|1|0|0|2.10172341319882|2.02513829870332|NUDT4|4
7246|positive regulation of interleukin-12 production (GO:0032735)|1/26|0.381531904551747|1|0|0|2.10172341319882|2.02513829870332|HMGB1|4
7247|positive regulation of nuclear division (GO:0051785)|1/26|0.381531904551747|1|0|0|2.10172341319882|2.02513829870332|NUSAP1|4
7248|regulation of interleukin-10 production (GO:0032653)|1/26|0.381531904551747|1|0|0|2.10172341319882|2.02513829870332|HMGB1|4
7249|regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)|1/26|0.381531904551747|1|0|0|2.10172341319882|2.02513829870332|KMT5A|4
7250|regulation of nervous system development (GO:0051960)|1/26|0.381531904551747|1|0|0|2.10172341319882|2.02513829870332|HMGB2|4
7251|RNA splicing, via transesterification reactions (GO:0000375)|1/26|0.381531904551747|1|0|0|2.10172341319882|2.02513829870332|PRPF8|4
7252|positive regulation of nitric oxide biosynthetic process (GO:0045429)|1/26|0.381531904551747|1|0|0|2.10172341319882|2.02513829870332|HSP90AA1|4
7253|positive regulation of glucose transport (GO:0010828)|1/26|0.381531904551747|1|0|0|2.10172341319882|2.02513829870332|C3|4
7254|positive regulation of nitric oxide metabolic process (GO:1904407)|1/26|0.381531904551747|1|0|0|2.10172341319882|2.02513829870332|HSP90AA1|4
7255|regulation of protein import into nucleus (GO:0042306)|1/26|0.381531904551747|1|0|0|2.10172341319882|2.02513829870332|ECT2|4
7256|peptidyl-serine modification (GO:0018209)|4/171|0.382077695355478|1|0|0|1.2782411401911|1.22983581001985|PLK1;CDK2;CDK1;CLSPN|4
7257|neutrophil degranulation (GO:0043312)|10/480|0.383502686812114|1|0|0|1.1384335154827|1.09108453115937|C3;HSPA8;HSP90AA1;IMPDH2;PDAP1;HMGB1;TUBB4B;PPIA;RHOA;KPNB1|4
7258|negative regulation of cysteine-type endopeptidase activity (GO:2000117)|2/73|0.387133288535642|1|0|0|1.49711804775807|1.42074441264877|CDKN2D;ARL6IP1|4
7259|response to metal ion (GO:0010038)|2/73|0.387133288535642|1|0|0|1.49711804775807|1.42074441264877|CALM3;CALM2|4
7260|regulation of phosphatase activity (GO:0010921)|2/73|0.387133288535642|1|0|0|1.49711804775807|1.42074441264877|KNL1;PKMYT1|4
7261|Ras protein signal transduction (GO:0007265)|5/224|0.390796626081166|1|0|0|1.21975019516003|1.14603824187066|CCNA2;CDKN1A;CDK2;RHOA;KPNB1|4
7262|apoptotic cell clearance (GO:0043277)|1/27|0.392864582911781|1|0|0|2.02388180530257|1.89089313749295|HMGB1|4
7263|cytoskeleton-dependent intracellular transport (GO:0030705)|1/27|0.392864582911781|1|0|0|2.02388180530257|1.89089313749295|TUBA1B|4
7264|response to gamma radiation (GO:0010332)|1/27|0.392864582911781|1|0|0|2.02388180530257|1.89089313749295|TMEM109|4
7265|regulation of centrosome cycle (GO:0046605)|1/27|0.392864582911781|1|0|0|2.02388180530257|1.89089313749295|KIF11|4
7266|regulation of NF-kappaB import into nucleus (GO:0042345)|1/27|0.392864582911781|1|0|0|2.02388180530257|1.89089313749295|RHOA|4
7267|GPI anchor metabolic process (GO:0006505)|1/27|0.392864582911781|1|0|0|2.02388180530257|1.89089313749295|DPM3|4
7268|negative chemotaxis (GO:0050919)|1/27|0.392864582911781|1|0|0|2.02388180530257|1.89089313749295|RHOA|4
7269|snRNA 3'-end processing (GO:0034472)|1/27|0.392864582911781|1|0|0|2.02388180530257|1.89089313749295|EXOSC8|4
7270|RNA biosynthetic process (GO:0032774)|1/27|0.392864582911781|1|0|0|2.02388180530257|1.89089313749295|POLA1|4
7271|regulation of supramolecular fiber organization (GO:1902903)|1/27|0.392864582911781|1|0|0|2.02388180530257|1.89089313749295|HSPA8|4
7272|neutrophil activation involved in immune response (GO:0002283)|10/484|0.393334380866587|1|0|0|1.12902497403243|1.05348776924304|C3;HSPA8;HSP90AA1;IMPDH2;PDAP1;HMGB1;TUBB4B;PPIA;RHOA;KPNB1|4
7273|protein N-linked glycosylation (GO:0006487)|2/74|0.393614056378879|1|0|0|1.47688672278836|1.37702614399202|ALG8;DPM3|4
7274|positive regulation of cytokine secretion (GO:0050715)|2/74|0.393614056378879|1|0|0|1.47688672278836|1.37702614399202|CD2;HMGB1|4
7275|neutrophil mediated immunity (GO:0002446)|10/488|0.403180259376093|1|0|0|1.11977067096659|1.01716779013737|C3;HSPA8;HSP90AA1;IMPDH2;PDAP1;HMGB1;TUBB4B;PPIA;RHOA;KPNB1|4
7276|ATP synthesis coupled proton transport (GO:0015986)|1/28|0.4039901601856|1|0|0|1.95160031225605|1.76886174335253|ATP5G2|4
7277|regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143)|1/28|0.4039901601856|1|0|0|1.95160031225605|1.76886174335253|CBFB|4
7278|cristae formation (GO:0042407)|1/28|0.4039901601856|1|0|0|1.95160031225605|1.76886174335253|ATP5G2|4
7279|regulation of protein transport (GO:0051223)|1/28|0.4039901601856|1|0|0|1.95160031225605|1.76886174335253|HSPA8|4
7280|modulation by host of viral transcription (GO:0043921)|1/28|0.4039901601856|1|0|0|1.95160031225605|1.76886174335253|NUCKS1|4
7281|regulation of vascular endothelial growth factor production (GO:0010574)|1/28|0.4039901601856|1|0|0|1.95160031225605|1.76886174335253|C3|4
7282|negative regulation of organelle assembly (GO:1902116)|1/28|0.4039901601856|1|0|0|1.95160031225605|1.76886174335253|TRIM37|4
7283|cellular response to topologically incorrect protein (GO:0035967)|1/28|0.4039901601856|1|0|0|1.95160031225605|1.76886174335253|HSPA8|4
7284|purine ribonucleotide biosynthetic process (GO:0009152)|2/76|0.40648086817638|1|0|0|1.43802128271498|1.29453324109664|IMPDH2;ATP5G2|4
7285|cytoskeleton organization (GO:0007010)|3/127|0.411388536108899|1|0|0|1.29082225377566|1.14653048626674|ANLN;SUN2;SYNE2|4
7286|transforming growth factor beta receptor signaling pathway (GO:0007179)|2/77|0.412864904703944|1|0|0|1.41934568164076|1.25560264961568|ID1;RHOA|4
7287|regulation of hematopoietic stem cell differentiation (GO:1902036)|2/77|0.412864904703944|1|0|0|1.41934568164076|1.25560264961568|HIST1H3A;CBFB|4
7288|nucleic acid-templated transcription (GO:0097659)|2/77|0.412864904703944|1|0|0|1.41934568164076|1.25560264961568|BAZ1B;PTMA|4
7289|phosphorylation (GO:0016310)|8/387|0.413714758161321|1|0|0|1.1296084494712|0.996968167710681|PLK4;CCNE1;PLK1;CDK2;CDK1;BIRC5;AURKB;CDC25B|4
7290|negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144)|1/29|0.414912410932019|1|0|0|1.88430374976446|1.65759909369219|CNOT1|4
7291|cellular response to hydrogen peroxide (GO:0070301)|1/29|0.414912410932019|1|0|0|1.88430374976446|1.65759909369219|ECT2|4
7292|cellular response to alcohol (GO:0097306)|1/29|0.414912410932019|1|0|0|1.88430374976446|1.65759909369219|RAD51|4
7293|carboxylic acid catabolic process (GO:0046395)|1/29|0.414912410932019|1|0|0|1.88430374976446|1.65759909369219|HMMR|4
7294|negative regulation of JNK cascade (GO:0046329)|1/29|0.414912410932019|1|0|0|1.88430374976446|1.65759909369219|GPS2|4
7295|regulation of lipid biosynthetic process (GO:0046890)|1/29|0.414912410932019|1|0|0|1.88430374976446|1.65759909369219|C3|4
7296|primary neural tube formation (GO:0014020)|1/29|0.414912410932019|1|0|0|1.88430374976446|1.65759909369219|LMO4|4
7297|positive regulation of fibroblast proliferation (GO:0048146)|1/29|0.414912410932019|1|0|0|1.88430374976446|1.65759909369219|CDKN1A|4
7298|lytic vacuole organization (GO:0080171)|1/29|0.414912410932019|1|0|0|1.88430374976446|1.65759909369219|CLN6|4
7299|bicellular tight junction assembly (GO:0070830)|1/29|0.414912410932019|1|0|0|1.88430374976446|1.65759909369219|ECT2|4
7300|transcription elongation from RNA polymerase I promoter (GO:0006362)|1/29|0.414912410932019|1|0|0|1.88430374976446|1.65759909369219|TAF1D|4
7301|regulation of hematopoietic progenitor cell differentiation (GO:1901532)|2/78|0.419214768488885|1|0|0|1.40114894213255|1.21811954101444|HIST1H3A;CBFB|4
7302|water-soluble vitamin metabolic process (GO:0006767)|2/78|0.419214768488885|1|0|0|1.40114894213255|1.21811954101444|DHFR;MTHFD2|4
7303|apoptotic process (GO:0006915)|5/232|0.419722236353781|1|0|0|1.17768984360279|1.02242572133812|CD2;ESPL1;CIDEC;CIT;MCM2|4
7304|fibroblast growth factor receptor signaling pathway (GO:0008543)|2/79|0.425529571226039|1|0|0|1.38341287957391|1.18201678880825|HNRNPF;SHCBP1|4
7305|dicarboxylic acid transport (GO:0006835)|1/30|0.425635041031103|1|0|0|1.82149362477231|1.55587069416052|SLC25A10|4
7306|very long-chain fatty acid metabolic process (GO:0000038)|1/30|0.425635041031103|1|0|0|1.82149362477231|1.55587069416052|ACOT1|4
7307|coenzyme biosynthetic process (GO:0009108)|1/30|0.425635041031103|1|0|0|1.82149362477231|1.55587069416052|DHFR|4
7308|tube closure (GO:0060606)|1/30|0.425635041031103|1|0|0|1.82149362477231|1.55587069416052|LMO4|4
7309|nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289)|1/30|0.425635041031103|1|0|0|1.82149362477231|1.55587069416052|CNOT1|4
7310|cortical cytoskeleton organization (GO:0030865)|1/30|0.425635041031103|1|0|0|1.82149362477231|1.55587069416052|ANLN|4
7311|positive regulation of myeloid cell differentiation (GO:0045639)|1/30|0.425635041031103|1|0|0|1.82149362477231|1.55587069416052|HMGB2|4
7312|regulation of activated T cell proliferation (GO:0046006)|1/30|0.425635041031103|1|0|0|1.82149362477231|1.55587069416052|HMGB1|4
7313|respiratory system development (GO:0060541)|1/30|0.425635041031103|1|0|0|1.82149362477231|1.55587069416052|SMCHD1|4
7314|regulation of neutrophil chemotaxis (GO:0090022)|1/30|0.425635041031103|1|0|0|1.82149362477231|1.55587069416052|KIF20B|4
7315|regulation of cellular biosynthetic process (GO:0031326)|1/30|0.425635041031103|1|0|0|1.82149362477231|1.55587069416052|C3|4
7316|positive regulation of interleukin-1 secretion (GO:0050716)|1/30|0.425635041031103|1|0|0|1.82149362477231|1.55587069416052|HMGB1|4
7317|negative regulation of lymphocyte proliferation (GO:0050672)|1/30|0.425635041031103|1|0|0|1.82149362477231|1.55587069416052|SPN|4
7318|regulation of macromolecule metabolic process (GO:0060255)|3/130|0.426020375975862|1|0|0|1.26103404791929|1.07600012979492|DDX39B;CDK2;CDK1|4
7319|negative regulation of mitotic cell cycle phase transition (GO:1901991)|2/80|0.431808468497992|1|0|0|1.36612021857923|1.14723107788178|CDKN1A;RBL1|4
7320|cell-cell junction assembly (GO:0007043)|2/80|0.431808468497992|1|0|0|1.36612021857923|1.14723107788178|ECT2;RHOA|4
7321|ribosomal large subunit assembly (GO:0000027)|1/31|0.4361616890896|1|0|0|1.76273576590869|1.46261635438728|RPL6|4
7322|regulation of cell migration involved in sprouting angiogenesis (GO:0090049)|1/31|0.4361616890896|1|0|0|1.76273576590869|1.46261635438728|RHOA|4
7323|aminoglycan metabolic process (GO:0006022)|1/31|0.4361616890896|1|0|0|1.76273576590869|1.46261635438728|CLN6|4
7324|response to estradiol (GO:0032355)|1/31|0.4361616890896|1|0|0|1.76273576590869|1.46261635438728|H2AFZ|4
7325|regulation of protein polymerization (GO:0032271)|1/31|0.4361616890896|1|0|0|1.76273576590869|1.46261635438728|TPPP3|4
7326|negative regulation of cell morphogenesis involved in differentiation (GO:0010771)|1/31|0.4361616890896|1|0|0|1.76273576590869|1.46261635438728|RHOA|4
7327|'de novo' posttranslational protein folding (GO:0051084)|1/31|0.4361616890896|1|0|0|1.76273576590869|1.46261635438728|HSPA8|4
7328|positive regulation of reactive oxygen species biosynthetic process (GO:1903428)|1/31|0.4361616890896|1|0|0|1.76273576590869|1.46261635438728|HSP90AA1|4
7329|regulation of ubiquitin-protein transferase activity (GO:0051438)|1/32|0.446495927454241|1|0|0|1.70765027322404|1.376921106131|PLK1|4
7330|lysosome organization (GO:0007040)|1/32|0.446495927454241|1|0|0|1.70765027322404|1.376921106131|CLN6|4
7331|termination of RNA polymerase I transcription (GO:0006363)|1/32|0.446495927454241|1|0|0|1.70765027322404|1.376921106131|TAF1D|4
7332|secondary alcohol metabolic process (GO:1902652)|1/32|0.446495927454241|1|0|0|1.70765027322404|1.376921106131|CLN6|4
7333|sarcomere organization (GO:0045214)|1/32|0.446495927454241|1|0|0|1.70765027322404|1.376921106131|KRT19|4
7334|liver development (GO:0001889)|1/32|0.446495927454241|1|0|0|1.70765027322404|1.376921106131|E2F8|4
7335|protein destabilization (GO:0031648)|1/32|0.446495927454241|1|0|0|1.70765027322404|1.376921106131|PLK1|4
7336|negative regulation of binding (GO:0051100)|2/83|0.450421911735885|1|0|0|1.31674237935348|1.05019494876239|ID1;AURKB|4
7337|mitochondrial transport (GO:0006839)|3/136|0.454885449608533|1|0|0|1.20540019286403|0.949505365031285|HSP90AA1;SLC25A10;ATP5G2|4
7338|positive regulation of protein ubiquitination (GO:0031398)|2/84|0.45654957246253|1|0|0|1.30106687483737|1.02011188182787|PLK1;CENPS|4
7339|negative regulation of fat cell differentiation (GO:0045599)|1/33|0.456641263656624|1|0|0|1.65590329524756|1.29799168306774|GPS2|4
7340|positive regulation of telomere maintenance via telomerase (GO:0032212)|1/33|0.456641263656624|1|0|0|1.65590329524756|1.29799168306774|AURKB|4
7341|positive regulation of transcription factor import into nucleus (GO:0042993)|1/33|0.456641263656624|1|0|0|1.65590329524756|1.29799168306774|RHOA|4
7342|regulation of erythrocyte differentiation (GO:0045646)|1/33|0.456641263656624|1|0|0|1.65590329524756|1.29799168306774|HMGB2|4
7343|positive regulation of telomere maintenance (GO:0032206)|1/33|0.456641263656624|1|0|0|1.65590329524756|1.29799168306774|AURKB|4
7344|regulation of nitric oxide biosynthetic process (GO:0045428)|1/33|0.456641263656624|1|0|0|1.65590329524756|1.29799168306774|HSP90AA1|4
7345|cyclic-nucleotide-mediated signaling (GO:0019935)|1/33|0.456641263656624|1|0|0|1.65590329524756|1.29799168306774|NUDT4|4
7346|ATP biosynthetic process (GO:0006754)|1/33|0.456641263656624|1|0|0|1.65590329524756|1.29799168306774|ATP5G2|4
7347|GPI anchor biosynthetic process (GO:0006506)|1/33|0.456641263656624|1|0|0|1.65590329524756|1.29799168306774|DPM3|4
7348|positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557)|1/33|0.456641263656624|1|0|0|1.65590329524756|1.29799168306774|CD2|4
7349|activation of GTPase activity (GO:0090630)|2/85|0.462637717283962|1|0|0|1.28576020572163|0.991078108972065|RANGAP1;ECT2|4
7350|cellular response to molecule of bacterial origin (GO:0071219)|2/85|0.462637717283962|1|0|0|1.28576020572163|0.991078108972065|HMGB2;RHOA|4
7351|transcription from RNA polymerase I promoter (GO:0006360)|1/34|0.466601141273485|1|0|0|1.60720025715204|1.22513737297065|TAF1D|4
7352|negative regulation of neurogenesis (GO:0050768)|1/34|0.466601141273485|1|0|0|1.60720025715204|1.22513737297065|ID1|4
7353|entry into host cell (GO:0030260)|1/34|0.466601141273485|1|0|0|1.60720025715204|1.22513737297065|PPIA|4
7354|neural tube closure (GO:0001843)|1/34|0.466601141273485|1|0|0|1.60720025715204|1.22513737297065|LMO4|4
7355|regulation of cell-substrate adhesion (GO:0010810)|1/34|0.466601141273485|1|0|0|1.60720025715204|1.22513737297065|RHOA|4
7356|negative regulation of multi-organism process (GO:0043901)|1/34|0.466601141273485|1|0|0|1.60720025715204|1.22513737297065|PCBP2|4
7357|platelet aggregation (GO:0070527)|1/34|0.466601141273485|1|0|0|1.60720025715204|1.22513737297065|CLIC1|4
7358|cellular glucose homeostasis (GO:0001678)|1/34|0.466601141273485|1|0|0|1.60720025715204|1.22513737297065|NUCKS1|4
7359|mRNA stabilization (GO:0048255)|1/34|0.466601141273485|1|0|0|1.60720025715204|1.22513737297065|HNRNPU|4
7360|regulation of interleukin-12 production (GO:0032655)|1/34|0.466601141273485|1|0|0|1.60720025715204|1.22513737297065|HMGB1|4
7361|transcription initiation from RNA polymerase I promoter (GO:0006361)|1/34|0.466601141273485|1|0|0|1.60720025715204|1.22513737297065|TAF1D|4
7362|establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197)|1/34|0.466601141273485|1|0|0|1.60720025715204|1.22513737297065|RHOA|4
7363|negative regulation of DNA binding (GO:0043392)|1/35|0.476378941541609|1|0|0|1.56128024980484|1.1577543259815|ID1|4
7364|ncRNA metabolic process (GO:0034660)|1/35|0.476378941541609|1|0|0|1.56128024980484|1.1577543259815|RAN|4
7365|negative regulation of T cell activation (GO:0050868)|1/35|0.476378941541609|1|0|0|1.56128024980484|1.1577543259815|SPN|4
7366|regulation of insulin receptor signaling pathway (GO:0046626)|1/35|0.476378941541609|1|0|0|1.56128024980484|1.1577543259815|NUCKS1|4
7367|negative regulation of endothelial cell migration (GO:0010596)|1/35|0.476378941541609|1|0|0|1.56128024980484|1.1577543259815|HMGB1|4
7368|positive regulation of telomere maintenance via telomere lengthening (GO:1904358)|1/35|0.476378941541609|1|0|0|1.56128024980484|1.1577543259815|AURKB|4
7369|macromolecule catabolic process (GO:0009057)|1/35|0.476378941541609|1|0|0|1.56128024980484|1.1577543259815|CLN6|4
7370|regulation of cellular component organization (GO:0051128)|3/141|0.47846973220855|1|0|0|1.16265550517382|0.857065836138081|HSPA8;HSP90AA1;HJURP|4
7371|mitochondrial translational elongation (GO:0070125)|2/88|0.480659150886341|1|0|0|1.24192747143567|0.909832198318914|MRPL51;MRPL14|4
7372|positive regulation of cellular component biogenesis (GO:0044089)|2/88|0.480659150886341|1|0|0|1.24192747143567|0.909832198318914|CDT1;TERF1|4
7373|positive regulation of protein phosphorylation (GO:0001934)|8/413|0.485403869295128|1|0|0|1.05849508461345|0.765052741494457|C3;CENPE;CDKN1A;MRNIP;PLK1;CALM3;HMGB1;CALM2|4
7374|negative regulation of cell-substrate adhesion (GO:0010812)|1/36|0.485977983969257|1|0|0|1.51791135397693|1.09531262383503|RHOA|4
7375|positive regulation of peptide secretion (GO:0002793)|1/36|0.485977983969257|1|0|0|1.51791135397693|1.09531262383503|PPIA|4
7376|carboxylic acid transmembrane transport (GO:1905039)|1/36|0.485977983969257|1|0|0|1.51791135397693|1.09531262383503|SLC25A10|4
7377|maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)|1/36|0.485977983969257|1|0|0|1.51791135397693|1.09531262383503|RPSA|4
7378|actin filament bundle organization (GO:0061572)|1/36|0.485977983969257|1|0|0|1.51791135397693|1.09531262383503|RHOA|4
7379|protein kinase B signaling (GO:0043491)|1/36|0.485977983969257|1|0|0|1.51791135397693|1.09531262383503|CDKN1A|4
7380|cholesterol biosynthetic process (GO:0006695)|1/36|0.485977983969257|1|0|0|1.51791135397693|1.09531262383503|LBR|4
7381|regulation of cellular macromolecule biosynthetic process (GO:2000112)|12/632|0.489591060906574|1|0|0|1.03755965968043|0.741009344161608|HINT1;HMGN5;HP1BP3;HMGB2;NUCKS1;ESCO2;BRD8;HMGB1;SSRP1;SMC3;RPL6;EZH2|4
7382|mitochondrial translational termination (GO:0070126)|2/90|0.492465633459752|1|0|0|1.21432908318154|0.860146448794011|MRPL51;MRPL14|4
7383|lymphocyte proliferation (GO:0046651)|1/37|0.495401527836459|1|0|0|1.47688672278836|1.03734555883251|HELLS|4
7384|natural killer cell activation (GO:0030101)|1/37|0.495401527836459|1|0|0|1.47688672278836|1.03734555883251|CD2|4
7385|inner mitochondrial membrane organization (GO:0007007)|1/37|0.495401527836459|1|0|0|1.47688672278836|1.03734555883251|ATP5G2|4
7386|secondary alcohol biosynthetic process (GO:1902653)|1/37|0.495401527836459|1|0|0|1.47688672278836|1.03734555883251|LBR|4
7387|regulation of JNK cascade (GO:0046328)|2/91|0.498305112165002|1|0|0|1.20098480754218|0.836537217962027|GPS2;HMGB1|4
7388|negative regulation of cell proliferation (GO:0008285)|7/364|0.500562565711343|1|0|0|1.05086170659941|0.727220136216102|CDKN2D;CDKN1A;CDKN2C;RBBP4;CTCF;HIST1H2AC;CDKN3|4
7389|cellular response to lipopolysaccharide (GO:0071222)|2/92|0.504101523369293|1|0|0|1.18793062485151|0.813705863553802|HMGB2;RHOA|4
7390|positive regulation of stress fiber assembly (GO:0051496)|1/38|0.504652773202285|1|0|0|1.43802128271498|0.983440701774621|RHOA|4
7391|negative regulation of Ras protein signal transduction (GO:0046580)|1/38|0.504652773202285|1|0|0|1.43802128271498|0.983440701774621|STMN1|4
7392|actin filament bundle assembly (GO:0051017)|1/38|0.504652773202285|1|0|0|1.43802128271498|0.983440701774621|RHOA|4
7393|positive regulation of axonogenesis (GO:0050772)|1/38|0.504652773202285|1|0|0|1.43802128271498|0.983440701774621|RHOA|4
7394|positive regulation of cellular metabolic process (GO:0031325)|2/93|0.509854484496718|1|0|0|1.17515717727246|0.791621033542264|CDKN1A;UHRF1|4
7395|actin-myosin filament sliding (GO:0033275)|1/39|0.513734861759626|1|0|0|1.40114894213255|0.93323242226025|VIM|4
7396|homotypic cell-cell adhesion (GO:0034109)|1/39|0.513734861759626|1|0|0|1.40114894213255|0.93323242226025|CLIC1|4
7397|muscle filament sliding (GO:0030049)|1/39|0.513734861759626|1|0|0|1.40114894213255|0.93323242226025|VIM|4
7398|cellular response to fibroblast growth factor stimulus (GO:0044344)|2/95|0.521228667049226|1|0|0|1.15041702617199|0.749573118470987|HNRNPF;SHCBP1|4
7399|signal transduction by p53 class mediator (GO:0072331)|1/40|0.522650878242586|1|0|0|1.36612021857923|0.886395593770738|HINT1|4
7400|positive regulation of reactive oxygen species metabolic process (GO:2000379)|1/40|0.522650878242586|1|0|0|1.36612021857923|0.886395593770738|CDKN1A|4
7401|negative regulation of protein catabolic process (GO:0042177)|1/40|0.522650878242586|1|0|0|1.36612021857923|0.886395593770738|MAD2L1|4
7402|inositol lipid-mediated signaling (GO:0048017)|1/40|0.522650878242586|1|0|0|1.36612021857923|0.886395593770738|RHOA|4
7403|regulation of RNA metabolic process (GO:0051252)|1/40|0.522650878242586|1|0|0|1.36612021857923|0.886395593770738|HNRNPF|4
7404|positive regulation of phagocytosis (GO:0050766)|1/40|0.522650878242586|1|0|0|1.36612021857923|0.886395593770738|C3|4
7405|ERBB2 signaling pathway (GO:0038128)|1/40|0.522650878242586|1|0|0|1.36612021857923|0.886395593770738|HSP90AA1|4
7406|cellular response to amino acid starvation (GO:0034198)|1/40|0.522650878242586|1|0|0|1.36612021857923|0.886395593770738|CDKN1A|4
7407|acyl-CoA metabolic process (GO:0006637)|1/40|0.522650878242586|1|0|0|1.36612021857923|0.886395593770738|ACOT1|4
7408|negative regulation of cell differentiation (GO:0045596)|3/151|0.524136209930413|1|0|0|1.08565845185105|0.701339361442873|HNRNPU;GPS2;ANP32B|4
7409|transcription elongation from RNA polymerase II promoter (GO:0006368)|2/96|0.526849261287895|1|0|0|1.1384335154827|0.729554648300798|TAF15;SSRP1|4
7410|regulation of heart contraction (GO:0008016)|2/96|0.526849261287895|1|0|0|1.1384335154827|0.729554648300798|CALM3;CALM2|4
7411|regulation of cytoskeleton organization (GO:0051493)|2/96|0.526849261287895|1|0|0|1.1384335154827|0.729554648300798|STMN1;RHOA|4
7412|cellular protein metabolic process (GO:0044267)|9/485|0.53033208093524|1|0|0|1.01402737873923|0.64314879247451|C3;RPS17;HIST1H3A;MRPL51;UBE2S;RPS5;RPS20;RPSA;RPL6|4
7413|regulation of cellular localization (GO:0060341)|1/41|0.531403851189964|1|0|0|1.33280021324803|0.842640275130232|SPAG5|4
7414|negative regulation of catabolic process (GO:0009895)|1/41|0.531403851189964|1|0|0|1.33280021324803|0.842640275130232|MAD2L1|4
7415|positive regulation of epithelial to mesenchymal transition (GO:0010718)|1/41|0.531403851189964|1|0|0|1.33280021324803|0.842640275130232|EZH2|4
7416|sensory organ development (GO:0007423)|1/41|0.531403851189964|1|0|0|1.33280021324803|0.842640275130232|SMCHD1|4
7417|positive regulation of cytokine biosynthetic process (GO:0042108)|1/41|0.531403851189964|1|0|0|1.33280021324803|0.842640275130232|SPN|4
7418|regulation of ATPase activity (GO:0043462)|1/41|0.531403851189964|1|0|0|1.33280021324803|0.842640275130232|DNAJC9|4
7419|sterol biosynthetic process (GO:0016126)|1/41|0.531403851189964|1|0|0|1.33280021324803|0.842640275130232|LBR|4
7420|translational termination (GO:0006415)|2/97|0.532425149459925|1|0|0|1.12669708748803|0.710171771362925|MRPL51;MRPL14|4
7421|protein stabilization (GO:0050821)|3/153|0.533005422078987|1|0|0|1.07146683810136|0.674192309130999|CDKN1A;HSP90AA1;HIST1H1B|4
7422|protein localization to organelle (GO:0033365)|2/98|0.53795608171654|1|0|0|1.11520017843203|0.691399971729233|RPA2;CNTLN|4
7423|DNA duplex unwinding (GO:0032508)|1/42|0.539996754166674|1|0|0|1.30106687483737|0.801707195217716|RAD51|4
7424|regulation of stress-activated MAPK cascade (GO:0032872)|1/42|0.539996754166674|1|0|0|1.30106687483737|0.801707195217716|FOXM1|4
7425|positive regulation of viral transcription (GO:0050434)|1/42|0.539996754166674|1|0|0|1.30106687483737|0.801707195217716|NUCKS1|4
7426|regulation of cellular metabolic process (GO:0031323)|1/42|0.539996754166674|1|0|0|1.30106687483737|0.801707195217716|FOXM1|4
7427|gluconeogenesis (GO:0006094)|1/42|0.539996754166674|1|0|0|1.30106687483737|0.801707195217716|SLC25A10|4
7428|positive regulation of neuron differentiation (GO:0045666)|2/99|0.543441832324787|1|0|0|1.10393553016504|0.673215877231107|ECT2;RHOA|4
7429|glycolipid biosynthetic process (GO:0009247)|1/43|0.548432506434767|1|0|0|1.2708095056551|0.763363906475424|DPM3|4
7430|cellular response to calcium ion (GO:0071277)|1/43|0.548432506434767|1|0|0|1.2708095056551|0.763363906475424|ECT2|4
7431|ceramide metabolic process (GO:0006672)|1/43|0.548432506434767|1|0|0|1.2708095056551|0.763363906475424|CLN6|4
7432|regulation of lipid metabolic process (GO:0019216)|2/101|0.554277000935924|1|0|0|1.08207542065682|0.638522659205381|RBL1;H2AFY|4
7433|cellular response to transforming growth factor beta stimulus (GO:0071560)|2/101|0.554277000935924|1|0|0|1.08207542065682|0.638522659205381|ID1;RHOA|4
7434|positive regulation of interferon-gamma production (GO:0032729)|1/44|0.556713974400079|1|0|0|1.24192747143567|0.727401492670318|CD2|4
7435|negative regulation of protein metabolic process (GO:0051248)|1/44|0.556713974400079|1|0|0|1.24192747143567|0.727401492670318|MAD2L1|4
7436|RNA catabolic process (GO:0006401)|1/44|0.556713974400079|1|0|0|1.24192747143567|0.727401492670318|FEN1|4
7437|protein transmembrane import into intracellular organelle (GO:0044743)|1/44|0.556713974400079|1|0|0|1.24192747143567|0.727401492670318|HSP90AA1|4
7438|intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332)|1/44|0.556713974400079|1|0|0|1.24192747143567|0.727401492670318|HINT1|4
7439|response to hydrogen peroxide (GO:0042542)|1/44|0.556713974400079|1|0|0|1.24192747143567|0.727401492670318|ECT2|4
7440|positive regulation of interleukin-6 production (GO:0032755)|1/44|0.556713974400079|1|0|0|1.24192747143567|0.727401492670318|HMGB1|4
7441|regulation of interferon-gamma production (GO:0032649)|1/44|0.556713974400079|1|0|0|1.24192747143567|0.727401492670318|HMGB1|4
7442|regulation of protein ubiquitination (GO:0031396)|2/102|0.559626080445378|1|0|0|1.07146683810136|0.621971961602134|HSP90AA1;CENPS|4
7443|intrinsic apoptotic signaling pathway (GO:0097193)|2/102|0.559626080445378|1|0|0|1.07146683810136|0.621971961602134|CDKN1A;HINT1|4
7444|negative regulation of type I interferon production (GO:0032480)|1/45|0.564843972199821|1|0|0|1.21432908318154|0.693631744228496|PCBP2|4
7445|regulation of focal adhesion assembly (GO:0051893)|1/45|0.564843972199821|1|0|0|1.21432908318154|0.693631744228496|RHOA|4
7446|sprouting angiogenesis (GO:0002040)|1/45|0.564843972199821|1|0|0|1.21432908318154|0.693631744228496|E2F8|4
7447|protein N-linked glycosylation via asparagine (GO:0018279)|1/45|0.564843972199821|1|0|0|1.21432908318154|0.693631744228496|DPM3|4
7448|hexose biosynthetic process (GO:0019319)|1/45|0.564843972199821|1|0|0|1.21432908318154|0.693631744228496|SLC25A10|4
7449|positive regulation of interleukin-8 production (GO:0032757)|1/45|0.564843972199821|1|0|0|1.21432908318154|0.693631744228496|CD2|4
7450|positive regulation of actin filament bundle assembly (GO:0032233)|1/45|0.564843972199821|1|0|0|1.21432908318154|0.693631744228496|RHOA|4
7451|regulation of T cell activation (GO:0050863)|1/45|0.564843972199821|1|0|0|1.21432908318154|0.693631744228496|CD2|4
7452|mitochondrial gene expression (GO:0140053)|1/46|0.572825262841378|1|0|0|1.18793062485151|0.661884723432813|MRPL51|4
7453|positive regulation of blood vessel endothelial cell migration (GO:0043536)|1/46|0.572825262841378|1|0|0|1.18793062485151|0.661884723432813|HMGB1|4
7454|peptidyl-asparagine modification (GO:0018196)|1/46|0.572825262841378|1|0|0|1.18793062485151|0.661884723432813|DPM3|4
7455|peptide metabolic process (GO:0006518)|2/105|0.575397710198896|1|0|0|1.04085349986989|0.575273283754415|HSPA8;HSP90AA1|4
7456|translational elongation (GO:0006414)|2/106|0.580562724761759|1|0|0|1.03103412722961|0.560632467975731|MRPL51;MRPL14|4
7457|regulation of fibroblast proliferation (GO:0048145)|1/47|0.580660558958023|1|0|0|1.16265550517382|0.632006660545401|CDKN1A|4
7458|regulation of cellular component movement (GO:0051270)|1/47|0.580660558958023|1|0|0|1.16265550517382|0.632006660545401|RHOA|4
7459|RNA secondary structure unwinding (GO:0010501)|1/47|0.580660558958023|1|0|0|1.16265550517382|0.632006660545401|DDX39B|4
7460|positive regulation of cell migration (GO:0030335)|4/222|0.581681264707918|1|0|0|0.984591148525575|0.533483617791154|SUN2;KIF20B;MAPRE1;SYNE2|4
7461|positive regulation of cellular component organization (GO:0051130)|2/107|0.585681525660778|1|0|0|1.02139829426485|0.546426749101644|CDC20;CDT1|4
7462|positive regulation of cellular catabolic process (GO:0031331)|2/107|0.585681525660778|1|0|0|1.02139829426485|0.546426749101644|HSP90AA1;CNOT1|4
7463|myofibril assembly (GO:0030239)|1/48|0.588352523926307|1|0|0|1.1384335154827|0.603858128692164|KRT19|4
7464|negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124)|1/48|0.588352523926307|1|0|0|1.1384335154827|0.603858128692164|TRIM59|4
7465|polyol metabolic process (GO:0019751)|1/48|0.588352523926307|1|0|0|1.1384335154827|0.603858128692164|NUDT4|4
7466|inositol phosphate metabolic process (GO:0043647)|1/48|0.588352523926307|1|0|0|1.1384335154827|0.603858128692164|NUDT4|4
7467|mitochondrial translation (GO:0032543)|2/108|0.59075407017511|1|0|0|1.01194090265129|0.53264063255945|MRPL51;MRPL14|4
7468|cellular response to starvation (GO:0009267)|2/108|0.59075407017511|1|0|0|1.01194090265129|0.53264063255945|HSPA8;CDKN1A|4
7469|negative regulation of hydrolase activity (GO:0051346)|2/109|0.595780332550484|1|0|0|1.00265704115907|0.519259286510658|KNL1;PKMYT1|4
7470|cytoplasmic microtubule organization (GO:0031122)|1/49|0.595903772715066|1|0|0|1.11520017843203|0.577312456928897|KPNB1|4
7471|pattern recognition receptor signaling pathway (GO:0002221)|1/49|0.595903772715066|1|0|0|1.11520017843203|0.577312456928897|HMGB1|4
7472|neuron projection development (GO:0031175)|3/168|0.596419166986246|1|0|0|0.975800156128025|0.504304799769771|STMN1;HMGB1;KIF20B|4
7473|cellular response to cytokine stimulus (GO:0071345)|8/457|0.600223810228918|1|0|0|0.956583085219596|0.488290395926255|HSPA8;CDKN1A;HSP90AA1;HNRNPU;BIRC5;PLP2;VIM;RHOA|4
7474|regulation of cell motility (GO:2000145)|2/110|0.600760303392946|1|0|0|0.993541977148534|0.506268508325544|LMO4;RHOA|4
7475|positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280)|2/110|0.600760303392946|1|0|0|0.993541977148534|0.506268508325544|ANP32B;HMGB1|4
7476|negative regulation of protein kinase activity (GO:0006469)|2/110|0.600760303392946|1|0|0|0.993541977148534|0.506268508325544|CDKN1A;H2AFY|4
7477|organic hydroxy compound biosynthetic process (GO:1901617)|1/50|0.60331687258593|1|0|0|1.09289617486339|0.552254346195967|LBR|4
7478|antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844)|1/50|0.60331687258593|1|0|0|1.09289617486339|0.552254346195967|HMGN2|4
7479|negative regulation of cytokine production (GO:0001818)|2/111|0.605693989158175|1|0|0|0.984591148525575|0.493654692894348|PCBP2;HMGB1|4
7480|regulation of cellular protein metabolic process (GO:0032268)|1/51|0.610594344176977|1|0|0|1.07146683810136|0.528578657938924|UHRF1|4
7481|neurogenesis (GO:0022008)|1/51|0.610594344176977|1|0|0|1.07146683810136|0.528578657938924|CIT|4
7482|regulation of blood vessel endothelial cell migration (GO:0043535)|1/51|0.610594344176977|1|0|0|1.07146683810136|0.528578657938924|HMGB1|4
7483|negative regulation of neuron projection development (GO:0010977)|1/52|0.617738662138976|1|0|0|1.05086170659941|0.5061893524168|RHOA|4
7484|response to organonitrogen compound (GO:0010243)|1/52|0.617738662138976|1|0|0|1.05086170659941|0.5061893524168|DHFR|4
7485|coenzyme metabolic process (GO:0006732)|1/52|0.617738662138976|1|0|0|1.05086170659941|0.5061893524168|ACOT1|4
7486|carboxylic acid transport (GO:0046942)|1/52|0.617738662138976|1|0|0|1.05086170659941|0.5061893524168|SLC25A10|4
7487|regulation of organelle organization (GO:0033043)|2/114|0.620217625094586|1|0|0|0.958680855143323|0.457947324623621|CDT1;STMN1|4
7488|activation of protein kinase activity (GO:0032147)|4/234|0.623133916925266|1|0|0|0.934099294755033|0.441823201492658|TPX2;CDK1;CLSPN;ECT2|4
7489|plasma membrane bounded cell projection morphogenesis (GO:0120039)|1/53|0.624752256375129|1|0|0|1.03103412722961|0.484998554107364|KIF20B|4
7490|positive regulation of nervous system development (GO:0051962)|1/53|0.624752256375129|1|0|0|1.03103412722961|0.484998554107364|CDC20|4
7491|positive regulation of secretion by cell (GO:1903532)|1/53|0.624752256375129|1|0|0|1.03103412722961|0.484998554107364|PPIA|4
7492|regulation of cell-matrix adhesion (GO:0001952)|1/53|0.624752256375129|1|0|0|1.03103412722961|0.484998554107364|RHOA|4
7493|positive regulation of protein import into nucleus (GO:0042307)|1/54|0.631637512227509|1|0|0|1.01194090265129|0.464925729593028|ECT2|4
7494|protein targeting to mitochondrion (GO:0006626)|1/55|0.638396771848897|1|0|0|0.993541977148534|0.445896959251854|HSP90AA1|4
7495|cellular response to nutrient levels (GO:0031669)|1/55|0.638396771848897|1|0|0|0.993541977148534|0.445896959251854|HSPA8|4
7496|negative regulation of cellular component organization (GO:0051129)|1/55|0.638396771848897|1|0|0|0.993541977148534|0.445896959251854|HSPA8|4
7497|glycosphingolipid metabolic process (GO:0006687)|1/55|0.638396771848897|1|0|0|0.993541977148534|0.445896959251854|CLN6|4
7498|positive regulation of response to stimulus (GO:0048584)|1/55|0.638396771848897|1|0|0|0.993541977148534|0.445896959251854|NSMCE4A|4
7499|cellular response to lipid (GO:0071396)|3/179|0.639213431642687|1|0|0|0.915834783405074|0.409851517119368|H2AFZ;HMGB2;RHOA|4
7500|negative regulation of protein phosphorylation (GO:0001933)|3/179|0.639213431642687|1|0|0|0.915834783405074|0.409851517119368|H2AFY;CALM3;CALM2|4
7501|positive regulation of cell motility (GO:2000147)|3/180|0.642942312466749|1|0|0|0.910746812386157|0.402277117481925|SUN2;MAPRE1;SYNE2|4
7502|plasma membrane bounded cell projection organization (GO:0120036)|2/119|0.643502757121991|1|0|0|0.918400146944023|0.404857388421982|STMN1;HMGB1|4
7503|regulation of cellular catabolic process (GO:0031329)|1/56|0.645032334590009|1|0|0|0.975800156128025|0.427844293809121|HMGB1|4
7504|positive regulation of cysteine-type endopeptidase activity (GO:2001056)|1/56|0.645032334590009|1|0|0|0.975800156128025|0.427844293809121|HMGB1|4
7505|long-chain fatty acid metabolic process (GO:0001676)|1/56|0.645032334590009|1|0|0|0.975800156128025|0.427844293809121|ACOT1|4
7506|regulation of axonogenesis (GO:0050770)|1/56|0.645032334590009|1|0|0|0.975800156128025|0.427844293809121|RHOA|4
7507|regulation of RNA splicing (GO:0043484)|1/56|0.645032334590009|1|0|0|0.975800156128025|0.427844293809121|HNRNPF|4
7508|Notch signaling pathway (GO:0007219)|1/56|0.645032334590009|1|0|0|0.975800156128025|0.427844293809121|DLGAP5|4
7509|brain development (GO:0007420)|2/120|0.648022501708612|1|0|0|0.910746812386157|0.395109160631864|CENPF;PHGDH|4
7510|cellular defense response (GO:0006968)|1/57|0.651546458178069|1|0|0|0.958680855143323|0.410705182053551|SPN|4
7511|phosphatidylinositol-mediated signaling (GO:0048015)|1/57|0.651546458178069|1|0|0|0.958680855143323|0.410705182053551|RHOA|4
7512|organonitrogen compound catabolic process (GO:1901565)|1/57|0.651546458178069|1|0|0|0.958680855143323|0.410705182053551|CLN6|4
7513|glycosaminoglycan catabolic process (GO:0006027)|1/57|0.651546458178069|1|0|0|0.958680855143323|0.410705182053551|HMMR|4
7514|regulation of cell differentiation (GO:0045595)|2/122|0.656925725639564|1|0|0|0.895816536773269|0.376408060257249|CBFB;ANP32B|4
7515|I-kappaB kinase/NF-kappaB signaling (GO:0007249)|1/58|0.657941359038966|1|0|0|0.942151874882231|0.394421963095737|CARD11|4
7516|regulation of neurogenesis (GO:0050767)|1/58|0.657941359038966|1|0|0|0.942151874882231|0.394421963095737|HMGB2|4
7517|regulation of Rho protein signal transduction (GO:0035023)|1/58|0.657941359038966|1|0|0|0.942151874882231|0.394421963095737|STMN1|4
7518|protein homotetramerization (GO:0051289)|1/58|0.657941359038966|1|0|0|0.942151874882231|0.394421963095737|TK1|4
7519|response to retinoic acid (GO:0032526)|1/58|0.657941359038966|1|0|0|0.942151874882231|0.394421963095737|CDKN2D|4
7520|positive regulation of cell morphogenesis involved in differentiation (GO:0010770)|1/59|0.664219213430629|1|0|0|0.926183199036769|0.378941412689985|RHOA|4
7521|positive regulation of transcription, DNA-templated (GO:0045893)|19/1121|0.668469669177965|1|0|0|0.926183199036769|0.373033486089644|TAF15;H2AFZ;UHRF1;ATAD2;HMGB2;CKAP2;HNRNPU;CTCF;HMGB1;FOXM1;CKS1B;HMGN5;RBL1;DDX39B;CCNE1;CKS2;PCBD2;RAN;E2F8|4
7522|cell junction assembly (GO:0034329)|1/60|0.670382157824249|1|0|0|0.910746812386157|0.364214339155192|RHOA|4
7523|regulation of GTPase activity (GO:0043087)|3/189|0.6752770915869|1|0|0|0.867377916558244|0.340560470369935|RACGAP1;ECT2;EZH2|4
7524|cell chemotaxis (GO:0060326)|1/61|0.676432289822919|1|0|0|0.895816536773269|0.350195221118055|HMGB2|4
7525|positive regulation of protein binding (GO:0032092)|1/61|0.676432289822919|1|0|0|0.895816536773269|0.350195221118055|RAN|4
7526|regulation of nucleic acid-templated transcription (GO:1903506)|10/608|0.678611519010053|1|0|0|0.898763301696865|0.34845633098537|HINT1;HMGN5;HP1BP3;HMGB2;RALY;BRD8;HMGB1;SSRP1;RPL6;EZH2|4
7527|protein homooligomerization (GO:0051260)|3/191|0.682162731033118|1|0|0|0.858295425285383|0.328286877562621|RAD51;TK1;ECT2|4
7528|actin cytoskeleton reorganization (GO:0031532)|1/62|0.682371669036005|1|0|0|0.881367882954345|0.336841882883386|RHOA|4
7529|negative regulation of MAP kinase activity (GO:0043407)|1/62|0.682371669036005|1|0|0|0.881367882954345|0.336841882883386|GPS2|4
7530|positive regulation of T cell proliferation (GO:0042102)|1/62|0.682371669036005|1|0|0|0.881367882954345|0.336841882883386|HMGB1|4
7531|positive regulation of leukocyte chemotaxis (GO:0002690)|1/62|0.682371669036005|1|0|0|0.881367882954345|0.336841882883386|HMGB1|4
7532|glycosaminoglycan metabolic process (GO:0030203)|1/62|0.682371669036005|1|0|0|0.881367882954345|0.336841882883386|CLN6|4
7533|regulation of tumor necrosis factor production (GO:0032680)|1/62|0.682371669036005|1|0|0|0.881367882954345|0.336841882883386|CD2|4
7534|positive regulation of cellular amide metabolic process (GO:0034250)|1/62|0.682371669036005|1|0|0|0.881367882954345|0.336841882883386|VIM|4
7535|positive regulation of NF-kappaB transcription factor activity (GO:0051092)|2/129|0.686673497133694|1|0|0|0.847206337103402|0.318461777128831|TRIM37;CARD11|4
7536|stress-activated MAPK cascade (GO:0051403)|1/63|0.688202317310361|1|0|0|0.867377916558244|0.324115203764073|GPS2|4
7537|negative regulation of G2/M transition of mitotic cell cycle (GO:0010972)|1/63|0.688202317310361|1|0|0|0.867377916558244|0.324115203764073|AURKB|4
7538|second-messenger-mediated signaling (GO:0019932)|1/63|0.688202317310361|1|0|0|0.867377916558244|0.324115203764073|NUDT4|4
7539|regulation of actin filament-based process (GO:0032970)|1/63|0.688202317310361|1|0|0|0.867377916558244|0.324115203764073|RHOA|4
7540|negative regulation of intrinsic apoptotic signaling pathway (GO:2001243)|1/63|0.688202317310361|1|0|0|0.867377916558244|0.324115203764073|CDKN2D|4
7541|regulation of T cell proliferation (GO:0042129)|1/63|0.688202317310361|1|0|0|0.867377916558244|0.324115203764073|SPN|4
7542|regulation of translational initiation (GO:0006446)|1/63|0.688202317310361|1|0|0|0.867377916558244|0.324115203764073|EIF1|4
7543|cilium organization (GO:0044782)|3/193|0.688939506118464|1|0|0|0.849401172173618|0.316488415323937|TRIM59;PCNT;CEP89|4
7544|positive regulation of GTPase activity (GO:0043547)|3/193|0.688939506118464|1|0|0|0.849401172173618|0.316488415323937|ECT2;RANGAP1;EZH2|4
7545|regulation of cell migration (GO:0030334)|5/317|0.691858582665761|1|0|0|0.861905500680905|0.317503322265153|SUN2;LMO4;MAPRE1;RHOA;SYNE2|4
7546|kidney development (GO:0001822)|1/64|0.693926219839335|1|0|0|0.853825136612022|0.31197885553065|CENPF|4
7547|ribosomal large subunit biogenesis (GO:0042273)|1/64|0.693926219839335|1|0|0|0.853825136612022|0.31197885553065|RPL6|4
7548|protein glycosylation (GO:0006486)|2/131|0.69477528371136|1|0|0|0.834271889208693|0.303814139648832|ALG8;DPM3|4
7549|inorganic anion transmembrane transport (GO:0098661)|1/65|0.699545325721002|1|0|0|0.840689365279529|0.3003990665507|SLC25A10|4
7550|glucose metabolic process (GO:0006006)|1/65|0.699545325721002|1|0|0|0.840689365279529|0.3003990665507|SLC25A10|4
7551|cellular response to decreased oxygen levels (GO:0036294)|1/65|0.699545325721002|1|0|0|0.840689365279529|0.3003990665507|HP1BP3|4
7552|negative regulation of neuron differentiation (GO:0045665)|1/65|0.699545325721002|1|0|0|0.840689365279529|0.3003990665507|ID1|4
7553|positive regulation of protein modification by small protein conjugation or removal (GO:1903322)|1/66|0.705061548276716|1|0|0|0.827951647623779|0.289344409223669|CENPS|4
7554|defense response to Gram-positive bacterium (GO:0050830)|1/66|0.705061548276716|1|0|0|0.827951647623779|0.289344409223669|HMGB2|4
7555|JNK cascade (GO:0007254)|1/67|0.71047676638255|1|0|0|0.815594160345812|0.278785606684671|GPS2|4
7556|phagocytosis (GO:0006909)|2/136|0.714274659308546|1|0|0|0.803600128576021|0.270401570000818|C3;HMGB1|4
7557|cellular response to organic cyclic compound (GO:0071407)|2/136|0.714274659308546|1|0|0|0.803600128576021|0.270401570000818|RAD51;H2AFZ|4
7558|extrinsic apoptotic signaling pathway (GO:0097191)|1/68|0.715792824432448|1|0|0|0.803600128576021|0.268695359404532|SIVA1|4
7559|regulation of gene expression (GO:0010468)|17/1038|0.715943254341501|1|0|0|0.894953515061541|0.299052626998049|H2AFY;HP1BP3;HMGB2;CTCF;HMGB1;SSRP1;RPL6;HINT1;HIST1H3A;HMGN5;RBL1;DDX39B;HNRNPF;CDK2;CDK1;BRD8;EZH2|4
7560|peptidyl-threonine phosphorylation (GO:0018107)|1/69|0.72101153321067|1|0|0|0.791953749901006|0.259048186975387|CDK1|4
7561|regulation of epithelial to mesenchymal transition (GO:0010717)|1/69|0.72101153321067|1|0|0|0.791953749901006|0.259048186975387|EZH2|4
7562|positive regulation of multicellular organismal process (GO:0051240)|3/203|0.721201099035338|1|0|0|0.807558749899055|0.26394029213922|H2AFY;CARD11;EZH2|4
7563|positive regulation of plasma membrane bounded cell projection assembly (GO:0120034)|1/70|0.726134670633036|1|0|0|0.78064012490242|0.249820284637013|ANLN|4
7564|regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122)|3/205|0.727332051336488|1|0|0|0.79968012794882|0.254595892728959|TRIM59;ECT2;RHOA|4
7565|cytokine-mediated signaling pathway (GO:0019221)|10/634|0.727460554243609|1|0|0|0.861905500680905|0.274254453791077|HSPA8;CDKN1A;HSP90AA1;HIST1H3A;HNRNPF;BIRC5;PLP2;VIM;PPIA;LMNB1|4
7566|regulation of programmed cell death (GO:0043067)|4/269|0.728398511252965|1|0|0|0.81256221179434|0.257506632530899|ANP32E;BIRC5;ANP32B;CIDEC|4
7567|neuron differentiation (GO:0030182)|2/140|0.729113842284605|1|0|0|0.78064012490242|0.246624041303326|MYEF2;ID1|4
7568|positive regulation of endothelial cell migration (GO:0010595)|1/71|0.731163982314104|1|0|0|0.769645193565766|0.240989393041322|HMGB1|4
7569|calcium-mediated signaling (GO:0019722)|1/71|0.731163982314104|1|0|0|0.769645193565766|0.240989393041322|NUDT4|4
7570|positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436)|1/71|0.731163982314104|1|0|0|0.769645193565766|0.240989393041322|PLK1|4
7571|protein ubiquitination involved in ubiquitin-dependent protein catabolic process (GO:0042787)|1/71|0.731163982314104|1|0|0|0.769645193565766|0.240989393041322|ANAPC11|4
7572|response to lipid (GO:0033993)|2/141|0.732720228008991|1|0|0|0.775103670115878|0.241050521804318|CDKN2D;HMGB2|4
7573|negative regulation of sequence-specific DNA binding transcription factor activity (GO:0043433)|2/141|0.732720228008991|1|0|0|0.775103670115878|0.241050521804318|ID1;TRIM37|4
7574|regulation of cell communication (GO:0010646)|1/72|0.736101181904303|1|0|0|0.758955676988464|0.232534679939803|BIRC5|4
7575|defense response to Gram-negative bacterium (GO:0050829)|1/72|0.736101181904303|1|0|0|0.758955676988464|0.232534679939803|HMGB2|4
7576|positive regulation of growth (GO:0045927)|1/72|0.736101181904303|1|0|0|0.758955676988464|0.232534679939803|HIST1H1B|4
7577|Rho protein signal transduction (GO:0007266)|1/73|0.740947951895114|1|0|0|0.748559023879033|0.224436631866525|RHOA|4
7578|SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146)|1/73|0.740947951895114|1|0|0|0.748559023879033|0.224436631866525|CCNF|4
7579|regulation of fat cell differentiation (GO:0045598)|1/73|0.740947951895114|1|0|0|0.748559023879033|0.224436631866525|GPS2|4
7580|chloride transport (GO:0006821)|1/74|0.745705944090216|1|0|0|0.738443361394181|0.216676955626383|CLIC1|4
7581|positive regulation of proteasomal protein catabolic process (GO:1901800)|1/74|0.745705944090216|1|0|0|0.738443361394181|0.216676955626383|PLK1|4
7582|neuron development (GO:0048666)|2/145|0.746740454632247|1|0|0|0.753721499905785|0.220115021304437|STMN1;HMGB1|4
7583|transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178)|2/145|0.746740454632247|1|0|0|0.753721499905785|0.220115021304437|ID1;RHOA|4
7584|glucose homeostasis (GO:0042593)|1/75|0.750376780400863|1|0|0|0.728597449908925|0.20923848796464|NUCKS1|4
7585|regulation of G-protein coupled receptor protein signaling pathway (GO:0008277)|1/75|0.750376780400863|1|0|0|0.728597449908925|0.20923848796464|C3|4
7586|regulation of actin cytoskeleton organization (GO:0032956)|1/76|0.75496205289739|1|0|0|0.719010641357492|0.20210511364632|RHOA|4
7587|positive regulation of JNK cascade (GO:0046330)|1/77|0.759463324757032|1|0|0|0.709672840820382|0.195261689574726|HMGB1|4
7588|negative regulation of programmed cell death (GO:0043069)|6/409|0.762217323672154|1|0|0|0.801635336085615|0.217662882110114|HMGN5;ARL6IP1;PLK1;CDK1;BIRC5;MAD2L1|4
7589|positive regulation of cytoskeleton organization (GO:0051495)|1/78|0.763882130785718|1|0|0|0.700574471066274|0.188693975615905|SPAG5|4
7590|intracellular protein transport (GO:0006886)|5/348|0.766237337798826|1|0|0|0.785126562401859|0.209050402584441|HIKESHI;CCHCR1;NXT2;KPNB1;RAN|4
7591|sensory perception of mechanical stimulus (GO:0050954)|1/79|0.768219977647586|1|0|0|0.691706439786954|0.182388571362563|BIRC5|4
7592|positive regulation of translation (GO:0045727)|1/79|0.768219977647586|1|0|0|0.691706439786954|0.182388571362563|VIM|4
7593|steroid biosynthetic process (GO:0006694)|1/80|0.772478344797333|1|0|0|0.683060109289617|0.176332857396154|LBR|4
7594|regulation of endothelial cell proliferation (GO:0001936)|1/80|0.772478344797333|1|0|0|0.683060109289617|0.176332857396154|HMGB2|4
7595|activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919)|1/80|0.772478344797333|1|0|0|0.683060109289617|0.176332857396154|ANP32B|4
7596|positive regulation of cytokine production (GO:0001819)|3/221|0.772633467338155|1|0|0|0.741784734070173|0.191343751858572|C3;HMGB1;CARD11|4
7597|positive regulation of stress-activated MAPK cascade (GO:0032874)|1/81|0.77665868443308|1|0|0|0.67462726843419|0.170514942115151|HMGB1|4
7598|regulation of hydrolase activity (GO:0051336)|1/81|0.77665868443308|1|0|0|0.67462726843419|0.170514942115151|RACGAP1|4
7599|ERBB signaling pathway (GO:0038127)|1/81|0.77665868443308|1|0|0|0.67462726843419|0.170514942115151|HSP90AA1|4
7600|negative regulation of MAPK cascade (GO:0043409)|1/81|0.77665868443308|1|0|0|0.67462726843419|0.170514942115151|FOXM1|4
7601|negative regulation of defense response (GO:0031348)|1/81|0.77665868443308|1|0|0|0.67462726843419|0.170514942115151|PCBP2|4
7602|sensory perception of sound (GO:0007605)|1/82|0.780762422423233|1|0|0|0.666400106624017|0.16492361192911|BIRC5|4
7603|positive regulation of protein targeting to mitochondrion (GO:1903955)|1/82|0.780762422423233|1|0|0|0.666400106624017|0.16492361192911|SAE1|4
7604|negative regulation of cell death (GO:0060548)|1/82|0.780762422423233|1|0|0|0.666400106624017|0.16492361192911|TMEM109|4
7605|response to lipopolysaccharide (GO:0032496)|2/156|0.782081057184894|1|0|0|0.700574471066274|0.172199026285117|HMGB2;RHOA|4
7606|positive regulation of protein secretion (GO:0050714)|1/83|0.784790958788039|1|0|0|0.65837118967674|0.15954828573306|PPIA|4
7607|negative regulation of NF-kappaB transcription factor activity (GO:0032088)|1/83|0.784790958788039|1|0|0|0.65837118967674|0.15954828573306|TRIM37|4
7608|ephrin receptor signaling pathway (GO:0048013)|1/83|0.784790958788039|1|0|0|0.65837118967674|0.15954828573306|RHOA|4
7609|post-translational protein modification (GO:0043687)|5/358|0.787110057242335|1|0|0|0.763195652837561|0.182699267579283|C3;CCNF;ESCO2;RBBP7;DTL|4
7610|positive regulation of homeostatic process (GO:0032846)|1/84|0.788745667792104|1|0|0|0.650533437418683|0.154378973223994|HMGB2|4
7611|protein maturation (GO:0051604)|1/84|0.788745667792104|1|0|0|0.650533437418683|0.154378973223994|LMF2|4
7612|negative regulation of apoptotic process (GO:0043066)|7/486|0.789233456212276|1|0|0|0.787065146506555|0.186292899792069|CDKN2D;HMGN5;ARL6IP1;PLK1;CDK1;BIRC5;MAD2L1|4
7613|positive regulation of supramolecular fiber organization (GO:1902905)|1/85|0.79262789882191|1|0|0|0.642880102860816|0.149406235760872|MAPRE1|4
7614|protein modification process (GO:0036211)|1/85|0.79262789882191|1|0|0|0.642880102860816|0.149406235760872|UBE2S|4
7615|regulation of type I interferon production (GO:0032479)|1/86|0.79643897649171|1|0|0|0.635404752827551|0.14462115080773|PCBP2|4
7616|toll-like receptor signaling pathway (GO:0002224)|1/87|0.800180201497901|1|0|0|0.628101249921487|0.140015278441824|HMGB1|4
7617|regulation of MAP kinase activity (GO:0043405)|1/88|0.803852850744769|1|0|0|0.620963735717834|0.135580630908701|EZH2|4
7618|regulation of signal transduction (GO:0009966)|3/234|0.804751743724767|1|0|0|0.700574471066274|0.152179796843862|CBFB;BIRC5;NUCKS1|4
7619|positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123)|2/164|0.804999246090621|1|0|0|0.666400106624017|0.144551471476344|ECT2;RHOA|4
7620|T cell activation (GO:0042110)|1/89|0.807458177716558|1|0|0|0.613986615091791|0.131309644211991|CD2|4
7621|regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434)|1/89|0.807458177716558|1|0|0|0.613986615091791|0.131309644211991|PLK1|4
7622|regulation of protein targeting to mitochondrion (GO:1903214)|1/89|0.807458177716558|1|0|0|0.613986615091791|0.131309644211991|SAE1|4
7623|Wnt signaling pathway, planar cell polarity pathway (GO:0060071)|1/89|0.807458177716558|1|0|0|0.613986615091791|0.131309644211991|RHOA|4
7624|regulation of establishment of planar polarity (GO:0090175)|1/90|0.810997413240604|1|0|0|0.607164541590771|0.127195151465793|RHOA|4
7625|peptidyl-threonine modification (GO:0018210)|1/90|0.810997413240604|1|0|0|0.607164541590771|0.127195151465793|CDK1|4
7626|regulation of Ras protein signal transduction (GO:0046578)|1/91|0.814471765587503|1|0|0|0.600492403771092|0.123230358649184|FOXM1|4
7627|regulation of cytokine-mediated signaling pathway (GO:0001959)|1/91|0.814471765587503|1|0|0|0.600492403771092|0.123230358649184|CBFB|4
7628|negative regulation of kinase activity (GO:0033673)|1/92|0.817882421006333|1|0|0|0.593965312425754|0.119408821758123|HNRNPU|4
7629|regulation of apoptotic process (GO:0042981)|12/816|0.818696357712873|1|0|0|0.803600128576021|0.160753786142945|TOP2A;HMGN5;ARL6IP1;PLK1;ANP32E;CDK1;BIRC5;ANP32B;HMGB1;ECT2;CIDEC;MAD2L1|4
7630|plasma membrane bounded cell projection assembly (GO:0120031)|3/242|0.822561204397159|1|0|0|0.677414984419455|0.132321085537306|TRIM59;PCNT;CEP89|4
7631|axon development (GO:0061564)|1/95|0.827743746521154|1|0|0|0.575208513085994|0.108744122735139|DHFR|4
7632|skin development (GO:0043588)|1/95|0.827743746521154|1|0|0|0.575208513085994|0.108744122735139|STMN1|4
7633|regulation of cell death (GO:0010941)|1/97|0.834020271798899|1|0|0|0.563348543744014|0.102246391868338|TMEM109|4
7634|positive regulation of neuron projection development (GO:0010976)|1/98|0.837072473293019|1|0|0|0.557600089216014|0.0991661789183326|RHOA|4
7635|positive regulation of MAP kinase activity (GO:0043406)|2/178|0.839994705249304|1|0|0|0.613986615091791|0.107054516141267|CDK1;EZH2|4
7636|phosphatidylinositol biosynthetic process (GO:0006661)|1/99|0.840068697693586|1|0|0|0.551967765082519|0.0961923097202998|DPM3|4
7637|positive regulation of cell growth (GO:0030307)|1/99|0.840068697693586|1|0|0|0.551967765082519|0.0961923097202998|HIST1H1B|4
7638|response to molecule of bacterial origin (GO:0002237)|1/99|0.840068697693586|1|0|0|0.551967765082519|0.0961923097202998|HMGB2|4
7639|cellular response to metal ion (GO:0071248)|1/101|0.845897291898127|1|0|0|0.54103771032841|0.0905466272367895|ECT2|4
7640|positive regulation of programmed cell death (GO:0043068)|3/258|0.854054405423929|1|0|0|0.635404752827551|0.100241695664855|TOP2A;HMGB1;ECT2|4
7641|transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169)|5/397|0.854918754978786|1|0|0|0.688221772583998|0.107877963123022|HSP90AA1;HNRNPF;STMN1;SHCBP1;RHOA|4
7642|phagocytosis, engulfment (GO:0006911)|1/105|0.856926571879654|1|0|0|0.520426749934947|0.0803554746165017|C3|4
7643|fatty acid metabolic process (GO:0006631)|1/107|0.862142341290493|1|0|0|0.510699147132424|0.0757545032651311|ACOT1|4
7644|positive regulation of epithelial cell proliferation (GO:0050679)|1/108|0.864678673628195|1|0|0|0.505970451325643|0.0735667459212413|HMGB2|4
7645|negative regulation of response to external stimulus (GO:0032102)|1/108|0.864678673628195|1|0|0|0.505970451325643|0.0735667459212413|PCBP2|4
7646|regulation of protein secretion (GO:0050708)|1/108|0.864678673628195|1|0|0|0.505970451325643|0.0735667459212413|PPIA|4
7647|regulation of protein activation cascade (GO:2000257)|1/109|0.867168466461879|1|0|0|0.501328520579536|0.0714503491415533|C3|4
7648|monocarboxylic acid metabolic process (GO:0032787)|1/109|0.867168466461879|1|0|0|0.501328520579536|0.0714503491415533|ACOT1|4
7649|regulation of cytokine production (GO:0001817)|1/109|0.867168466461879|1|0|0|0.501328520579536|0.0714503491415533|CARD11|4
7650|regulation of complement activation (GO:0030449)|1/110|0.869612571396447|1|0|0|0.496770988574267|0.0694026263050072|C3|4
7651|regulation of Wnt signaling pathway (GO:0030111)|1/110|0.869612571396447|1|0|0|0.496770988574267|0.0694026263050072|CBFB|4
7652|positive regulation of establishment of protein localization to mitochondrion (GO:1903749)|1/111|0.87201182459852|1|0|0|0.492295574262787|0.0674210086376674|SAE1|4
7653|regulation of humoral immune response (GO:0002920)|1/114|0.878948607646837|1|0|0|0.479340427571661|0.0618487440548013|C3|4
7654|regulation of immune effector process (GO:0002697)|1/115|0.881176514045531|1|0|0|0.475172249940603|0.0601080145639276|C3|4
7655|cellular response to oxygen-containing compound (GO:1901701)|3/275|0.882070789658373|1|0|0|0.596125186289121|0.0748035563710251|H2AFZ;HMGB2;RHOA|4
7656|protein O-linked glycosylation (GO:0006493)|1/116|0.883363525786035|1|0|0|0.471075937441115|0.0584221166002319|DPM3|4
7657|positive regulation of macromolecule metabolic process (GO:0010604)|3/277|0.88503175929088|1|0|0|0.591821033319524|0.0722801375473268|HMGN5;HMGB2;CTCF|4
7658|activation of MAPK activity (GO:0000187)|1/118|0.887617846399315|1|0|0|0.463091599518385|0.05520699350393|CDK1|4
7659|actin filament organization (GO:0007015)|1/121|0.893710894598263|1|0|0|0.45160998961297|0.0507487423686114|RHOA|4
7660|macromolecular complex assembly (GO:0065003)|1/121|0.893710894598263|1|0|0|0.45160998961297|0.0507487423686114|PPIH|4
7661|regulation of acute inflammatory response (GO:0002673)|1/122|0.895667790220595|1|0|0|0.447908268386634|0.0493530881494336|C3|4
7662|stimulatory C-type lectin receptor signaling pathway (GO:0002223)|1/122|0.895667790220595|1|0|0|0.447908268386634|0.0493530881494336|CARD11|4
7663|Golgi organization (GO:0007030)|1/122|0.895667790220595|1|0|0|0.447908268386634|0.0493530881494336|CDK1|4
7664|positive regulation of phosphorylation (GO:0042327)|2/209|0.89808450010922|1|0|0|0.522916830078176|0.0562089141578245|C3;LMO4|4
7665|innate immune response activating cell surface receptor signaling pathway (GO:0002220)|1/125|0.901325501127545|1|0|0|0.437158469945355|0.04541587764047|CARD11|4
7666|platelet degranulation (GO:0002576)|1/125|0.901325501127545|1|0|0|0.437158469945355|0.04541587764047|TAGLN2|4
7667|negative regulation of macromolecule metabolic process (GO:0010605)|1/125|0.901325501127545|1|0|0|0.437158469945355|0.04541587764047|RBL1|4
7668|G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)|1/126|0.903142566342199|1|0|0|0.433688958279122|0.0441820007153184|DHX15|4
7669|negative regulation of response to stimulus (GO:0048585)|1/128|0.906677192596703|1|0|0|0.426912568306011|0.0418241115718644|RBL1|4
7670|non-canonical Wnt signaling pathway (GO:0035567)|1/128|0.906677192596703|1|0|0|0.426912568306011|0.0418241115718644|RHOA|4
7671|protein lipidation (GO:0006497)|1/128|0.906677192596703|1|0|0|0.426912568306011|0.0418241115718644|DPM3|4
7672|positive regulation of sequence-specific DNA binding transcription factor activity (GO:0051091)|2/216|0.908154262437591|1|0|0|0.505970451325643|0.0487457105133254|TRIM37;CARD11|4
7673|positive regulation of mitochondrion organization (GO:0010822)|1/129|0.908395964942359|1|0|0|0.423603168551701|0.04069763659079|SAE1|4
7674|regulation of protein processing (GO:0070613)|1/129|0.908395964942359|1|0|0|0.423603168551701|0.04069763659079|C3|4
7675|protein oligomerization (GO:0051259)|2/218|0.910856020068966|1|0|0|0.501328520579536|0.0468092646715035|RAD51;ECT2|4
7676|positive regulation of transcription from RNA polymerase II promoter (GO:0045944)|11/849|0.912171704306564|1|0|0|0.70800105556521|0.0650844373638668|RBL1;H2AFZ;UHRF1;ATAD2;HMGB2;CKAP2;HNRNPU;HMGB1;FOXM1;DLGAP5;E2F8|4
7677|cellular response to hypoxia (GO:0071456)|1/133|0.914961071569221|1|0|0|0.410863223632853|0.0365149592607584|HP1BP3|4
7678|Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096)|1/134|0.916527666029489|1|0|0|0.407797080172906|0.0355448273168705|HSP90AA1|4
7679|positive regulation of cytosolic calcium ion concentration (GO:0007204)|1/134|0.916527666029489|1|0|0|0.407797080172906|0.0355448273168705|HMGB1|4
7680|Fc-gamma receptor signaling pathway (GO:0038094)|1/135|0.918065477070898|1|0|0|0.404776361060514|0.0346029407488027|HSP90AA1|4
7681|Fc receptor mediated stimulatory signaling pathway (GO:0002431)|1/136|0.919575032132169|1|0|0|0.40180006428801|0.0336883788384623|HSP90AA1|4
7682|muscle contraction (GO:0006936)|1/138|0.922511436366904|1|0|0|0.395976874950503|0.0319377152128786|VIM|4
7683|regulation of cytosolic calcium ion concentration (GO:0051480)|1/138|0.922511436366904|1|0|0|0.395976874950503|0.0319377152128786|HMGB1|4
7684|positive regulation of apoptotic process (GO:0043065)|3/308|0.923152837716109|1|0|0|0.532254630615286|0.042559330528003|TOP2A;HMGB1;ECT2|4
7685|regulation of primary metabolic process (GO:0080090)|1/140|0.925340908319758|1|0|0|0.39032006245121|0.0302861279596159|H2AFY|4
7686|cellular protein modification process (GO:0006464)|13/1002|0.927128294432871|1|0|0|0.708964584492218|0.0536426181569219|PLK4;CCNF;PLK1;AURKB;CDC25B;C3;CCNE1;UBE2S;CDK2;CDK1;BIRC5;RBBP7;DTL|4
7687|regulated exocytosis (GO:0045055)|1/149|0.936851136781341|1|0|0|0.366743682840063|0.0239230137273229|TAGLN2|4
7688|defense response to bacterium (GO:0042742)|2/242|0.937967537116942|1|0|0|0.45160998961297|0.0289210762733763|SPN;HMGB2|4
7689|protein transport (GO:0015031)|3/327|0.94040867761507|1|0|0|0.501328520579536|0.0308019926705932|NDC1;CENPF;HIKESHI|4
7690|spermatogenesis (GO:0007283)|1/154|0.942462242734916|1|0|0|0.354836420410191|0.0210274009016871|RACGAP1|4
7691|male gamete generation (GO:0048232)|1/155|0.943523315454344|1|0|0|0.352547153181738|0.0204950477051078|RACGAP1|4
7692|negative regulation of intracellular signal transduction (GO:1902532)|1/162|0.950423973056608|1|0|0|0.337313634217095|0.0171514222883886|TRIM59|4
7693|neuron projection morphogenesis (GO:0048812)|1/164|0.952236364470421|1|0|0|0.333200053312009|0.0163074746770969|KIF20B|4
7694|T cell receptor signaling pathway (GO:0050852)|1/164|0.952236364470421|1|0|0|0.333200053312009|0.0163074746770969|CARD11|4
7695|regulation of protein phosphorylation (GO:0001932)|2/262|0.954396143072638|1|0|0|0.417135944604347|0.0194704248166558|C3;ECT2|4
7696|protein autophosphorylation (GO:0046777)|1/176|0.961804038693943|1|0|0|0.310481867858917|0.0120915769522619|AURKB|4
7697|Fc-epsilon receptor signaling pathway (GO:0038095)|1/183|0.966475621028434|1|0|0|0.298605512257756|0.010182210465108|CARD11|4
7698|phosphate-containing compound metabolic process (GO:0006796)|1/184|0.967094740347751|1|0|0|0.296982656212877|0.00993668770954861|NUDT4|4
7699|Fc receptor signaling pathway (GO:0038093)|1/184|0.967094740347751|1|0|0|0.296982656212877|0.00993668770954861|CARD11|4
7700|negative regulation of signal transduction (GO:0009968)|2/284|0.96765358082882|1|0|0|0.384822596782883|0.0126534006008204|CNOT1;EZH2|4
7701|receptor-mediated endocytosis (GO:0006898)|1/189|0.970023410356827|1|0|0|0.289125972186081|0.00879957018170319|HSP90AA1|4
7702|ion transport (GO:0006811)|2/290|0.970570861991913|1|0|0|0.376860749952892|0.0112571558604829|SLC25A10;PLP2|4
7703|positive regulation of MAPK cascade (GO:0043410)|2/290|0.970570861991913|1|0|0|0.376860749952892|0.0112571558604829|HMGB1;EZH2|4
7704|positive regulation of cell differentiation (GO:0045597)|1/195|0.973196634563661|1|0|0|0.28022978842651|0.00761359848466791|EZH2|4
7705|positive regulation of ERK1 and ERK2 cascade (GO:0070374)|1/202|0.976477714830762|1|0|0|0.270518855164205|0.00643925509919691|HMGB1|4
7706|regulation of autophagy (GO:0010506)|1/204|0.977339309587811|1|0|0|0.26786670952534|0.00613987726467276|HMGB1|4
7707|regulation of MAPK cascade (GO:0043408)|1/204|0.977339309587811|1|0|0|0.26786670952534|0.00613987726467276|HMGB1|4
7708|positive regulation of signal transduction (GO:0009967)|1/207|0.978573037283712|1|0|0|0.263984583300335|0.0057178672270982|C3|4
7709|central nervous system development (GO:0007417)|1/218|0.982550443299681|1|0|0|0.250664260289768|0.0044125920629216|PHGDH|4
7710|cellular protein localization (GO:0034613)|2/328|0.983946482401501|1|0|0|0.333200053312009|0.00539243343073003|ID1;CNTLN|4
7711|regulation of ERK1 and ERK2 cascade (GO:0070372)|1/248|0.990038181053687|1|0|0|0.220341970738586|0.00220601310512136|HMGB1|4
7712|regulation of immune response (GO:0050776)|1/252|0.990756136982103|1|0|0|0.216844479139561|0.00201380272608021|C3|4
7713|inflammatory response (GO:0006954)|1/253|0.990927409783928|1|0|0|0.215987386336638|0.00196850834710142|HMGB1|4
7714|antigen receptor-mediated signaling pathway (GO:0050851)|1/258|0.99173743769621|1|0|0|0.21180158427585|0.00175729369950703|CARD11|4
7715|endocytosis (GO:0006897)|1/264|0.992614788574022|1|0|0|0.206987911905945|0.001534322138279|HSP90AA1|4
7716|positive regulation of intracellular signal transduction (GO:1902533)|3/480|0.993409236920034|1|0|0|0.341530054644809|0.00225839414732799|HMGB1;ECT2;RHOA|4
7717|vesicle-mediated transport (GO:0016192)|2/411|0.995881720671565|1|0|0|0.265911478068951|0.00109735891274447|HSPA8;KIF20A|4
7718|DNA metabolic process (GO:0006259)|25/315|8.48062339187652e-27|4.32766211687459e-23|0|0|21.1640211640212|1270.51880530253|FEN1;DNMT1;PCNA;MCM7;UHRF1;UNG;CDC45;ORC6;POLD1;TOPBP1;HELLS;WDHD1;TIPIN;DUT;LIG1;RPA2;NAP1L1;NASP;MCM3;TIMELESS;MCM4;MCM5;MCM6;MCM2;CENPS|5
7719|DNA replication (GO:0006260)|18/121|2.26889503764697e-24|5.78908568855625e-21|0|0|39.6694214876033|2159.7123683873|WDHD1;FEN1;TIPIN;DUT;MCM7;RPA2;NAP1L1;CDC45;ORC6;NASP;POLD1;MCM3;TIMELESS;MCM4;MCM5;TOPBP1;MCM6;MCM2|5
7720|G1/S transition of mitotic cell cycle (GO:0000082)|15/106|4.58243503704711e-20|7.79472199801714e-17|0|0|37.7358490566038|1680.35740888915|CDT1;PCNA;MCM7;RPA2;DHFR;CDC45;ORC6;CCNE2;NASP;MCM3;E2F1;MCM4;MCM5;MCM6;MCM2|5
7721|cellular macromolecule biosynthetic process (GO:0034645)|19/368|7.5918971948116e-17|9.6853628462809e-14|0|0|13.768115942029|511.029301563601|FEN1;TIPIN;DUT;MCM7;RPA2;NAP1L1;CDC45;ORC6;NASP;POLD1;MCM3;TIMELESS;E2F1;MCM4;MCM5;TOPBP1;MCM6;PTMA;MCM2|5
7722|cell cycle G1/S phase transition (GO:0044843)|12/93|1.00758685628994e-15|1.02834314552952e-12|0|0|34.4086021505376|1188.17094792502|CDT1;CDC45;ORC6;MCM7;CCNE2;NASP;MCM3;MCM4;RPA2;MCM5;MCM6;MCM2|5
7723|mitotic cell cycle phase transition (GO:0044772)|15/222|3.76246772180948e-15|3.19997879739897e-12|0|0|18.018018018018|598.445069257542|CDT1;HSP90AA1;MCM7;RPA2;PKMYT1;CDC45;ORC6;CCNE2;NASP;MCM3;MCM4;MCM5;MCM6;PHLDA1;MCM2|5
7724|DNA replication checkpoint (GO:0000076)|5/17|3.86832727221031e-09|2.82001058144131e-06|0|0|78.4313725490196|1519.2504825683|CDT1;TIPIN;CDC45;TIMELESS;TOPBP1|5
7725|regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083)|5/27|4.90170053946229e-08|3.12667223160951e-05|0|0|49.3827160493827|831.165360502393|DHFR;CDT1;PCNA;CDC45;E2F1|5
7726|DNA-dependent DNA replication (GO:0006261)|6/57|7.07254700465634e-08|4.01013415164014e-05|0|0|28.0701754385965|462.160282769536|WDHD1;ORC6;CDC45;POLD1;TOPBP1;MCM2|5
7727|DNA repair (GO:0006281)|10/289|1.23038335929364e-07|6.27864628247546e-05|0|0|9.22722029988466|146.812178601263|WDHD1;FEN1;PCNA;LIG1;POLD1;TIMELESS;RPA2;TOPBP1;UNG;CENPS|5
7728|DNA-dependent DNA replication maintenance of fidelity (GO:0045005)|5/36|2.22970056556119e-07|0.000103437836236898|0|0|37.037037037037|567.267716667969|TIPIN;PCNA;POLD1;TIMELESS;CENPS|5
7729|cellular response to DNA damage stimulus (GO:0006974)|10/330|4.1857397811678e-07|0.000177998584194161|0|0|8.08080808080808|118.67807832683|WDHD1;FEN1;MCM7;LIG1;POLD1;TIMELESS;E2F1;TOPBP1;UNG;CENPS|5
7730|nucleotide-excision repair, DNA gap filling (GO:0006297)|4/23|1.52986628402731e-06|0.000600531357491644|0|0|46.3768115942029|621.00082191025|PCNA;LIG1;POLD1;RPA2|5
7731|DNA replication initiation (GO:0006270)|4/25|2.17315293742817e-06|0.000792114245692568|0|0|42.6666666666667|556.344809744628|ORC6;CDC45;TOPBP1;MCM2|5
7732|mismatch repair (GO:0006298)|4/33|6.87190284024458e-06|0.00233782134625121|0|0|32.3232323232323|384.260832707228|PCNA;LIG1;POLD1;RPA2|5
7733|regulation of chromatin silencing (GO:0031935)|3/11|8.17816867394668e-06|0.00260832467144687|0|0|72.7272727272727|851.930349883984|CDC45;UHRF1;ATAD2|5
7734|nucleic acid phosphodiester bond hydrolysis (GO:0090305)|5/74|8.52867063732569e-06|0.00256010625072194|0|0|18.018018018018|210.307694669756|FEN1;PCNA;POLD1;RNASE6;RPA2|5
7735|regulation of DNA-dependent DNA replication (GO:0090329)|3/12|1.08748460306312e-05|0.00308301884968393|0|0|66.6666666666667|761.937209279509|CDT1;TIPIN;GMNN|5
7736|base-excision repair (GO:0006284)|4/38|1.22215639265294e-05|0.00328245477458313|0|0|28.0701754385965|317.538487902184|LIG1;POLD1;RPA2;UNG|5
7737|negative regulation of DNA-dependent DNA replication (GO:2000104)|3/15|2.23098672325577e-05|0.00569236262438709|0|0|53.3333333333333|571.22568003018|TIPIN;GMNN;TIMELESS|5
7738|regulation of G1/S transition of mitotic cell cycle (GO:2000045)|4/47|2.87879239424866e-05|0.00699546551802425|0|0|22.6950354609929|237.289181646727|CDC45;CCND2;E2F1;CDK2AP2|5
7739|DNA ligation (GO:0006266)|3/18|3.96882183908507e-05|0.00920586265675051|0|0|44.4444444444444|450.420274679484|PCNA;LIG1;POLD1|5
7740|positive regulation of nitric oxide biosynthetic process (GO:0045429)|3/26|0.000123759636880974|0.0274584968262439|0|0|30.7692307692308|276.835978023441|HSP90AA1;HSP90AB1;CD36|5
7741|positive regulation of nitric oxide metabolic process (GO:1904407)|3/26|0.000123759636880974|0.026314392791817|0|0|30.7692307692308|276.835978023441|HSP90AA1;HSP90AB1;CD36|5
7742|transcription-coupled nucleotide-excision repair (GO:0006283)|4/74|0.000172042276138253|0.0351172694053402|0|0|14.4144144144144|124.940833439296|PCNA;LIG1;POLD1;RPA2|5
7743|positive regulation of reactive oxygen species biosynthetic process (GO:1903428)|3/31|0.000211099099822834|0.0414322579383047|0|0|25.8064516129032|218.404719157177|HSP90AA1;HSP90AB1;CD36|5
7744|regulation of nitric oxide biosynthetic process (GO:0045428)|3/33|0.00025485462495062|0.0481675241156673|0|0|24.2424242424242|200.601630875309|HSP90AA1;HSP90AB1;CD36|5
7745|chromatin remodeling at centromere (GO:0031055)|3/33|0.00025485462495062|0.0464472553972506|0|0|24.2424242424242|200.601630875309|HELLS;NASP;CENPS|5
7746|replication fork protection (GO:0048478)|2/7|0.00028785384029208|0.0506523498969132|0|0|76.1904761904762|621.185349000789|TIPIN;TIMELESS|5
7747|regulation of double-strand break repair (GO:2000779)|3/35|0.000304081436441588|0.0517242523387142|0|0|22.8571428571429|185.102057357732|TIMELESS;RPA2;DEK|5
7748|anatomical structure homeostasis (GO:0060249)|3/36|0.000330833711165039|0.054459497679845|0|0|22.2222222222222|178.086548711358|PCNA;POLD1;RPA2|5
7749|centromere complex assembly (GO:0034508)|3/37|0.000359057506921508|0.0572584518068892|0|0|21.6216216216216|171.503308019321|HELLS;NASP;CENPS|5
7750|histone exchange (GO:0043486)|3/37|0.000359057506921508|0.0555233472066805|0|0|21.6216216216216|171.503308019321|NASP;ANP32B;CENPS|5
7751|positive regulation of chromatin binding (GO:0035563)|2/8|0.000382873169302544|0.0574647583220847|0|0|66.6666666666667|524.520451618147|CDT1;GMNN|5
7752|nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)|3/38|0.000388786495630799|0.0566850710629705|0|0|21.0526315789474|165.315373040865|PCNA;POLD1;RPA2|5
7753|mitotic DNA damage checkpoint (GO:0044773)|3/40|0.000452892622471967|0.0641975292354013|0|0|20|153.997109941291|TIPIN;RPA2;TOPBP1|5
7754|nucleotide-excision repair, DNA incision (GO:0033683)|3/41|0.000487334997310735|0.0672127159804508|0|0|19.5121951219512|148.810903256082|PCNA;POLD1;RPA2|5
7755|regulation of methylation-dependent chromatin silencing (GO:0090308)|2/9|0.000491070345932343|0.0659455782971775|0|0|59.2592592592593|451.491743389277|DNMT1;UHRF1|5
7756|telomere organization (GO:0032200)|3/42|0.000523413044782931|0.0684865837827512|0|0|19.047619047619|143.907421809846|PCNA;POLD1;RPA2|5
7757|translesion synthesis (GO:0019985)|3/43|0.000561158348760635|0.0715897763431381|0|0|18.6046511627907|139.26525452399|PCNA;POLD1;RPA2|5
7758|DNA replication-dependent nucleosome organization (GO:0034723)|2/10|0.000612347858281016|0.0762149053855616|0|0|53.3333333333333|394.571202188997|CHAF1A;NASP|5
7759|DNA replication-dependent nucleosome assembly (GO:0006335)|2/10|0.000612347858281016|0.0744002647811435|0|0|53.3333333333333|394.571202188997|CHAF1A;NASP|5
7760|regulation of chromatin binding (GO:0035561)|2/11|0.000746608721417386|0.0886033559393702|0|0|48.4848484848485|349.089421092815|CDT1;GMNN|5
7761|nucleotide-excision repair (GO:0006289)|4/109|0.000753531532547421|0.087392532058852|0|0|9.78593272171254|70.3680948517963|PCNA;LIG1;POLD1;RPA2|5
7762|postreplication repair (GO:0006301)|3/48|0.000775970738795886|0.0879950817794535|0|0|16.6666666666667|119.356595770488|PCNA;POLD1;RPA2|5
7763|pyrimidine deoxyribonucleotide catabolic process (GO:0009223)|2/12|0.000893756474842288|0.0991486802417434|0|0|44.4444444444444|312.00343197349|DUT;UNG|5
7764|telomere maintenance (GO:0000723)|3/52|0.000980904260816373|0.106501158360552|0|0|15.3846153846154|106.569779948013|PCNA;POLD1;RPA2|5
7765|regulation of protein modification by small protein conjugation or removal (GO:1903320)|2/14|0.00122632942389695|0.130374146878045|0|0|38.0952380952381|255.380182073886|HSP90AA1;HSP90AB1|5
7766|nitric oxide mediated signal transduction (GO:0007263)|2/15|0.00141156430376112|0.147004339634551|0|0|35.5555555555556|233.353129040676|FPR1;CD36|5
7767|nucleosome assembly (GO:0006334)|3/61|0.00155929802850381|0.159141956789099|0|0|13.1147540983607|84.7674693865072|CHAF1A;NASP;ANP32B|5
7768|DNA strand elongation involved in DNA replication (GO:0006271)|2/16|0.00160930543834722|0.161025208860507|0|0|33.3333333333333|214.398419927362|PCNA;LIG1|5
7769|positive regulation of G1/S transition of mitotic cell cycle (GO:1900087)|2/16|0.00160930543834722|0.157928570228575|0|0|33.3333333333333|214.398419927362|CDC45;CCND2|5
7770|chaperone-mediated protein complex assembly (GO:0051131)|2/17|0.0018194589583724|0.175183001218384|0|0|31.3725490196078|197.936191300648|HSP90AA1;HSP90AB1|5
7771|DNA synthesis involved in DNA repair (GO:0000731)|3/66|0.00195619952171806|0.184860854802357|0|0|12.1212121212121|75.5969903951919|PCNA;POLD1;RPA2|5
7772|regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079)|3/68|0.00213096679699279|0.197714973910076|0|0|11.7647058823529|72.3668177286863|CCND2;CCNE2;PKMYT1|5
7773|error-free translesion synthesis (GO:0070987)|2/19|0.00227663023262949|0.207457929948363|0|0|28.0701754385965|170.808670805137|PCNA;RPA2|5
7774|error-prone translesion synthesis (GO:0042276)|2/20|0.00252346279550895|0.225916327113722|0|0|26.6666666666667|159.52328521341|PCNA;RPA2|5
7775|telomere maintenance via telomerase (GO:0007004)|2/20|0.00252346279550895|0.222021218025555|0|0|26.6666666666667|159.52328521341|HSP90AA1;HSP90AB1|5
7776|RNA-dependent DNA biosynthetic process (GO:0006278)|2/21|0.00278233735733153|0.240648602279031|0|0|25.3968253968254|149.446702946418|HSP90AA1;HSP90AB1|5
7777|double-strand break repair via homologous recombination (GO:0000724)|3/77|0.00303635404660003|0.258241911663333|0|0|10.3896103896104|60.229587637488|FEN1;CDC45;RPA2|5
7778|positive regulation of cellular biosynthetic process (GO:0031328)|4/160|0.00308544333324469|0.258115038189306|0|0|6.66666666666667|38.5403995058229|HSP90AA1;HSP90AB1;PCNA;CD36|5
7779|regulation of cellular response to heat (GO:1900034)|3/79|0.00326494779876482|0.268726268017692|0|0|10.126582278481|57.9697367545186|HSP90AA1;HSP90AB1;RPA2|5
7780|regulation of microtubule cytoskeleton organization (GO:0070507)|2/23|0.00333584763034024|0.270203658057559|0|0|23.1884057971014|132.244138432167|STMN1;CDK2AP2|5
7781|nucleosome organization (GO:0034728)|3/80|0.00338309555790274|0.269749009874651|0|0|10|56.8896414308449|CHAF1A;NASP;ANP32B|5
7782|positive regulation of binding (GO:0051099)|3/82|0.00362718322198834|0.284761784335485|0|0|9.75609756097561|54.8224283300629|CDT1;GMNN;STMN1|5
7783|negative regulation of cell cycle process (GO:0010948)|3/82|0.00362718322198834|0.280447211845553|0|0|9.75609756097561|54.8224283300629|CDT1;HSP90AB1;E2F1|5
7784|positive regulation of cell cycle G1/S phase transition (GO:1902808)|2/24|0.00363030216608761|0.27649898438127|0|0|22.2222222222222|124.854208729407|CDC45;CCND2|5
7785|positive regulation of protein complex assembly (GO:0031334)|3/89|0.0045651108833932|0.342584718205228|0|0|8.98876404494382|48.4432582052159|CDT1;RPA2;CD36|5
7786|telomere maintenance via telomere lengthening (GO:0010833)|2/28|0.00492402564545741|0.364163809692306|0|0|19.047619047619|101.211978331743|HSP90AA1;HSP90AB1|5
7787|protein-DNA complex assembly (GO:0065004)|3/92|0.00500787257232632|0.365073910522588|0|0|8.69565217391304|46.0586442637486|CHAF1A;RPA2;ANP32B|5
7788|ATP-dependent chromatin remodeling (GO:0043044)|2/31|0.00601354432043434|0.432212910805302|0|0|17.2043010752688|87.978339218659|NASP;ANP32B|5
7789|replication fork processing (GO:0031297)|2/31|0.00601354432043434|0.426209953710784|0|0|17.2043010752688|87.978339218659|PCNA;CENPS|5
7790|CENP-A containing nucleosome assembly (GO:0034080)|2/31|0.00601354432043434|0.420371461194198|0|0|17.2043010752688|87.978339218659|NASP;CENPS|5
7791|CENP-A containing chromatin organization (GO:0061641)|2/31|0.00601354432043434|0.414690765772655|0|0|17.2043010752688|87.978339218659|NASP;CENPS|5
7792|response to UV (GO:0009411)|3/99|0.00613911562812676|0.417705427337745|0|0|8.08080808080808|41.1561582359927|FEN1;PCNA;POLD1|5
7793|nucleobase-containing small molecule interconversion (GO:0015949)|2/32|0.00639896140742268|0.429656579764184|0|0|16.6666666666667|84.1936596979259|DUT;RRM1|5
7794|regulation of protein ubiquitination (GO:0031396)|3/102|0.00666686843115987|0.441831553301413|0|0|7.84313725490196|39.2988629794529|HSP90AA1;HSP90AB1;CENPS|5
7795|regulation of cellular response to stress (GO:0080135)|3/105|0.00722086724314876|0.472411353099848|0|0|7.61904761904762|37.5678492686571|HSP90AA1;HSP90AB1;RPA2|5
7796|regulation of cyclin-dependent protein kinase activity (GO:1904029)|2/36|0.00804956133154531|0.519960904745262|0|0|14.8148148148148|71.4390767705511|CCNE2;PKMYT1|5
7797|positive regulation of telomerase activity (GO:0051973)|2/36|0.00804956133154531|0.513461393435946|0|0|14.8148148148148|71.4390767705511|HSP90AA1;HSP90AB1|5
7798|positive regulation of DNA replication (GO:0045740)|2/36|0.00804956133154531|0.507122363887354|0|0|14.8148148148148|71.4390767705511|CDT1;PCNA|5
7799|regulation of nitric-oxide synthase activity (GO:0050999)|2/37|0.00848902025522045|0.528286223931585|0|0|14.4144144144144|68.7420783448534|DHFR;HSP90AA1|5
7800|regulation of DNA repair (GO:0006282)|2/38|0.00893903481458851|0.549589092275243|0|0|14.0350877192982|66.2081074834959|PCNA;DEK|5
7801|positive regulation of DNA repair (GO:0045739)|2/39|0.00939952184830962|0.571020952284809|0|0|13.6752136752137|63.8235413087325|PCNA;TIMELESS|5
7802|DNA replication-independent nucleosome assembly (GO:0006336)|2/40|0.00987039865824951|0.592572286506438|0|0|13.3333333333333|61.5762004726093|NASP;CENPS|5
7803|positive regulation of mitotic cell cycle phase transition (GO:1901992)|2/41|0.0103515830050206|0.614234047379306|0|0|13.0081300813008|59.4551651853141|CDC45;CCND2|5
7804|cellular response to peptide (GO:1901653)|2/42|0.0108429931046369|0.635997630034048|0|0|12.6984126984127|57.4506184688242|TIMELESS;CD36|5
7805|regulation of telomerase activity (GO:0051972)|2/43|0.0113445476278684|0.657854847102413|0|0|12.4031007751938|55.5537120705302|HSP90AA1;HSP90AB1|5
7806|response to unfolded protein (GO:0006986)|2/44|0.0118561656942457|0.679797904918382|0|0|12.1212121212121|53.7564513329155|HSP90AA1;HSP90AB1|5
7807|RNA catabolic process (GO:0006401)|2/44|0.0118561656942457|0.672244594863733|0|0|12.1212121212121|53.7564513329155|FEN1;RNASE6|5
7808|G2/M transition of mitotic cell cycle (GO:0000086)|3/127|0.0121118691886139|0.679196356807656|0|0|6.2992125984252|27.8020118582226|HSP90AA1;PKMYT1;PHLDA1|5
7809|cell cycle G2/M phase transition (GO:0044839)|3/128|0.012369683388269|0.686114068808007|0|0|6.25|27.453166800207|HSP90AA1;PKMYT1;PHLDA1|5
7810|positive regulation of gene expression, epigenetic (GO:0045815)|2/48|0.0140016715470792|0.768285267792957|0|0|11.1111111111111|47.4286506697122|ATAD2;DEK|5
7811|interstrand cross-link repair (GO:0036297)|2/49|0.0145624098315062|0.790552950746554|0|0|10.8843537414966|46.0333250558181|RPA2;CENPS|5
7812|positive regulation of transferase activity (GO:0051347)|3/138|0.0151215986828594|0.812268611354015|0|0|5.79710144927536|24.2993111931985|HSP90AA1;HSP90AB1;LMO4|5
7813|regulation of DNA binding (GO:0051101)|2/53|0.0169004638400652|0.898365280998468|0|0|10.062893081761|41.0607719373287|CDT1;E2F1|5
7814|regulation of cell-matrix adhesion (GO:0001952)|2/53|0.0169004638400652|0.889103783256216|0|0|10.062893081761|41.0607719373287|CD36;PLET1|5
7815|positive regulation of DNA biosynthetic process (GO:2000573)|2/56|0.0187517067922135|0.976428160823116|0|0|9.52380952380952|37.8711476361004|HSP90AA1;HSP90AB1|5
7816|positive regulation of interferon-gamma secretion (GO:1902715)|1/6|0.0222927146382014|1|0|0|44.4444444444444|169.044237854752|CD2|5
7817|regulation of fat cell proliferation (GO:0070344)|1/6|0.0222927146382014|1|0|0|44.4444444444444|169.044237854752|E2F1|5
7818|nucleus localization (GO:0051647)|1/6|0.0222927146382014|1|0|0|44.4444444444444|169.044237854752|SYNE2|5
7819|negative regulation of transforming growth factor beta production (GO:0071635)|1/6|0.0222927146382014|1|0|0|44.4444444444444|169.044237854752|HSP90AB1|5
7820|regulation of cellular response to oxidative stress (GO:1900407)|1/6|0.0222927146382014|1|0|0|44.4444444444444|169.044237854752|DHFR|5
7821|sterol import (GO:0035376)|1/6|0.0222927146382014|1|0|0|44.4444444444444|169.044237854752|CD36|5
7822|folic acid-containing compound biosynthetic process (GO:0009396)|1/6|0.0222927146382014|1|0|0|44.4444444444444|169.044237854752|DHFR|5
7823|regulation of superoxide metabolic process (GO:0090322)|1/6|0.0222927146382014|1|0|0|44.4444444444444|169.044237854752|DHFR|5
7824|regulation of nuclear cell cycle DNA replication (GO:0033262)|1/6|0.0222927146382014|1|0|0|44.4444444444444|169.044237854752|TIPIN|5
7825|regulation of cell cycle checkpoint (GO:1901976)|1/6|0.0222927146382014|1|0|0|44.4444444444444|169.044237854752|RPA2|5
7826|cellular response to bacterial lipopeptide (GO:0071221)|1/6|0.0222927146382014|1|0|0|44.4444444444444|169.044237854752|CD36|5
7827|pyrimidine deoxyribonucleotide biosynthetic process (GO:0009221)|1/6|0.0222927146382014|1|0|0|44.4444444444444|169.044237854752|DUT|5
7828|cholesterol import (GO:0070508)|1/6|0.0222927146382014|1|0|0|44.4444444444444|169.044237854752|CD36|5
7829|regulation of DNA replication (GO:0006275)|2/62|0.0226966040981064|1|0|0|8.60215053763441|32.5637846441997|PCNA;GMNN|5
7830|DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)|2/63|0.023384648048073|1|0|0|8.46560846560847|31.7940786306525|PCNA;E2F1|5
7831|second-messenger-mediated signaling (GO:0019932)|2/63|0.023384648048073|1|0|0|8.46560846560847|31.7940786306525|FPR1;CD36|5
7832|signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431)|2/64|0.0240812296007285|1|0|0|8.33333333333333|31.0526883057668|PCNA;E2F1|5
7833|regulation of cell division (GO:0051302)|2/66|0.0254997184173671|1|0|0|8.08080808080808|29.6491949037165|ORC6;CDK2AP2|5
7834|chromatin assembly (GO:0031497)|2/66|0.0254997184173671|1|0|0|8.08080808080808|29.6491949037165|CHAF1A;ANP32B|5
7835|membrane raft polarization (GO:0001766)|1/7|0.0259602034362563|1|0|0|38.0952380952381|139.092973358071|CD2|5
7836|axon regeneration (GO:0031103)|1/7|0.0259602034362563|1|0|0|38.0952380952381|139.092973358071|DHFR|5
7837|positive regulation of isomerase activity (GO:0010912)|1/7|0.0259602034362563|1|0|0|38.0952380952381|139.092973358071|UHRF1|5
7838|outer mitochondrial membrane organization (GO:0007008)|1/7|0.0259602034362563|1|0|0|38.0952380952381|139.092973358071|HSP90AA1|5
7839|regulation of protein heterodimerization activity (GO:0043497)|1/7|0.0259602034362563|1|0|0|38.0952380952381|139.092973358071|CD36|5
7840|wound healing, spreading of epidermal cells (GO:0035313)|1/7|0.0259602034362563|1|0|0|38.0952380952381|139.092973358071|PLET1|5
7841|long-chain fatty acid import (GO:0044539)|1/7|0.0259602034362563|1|0|0|38.0952380952381|139.092973358071|CD36|5
7842|pteridine-containing compound biosynthetic process (GO:0042559)|1/7|0.0259602034362563|1|0|0|38.0952380952381|139.092973358071|DHFR|5
7843|membrane raft distribution (GO:0031580)|1/7|0.0259602034362563|1|0|0|38.0952380952381|139.092973358071|CD2|5
7844|cellular response to hydroxyurea (GO:0072711)|1/7|0.0259602034362563|1|0|0|38.0952380952381|139.092973358071|TIMELESS|5
7845|cellular response to light stimulus (GO:0071482)|2/67|0.0262214831473971|1|0|0|7.96019900497512|28.9844874566913|PCNA;POLD1|5
7846|positive regulation of cellular protein localization (GO:1903829)|2/67|0.0262214831473971|1|0|0|7.96019900497512|28.9844874566913|CDT1;HSP90AB1|5
7847|cellular response to UV (GO:0034644)|2/68|0.0269515004105609|1|0|0|7.84313725490196|28.34287301424|PCNA;POLD1|5
7848|regulation of innate immune response (GO:0045088)|2/70|0.0284360118658026|1|0|0|7.61904761904762|27.124563151497|HSP90AB1;CD36|5
7849|lipoprotein transport (GO:0042953)|1/8|0.0296141189261147|1|0|0|33.3333333333333|117.316801354298|CD36|5
7850|cGMP-mediated signaling (GO:0019934)|1/8|0.0296141189261147|1|0|0|33.3333333333333|117.316801354298|CD36|5
7851|depyrimidination (GO:0045008)|1/8|0.0296141189261147|1|0|0|33.3333333333333|117.316801354298|UNG|5
7852|lipoprotein localization (GO:0044872)|1/8|0.0296141189261147|1|0|0|33.3333333333333|117.316801354298|CD36|5
7853|amyloid fibril formation (GO:1990000)|1/8|0.0296141189261147|1|0|0|33.3333333333333|117.316801354298|CD36|5
7854|positive regulation of protein localization to cell surface (GO:2000010)|1/8|0.0296141189261147|1|0|0|33.3333333333333|117.316801354298|HSP90AB1|5
7855|cytoskeletal anchoring at nuclear membrane (GO:0090286)|1/8|0.0296141189261147|1|0|0|33.3333333333333|117.316801354298|SYNE2|5
7856|interleukin-1 beta secretion (GO:0050702)|1/8|0.0296141189261147|1|0|0|33.3333333333333|117.316801354298|CD36|5
7857|lagging strand elongation (GO:0006273)|1/8|0.0296141189261147|1|0|0|33.3333333333333|117.316801354298|LIG1|5
7858|response to hydroxyurea (GO:0072710)|1/8|0.0296141189261147|1|0|0|33.3333333333333|117.316801354298|TIMELESS|5
7859|intestinal cholesterol absorption (GO:0030299)|1/8|0.0296141189261147|1|0|0|33.3333333333333|117.316801354298|CD36|5
7860|heterochromatin assembly (GO:0031507)|1/8|0.0296141189261147|1|0|0|33.3333333333333|117.316801354298|HELLS|5
7861|positive regulation of chromatin silencing (GO:0031937)|1/8|0.0296141189261147|1|0|0|33.3333333333333|117.316801354298|DNMT1|5
7862|recombinational repair (GO:0000725)|2/72|0.0299526954634575|1|0|0|7.40740740740741|25.9861922940033|FEN1;RPA2|5
7863|regulation of protein complex assembly (GO:0043254)|2/74|0.0315010001812454|1|0|0|7.20720720720721|24.9206196891464|CDT1;HSP90AA1|5
7864|regulation of gene expression, epigenetic (GO:0040029)|2/75|0.0322868399803818|1|0|0|7.11111111111111|24.4131240015929|DNMT1;DEK|5
7865|negative regulation of chromatin silencing (GO:0031936)|1/9|0.0332545104577823|1|0|0|29.6296296296296|100.846366465619|ATAD2|5
7866|mitotic DNA replication checkpoint (GO:0033314)|1/9|0.0332545104577823|1|0|0|29.6296296296296|100.846366465619|TOPBP1|5
7867|intestinal lipid absorption (GO:0098856)|1/9|0.0332545104577823|1|0|0|29.6296296296296|100.846366465619|CD36|5
7868|negative regulation of microtubule polymerization (GO:0031115)|1/9|0.0332545104577823|1|0|0|29.6296296296296|100.846366465619|STMN1|5
7869|positive regulation of mitotic metaphase/anaphase transition (GO:0045842)|1/9|0.0332545104577823|1|0|0|29.6296296296296|100.846366465619|CDT1|5
7870|regulation of interferon-gamma secretion (GO:1902713)|1/9|0.0332545104577823|1|0|0|29.6296296296296|100.846366465619|CD2|5
7871|fatty acid homeostasis (GO:0055089)|1/9|0.0332545104577823|1|0|0|29.6296296296296|100.846366465619|POLD1|5
7872|interleukin-1 secretion (GO:0050701)|1/9|0.0332545104577823|1|0|0|29.6296296296296|100.846366465619|CD36|5
7873|nuclear migration (GO:0007097)|1/9|0.0332545104577823|1|0|0|29.6296296296296|100.846366465619|SYNE2|5
7874|negative regulation of histone methylation (GO:0031061)|1/9|0.0332545104577823|1|0|0|29.6296296296296|100.846366465619|DNMT1|5
7875|interleukin-1 beta production (GO:0032611)|1/9|0.0332545104577823|1|0|0|29.6296296296296|100.846366465619|CD36|5
7876|nucleic acid-templated transcription (GO:0097659)|2/77|0.0338815568885846|1|0|0|6.92640692640693|23.4450871496188|E2F1;PTMA|5
7877|receptor-mediated endocytosis (GO:0006898)|3/189|0.0341576807158361|1|0|0|4.23280423280423|14.2931970670992|MARCO;HSP90AA1;CD36|5
7878|neutrophil degranulation (GO:0043312)|5/480|0.0341908510440192|1|0|0|2.77777777777778|9.37721440009562|RAB44;HSP90AA1;HSP90AB1;FPR1;CD36|5
7879|neutrophil activation involved in immune response (GO:0002283)|5/484|0.0352427891547265|1|0|0|2.75482093663912|9.21623783370855|RAB44;HSP90AA1;HSP90AB1;FPR1;CD36|5
7880|RNA metabolic process (GO:0016070)|3/192|0.0355380690346844|1|0|0|4.16666666666667|13.9047949579229|PCNA;LIG1;RNASE6|5
7881|neutrophil mediated immunity (GO:0002446)|5/488|0.0363147146123757|1|0|0|2.73224043715847|9.05883130772001|RAB44;HSP90AA1;HSP90AB1;FPR1;CD36|5
7882|mitotic G1/S transition checkpoint (GO:0044819)|1/10|0.0368814272661001|1|0|0|26.6666666666667|88.0012581538324|RPA2|5
7883|complement receptor mediated signaling pathway (GO:0002430)|1/10|0.0368814272661001|1|0|0|26.6666666666667|88.0012581538324|FPR1|5
7884|mitotic G1 DNA damage checkpoint (GO:0031571)|1/10|0.0368814272661001|1|0|0|26.6666666666667|88.0012581538324|RPA2|5
7885|regulation of DNA damage checkpoint (GO:2000001)|1/10|0.0368814272661001|1|0|0|26.6666666666667|88.0012581538324|RPA2|5
7886|neuron projection regeneration (GO:0031102)|1/10|0.0368814272661001|1|0|0|26.6666666666667|88.0012581538324|DHFR|5
7887|actin filament-based transport (GO:0099515)|1/10|0.0368814272661001|1|0|0|26.6666666666667|88.0012581538324|SYNE2|5
7888|virion attachment to host cell (GO:0019062)|1/10|0.0368814272661001|1|0|0|26.6666666666667|88.0012581538324|HSP90AB1|5
7889|G1 DNA damage checkpoint (GO:0044783)|1/10|0.0368814272661001|1|0|0|26.6666666666667|88.0012581538324|RPA2|5
7890|positive regulation of nuclease activity (GO:0032075)|1/10|0.0368814272661001|1|0|0|26.6666666666667|88.0012581538324|PCNA|5
7891|regulation of NLRP3 inflammasome complex assembly (GO:1900225)|1/10|0.0368814272661001|1|0|0|26.6666666666667|88.0012581538324|CD36|5
7892|base-excision repair, AP site formation (GO:0006285)|1/10|0.0368814272661001|1|0|0|26.6666666666667|88.0012581538324|UNG|5
7893|UV protection (GO:0009650)|1/10|0.0368814272661001|1|0|0|26.6666666666667|88.0012581538324|FEN1|5
7894|nucleic acid metabolic process (GO:0090304)|2/81|0.0371612737198757|1|0|0|6.5843621399177|21.6789339192476|FEN1;TOPBP1|5
7895|regulation of protein serine/threonine kinase activity (GO:0071900)|2/81|0.0371612737198757|1|0|0|6.5843621399177|21.6789339192476|CCNE2;PKMYT1|5
7896|DNA damage response, signal transduction by p53 class mediator (GO:0030330)|2/83|0.0388452208872776|1|0|0|6.42570281124498|20.8717765411719|PCNA;E2F1|5
7897|positive regulation of DNA metabolic process (GO:0051054)|2/83|0.0388452208872776|1|0|0|6.42570281124498|20.8717765411719|DNMT1;PCNA|5
7898|positive regulation of cell cycle (GO:0045787)|2/83|0.0388452208872776|1|0|0|6.42570281124498|20.8717765411719|HSP90AB1;CCND2|5
7899|positive regulation of cell cycle arrest (GO:0071158)|2/83|0.0388452208872776|1|0|0|6.42570281124498|20.8717765411719|PCNA;E2F1|5
7900|regulation of histone H3-K9 methylation (GO:0051570)|1/11|0.0404949184271054|1|0|0|24.2424242424242|77.7352432406654|DNMT1|5
7901|positive regulation of chromosome segregation (GO:0051984)|1/11|0.0404949184271054|1|0|0|24.2424242424242|77.7352432406654|FEN1|5
7902|negative regulation of cell division (GO:0051782)|1/11|0.0404949184271054|1|0|0|24.2424242424242|77.7352432406654|ORC6|5
7903|methylation-dependent chromatin silencing (GO:0006346)|1/11|0.0404949184271054|1|0|0|24.2424242424242|77.7352432406654|HELLS|5
7904|hepatocyte growth factor receptor signaling pathway (GO:0048012)|1/11|0.0404949184271054|1|0|0|24.2424242424242|77.7352432406654|STMN1|5
7905|positive regulation of phosphorylation (GO:0042327)|3/209|0.043896594110408|1|0|0|3.82775119617225|11.9652384490608|MARCO;CCND2;LMO4|5
7906|positive regulation of pseudopodium assembly (GO:0031274)|1/12|0.0440950328838917|1|0|0|22.2222222222222|69.3646252420276|CDC42EP3|5
7907|establishment of protein localization to mitochondrial membrane (GO:0090151)|1/12|0.0440950328838917|1|0|0|22.2222222222222|69.3646252420276|HSP90AA1|5
7908|kinetochore organization (GO:0051383)|1/12|0.0440950328838917|1|0|0|22.2222222222222|69.3646252420276|CDT1|5
7909|response to axon injury (GO:0048678)|1/12|0.0440950328838917|1|0|0|22.2222222222222|69.3646252420276|DHFR|5
7910|regulation of pseudopodium assembly (GO:0031272)|1/12|0.0440950328838917|1|0|0|22.2222222222222|69.3646252420276|CDC42EP3|5
7911|DNA ligation involved in DNA repair (GO:0051103)|1/12|0.0440950328838917|1|0|0|22.2222222222222|69.3646252420276|LIG1|5
7912|carbohydrate derivative transport (GO:1901264)|1/12|0.0440950328838917|1|0|0|22.2222222222222|69.3646252420276|SLC29A1|5
7913|positive regulation of DNA-dependent DNA replication (GO:2000105)|1/12|0.0440950328838917|1|0|0|22.2222222222222|69.3646252420276|CDT1|5
7914|regulation of sister chromatid cohesion (GO:0007063)|1/12|0.0440950328838917|1|0|0|22.2222222222222|69.3646252420276|FEN1|5
7915|attachment of mitotic spindle microtubules to kinetochore (GO:0051315)|1/12|0.0440950328838917|1|0|0|22.2222222222222|69.3646252420276|CDT1|5
7916|transcription, DNA-templated (GO:0006351)|4/357|0.045166072573936|1|0|0|2.98786181139122|9.25463030666394|LMO4;E2F1;DEK;PTMA|5
7917|positive regulation of cellular process (GO:0048522)|5/520|0.0456180419678949|1|0|0|2.56410256410256|7.91654354749432|TIPIN;HSP90AB1;CCND2;NAP1L1;CD36|5
7918|regulation of cell cycle process (GO:0010564)|2/91|0.0458629311711532|1|0|0|5.86080586080586|18.063578537477|TIPIN;PKMYT1|5
7919|positive regulation of cellular protein metabolic process (GO:0032270)|2/92|0.0467708228297801|1|0|0|5.79710144927536|17.7535983437018|HSP90AA1;UHRF1|5
7920|positive regulation of histone H3-K4 methylation (GO:0051571)|1/13|0.0476818194198419|1|0|0|20.5128205128205|62.4247199585617|DNMT1|5
7921|cellular response to low-density lipoprotein particle stimulus (GO:0071404)|1/13|0.0476818194198419|1|0|0|20.5128205128205|62.4247199585617|CD36|5
7922|intestinal absorption (GO:0050892)|1/13|0.0476818194198419|1|0|0|20.5128205128205|62.4247199585617|CD36|5
7923|DNA replication-independent nucleosome organization (GO:0034724)|1/13|0.0476818194198419|1|0|0|20.5128205128205|62.4247199585617|NASP|5
7924|response to fatty acid (GO:0070542)|1/13|0.0476818194198419|1|0|0|20.5128205128205|62.4247199585617|CD36|5
7925|tetrahydrofolate metabolic process (GO:0046653)|1/13|0.0476818194198419|1|0|0|20.5128205128205|62.4247199585617|DHFR|5
7926|chromatin assembly or disassembly (GO:0006333)|1/13|0.0476818194198419|1|0|0|20.5128205128205|62.4247199585617|CHAF1A|5
7927|mitotic DNA integrity checkpoint (GO:0044774)|1/13|0.0476818194198419|1|0|0|20.5128205128205|62.4247199585617|TOPBP1|5
7928|sensory perception of taste (GO:0050909)|1/13|0.0476818194198419|1|0|0|20.5128205128205|62.4247199585617|CD36|5
7929|regulation of cytoskeleton organization (GO:0051493)|2/96|0.0504678942317755|1|0|0|5.55555555555556|16.5912105703729|STMN1;CDK2AP2|5
7930|DNA modification (GO:0006304)|1/14|0.0512553266419404|1|0|0|19.047619047619|56.5892520359533|UNG|5
7931|regulation of lymphocyte differentiation (GO:0045619)|1/14|0.0512553266419404|1|0|0|19.047619047619|56.5892520359533|CD2|5
7932|lipid particle organization (GO:0034389)|1/14|0.0512553266419404|1|0|0|19.047619047619|56.5892520359533|CIDEC|5
7933|regulation of response to interferon-gamma (GO:0060330)|1/14|0.0512553266419404|1|0|0|19.047619047619|56.5892520359533|HSP90AB1|5
7934|regulation of phosphate metabolic process (GO:0019220)|1/14|0.0512553266419404|1|0|0|19.047619047619|56.5892520359533|MCM7|5
7935|cellular response to nitrogen compound (GO:1901699)|1/14|0.0512553266419404|1|0|0|19.047619047619|56.5892520359533|TIMELESS|5
7936|positive regulation of interleukin-8 secretion (GO:2000484)|1/14|0.0512553266419404|1|0|0|19.047619047619|56.5892520359533|CD2|5
7937|negative regulation of Rho protein signal transduction (GO:0035024)|1/14|0.0512553266419404|1|0|0|19.047619047619|56.5892520359533|STMN1|5
7938|regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266)|1/14|0.0512553266419404|1|0|0|19.047619047619|56.5892520359533|CDT1|5
7939|Ras protein signal transduction (GO:0007265)|3/224|0.0520148034924465|1|0|0|3.57142857142857|10.5579532798859|RAB44;DNMT1;CDC42EP3|5
7940|positive regulation of double-strand break repair (GO:2000781)|1/15|0.0548156030017759|1|0|0|17.7777777777778|51.6227626532486|TIMELESS|5
7941|positive regulation of protein export from nucleus (GO:0046827)|1/15|0.0548156030017759|1|0|0|17.7777777777778|51.6227626532486|ANP32B|5
7942|intra-S DNA damage checkpoint (GO:0031573)|1/15|0.0548156030017759|1|0|0|17.7777777777778|51.6227626532486|TIPIN|5
7943|microtubule depolymerization (GO:0007019)|1/15|0.0548156030017759|1|0|0|17.7777777777778|51.6227626532486|STMN1|5
7944|positive regulation of phosphoprotein phosphatase activity (GO:0032516)|1/15|0.0548156030017759|1|0|0|17.7777777777778|51.6227626532486|HSP90AB1|5
7945|regulation of lipid metabolic process (GO:0019216)|2/101|0.0552321202058897|1|0|0|5.28052805280528|15.293521357847|FABP1;CD36|5
7946|apoptotic process (GO:0006915)|3/232|0.0566219708579334|1|0|0|3.44827586206897|9.90123514273265|CD2;CIDEC;MCM2|5
7947|regulation of energy homeostasis (GO:2000505)|1/16|0.0583626967999996|1|0|0|16.6666666666667|47.3513057777084|CD36|5
7948|DNA methylation or demethylation (GO:0044728)|1/16|0.0583626967999996|1|0|0|16.6666666666667|47.3513057777084|DNMT1|5
7949|DNA alkylation (GO:0006305)|1/16|0.0583626967999996|1|0|0|16.6666666666667|47.3513057777084|DNMT1|5
7950|establishment of skin barrier (GO:0061436)|1/16|0.0583626967999996|1|0|0|16.6666666666667|47.3513057777084|STMN1|5
7951|positive regulation of nitric-oxide synthase activity (GO:0051000)|1/16|0.0583626967999996|1|0|0|16.6666666666667|47.3513057777084|DHFR|5
7952|positive regulation of macrophage derived foam cell differentiation (GO:0010744)|1/16|0.0583626967999996|1|0|0|16.6666666666667|47.3513057777084|CD36|5
7953|regulation of reactive oxygen species biosynthetic process (GO:1903426)|1/16|0.0583626967999996|1|0|0|16.6666666666667|47.3513057777084|CD36|5
7954|regulation of water loss via skin (GO:0033561)|1/16|0.0583626967999996|1|0|0|16.6666666666667|47.3513057777084|STMN1|5
7955|regulation of histone H3-K4 methylation (GO:0051569)|1/16|0.0583626967999996|1|0|0|16.6666666666667|47.3513057777084|DNMT1|5
7956|negative regulation of DNA replication (GO:0008156)|1/16|0.0583626967999996|1|0|0|16.6666666666667|47.3513057777084|GMNN|5
7957|positive regulation of dendrite extension (GO:1903861)|1/17|0.0618966561391051|1|0|0|15.6862745098039|43.643750919539|CPNE5|5
7958|regulation of cellular protein catabolic process (GO:1903362)|1/17|0.0618966561391051|1|0|0|15.6862745098039|43.643750919539|HSP90AA1|5
7959|positive regulation of leukocyte activation (GO:0002696)|1/17|0.0618966561391051|1|0|0|15.6862745098039|43.643750919539|CD2|5
7960|cellular response to inorganic substance (GO:0071241)|1/17|0.0618966561391051|1|0|0|15.6862745098039|43.643750919539|TIMELESS|5
7961|RNA stabilization (GO:0043489)|1/17|0.0618966561391051|1|0|0|15.6862745098039|43.643750919539|E2F1|5
7962|negative regulation of stress fiber assembly (GO:0051497)|1/17|0.0618966561391051|1|0|0|15.6862745098039|43.643750919539|STMN1|5
7963|positive regulation of cellular protein catabolic process (GO:1903364)|1/17|0.0618966561391051|1|0|0|15.6862745098039|43.643750919539|HSP90AA1|5
7964|DNA packaging (GO:0006323)|1/17|0.0618966561391051|1|0|0|15.6862745098039|43.643750919539|CHAF1A|5
7965|mitotic G2 DNA damage checkpoint (GO:0007095)|1/17|0.0618966561391051|1|0|0|15.6862745098039|43.643750919539|TOPBP1|5
7966|viral life cycle (GO:0019058)|2/108|0.0621556496579175|1|0|0|4.93827160493827|13.7190793163957|HSP90AB1;DEK|5
7967|DNA methylation (GO:0006306)|1/18|0.0654175289767129|1|0|0|14.8148148148148|40.3994819150368|DNMT1|5
7968|regulation of microtubule polymerization or depolymerization (GO:0031110)|1/18|0.0654175289767129|1|0|0|14.8148148148148|40.3994819150368|STMN1|5
7969|mitotic recombination (GO:0006312)|1/18|0.0654175289767129|1|0|0|14.8148148148148|40.3994819150368|CENPS|5
7970|regulation of dendrite extension (GO:1903859)|1/18|0.0654175289767129|1|0|0|14.8148148148148|40.3994819150368|CPNE5|5
7971|anion homeostasis (GO:0055081)|1/18|0.0654175289767129|1|0|0|14.8148148148148|40.3994819150368|POLD1|5
7972|regulation of organelle organization (GO:0033043)|2/114|0.0683123410393738|1|0|0|4.67836257309941|12.5551571462484|CDT1;STMN1|5
7973|positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511)|1/19|0.0689253631035834|1|0|0|14.0350877192982|37.5400849682693|HSP90AB1|5
7974|positive regulation of chromosome organization (GO:2001252)|1/19|0.0689253631035834|1|0|0|14.0350877192982|37.5400849682693|FEN1|5
7975|positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846)|1/19|0.0689253631035834|1|0|0|14.0350877192982|37.5400849682693|HSP90AB1|5
7976|morphogenesis of an epithelium (GO:0002009)|1/19|0.0689253631035834|1|0|0|14.0350877192982|37.5400849682693|TIMELESS|5
7977|folic acid metabolic process (GO:0046655)|1/19|0.0689253631035834|1|0|0|14.0350877192982|37.5400849682693|DHFR|5
7978|epithelium development (GO:0060429)|2/116|0.0704079577954225|1|0|0|4.59770114942529|12.1997654498369|PCNA;TIMELESS|5
7979|chromatin remodeling (GO:0006338)|2/117|0.0714636593121146|1|0|0|4.55840455840456|12.0276522842612|DEK;ANP32B|5
7980|covalent chromatin modification (GO:0016569)|1/20|0.0724202061022377|1|0|0|13.3333333333333|35.0035990495849|HELLS|5
7981|regulation of toll-like receptor signaling pathway (GO:0034121)|1/20|0.0724202061022377|1|0|0|13.3333333333333|35.0035990495849|CD36|5
7982|negative regulation of actin filament bundle assembly (GO:0032232)|1/20|0.0724202061022377|1|0|0|13.3333333333333|35.0035990495849|STMN1|5
7983|immune response-activating cell surface receptor signaling pathway (GO:0002429)|1/20|0.0724202061022377|1|0|0|13.3333333333333|35.0035990495849|FPR1|5
7984|wound healing, spreading of cells (GO:0044319)|1/20|0.0724202061022377|1|0|0|13.3333333333333|35.0035990495849|PLET1|5
7985|regulation of transcription, DNA-templated (GO:0006355)|10/1599|0.0746982373029976|1|0|0|1.66770898478216|4.32653539151392|TCF19;DHFR;CDT1;PCNA;CDC45;GMNN;ATAD2;TIMELESS;E2F1;DEK|5
7986|positive regulation of cell proliferation (GO:0008284)|4/425|0.0755101801911448|1|0|0|2.50980392156863|6.4840477988343|TIPIN;CCND2;E2F1;NAP1L1|5
7987|regulation of nuclear division (GO:0051783)|1/21|0.0759021054679521|1|0|0|12.6984126984127|32.7404553008201|PKMYT1|5
7988|nucleotide-excision repair, preincision complex stabilization (GO:0006293)|1/21|0.0759021054679521|1|0|0|12.6984126984127|32.7404553008201|RPA2|5
7989|negative regulation of G-protein coupled receptor protein signaling pathway (GO:0045744)|1/21|0.0759021054679521|1|0|0|12.6984126984127|32.7404553008201|STMN1|5
7990|negative regulation of cell cycle arrest (GO:0071157)|1/21|0.0759021054679521|1|0|0|12.6984126984127|32.7404553008201|HSP90AB1|5
7991|histone ubiquitination (GO:0016574)|1/21|0.0759021054679521|1|0|0|12.6984126984127|32.7404553008201|UHRF1|5
7992|regulation of cell differentiation (GO:0045595)|2/122|0.076818993034902|1|0|0|4.37158469945355|11.2188125213615|HSP90AB1;ANP32B|5
7993|endocytosis (GO:0006897)|3/264|0.0768942648906345|1|0|0|3.03030303030303|7.77370904256686|MARCO;HSP90AA1;CD36|5
7994|negative regulation of cell cycle G1/S phase transition (GO:1902807)|1/22|0.0793711084262535|1|0|0|12.1212121212121|30.7105557657203|CDK2AP2|5
7995|regulation of interferon-gamma-mediated signaling pathway (GO:0060334)|1/22|0.0793711084262535|1|0|0|12.1212121212121|30.7105557657203|HSP90AB1|5
7996|negative regulation of protein polymerization (GO:0032272)|1/22|0.0793711084262535|1|0|0|12.1212121212121|30.7105557657203|STMN1|5
7997|positive regulation of biosynthetic process (GO:0009891)|1/22|0.0793711084262535|1|0|0|12.1212121212121|30.7105557657203|CD36|5
7998|positive regulation of phosphatase activity (GO:0010922)|1/22|0.0793711084262535|1|0|0|12.1212121212121|30.7105557657203|HSP90AB1|5
7999|sterol transport (GO:0015918)|1/22|0.0793711084262535|1|0|0|12.1212121212121|30.7105557657203|CD36|5
8000|nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)|1/22|0.0793711084262535|1|0|0|12.1212121212121|30.7105557657203|RPA2|5
8001|triglyceride catabolic process (GO:0019433)|1/22|0.0793711084262535|1|0|0|12.1212121212121|30.7105557657203|FABP1|5
8002|viral genome replication (GO:0019079)|1/22|0.0793711084262535|1|0|0|12.1212121212121|30.7105557657203|DEK|5
8003|negative regulation of gene expression (GO:0010629)|5/619|0.0827278731708788|1|0|0|2.15401184706516|5.36822551251789|DHFR;DNMT1;GMNN;TIMELESS;E2F1|5
8004|mitotic G2/M transition checkpoint (GO:0044818)|1/23|0.0828272621163735|1|0|0|11.5942028985507|28.8811364541387|TOPBP1|5
8005|regulation of monooxygenase activity (GO:0032768)|1/23|0.0828272621163735|1|0|0|11.5942028985507|28.8811364541387|HSP90AA1|5
8006|microtubule polymerization or depolymerization (GO:0031109)|1/23|0.0828272621163735|1|0|0|11.5942028985507|28.8811364541387|STMN1|5
8007|cellular response to amyloid-beta (GO:1904646)|1/23|0.0828272621163735|1|0|0|11.5942028985507|28.8811364541387|CD36|5
8008|positive regulation of monooxygenase activity (GO:0032770)|1/23|0.0828272621163735|1|0|0|11.5942028985507|28.8811364541387|DHFR|5
8009|regulation of interleukin-8 secretion (GO:2000482)|1/23|0.0828272621163735|1|0|0|11.5942028985507|28.8811364541387|CD2|5
8010|folic acid-containing compound metabolic process (GO:0006760)|1/23|0.0828272621163735|1|0|0|11.5942028985507|28.8811364541387|DHFR|5
8011|positive regulation of macromolecule metabolic process (GO:0010604)|3/277|0.085929062266976|1|0|0|2.88808664259928|7.08803806634339|DNMT1;E2F1;CD36|5
8012|positive regulation of histone methylation (GO:0031062)|1/25|0.0897012092618636|1|0|0|10.6666666666667|25.7202243074993|DNMT1|5
8013|histone monoubiquitination (GO:0010390)|1/25|0.0897012092618636|1|0|0|10.6666666666667|25.7202243074993|UHRF1|5
8014|regulation of chromosome organization (GO:0033044)|1/25|0.0897012092618636|1|0|0|10.6666666666667|25.7202243074993|CDT1|5
8015|negative regulation of G1/S transition of mitotic cell cycle (GO:2000134)|1/25|0.0897012092618636|1|0|0|10.6666666666667|25.7202243074993|CDK2AP2|5
8016|negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435)|1/25|0.0897012092618636|1|0|0|10.6666666666667|25.7202243074993|HSP90AB1|5
8017|regulation of cell cycle G1/S phase transition (GO:1902806)|1/25|0.0897012092618636|1|0|0|10.6666666666667|25.7202243074993|E2F1|5
8018|positive regulation of cytosolic calcium ion concentration (GO:0007204)|2/134|0.0901629446183339|1|0|0|3.98009950248756|9.57666368105286|FPR1;CD36|5
8019|Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096)|2/134|0.0901629446183339|1|0|0|3.98009950248756|9.57666368105286|HSP90AA1;HSP90AB1|5
8020|Fc-gamma receptor signaling pathway (GO:0038094)|2/135|0.0913043026797096|1|0|0|3.95061728395062|9.45602909890456|HSP90AA1;HSP90AB1|5
8021|adenylate cyclase-modulating G-protein coupled receptor signaling pathway (GO:0007188)|2/135|0.0913043026797096|1|0|0|3.95061728395062|9.45602909890456|MARCO;FPR1|5
8022|Fc receptor mediated stimulatory signaling pathway (GO:0002431)|2/136|0.0924499527919974|1|0|0|3.92156862745098|9.33759934032132|HSP90AA1;HSP90AB1|5
8023|heterotypic cell-cell adhesion (GO:0034113)|1/26|0.0931190960947256|1|0|0|10.2564102564103|24.3474461736683|CD2|5
8024|long-chain fatty acid transport (GO:0015909)|1/26|0.0931190960947256|1|0|0|10.2564102564103|24.3474461736683|CD36|5
8025|negative regulation of gene expression, epigenetic (GO:0045814)|1/26|0.0931190960947256|1|0|0|10.2564102564103|24.3474461736683|DNMT1|5
8026|protein depolymerization (GO:0051261)|1/26|0.0931190960947256|1|0|0|10.2564102564103|24.3474461736683|STMN1|5
8027|negative regulation of cellular protein localization (GO:1903828)|1/26|0.0931190960947256|1|0|0|10.2564102564103|24.3474461736683|CDT1|5
8028|response to amyloid-beta (GO:1904645)|1/26|0.0931190960947256|1|0|0|10.2564102564103|24.3474461736683|CD36|5
8029|regulation of cytosolic calcium ion concentration (GO:0051480)|2/138|0.0947539407521392|1|0|0|3.86473429951691|9.10713756457153|FPR1;CD36|5
8030|regulation of signal transduction by p53 class mediator (GO:1901796)|2/139|0.0959121851144226|1|0|0|3.83693045563549|8.99500141787704|RPA2;TOPBP1|5
8031|positive regulation of cyclin-dependent protein kinase activity (GO:1904031)|1/27|0.0965243203976376|1|0|0|9.87654320987654|23.0909657041396|CCND2|5
8032|cytoskeleton-dependent intracellular transport (GO:0030705)|1/27|0.0965243203976376|1|0|0|9.87654320987654|23.0909657041396|TUBA1B|5
8033|regulation of microtubule-based process (GO:0032886)|1/27|0.0965243203976376|1|0|0|9.87654320987654|23.0909657041396|CDK2AP2|5
8034|nucleotide biosynthetic process (GO:0009165)|1/27|0.0965243203976376|1|0|0|9.87654320987654|23.0909657041396|RRM1|5
8035|regulation of primary metabolic process (GO:0080090)|2/140|0.0970745345359643|1|0|0|3.80952380952381|8.88486170768312|FABP1;CD36|5
8036|double-strand break repair (GO:0006302)|2/142|0.0994113646892493|1|0|0|3.75586854460094|8.67038061583205|FEN1;RPA2|5
8037|negative regulation of cell-matrix adhesion (GO:0001953)|1/28|0.0999169284620474|1|0|0|9.52380952380952|21.9372967010362|PLET1|5
8038|negative regulation of microtubule polymerization or depolymerization (GO:0031111)|1/28|0.0999169284620474|1|0|0|9.52380952380952|21.9372967010362|STMN1|5
8039|regulation of double-strand break repair via homologous recombination (GO:0010569)|1/28|0.0999169284620474|1|0|0|9.52380952380952|21.9372967010362|RPA2|5
8040|protein localization to chromosome (GO:0034502)|1/28|0.0999169284620474|1|0|0|9.52380952380952|21.9372967010362|RPA2|5
8041|regulation of protein localization to cell surface (GO:2000008)|1/28|0.0999169284620474|1|0|0|9.52380952380952|21.9372967010362|HSP90AB1|5
8042|cellular protein complex assembly (GO:0043623)|2/145|0.102946255919307|1|0|0|3.67816091954023|8.36247618987403|HSP90AA1;HSP90AB1|5
8043|cellular response to hydrogen peroxide (GO:0070301)|1/29|0.103296966374445|1|0|0|9.19540229885057|20.8749174292202|FABP1|5
8044|RNA phosphodiester bond hydrolysis (GO:0090501)|1/29|0.103296966374445|1|0|0|9.19540229885057|20.8749174292202|RNASE6|5
8045|negative regulation of proteasomal protein catabolic process (GO:1901799)|1/29|0.103296966374445|1|0|0|9.19540229885057|20.8749174292202|HSP90AB1|5
8046|primary neural tube formation (GO:0014020)|1/29|0.103296966374445|1|0|0|9.19540229885057|20.8749174292202|LMO4|5
8047|positive regulation of fibroblast proliferation (GO:0048146)|1/29|0.103296966374445|1|0|0|9.19540229885057|20.8749174292202|E2F1|5
8048|nucleotide-excision repair, preincision complex assembly (GO:0006294)|1/30|0.106664480081935|1|0|0|8.88888888888889|19.8939295226529|RPA2|5
8049|regulation of macrophage derived foam cell differentiation (GO:0010743)|1/30|0.106664480081935|1|0|0|8.88888888888889|19.8939295226529|CD36|5
8050|MyD88-dependent toll-like receptor signaling pathway (GO:0002755)|1/30|0.106664480081935|1|0|0|8.88888888888889|19.8939295226529|CD36|5
8051|coenzyme biosynthetic process (GO:0009108)|1/30|0.106664480081935|1|0|0|8.88888888888889|19.8939295226529|DHFR|5
8052|tube closure (GO:0060606)|1/30|0.106664480081935|1|0|0|8.88888888888889|19.8939295226529|LMO4|5
8053|carbohydrate derivative biosynthetic process (GO:1901137)|1/30|0.106664480081935|1|0|0|8.88888888888889|19.8939295226529|RRM1|5
8054|positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740)|1/31|0.110019515356612|1|0|0|8.60215053763441|18.9857850889686|E2F1|5
8055|regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739)|1/31|0.110019515356612|1|0|0|8.60215053763441|18.9857850889686|E2F1|5
8056|acylglycerol catabolic process (GO:0046464)|1/31|0.110019515356612|1|0|0|8.60215053763441|18.9857850889686|FABP1|5
8057|positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737)|1/31|0.110019515356612|1|0|0|8.60215053763441|18.9857850889686|CCND2|5
8058|negative regulation of cell differentiation (GO:0045596)|2/151|0.110118342537561|1|0|0|3.53200883002208|7.79231664544505|E2F1;ANP32B|5
8059|protein stabilization (GO:0050821)|2/153|0.112538066128137|1|0|0|3.48583877995643|7.61468844962771|HSP90AA1;HSP90AB1|5
8060|regulation of protein export from nucleus (GO:0046825)|1/32|0.113362117833025|1|0|0|8.33333333333333|18.1430666784008|ANP32B|5
8061|sarcomere organization (GO:0045214)|1/32|0.113362117833025|1|0|0|8.33333333333333|18.1430666784008|KRT19|5
8062|positive regulation of protein dephosphorylation (GO:0035307)|1/32|0.113362117833025|1|0|0|8.33333333333333|18.1430666784008|HSP90AB1|5
8063|regulation of cell migration (GO:0030334)|3/317|0.116341362605399|1|0|0|2.52365930599369|5.42896309980796|LMO4;PLET1;SYNE2|5
8064|cyclic-nucleotide-mediated signaling (GO:0019935)|1/33|0.11669233292012|1|0|0|8.08080808080808|17.359308613368|CD36|5
8065|negative regulation of fat cell differentiation (GO:0045599)|1/33|0.11669233292012|1|0|0|8.08080808080808|17.359308613368|E2F1|5
8066|G2 DNA damage checkpoint (GO:0031572)|1/33|0.11669233292012|1|0|0|8.08080808080808|17.359308613368|TOPBP1|5
8067|positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557)|1/33|0.11669233292012|1|0|0|8.08080808080808|17.359308613368|CD2|5
8068|ribonucleoprotein complex assembly (GO:0022618)|2/157|0.117419001790254|1|0|0|3.39702760084926|7.27645530215667|HSP90AA1;HSP90AB1|5
8069|positive regulation of cell-matrix adhesion (GO:0001954)|1/34|0.120010205926817|1|0|0|7.84313725490196|16.6288509053055|CD36|5
8070|regulation of DNA recombination (GO:0000018)|1/34|0.120010205926817|1|0|0|7.84313725490196|16.6288509053055|RPA2|5
8071|regulation of T cell differentiation (GO:0045580)|1/34|0.120010205926817|1|0|0|7.84313725490196|16.6288509053055|CD2|5
8072|positive regulation of nucleocytoplasmic transport (GO:0046824)|1/34|0.120010205926817|1|0|0|7.84313725490196|16.6288509053055|ANP32B|5
8073|mRNA stabilization (GO:0048255)|1/34|0.120010205926817|1|0|0|7.84313725490196|16.6288509053055|E2F1|5
8074|neural tube closure (GO:0001843)|1/34|0.120010205926817|1|0|0|7.84313725490196|16.6288509053055|LMO4|5
8075|negative regulation of DNA binding (GO:0043392)|1/35|0.123315781960114|1|0|0|7.61904761904762|15.9467190900593|E2F1|5
8076|positive regulation of protein modification process (GO:0031401)|2/164|0.126086816224755|1|0|0|3.2520325203252|6.73425883459369|MARCO;CCND2|5
8077|negative regulation of cellular macromolecule biosynthetic process (GO:2000113)|4/513|0.12657965200048|1|0|0|2.07927225471085|4.29761353374285|DHFR;GMNN;TIMELESS;E2F1|5
8078|positive regulation of ATPase activity (GO:0032781)|1/36|0.126609105996689|1|0|0|7.40740740740741|15.3085247744791|UHRF1|5
8079|regulation of phosphoprotein phosphatase activity (GO:0043666)|1/36|0.126609105996689|1|0|0|7.40740740740741|15.3085247744791|HSP90AB1|5
8080|antibacterial humoral response (GO:0019731)|1/36|0.126609105996689|1|0|0|7.40740740740741|15.3085247744791|RNASE6|5
8081|negative regulation of cell-substrate adhesion (GO:0010812)|1/36|0.126609105996689|1|0|0|7.40740740740741|15.3085247744791|PLET1|5
8082|regulation of microtubule polymerization (GO:0031113)|1/36|0.126609105996689|1|0|0|7.40740740740741|15.3085247744791|STMN1|5
8083|lymphocyte proliferation (GO:0046651)|1/37|0.129890222808885|1|0|0|7.20720720720721|14.7103828843132|HELLS|5
8084|natural killer cell activation (GO:0030101)|1/37|0.129890222808885|1|0|0|7.20720720720721|14.7103828843132|CD2|5
8085|regulation of response to DNA damage stimulus (GO:2001020)|1/37|0.129890222808885|1|0|0|7.20720720720721|14.7103828843132|RPA2|5
8086|negative regulation of Ras protein signal transduction (GO:0046580)|1/38|0.133159177056584|1|0|0|7.01754385964912|14.1488424309065|STMN1|5
8087|protein monoubiquitination (GO:0006513)|1/38|0.133159177056584|1|0|0|7.01754385964912|14.1488424309065|UHRF1|5
8088|negative regulation of G0 to G1 transition (GO:0070317)|1/38|0.133159177056584|1|0|0|7.01754385964912|14.1488424309065|E2F1|5
8089|positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030)|1/38|0.133159177056584|1|0|0|7.01754385964912|14.1488424309065|E2F1|5
8090|DNA damage checkpoint (GO:0000077)|1/39|0.136416013206019|1|0|0|6.83760683760684|13.6208283185803|E2F1|5
8091|positive regulation of reactive oxygen species metabolic process (GO:2000379)|1/40|0.139660775543874|1|0|0|6.66666666666667|13.1235921899634|CD36|5
8092|ERBB2 signaling pathway (GO:0038128)|1/40|0.139660775543874|1|0|0|6.66666666666667|13.1235921899634|HSP90AA1|5
8093|regulation of G0 to G1 transition (GO:0070316)|1/40|0.139660775543874|1|0|0|6.66666666666667|13.1235921899634|E2F1|5
8094|regulation of type I interferon-mediated signaling pathway (GO:0060338)|1/40|0.139660775543874|1|0|0|6.66666666666667|13.1235921899634|HSP90AB1|5
8095|DNA biosynthetic process (GO:0071897)|1/40|0.139660775543874|1|0|0|6.66666666666667|13.1235921899634|POLD1|5
8096|negative regulation of cellular process (GO:0048523)|4/535|0.141191682775378|1|0|0|1.99376947040498|3.90307660464049|CD164;ORC6;GMNN;ANP32B|5
8097|positive regulation of cell motility (GO:2000147)|2/180|0.146436201498844|1|0|0|2.96296296296296|5.69234201489043|PLET1;SYNE2|5
8098|positive regulation of interferon-gamma production (GO:0032729)|1/44|0.152519967788107|1|0|0|6.06060606060606|11.3967257890341|CD2|5
8099|nucleobase-containing compound catabolic process (GO:0034655)|1/44|0.152519967788107|1|0|0|6.06060606060606|11.3967257890341|RNASE6|5
8100|mitotic metaphase plate congression (GO:0007080)|1/44|0.152519967788107|1|0|0|6.06060606060606|11.3967257890341|CDT1|5
8101|negative regulation of DNA metabolic process (GO:0051053)|1/44|0.152519967788107|1|0|0|6.06060606060606|11.3967257890341|GMNN|5
8102|response to hydrogen peroxide (GO:0042542)|1/44|0.152519967788107|1|0|0|6.06060606060606|11.3967257890341|FABP1|5
8103|protein transmembrane import into intracellular organelle (GO:0044743)|1/44|0.152519967788107|1|0|0|6.06060606060606|11.3967257890341|HSP90AA1|5
8104|regulation of mitotic cell cycle phase transition (GO:1901990)|2/185|0.152930156515635|1|0|0|2.88288288288288|5.41340239330128|HSP90AA1;E2F1|5
8105|positive regulation of interleukin-8 production (GO:0032757)|1/45|0.155705020336328|1|0|0|5.92592592592593|11.0209893748851|CD2|5
8106|cholesterol transport (GO:0030301)|1/45|0.155705020336328|1|0|0|5.92592592592593|11.0209893748851|CD36|5
8107|regulation of T cell activation (GO:0050863)|1/45|0.155705020336328|1|0|0|5.92592592592593|11.0209893748851|CD2|5
8108|microtubule cytoskeleton organization involved in mitosis (GO:1902850)|1/45|0.155705020336328|1|0|0|5.92592592592593|11.0209893748851|STMN1|5
8109|protein complex subunit organization (GO:0071822)|1/46|0.15887826166449|1|0|0|5.79710144927536|10.6644464923499|CDT1|5
8110|regulation of fibroblast proliferation (GO:0048145)|1/47|0.162039734957786|1|0|0|5.67375886524823|10.3257514684151|E2F1|5
8111|regulation of DNA metabolic process (GO:0051052)|1/47|0.162039734957786|1|0|0|5.67375886524823|10.3257514684151|UHRF1|5
8112|positive regulation of gene expression (GO:0010628)|5/772|0.163489601789992|1|0|0|1.72711571675302|3.12781673278406|DNMT1;ATAD2;E2F1;CD36;DEK|5
8113|heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157)|1/48|0.165189483287278|1|0|0|5.55555555555556|10.0036782245017|CD164|5
8114|positive regulation of tumor necrosis factor production (GO:0032760)|1/48|0.165189483287278|1|0|0|5.55555555555556|10.0036782245017|CD2|5
8115|myofibril assembly (GO:0030239)|1/48|0.165189483287278|1|0|0|5.55555555555556|10.0036782245017|KRT19|5
8116|positive regulation of cell differentiation (GO:0045597)|2/195|0.1660830241145|1|0|0|2.73504273504274|4.91013325234456|HSP90AB1;CD36|5
8117|negative regulation of mitotic cell cycle (GO:0045930)|1/49|0.168327549526885|1|0|0|5.4421768707483|9.69710747325935|CDT1|5
8118|intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630)|1/49|0.168327549526885|1|0|0|5.4421768707483|9.69710747325935|E2F1|5
8119|cellular macromolecule catabolic process (GO:0044265)|1/49|0.168327549526885|1|0|0|5.4421768707483|9.69710747325935|RNASE6|5
8120|pattern recognition receptor signaling pathway (GO:0002221)|1/49|0.168327549526885|1|0|0|5.4421768707483|9.69710747325935|CD36|5
8121|regulation of cell cycle arrest (GO:0071156)|1/49|0.168327549526885|1|0|0|5.4421768707483|9.69710747325935|HSP90AB1|5
8122|positive regulation of response to DNA damage stimulus (GO:2001022)|1/50|0.171453976440458|1|0|0|5.33333333333333|9.40501550580596|PCNA|5
8123|antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844)|1/50|0.171453976440458|1|0|0|5.33333333333333|9.40501550580596|RNASE6|5
8124|protein autoubiquitination (GO:0051865)|1/50|0.171453976440458|1|0|0|5.33333333333333|9.40501550580596|UHRF1|5
8125|lipid homeostasis (GO:0055088)|1/50|0.171453976440458|1|0|0|5.33333333333333|9.40501550580596|POLD1|5
8126|regulation of cellular protein metabolic process (GO:0032268)|1/51|0.174568806612126|1|0|0|5.22875816993464|9.12646435464318|UHRF1|5
8127|receptor internalization (GO:0031623)|1/51|0.174568806612126|1|0|0|5.22875816993464|9.12646435464318|CD36|5
8128|positive regulation of ERK1 and ERK2 cascade (GO:0070374)|2/202|0.175406293227658|1|0|0|2.64026402640264|4.59577642348939|MARCO;CD36|5
8129|response to organonitrogen compound (GO:0010243)|1/52|0.177672082461433|1|0|0|5.12820512820513|8.86059313359808|DHFR|5
8130|positive regulation of developmental growth (GO:0048639)|1/52|0.177672082461433|1|0|0|5.12820512820513|8.86059313359808|CPNE5|5
8131|positive regulation of actin filament polymerization (GO:0030838)|1/52|0.177672082461433|1|0|0|5.12820512820513|8.86059313359808|CDC42EP3|5
8132|triglyceride metabolic process (GO:0006641)|1/53|0.180763846278519|1|0|0|5.0314465408805|8.60661039644509|FABP1|5
8133|positive regulation of cell-substrate adhesion (GO:0010811)|1/53|0.180763846278519|1|0|0|5.0314465408805|8.60661039644509|CD36|5
8134|protein targeting to mitochondrion (GO:0006626)|1/55|0.186913006220593|1|0|0|4.84848484848485|8.13145201331677|HSP90AA1|5
8135|negative regulation of supramolecular fiber organization (GO:1902904)|1/55|0.186913006220593|1|0|0|4.84848484848485|8.13145201331677|STMN1|5
8136|DNA recombination (GO:0006310)|1/56|0.189970486148674|1|0|0|4.76190476190476|7.90898359498646|CENPS|5
8137|regulation of apoptotic process (GO:0042981)|5/816|0.191183571929492|1|0|0|1.63398692810458|2.70346601785474|FABP1;CCND2;E2F1;ANP32B;CIDEC|5
8138|chromosome organization (GO:0051276)|1/57|0.193016621631011|1|0|0|4.67836257309941|7.69580805307652|CDT1|5
8139|regulation of cell cycle (GO:0051726)|2/216|0.194292099729515|1|0|0|2.46913580246914|4.04541378664835|GMNN;PKMYT1|5
8140|positive regulation of cell death (GO:0010942)|1/58|0.196051454213978|1|0|0|4.59770114942529|7.49139371358377|CD36|5
8141|regulation of Rho protein signal transduction (GO:0035023)|1/58|0.196051454213978|1|0|0|4.59770114942529|7.49139371358377|STMN1|5
8142|receptor metabolic process (GO:0043112)|1/59|0.199075025286932|1|0|0|4.51977401129944|7.29524752007456|CD36|5
8143|response to light stimulus (GO:0009416)|1/59|0.199075025286932|1|0|0|4.51977401129944|7.29524752007456|POLD1|5
8144|dicarboxylic acid metabolic process (GO:0043648)|1/60|0.202087376056138|1|0|0|4.44444444444444|7.10691164609958|DHFR|5
8145|mitotic cytokinesis (GO:0000281)|1/60|0.202087376056138|1|0|0|4.44444444444444|7.10691164609958|STMN1|5
8146|positive regulation of cell migration (GO:0030335)|2/222|0.202467631241738|1|0|0|2.4024024024024|3.83705765989681|PLET1;SYNE2|5
8147|regulation of stress fiber assembly (GO:0051492)|1/61|0.205088547600307|1|0|0|4.37158469945355|6.92596045284832|STMN1|5
8148|cell chemotaxis (GO:0060326)|1/61|0.205088547600307|1|0|0|4.37158469945355|6.92596045284832|FPR1|5
8149|regulation of tumor necrosis factor production (GO:0032680)|1/62|0.208078580865853|1|0|0|4.3010752688172|6.75199775484814|CD2|5
8150|diterpenoid metabolic process (GO:0016101)|1/63|0.211057516597305|1|0|0|4.23280423280423|6.58465435827962|E2F1|5
8151|negative regulation of dephosphorylation (GO:0035305)|1/64|0.214025395492633|1|0|0|4.16666666666667|6.42358583531148|PKMYT1|5
8152|adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway (GO:0007193)|1/64|0.214025395492633|1|0|0|4.16666666666667|6.42358583531148|MARCO|5
8153|cellular response to decreased oxygen levels (GO:0036294)|1/65|0.216982257960242|1|0|0|4.1025641025641|6.26847052035336|FABP1|5
8154|positive regulation of protein polymerization (GO:0032273)|1/65|0.216982257960242|1|0|0|4.1025641025641|6.26847052035336|CDC42EP3|5
8155|cellular response to reactive oxygen species (GO:0034614)|1/66|0.219928144383953|1|0|0|4.04040404040404|6.11900768653381|FABP1|5
8156|defense response to Gram-positive bacterium (GO:0050830)|1/66|0.219928144383953|1|0|0|4.04040404040404|6.11900768653381|RNASE6|5
8157|negative regulation of cell adhesion (GO:0007162)|1/66|0.219928144383953|1|0|0|4.04040404040404|6.11900768653381|CD164|5
8158|positive regulation of protein modification by small protein conjugation or removal (GO:1903322)|1/66|0.219928144383953|1|0|0|4.04040404040404|6.11900768653381|CENPS|5
8159|regulation of actin filament polymerization (GO:0030833)|1/69|0.228700348546935|1|0|0|3.86473429951691|5.70180735814104|CDC42EP3|5
8160|negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154)|1/69|0.228700348546935|1|0|0|3.86473429951691|5.70180735814104|FABP1|5
8161|protein sumoylation (GO:0016925)|1/69|0.228700348546935|1|0|0|3.86473429951691|5.70180735814104|PCNA|5
8162|negative regulation of phosphatase activity (GO:0010923)|1/69|0.228700348546935|1|0|0|3.86473429951691|5.70180735814104|PKMYT1|5
8163|response to organic cyclic compound (GO:0014070)|1/70|0.231602731258814|1|0|0|3.80952380952381|5.57231139182009|DHFR|5
8164|positive regulation of plasma membrane bounded cell projection assembly (GO:0120034)|1/70|0.231602731258814|1|0|0|3.80952380952381|5.57231139182009|CDC42EP3|5
8165|negative regulation of nucleic acid-templated transcription (GO:1903507)|3/445|0.233377314008819|1|0|0|1.79775280898876|2.61590788630897|GMNN;TIMELESS;E2F1|5
8166|negative regulation of developmental process (GO:0051093)|1/71|0.234494337459798|1|0|0|3.75586854460094|5.44722568518433|ANP32B|5
8167|Rab protein signal transduction (GO:0032482)|1/71|0.234494337459798|1|0|0|3.75586854460094|5.44722568518433|RAB44|5
8168|vascular endothelial growth factor receptor signaling pathway (GO:0048010)|1/71|0.234494337459798|1|0|0|3.75586854460094|5.44722568518433|HSP90AA1|5
8169|cytoskeleton-dependent cytokinesis (GO:0061640)|1/71|0.234494337459798|1|0|0|3.75586854460094|5.44722568518433|STMN1|5
8170|actomyosin structure organization (GO:0031032)|1/72|0.237375206592249|1|0|0|3.7037037037037|5.32634533159223|KRT19|5
8171|defense response to Gram-negative bacterium (GO:0050829)|1/72|0.237375206592249|1|0|0|3.7037037037037|5.32634533159223|RNASE6|5
8172|regulation of ERK1 and ERK2 cascade (GO:0070372)|2/248|0.238287198100678|1|0|0|2.1505376344086|3.08447014644502|MARCO;CD36|5
8173|negative regulation of cysteine-type endopeptidase activity (GO:2000117)|1/73|0.240245378007423|1|0|0|3.65296803652968|5.20947751444507|FABP1|5
8174|regulation of phosphatase activity (GO:0010921)|1/73|0.240245378007423|1|0|0|3.65296803652968|5.20947751444507|PKMYT1|5
8175|Rho protein signal transduction (GO:0007266)|1/73|0.240245378007423|1|0|0|3.65296803652968|5.20947751444507|CDC42EP3|5
8176|negative regulation of cell cycle (GO:0045786)|1/73|0.240245378007423|1|0|0|3.65296803652968|5.20947751444507|GMNN|5
8177|regulation of fat cell differentiation (GO:0045598)|1/73|0.240245378007423|1|0|0|3.65296803652968|5.20947751444507|E2F1|5
8178|positive regulation of cytokine secretion (GO:0050715)|1/74|0.243104890883722|1|0|0|3.6036036036036|5.09644064521903|CD2|5
8179|cellular response to cytokine stimulus (GO:0071345)|3/457|0.245360255264234|1|0|0|1.75054704595186|2.45956712264429|HSP90AA1;FPR1;CD36|5
8180|mitotic spindle organization (GO:0007052)|1/75|0.245953784241585|1|0|0|3.55555555555556|4.98706357203911|STMN1|5
8181|antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)|1/76|0.24879209709571|1|0|0|3.50877192982456|4.8811848516013|CD36|5
8182|negative regulation of cellular amide metabolic process (GO:0034249)|1/76|0.24879209709571|1|0|0|3.50877192982456|4.8811848516013|DHFR|5
8183|C-terminal protein lipidation (GO:0006501)|1/76|0.24879209709571|1|0|0|3.50877192982456|4.8811848516013|PLET1|5
8184|retinoid metabolic process (GO:0001523)|1/76|0.24879209709571|1|0|0|3.50877192982456|4.8811848516013|E2F1|5
8185|hemopoiesis (GO:0030097)|1/77|0.251619868089879|1|0|0|3.46320346320346|4.77865208762832|CD164|5
8186|positive regulation of cytoskeleton organization (GO:0051495)|1/78|0.254437135924668|1|0|0|3.41880341880342|4.67932131153082|CDC42EP3|5
8187|water-soluble vitamin metabolic process (GO:0006767)|1/78|0.254437135924668|1|0|0|3.41880341880342|4.67932131153082|DHFR|5
8188|response to ionizing radiation (GO:0010212)|1/78|0.254437135924668|1|0|0|3.41880341880342|4.67932131153082|TOPBP1|5
8189|antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590)|1/79|0.257243939077163|1|0|0|3.37552742616034|4.58305642188746|CD36|5
8190|regulation of protein phosphorylation (GO:0001932)|2/262|0.257733164316071|1|0|0|2.03562340966921|2.75996025669163|MARCO;CCND2|5
8191|negative regulation of mitotic cell cycle phase transition (GO:1901991)|1/80|0.260040315844136|1|0|0|3.33333333333333|4.48972866349444|CDK2AP2|5
8192|activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919)|1/80|0.260040315844136|1|0|0|3.33333333333333|4.48972866349444|ANP32B|5
8193|regulation of transforming growth factor beta receptor signaling pathway (GO:0017015)|1/80|0.260040315844136|1|0|0|3.33333333333333|4.48972866349444|HSP90AB1|5
8194|ERBB signaling pathway (GO:0038127)|1/81|0.262826304470418|1|0|0|3.29218106995885|4.39921614573313|HSP90AA1|5
8195|protein catabolic process (GO:0030163)|1/82|0.265601943018023|1|0|0|3.2520325203252|4.31140340106247|HSP90AA1|5
8196|positive regulation of protein catabolic process (GO:0045732)|1/82|0.265601943018023|1|0|0|3.2520325203252|4.31140340106247|HSP90AA1|5
8197|regulation of programmed cell death (GO:0043067)|2/269|0.267471955154068|1|0|0|1.98265179677819|2.61460333816658|ANP32B;CIDEC|5
8198|negative regulation of binding (GO:0051100)|1/83|0.268367269439833|1|0|0|3.21285140562249|4.22618097434931|E2F1|5
8199|positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100)|1/83|0.268367269439833|1|0|0|3.21285140562249|4.22618097434931|HSP90AB1|5
8200|C-terminal protein amino acid modification (GO:0018410)|1/83|0.268367269439833|1|0|0|3.21285140562249|4.22618097434931|PLET1|5
8201|positive regulation of protein ubiquitination (GO:0031398)|1/84|0.271122321528605|1|0|0|3.17460317460317|4.1434450443981|CENPS|5
8202|regulation of mitotic nuclear division (GO:0007088)|1/85|0.273867136946786|1|0|0|3.13725490196078|4.0630970724736|PKMYT1|5
8203|positive regulation of supramolecular fiber organization (GO:1902905)|1/85|0.273867136946786|1|0|0|3.13725490196078|4.0630970724736|CDC42EP3|5
8204|regulation of cell cycle G2/M phase transition (GO:1902749)|1/85|0.273867136946786|1|0|0|3.13725490196078|4.0630970724736|HSP90AA1|5
8205|toll-like receptor signaling pathway (GO:0002224)|1/87|0.279326207655444|1|0|0|3.06513409961686|3.90919533204676|CD36|5
8206|positive regulation of cellular component biogenesis (GO:0044089)|1/88|0.282040537593283|1|0|0|3.03030303030303|3.83546808498279|CDT1|5
8207|T cell activation (GO:0042110)|1/89|0.284744780122457|1|0|0|2.99625468164794|3.76378129816593|CD2|5
8208|regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434)|1/89|0.284744780122457|1|0|0|2.99625468164794|3.76378129816593|HSP90AB1|5
8209|negative regulation of translation (GO:0017148)|1/89|0.284744780122457|1|0|0|2.99625468164794|3.76378129816593|DHFR|5
8210|negative regulation of cellular protein metabolic process (GO:0032269)|1/90|0.287438972224247|1|0|0|2.96296296296296|3.69405840533827|DHFR|5
8211|regulation of cytokine-mediated signaling pathway (GO:0001959)|1/91|0.29012315080615|1|0|0|2.93040293040293|3.62622648554153|HSP90AB1|5
8212|phospholipase C-activating G-protein coupled receptor signaling pathway (GO:0007200)|1/92|0.292797352486517|1|0|0|2.89855072463768|3.56021605504379|FPR1|5
8213|positive regulation of cellular metabolic process (GO:0031325)|1/93|0.295461613903074|1|0|0|2.8673835125448|3.49596086813839|UHRF1|5
8214|positive regulation of MAPK cascade (GO:0043410)|2/290|0.296669930274925|1|0|0|1.83908045977011|2.23473122585353|MARCO;CD36|5
8215|regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281)|1/94|0.298115971484896|1|0|0|2.83687943262411|3.43339773652625|FABP1|5
8216|axon development (GO:0061564)|1/95|0.300760461607955|1|0|0|2.80701754385965|3.37246635696415|DHFR|5
8217|skin development (GO:0043588)|1/95|0.300760461607955|1|0|0|2.80701754385965|3.37246635696415|STMN1|5
8218|regulation of cell proliferation (GO:0042127)|4/741|0.302262459914788|1|0|0|1.43949617633828|1.7222989710721|CD164;TIPIN;CCND2;NAP1L1|5
8219|positive regulation of protein localization to membrane (GO:1905477)|1/96|0.303395120396658|1|0|0|2.77777777777778|3.31310915351867|E2F1|5
8220|regulation of cell death (GO:0010941)|1/97|0.306019983922236|1|0|0|2.74914089347079|3.25527112639657|CD36|5
8221|positive regulation of protein metabolic process (GO:0051247)|1/97|0.306019983922236|1|0|0|2.74914089347079|3.25527112639657|UHRF1|5
8222|ciliary basal body-plasma membrane docking (GO:0097711)|1/97|0.306019983922236|1|0|0|2.74914089347079|3.25527112639657|HSP90AA1|5
8223|epithelial cell differentiation (GO:0030855)|1/97|0.306019983922236|1|0|0|2.74914089347079|3.25527112639657|PCNA|5
8224|positive regulation of neuron projection development (GO:0010976)|1/98|0.308635088137686|1|0|0|2.72108843537415|3.19889971289009|CPNE5|5
8225|protein localization to organelle (GO:0033365)|1/98|0.308635088137686|1|0|0|2.72108843537415|3.19889971289009|RPA2|5
8226|positive regulation of cell growth (GO:0030307)|1/99|0.311240468840659|1|0|0|2.69360269360269|3.14394465689098|CPNE5|5
8227|histone modification (GO:0016570)|1/99|0.311240468840659|1|0|0|2.69360269360269|3.14394465689098|UHRF1|5
8228|small GTPase mediated signal transduction (GO:0007264)|1/100|0.313836161648445|1|0|0|2.66666666666667|3.09035788649909|DNMT1|5
8229|regulation of kinase activity (GO:0043549)|1/102|0.318998625722467|1|0|0|2.61437908496732|2.98710714846173|LMO4|5
8230|intrinsic apoptotic signaling pathway (GO:0097193)|1/102|0.318998625722467|1|0|0|2.61437908496732|2.98710714846173|E2F1|5
8231|peptide metabolic process (GO:0006518)|1/105|0.326670547136828|1|0|0|2.53968253968254|2.84140474175465|HSP90AA1|5
8232|positive regulation of cellular catabolic process (GO:0031331)|1/107|0.331737720208307|1|0|0|2.49221183800623|2.74993301346334|HSP90AA1|5
8233|positive regulation of cellular component organization (GO:0051130)|1/107|0.331737720208307|1|0|0|2.49221183800623|2.74993301346334|CDT1|5
8234|positive regulation of cell cycle process (GO:0090068)|1/108|0.334257178778386|1|0|0|2.46913580246914|2.70578910113101|FEN1|5
8235|negative regulation of hydrolase activity (GO:0051346)|1/109|0.336767264719156|1|0|0|2.44648318042813|2.66266225407239|PKMYT1|5
8236|regulation of cell motility (GO:2000145)|1/110|0.339268012445516|1|0|0|2.42424242424242|2.62052093763541|LMO4|5
8237|positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280)|1/110|0.339268012445516|1|0|0|2.42424242424242|2.62052093763541|ANP32B|5
8238|positive regulation of establishment of protein localization to mitochondrion (GO:1903749)|1/111|0.34175945620001|1|0|0|2.4024024024024|2.5793348560401|E2F1|5
8239|regulation of protein binding (GO:0043393)|1/112|0.344241630167424|1|0|0|2.38095238095238|2.53907489263831|CD36|5
8240|protein transport (GO:0015031)|2/327|0.347647877417577|1|0|0|1.63098878695209|1.72324592533518|RAB44;CD36|5
8241|positive regulation of developmental process (GO:0051094)|1/114|0.349178304754126|1|0|0|2.33918128654971|2.46122242192129|HSP90AB1|5
8242|positive regulation of kinase activity (GO:0033674)|1/114|0.349178304754126|1|0|0|2.33918128654971|2.46122242192129|LMO4|5
8243|peptidyl-lysine modification (GO:0018205)|1/116|0.3540783069041|1|0|0|2.29885057471264|2.38675214797013|PCNA|5
8244|activation of MAPK activity (GO:0000187)|1/118|0.358941905347299|1|0|0|2.25988700564972|2.31546830990696|FPR1|5
8245|positive regulation of protein serine/threonine kinase activity (GO:0071902)|1/119|0.361360136584465|1|0|0|2.24089635854342|2.28096405526604|CCND2|5
8246|plasma membrane bounded cell projection organization (GO:0120036)|1/119|0.361360136584465|1|0|0|2.24089635854342|2.28096405526604|STMN1|5
8247|regulation of phosphorylation (GO:0042325)|1/120|0.363769366896261|1|0|0|2.22222222222222|2.24718937686059|MCM7|5
8248|negative regulation of transcription, DNA-templated (GO:0045892)|4/814|0.364747461192504|1|0|0|1.31040131040131|1.32160530975638|UHRF1;GMNN;TIMELESS;E2F1|5
8249|platelet degranulation (GO:0002576)|1/125|0.375681655662611|1|0|0|2.13333333333333|2.08856139665799|CD36|5
8250|G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)|1/126|0.378037569753694|1|0|0|2.11640211640212|2.05875491517187|FPR1|5
8251|cytoskeleton organization (GO:0007010)|1/127|0.380384711708721|1|0|0|2.0997375328084|2.02954779875845|SYNE2|5
8252|protein lipidation (GO:0006497)|1/128|0.382723113740222|1|0|0|2.08333333333333|2.00092394140653|PLET1|5
8253|regulation of mRNA stability (GO:0043488)|1/129|0.385052807962504|1|0|0|2.0671834625323|1.97286778410633|E2F1|5
8254|positive regulation of NF-kappaB transcription factor activity (GO:0051092)|1/129|0.385052807962504|1|0|0|2.0671834625323|1.97286778410633|CD36|5
8255|cellular response to hypoxia (GO:0071456)|1/133|0.394285144602462|1|0|0|2.00501253132832|1.86602689559123|FABP1|5
8256|negative regulation of cell proliferation (GO:0008285)|2/364|0.397419042197953|1|0|0|1.46520146520147|1.35203521327078|CD164;E2F1|5
8257|mitochondrial transport (GO:0006839)|1/136|0.401119520956859|1|0|0|1.96078431372549|1.79116831144467|HSP90AA1|5
8258|response to lipid (GO:0033993)|1/141|0.412341457464369|1|0|0|1.89125295508274|1.67546759835083|CD36|5
8259|regulation of cellular component organization (GO:0051128)|1/141|0.412341457464369|1|0|0|1.89125295508274|1.67546759835083|HSP90AA1|5
8260|modification-dependent protein catabolic process (GO:0019941)|1/142|0.414560819316854|1|0|0|1.87793427230047|1.65358795458667|UHRF1|5
8261|positive regulation of macromolecule biosynthetic process (GO:0010557)|1/143|0.416771910775246|1|0|0|1.86480186480186|1.63210477088624|PCNA|5
8262|cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742)|1/143|0.416771910775246|1|0|0|1.86480186480186|1.63210477088624|CD164|5
8263|neuron development (GO:0048666)|1/145|0.421169404114597|1|0|0|1.83908045977011|1.5902899147855|STMN1|5
8264|cytokine-mediated signaling pathway (GO:0019221)|3/634|0.426160949613645|1|0|0|1.26182965299685|1.07626269788364|HSP90AA1;FPR1;CD36|5
8265|regulated exocytosis (GO:0045055)|1/149|0.429866476928295|1|0|0|1.78970917225951|1.51101680051342|CD36|5
8266|regulation of G2/M transition of mitotic cell cycle (GO:0010389)|1/150|0.432020520984081|1|0|0|1.77777777777778|1.49205722593468|HSP90AA1|5
8267|positive regulation of intracellular protein transport (GO:0090316)|1/153|0.438434590150272|1|0|0|1.74291938997821|1.43711485066775|ANP32B|5
8268|transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169)|2/397|0.440345207140829|1|0|0|1.34340890008396|1.10185900654074|HSP90AA1;STMN1|5
8269|protein modification by small protein conjugation (GO:0032446)|2/399|0.442895346867345|1|0|0|1.33667502088555|1.08861724199191|PCNA;UHRF1|5
8270|negative regulation of programmed cell death (GO:0043069)|2/409|0.455551693666888|1|0|0|1.3039934800326|1.02525976329712|FABP1;CCND2|5
8271|gene expression (GO:0010467)|2/412|0.459317347289425|1|0|0|1.29449838187702|1.0071377597286|E2F1;PTMA|5
8272|positive regulation of protein phosphorylation (GO:0001934)|2/413|0.460569306299341|1|0|0|1.29136400322841|1.00118409340747|MARCO;CCND2|5
8273|regulation of mitotic cell cycle (GO:0007346)|1/166|0.465412950130758|1|0|0|1.60642570281125|1.22864289589348|PKMYT1|5
8274|neuron projection development (GO:0031175)|1/168|0.469448358408346|1|0|0|1.58730158730159|1.2003126652761|STMN1|5
8275|regulation of intracellular signal transduction (GO:1902531)|2/423|0.472997901052462|1|0|0|1.26083530338849|0.943942415156844|RPA2;TOPBP1|5
8276|positive regulation of MAP kinase activity (GO:0043406)|1/178|0.489178911489665|1|0|0|1.49812734082397|1.07120147453957|FPR1|5
8277|transcription from RNA polymerase II promoter (GO:0006366)|2/486|0.547251347488515|1|0|0|1.09739368998628|0.661560581938683|LMO4;DEK|5
8278|negative regulation of apoptotic process (GO:0043066)|2/486|0.547251347488515|1|0|0|1.09739368998628|0.661560581938683|FABP1;CCND2|5
8279|regulation of translation (GO:0006417)|1/214|0.55439707159237|1|0|0|1.24610591900312|0.735045623976247|DHFR|5
8280|positive regulation of sequence-specific DNA binding transcription factor activity (GO:0051091)|1/216|0.557768913171254|1|0|0|1.23456790123457|0.720753748740408|CD36|5
8281|positive regulation of nucleic acid-templated transcription (GO:1903508)|2/503|0.566027758294008|1|0|0|1.06030483764082|0.603432375410728|ATAD2;E2F1|5
8282|viral process (GO:0016032)|1/221|0.566088773595497|1|0|0|1.20663650075415|0.686581441049002|DEK|5
8283|protein ubiquitination (GO:0016567)|2/507|0.570365478304412|1|0|0|1.05193951347798|0.590640824321143|PCNA;UHRF1|5
8284|regulation of signal transduction (GO:0009966)|1/234|0.587004502909594|1|0|0|1.13960113960114|0.607091496442093|CD36|5
8285|activation of protein kinase activity (GO:0032147)|1/234|0.587004502909594|1|0|0|1.13960113960114|0.607091496442093|FPR1|5
8286|defense response to bacterium (GO:0042742)|1/242|0.599377937270844|1|0|0|1.10192837465565|0.564036289587095|RNASE6|5
8287|inflammatory response (GO:0006954)|1/253|0.615796126791925|1|0|0|1.05401844532279|0.511029600241454|FPR1|5
8288|positive regulation of transcription from RNA polymerase II promoter (GO:0045944)|3/849|0.622548208695077|1|0|0|0.942285041224971|0.446581116565381|UHRF1;ATAD2;E2F1|5
8289|positive regulation of programmed cell death (GO:0043068)|1/258|0.62303773714285|1|0|0|1.03359173126615|0.489042055572267|E2F1|5
8290|negative regulation of transcription from RNA polymerase II promoter (GO:0000122)|2/566|0.630758489301191|1|0|0|0.942285041224971|0.434235319192439|UHRF1;E2F1|5
8291|regulation of transcription from RNA polymerase II promoter (GO:0006357)|5/1479|0.659247422635738|1|0|0|0.901510029299076|0.375619890282992|TCF19;UHRF1;ATAD2;E2F1;DEK|5
8292|cilium assembly (GO:0060271)|1/289|0.665022919837807|1|0|0|0.922722029988466|0.376409479122219|HSP90AA1|5
8293|positive regulation of apoptotic process (GO:0043065)|1/308|0.688438511843274|1|0|0|0.865800865800866|0.3232288071158|E2F1|5
8294|cellular protein localization (GO:0034613)|1/328|0.711342270093639|1|0|0|0.813008130081301|0.27691184754012|RAB44|5
8295|sensory perception of chemical stimulus (GO:0007606)|1/328|0.711342270093639|1|0|0|0.813008130081301|0.27691184754012|CD36|5
8296|ubiquitin-dependent protein catabolic process (GO:0006511)|1/342|0.726378201202033|1|0|0|0.779727095516569|0.24926663665012|UHRF1|5
8297|intracellular protein transport (GO:0006886)|1/348|0.732583108443032|1|0|0|0.766283524904215|0.238450947051002|RAB44|5
8298|regulation of gene expression (GO:0010468)|3/1038|0.754022199608559|1|0|0|0.770712909441233|0.217598049291663|DNMT1;E2F1;CD36|5
8299|positive regulation of transcription, DNA-templated (GO:0045893)|3/1121|0.799124732362694|1|0|0|0.713648528099911|0.160027286214627|UHRF1;ATAD2;E2F1|5
8300|regulation of nucleic acid-templated transcription (GO:1903506)|1/608|0.901699034565912|1|0|0|0.43859649122807|0.045383543490786|E2F1|5
8301|regulation of cellular macromolecule biosynthetic process (GO:2000112)|1/632|0.910433740855322|1|0|0|0.421940928270042|0.0395924703479509|E2F1|5
8302|cellular response to type I interferon (GO:0071357)|18/66|4.2790579587689e-27|2.18360327635977e-23|0|0|54.5454545454545|3311.78534337617|IFITM3;SP100;RSAD2;STAT1;STAT2;MX1;ISG15;IFIT1;SAMHD1;IFIT3;PSMB8;IFIT2;BST2;OAS3;IRF7;GBP2;XAF1;IRF9|6
8303|type I interferon signaling pathway (GO:0060337)|18/66|4.2790579587689e-27|1.09180163817989e-23|0|0|54.5454545454545|3311.78534337617|IFITM3;SP100;RSAD2;STAT1;STAT2;MX1;ISG15;IFIT1;SAMHD1;IFIT3;PSMB8;IFIT2;BST2;OAS3;IRF7;GBP2;XAF1;IRF9|6
8304|cytokine-mediated signaling pathway (GO:0019221)|20/634|3.90732434029271e-11|6.64635870283789e-08|0|0|6.30914826498423|151.202417634897|IFITM3;SP100;RSAD2;STAT1;STAT2;MX1;ISG15;IFIT1;SAMHD1;IFIT3;PSMB8;IFIT2;BST2;TRIM5;OAS3;IRF7;XAF1;GBP2;B2M;IRF9|6
8305|negative regulation of viral life cycle (GO:1903901)|8/62|7.95175925712124e-10|1.01444568722724e-06|0|0|25.8064516129032|540.708586723906|IFITM3;BST2;RSAD2;TRIM5;OAS3;MX1;ISG15;IFIT1|6
8306|response to cytokine (GO:0034097)|10/139|1.92841016141179e-09|1.96813541073688e-06|0|0|14.3884892086331|288.727624806653|IFITM3;BST2;SP100;STAT1;MX1;TRAFD1;ISG15;LGALS9;XAF1;IKBKE|6
8307|interferon-gamma-mediated signaling pathway (GO:0060333)|8/71|2.4116064830201e-09|2.0510713138086e-06|0|0|22.5352112676056|447.165582446238|SP100;TRIM5;STAT1;OAS3;IRF7;GBP2;B2M;IRF9|6
8308|negative regulation of viral genome replication (GO:0045071)|7/51|6.10438602604968e-09|4.45009741299022e-06|0|0|27.4509803921569|519.214933820876|IFITM3;BST2;RSAD2;OAS3;MX1;ISG15;IFIT1|6
8309|cellular response to interferon-gamma (GO:0071346)|9/117|7.15822282236076e-09|4.56605138281337e-06|0|0|15.3846153846154|288.538524553082|SP100;TRIM5;STAT1;OAS3;IRF7;LGALS9;GBP2;B2M;IRF9|6
8310|response to type I interferon (GO:0034340)|4/7|2.03532203771726e-08|1.15402759538569e-05|0|0|114.285714285714|2024.00305006691|SP100;MX1;ISG15;IFIT1|6
8311|regulation of viral genome replication (GO:0045069)|7/64|3.10656525794278e-08|1.5852802511282e-05|0|0|21.875|378.156691647631|IFITM3;BST2;RSAD2;OAS3;MX1;ISG15;IFIT1|6
8312|response to interferon-beta (GO:0035456)|5/19|3.10673563759543e-08|1.44124290533177e-05|0|0|52.6315789473684|909.847800169825|IFITM3;BST2;STAT1;XAF1;IKBKE|6
8313|regulation of type I interferon production (GO:0032479)|7/86|2.45683394418048e-07|0.000104476863476275|0|0|16.2790697674419|247.754779096338|ZBP1;DDX58;DHX58;IRF7;UBE2L6;ISG15;IKBKE|6
8314|regulation of defense response to virus by host (GO:0050691)|5/31|4.32904304194079e-07|0.000169931589561722|0|0|32.258064516129|472.669327091924|DTX3L;DDX58;STAT1;IFIT1;PARP9|6
8315|regulation of innate immune response (GO:0045088)|6/70|1.35927227951736e-06|0.000495454745884077|0|0|17.1428571428571|231.575332971728|STAT1;STAT2;DHX58;TRAFD1;PARP9;SAMHD1|6
8316|negative regulation of cytokine production (GO:0001818)|7/111|1.40274581247481e-06|0.000477214125403931|0|0|12.6126126126126|169.981175914987|DDX58;DHX58;UBE2L6;ISG15;LGALS9;IKBKE;CMKLR1|6
8317|negative regulation of type I interferon production (GO:0032480)|5/45|2.94511800616161e-06|0.000939308574090168|0|0|22.2222222222222|283.00803714799|DDX58;DHX58;UBE2L6;ISG15;IKBKE|6
8318|positive regulation of defense response to virus by host (GO:0002230)|4/21|3.2983007697773e-06|0.00099007228401021|0|0|38.0952380952381|480.842024394555|DTX3L;STAT1;DDX58;PARP9|6
8319|positive regulation of type I interferon production (GO:0032481)|5/63|1.57800160031975e-05|0.00447363453690649|0|0|15.8730158730159|175.504225847662|ZBP1;DDX58;STAT1;DHX58;IRF7|6
8320|response to interferon-gamma (GO:0034341)|5/69|2.46401341307612e-05|0.00661782128785654|0|0|14.4927536231884|153.784550372394|IFITM3;BST2;SP100;STAT1;LGALS9|6
8321|regulation of interferon-alpha production (GO:0032647)|3/16|6.4781775896681e-05|0.0165290701200382|0|0|37.5|361.668233637101|STAT1;DDX58;IRF7|6
8322|positive regulation of interferon-alpha production (GO:0032727)|3/20|0.00012997496316054|0.0315839160480113|0|0|30|268.445061513885|DDX58;STAT1;IRF7|6
8323|regulation of interferon-gamma-mediated signaling pathway (GO:0060334)|3/22|0.000174309995477304|0.0404319957691219|0|0|27.2727272727273|236.036598018649|STAT1;PARP14;PARP9|6
8324|positive regulation of immune effector process (GO:0002699)|3/25|0.000257514521493891|0.0571346349210142|0|0|24|198.346426687189|DHX58;LGALS9;DDX60|6
8325|regulation of viral entry into host cell (GO:0046596)|3/27|0.000325124352919345|0.0691295655394757|0|0|22.2222222222222|178.473396098875|IFITM3;TRIM5;LGALS9|6
8326|antigen processing and presentation of endogenous peptide antigen (GO:0002483)|2/6|0.000366432168048497|0.0747961341420592|0|0|66.6666666666667|527.446475608391|TAP1;B2M|6
8327|regulation by virus of viral protein levels in host cell (GO:0046719)|2/7|0.00051133277923463|0.100358891247474|0|0|57.1428571428571|433.056568476616|STAT1;IFIT1|6
8328|positive regulation of RIG-I signaling pathway (GO:1900246)|2/7|0.00051133277923463|0.096641895275345|0|0|57.1428571428571|433.056568476616|DHX58;DDX60|6
8329|regulation of MDA-5 signaling pathway (GO:0039533)|2/7|0.00051133277923463|0.0931903990155113|0|0|57.1428571428571|433.056568476616|DHX58;DDX60|6
8330|positive regulation of cytokine-mediated signaling pathway (GO:0001961)|3/34|0.000648483947959066|0.114110813325349|0|0|17.6470588235294|129.544823066171|ZBP1;PARP14;PARP9|6
8331|positive regulation of chromatin binding (GO:0035563)|2/8|0.000679555166686154|0.115592333853315|0|0|50|364.703607024624|DTX3L;PARP9|6
8332|positive regulation of cytokine production (GO:0001819)|6/221|0.000854873957676149|0.140723284065206|0|0|5.42986425339367|38.359582902175|ZBP1;DDX58;DHX58;IRF7;LGALS9;DDX60|6
8333|positive regulation of innate immune response (GO:0045089)|3/39|0.000972629455166433|0.155104003428572|0|0|15.3846153846154|106.700113468899|ZBP1;DHX58;DDX60|6
8334|regulation of type I interferon-mediated signaling pathway (GO:0060338)|3/40|0.00104769503107265|0.162011749804962|0|0|15|102.917441044757|ZBP1;STAT1;STAT2|6
8335|proteolysis involved in cellular protein catabolic process (GO:0051603)|4/94|0.00127139771341329|0.190821839163176|0|0|8.51063829787234|56.7458589101531|ISG15;CTSS;CTSC;PSMB8|6
8336|positive regulation of tumor necrosis factor secretion (GO:1904469)|2/11|0.0013218400851343|0.192724284412581|0|0|36.3636363636364|241.044745789659|DDX58;LGALS9|6
8337|regulation of chromatin binding (GO:0035561)|2/11|0.0013218400851343|0.187370832067788|0|0|36.3636363636364|241.044745789659|DTX3L;PARP9|6
8338|regulation of double-strand break repair via nonhomologous end joining (GO:2001032)|2/12|0.00158104510229119|0.218056031270052|0|0|33.3333333333333|214.988973115443|DTX3L;PARP9|6
8339|positive regulation of T cell cytokine production (GO:0002726)|2/12|0.00158104510229119|0.212317714657683|0|0|33.3333333333333|214.988973115443|RSAD2;B2M|6
8340|cellular response to exogenous dsRNA (GO:0071360)|2/13|0.00186242805035638|0.243691547204323|0|0|30.7692307692308|193.411515050396|DDX58;IFIT1|6
8341|regulation of response to interferon-gamma (GO:0060330)|2/14|0.00216576516004231|0.276297490292398|0|0|28.5714285714286|175.285187351841|STAT1;PARP9|6
8342|purine-containing compound salvage (GO:0043101)|2/14|0.00216576516004231|0.269558527114535|0|0|28.5714285714286|175.285187351841|PNP;DCK|6
8343|regulation of cytokine production (GO:0001817)|4/109|0.00219090583353209|0.266195058774149|0|0|7.3394495412844|44.9426803526942|ZBP1;DDX58;IRF7;ISG15|6
8344|regulation of protein binding (GO:0043393)|4/112|0.00241823548284816|0.286982689976143|0|0|7.14285714285714|43.0336938863132|DTX3L;IFIT1;B2M;IFIT2|6
8345|positive regulation of double-strand break repair (GO:2000781)|2/15|0.00249083430520832|0.288880169533592|0|0|26.6666666666667|159.870334994499|DTX3L;PARP9|6
8346|regulation of tumor necrosis factor secretion (GO:1904467)|2/15|0.00249083430520832|0.282460610210623|0|0|26.6666666666667|159.870334994499|DDX58;LGALS9|6
8347|NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356)|2/15|0.00249083430520832|0.276320162162566|0|0|26.6666666666667|159.870334994499|PNP;PARP9|6
8348|negative regulation of viral entry into host cell (GO:0046597)|2/15|0.00249083430520832|0.270441009776128|0|0|26.6666666666667|159.870334994499|IFITM3;TRIM5|6
8349|cellular response to dsRNA (GO:0071359)|2/16|0.00283741499181759|0.301652681317608|0|0|25|146.621546386355|DDX58;IFIT1|6
8350|regulation of RIG-I signaling pathway (GO:0039535)|2/16|0.00283741499181759|0.295496504147861|0|0|25|146.621546386355|DHX58;DDX60|6
8351|nucleobase-containing compound biosynthetic process (GO:0034654)|2/17|0.00320528834894988|0.327131728893825|0|0|23.5294117647059|135.128311157302|PNP;DCK|6
8352|response to interferon-alpha (GO:0035455)|2/17|0.00320528834894988|0.320717381268456|0|0|23.5294117647059|135.128311157302|IFITM3;BST2|6
8353|positive regulation of interleukin-6 secretion (GO:2000778)|2/17|0.00320528834894988|0.314549739320985|0|0|23.5294117647059|135.128311157302|DDX58;LGALS9|6
8354|nucleotide catabolic process (GO:0009166)|2/17|0.00320528834894988|0.30861483857908|0|0|23.5294117647059|135.128311157302|PNP;SAMHD1|6
8355|positive regulation of response to biotic stimulus (GO:0002833)|2/17|0.00320528834894988|0.302899748975764|0|0|23.5294117647059|135.128311157302|DHX58;DDX60|6
8356|regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122)|5/205|0.00369249823546963|0.342596699920028|0|0|4.8780487804878|27.3241562020859|BST2;TRIM5;STAT1;LGALS9;IKBKE|6
8357|protein ADP-ribosylation (GO:0006471)|2/19|0.00400404563880334|0.364868658835954|0|0|21.0526315789474|116.220000406139|PARP14;PARP9|6
8358|negative regulation of innate immune response (GO:0045824)|2/20|0.00443449984753605|0.397004433718885|0|0|20|108.366808870582|DHX58;TRAFD1|6
8359|regulation of response to cytokine stimulus (GO:0060759)|2/20|0.00443449984753605|0.390159529689249|0|0|20|108.366808870582|DDX58;PARP9|6
8360|negative regulation of protein binding (GO:0032091)|3/68|0.00480405471030925|0.415510020113696|0|0|8.82352941176471|47.1026028206344|IFIT1;B2M;IFIT2|6
8361|negative regulation of viral process (GO:0048525)|2/21|0.00488538725831669|0.415502186319834|0|0|19.047619047619|101.36203279317|IFITM3;STAT1|6
8362|purine-containing compound biosynthetic process (GO:0072522)|2/22|0.00535649695773258|0.448101704513268|0|0|18.1818181818182|95.0808194585436|PNP;DCK|6
8363|STAT cascade (GO:0097696)|2/22|0.00535649695773258|0.44087425766628|0|0|18.1818181818182|95.0808194585436|STAT1;STAT2|6
8364|NAD biosynthetic process (GO:0009435)|2/22|0.00535649695773258|0.433876253576339|0|0|18.1818181818182|95.0808194585436|PNP;PARP9|6
8365|antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)|3/76|0.00654799848395007|0.522100566618707|0|0|7.89473684210526|39.699440928963|TAP1;B2M;PSMB8|6
8366|antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590)|3/79|0.0072868662544486|0.572075053791557|0|0|7.59493670886076|37.3798609705522|TAP1;B2M;PSMB8|6
8367|positive regulation of interferon-beta production (GO:0032728)|2/27|0.00800810651058956|0.619172235205129|0|0|14.8148148148148|71.5155694301407|DDX58;IRF7|6
8368|positive regulation of binding (GO:0051099)|3/82|0.00807321977106542|0.614890156593236|0|0|7.31707317073171|35.2624602143872|DTX3L;PARP9;B2M|6
8369|negative regulation of binding (GO:0051100)|3/83|0.00834600734283341|0.626318756918807|0|0|7.2289156626506|34.5973880747744|SP100;IFIT1;IFIT2|6
8370|negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732)|2/28|0.00859620747114401|0.635745604713738|0|0|14.2857142857143|67.9490594959366|SEMA4D;PARP14|6
8371|regulation of protein localization to nucleus (GO:1900180)|2/28|0.00859620747114401|0.626663524646398|0|0|14.2857142857143|67.9490594959366|DTX3L;PARP9|6
8372|antigen processing and presentation of peptide antigen via MHC class I (GO:0002474)|2/29|0.00920309747511436|0.661456428387445|0|0|13.7931034482759|64.6650368208853|TAP1;B2M|6
8373|positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123)|4/164|0.00929232507172902|0.658593539458795|0|0|4.8780487804878|22.8222755153305|BST2;TRIM5;LGALS9;IKBKE|6
8374|TRIF-dependent toll-like receptor signaling pathway (GO:0035666)|2/30|0.00982857782071015|0.687057981083341|0|0|13.3333333333333|61.6328137698055|IRF7;IKBKE|6
8375|positive regulation of intracellular signal transduction (GO:1902533)|7/480|0.0103610638559698|0.714493362932619|0|0|2.91666666666667|13.3282927126497|BST2;SEMA4D;TRIM5;DHX58;LGALS9;DDX60;IKBKE|6
8376|neutrophil degranulation (GO:0043312)|7/480|0.0103610638559698|0.704966784760184|0|0|2.91666666666667|13.3282927126497|BST2;GRN;PNP;B2M;CTSS;CTSC;CKAP4|6
8377|MyD88-independent toll-like receptor signaling pathway (GO:0002756)|2/31|0.0104724512850622|0.703169985627271|0|0|12.9032258064516|58.8258987981266|IRF7;IKBKE|6
8378|neutrophil activation involved in immune response (GO:0002283)|7/484|0.0108100763365378|0.716413240848729|0|0|2.89256198347107|13.0954281404447|BST2;GRN;PNP;B2M;CTSS;CTSC;CKAP4|6
8379|neutrophil mediated immunity (GO:0002446)|7/488|0.0112731287351143|0.737522768401132|0|0|2.86885245901639|12.867759677244|BST2;GRN;PNP;B2M;CTSS;CTSC;CKAP4|6
8380|positive regulation of transcription factor import into nucleus (GO:0042993)|2/33|0.0118145960439168|0.76316308369756|0|0|12.1212121212121|53.7990249579653|DDX58;LGALS9|6
8381|response to exogenous dsRNA (GO:0043330)|2/34|0.0125124802245356|0.798139832322562|0|0|11.7647058823529|51.5415142917499|DDX58;IFIT1|6
8382|regulation of interferon-beta production (GO:0032648)|2/35|0.0132279832722483|0.833362946151646|0|0|11.4285714285714|49.4333799821129|DDX58;IRF7|6
8383|protein polyubiquitination (GO:0000209)|5/284|0.0140533199676593|0.874562095060555|0|0|3.52112676056338|15.017241600301|RNF213;DTX3L;TRIM5;PSMB8;HERC6|6
8384|positive regulation of multi-organism process (GO:0043902)|2/38|0.0154783132235365|0.951636534695263|0|0|10.5263157894737|43.8770040173209|DHX58;DDX60|6
8385|JAK-STAT cascade (GO:0007259)|2/41|0.0178804597481127|1|0|0|9.75609756097561|39.2589931374209|STAT1;STAT2|6
8386|positive regulation of protein localization to nucleus (GO:1900182)|2/43|0.0195637897091909|1|0|0|9.30232558139535|36.5960454439863|DTX3L;PARP9|6
8387|translesion synthesis (GO:0019985)|2/43|0.0195637897091909|1|0|0|9.30232558139535|36.5960454439863|UBE2L6;ISG15|6
8388|positive regulation of interleukin-6 production (GO:0032755)|2/44|0.0204294838615153|1|0|0|9.09090909090909|35.3706921293207|DDX58;LGALS9|6
8389|regulation of interferon-gamma production (GO:0032649)|2/44|0.0204294838615153|1|0|0|9.09090909090909|35.3706921293207|ISG15;LGALS9|6
8390|positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731)|3/117|0.0209289640116766|1|0|0|5.12820512820513|19.8288268795854|SEMA4D;PARP14;PARP9|6
8391|positive regulation of interleukin-8 production (GO:0032757)|2/45|0.0213109604144822|1|0|0|8.88888888888889|34.2091890236836|DDX58;LGALS9|6
8392|negative regulation of immune response (GO:0050777)|2/45|0.0213109604144822|1|0|0|8.88888888888889|34.2091890236836|DHX58;TRAFD1|6
8393|positive regulation of viral life cycle (GO:1903902)|2/45|0.0213109604144822|1|0|0|8.88888888888889|34.2091890236836|LGALS9;IFIT1|6
8394|positive regulation of tumor necrosis factor production (GO:0032760)|2/48|0.0240483300532172|1|0|0|8.33333333333333|31.0640810108155|DDX58;LGALS9|6
8395|postreplication repair (GO:0006301)|2/48|0.0240483300532172|1|0|0|8.33333333333333|31.0640810108155|UBE2L6;ISG15|6
8396|negative regulation of macromolecule metabolic process (GO:0010605)|3/125|0.0248487630651258|1|0|0|4.8|17.7357470579023|LGALS9;PARP14;PARP9|6
8397|protein autoubiquitination (GO:0051865)|2/50|0.0259489619459531|1|0|0|8|29.2129893780246|RNF213;DTX3L|6
8398|negative regulation of protein ubiquitination (GO:0031397)|2/51|0.0269214810715392|1|0|0|7.84313725490196|28.3516137898251|DTX3L;ISG15|6
8399|regulation of protein localization to early endosome (GO:1902965)|1/6|0.0296309633944118|1|0|0|33.3333333333333|117.297846792342|DTX3L|6
8400|macrophage derived foam cell differentiation (GO:0010742)|1/6|0.0296309633944118|1|0|0|33.3333333333333|117.297846792342|STAT1|6
8401|positive regulation of interferon-gamma secretion (GO:1902715)|1/6|0.0296309633944118|1|0|0|33.3333333333333|117.297846792342|LGALS9|6
8402|mesenchymal cell differentiation involved in kidney development (GO:0072161)|1/6|0.0296309633944118|1|0|0|33.3333333333333|117.297846792342|STAT1|6
8403|regulation of macrophage apoptotic process (GO:2000109)|1/6|0.0296309633944118|1|0|0|33.3333333333333|117.297846792342|IRF7|6
8404|arginine biosynthetic process (GO:0006526)|1/6|0.0296309633944118|1|0|0|33.3333333333333|117.297846792342|ASS1|6
8405|negative regulation of interferon-gamma-mediated signaling pathway (GO:0060336)|1/6|0.0296309633944118|1|0|0|33.3333333333333|117.297846792342|PARP14|6
8406|positive regulation of protein localization to endosome (GO:1905668)|1/6|0.0296309633944118|1|0|0|33.3333333333333|117.297846792342|DTX3L|6
8407|negative regulation of response to interferon-gamma (GO:0060331)|1/6|0.0296309633944118|1|0|0|33.3333333333333|117.297846792342|PARP14|6
8408|citrulline metabolic process (GO:0000052)|1/6|0.0296309633944118|1|0|0|33.3333333333333|117.297846792342|ASS1|6
8409|negative regulation of myeloid cell apoptotic process (GO:0033033)|1/6|0.0296309633944118|1|0|0|33.3333333333333|117.297846792342|IRF7|6
8410|cellular response to iron ion (GO:0071281)|1/6|0.0296309633944118|1|0|0|33.3333333333333|117.297846792342|B2M|6
8411|positive regulation of protein localization to early endosome (GO:1902966)|1/6|0.0296309633944118|1|0|0|33.3333333333333|117.297846792342|DTX3L|6
8412|regulation of nuclease activity (GO:0032069)|1/6|0.0296309633944118|1|0|0|33.3333333333333|117.297846792342|OAS3|6
8413|regulation of interleukin-13 secretion (GO:2000665)|1/6|0.0296309633944118|1|0|0|33.3333333333333|117.297846792342|LGALS9|6
8414|regulation of interleukin-10 secretion (GO:2001179)|1/6|0.0296309633944118|1|0|0|33.3333333333333|117.297846792342|LGALS9|6
8415|positive regulation of receptor binding (GO:1900122)|1/6|0.0296309633944118|1|0|0|33.3333333333333|117.297846792342|B2M|6
8416|negative regulation of leukocyte degranulation (GO:0043301)|1/6|0.0296309633944118|1|0|0|33.3333333333333|117.297846792342|LGALS9|6
8417|alpha-beta T cell activation (GO:0046631)|1/6|0.0296309633944118|1|0|0|33.3333333333333|117.297846792342|RSAD2|6
8418|vesicle fusion with endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membrane (GO:1990668)|1/6|0.0296309633944118|1|0|0|33.3333333333333|117.297846792342|TAP1|6
8419|pyrimidine deoxyribonucleotide biosynthetic process (GO:0009221)|1/6|0.0296309633944118|1|0|0|33.3333333333333|117.297846792342|CMPK2|6
8420|regulation of interleukin-12 secretion (GO:2001182)|1/6|0.0296309633944118|1|0|0|33.3333333333333|117.297846792342|LGALS9|6
8421|regulation of interferon-alpha secretion (GO:1902739)|1/6|0.0296309633944118|1|0|0|33.3333333333333|117.297846792342|DDX58|6
8422|foam cell differentiation (GO:0090077)|1/6|0.0296309633944118|1|0|0|33.3333333333333|117.297846792342|STAT1|6
8423|positive regulation of interferon-alpha secretion (GO:1902741)|1/6|0.0296309633944118|1|0|0|33.3333333333333|117.297846792342|DDX58|6
8424|regulation of dendritic cell chemotaxis (GO:2000508)|1/6|0.0296309633944118|1|0|0|33.3333333333333|117.297846792342|LGALS9|6
8425|positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531)|2/54|0.029925836282038|1|0|0|7.40740740740741|25.9928376444134|PARP9;PARP14|6
8426|regulation of cellular component organization (GO:0051128)|3/141|0.0337928567698919|1|0|0|4.25531914893617|14.4149184553068|OGFR;SEMA4D;CHPT1|6
8427|modification-dependent protein catabolic process (GO:0019941)|3/142|0.0344004256970443|1|0|0|4.22535211267606|14.2381112947829|RNF213;DTX3L;ISG15|6
8428|regulation of sterol transport (GO:0032371)|1/7|0.0344842492004147|1|0|0|28.5714285714286|96.2072172602486|TSPO|6
8429|regulation of collateral sprouting (GO:0048670)|1/7|0.0344842492004147|1|0|0|28.5714285714286|96.2072172602486|SEMA4D|6
8430|regulation of toll-like receptor 9 signaling pathway (GO:0034163)|1/7|0.0344842492004147|1|0|0|28.5714285714286|96.2072172602486|RSAD2|6
8431|regulation of alpha-beta T cell differentiation (GO:0046637)|1/7|0.0344842492004147|1|0|0|28.5714285714286|96.2072172602486|PNP|6
8432|regulation of cell projection organization (GO:0031344)|1/7|0.0344842492004147|1|0|0|28.5714285714286|96.2072172602486|SEMA4D|6
8433|positive regulation of macrophage chemotaxis (GO:0010759)|1/7|0.0344842492004147|1|0|0|28.5714285714286|96.2072172602486|CMKLR1|6
8434|positive regulation of type I interferon-mediated signaling pathway (GO:0060340)|1/7|0.0344842492004147|1|0|0|28.5714285714286|96.2072172602486|ZBP1|6
8435|regulation of monocyte chemotactic protein-1 production (GO:0071637)|1/7|0.0344842492004147|1|0|0|28.5714285714286|96.2072172602486|LGALS9|6
8436|regulation of dendritic cell differentiation (GO:2001198)|1/7|0.0344842492004147|1|0|0|28.5714285714286|96.2072172602486|LGALS9|6
8437|negative regulation of RIG-I signaling pathway (GO:0039536)|1/7|0.0344842492004147|1|0|0|28.5714285714286|96.2072172602486|DHX58|6
8438|positive regulation of dendritic cell chemotaxis (GO:2000510)|1/7|0.0344842492004147|1|0|0|28.5714285714286|96.2072172602486|LGALS9|6
8439|regulation of response to biotic stimulus (GO:0002831)|1/7|0.0344842492004147|1|0|0|28.5714285714286|96.2072172602486|TRIM5|6
8440|cellular response to laminar fluid shear stress (GO:0071499)|1/7|0.0344842492004147|1|0|0|28.5714285714286|96.2072172602486|ASS1|6
8441|nucleoside diphosphate metabolic process (GO:0009132)|1/7|0.0344842492004147|1|0|0|28.5714285714286|96.2072172602486|CMPK2|6
8442|positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)|1/7|0.0344842492004147|1|0|0|28.5714285714286|96.2072172602486|LGALS9|6
8443|leukocyte aggregation (GO:0070486)|1/7|0.0344842492004147|1|0|0|28.5714285714286|96.2072172602486|SEMA4D|6
8444|positive regulation of macrophage migration (GO:1905523)|1/7|0.0344842492004147|1|0|0|28.5714285714286|96.2072172602486|CMKLR1|6
8445|positive regulation of protein binding (GO:0032092)|2/61|0.0374213004237331|1|0|0|6.55737704918033|21.5443620107278|DTX3L;B2M|6
8446|regulation of immune response (GO:0050776)|4/252|0.0377569145088387|1|0|0|3.17460317460317|10.4018623944853|DHX58;IRF7;SAMHD1;B2M|6
8447|positive regulation of leukocyte chemotaxis (GO:0002690)|2/62|0.0385451967593686|1|0|0|6.45161290322581|21.0059598994676|LGALS9;CMKLR1|6
8448|regulation of tyrosine phosphorylation of STAT protein (GO:0042509)|2/62|0.0385451967593686|1|0|0|6.45161290322581|21.0059598994676|PARP9;PARP14|6
8449|positive regulation of viral entry into host cell (GO:0046598)|1/8|0.0393135041520565|1|0|0|25|80.904680050727|LGALS9|6
8450|nucleoside diphosphate phosphorylation (GO:0006165)|1/8|0.0393135041520565|1|0|0|25|80.904680050727|CMPK2|6
8451|cellular response to interleukin-21 (GO:0098757)|1/8|0.0393135041520565|1|0|0|25|80.904680050727|STAT1|6
8452|negative regulation of leukocyte mediated cytotoxicity (GO:0001911)|1/8|0.0393135041520565|1|0|0|25|80.904680050727|LGALS9|6
8453|positive regulation of alpha-beta T cell differentiation (GO:0046638)|1/8|0.0393135041520565|1|0|0|25|80.904680050727|PNP|6
8454|positive regulation of transforming growth factor beta production (GO:0071636)|1/8|0.0393135041520565|1|0|0|25|80.904680050727|LGALS9|6
8455|regulation of T-helper 2 cell cytokine production (GO:2000551)|1/8|0.0393135041520565|1|0|0|25|80.904680050727|RSAD2|6
8456|negative regulation of activated T cell proliferation (GO:0046007)|1/8|0.0393135041520565|1|0|0|25|80.904680050727|LGALS9|6
8457|interleukin-21-mediated signaling pathway (GO:0038114)|1/8|0.0393135041520565|1|0|0|25|80.904680050727|STAT1|6
8458|regulation of receptor binding (GO:1900120)|1/8|0.0393135041520565|1|0|0|25|80.904680050727|B2M|6
8459|nucleotide phosphorylation (GO:0046939)|1/8|0.0393135041520565|1|0|0|25|80.904680050727|CMPK2|6
8460|regulation of MyD88-independent toll-like receptor signaling pathway (GO:0034127)|1/8|0.0393135041520565|1|0|0|25|80.904680050727|IRF7|6
8461|cellular protein catabolic process (GO:0044257)|2/63|0.0396819029137974|1|0|0|6.34920634920635|20.4880002617043|CTSS;CTSC|6
8462|positive regulation of JAK-STAT cascade (GO:0046427)|2/65|0.041993132410768|1|0|0|6.15384615384615|19.5092257729106|PARP9;PARP14|6
8463|DNA synthesis involved in DNA repair (GO:0000731)|2/66|0.043167352566795|1|0|0|6.06060606060606|19.0464896791432|UBE2L6;ISG15|6
8464|positive regulation of leukocyte apoptotic process (GO:2000108)|1/9|0.0441188457824273|1|0|0|22.2222222222222|69.3526276846394|LGALS9|6
8465|nucleoside triphosphate biosynthetic process (GO:0009142)|1/9|0.0441188457824273|1|0|0|22.2222222222222|69.3526276846394|CMPK2|6
8466|regulation of helicase activity (GO:0051095)|1/9|0.0441188457824273|1|0|0|22.2222222222222|69.3526276846394|IFIT1|6
8467|acidic amino acid transport (GO:0015800)|1/9|0.0441188457824273|1|0|0|22.2222222222222|69.3526276846394|SLC25A22|6
8468|establishment of viral latency (GO:0019043)|1/9|0.0441188457824273|1|0|0|22.2222222222222|69.3526276846394|IRF7|6
8469|dynamin family protein polymerization involved in mitochondrial fission (GO:0003374)|1/9|0.0441188457824273|1|0|0|22.2222222222222|69.3526276846394|MX1|6
8470|basement membrane organization (GO:0071711)|1/9|0.0441188457824273|1|0|0|22.2222222222222|69.3526276846394|CTSS|6
8471|antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (GO:0002480)|1/9|0.0441188457824273|1|0|0|22.2222222222222|69.3526276846394|B2M|6
8472|nucleoside phosphate biosynthetic process (GO:1901293)|1/9|0.0441188457824273|1|0|0|22.2222222222222|69.3526276846394|CMPK2|6
8473|regulation of interferon-gamma secretion (GO:1902713)|1/9|0.0441188457824273|1|0|0|22.2222222222222|69.3526276846394|LGALS9|6
8474|regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267)|1/9|0.0441188457824273|1|0|0|22.2222222222222|69.3526276846394|LGALS9|6
8475|negative regulation of natural killer cell mediated cytotoxicity (GO:0045953)|1/9|0.0441188457824273|1|0|0|22.2222222222222|69.3526276846394|LGALS9|6
8476|negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532)|1/9|0.0441188457824273|1|0|0|22.2222222222222|69.3526276846394|PARP14|6
8477|positive regulation of cellular protein localization (GO:1903829)|2/67|0.0443537761760119|1|0|0|5.97014925373134|18.6003428594508|DTX3L;PARP9|6
8478|positive regulation of T cell activation (GO:0050870)|2/69|0.0467626402187707|1|0|0|5.79710144927536|17.7546126422152|PNP;LGALS9|6
8479|negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532)|1/10|0.0489003911418305|1|0|0|20|60.3593976744572|DHX58|6
8480|positive regulation of interleukin-13 production (GO:0032736)|1/10|0.0489003911418305|1|0|0|20|60.3593976744572|LGALS9|6
8481|cell differentiation involved in metanephros development (GO:0072202)|1/10|0.0489003911418305|1|0|0|20|60.3593976744572|STAT1|6
8482|positive regulation of lipid localization (GO:1905954)|1/10|0.0489003911418305|1|0|0|20|60.3593976744572|IKBKE|6
8483|dynamin family protein polymerization involved in membrane fission (GO:0003373)|1/10|0.0489003911418305|1|0|0|20|60.3593976744572|MX1|6
8484|cellular response to thyroid hormone stimulus (GO:0097067)|1/10|0.0489003911418305|1|0|0|20|60.3593976744572|CTSS|6
8485|regulation of myeloid leukocyte differentiation (GO:0002761)|1/10|0.0489003911418305|1|0|0|20|60.3593976744572|IRF7|6
8486|positive regulation of T cell apoptotic process (GO:0070234)|1/10|0.0489003911418305|1|0|0|20|60.3593976744572|LGALS9|6
8487|response to acidic pH (GO:0010447)|1/10|0.0489003911418305|1|0|0|20|60.3593976744572|CTSS|6
8488|regulation of dendritic cell apoptotic process (GO:2000668)|1/10|0.0489003911418305|1|0|0|20|60.3593976744572|LGALS9|6
8489|response to laminar fluid shear stress (GO:0034616)|1/10|0.0489003911418305|1|0|0|20|60.3593976744572|ASS1|6
8490|histone H2B ubiquitination (GO:0033523)|1/10|0.0489003911418305|1|0|0|20|60.3593976744572|DTX3L|6
8491|L-glutamate transport (GO:0015813)|1/10|0.0489003911418305|1|0|0|20|60.3593976744572|SLC25A22|6
8492|aspartate family amino acid metabolic process (GO:0009066)|1/10|0.0489003911418305|1|0|0|20|60.3593976744572|ASS1|6
8493|regulation of transforming growth factor beta production (GO:0071634)|1/10|0.0489003911418305|1|0|0|20|60.3593976744572|LGALS9|6
8494|positive regulation of type 2 immune response (GO:0002830)|1/10|0.0489003911418305|1|0|0|20|60.3593976744572|RSAD2|6
8495|mitochondrion organization (GO:0007005)|3/168|0.0521548749739569|1|0|0|3.57142857142857|10.5483486502091|MX1;TSPO;IFIT2|6
8496|positive regulation of cytokine secretion (GO:0050715)|2/74|0.0529880944930012|1|0|0|5.40540540540541|15.8793947182223|DDX58;LGALS9|6
8497|cellular response to interferon-beta (GO:0035458)|1/11|0.0536582567508638|1|0|0|18.1818181818182|53.1839985718395|STAT1|6
8498|negative regulation of morphogenesis of an epithelium (GO:1905331)|1/11|0.0536582567508638|1|0|0|18.1818181818182|53.1839985718395|STAT1|6
8499|negative regulation of defense response to virus (GO:0050687)|1/11|0.0536582567508638|1|0|0|18.1818181818182|53.1839985718395|IFIT1|6
8500|interleukin-27-mediated signaling pathway (GO:0070106)|1/11|0.0536582567508638|1|0|0|18.1818181818182|53.1839985718395|STAT1|6
8501|negative regulation of peptide secretion (GO:0002792)|1/11|0.0536582567508638|1|0|0|18.1818181818182|53.1839985718395|RSAD2|6
8502|carbohydrate derivative catabolic process (GO:1901136)|1/11|0.0536582567508638|1|0|0|18.1818181818182|53.1839985718395|SAMHD1|6
8503|arginine metabolic process (GO:0006525)|1/11|0.0536582567508638|1|0|0|18.1818181818182|53.1839985718395|ASS1|6
8504|positive regulation of mesenchymal cell proliferation (GO:0002053)|1/11|0.0536582567508638|1|0|0|18.1818181818182|53.1839985718395|STAT1|6
8505|metanephric mesenchyme development (GO:0072075)|1/11|0.0536582567508638|1|0|0|18.1818181818182|53.1839985718395|STAT1|6
8506|negative regulation of leukocyte cell-cell adhesion (GO:1903038)|1/11|0.0536582567508638|1|0|0|18.1818181818182|53.1839985718395|ASS1|6
8507|interleukin-35-mediated signaling pathway (GO:0070757)|1/11|0.0536582567508638|1|0|0|18.1818181818182|53.1839985718395|STAT1|6
8508|urate metabolic process (GO:0046415)|1/11|0.0536582567508638|1|0|0|18.1818181818182|53.1839985718395|PNP|6
8509|urea cycle (GO:0000050)|1/11|0.0536582567508638|1|0|0|18.1818181818182|53.1839985718395|ASS1|6
8510|regulation of non-canonical Wnt signaling pathway (GO:2000050)|1/11|0.0536582567508638|1|0|0|18.1818181818182|53.1839985718395|RNF213|6
8511|negative regulation of nucleocytoplasmic transport (GO:0046823)|1/11|0.0536582567508638|1|0|0|18.1818181818182|53.1839985718395|SP100|6
8512|negative regulation of receptor binding (GO:1900121)|1/11|0.0536582567508638|1|0|0|18.1818181818182|53.1839985718395|B2M|6
8513|response to thyroid hormone (GO:0097066)|1/11|0.0536582567508638|1|0|0|18.1818181818182|53.1839985718395|CTSS|6
8514|C-terminal protein lipidation (GO:0006501)|2/76|0.0555565913641186|1|0|0|5.26315789473684|15.2123848079781|CD52;LY6E|6
8515|regulation of defense response (GO:0031347)|2/76|0.0555565913641186|1|0|0|5.26315789473684|15.2123848079781|DHX58;SAMHD1|6
8516|cellular response to fluid shear stress (GO:0071498)|1/12|0.0583925585800791|1|0|0|16.6666666666667|47.3427803140127|ASS1|6
8517|regulation of mesenchymal cell proliferation (GO:0010464)|1/12|0.0583925585800791|1|0|0|16.6666666666667|47.3427803140127|STAT1|6
8518|pyrimidine-containing compound salvage (GO:0008655)|1/12|0.0583925585800791|1|0|0|16.6666666666667|47.3427803140127|DCK|6
8519|regulation of mononuclear cell migration (GO:0071675)|1/12|0.0583925585800791|1|0|0|16.6666666666667|47.3427803140127|CMKLR1|6
8520|regulation of leukocyte cell-cell adhesion (GO:1903037)|1/12|0.0583925585800791|1|0|0|16.6666666666667|47.3427803140127|ASS1|6
8521|pyrimidine nucleoside salvage (GO:0043097)|1/12|0.0583925585800791|1|0|0|16.6666666666667|47.3427803140127|DCK|6
8522|modification-dependent macromolecule catabolic process (GO:0043632)|1/12|0.0583925585800791|1|0|0|16.6666666666667|47.3427803140127|ISG15|6
8523|protein insertion into membrane (GO:0051205)|1/12|0.0583925585800791|1|0|0|16.6666666666667|47.3427803140127|RTP4|6
8524|negative regulation of interleukin-12 production (GO:0032695)|1/12|0.0583925585800791|1|0|0|16.6666666666667|47.3427803140127|CMKLR1|6
8525|negative regulation of leukocyte apoptotic process (GO:2000107)|1/12|0.0583925585800791|1|0|0|16.6666666666667|47.3427803140127|IRF7|6
8526|positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725)|1/12|0.0583925585800791|1|0|0|16.6666666666667|47.3427803140127|DDX58|6
8527|negative regulation of defense response (GO:0031348)|2/81|0.0621638842786596|1|0|0|4.93827160493827|13.718425118418|DHX58;TRAFD1|6
8528|response to iron ion (GO:0010039)|1/13|0.0631034120924419|1|0|0|15.3846153846154|42.507391331258|B2M|6
8529|glutamine family amino acid biosynthetic process (GO:0009084)|1/13|0.0631034120924419|1|0|0|15.3846153846154|42.507391331258|ASS1|6
8530|regulation of granulocyte chemotaxis (GO:0071622)|1/13|0.0631034120924419|1|0|0|15.3846153846154|42.507391331258|CMKLR1|6
8531|negative regulation of ubiquitin-protein transferase activity (GO:0051444)|1/13|0.0631034120924419|1|0|0|15.3846153846154|42.507391331258|DTX3L|6
8532|negative regulation of chemokine production (GO:0032682)|1/13|0.0631034120924419|1|0|0|15.3846153846154|42.507391331258|LGALS9|6
8533|negative regulation of viral release from host cell (GO:1902187)|1/13|0.0631034120924419|1|0|0|15.3846153846154|42.507391331258|TRIM5|6
8534|nucleotide metabolic process (GO:0009117)|1/13|0.0631034120924419|1|0|0|15.3846153846154|42.507391331258|DCK|6
8535|regulation of T cell cytokine production (GO:0002724)|1/13|0.0631034120924419|1|0|0|15.3846153846154|42.507391331258|B2M|6
8536|positive regulation of alpha-beta T cell proliferation (GO:0046641)|1/13|0.0631034120924419|1|0|0|15.3846153846154|42.507391331258|LGALS9|6
8537|tricarboxylic acid metabolic process (GO:0072350)|1/13|0.0631034120924419|1|0|0|15.3846153846154|42.507391331258|ASS1|6
8538|regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645)|1/13|0.0631034120924419|1|0|0|15.3846153846154|42.507391331258|DDX58|6
8539|regulation of anatomical structure morphogenesis (GO:0022603)|2/83|0.0648783802345316|1|0|0|4.81927710843374|13.1818835423886|SP100;STAT2|6
8540|C-terminal protein amino acid modification (GO:0018410)|2/83|0.0648783802345316|1|0|0|4.81927710843374|13.1818835423886|CD52;LY6E|6
8541|positive regulation of homeostatic process (GO:0032846)|2/84|0.0662504359060044|1|0|0|4.76190476190476|12.9253011163056|STAT1;LGALS9|6
8542|nucleoside triphosphate metabolic process (GO:0009141)|1/14|0.0677909321684321|1|0|0|14.2857142857143|38.4475262401246|CMPK2|6
8543|nucleoside salvage (GO:0043174)|1/14|0.0677909321684321|1|0|0|14.2857142857143|38.4475262401246|DCK|6
8544|interleukin-6-mediated signaling pathway (GO:0070102)|1/14|0.0677909321684321|1|0|0|14.2857142857143|38.4475262401246|STAT1|6
8545|regulation of adaptive immune response (GO:0002819)|1/14|0.0677909321684321|1|0|0|14.2857142857143|38.4475262401246|IRF7|6
8546|positive regulation of response to cytokine stimulus (GO:0060760)|1/14|0.0677909321684321|1|0|0|14.2857142857143|38.4475262401246|DDX58|6
8547|positive regulation of interleukin-8 secretion (GO:2000484)|1/14|0.0677909321684321|1|0|0|14.2857142857143|38.4475262401246|LGALS9|6
8548|DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)|1/14|0.0677909321684321|1|0|0|14.2857142857143|38.4475262401246|SP100|6
8549|purine-containing compound catabolic process (GO:0072523)|1/14|0.0677909321684321|1|0|0|14.2857142857143|38.4475262401246|PNP|6
8550|regulation of monocyte differentiation (GO:0045655)|1/14|0.0677909321684321|1|0|0|14.2857142857143|38.4475262401246|IRF7|6
8551|purine nucleotide catabolic process (GO:0006195)|1/14|0.0677909321684321|1|0|0|14.2857142857143|38.4475262401246|PNP|6
8552|protein homooligomerization (GO:0051260)|3/191|0.070867771508189|1|0|0|3.1413612565445|8.31499322964795|RNF213;SAMHD1;IKBKE|6
8553|positive regulation of alpha-beta T cell activation (GO:0046635)|1/15|0.0724552331756038|1|0|0|13.3333333333333|34.9971517503559|PNP|6
8554|regulation of mast cell degranulation (GO:0043304)|1/15|0.0724552331756038|1|0|0|13.3333333333333|34.9971517503559|LGALS9|6
8555|DNA damage response, signal transduction resulting in transcription (GO:0042772)|1/15|0.0724552331756038|1|0|0|13.3333333333333|34.9971517503559|SP100|6
8556|regulation of macrophage chemotaxis (GO:0010758)|1/15|0.0724552331756038|1|0|0|13.3333333333333|34.9971517503559|CMKLR1|6
8557|positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001269)|1/15|0.0724552331756038|1|0|0|13.3333333333333|34.9971517503559|LGALS9|6
8558|negative regulation of axon extension involved in axon guidance (GO:0048843)|1/15|0.0724552331756038|1|0|0|13.3333333333333|34.9971517503559|SEMA4D|6
8559|amide transport (GO:0042886)|1/15|0.0724552331756038|1|0|0|13.3333333333333|34.9971517503559|TAP1|6
8560|pyrimidine nucleoside biosynthetic process (GO:0046134)|1/15|0.0724552331756038|1|0|0|13.3333333333333|34.9971517503559|DCK|6
8561|positive regulation of interleukin-4 production (GO:0032753)|1/15|0.0724552331756038|1|0|0|13.3333333333333|34.9971517503559|LGALS9|6
8562|positive regulation of NF-kappaB import into nucleus (GO:0042346)|1/15|0.0724552331756038|1|0|0|13.3333333333333|34.9971517503559|LGALS9|6
8563|L-alpha-amino acid transmembrane transport (GO:1902475)|1/15|0.0724552331756038|1|0|0|13.3333333333333|34.9971517503559|SLC25A22|6
8564|cellular response to virus (GO:0098586)|1/15|0.0724552331756038|1|0|0|13.3333333333333|34.9971517503559|LGALS9|6
8565|negative regulation of cellular component movement (GO:0051271)|1/15|0.0724552331756038|1|0|0|13.3333333333333|34.9971517503559|SP100|6
8566|positive regulation of cytokine production involved in immune response (GO:0002720)|1/15|0.0724552331756038|1|0|0|13.3333333333333|34.9971517503559|B2M|6
8567|regulation of interleukin-4 production (GO:0032673)|1/15|0.0724552331756038|1|0|0|13.3333333333333|34.9971517503559|LGALS9|6
8568|positive regulation of response to external stimulus (GO:0032103)|2/91|0.0761192182371278|1|0|0|4.3956043956044|11.3206791505253|DHX58;DDX60|6
8569|regulation of cytokine-mediated signaling pathway (GO:0001959)|2/91|0.0761192182371278|1|0|0|4.3956043956044|11.3206791505253|STAT1;STAT2|6
8570|heme biosynthetic process (GO:0006783)|1/16|0.0770964289305897|1|0|0|12.5|32.0337289607239|TSPO|6
8571|C21-steroid hormone biosynthetic process (GO:0006700)|1/16|0.0770964289305897|1|0|0|12.5|32.0337289607239|TSPO|6
8572|positive regulation of immune system process (GO:0002684)|1/16|0.0770964289305897|1|0|0|12.5|32.0337289607239|LGALS9|6
8573|pyrimidine-containing compound metabolic process (GO:0072527)|1/16|0.0770964289305897|1|0|0|12.5|32.0337289607239|DCK|6
8574|regulation of cell growth (GO:0001558)|3/202|0.0807477880229416|1|0|0|2.97029702970297|7.47452884205736|BST2;OGFR;CHPT1|6
8575|negative regulation of axon guidance (GO:1902668)|1/17|0.0817146326715557|1|0|0|11.7647058823529|29.4649669492481|SEMA4D|6
8576|response to purine-containing compound (GO:0014074)|1/17|0.0817146326715557|1|0|0|11.7647058823529|29.4649669492481|STAT1|6
8577|positive regulation of cation transmembrane transport (GO:1904064)|1/17|0.0817146326715557|1|0|0|11.7647058823529|29.4649669492481|CTSS|6
8578|positive regulation of transcription of Notch receptor target (GO:0007221)|1/17|0.0817146326715557|1|0|0|11.7647058823529|29.4649669492481|STAT1|6
8579|negative regulation of intracellular transport (GO:0032387)|1/17|0.0817146326715557|1|0|0|11.7647058823529|29.4649669492481|LGALS9|6
8580|positive regulation of cellular protein catabolic process (GO:1903364)|1/17|0.0817146326715557|1|0|0|11.7647058823529|29.4649669492481|CTSC|6
8581|histone H2A ubiquitination (GO:0033522)|1/17|0.0817146326715557|1|0|0|11.7647058823529|29.4649669492481|DTX3L|6
8582|porphyrin-containing compound biosynthetic process (GO:0006779)|1/18|0.0863099571505928|1|0|0|11.1111111111111|27.2201145467784|TSPO|6
8583|negative regulation of protein transport (GO:0051224)|1/18|0.0863099571505928|1|0|0|11.1111111111111|27.2201145467784|RSAD2|6
8584|regulation of peptidase activity (GO:0052547)|1/18|0.0863099571505928|1|0|0|11.1111111111111|27.2201145467784|PSMB8|6
8585|regulation of chemokine production (GO:0032642)|1/18|0.0863099571505928|1|0|0|11.1111111111111|27.2201145467784|LGALS9|6
8586|regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664)|1/18|0.0863099571505928|1|0|0|11.1111111111111|27.2201145467784|TRIM5|6
8587|response to organophosphorus (GO:0046683)|1/18|0.0863099571505928|1|0|0|11.1111111111111|27.2201145467784|STAT1|6
8588|positive regulation of toll-like receptor signaling pathway (GO:0034123)|1/19|0.0908825145361798|1|0|0|10.5263157894737|25.2440805856852|RSAD2|6
8589|positive regulation of lipid storage (GO:0010884)|1/19|0.0908825145361798|1|0|0|10.5263157894737|25.2440805856852|IKBKE|6
8590|regulation of mitochondrial fission (GO:0090140)|1/19|0.0908825145361798|1|0|0|10.5263157894737|25.2440805856852|STAT2|6
8591|regulation of transcription factor import into nucleus (GO:0042990)|1/19|0.0908825145361798|1|0|0|10.5263157894737|25.2440805856852|DDX58|6
8592|cellular response to metal ion (GO:0071248)|2/101|0.0909569913965944|1|0|0|3.96039603960396|9.49452873743255|RASA4;B2M|6
8593|positive regulation of gene expression (GO:0010628)|7/772|0.091986430488645|1|0|0|1.81347150259067|4.32715011722825|SP100;DTX3L;DDX58;STAT1;IRF7;LGALS9;PARP9|6
8594|positive regulation of sequence-specific DNA binding transcription factor activity (GO:0051091)|3/216|0.0941331217907138|1|0|0|2.77777777777778|6.56401474805409|TRIM5;DDX58;LGALS9|6
8595|negative regulation of interferon-gamma production (GO:0032689)|1/20|0.0954324164624815|1|0|0|10|23.49336963041|LGALS9|6
8596|negative regulation of intracellular protein transport (GO:0090317)|1/20|0.0954324164624815|1|0|0|10|23.49336963041|SP100|6
8597|regulation of toll-like receptor signaling pathway (GO:0034121)|1/20|0.0954324164624815|1|0|0|10|23.49336963041|IRF7|6
8598|regulation of cholesterol transport (GO:0032374)|1/20|0.0954324164624815|1|0|0|10|23.49336963041|TSPO|6
8599|purine nucleotide metabolic process (GO:0006163)|1/20|0.0954324164624815|1|0|0|10|23.49336963041|PNP|6
8600|ERK1 and ERK2 cascade (GO:0070371)|1/21|0.0999597740324998|1|0|0|9.52380952380952|21.9332136533064|LGALS9|6
8601|histone ubiquitination (GO:0016574)|1/21|0.0999597740324998|1|0|0|9.52380952380952|21.9332136533064|DTX3L|6
8602|positive regulation of T cell mediated immunity (GO:0002711)|1/21|0.0999597740324998|1|0|0|9.52380952380952|21.9332136533064|B2M|6
8603|mitochondrial fission (GO:0000266)|1/21|0.0999597740324998|1|0|0|9.52380952380952|21.9332136533064|MX1|6
8604|negative regulation of hydrolase activity (GO:0051346)|2/109|0.1033831480897|1|0|0|3.6697247706422|8.32775525888457|RASA4;IFIT1|6
8605|negative regulation of GTPase activity (GO:0034260)|1/22|0.104464697819105|1|0|0|9.09090909090909|20.535509859674|RASA4|6
8606|positive regulation of interleukin-10 production (GO:0032733)|1/22|0.104464697819105|1|0|0|9.09090909090909|20.535509859674|LGALS9|6
8607|C21-steroid hormone metabolic process (GO:0008207)|1/22|0.104464697819105|1|0|0|9.09090909090909|20.535509859674|TSPO|6
8608|positive regulation of erythrocyte differentiation (GO:0045648)|1/22|0.104464697819105|1|0|0|9.09090909090909|20.535509859674|STAT1|6
8609|positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052)|1/22|0.104464697819105|1|0|0|9.09090909090909|20.535509859674|CTSC|6
8610|positive regulation of nucleic acid-templated transcription (GO:1903508)|5/503|0.10776079005071|1|0|0|1.98807157057654|4.42910818157089|SP100;DTX3L;STAT1;IRF7;PARP9|6
8611|regulation of natural killer cell mediated cytotoxicity (GO:0042269)|1/23|0.108947297836033|1|0|0|8.69565217391304|19.2773132154017|LGALS9|6
8612|regulation of axon extension involved in axon guidance (GO:0048841)|1/23|0.108947297836033|1|0|0|8.69565217391304|19.2773132154017|SEMA4D|6
8613|negative regulation of viral transcription (GO:0032897)|1/23|0.108947297836033|1|0|0|8.69565217391304|19.2773132154017|IFITM3|6
8614|positive regulation of ion transmembrane transporter activity (GO:0032414)|1/23|0.108947297836033|1|0|0|8.69565217391304|19.2773132154017|CTSS|6
8615|regulation of interleukin-8 secretion (GO:2000482)|1/23|0.108947297836033|1|0|0|8.69565217391304|19.2773132154017|LGALS9|6
8616|cellular response to interleukin-6 (GO:0071354)|1/23|0.108947297836033|1|0|0|8.69565217391304|19.2773132154017|STAT1|6
8617|regulation of proteolysis involved in cellular protein catabolic process (GO:1903050)|1/23|0.108947297836033|1|0|0|8.69565217391304|19.2773132154017|CTSC|6
8618|negative regulation of axon extension (GO:0030517)|1/23|0.108947297836033|1|0|0|8.69565217391304|19.2773132154017|SEMA4D|6
8619|protein ubiquitination (GO:0016567)|5/507|0.110456683130336|1|0|0|1.9723865877712|4.34542769773129|RNF213;DTX3L;ISG15;PSMB8;HERC6|6
8620|apoptotic process (GO:0006915)|3/232|0.110465912159545|1|0|0|2.58620689655172|5.69753868843167|MX1;TSPO;IFIT2|6
8621|chromatin remodeling (GO:0006338)|2/117|0.11624255158408|1|0|0|3.41880341880342|7.35752584260651|SP100;SP110|6
8622|histone monoubiquitination (GO:0010390)|1/25|0.117845964040422|1|0|0|8|17.1070151741399|DTX3L|6
8623|transition metal ion homeostasis (GO:0055076)|1/25|0.117845964040422|1|0|0|8|17.1070151741399|B2M|6
8624|negative regulation of T cell proliferation (GO:0042130)|1/25|0.117845964040422|1|0|0|8|17.1070151741399|LGALS9|6
8625|proteasomal ubiquitin-independent protein catabolic process (GO:0010499)|1/25|0.117845964040422|1|0|0|8|17.1070151741399|PSMB8|6
8626|negative regulation of locomotion (GO:0040013)|1/26|0.122262247628669|1|0|0|7.69230769230769|16.1660536195674|TRIM5|6
8627|regulation of viral release from host cell (GO:1902186)|1/26|0.122262247628669|1|0|0|7.69230769230769|16.1660536195674|TRIM5|6
8628|L-amino acid transport (GO:0015807)|1/26|0.122262247628669|1|0|0|7.69230769230769|16.1660536195674|SLC25A22|6
8629|positive regulation of nitric oxide biosynthetic process (GO:0045429)|1/26|0.122262247628669|1|0|0|7.69230769230769|16.1660536195674|ASS1|6
8630|positive regulation of interleukin-1 beta secretion (GO:0050718)|1/26|0.122262247628669|1|0|0|7.69230769230769|16.1660536195674|LGALS9|6
8631|positive regulation of interleukin-12 production (GO:0032735)|1/26|0.122262247628669|1|0|0|7.69230769230769|16.1660536195674|LGALS9|6
8632|positive regulation of nitric oxide metabolic process (GO:1904407)|1/26|0.122262247628669|1|0|0|7.69230769230769|16.1660536195674|ASS1|6
8633|regulation of NF-kappaB import into nucleus (GO:0042345)|1/27|0.126656642302827|1|0|0|7.40740740740741|15.3057441316745|LGALS9|6
8634|negative chemotaxis (GO:0050919)|1/27|0.126656642302827|1|0|0|7.40740740740741|15.3057441316745|SEMA4D|6
8635|negative regulation of catalytic activity (GO:0043086)|1/27|0.126656642302827|1|0|0|7.40740740740741|15.3057441316745|PARP9|6
8636|tumor necrosis factor-mediated signaling pathway (GO:0033209)|2/124|0.127808625420924|1|0|0|3.2258064516129|6.63619757341816|STAT1;PSMB8|6
8637|negative regulation of osteoblast differentiation (GO:0045668)|1/28|0.131029255394866|1|0|0|7.14285714285714|14.5166761220647|SEMA4D|6
8638|leukocyte cell-cell adhesion (GO:0007159)|1/28|0.131029255394866|1|0|0|7.14285714285714|14.5166761220647|SEMA4D|6
8639|negative regulation of small GTPase mediated signal transduction (GO:0051058)|1/28|0.131029255394866|1|0|0|7.14285714285714|14.5166761220647|RASA4|6
8640|protein lipidation (GO:0006497)|2/128|0.13453591644741|1|0|0|3.125|6.26851274626406|CD52;LY6E|6
8641|regulation of vasculature development (GO:1901342)|1/29|0.13538019382269|1|0|0|6.89655172413793|13.7908152290277|SP100|6
8642|regulation of defense response to virus by virus (GO:0050690)|1/29|0.13538019382269|1|0|0|6.89655172413793|13.7908152290277|B2M|6
8643|neural crest cell migration (GO:0001755)|1/29|0.13538019382269|1|0|0|6.89655172413793|13.7908152290277|SEMA4D|6
8644|organelle fission (GO:0048285)|1/29|0.13538019382269|1|0|0|6.89655172413793|13.7908152290277|MX1|6
8645|positive regulation of NF-kappaB transcription factor activity (GO:0051092)|2/129|0.136230230372323|1|0|0|3.10077519379845|6.18111303612816|TRIM5;LGALS9|6
8646|protein glycosylation (GO:0006486)|2/131|0.139633215691308|1|0|0|3.05343511450382|6.01140818993697|PARP14;PARP9|6
8647|positive regulation of myeloid cell differentiation (GO:0045639)|1/30|0.139709563918842|1|0|0|6.66666666666667|13.1212636977043|STAT1|6
8648|dicarboxylic acid transport (GO:0006835)|1/30|0.139709563918842|1|0|0|6.66666666666667|13.1212636977043|SLC25A22|6
8649|regulation of activated T cell proliferation (GO:0046006)|1/30|0.139709563918842|1|0|0|6.66666666666667|13.1212636977043|LGALS9|6
8650|semaphorin-plexin signaling pathway (GO:0071526)|1/30|0.139709563918842|1|0|0|6.66666666666667|13.1212636977043|SEMA4D|6
8651|positive regulation of interleukin-1 secretion (GO:0050716)|1/30|0.139709563918842|1|0|0|6.66666666666667|13.1212636977043|LGALS9|6
8652|positive regulation of cation channel activity (GO:2001259)|1/31|0.144017471501311|1|0|0|6.45161290322581|12.5020687541664|CTSS|6
8653|negative regulation of secretion by cell (GO:1903531)|1/31|0.144017471501311|1|0|0|6.45161290322581|12.5020687541664|RSAD2|6
8654|negative regulation of endothelial cell proliferation (GO:0001937)|1/31|0.144017471501311|1|0|0|6.45161290322581|12.5020687541664|STAT1|6
8655|positive regulation of reactive oxygen species biosynthetic process (GO:1903428)|1/31|0.144017471501311|1|0|0|6.45161290322581|12.5020687541664|ASS1|6
8656|negative regulation of transferase activity (GO:0051348)|1/31|0.144017471501311|1|0|0|6.45161290322581|12.5020687541664|DTX3L|6
8657|protein targeting (GO:0006605)|2/134|0.144772261600204|1|0|0|2.98507462686567|5.76893546541988|RTP4;TSPO|6
8658|mitochondrial transport (GO:0006839)|2/136|0.148220323777077|1|0|0|2.94117647058824|5.61486893536909|TSPO;SLC25A22|6
8659|positive regulation of interleukin-1 beta production (GO:0032731)|1/32|0.148304021933978|1|0|0|6.25|11.9280681871869|LGALS9|6
8660|negative regulation of cell-cell adhesion (GO:0022408)|1/32|0.148304021933978|1|0|0|6.25|11.9280681871869|ASS1|6
8661|regulation of protein export from nucleus (GO:0046825)|1/32|0.148304021933978|1|0|0|6.25|11.9280681871869|SP100|6
8662|positive regulation of bone mineralization (GO:0030501)|1/32|0.148304021933978|1|0|0|6.25|11.9280681871869|ISG15|6
8663|negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556)|1/32|0.148304021933978|1|0|0|6.25|11.9280681871869|LGALS9|6
8664|regulation of ubiquitin-protein transferase activity (GO:0051438)|1/32|0.148304021933978|1|0|0|6.25|11.9280681871869|DTX3L|6
8665|alpha-amino acid metabolic process (GO:1901605)|1/32|0.148304021933978|1|0|0|6.25|11.9280681871869|ASS1|6
8666|positive regulation of viral genome replication (GO:0045070)|1/32|0.148304021933978|1|0|0|6.25|11.9280681871869|IFIT1|6
8667|regulation of nitric oxide biosynthetic process (GO:0045428)|1/33|0.152569319997184|1|0|0|6.06060606060606|11.3947650233696|ASS1|6
8668|phosphatidylcholine biosynthetic process (GO:0006656)|1/33|0.152569319997184|1|0|0|6.06060606060606|11.3947650233696|CHPT1|6
8669|positive regulation of T cell differentiation (GO:0045582)|1/33|0.152569319997184|1|0|0|6.06060606060606|11.3947650233696|PNP|6
8670|regulation of erythrocyte differentiation (GO:0045646)|1/33|0.152569319997184|1|0|0|6.06060606060606|11.3947650233696|STAT1|6
8671|negative regulation of transcription from RNA polymerase II promoter (GO:0000122)|5/566|0.15387370299474|1|0|0|1.76678445229682|3.30675463510036|SP100;SEMA4D;STAT1;IRF7;PARP9|6
8672|positive regulation of biomineral tissue development (GO:0070169)|1/34|0.156813470025957|1|0|0|5.88235294117647|10.8982251116337|ISG15|6
8673|regulation of interleukin-12 production (GO:0032655)|1/34|0.156813470025957|1|0|0|5.88235294117647|10.8982251116337|CMKLR1|6
8674|negative regulation of sequence-specific DNA binding transcription factor activity (GO:0043433)|2/141|0.156912649394293|1|0|0|2.83687943262411|5.25408794823158|SP100;CMKLR1|6
8675|double-strand break repair (GO:0006302)|2/142|0.158662824856746|1|0|0|2.8169014084507|5.1858420473231|DTX3L;PARP9|6
8676|positive regulation of chemokine production (GO:0032722)|1/35|0.161036575774195|1|0|0|5.71428571428571|10.4349929204408|LGALS9|6
8677|regulation of interleukin-1 beta secretion (GO:0050706)|1/35|0.161036575774195|1|0|0|5.71428571428571|10.4349929204408|LGALS9|6
8678|apoptotic mitochondrial changes (GO:0008637)|1/35|0.161036575774195|1|0|0|5.71428571428571|10.4349929204408|IFIT2|6
8679|regulation of interleukin-8 production (GO:0032677)|1/35|0.161036575774195|1|0|0|5.71428571428571|10.4349929204408|DDX58|6
8680|negative regulation of DNA binding (GO:0043392)|1/35|0.161036575774195|1|0|0|5.71428571428571|10.4349929204408|SP100|6
8681|response to peptide (GO:1901652)|1/35|0.161036575774195|1|0|0|5.71428571428571|10.4349929204408|STAT1|6
8682|negative regulation of endothelial cell migration (GO:0010596)|1/35|0.161036575774195|1|0|0|5.71428571428571|10.4349929204408|SP100|6
8683|positive regulation of macromolecule metabolic process (GO:0010604)|3/277|0.161469791265217|1|0|0|2.16606498194946|3.94968347611194|DTX3L;DDX58;LGALS9|6
8684|MAPK cascade (GO:0000165)|3/279|0.163885028708768|1|0|0|2.1505376344086|3.88944116443709|RASA4;LGALS9;PSMB8|6
8685|negative regulation of tumor necrosis factor production (GO:0032720)|1/36|0.165238740567014|1|0|0|5.55555555555556|10.002021879575|LGALS9|6
8686|anatomical structure homeostasis (GO:0060249)|1/36|0.165238740567014|1|0|0|5.55555555555556|10.002021879575|SP100|6
8687|neural crest cell development (GO:0014032)|1/36|0.165238740567014|1|0|0|5.55555555555556|10.002021879575|SEMA4D|6
8688|negative regulation of epithelial cell migration (GO:0010633)|1/36|0.165238740567014|1|0|0|5.55555555555556|10.002021879575|SP100|6
8689|regulation of receptor-mediated endocytosis (GO:0048259)|1/37|0.169420067180126|1|0|0|5.40540540540541|9.59661645107424|B2M|6
8690|regulation of cell morphogenesis involved in differentiation (GO:0010769)|1/37|0.169420067180126|1|0|0|5.40540540540541|9.59661645107424|SEMA4D|6
8691|negative regulation of Ras protein signal transduction (GO:0046580)|1/38|0.173580657931626|1|0|0|5.26315789473684|9.21638368635697|RASA4|6
8692|positive regulation of smooth muscle cell proliferation (GO:0048661)|1/38|0.173580657931626|1|0|0|5.26315789473684|9.21638368635697|STAT1|6
8693|protein monoubiquitination (GO:0006513)|1/38|0.173580657931626|1|0|0|5.26315789473684|9.21638368635697|DTX3L|6
8694|protein K63-linked ubiquitination (GO:0070534)|1/38|0.173580657931626|1|0|0|5.26315789473684|9.21638368635697|TRIM5|6
8695|positive regulation of axonogenesis (GO:0050772)|1/38|0.173580657931626|1|0|0|5.26315789473684|9.21638368635697|SEMA4D|6
8696|regulation of dendrite development (GO:0050773)|1/38|0.173580657931626|1|0|0|5.26315789473684|9.21638368635697|SEMA4D|6
8697|retina homeostasis (GO:0001895)|1/39|0.17772061456847|1|0|0|5.12820512820513|8.8591925274302|B2M|6
8698|regulation of RNA metabolic process (GO:0051252)|1/40|0.181840038445641|1|0|0|5|8.5231394400611|OAS3|6
8699|positive regulation of fat cell differentiation (GO:0045600)|1/40|0.181840038445641|1|0|0|5|8.5231394400611|CMKLR1|6
8700|regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041)|1/40|0.181840038445641|1|0|0|5|8.5231394400611|SP100|6
8701|regulation of viral transcription (GO:0046782)|1/41|0.185939030336605|1|0|0|4.8780487804878|8.2065192824113|IFITM3|6
8702|negative regulation of transport (GO:0051051)|1/41|0.185939030336605|1|0|0|4.8780487804878|8.2065192824113|BST2|6
8703|response to peptide hormone (GO:0043434)|1/41|0.185939030336605|1|0|0|4.8780487804878|8.2065192824113|STAT1|6
8704|response to cAMP (GO:0051591)|1/41|0.185939030336605|1|0|0|4.8780487804878|8.2065192824113|STAT1|6
8705|detection of chemical stimulus involved in sensory perception of bitter taste (GO:0001580)|1/41|0.185939030336605|1|0|0|4.8780487804878|8.2065192824113|RTP4|6
8706|negative regulation of cytokine-mediated signaling pathway (GO:0001960)|1/41|0.185939030336605|1|0|0|4.8780487804878|8.2065192824113|PARP14|6
8707|ameboidal-type cell migration (GO:0001667)|1/41|0.185939030336605|1|0|0|4.8780487804878|8.2065192824113|SEMA4D|6
8708|sensory perception of bitter taste (GO:0050913)|1/42|0.190017690585897|1|0|0|4.76190476190476|7.90780048956731|RTP4|6
8709|regulation of protein localization (GO:0032880)|1/42|0.190017690585897|1|0|0|4.76190476190476|7.90780048956731|TRIM5|6
8710|regulation of calcium-mediated signaling (GO:0050848)|1/42|0.190017690585897|1|0|0|4.76190476190476|7.90780048956731|CMKLR1|6
8711|peptide transport (GO:0015833)|1/42|0.190017690585897|1|0|0|4.76190476190476|7.90780048956731|TAP1|6
8712|telomere organization (GO:0032200)|1/42|0.190017690585897|1|0|0|4.76190476190476|7.90780048956731|SP100|6
8713|positive regulation of receptor-mediated endocytosis (GO:0048260)|1/42|0.190017690585897|1|0|0|4.76190476190476|7.90780048956731|B2M|6
8714|negative regulation of protein secretion (GO:0050709)|1/43|0.19407611900782|1|0|0|4.65116279069767|7.62560386443971|RSAD2|6
8715|regulation of interleukin-6 production (GO:0032675)|1/43|0.19407611900782|1|0|0|4.65116279069767|7.62560386443971|DDX58|6
8716|cellular response to calcium ion (GO:0071277)|1/43|0.19407611900782|1|0|0|4.65116279069767|7.62560386443971|RASA4|6
8717|regulation of protein modification process (GO:0031399)|1/43|0.19407611900782|1|0|0|4.65116279069767|7.62560386443971|STAT2|6
8718|cellular response to cytokine stimulus (GO:0071345)|4/457|0.195539784863373|1|0|0|1.75054704595186|2.85687775426383|STAT1;STAT2;LGALS9;IFIT1|6
8719|positive regulation of interferon-gamma production (GO:0032729)|1/44|0.1981144149655|1|0|0|4.54545454545455|7.35868437190662|LGALS9|6
8720|regulation of dendrite morphogenesis (GO:0048814)|1/45|0.202132677279174|1|0|0|4.44444444444444|7.10591546212389|SEMA4D|6
8721|posttranscriptional regulation of gene expression (GO:0010608)|1/45|0.202132677279174|1|0|0|4.44444444444444|7.10591546212389|PARP9|6
8722|sprouting angiogenesis (GO:0002040)|1/45|0.202132677279174|1|0|0|4.44444444444444|7.10591546212389|RNF213|6
8723|detection of chemical stimulus involved in sensory perception of taste (GO:0050912)|1/45|0.202132677279174|1|0|0|4.44444444444444|7.10591546212389|RTP4|6
8724|regulation of smooth muscle cell proliferation (GO:0048660)|1/45|0.202132677279174|1|0|0|4.44444444444444|7.10591546212389|STAT1|6
8725|amide biosynthetic process (GO:0043604)|1/45|0.202132677279174|1|0|0|4.44444444444444|7.10591546212389|ASS1|6
8726|negative regulation of ossification (GO:0030279)|1/46|0.206131004383124|1|0|0|4.34782608695652|6.86627551613742|SEMA4D|6
8727|regulation of cellular component movement (GO:0051270)|1/47|0.210109494168341|1|0|0|4.25531914893617|6.63883609934132|SP100|6
8728|negative regulation of protein modification by small protein conjugation or removal (GO:1903321)|1/47|0.210109494168341|1|0|0|4.25531914893617|6.63883609934132|ISG15|6
8729|regulation of cell migration (GO:0030334)|3/317|0.211627675374313|1|0|0|1.89274447949527|2.93929362124253|BST2;SEMA4D;DDX58|6
8730|negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124)|1/48|0.214068244088033|1|0|0|4.16666666666667|6.42275173829037|STAT1|6
8731|negative regulation of JAK-STAT cascade (GO:0046426)|1/48|0.214068244088033|1|0|0|4.16666666666667|6.42275173829037|PARP14|6
8732|endosome to lysosome transport (GO:0008333)|1/49|0.21800735103248|1|0|0|4.08163265306122|6.21725100583301|DTX3L|6
8733|intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630)|1/49|0.21800735103248|1|0|0|4.08163265306122|6.21725100583301|IKBKE|6
8734|protein K48-linked ubiquitination (GO:0070936)|1/49|0.21800735103248|1|0|0|4.08163265306122|6.21725100583301|DTX3L|6
8735|regulation of mitochondrion organization (GO:0010821)|1/49|0.21800735103248|1|0|0|4.08163265306122|6.21725100583301|STAT2|6
8736|pattern recognition receptor signaling pathway (GO:0002221)|1/49|0.21800735103248|1|0|0|4.08163265306122|6.21725100583301|CTSS|6
8737|negative regulation of Wnt signaling pathway (GO:0030178)|2/175|0.218055879258723|1|0|0|2.28571428571429|3.48115182208981|RNF213;PSMB8|6
8738|establishment of protein localization to mitochondrion (GO:0072655)|1/50|0.221926911560385|1|0|0|4|6.02162871409002|TSPO|6
8739|regulation of angiogenesis (GO:0045765)|2/178|0.223566841614148|1|0|0|2.24719101123595|3.36639290340562|SP100;STAT1|6
8740|regulation of bone mineralization (GO:0030500)|1/51|0.225827021656465|1|0|0|3.92156862745098|5.835239073222|ISG15|6
8741|blood circulation (GO:0008015)|1/51|0.225827021656465|1|0|0|3.92156862745098|5.835239073222|STAT1|6
8742|cellular response to DNA damage stimulus (GO:0006974)|3/330|0.228624931678316|1|0|0|1.81818181818182|2.68304085656087|DTX3L;IRF7;IKBKE|6
8743|regulation of cellular amino acid metabolic process (GO:0006521)|1/52|0.229707776816989|1|0|0|3.84615384615385|5.65748966712265|PSMB8|6
8744|regulation of cellular amine metabolic process (GO:0033238)|1/52|0.229707776816989|1|0|0|3.84615384615385|5.65748966712265|PSMB8|6
8745|positive regulation of developmental growth (GO:0048639)|1/52|0.229707776816989|1|0|0|3.84615384615385|5.65748966712265|SEMA4D|6
8746|telomere maintenance (GO:0000723)|1/52|0.229707776816989|1|0|0|3.84615384615385|5.65748966712265|SP100|6
8747|organonitrogen compound biosynthetic process (GO:1901566)|2/182|0.230931972138144|1|0|0|2.1978021978022|3.22116946096784|CHPT1;ASS1|6
8748|regulation of DNA binding (GO:0051101)|1/53|0.233569272224541|1|0|0|3.77358490566038|5.48783613892414|SP100|6
8749|positive regulation of proteolysis (GO:0045862)|1/53|0.233569272224541|1|0|0|3.77358490566038|5.48783613892414|CTSC|6
8750|positive regulation of ossification (GO:0045778)|1/53|0.233569272224541|1|0|0|3.77358490566038|5.48783613892414|ISG15|6
8751|positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068)|1/54|0.237411602446854|1|0|0|3.7037037037037|5.32577750005522|SEMA4D|6
8752|positive regulation of protein import into nucleus (GO:0042307)|1/54|0.237411602446854|1|0|0|3.7037037037037|5.32577750005522|DDX58|6
8753|protein targeting to mitochondrion (GO:0006626)|1/55|0.241234861655302|1|0|0|3.63636363636364|5.17085196489895|TSPO|6
8754|positive regulation of immune response (GO:0050778)|1/55|0.241234861655302|1|0|0|3.63636363636364|5.17085196489895|LGALS9|6
8755|membrane fusion (GO:0061025)|1/55|0.241234861655302|1|0|0|3.63636363636364|5.17085196489895|MX1|6
8756|positive regulation of response to stimulus (GO:0048584)|1/55|0.241234861655302|1|0|0|3.63636363636364|5.17085196489895|DDX58|6
8757|regulation of GTPase activity (GO:0043087)|2/189|0.243858065056649|1|0|0|2.11640211640212|2.9866008963595|SEMA4D;RASA4|6
8758|ubiquitin-dependent protein catabolic process (GO:0006511)|3/342|0.244540444482952|1|0|0|1.75438596491228|2.47083257305074|RNF213;DTX3L;PSMB8|6
8759|Notch signaling pathway (GO:0007219)|1/56|0.245039143568043|1|0|0|3.57142857142857|5.02263325547765|STAT1|6
8760|fat cell differentiation (GO:0045444)|1/56|0.245039143568043|1|0|0|3.57142857142857|5.02263325547765|PSMB8|6
8761|anion transport (GO:0006820)|1/57|0.248824541413001|1|0|0|3.50877192982456|4.88072731179598|TSPO|6
8762|cellular defense response (GO:0006968)|1/57|0.248824541413001|1|0|0|3.50877192982456|4.88072731179598|LGALS3BP|6
8763|protein homotetramerization (GO:0051289)|1/58|0.252591147960672|1|0|0|3.44827586206897|4.74476935649171|SAMHD1|6
8764|cellular response to tumor necrosis factor (GO:0071356)|2/195|0.254963277350062|1|0|0|2.05128205128205|2.8033553940228|STAT1;PSMB8|6
8765|renal system development (GO:0072001)|1/60|0.260068356267662|1|0|0|3.33333333333333|4.48936924599758|STAT1|6
8766|dicarboxylic acid metabolic process (GO:0043648)|1/60|0.260068356267662|1|0|0|3.33333333333333|4.48936924599758|ASS1|6
8767|regulation of extrinsic apoptotic signaling pathway (GO:2001236)|1/60|0.260068356267662|1|0|0|3.33333333333333|4.48936924599758|SP100|6
8768|regulation of gene expression (GO:0010468)|7/1038|0.262411782729976|1|0|0|1.34874759152216|1.80440890839432|SP100;SP110;DDX58;LGALS9;PARP14;PARP9;SAP30|6
8769|transcription, DNA-templated (GO:0006351)|3/357|0.264678736882378|1|0|0|1.68067226890756|2.23401428923356|IRF7;ELOA;IRF9|6
8770|positive regulation of T cell proliferation (GO:0042102)|1/62|0.267471501800711|1|0|0|3.2258064516129|4.2540072698252|PNP|6
8771|regulation of cellular ketone metabolic process (GO:0010565)|1/62|0.267471501800711|1|0|0|3.2258064516129|4.2540072698252|PSMB8|6
8772|regulation of tumor necrosis factor production (GO:0032680)|1/62|0.267471501800711|1|0|0|3.2258064516129|4.2540072698252|LGALS9|6
8773|protein targeting to membrane (GO:0006612)|1/62|0.267471501800711|1|0|0|3.2258064516129|4.2540072698252|RTP4|6
8774|stress-activated MAPK cascade (GO:0051403)|1/63|0.271145528260931|1|0|0|3.17460317460317|4.14317332566652|LGALS9|6
8775|regulation of actin filament-based process (GO:0032970)|1/63|0.271145528260931|1|0|0|3.17460317460317|4.14317332566652|BST2|6
8776|negative regulation of G2/M transition of mitotic cell cycle (GO:0010972)|1/63|0.271145528260931|1|0|0|3.17460317460317|4.14317332566652|PSMB8|6
8777|regulation of T cell proliferation (GO:0042129)|1/63|0.271145528260931|1|0|0|3.17460317460317|4.14317332566652|PNP|6
8778|iron ion homeostasis (GO:0055072)|1/64|0.274801310842782|1|0|0|3.125|4.03658421398463|B2M|6
8779|vesicle targeting, rough ER to cis-Golgi (GO:0048207)|1/64|0.274801310842782|1|0|0|3.125|4.03658421398463|CTSC|6
8780|vesicle coating (GO:0006901)|1/64|0.274801310842782|1|0|0|3.125|4.03658421398463|CTSC|6
8781|COPII vesicle coating (GO:0048208)|1/64|0.274801310842782|1|0|0|3.125|4.03658421398463|CTSC|6
8782|positive regulation of endocytosis (GO:0045807)|1/65|0.278438939213788|1|0|0|3.07692307692308|3.93401997672877|B2M|6
8783|negative regulation of cellular process (GO:0048523)|4/535|0.279216084695689|1|0|0|1.49532710280374|1.90769241093343|BST2;SP100;SEMA4D;IFIT3|6
8784|negative regulation of cell adhesion (GO:0007162)|1/66|0.282058502576368|1|0|0|3.03030303030303|3.83527507156201|SEMA4D|6
8785|negative regulation of blood vessel morphogenesis (GO:2000181)|1/66|0.282058502576368|1|0|0|3.03030303030303|3.83527507156201|STAT1|6
8786|negative regulation of epithelial cell proliferation (GO:0050680)|1/67|0.285660089808726|1|0|0|2.98507462686567|3.74015723032068|STAT1|6
8787|regulation of endopeptidase activity (GO:0052548)|1/69|0.29280968888067|1|0|0|2.89855072463768|3.56009393334206|PSMB8|6
8788|COPII-coated vesicle budding (GO:0090114)|1/69|0.29280968888067|1|0|0|2.89855072463768|3.56009393334206|CTSC|6
8789|negative regulation of phosphatase activity (GO:0010923)|1/69|0.29280968888067|1|0|0|2.89855072463768|3.56009393334206|SEMA4D|6
8790|negative regulation of angiogenesis (GO:0016525)|1/70|0.296357876203525|1|0|0|2.85714285714286|3.4748214678049|STAT1|6
8791|regulation of endothelial cell migration (GO:0010594)|1/70|0.296357876203525|1|0|0|2.85714285714286|3.4748214678049|SP100|6
8792|regulation of osteoblast differentiation (GO:0045667)|1/70|0.296357876203525|1|0|0|2.85714285714286|3.4748214678049|SEMA4D|6
8793|negative regulation of cell cycle G2/M phase transition (GO:1902750)|1/70|0.296357876203525|1|0|0|2.85714285714286|3.4748214678049|PSMB8|6
8794|protein oligomerization (GO:0051259)|2/218|0.297557155004617|1|0|0|1.8348623853211|2.22412652254332|RNF213;IKBKE|6
8795|viral process (GO:0016032)|2/221|0.303097161146387|1|0|0|1.80995475113122|2.16054635479632|IRF7;B2M|6
8796|regulation of cation channel activity (GO:2001257)|1/72|0.303401461859655|1|0|0|2.77777777777778|3.31305109394646|CTSS|6
8797|negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436)|1/72|0.303401461859655|1|0|0|2.77777777777778|3.31305109394646|PSMB8|6
8798|positive regulation of lymphocyte proliferation (GO:0050671)|1/72|0.303401461859655|1|0|0|2.77777777777778|3.31305109394646|PNP|6
8799|phosphatidylcholine metabolic process (GO:0046470)|1/72|0.303401461859655|1|0|0|2.77777777777778|3.31305109394646|CHPT1|6
8800|regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439)|1/73|0.306897033111884|1|0|0|2.73972602739726|3.23628214981589|PSMB8|6
8801|SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146)|1/73|0.306897033111884|1|0|0|2.73972602739726|3.23628214981589|PSMB8|6
8802|lysosomal transport (GO:0007041)|1/73|0.306897033111884|1|0|0|2.73972602739726|3.23628214981589|DTX3L|6
8803|regulation of fat cell differentiation (GO:0045598)|1/73|0.306897033111884|1|0|0|2.73972602739726|3.23628214981589|CMKLR1|6
8804|regulation of actin cytoskeleton organization (GO:0032956)|1/76|0.317279889350664|1|0|0|2.63157894736842|3.02097621830054|BST2|6
8805|positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition (GO:0051437)|1/77|0.320706505558706|1|0|0|2.5974025974026|2.95384126491518|PSMB8|6
8806|regulation of hematopoietic stem cell differentiation (GO:1902036)|1/77|0.320706505558706|1|0|0|2.5974025974026|2.95384126491518|PSMB8|6
8807|response to interleukin-1 (GO:0070555)|1/77|0.320706505558706|1|0|0|2.5974025974026|2.95384126491518|LGALS9|6
8808|positive regulation of apoptotic signaling pathway (GO:2001235)|1/77|0.320706505558706|1|0|0|2.5974025974026|2.95384126491518|LGALS9|6
8809|protein modification by small protein conjugation (GO:0032446)|3/399|0.321928809019472|1|0|0|1.50375939849624|1.70439826749378|RNF213;ISG15;HERC6|6
8810|regulation of hematopoietic progenitor cell differentiation (GO:1901532)|1/78|0.324116094429913|1|0|0|2.56410256410256|2.88885515699487|PSMB8|6
8811|negative regulation of ubiquitin protein ligase activity (GO:1904667)|1/78|0.324116094429913|1|0|0|2.56410256410256|2.88885515699487|PSMB8|6
8812|regulation of signal transduction (GO:0009966)|2/234|0.327008217981485|1|0|0|1.70940170940171|1.91071790933132|SP100;TRIM5|6
8813|regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418)|1/79|0.32750873980153|1|0|0|2.53164556962025|2.82592541226841|PSMB8|6
8814|extracellular matrix disassembly (GO:0022617)|1/79|0.32750873980153|1|0|0|2.53164556962025|2.82592541226841|CTSS|6
8815|steroid biosynthetic process (GO:0006694)|1/80|0.330884524972772|1|0|0|2.5|2.7649645790628|TSPO|6
8816|anaphase-promoting complex-dependent catabolic process (GO:0031145)|1/80|0.330884524972772|1|0|0|2.5|2.7649645790628|PSMB8|6
8817|negative regulation of mitotic cell cycle phase transition (GO:1901991)|1/80|0.330884524972772|1|0|0|2.5|2.7649645790628|PSMB8|6
8818|regulation of endothelial cell proliferation (GO:0001936)|1/80|0.330884524972772|1|0|0|2.5|2.7649645790628|STAT1|6
8819|response to calcium ion (GO:0051592)|1/80|0.330884524972772|1|0|0|2.5|2.7649645790628|RASA4|6
8820|cellular response to hormone stimulus (GO:0032870)|1/81|0.334243532854352|1|0|0|2.46913580246914|2.70588990473229|CTSS|6
8821|NIK/NF-kappaB signaling (GO:0038061)|1/81|0.334243532854352|1|0|0|2.46913580246914|2.70588990473229|PSMB8|6
8822|regulation of phosphatidylinositol 3-kinase signaling (GO:0014066)|1/81|0.334243532854352|1|0|0|2.46913580246914|2.70588990473229|SEMA4D|6
8823|protein catabolic process (GO:0030163)|1/82|0.337585846063778|1|0|0|2.4390243902439|2.64862303001403|PSMB8|6
8824|DNA damage response, signal transduction by p53 class mediator (GO:0030330)|1/83|0.340911546721369|1|0|0|2.40963855421687|2.59308970873731|SP100|6
8825|negative regulation of NF-kappaB transcription factor activity (GO:0032088)|1/83|0.340911546721369|1|0|0|2.40963855421687|2.59308970873731|CMKLR1|6
8826|positive regulation of ubiquitin protein ligase activity (GO:1904668)|1/83|0.340911546721369|1|0|0|2.40963855421687|2.59308970873731|PSMB8|6
8827|protein maturation (GO:0051604)|1/84|0.344220716526821|1|0|0|2.38095238095238|2.53921954654028|CTSS|6
8828|establishment of protein localization to membrane (GO:0090150)|1/84|0.344220716526821|1|0|0|2.38095238095238|2.53921954654028|RTP4|6
8829|protein modification process (GO:0036211)|1/85|0.347513436866072|1|0|0|2.35294117647059|2.48694575878671|UBE2L6|6
8830|regulation of peptidyl-tyrosine phosphorylation (GO:0050730)|1/86|0.350789788685405|1|0|0|2.32558139534884|2.43620494780994|SEMA4D|6
8831|toll-like receptor signaling pathway (GO:0002224)|1/87|0.354049852499014|1|0|0|2.29885057471264|2.38693689539092|CTSS|6
8832|organic substance transport (GO:0071702)|1/88|0.357293708483398|1|0|0|2.27272727272727|2.33908436956034|TAP1|6
8833|positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process (GO:2000060)|1/88|0.357293708483398|1|0|0|2.27272727272727|2.33908436956034|PSMB8|6
8834|regulation of stem cell differentiation (GO:2000736)|1/89|0.360521436424534|1|0|0|2.24719101123595|2.29259294604232|PSMB8|6
8835|Wnt signaling pathway, planar cell polarity pathway (GO:0060071)|1/89|0.360521436424534|1|0|0|2.24719101123595|2.29259294604232|PSMB8|6
8836|regulation of establishment of planar polarity (GO:0090175)|1/90|0.363733115678147|1|0|0|2.22222222222222|2.24741084211871|PSMB8|6
8837|protein tetramerization (GO:0051262)|1/91|0.366928825262423|1|0|0|2.1978021978022|2.20348876120957|SAMHD1|6
8838|regulation of Ras protein signal transduction (GO:0046578)|1/91|0.366928825262423|1|0|0|2.1978021978022|2.20348876120957|RASA4|6
8839|protein deubiquitination (GO:0016579)|2/258|0.37054382795517|1|0|0|1.55038759689922|1.53919929793203|DDX58;PSMB8|6
8840|regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618)|1/94|0.376420920115876|1|0|0|2.12765957446809|2.07882402837542|PSMB8|6
8841|regulation of protein phosphorylation (GO:0001932)|2/262|0.377700202002356|1|0|0|1.52671755725191|1.48649544189563|SEMA4D;STAT2|6
8842|protein modification by small protein removal (GO:0070646)|2/262|0.377700202002356|1|0|0|1.52671755725191|1.48649544189563|DDX58;PSMB8|6
8843|vesicle fusion (GO:0006906)|1/95|0.379553533216983|1|0|0|2.10526315789474|2.03949395705155|TAP1|6
8844|transcription elongation from RNA polymerase II promoter (GO:0006368)|1/96|0.382670565880735|1|0|0|2.08333333333333|2.00121000258093|ELOA|6
8845|interleukin-1-mediated signaling pathway (GO:0070498)|1/96|0.382670565880735|1|0|0|2.08333333333333|2.00121000258093|PSMB8|6
8846|regulation of cytoskeleton organization (GO:0051493)|1/96|0.382670565880735|1|0|0|2.08333333333333|2.00121000258093|BST2|6
8847|negative regulation of transcription, DNA-templated (GO:0045892)|5/814|0.385108400572641|1|0|0|1.22850122850123|1.1722732486437|SP100;SEMA4D;STAT1;IRF7;PARP9|6
8848|negative regulation of cell motility (GO:2000146)|1/98|0.388858196397513|1|0|0|2.04081632653061|1.92763374592802|BST2|6
8849|antigen processing and presentation of exogenous peptide antigen (GO:0002478)|1/98|0.388858196397513|1|0|0|2.04081632653061|1.92763374592802|CTSS|6
8850|antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886)|1/98|0.388858196397513|1|0|0|2.04081632653061|1.92763374592802|CTSS|6
8851|response to molecule of bacterial origin (GO:0002237)|1/99|0.391928946523868|1|0|0|2.02020202020202|1.89227215048228|LGALS9|6
8852|positive regulation of cell growth (GO:0030307)|1/99|0.391928946523868|1|0|0|2.02020202020202|1.89227215048228|SEMA4D|6
8853|antigen processing and presentation of peptide antigen via MHC class II (GO:0002495)|1/99|0.391928946523868|1|0|0|2.02020202020202|1.89227215048228|CTSS|6
8854|steroid metabolic process (GO:0008202)|1/100|0.394984420817951|1|0|0|2|1.85781791165209|TSPO|6
8855|protein processing (GO:0016485)|1/102|0.401049842395342|1|0|0|1.96078431372549|1.79150894931245|CTSS|6
8856|regulation of protein ubiquitination (GO:0031396)|1/102|0.401049842395342|1|0|0|1.96078431372549|1.79150894931245|ISG15|6
8857|intrinsic apoptotic signaling pathway (GO:0097193)|1/102|0.401049842395342|1|0|0|1.96078431372549|1.79150894931245|IKBKE|6
8858|positive regulation of cellular catabolic process (GO:0031331)|1/107|0.41595129052059|1|0|0|1.86915887850467|1.63960208536671|DTX3L|6
8859|regulation of protein secretion (GO:0050708)|1/108|0.41888723576301|1|0|0|1.85185185185185|1.61139541173785|RSAD2|6
8860|regulation of response to external stimulus (GO:0032101)|1/108|0.41888723576301|1|0|0|1.85185185185185|1.61139541173785|TRIM5|6
8861|regulation of protein activation cascade (GO:2000257)|1/109|0.421808569139365|1|0|0|1.8348623853211|1.58385999173964|CFB|6
8862|DNA-templated transcription, elongation (GO:0006354)|1/109|0.421808569139365|1|0|0|1.8348623853211|1.58385999173964|ELOA|6
8863|regulation of cell motility (GO:2000145)|1/110|0.424715362613925|1|0|0|1.81818181818182|1.55697467173903|DDX58|6
8864|regulation of complement activation (GO:0030449)|1/110|0.424715362613925|1|0|0|1.81818181818182|1.55697467173903|CFB|6
8865|positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280)|1/110|0.424715362613925|1|0|0|1.81818181818182|1.55697467173903|LGALS9|6
8866|DNA repair (GO:0006281)|2/289|0.425072719924934|1|0|0|1.3840830449827|1.1840761508497|DTX3L;PARP9|6
8867|ion transport (GO:0006811)|2/290|0.426792951548677|1|0|0|1.37931034482759|1.17442244736258|TSPO;SLC25A22|6
8868|positive regulation of MAPK cascade (GO:0043410)|2/290|0.426792951548677|1|0|0|1.37931034482759|1.17442244736258|TRIM5;LGALS9|6
8869|proteolysis (GO:0006508)|2/292|0.430225506881204|1|0|0|1.36986301369863|1.15540516870527|CTSS;CTSC|6
8870|positive regulation of canonical Wnt signaling pathway (GO:0090263)|1/114|0.436198565833718|1|0|0|1.75438596491228|1.45553984751583|PSMB8|6
8871|regulation of humoral immune response (GO:0002920)|1/114|0.436198565833718|1|0|0|1.75438596491228|1.45553984751583|CFB|6
8872|cellular protein metabolic process (GO:0044267)|3/485|0.438426405252473|1|0|0|1.23711340206186|1.02007832684912|UBE2L6;B2M;CKAP4|6
8873|regulation of immune effector process (GO:0002697)|1/115|0.439033727758999|1|0|0|1.73913043478261|1.4316157221738|CFB|6
8874|transcription from RNA polymerase II promoter (GO:0006366)|3/486|0.439747344727266|1|0|0|1.23456790123457|1.0142653500299|IRF7;ELOA;IRF9|6
8875|negative regulation of cell growth (GO:0030308)|1/116|0.441854774426629|1|0|0|1.72413793103448|1.40823106127459|BST2|6
8876|epithelium development (GO:0060429)|1/116|0.441854774426629|1|0|0|1.72413793103448|1.40823106127459|STAT1|6
8877|regulation of phosphorylation (GO:0042325)|1/120|0.452999195235667|1|0|0|1.66666666666667|1.31977488337065|STAT2|6
8878|negative regulation of growth (GO:0045926)|1/121|0.455750702577925|1|0|0|1.65289256198347|1.29885838650962|BST2|6
8879|negative regulation of cell migration (GO:0030336)|1/122|0.458488507016457|1|0|0|1.63934426229508|1.27839353128715|BST2|6
8880|regulation of acute inflammatory response (GO:0002673)|1/122|0.458488507016457|1|0|0|1.63934426229508|1.27839353128715|CFB|6
8881|stimulatory C-type lectin receptor signaling pathway (GO:0002223)|1/122|0.458488507016457|1|0|0|1.63934426229508|1.27839353128715|PSMB8|6
8882|innate immune response activating cell surface receptor signaling pathway (GO:0002220)|1/125|0.46662037707619|1|0|0|1.6|1.21958279831414|PSMB8|6
8883|platelet degranulation (GO:0002576)|1/125|0.46662037707619|1|0|0|1.6|1.21958279831414|LGALS3BP|6
8884|non-canonical Wnt signaling pathway (GO:0035567)|1/128|0.474631333638161|1|0|0|1.5625|1.16440143126405|PSMB8|6
8885|regulation of mRNA stability (GO:0043488)|1/129|0.477275091201804|1|0|0|1.55038759689922|1.14676316777186|PSMB8|6
8886|regulation of protein processing (GO:0070613)|1/129|0.477275091201804|1|0|0|1.55038759689922|1.14676316777186|CFB|6
8887|cellular response to hypoxia (GO:0071456)|1/133|0.487719053875974|1|0|0|1.50375939849624|1.07972292959962|PSMB8|6
8888|positive regulation of cytosolic calcium ion concentration (GO:0007204)|1/134|0.490297600070642|1|0|0|1.49253731343284|1.06379511217182|CD52|6
8889|positive regulation of transcription, DNA-templated (GO:0045893)|6/1121|0.492182925178744|1|0|0|1.07047279214987|0.758863335357232|SP100;DTX3L;DDX58;STAT1;IRF7;PARP9|6
8890|regulation of cytosolic calcium ion concentration (GO:0051480)|1/138|0.500483918197201|1|0|0|1.44927536231884|1.00315914814089|CD52|6
8891|positive regulation of transferase activity (GO:0051347)|1/138|0.500483918197201|1|0|0|1.44927536231884|1.00315914814089|DTX3L|6
8892|regulation of primary metabolic process (GO:0080090)|1/140|0.505501237241334|1|0|0|1.42857142857143|0.974578275664418|PSMB8|6
8893|response to lipid (GO:0033993)|1/141|0.507991154544595|1|0|0|1.41843971631206|0.960696799814241|LGALS9|6
8894|positive regulation of Wnt signaling pathway (GO:0030177)|1/141|0.507991154544595|1|0|0|1.41843971631206|0.960696799814241|PSMB8|6
8895|peptidyl-serine phosphorylation (GO:0018105)|1/146|0.520255772624573|1|0|0|1.36986301369863|0.895116051922466|IKBKE|6
8896|skeletal system development (GO:0001501)|1/147|0.522672127159014|1|0|0|1.36054421768707|0.882722339352251|CMKLR1|6
8897|negative regulation of canonical Wnt signaling pathway (GO:0090090)|1/149|0.527468747150282|1|0|0|1.34228187919463|0.858611627510826|PSMB8|6
8898|regulated exocytosis (GO:0045055)|1/149|0.527468747150282|1|0|0|1.34228187919463|0.858611627510826|LGALS3BP|6
8899|regulation of G2/M transition of mitotic cell cycle (GO:0010389)|1/150|0.529849131261317|1|0|0|1.33333333333333|0.846883961275017|PSMB8|6
8900|cellular response to interleukin-1 (GO:0071347)|1/151|0.5322176434695|1|0|0|1.32450331125828|0.835367906006422|PSMB8|6
8901|negative regulation of cell differentiation (GO:0045596)|1/151|0.5322176434695|1|0|0|1.32450331125828|0.835367906006422|SEMA4D|6
8902|post-translational protein modification (GO:0043687)|2/358|0.536896749774298|1|0|0|1.11731843575419|0.694915614816851|CKAP4;PSMB8|6
8903|response to lipopolysaccharide (GO:0032496)|1/156|0.54388416660054|1|0|0|1.28205128205128|0.780793569028112|LGALS9|6
8904|regulation of transcription, DNA-templated (GO:0006355)|8/1599|0.552494785332651|1|0|0|1.00062539086929|0.593682335406343|SP100;DTX3L;SP110;STAT1;STAT2;IRF7;PARP9;SAP30|6
8905|positive regulation of cellular biosynthetic process (GO:0031328)|1/160|0.553009592723917|1|0|0|1.25|0.740474913640491|ASS1|6
8906|negative regulation of intracellular signal transduction (GO:1902532)|1/162|0.557504289374834|1|0|0|1.23456790123457|0.721339607076013|STAT1|6
8907|positive regulation of protein modification process (GO:0031401)|1/164|0.56195423704509|1|0|0|1.21951219512195|0.702847391645533|SEMA4D|6
8908|T cell receptor signaling pathway (GO:0050852)|1/164|0.56195423704509|1|0|0|1.21951219512195|0.702847391645533|PSMB8|6
8909|glycerophospholipid biosynthetic process (GO:0046474)|1/165|0.564162568027238|1|0|0|1.21212121212121|0.693833730708535|CHPT1|6
8910|cellular protein modification process (GO:0006464)|5/1002|0.566247925386578|1|0|0|0.998003992015968|0.567588089788491|UBE2L6;ISG15;IKBKE;CKAP4;PSMB8|6
8911|transmembrane transport (GO:0055085)|2/379|0.567898224526514|1|0|0|1.05540897097625|0.597164177823387|TAP1;PSMB8|6
8912|peptidyl-serine modification (GO:0018209)|1/171|0.577182984911913|1|0|0|1.16959064327485|0.642802258697678|IKBKE|6
8913|positive regulation of hydrolase activity (GO:0051345)|1/173|0.581436958568339|1|0|0|1.15606936416185|0.626881762599697|SEMA4D|6
8914|regulation of apoptotic process (GO:0042981)|4/816|0.586821195538518|1|0|0|0.980392156862745|0.522583443937274|SEMA4D;STAT1;IFIT3;IFIT2|6
8915|regulation of nucleic acid-templated transcription (GO:1903506)|3/608|0.589829609637526|1|0|0|0.986842105263158|0.520975244424527|SP100;SP110;SAP30|6
8916|negative regulation of protein phosphorylation (GO:0001933)|1/179|0.593946292416423|1|0|0|1.11731843575419|0.582085341357214|SEMA4D|6
8917|positive regulation of cell motility (GO:2000147)|1/180|0.595994889569521|1|0|0|1.11111111111111|0.575025762779258|SEMA4D|6
8918|ER to Golgi vesicle-mediated transport (GO:0006888)|1/181|0.598033254092167|1|0|0|1.10497237569061|0.568076152185461|CTSC|6
8919|negative regulation of gene expression (GO:0010629)|3/619|0.602075022078791|1|0|0|0.969305331179321|0.491799567086827|LGALS9;PARP14;PARP9|6
8920|Fc-epsilon receptor signaling pathway (GO:0038095)|1/183|0.6020794872594|1|0|0|1.09289617486339|0.554498146177893|PSMB8|6
8921|Fc receptor signaling pathway (GO:0038093)|1/184|0.604087456347206|1|0|0|1.08695652173913|0.547865539404691|PSMB8|6
8922|regulation of mitotic cell cycle phase transition (GO:1901990)|1/185|0.606085393723219|1|0|0|1.08108108108108|0.541334474708698|PSMB8|6
8923|negative regulation of programmed cell death (GO:0043069)|2/409|0.609578638549585|1|0|0|0.97799511002445|0.48409517552376|SEMA4D;IFIT3|6
8924|positive regulation of protein phosphorylation (GO:0001934)|2/413|0.614902626198812|1|0|0|0.968523002421308|0.470984363288525|SEMA4D;TRIM5|6
8925|regulation of transcription from RNA polymerase II promoter (GO:0006357)|7/1479|0.615337008055836|1|0|0|0.94658553076403|0.45964790598849|SP100;SEMA4D;DDX58;STAT1;STAT2;IRF7;PARP9|6
8926|protein complex assembly (GO:0006461)|1/190|0.615926332366024|1|0|0|1.05263157894737|0.51013464517369|CTSC|6
8927|regulation of cellular macromolecule biosynthetic process (GO:2000112)|3/632|0.616240346765777|1|0|0|0.949367088607595|0.459605903378513|SP100;SP110;SAP30|6
8928|positive regulation of GTPase activity (GO:0043547)|1/193|0.621713652685644|1|0|0|1.03626943005181|0.492513634923143|SEMA4D|6
8929|positive regulation of cell differentiation (GO:0045597)|1/195|0.625523817045148|1|0|0|1.02564102564103|0.481195767168499|CMKLR1|6
8930|positive regulation of ERK1 and ERK2 cascade (GO:0070374)|1/202|0.638562619762378|1|0|0|0.99009900990099|0.444094589188655|LGALS9|6
8931|regulation of MAPK cascade (GO:0043408)|1/204|0.642204728471937|1|0|0|0.980392156862745|0.43416483767303|TRIM5|6
8932|positive regulation of phosphorylation (GO:0042327)|1/209|0.651151808154468|1|0|0|0.956937799043062|0.410538250439319|SEMA4D|6
8933|regulation of canonical Wnt signaling pathway (GO:0060828)|1/214|0.659877336669453|1|0|0|0.934579439252336|0.388505901650191|PSMB8|6
8934|positive regulation of cell migration (GO:0030335)|1/222|0.673390864623446|1|0|0|0.900900900900901|0.356242647202641|SEMA4D|6
8935|endosomal transport (GO:0016197)|1/230|0.686372636337623|1|0|0|0.869565217391304|0.327247475720456|DTX3L|6
8936|extracellular matrix organization (GO:0030198)|1/230|0.686372636337623|1|0|0|0.869565217391304|0.327247475720456|CTSS|6
8937|proteasomal protein catabolic process (GO:0010498)|1/238|0.698843373301633|1|0|0|0.840336134453781|0.301116499484184|PSMB8|6
8938|negative regulation of apoptotic process (GO:0043066)|2/486|0.702550241170716|1|0|0|0.823045267489712|0.290566553622033|SEMA4D;IFIT3|6
8939|defense response to bacterium (GO:0042742)|1/242|0.704893359757399|1|0|0|0.826446280991736|0.289015496170822|ISG15|6
8940|regulation of ERK1 and ERK2 cascade (GO:0070372)|1/248|0.713743427929384|1|0|0|0.806451612903226|0.271961069241149|LGALS9|6
8941|inflammatory response (GO:0006954)|1/253|0.720917377393878|1|0|0|0.790513833992095|0.258680429031048|LGALS9|6
8942|antigen receptor-mediated signaling pathway (GO:0050851)|1/258|0.727913290673827|1|0|0|0.775193798449612|0.246180886896458|PSMB8|6
8943|positive regulation of programmed cell death (GO:0043068)|1/258|0.727913290673827|1|0|0|0.775193798449612|0.246180886896458|IFIT2|6
8944|regulation of programmed cell death (GO:0043067)|1/269|0.742699014212871|1|0|0|0.743494423791822|0.221163131308311|STAT1|6
8945|Golgi vesicle transport (GO:0048193)|1/272|0.746591527340346|1|0|0|0.735294117647059|0.214880191831857|CTSC|6
8946|proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161)|1/292|0.771092573236891|1|0|0|0.684931506849315|0.178045783272173|PSMB8|6
8947|positive regulation of apoptotic process (GO:0043065)|1/308|0.788992179375311|1|0|0|0.649350649350649|0.153895370296907|IFIT2|6
8948|DNA metabolic process (GO:0006259)|1/315|0.796380709656942|1|0|0|0.634920634920635|0.144557415246316|SP100|6
8949|positive regulation of transcription from RNA polymerase II promoter (GO:0045944)|3/849|0.802614177235025|1|0|0|0.706713780918728|0.155393043936388|DDX58;STAT1;IRF7|6
8950|cellular protein localization (GO:0034613)|1/328|0.809429181545872|1|0|0|0.609756097560976|0.128918288953831|RTP4|6
8951|negative regulation of cell proliferation (GO:0008285)|1/364|0.841398644336136|1|0|0|0.549450549450549|0.0948844610039742|IFIT3|6
8952|phosphorylation (GO:0016310)|1/387|0.858980507507642|1|0|0|0.516795865633075|0.0785576482326991|IKBKE|6
8953|vesicle-mediated transport (GO:0016192)|1/411|0.875270580739161|1|0|0|0.48661800486618|0.064828323745684|DTX3L|6
8954|regulation of intracellular signal transduction (GO:1902531)|1/423|0.88270236416358|1|0|0|0.472813238770686|0.0589915880036046|CMKLR1|6
8955|positive regulation of cell proliferation (GO:0008284)|1/425|0.883897636404455|1|0|0|0.470588235294118|0.0580771853985511|STAT1|6
8956|protein phosphorylation (GO:0006468)|1/471|0.908292083706798|1|0|0|0.424628450106157|0.0408447023426585|IKBKE|6
8957|regulation of cell proliferation (GO:0042127)|1/741|0.977287616208721|1|0|0|0.269905533063428|0.006200886140468|IFIT3|6
